PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	PATTERSON, SL; GROVER, LM; SCHWARTZKROIN, PA; BOTHWELL, M				PATTERSON, SL; GROVER, LM; SCHWARTZKROIN, PA; BOTHWELL, M			NEUROTROPHIN EXPRESSION IN RAT HIPPOCAMPAL SLICES - A STIMULUS PARADIGM INDUCING LTP IN CA1 EVOKES INCREASES IN BDNF AND NT-3 MESSENGER-RNAS	NEURON			English	Article							NERVE GROWTH-FACTOR; CHOLINE-ACETYLTRANSFERASE ACTIVITY; DOPAMINE-BETA-HYDROXYLASE; TYROSINE-HYDROXYLASE; SELECTIVE INDUCTION; ALZHEIMERS-DISEASE; PROTEIN-KINASE; NEURONAL DEATH; FACTOR FAMILY; NGF RECEPTOR	We report that stimulation inducing long-term potentiation (LTP) in the CA1 pyramidal cell layer of the hippocampus evokes significant increases in both BDNF and NT-3 mRNAs in CA1 neurons. No changes in BDNF or NT-3 mRNA levels were seen in the nonstimulated regions of the pyramidal cell layer or the dentate. No change was seen in the levels of NGF mRNA at the time point examined. These results suggest that relatively normal levels of activity may regulate region-specific neurotrophin levels in the hippocampus. Given that known effects of NGF (and presumably of BDNF and NT-3) include elevation of neurotransmitter levels, elevation of sodium channels, and promotion of axonal terminal sprouting, activity-associated changes in neurotrophin levels may play a role in regulating neural connections in the adult as well as the developing nervous system.	UNIV WASHINGTON,DEPT NEUROL SURG,SEATTLE,WA 98195; NE OHIO UNIV,COLL MED,DEPT NEUROBIOL,ROOTSTOWN,OH 44272	University of Washington; University of Washington Seattle; Northeast Ohio Medical University (NEOMED)	PATTERSON, SL (corresponding author), UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195, USA.				NINDS NIH HHS [NS23343, NS20482, NS15317] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015317, R01NS023343, P01NS020482] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; [Anonymous], [No title captured]; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BAIMBRIDGE KG, 1982, BRAIN RES, V239, P519, DOI 10.1016/0006-8993(82)90526-1; BAIMBRIDGE KG, 1991, SYNAPSE, V7, P269, DOI 10.1002/syn.890070404; BALLARIN M, 1991, EXP NEUROL, V114, P35, DOI 10.1016/0014-4886(91)90082-N; BAUDRY M, 1991, LONG TERM POTENTIATI; BECKMEIER LR, 1991, NEURON, V7, P857; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BUCK CR, 1987, P NATL ACAD SCI USA, V84, P3060, DOI 10.1073/pnas.84.9.3060; COUGHLIN MD, 1978, DEV BIOL, V66, P513, DOI 10.1016/0012-1606(78)90256-7; DIAMOND J, 1987, P NATL ACAD SCI USA, V84, P6596, DOI 10.1073/pnas.84.18.6596; ERNFORS P, 1989, P NATL ACAD SCI USA, V86, P4756, DOI 10.1073/pnas.86.12.4756; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; GALL C, 1990, Molecular Brain Research, V9, P113; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; HAGG T, 1990, J NEUROSCI, V10, P3087; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEFTI F, 1984, BRAIN RES, V293, P305, DOI 10.1016/0006-8993(84)91237-X; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEUER JG, 1990, DEV BIOL, V137, P287, DOI 10.1016/0012-1606(90)90255-H; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; KALMAN D, 1990, NEURON, V4, P355, DOI 10.1016/0896-6273(90)90048-K; KESSLER JA, 1980, P NATL ACAD SCI-BIOL, V77, P649, DOI 10.1073/pnas.77.1.649; KESSLER JA, 1981, BRAIN RES, V208, P135, DOI 10.1016/0006-8993(81)90626-0; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LINDEFORS N, 1992, EXP BRAIN RES, V88, P78, DOI 10.1007/BF02259130; LU B, 1991, P NATL ACAD SCI USA, V88, P6289, DOI 10.1073/pnas.88.14.6289; MOBLEY WC, 1985, SCIENCE, V229, P284, DOI 10.1126/science.2861660; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; OTTEN U, 1977, BRAIN RES, V133, P291, DOI 10.1016/0006-8993(77)90765-X; OTTEN U, 1980, NATURE, V287, P158, DOI 10.1038/287158a0; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SCHWARTZKROIN PA, 1975, BRAIN RES, V89, P107, DOI 10.1016/0006-8993(75)90138-9; SNIDER WD, 1988, J NEUROSCI, V8, P2628; THOENEN H, 1971, P NATL ACAD SCI USA, V68, P1598, DOI 10.1073/pnas.68.7.1598; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	49	469	477	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1081	1088		10.1016/0896-6273(92)90067-N	http://dx.doi.org/10.1016/0896-6273(92)90067-N			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1463608				2022-12-28	WOS:A1992KD71600007
J	CONROY, WG; VERNALLIS, AB; BERG, DK				CONROY, WG; VERNALLIS, AB; BERG, DK			THE ALPHA-5-GENE PRODUCT ASSEMBLES WITH MULTIPLE ACETYLCHOLINE-RECEPTOR SUBUNITS TO FORM DISTINCTIVE RECEPTOR SUBTYPES IN BRAIN	NEURON			English	Article							CHICK CILIARY GANGLIA; ALPHA-BUNGAROTOXIN BINDING; MONOCLONAL-ANTIBODIES; GENE FAMILY; FUNCTIONAL EXPRESSION; XENOPUS OOCYTES; MESSENGER-RNA; RAT-BRAIN; PURIFICATION; COMPONENT	The acetylcholine receptor (AChR) alpha5 gene has been classified as a member of the AChR gene family based on sequence homology. Expression studies, however, have yet to identify a function for the alpha5 gene product or even to demonstrate an interaction with known AChR subunits. We report here that the alpha5 gene product is identical to the 49 kd protein previously found on immunoblots of AChRs purified from brain and ciliary ganglia. In brain the alpha5 gene product is present both in alpha3- and in alpha4-based receptor subtypes, while in the ganglion it is found in an alpha3-based receptor subtype concentrated in postsynaptic membrane. Immunoprecipitation experiments with subunit-specific monoclonal antibodies indicate that some native AChRs are likely to have at least three kinds of subunits, with two being of the alpha type. These findings support new views about the construction of AChRs in neurons.			CONROY, WG (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.				NINDS NIH HHS [R01 NS12601, P01 NS25916] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012601, P01NS025916] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666; ANAND R, 1991, J BIOL CHEM, V266, P11192; BALLIVET M, 1988, NEURON, V1, P847, DOI 10.1016/0896-6273(88)90132-8; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BOULTER J, 1990, J BIOL CHEM, V265, P4472; BOYD RT, 1988, NEURON, V1, P495; COHEN JB, 1991, J BIOL CHEM, V266, P23354; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; HALVORSEN SW, 1990, J NEUROSCI, V10, P1711; HANKE W, 1986, NATURE, V321, P171, DOI 10.1038/321171a0; Harlow E, 1988, ANTIBODIES LAB MANUA, P139; HIGGINS LS, 1987, J NEUROSCI, V7, P1792; JACOB MH, 1984, P NATL ACAD SCI-BIOL, V81, P3223, DOI 10.1073/pnas.81.10.3223; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; MCLANE KE, 1991, BIOCHEMISTRY-US, V30, P10730, DOI 10.1021/bi00108a018; NAKAYAMA H, 1990, MOL BRAIN RES, V7, P221, DOI 10.1016/0169-328X(90)90031-8; SARGENT PB, 1989, J NEUROSCI, V9, P565; SCHOEPFER R, 1989, FEBS LETT, V257, P393, DOI 10.1016/0014-5793(89)81580-7; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; SCHOEPFER R, 1988, NEURON, V1, P241, DOI 10.1016/0896-6273(88)90145-6; SMITH MA, 1985, J NEUROSCI, V5, P2726; SWANSON LW, 1983, P NATL ACAD SCI-BIOL, V80, P4532, DOI 10.1073/pnas.80.14.4532; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TZARTOS S, 1987, J NEUROIMMUNOL, V15, P185, DOI 10.1016/0165-5728(87)90092-0; TZARTOS S, 1981, J BIOL CHEM, V250, P8635; WADA E, 1990, BRAIN RES, V526, P45, DOI 10.1016/0006-8993(90)90248-A; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952; WHITING P, 1986, J NEUROSCI, V6, P3061; WHITING P, 1987, FEBS LETT, V219, P459, DOI 10.1016/0014-5793(87)80272-7; WHITING P, 1991, MOL PHARMACOL, V40, P463; WHITING P, 1987, P NATL ACAD SCI USA, V84, P595, DOI 10.1073/pnas.84.2.595; WHITING PJ, 1991, MOL BRAIN RES, V10, P61, DOI 10.1016/0169-328X(91)90057-5; WHITING PJ, 1986, BIOCHEMISTRY-US, V25, P2082, DOI 10.1021/bi00356a037; WHITING PJ, 1988, J NEUROSCI, V8, P3395; WHITING PJ, 1987, J NEUROSCI, V7, P4005	38	186	188	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					679	691		10.1016/0896-6273(92)90031-8	http://dx.doi.org/10.1016/0896-6273(92)90031-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1389183				2022-12-28	WOS:A1992JT51600009
J	DASTON, MM; SCRABLE, H; NORDLUND, M; STURBAUM, AK; NISSEN, LM; RATNER, N				DASTON, MM; SCRABLE, H; NORDLUND, M; STURBAUM, AK; NISSEN, LM; RATNER, N			THE PROTEIN PRODUCT OF THE NEUROFIBROMATOSIS TYPE-1 GENE IS EXPRESSED AT HIGHEST ABUNDANCE IN NEURONS, SCHWANN-CELLS, AND OLIGODENDROCYTES	NEURON			English	Article							VONRECKLINGHAUSEN NEUROFIBROMATOSIS; INTERMEDIATE FILAMENTS; GROWTH-FACTOR; PC12 CELLS; RAS GENE; DIFFERENTIATION; GAP; LOCALIZATION; MITOGEN; IDENTIFICATION	von Recklinghausen's neurofibromatosis (NF1) is a common inherited human disease. The events leading to patient symptoms from inheritance of a defective NF1 gene are unknown. Since knowledge of the distribution of the normal NF1 gene product should improve understanding of the pathogenesis of the disease, we raised antibodies against peptides coded by portions of the recently cloned human NF1 cDNA. These antibodies specifically recognize a 220 kd protein (neurofibromin) in both human and rat spinal cord. Neurofibromin is most abundant in the nervous system. Immunostaining of tissue sections indicates that neurons, oligodendrocytes, and nonmyelinating Schwann cells contain neurofibromin while astrocytes and myelinating Schwann cells do not. These results suggest a function for neurofibromin in the normal nervous system. Some NF1 disease manifestations, such as Schwann cell tumors and learning disabilities, may result from abnormalities in the cells that express neurofibromin.			DASTON, MM (corresponding author), UNIV CINCINNATI, COLL MED, DEPT ANAT & CELL BIOL, CINCINNATI, OH 45267 USA.			RATNER, NANCY/0000-0001-5030-9354	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028840] Funding Source: NIH RePORTER; NINDS NIH HHS [1 RO1 NS28840] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BADER JL, 1986, ANN NY ACAD SCI, V486, P57, DOI 10.1111/j.1749-6632.1986.tb48062.x; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BUCHBERG AM, 1990, NATURE, V347, P291, DOI 10.1038/347291a0; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Davis FA, 1940, ARCH OPHTHALMOL-CHIC, V23, P957, DOI 10.1001/archopht.1940.00860131081007; Davis FA, 1940, ARCH OPHTHALMOL-CHIC, V23, P735, DOI 10.1001/archopht.1940.00860130827006; DECLUE JE, 1991, P NATL ACAD SCI USA, V88, P9914, DOI 10.1073/pnas.88.22.9914; DOWNWARD J, 1990, TRENDS BIOCHEM SCI, V15, P469, DOI 10.1016/0968-0004(90)90300-Z; DUFFNER PK, 1989, NEUROLOGY, V39, P373, DOI 10.1212/WNL.39.3.373; ELDRIDGE R, 1989, AM J DIS CHILD, V143, P833, DOI 10.1001/archpedi.1989.02150190083027; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HALL A, 1990, CELL, V61, P921, DOI 10.1016/0092-8674(90)90054-I; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; JESSEN KR, 1984, J NEUROCYTOL, V13, P923, DOI 10.1007/BF01148594; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; LAWSON SN, 1992, SENSORY NEURONES DIV, P1; LEMKE G, 1990, NATURE, V348, P201, DOI 10.1038/348201b0; LEMKE GE, 1984, J NEUROSCI, V4, P75; LEVINE SM, 1988, BRAIN RES, V444, P199, DOI 10.1016/0006-8993(88)90930-4; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MULVIHILL JJ, 1990, ANN INTERN MED, V113, P39, DOI 10.7326/0003-4819-113-1-39; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; PARYSEK LM, 1987, J NEUROSCI, V7, P781; PELTONEN J, 1988, LAB INVEST, V59, P760; Penfield W, 1924, BRAIN, V47, P430, DOI 10.1093/brain/47.4.430; PENSAK ML, 1989, LARYNGOSCOPE, V99, P702; RATNER N, 1988, P NATL ACAD SCI USA, V85, P6992, DOI 10.1073/pnas.85.18.6992; RATNER N, 1990, ANN NEUROL, V27, P298, DOI 10.1002/ana.410270312; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; SALZER JL, 1980, J CELL BIOL, V84, P767, DOI 10.1083/jcb.84.3.767; SHARP GA, 1982, EXP CELL RES, V137, P403, DOI 10.1016/0014-4827(82)90042-8; SHEELA S, 1990, J CELL BIOL, V111, P645, DOI 10.1083/jcb.111.2.645; SUGIMOTO Y, 1988, J BIOL CHEM, V263, P12102; SUGITA H, 1987, P JPN ACAD B-PHYS, V63, P107, DOI 10.2183/pjab.63.107; VARON SS, 1978, ANNU REV NEUROSCI, V1, P327, DOI 10.1146/annurev.ne.01.030178.001551; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WATANABE S, 1989, J INVEST DERMATOL, V92, P538; WILLIAMS RK, 1985, J CELL BIOL, V101, P36, DOI 10.1083/jcb.101.1.36; WOOD PM, 1975, NATURE, V256, P662, DOI 10.1038/256662a0; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	50	237	240	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1992	8	3					415	428		10.1016/0896-6273(92)90270-N	http://dx.doi.org/10.1016/0896-6273(92)90270-N			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550670				2022-12-28	WOS:A1992HK67500002
J	LLEDO, PM; HOMBURGER, V; BOCKAERT, J; VINCENT, JD				LLEDO, PM; HOMBURGER, V; BOCKAERT, J; VINCENT, JD			DIFFERENTIAL G-PROTEIN MEDIATED COUPLING OF D2 DOPAMINE-RECEPTORS TO K+ AND CA2+ CURRENTS IN RAT ANTERIOR-PITUITARY-CELLS	NEURON			English	Article							GTP-BINDING-PROTEIN; INOSITOL PHOSPHATE PRODUCTION; DEPENDENT CALCIUM CURRENTS; LACTOTROPH CELLS; ALPHA-SUBUNIT; D2-DOPAMINE RECEPTOR; PROLACTIN SECRETION; MOLECULAR-CLONING; PRIMARY CULTURES; ANGIOTENSIN-II	In anterior pituitary cells, dopamine, acting on D2 dopamine receptors, concomitantly reduces calcium currents and increases potassium currents. These dopamine effects require the presence of intracellular GTP and are blocked by pretreatment of the cells with pertussis toxin, suggesting that one or more G protein is involved. To identify the G proteins involved in coupling D2 receptors to these currents, we performed patch-clamp recordings in the whole-cell configuration using pipettes containing affinity-purified polyclonal antibodies raised against either G(o-alpha), G(i3-alpha), or G(i1,2-alpha). Dialysis with G(o-alpha) antiserum significantly reduced the inhibition of calcium currents induced by dopamine, while increase of potassium currents was markedly attenuated only by G(i3-alpha) antiserum. We therefore conclude that in pituitary cells, two different G proteins are involved in the signal transduction mechanism that links D2 receptor activation to a specific modulation of the four types of ionic channels studied here.	INSERM,U176,NEUROBIOL INTEGRAT LAB,F-33077 BORDEAUX,FRANCE; CCIPE,F-34094 MONTPELLIER 5,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)								BENJONATHAN N, 1985, ENDOCR REV, V6, P564, DOI 10.1210/edrv-6-4-564; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BRABET P, 1988, J NEUROSCI, V8, P701; BRABET P, 1990, J NEUROCHEM, V54, P1310, DOI 10.1111/j.1471-4159.1990.tb01964.x; BRABET P, 1991, J BIOL CHEM, V266, P12825; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BROWN DA, 1989, J PHYSIOL-LONDON, V415, pP20; BROWN DA, 1990, ANNU REV PHYSIOL, V52, P215; CANONICO PL, 1983, ENDOCRINOLOGY, V113, P7, DOI 10.1210/endo-113-1-7; ENJALBERT A, 1989, HORM RES, V31, P6, DOI 10.1159/000181079; ENJALBERT A, 1983, MOL PHARMACOL, V23, P576; ENJALBERT A, 1986, J BIOL CHEM, V261, P4071; ENJALBERT A, 1990, J BIOL CHEM, V265, P18816; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; EY PL, 1986, METHOD ENZYMOL, V121, P497; FOORD SM, 1983, ENDOCRINOLOGY, V112, P1567, DOI 10.1210/endo-112-5-1567; FORSCHER P, 1985, J GEN PHYSIOL, V85, P743, DOI 10.1085/jgp.85.5.743; GABRION J, 1989, CELL SIGNAL, V1, P107, DOI 10.1016/0898-6568(89)90025-9; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; GUILLEN A, 1990, EMBO J, V9, P1449, DOI 10.1002/j.1460-2075.1990.tb08261.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISWARRICK RM, 1988, NEURON, V1, P27, DOI 10.1016/0896-6273(88)90206-1; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HSU WH, 1990, J BIOL CHEM, V265, P11220; ISRAEL JM, 1987, J PHYSIOL-LONDON, V390, P1, DOI 10.1113/jphysiol.1987.sp016682; JOURNOT L, 1987, J BIOL CHEM, V262, P15106; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KUKSTAS LA, 1991, ENDOCRINOLOGY, V129, P1101, DOI 10.1210/endo-129-2-1101; LLEDO PM, 1990, BRAIN RES, V528, P143, DOI 10.1016/0006-8993(90)90207-R; LLEDO PM, 1990, ENDOCRINOLOGY, V127, P990, DOI 10.1210/endo-127-3-990; LLEDO PM, 1990, NEUROENDOCRINOLOGY, V52, P545, DOI 10.1159/000125650; LLEDO PM, 1990, J PHYSIOL-LONDON, V435, pP49; MALGAROLI A, 1987, J BIOL CHEM, V262, P13920; MCCLUE SJ, 1990, FEBS LETT, V269, P430, DOI 10.1016/0014-5793(90)81209-7; MCFADZEAN I, 1989, NEURON, V3, P177, DOI 10.1016/0896-6273(89)90030-5; MCKENZIE FR, 1988, BIOCHEM J, V249, P653, DOI 10.1042/bj2490653; MILLIGAN G, 1988, BIOCHEM J, V255, P1; NEILL JD, 1983, ENDOCRINOLOGY, V112, P1135, DOI 10.1210/endo-112-3-1135; NEVE KA, 1991, P NATL ACAD SCI USA, V88, P2802, DOI 10.1073/pnas.88.7.2802; ROUOT B, 1992, IN PRESS MOL PHARM; SENOGLES SE, 1990, J BIOL CHEM, V265, P4507; SENOGLES SE, 1987, J BIOL CHEM, V262, P4860; SIBLEY DR, 1991, TRENDS PHARMACOL SCI, V12, P7, DOI 10.1016/0165-6147(91)90480-G; SIMMONDS SH, 1985, NEUROSCI LETT, V60, P267, DOI 10.1016/0304-3940(85)90588-9; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; STACK J, 1991, J PHYSIOL-LONDON, V439, P37, DOI 10.1113/jphysiol.1991.sp018655; STRANGE PG, 1991, TRENDS NEUROSCI, V14, P43, DOI 10.1016/0166-2236(91)90017-O; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P6477, DOI 10.1073/pnas.87.17.6477; TOSELLI M, 1989, PFLUG ARCH EUR J PHY, V413, P319, DOI 10.1007/BF00583548; VALLAR L, 1989, TRENDS PHARMACOL SCI, V10, P74, DOI 10.1016/0165-6147(89)90082-5; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; YATANI A, 1987, MOL ENDOCRINOL, V1, P283, DOI 10.1210/mend-1-4-283; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0	57	199	200	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					455	463		10.1016/0896-6273(92)90273-G	http://dx.doi.org/10.1016/0896-6273(92)90273-G			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1312848				2022-12-28	WOS:A1992HK67500005
J	SUIDAN, HS; STONE, SR; HEMMINGS, BA; MONARD, D				SUIDAN, HS; STONE, SR; HEMMINGS, BA; MONARD, D			THROMBIN CAUSES NEURITE RETRACTION IN NEURONAL CELLS THROUGH ACTIVATION OF CELL-SURFACE RECEPTORS	NEURON			English	Article							PROTEIN-KINASE-C; HUMAN ALPHA-THROMBIN; BLASTOMA CELLS; GROWTH CONE; MORPHOLOGICAL-DIFFERENTIATION; CALCIUM-CONCENTRATION; SYMPATHETIC NEURONS; ENDOTHELIAL-CELLS; SERINE PROTEASES; NERVE GROWTH	The mechanism by which thrombin induces neurite retraction was studied in NB2a mouse neuroblastoma cells. The rapid effect of thrombin (completed within minutes) appears to involve an interaction between its anion-binding exosite and the thrombin receptor. Structural alterations of this site increase the EC50 for thrombin-mediated retraction, and a hirudin C-terminal peptide that blocks this site inhibits the response. The thrombin effect was mimicked by a 14 amino acid peptide starting with Ser-42, at the proposed cleavage site of the human thrombin receptor. The protein kinase inhibitors staurosporine and H-7 blocked thrombin-induced retraction. It is therefore proposed that thrombin-mediated neurite retraction is caused by cleavage-induced activation of the thrombin receptor and involves stimulation of a protein kinase(s).			SUIDAN, HS (corresponding author), FRIEDRICH MIESCHER INST, CH-4002 BASEL, SWITZERLAND.							ADAMS DJ, 1989, FASEB J, V3, P2389, DOI 10.1096/fasebj.3.12.2477294; ASHKENAZI A, 1989, CELL, V56, P487, DOI 10.1016/0092-8674(89)90251-1; ATKINSON DE, 1977, CELLULAR ENERGY META, P201; BRASS LF, 1991, J BIOL CHEM, V266, P958; BRAUN PJ, 1988, THROMB RES, V50, P273, DOI 10.1016/0049-3848(88)90228-9; CARNEY DH, 1978, J CELL PHYSIOL, V95, P13, DOI 10.1002/jcp.1040950103; CAVANAUGH KP, 1990, J NEUROCHEM, V54, P1735, DOI 10.1111/j.1471-4159.1990.tb01228.x; CHOI BH, 1990, AM J PATHOL, V137, P741; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIHANICH M, 1991, NEURON, V6, P575, DOI 10.1016/0896-6273(91)90060-D; FARMER L, 1990, DEV NEUROSCI-BASEL, V12, P73, DOI 10.1159/000111836; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FENTON JW, 1988, SEMIN THROMB HEMOST, V14, P234, DOI 10.1055/s-2007-1002783; GLOOR S, 1986, CELL, V47, P687; GRABHAM PW, 1991, EUR J NEUROSCI, V3, P663, DOI 10.1111/j.1460-9568.1991.tb00852.x; GRAND RJA, 1989, EMBO J, V8, P2209, DOI 10.1002/j.1460-2075.1989.tb08344.x; GURWITZ D, 1988, P NATL ACAD SCI USA, V85, P3440, DOI 10.1073/pnas.85.10.3440; HALLAM TJ, 1988, BIOCHEM J, V251, P243, DOI 10.1042/bj2510243; HALLAM TJ, 1988, BIOCHEM J, V255, P179, DOI 10.1042/bj2550179; HAWKINS RL, 1989, DEV BRAIN RES, V45, P203, DOI 10.1016/0165-3806(89)90039-4; HAWKINS RL, 1986, BRAIN RES, V398, P63, DOI 10.1016/0006-8993(86)91250-3; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIGGINS DL, 1983, J BIOL CHEM, V258, P9276; HOFSTEENGE J, 1988, BIOCHEMISTRY-US, V27, P2144, DOI 10.1021/bi00406a049; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; KAWAMOTO S, 1984, BIOCHEM BIOPH RES CO, V125, P258, DOI 10.1016/S0006-291X(84)80362-9; KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054; LETOURNEAU PC, 1989, CELL SHAPE DETERMINA, P247; LEWIS SD, 1987, BIOCHEMISTRY-US, V26, P7597, DOI 10.1021/bi00398a010; MCKINNEY M, 1983, MAYO CLIN PROC, V58, P829; MEANS ED, 1986, ANN NY ACAD SCI, V485, P314, DOI 10.1111/j.1749-6632.1986.tb34593.x; MEYER T, 1989, INT J CANCER, V43, P851, DOI 10.1002/ijc.2910430519; MILLS LR, 1990, NEURON, V4, P149, DOI 10.1016/0896-6273(90)90451-K; MINANA MD, 1990, P NATL ACAD SCI USA, V87, P4335, DOI 10.1073/pnas.87.11.4335; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; MONARD D, 1973, P NATL ACAD SCI USA, V70, P1894, DOI 10.1073/pnas.70.6.1894; MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8; MONARD D, 1983, PROG BRAIN RES, V58, P359, DOI 10.1016/S0079-6123(08)60037-0; MONARD D, 1990, HDB EXP PHARM, V95, P167; MURATO K, 1982, FEBS LETT, V144, P321, DOI 10.1016/0014-5793(82)80663-7; MURAYAMA T, 1987, J BIOL CHEM, V262, P5522; NELSON RB, 1990, DEV BRAIN RES, V54, P93, DOI 10.1016/0165-3806(90)90069-B; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PARIS S, 1986, EMBO J, V5, P55, DOI 10.1002/j.1460-2075.1986.tb04177.x; PATTERSON PH, 1985, J PHYSIOLOGY PARIS, V80, P207; PITTMAN RN, 1989, J NEUROSCI, V9, P4269; PULL I, 1972, BIOCHEM J, V126, P965, DOI 10.1042/bj1260965; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; RINK TJ, 1982, FEBS LETT, V148, P21, DOI 10.1016/0014-5793(82)81234-9; RINK TJ, 1990, ANNU REV PHYSIOL, V52, P431, DOI 10.1146/annurev.ph.52.030190.002243; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; SILVER RA, 1989, J NEUROSCI, V9, P4007; SLACK RS, 1990, BIOCHIM BIOPHYS ACTA, V1053, P89, DOI 10.1016/0167-4889(90)90030-H; SNIDER RM, 1986, ANN NY ACAD SCI, V485, P310, DOI 10.1111/j.1749-6632.1986.tb34592.x; SNIDER RM, 1983, SCIENCE, V221, P566, DOI 10.1126/science.6306770; SOLOMON F, 1981, J CELL BIOL, V89, P157, DOI 10.1083/jcb.89.1.157; STERN PH, 1990, J BONE MINER RES, V5, P443, DOI 10.1002/jbmr.5650050505; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; SUIDAN HS, 1991, CELL REGUL, V2, P13, DOI 10.1091/mbc.2.1.13; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TAS PWL, 1990, EXP CELL RES, V189, P22, DOI 10.1016/0014-4827(90)90251-5; TISCHLER AS, 1990, J NEUROCHEM, V55, P1159, DOI 10.1111/j.1471-4159.1990.tb03120.x; TOLKOVSKY AM, 1987, NEUROSCIENCE, V23, P1133, DOI 10.1016/0306-4522(87)90187-4; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; VASWANI KK, 1990, J NEUROCHEM, V55, P492, DOI 10.1111/j.1471-4159.1990.tb04162.x; VRBOVA G, 1988, CIBA F SYMP, V138, P131; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WAGNER SL, 1989, P NATL ACAD SCI USA, V86, P8284, DOI 10.1073/pnas.86.21.8284; WU GS, 1991, J NEUROCHEM, V56, P95, DOI 10.1111/j.1471-4159.1991.tb02567.x; ZSCHAUER A, 1988, NATURE, V334, P703, DOI 10.1038/334703a0; ZURN AD, 1988, DEV NEUROSCI-BASEL, V10, P17, DOI 10.1159/000111951	71	257	257	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1992	8	2					363	375		10.1016/0896-6273(92)90302-T	http://dx.doi.org/10.1016/0896-6273(92)90302-T			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1310864				2022-12-28	WOS:A1992HE93000016
J	KILLISCH, I; DOTTI, CG; LAURIE, DJ; LUDDENS, H; SEEBURG, PH				KILLISCH, I; DOTTI, CG; LAURIE, DJ; LUDDENS, H; SEEBURG, PH			EXPRESSION PATTERNS OF GABA-A RECEPTOR SUBTYPES IN DEVELOPING HIPPOCAMPAL-NEURONS	NEURON			English	Article							FUNCTIONAL EXPRESSION; ALPHA-SUBUNIT; A RECEPTOR; RAT-BRAIN; BENZODIAZEPINE RECEPTORS; ACETYLCHOLINE-RECEPTORS; CULTURE; COMPLEX; PROTEINS; IDENTIFICATION	Developing cultured hippocampal neurons were studied for the expression of GABA(A) receptor subunits using anti-peptide antibodies. The antibodies decorated the plasma membrane of cell bodies and all neurites in immature neurons, whereas the immunoreactivity was restricted to somata and dendrites in fully developed cells. Most receptor subunits were expressed throughout the entire culture period. However, the alpha-1 and gamma-2 subunits were detected only late in culture, while alpha-6 disappeared around this time. These findings were partly corroborated by in situ hybridization data in the developing rat hippocampus. Our results reveal a temporal control of gene expression for subsets of receptor subunits in hippocampal neurons and suggest a change in the subunit composition of GABA(A) receptors in the developing brain.	EUROPEAN MOLEC BIOL LAB,W-6900 HEIDELBERG,GERMANY	European Molecular Biology Laboratory (EMBL)	KILLISCH, I (corresponding author), UNIV HEIDELBERG,CTR MOLEC BIOL,MOLEC NEUROENDOCRINOL LAB,NEUENHEIMER FELD 282,W-6900 HEIDELBERG,GERMANY.		Dotti, Carlos G/I-5533-2015	Dotti, Carlos G/0000-0003-4052-1719; Killisch, Iris/0000-0002-5541-3430				BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BANKER GA, 1988, INTRINSIC DETERMINAN, P621; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; DUGGAN MJ, 1989, J NEUROCHEM, V53, P132, DOI 10.1111/j.1471-4159.1989.tb07304.x; EICHINGER A, 1986, J NEUROCHEM, V46, P173, DOI 10.1111/j.1471-4159.1986.tb12941.x; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FUCHS K, 1990, FEBS LETT, V261, P52, DOI 10.1016/0014-5793(90)80634-U; HOFMANN HD, 1988, J NEUROSCI, V8, P1361; JARAMILLO F, 1988, NATURE, V335, P66, DOI 10.1038/335066a0; KHRESTCHATISKY M, 1989, NEURON, V3, P745, DOI 10.1016/0896-6273(89)90243-2; KORDELI E, 1989, J CELL BIOL, V108, P127, DOI 10.1083/jcb.108.1.127; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LUDDENS H, 1991, J RECEPTOR RES, V11, P535, DOI 10.3109/10799899109066426; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MALHERBE P, 1990, FEBS LETT, V260, P261, DOI 10.1016/0014-5793(90)80118-3; MARGIOTTA JF, 1989, DEV BIOL, V135, P326, DOI 10.1016/0012-1606(89)90183-8; MEINECKE DL, 1990, DEV BRAIN RES, V55, P73, DOI 10.1016/0165-3806(90)90107-A; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; Olsen RW, 1986, BENZODIAZEPINE GABA; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Paxinos G., 1991, ATLAS DEV RAT BRAIN; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; ROTHMAN S, 1981, J COMP NEUROL, V195, P141, DOI 10.1002/cne.901950108; SATO TN, 1989, J NEUROCHEM, V52, P1114, DOI 10.1111/j.1471-4159.1989.tb01855.x; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SEEBURG PH, 1990, COLD SH Q B, V55, P29; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SMITH KE, 1988, J NEUROSCI, V8, P2406; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; VITORICA J, 1990, J NEUROCHEM, V54, P187, DOI 10.1111/j.1471-4159.1990.tb13300.x; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; WISDEN W, 1988, NEURON, V1, P937, DOI 10.1016/0896-6273(88)90151-1; WISDEN W, 1991, MOL NEUROBIOLOGY PRA, V2, P205; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x	42	115	115	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					927	936		10.1016/0896-6273(91)90338-Z	http://dx.doi.org/10.1016/0896-6273(91)90338-Z			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1662520				2022-12-28	WOS:A1991GY43800006
J	BHATTACHARYYA, A; FRANK, E; RATNER, N; BRACKENBURY, R				BHATTACHARYYA, A; FRANK, E; RATNER, N; BRACKENBURY, R			PO IS AN EARLY MARKER OF THE SCHWANN-CELL LINEAGE IN CHICKENS	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; NEURAL CREST; MONOCLONAL-ANTIBODY; PERIPHERAL-NERVE; ADHESION MOLECULE; GLIAL-CELLS; MYELIN; SURFACE; EMBRYO; TRUNK	We have generated a monoclonal antibody, termed 1E8, that is specific for myelinating and nonmyelinating Schwann cells in mature chickens. 1E8 first stains cells at the edge of the neural crest; later, cells located between the neural tube and somites and in the sclerotome are immunopositive. Double labeling with HNK-1 indicates that these 1E8-positive cells represent a subset of neural crest cells in the ventral migratory pathways. 1E8-positive cells are later associated with the dorsal and ventral roots and with extending nerve trunks. In Western blots, 1E8 reacts with proteins comigrating with P0. Immunodepletion experiments establish that all P0 molecules carry the 1E8 determinant. The developmental distribution of P0, as determined by 1E8 immunoreactivity, differs from that reported for P0 in mammals and suggests that, in chicken, P0 is an early marker for the Schwann cell lineage.	UNIV PITTSBURGH,DEPT NEUROBIOL ANAT & CELL SCI,PITTSBURGH,PA 15260	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	BHATTACHARYYA, A (corresponding author), UNIV CINCINNATI,SCH MED,DEPT ANAT & CELL BIOL,CINCINNATI,OH 45267, USA.			Brackenbury, Robert/0000-0002-1332-4018; RATNER, NANCY/0000-0001-5030-9354; Bhattacharyya, Anita/0000-0002-0360-7145	NINDS NIH HHS [NS27227, NS24373] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027227, R01NS024373] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akester A.R., 1979, P381; BARBU M, 1990, J NEUROSCI RES, V25, P143, DOI 10.1002/jnr.490250119; BARBU M, 1986, J NEUROSCI, V6, P2215; BARCLAY SL, 1986, P NATL ACAD SCI USA, V83, P4336, DOI 10.1073/pnas.83.12.4336; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; BRONNERFRASER M, 1989, NEURON, V3, P755, DOI 10.1016/0896-6273(89)90244-4; BRUNDEN KR, 1987, ANAL BIOCHEM, V164, P474, DOI 10.1016/0003-2697(87)90521-5; DULAC C, 1988, NEURON, V1, P211, DOI 10.1016/0896-6273(88)90141-9; DUPIN E, 1990, P NATL ACAD SCI USA, V87, P1119, DOI 10.1073/pnas.87.3.1119; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; FRANK E, 1991, DEVELOPMENT, V111, P895; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harrison RG, 1924, J COMP NEUROL, V37, P123, DOI 10.1002/cne.900370107; HOFFMAN S, 1982, J BIOL CHEM, V257, P7720; JESSEN KR, 1984, J NEUROCYTOL, V13, P923, DOI 10.1007/BF01148594; JESSEN KR, 1984, J NEUROCYTOL, V13, P187, DOI 10.1007/BF01148114; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; JESSEN KR, 1983, J NEUROSCI, V3, P2206; JESSEN KR, 1980, NATURE, V286, P736, DOI 10.1038/286736a0; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALLIER TE, 1988, DEV BIOL, V127, P99, DOI 10.1016/0012-1606(88)90192-3; LEMKE G, 1988, DEVELOPMENT, V102, P499; LEMMON V, 1982, DEV BRAIN RES, V3, P349, DOI 10.1016/0165-3806(82)90003-7; LORING JF, 1987, DEV BIOL, V121, P220, DOI 10.1016/0012-1606(87)90154-0; LUNN ER, 1987, DEVELOPMENT, V101, P247; MARTINI R, 1988, DEV BIOL, V129, P330, DOI 10.1016/0012-1606(88)90380-6; NOAKES PG, 1987, J COMP NEUROL, V259, P330, DOI 10.1002/cne.902590303; POLITIS MJ, 1982, J NEUROSCI, V2, P1252; Raven CP, 1937, J COMP NEUROL, V67, P221, DOI 10.1002/cne.900670205; RICKMANN M, 1985, J EMBRYOL EXP MORPH, V90, P427; SIEBERBLUM M, 1989, DEV BIOL, V134, P362, DOI 10.1016/0012-1606(89)90108-5; THIERY JP, 1982, DEV BIOL, V93, P324, DOI 10.1016/0012-1606(82)90121-X; TRAPP BD, 1981, J CELL BIOL, V90, P1, DOI 10.1083/jcb.90.1.1; TUCKER GC, 1984, CELL DIFFER DEV, V14, P223, DOI 10.1016/0045-6039(84)90049-6; UYEMURA K, 1979, J NEUROCHEM, V32, P779, DOI 10.1111/j.1471-4159.1979.tb04561.x; VINCENT M, 1983, DEV BRAIN RES, V9, P235, DOI 10.1016/0165-3806(83)90058-5; WESTON JA, 1963, DEV BIOL, V6, P279, DOI 10.1016/0012-1606(63)90016-2; WINTER J, 1982, J NEUROCYTOL, V11, P351, DOI 10.1007/BF01257982; Yntema CL, 1943, J EXP ZOOL, V94, P319, DOI 10.1002/jez.1400940303	41	90	90	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1991	7	5					831	844		10.1016/0896-6273(91)90285-8	http://dx.doi.org/10.1016/0896-6273(91)90285-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1720625				2022-12-28	WOS:A1991GT93900013
J	GORHAM, JD; ZIFF, EB; BAKER, H				GORHAM, JD; ZIFF, EB; BAKER, H			DIFFERENTIAL SPATIAL AND TEMPORAL EXPRESSION OF 2 TYPE-III INTERMEDIATE FILAMENT PROTEINS IN OLFACTORY RECEPTOR NEURONS	NEURON			English	Article							MONOCLONAL-ANTIBODIES DISTINGUISH; FIBRILLARY ACIDIC PROTEIN; NERVOUS-SYSTEM; NUCLEAR-ENVELOPE; ADULT-RATS; AVIAN ERYTHROCYTES; CONTAIN VIMENTIN; PLASMA-MEMBRANE; MOUSE EMBRYO; CALPAIN-I	Olfactory receptor neurons (ORNs) do not express the typical neuronal intermediate filament proteins (IFPs), the neurofilament triplet proteins. Immunocytochemical evidence shows that ORNs coexpress vimentin and peripherin but distribute them differently. Specifically, ORNs contain vimentin in dendrites, cell bodies, and axons, but not in terminals in glomeruli; peripherin is present in axons, but excluded from dendrites, cell bodies, and terminal glomeruli. In adult rats, ORN axon fascicles are variably stained with antisera for peripherin; in juvenile rats, staining of fascicles is uniform. Staining with antibody to vimentin is uniform in both adult and juvenile ORN axon fascicles. The unusual pattern of IFP expression and intracellular sorting may have implications for the unique plastic and regenerative capacities of these neurons.	NYU MED CTR,KAPLAN CANC CTR,NEW YORK,NY 10016; CORNELL UNIV,COLL MED,BURKE REHABIL CTR,MOLEC NEUROBIOL LAB,WHITE PLAINS,NY 10605	New York University; Cornell University	GORHAM, JD (corresponding author), NYU MED CTR,HOWARD HUGHES MED INST,DEPT BIOCHEM,NEW YORK,NY 10016, USA.			Ziff, Edward/0000-0001-7389-8649	NIGMS NIH HHS [T32 GM 07308] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERS K, 1989, J CELL BIOL, V108, P1477, DOI 10.1083/jcb.108.4.1477; ALETTA JM, 1988, J NEUROCHEM, V51, P1317, DOI 10.1111/j.1471-4159.1988.tb03104.x; ANGELIDES KJ, 1989, J CELL BIOL, V108, P1495, DOI 10.1083/jcb.108.4.1495; BAKER H, 1989, J COMP NEUROL, V285, P246, DOI 10.1002/cne.902850207; BARBER PC, 1982, NEUROSCIENCE, V7, P3077, DOI 10.1016/0306-4522(82)90231-7; BRODY BA, 1989, J NEUROSCI, V9, P2391; COCHARD P, 1984, J NEUROSCI, V4, P2080; DJABALI K, 1991, CELL, V64, P109, DOI 10.1016/0092-8674(91)90213-I; DOUCETTE R, 1990, GLIA, V3, P433, DOI 10.1002/glia.440030602; ESCURAT M, 1990, J NEUROSCI, V10, P764; FISCHER S, 1986, BIOL CHEM H-S, V367, P1147, DOI 10.1515/bchm3.1986.367.2.1147; FRANK ED, 1981, P NATL ACAD SCI-BIOL, V78, P3020, DOI 10.1073/pnas.78.5.3020; GEORGATOS SD, 1987, J CELL BIOL, V105, P117, DOI 10.1083/jcb.105.1.117; GEORGATOS SD, 1987, P NATL ACAD SCI USA, V84, P6780, DOI 10.1073/pnas.84.19.6780; GEORGATOS SD, 1987, J CELL BIOL, V105, P105, DOI 10.1083/jcb.105.1.105; GORHAM JD, 1990, DEV BRAIN RES, V57, P235, DOI 10.1016/0165-3806(90)90049-5; GRANGER BL, 1979, CELL, V18, P1053, DOI 10.1016/0092-8674(79)90218-6; Graziadei PPC, 1978, NEURONAL PLASTICITY, P131; GREENE LA, 1989, TRENDS NEUROSCI, V12, P228, DOI 10.1016/0166-2236(89)90127-6; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; HUC C, 1989, BIOCHEM BIOPH RES CO, V160, P772, DOI 10.1016/0006-291X(89)92500-X; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; JULIEN JP, 1983, J BIOL CHEM, V258, P4019; LEE VMY, 1987, J NEUROSCI, V7, P3474; LEONARD DGB, 1988, J CELL BIOL, V106, P181, DOI 10.1083/jcb.106.1.181; MARGOLIS FL, 1972, P NATL ACAD SCI USA, V69, P1221, DOI 10.1073/pnas.69.5.1221; MARGOLIS FL, 1988, MOL NEUROBIOLOGY OLF, P237; MIRAGALL F, 1988, DEV BIOL, V129, P516, DOI 10.1016/0012-1606(88)90397-1; MORRIS JR, 1982, J CELL BIOL, V92, P192, DOI 10.1083/jcb.92.1.192; OBLINGER MM, 1989, J NEUROSCI, V9, P3766; OBLINGER MM, 1989, J NEUROSCI, V9, P2645; OPHIR D, 1988, ANAT REC, V221, P754, DOI 10.1002/ar.1092210311; PARYSEK LM, 1987, J NEUROSCI, V7, P781; PARYSEK LM, 1988, NEURON, V1, P395, DOI 10.1016/0896-6273(88)90189-4; PARYSEK LM, 1988, J NEUROSCI, V8, P555; PERIDES G, 1987, EUR J CELL BIOL, V43, P450; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; POMEROY SL, 1990, J NEUROSCI, V10, P1952; QUINLAN RA, 1983, EUR J BIOCHEM, V132, P477, DOI 10.1111/j.1432-1033.1983.tb07386.x; ROOTS BI, 1983, SCIENCE, V221, P971, DOI 10.1126/science.6192501; SARRIA AJ, 1990, J CELL BIOL, V111, P553, DOI 10.1083/jcb.111.2.553; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; SCHWOB JE, 1986, J NEUROSCI, V6, P208; SHAW G, 1981, EUR J CELL BIOL, V26, P68; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; STEINERT PM, 1990, CELL, V60, P521, DOI 10.1016/0092-8674(90)90651-T; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P3692, DOI 10.1073/pnas.78.6.3692; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; TALAMO BR, 1989, NATURE, V337, P736, DOI 10.1038/337736a0; TOKUYASU KT, 1984, J CELL BIOL, V98, P1961, DOI 10.1083/jcb.98.6.1961; TROY CM, 1990, NEUROSCIENCE, V36, P217, DOI 10.1016/0306-4522(90)90364-A; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; VOLLRATH M, 1985, DIFFERENTIATION, V29, P243, DOI 10.1111/j.1432-0436.1985.tb00323.x; VOSATKA RJ, 1989, J CELL PHYSIOL, V138, P493, DOI 10.1002/jcp.1041380308; WU XR, 1990, J BIOL CHEM, V265, P19170	56	43	43	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1991	7	3					485	497		10.1016/0896-6273(91)90300-O	http://dx.doi.org/10.1016/0896-6273(91)90300-O			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1910790	Bronze			2022-12-28	WOS:A1991GG88700013
J	YANG, JSJ; SLADKY, JT; KALLEN, RG; BARCHI, RL				YANG, JSJ; SLADKY, JT; KALLEN, RG; BARCHI, RL			TTX-SENSITIVE AND TTX-INSENSITIVE SODIUM-CHANNEL MESSENGER-RNA TRANSCRIPTS ARE INDEPENDENTLY REGULATED IN ADULT SKELETAL-MUSCLE AFTER DENERVATION	NEURON			English	Article							CELLS DEVELOPING INVITRO; ACETYLCHOLINE-RECEPTORS; RAT MUSCLE; NEUROMUSCULAR-JUNCTIONS; TETRODOTOXIN; EXPRESSION; BINDING; TOXIN; INNERVATION; MEMBRANE	The expression of mRNA encoding the TTX-sensitive (SkM1) and TTX-insensitive (SkM2) voltage-dependent sodium channels in adult skeletal muscle is independently regulated. In normal skeletal muscle, only the SkM1 message is expressed and the level varies with muscle fiber type. After surgical denervation, the steady-state SkM1 mRNA level declines transiently, but returns to control levels within 5 days. Expression of SkM2 transcripts is markedly activated, reaching a peak 3 days after axotomy and then declining to a maintained level at approximately 30% of peak. Chemical denervation with botulinum toxin results in higher levels of SkM2 mRNA, which by 7 days posttreatment are 7-fold greater than levels in paired axotomized muscles. SkM2 expression subsequently declines as functional reinnervation appears. Quantal acetylcholine release appears to play a major role in suppression of SkM2 expression in adult innervated or reinnervated muscle, whereas nonquantal factors in toxin-treated, but not axotomized, muscle may sustain high level SkM2 mRNA expression.			YANG, JSJ (corresponding author), UNIV PENN, SCH MED, MAHONEY INST NEUROL SCI, PHILADELPHIA, PA 19104 USA.				NINDS NIH HHS [NS-18013] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018013] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBUQUERQUE EX, 1971, PFLUG ARCH EUR J PHY, V328, P36, DOI 10.1007/BF00587359; ANGAUTPETIT D, 1990, NEUROSCIENCE, V37, P799, DOI 10.1016/0306-4522(90)90109-H; AUSONI S, 1990, J NEUROSCI, V10, P153; BAMBRICK L, 1987, J PHYSIOL-LONDON, V382, P69, DOI 10.1113/jphysiol.1987.sp016356; BAMBRICK LL, 1988, J PHYSIOL-LONDON, V407, P263, DOI 10.1113/jphysiol.1988.sp017414; BARCHI RL, 1979, J PHYSIOL-LONDON, V295, P383, DOI 10.1113/jphysiol.1979.sp012975; BARCHI RL, 1988, ANNU REV NEUROSCI, V11, P455, DOI 10.1146/annurev.ne.11.030188.002323; BRENNER HR, 1989, J PHYSIOL-LONDON, V410, P501, DOI 10.1113/jphysiol.1989.sp017546; BRENNER HR, 1987, J PHYSIOL-LONDON, V388, P367, DOI 10.1113/jphysiol.1987.sp016619; BRODIE C, 1989, ENDOCRINOLOGY, V125, P842, DOI 10.1210/endo-125-2-842; BROWN MC, 1978, NATURE, V275, P652, DOI 10.1038/275652a0; BUCKINGHAM ME, 1989, BRIT MED BULL, V45, P608, DOI 10.1093/oxfordjournals.bmb.a072348; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; BURGEN ASV, 1949, J PHYSIOL-LONDON, V109, P10, DOI 10.1113/jphysiol.1949.sp004364; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHANGEUX JP, 1989, PROG BRAIN RES, V79, P15; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; DUCHEN LW, 1968, Q J EXP PHYSIOL CMS, V53, P84, DOI 10.1113/expphysiol.1968.sp001948; EMMELIN N, 1965, Q J EXP PHYSIOL CMS, V50, P142, DOI 10.1113/expphysiol.1965.sp001776; FRELIN C, 1983, J BIOL CHEM, V258, P7256; FUMAGALLI G, 1990, NEURON, V4, P563, DOI 10.1016/0896-6273(90)90114-U; GELLENS ME, 1991, IN PRESS BIOPHYS J; GONOI T, 1987, J NEUROSCI, V7, P1728; GRAMPP W, 1972, J PHYSIOL-LONDON, V221, P743, DOI 10.1113/jphysiol.1972.sp009780; GRUENER R, 1976, J NEUROBIOL, V7, P513, DOI 10.1002/neu.480070605; HAN JH, 1987, BIOCHEMISTRY-US, V26, P1617, DOI 10.1021/bi00380a020; HARRIS JB, 1972, NATURE-NEW BIOL, V236, P60, DOI 10.1038/newbio236060a0; HITE MM, 1991, MOL PHARMACOL, V39, P604; JOLESZ F, 1981, ANNU REV PHYSIOL, V43, P531, DOI 10.1146/annurev.ph.43.030181.002531; JOSEFSSON J, 1961, ACTA PHYSIOL SCAND, V51, P163, DOI 10.1111/j.1748-1716.1961.tb02124.x; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; LOMO T, 1974, PROC R SOC SER B-BIO, V187, P99, DOI 10.1098/rspb.1974.0064; LUCO JV, 1955, J NEUROPHYSIOL, V18, P65, DOI 10.1152/jn.1955.18.1.65; MATHERS DA, 1978, J PHYSIOL-LONDON, V282, P105, DOI 10.1113/jphysiol.1978.sp012451; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; OFFORD J, 1989, NEURON, V2, P1447, DOI 10.1016/0896-6273(89)90190-6; PAPPONE PA, 1980, J PHYSIOL-LONDON, V306, P377, DOI 10.1113/jphysiol.1980.sp013403; PESTRONK A, 1978, SCIENCE, V199, P1223, DOI 10.1126/science.204007; Purves, 1985, PRINCIPLES NEURAL DE; REDFERN P, 1971, ACTA PHYSIOL SCAND, V82, P70, DOI 10.1111/j.1748-1716.1971.tb04943.x; RITCHIE JM, 1977, REV PHYSIOL BIOCH P, V79, P1, DOI 10.1007/BFb0037088; ROGART RB, 1983, P NATL ACAD SCI-BIOL, V80, P1106, DOI 10.1073/pnas.80.4.1106; ROGART RB, 1985, BRAIN RES, V329, P314, DOI 10.1016/0006-8993(85)90541-4; SALPETER M, 1987, VERTEBRATE NEUROMUSC; SCHUETZE SM, 1987, ANNU REV NEUROSCI, V10, P403, DOI 10.1146/annurev.ne.10.030187.002155; SHERMAN SJ, 1983, J BIOL CHEM, V258, P2488; SHERMAN SJ, 1982, J GEN PHYSIOL, V80, P753, DOI 10.1085/jgp.80.5.753; Simpson L.L., 1989, BOTULINUM NEUROTOXIN; THESLEFF S, 1989, Q J EXP PHYSIOL CMS, V74, P1003, DOI 10.1113/expphysiol.1989.sp003329; Tower SS, 1939, PHYSIOL REV, V19, P1; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; WEISS RE, 1986, SCIENCE, V233, P361, DOI 10.1126/science.2425432; WITZEMANN V, 1987, FEBS LETT, V223, P104, DOI 10.1016/0014-5793(87)80518-5	53	80	81	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1991	7	3					421	427		10.1016/0896-6273(91)90294-A	http://dx.doi.org/10.1016/0896-6273(91)90294-A			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1654949	Bronze			2022-12-28	WOS:A1991GG88700007
J	FISHER, LJ; JINNAH, HA; KALE, LC; HIGGINS, GA; GAGE, FH				FISHER, LJ; JINNAH, HA; KALE, LC; HIGGINS, GA; GAGE, FH			SURVIVAL AND FUNCTION OF INTRASTRIATALLY GRAFTED PRIMARY FIBROBLASTS GENETICALLY MODIFIED TO PRODUCE L-DOPA	NEURON			English	Article							SUBSTANTIA NIGRA; MODIFIED CELLS; BRAIN GRAFTS; RAT STRIATUM; RETROVIRUS; DISEASE; GENE; EXPRESSION; LEVODOPA; SYSTEM	A combination of gene transfer and intracerebral grafting may provide a powerful technique for examining the role of discrete substances in the development or functioning of the brain. In the present study, primary fibroblasts obtained from a skin biopsy from inbred Fischer rats were used as donor cells for genetic modification and grafting. When grafted to the striatum of Fischer rats with a prior 6-hydroxydopamine lesion, primary fibroblasts containing a transgene for either tyrosine hydroxylase (TH) or beta-galactosidase survived for 10 weeks and continued to express the transgene. TH synthesized by the implanted fibroblasts appeared to convert tyrosine to L-dopa actively, as observed in vitro, and to affect the host brain, as assessed through a behavioral measurement. These results suggest that primary fibroblasts genetically altered to express TH have the capacity to deliver L-dopa locally to the striatum in quantities sufficient to compensate partially for the loss of intrinsic striatal dopaminergic input.	NATL INST AGING,GERONTOL RES CTR,BIOL CHEM LAB,BALTIMORE,MD 21224	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	FISHER, LJ (corresponding author), UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093, USA.			Higgins, Gerry/0000-0002-0434-1465	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR004754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008514, R37AG008514] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR 04754-01] Funding Source: Medline; NIA NIH HHS [AG08514] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEVAN P, 1983, NEUROSCI LETT, V35, P185, DOI 10.1016/0304-3940(83)90548-7; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; Bjorklund A., 1985, NEURAL GRAFTING MAMM; CASTRO R, 1985, PSYCHOPHARMACOLOGY, V85, P333, DOI 10.1007/BF00428198; DAWSON TM, 1991, IN PRESS EXP NEUROL; DEAN M, 1986, J BIOL CHEM, V261, P9161; FREED WJ, 1989, BEHAV BRAIN RES, V32, P279, DOI 10.1016/S0166-4328(89)80060-9; FREED WJ, 1980, ANN NEUROL, V8, P510, DOI 10.1002/ana.410080508; FREED WJ, 1983, SCIENCE, V222, P937, DOI 10.1126/science.6635666; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; FUJITA H, 1989, BIOMED RES-TOKYO, V10, P527; GAGE FH, 1987, NEUROSCIENCE, V23, P795, DOI 10.1016/0306-4522(87)90159-X; GAGE FH, 1991, NEURON, V6, P1, DOI 10.1016/0896-6273(91)90116-H; HIGGINS GA, 1988, P NATL ACAD SCI USA, V85, P1297, DOI 10.1073/pnas.85.4.1297; HORELLOU P, 1990, NEURON, V5, P393, DOI 10.1016/0896-6273(90)90078-T; HORELLOU P, 1990, EUR J NEUROSCI, V2, P116, DOI 10.1111/j.1460-9568.1990.tb00389.x; IUVONE PM, 1984, J NEUROCHEM, V43, P1359, DOI 10.1111/j.1471-4159.1984.tb05395.x; LANGLAIS PJ, 1986, MONITORING NEUROTRAN, P224; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MARSDEN CD, 1976, LANCET, V1, P292, DOI 10.1016/S0140-6736(76)91416-1; MATSON WR, 1984, CLIN CHEM, V30, P1477; MATSON WR, 1987, LIFE SCI, V41, P905, DOI 10.1016/0024-3205(87)90192-5; Melamed E, 1984, Adv Neurol, V40, P149; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; NUTT JG, 1984, NEW ENGL J MED, V310, P483, DOI 10.1056/NEJM198402233100802; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; QUINN N, 1984, NEUROLOGY, V34, P1131, DOI 10.1212/WNL.34.9.1131; RAO GN, 1988, EXP CELL RES, V178, P449, DOI 10.1016/0014-4827(88)90413-2; SHIMOHAMA S, 1989, MOL BRAIN RES, V5, P271, DOI 10.1016/0169-328X(89)90061-2; Sly W S, 1979, Methods Enzymol, V58, P444; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P49; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; WOLFF JA, 1989, P NATL ACAD SCI USA, V86, P9011, DOI 10.1073/pnas.86.22.9011; XU L, 1989, VIROLOGY, V171, P331, DOI 10.1016/0042-6822(89)90600-4	37	211	222	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					371	380		10.1016/0896-6273(91)90246-V	http://dx.doi.org/10.1016/0896-6273(91)90246-V			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1672072				2022-12-28	WOS:A1991FC47000006
J	DRAIN, P; FOLKERS, E; QUINN, WG				DRAIN, P; FOLKERS, E; QUINN, WG			CAMP-DEPENDENT PROTEIN-KINASE AND THE DISRUPTION OF LEARNING IN TRANSGENIC FLIES	NEURON			English	Article							AMINO-ACID SEQUENCE; DROSOPHILA-MELANOGASTER; BEHAVIORAL SENSITIZATION; PRESYNAPTIC FACILITATION; CATALYTIC SUBUNIT; SENSORY NEURONS; EXPRESSION; INHIBITOR; APLYSIA; GENE	A molecular genetic approach was used to test for a role of cAMP-dependent protein kinase (PKA) in learning and memory in Drosophila. We used genes encoding a peptide inhibitor of PKA, an N-terminal regulatory subunit fragment containing a pseudosubstrate inhibitory domain, and a wild-type catalytic subunit. These dominantly acting genes were placed under control of the hsp70 promoter and transformed into wild-type flies. Induction of the transgenes by 1 hr heat shock results in overproduction of their RNA in adult flies. The same heat shock treatment disrupts the ability of the flies to learn in an odor discrimination task reinforced with electric shock. The results demonstrate the involvement of PKA in the associative learning of Drosophila.	MIT,DEPT BRAIN & COGNIT SCI,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)								ACEVESPINA EO, 1983, COLD SPRING HARB SYM, V48, P831, DOI 10.1101/SQB.1983.048.01.086; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; BASLER K, 1989, EMBO J, V8, P2381, DOI 10.1002/j.1460-2075.1989.tb08367.x; BELLEN HJ, 1987, DEV BIOL, V121, P432, DOI 10.1016/0012-1606(87)90180-1; BERNIER L, 1982, J NEUROSCI, V2, P1682; BOWTELL DDL, 1989, CELL, V56, P931, DOI 10.1016/0092-8674(89)90626-0; BUXBAUM JD, 1988, ANAL BIOCHEM, V169, P209, DOI 10.1016/0003-2697(88)90276-X; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CASTELLUCCI V, 1976, SCIENCE, V194, P1176, DOI 10.1126/science.11560; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CHEN CN, 1986, P NATL ACAD SCI USA, V83, P9313, DOI 10.1073/pnas.83.24.9313; CLINE TW, 1978, GENETICS, V90, P683; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; DUDAI Y, 1977, J COMP PHYSIOL, V114, P69, DOI 10.1007/BF00656809; DUDAI Y, 1988, ANNU REV NEUROSCI, V11, P537, DOI 10.1146/annurev.ne.11.030188.002541; DUGUID JR, 1988, P NATL ACAD SCI USA, V85, P5738, DOI 10.1073/pnas.85.15.5738; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FEANY MB, 1990, P NATL ACAD SCI USA, V87, P2795, DOI 10.1073/pnas.87.7.2795; FOSTER JL, 1984, J BIOL CHEM, V259, P3049; FOSTER JL, 1988, J BIOL CHEM, V263, P1676; Gill G N, 1979, Adv Cyclic Nucleotide Res, V10, P93; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; GROVE JR, 1989, J BIOL CHEM, V264, P19506; GROVE JR, 1987, SCIENCE, V238, P530; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARDIE G, 1988, NATURE, V335, P592, DOI 10.1038/335592a0; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HIXSON CS, 1980, J BIOL CHEM, V255, P2137; HOVEMANN B, 1988, NUCLEIC ACIDS RES, V16, P3175, DOI 10.1093/nar/16.8.3175; KALDERON D, 1988, GENE DEV, V2, P1539, DOI 10.1101/gad.2.12a.1539; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KLEIN M, 1980, P NATL ACAD SCI-BIOL, V77, P6912, DOI 10.1073/pnas.77.11.6912; KNIPPLE DC, 1988, NUCLEIC ACIDS RES, V16, P7748, DOI 10.1093/nar/16.15.7748; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; KUO JF, 1969, P NATL ACAD SCI USA, V64, P1349, DOI 10.1073/pnas.64.4.1349; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKI FA, 1986, CELL, V44, P7, DOI 10.1016/0092-8674(86)90480-0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEVITAN IB, 1988, ANNU REV NEUROSCI, V11, P119, DOI 10.1146/annurev.neuro.11.1.119; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MCKNIGHT GS, 1988, COLD SPRING HARB SYM, V53, P111, DOI 10.1101/SQB.1988.053.01.017; MENNE D, 1977, J COMP PHYSIOL, V114, P301, DOI 10.1007/BF00657325; MISMER D, 1987, GENETICS, V116, P565; MULLER U, 1989, J NEUROGENET, V6, P95, DOI 10.3109/01677068909107104; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; POTTER RL, 1980, J BIOL CHEM, V255, P9706; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; QUINN WG, 1984, BIOL LEARNING, P197; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCOTT JD, 1985, P NATL ACAD SCI USA, V82, P4379, DOI 10.1073/pnas.82.13.4379; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; SCOTT JD, 1985, P NATL ACAD SCI USA, V82, P5732, DOI 10.1073/pnas.82.17.5732; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; TAYLOR SS, 1988, COLD SPRING HARB SYM, V53, P121, DOI 10.1101/SQB.1988.053.01.018; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; TULLY T, 1987, TRENDS NEUROSCI, V10, P330, DOI 10.1016/0166-2236(87)90090-7; WALSH DA, 1971, J BIOL CHEM, V246, P1977; ZIMARINO V, 1990, MOL CELL BIOL, V10, P752, DOI 10.1128/MCB.10.2.752	62	156	162	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1991	6	1					71	82		10.1016/0896-6273(91)90123-H	http://dx.doi.org/10.1016/0896-6273(91)90123-H			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1702651				2022-12-28	WOS:A1991EU27800008
J	GIAUME, C; FROMAGET, C; ELAOUMARI, A; CORDIER, J; GLOWINSKI, J; GROS, D				GIAUME, C; FROMAGET, C; ELAOUMARI, A; CORDIER, J; GLOWINSKI, J; GROS, D			GAP-JUNCTIONS IN CULTURED ASTROCYTES - SINGLE-CHANNEL CURRENTS AND CHARACTERIZATION OF CHANNEL-FORMING PROTEIN	NEURON			English	Article							RAT OPTIC-NERVE; LIVER; CELLS; HEART; CONDUCTANCE; POLYPEPTIDE; TISSUES; MICROINJECTION; COMMUNICATION; ANTIBODIES	Currents from gap junction channels were recorded from pairs of astrocytes in primary culture using the double whole-cell recording technique. In weakly coupled pairs, single-channel events could be resolved without pharmacological uncoupling treatment. Under these conditions, unitary conductance was 56 +/- 7 pS, and except for multiples of this value, no other level of conductance was observed consistently. To characterize the type of junctional protein constituting astrocyte gap junction channels, immunological and biochemical experiments were carried out on the same material. Specific cDNA probes for three connexins identified in mammals (Cx26, Cx32, and Cx43) showed that only Cx43 mRNA was expressed in cultured astrocytes. The presence of Cx43 protein in cultured astrocytes was demonstrated by immunoblotting, immunofluorescence, and immunogold labeling using anti-peptide antibodies specific to Cx43. These results strongly suggest that gap junctions in astrocytes have a 50-60 pS unitary conductance associated with channels composed of Cx43 protein.	FAC SCI LUMINY, CNRS, UA 179, BIOL DIFFERENCIAT CELLULAIRE LAB, F-13288 MARSEILLE 9, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	GIAUME, C (corresponding author), COLL FRANCE, CHAIRE NEUROPHARMACOL, INSERM, U114, 11 PL MARCELIN BERTHELOT, F-75231 PARIS 05, FRANCE.							ANDERS JJ, 1988, GLIA, V1, P371, DOI 10.1002/glia.440010604; Bennett M., 1977, HDB PHYSL          1, P357; BEYER EC, 1989, J CELL BIOL, V108, P595, DOI 10.1083/jcb.108.2.595; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; BURT JM, 1988, AM J PHYSIOL, V254, pH1206, DOI 10.1152/ajpheart.1988.254.6.H1206; BURT JM, 1988, P NATL ACAD SCI USA, V85, P3431, DOI 10.1073/pnas.85.10.3431; CHOCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156; CHOW I, 1987, DEV BIOL, V122, P332, DOI 10.1016/0012-1606(87)90298-3; CONNORS BW, 1984, J NEUROSCI, V4, P1324; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; De Mello WC, 1988, GAP JUNCTIONS, P245; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; DEVON RM, 1988, GLIA, V1, P151, DOI 10.1002/glia.440010207; DUDEK FE, 1988, BRAIN RES, V439, P275; DUPONT E, 1988, J MEMBRANE BIOL, V104, P119, DOI 10.1007/BF01870924; EGHBALI B, 1990, P NATL ACAD SCI USA, V87, P1328, DOI 10.1073/pnas.87.4.1328; ELAOUMARI A, 1990, J MEMBRANE BIOL, V115, P229; ELETR M, 1989, J NEUROSCI, V9, P1473; Federoff S, 1986, ASTROCYTES DEV MORPH, P329, DOI [10.1016/B978-0-12-250451-8.50018-7, DOI 10.1016/B978-0-12-250451-8.50018-7]; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISHER G, 1985, EXP CELL RES, V159, P273; FISHMAN GI, 1990, J CELL BIOL, V111, P589, DOI 10.1083/jcb.111.2.589; FROMAGET C, 1990, IN PRESS J MOL CELL; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P393, DOI 10.1113/jphysiol.1983.sp014541; GIAUME C, 1990, IN PRESS BIOPHYSICS; HERTZBERG EL, 1985, P NATL ACAD SCI USA, V82, P2412, DOI 10.1073/pnas.82.8.2412; HERTZBERG EL, 1984, CELL, V39, P61, DOI 10.1016/0092-8674(84)90191-0; Jaslove S.W., 1987, P103; KETTENMANN H, 1988, GLIA, V1, P64, DOI 10.1002/glia.440010108; KETTENMANN H, 1983, J NEUROSCI, V3, P506; KISTLER J, 1988, NATURE, V331, P721, DOI 10.1038/331721a0; KUMAR NM, 1986, J CELL BIOL, V103, P767, DOI 10.1083/jcb.103.3.767; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACMAHON DG, 1989, P NATL ACAD SCI USA, V86, P7639; MASSA PT, 1985, NEUROSCIENCE, V14, P695, DOI 10.1016/0306-4522(85)90320-3; MILLER RH, 1984, J NEUROSCI, V4, P585; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; NAUS CCG, 1990, NEUROSCI LETT, V111, P297, DOI 10.1016/0304-3940(90)90278-H; NEYTON J, 1985, NATURE, V317, P331, DOI 10.1038/317331a0; NICHOLSON BJ, 1988, GAP JUNCTIONS MODERN, V7, P41; NOWAK L, 1987, J NEUROSCI, V7, P101; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; PAUL DL, 1986, J CELL BIOL, V103, P123, DOI 10.1083/jcb.103.1.123; PICCOLINO M, 1984, J NEUROSCI, V4, P2477; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; ROOK MB, 1988, AM J PHYSIOL, V255, pH770, DOI 10.1152/ajpheart.1988.255.4.H770; ROTH J, 1981, J HISTOCHEM CYTOCHEM, V29, P663, DOI 10.1177/29.5.6166664; SAEZ JC, 1986, P NATL ACAD SCI USA, V83, P2473, DOI 10.1073/pnas.83.8.2473; SHIOSAKA S, 1989, J COMP NEUROL, V281, P282, DOI 10.1002/cne.902810210; SOMOGYI R, 1988, PFLUG ARCH EUR J PHY, V412, P54, DOI 10.1007/BF00583731; Sotelo C, 1978, Int Rev Cytol, V55, P67; TARDY M, 1990, DIFFERENTIATION FUNC, V55, P47; TRAUB O, 1989, J CELL BIOL, V108, P1039, DOI 10.1083/jcb.108.3.1039; VEENSTRA RD, 1986, SCIENCE, V233, P972, DOI 10.1126/science.2426781; WILKIN GP, 1990, TRENDS NEUROSCI, V13, P43, DOI 10.1016/0166-2236(90)90065-I; WILLECKE K, 1990, PARALLELS CELL CELL, P21; YAMAMOTO T, 1990, BRAIN RES, V508, P313, DOI 10.1016/0006-8993(90)90415-8; YANCEY SB, 1989, J CELL BIOL, V108, P2241, DOI 10.1083/jcb.108.6.2241; ZHANG JT, 1989, J CELL BIOL, V109, P3391, DOI 10.1083/jcb.109.6.3391	62	306	309	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1991	6	1					133	143		10.1016/0896-6273(91)90128-M	http://dx.doi.org/10.1016/0896-6273(91)90128-M			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1702648				2022-12-28	WOS:A1991EU27800013
J	MALENKA, RC				MALENKA, RC			POSTSYNAPTIC FACTORS CONTROL THE DURATION OF SYNAPTIC ENHANCEMENT IN AREA CA1 OF THE HIPPOCAMPUS	NEURON			English	Article							LONG-TERM POTENTIATION; METHYL-D-ASPARTATE; PROTEIN KINASE-C; RAT HIPPOCAMPUS; FASCIA DENTATA; TRANSMISSION; INDUCTION; MECHANISMS; CALCIUM; NEURONS	In area CA1 of the hippocampus, at least two phases of long-term potentiation (LTP) can be isolated: an early decremental component referred to as short-term potentiation (STP), which precedes a long-lasting, nondecremental component commonly considered to be stable LTP. Utilizing the hippocampal slice preparation, experiments were performed to determine the physiological factor controlling the conversion of STP to LTP. The duration of NMDA receptor-dependent synaptic enhancement was influenced by several factors, including the degree of postsynaptic NMDA receptor activation and the magnitude and timing of postsynaptic membrane depolarization during synaptic transmission. It was possible to convert STP to LTP by manipulations that increased the influx of calcium into the postsynaptic cell. These results demonstrate that NMDA receptor activation can result in distinct forms of synaptic potentiation and imply that the magnitude of postsynaptic calcium increase is a critical variable controlling the duration of synaptic enhancement.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	MALENKA, RC (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH045334] Funding Source: NIH RePORTER; NIMH NIH HHS [MH45334] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANWYL R, 1989, BRAIN RES, V503, P148, DOI 10.1016/0006-8993(89)91716-2; ASZTELY F, 1990, BRAIN RES, V521, P355, DOI 10.1016/0006-8993(90)91567-Z; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V399, P301; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; GAMBLE E, 1987, SCIENCE, V236, P1311, DOI 10.1126/science.3495885; GUSTAFSSON B, 1988, TRENDS NEUROSCI, V11, P156, DOI 10.1016/0166-2236(88)90142-7; GUSTAFSSON B, 1989, EUR J NEUROSCI, V1, P382, DOI 10.1111/j.1460-9568.1989.tb00803.x; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; GUSTAFSSON B, 1986, J NEUROSCI, V6, P1575; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; KANDEL ER, 1987, MOL NEUROBIOLOGY NEU, P111; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; KELSO SR, 1986, SCIENCE, V232, P85, DOI 10.1126/science.3952501; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5236; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LINDEN DJ, 1989, BRAIN RES REV, V14, P279, DOI 10.1016/0165-0173(89)90004-0; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYER ML, 1987, J NEUROSCI, V7, P3230; MCDONALD JF, 1989, J PHYSL, V414, P17; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; MCNAUGHTON BL, 1982, J PHYSIOL-LONDON, V324, P249, DOI 10.1113/jphysiol.1982.sp014110; MULLER D, 1990, P NATL ACAD SCI USA, V87, P4073, DOI 10.1073/pnas.87.11.4073; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; PERKEL DJ, 1991, LONG TERM POTENTIATI; RACINE RJ, 1983, BRAIN RES, V260, P201, DOI 10.1016/0006-8993(83)90675-3; REYMANN KG, 1988, BRAIN RES, V440, P305, DOI 10.1016/0006-8993(88)91000-1; REYMANN KG, 1990, EUR J NEUROSCI, V2, P481, DOI 10.1111/j.1460-9568.1990.tb00439.x; SASTRY BR, 1986, SCIENCE, V232, P988, DOI 10.1126/science.3010459; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; THIBAULT O, 1989, BRAIN RES, V476, P170, DOI 10.1016/0006-8993(89)91553-9; VONDERMALSBURG C, 1986, BIOL CYBERN, V54, P29, DOI 10.1007/BF00337113; ZADOR A, 1990, P NATL ACAD SCI USA, V87, P6718, DOI 10.1073/pnas.87.17.6718; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	40	258	260	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1991	6	1					53	60		10.1016/0896-6273(91)90121-F	http://dx.doi.org/10.1016/0896-6273(91)90121-F			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1670922				2022-12-28	WOS:A1991EU27800006
J	LIAO, D; JONES, A; MALINOW, R				LIAO, D; JONES, A; MALINOW, R			DIRECT MEASUREMENT OF QUANTAL CHANGES UNDERLYING LONG-TERM POTENTIATION IN CA1 HIPPOCAMPUS	NEURON			English	Article							SYNAPTIC TRANSMISSION; NEURONS	The modification responsible for the long-term synaptic potentiation (LTP) that follows a brief conditioning period is not known. To elucidate this change, we have resolved quantal levels of transmission before and after induction of LTP. We find an increase both in the number of quanta released and in quantal amplitude, consistent with combined pre- and postsynaptic modifications. On average, about 60% of LTP can be accounted for by presynaptic enhancement. The increase in either quantal amplitude or quantal content varies significantly among different experiments, but is inversely correlated with its initial value. These results may help to reconcile the different views concerning the site of LTP expression.	REED COLL, DEPT MATH, PORTLAND, OR 97202 USA	Reed College - Oregon	LIAO, D (corresponding author), UNIV IOWA, DEPT PHYSIOL & BIOPHYS, IOWA CITY, IA 52242 USA.							BEKKERS J, 1972, NATURE, P346; BLISS T, 1988, LONG TERM POTENTIATI; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; CLEMENTS J, 1991, NATURE, V353, P396, DOI 10.1038/353396a0; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DOLPHIN AC, 1982, NATURE, V297, P496, DOI 10.1038/297496a0; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; Foster T C, 1991, Hippocampus, V1, P79, DOI 10.1002/hipo.450010108; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KORN H, 1987, NATURE, V357, P240; KUNO M, 1971, PHYSIOL REV, V51, P647, DOI 10.1152/physrev.1971.51.4.647; LARKMAN A, 1991, NATURE, V350, P344, DOI 10.1038/350344a0; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MULLER D, 1988, P NATL ACAD SCI USA, V85, P6997, DOI 10.1073/pnas.85.18.6997; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; SILVERMAN V, 1986, DENSITY ESTIMATE STA; TITTERINGTON DM, 1985, STATISTICAL ANAL FIN; VORONIN L, 1987, NEUROSCIENCE S, V22, P41; WALMSLEY B, 1987, J NEUROSCI, V7, P1037	30	173	174	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1992	9	6					1089	1097		10.1016/0896-6273(92)90068-O	http://dx.doi.org/10.1016/0896-6273(92)90068-O			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1334418				2022-12-28	WOS:A1992KD71600008
J	FEDDERSEN, RM; EHLENFELDT, R; YUNIS, WS; CLARK, HB; ORR, HT				FEDDERSEN, RM; EHLENFELDT, R; YUNIS, WS; CLARK, HB; ORR, HT			DISRUPTED CEREBELLAR CORTICAL DEVELOPMENT AND PROGRESSIVE DEGENERATION OF PURKINJE-CELLS IN SV40-T ANTIGEN TRANSGENIC MICE	NEURON			English	Article							LARGE-T-ANTIGEN; NEURONS; EXPRESSION; MOUSE; GENE; PROTEIN; BINDING; COMPLEX; BRAIN; CDNA	SV40 T antigen (Tag) expression directed to cerebellar Purkinje cells resulted in the generation of three transgenic mouse lines that displayed ataxia, a neurological phenotype characteristic of cerebellar dysfunction. Onset of symptoms and cerebellar pathology, characterized by specific Purkinje cell degeneration, appeared to be directly dependent upon transgene copy number. The SV5 line (containing >30 transgene copies), exhibited embryonic transgene expression that caused selective death of immature Purkinje cells and a subsequent block in cerebellar development and ataxia at 2 weeks. The developmental effect of the disruption of Purkinje cells in SV5 mice suggests that a normal complement of these cells is required for early development of the cerebellar cortex, especially granule cell proliferation and migration from external to internal layers. Transgene expression in a second line, SV4 (10 copies), was detectable during the second postnatal week. Death of mature Purkinje cells in the SV4 line resulted in onset of ataxia at 9 weeks. Ataxia in a third line, SV6 (2 copies), was detected after 15 weeks. The distinct cerebellar phenotypes of the SV4-6 lines correlate with specific Tag-induced Purkinje cell ablation as opposed to tumorigenesis.	UNIV MINNESOTA, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	FEDDERSEN, RM (corresponding author), UNIV MINNESOTA, INST HUMAN GENET, MINNEAPOLIS, MN 55455 USA.			Orr, Harry/0000-0001-6118-741X				BAETGE EE, 1988, P NATL ACAD SCI USA, V85, P3648, DOI 10.1073/pnas.85.10.3648; BAETSCHER M, 1991, ONCOGENE, V6, P1133; BANARA LR, 1991, NATURE, V351, P494; BIRD ED, 1980, ANNU REV PHARMACOL, V20, P533, DOI 10.1146/annurev.pa.20.040180.002533; Brun A., 1983, ALZHEIMERS DISEASE S, P37; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CAJAL SRY, 1889, REV TRIM HISTOL NORM, V4; CAJAL SRY, 1889, REV TRIM HISTOL NORM, V3; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHEN SL, 1990, NUCLEIC ACIDS RES, V18, P1304; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTAKOS S, 1989, ENDOCR REV, V10, P3, DOI 10.1210/edrv-10-1-3; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; EFRAT S, 1989, CURR TOP MICROBIOL, V144, P89; FUJITA S, 1967, J CELL BIOL, V32, P277, DOI 10.1083/jcb.32.2.277; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HAMMANG JP, 1990, NEURON, V4, P775, DOI 10.1016/0896-6273(90)90204-S; HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032; HANLEY T, 1991, BIOTECHNIQUES, V10, P56; HARLOW E, 1981, J VIROL, V37, P564, DOI 10.1128/JVI.37.2.564-573.1981; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; HOGAN B, 1986, MANIPULATING MOUSE E; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; Jacobson M., 1991, DEV NEUROBIOLOGY; LANDIS DMD, 1974, ARCH NEUROL-CHICAGO, V31, P295, DOI 10.1001/archneur.1974.00490410043003; LANDIS SC, 1973, BRAIN RES, V61, P175, DOI 10.1016/0006-8993(73)90526-X; Lebowitz P, 1979, Curr Top Microbiol Immunol, V87, P43; LIVINGSTON DM, 1987, MOL BIOL MED, V4, P63; Maniatis T., 1982, MOL CLONING; MARTIN DJ, 1990, MOL CELL BIOL, V10, P1950, DOI 10.1128/MCB.10.5.1950; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; NORDQUIST DT, 1988, J NEUROSCI, V8, P4780; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; Palay S. L., 1974, CEREBELLAR CORTEX CY; Rakic P, 1985, CELL CONTACT ADHESIO, P67; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; ROSENFELD MG, 1988, ANNU REV NEUROSCI, V11, P353, DOI 10.1146/annurev.neuro.11.1.353; ROSS CA, 1990, TRENDS NEUROSCI, V13, P216, DOI 10.1016/0166-2236(90)90163-5; ROSSANT J, 1990, NEURON, V4, P323, DOI 10.1016/0896-6273(90)90045-H; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SIDMAN R L, 1968, PHYSIOLOGICAL AND BIOCHEMICAL ASPECTS OF NERVOUS INTEGRATION, P163; SIDMAN RL, 1983, GENETICS NEUROLOGICA, P19; SMEYNE RJ, 1991, SCIENCE, V254, P719, DOI 10.1126/science.1948052; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; STITT TN, 1990, NEURON, V5, P639, DOI 10.1016/0896-6273(90)90218-5; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; WETTS R, 1983, DEV BRAIN RES, V10, P41, DOI 10.1016/0165-3806(83)90119-0; Zoghbi HY, 1991, CURR NEUROL, V11, P121	54	180	186	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1992	9	5					955	966		10.1016/0896-6273(92)90247-B	http://dx.doi.org/10.1016/0896-6273(92)90247-B			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1419002				2022-12-28	WOS:A1992JY55200014
J	HESTRIN, S				HESTRIN, S			ACTIVATION AND DESENSITIZATION OF GLUTAMATE-ACTIVATED CHANNELS MEDIATING FAST EXCITATORY SYNAPTIC CURRENTS IN THE VISUAL-CORTEX	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; AMINO-ACID RECEPTORS; METHYL-D-ASPARTATE; HIPPOCAMPAL-NEURONS; TIME COURSE; QUISQUALATE RECEPTORS; RAT HIPPOCAMPUS; NMDA-RECEPTOR; SLICES; ANIRACETAM	Brief glutamate applications to membrane patches, excised from neurons in the rat visual cortex, were used to assess the role of desensitization in determining the AMPA/kainate receptor-mediated excitatory postsynaptic current (EPSC) time course. A brief (1 ms) application of glutamate (1-10 mM) produced a response that mimicked the time course of miniature EPSCs (mEPSCs). Direct evidence is presented that the rate of onset of desensitization is much slower than the decay rate of the response to a brief application of glutamate, implying that the decay of mEPSCs reflects channel closure into a state readily available for reactivation. Rapid application of glutamate combined with nonstationary variance analysis provided an estimate of the single-channel conductance and open probability, allowing an approximation of the number of available channels at a single synaptic site.			HESTRIN, S (corresponding author), UNIV CALIF SAN FRANCISCO, SCH MED, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA.		Hestrin, Shaul/F-4410-2010		NATIONAL EYE INSTITUTE [R01EY009120] Funding Source: NIH RePORTER; NEI NIH HHS [EY09120] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARTOLA A, 1990, EUR J NEUROSCI, V2, P254, DOI 10.1111/j.1460-9568.1990.tb00417.x; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; CULLCANDY SG, 1992, EXCITATORY AMINO ACI, P69; DILGER JP, 1990, BIOPHYS J, V57, P723, DOI 10.1016/S0006-3495(90)82593-5; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1986, NEUROSCIENCE, V19, P857, DOI 10.1016/0306-4522(86)90304-0; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HHESTRIN S, 1992, NATURE, V357, P686; HILLE B, 1992, IONIC CHANNELS EXCIT, P321; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; ISAACSON JS, 1991, P NATL ACAD SCI USA, V88, P10936, DOI 10.1073/pnas.88.23.10936; ITO I, 1990, J PHYSIOL-LONDON, V424, P533, DOI 10.1113/jphysiol.1990.sp018081; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; JONES KA, 1988, J NEUROSCI, V8, P3522; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LIVSEY CT, 1992, NEURON, V8, P745, DOI 10.1016/0896-6273(92)90095-U; LOTURCO JJ, 1990, NEUROSCI LETT, V114, P265, DOI 10.1016/0304-3940(90)90574-S; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MILLER LP, 1990, NEUROSCIENCE, V35, P45, DOI 10.1016/0306-4522(90)90118-N; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; NICOLL RA, 1990, PHYSIOL REV, V70, P514; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; STERN P, 1992, J PHYSIOL-LONDON, V449, P247, DOI 10.1113/jphysiol.1992.sp019085; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W	39	198	201	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1992	9	5					991	999		10.1016/0896-6273(92)90250-H	http://dx.doi.org/10.1016/0896-6273(92)90250-H			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1384578				2022-12-28	WOS:A1992JY55200017
J	TANG, J; LANDMESSER, L; RUTISHAUSER, U				TANG, J; LANDMESSER, L; RUTISHAUSER, U			POLYSIALIC ACID INFLUENCES SPECIFIC PATHFINDING BY AVIAN MOTONEURONS	NEURON			English	Article							CELL-ADHESION MOLECULE; VERTEBRATE NEURAL DEVELOPMENT; CHICK HIND LIMB; PROJECTION PATTERNS; NEURITE OUTGROWTH; PATHWAY SELECTION; MOTO-NEURONS; SPINAL-CORD; EMBRYO; INNERVATION	The influence of polysialic acid (PSA) on the neural cell adhesion molecule on motoneuron outgrowth and pathway formation was investigated by determining its temporal and spatial pattern of expression and by the effect that its removal had on motoneuron projection patterns. Motoneurons first expressed PSA as their growth cones began to segregate into motoneuron pool-specific groups in the plexus region; furthermore, PSA levels differed between motoneurons projecting to different targets. When PSA was removed during the period of axonal segregation in the plexus region projection errors were common. However, later removal during the process of muscle nerve formation did not result in projection errors. These results suggest that PSA modulates interactions between motoneuron axons and guidance molecules in the plexus region during axonal pathfinding.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT NEUROSCI,CLEVELAND,OH 44106	Case Western Reserve University; Case Western Reserve University	TANG, J (corresponding author), UNIV CONNECTICUT,DEPT PHYSIOL & NEUROBIOL,STORRS,CT 06269, USA.				NICHD NIH HHS [HD 18369] Funding Source: Medline; NINDS NIH HHS [NS 25557, NS 19640] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018369, R37HD018369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025557, R01NS019640] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; BOISSEAU S, 1991, DEVELOPMENT, V112, P69; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; CHUONG CM, 1984, J NEUROSCI, V4, P2354; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; ELDEEB S, 1992, DEV BIOL, V149, P213, DOI 10.1016/0012-1606(92)90278-O; FERGUSON BA, 1983, J NEUROSCI, V3, P1760; FRELINGER AL, 1986, J CELL BIOL, V103, P1729, DOI 10.1083/jcb.103.5.1729; HEKMAT A, 1990, J COMP NEUROL, V291, P457, DOI 10.1002/cne.902910311; HOFFMAN S, 1983, P NATL ACAD SCI USA, V80, P5761; HOLLYDAY M, 1980, J COMP NEUROL, V194, P143, DOI 10.1002/cne.901940108; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P19, DOI 10.1098/rspb.1981.0080; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANDMESSER L, 1975, J PHYSIOL-LONDON, V249, P301, DOI 10.1113/jphysiol.1975.sp011017; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; ODONOVAN MJ, 1987, J NEUROSCI, V7, P3256; PETTIGREW AG, 1979, J EMBRYOL EXP MORPH, V49, P115; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SCHLOSSHAUER B, 1984, NATURE, V310, P141, DOI 10.1038/310141a0; SUNSHINE J, 1987, P NATL ACAD SCI USA, V84, P5986, DOI 10.1073/pnas.84.16.5986; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; TANAKA H, 1984, DEV BIOL, V106, P26, DOI 10.1016/0012-1606(84)90057-5; Tosney K, 1986, DEV BIOL, V114, P1468; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1985, J NEUROSCI, V5, P2336; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; TOSNEY KW, 1984, J NEUROSCI, V4, P2518; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; ZHANG H, 1992, IN PRESS J NEUROSCI; ZIPSER B, 1989, NEURON, V3, P621, DOI 10.1016/0896-6273(89)90272-9	36	219	221	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1031	1044		10.1016/0896-6273(92)90125-W	http://dx.doi.org/10.1016/0896-6273(92)90125-W			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1319183				2022-12-28	WOS:A1992JA42900004
J	BENFENATI, F; VALTORTA, F; CHIEREGATTI, E; GREENGARD, P				BENFENATI, F; VALTORTA, F; CHIEREGATTI, E; GREENGARD, P			INTERACTION OF FREE AND SYNAPTIC VESICLE BOUND SYNAPSIN-I WITH F-ACTIN	NEURON			English	Article							PROTEIN KINASE-II; SQUID GIANT SYNAPSE; NEUROTRANSMITTER RELEASE; DICTYOSTELIUM-DISCOIDEUM; PLASMA-MEMBRANES; BINDING; CYTOCHALASIN; POLYMERIZATION; FRAGMENTS; PHOSPHOPROTEIN	Synapsin I is a neuron-specific phosphoprotein that binds to small synaptic vesicles and F-actin in a phosphorylation-dependent fashion. We have found that dephosphorylated synapsin I induces a dose-dependent increase in the number of actin filaments, which at high ionic strength is abolished by synapsin I phosphorylation. The increase in filament number appears to be due to a nucleating effect of synapsin I and not to a barbed-end capping/severing activity. Synaptic vesicle-bound synapsin I was as effective as free synapsin I in increasing the number of filaments. These data support the view that synapsin I is involved in the regulation of the dynamics of the actin-based network during the exo-endocytotic cycle.	UNIV MILAN,BRUNO CECCARELLI CTR,DEPT MED PHARMACOL,NATL RES COUNCIL,I-20129 MILAN,ITALY; ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021	University of Milan; Rockefeller University	BENFENATI, F (corresponding author), UNIV MODENA,INST HUMAN PHYSIOL,I-41100 MODENA,ITALY.		Flavia, Valtorta/F-3450-2012; Chieregatti, Evelina/G-2917-2013	Flavia, Valtorta/0000-0001-9556-4746; Chieregatti, Evelina/0000-0001-9066-3606	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039327, R37MH039327] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 39327] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AUNIS D, 1984, J NEUROCHEM, V42, P1558, DOI 10.1111/j.1471-4159.1984.tb12742.x; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BAHLER M, 1989, J CELL BIOL, V108, P1841, DOI 10.1083/jcb.108.5.1841; BAHLER M, 1990, BIOESSAYS, V12, P259, DOI 10.1002/bies.950120603; BENFENATI F, 1989, J CELL BIOL, V108, P1863, DOI 10.1083/jcb.108.5.1863; BENFENATI F, 1989, J CELL BIOL, V108, P1851, DOI 10.1083/jcb.108.5.1851; BENFENATI F, 1991, P NATL ACAD SCI USA, V88, P575, DOI 10.1073/pnas.88.2.575; BENFENATI F, 1984, PRINCIPLES METHODS R, P41; BERNSTEIN BW, 1989, NEURON, V3, P257, DOI 10.1016/0896-6273(89)90039-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER SL, 1979, J BIOL CHEM, V254, P9982; BROWN SS, 1981, J CELL BIOL, V88, P487, DOI 10.1083/jcb.88.3.487; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; FOWLER VM, 1982, NATURE, V295, P336, DOI 10.1038/295336a0; GAERTNER A, 1989, J MUSCLE RES CELL M, V10, P1, DOI 10.1007/BF01739852; HACKETT JT, 1990, J NEUROPHYSIOL, V63, P701, DOI 10.1152/jn.1990.63.4.701; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN JW, 1990, P NATL ACAD SCI USA, V87, P8257, DOI 10.1073/pnas.87.21.8257; LINSTEDT AD, 1987, TRENDS NEUROSCI, V10, P446, DOI 10.1016/0166-2236(87)90095-6; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Martell A. E., 1974, CRITICAL STABILITY C; MCGUINNESS TL, 1985, J BIOL CHEM, V260, P1696; NESTLER EJ, 1984, PROTEIN PHOSPHORYLAT, P1; NICHOLS RA, 1990, NATURE, V343, P647, DOI 10.1038/343647a0; PETRUCCI TC, 1987, J CELL BIOL, V105, P1355, DOI 10.1083/jcb.105.3.1355; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; POLLARD TD, 1976, J CELL BIOL, V68, P579, DOI 10.1083/jcb.68.3.579; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; SCHWARTZ MA, 1986, J CELL BIOL, V102, P2067, DOI 10.1083/jcb.102.6.2067; SHARIFF A, 1990, J CELL BIOL, V110, P681, DOI 10.1083/jcb.110.3.681; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TALLARIDA RJ, 1981, MANUAL PHARM CALCULA, P1; UEDA T, 1977, J BIOL CHEM, V252, P5155; VALTORTA F, 1990, NEUROSCIENCE, V35, P477, DOI 10.1016/0306-4522(90)90323-V	45	126	128	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1992	8	2					377	386		10.1016/0896-6273(92)90303-U	http://dx.doi.org/10.1016/0896-6273(92)90303-U			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1739463				2022-12-28	WOS:A1992HE93000017
J	BARGMANN, CI; HORVITZ, HR				BARGMANN, CI; HORVITZ, HR			CHEMOSENSORY NEURONS WITH OVERLAPPING FUNCTIONS DIRECT CHEMOTAXIS TO MULTIPLE CHEMICALS IN C-ELEGANS	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; EMBRYONIC CELL LINEAGES; MOTOR NEURONS; NERVOUS-SYSTEM; DAUER LARVA; MUTANTS; IDENTIFICATION; RESPONSES; OUTPUT; INPUT	The functions of the 11 classes of exposed chemosensory neurons of C. elegans were tested by killing cells with a laser microbeam. One pair of neurons, the ASE neurons, is uniquely important for chemotaxis: killing the ASE neurons greatly reduced chemotaxis to cAMP, biotin, Cl-, and Na+. Additional chemosensory function is distributed among several other cell types. Thus, 3 pairs of chemosensory neurons (ADF, ASG, and ASI) contribute to a residual response to cAMP, biotin, Cl-, and Na+ after ASE is killed. Chemotaxis to lysine similarly depends on the partly redundant functions of 4 pairs of chemosensory neurons (ASE, ASG, ASI, and ASK). The combined activity of several neuron types that act in parallel might increase the fidelity of chemotaxis.	MIT,DEPT BIOL,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02139	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)				Bargmann, Cornelia/0000-0002-8484-0618	NIGMS NIH HHS [GM24663] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024663, R01GM024663] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ache B.W., 1987, NEUROBIOLOGY TASTE S, P39; ADLER J, 1975, ANNU REV BIOCHEM, V44, P341, DOI 10.1146/annurev.bi.44.070175.002013; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN CI, 1990, COLD SPRING HARB SYM, V55, P529; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BRENNER S, 1974, GENETICS, V77, P71; BURROWS M, 1987, J NEUROSCI, V7, P1064; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHIEL HJ, 1986, J NEUROSCI, V6, P2427; DESAI C, 1989, GENETICS, V121, P703; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOY MF, 1977, P NATL ACAD SCI USA, V74, P4964, DOI 10.1073/pnas.74.11.4964; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEILIGENBERG W, 1988, BRAIN BEHAV EVOLUT, V31, P6, DOI 10.1159/000116571; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; KOSHLAND DE, 1988, BIOCHEMISTRY-US, V27, P5829, DOI 10.1021/bi00416a001; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; LOCKERY SR, 1990, J NEUROSCI, V10, P1811; NUSBAUM MP, 1989, J NEUROSCI, V9, P1591; OKAMOTO H, 1985, J NEUROSCI, V5, P643; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Rosner B., 1986, FUNDAMENTALS BIOSTAT, V2nd, P442; SCOTT TR, 1984, CHEM SENSES, V8, P297, DOI 10.1093/chemse/8.3.297; SELVERSTON AI, 1980, J NEUROPHYSIOL, V44, P1102, DOI 10.1152/jn.1980.44.6.1102; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; SIDDIQI O, 1987, TRENDS GENET, V3, P137, DOI 10.1016/0168-9525(87)90204-6; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; TRENT C, 1983, GENETICS, V104, P619; Van Houten J., 1981, BIOCH PHYSL PROTOZOA, V4, P67; VANHAASTERT PJM, 1982, EXP CELL RES, V140, P453, DOI 10.1016/0014-4827(82)90139-2; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	48	500	514	2	121	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1991	7	5					729	742		10.1016/0896-6273(91)90276-6	http://dx.doi.org/10.1016/0896-6273(91)90276-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1660283				2022-12-28	WOS:A1991GT93900004
J	MURPHY, TH; WORLEY, PF; BARABAN, JM				MURPHY, TH; WORLEY, PF; BARABAN, JM			L-TYPE VOLTAGE-SENSITIVE CALCIUM CHANNELS MEDIATE SYNAPTIC ACTIVATION OF IMMEDIATE EARLY GENES	NEURON			English	Article							CEREBELLAR GRANULE CELLS; SPINAL-CORD NEURONS; C-FOS; NMDA-RECEPTOR; MEMBRANE DEPOLARIZATION; TRANSMITTER RELEASE; GLUTAMATE RECEPTORS; OMEGA-CONOTOXIN; MESSENGER-RNAS; GROWTH-FACTORS	Although L-type voltage-sensitive calcium channels (VSCCs) have been well characterized electrophysiologically, their role in synaptic physiology has remained unclear. To assess their involvement in synaptic regulation of gene expression, we have examined the effects of selective VSCC antagonists on basal, synaptically mediated activation of several transcription factor genes in cultured cortical neurons. Basal expression of c-fos, jun-B, zif268, and fos-B is rapidly suppressed by exposure to L-type VSCC antagonists and increased by (-)BayK-8644, a VSCC agonist. Although VSCC antagonists block kainate-induced rises in intracellular calcium and gene expression, these agents have little effect on spontaneous electrical activity or synaptically induced calcium transients in these neurons. These findings suggest that even though L-type VSCCs contribute a relatively minor component of synaptic calcium transients, they appear to play a key role in coupling synaptic excitation to activation of transcriptional events thought to contribute to neuronal plasticity.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University	MURPHY, TH (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.		Murphy, Timothy H/I-4982-2014; Murphy, Timothy/AAW-1975-2021	Murphy, Timothy H/0000-0002-0093-4490; Murphy, Timothy/0000-0002-0093-4490; Baraban, Jay/0000-0002-8165-2638	NEI NIH HHS [EY-08900] Funding Source: Medline; NIDA NIH HHS [DA-00266] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AGOSTON DV, 1991, J NEUROSCI RES, V28, P140, DOI 10.1002/jnr.490280115; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CARBONI E, 1988, J NEUROCHEM, V50, P1279, DOI 10.1111/j.1471-4159.1988.tb10605.x; CHOI DW, 1987, J NEUROSCI, V7, P357; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; COURTNEY MJ, 1990, J NEUROSCI, V10, P3873, DOI 10.1523/JNEUROSCI.10-12-03873.1990; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; JONES KA, 1988, J NEUROSCI, V8, P3522; KAMIYA H, 1988, NEUROSCI LETT, V91, P84, DOI 10.1016/0304-3940(88)90253-4; KINGSBURY A, 1987, EUR J PHARMACOL, V140, P275, DOI 10.1016/0014-2999(87)90284-6; KLEY N, 1987, J BIOL CHEM, V262, P4083; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; KUAN YF, 1986, EUR J PHARMACOL, V130, P273, DOI 10.1016/0014-2999(86)90278-5; LAU LF, 1991, MOL ASPECTS CELLULAR, V6, P165; MARANGOS PJ, 1979, J NEUROCHEM, V33, P319, DOI 10.1111/j.1471-4159.1979.tb11735.x; MAYER ML, 1987, J NEUROSCI, V7, P3230; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MINTA A, 1989, J BIOL CHEM, V264, P8171; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; MURPHY SN, 1989, J PHARMACOL EXP THER, V249, P184; MURPHY TH, 1988, BRAIN RES, V460, P155, DOI 10.1016/0006-8993(88)91216-4; MURPHY TH, 1990, DEV BRAIN RES, V57, P146, DOI 10.1016/0165-3806(90)90195-5; MURPHY TH, 1991, IN PRESS J NEUROCHEM; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; PELLEGRINIGIAMPIETRO DE, 1989, BRIT J PHARMACOL, V98, P1281, DOI 10.1111/j.1476-5381.1989.tb12675.x; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; SZEKELY AM, 1989, MOL PHARMACOL, V35, P401; TEO TS, 1973, J BIOL CHEM, V248, P5950; TRIGGLE DJ, 1987, ANNU REV PHARMACOL, V27, P347; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; YU C, 1988, EXP BRAIN RES, V71, P467, DOI 10.1007/BF00248740; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	51	387	390	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1991	7	4					625	635		10.1016/0896-6273(91)90375-A	http://dx.doi.org/10.1016/0896-6273(91)90375-A			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1657056				2022-12-28	WOS:A1991GM95400011
J	REGEHR, WG; TANK, DW				REGEHR, WG; TANK, DW			THE MAINTENANCE OF LTP AT HIPPOCAMPAL MOSSY FIBER SYNAPSES IS INDEPENDENT OF SUSTAINED PRESYNAPTIC CALCIUM	NEURON			English	Article							LONG-TERM POTENTIATION; TRANSMITTER RELEASE; POSTTETANIC POTENTIATION; SYNAPTIC TRANSMISSION; INDUCTION; NEURONS; STIMULATION; MECHANISM; INVITRO; APLYSIA	We have examined the role of presynaptic residual calcium in maintaining long-term changes in synaptic efficacy observed at mossy fiber synapses between hippocampal dentate granule cells and CA3 pyramidal cells. Calcium concentrations in individual mossy fiber terminals in hippocampal slice were optically measured with the calcium indicator fura-2 while stimulating the mossy fiber pathway and recording excitatory postsynaptic potentials extracellularly. Short-term synaptic enhancement was accompanied by increased presynaptic residual calcium concentration. A 2-fold enhancement of transmitter release was accompanied by a 10-30 nM increase in residual calcium. Following induction of mossy fiber LTP, transiently elevated presynaptic calcium decayed to prestimulus levels, whereas enhancement of synaptic transmission persisted. Our results demonstrate that, despite an apparent strong sensitivity of synaptic enhancement to presynaptic residual calcium levels, sustained increases in presynaptic residual calcium levels are not responsible for the maintained synaptic enhancement observed during mossy fiber LTP.	AT&T BELL LABS,BIOPHYS RES DEPT,MURRAY HILL,NJ 07974	AT&T; Nokia Corporation; Nokia Bell Labs								AMARAL DG, 1979, ANAT EMBRYOL, V155, P241, DOI 10.1007/BF00317638; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BARRIONUEVO G, 1986, J NEUROPHYSIOL, V55, P540, DOI 10.1152/jn.1986.55.3.540; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BROWN TH, 1990, HIPPOCAMPUS SYNAPTIC; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; CONNOR JA, 1986, J PHYSIOL-LONDON, V375, P625, DOI 10.1113/jphysiol.1986.sp016137; DALE N, 1990, J PHYSIOL-LONDON, V421, P203, DOI 10.1113/jphysiol.1990.sp017941; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DELANEY KR, 1991, IN PRESS J NEUROSCI; DELANEY KR, 1991, IN PRESS ANN NY ACAD; GRIFFITH WH, 1990, J NEUROPHYSIOL, V63, P491, DOI 10.1152/jn.1990.63.3.491; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; JAFFE D, 1990, J NEUROPHYSIOL, V64, P948, DOI 10.1152/jn.1990.64.3.948; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MAGELBY KL, 1987, SHORT TERM CHANGES S; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; MILES R, 1987, NATURE, V329, P724, DOI 10.1038/329724a0; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; SCHWARTZKROIN PA, 1975, BRAIN RES, V85, P423, DOI 10.1016/0006-8993(75)90817-3; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	32	74	74	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1991	7	3					451	459		10.1016/0896-6273(91)90297-D	http://dx.doi.org/10.1016/0896-6273(91)90297-D			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1654950	Bronze			2022-12-28	WOS:A1991GG88700010
J	HE, X; ROSENFELD, MG				HE, X; ROSENFELD, MG			MECHANISMS OF COMPLEX TRANSCRIPTIONAL REGULATION - IMPLICATIONS FOR BRAIN-DEVELOPMENT	NEURON			English	Article							NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; DNA-BINDING DOMAIN; SEGMENT-SPECIFIC EXPRESSION; HOMEOBOX-CONTAINING GENES; STEROID-HORMONE RECEPTOR; RETINOIC ACID RECEPTORS; SEX-DETERMINING REGION; IMMEDIATE EARLY GENES; LOOP-HELIX PROTEINS		UNIV CALIF SAN DIEGO, SCH MED, DEPT BIOL, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, SCH MED, HOWARD HUGHES MED INST, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	HE, X (corresponding author), UNIV CALIF SAN DIEGO, SCH MED, EUKARYOT REGULATORY BIOL PROGRAM, LA JOLLA, CA 92093 USA.							AGRE P, 1989, SCIENCE, V246, P922, DOI 10.1126/science.2530632; ALONSO MC, 1988, EMBO J, V7, P2585, DOI 10.1002/j.1460-2075.1988.tb03108.x; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BASTIAN H, 1990, EMBO J, V9, P1839, DOI 10.1002/j.1460-2075.1990.tb08309.x; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BLACK IB, 1987, SCIENCE, V236, P1263, DOI 10.1126/science.2884727; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BROCKES JP, 1989, NEURON, V2, P1285, DOI 10.1016/0896-6273(89)90066-4; BRUGGEMEIER U, 1991, CELL, V64, P565, DOI 10.1016/0092-8674(91)90240-Y; BURGLIN TR, 1989, NATURE, V341, P239, DOI 10.1038/341239a0; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CEPKO C, 1988, NEURON, V1, P345, DOI 10.1016/0896-6273(88)90184-5; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; COMB M, 1987, TRENDS NEUROSCI, V10, P473, DOI 10.1016/0166-2236(87)90103-2; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS LCA, GENE DEV, V2, P1736; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; EICHELE G, 1989, TRENDS GENET, V5, P246, DOI 10.1016/0168-9525(89)90096-6; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; EVANS RM, 1989, NEURON, V2, P1105, DOI 10.1016/0896-6273(89)90177-3; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; FRIEDMAN AD, 1990, GENE DEV, V4, P1416, DOI 10.1101/gad.4.8.1416; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GHYSEN A, 1989, TRENDS GENET, V5, P251, DOI 10.1016/0168-9525(89)90097-8; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1990, CELL, V63, P729, DOI 10.1016/0092-8674(90)90139-6; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HE X, 1991, MOL CELL BIOL, V11, P1739, DOI 10.1128/MCB.11.3.1739; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; HOPE IA, 1988, NATURE, V333, P635, DOI 10.1038/333635a0; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; IZISUABELMONTE JC, 1991, NATURE, V350, P585; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; JOHNSON WA, 1990, NATURE, V343, P467, DOI 10.1038/343467a0; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; KAPILOFF MS, 1991, P NATL ACAD SCI USA, V88, P3710, DOI 10.1073/pnas.88.9.3710; KAPILOFF MS, 1991, IN PRESS SCIENCE; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KENYON C, 1988, SCIENCE, V240, P1448, DOI 10.1126/science.3287621; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KLOCK G, 1987, NATURE, V329, P734, DOI 10.1038/329734a0; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; KORNER M, 1989, NEURON, V3, P563, DOI 10.1016/0896-6273(89)90266-3; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; KRISTIE TM, 1990, GENE DEV, V4, P2383, DOI 10.1101/gad.4.12b.2383; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LEROY P, 1991, EMBO J, V10, P59, DOI 10.1002/j.1460-2075.1991.tb07921.x; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LICHT JD, 1990, NATURE, V346, P76, DOI 10.1038/346076a0; LONAI P, 1990, FASEB J, V4, P1436, DOI 10.1096/fasebj.4.5.1968407; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MCEWEN BS, 1991, TRENDS ENDOCRIN MET, V2, P62, DOI 10.1016/1043-2760(91)90042-L; MCKAY R, 1988, PROG BRAIN RES, V78, P647; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; MONUKI ES, 1990, SCIENCE, V249, P1300, DOI 10.1126/science.1975954; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MURPHY P, 1989, NATURE, V341, P156, DOI 10.1038/341156a0; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; NOHNO T, 1991, CELL, V64, P1197, DOI 10.1016/0092-8674(91)90274-3; NOJI S, 1991, NATURE, V350, P83, DOI 10.1038/350083a0; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; NORNES HO, 1990, DEVELOPMENT, V109, P797; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; ORO AE, 1990, NATURE, V347, P298, DOI 10.1038/347298a0; ORO AE, 1989, DEVELOPMENT, V107, P133; OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x; PASSMORE S, 1988, J MOL BIOL, V204, P593, DOI 10.1016/0022-2836(88)90358-0; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PFEIFER K, 1987, CELL, V49, P19, DOI 10.1016/0092-8674(87)90751-3; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PIGNONI F, 1990, CELL, V62, P151, DOI 10.1016/0092-8674(90)90249-E; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; READY DF, 1989, TRENDS NEUROSCI, V12, P102, DOI 10.1016/0166-2236(89)90166-5; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; ROSSANT J, 1990, NEURON, V4, P323, DOI 10.1016/0896-6273(90)90045-H; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUBERTE E, 1991, DEVELOPMENT, V111, P45; RUBIN GM, 1988, SCIENCE, V240, P1453, DOI 10.1126/science.3131880; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; RUVKUN G, 1991, CELL, V64, P475, DOI 10.1016/0092-8674(91)90227-P; SAINT R, 1988, NATURE, V334, P151, DOI 10.1038/334151a0; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; SCHULE R, 1988, NATURE, V332, P87, DOI 10.1038/332087a0; SCHULE R, 1990, CELL, V61, P497, DOI 10.1016/0092-8674(90)90531-I; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SCHULMAN H, 1988, ADV SEC MESS PHOSPH, V22, P39; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STRUHL K, 1991, NEURON, V7, P177, DOI 10.1016/0896-6273(91)90256-Y; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; TOMLINSON A, 1988, CELL, V55, P771, DOI 10.1016/0092-8674(88)90133-X; TREACY MN, 1991, NATURE, V350, P577, DOI 10.1038/350577a0; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; TSAI SY, 1989, CELL, V57, P443, DOI 10.1016/0092-8674(89)90919-7; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; URBAN MB, 1990, GENE DEV, V4, P1975, DOI 10.1101/gad.4.11.1975; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WAGNER M, 1990, NATURE, V345, P819, DOI 10.1038/345819a0; WANEK N, 1991, NATURE, V350, P81, DOI 10.1038/350081a0; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WILKINSON DG, 1990, TRENDS NEUROSCI, V13, P335, DOI 10.1016/0166-2236(90)90145-Z; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; ZELENT A, 1991, EMBO J, V10, P71, DOI 10.1002/j.1460-2075.1991.tb07922.x; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; ZIPURSKY SL, 1989, TRENDS NEUROSCI, V12, P183, DOI 10.1016/0166-2236(89)90069-6	195	192	194	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1991	7	2					183	196		10.1016/0896-6273(91)90257-Z	http://dx.doi.org/10.1016/0896-6273(91)90257-Z			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1873026				2022-12-28	WOS:A1991GB93300002
J	SEGAL, RA; TAKAHASHI, H; MCKAY, RDG				SEGAL, RA; TAKAHASHI, H; MCKAY, RDG			CHANGES IN NEUROTROPHIN RESPONSIVENESS DURING THE DEVELOPMENT OF CEREBELLAR GRANULE NEURONS	NEURON			English	Article							NERVE GROWTH-FACTOR; TYROSINE PROTEIN-KINASE; FACTOR MESSENGER-RNA; SENSORY NEURONS; NGF-RECEPTOR; INSITU HYBRIDIZATION; BRAIN; TRKB; SURVIVAL; RAT	Neurotrophins and their receptors are widespread in the developing and mature CNS. Identifying the differentiation state of neurotrophin-responsive cells provides a basis for understanding the developmental functions of these factors. Studies using dissociated and organotypic cultures of rat cerebellum demonstrated that the neurotrophins brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) affect developing granule cells at distinct stages in differentiation. While early granule neurons in the external germinal layer responded to BDNF, more mature granule cells responded to NT-3. BDNF, but not NT-3, enhanced survival of granule cells in cultures of embryonic cerebella. Thus, BDNF and NT-3 have distinct sequential functions that are likely to be critical in the development of the cerebellum. BDNF may promote the initial commitment, while NT-3 may direct the subsequent maturation of granule cells.	MIT,DEPT BRAIN & COGNIT SCI,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	SEGAL, RA (corresponding author), MIT,DEPT BIOL,CAMBRIDGE,MA 02139, USA.							ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; AUSUBEL A, 1989, PROTOCOLS MOL BIOL, P139; BARDE YA, 1980, P NATL ACAD SCI-BIOL, V77, P1199, DOI 10.1073/pnas.77.2.1199; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; BOTTENSTEIN JE, 1985, CELL CULTURE NEUROSC, P3; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; COHENCORY S, 1991, J NEUROSCI, V11, P462; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DAVIES AM, 1986, J NEUROSCI, V6, P1897; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; GAHWILER BH, 1984, EXPERIENTIA, V40, P235, DOI 10.1007/BF01947561; GAO WQ, 1992, CELL, V68, P841, DOI 10.1016/0092-8674(92)90028-B; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GRAVEL C, 1987, J NEUROSCI METH, V21, P145, DOI 10.1016/0165-0270(87)90112-9; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; HATANAKA H, 1988, DEV BRAIN RES, V39, P85, DOI 10.1016/0165-3806(88)90069-7; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HENDRY IA, 1975, BRAIN RES, V94, P87, DOI 10.1016/0006-8993(75)90879-3; HEUER JG, 1990, NEURON, V5, P283, DOI 10.1016/0896-6273(90)90165-C; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; JAEGER CB, 1988, NEUROSCIENCE, V26, P509, DOI 10.1016/0306-4522(88)90165-0; JANDE SS, 1981, NATURE, V294, P765, DOI 10.1038/294765a0; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON EM, 1978, BRAIN RES, V141, P105, DOI 10.1016/0006-8993(78)90620-0; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; ROHDE BH, 1979, J NEUROCHEM, V32, P1431, DOI 10.1111/j.1471-4159.1979.tb11081.x; SNIDER WD, 1989, ANN NEUROL, V26, P489, DOI 10.1002/ana.410260402; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TUSZYNSKI MH, 1990, J NEUROSCI, V10, P3604; VOGEL KS, 1991, NEURON, V7, P819, DOI 10.1016/0896-6273(91)90284-7; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WILLCUTTS MD, 1991, DEV BRAIN RES, V63, P253, DOI 10.1016/0165-3806(91)90085-W	51	223	224	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1041	1052		10.1016/0896-6273(92)90064-K	http://dx.doi.org/10.1016/0896-6273(92)90064-K			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1463606				2022-12-28	WOS:A1992KD71600004
J	MULKEY, RM; MALENKA, RC				MULKEY, RM; MALENKA, RC			MECHANISMS UNDERLYING INDUCTION OF HOMOSYNAPTIC LONG-TERM DEPRESSION IN AREA CA1 OF THE HIPPOCAMPUS	NEURON			English	Article							POTENTIATED SYNAPTIC RESPONSES; CALCIUM CHANNELS; RAT HIPPOCAMPUS; NMDA RECEPTORS; NEURONS; SLICES; STIMULATION; ENHANCEMENT; CURRENTS; BLOCK	The mechanisms responsible for long-lasting, activity-dependent decreases in synaptic efficacy are not well understood. We have examined the initial steps required for the induction of long-term depression (LTD) in CA1 pyramidal cells by repetitive low frequency (1 Hz) synaptic stimulation. This form of LTD was synapse specific, was saturable, and required activation of post-synaptic NMDA receptors. Loading CA1 cells with the Ca2+ chelator BAPTA prevented LTD, whereas lowering extracellular Ca2+ resulted in the induction of LTD by stimulation that previously elicited long-term potentiation. following LTD, synaptic strength could be increased to its original maximal level, indicating that LTD is reversible and not due to deterioration of individual synapses. Induction of homosynaptic LTD therefore requires an NMDA receptor-dependent change in postsynaptic Ca2+ which may be distinct from that required for long-term potentiation.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	MULKEY, RM (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143, USA.				NIMH NIH HHS [MH00942, MH45334] Funding Source: Medline; NINDS NIH HHS [NS07067] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH045334, K02MH000942] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAHAM WC, 1991, BRAIN RES, V546, P336, DOI 10.1016/0006-8993(91)91498-P; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BARRIONUEVO G, 1980, LIFE SCI, V27, P2385, DOI 10.1016/0024-3205(80)90509-3; BASKYS A, 1991, J PHYSIOL-LONDON, V444, P687, DOI 10.1113/jphysiol.1991.sp018901; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BROCHER S, 1992, P NATL ACAD SCI USA, V89, P123, DOI 10.1073/pnas.89.1.123; CHERNEVSKAYA NI, 1991, NATURE, V349, P418, DOI 10.1038/349418a0; CHERUBINI E, 1991, J PHYSIOL-LONDON, V436, P531, DOI 10.1113/jphysiol.1991.sp018565; Cohen P, 1988, CALMODULIN; COLEMAN PA, 1989, J NEUROPHYSIOL, V61, P218, DOI 10.1152/jn.1989.61.1.218; COLINO A, 1992, J NEUROSCI, V12, P180; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; HARRIS EW, 1983, EXP BRAIN RES, V52, P455; HIRSCH JC, 1991, EXP BRAIN RES, V85, P621; HIRSCH JC, 1992, SYNAPSE, V10, P173, DOI 10.1002/syn.890100211; HUANG YY, 1992, IN PRESS J NEUROSCI; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; KELLER BU, 1991, J PHYSIOL-LONDON, V435, P275, DOI 10.1113/jphysiol.1991.sp018510; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCNAUGHTON BL, 1982, J PHYSIOL-LONDON, V324, P249, DOI 10.1113/jphysiol.1982.sp014110; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MULLER D, 1989, BRAIN RES, V479, P290, DOI 10.1016/0006-8993(89)91631-4; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; POCKETT S, 1990, EXP BRAIN RES, V80, P196; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; SCHULMAN H, 1992, CELL CALCIUM, V13, P401, DOI 10.1016/0143-4160(92)90053-U; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WICKENS JR, 1991, NEUROSCI LETT, V130, P128, DOI 10.1016/0304-3940(91)90244-N; XIE XP, 1992, J NEUROPHYSIOL, V67, P1009, DOI 10.1152/jn.1992.67.4.1009; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	48	845	860	1	39	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1992	9	5					967	975		10.1016/0896-6273(92)90248-C	http://dx.doi.org/10.1016/0896-6273(92)90248-C			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1419003				2022-12-28	WOS:A1992JY55200015
J	BAILEY, CH; MONTAROLO, P; CHEN, M; KANDEL, ER; SCHACHER, S				BAILEY, CH; MONTAROLO, P; CHEN, M; KANDEL, ER; SCHACHER, S			INHIBITORS OF PROTEIN AND RNA-SYNTHESIS BLOCK STRUCTURAL-CHANGES THAT ACCOMPANY LONG-TERM HETEROSYNAPTIC PLASTICITY IN APLYSIA	NEURON			English	Article							GILL-WITHDRAWAL REFLEX; DISSOCIATED CELL-CULTURE; SENSORY NEURONS; NEURITE OUTGROWTH; SYNAPSE FORMATION; FACILITATION; SENSITIZATION; MEMORY; HABITUATION; NEUROBIOLOGY	Synaptic connections between the sensory and motor neurons of Aplysia in culture undergo long-term facilitation in response to serotonin (5-HT) and long-term depression in response to FMRFamide. These long-term functional changes are dependent on the synthesis of macromolecules during the period in which the transmitter is applied and are accompanied by structural changes. There is an increase and a decrease, respectively, in the number of sensory neuron varicosities in response to 5-HT and FMRFamide. To determine whether macromolecular synthesis is also required for the structural changes, we examined in parallel the effects of inhibitors of protein (anisomycin) or RNA (actinomycin D) synthesis on the structural and functional changes. We have found that anisomycin and actinomycin D block both the enduring alterations in varicosity number and the long-lasting changes in synaptic potential. These results indicate that macromolecular synthesis is required for expression of the long-lasting structural changes in the sensory cells and that this synthesis is correlated with the long-term functional modulation of sensorimotor synapses.	COLUMBIA UNIV COLL PHYS & SURG,NEW YORK STATE PSYCHIAT INST,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; New York State Psychiatry Institute; Columbia University; Howard Hughes Medical Institute	BAILEY, CH (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032099] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32099] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGRANOFF BW, 1967, NEUROSCIENCES STUDY, P756; ATWOOD HL, 1989, J NEUROBIOL, V20, P373, DOI 10.1002/neu.480200509; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P9356, DOI 10.1073/pnas.85.23.9356; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1989, J NEUROBIOL, V20, P356, DOI 10.1002/neu.480200508; BAILEY CH, 1989, J NEUROSCI, V9, P1774; BAILEY CH, 1979, J NEUROCYTOL, V8, P415, DOI 10.1007/BF01214801; Bailey CH, 1991, PERSPECTIVES COGNITI, P76; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2372; BAILEY CH, 1992, IN PRESS ENCY LEARNI; BARONDES SH, 1975, SHORT TERM MEMORY, P379; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; BERGOLD PJ, 1990, P NATL ACAD SCI USA, V87, P3788, DOI 10.1073/pnas.87.10.3788; CAREW T J, 1971, International Journal of Neuroscience, V2, P79, DOI 10.3109/00207457109146995; CAREW TJ, 1972, SCIENCE, V175, P451, DOI 10.1126/science.175.4020.451; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CASTELLUCCI VF, 1978, SCIENCE, V202, P1036; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; DALE N, 1987, J NEUROSCI, V7, P2232; DALE N, 1988, SCIENCE, V239, P282, DOI 10.1126/science.2892269; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; FLEXNER JB, 1963, SCIENCE, V141, P567; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; GLANZMAN DL, 1989, NEURON, V3, P441, DOI 10.1016/0896-6273(89)90203-1; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GREENOUGH WT, 1988, TRENDS NEUROSCI, V11, P142, DOI 10.1016/0166-2236(88)90139-7; GREENOUGH WT, 1985, SYNAPTIC PLASTICITY, P335; HAN HQ, 1991, NATURE, V349, P697, DOI 10.1038/349697a0; KELLY RB, 1991, NATURE, V349, P650, DOI 10.1038/349650a0; LEE K, 1981, ELECTRICAL ACTIVITY, P189; LEE KS, 1980, J NEUROPHYSIOL, V44, P247, DOI 10.1152/jn.1980.44.2.247; MATTIES H, 1991, LONG TERM POTENTIATI, P233; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTAROLO PG, 1988, NATURE, V333, P171, DOI 10.1038/333171a0; NAZIF FA, 1991, BRAIN RES, V539, P324, DOI 10.1016/0006-8993(91)91638-H; PINSKER H, 1970, SCIENCE, V167, P1740, DOI 10.1126/science.167.3926.1740; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; PURVES D, 1985, PRINCIPLES NEURAL DE; RAYPORT SG, 1986, J NEUROSCI, V6, P759; SCHACHER S, 1991, NEURON, V6, P679, DOI 10.1016/0896-6273(91)90166-W; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHACHER S, 1990, J NEUROSCI, V10, P3286; SCHACHER S, 1985, J NEUROSCI, V5, P2028; Squire L. R., 1987, MEMORY BRAIN; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; WALLACE CS, 1991, LONG TERM POTENTIATI, P189; WOJTOWICZ JM, 1989, CAN J PHYSIOL PHARM, V67, P167, DOI 10.1139/y89-028	50	160	160	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					749	758		10.1016/0896-6273(92)90037-E	http://dx.doi.org/10.1016/0896-6273(92)90037-E			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1356372				2022-12-28	WOS:A1992JT51600015
J	JOLY, E; OLDSTONE, MBA				JOLY, E; OLDSTONE, MBA			NEURONAL CELLS ARE DEFICIENT IN LOADING PEPTIDES ONTO MHC CLASS-I MOLECULES	NEURON			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CYTOTOXIC T-CELLS; MONOCLONAL-ANTIBODIES; VIRAL PEPTIDES; ANTIGEN; EXPRESSION; INVITRO; REGION; GENE; VECTORS	Virally infected neurons avoid destruction by cytotoxic T lymphocytes (CTLs) by failing to express major histocompatibility complex (MHC) class I molecules. Like neurons in vivo and in primary culture, the OBL21 neuronal cell line expressed barely detectable levels of MHC class I molecules. This correlated with very low levels of mRNAs for the MHC class I heavy chains (alpha-C). OBL21 cells also fail to provide MHC class I molecules with the peptides necessary for their efficient assembly and transport to the cell surface. This function can be restored by treatment with interferon-gamma (IFN-gamma). The mRNA for peptide transporters HAM1 and HAM2 was not detectable in OBL21 neuronal cells, but was induced by IFN-gamma treatment. Hence, the ability of neurons to evade CTL-mediated killing results from expression at low levels of the MHC class I alpha-C, the peptide transporters HAM1 and HAM2, and possibly other genes of the peptide-loading machinery.	Scripps Res Inst, DEPT NEUROPHARMACOL, DIV VIROL, LA JOLLA, CA 92037 USA	Scripps Research Institute			Joly, Etienne/A-5644-2009	Joly, Etienne/0000-0002-7264-2681	NIAID NIH HHS [AI-09484] Funding Source: Medline; NIMH NIH HHS [MH-47680] Funding Source: Medline; NINDS NIH HHS [NS-12428] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009484, R37AI009484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH047680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS012428] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmed R., 1990, VIROLOGY, P241; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; BIKOFF EK, 1991, NATURE, V354, P235, DOI 10.1038/354235a0; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; CERUNDOLO V, 1990, NATURE, V345, P449, DOI 10.1038/345449a0; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; DOHERTY PC, 1984, CONCEPTS VIRAL PATHO, P53; ELLIOTT T, 1991, NATURE, V351, P402, DOI 10.1038/351402a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; JOHNSON RT, 1980, BRAIN, V103, P447, DOI 10.1093/brain/103.3.447; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; JOLY E, 1991, IMMUNOGENETICS, V34, P62, DOI 10.1007/BF00212315; KORMAN AJ, 1987, P NATL ACAD SCI USA, V84, P2150, DOI 10.1073/pnas.84.8.2150; KVIST S, 1990, NATURE, V348, P446, DOI 10.1038/348446a0; LAMPSON LA, 1987, TRENDS NEUROSCI, V10, P211, DOI 10.1016/0166-2236(87)90153-6; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; LJUGGREN HG, 1990, NATURE, V346, P476; Maniatis T., 1982, MOL CLONING; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Mims C.A., 1984, VIRAL PATHOGENESIS I; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; OLDSTONE MBA, 1988, J EXP MED, V168, P559, DOI 10.1084/jem.168.2.559; OZATO K, 1980, J IMMUNOL, V125, P2473; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; RAHMSDORF HJ, 1986, J IMMUNOL, V136, P2293; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; VANBLEEK GM, 1990, NATURE, V348, P213; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0; ZINKERNAGEL RM, 1977, J EXP MED, V145, P644, DOI 10.1084/jem.145.3.644	38	89	89	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1185	1190		10.1016/0896-6273(92)90138-4	http://dx.doi.org/10.1016/0896-6273(92)90138-4			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1610569				2022-12-28	WOS:A1992JA42900017
J	LI, M; WEST, JW; LAI, Y; SCHEUER, T; CATTERALL, WA				LI, M; WEST, JW; LAI, Y; SCHEUER, T; CATTERALL, WA			FUNCTIONAL MODULATION OF BRAIN SODIUM-CHANNELS BY CAMP-DEPENDENT PHOSPHORYLATION	NEURON			English	Article							RAT-BRAIN; PROTEIN-KINASE; ALPHA-SUBUNIT; CYCLIC-AMP; ADENYLATE-CYCLASE; CLONED CDNA; INHIBITION; EXPRESSION; NEURONS; CELLS	Voltage-gated Na+ channels, which are responsible for the generation of action potentials in brain, are phosphorylated by cAMP-dependent protein kinase in vitro and in intact neurons. Phosphorylation by cAMP-dependent protein kinase reduces peak Na+ currents 40%-50% in membrane patches excised from rat brain neurons or from CHO cells expressing type IIA Na+ channels. Inhibition of basal cAMP-dependent protein kinase activity by transfection with a plasmid encoding a dominant negative mutant regulatory subunit increases Na+ channel number and activity, indicating that even the basal level of kinase activity is sufficient to reduce Na+ channel activity significantly. Na+ currents in membrane patches from kinase-deficient cells were reduced up to 80% by phosphorylation by cAMP-dependent protein kinase. These effects could be blocked by a specific peptide inhibitor of cAMP-dependent protein kinase and reversed by phosphoprotein phosphatases. Convergent modulation of brain Na+ channels by neurotransmitters acting through the cAMP and protein kinase C signaling pathways may result in associative regulation of electrical activity by different synaptic inputs.			LI, M (corresponding author), UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195, USA.		Mackie, Ken/E-3384-2013		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025704, R01NS015751] Funding Source: NIH RePORTER; NINDS NIH HHS [R0-1 NS25704, R0-1 NS15751] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG HC, 1986, J BIOL CHEM, V261, P989; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; COSTA MRC, 1982, J BIOL CHEM, V257, P7918; COSTA MRC, 1984, J BIOL CHEM, V259, P8210; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; DRUMMOND GI, 1983, ADV CYCLIC NUCL PROT, V15, P373; DUDAI Y, 1988, ANNU REV NEUROSCI, V11, P537, DOI 10.1146/annurev.ne.11.030188.002541; GOTTESMAN MM, 1980, SOMAT CELL GENET, V6, P45, DOI 10.1007/BF01538695; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; JAKOBS KH, 1983, J RECEPTOR RES, V3, P137, DOI 10.3109/10799898309041929; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; LEVITAN IB, 1985, J MEMBRANE BIOL, V87, P177, DOI 10.1007/BF01871217; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; ONO K, 1989, AM J PHYSIOL, V256, pC1131, DOI 10.1152/ajpcell.1989.256.6.C1131; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RESINK TJ, 1983, EUR J BIOCHEM, V133, P455, DOI 10.1111/j.1432-1033.1983.tb07485.x; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; ROSSIE S, 1987, J BIOL CHEM, V262, P12735; ROSSIE S, 1989, J BIOL CHEM, V264, P14220; ROSSIE S, 1987, J BIOL CHEM, V262, P17530; ROSSIE S, 1987, ENZYMES, V18, P335; SARAO R, 1991, NUCLEIC ACIDS RES, V19, P5673, DOI 10.1093/nar/19.20.5673; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHECTERSON LC, 1991, MOL ENDOCRINOL, V5, P170, DOI 10.1210/mend-5-2-170; SCHEUER T, 1990, SCIENCE, V247, P854, DOI 10.1126/science.2154850; SCHRAMM M, 1984, SCIENCE, V225, P1350, DOI 10.1126/science.6147897; SCHUBERT B, 1989, SCIENCE, V245, P516, DOI 10.1126/science.2547248; SCHUBERT B, 1990, AM J PHYSIOL, V258, pH977, DOI 10.1152/ajpheart.1990.258.4.H977; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SORBERA LA, 1991, SCIENCE, V253, P1286, DOI 10.1126/science.1653970; SUZUKI H, 1988, FEBS LETT, V228, P195, DOI 10.1016/0014-5793(88)80615-X; TRAUTWEIN W, 1990, ANNU REV PHYSIOL, V52, P257, DOI 10.1146/annurev.ph.52.030190.001353; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; WEST JW, 1992, NEURON, V8, P59, DOI 10.1016/0896-6273(92)90108-P; YAROWSKY PJ, 1991, P NATL ACAD SCI USA, V88, P9453, DOI 10.1073/pnas.88.21.9453	44	202	206	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1151	1159		10.1016/0896-6273(92)90135-Z	http://dx.doi.org/10.1016/0896-6273(92)90135-Z			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1319185				2022-12-28	WOS:A1992JA42900014
J	KLEIN, R; LAMBALLE, F; BRYANT, S; BARBACID, M				KLEIN, R; LAMBALLE, F; BRYANT, S; BARBACID, M			THE TRKB TYROSINE PROTEIN-KINASE IS A RECEPTOR FOR NEUROTROPHIN-4	NEURON			English	Article							NERVE GROWTH-FACTOR; MOLECULAR-CLONING; FACTOR FAMILY; EXPRESSION; BRAIN; GENE; DOMAIN; CELLS; MEMBER; DNA	Neurotrophin-4 is a novel member of the nerve growth factor family of neurotrophins recently isolated from Xenopus and viper DNA. We now report that the Xenopus NT-4 protein (XNT-4) can mediate some of its biological properties through gp 145trkB, a murine tyrosine protein kinase previously identified as a primary receptor for the related brain-derived neurotrophic factor (BDNF). XNT-4 displaces I-125-labeled BDNF from binding to cells expressing gp 145trkB receptors, induces their rapid phosphorylation on tyrosine residues, and causes the morphologic transformation of NIH 3T3 cells when coexpressed with gp 145trkB. Moreover, XNT-4 induces the differentiation of PC12 cells into sympathetic-like neurons only if they ectopically express gp 145trkB receptors. None of these biochemical or biological effects could be observed when XNT-4 was added to cells expressing the related receptors. Replacement of one of the extracellular cysteines (Cys-345) of gp 145trkB by a serine residue prevents its activation by XNT-4 but not by BDNF. Therefore, XNT-4 and BDNF may interact with at least partially distinct domains within the gp 145trkB receptor.			KLEIN, R (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT MOLEC BIOL,PRINCETON,NJ 08543, USA.		Klein, Ruediger/C-6147-2008; Lamballe, Fabienne/P-4293-2017; Lamballe, Fabienne/GLT-0820-2022	Klein, Ruediger/0000-0002-3109-0163; Lamballe, Fabienne/0000-0001-7631-942X				BARBACID M, 1991, CANCER, V1072, P115; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; COULIER F, 1990, MOL CELL BIOL, V10, P4202, DOI 10.1128/MCB.10.8.4202; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LUCKOW VA, 1988, VIROLOGY, V167, P56, DOI 10.1016/0042-6822(88)90054-2; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MULLER SR, 1990, DNA CELL BIOL, V9, P221, DOI 10.1089/dna.1990.9.221; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER R, 1991, ONCOGENE, V6, P1807; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; SUMMERS MD, 1987, B TEXAS AGR EXPT STA, V1555, P10	44	290	300	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					947	956		10.1016/0896-6273(92)90209-V	http://dx.doi.org/10.1016/0896-6273(92)90209-V			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1375038				2022-12-28	WOS:A1992HV46700014
J	BETTLER, B; EGEBJERG, J; SHARMA, G; PECHT, G; HERMANSBORGMEYER, I; MOLL, C; STEVENS, CF; HEINEMANN, S				BETTLER, B; EGEBJERG, J; SHARMA, G; PECHT, G; HERMANSBORGMEYER, I; MOLL, C; STEVENS, CF; HEINEMANN, S			CLONING OF A PUTATIVE GLUTAMATE RECEPTOR - A LOW AFFINITY KAINATE-BINDING SUBUNIT	NEURON			English	Article							AMINO-ACID RECEPTORS; CENTRAL NERVOUS-SYSTEM; KAINIC ACID; RAT-BRAIN; FUNCTIONAL EXPRESSION; AUTORADIOGRAPHIC LOCALIZATION; QUANTITATIVE AUTORADIOGRAPHY; H-3 AMPA; SITES; NEUROTOXICITY	Kainate, a glutamate receptor agonist, is a potent neuroexcitatory agent that produces epileptiform activity and selective neuronal degeneration. Binding studies using neuronal membrane homogenates or brain sections have identified sites having either high or low affinity for [H-3]kainate. Here we report the cloning of a gene, GluR7, with approximately 75% sequence identity with the previously cloned GluR5 and GluR6 subunit genes. Transcripts of the GluR7 gene are evident in brain areas that bind [H-3]kainate and are susceptible to kainate-induced neurotoxicity. We have performed ligand binding studies with membranes of transfected HeLa cells expressing GluR6 or GluR7 subunits. Our data show that the GluR6 and GluR7 subunits have a rank order of agonist affinity (domoate > kainate >> L-glutamate, quisqualate >> AMPA, NMDA) and a dissociation constant for kainate (95 and 77 nM, respectively) characteristic of the low affinity kainate-binding sites described in the brain.	SALK INST BIOL STUDIES, HOWARD HUGHES MED INST, LA JOLLA, CA 92037 USA; UNIV CALIF SAN DIEGO, DEPT NEUROSCI, LA JOLLA, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	BETTLER, B (corresponding author), SALK INST BIOL STUDIES, MOLEC NEUROBIOL LAB, LA JOLLA, CA 92037 USA.		bettler, bernhard/AAO-8018-2020	Bettler, Bernhard/0000-0003-0842-8207	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028709, R01NS011549] Funding Source: NIH RePORTER; NINDS NIH HHS [NS28709-01, NS11549] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Carpenter S, 1990, Can Dis Wkly Rep, V16 Suppl 1E, P73; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COLQUHOUN D, 1979, RECEPTORS, V1, P93; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; COYLE JT, 1983, J NEUROCHEM, V41, P1; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; DENERIS ES, 1991, TRENDS PHARMACOL SCI, V12, P34, DOI 10.1016/0165-6147(91)90486-C; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P379; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; FOSTER AC, 1984, BRAIN RES REV, V7, P103, DOI 10.1016/0165-0173(84)90020-1; FOSTER AC, 1981, NATURE, V289, P73, DOI 10.1038/289073a0; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; HAMPSON DR, 1987, J NEUROCHEM, V49, P1209, DOI 10.1111/j.1471-4159.1987.tb10012.x; HAMPSON DR, 1988, J BIOL CHEM, V263, P2500; HENKE H, 1981, BRAIN RES, V219, P95, DOI 10.1016/0006-8993(81)90270-5; HERNDON RM, 1980, NEUROSCIENCE, V5, P1015, DOI 10.1016/0306-4522(80)90182-7; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; KROGSGAARDLARSEN P, 1980, NATURE, V284, P64, DOI 10.1038/284064a0; LONDON ED, 1979, MOL PHARMACOL, V15, P492; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MONAGHAN DT, 1984, BRAIN RES, V324, P160, DOI 10.1016/0006-8993(84)90636-X; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MONAGHAN DT, 1983, NATURE, V306, P176, DOI 10.1038/306176a0; MONAGHAN DT, 1985, BRAIN RES, V340, P378, DOI 10.1016/0006-8993(85)90936-9; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; NADLER JV, 1980, BRAIN RES, V195, P47; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; OBRIEN RJ, 1986, J NEUROSCI, V6, P3275; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P162, DOI 10.1152/jn.1989.61.1.162; OLNEY JW, 1974, BRAIN RES, V77, P507, DOI 10.1016/0006-8993(74)90640-4; OLSEN RW, 1987, BRAIN RES, V402, P243, DOI 10.1016/0006-8993(87)90030-8; RAINBOW TC, 1984, BRAIN RES, V309, P173, DOI 10.1016/0006-8993(84)91025-4; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SCHWARCZ R, 1979, LIFE SCI, V24, P1471, DOI 10.1016/0024-3205(79)90030-4; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; SHINOZAKI H, 1970, Brain Research, V24, P368, DOI 10.1016/0006-8993(70)90122-8; SIMON JR, 1976, J NEUROCHEM, V26, P141; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; SOMMER B, 1991, CELL, V67, P1; UNNERSTALL JR, 1983, EUR J PHARMACOL, V86, P361, DOI 10.1016/0014-2999(83)90185-1; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WATKINS JC, 1987, TRENDS NEUROSCI, V10, P265, DOI 10.1016/0166-2236(87)90171-8; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; YOUNG AB, 1990, TRENDS PHARMACOL SCI, V11, P126, DOI 10.1016/0165-6147(90)90199-I	61	321	330	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1992	8	2					257	265		10.1016/0896-6273(92)90292-L	http://dx.doi.org/10.1016/0896-6273(92)90292-L			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1371217				2022-12-28	WOS:A1992HE93000006
J	LANDMESSER, L; SWAIN, S				LANDMESSER, L; SWAIN, S			TEMPORAL AND SPATIAL MODULATION OF A CYTOSKELETAL ANTIGEN DURING PERIPHERAL AXONAL PATHFINDING	NEURON			English	Article							MONOCLONAL-ANTIBODIES DISTINGUISH; MOTONEURON PROJECTION PATTERNS; DEPENDENT PROTEIN-KINASE; GANGLION-CELL NEURONS; CHICK VISUAL-SYSTEM; NEUROFILAMENT PROTEINS; POSTTRANSLATIONAL MODIFICATION; PHOSPHORYLATION STATE; NERVOUS-SYSTEM; MAMMALIAN NEUROFILAMENTS	A neuron-specific cytoskeletal antigen (5E10), whose expression pattern during initial motoneuron outgrowth into the chick limb suggests that it is playing a role in axon guidance, is described. This antigen, which was shown to be a phosphorylated epitope, probably of the intermediate weight neurofilament protein (NF-M), exhibits a highly stereotyped and spatially heterogeneous pattern of expression. The point of onset of expression, which was abrupt and occurred in the distal axon and base of the growth cone, differed between groups of neurons that projected to different targets. Specifically, expression occurred from positions where previous perturbation experiments suggested that the axons in question would begin responding to specific guidance cues, and it remained high along the axon from this point to the target. Expression of this antigen could also be induced in cultured motoneurons by activating several second messenger systems.			LANDMESSER, L (corresponding author), UNIV CONNECTICUT,DEPT PHYSIOL & NEUROBIOL,STORRS,CT 06269, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019640, T32NS007324] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 19640, T32 NS07324] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamburg J. R., 1991, NEURONAL CYTOSKELETO, P121; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; BASTIANI MJ, 1985, TRENDS NEUROSCI, V8, P257, DOI 10.1016/0166-2236(85)90099-2; BENNETT GS, 1984, BRAIN RES, V304, P291, DOI 10.1016/0006-8993(84)90333-0; BENNETT GS, 1985, J CELL BIOL, V100, P1799, DOI 10.1083/jcb.100.5.1799; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; BURN P, 1988, P NATL ACAD SCI USA, V85, P497, DOI 10.1073/pnas.85.2.497; CARDEN MJ, 1985, J BIOL CHEM, V260, P9805; CARDEN MJ, 1987, J NEUROSCI, V7, P3489; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; CLARK E, 1991, J NEUROCHEM, V52, P802; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EISEN JS, 1989, NEURON, V2, P1097, DOI 10.1016/0896-6273(89)90234-1; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; EYER J, 1988, BIOCHEM J, V252, P655, DOI 10.1042/bj2520655; FERGUSON BA, 1983, J NEUROSCI, V3, P1760; FRELINGER AL, 1986, J CELL BIOL, V103, P1729, DOI 10.1083/jcb.103.5.1729; GEORGES E, 1986, J NEUROCHEM, V47, P477; GO MJ, 1989, DEV BIOL, V134, P85, DOI 10.1016/0012-1606(89)90080-8; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HIROKAWA N, 1988, J NEUROSCI, V8, P2769; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; HISANAGA S, 1989, J NEUROSCI, V9, P959; HISANAGA S, 1990, J BIOL CHEM, V265, P21852; HOLLYDAY M, 1983, LIMB DEV REGENERAT A, P183; JULIEN JP, 1981, J NEUROCHEM, V37, P1579, DOI 10.1111/j.1471-4159.1981.tb06330.x; JULIEN JP, 1983, J BIOL CHEM, V258, P4019; JULIEN JP, 1983, BIOCHIM BIOPHYS ACTA, V755, P25, DOI 10.1016/0304-4165(83)90268-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANCEJONES C, 1981, P ROY SOC LOND B BIO, V214, P119; LANCEJONES CC, 1986, DEV BIOL, V116, P387, DOI 10.1016/0012-1606(86)90141-7; Lankford K, 1990, CURR OPIN CELL BIOL, V2, P80, DOI 10.1016/S0955-0674(05)80035-3; LEE VMY, 1987, J NEUROSCI, V7, P3474; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P1998, DOI 10.1073/pnas.85.6.1998; LETERRIER JF, 1981, J CELL BIOL, V90, P755, DOI 10.1083/jcb.90.3.755; LEWIS SE, 1988, J CELL BIOL, V107, P2689, DOI 10.1083/jcb.107.6.2689; LINDENBAUM MH, 1987, J BIOL CHEM, V262, P605; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; MATTHEW WD, 1987, J IMMUNOL METHODS, V100, P73, DOI 10.1016/0022-1759(87)90174-8; MEIRI KF, 1991, J CELL BIOL, V112, P991, DOI 10.1083/jcb.112.5.991; MINAMI Y, 1985, FEBS LETT, V185, P239, DOI 10.1016/0014-5793(85)80914-5; MYERS MW, 1987, EMBO J, V6, P1617, DOI 10.1002/j.1460-2075.1987.tb02409.x; NAKAMURA Y, 1990, BIOCHEM BIOPH RES CO, V169, P744, DOI 10.1016/0006-291X(90)90394-3; NAPOLITANO EW, 1987, J NEUROSCI, V7, P2590; NIXON RA, 1986, J BIOL CHEM, V261, P6298; NIXON RA, 1986, J CELL BIOL, V102, P647, DOI 10.1083/jcb.102.2.647; NIXON RA, 1982, J CELL BIOL, V94, P150, DOI 10.1083/jcb.94.1.150; NIXON RA, 1987, J NEUROSCI, V7, P1145; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; PAPASOZOMENOS SC, 1987, CELL MOTIL CYTOSKEL, V8, P210, DOI 10.1002/cm.970080303; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PLACZEK M, 1990, DEVELOPMENT, V110, P19; POO M, 1992, NERVE GROWTH CONE, P231; QWARNSTROM EE, 1991, P NATL ACAD SCI USA, V88, P1232, DOI 10.1073/pnas.88.4.1232; RUNGE MS, 1981, BIOCHEMISTRY-US, V20, P175, DOI 10.1021/bi00504a029; SATOYOSHITAKE R, 1989, NEURON, V3, P229, DOI 10.1016/0896-6273(89)90036-6; SCHLAEPFER WW, 1985, J NEUROCHEM, V44, P502, DOI 10.1111/j.1471-4159.1985.tb05442.x; SHAW G, 1991, NEURONAL CYTOSKELETO, P185; SIHAG RK, 1989, J BIOL CHEM, V264, P457; SIHAG RK, 1990, J BIOL CHEM, V265, P4166; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; TORUDELBAUFFE D, 1986, BIOCHEM J, V235, P283, DOI 10.1042/bj2350283; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1985, J NEUROSCI, V5, P2336; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; TOSNEY KW, 1984, J NEUROSCI, V4, P2518; VALLANO ML, 1985, BIOCHEM BIOPH RES CO, V130, P957, DOI 10.1016/0006-291X(85)91708-5; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; WIBLE BA, 1989, P NATL ACAD SCI USA, V86, P720, DOI 10.1073/pnas.86.2.720; ZIPSER B, 1989, NEURON, V3, P621, DOI 10.1016/0896-6273(89)90272-9; ZOPF D, 1987, GENE DEV, V1, P699, DOI 10.1101/gad.1.7.699	76	32	33	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1992	8	2					291	305		10.1016/0896-6273(92)90296-P	http://dx.doi.org/10.1016/0896-6273(92)90296-P			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1371220				2022-12-28	WOS:A1992HE93000010
J	WILLIAMS, BP; READ, J; PRICE, J				WILLIAMS, BP; READ, J; PRICE, J			THE GENERATION OF NEURONS AND OLIGODENDROCYTES FROM A COMMON PRECURSOR CELL	NEURON			English	Article							RAT OPTIC-NERVE; MEDIATED GENE-TRANSFER; GLIAL PROGENITOR-CELL; RECOMBINANT RETROVIRUS; MONOCLONAL-ANTIBODIES; CEREBRAL-CORTEX; CLONAL ANALYSIS; LINEAGE; ASTROCYTES; INVITRO	We have used a recombinant retrovirus carrying the lacZ gene to study the developmental potential of precursor cells from the embryonic rat cerebral cortex in dissociated cell culture. Virus was used to label a small number of cultured cells genetically so that their fate could be determined. Infected clones were detected with an anti-beta-galactosidase serum, and the labeled cells were identified using monoclonal antibodies. The results revealed that most precursor cells generated a single cell type, the majority being either neurons or oligodendrocytes. However, a proportion of the neuronal clones also included oligodendrocytes. This proportion increased until embryonic day 16 when 18% of the neuronal clones were of this type. This suggests that during neurogenesis in the cerebral cortex there exists a cell with the potential to generate these two quite different neural cell types.			WILLIAMS, BP (corresponding author), NATL INST MED RES,EMBRYOGENESIS LAB,RIDGEWAY,MILL HILL,LONDON NW7 1AA,ENGLAND.		Messier, Claude/A-2322-2008; Price, Jack/G-9510-2011	Messier, Claude/0000-0002-4791-1763; Williams, Brenda Patricia/0000-0003-4690-5932				BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BINDER LI, 1986, ANN NY ACAD SCI, V466, P145, DOI 10.1111/j.1749-6632.1986.tb38392.x; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; CEPKO C, 1988, NEURON, V1, P345, DOI 10.1016/0896-6273(88)90184-5; CURTIS R, 1988, J NEUROCYTOL, V17, P43, DOI 10.1007/BF01735376; DUBOISDALCQ M, 1987, EMBO J, V6, P2587, DOI 10.1002/j.1460-2075.1987.tb02549.x; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GARNER CC, 1988, J NEUROCHEM, V50, P609, DOI 10.1111/j.1471-4159.1988.tb02954.x; GRINSPAN JB, 1990, J NEUROSCI, V10, P1866; HARDY R, 1991, DEVELOPMENT, V111, P1061; INGRAHAM CA, 1989, J NEUROSCI, V9, P63; LEBER SM, 1990, J NEUROSCI, V10, P2451; LILLIEN LE, 1988, NEURON, V1, P485, DOI 10.1016/0896-6273(88)90179-1; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MILLER MW, 1986, SCIENCE, V233, P1308, DOI 10.1126/science.3749878; NOBLE M, 1984, EMBO J, V3, P2243, DOI 10.1002/j.1460-2075.1984.tb02122.x; PRICE J, 1988, DEVELOPMENT, V104, P473; PRICE J, 1987, DEVELOPMENT, V101, P409; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SKOFF RP, 1990, DEV BIOL, V139, P149, DOI 10.1016/0012-1606(90)90285-Q; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VAYSSE PJJ, 1990, NEURON, V5, P227, DOI 10.1016/0896-6273(90)90160-H; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; WILLIAMS BP, 1985, DEV BIOL, V112, P126, DOI 10.1016/0012-1606(85)90126-5; WOOD JN, 1981, BIOSCIENCE REP, V1, P263, DOI 10.1007/BF01114913	35	220	223	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1991	7	4					685	693		10.1016/0896-6273(91)90381-9	http://dx.doi.org/10.1016/0896-6273(91)90381-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1931054				2022-12-28	WOS:A1991GM95400017
J	CHITNIS, AB; KUWADA, JY				CHITNIS, AB; KUWADA, JY			ELIMINATION OF A BRAIN TRACT INCREASES ERRORS IN PATHFINDING BY FOLLOWER GROWTH CONES IN THE ZEBRAFISH EMBRYO	NEURON			English	Article							IDENTIFIED MOTONEURONS; NEURONAL DEVELOPMENT; FASCICLIN-II; EXPRESSION; OUTGROWTH; GUIDANCE	The early zebrafish brain contains a simple axon scaffold of longitudinal tracts connected by commissures. Neurons in the nucleus of the posterior commissure (nuc PC) project growth cones along a specific route in this axonal scaffold, raising the possibility that specific axons in the early scaffold guide nuc PC growth cones. We tested this possibility by analyzing the behavior of nuc PC growth cones in embryos in which a portion of the scaffold, normally traversed by nuc PC growth cones, was surgically prevented from forming. Under these conditions nuc PC growth cones extended along both normal and aberrant pathways. This suggests that specific axons do provide guidance cues, since their removal leads to errors. However, these cues are not obligatory, since some growth cones still followed normal pathways.	UNIV MICHIGAN,DEPT BIOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,INST GERONTOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	CHITNIS, AB (corresponding author), UNIV MICHIGAN,NEUROSCI PROGRAM,ANN ARBOR,MI 48109, USA.		Kuwada, John Y/B-1447-2009		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024848] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24848] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS JC, 1981, J HISTOCHEM CYTOCHEM, V29, P775, DOI 10.1177/29.6.7252134; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BERNHARDT RR, 1990, J COMP NEUROL, V302, P607; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HARRIS WA, 1989, NATURE, V339, P218, DOI 10.1038/339218a0; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Kirchen R. V, 1976, JAPANESE MEDAKA ITS; KUWADA JY, 1990, J COMP NEUROL, V302, P617, DOI 10.1002/cne.903020316; LUMSDEN AGS, 1988, MAKING NERVOUS SYSTE, P166; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; MYERS PZ, 1986, J NEUROSCI, V6, P2278; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Raper J.A., 1988, P188; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; WILSON SW, 1990, DEVELOPMENT, V108, P121	23	53	53	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					277	285		10.1016/0896-6273(91)90266-3	http://dx.doi.org/10.1016/0896-6273(91)90266-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1873031	Green Submitted			2022-12-28	WOS:A1991GB93300011
J	DIHANICH, M; KASER, M; REINHARD, E; CUNNINGHAM, D; MONARD, D				DIHANICH, M; KASER, M; REINHARD, E; CUNNINGHAM, D; MONARD, D			PROTHROMBIN MESSENGER-RNA IS EXPRESSED BY CELLS OF THE NERVOUS-SYSTEM	NEURON			English	Article							PROTEASE INHIBITORY ACTIVITY; GLIA-DERIVED-NEXIN; NEURITE-PROMOTING FACTOR; ALZHEIMERS-DISEASE; BLOOD-COAGULATION; SERINE-PROTEASES; THROMBIN; OUTGROWTH; PRECURSOR; BRAIN	Thrombin, a serine protease of the blood coagulation system, has additional effects on cells in vitro. It is mitogenic for fibroblasts and astrocytes and contributes to the regulation of neurite outgrowth and astrocyte stellation. Until now the expression of thrombin or its precursor prothrombin in tissues other than liver has not been demonstrated conclusively because of difficulty in avoiding serum contamination. Using sensitive mRNA detection methods, we show here that prothrombin is expressed not only in the liver, but also in the brain throughout development. Polymerase chain reaction, Northern, and in situ hybridization studies demonstrate the presence of prothrombin transcripts in the olfactory bulb, the cortex, the cerebellum, and other regions of the rat and human nervous system, as well as in neural cell lines. These results support an involvement of (pro)thrombin in the regulation of cellular events in the nervous system.	UNIV CALIF IRVINE,DEPT MICROBIOL & MOLEC GENET,IRVINE,CA 92717	University of California System; University of California Irvine	DIHANICH, M (corresponding author), FRIEDRICH MIESCHER INST,CH-4002 BASEL,SWITZERLAND.							ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; CAVANAUGH KP, 1990, J NEUROCHEM, V54, P1735, DOI 10.1111/j.1471-4159.1990.tb01228.x; CHEN LB, 1975, P NATL ACAD SCI USA, V72, P131, DOI 10.1073/pnas.72.1.131; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Davie E W, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P277; DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P6165, DOI 10.1021/bi00393a033; DIHANICH M, 1990, NUCLEIC ACIDS RES, V18, P4251, DOI 10.1093/nar/18.14.4251; Fenton J W 2nd, 1981, Ann N Y Acad Sci, V370, P468, DOI 10.1111/j.1749-6632.1981.tb29757.x; FENTON JW, 1987, CONTROL ANIMAL CELL, V2, P133; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FURIE B, 1982, J BIOL CHEM, V257, P3875; Gilliland G., 1990, PCR PROTOCOLS GUIDE, P60; GLOOR S, 1986, CELL, V47, P687; GRAND RJA, 1989, EMBO J, V8, P2209, DOI 10.1002/j.1460-2075.1989.tb08344.x; GUENTHER J, 1985, EMBO J, V4, P1963, DOI 10.1002/j.1460-2075.1985.tb03878.x; GURWITZ D, 1988, P NATL ACAD SCI USA, V85, P3440, DOI 10.1073/pnas.85.10.3440; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; MAHMOUDI M, 1989, BIOTECHNIQUES, V7, P332; Maniatis T., 1982, MOL CLONING; MCGUIRE PG, 1990, NEURON, V4, P633, DOI 10.1016/0896-6273(90)90121-U; MEIER R, 1989, NATURE, V342, P548, DOI 10.1038/342548a0; MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8; MONARD D, 1983, PROG BRAIN RES, V58, P359, DOI 10.1016/S0079-6123(08)60037-0; PIGUET V, 1985, SPRINGER SEMIN IMMUN, V8, P111, DOI 10.1007/BF00197250; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; REINHARD E, 1988, NEURON, V1, P387, DOI 10.1016/0896-6273(88)90188-2; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; WAGNER SL, 1989, P NATL ACAD SCI USA, V86, P8284, DOI 10.1073/pnas.86.21.8284; WALLACE A, 1989, BIOCHEM J, V257, P191, DOI 10.1042/bj2570191	31	322	325	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					575	581		10.1016/0896-6273(91)90060-D	http://dx.doi.org/10.1016/0896-6273(91)90060-D			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	2015093				2022-12-28	WOS:A1991FH80200009
J	BROWN, MC; PERRY, VH; LUNN, ER; GORDON, S; HEUMANN, R				BROWN, MC; PERRY, VH; LUNN, ER; GORDON, S; HEUMANN, R			MACROPHAGE DEPENDENCE OF PERIPHERAL SENSORY NERVE REGENERATION - POSSIBLE INVOLVEMENT OF NERVE GROWTH-FACTOR	NEURON			English	Article							SCHWANN-CELLS; SCIATIC-NERVE; FACTOR RECEPTORS; NEONATAL RATS; AXONS; NEURONS; EXPRESSION; INJURY; INVIVO; ADULT	The levels of NGF and NGF receptor mRNA, the degree of macrophage recruitment, and the ability of sensory and motor axons to regenerate were measured in C57BL/Ola mice, in which Wallerian degeneration following a nerve lesion is very slow. Results were compared with those from C57BL/6J and BALB/c mice, in which degeneration is normal. We found that in C57BL/Ola mice, apart from the actual lesion site, recruitment of macrophages was much lower, levels of mRNA for both NGF and its receptor were raised only slightly above normal, and sensory axon regeneration was much impaired. Motor axons regenerated quite well. These results provide in vivo evidence that macrophage recruitment is an important component of NGF synthesis and of sensory (but not motor) axon maintenance and regrowth.	DEPT EXPTL PSYCHOL, OXFORD OX1 3UD, ENGLAND; UNIV OXFORD, OXFORD OX1 3RE, ENGLAND; MAX PLANCK INST PSYCHIAT, NEUROCHEM ABT, W-8033 MARTINSRIED, GERMANY	University of Oxford; Max Planck Society	BROWN, MC (corresponding author), UNIV OXFORD, PHYSIOL LAB, PK RD, OXFORD OX1 3PT, ENGLAND.		Heumann, Rolf/AAK-4390-2020; Heumann, Rolf/ABB-9675-2021; Perry, V. Hugh/Y-2935-2019	Heumann, Rolf/0000-0003-4364-2655; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALDSKOGIUS H, 1985, BRAIN RES REV, V10, P27, DOI 10.1016/0165-0173(85)90006-2; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BANDTLOW CE, 1987, EMBO J, V6, P891, DOI 10.1002/j.1460-2075.1987.tb04835.x; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; BEUCHE W, 1984, J NEUROCYTOL, V13, P767, DOI 10.1007/BF01148493; BISBYU MA, 1974, BRAIN RES, V148, P441; CORNBROOKS CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3850, DOI 10.1073/pnas.80.12.3850; DAVIES AM, 1986, DEV BIOL, V115, P56, DOI 10.1016/0012-1606(86)90227-7; DIAMOND J, 1987, P NATL ACAD SCI USA, V84, P6596, DOI 10.1073/pnas.84.18.6596; ENFORS P, 1989, NEURON, V2, P1605; HALL SM, 1977, NEUROPATH APPL NEURO, V3, P65, DOI 10.1111/j.1365-2990.1977.tb00570.x; HALL SM, 1986, NEUROPATH APPL NEURO, V12, P401, DOI 10.1111/j.1365-2990.1986.tb00151.x; HENGERER B, 1990, P NATL ACAD SCI USA, V87, P3899, DOI 10.1073/pnas.87.10.3899; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; HEUMANN R, 1986, J BIOL CHEM, V261, P9246; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; HEUMANN R, 1990, ADV NEURAL REGENERAT; HIMES BT, 1989, J COMP NEUROL, V284, P215, DOI 10.1002/cne.902840206; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; IGNATIUS MJ, 1987, SCIENCE, V236, P959, DOI 10.1126/science.3576212; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; KUFFLER DP, 1986, J COMP NEUROL, V249, P57, DOI 10.1002/cne.902490106; Langley JN, 1904, J PHYSIOL-LONDON, V31, P365; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LINDHOLM D, 1990, EUR J NEUROSCI, V2, P795, DOI 10.1111/j.1460-9568.1990.tb00471.x; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; LUNDBORG G, 1982, BRAIN RES, V232, P157, DOI 10.1016/0006-8993(82)90618-7; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; MIRSKY R, 1986, J NEUROCYTOL, V15, P799, DOI 10.1007/BF01625196; OWEN DJ, 1989, BRAIN RES, V476, P248, DOI 10.1016/0006-8993(89)91245-6; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; PERRY VH, 1990, EUR J NEUROSCI, V2, P802, DOI 10.1111/j.1460-9568.1990.tb00472.x; POLITIS MJ, 1982, BRAIN RES, V253, P1, DOI 10.1016/0006-8993(82)90667-9; Ramon y Cajal S., 1928, DEGENERATION REGENER; RICH KM, 1984, J COMP NEUROL, V230, P110, DOI 10.1002/cne.902300110; RICH KM, 1989, EXP NEUROL, V105, P162, DOI 10.1016/0014-4886(89)90115-5; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; SANDROCK AW, 1987, BRAIN RES, V425, P360, DOI 10.1016/0006-8993(87)90520-8; SEKIYA S, 1986, J NEUROSCI, V6, P2019; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SKETELJ J, 1989, J NEUROSCI RES, V24, P153, DOI 10.1002/jnr.490240205; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; TANIUCHI M, 1988, J NEUROSCI, V8, P664; VERGE VMK, 1989, J NEUROCYTOL, V18, P583, DOI 10.1007/BF01187079; XIN L, 1990, BRAIN RES, V510, P144, DOI 10.1016/0006-8993(90)90741-S	46	291	293	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1991	6	3					359	370		10.1016/0896-6273(91)90245-U	http://dx.doi.org/10.1016/0896-6273(91)90245-U			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1848079				2022-12-28	WOS:A1991FC47000005
J	GIFFIN, K; SOLOMON, JS; BURKHALTER, A; NERBONNE, JM				GIFFIN, K; SOLOMON, JS; BURKHALTER, A; NERBONNE, JM			DIFFERENTIAL EXPRESSION OF VOLTAGE GATED CALCIUM CHANNELS IN IDENTIFIED VISUAL CORTICAL-NEURONS	NEURON			English	Article							NEOCORTICAL NEURONS; SENSORY NEURONS; CORTEX; RAT; INVITRO; CELLS; CULTURE; MORPHOLOGY; MARKERS; LAYERS	Using the whole-cell patch-clamp technique, Ca2+ channel currents were examined in three distinct types of neurons derived from rat primary visual cortex. Callosal-projecting and superior colliculus-projecting neurons were identified following in vivo retrograde labeling with fluorescent "beads." A subset of intrinsic GABAergic visual cortical neurons was identified with the monoclonal antibody VC1.1. Although high voltage-activated Ca2+ channel currents were measured in all three cell types, clear differences in the densities of these channels were observed. There were also marked variations in the relative amplitudes of the inactivating and noninactivating components of the high voltage-activated currents, suggesting that N- and L-type Ca2+ channels are differentially distributed. Although low voltage-activated or T-type currents were measured in subsets of both types of projection neurons, they were not observed in VC1.1-positive cells. These results provide a direct demonstration that voltage-gated Ca2+ channels are expressed in neurons of the mammalian visual cortex and reveal that the distributions and densities of different Ca2+ channel types in diverse classes of visual cortical neurons are distinct.	WASHINGTON UNIV,SCH MED,DEPT NEUROSURG,ST LOUIS,MO 63110	Washington University (WUSTL)	GIFFIN, K (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PHARMACOL,ST LOUIS,MO 63110, USA.		Tuluc, Petronel/C-2527-2011		NHLBI NIH HHS [T32-HL07275] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGMON A, 1989, NEUROSCI LETT, V99, P137, DOI 10.1016/0304-3940(89)90278-4; ARIMATSU Y, 1987, J NEUROSCI, V7, P1250; ARTOLA A, 1990, EUR J NEUROSCI, V2, P254, DOI 10.1111/j.1460-9568.1990.tb00417.x; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BRAY D, 1970, P NATL ACAD SCI USA, V65, P905, DOI 10.1073/pnas.65.4.905; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P547, DOI 10.1113/jphysiol.1987.sp016551; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; DICHTER MA, 1983, BRAIN RES, V289, P99, DOI 10.1016/0006-8993(83)90010-0; ECKERT R, 1984, PROG BIOPHYS MOL BIO, V44, P215, DOI 10.1016/0079-6107(84)90009-9; FRANZ P, 1986, BRAIN RES, V366, P262, DOI 10.1016/0006-8993(86)91303-X; FRIEDMAN A, 1987, NEUROSCI LETT, V81, P117, DOI 10.1016/0304-3940(87)90350-8; GALVAN M, 1986, EXP BRAIN RES SER, V14, P61; GEIGER H, 1986, EXPL BRAIN RES SER, V14, P256; GOTTLIEB DI, 1986, P NATL ACAD SCI USA, V83, P8808, DOI 10.1073/pnas.83.22.8808; HAGIWARA S, 1981, ANNU REV NEUROSCI, V4, P69, DOI 10.1146/annurev.ne.04.030181.000441; HALLMAN LE, 1988, J COMP NEUROL, V272, P149, DOI 10.1002/cne.902720111; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS NC, 1989, EXP BRAIN RES, V74, P411; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; HUETTNER JE, 1988, J NEUROSCI, V8, P160; KATZ LC, 1990, NEUROSCIENCE, V34, P511, DOI 10.1016/0306-4522(90)90159-2; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; LARKMAN A, 1990, J NEUROSCI, V10, P1407; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P569, DOI 10.1113/jphysiol.1981.sp013764; LOVINGER DM, 1989, NEUROSCI LETT, V102, P50, DOI 10.1016/0304-3940(89)90306-6; MASON A, 1990, ELECTROPHYSIOLOGY J, V10, P1415; MCCLESKEY EW, 1986, J EXP BIOL, V124, P177; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V393, P743, DOI 10.1113/jphysiol.1987.sp016851; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; NAEGELE JR, 1988, J NEUROSCI, V8, P79; NAEGELE JR, 1989, TRENDS NEUROSCI, V12, P28, DOI 10.1016/0166-2236(89)90153-7; OLAVARRIA J, 1985, J COMP NEUROL, V239, P1, DOI 10.1002/cne.902390102; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PETERS A, 1990, J COMP NEUROL, V302, P124, DOI 10.1002/cne.903020110; PRINCE DA, 1986, EXP BRAINR ES SER, V14, P318; PUMAIN R, 1986, EXP BRAIN RES SER, V14, P345; RAFF MC, 1979, BRAIN RES, V174, P283, DOI 10.1016/0006-8993(79)90851-5; SCHOFIELD BR, 1987, J COMP NEUROL, V261, P85, DOI 10.1002/cne.902610107; SEFTON AJ, 1981, BRAIN RES, V215, P1, DOI 10.1016/0006-8993(81)90487-X; SINGER W, 1985, VISION RES, V25, P389, DOI 10.1016/0042-6989(85)90064-1; SUTOR B, 1987, PFLUG ARCH EUR J PHY, V410, P102, DOI 10.1007/BF00581902; SWANDULLA D, 1988, J GEN PHYSIOL, V92, P197, DOI 10.1085/jgp.92.2.197; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; WHITE G, 1989, P NATL ACAD SCI USA, V86, P6802, DOI 10.1073/pnas.86.17.6802; WOLFSON B, 1989, EXP BRAIN RES, V76, P122; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; ZILLES K, 1984, J COMP NEUROL, V226, P391, DOI 10.1002/cne.902260308	50	45	45	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					321	332		10.1016/0896-6273(91)90242-R	http://dx.doi.org/10.1016/0896-6273(91)90242-R			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1848078				2022-12-28	WOS:A1991FC47000002
J	LO, DC; PINKHAM, JL; STEVENS, CF				LO, DC; PINKHAM, JL; STEVENS, CF			ROLE OF A KEY CYSTEINE RESIDUE IN THE GATING OF THE ACETYLCHOLINE-RECEPTOR	NEURON			English	Article							ALPHA-SUBUNIT; TORPEDO-CALIFORNICA; GLOBULAR-PROTEINS; GAMMA-SUBUNIT; ION CHANNEL; MUSCLE; SITE; COMPRESSIBILITY; SEQUENCE; CURRENTS	We have examined changes in single-channel behavior that result from conservative amino acid substitutions at the Cys230 residue in the putative first transmembrane region (M1) of the murine nicotinic acetylcholine receptor. Mutations made in the gamma subunit altered the energy barrier for a single closing rate constant in proportion to the size of the substituted side chain. One of these substitutions, when made in the alpha subunits, had no effect on gating. No mutations altered permeation. We conclude that the region surrounding the M1 Cys is involved in the gating of the nicotinic acetylcholine receptor and that the gamma subunit contributes significantly to the control of channel closure.	YALE UNIV,SCH MED,MOLEC NEUROBIOL SECT,NEW HAVEN,CT 06510; SALK INST BIOL STUDIES,SAN DIEGO,CA 92186	Yale University; Salk Institute					NINDS NIH HHS [NS12961] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOULTER J, 1985, J NEUROSCI, V5, P2545; BOULTER J, 1986, J NEUROSCI RES, V16, P37, DOI 10.1002/jnr.490160106; BRISSON A, 1985, NATURE, V315, P474, DOI 10.1038/315474a0; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; CLAUDIO T, 1989, FRONTIERS MOL BIOL M, P63; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COX RN, 1985, J BIOL CHEM, V260, P7186; DIPAOLA M, 1990, IN PRESS J BIOL CHEM; GAVISH B, 1983, P NATL ACAD SCI-BIOL, V80, P750, DOI 10.1073/pnas.80.3.750; GEKKO K, 1986, BIOCHEMISTRY-US, V25, P6563, DOI 10.1021/bi00369a034; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; GU Y, 1988, J BIOL CHEM, V263, P12878; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HERMANSBORGMEYER I, 1986, EMBO J, V5, P1503, DOI 10.1002/j.1460-2075.1986.tb04389.x; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JAHR CE, 1990, J NEUROSCI, V10, P1830; KALDANY RRJ, 1983, J BIOL CHEM, V258, P6232; KARLIN A, 1983, J BIOL CHEM, V258, P6678; KARPUSAS M, 1989, P NATL ACAD SCI USA, V86, P8237, DOI 10.1073/pnas.86.21.8237; KELLIS JT, 1988, NATURE, V333, P784, DOI 10.1038/333784a0; KELLIS JT, 1989, BIOCHEMISTRY-US, V28, P4914, DOI 10.1021/bi00437a058; KISTLER J, 1982, BIOPHYS J, V37, P371, DOI 10.1016/S0006-3495(82)84685-7; KUNDROT CE, 1987, J MOL BIOL, V193, P157, DOI 10.1016/0022-2836(87)90634-6; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LO DC, 1990, IN PRESS NEURON; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; MARQUEZ J, 1989, BIOCHEMISTRY-US, V28, P7433, DOI 10.1021/bi00444a042; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; MOSKOVITZ R, 1988, J BIOL CHEM, V263, P1017; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SINE SM, 1986, J PHYSIOL-LONDON, V373, P129, DOI 10.1113/jphysiol.1986.sp016039; TOYOSHIMA C, 1988, NATURE, V336, P247, DOI 10.1038/336247a0; WITZEMANN V, 1987, FEBS LETT, V223, P104, DOI 10.1016/0014-5793(87)80518-5	39	42	42	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1991	6	1					31	40		10.1016/0896-6273(91)90119-K	http://dx.doi.org/10.1016/0896-6273(91)90119-K			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1986773				2022-12-28	WOS:A1991EU27800004
J	MAISONPIERRE, PC; BELLUSCIO, L; FRIEDMAN, B; ALDERSON, RF; WIEGAND, SJ; FURTH, ME; LINDSAY, RM; YANCOPOULOS, GD				MAISONPIERRE, PC; BELLUSCIO, L; FRIEDMAN, B; ALDERSON, RF; WIEGAND, SJ; FURTH, ME; LINDSAY, RM; YANCOPOULOS, GD			NT-3, BDNF, AND NGF IN THE DEVELOPING RAT NERVOUS-SYSTEM - PARALLEL AS WELL AS RECIPROCAL PATTERNS OF EXPRESSION	NEURON			English	Article											MAISONPIERRE, PC (corresponding author), REGENERON PHARMACEUT INC,TARRYTOWN,NY 10591, USA.		Lindsay, Ronald/GQP-8001-2022					ALDERSON RF, 1990, IN PRESS NEURON; ALTMAN J, 1966, J COMP NEUROL, V128, P431, DOI 10.1002/cne.901280404; ALTMAN J, 1982, ADV ANATOMY EMBRYOLO, V74; ALTMAN J, 1984, ADV ANATOMY EMBRYOLO, V85; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Bothwell A., 1990, METHODS CLONING ANAL; BUCK CR, 1988, DEV BRAIN RES, V44, P259, DOI 10.1016/0165-3806(88)90224-6; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; CLEGG DO, 1989, DEV BIOL, V134, P30, DOI 10.1016/0012-1606(89)90075-4; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; HAMBURGER V, 1989, ANNU REV NEUROSCI, V12, P1; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; KOH SY, 1989, J NEUROSCI, V9, P2999; LARGE TH, 1986, SCIENCE, V234, P352, DOI 10.1126/science.3764415; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; MAHMOUDI M, 1989, BIOTECHNIQUES, V7, P331; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; SNIDER WD, 1989, ANN NEUROL, V26, P489, DOI 10.1002/ana.410260402; THOENEN H, 1987, REV PHYSIOL BIOCH P, V109, P145, DOI 10.1007/BFb0031026; WHITTEMORE SR, 1987, BRAIN RES REV, V12, P439, DOI 10.1016/0165-0173(87)90008-7; YAMAMOTO M, 1986, J NEUROSCI, V6, P3576	31	1108	1139	0	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1990	5	4					501	509		10.1016/0896-6273(90)90089-X	http://dx.doi.org/10.1016/0896-6273(90)90089-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED517	1688327				2022-12-28	WOS:A1990ED51700013
J	HOLT, CE; GARLICK, N; CORNEL, E				HOLT, CE; GARLICK, N; CORNEL, E			LIPOFECTION OF CDNAS IN THE EMBRYONIC VERTEBRATE CENTRAL-NERVOUS-SYSTEM	NEURON			English	Article											HOLT, CE (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.			Holt, Christine Elizabeth/0000-0003-2829-121X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023780] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 23780-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTABA AR, 1989, CELL, V57, P317, DOI 10.1016/0092-8674(89)90969-0; BIENZ M, 1984, EMBO J, V3, P2477, DOI 10.1002/j.1460-2075.1984.tb02159.x; CABRERA CV, 1987, CELL, V50, P659, DOI 10.1016/0092-8674(87)90039-0; CHANG ACY, 1989, FOCUS, V10, P66; DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; ETKIN LD, 1987, DEVELOPMENT, V99, P15; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FELGNER PL, 1989, NATURE, V337, P387, DOI 10.1038/337387a0; GIEBELHAUS DH, 1988, CELL, V53, P601, DOI 10.1016/0092-8674(88)90576-4; GIMLICH RL, 1984, DEV BIOL, V104, P117, DOI 10.1016/0012-1606(84)90042-3; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; HOLT C, 1980, NATURE, V287, P850, DOI 10.1038/287850a0; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; JONAS EA, 1989, DEVELOPMENT, V106, P399; KELLER GA, 1987, P NATL ACAD SCI USA, V84, P3264, DOI 10.1073/pnas.84.10.3264; KINTNER C, 1988, NEURON, V1, P545, DOI 10.1016/0896-6273(88)90104-3; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; MARINI NJ, 1988, DEV BIOL, V127, P421, DOI 10.1016/0012-1606(88)90328-4; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327	32	191	203	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1990	4	2					203	214		10.1016/0896-6273(90)90095-W	http://dx.doi.org/10.1016/0896-6273(90)90095-W			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT254	1689586				2022-12-28	WOS:A1990CT25400003
J	GHIRARDI, M; BRAHA, O; HOCHNER, B; MONTAROLO, PG; KANDEL, ER; DALE, N				GHIRARDI, M; BRAHA, O; HOCHNER, B; MONTAROLO, PG; KANDEL, ER; DALE, N			ROLES OF PKA AND PKC IN FACILITATION OF EVOKED AND SPONTANEOUS TRANSMITTER RELEASE AT DEPRESSED AND NONDEPRESSED SYNAPSES IN APLYSIA SENSORY NEURONS	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; PRESYNAPTIC FACILITATION; CYCLIC-AMP; BEHAVIORAL SENSITIZATION; SYNAPTIC FACILITATION; SENSORIMOTOR SYNAPSES; WITHDRAWAL REFLEX; GILL-WITHDRAWAL; 2ND MESSENGERS; SEROTONIN	Two second messenger pathways, one that uses the cAMP-dependent protein kinase A (PKA), the other that uses protein kinase C (PKC), have been found to contribute to the short-term presynaptic facilitation of the connections between the sensory neurons in Aplysia and their target cells, the interneurons and motor neurons of the gill-withdrawal reflex. To study their relative contributions as a function of the previous history of the neuron's activity, we have examined the effects of inhibiting PKA (using Rp-cAMPS) and PKC (using H7) on the short-term facilitation of spontaneous release as well as of the evoked release induced by serotonin at nondepressed, partially depressed, and highly depressed synapses. Our results suggest that whereas activation of PKA is sufficient to trigger the facilitation of nondepressed synapses, activation of both PKA and PKC is required to facilitate depressed synapses, with the contribution of PKC becoming progressively more important as synaptic transmission becomes more depressed.	COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032	Columbia University; Howard Hughes Medical Institute; Columbia University	GHIRARDI, M (corresponding author), DIPARTIMENTO ANAT & FISIOL UMANA,C RAFFAELLO 30,I-10125 TURIN,ITALY.		ghirardi, mirella/AEQ-0420-2022; Dale, Nicholas/C-7772-2011	Dale, Nicholas/0000-0003-2196-2949				ABRAMS TW, 1984, P NATL ACAD SCI-BIOL, V81, P7956, DOI 10.1073/pnas.81.24.7956; BAXTER DA, 1990, J NEUROPHYSIOL, V64, P978, DOI 10.1152/jn.1990.64.3.978; BAXTER DA, 1989, J NEUROPHYSIOL, V62, P665, DOI 10.1152/jn.1989.62.3.665; BRAHA O, 1990, P NATL ACAD SCI USA, V87, P2040, DOI 10.1073/pnas.87.5.2040; BRUNELLI M, 1976, SCIENCE, V194, P1178, DOI 10.1126/science.186870; CAREW T J, 1971, International Journal of Neuroscience, V2, P79, DOI 10.3109/00207457109146995; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CONN PJ, 1989, J NEUROSCI, V9, P473; DALE N, 1990, J PHYSIOL-LONDON, V421, P203, DOI 10.1113/jphysiol.1990.sp017941; DALE N, 1988, SCIENCE, V239, P282, DOI 10.1126/science.2892269; ERNEUX C, 1986, BIOCHEM J, V234, P193, DOI 10.1042/bj2340193; GINGRICH KJ, 1985, J NEUROPHYSIOL, V53, P652, DOI 10.1152/jn.1985.53.3.652; GLANZMAN DL, 1989, J NEUROSCI, V9, P4200; GOLDSMITH BA, 1991, P NATL ACAD SCI USA, V88, P9021, DOI 10.1073/pnas.88.20.9021; HOCHNER B, 1986, P NATL ACAD SCI USA, V83, P8794, DOI 10.1073/pnas.83.22.8794; KLEIN M, 1980, J EXP BIOL, V89, P117; KLEIN M, 1980, P NATL ACAD SCI-BIOL, V77, P6912, DOI 10.1073/pnas.77.11.6912; MARCUS EA, 1988, SCIENCE, V241, P210, DOI 10.1126/science.3388032; MONTAROLO PG, 1988, NATURE, V333, P171, DOI 10.1038/333171a0; PEREIRA ME, 1987, J BIOL CHEM, V262, P6093; ROTHERMEL JD, 1984, J BIOL CHEM, V259, P8151; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; SACKTOR TC, 1990, P NATL ACAD SCI USA, V87, P2036, DOI 10.1073/pnas.87.5.2036; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SCHACHER S, 1990, J NEUROSCI, V10, P3286; SCHUSTER MJ, 1985, NATURE, V313, P392; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SOSSIN WS, 1992, J NEUROSCI, V12, P1160; TAUSSIG R, 1989, J NEUROSCI, V9, P3218	30	192	196	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					479	489		10.1016/0896-6273(92)90185-G	http://dx.doi.org/10.1016/0896-6273(92)90185-G			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1355977				2022-12-28	WOS:A1992JM57100009
J	YOON, SO; CHIKARAISHI, DM				YOON, SO; CHIKARAISHI, DM			TISSUE-SPECIFIC TRANSCRIPTION OF THE RAT TYROSINE-HYDROXYLASE GENE REQUIRES SYNERGY BETWEEN AN AP-1 MOTIF AND AN OVERLAPPING E-BOX CONTAINING DYAD	NEURON			English	Article							NERVE GROWTH-FACTOR; INSULIN GENE; DNA-BINDING; MESSENGER-RNA; CYCLIC-AMP; PROTEIN COMPLEXES; SOMATOSTATIN GENE; ADRENAL-GLAND; POU-DOMAIN; BETA-CELLS	Transcription of tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine biosynthesis, is regulated in a tissue-specific manner. We have identified sequences from -205 to -182 as the minimal enhancer for TH in pheochromocytoma cells using site-directed mutagenesis. This segment (TGATTCAGAGGCAGGTG-CCTGTGA) is composed of an AP-1 motif (TGATTCA) and an overlapping 20 bp dyad whose core resembles an E box site (CANNTG). Interaction between the two elements is necessary both in vivo and in vitro: mutation of either element caused a 65%-95% reduction in transcription, and the combination of the two elements conferred cell-specific activation on a heterologous promoter; separation of the two elements by an additional helical turn not only disrupted a DNA-protein complex unique to the two elements, but also abolished expression in vivo. Therefore, we conclude that the interaction between the AP-1 and the E box dyad motifs is responsible for cell-specific TH expression.	TUFTS UNIV, SCH MED, NEUROSCI PROGRAM, BOSTON, MA 02111 USA	Tufts University	YOON, SO (corresponding author), TUFTS UNIV, SCH MED, DEPT MOLEC BIOL & MICROBIOL, BOSTON, MA 02111 USA.		Yoon, Sung Ok/C-5992-2012; Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NINDS NIH HHS [NS22675] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022675] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BIGUET NF, 1986, EMBO J, V5, P287, DOI 10.1002/j.1460-2075.1986.tb04211.x; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; BLACK IB, 1985, BRAIN RES, V339, P151, DOI 10.1016/0006-8993(85)90635-3; BLACK IB, 1978, ANNU REV NEUROSCI, V1, P183, DOI 10.1146/annurev.ne.01.030178.001151; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BOULET AM, 1986, P NATL ACAD SCI USA, V83, P3599, DOI 10.1073/pnas.83.11.3599; CAMBI F, 1989, J NEUROCHEM, V53, P1656, DOI 10.1111/j.1471-4159.1989.tb08567.x; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FINK JS, 1988, P NATL ACAD SCI USA, V85, P6662, DOI 10.1073/pnas.85.18.6662; GIZANGGINSBERG E, 1990, GENE DEV, V4, P477, DOI 10.1101/gad.4.4.477; GOLDSTEIN M, 1976, BRAIN RES, V109, P563, DOI 10.1016/0006-8993(76)90035-4; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HARRINGTON CA, 1987, NUCLEIC ACIDS RES, V15, P2363, DOI 10.1093/nar/15.5.2363; INOUYE S, 1987, DNA RNA SYNTHESIS, P181; JOHNSON WA, 1990, NATURE, V343, P467, DOI 10.1038/343467a0; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; KARLSSON O, 1989, MOL CELL BIOL, V9, P823, DOI 10.1128/MCB.9.2.823; KEMLER I, 1989, EMBO J, V8, P2001, DOI 10.1002/j.1460-2075.1989.tb03607.x; KOBAYASHI K, 1988, J BIOCHEM, V103, P907, DOI 10.1093/oxfordjournals.jbchem.a122386; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LEDOUARIN NM, 1988, CELL, V53, P169, DOI 10.1016/0092-8674(88)90375-3; LEWIS EJ, 1987, MOL CELL BIOL, V7, P3332, DOI 10.1128/MCB.7.9.3332; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; LLOYD T, 1974, BIOCHEM BIOPH RES CO, V59, P1262, DOI 10.1016/0006-291X(74)90450-1; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NELSON C, 1990, GENE DEV, V4, P1035, DOI 10.1101/gad.4.6.1035; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; POWERS AC, 1989, J BIOL CHEM, V264, P10048; RISSE G, 1989, EMBO J, V8, P3825, DOI 10.1002/j.1460-2075.1989.tb08560.x; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; STACHOWIAK M, 1985, BRAIN RES, V359, P356, DOI 10.1016/0006-8993(85)91450-7; TANK AW, 1985, J NEUROCHEM, V45, P1030, DOI 10.1111/j.1471-4159.1985.tb05519.x; TEITELMAN G, 1988, CELL, V52, P97, DOI 10.1016/0092-8674(88)90534-X; TEITELMAN G, 1987, DEV BIOL, V121, P454, DOI 10.1016/0012-1606(87)90182-5; WALKER MD, 1990, NUCLEIC ACIDS RES, V18, P1159, DOI 10.1093/nar/18.5.1159; WEINRICH SL, 1991, MOL CELL BIOL, V11, P4985, DOI 10.1128/MCB.11.10.4985; WESTIN G, 1987, NUCLEIC ACIDS RES, V15, P6787, DOI 10.1093/nar/15.17.6787; WHELAN J, 1990, MOL CELL BIOL, V10, P1564, DOI 10.1128/MCB.10.4.1564; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	53	160	162	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1992	9	1					55	67		10.1016/0896-6273(92)90220-8	http://dx.doi.org/10.1016/0896-6273(92)90220-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1352985				2022-12-28	WOS:A1992JE75600006
J	MALOUF, NN; MCMAHON, DK; HAINSWORTH, CN; KAY, BK				MALOUF, NN; MCMAHON, DK; HAINSWORTH, CN; KAY, BK			A 2-MOTIF ISOFORM OF THE MAJOR CALCIUM-CHANNEL SUBUNIT IN SKELETAL-MUSCLE	NEURON			English	Article							DEPENDENT CA-2+ CHANNEL; MONOCLONAL-ANTIBODY; SARCOPLASMIC-RETICULUM; POTASSIUM CHANNELS; RYANODINE RECEPTOR; DIHYDROPYRIDINE RECEPTOR; CHARGE MOVEMENT; XENOPUS-OOCYTES; RELEASE CHANNEL; EXPRESSION	Evidence is presented that two isoforms of the voltage-dependent, dihydropyridine-sensitive calcium channel alpha-1 subunit are present in newborn and adult skeletal muscle and that expression of these isoforms is developmentally regulated. A voltage-dependent calcium channel alpha-1 cDNA from newborn muscle was cloned and found to be identical to that published from the adult, except that it was 2 kb shorter owing to an internal deletion. Nucleotide sequences, Northern blots, reverse-transcriptase PCR experiments, and sequencing of the PCR product confirmed that a segment corresponding to the inner two repeats of the structural prototype four homologous motifs is missing from the immature isoform. Immunological studies using antisera raised against synthetic peptides that correspond to sequences in the two isoforms show that the abbreviated transcript is predominant in newborn muscle, whereas the four-repeat isoform is the major species in the adult.	UNIV N CAROLINA,DEPT BIOL,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill	MALOUF, NN (corresponding author), UNIV N CAROLINA,DEPT PATHOL,CHAPEL HILL,NC 27599, USA.				NHLBI NIH HHS [HL20749, HL42250] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042250, R01HL020749] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALDRICH RW, 1990, NATURE, V345, P475, DOI 10.1038/345475a0; ALMERS W, 1981, J PHYSIOL-LONDON, V312, P177, DOI 10.1113/jphysiol.1981.sp013623; ANDREADIS A, 1987, ANNU REV CELL BIOL, V3, P207, DOI 10.1146/annurev.cellbio.3.1.207; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BADLEY JE, 1988, BIOTECHNIQUES, V6, P114; BEAM KG, 1988, J GEN PHYSIOL, V91, P799, DOI 10.1085/jgp.91.6.799; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; BORSOTTO M, 1984, EUR J BIOCHEM, V142, P449, DOI 10.1111/j.1432-1033.1984.tb08307.x; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHANG KJ, 1988, P NATL ACAD SCI USA, V85, P4929, DOI 10.1073/pnas.85.13.4929; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; FLUCHER BE, 1990, NEURON, V5, P339, DOI 10.1016/0896-6273(90)90170-K; GONOI T, 1988, J PHYSIOL-LONDON, V401, P617, DOI 10.1113/jphysiol.1988.sp017183; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; IMAGAWA T, 1987, J BIOL CHEM, V262, P16636; INUI M, 1987, J BIOL CHEM, V262, P1740; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LEE CC, 1988, SCIENCE, V239, P1288, DOI 10.1126/science.3344434; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MALOUF NN, 1987, P NATL ACAD SCI USA, V84, P5019, DOI 10.1073/pnas.84.14.5019; MALOUF NN, 1986, J HISTOCHEM CYTOCHEM, V34, P347, DOI 10.1177/34.3.3950385; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MORTON ME, 1987, J BIOL CHEM, V262, P11904; MORTON ME, 1988, J BIOL CHEM, V263, P613; RAGAN CI, 1986, TECHNIQUES ANAL MEMB, P15; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANCHEZ JA, 1978, J PHYSIOL-LONDON, V283, P197, DOI 10.1113/jphysiol.1978.sp012496; SCHIAFFINO S, 1969, J CELL BIOL, V41, P855, DOI 10.1083/jcb.41.3.855; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; STEVENS CF, 1991, NATURE, V349, P657, DOI 10.1038/349657a0; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1987, NATURE, V328, P343; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	45	49	49	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					899	906		10.1016/0896-6273(92)90204-Q	http://dx.doi.org/10.1016/0896-6273(92)90204-Q			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1316766				2022-12-28	WOS:A1992HV46700009
J	NEHER, E				NEHER, E			ION CHANNELS FOR COMMUNICATION BETWEEN AND WITHIN CELLS	NEURON			English	Article							BOVINE CHROMAFFIN CELLS; PERITONEAL MAST-CELLS; PATCH-CLAMP; MEMBRANE CAPACITANCE; GUANINE-NUCLEOTIDES; CALCIUM CHANNELS; BINDING-PROTEIN; CYTOSOLIC CA-2+; DE-GRANULATION; TIME COURSE				NEHER, E (corresponding author), MAX PLANCK INST BIOPHYS CHEM,W-3400 GOTTINGEN,GERMANY.							ALMERS W, 1987, J PHYSIOL-LONDON, V386, P205, DOI 10.1113/jphysiol.1987.sp016530; ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; ANDERSON CR, 1973, J PHYSIOL-LONDON, V235, P655, DOI 10.1113/jphysiol.1973.sp010410; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BEAN RC, 1969, J GEN PHYSIOL, V53, P741, DOI 10.1085/jgp.53.6.741; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; COCKCROFT S, 1985, NATURE, V314, P534, DOI 10.1038/314534a0; DIVIRGILIO F, 1984, NATURE, V310, P691, DOI 10.1038/310691a0; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; FENWICK EM, 1981, J PHYSIOL-LONDON, V319, pP100; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FISHMAN HM, 1973, P NATL ACAD SCI USA, V70, P876, DOI 10.1073/pnas.70.3.876; FRANK K, 1964, CELLULAR FUNCTION ME; GILLESPIE JI, 1979, PROC R SOC SER B-BIO, V206, P293, DOI 10.1098/rspb.1979.0106; GOMPERTS BD, 1986, FASEB J, V45, P2156; Hamill O.P., 1983, SINGLE CHANNEL RECOR, P451; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMILL OP, 1981, J PHYSIOL-LONDON, V312, pP41; HASLAM RJ, 1984, FEBS LETT, V174, P90, DOI 10.1016/0014-5793(84)81084-4; HEIMAN AS, 1985, J IMMUNOL, V134, P548; HESCHELER J, 1986, PFLUG ARCH EUR J PHY, V407, P182, DOI 10.1007/BF00580674; Hille B., 1970, Progr. Biophys. molec. Biol., V21, P1, DOI 10.1016/0079-6107(70)90022-2; HILLE B, 1989, Q J EXP PHYSIOL CMS, V74, P785, DOI 10.1113/expphysiol.1989.sp003349; HLADKY SB, 1970, NATURE, V225, P451, DOI 10.1038/225451a0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; JAFFE LA, 1978, DEV BIOL, V67, P243, DOI 10.1016/0012-1606(78)90314-7; KAMEYAMA M, 1986, PFLUG ARCH EUR J PHY, V407, P123, DOI 10.1007/BF00580662; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; Katz B., 1966, NERVE MUSCLE SYNAPSE; KOSTYUK PG, 1980, NEUROSCIENCE, V5, P945, DOI 10.1016/0306-4522(80)90178-5; LIM NF, 1990, NATURE, V344, P449, DOI 10.1038/344449a0; LINDAU M, 1992, BIOPHYS J, V61, P19, DOI 10.1016/S0006-3495(92)81812-X; LINDAU M, 1986, NATURE, V319, P150, DOI 10.1038/319150a0; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; Marty A., 1983, SINGLE CHANNEL RECOR, P107; MORAD M, 1988, SCIENCE, V241, P842, DOI 10.1126/science.2457253; MULLER P, 1963, J THEOR BIOL, V4, P268; NEHER E, 1969, PFLUG ARCH EUR J PHY, V311, P272, DOI 10.1007/BF00590532; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193, DOI 10.1113/jphysiol.1988.sp016914; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; NEHER E, 1988, A BENZON S, V25; PARNAS H, 1986, PFLUG ARCH EUR J PHY, V406, P121, DOI 10.1007/BF00586672; PENNER R, 1988, J EXP BIOL, V139, P329; PENNER R, 1989, TRENDS NEUROSCI, V12, P159, DOI 10.1016/0166-2236(89)90059-3; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; PENNER R, 1988, P NATL ACAD SCI USA, V85, P9856, DOI 10.1073/pnas.85.24.9856; Pratt FH, 1919, AM J PHYSIOL, V49, P1; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; SAKMANN B, 1978, FED PROC, V37, P2654; SAKMANN B, 1978, NATURE, V282, P336; SHAAFI RI, 1983, BIOCHEM BIOPH RES CO, V114, P638, DOI 10.1016/0006-291X(83)90828-8; SIGWORTH FJ, 1980, NATURE, V287, P447, DOI 10.1038/287447a0; STRICKHOLM A, 1961, J GEN PHYSIOL, V44, P1073, DOI 10.1085/jgp.44.6.1073; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6	62	21	22	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					605	612		10.1016/0896-6273(92)90083-P	http://dx.doi.org/10.1016/0896-6273(92)90083-P			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1373630				2022-12-28	WOS:A1992HQ18800001
J	KAPUR, RP; HOYLE, GW; MERCER, EH; BRINSTER, RL; PALMITER, RD				KAPUR, RP; HOYLE, GW; MERCER, EH; BRINSTER, RL; PALMITER, RD			SOME NEURONAL CELL-POPULATIONS EXPRESS HUMAN DOPAMINE BETA-HYDROXYLASE-LACZ TRANSGENES TRANSIENTLY DURING EMBRYONIC-DEVELOPMENT	NEURON			English	Article							PRIMARY SENSORY NEURONS; CATECHOLAMINERGIC TC CELLS; TYROSINE-HYDROXYLASE; ADULT-RAT; CILIARY GANGLION; ENTERIC NEURONS; VAGUS NERVES; PHENOTYPE; INVIVO; BOWEL	The 5' flanking region from the human dopamine beta-hydroxylase gene directs expression of bacterial beta-galactosidase reporter genes to a subset of adult neurons and adrenal chromaffin cells of transgenic mice. In this paper, we examine the spatial and temporal patterns of expression of these transgenes during embryogenesis. Expression begins at embryonic day 9 in the developing central and peripheral nervous systems and persists in cell populations in which expression is observed in adult transgenic mice. However, transient embryonic expression occurs in presumptive neuroblasts in developing sensory ganglia and ventrolateral neural tube that are destined to synthesize neurotransmitters other than catecholamines. These observations support the concept that some cells fated to become "non-catecholaminergic" neurons exhibit transient catecholaminergic features during their differentiation.	UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; UNIV PENN,SCH VET MED,REPROD PHYSIOL LAB,PHILADELPHIA,PA 19104	University of Washington; University of Washington Seattle; University of Pennsylvania	KAPUR, RP (corresponding author), UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195, USA.		Mercer, Eric H/AAX-6173-2021	Mercer, Eric H/0000-0002-6737-765X; Brinster, Ralph/0000-0003-1408-7656	NICHD NIH HHS [HD09172] Funding Source: Medline; NINDS NIH HHS [NS29018] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD009172, R01HD009172] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AXELROD J, 1972, PHARMACOL REV, V24, P233; BAETGE G, 1989, DEV BIOL, V132, P189, DOI 10.1016/0012-1606(89)90217-0; BAETGE G, 1990, DEV BIOL, V141, P353, DOI 10.1016/0012-1606(90)90391-U; BAETGE G, 1990, DEVELOPMENT, V110, P689; Bjorklund A.H.T., 1988, HATLDBOOK CHEM NEURO, V6, P599; BONNEROT C, 1987, P NATL ACAD SCI USA, V84, P6795, DOI 10.1073/pnas.84.19.6795; COCHARD P, 1978, P NATL ACAD SCI USA, V75, P2986, DOI 10.1073/pnas.75.6.2986; Costa M., 1987, PHYSL GASTROINTESTIN, P1; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; FONTAINEPERUS J, 1985, DEV BIOL, V107, P227, DOI 10.1016/0012-1606(85)90391-4; GERSHON MD, 1987, 1986 FID RES F NEUR, P108; JONAKAIT GM, 1985, DEV BIOL, V108, P6, DOI 10.1016/0012-1606(85)90003-X; JONAKAIT GM, 1984, DEV BIOL, V101, P51, DOI 10.1016/0012-1606(84)90116-7; KATZ DM, 1983, P NATL ACAD SCI-BIOL, V80, P3526, DOI 10.1073/pnas.80.11.3526; KATZ DM, 1990, DEV BIOL, V137, P233, DOI 10.1016/0012-1606(90)90250-M; KATZ DM, 1987, FASEB J, V46, P24; Kimura H., 1984, HDB CHEM NEUROANAT 2, V3, P51; LANDIS SC, 1987, J NEUROSCI, V7, P3574; Landis SC, 1988, HDB CHEM NEUROANATOM, V6, P65; LAWRENCE IE, 1973, AM J ANAT, V137, P199, DOI 10.1002/aja.1001370206; LEBLANC GG, 1989, DEV BIOL, V131, P44, DOI 10.1016/S0012-1606(89)80037-5; MANIER M, 1987, NEUROSCI LETT, V80, P141, DOI 10.1016/0304-3940(87)90643-4; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; PISANO MM, 1985, IRCS MED SCI-BIOCHEM, V13, P900; POURQUIE O, 1990, DEVELOPMENT, V109, P743; PRICE J, 1983, NATURE, V301, P241, DOI 10.1038/301241a0; SCHOTZINGER RJ, 1988, NATURE, V335, P637, DOI 10.1038/335637a0; SCHULTZBERG M, 1988, HDB CHEM NEUROANATOM, V6, P297; TEITELMAN G, 1978, BRAIN RES, V158, P229, DOI 10.1016/0006-8993(78)90021-5; TEITELMAN G, 1981, DEV BIOL, V86, P348, DOI 10.1016/0012-1606(81)90192-5; UEMURA Y, 1987, BRAIN RES, V416, P200, DOI 10.1016/0006-8993(87)91519-8; XUE ZG, 1987, DEV BRAIN RES, V34, P99, DOI 10.1016/0165-3806(87)90199-4; ZIMMERMAN EF, 1981, J EMBRYOL EXP MORPH, V64, P233	33	74	74	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1991	7	5					717	727		10.1016/0896-6273(91)90275-5	http://dx.doi.org/10.1016/0896-6273(91)90275-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1742022				2022-12-28	WOS:A1991GT93900003
J	MCCOBB, DP; BEAM, KG				MCCOBB, DP; BEAM, KG			ACTION-POTENTIAL WAVE-FORM VOLTAGE-CLAMP COMMANDS REVEAL STRIKING DIFFERENCES IN CALCIUM ENTRY VIA LOW AND HIGH-VOLTAGE ACTIVATED CALCIUM CHANNELS	NEURON			English	Article							CHICK SENSORY NEURONS; NEUROTRANSMITTER RELEASE; SELECTIVE MODULATION; TRANSMITTER RELEASE; POTASSIUM CHANNELS; LIMB MOTONEURONS; PITUITARY-CELLS; ARSENAZO-III; CURRENTS; DEPOLARIZATION	Calcium channels transduce natural voltage transients, like action potentials, into functionally important intracellular calcium transients. We have used digitally constructed waveforms that simulate natural action potentials as voltage-clamp commands to study channel function in transduction. Whole-cell calcium currents elicited by several action potential waveforms (APWs) were studied. The currents were subdivided into T (or low voltage-activated) and high voltage-activated components. Calcium entry through T channels constituted a disproportionately large fraction of the total during normal, brief APWs. Entry through high voltage-activated channels was much more responsive to APW, increasing more significantly as APW duration increased. Thus the results indicate that differences in the gating properties of these two channel classes combine to endow them with strikingly different transducer properties.	COLORADO STATE UNIV,DEPT PHYSIOL,FT COLLINS,CO 80523	Colorado State University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS008373, R01NS026416] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-26416, NS-08373] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED Z, 1979, J PHYSIOL-LONDON, V286, P61, DOI 10.1113/jphysiol.1979.sp012607; ARMSTRONG CM, 1985, SCIENCE, V227, P65, DOI 10.1126/science.2578071; ATCHISON WD, 1987, BRAIN RES, V419, P315, DOI 10.1016/0006-8993(87)90599-3; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P143, DOI 10.1113/jphysiol.1985.sp015818; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BARRES BA, 1989, J NEUROSCI, V9, P3169; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEVINGTON PR, 1969, DATA REDUCTION ERROR, P239; BOLSOVER SR, 1986, J NEUROSCI, V6, P1934; BOSSU JL, 1985, PFLUG ARCH EUR J PHY, V403, P360, DOI 10.1007/BF00589247; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P571, DOI 10.1113/jphysiol.1987.sp016552; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P547, DOI 10.1113/jphysiol.1987.sp016551; CHEN CF, 1988, SCIENCE, V239, P1024, DOI 10.1126/science.2449730; CHESNOYMARCHAIS D, 1988, J PHYSIOL-LONDON, V398, P291, DOI 10.1113/jphysiol.1988.sp017043; CONNOR JA, 1987, J NEUROSCI, V7, P1384; DOERR T, 1989, PFLUG ARCH EUR J PHY, V413, P599, DOI 10.1007/BF00581808; FEDULOVA SA, 1985, J PHYSIOL-LONDON, V359, P431, DOI 10.1113/jphysiol.1985.sp015594; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FUCHS PA, 1982, J PHYSIOL-LONDON, V323, P195, DOI 10.1113/jphysiol.1982.sp014068; GORDON TR, 1988, BRAIN RES, V447, P1, DOI 10.1016/0006-8993(88)90959-6; GORMAN ALF, 1984, J PHYSIOL-LONDON, V353, P127, DOI 10.1113/jphysiol.1984.sp015327; GORMAN ALF, 1980, J PHYSIOL-LONDON, V308, P259, DOI 10.1113/jphysiol.1980.sp013471; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HOCHNER B, 1986, P NATL ACAD SCI USA, V83, P8410, DOI 10.1073/pnas.83.21.8410; KATZ B, 1967, J PHYSIOL-LONDON, V192, P407, DOI 10.1113/jphysiol.1967.sp008307; KOCSIS JD, 1987, NEUROSCI LETT, V75, P193, DOI 10.1016/0304-3940(87)90296-5; KUSANO K, 1967, SCIENCE, V155, P154; LIN JW, 1988, J NEUROSCI, V8, P1313; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LLINAS RR, 1961, BIOPHYS J, V33, P289; MATTESON DR, 1986, J GEN PHYSIOL, V87, P161, DOI 10.1085/jgp.87.1.161; MCCOBB DP, 1990, J NEUROSCI, V10, P2974; MCCOBB DP, 1989, NEURON, V2, P1633, DOI 10.1016/0896-6273(89)90052-4; MILEDI R, 1977, PROC R SOC SER B-BIO, V198, P201, DOI 10.1098/rspb.1977.0094; NARAHASHI T, 1987, J PHYSIOL-LONDON, V383, P231; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; PERNEY TM, 1986, P NATL ACAD SCI USA, V83, P6656, DOI 10.1073/pnas.83.17.6656; RANE SG, 1987, PFLUG ARCH EUR J PHY, V409, P361, DOI 10.1007/BF00583789; SCHROEDER JE, 1990, J NEUROSCI, V10, P947; SPENCER AN, 1989, NATURE, V340, P636, DOI 10.1038/340636a0; Spitzer N.C., 1985, P67; SUZUKI S, 1989, P NATL ACAD SCI USA, V86, P7228, DOI 10.1073/pnas.86.18.7228; SWANDULLA D, 1988, J GEN PHYSIOL, V92, P197, DOI 10.1085/jgp.92.2.197; TANG CM, 1988, SCIENCE, V240, P213, DOI 10.1126/science.2451291; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WHITE G, 1989, P NATL ACAD SCI USA, V86, P6802, DOI 10.1073/pnas.86.17.6802	52	153	153	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1991	7	1					119	127		10.1016/0896-6273(91)90080-J	http://dx.doi.org/10.1016/0896-6273(91)90080-J			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1648936				2022-12-28	WOS:A1991FY48100012
J	WESTAWAY, D; MIRENDA, CA; FOSTER, D; ZEBARJADIAN, Y; SCOTT, M; TORCHIA, M; YANG, SL; SERBAN, H; DEARMOND, SJ; EBELING, C; PRUSINER, SB; CARLSON, GA				WESTAWAY, D; MIRENDA, CA; FOSTER, D; ZEBARJADIAN, Y; SCOTT, M; TORCHIA, M; YANG, SL; SERBAN, H; DEARMOND, SJ; EBELING, C; PRUSINER, SB; CARLSON, GA			PARADOXICAL SHORTENING OF SCRAPIE INCUBATION TIMES BY EXPRESSION OF PRION PROTEIN TRANSGENES DERIVED FROM LONG INCUBATION PERIOD MICE	NEURON			English	Article							POLYMERASE CHAIN-REACTION; CULTURED-CELLS; MESSENGER-RNA; DNA FRAGMENTS; GENE; BRAIN; INFECTIVITY; LINKAGE; AMPLIFICATION; HYBRIDIZATION	Prolonged incubation times for experimental scrapie in I/LnJ mice are dictated by a dominant gene linked to the prion protein gene (Prn-p). Transgenic mice were analyzed to discriminate between an effect of the I/LnJ Prn-p(b) allele and a distinct incubation time locus designated Prn-i. Paradoxically, 4 independent Prn-p(b) transgenic mouse lines had scrapie incubation times shorter than nontransgenic controls, instead of the anticipated prolonged incubation periods. Aberrant or overexpression of the Prn-p(b) transgenes may dictate abbreviated incubation times, masking genuine Prn-p/Prn-i congruence; alternatively, a discrete Prn-i gene lies adjacent to Prn-p.	UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143; MCLAUGHLIN RES INST,GREAT FALLS,MT 59401	University of California System; University of California San Francisco; University of California System; University of California San Francisco; McLaughlin Research Institute for Biomedical Sciences, Inc.	WESTAWAY, D (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143, USA.				NIA NIH HHS [AG08967, AG02131] Funding Source: Medline; NINDS NIH HHS [NS14069] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS014069, P50NS014069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R35AG008967] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; CARLSON GA, 1989, P NATL ACAD SCI USA, V86, P7475, DOI 10.1073/pnas.86.19.7475; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; CHANDLER RL, 1961, LANCET, V1, P1378; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CROCE CM, 1987, CELL, V49, P155, DOI 10.1016/0092-8674(87)90552-6; DEARMOND SJ, 1987, NEUROLOGY, V37, P1271, DOI 10.1212/WNL.37.8.1271; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; EHRICH E, 1987, GENE, V57, P229, DOI 10.1016/0378-1119(87)90126-0; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; HUNTER N, 1987, J GEN VIROL, V68, P2711, DOI 10.1099/0022-1317-68-10-2711; KIMBERLIN RH, 1979, SLOW TRANSMISSIBLE D, V2, P33; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; LOCHT C, 1986, P NATL ACAD SCI USA, V83, P6372, DOI 10.1073/pnas.83.17.6372; LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MCKINLEY MP, 1987, DEV BIOL, V121, P105, DOI 10.1016/0012-1606(87)90143-6; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; PRUSINER SB, 1990, CELL, V63, P676; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; RACE RE, 1990, J GEN VIROL, V71, P493, DOI 10.1099/0022-1317-71-2-493; Rosen K., 1990, FOCUS, V12, P23; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; SINGH L, 1984, NUCLEIC ACIDS RES, V12, P5627, DOI 10.1093/nar/12.14.5627; STERNBERG N, 1990, P NATL ACAD SCI USA, V87, P103, DOI 10.1073/pnas.87.1.103; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6	43	105	107	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1991	7	1					59	68		10.1016/0896-6273(91)90074-A	http://dx.doi.org/10.1016/0896-6273(91)90074-A			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1676894				2022-12-28	WOS:A1991FY48100006
J	SCHANENKING, C; NEL, A; WILLIAMS, LK; LANDRETH, G				SCHANENKING, C; NEL, A; WILLIAMS, LK; LANDRETH, G			NERVE GROWTH-FACTOR STIMULATES THE TYROSINE PHOSPHORYLATION OF MAP2 KINASE IN PC12-CELLS	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; PC12 PHEOCHROMOCYTOMA CELLS; SERINE-THREONINE KINASE; KDA CYTOSKELETAL PROTEIN; PDGF BETA-RECEPTOR; V-SRC; INTERLEUKIN-2 RECEPTOR; SELECTIVE-INHIBITION; MOLECULAR ANALYSIS; FREE-EXTRACTS	NGF treatment of PC12 cells results in the rapid activation of MAP2 kinase. We report here that the induction of enzyme activity was correlated with the phosphorylation of MAP2 kinase, detected by metabolic labeling of the enzyme and with anti-phosphotyrosine antibodies. NGF stimulated the phosphorylation of MAP2 kinase on tyrosine, as well as serine and threonine residues. Western blot analysis using a polyclonal anti-phosphotyrosine antibody demonstrated that the tyrosine phosphorylation of MAP2 kinase was maximal within 2 min following NGF exposure and preceded the induction of MAP2 kinase activity. The NGF-stimulated tyrosine phosphorylation of an identified substrate provides direct evidence for the participation of a tyrosine kinase in the mechanism of action of NGF.	UNIV CALIF LOS ANGELES,DEPT CLIN IMMUNOL,LOS ANGELES,CA 90024; CASE WESTERN RESERVE UNIV,SCH MED,ALZHEIMER RES LAB,DEPT NEUROSCI,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,ALZHEIMER RES LAB,DEPT NEUROL,CLEVELAND,OH 44106	University of California System; University of California Los Angeles; Case Western Reserve University; Case Western Reserve University	SCHANENKING, C (corresponding author), MED UNIV S CAROLINA,MED SCIENTIST TRAINING PROGRAM,CHARLESTON,SC 29425, USA.		Nel, Andre E/J-2808-2012		NIGMS NIH HHS [GM34908] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034908] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEMA S, 1985, NATURE, V316, P557, DOI 10.1038/316557a0; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BLENIS J, 1986, EMBO J, V5, P3441, DOI 10.1002/j.1460-2075.1986.tb04667.x; BOLEN JB, 1989, TRENDS BIOCHEM SCI, V14, P404, DOI 10.1016/0968-0004(89)90288-0; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; COOPER JA, 1984, MOL CELL BIOL, V4, P30, DOI 10.1128/MCB.4.1.30; COTTON PC, 1983, MOL CELL BIOL, V3, P1157, DOI 10.1128/MCB.3.6.1157; CREMINS J, 1986, J CELL BIOL, V103, P887, DOI 10.1083/jcb.103.3.887; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; GREENE LA, 1980, ANNU REV NEUROSCI, V3, P353, DOI 10.1146/annurev.ne.03.030180.002033; HALEGOUA S, 1980, CELL, V22, P571, DOI 10.1016/0092-8674(80)90367-0; HAMA T, 1986, P NATL ACAD SCI USA, V83, P2353, DOI 10.1073/pnas.83.8.2353; HAMAGUCHI M, 1987, P NATL ACAD SCI USA, V84, P2312, DOI 10.1073/pnas.84.8.2312; HANEKOM C, 1989, BIOCHEM J, V262, P449, DOI 10.1042/bj2620449; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HEASLEY LE, 1989, J BIOL CHEM, V264, P8646; HEMPSTEAD B, 1988, COLD SPRING HARB SYM, V53, P477, DOI 10.1101/SQB.1988.053.01.055; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HOSANG M, 1985, J BIOL CHEM, V260, P655; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAMPS MP, 1988, ONCOGENE, V2, P305; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KOIZUMI S, 1988, J NEUROSCI, V8, P715; LANDRETH GE, 1987, NEUROCHEM RES, V12, P943, DOI 10.1007/BF00966317; LANDRETH GE, 1985, J CELL BIOL, V100, P677, DOI 10.1083/jcb.100.3.677; LANDRETH GE, 1990, J NEUROCHEM, V55, P514, DOI 10.1111/j.1471-4159.1990.tb04165.x; LANE PJL, 1991, J IMMUNOL, V146, P715; LOUIE R, 1989, J VIROL, V62, P4673; MAHER PA, 1989, J NEUROSCI RES, V24, P29, DOI 10.1002/jnr.490240106; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MERIDA I, 1990, J BIOL CHEM, V265, P5690; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; MIYASAKA T, 1990, BIOCHEM BIOPH RES CO, V168, P1237, DOI 10.1016/0006-291X(90)91161-K; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MUTOH T, 1988, J BIOL CHEM, V263, P15853; NEL AE, 1990, J IMMUNOL, V145, P971; PYPER JM, 1989, J NEUROSCI RES, V24, P89, DOI 10.1002/jnr.490240113; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RAUSCH DM, 1989, J NEUROSCI RES, V24, P49, DOI 10.1002/jnr.490240108; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RAY LB, 1988, J BIOL CHEM, V263, P12721; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SMITH DS, 1989, J NEUROCHEM, V53, P800, DOI 10.1111/j.1471-4159.1989.tb11776.x; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SUDOL M, 1986, MOL CELL BIOL, V6, P2839, DOI 10.1128/MCB.6.8.2839; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; VALE RD, 1983, BIOCHEMISTRY-US, V22, P5022, DOI 10.1021/bi00290a022; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303	60	52	52	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1991	6	6					915	922		10.1016/0896-6273(91)90232-O	http://dx.doi.org/10.1016/0896-6273(91)90232-O			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	1647176				2022-12-28	WOS:A1991FT94900007
J	KROGER, S; WALTER, J				KROGER, S; WALTER, J			MOLECULAR MECHANISMS SEPARATING 2 AXONAL PATHWAYS DURING EMBRYONIC-DEVELOPMENT OF THE AVIAN OPTIC TECTUM	NEURON			English	Article							NEURONAL PROCESS OUTGROWTH; CELL-ADHESION MOLECULES; RETINAL AXONS; IDENTIFIED NEURONS; NEURITE EXTENSION; CHICK-EMBRYO; GROWTH; LAMININ; INVITRO; CULTURE	During embryonic development of the avian optic tectum, retinal and tectobulbar axons form an orthogonal array of nerve processes. Growing axons of both tracts are transiently very closely apposed to each other. Despite this spatial proximity, axons from the two pathways do not intermix, but instead restrict their growth to defined areas, thus forming two separate plexiform layers, the stratum opticum and the stratum album centrale. In this study we present experimental evidence indicating that the following three mechanisms might play a role in segregating both axonal populations: Retinal and tectobulbar axons differ in their ability to use the extracellular matrix protein laminin as a substrate for axonal elongation; the environment in the optic tectum is generally permissive for retinal axons, but is specifically nonpermissive for tectobulbar axons, resulting in a strong fasciculation of the latter; and growth cones of temporal retinal axons are reversibly inhibited in their motility by direct contact with the tectobulbar axon's membrane.	MAX PLANCK INST ENTWICKLUNGSBIOL, BIOCHEM ABT, W-7400 TUBINGEN, GERMANY	Max Planck Society				Kroger, Stephan/0000-0002-4626-1690				ADLER R, 1985, DEV BIOL, V112, P100, DOI 10.1016/0012-1606(85)90124-1; ALVARADOMALLART RM, 1984, DEV BIOL, V103, P378, DOI 10.1016/0012-1606(84)90326-9; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BONHOEFFER F, 1982, EMBO J, V1, P427, DOI 10.1002/j.1460-2075.1982.tb01186.x; BONHOEFFER F, 1985, NATURE, V315, P408, DOI 10.1038/315409a0; BRAY D, 1980, EXP CELL RES, V130, P241, DOI 10.1016/0014-4827(80)90060-9; COHEN J, 1987, DEV BIOL, V122, P407, DOI 10.1016/0012-1606(87)90305-8; EDELMAN GM, 1983, SCIENCE, V219, P450, DOI 10.1126/science.6823544; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; GOLDBERG S, 1974, DEV BIOL, V36, P24, DOI 10.1016/0012-1606(74)90188-2; GOLDBERG S, 1977, EXP EYE RES, V25, P399, DOI 10.1016/0014-4835(77)90107-5; HALFTER W, 1987, CELL TISSUE RES, V249, P487; HALFTER W, 1986, DEV BIOL, V114, P296, DOI 10.1016/0012-1606(86)90194-6; HALFTER W, 1981, NATURE, V292, P67, DOI 10.1038/292067a0; HALFTER W, 1987, J NEUROSCI, V7, P3712; HALFTER W, 1983, DEV BIOL, V95, P56, DOI 10.1016/0012-1606(83)90006-4; HALFTER W, 1984, DEV BIOL, V102, P344, DOI 10.1016/0012-1606(84)90199-4; HALFTER W, 1988, J COMP NEUROL, V268, P161, DOI 10.1002/cne.902680203; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HANKIN MH, 1987, J COMP NEUROL, V263, P455, DOI 10.1002/cne.902630310; HARRIS WA, 1986, NATURE, V320, P266, DOI 10.1038/320266a0; HAYDON PG, 1984, SCIENCE, V226, P561, DOI 10.1126/science.6093252; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; KAPFHAMMER JP, 1986, J NEUROSCI, V6, P2527; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; KATZ MJ, 1980, NEUROSCIENCE, V5, P821, DOI 10.1016/0306-4522(80)90151-7; KROGER S, 1990, J NEUROSCI RES, V27, P169, DOI 10.1002/jnr.490270207; KROGER S, 1990, J NEUROSCI, V10, P3118; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6; LETOURNEAU PC, 1988, DEV BIOL, V125, P135, DOI 10.1016/0012-1606(88)90066-8; LIESI P, 1988, DEV BIOL, V130, P774, DOI 10.1016/0012-1606(88)90366-1; LINSER PJ, 1987, DEV BRAIN RES, V31, P277, DOI 10.1016/0165-3806(87)90125-8; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MCCOBB DP, 1988, J NEUROSCI RES, V19, P19, DOI 10.1002/jnr.490190104; MCLOON SC, 1982, EXP BRAIN RES, V45, P277; OLEARY DDM, 1983, DEV BRAIN RES, V10, P93, DOI 10.1016/0165-3806(83)90124-4; PUELLES L, 1978, NEUROSCIENCE, V3, P307, DOI 10.1016/0306-4522(78)90079-9; RAGER GH, 1980, ADV ANAT EMBRYOL CEL, V63; RAPER JA, 1990, DEV NEUROL, V109, P70; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0; ROSNER H, 1988, DEV BRAIN RES, V42, P161, DOI 10.1016/0165-3806(88)90234-9; ROSNER H, 1989, DEV BRAIN RES, V12, P491; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SILVER J, 1987, J NEUROSCI, V7, P2264; SILVER J, 1984, J COMP NEUROL, V223, P238, DOI 10.1002/cne.902230207; SMALHEISER NR, 1984, DEV BRAIN RES, V12, P136, DOI 10.1016/0165-3806(84)90184-6; THANOS S, 1984, J COMP NEUROL, V224, P407, DOI 10.1002/cne.902240308; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; VANSELOW J, 1989, DEV BRAIN RES, V45, P15, DOI 10.1016/0165-3806(89)90003-5; VONBOXBERG Y, 1990, EUR J BIOCHEM, V190, P249; WALTER J, 1987, DEVELOPMENT, V101, P685; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; ZIPSER B, 1989, NEURON, V3, P621, DOI 10.1016/0896-6273(89)90272-9	57	21	21	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1991	6	2					291	303		10.1016/0896-6273(91)90364-6	http://dx.doi.org/10.1016/0896-6273(91)90364-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1993124	Green Published			2022-12-28	WOS:A1991EY70900011
J	HESS, EJ; WILSON, MC				HESS, EJ; WILSON, MC			TOTTERING AND LEANER MUTATIONS PERTURB TRANSIENT DEVELOPMENTAL EXPRESSION OF TYROSINE-HYDROXYLASE IN EMBRYOLOGICALLY DISTINCT PURKINJE-CELLS	NEURON			English	Article							MONOAMINE NEURON SYSTEMS; MUTANT MOUSE; POSTNATAL-DEVELOPMENT; EMBRYONIC-DEVELOPMENT; CEREBELLAR CORTEX; RAT CEREBELLUM; BRAIN; LOCALIZATION; MATURATION; EPILEPSIES	The mouse mutants tottering and leaner exhibit neurologic disorders associated, in part, with global noradrenergic hyperinnervation. Therefore, the expression of tyrosine hydroxylase (TH) mRNA and protein was examined in mutant and control mice. TH expression was normal in the major catecholaminergic nuclei. However, TH was expressed in vermal Purkinje cells of adult mutant but not control mice. TH expression in the Purkinje cells of both mutants was first observed on P21 and persisted throughout adulthood; in contrast, Purkinje cells of normal mice expressed TH transiently during development from P21 to P35. Thus, tottering and leaner mice are deficient in suppressing the normal transient expression of TH in developing Purkinje cells, suggesting that the protein encoded by the tg locus may play a crucial role in neuronal development.			HESS, EJ (corresponding author), SCRIPPS CLIN & RES FDN,RADIAT ONCOL RES INST,LA JOLLA,CA 92037, USA.				NCI NIH HHS [CA 33730] Funding Source: Medline; NINDS NIH HHS [NS 23038] Funding Source: Medline; PHS HHS [07456] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA033730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023038] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1985, J COMP NEUROL, V231, P1, DOI 10.1002/cne.902310103; ALTMAN J, 1985, J COMP NEUROL, V231, P42, DOI 10.1002/cne.902310105; ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; BERGER B, 1985, DEV BRAIN RES, V23, P141, DOI 10.1016/0165-3806(85)90013-6; BEROD A, 1987, P NATL ACAD SCI USA, V84, P1699, DOI 10.1073/pnas.84.6.1699; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; GOMEZ MR, 1983, ANN NEUROL, V13, P113, DOI 10.1002/ana.410130202; GREEN MC, 1962, J HERED, V53, P233, DOI 10.1093/oxfordjournals.jhered.a107180; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; HENDELMAN WJ, 1980, J COMP NEUROL, V193, P1063, DOI 10.1002/cne.901930417; HERRUP K, 1982, NEUROSCIENCE, V7, P2185, DOI 10.1016/0306-4522(82)90129-4; HOKFELT T, 1977, MED BIOL, V55, P21; HOKFELT T, 1976, MED BIOL, V54, P427; HOLLANDER WF, 1977, J HERED, V68, P403, DOI 10.1093/oxfordjournals.jhered.a108869; JAEGER CB, 1983, DEV BRAIN RES, V11, P128, DOI 10.1016/0165-3806(83)90208-0; KAPLAN BJ, 1979, EXP NEUROL, V66, P577, DOI 10.1016/0014-4886(79)90203-6; KAUFMAN DL, 1986, SCIENCE, V232, P1138, DOI 10.1126/science.3518061; LEVITT P, 1981, P NATL ACAD SCI-BIOL, V78, P4630, DOI 10.1073/pnas.78.7.4630; MEIER H, 1971, J HERED, V62, P297, DOI 10.1093/oxfordjournals.jhered.a108176; NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084; NOEBELS JL, 1984, NATURE, V310, P409, DOI 10.1038/310409a0; NOEBELS JL, 1984, ANN NEUROL, V16, pS18, DOI 10.1002/ana.410160705; PENRY JK, 1975, BRAIN, V98, P427, DOI 10.1093/brain/98.3.427; ROSS ME, 1990, P NATL ACAD SCI USA, V87, P4189, DOI 10.1073/pnas.87.11.4189; SADLER M, 1984, PROC R SOC SER B-BIO, V221, P349, DOI 10.1098/rspb.1984.0037; SATOH J, 1990, DEV BRAIN RES, V53, P1, DOI 10.1016/0165-3806(90)90119-J; SEYFRIED TN, 1981, BRAIN RES, V216, P429, DOI 10.1016/0006-8993(81)90145-1; TSUJI S, 1971, GENET RES, V17, P83, DOI 10.1017/S0016672300012040; VERNEY C, 1988, DEV BRAIN RES, V42, P45, DOI 10.1016/0165-3806(88)90200-3; WEISS GM, 1978, BRAIN RES, V154, P219, DOI 10.1016/0006-8993(78)90696-0; WILSON MC, 1989, NEUROMETHODS, V16, P239; WOODWARD DJ, 1971, BRAIN RES, V34, P73, DOI 10.1016/0006-8993(71)90352-0; YOON CH, 1969, DEV BIOL, V20, P158, DOI 10.1016/0012-1606(69)90011-6	34	126	128	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1991	6	1					123	132		10.1016/0896-6273(91)90127-L	http://dx.doi.org/10.1016/0896-6273(91)90127-L			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1670919				2022-12-28	WOS:A1991EU27800012
J	SCHROEDER, JE; FISCHBACH, PS; ZHENG, D; MCCLESKEY, EW				SCHROEDER, JE; FISCHBACH, PS; ZHENG, D; MCCLESKEY, EW			ACTIVATION OF MU-OPIOID RECEPTORS INHIBITS TRANSIENT HIGH-THRESHOLD AND LOW-THRESHOLD CA2+ CURRENTS, BUT SPARES A SUSTAINED CURRENT	NEURON			English	Article							ACTION-POTENTIAL DURATION; CHICK SENSORY NEURONS; CALCIUM ACTION-POTENTIALS; LOCUS COERULEUS NEURONS; ROOT GANGLION NEURONS; SUBSTANCE-P RELEASE; OPIATE RECEPTORS; POTASSIUM CONDUCTANCE; TRANSMITTER RELEASE; OMEGA-CONOTOXIN	Opioids and opiates decrease the duration of action potentials and the amount of neurotransmitter released from sensory neurons. The mu-type opioid receptor, the binding site for morphine, is thought to act exclusively on K+ channels. Here, we show that activation of the mu receptor inhibits Ca2+ channels in rat sensory neurons; the effect is blocked by a mu antagonist and is not mimicked by kappa or delta receptor agonists. Both low-threshold (T-type) and high-threshold Ca2+ currents are partially suppressed. omega-Conotoxin-sensitive and omega-conotoxin-insensitive, high-threshold Ca2+ currents are inhibited. The kinetic effect on high-threshold current is like that caused by diminished rest potential: the transient component is selectively lost, whereas the sustained component is spared.			SCHROEDER, JE (corresponding author), WASHINGTON UNIV,DEPT CELL BIOL & PHYSIOL,ST LOUIS,MO 63110, USA.		Fischbach, Peter/AAV-1715-2021					AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; ARMSTRONG CM, 1985, SCIENCE, V227, P65, DOI 10.1126/science.2578071; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V369, P163; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BIXBY JL, 1983, J NEUROSCI, V3, P1014; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CHANG KJ, 1979, J BIOL CHEM, V254, P2610; CHANG KJ, 1981, SCIENCE, V212, P75, DOI 10.1126/science.6259732; CHAVKIN C, 1988, OPIATE RECEPTORS, P273; CHERUBINI E, 1985, P NATL ACAD SCI USA, V82, P1860, DOI 10.1073/pnas.82.6.1860; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; GOLDSTEIN A, 1981, P NATL ACAD SCI-BIOL, V78, P7219, DOI 10.1073/pnas.78.11.7219; GROSS RA, 1987, P NATL ACAD SCI USA, V84, P5469, DOI 10.1073/pnas.84.15.5469; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HANDA BK, 1981, EUR J PHARMACOL, V70, P531, DOI 10.1016/0014-2999(81)90364-2; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; ITZHAK Y, 1988, OPIATE RECEPTORS, P95; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JESSELL TM, 1977, NATURE, V268, P549, DOI 10.1038/268549a0; LADURON PM, 1984, BRAIN RES, V294, P157, DOI 10.1016/0006-8993(84)91322-2; LEMBECK F, 1982, SUBSTANCE P NERVOUS, P35; LIM NF, 1990, NATURE, V344, P449, DOI 10.1038/344449a0; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MACDONALD RL, 1978, SCIENCE, V199, P1449, DOI 10.1126/science.204015; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; MORITA K, 1982, BRAIN RES, V242, P145, DOI 10.1016/0006-8993(82)90504-2; MOSBERG HI, 1983, P NATL ACAD SCI-BIOL, V80, P5871, DOI 10.1073/pnas.80.19.5871; MUDGE AW, 1979, P NATL ACAD SCI USA, V76, P526, DOI 10.1073/pnas.76.1.526; NORTH RA, 1983, BRIT J PHARMACOL, V80, P225, DOI 10.1111/j.1476-5381.1983.tb10023.x; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; NORTH RA, 1986, TRENDS NEUROSCI, V9, P114; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; OTSUKA M, 1983, TRENDS NEUROSCI, V6, P317, DOI 10.1016/0166-2236(83)90147-9; PEPPER CM, 1980, SCIENCE, V209, P394, DOI 10.1126/science.7384811; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANE SG, 1987, PFLUG ARCH EUR J PHY, V409, P361, DOI 10.1007/BF00583789; SCHROEDER JE, 1990, J NEUROSCI, V10, P947; SCHROEDER JE, 1990, NEURON, V5, P445, DOI 10.1016/0896-6273(90)90083-R; SEABROOK GR, 1989, BRIT J PHARMACOL, V97, P1125, DOI 10.1111/j.1476-5381.1989.tb12570.x; SHEN KF, 1989, BRAIN RES, V491, P227, DOI 10.1016/0006-8993(89)90059-0; SHIMAHARA T, 1987, BRAIN RES, V415, P357, DOI 10.1016/0006-8993(87)90220-4; STEIN C, 1989, J PHARMACOL EXP THER, V248, P1269; SWANDULLA D, 1988, J GEN PHYSIOL, V92, P197, DOI 10.1085/jgp.92.2.197; TAKEMORI AE, 1981, EUR J PHARMACOL, V70, P445, DOI 10.1016/0014-2999(81)90355-1; VONVOIGTLANDER PF, 1983, J PHARMACOL EXP THER, V224, P7; WERZ MA, 1983, NEUROSCI LETT, V42, P173, DOI 10.1016/0304-3940(83)90402-0; WERZ MA, 1985, J PHARMACOL EXP THER, V234, P49; WHITE G, 1989, P NATL ACAD SCI USA, V86, P6802, DOI 10.1073/pnas.86.17.6802; YAKSH TL, 1988, BRAIN RES, V458, P319, DOI 10.1016/0006-8993(88)90474-X; YOSHIMURA M, 1983, NATURE, V305, P529, DOI 10.1038/305529a0	58	193	199	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1991	6	1					13	20		10.1016/0896-6273(91)90117-I	http://dx.doi.org/10.1016/0896-6273(91)90117-I			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1846076				2022-12-28	WOS:A1991EU27800002
J	BARRES, BA; KOROSHETZ, WJ; SWARTZ, KJ; CHUN, LLY; COREY, DP				BARRES, BA; KOROSHETZ, WJ; SWARTZ, KJ; CHUN, LLY; COREY, DP			ION CHANNEL EXPRESSION BY WHITE MATTER GLIA - THE O-2A GLIAL PROGENITOR-CELL	NEURON			English	Article									MASSACHUSETTS GEN HOSP, DEPT NEUROSURG, BOSTON, MA 02114 USA; HOWARD HUGHES MED INST, NEUROSCI GRP, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, DEPT NEUROL, BOSTON, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	BARRES, BA (corresponding author), HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA.			Corey, David/0000-0003-4497-6016	NINDS NIH HHS [F32 NS 07970, NS-22059, NS-21269] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021269, F32NS007970, R01NS022059] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIZENMAN E, 1988, J PHYSIOL-LONDON, V396, P75, DOI 10.1113/jphysiol.1988.sp016951; AKAIKE N, 1988, NEUROSCI LETT, V87, P75, DOI 10.1016/0304-3940(88)90148-6; ALLISON LA, 1984, ANAL CHEM, V56, P1089, DOI 10.1021/ac00271a010; ARIMATSU Y, 1987, J NEUROSCI, V7, P1250; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P227; ASHKENAZI A, 1989, NATURE, V340, P146, DOI 10.1038/340146a0; BARBOUR B, 1988, NATURE, V335, P433, DOI 10.1038/335433a0; BARRES BA, 1989, NATURE, V339, P343, DOI 10.1038/339343a0; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BARRES BA, 1989, NEURON, V2, P1375, DOI 10.1016/0896-6273(89)90076-7; BARRES BA, 1988, GLIA, V1, P10, DOI 10.1002/glia.440010104; BEVAN S, 1985, NATURE, V315, P229, DOI 10.1038/315229a0; BEVAN S, 1987, J PHYSIOLOGY PARIS, V82, P327; BHISITKUL RB, 1987, EXP BRAIN RES, V66, P659, DOI 10.1007/BF00270698; BORMANN J, 1988, P NATL ACAD SCI USA, V85, P9336, DOI 10.1073/pnas.85.23.9336; BREW H, 1986, NATURE, V324, P466, DOI 10.1038/324466a0; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; CARD JP, 1981, J NEUROSCI, V1, P1289; CARON PC, 1988, BIOCHEM J, V251, P559, DOI 10.1042/bj2510559; CASSAB GI, 1987, J CELL BIOL, V105, P2581, DOI 10.1083/jcb.105.6.2581; CHANG YC, 1988, J NEUROSCI, V8, P2123; Corey D.P., 1983, SINGLE CHANNEL RECOR, P53; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; De Mello F G, 1976, J Neurochem, V27, P847; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; ELLISON DW, 1987, J NEUROSCI METH, V19, P305, DOI 10.1016/0165-0270(87)90073-2; FFRENCHCONSTANT C, 1986, NATURE, V323, P335, DOI 10.1038/323335a0; FRIEDMAN S, 1990, IN PRESS EUR J NEURO; GALLO V, 1986, EUR J PHARMACOL, V132, P319, DOI 10.1016/0014-2999(86)90624-2; GALLO V, 1989, J NEUROCHEM, V52, P1, DOI 10.1111/j.1471-4159.1989.tb10890.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; HUGHES SM, 1987, DEVELOPMENT, V101, P157; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; JUNG MJ, 1977, J NEUROCHEM, V29, P797, DOI 10.1111/j.1471-4159.1977.tb10721.x; KREMZNER LT, 1975, J NEUROCHEM, V25, P889, DOI 10.1111/j.1471-4159.1975.tb04423.x; LILLIEN LE, 1988, NEURON, V1, P485, DOI 10.1016/0896-6273(88)90179-1; LILLIEN LE, 1990, NEURON, V4, P525, DOI 10.1016/0896-6273(90)90110-2; LLANO I, 1988, P NATL ACAD SCI USA, V85, P3221, DOI 10.1073/pnas.85.9.3221; MALCHOW RP, 1989, P NATL ACAD SCI USA, V86, P4326, DOI 10.1073/pnas.86.11.4326; MATTSON MP, 1988, NEURON, V1, P865, DOI 10.1016/0896-6273(88)90134-1; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; MILLER RH, 1989, ANNU REV NEUROSCI, V12, P517, DOI 10.1146/annurev.ne.12.030189.002505; MILLER RH, 1984, J NEUROSCI, V4, P585; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; MILLER RH, 1989, EUR J NEUROSCI, V1, P172, DOI 10.1111/j.1460-9568.1989.tb00785.x; NAEGELE JR, 1988, J NEUROSCI, V8, P79; NEWMAN EA, 1984, NATURE, V309, P155, DOI 10.1038/309155a0; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; NOTO T, 1987, J NEUROCHEM, V48, P684, DOI 10.1111/j.1471-4159.1987.tb05570.x; OMALLEY DM, 1989, P NATL ACAD SCI USA, V86, P3414, DOI 10.1073/pnas.86.9.3414; PERRY VH, 1983, J COMP NEUROL, V219, P356, DOI 10.1002/cne.902190309; PRINGLE N, 1989, EMBO J, V8, P1049, DOI 10.1002/j.1460-2075.1989.tb03472.x; RAFF MC, 1985, CELL, V42, P61, DOI 10.1016/S0092-8674(85)80101-X; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1983, J NEUROSCI, V3, P1289; RAFF MC, 1984, EMBO J, V3, P1857, DOI 10.1002/j.1460-2075.1984.tb02059.x; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAFF MC, 1978, NATURE, V274, P813, DOI 10.1038/274813a0; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; SEILER N, 1974, BIOCHEM J, V144, P29, DOI 10.1042/bj1440029; SEILER N, 1979, J BIOCH, V86, P227; SIMONS SS, 1976, J AM CHEM SOC, V98, P7098, DOI 10.1021/ja00438a070; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; SOBUE K, 1977, J BIOCHEM-TOKYO, V82, P1121, DOI 10.1093/oxfordjournals.jbchem.a131784; SONTHEIMER H, 1989, NEURON, V2, P1135, DOI 10.1016/0896-6273(89)90180-3; STORMMATHISEN J, 1983, NATURE, V301, P517, DOI 10.1038/301517a0; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0; TSUJI M, 1978, J BIOCHEM-TOKYO, V83, P1407, DOI 10.1093/oxfordjournals.jbchem.a132050; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; WU JY, 1986, BRAIN RES, V373, P1, DOI 10.1016/0006-8993(86)90309-4	75	273	274	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1990	4	4					507	524		10.1016/0896-6273(90)90109-S	http://dx.doi.org/10.1016/0896-6273(90)90109-S			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB168	1691005				2022-12-28	WOS:A1990DB16800004
J	TARELLI, FT; BOSSI, M; FESCE, R; GREENGARD, P; VALTORTA, F				TARELLI, FT; BOSSI, M; FESCE, R; GREENGARD, P; VALTORTA, F			SYNAPSIN-I PARTIALLY DISSOCIATES FROM SYNAPTIC VESICLES DURING EXOCYTOSIS INDUCED BY ELECTRICAL-STIMULATION	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; SQUID GIANT SYNAPSE; PROTEIN-KINASE-II; TERMINAL-SPECIFIC PHOSPHOPROTEIN; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; MEMBRANE FRACTIONS; COATED VESICLES; F-ACTIN; PHOSPHORYLATION	The distribution of the synaptic vesicle-associated phosphoprotein synapsin I after electrical stimulation of the frog neuromuscular junction was investigated by immunogold labeling and compared with the distribution of the integral synaptic vesicle protein synaptophysin. In resting terminals both proteins were localized exclusively on synaptic vesicles. In stimulated terminals they appeared also in the axolemma and its infoldings, which however exhibited a lower synapsin I/synaptophysin ratio with respect to synaptic vesicles at rest. The value of this ratio was intermediate in synaptic vesicles of stimulated terminals, and an increased synapsin I labeling of the cytomatrix was observed. These results indicate that synapsin I undergoes partial dissociation from and reassociation with synaptic vesicles, following physiological stimulation, and are consistent with the proposed modulatory role of the protein in neurotransmitter release.	S RAFFAELE SCI INST,I-20129 MILAN,ITALY; ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021	Rockefeller University	TARELLI, FT (corresponding author), B CECCARELLI CTR,CNR,CTR CYTOPHARMACOL,DEPT PHARMACOL,I-20129 MILAN,ITALY.		fesce, riccardo/A-6317-2008; Flavia, Valtorta/F-3450-2012	Flavia, Valtorta/0000-0001-9556-4746; fesce, riccardo/0000-0001-9473-896X	NIMH NIH HHS [MH 39327] Funding Source: Medline; Telethon [112] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039327, R01MH039327] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fondazione Telethon(Fondazione Telethon)		BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BAHLER M, 1989, J CELL BIOL, V108, P1841, DOI 10.1083/jcb.108.5.1841; BENFENATI F, 1991, P NATL ACAD SCI USA, V88, P575, DOI 10.1073/pnas.88.2.575; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; CECCARELLI B, 1979, J CELL BIOL, V81, P163, DOI 10.1083/jcb.81.1.163; CECCARELLI B, 1972, J CELL BIOL, V54, P30, DOI 10.1083/jcb.54.1.30; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; FESCE R, 1992, J BIOL CHEM, V267, P11289; FESCE R, 1990, PROG NEUROBIOL, V35, P85, DOI 10.1016/0301-0082(90)90019-D; Ginsborg BL, 1976, NEUROMUSCULAR JUNCTI, P229; GREENGARD P, 1989, J CELL BIOL, V108, P1841; HACKETT JT, 1990, J NEUROPHYSIOL, V63, P701, DOI 10.1152/jn.1990.63.4.701; HAIMANN C, 1985, J CELL BIOL, V101, P1953, DOI 10.1083/jcb.101.5.1953; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HURLBUT WP, 1971, J PHYSIOL-LONDON, V219, P17, DOI 10.1113/jphysiol.1971.sp009647; HUTTNER WB, 1981, J BIOL CHEM, V256, P1482; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSON EM, 1972, J BIOL CHEM, V247, P5650; LIN JW, 1990, P NATL ACAD SCI USA, V87, P8257, DOI 10.1073/pnas.87.21.8257; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; MELDOLESI JH, 1984, P NATL ACAD SCI USA, V81, P320; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Nestler E. J., 1984, PROTEIN PHOSPHORYLAT; NICHOLS RA, 1992, J NEUROCHEM, V58, P783, DOI 10.1111/j.1471-4159.1992.tb09788.x; PETRUCCI TC, 1925, J CELL BIOL, V105, P1344; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; SCHULMAN H, 1978, NATURE, V271, P478, DOI 10.1038/271478a0; SEGAL JR, 1985, BIOPHYS, V17, P183; SIHRA TS, 1989, P NATL ACAD SCI USA, V86, P8108, DOI 10.1073/pnas.86.20.8108; TARELLI FT, 1990, J CELL BIOL, V110, P449; TORRITARELLI F, 1987, J NEUROCYTOL, V16, P205, DOI 10.1007/BF01795304; UEDA T, 1973, J BIOL CHEM, V248, P8295; UEDA T, 1977, J BIOL CHEM, V252, P5155; VALTORTA F, 1992, J BIOL CHEM, V267, P7195; VALTORTA F, 1992, J BIOL CHEM, V267, P11281; VALTORTA F, 1990, NEUROSCIENCE, V35, P477, DOI 10.1016/0306-4522(90)90323-V; VALTORTA F, 1984, J CELL BIOL, V99, P124, DOI 10.1083/jcb.99.1.124; VALTORTA F, 1978, J CELL BIOL, V107, P2719; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9	46	75	76	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1143	1153		10.1016/0896-6273(92)90072-L	http://dx.doi.org/10.1016/0896-6273(92)90072-L			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1463610				2022-12-28	WOS:A1992KD71600012
J	LIMAN, ER; TYTGAT, J; HESS, P				LIMAN, ER; TYTGAT, J; HESS, P			SUBUNIT STOICHIOMETRY OF A MAMMALIAN K+ CHANNEL DETERMINED BY CONSTRUCTION OF MULTIMERIC CDNAS	NEURON			English	Article							BRAIN POTASSIUM-CHANNEL; RAT-BRAIN; XENOPUS OOCYTES; SEQUENCE; DROSOPHILA; EXPRESSION; SKELETAL	The subunit stoichiometry of the mammalian K+ channel KV1.1 (RCK1) was examined by linking together the coding sequences of 2-5 K+ channel subunits in a single open reading frame and tagging the expression of individual subunits with a mutation (Y379K or Y379R) that altered the sensitivity of the channel to block by external tetraethylammonium ion. Two lines of evidence argue that these constructs lead to K+ channel expression only through the formation of functional tetramers. First, currents expressed by tetrameric constructs containing a single mutant subunit have a sensitivity to tetraethylammonium that is well fitted by a single site binding isotherm. Second, a mutant subunit (Y379K) that expresses only as part of a heteromultimer contributes to the expression of functional channels when coexpressed with a trimeric construct but not a tetrameric construct.	HARVARD UNIV,SCH MED,NEUROSCI PROGRAM,BOSTON,MA 02115	Harvard University; Harvard Medical School	LIMAN, ER (corresponding author), HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,BOSTON,MA 02115, USA.		Tytgat, Jan/F-1560-2010; Liman, Emily/AAC-7383-2021	Tytgat, Jan/0000-0003-1778-6022; liman, emily/0000-0003-4765-5496				BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; FALCONE D, 1991, MOL CELL BIOL, V11, P2656, DOI 10.1128/MCB.11.5.2656; GALILI G, 1988, J BIOL CHEM, V263, P5764; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; ISAACOFF EY, 1990, NATURE, V345, P530; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; KREIG PA, 1984, NUCLEIC ACIDS RES, V12, P7057; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MATSUBARA H, 1991, J BIOL CHEM, V266, P13324; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TYTGAT J, 1992, IN PRESS NATURE	20	989	1035	1	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1992	9	5					861	871		10.1016/0896-6273(92)90239-A	http://dx.doi.org/10.1016/0896-6273(92)90239-A			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1419000				2022-12-28	WOS:A1992JY55200006
J	ALDER, J; XIE, ZP; VALTORTA, F; GREENGARD, P; POO, MM				ALDER, J; XIE, ZP; VALTORTA, F; GREENGARD, P; POO, MM			ANTIBODIES TO SYNAPTOPHYSIN INTERFERE WITH TRANSMITTER SECRETION AT NEUROMUSCULAR SYNAPSES	NEURON			English	Article							SYNAPTIC VESICLE MEMBRANE; ACETYLCHOLINE RECEPTORS; CHROMAFFIN CELLS; BINDING PROTEIN; EXOCYTOSIS; P38; IDENTIFICATION; LOCALIZATION; CULTURE; RELEASE	The involvement of synaptophysin, a synaptic vesicle-specific protein, in transmitter release at neuromuscular synapses was studied by intracellular application of synaptophysin antibodies into presynaptic neurons. Polyclonal antibodies or their Fab fragments were loaded into spinal neurons by injection into one of the early blastomeres of Xenopus embryos 1 day prior to culturing or, alternatively, directly through a whole-cell recording pipette at the soma of cultured neurons. At synapses made by antibody-loaded neurons in culture, the spontaneous synaptic currents showed marked reduction in frequency without significant change in their mean amplitude. The impulse-evoked synaptic currents showed reduced amplitude and increased failure rate. These results suggest that interference with synaptophysin function by antibody binding inhibits transmitter secretion.	UNIV MILAN,CNR,CTR CYTOPHARMACOL,DEPT PHARMACOL,B CECCARELLI CTR,I-20129 MILAN,ITALY; ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021	Consiglio Nazionale delle Ricerche (CNR); University of Milan; Rockefeller University	ALDER, J (corresponding author), COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027, USA.		Flavia, Valtorta/F-3450-2012	Flavia, Valtorta/0000-0001-9556-4746; Alder, Janet/0000-0002-5694-4946	NIMH NIH HHS [MH39327] Funding Source: Medline; NINDS NIH HHS [NS 22764] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039327, R37MH039327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDER J, 1992, SCIENCE, V257, P657, DOI 10.1126/science.1353905; ALI SM, 1989, NATURE, V340, P313, DOI 10.1038/340313a0; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; BUCKLEY KM, 1987, J CELL BIOL, V105, P2447, DOI 10.1083/jcb.105.6.2447; BURGOYNE RD, 1990, ANNU REV PHYSIOL, V52, P647; EVERS J, 1989, J NEUROSCI, V9, P1523; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JACOBSON M, 1982, CURRENT TOPICS NEURO, P45; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; JOHNSTON PA, 1990, J BIOL CHEM, V265, P7849; KENIGSBERG RL, 1985, NEUROSCIENCE, V14, P335, DOI 10.1016/0306-4522(85)90183-6; KNAUS P, 1990, FEBS LETT, V261, P358, DOI 10.1016/0014-5793(90)80591-6; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; MOODY SA, 1983, J NEUROSCI, V3, P1670; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; ORIDA N, 1978, NATURE, V275, P31, DOI 10.1038/275031a0; POPOV S, 1992, J NEUROSCI, V12, P77; RAHAMIMOFF R, 1988, P NATL ACAD SCI USA, V85, P5310, DOI 10.1073/pnas.85.14.5310; REHM H, 1986, EMBO J, V5, P535, DOI 10.1002/j.1460-2075.1986.tb04243.x; SANES DH, 1989, NEURON, V2, P1237, DOI 10.1016/0896-6273(89)90308-5; SCHWEIZER FE, 1989, NATURE, V339, P709; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; TARELLI FT, 1990, J CELL BIOL, V110, P449; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; THOMAS L, 1990, J CELL BIOL, V111, P2041, DOI 10.1083/jcb.111.5.2041; TRIMBLE AW, 1991, ANN REV NEUROSCI, V14, P93; VALTORTA F, 1988, J CELL BIOL, V107, P2717, DOI 10.1083/jcb.107.6.2717; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0	33	108	109	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					759	768		10.1016/0896-6273(92)90038-F	http://dx.doi.org/10.1016/0896-6273(92)90038-F			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1356373				2022-12-28	WOS:A1992JT51600016
J	SCHOLZ, KP; MILLER, RJ				SCHOLZ, KP; MILLER, RJ			INHIBITION OF QUANTAL TRANSMITTER RELEASE IN THE ABSENCE OF CALCIUM INFLUX BY A G-PROTEIN LINKED ADENOSINE RECEPTOR AT HIPPOCAMPAL SYNAPSES	NEURON			English	Article							RAT HIPPOCAMPUS; SYNAPTIC TRANSMISSION; NEUROTRANSMITTER RELEASE; CYCLIC-AMP; ADENYLATE-CYCLASE; PYRAMIDAL NEURONS; INSULIN-SECRETION; PATCH-CLAMP; SLICES; INVITRO	Spontaneous miniature excitatory postsynaptic currents (MEPSCs) were recorded by whole-cell voltage-clamp techniques in cultured rat hippocampal pyramidal neurons. The specific adenosine A1 receptor agonist cyclopentyladenosine (CPA) reduced the frequency of MEPSCs without affecting their amplitude distribution or kinetic properties. This action was blocked by pretreatment of the cells with pertussis toxin. In the presence of divalent cation Ca2+ channel blockers, CPA was still effective in reducing the frequency of MEPSCs. It was shown that this effect cannot be explained by changes in basal Ca2+ influx. These results suggest that neurotransmitters that produce presynaptic inhibition at hippocampal synapses utilize several mechanisms, one of which may involve inhibition of some component of the quantal release apparatus that occurs independently of inhibition of Ca2+ influx.			SCHOLZ, KP (corresponding author), UNIV CHICAGO,DEPT PHARMACOL & PHYSIOL SCI,CHICAGO,IL 60637, USA.				NIDA NIH HHS [DA02575, DA02121] Funding Source: Medline; NIMH NIH HHS [MH40165] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040165, R37MH040165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002575, R01DA002121] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BENNETT MR, 1991, J PHYSIOL-LONDON, V433, P421, DOI 10.1113/jphysiol.1991.sp018435; BOYD IA, 1956, J PHYSIOL-LONDON, V132, P61, DOI 10.1113/jphysiol.1956.sp005502; COHEN I, 1974, J PHYSIOL-LONDON, V236, P327, DOI 10.1113/jphysiol.1974.sp010437; DALE N, 1990, J PHYSIOL-LONDON, V421, P203, DOI 10.1113/jphysiol.1990.sp017941; DELANEY K, 1991, J NEUROSCI, V11, P2631; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P553, DOI 10.1113/jphysiol.1954.sp005128; DOLPHIN AC, 1985, NATURE, V316, P148, DOI 10.1038/316148a0; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P543, DOI 10.1113/jphysiol.1961.sp006646; DUNWIDDIE TV, 1984, J PHYSIOL-LONDON, V350, P545, DOI 10.1113/jphysiol.1984.sp015217; DUNWIDDIE TV, 1989, J PHARMACOL EXP THER, V249, P31; DUNWIDDIE TV, 1985, J PHYSIOL-LONDON, V369, P365, DOI 10.1113/jphysiol.1985.sp015907; EBERSOLT C, 1983, BRAIN RES, V267, P123, DOI 10.1016/0006-8993(83)91045-4; ECCLES JC, 1962, J PHYSIOL-LONDON, V161, P237, DOI 10.1113/jphysiol.1962.sp006884; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; FINCH DM, 1990, BRAIN RES, V518, P257, DOI 10.1016/0006-8993(90)90978-K; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FORSYTHE ID, 1988, J NEUROSCI, V8, P3733; FREDHOLM BB, 1986, N-S ARCH PHARMACOL, V332, P173, DOI 10.1007/BF00511409; GAGE PW, 1965, NATURE, V208, P395, DOI 10.1038/208395a0; GINGRICH KJ, 1988, BRAIN RES BULL, V21, P513, DOI 10.1016/0361-9230(88)90167-0; GINSBORG BL, 1972, J PHYSIOL-LONDON, V224, P629, DOI 10.1113/jphysiol.1972.sp009916; HAAS HL, 1988, N-S ARCH PHARMACOL, V337, P561; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYDON PG, 1991, J NEUROSCI, V11, P3851; HUTTNER WB, 1979, P NATL ACAD SCI USA, V76, P5402, DOI 10.1073/pnas.76.10.5402; KATZ B, 1969, SHERRINGTON LECTURES, V10; KNIGHT DE, 1984, NATURE, V309, P66, DOI 10.1038/309066a0; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; MILLER AM, 1983, J PHYSIOL-LONDON, V334, P325, DOI 10.1113/jphysiol.1983.sp014497; MILLER RJ, 1990, FASEB J, V4, P3291, DOI 10.1096/fasebj.4.15.1979294; MULLER D, 1987, EUR J PHARMACOL, V133, P225, DOI 10.1016/0014-2999(87)90154-3; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; OKADA Y, 1980, EUR J PHARMACOL, V68, P483; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; PIERONI JP, 1992, IN PRESS J NEUROSCI; PRZYWARA DA, 1991, J PHYSIOL-LONDON, V437, P201, DOI 10.1113/jphysiol.1991.sp018591; ROPERT N, 1990, J PHYSIOL-LONDON, V428, P707, DOI 10.1113/jphysiol.1990.sp018236; ROSENTHAL L, 1989, PHARMACOL THERAPEUT, V42, P115, DOI 10.1016/0163-7258(89)90024-7; ROTSHENKER S, 1970, SCIENCE, V170, P649; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V435, P373, DOI 10.1113/jphysiol.1991.sp018515; SCHOLZ WK, 1988, J NEUROSCI, V8, P1039; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; SILINSKY EM, 1981, BRIT J PHARMACOL, V73, P413, DOI 10.1111/j.1476-5381.1981.tb10438.x; SMITH DO, 1991, J PHYSIOL-LONDON, V432, P343, DOI 10.1113/jphysiol.1991.sp018388; TAKEUCHI A, 1966, J PHYSIOL-LONDON, V183, P418, DOI 10.1113/jphysiol.1966.sp007874; TRUSSELL LO, 1987, J NEUROSCI, V7, P3306; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; ULLRICH S, 1988, J BIOL CHEM, V263, P8615; ULLRICH S, 1990, BIOCHEM J, V270, P273, DOI 10.1042/bj2700273; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; WILLIAMS SH, 1991, J NEUROPHYSIOL, V66, P1010, DOI 10.1152/jn.1991.66.3.1010; ZAR JH, 1984, BIOSTAT ANAL, P406; ZUCKER RS, 1988, NATURE, V335, P360, DOI 10.1038/335360a0	61	191	196	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1139	1150		10.1016/0896-6273(92)90134-Y	http://dx.doi.org/10.1016/0896-6273(92)90134-Y			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1351733				2022-12-28	WOS:A1992JA42900013
J	JOHANSEN, KM; KOPP, DM; JELLIES, J; JOHANSEN, J				JOHANSEN, KM; KOPP, DM; JELLIES, J; JOHANSEN, J			TRACT FORMATION AND AXON FASCICULATION OF MOLECULARLY DISTINCT PERIPHERAL NEURON SUBPOPULATIONS DURING LEECH EMBRYOGENESIS	NEURON			English	Article							IMMUNOGLOBULIN SUPERFAMILY; EMBRYONIC-DEVELOPMENT; HIRUDO-MEDICINALIS; NERVOUS-SYSTEM; FASCICLIN-I; GLYCOPROTEIN; EXPRESSION; MEMBER; GRASSHOPPER; ADHESION	In leech, the central projections of peripheral sensory neurons segregate into specific axonal tracts, which are distinguished by differential expression of surface antigens recognized by the monoclonal antibodies Lan3-2 and Lan4-2. Lan3-2 recognizes an epitope expressed on axons that segregate into three distinct axon fascicles. In contrast, the Lan4-2-positive axons selectively project into only one of the Lan3-2-positive axon tracts. These observations provide evidence for a hierarchy of guidance cues mediating specific pathway formation in this system. Since the Lan3-2 antibody has been shown to perturb this process and since, as shown here, the Lan3-2 and Lan4-2 antigens are closely molecularly interrelated, these antibodies may help define molecules and epitopes mediating neuronal recognition and axonal guidance.	UNIV ALABAMA,DEPT PHYSIOL & BIOPHYS,NEUROBIOL RES CTR,BIRMINGHAM,AL 35294	University of Alabama System; University of Alabama Birmingham	JOHANSEN, KM (corresponding author), IOWA STATE UNIV SCI & TECHNOL,DEPT ZOOL & GENET,AMES,IA 50011, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028603, R29NS028857, R01NS028857] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 28857, NS 28603] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAJT ML, 1990, J NEUROCHEM, V5, P2117; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; ELDRED WD, 1983, J HISTOCHEM CYTOCHEM, V31, P285, DOI 10.1177/31.2.6339606; FERNANDEZ J, 1982, J EMBRYOL EXP MORPH, V72, P71; FLANAGAN T, 1986, BRAIN RES, V378, P152, DOI 10.1016/0006-8993(86)90297-0; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HOCKFIELD S, 1983, J NEUROSCI, V3, P369; JAY DG, 1990, NATURE, V348, P548, DOI 10.1038/348548a0; JELLIES J, 1987, J NEUROSCI, V7, P2618; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; JOHANSEN J, 1984, J COMP NEUROL, V226, P263, DOI 10.1002/cne.902260210; JOHANSEN J, 1985, BRAIN RES, V343, P1, DOI 10.1016/0006-8993(85)91151-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCGLADEMCCULLOH E, 1990, J COMP NEUROL, V299, P123, DOI 10.1002/cne.902990109; MCKAY RD, 1983, COLD SPRING HARB SYM, V58, P599; MCKAY RDG, 1983, SCIENCE, V222, P788, DOI 10.1126/science.6356361; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MORRISSEY AM, 1988, J NEUROSCI RES, V21, P513, DOI 10.1002/jnr.490210242; MULLER KJ, 1981, NEUROBIOLOGY LEECH; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PEINADO A, 1987, BRAIN RES, V410, P335, DOI 10.1016/0006-8993(87)90333-7; PEINADO A, 1987, BRAIN RES, V410, P330, DOI 10.1016/0006-8993(87)90332-5; PEINADO A, 1990, J COMP NEUROL, V301, P232, DOI 10.1002/cne.903010207; PHILLIPS CE, 1982, J NEUROBIOL, V13, P473, DOI 10.1002/neu.480130603; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; RAPER JA, 1983, J NEUROSCI, V3, P31; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; STANIER DYR, 1990, P NATL ACAD SCI USA, V87, P923; STENT G.S., 1982, NEURONAL DEV, P1; STEWART RR, 1985, BRAIN RES, V332, P150, DOI 10.1016/0006-8993(85)90398-1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0; ZIPSER B, 1981, NATURE, V289, P549, DOI 10.1038/289549a0; ZIPSER B, 1989, NEURON, V3, P621, DOI 10.1016/0896-6273(89)90272-9	39	27	27	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					559	572		10.1016/0896-6273(92)90283-J	http://dx.doi.org/10.1016/0896-6273(92)90283-J			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550678				2022-12-28	WOS:A1992HK67500015
J	LU, B; GREENGARD, P; POO, MM				LU, B; GREENGARD, P; POO, MM			EXOGENOUS SYNAPSIN-I PROMOTES FUNCTIONAL MATURATION OF DEVELOPING NEUROMUSCULAR SYNAPSES	NEURON			English	Article							NERVE-MUSCLE INTERACTIONS; XENOPUS CELL-CULTURE; SQUID GIANT SYNAPSE; PROTEIN KINASE-II; NEUROTRANSMITTER RELEASE; EMBRYONIC NEURON; PHOSPHOPROTEINS; ACETYLCHOLINE; EXPRESSION; JUNCTION	We have investigated the possible role of synapsin I, a nerve terminal-specific protein, in the maturation of neuromuscular synapses in Xenopus cell cultures. Purified synapsin I was loaded into embryonic spinal neurons by injection of the protein into one of the early blastomeres of a Xenopus embryo. At synapses made by synapsin I-loaded neurons, spontaneous synaptic currents occurred with higher frequency and amplitude, and the amplitude exhibited an earlier appearance of a bell-shaped distribution. These characteristics are indicative of more mature quantal secretion. Impulse-evoked synaptic currents also showed a significant increase in amplitude. Using cell manipulation techniques, enhanced transmitter release from synapsin I-loaded neurons was shown to occur at the onset of synaptogenesis, suggesting a presynaptic developmental action of synapsin I prior to synaptic contact. Taken together, these results suggest that endogenous synapsin I may participate in the functional maturation of synapses.	COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027	Columbia University	LU, B (corresponding author), ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021, USA.		Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	NIMH NIH HHS [MH-39327] Funding Source: Medline; NINDS NIH HHS [NS 22764] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039327, R01MH039327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BAHLER M, 1990, BIOESSAYS, V12, P259, DOI 10.1002/bies.950120603; BENFENATI F, 1991, P NATL ACAD SCI USA, V88, P575, DOI 10.1073/pnas.88.2.575; BIXBY JL, 1985, J NEUROSCI, V5, P3070; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DEGENNARO LJ, 1983, COLD SPRING HARB SYM, V48, P337, DOI 10.1101/SQB.1983.048.01.037; DENNIS MJ, 1981, ANNU REV NEUROSCI, V4, P43, DOI 10.1146/annurev.ne.04.030181.000355; EVERS J, 1989, J NEUROSCI, V9, P1523; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FU WM, 1991, NEURON, V6, P837, DOI 10.1016/0896-6273(91)90179-4; HACKETT JT, 1990, J NEUROPHYSIOL, V63, P701, DOI 10.1152/jn.1990.63.4.701; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAN HQ, 1991, NATURE, V349, P697, DOI 10.1038/349697a0; JACOBSON M, 1982, NEURONAL DEV, P45; KIDOKORO Y, 1984, Neuroscience Research, V1, P157, DOI 10.1016/S0168-0102(84)80013-9; KULLBERG RW, 1977, DEV BIOL, V60, P101, DOI 10.1016/0012-1606(77)90113-0; LEVITT P, 1984, J NEUROSCI, V4, P2553; LIN JW, 1990, P NATL ACAD SCI USA, V87, P8257, DOI 10.1073/pnas.87.21.8257; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LOHMANN SM, 1978, P NATL ACAD SCI USA, V75, P4037, DOI 10.1073/pnas.75.8.4037; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; MASON CA, 1986, NEUROSCIENCE, V19, P1919; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; SANES DH, 1989, NEURON, V2, P1237, DOI 10.1016/0896-6273(89)90308-5; SANES JR, 1990, COLD SH Q B, V55, P419; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; Tabti N., 1991, CULTURING NERVE CELL, P137; TRIMBLE WS, 1991, ANNU REV NEUROSCI, V14, P93, DOI 10.1146/annurev.ne.14.030191.000521; WEISS S, 1986, P NATL ACAD SCI USA, V83, P2238, DOI 10.1073/pnas.83.7.2238; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	39	130	132	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					521	529		10.1016/0896-6273(92)90280-Q	http://dx.doi.org/10.1016/0896-6273(92)90280-Q			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1312849				2022-12-28	WOS:A1992HK67500012
J	RORDORF, G; KOROSHETZ, WJ; BONVENTRE, JV				RORDORF, G; KOROSHETZ, WJ; BONVENTRE, JV			HEAT-SHOCK PROTECTS CULTURED NEURONS FROM GLUTAMATE TOXICITY	NEURON			English	Article							TRANSIENT ISCHEMIA; HYPERTHERMIA PROTECTS; STRIATAL CULTURES; GENE-EXPRESSION; BINDING-PROTEIN; HSP70; RAT; CELLS; INDUCTION; RECEPTOR	Expression of heat shock proteins (HSPs) occurs in brain after ischemia and status epilepticus. We report that induction of the heat shock response in cortical cultures protects neurons from glutamate-induced excitotoxicity. Cultures heated to 42.2-degrees-C for 20 min showed an overall decrease in protein synthesis but an increase in the synthesis of approximately 72 and approximately 85 kd proteins and in the levels of HSP70 mRNA. Heat shock inhibited excitotoxicity in cells exposed to glutamate at 3 or 24 hr following heat exposure, but not when the interval between heat and glutamate exposure was shortened to 15 min or lengthened to 48 hr. Protection due to heat shock required new protein synthesis, since it did not occur when protein or RNA synthesis inhibitors were added. By ameliorating excitotoxic processes, HSPs may attenuate brain injury in certain pathologic conditions.	MASSACHUSETTS GEN HOSP,MED SERV,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,NEUROL SERV,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	RORDORF, G (corresponding author), MASSACHUSETTS GEN HOSP,STROKE RES CTR,BOSTON,MA 02114, USA.				NIDDK NIH HHS [DK39773] Funding Source: Medline; NINDS NIH HHS [NS10828] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039773, R37DK039773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS010828, P01NS010828] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASHBURNER M, 1979, CELL, V17, P241, DOI 10.1016/0092-8674(79)90150-8; BARBE MF, 1988, SCIENCE, V241, P1817, DOI 10.1126/science.3175623; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOPP M, 1989, NEUROLOGY, V39, P1396, DOI 10.1212/WNL.39.10.1396; DWYER BE, 1989, EXP NEUROL, V104, P28, DOI 10.1016/0014-4886(89)90005-8; FREESE A, 1990, BRAIN RES, V521, P254, DOI 10.1016/0006-8993(90)91550-Z; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; GONZALEZ MF, 1989, MOL BRAIN RES, V6, P93, DOI 10.1016/0169-328X(89)90033-8; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; JOHNSTON RN, 1988, SCIENCE, V242, P1551, DOI 10.1126/science.3201244; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; KOROSHETZ W, 1990, NEUROSCI RES       S, V13, P65; KOROSHETZ WJ, 1990, BRAIN RES, V521, P265, DOI 10.1016/0006-8993(90)91551-Q; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MARINI AM, 1990, J NEUROCHEM, V54, P1509, DOI 10.1111/j.1471-4159.1990.tb01198.x; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MILLER EK, 1991, J NEUROCHEM, V56, P2060, DOI 10.1111/j.1471-4159.1991.tb03467.x; MOORE SK, 1989, J BIOL CHEM, V264, P5343; MORANGE M, 1984, MOL CELL BIOL, V4, P730, DOI 10.1128/MCB.4.4.730; NOWAK TS, 1989, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1988, P229; NOWAK TS, 1985, J NEUROCHEM, V45, P1635, DOI 10.1111/j.1471-4159.1985.tb07236.x; NOWAK TS, 1990, STROKE, V21, P107; NOWAK TS, 1990, J NEUROCHEM, V54, P451, DOI 10.1111/j.1471-4159.1990.tb01893.x; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PELHAM HRB, 1989, EMBO J, V8, P3171, DOI 10.1002/j.1460-2075.1989.tb08475.x; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; RIABOWOL KT, 1988, SCIENCE, V242, P433, DOI 10.1126/science.3175665; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; SANCHEZ ER, 1985, J BIOL CHEM, V260, P2398; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; SCHUH S, 1985, J BIOL CHEM, V260, P4292; SELLMAYER A, 1991, J BIOL CHEM, V266, P3800; SIMON RP, 1991, J NEUROSCI, V11, P881; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; SZEKELY AM, 1990, MOL PHARMACOL, V38, P624; TYTELL M, 1986, BRAIN RES, V363, P161, DOI 10.1016/0006-8993(86)90671-2; VASS K, 1989, NEUROSCI LETT, V100, P259, DOI 10.1016/0304-3940(89)90695-2; WALKER WEC, 1956, NEW ENGL J MED, V255, P449; WELCH WJ, 1986, J CELL BIOL, V103, P2035, DOI 10.1083/jcb.103.5.2035; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; WU C, 1987, SCIENCE, V238, P1247, DOI 10.1126/science.3685975	45	189	196	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					1043	1051		10.1016/0896-6273(91)90348-4	http://dx.doi.org/10.1016/0896-6273(91)90348-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1722411				2022-12-28	WOS:A1991GY43800016
J	DESARMENIEN, MG; SPITZER, NC				DESARMENIEN, MG; SPITZER, NC			ROLE OF CALCIUM AND PROTEIN-KINASE-C IN DEVELOPMENT OF THE DELAYED RECTIFIER POTASSIUM CURRENT IN XENOPUS SPINAL NEURONS	NEURON			English	Article							CHICK LIMB MOTONEURONS; EARLY DIFFERENTIATION; NEURAL INDUCTION; CHANNEL ACTIVITY; CORD NEURONS; CULTURE; MODULATION; SODIUM; CA-2+; CELLS	The delayed rectifier current of embryonic Xenopus spinal neurons plays the central role in developmental conversion of calcium-dependent action potentials to sodium-dependent spikes. During its maturation, this potassium current undergoes a pronounced increase in rate of activation. The mechanism underlying the change in kinetics was analyzed with whole-cell voltage clamp of neurons cultured under various conditions. Calcium is necessary at an early stage of development, to permit influx that triggers subsequent release of calcium from intracellular stores. Its action is prevented by depletion of protein kinase C and mimicked by stimulation of the kinase. Calcium influx through voltage-dependent channels at early stages of development regulates the differentiation of potassium current kinetics and modulation of the ionic dependence of action potentials.	UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, CTR MOLEC GENET, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego				Spitzer, Nicholas/0000-0002-3523-1103	NINDS NIH HHS [NS25916] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS025916] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUGUSTINE CK, 1990, J GEN PHYSIOL, V95, P245, DOI 10.1085/jgp.95.2.245; BACCAGLINI PI, 1977, J PHYSIOL-LONDON, V271, P93, DOI 10.1113/jphysiol.1977.sp011992; BADER CR, 1985, J PHYSIOL-LONDON, V366, P129, DOI 10.1113/jphysiol.1985.sp015789; BARISH ME, 1986, J PHYSIOL-LONDON, V375, P229, DOI 10.1113/jphysiol.1986.sp016114; BIXBY JL, 1984, DEV BIOL, V106, P89, DOI 10.1016/0012-1606(84)90065-4; BLAIR LAC, 1983, J NEUROSCI, V3, P1430; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; HARRIS GL, 1988, NEURON, V1, P739, DOI 10.1016/0896-6273(88)90172-9; HENDERSON LP, 1986, DEV BIOL, V113, P381, DOI 10.1016/0012-1606(86)90173-9; HEPLER JR, 1988, J BIOL CHEM, V263, P7610; HOLLIDAY J, 1991, NEURON, V7, P787, DOI 10.1016/0896-6273(91)90281-4; HOLLIDAY J, 1990, DEV BIOL, V141, P13, DOI 10.1016/0012-1606(90)90098-4; HUSSY N, 1991, DEV BIOL, V147, P225, DOI 10.1016/S0012-1606(05)80020-X; KIDOKORO Y, 1980, DEV BIOL, V78, P464, DOI 10.1016/0012-1606(80)90347-4; KIKKAWA U, 1986, ANNU REV CELL BIOL, V2, P149, DOI 10.1146/annurev.cb.02.110186.001053; KRIEGER C, 1988, CAN J PHYSIOL PHARM, V66, P1328, DOI 10.1139/y88-217; LEVITAN IB, 1988, ANNU REV NEUROSCI, V11, P119, DOI 10.1146/annurev.neuro.11.1.119; MCCOBB DP, 1990, J NEUROSCI, V10, P2974; MCCOBB DP, 1989, NEURON, V2, P1633, DOI 10.1016/0896-6273(89)90052-4; MOORE GA, 1987, FEBS LETT, V224, P331, DOI 10.1016/0014-5793(87)80479-9; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; ODOWD DK, 1983, NATURE, V303, P619, DOI 10.1038/303619a0; ODOWD DK, 1988, J NEUROSCI, V8, P792; OLDERSHAW KA, 1990, FEBS LETT, V274, P214, DOI 10.1016/0014-5793(90)81366-V; OTTE AP, 1990, DEVELOPMENT, V110, P461; OTTE AP, 1989, CELL, V58, P641, DOI 10.1016/0092-8674(89)90099-8; RECIOPINTO E, 1990, NEURON, V5, P675, DOI 10.1016/0896-6273(90)90221-Z; RIBERA AB, 1987, P NATL ACAD SCI USA, V84, P6577, DOI 10.1073/pnas.84.18.6577; RIBERA AB, 1991, DEV BIOL, V144, P119, DOI 10.1016/0012-1606(91)90484-K; RIBERA AB, 1990, J NEUROSCI, V10, P1886; RIBERA AB, 1989, NEURON, V2, P1055, DOI 10.1016/0896-6273(89)90229-8; RIBERA AB, 1990, NEURON, V5, P691, DOI 10.1016/0896-6273(90)90223-3; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; RUDY B, 1987, J NEUROSCI, V7, P1613; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SHEARMAN MS, 1989, PHARMACOL REV, V41, P211; SHINOMURA T, 1991, P NATL ACAD SCI USA, V88, P5149, DOI 10.1073/pnas.88.12.5149; Spitzer N.C., 1985, P67; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; YOOL AJ, 1988, J NEUROSCI, V8, P1971; YOUNG S, 1987, BIOCHEM J, V244, P775, DOI 10.1042/bj2440775	41	91	91	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1991	7	5					797	805		10.1016/0896-6273(91)90282-5	http://dx.doi.org/10.1016/0896-6273(91)90282-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1742026				2022-12-28	WOS:A1991GT93900010
J	CLEMENTS, JD; WESTBROOK, GL				CLEMENTS, JD; WESTBROOK, GL			ACTIVATION KINETICS REVEAL THE NUMBER OF GLUTAMATE AND GLYCINE BINDING-SITES ON THE N-METHYL-D-ASPARTATE RECEPTOR	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; MOUSE CENTRAL NEURONS; NMDA RECEPTOR; ACETYLCHOLINE-RECEPTOR; SYNAPTIC CURRENTS; EXCISED PATCHES; XENOPUS OOCYTES; TIME COURSE; CHANNELS; RAT	The activation kinetics of N-methyl-D-aspartate (NMDA) channels in outside-out patches from cultured hippocampal neurons were analyzed to determine the number of glutamate and glycine binding sites per channel. Following rapid steps into high concentrations of glutamate, the activation time course was concentration-independent and limited by transitions between the shut, but fully liganded state and the open state. At lower concentrations, ligand binding was rate-limiting. The resulting sigmoidal activation time course was best fitted by a kinetic model with two glutamate binding sites. Glycine concentration jumps in the continuous presence of glutamate were also best fitted with a two-site model. Agonist and coagonist binding were better described by an independent, rather than a sequential model. We suggest that the NMDA receptor is at least a tetramer containing four ligand binding subunits, assuming a single binding site per subunit.	OREGON HLTH SCI UNIV, DEPT NEUROL, PORTLAND, OR 97201 USA	Oregon Health & Science University	CLEMENTS, JD (corresponding author), OREGON HLTH SCI UNIV, VOLLUM INST, PORTLAND, OR 97201 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046613, R37MH046613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS026494, R01NS026494] Funding Source: NIH RePORTER; NIMH NIH HHS [MH46613] Funding Source: Medline; NINDS NIH HHS [NS26494] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1981, J MEMBRANE BIOL, V58, P161, DOI 10.1007/BF01870902; ALDRICH RW, 1987, J NEUROSCI, V7, P418; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P207; BEAN BP, 1990, J NEUROSCI, V10, P1; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; BIRCH PJ, 1988, EUR J PHARMACOL, V156, P177, DOI 10.1016/0014-2999(88)90163-X; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; CACHELIN AB, 1989, J PHYSIOL-LONDON, V415, P159, DOI 10.1113/jphysiol.1989.sp017717; CHANGEUX JP, 1984, SCIENCE, V225, P1335, DOI 10.1126/science.6382611; COLQUHOUN D, 1988, J PHYSIOL-LONDON, V395, P131, DOI 10.1113/jphysiol.1988.sp016912; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COLQUHOUN D, 1977, PROC R SOC SER B-BIO, V199, P231, DOI 10.1098/rspb.1977.0137; Colquhoun D., 1973, DRUG RECEPTORS, P149, DOI [10.1007/978-1-349-00910-7_11, DOI 10.1007/978-1-349-00910-7_11]; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; DIONNE VE, 1978, J PHYSIOL-LONDON, V281, P421, DOI 10.1113/jphysiol.1978.sp012431; EIGEN M, 1963, ADV ENZYMOL REL S BI, V25, P1; FRANKE C, 1987, NEUROSCI LETT, V77, P199, DOI 10.1016/0304-3940(87)90586-6; GIBB AJ, 1991, P ROY SOC B-BIOL SCI, V243, P39, DOI 10.1098/rspb.1991.0007; HARRIS KM, 1986, NEUROSCIENCE, V19, P857, DOI 10.1016/0306-4522(86)90304-0; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HENDERSON G, 1990, J PHYSIOL-LONDON, V430, P189, DOI 10.1113/jphysiol.1990.sp018288; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; HUETTNER JE, 1989, SCIENCE, V243, P1611, DOI 10.1126/science.2467381; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; JAHR CE, 1990, J NEUROSCI, V10, P1830; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Kowalik J.S., 1968, METHODS UNCONSTRAINE; KUSHNER L, 1988, P NATL ACAD SCI USA, V85, P3250, DOI 10.1073/pnas.85.9.3250; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; LEGENDRE P, 1991, IN PRESS MOL PHARM, V40; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1989, MOL PHARMACOL, V35, P565; MACONOCHIE DJ, 1989, PFLUG ARCH EUR J PHY, V414, P589, DOI 10.1007/BF00580996; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MONAGHAN DT, 1988, P NATL ACAD SCI USA, V85, P9836, DOI 10.1073/pnas.85.24.9836; OLVERMAN HJ, 1988, NEUROSCIENCE, V26, P17, DOI 10.1016/0306-4522(88)90124-8; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; THEDINGA KH, 1989, NEUROSCI LETT, V104, P217, DOI 10.1016/0304-3940(89)90357-1; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; ZIMMERMAN AL, 1986, NATURE, V321, P70, DOI 10.1038/321070a0	49	271	277	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1991	7	4					605	613		10.1016/0896-6273(91)90373-8	http://dx.doi.org/10.1016/0896-6273(91)90373-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1681832				2022-12-28	WOS:A1991GM95400009
J	DASCAL, N; LOTAN, I				DASCAL, N; LOTAN, I			ACTIVATION OF PROTEIN-KINASE-C ALTERS VOLTAGE DEPENDENCE OF A NA+ CHANNEL	NEURON			English	Article							FUNCTIONAL SODIUM-CHANNELS; NEURO-BLASTOMA CELLS; RAT-BRAIN NEURONS; XENOPUS-OOCYTES; ALPHA-SUBUNIT; MESSENGER-RNAS; ION CHANNELS; EXPRESSION; PHOSPHORYLATION; INACTIVATION	Phorbol esters and purified protein kinase C (PKC) have been shown to down-modulate the voltage-dependent Na+ channels expressed in Xenopus oocytes injected with chick brain RNA. We used the two-electrode voltage-clamp technique to demonstrate that a Na+ channel expressed in oocytes injected with RNA coding for the alpha subunit of the channel alone (VA200, a variant of rat brain type IIA) is also inhibited by PKC activation. The inhibition of Na+ currents, expressed in oocytes injected with either alpha subunit RNA (rat) or total brain RNA (chick), is voltage-dependent, being stronger at negative potentials. It appears to result mainly from a shift in the activation curve to the right and possibly a decrease in the steepness of the voltage dependence of activation. There is little effect on the inactivation process and maximal Na+ conductance. Thus, PKC modulates the Na+ channel by a mechanism involving changes in voltage-dependent properties of its main, channel-forming alpha subunit.			DASCAL, N (corresponding author), TEL AVIV UNIV,SACKLER FAC MED,DEPT PHYSIOL & PHARMACOL,IL-69978 TEL AVIV,ISRAEL.		Dascal, Nathan/O-3915-2015	Dascal, Nathan/0000-0002-5397-4146				ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BARCHI RL, 1988, ANNU REV NEUROSCI, V11, P455, DOI 10.1146/annurev.ne.11.030188.002323; BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BOTON R, 1989, J PHYSIOL-LONDON, V408, P511, DOI 10.1113/jphysiol.1989.sp017473; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; COHEN-ARMON M, 1989, BRAIN RES, V496, P197, DOI 10.1016/0006-8993(89)91066-4; COSTA MRC, 1984, CELL MOL NEUROBIOL, V4, P291, DOI 10.1007/BF00733592; COSTA MRC, 1984, J BIOL CHEM, V259, P8210; COTA G, 1989, J GEN PHYSIOL, V94, P213, DOI 10.1085/jgp.94.2.213; DASCAL N, 1984, J PHYSIOL-LONDON, V352, P551, DOI 10.1113/jphysiol.1984.sp015310; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; DASCAL N, 1986, SCIENCE, V231, P1147, DOI 10.1126/science.2418503; DIERKS P, 1981, P NATL ACAD SCI-BIOL, V78, P1411, DOI 10.1073/pnas.78.3.1411; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; Hille B, 1984, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kaczmarek LK, 1987, NEUROMODULATION BIOC; KADO RT, 1983, PHYSL EXCITABLE CELL, V5, P247; KEGEL DR, 1985, J NEUROSCI METH, V12, P317, DOI 10.1016/0165-0270(85)90016-0; KRAFTE DS, 1989, J NEUROSCI METH, V26, P211, DOI 10.1016/0165-0270(89)90118-0; KRAFTE DS, 1988, J NEUROSCI, V8, P2859; KRAFTE DS, 1990, IN PRESS J GEN PHYSL; LESTER HA, 1988, SCIENCE, V241, P1057, DOI 10.1126/science.2457947; LILES WC, 1986, J BIOL CHEM, V261, P5307; LINDEN DJ, 1989, J PHYSIOL-LONDON, V419, P95, DOI 10.1113/jphysiol.1989.sp017863; LONNENDONKER U, 1989, BIOCHIM BIOPHYS ACTA, V985, P153, DOI 10.1016/0005-2736(89)90360-X; LOTAN I, 1988, NEURON, V1, P963, DOI 10.1016/0896-6273(88)90153-5; LOTAN I, 1990, FEBS LETT, V267, P25, DOI 10.1016/0014-5793(90)80279-R; MEIRI H, 1989, BRAIN RES, V502, P401, DOI 10.1016/0006-8993(89)90636-7; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; MORAN O, 1989, MOL BRAIN RES, V5, P193, DOI 10.1016/0169-328X(89)90035-1; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PARKER I, 1987, PROC R SOC SER B-BIO, V232, P289, DOI 10.1098/rspb.1987.0075; ROSSIE S, 1987, J BIOL CHEM, V262, P12735; ROSSIE S, 1989, J BIOL CHEM, V264, P14220; ROSSIE S, 1987, J BIOL CHEM, V36, P15730; SCHEUER T, 1990, SCIENCE, V247, P854, DOI 10.1126/science.2154850; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; SCHUBERT B, 1989, SCIENCE, V245, P516, DOI 10.1126/science.2547248; SHEARMAN MS, 1989, PHARMACOL REV, V41, P211; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0	54	109	110	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1991	6	1					165	175		10.1016/0896-6273(91)90131-I	http://dx.doi.org/10.1016/0896-6273(91)90131-I			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1702650				2022-12-28	WOS:A1991EU27800016
J	MATTSON, MP; RYCHLIK, B; CHU, C; CHRISTAKOS, S				MATTSON, MP; RYCHLIK, B; CHU, C; CHRISTAKOS, S			EVIDENCE FOR CALCIUM-REDUCING AND EXCITO-PROTECTIVE ROLES FOR THE CALCIUM-BINDING PROTEIN CALBINDIN-D(28K) IN CULTURED HIPPOCAMPAL-NEURONS	NEURON			English	Article							IMMUNOCYTOCHEMICAL LOCALIZATION; RAT; GLUTAMATE; BRAIN; NEUROARCHITECTURE; PARVALBUMIN; NEUROTOXICITY; PURIFICATION; DEGENERATION; DEPENDENCE	Neuronal systems for calcium homeostasis are crucial for neuronal development and function and may also contribute to selective neuronal vulnerability in adverse conditions such as exposure to excitatory amino acids or anoxia, and in neurodegenerative diseases. Previous work demonstrated the presence and differential distribution of calcium-binding proteins in the CNS. We now report that a subpopulation of neurons in disociated cell cultures of embryonic rat hippocampus expresses calbindin-D28k (M(r) 28,000 calcium-binding protein) immunoreactivity and that these neurons are relatively resistant to neurotoxicity induced by either glutamate or calcium ionophore. Direct comparisons of dynamic aspects of intracellular calcium levels and calbindin-D28k immunoreactivity in the same neurons revealed that calbindin-D28k-positive neurons were better able to reduce free intracellular calcium levels than calbindin-D28k-negative neurons. These findings indicate that the differential expression of calbindin-D28k in hippocampal neurons occurs early in development and may be one determinant of selective neuronal vulnerability to excitotoxic insults.	UNIV KENTUCKY, DEPT ANAT & NEUROBIOL, LEXINGTON, KY 40536 USA; UNIV MED & DENT NEW JERSEY, NEW JERSEY MED SCH, DEPT BIOCHEM & MOLEC BIOL, NEWARK, NJ 07103 USA	University of Kentucky; Rutgers State University New Brunswick; Rutgers State University Medical Center	MATTSON, MP (corresponding author), UNIV KENTUCKY, SANDERS BROWN RES CTR AGING, LEXINGTON, KY 40536 USA.		Mattson, Mark P/F-6038-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020270] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38961] Funding Source: Medline; NINDS NIH HHS [NS20270] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BAIMBRIDGE KG, 1982, BRAIN RES, V245, P223, DOI 10.1016/0006-8993(82)90804-6; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BAUDIER J, 1985, J BIOL CHEM, V260, P662; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; BORLE AB, 1987, CALCIUM CELL FUNCTIO, V7, P159; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CACERES A, 1986, J NEUROSCI, V6, P714; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CELIO MR, 1981, NATURE, V293, P300, DOI 10.1038/293300a0; CHOI DW, 1987, J NEUROSCI, V7, P369; CHRISTAKOS S, 1989, ENDOCR REV, V10, P3, DOI 10.1210/edrv-10-1-3; CHRISTAKOS S, 1987, METHOD ENZYMOL, V139, P534; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; FELDMAN SC, 1983, ENDOCRINOLOGY, V112, P290, DOI 10.1210/endo-112-1-290; GIBSON GE, 1987, NEUROBIOL AGING, V8, P329, DOI 10.1016/0197-4580(87)90072-8; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; IACOPINO AM, 1990, J BIOL CHEM, V265, P10177; IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078; ICHIMIYA Y, 1989, BRAIN RES, V499, P402, DOI 10.1016/0006-8993(89)90793-2; JANDE SS, 1981, NATURE, V294, P765, DOI 10.1038/294765a0; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; KHACHATURIAN ZS, 1989, ANN NY ACAD SCI, V568, P1, DOI 10.1111/j.1749-6632.1989.tb12485.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LLINAS RR, 1982, SCI AM, V247, P56, DOI 10.1038/scientificamerican1082-56; MATTSON MP, 1989, MECH AGEING DEV, V50, P103, DOI 10.1016/0047-6374(89)90010-9; MATTSON MP, 1988, INT J DEV NEUROSCI, V6, P439, DOI 10.1016/0736-5748(88)90050-0; MATTSON MP, 1989, BRAIN RES, V490, P110, DOI 10.1016/0006-8993(89)90436-8; MATTSON MP, 1989, FASEB J, V3, P2519, DOI 10.1096/fasebj.3.13.2572500; MATTSON MP, 1990, INT J DEV NEUROSCI, V8, P399, DOI 10.1016/0736-5748(90)90073-B; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MATTSON MP, 1990, NEURON, V4, P105, DOI 10.1016/0896-6273(90)90447-N; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MATTSON MP, 1990, CURRENT ASPECTS NEUR, P1; McLachlan D R, 1987, Alzheimer Dis Assoc Disord, V1, P171, DOI 10.1097/00002093-198701030-00009; MILLS LR, 1990, NEURON, V4, P149, DOI 10.1016/0896-6273(90)90451-K; MORGAN DW, 1986, BIOCHEM BIOPH RES CO, V138, P547, DOI 10.1016/S0006-291X(86)80531-9; NADLER JV, 1980, BRAIN RES, V195, P47; NITSCH C, 1989, NEUROSCI LETT, V105, P263, DOI 10.1016/0304-3940(89)90631-9; OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; SCANLON M, 1987, J BIOL CHEM, V262, P6308; SCHARFMAN HE, 1989, SCIENCE, V246, P257, DOI 10.1126/science.2508225; SETOOHSHIMA A, 1988, LANCET, V1, P1252; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; SONNENBERG J, 1990, IN PRESS MOL BRAIN R; VANELDIK LJ, 1982, INT REV CYTOL, V77, P1, DOI 10.1016/S0074-7696(08)62463-8; VARGHESE S, 1988, J BIOL CHEM, V263, P9776; WASSERMA.RH, 1966, SCIENCE, V152, P791, DOI 10.1126/science.152.3723.791	53	509	515	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1991	6	1					41	51		10.1016/0896-6273(91)90120-O	http://dx.doi.org/10.1016/0896-6273(91)90120-O			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1670921				2022-12-28	WOS:A1991EU27800005
J	FADOOL, DA; ACHE, BW				FADOOL, DA; ACHE, BW			PLASMA-MEMBRANE INOSITOL 1,4,5-TRISPHOSPHATE-ACTIVATED CHANNELS MEDIATE SIGNAL TRANSDUCTION IN LOBSTER OLFACTORY RECEPTOR NEURONS	NEURON			English	Article							2ND MESSENGER PATHWAYS; CALCIUM RELEASE; SMOOTH-MUSCLE; TRISPHOSPHATE RECEPTOR; GUANINE-NUCLEOTIDE; MOUSE CEREBELLUM; CELLS; HEPARIN; CONDUCTANCE; CILIA	Inositol 1,4,5-trisphosphate (IP3) selectively evokes an inward (excitatory) current in cultured lobster olfactory receptor neurons (ORNs) and directly activates two types of channels in cell-free patches of plasma membrane from the ORNs. The IP3-activated channels have kinetic properties of odor-activated channels in the ORNs and pharmacological properties of intracellular IP3-activated channels in other systems. An antibody directed against an intracellular, cerebellar IP3 receptor recognizes a protein with a molecular weight similar to the mammalian receptor in the ORNs. The antibody selectively increases odor-evoked inward currents and IP3-activated unitary currents in the ORNs. The data provide further evidence for IP3 as an olfactory second messenger and implicate at least one and possibly two novel plasma membrane IP3 receptors in olfactory transduction.	UNIV FLORIDA,DEPT ZOOL,ST AUGUSTINE,FL 32086; UNIV FLORIDA,DEPT NEUROSCI,ST AUGUSTINE,FL 32086	State University System of Florida; University of Florida; State University System of Florida; University of Florida	FADOOL, DA (corresponding author), UNIV FLORIDA,WHITNEY LAB,ST AUGUSTINE,FL 32086, USA.				NIDCD NIH HHS [1 R01 DC01655-01, R01 DC001655] Funding Source: Medline; NIMH NIH HHS [F31 MH010124, 1F31MH10124-01A1, F31 MH010124-03] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH010124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001655] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANHOLT RRH, 1991, CHEM SENSES, V16, P421, DOI 10.1093/chemse/16.5.421; BERRIDGE MJ, 1989, JAMA-J AM MED ASSOC, V262, P1834; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BREER H, 1991, CHEM SENSES, V16, P19, DOI 10.1093/chemse/16.1.19; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Carr W.E.S., 1988, P3; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; DECAMILLI P, 1990, NATURE, V344, P495, DOI 10.1038/344495a0; DIONNE VE, 1992, J GEN PHYSIOL, V99, P415, DOI 10.1085/jgp.99.3.415; EHRLICH BE, 1988, NATURE, V336, P583, DOI 10.1038/336583a0; FADOOL DA, 1991, TISSUE CELL, V23, P719, DOI 10.1016/0040-8166(91)90025-O; FADOOL DA, 1993, IN PRESS J EXP BIOL; FERRIS CD, 1990, P NATL ACAD SCI USA, V87, P2147, DOI 10.1073/pnas.87.6.2147; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P469, DOI 10.1146/annurev.physiol.54.1.469; FFISHER SK, 1992, J NEUROCHEM, V58, P18; FIRESTEIN S, 1991, J NEUROSCI, V11, P3565; FIRESTEIN S, 1991, TRENDS NEUROSCI, V14, P270, DOI 10.1016/0166-2236(91)90135-H; FRANK TM, 1991, J GEN PHYSIOL, V97, P697, DOI 10.1085/jgp.97.4.697; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILL TD, 1987, BIOCHEM BIOPH RES CO, V149, P897, DOI 10.1016/0006-291X(87)90492-X; HUQUE T, 1986, BIOCHEM BIOPH RES CO, V137, P36, DOI 10.1016/0006-291X(86)91172-1; KALINOSKI DL, 1992, BIOCHEM J, V281, P449, DOI 10.1042/bj2810449; KHAN AA, 1992, P NATL ACAD SCI USA, V89, P2849, DOI 10.1073/pnas.89.7.2849; KOBAYASHI S, 1988, BIOCHEM BIOPH RES CO, V153, P625, DOI 10.1016/S0006-291X(88)81141-0; KOMORI S, 1991, PFLUG ARCH EUR J PHY, V418, P437, DOI 10.1007/BF00497770; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; MAEDA N, 1991, J BIOL CHEM, V266, P1109; MAEDA N, 1989, DEV BIOL, V133, P67, DOI 10.1016/0012-1606(89)90297-2; MAYRLEITNER M, 1991, CELL CALCIUM, V12, P505, DOI 10.1016/0143-4160(91)90032-A; MCCLINTOCK TS, 1989, CHEM SENSES, V14, P637, DOI 10.1093/chemse/14.5.637; MICHEL WC, 1991, J NEUROPHYSIOL, V65, P446, DOI 10.1152/jn.1991.65.3.446; MICHEL WM, 1992, IN PRESS J NEUROSCI; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MITTMAN S, 1987, J NEUROSCI METH, V22, P161, DOI 10.1016/0165-0270(87)90010-0; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; REED RR, 1992, NEURON, V8, P205, DOI 10.1016/0896-6273(92)90287-N; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; VIVEN J, 1988, NATURE, V336, P587; WATRAS J, 1991, J NEUROSCI, V11, P3239; WORLEY PF, 1987, NATURE, V325, P159, DOI 10.1038/325159a0	46	227	229	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1992	9	5					907	918		10.1016/0896-6273(92)90243-7	http://dx.doi.org/10.1016/0896-6273(92)90243-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1384577	Green Accepted			2022-12-28	WOS:A1992JY55200010
J	ROBINSON, PR; COHEN, GB; ZHUKOVSKY, EA; OPRIAN, DD				ROBINSON, PR; COHEN, GB; ZHUKOVSKY, EA; OPRIAN, DD			CONSTITUTIVELY ACTIVE MUTANTS OF RHODOPSIN	NEURON			English	Article							DOMINANT RETINITIS-PIGMENTOSA; SCHIFF-BASE COUNTERION; BOVINE RHODOPSIN; G-PROTEIN; TRANSDUCIN ACTIVATION; METARHODOPSIN-II; RESONANCE RAMAN; VISUAL PIGMENTS; GENE; MUTATIONS	Two critical amino acids in the visual pigment rhodopsin are Lys-296, the site of attachment of retinal to the protein through a protonated Schiff base linkage, and Glu-113, the Schiff base counterion. Mutation of Lys-296 or Glu-113 results in constitutive activation of opsin, as assayed by its ability to activate transducin in the absence of added chromophore. We conclude that opsin is constrained to an inactive conformation by a salt bridge between Lys-296 and Glu-113. Recently, one of the mutants, K296E, was found in a family with retinitis pigmentosa, suggesting that degeneration of the photoreceptor cells in individuals with this mutation may result from persistent stimulation of the phototransduction pathway.			ROBINSON, PR (corresponding author), BRANDEIS UNIV,GRAD DEPT BIOCHEM,WALTHAM,MA 02254, USA.		Zhukovsky, Eugene/Q-3218-2019		NATIONAL EYE INSTITUTE [R01EY007965] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY007965, EY07965] Funding Source: Medline; NIGMS NIH HHS [5T32 GM0796] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN LF, 1991, P NATL ACAD SCI USA, V88, P11354, DOI 10.1073/pnas.88.24.11354; APPLEBURY ML, 1990, NATURE, V343, P316, DOI 10.1038/343316a0; BAEHR W, 1982, J BIOL CHEM, V257, P6452; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DOUKAS AG, 1978, BIOCHEMISTRY-US, V17, P2430, DOI 10.1021/bi00605a028; DRATZ EA, 1983, TRENDS BIOCHEM SCI, V8, P128, DOI 10.1016/0968-0004(83)90235-9; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; EMEIS D, 1982, FEBS LETT, V143, P29, DOI 10.1016/0014-5793(82)80266-4; FARRAR GJ, 1990, AM J HUM GENET, V47, P941; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; FINDLAY JBC, 1986, BIOCHEM J, V238, P6265; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; HONIG B, 1979, P NATL ACAD SCI USA, V76, P2503, DOI 10.1073/pnas.76.6.2503; KEEN TJ, 1991, GENOMICS, V11, P199, DOI 10.1016/0888-7543(91)90119-Y; KHORANA HG, 1992, J BIOL CHEM, V267, P1; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; LONGSTAFF C, 1986, P NATL ACAD SCI USA, V83, P4209, DOI 10.1073/pnas.83.12.4209; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; OPRIAN DD, 1992, J BIOENERG BIOMEMBR, V24, P211, DOI 10.1007/BF00762679; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; OSEROFF AR, 1974, BIOCHEMISTRY-US, V13, P4243, DOI 10.1021/bi00717a027; OVCHINNIKOV YA, 1982, BIOORG KHIM+, V8, P1011; RADDING CM, 1956, J GEN PHYSIOL, V39, P909, DOI 10.1085/jgp.39.6.909; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; STROSBERG AD, 1991, EUR J BIOCHEM, V196, P1, DOI 10.1111/j.1432-1033.1991.tb15778.x; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P3697; ZHUKOVSKY EA, 1991, SCIENCE, V251, P558, DOI 10.1126/science.1990431; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	42	439	442	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					719	725		10.1016/0896-6273(92)90034-B	http://dx.doi.org/10.1016/0896-6273(92)90034-B			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1356370				2022-12-28	WOS:A1992JT51600012
J	GUNDERSEN, CB; UMBACH, JA				GUNDERSEN, CB; UMBACH, JA			SUPPRESSION CLONING OF THE CDNA FOR A CANDIDATE SUBUNIT OF A PRESYNAPTIC CALCIUM-CHANNEL	NEURON			English	Article								A novel strategy, termed suppression cloning, was used to identify a 7.4 kb cDNA encoding a putative subunit of the calcium channels that regulate transmitter release at nerve endings of Torpedo californica. The 585 nt open reading frame of this cDNA encodes a polypeptide of about 21.7 kd that is essential for the expression in frog oocytes of omega-conotoxin-sensitive, dihydropyridine-resistant, calcium channels. Sequence analysis reveals that this protein is closely related to two cloned cysteine string proteins of undetermined function that were recently localized to Drosophila nerve terminals using monoclonal antibodies.	UNIV CALIF LOS ANGELES, SCH MED, DEPT PHARMACOL, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	GUNDERSEN, CB (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, JERRY LEWIS NEUROMUSCULAR RES CTR, LOS ANGELES, CA 90024 USA.							ABE T, 1987, J BIOL CHEM, V262, P9877; AHLIJANIAN MK, 1991, J BIOL CHEM, V266, P20192; BARHANIN J, 1988, BIOCHEM BIOPH RES CO, V150, P1051, DOI 10.1016/0006-291X(88)90736-X; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; CATTERALL WA, 1991, SCIENCE, V253, P1499, DOI 10.1126/science.1654596; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COHEN MW, 1991, J NEUROSCI, V11, P1032; CREIGHTON TC, 1983, PROTEINS STRUCTURES, P20; CRUZ LJ, 1987, BIOCHEMISTRY-US, V26, P820, DOI 10.1021/bi00377a024; DASCAL N, 1986, SCIENCE, V231, P1147, DOI 10.1126/science.2418503; DASH P, 1987, P NATL ACAD SCI USA, V84, P7896, DOI 10.1073/pnas.84.22.7896; DOOLITTLE RF, 1986, PRIMER ANAL DERIVED, P55; FELDMAN DH, 1987, FEBS LETT, V214, P295, DOI 10.1016/0014-5793(87)80073-X; HAY B, 1992, STRATEGIES, V5, P16; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HORNE WA, 1991, J BIOL CHEM, V266, P13719; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; KASAI H, 1987, Neuroscience Research, V4, P228, DOI 10.1016/0168-0102(87)90014-9; KELLY RB, 1988, NEURON, V1, P431, DOI 10.1016/0896-6273(88)90174-2; KERR LM, 1984, NATURE, V308, P282, DOI 10.1038/308282a0; KOYANO K, 1987, EUR J PHARMACOL, V135, P337, DOI 10.1016/0014-2999(87)90683-2; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRUYS V, 1987, P NATL ACAD SCI USA, V84, P6030, DOI 10.1073/pnas.84.17.6030; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEONARD JP, 1987, J NEUROSCI, V7, P875; LOTAN I, 1989, SCIENCE, V243, P666, DOI 10.1126/science.2464853; LUBBERT H, 1987, P NATL ACAD SCI USA, V84, P4332, DOI 10.1073/pnas.84.12.4332; MAGEE T, 1988, NATURE, V335, P114, DOI 10.1038/335114a0; Maniatis T., 1982, MOL CLONING; MARQUEZE B, 1988, MOL PHARMACOL, V34, P87; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MCENERY MW, 1991, P NATL ACAD SCI USA, V88, P11095, DOI 10.1073/pnas.88.24.11095; MCGOOKIN R, 1984, METHOD MOL BIOL, V2, P121; MELTON DA, 1985, P NATL ACAD SCI USA, V82, P144, DOI 10.1073/pnas.82.1.144; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; NODA M, 1983, NATURE, V301, P251, DOI 10.1038/301251a0; OLIVERA BM, 1984, BIOCHEMISTRY-US, V23, P5087, DOI 10.1021/bi00317a001; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; ROSENBERG RL, 1989, ANN NY ACAD SCI, V560, P39, DOI 10.1111/j.1749-6632.1989.tb24077.x; SAISU H, 1991, BIOCHEM BIOPH RES CO, V181, P59, DOI 10.1016/S0006-291X(05)81381-6; SAKAMOTO J, 1991, J BIOL CHEM, V266, P18914; SAKMANN B, 1985, NATURE, V318, P538, DOI 10.1038/318538a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANGUINETTI MC, 1984, CIRC RES, V55, P336, DOI 10.1161/01.RES.55.3.336; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SCHWARZ TL, 1990, NEURON, V4, P119, DOI 10.1016/0896-6273(90)90448-O; SCHWARZ TL, 1991, NEURON, V42, P301; SHER E, 1991, NEUROSCIENCE, V42, P301, DOI 10.1016/0306-4522(91)90376-Y; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; SUMIKAWA K, 1988, P NATL ACAD SCI USA, V85, P1302, DOI 10.1073/pnas.85.4.1302; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; UMBACH JA, 1991, ANN NY ACAD SCI, V635, P443, DOI 10.1111/j.1749-6632.1991.tb36522.x; UMBACH JA, 1987, P NATL ACAD SCI USA, V84, P5464, DOI 10.1073/pnas.84.15.5464; UMBACH JA, 1988, CALCIUM ION CHANNEL, P75; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; WEI XY, 1991, J BIOL CHEM, V266, P21943; WONG KR, 1991, J BIOL CHEM, V266, P14451; YAMAGUCHI T, 1988, J BIOL CHEM, V263, P9491; YEAGER RE, 1987, J NEUROSCI, V7, P2390; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	66	127	128	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1992	9	3					527	537		10.1016/0896-6273(92)90190-O	http://dx.doi.org/10.1016/0896-6273(92)90190-O			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1326297				2022-12-28	WOS:A1992JM57100014
J	KUO, CC; HESS, P				KUO, CC; HESS, P			A FUNCTIONAL VIEW OF THE ENTRANCES OF L-TYPE CA2+ CHANNELS - ESTIMATES OF THE SIZE AND SURFACE-POTENTIAL AT THE PORE MOUTHS	NEURON			English	Article							GRAMICIDIN-A CHANNELS; CALCIUM CHANNELS; ION MOVEMENT; CONCENTRATION-DEPENDENCE; SINGLE; CONDUCTANCE; PERMEATION; VOLTAGE; MUSCLE; CHARGE	At extreme membrane potentials, the unitary inward and outward currents through L-type Ca2+ channels become diffusion controlled and saturate. The magnitudes of these currents indicate that the pore entrances are asymmetric, with the external mouth being much larger than the internal one. On the other hand, negative surface potentials at the two ends of the pore are rather similar. Both would be significant only when the ambient ionic strength is 110 mM or less. We conclude that the surface charges will not help much in concentrating the channel's favorite divalent cations in the physiological condition. However, the pore does possess an external mouth large enough to make the important inward Ca2+ flow not limited by diffusion, even with only 1 mM external Ca2+.	HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,PROGRAM NEUROSCI,BOSTON,MA 02115	Harvard University; Harvard Medical School				Kuo, Chung-Chin/0000-0001-8208-6829	NHLBI NIH HHS [HL-37124] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037124] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSEN OS, 1983, BIOPHYS J, V41, P119, DOI 10.1016/S0006-3495(83)84414-2; ANDERSEN OS, 1983, BIOPHYS J, V41, P147, DOI 10.1016/S0006-3495(83)84416-6; ANDERSEN OS, 1983, BIOPHYS J, V41, P135, DOI 10.1016/S0006-3495(83)84415-4; BERG HC, 1983, RANDOM WALKS BIOL, P17; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; CORONADO R, 1986, J GEN PHYSIOL, V87, P933, DOI 10.1085/jgp.87.6.933; DANI JA, 1986, BIOPHYS J, V49, P607, DOI 10.1016/S0006-3495(86)83688-8; EISENBERG D, 1969, STRUCTURE PROPERTIES, P296; GARYBOBO CM, 1969, J GEN PHYSIOL, V54, P369, DOI 10.1085/jgp.54.3.369; GRAHAME DC, 1947, CHEM REV, V41, P441, DOI 10.1021/cr60130a002; GREEN WN, 1991, ANNU REV PHYSIOL, V53, P341, DOI 10.1146/annurev.ph.53.030191.002013; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; KATZ Y, 1974, J MEMBRANE BIOL, V17, P87, DOI 10.1007/BF01870174; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MCCLESKEY EW, 1985, P NATL ACAD SCI USA, V82, P7149, DOI 10.1073/pnas.82.20.7149; NEYTON J, 1988, J GEN PHYSIOL, V92, P549, DOI 10.1085/jgp.92.5.549; Pauling L., 1960, NATURE CHEM BOND, P644; PIETROBON D, 1989, J GEN PHYSIOL, V94, P1, DOI 10.1085/jgp.94.1.1; SCHULTZ SG, 1961, J GEN PHYSIOL, V44, P1189, DOI 10.1085/jgp.44.6.1189; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; WESAST RC, 1987, HDB CHEM PHYSICS, pD232	23	34	34	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					515	526		10.1016/0896-6273(92)90189-K	http://dx.doi.org/10.1016/0896-6273(92)90189-K			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1381926				2022-12-28	WOS:A1992JM57100013
J	JAHROMI, BS; ROBITAILLE, R; CHARLTON, MP				JAHROMI, BS; ROBITAILLE, R; CHARLTON, MP			TRANSMITTER RELEASE INCREASES INTRACELLULAR CALCIUM IN PERISYNAPTIC SCHWANN-CELLS INSITU	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; PRIMARY ASTROCYTE CULTURES; CYTOSOLIC CA-2+; PEPTIDE; POTASSIUM; CHANNELS; SQUID	Glial cells isolated from the nervous system are sensitive to neurotransmitters and may therefore be involved in synaptic transmission. The sensitivity of individual perisynaptic Schwann cells to activity of a single synapse was investigated, in situ, at the frog neuromuscular junction by monitoring changes in intracellular Ca2+ in the Schwann cells. Motor nerve stimulation induced an increase in intracellular Ca2+ in these Schwann cells; this increase was greatly reduced when transmitter release was blocked. Furthermore, local application of the cotransmitters acetylcholine and ATP evoked Ca2+ responses even in the absence of extracellular Ca2+. Successive trains of nerve stimuli or applications of transmitters resulted in progressively smaller Ca2+ reponses. We conclude that transmitter released during synaptic activity can evoke release of intracellular Ca2+ in perisynaptic Schwann cells. This Ca2+ signal may play a role in the maintenance or modulation of a synapse. These data show that synaptic transmission involves three cellular components with both postsynaptic and glial components responding to transmitter secretion.			JAHROMI, BS (corresponding author), UNIV TORONTO,NATL CTR EXCELLENCE,DEPT PHYSIOL,MED SCI BLDG,TORONTO M5S 1A8,ONTARIO,CANADA.			Robitaille, Richard/0000-0001-6628-0146; Jahromi, Babak S./0000-0001-5064-5278				AHMED Z, 1990, BRAIN RES, V516, P165, DOI 10.1016/0006-8993(90)90914-W; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BERWALDNETTER Y, 1986, ASTROCYTES, P51; BEVAN S, 1973, NATURE-NEW BIOL, V241, P85, DOI 10.1038/newbio241085a0; BIRKS R, 1960, J PHYSIOL-LONDON, V150, P134, DOI 10.1113/jphysiol.1960.sp006378; COHEN MW, 1991, J NEUROSCI, V11, P1032; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CORNELLBELL AH, 1991, CELL CALCIUM, V12, P185, DOI 10.1016/0143-4160(91)90020-F; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DAVE V, 1991, GLIA, V4, P440, DOI 10.1002/glia.440040503; DENNIS MJ, 1974, J PHYSIOL-LONDON, V237, P431, DOI 10.1113/jphysiol.1974.sp010490; DEROUICHE A, 1991, BRAIN RES, V552, P346, DOI 10.1016/0006-8993(91)90103-3; DREYER F, 1974, PFLUG ARCH EUR J PHY, V348, P257, DOI 10.1007/BF00587416; ENKVIST MOK, 1989, BRAIN RES, V500, P46, DOI 10.1016/0006-8993(89)90298-9; ERULKAR SD, 1977, J PHYSIOL-LONDON, V266, P209, DOI 10.1113/jphysiol.1977.sp011764; GRAY WR, 1988, ANNU REV BIOCHEM, V57, P665, DOI 10.1146/annurev.bi.57.070188.003313; HAMPRECHT B, 1986, ASTROCYTES BIOCH PHY, V2, P77; Heuser JE, 1977, HDB PHYSL, VI, P261; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KERR LM, 1984, NATURE, V308, P282, DOI 10.1038/308282a0; KIMELBERG HK, 1989, SCI AM, V260, P66, DOI 10.1038/scientificamerican0489-66; LAUDER JM, 1986, ASTROCYTES, P295; MACVICAR BA, 1984, SCIENCE, V226, P1345, DOI 10.1126/science.6095454; MARRERO H, 1989, NATURE, V339, P378, DOI 10.1038/339378a0; MARTIN DL, 1992, GLIA, V5, P81, DOI 10.1002/glia.440050202; MASSARELLI R, 1986, ASTROCYTES, P155; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; MATTEOLI M, 1990, NEUROSCIENCE, V37, P271, DOI 10.1016/0306-4522(90)90213-N; MCMAHAN UJ, 1972, PROC R SOC SER B-BIO, V181, P421, DOI 10.1098/rspb.1972.0059; NEARY JT, 1988, BIOCHEM BIOPH RES CO, V157, P1410, DOI 10.1016/S0006-291X(88)81032-5; NEWMAN EA, 1985, NATURE, V317, P809, DOI 10.1038/317809a0; NEWMAN EA, 1986, SCIENCE, V233, P453, DOI 10.1126/science.3726539; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; ORKAND RK, 1982, NEURONAL GLIAL CELL, P147; PEARCE B, 1985, J NEUROCHEM, V45, P1534, DOI 10.1111/j.1471-4159.1985.tb07224.x; PHILIBERT RA, 1988, J NEUROCHEM, V51, P122, DOI 10.1111/j.1471-4159.1988.tb04844.x; Ransom B. R, 1986, ASTROCYTES, P1; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; SHOTTON DM, 1989, J CELL SCI, V94, P175; SILINSKY EM, 1975, J PHYSIOL-LONDON, V247, P145, DOI 10.1113/jphysiol.1975.sp010925; SMITH DO, 1991, J PHYSIOL-LONDON, V432, P343, DOI 10.1113/jphysiol.1991.sp018388; TAKEUCHI A, 1961, J PHYSIOL-LONDON, V155, P46, DOI 10.1113/jphysiol.1961.sp006612; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; VILLEGAS J, 1981, J EXP BIOL, V95, P135	47	187	189	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1069	1077		10.1016/0896-6273(92)90128-Z	http://dx.doi.org/10.1016/0896-6273(92)90128-Z			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1351731				2022-12-28	WOS:A1992JA42900007
J	MILLER, M; BOWER, E; LEVITT, P; LI, DQ; CHANTLER, PD				MILLER, M; BOWER, E; LEVITT, P; LI, DQ; CHANTLER, PD			MYOSIN-II DISTRIBUTION IN NEURONS IS CONSISTENT WITH A ROLE IN GROWTH CONE MOTILITY BUT NOT SYNAPTIC VESICLE MOBILIZATION	NEURON			English	Article							PROTEIN KINASE-C; LONG-TERM POTENTIATION; ACTOMYOSIN-LIKE PROTEIN; LIGHT-CHAIN KINASE; DENDRITIC SPINES; CONTRACTILE PROTEINS; PLASMA-MEMBRANE; BRAIN MYOSIN; ACTIN; CELLS	We have generated a polyclonal antibody against myosin II from a neuronally derived cell line in order to assess potential roles for myosin II in growth cone movement and synaptic transmission. The distribution of neuronal myosin II, in isolated cells as well as in tissues of the adult rat brain and spinal cord, was examined at the light microscopic and ultrastructural levels. In isolated neuroblastoma cells and dorsal root ganglion neurons, myosin II was found at the leading edge of growth cones, within neuritic processes and cell soma, and adjacent to the plasma membrane. The subcellular distribution of myosin II overlapped significantly with that of both actin and single-headed myosin I. These results implicate both myosin I and myosin II as molecular motors required for neurite elongation and growth cone motility. An exclusive postsynaptic distribution of myosin II in neurons of the mature central nervous system suggests that myosin II cannot play a role in the mobilization of synaptic vesicles, but could participate in synaptic plasticity.			MILLER, M (corresponding author), MED COLL PENN,DEPT ANAT & NEUROBIOL,PHILADELPHIA,PA 19129, USA.				NIAMS NIH HHS [AR 32858] Funding Source: Medline; NIMH NIH HHS [MH 45507] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH045507, R01MH045507] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; ADAMS RJ, 1986, NATURE, V322, P754, DOI 10.1038/322754a0; AHMED I, 1989, TISSUE CULTURE NEURO, P149; AKERS RF, 1986, SCIENCE, V231, P587, DOI 10.1126/science.3003904; BARYLKO B, 1986, EUR J BIOCHEM, V158, P271, DOI 10.1111/j.1432-1033.1986.tb09747.x; BEACH RL, 1981, BRAIN RES, V225, P75, DOI 10.1016/0006-8993(81)90319-X; BERL S, 1973, SCIENCE, V179, P441, DOI 10.1126/science.179.4072.441; BERL S, 1970, BIOCHEMISTRY-US, V9, P2058, DOI 10.1021/bi00812a005; BLITZ AL, 1974, P NATL ACAD SCI USA, V71, P4472, DOI 10.1073/pnas.71.11.4472; BOTTENSTEIN JE, 1983, ADV CELL NEUROBIOL, V4, P333; BOTTOMLEY RC, 1975, BIOCHEM J, V149, P365, DOI 10.1042/bj1490365; BRAY D, 1977, BIOCHIMIE, V59, P1, DOI 10.1016/S0300-9084(77)80079-5; BRAY D, 1973, NATURE, V244, P93, DOI 10.1038/244093a0; BRIDGMAN PC, 1989, J CELL BIOL, V108, P95, DOI 10.1083/jcb.108.1.95; BURRIDGE K, 1975, J MOL BIOL, V99, P1, DOI 10.1016/S0022-2836(75)80154-9; CARLIN RK, 1983, J CELL BIOL, V96, P443, DOI 10.1083/jcb.96.2.443; CHANTLER PD, 1978, BIOCHEMISTRY-US, V17, P5440, DOI 10.1021/bi00618a018; CHANTLER PD, 1985, J CELL BIOL, V101, P207, DOI 10.1083/jcb.101.1.207; CONTI MA, 1991, BIOCHEMISTRY-US, V30, P966, DOI 10.1021/bi00218a012; DECAMILLI P, 1979, P NATL ACAD SCI USA, V76, P5977; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DRENCKHAHN D, 1983, EUR J CELL BIOL, V31, P235; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; FRIDOVICH I, 1963, J BIOL CHEM, V238, P3921; FUKUI Y, 1989, NATURE, V341, P328, DOI 10.1038/341328a0; GADASI H, 1980, NATURE, V286, P452, DOI 10.1038/286452a0; GLENNEY J, 1986, ANAL BIOCHEM, V156, P315, DOI 10.1016/0003-2697(86)90259-9; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; KATSURAGAWA Y, 1989, EUR J BIOCHEM, V184, P611, DOI 10.1111/j.1432-1033.1989.tb15057.x; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; KERRICK WGL, 1984, P NATL ACAD SCI-BIOL, V81, P165, DOI 10.1073/pnas.81.1.165; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; KUCZMARSKI ER, 1979, J CELL BIOL, V80, P356, DOI 10.1083/jcb.80.2.356; LETOURNEAU PC, 1989, DEVELOPMENT, V105, P505; LETOURNEAU PC, 1981, DEV BIOL, V85, P113, DOI 10.1016/0012-1606(81)90240-2; LETOURNEAU PC, 1985, MOL BASES NEURAL DEV, P269; LEVITT P, 1981, J NEUROSCI, V1, P27, DOI 10.1523/JNEUROSCI.01-01-00027.1981; LUDOWYKE RI, 1989, J BIOL CHEM, V264, P12492; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MATSUDAIRA PT, 1978, ANAL BIOCHEM, V87, P386, DOI 10.1016/0003-2697(78)90688-7; MATSUMURA S, 1985, J BIOL CHEM, V260, P1959; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MILLER C, 1976, BRAIN RES, V108, P115, DOI 10.1016/0006-8993(76)90168-2; MIYATA H, 1989, J CELL BIOL, V109, P1519, DOI 10.1083/jcb.109.4.1519; MORALES M, 1989, CELL TISSUE RES, V256, P447; MORALES M, 1989, J COMP NEUROL, V279, P666, DOI 10.1002/cne.902790412; MULLER D, 1990, P NATL ACAD SCI USA, V87, P4073, DOI 10.1073/pnas.87.11.4073; MURAKAMI N, 1991, FEBS LETT, V278, P23, DOI 10.1016/0014-5793(91)80074-D; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; PASTERNAK C, 1989, NATURE, V341, P549, DOI 10.1038/341549a0; PENNYPACKER K, 1991, EXP NEUROL, V111, P25, DOI 10.1016/0014-4886(91)90047-G; PLATT JL, 1983, J HISTOCHEM CYTOCHEM, V31, P840, DOI 10.1177/31.6.6341464; POLLARD TD, 1982, METHOD ENZYMOL, V85, P331; PUSZKIN S, 1972, J NEUROCHEM, V19, P1319, DOI 10.1111/j.1471-4159.1972.tb01457.x; PUSZKIN S, 1968, SCIENCE, V161, P170, DOI 10.1126/science.161.3837.170; ROISEN F, 1978, SCIENCE, V199, P1445, DOI 10.1126/science.343252; SHAW G, 1981, EUR J CELL BIOL, V24, P20; SHIMOOKA T, 1980, BIOCHEMISTRY-US, V19, P4921, DOI 10.1021/bi00562a034; SINARD JH, 1989, CELL MOTIL CYTOSKEL, V12, P42, DOI 10.1002/cm.970120106; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; SOBIESZEK A, 1977, J MOL BIOL, V112, P559, DOI 10.1016/S0022-2836(77)80164-2; SPUDICH JA, 1989, CELL REGUL, V1, P1; SUN WD, 1991, BIOCHEM BIOPH RES CO, V175, P244, DOI 10.1016/S0006-291X(05)81226-4; TITUS MA, 1989, CELL REGUL, V1, P55, DOI 10.1091/mbc.1.1.55; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRIFARO JM, 1978, NEUROSCIENCE, V3, P1, DOI 10.1016/0306-4522(78)90150-1; ZACCO A, 1990, J NEUROSCI, V10, P73	71	102	102	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1992	8	1					25	44		10.1016/0896-6273(92)90106-N	http://dx.doi.org/10.1016/0896-6273(92)90106-N			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1730005				2022-12-28	WOS:A1992HB18500003
J	HOSHI, T; ZAGOTTA, WN; ALDRICH, RW				HOSHI, T; ZAGOTTA, WN; ALDRICH, RW			2 TYPES OF INACTIVATION IN SHAKER K+ CHANNELS - EFFECTS OF ALTERATIONS IN THE CARBOXY-TERMINAL REGION	NEURON			English	Article							DELAYED RECTIFIER PROPERTIES; GATED POTASSIUM CHANNELS; DROSOPHILA MUSCLE; XENOPUS OOCYTES; MYELINATED NERVE; VOLTAGE CLAMP; RAT-BRAIN; CURRENTS; LOCUS; CDNA	Shaker potassium channels inactivate and recover from inactivation with multiple exponential components, suggesting the presence of multiple inactivation processes. We describe two different types of inactivation in Shaker potassium channels. N-type inactivation can occur as rapidly as a few milliseconds and has been shown to involve an intracellular region at the amino-terminal acting as a blocker of the pore. C-type inactivation is independent of voltage over a range of -25 to +50 mV. It does not require intact N-type inactivation, but is partially coupled to it. The kinetics of C-type inactivation are quite different for channels with different alternatively spliced carboxy-terminal regions. We have localized the differences in C-type inactivation between the ShB and ShA variants to a single amino acid in the sixth membrane-spanning region. N- and C-type inactivation occur by distinct molecular mechanisms.			HOSHI, T (corresponding author), STANFORD UNIV, MED CTR, SCH MED, HOWARD HUGHES MED INST, DEPT MOLEC & CELLULAR PHYSIOL, STANFORD, CA 94305 USA.				NINDS NIH HHS [NS23294] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023294] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADELMAN WJ, 1969, J GEN PHYSIOL, V54, P589, DOI 10.1085/jgp.54.5.589; ADRIAN RH, 1970, J PHYSIOL-LONDON, V208, P645, DOI 10.1113/jphysiol.1970.sp009140; ALDRICH RW, 1979, J PHYSIOL-LONDON, V291, P507, DOI 10.1113/jphysiol.1979.sp012828; ALDRICH RW, 1990, COLD SPRING HARB SYM, V55, P19; ALMERS W, 1983, J PHYSIOL-LONDON, V339, P253, DOI 10.1113/jphysiol.1983.sp014715; CHANDLER WK, 1970, J PHYSIOL-LONDON, V211, P707, DOI 10.1113/jphysiol.1970.sp009300; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; EHRENSTEIN G, 1966, BIOPHYS J, V6, P553, DOI 10.1016/S0006-3495(66)86677-8; FOX JM, 1976, BIOCHIM BIOPHYS ACTA, V426, P232, DOI 10.1016/0005-2736(76)90334-5; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; HAGIWARA S, 1961, J PHYSIOL-LONDON, V155, P470, DOI 10.1113/jphysiol.1961.sp006640; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1988, J GEN PHYSIOL, V91, P73, DOI 10.1085/jgp.91.1.73; IVERSON LE, 1990, J NEUROSCI, V10, P2903; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KHODOROV B, 1976, BIOCHIM BIOPHYS ACTA, V433, P409, DOI 10.1016/0005-2736(76)90105-X; KHODOROV BI, 1974, B EXP BIOL MED+, V77, P10; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; NARAHASHI T, 1974, PHYSIOL REV, V54, P813, DOI 10.1152/physrev.1974.54.4.813; NEHER E, 1971, J GEN PHYSIOL, V58, P36, DOI 10.1085/jgp.58.1.36; PEGANOV EM, 1973, B EXP BIOL MED+, V76, P15; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; SCHWARZ JR, 1971, PFLUG ARCH EUR J PHY, V330, P61, DOI 10.1007/BF00588735; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SOLC CK, 1988, J NEUROSCI, V8, P2556; STOCKER M, 1990, P NATL ACAD SCI USA, V87, P8903, DOI 10.1073/pnas.87.22.8903; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; Tukey J. W., 1977, EXPLORATORY DATA ANA; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; VELLEMAN PF, 1981, APPLICATIONS BASICS, pCH3; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; ZAGOTTA WN, 1988, J NEUROSCI, V8, P4765	41	590	604	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1991	7	4					547	556		10.1016/0896-6273(91)90367-9	http://dx.doi.org/10.1016/0896-6273(91)90367-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1931050				2022-12-28	WOS:A1991GM95400003
J	LILLYCROP, KA; DENT, CL; WHEATLEY, SC; BEECH, MN; NINKINA, NN; WOOD, JN; LATCHMAN, DS				LILLYCROP, KA; DENT, CL; WHEATLEY, SC; BEECH, MN; NINKINA, NN; WOOD, JN; LATCHMAN, DS			THE OCTAMER-BINDING PROTEIN OCT-2 REPRESSES HSV IMMEDIATE-EARLY GENES IN CELL-LINES DERIVED FROM LATENTLY INFECTABLE SENSORY NEURONS	NEURON			English	Article							HERPES-SIMPLEX VIRUS; ROOT GANGLION NEURONS; INSITU HYBRIDIZATION; REGULATORY ELEMENTS; TRIGEMINAL GANGLIA; BLASTOMA CELLS; TRANSCRIPTION; INVITRO; EXPRESSION; PROMOTERS	Transcription of herpes simplex virus (HSV) immediate-early (IE) genes does not occur in sensory neurons latently infected with the virus or following infection of neuronal cell lines. In neuronal cell lines this inability results from the weak activity of the viral IE promoters, which is caused by a neuron-specific repressor factor that binds specifically to the TAATGARAT motif in these promoters and to related octamer elements. Cells expressing this repressor contain an additional octamer-binding protein that is absent from permissive cells. We identify this factor as the lymphocyte- and neuron-specific octamer-binding protein Oct-2 and show that Oct-2 mRNA is also present in dorsal root ganglion neurons, the natural site of HSV latency in vivo. Moreover, artificially elevated expression of Oct-2 can repress the IE promoter. The potential role of Oct-2 in the initiation and maintenance of in vivo latent infection with HSV is discussed.	SANDOZ INST MED RES, DEPT NEUROIMMUNOL, LONDON WC1E 6BN, ENGLAND	Novartis; Sandoz	LILLYCROP, KA (corresponding author), UNIV COLL & MIDDLESEX SCH MED, DEPT BIOCHEM, MED MOLEC BIOL UNIT, LONDON W1P 6DB, ENGLAND.		Ninkina, Natalia N/A-1732-2011					ASH RJ, 1986, VIROLOGY, V155, P584, DOI 10.1016/0042-6822(86)90218-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; CROEN KD, 1987, NEW ENGL J MED, V317, P1427, DOI 10.1056/NEJM198712033172302; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DODD J, 1985, J NEUROSCI, V5, P3278; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; FALKNER FG, 1986, NUCLEIC ACIDS RES, V13, P7847; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GELMAN IH, 1987, J VIROL, V61, P2286, DOI 10.1128/JVI.61.7.2286-2296.1987; GERSTER T, 1988, P NATL ACAD SCI USA, V85, P6347, DOI 10.1073/pnas.85.17.6347; GOLDSBOROUGH A, 1990, NUCLEIC ACIDS RES, V18, P1634, DOI 10.1093/nar/18.6.1634; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; HATZOPOULOS AK, 1990, DEVELOPMENT, V109, P349; HENLE W, 1969, CANCER RES, V29, P489; JONES KA, 1985, NATURE, V317, P179, DOI 10.1038/317179a0; KAY R, 1987, NUCLEIC ACIDS RES, V15, P2778, DOI 10.1093/nar/15.6.2778; KEMP LM, 1990, NEURON, V4, P215, DOI 10.1016/0896-6273(90)90096-X; KEMP LM, 1989, VIROLOGY, V171, P607, DOI 10.1016/0042-6822(89)90631-4; KIYAMA H, 1990, MOL BRAIN RES, V7, P213, DOI 10.1016/0169-328X(90)90030-H; LATCHMAN DS, 1990, J EXP PATHOL, V71, P133; LEIB DA, 1989, J VIROL, V63, P759, DOI 10.1128/JVI.63.2.759-768.1989; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MACPHERSON I, 1962, VIROLOGY, V16, P147, DOI 10.1016/0042-6822(62)90290-8; MCKNIGHT JLC, 1987, P NATL ACAD SCI USA, V84, P7061, DOI 10.1073/pnas.84.20.7061; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; OHARE P, 1988, CELL, V52, P435, DOI 10.1016/S0092-8674(88)80036-9; PERRY LJ, 1986, J GEN VIROL, V67, P2365, DOI 10.1099/0022-1317-67-11-2365; PRESTON CM, 1988, CELL, V52, P425, DOI 10.1016/S0092-8674(88)80035-7; ROBEY WG, 1976, J GEN VIROL, V32, P51, DOI 10.1099/0022-1317-32-1-51; ROIZMAN B, 1987, ANNU REV MICROBIOL, V41, P543, DOI 10.1146/annurev.mi.41.100187.002551; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; STEINER I, 1990, J VIROL, V64, P1630, DOI 10.1128/JVI.64.4.1630-1638.1990; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; THIELE K, 1989, J GEN VIROL, V70, P1907, DOI 10.1099/0022-1317-70-7-1907; VAHLNE A, 1978, J GEN VIROL, V39, P321, DOI 10.1099/0022-1317-39-2-321; WHEATLEY SC, 1991, EXP CELL RES, V194, P78, DOI 10.1016/0014-4827(91)90132-E; WHEATLEY SC, 1990, EXP CELL RES, V190, P243, DOI 10.1016/0014-4827(90)90192-D; WHITTON JL, 1984, NUCLEIC ACIDS RES, V12, P2061, DOI 10.1093/nar/12.4.2061; WILCOX CL, 1988, J VIROL, V62, P393, DOI 10.1128/JVI.62.2.393-399.1988; WILCOX CL, 1990, J NEUROSCI, V10, P1268; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; [No title captured]	49	121	125	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1991	7	3					381	390		10.1016/0896-6273(91)90290-G	http://dx.doi.org/10.1016/0896-6273(91)90290-G			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1654947	Bronze			2022-12-28	WOS:A1991GG88700003
J	RAIVICH, G; HELLWEG, R; KREUTZBERG, GW				RAIVICH, G; HELLWEG, R; KREUTZBERG, GW			NGF RECEPTOR MEDIATED REDUCTION IN AXONAL NGF UPTAKE AND RETROGRADE TRANSPORT FOLLOWING SCIATIC-NERVE INJURY AND DURING REGENERATION	NEURON			English	Article							GROWTH-FACTOR RECEPTOR; PERIPHERAL TARGET TISSUES; ADULT SENSORY NEURONS; MESSENGER-RNA; SCHWANN-CELLS; SYMPATHETIC-GANGLIA; CHOLINERGIC NEURONS; BINDING-PROPERTIES; NONNEURONAL CELLS; HIGH-AFFINITY	Injury to the rat sciatic nerve leads to the induction of nerve growth factor (NGF) receptors on the denervated Schwann cells and their disappearance on the regenerating axons of the axotomized, normally NGF-sensitive sensory and sympathetic neurons. This disappearance in the axonal expression and retrograde transport of NGF receptors is associated with a similarly dramatic reduction in the axonal uptake and retrograde transport of NGF following axotomy and during regeneration. In view of the massive NGF synthesis occurring in the injured nerve, these results suggest that, while sensory and sympathetic neurons are the primary targets of NGF in the normal peripheral nervous system, the denervated Schwann cells may become its primary target in the aftermath of nerve injury.	MAX PLANCK INST PSYCHIAT, INST CLIN, W-8033 MARTINSRIED, GERMANY	Max Planck Society	RAIVICH, G (corresponding author), MAX PLANCK INST PSYCHIAT, DEPT NEUROMORPHOL, AM KLOPFERSPITZ 18A, W-8033 MARTINSRIED, GERMANY.		Raivich, Gennadij/A-6770-2011; Raivich, Gennadij/AAL-7229-2021					ARVIDSSON J, 1986, BRAIN RES, V373, P15, DOI 10.1016/0006-8993(86)90310-0; BAILEY NT, 1974, STATISTICAL METHODS, P172; BARBUT D, 1981, BRAIN RES, V205, P289, DOI 10.1016/0006-8993(81)90340-1; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BERND P, 1984, J BIOL CHEM, V259, P5509; CAVICCHIOLI L, 1989, EUR J NEUROSCI, V1, P258, DOI 10.1111/j.1460-9568.1989.tb00793.x; CHALAZONITIS A, 1987, P NATL ACAD SCI USA, V84, P289, DOI 10.1073/pnas.84.1.289; CSILLIK B, 1985, BRAIN RES, V331, P11, DOI 10.1016/0006-8993(85)90709-7; DIAMOND J, 1987, P NATL ACAD SCI USA, V84, P6596, DOI 10.1073/pnas.84.18.6596; FITZGERALD M, 1985, BRAIN RES, V332, P131, DOI 10.1016/0006-8993(85)90396-8; GRAEBER MB, 1988, J NEUROCYTOL, V17, P573, DOI 10.1007/BF01189811; HAGG T, 1989, BRAIN RES, V505, P29, DOI 10.1016/0006-8993(89)90112-1; HELLWEG R, 1988, EXP CELL RES, V179, P18, DOI 10.1016/0014-4827(88)90344-8; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; HEUMANN R, 1984, EMBO J, V3, P3183, DOI 10.1002/j.1460-2075.1984.tb02277.x; JESSELL T, 1979, BRAIN RES, V168, P247, DOI 10.1016/0006-8993(79)90167-7; JOHNSON EM, 1987, J NEUROSCI, V7, P923; JOHNSON EM, 1985, NATURE, V314, P751, DOI 10.1038/314751a0; KORSCHING S, 1985, NEUROSCI LETT, V54, P201, DOI 10.1016/S0304-3940(85)80079-3; KORSCHING S, 1983, NEUROSCI LETT, V39, P1, DOI 10.1016/0304-3940(83)90155-6; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; LINDSAY RM, 1990, EUR J NEUROSCI, V2, P389, DOI 10.1111/j.1460-9568.1990.tb00431.x; NIEKE J, 1985, DIFFERENTIATION, V30, P141, DOI 10.1111/j.1432-0436.1985.tb00525.x; OLSSON Y, 1969, EXP NEUROL, V23, P102, DOI 10.1016/0014-4886(69)90037-5; OTTEN U, 1980, NATURE, V287, P158, DOI 10.1038/287158a0; PALMATIER MA, 1984, J NEUROSCI, V4, P751; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; PURVES D, 1976, NATURE, V260, P535, DOI 10.1038/260535a0; Raivich G, 1990, Restor Neurol Neurosci, V1, P217, DOI 10.3233/RNN-1990-13407; RAIVICH G, 1985, EMBO J, V4, P637, DOI 10.1002/j.1460-2075.1985.tb03677.x; RAIVICH G, 1987, J NEUROCYTOL, V16, P689, DOI 10.1007/BF01637660; RAIVICH G, 1987, NEUROSCIENCE, V20, P23, DOI 10.1016/0306-4522(87)90003-0; RICH KM, 1987, J NEUROCYTOL, V16, P261, DOI 10.1007/BF01795309; RICH KM, 1989, EXP NEUROL, V105, P162, DOI 10.1016/0014-4886(89)90115-5; RUSH RA, 1984, NATURE, V312, P364, DOI 10.1038/312364a0; SEILHEIMER B, 1987, EMBO J, V6, P1611, DOI 10.1002/j.1460-2075.1987.tb02408.x; SHELTON DL, 1984, P NATL ACAD SCI-BIOL, V81, P7951, DOI 10.1073/pnas.81.24.7951; SINGER PA, 1988, NEUROSCI LETT, V84, P155, DOI 10.1016/0304-3940(88)90400-4; SUTTER A, 1979, J BIOL CHEM, V254, P5972; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; TANIUCHI M, 1985, J CELL BIOL, V101, P1100, DOI 10.1083/jcb.101.3.1100; TANIUCHI M, 1988, J NEUROSCI, V8, P664; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; ZIMMERMANN A, 1983, EMBO J, V2, P879, DOI 10.1002/j.1460-2075.1983.tb01517.x	47	160	167	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1991	7	1					151	164		10.1016/0896-6273(91)90083-C	http://dx.doi.org/10.1016/0896-6273(91)90083-C			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1648938				2022-12-28	WOS:A1991FY48100015
J	OCORR, KA; SCHULMAN, H				OCORR, KA; SCHULMAN, H			ACTIVATION OF MULTIFUNCTIONAL CA-2+ CALMODULIN-DEPENDENT KINASE IN INTACT HIPPOCAMPAL SLICES	NEURON			English	Article							LONG-TERM POTENTIATION; CA-2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; SYNAPTIC TRANSMISSION; POTASSIUM CONCENTRATION; CA-2+-INDEPENDENT FORM; SUBSTRATE-SPECIFICITY; AUTONOMOUS ENZYME; BASIC RESIDUES; TISSUE-SLICES; RAT	In vitro phosphorylation of multifunctional Ca2+/calmodulin-dependent protein kinase (CaM kinase) converts it to a form that is independent of Ca2+. We demonstrate that significant Ca2+-independent CaM kinase activity is present in untreated hippocampal slices. Two manipulations that produce a long-lasting enhancement of neuronal activity in hippocampal slices, elevated extracellular Ca2+ or depolarization with high K+, generate additional Ca2+-independent activity. This increase is dependent on extracellular Ca2+ and is correlated with an increased phosphorylation of CaM kinase. In contrast, CaM kinase in posterior pituitary, a brain structure that is not thought to be involved in memory-related processes, is not modulated by depolarization. These results suggest that the Ca2+-independent form of CaM kinase may modulate neuronal activity in the hippocampus.			OCORR, KA (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT PHARMACOL,STANFORD,CA 94305, USA.			Ocorr, Karen/0000-0003-2593-0119	NIGMS NIH HHS [GM30179] Funding Source: Medline; NIMH NIH HHS [F32MH09041-03A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179, R37GM030179] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALGER BE, 1982, J PHYSIOL-LONDON, V328, P125, DOI 10.1113/jphysiol.1982.sp014256; Beavo J A, 1974, Methods Enzymol, V38, P299; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1986, EXCITATORY AMINO ACI, P337; BLISS TVP, 1988, NEUROLOGY NEUROBIOLO, V35, P3; CAZALIS M, 1987, J PHYSIOL-LONDON, V390, P55, DOI 10.1113/jphysiol.1987.sp016686; CHENG HC, 1986, J BIOL CHEM, V261, P989; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DOUGLASS WW, 1964, J PHYSIOL-LONDON, V172, P1; DUNKLEY PR, 1986, J NEUROCHEM, V46, P1692; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FUKUNAGA K, 1989, J BIOL CHEM, V264, P21830; GORELICK FS, 1988, J BIOL CHEM, V263, P17209; GROVER LM, 1990, BRAIN RES, V506, P53, DOI 10.1016/0006-8993(90)91198-P; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HIGASHIMA M, 1985, EXP NEUROL, V90, P529, DOI 10.1016/0014-4886(85)90150-5; HOUSE C, 1987, J BIOL CHEM, V262, P772; JEFFERSON AB, 1991, J BIOL CHEM, V266, P1484; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; KAWASAKI K, 1988, BRAIN RES, V457, P322, DOI 10.1016/0006-8993(88)90702-0; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; LOU LL, 1989, J NEUROSCI, V9, P2020; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; LYNCH MA, 1986, NEUROSCI LETT, V65, P171, DOI 10.1016/0304-3940(86)90299-5; MACNICOL M, 1990, J BIOL CHEM, V265, P18055; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MODY I, 1984, NEUROPHARMACOLOGY, V23, P625, DOI 10.1016/0028-3908(84)90142-4; NORDMAN JJ, 1986, CELL TISSUE RES, V246, P177; OCORR KA, 1989, ADV GENE TECHNOL, V9, P94; REYMANN KG, 1986, BRAIN RES BULL, V17, P291, DOI 10.1016/0361-9230(86)90234-0; SAITOH T, 1985, J CELL BIOL, V100, P835, DOI 10.1083/jcb.100.3.835; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SCHULMAN H, 1978, P NATL ACAD SCI USA, V75, P5432, DOI 10.1073/pnas.75.11.5432; SCHWARTZKROIN PA, 1975, BRAIN RES, V89, P107, DOI 10.1016/0006-8993(75)90138-9; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; TURNER RW, 1982, NEUROSCIENCE, V7, P1411, DOI 10.1016/0306-4522(82)90254-8; YIP RK, 1989, J NEUROSCI, V9, P3618	46	86	86	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1991	6	6					907	914		10.1016/0896-6273(91)90231-N	http://dx.doi.org/10.1016/0896-6273(91)90231-N			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	1647175				2022-12-28	WOS:A1991FT94900006
J	WESKAMP, G; REICHARDT, LF				WESKAMP, G; REICHARDT, LF			EVIDENCE THAT BIOLOGICAL-ACTIVITY OF NGF IS MEDIATED THROUGH A NOVEL SUBCLASS OF HIGH-AFFINITY RECEPTORS	NEURON			English	Article							NERVE GROWTH-FACTOR; PC12 CELLS; PHEOCHROMOCYTOMA CELLS; RETROGRADE TRANSPORT; BINDING-PROPERTIES; MOLECULAR-CLONING; SENSORY GANGLIA; DEVELOPING RATS; MESSENGER-RNA; GENE-TRANSFER	Trophic factors, such as NGF, regulate survival and differentiation of many classes of neurons by binding specific receptors. Two types of NGF receptors have been identified, which bind NGF with low and high affinity. The latter mediates the major biological actions of NGF. To determine the relationship between these two receptor types, polyclonal antibodies to the low affinity receptor have been prepared and used in ligand-binding, ligand-cross-linking, and biological assays. These antibodies eliminated binding of NGF to low affinity receptors and to one class of high affinity receptors, but did not prevent binding to a second class of high affinity receptors. The same antibodies did not inhibit NGF-stimulated neuronal survival or neurite outgrowth. Thus, a biologically important class of high affinity NGF receptors is antigenically distinct from the low affinity receptor and may be encoded by a novel gene.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco	WESKAMP, G (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021824] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21824] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BLOCK T, 1983, J NEUROCHEM, V40, P1654, DOI 10.1111/j.1471-4159.1983.tb08139.x; BOTHWELL MA, 1980, CELL, V21, P857, DOI 10.1016/0092-8674(80)90449-3; BUTTERS TD, 1981, BIOCHIM BIOPHYS ACTA, V640, P672, DOI 10.1016/0005-2736(81)90097-3; BUXSER S, 1985, J BIOL CHEM, V260, P1917; BUXSER S, 1990, J BIOL CHEM, V265, P12701; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; DAVIES AM, 1989, NERVE GROWTH FACTORS, P95; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; EVELETH DD, 1988, NEURON, V1, P929, DOI 10.1016/0896-6273(88)90150-X; FIELDS KL, 1978, CELL, V14, P43, DOI 10.1016/0092-8674(78)90299-4; FRAZIER WA, 1974, J BIOL CHEM, V249, P5513; GNAHN H, 1983, BRAIN RES, V285, P45; GREEN SH, 1986, J BIOL CHEM, V261, P5316; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HOSANG M, 1987, EMBO J, V6, P1197, DOI 10.1002/j.1460-2075.1987.tb02354.x; HOSANG M, 1985, J BIOL CHEM, V260, P655; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON EM, 1980, SCIENCE, V210, P916, DOI 10.1126/science.7192014; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KOUCHALAKOS RN, 1986, J BIOL CHEM, V261, P6054; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; LUCKOW VA, 1989, VIROLOGY, V170, P31, DOI 10.1016/0042-6822(89)90348-6; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MATSUSHIMA H, 1990, MOL CELL BIOL, V10, P8060; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MILBRANDT J, 1986, P NATL ACAD SCI USA, V83, P4789, DOI 10.1073/pnas.83.13.4789; MOBLEY WC, 1986, MOL BRAIN RES, V1, P53, DOI 10.1016/0169-328X(86)90020-3; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MURLAS C, 1982, J APPL PHYSIOL, V52, P1084, DOI 10.1152/jappl.1982.52.4.1084; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RAIVICH G, 1985, EMBO J, V4, P637, DOI 10.1002/j.1460-2075.1985.tb03677.x; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SEGAL DM, 1977, J IMMUNOL, V118, P1338; SEILER M, 1984, BRAIN RES, V300, P33, DOI 10.1016/0006-8993(84)91338-6; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; Summers MD, 1987, MANUAL METHODS BACUL; SUTTER A, 1979, J BIOL CHEM, V254, P5972; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P1950, DOI 10.1073/pnas.83.6.1950; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; VALE RD, 1983, BIOCHEMISTRY-US, V22, P5022, DOI 10.1021/bi00290a022; VALE RD, 1985, METHOD ENZYMOL, V109, P21; VALE RD, 1985, DEV NEUROSCI-BASEL, V7, P55, DOI 10.1159/000112276; VALE RD, 1982, J CELL BIOL, V94, P710, DOI 10.1083/jcb.94.3.710; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; WOODRUFF NR, 1986, BIOCHEMISTRY-US, V25, P7956, DOI 10.1021/bi00372a026; YAN Q, 1988, NEURON, V1, P335; YAN Q, 1988, J NEUROSCI, V8, P3481; ZIMMERMANN A, 1983, EMBO J, V2, P879, DOI 10.1002/j.1460-2075.1983.tb01517.x	70	270	284	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					649	663		10.1016/0896-6273(91)90067-A	http://dx.doi.org/10.1016/0896-6273(91)90067-A			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	1849725				2022-12-28	WOS:A1991FH80200016
J	ALMERS, W; TSE, FW				ALMERS, W; TSE, FW			TRANSMITTER RELEASE FROM SYNAPSES - DOES A PREASSEMBLED FUSION PORE INITIATE EXOCYTOSIS	NEURON			English	Review											ALMERS, W (corresponding author), UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195, USA.		Tse, Frederick/C-3449-2013		NIAMS NIH HHS [AR-17803] Funding Source: Medline; NIGMS NIH HHS [GM-39520] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR017803, R37AR017803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039520] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMERS W, 1990, ANNU REV PHYSIOL, V52, P607, DOI 10.1146/annurev.ph.52.030190.003135; ALMERS W, 1989, SECRETION ITS CONTRO, P269; ATWOOD HL, 1988, J PHYSIOL-LONDON, V402, P177, DOI 10.1113/jphysiol.1988.sp017199; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V369, P163; BALCH WE, 1984, CELL, V39, P525, DOI 10.1016/0092-8674(84)90459-8; BENTZ J, 1985, BIOCHEMISTRY-US, V24, P1064, DOI 10.1021/bi00325a039; BOWEN WJ, 1964, ARCH BIOCHEM BIOPHYS, V107, P30, DOI 10.1016/0003-9861(64)90265-6; BRAELL WA, 1987, P NATL ACAD SCI USA, V84, P1137, DOI 10.1073/pnas.84.5.1137; BRECKENRIDGE LJ, 1987, P NATL ACAD SCI USA, V84, P1945, DOI 10.1073/pnas.84.7.1945; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; CECARELLI B, 1980, PHYSIOL REV, V60, P396; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; CLAGUE MJ, 1990, BIOCHEMISTRY-US, V29, P1303, DOI 10.1021/bi00457a028; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P553, DOI 10.1113/jphysiol.1954.sp005128; DIAZ R, 1989, NATURE, V339, P398, DOI 10.1038/339398a0; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DUZGUNES N, 1984, BIOCHEMISTRY-US, V23, P2486; ELLENS H, 1989, BIOCHEMISTRY-US, V28, P3692, DOI 10.1021/bi00435a011; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; HILLE B, 1984, IONIC CHANNELS EXCIT, P157; HOCHNER B, 1989, NATURE, V342, P433, DOI 10.1038/342433a0; JACKSON RC, 1988, CURR TOP MEMBR TRANS, V32, P45; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MALLART A, 1982, J PHYSIOLOGY PARIS, V78, P407; McLachlan E M, 1978, Int Rev Physiol, V17, P49; MIYAMOTO MD, 1975, J PHYSIOL-LONDON, V250, P121, DOI 10.1113/jphysiol.1975.sp011045; MORRIS SJ, 1989, J BIOL CHEM, V264, P3972; NIR S, 1986, BIOCHEMISTRY-US, V25, P2155, DOI 10.1021/bi00356a046; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; POLLARD HB, 1988, J EXP BIOL, V139, P267; RAND RP, 1986, ANNU REV PHYSIOL, V48, P201; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; STEGMANN T, 1989, ANNU REV BIOPHYS BIO, V18, P187, DOI 10.1146/annurev.bb.18.060189.001155; STEGMANN T, 1989, BIOCHEMISTRY-US, V28, P1698, DOI 10.1021/bi00430a041; Steinbach J.H., 1976, P33; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; VERKLEIJ AJ, 1984, BIOCHIM BIOPHYS ACTA, V779, P43, DOI 10.1016/0304-4157(84)90003-0; WHITE JM, 1990, ANNU REV PHYSIOL, V52, P675, DOI 10.1146/annurev.ph.52.030190.003331; WILSCHUT J, 1985, BIOCHEMISTRY-US, V24, P4630, DOI 10.1021/bi00338a023; WOODMAN PG, 1988, EUR J BIOCHEM, V173, P101, DOI 10.1111/j.1432-1033.1988.tb13972.x; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032	48	155	159	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1990	4	6					813	818		10.1016/0896-6273(90)90134-2	http://dx.doi.org/10.1016/0896-6273(90)90134-2			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK185	1972885				2022-12-28	WOS:A1990DK18500001
J	SPIEGEL, K; WONG, V; KESSLER, JA				SPIEGEL, K; WONG, V; KESSLER, JA			TRANSLATIONAL REGULATION OF SOMATOSTATIN IN CULTURED SYMPATHETIC NEURONS	NEURON			English	Article									YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT NEUROSCI, DEPT NEUROL, BRONX, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020013, R01NS020778] Funding Source: NIH RePORTER; NINDS NIH HHS [NS20778, NS20013] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER JE, 1989, P NATL ACAD SCI USA, V86, P1080, DOI 10.1073/pnas.86.3.1080; ADLER JE, 1984, DEV BIOL, V102, P417, DOI 10.1016/0012-1606(84)90206-9; ARNOLD MA, 1982, J NEUROSCI, V2, P674; BLACK IB, 1982, SCIENCE, V215, P1198, DOI 10.1126/science.215.4537.1198; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; BUNGE R, 1978, SCIENCE, V199, P1409, DOI 10.1126/science.24273; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; FIELDS KL, 1978, CELL, V14, P43, DOI 10.1016/0092-8674(78)90299-4; GOODMAN RH, 1983, J BIOL CHEM, V258, P5571; HAWROT E, 1980, DEV BIOL, V74, P136, DOI 10.1016/0012-1606(80)90057-3; HOKFELT T, 1977, NEUROSCIENCE, V2, P885, DOI 10.1016/0306-4522(77)90112-9; HOKFELT T, 1977, P NATL ACAD SCI USA, V74, P3587, DOI 10.1073/pnas.74.8.3587; KESSLER JA, 1979, BRAIN RES, V171, P415, DOI 10.1016/0006-8993(79)91046-1; KESSLER JA, 1985, NEUROSCIENCE, V15, P827, DOI 10.1016/0306-4522(85)90081-8; KESSLER JA, 1984, DEV BIOL, V106, P61, DOI 10.1016/0012-1606(84)90061-7; KESSLER JA, 1983, SCIENCE, V221, P1059, DOI 10.1126/science.6192502; KESSLER JA, 1986, P NATL ACAD SCI USA, V83, P8726; LEWIS EJ, 1983, J BIOL CHEM, V258, P4632; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MUDGE AW, 1981, NATURE, V292, P764, DOI 10.1038/292764a0; PATTERSON PH, 1977, DEV BIOL, V56, P263, DOI 10.1016/0012-1606(77)90269-X; PETERSON PH, 1974, P NATL ACAD SCI USA, V71, P3607; PETERSON PH, 1978, ANNU REV NEUROSCI, V1, P1; PORTER S, 1986, J NEUROSCI, V6, P3070; PROCHIANTZ A, 1981, NATURE, V293, P570, DOI 10.1038/293570a0; RAYNAUD B, 1987, DEV BIOL, V119, P305, DOI 10.1016/0012-1606(87)90036-4; SAADAT S, 1987, J BIOL CHEM, V262, P13007; SAADAT S, 1986, J CELL BIOL, V103, P1991, DOI 10.1083/jcb.103.5.1991; SMITH KE, 1988, J NEUROSCI, V8, P2406; STOLLER TJ, 1988, J CELL BIOL, V107, P2087, DOI 10.1083/jcb.107.6.2087; WEBER MJ, 1981, J BIOL CHEM, V256, P3347; WONG V, 1987, P NATL ACAD SCI USA, V84, P8726, DOI 10.1073/pnas.84.23.8726	33	25	25	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1990	4	2					303	311		10.1016/0896-6273(90)90104-N	http://dx.doi.org/10.1016/0896-6273(90)90104-N			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT254	1968345				2022-12-28	WOS:A1990CT25400012
J	SIMON, DK; OLEARY, DDM				SIMON, DK; OLEARY, DDM			RESPONSES OF RETINAL AXONS INVIVO AND INVITRO TO POSITION-ENCODING MOLECULES IN THE EMBRYONIC SUPERIOR COLLICULUS	NEURON			English	Article							TECTAL CELL-MEMBRANES; RETINOTECTAL PROJECTION; MAP FORMATION; RETINOCOLLICULAR PROJECTION; PRENATAL DEVELOPMENT; XENOPUS TADPOLES; IMPULSE ACTIVITY; NERVE-FIBERS; TARGETS; GROWTH	We show that rat retinal ganglion cell axons exhibit no topographic specificity in growth along the rostral-caudal axis of the embryonic superior colliculus (SC). Position-related, morphological differences are not found between temporal and nasal axon growth cones. However, embryonic retinal axons respond in vitro to a position-dependent molecular property of SC membranes. In vivo, regional specificity in side branching is the earliest indication that axons make topographic distinctions along the rostral-caudal SC axis. Our contrasting in vivo and in vitro results indicate that molecules encoding rostral-caudal position in the SC neither guide nor restrict retinal axon growth, but may promote the development of topographic connections by controlling specificity in the extension or stabilization of branches.			SIMON, DK (corresponding author), SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,LA JOLLA,CA 92037, USA.				NATIONAL EYE INSTITUTE [R01EY007025] Funding Source: NIH RePORTER; NEI NIH HHS [EY07025] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BHIDE PG, 1991, J NEUROSCI, V11, P485; BONHOEFFER F, 1984, TRENDS NEUROSCI, V7, P378, DOI 10.1016/S0166-2236(84)80060-0; BOVOLENTA P, 1987, J NEUROSCI, V7, P1447; BUNT SM, 1983, DEV BRAIN RES, V6, P149, DOI 10.1016/0165-3806(83)90093-7; CONSTANTINEPATON M, 1986, NATURE, V324, P459, DOI 10.1038/324459a0; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; COX EC, 1990, NEURON, V2, P31; CRESPO D, 1985, DEV BRAIN RES, V19, P129, DOI 10.1016/0165-3806(85)90238-X; Fraser S E, 1992, Curr Opin Neurobiol, V2, P83, DOI 10.1016/0959-4388(92)90167-J; FRASER SE, 1990, J NEUROBIOL, V21, P51, DOI 10.1002/neu.480210105; FRASER SE, 1980, DEV BIOL, V79, P453, DOI 10.1016/0012-1606(80)90130-X; FUJISAWA H, 1984, DEV GROWTH DIFFER, V26, P545; FUJISAWA H, 1987, J COMP NEUROL, V260, P127, DOI 10.1002/cne.902600110; GIERER A, 1987, DEVELOPMENT, V101, P479; GODEMENT P, 1989, DEVELOPMENT, V106, P313; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HARRIS WA, 1980, J COMP NEUROL, V194, P303, DOI 10.1002/cne.901940203; HOLT CE, 1989, J NEUROSCI, V9, P3123; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HOLT CE, 1984, J NEUROSCI, V4, P1130; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; JOHNSTON AR, 1991, DEVELOPMENT, V113, P409; LUND RD, 1976, J COMP NEUROL, V165, P247, DOI 10.1002/cne.901650209; MCCAFFERY P, 1991, DEVELOPMENT, V112, P693; MCLOON SC, 1991, J NEUROSCI, V11, P1470; MENDEZOTERO R, 1988, J NEUROSCI, V8, P564; Montague PR, 1991, CEREB CORTEX, V1, P199, DOI 10.1093/cercor/1.3.199; MUNEOKA K, 1986, J EXP ZOOL, V239, P289, DOI 10.1002/jez.1402390216; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; OLEARY DDM, 1990, COLD SH Q B, V55, P453; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; OLEARY DDM, 1986, J NEUROSCI, V6, P3692; OLEARY DDM, 1992, SEMIN NEUROSCI, V4, P365; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; OROURKE NA, 1986, DEV BIOL, V114, P265, DOI 10.1016/0012-1606(86)90191-0; RABACCHI SA, 1990, DEVELOPMENT, V109, P521; SACHS GM, 1986, J COMP NEUROL, V246, P395, DOI 10.1002/cne.902460308; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SCHLOSSHAUER B, 1988, J NEUROSCI, V8, P580; SCHMIDT JT, 1989, COMMENTS DEV NEUROBI, V1, P11; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SIMINOFF R, 1966, J COMP NEUROL, V127, P435, DOI 10.1002/cne.901270402; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMON DK, 1991, J COMP NEUROL, V307, P393, DOI 10.1002/cne.903070305; SIMON DK, 1992, J NEUROSCI, V12, P1212; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; STURMER CAO, 1990, J NEUROSCI, V10, P3615; STURMER CAO, 1988, J NEUROSCI, V8, P4513; TRISLER D, 1987, SCIENCE, V237, P1208, DOI 10.1126/science.3629237; TRISLER D, 1990, J EXP BIOL, V153, P11; TRISLER GD, 1981, P NATL ACAD SCI-BIOL, V78, P2145, DOI 10.1073/pnas.78.4.2145; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; VIELMETTER J, 1989, NEURON, V2, P1331, DOI 10.1016/0896-6273(89)90071-8; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; WALTER J, 1990, TRENDS NEUROSCI, V13, P447, DOI 10.1016/0166-2236(90)90097-T; YHIP JPA, 1990, VISUAL NEUROSCI, V4, P313	58	97	98	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1992	9	5					977	989		10.1016/0896-6273(92)90249-D	http://dx.doi.org/10.1016/0896-6273(92)90249-D			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1419004				2022-12-28	WOS:A1992JY55200016
J	HILLE, B				HILLE, B			G-PROTEIN-COUPLED MECHANISMS AND NERVOUS SIGNALING	NEURON			English	Review							RAT SYMPATHETIC NEURONS; BETA-GAMMA-SUBUNITS; GTP-BINDING-PROTEINS; MUSCARINIC K+-CHANNEL; ADRENERGIC MODULATION; DOPAMINE OVERFLOW; RECEPTOR SUBTYPES; CALCIUM CURRENTS; GANGLION NEURONS; ADENYLYL CYCLASE				HILLE, B (corresponding author), UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174] Funding Source: NIH RePORTER; NINDS NIH HHS [NS08174] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; ABRAMS TW, 1991, J NEUROSCI, V11, P2655; ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; ASHKENAZI A, 1989, CELL, V56, P487, DOI 10.1016/0092-8674(89)90251-1; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BERNHEIM L, 1992, IN PRESS P NATL ACAD; BERNSTEIN G, 1992, J BIOL CHEM, V267, P8081; BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P471, DOI 10.1073/pnas.89.2.471; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BULL DR, 1990, J NEUROSCI METH, V32, P37, DOI 10.1016/0165-0270(90)90069-R; CAVALIE A, 1991, PFLUG ARCH EUR J PHY, V419, P433, DOI 10.1007/BF00370785; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DOLPHIN AC, 1991, BIOCHIM BIOPHYS ACTA, V1091, P68, DOI 10.1016/0167-4889(91)90224-L; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; FORSCHER P, 1986, J PHYSIOL-LONDON, V379, P131, DOI 10.1113/jphysiol.1986.sp016244; Fuxe K, 1991, VOLUME TRANSMISSION; HARTZELL HC, 1980, J CELL BIOL, V86, P6, DOI 10.1083/jcb.86.1.6; HARTZELL HC, 1988, PROG BIOPHYS MOL BIO, V52, P165, DOI 10.1016/0079-6107(88)90014-4; HARTZELL HC, 1991, NATURE, V351, P573, DOI 10.1038/351573a0; HERKENHAM M, 1991, VOLUME TRANSMISSION, P63; HILLE B, 1986, DISCUSSIONS NEUROSCI, V3, P75; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; JELSEMA CL, 1987, P NATL ACAD SCI USA, V84, P3623, DOI 10.1073/pnas.84.11.3623; KASAI H, 1992, J PHYSIOL-LONDON, V448, P189, DOI 10.1113/jphysiol.1992.sp019036; KIM D, 1989, NATURE, V337, P557, DOI 10.1038/337557a0; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KURACHI Y, 1989, PFLUG ARCH EUR J PHY, V413, P325, DOI 10.1007/BF00583550; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MATHIE A, 1992, NEURON, V8, P907, DOI 10.1016/0896-6273(92)90205-R; MCCORMICK DA, 1989, P NATL ACAD SCI USA, V86, P8098, DOI 10.1073/pnas.86.20.8098; MCCORMICK DA, 1989, TRENDS NEUROSCI, V12, P215, DOI 10.1016/0166-2236(89)90125-2; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; NICHOLSON C, 1988, Acta Morphologica Neerlando-Scandinavica, V26, P69; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; PARKER EM, 1991, J BIOL CHEM, V266, P519; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; ROONEY TA, 1991, J BIOL CHEM, V266, P15068; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; STRYER L, 1991, J BIOL CHEM, V266, P10711; SURPRENANT A, 1988, PROC R SOC SER B-BIO, V234, P85, DOI 10.1098/rspb.1988.0039; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TAUSSIG R, 1992, NEURON, V8, P799, DOI 10.1016/0896-6273(92)90100-R; WALAAS SI, 1991, PHARMACOL REV, V43, P299; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; WIGHTMAN RM, 1988, NEUROSCIENCE, V25, P513, DOI 10.1016/0306-4522(88)90255-2; WILKIE TM, 1992, NAT GENET, V1, P85, DOI 10.1038/ng0592-85; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0; YATANI A, 1989, SCIENCE, V245, P71, DOI 10.1126/science.2544999	67	433	437	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					187	195		10.1016/0896-6273(92)90158-A	http://dx.doi.org/10.1016/0896-6273(92)90158-A			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1353972				2022-12-28	WOS:A1992JJ33200001
J	RAMAN, IM; TRUSSELL, LO				RAMAN, IM; TRUSSELL, LO			THE KINETICS OF THE RESPONSE TO GLUTAMATE AND KAINATE IN NEURONS OF THE AVIAN COCHLEAR NUCLEUS	NEURON			English	Article							AMINO-ACID RECEPTORS; METHYL-D-ASPARTATE; RAT HIPPOCAMPAL-NEURONS; NEUROMUSCULAR-JUNCTION; QUISQUALATE RECEPTORS; SYNAPTIC TRANSMISSION; ACTIVATED CHANNELS; BRAIN-SLICES; DESENSITIZATION; ACETYLCHOLINE	Neurons in the nucleus magnocellularis (nMAG) of the chicken precisely transmit auditory nerve activity via glutamatergic synapses. Using techniques for rapid application of solutions, we have explored the properties of CNQX-sensitive glutamate receptors in whole cells and outside-out patches from the nMAG. Glutamate-evoked current in patches desensitized biphasically to less than 1% of the peak current, with a fast time constant of 960-mu-s at 22-degrees-C, decreasing to 570-mu-s at 33-degrees-C. Dose-response studies using kainate indicated that at least two agonist molecules bind to gate the channel. We propose a kinetic model that quantitatively describes our experimental observations. The rapid kinetics of this receptor are well suited to allow phase locking of synaptic signals to auditory stimuli.	UNIV WISCONSIN, DEPT NEUROPHYSIOL, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	RAMAN, IM (corresponding author), UNIV WISCONSIN, NEUROSCI TRAINING PROGRAM, MADISON, WI 53706 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028901, R37NS028901] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 28901] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAIKE N, 1987, J PHYSIOL-LONDON, V391, P219, DOI 10.1113/jphysiol.1987.sp016735; AKAIKE N, 1988, NEUROSCI LETT, V87, P75, DOI 10.1016/0304-3940(88)90148-6; ALLEN CN, 1988, BRAIN RES, V458, P147, DOI 10.1016/0006-8993(88)90507-0; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P227; BEAN BP, 1990, J NEUROSCI, V10, P1; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BOYD ND, 1987, J PHYSIOL-LONDON, V389, P45, DOI 10.1113/jphysiol.1987.sp016646; COLQUHOUN D, 1988, J PHYSIOL-LONDON, V395, P131, DOI 10.1113/jphysiol.1988.sp016912; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; DAVIES CW, 1950, J CHEM SOC, P301, DOI 10.1039/jr9500000301; DUDEL J, 1990, NEUROSCI LETT, V114, P207, DOI 10.1016/0304-3940(90)90073-I; DUDEL J, 1990, J COMP PHYSIOL A, V166, P757; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; FELTZ A, 1982, J PHYSIOL-LONDON, V322, P257, DOI 10.1113/jphysiol.1982.sp014036; FRANKE C, 1987, NEUROSCI LETT, V77, P199, DOI 10.1016/0304-3940(87)90586-6; GEOFFROY M, 1991, MOL PHARMACOL, V39, P587; HACKETT JT, 1982, NEUROSCIENCE, V7, P1455, DOI 10.1016/0306-4522(82)90257-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; JACKSON MB, 1988, J PHYSIOL-LONDON, V397, P555, DOI 10.1113/jphysiol.1988.sp017019; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JHAVERI S, 1982, NEUROSCIENCE, V7, P837, DOI 10.1016/0306-4522(82)90046-X; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KISKIN NI, 1990, EUR J NEUROSCI, V2, P461, DOI 10.1111/j.1460-9568.1990.tb00437.x; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; KONISHI M, 1989, AUDITORY FUNCTION NE, P721; MANIS PB, 1991, J NEUROSCI, V11, P2865; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; NEMETH EF, 1983, NEUROSCI LETT, V40, P39, DOI 10.1016/0304-3940(83)90089-7; OBRIEN RJ, 1986, J NEUROSCI, V6, P3275; Oertel D, 1991, Curr Opin Neurobiol, V1, P221, DOI 10.1016/0959-4388(91)90082-I; OERTEL D, 1983, J NEUROSCI, V3, P2043; Onsager L, 1931, PHYS REV, V37, P405, DOI 10.1103/PhysRev.37.405; PATNEAU DK, 1992, J NEUROSCI, V12, P595; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; Pickles J. O, 1988, INTRO PHYSL HEARING; Sakmann B, 1983, SINGLE CHANNEL RECOR, P37; SMITH DO, 1991, J NEUROPHYSIOL, V66, P369, DOI 10.1152/jn.1991.66.2.369; SMITH DO, 1991, J NEUROPHYSIOL, V66, P1166, DOI 10.1152/jn.1991.66.4.1166; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STRECKER GJ, 1989, BIOPHYS J, V56, P795, DOI 10.1016/S0006-3495(89)82726-2; TAKAHASHI T, 1984, J NEUROSCI, V4, P1781; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; THIO LL, 1991, J NEUROSCI, V11, P3430; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P2834, DOI 10.1073/pnas.85.8.2834; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VERDOORN TA, 1988, MOL PHARMACOL, V34, P298; VLACHOVA V, 1987, J PHYSIOL-LONDON, V386, P425, DOI 10.1113/jphysiol.1987.sp016542; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; WARCHOL ME, 1990, J COMP PHYSIOL A, V166, P721; WHITTOW GC, 1984, AVIAN PHYSL, P223; WICKESBERG RE, 1989, BRAIN RES, V486, P39, DOI 10.1016/0006-8993(89)91275-4; YELLEN G, 1982, NATURE, V296, P357, DOI 10.1038/296357a0	60	207	207	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1992	9	1					173	186		10.1016/0896-6273(92)90232-3	http://dx.doi.org/10.1016/0896-6273(92)90232-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1352983				2022-12-28	WOS:A1992JE75600018
J	TSIM, KWK; RUEGG, MA; ESCHER, G; KROGER, S; MCMAHAN, UJ				TSIM, KWK; RUEGG, MA; ESCHER, G; KROGER, S; MCMAHAN, UJ			CDNA THAT ENCODES ACTIVE AGRIN	NEURON			English	Article							TORPEDO ELECTRIC ORGAN; DNA-SEQUENCE ANALYSIS; AMINO-ACID SEQUENCES; DROSOPHILA-MELANOGASTER; MOTOR NEURONS; LAMININ B2-CHAIN; NERVOUS-SYSTEM; PROTEIN; MOLECULES; CELLS	Agrin is thought to mediate the motor neuron-induced aggregation of AChRs and AChE on the surface of muscle fibers at neuromuscular junctions. We have isolated a cDNA from a chick brain library that, based on sequence homology and expression experiments, codes for active agrin. Examination of the sequence reveals considerable similarity to homologous cDNAs previously isolated from ray and rat libraries. A conspicuous difference is an insertion of 33 bp in chick agrin cDNA, which endows the encoded protein with AChR/AChE aggregating activity. Homologous transcripts having the 33 bp insertion were detected in the ray CNS, which indicates that an insertion of similar size is conserved in agrin in many, if not all, vertebrate species. Results of in situ hybridization studies and PCR experiments on mRNA isolated from motor neuron-enriched fractions of the spinal cord indicate that, consistent with the agrin hypothesis, motor neurons contain transcripts that code for active agrin.			TSIM, KWK (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305, USA.		Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Escher, Gerard/0000-0002-9515-4736; Kroger, Stephan/0000-0002-4626-1690; Tsim, Karl/0000-0003-4808-1674				BOLANDER ME, 1988, P NATL ACAD SCI USA, V85, P2919, DOI 10.1073/pnas.85.9.2919; BOURGEOIS JP, 1982, J COMP NEUROL, V208, P1, DOI 10.1002/cne.902080102; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; CHI HC, 1988, NUCLEIC ACIDS RES, V16, P7205, DOI 10.1093/nar/16.14.7205; DAHM LM, 1991, J NEUROSCI, V11, P238; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOHRMANN U, 1986, DEV BIOL, V118, P209, DOI 10.1016/0012-1606(86)90089-8; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GODFREY EW, 1991, EXP CELL RES, V195, P99, DOI 10.1016/0014-4827(91)90504-N; GODFREY EW, 1988, J CELL BIOL, V106, P1263, DOI 10.1083/jcb.106.4.1263; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HUNTER DD, 1989, CELL, V59, P905, DOI 10.1016/0092-8674(89)90613-2; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KNUST E, 1987, EMBO J, V6, P761, DOI 10.1002/j.1460-2075.1987.tb04818.x; LANKATBUTTGEREIT B, 1988, FEBS LETT, V236, P352, DOI 10.1016/0014-5793(88)80054-1; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MAGILLSOLC C, 1990, J EXP BIOL, V153, P1; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V50, P407; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PIKKARAINEN T, 1987, J BIOL CHEM, V262, P10454; PIKKARAINEN T, 1988, J BIOL CHEM, V263, P6751; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TSIM KWK, 1988, J NEUROCHEM, V51, P95, DOI 10.1111/j.1471-4159.1988.tb04840.x; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; WALLACE BG, 1986, J CELL BIOL, V102, P783, DOI 10.1083/jcb.102.3.783; WILSON MC, 1989, NEUROMETHODS, V16, P239	42	192	199	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					677	689		10.1016/0896-6273(92)90089-V	http://dx.doi.org/10.1016/0896-6273(92)90089-V			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1314620	Green Published			2022-12-28	WOS:A1992HQ18800007
J	NAWY, S; JAHR, CE				NAWY, S; JAHR, CE			CGMP-GATED CONDUCTANCE IN RETINAL BIPOLAR CELLS IS SUPPRESSED BY THE PHOTORECEPTOR TRANSMITTER	NEURON			English	Article							C-LIKE IMMUNOREACTIVITY; ROD OUTER-SEGMENT; CYCLIC-GMP; CARP RETINA; GLUTAMATE RECEPTOR; IONIC MECHANISMS; PROTEIN; EXCITATION; RESPONSES; ASPARTATE	Transmitter release from photoreceptors is decreased by light, resulting in a conductance increase in depolarizing bipolar cells. Addition of exogenous cGMP through a patch pipette to depolarizing bipolar cells from slices of dark-adapted tiger salamander retina resulted in an enhancement of the light response. This enhancement was blocked by GTP-gamma-S and dipyridamole, an inhibitor of phosphodiesterase. GTP-gamma-S and dipyridamole also blocked responses to exogenously applied 2-amino-4-phosphonobutyrate (APB), the glutamate agonist selective for this receptor. These data support the hypothesis that the postsynaptic receptor is linked via a G protein to a phosphodiesterase. The binding of glutamate or APB to the receptor suppresses a cGMP-activated current by increasing the rate of cyclic nucleotide hydrolysis.			NAWY, S (corresponding author), OREGON HLTH SCI UNIV, VOLLUM INST, PORTLAND, OR 97201 USA.			Nawy, Scott/0000-0003-4679-6756	NEI NIH HHS [EY06136, EY09139] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009139, F32EY006136] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P115, DOI 10.1113/jphysiol.1980.sp013155; ATTWELL D, 1987, J PHYSIOL-LONDON, V387, P125, DOI 10.1113/jphysiol.1987.sp016567; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; COBBS WH, 1985, NATURE, V317, P64, DOI 10.1038/317064a0; COBBS WH, 1985, NATURE, V313, P585, DOI 10.1038/313585a0; COPENHAGEN DR, 1983, VISION RES, V23, P363, DOI 10.1016/0042-6989(83)90083-4; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; HIRANO AA, 1991, P NATL ACAD SCI USA, V88, P805, DOI 10.1073/pnas.88.3.805; KARSCHIN A, 1990, J NEUROPHYSIOL, V63, P860, DOI 10.1152/jn.1990.63.4.860; MATTHEWS HR, 1985, NATURE, V313, P582, DOI 10.1038/313582a0; MURAKAMI M, 1975, VISION RES, V15, P456, DOI 10.1016/0042-6989(75)90101-7; NAWY S, 1990, NEUROSCI LETT, V108, P279, DOI 10.1016/0304-3940(90)90654-R; NAWY S, 1990, VISION RES, V30, P967, DOI 10.1016/0042-6989(90)90105-T; NAWY S, 1987, NATURE, V325, P56, DOI 10.1038/325056a0; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; NEGISHI K, 1988, NEUROSCI LETT, V94, P247, DOI 10.1016/0304-3940(88)90025-0; PUGH EN, 1990, VISION RES, V30, P1923, DOI 10.1016/0042-6989(90)90013-B; RISPOLI G, 1990, NATO ADV SCI I A-LIF, V194, P157; SAITO T, 1978, VISION RES, V18, P591, DOI 10.1016/0042-6989(78)90208-0; SAITO T, 1979, J GEN PHYSIOL, V73, P73, DOI 10.1085/jgp.73.1.73; SAITO T, 1982, J COMP NEUROL, V205, P161, DOI 10.1002/cne.902050207; SATHER WA, 1987, P NATL ACAD SCI USA, V84, P9290, DOI 10.1073/pnas.84.24.9290; SHIELLS RA, 1990, P ROY SOC B-BIOL SCI, V242, P91, DOI 10.1098/rspb.1990.0109; SHIELLS RA, 1981, NATURE, V294, P592, DOI 10.1038/294592a0; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; SLAUGHTER MM, 1985, J NEUROSCI, V5, P224; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; YAU KW, 1985, NATURE, V317, P252, DOI 10.1038/317252a0	29	177	178	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT	1991	7	4					677	683		10.1016/0896-6273(91)90380-I	http://dx.doi.org/10.1016/0896-6273(91)90380-I			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1681833				2022-12-28	WOS:A1991GM95400016
J	LIPTON, SA; SUCHER, NJ; KAISER, PK; DREYER, EB				LIPTON, SA; SUCHER, NJ; KAISER, PK; DREYER, EB			SYNERGISTIC EFFECTS OF HIV COAT PROTEIN AND NMDA RECEPTOR-MEDIATED NEUROTOXICITY	NEURON			English	Article							AMINO-ACID NEUROTOXICITY; RETINAL GANGLION-CELLS; CEREBELLAR GRANULE CELLS; GLUTAMATE NEUROTOXICITY; ENVELOPE GLYCOPROTEIN; CENTRAL NEURONS; KINASE-C; RAT; ANTAGONISTS; AGONISTS	Exposure of rat retinal cultures to HIV-1 coat protein gp120 for several minutes increases [Ca2+]i in approximately half of the ganglion cells; this effect is associated with delayed-onset neuronal injury, similar to that previously reported in NMDA receptor-mediated neurotoxicity. Here we show that NMDA antagonists can prevent both the rise in [Ca2+]i and subsequent neuronal damage engendered by 20 pM gp120. However, whole-cell patch-clamp recordings demonstrate that gp120 does not directly evoke an NMDA-like response or enhance glutamate/NMDA-activated currents. Moreover, complete protection from gp120-induced [Ca2+]i increases and neurotoxicity is afforded by incubation with glutamate-pyruvate transaminase, which breaks down endogenous glutamate as verified by HPLC. Since, under standard conditions in these cultures, neither glutamate nor a low picomolar concentration of gp120 is deleterious on its own, our results suggest that their neurotoxicity is synergistic.	HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT NEUROL,BOSTON,MA 02115; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT NEUROL,PROGRAM NEUROSCI,BOSTON,MA 02114	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	LIPTON, SA (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT NEUROL,CELLULAR & MOLEC NEUROSCI LAB,BOSTON,MA 02115, USA.			Sucher, Nikolaus/0000-0001-6233-1612; Lipton, Stuart/0000-0002-3490-1259; Kaiser, Peter/0000-0001-5126-045X	NEI NIH HHS [EY05477, EY09024] Funding Source: Medline; NINDS NIH HHS [NS07264] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009024, R01EY005477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007264] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELE AE, 1990, NEURON, V4, P413, DOI 10.1016/0896-6273(90)90053-I; AIZENMAN E, 1988, J PHYSIOL-LONDON, V396, P75, DOI 10.1113/jphysiol.1988.sp016951; BERMAN PW, 1985, SCIENCE, V227, P1490, DOI 10.1126/science.2983428; BRENNEMAN DE, 1988, NATURE, V335, P639, DOI 10.1038/335639a0; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1987, J NEUROSCI, V7, P369; DEERAUSQUIN GA, 1990, P NATL ACAD SCI USA, V87, P8017, DOI 10.1073/pnas.87.20.8017; DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; FAVARON M, 1990, P NATL ACAD SCI USA, V87, P1983, DOI 10.1073/pnas.87.5.1983; GARTHWAITE G, 1986, NEUROSCI LETT, V66, P193, DOI 10.1016/0304-3940(86)90189-8; GIULIAN D, 1990, SCIENCE, V250, P1593, DOI 10.1126/science.2148832; GOLDBERG MP, 1988, NEUROSCI LETT, V94, P52, DOI 10.1016/0304-3940(88)90269-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAHN JS, 1988, P NATL ACAD SCI USA, V85, P6556, DOI 10.1073/pnas.85.17.6556; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEYES MP, 1991, ANN NEUROL, V29, P202, DOI 10.1002/ana.410290215; HEYES MP, 1989, ANN NEUROL, V26, P275; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; KAISER PK, 1990, NEURON, V5, P373, DOI 10.1016/0896-6273(90)90173-D; KARSCHIN A, 1988, J NEUROSCI, V8, P2895; KETZLER S, 1990, ACTA NEUROPATHOL, V80, P92, DOI 10.1007/BF00294228; KORNFELD H, 1988, NATURE, V335, P445, DOI 10.1038/335445a0; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; LEIFER D, 1984, SCIENCE, V224, P303, DOI 10.1126/science.6143400; LEVY DI, 1990, NEUROSCI LETT, V110, P291, DOI 10.1016/0304-3940(90)90862-4; LEVY DI, 1990, NEUROLOGY, V40, P852, DOI 10.1212/WNL.40.5.852; LIPTON SA, 1987, J PHYSIOL-LONDON, V385, P361, DOI 10.1113/jphysiol.1987.sp016497; LIPTON SA, 1991, IN PRESS BRAIN PATHO; LYSKO PG, 1989, BRAIN RES, V499, P258, DOI 10.1016/0006-8993(89)90773-7; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1987, J NEUROSCI, V7, P3230; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MURPHY SN, 1989, J PHARMACOL EXP THER, V249, P184; OBRIEN RJ, 1986, J NEUROSCI, V6, P3290; PEARCE IA, 1987, FEBS LETT, V223, P143, DOI 10.1016/0014-5793(87)80525-2; PELLEGRINIGIAMPIETRO DE, 1990, J NEUROSCI, V10, P1035, DOI 10.1523/jneurosci.10-03-01035.1990; PRICE RW, 1988, SCIENCE, V239, P5586; ROSENBERG PA, 1991, GLIA, V4, P91, DOI 10.1002/glia.440040111; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; Sucher N J, 1990, Neuroreport, V1, P29, DOI 10.1097/00001756-199009000-00009; SUCHER NJ, 1991, IN PRESS BRAIN RES; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; ZORN NE, 1990, BIOCHEM BIOPH RES CO, V166, P1133, DOI 10.1016/0006-291X(90)90984-U	45	369	374	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1991	7	1					111	118		10.1016/0896-6273(91)90079-F	http://dx.doi.org/10.1016/0896-6273(91)90079-F			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1676893				2022-12-28	WOS:A1991FY48100011
J	WAFFORD, KA; BURNETT, DM; LEIDENHEIMER, NJ; BURT, DR; WANG, JB; KOFUJI, P; DUNWIDDIE, TV; HARRIS, RA; SIKELA, JM				WAFFORD, KA; BURNETT, DM; LEIDENHEIMER, NJ; BURT, DR; WANG, JB; KOFUJI, P; DUNWIDDIE, TV; HARRIS, RA; SIKELA, JM			ETHANOL SENSITIVITY OF THE GABA-A RECEPTOR EXPRESSED IN XENOPUS OOCYTES REQUIRES 8 AMINO-ACIDS CONTAINED IN THE GAMMA-2L SUBUNIT	NEURON			English	Article							AMINOBUTYRIC ACID; A RECEPTORS; CHLORIDE CHANNELS; GENETIC-DIFFERENCES; NEURONS; SITE; RNA	Expression of brain mRNA or cRNAs in Xenopus oocytes was used to determine what subunits of the GABA(A) receptor are required for modulation by barbiturates, benzodiazepines, and ethanol. Mouse brain mRNA was hybridized with antisense oligonucleotides complementary to sequences unique to specific subunits and injected into oocytes. Antisense oligonucleotides to the alpha-1, beta-1, gamma-1, gamma-2S + 2L, gamma-2L, or gamma-3 subunits did not alter GABA action or enhancement by pentobarbital. Action of diazepam was prevented by antisense oligonucleotides to gamma-2S + 2L and reduced by antisense sequences to gamma-2L, but was not affected by the other oligonucleotides. Ethanol enhancement of GABA action was prevented only by antisense oligonucleotides to gamma-2L (which differs from gamma-2S by the addition of 8 amino acids). Expression of either the alpha-1-beta-1-gamma-2S or the alpha-1-beta-1-gamma-2L subunit cRNA combination in oocytes resulted in GABA responses that were enhanced by diazepam or pentobarbital, but only the combination containing the gamma-2L subunit was affected by ethanol.	VET ADM MED CTR,DENVER,CO 80262; UNIV MARYLAND,SCH MED,DEPT PHARMACOL,BALTIMORE,MD 21201	US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Maryland; University of Maryland Baltimore	WAFFORD, KA (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT PHARMACOL,DENVER,CO 80262, USA.		Kofuji, Paulo/AAR-7835-2021	Kofuji, Paulo/0000-0002-4840-9986	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA006399, R01AA006399, P50AA003527] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA03527, AA07559, AA06399] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AGUAYO LG, 1990, EUR J PHARMACOL, V187, P127, DOI 10.1016/0014-2999(90)90349-B; ALLAN AM, 1986, LIFE SCI, V39, P2005, DOI 10.1016/0024-3205(86)90324-3; ALLAN AM, 1991, CLIN EXP RES, V15, P233; DEITRICH RA, 1989, PHARMACOL REV, V41, P491; GIVENS BS, 1990, J PHARMACOL EXP THER, V254, P528; HARLAND R, 1985, J CELL BIOL, V101, P1094, DOI 10.1083/jcb.101.3.1094; HARRIS RA, 1989, BRAIN RES, V490, P26; HARRIS RA, 1989, FASEB J, V3, P1689, DOI 10.1096/fasebj.3.6.2467834; HARRIS RA, 1990, ALCOHOL, V7, P273, DOI 10.1016/0741-8329(90)90017-7; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KEIR WJ, 1991, GENOMICS, V9, P390, DOI 10.1016/0888-7543(91)90272-G; KOFUJI P, 1991, J NEUROCHEM, V56, P713, DOI 10.1111/j.1471-4159.1991.tb08209.x; LIN AMY, 1991, NEUROSCI LETT, V122, P154, DOI 10.1016/0304-3940(91)90846-L; MEHTA AK, 1988, J PHARMACOL EXP THER, V246, P558; MODY I, 1991, BRAIN RES, V538, P319, DOI 10.1016/0006-8993(91)90447-4; MOSS SJ, 1991, NEUROSCI LETT, V123, P265, DOI 10.1016/0304-3940(91)90947-R; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SUMIKAWA K, 1988, P NATL ACAD SCI USA, V85, P1302, DOI 10.1073/pnas.85.4.1302; SUZDAK PD, 1986, P NATL ACAD SCI USA, V83, P4071, DOI 10.1073/pnas.83.11.4071; WAFFORD KA, 1990, SCIENCE, V249, P291, DOI 10.1126/science.1695761; WAFFORD KA, 1989, BRAIN RES, V505, P215, DOI 10.1016/0006-8993(89)91445-5; WHITE G, 1990, BRAIN RES, V507, P332, DOI 10.1016/0006-8993(90)90292-J; WHITING P, 1990, P NATL ACAD SCI USA, V87, P9966, DOI 10.1073/pnas.87.24.9966; WILSONSHAW D, 1991, FEBS LETT, V284, P211, DOI 10.1016/0014-5793(91)80687-X	27	359	363	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1991	7	1					27	33		10.1016/0896-6273(91)90071-7	http://dx.doi.org/10.1016/0896-6273(91)90071-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1712603				2022-12-28	WOS:A1991FY48100003
J	ISACKSON, PJ; HUNTSMAN, MM; MURRAY, KD; GALL, CM				ISACKSON, PJ; HUNTSMAN, MM; MURRAY, KD; GALL, CM			BDNF MESSENGER-RNA EXPRESSION IS INCREASED IN ADULT-RAT FOREBRAIN AFTER LIMBIC SEIZURES - TEMPORAL PATTERNS OF INDUCTION DISTINCT FROM NGF	NEURON			English	Article							NERVE GROWTH-FACTOR; SEPTAL CHOLINERGIC NEURONS; HUMAN NEUROTROPHIC FACTOR; RETINAL GANGLION-CELLS; FACTOR MESSENGER-RNA; BASAL FOREBRAIN; FACTOR FAMILY; C-FOS; BRAIN; HIPPOCAMPUS	We have localized brain-derived neurotrophic factor (BDNF) mRNA in rat brain and examined its regulation by seizure activity. In situ hybridization of BDNF S-35-cRNA most prominently labeled neurons in hippocampal stratum pyramidale and stratum granulosum, superficial olfactory cortex, pyramidal cell layers of neocortex, amygdala, claustrum, endopiriform nucleus, anterior olfactory nucleus, and ventromedial hypothalamus. Hybridization to BDNF mRNA was markedly increased in all of these regions after lesion-induced recurrent limbic seizures and within dentate gyrus granule cells following one electrically stimulated epileptiform afterdischarge. In contrast to seizure-elicited changes in nerve growth factor (NGF) mRNA expression, increases in BDNF mRNA occur in a greater number of different neuronal populations and develop several hours more rapidly in extrahippocampal loci. These results indicate that regulation by physiological activity may be an intrinsic property of this class of neurotrophic factor but that, in the recurrent seizure paradigm, different mechanisms mediate increased expression of mRNAs for BDNF and NGF outside hippocampus.	UNIV CALIF IRVINE, DEPT BIOL CHEM, IRVINE, CA 92717 USA	University of California System; University of California Irvine	ISACKSON, PJ (corresponding author), UNIV CALIF IRVINE, DEPT ANAT, IRVINE, CA 92717 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026748, R29NS024747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R35AG007918] Funding Source: NIH RePORTER; NIA NIH HHS [AG07918] Funding Source: Medline; NINDS NIH HHS [NS24747, NS26748] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; [Anonymous], [No title captured]; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BAUDRY M, 1986, J NEUROSCI, V6, P3430; CAMPBELL KA, 1984, EXP NEUROL, V86, P506, DOI 10.1016/0014-4886(84)90085-2; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; de Olmos J.S., 1985, RAT NERVOUS SYSTEM, VI, P223; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; GALL C, 1990, PROG BRAIN RES, V83, P371; GALL C, 1991, MOL BRAIN RES, V9, P113, DOI 10.1016/0169-328X(91)90136-L; Gall C M, 1988, Peptides, V9 Suppl 1, P79, DOI 10.1016/0196-9781(88)90228-8; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; HEFTI F, 1986, J NEUROSCI, V6, P2155; HENGERER B, 1990, P NATL ACAD SCI USA, V87, P3899, DOI 10.1073/pnas.87.10.3899; HIGGINS GA, 1989, NEURON, V3, P247, DOI 10.1016/0896-6273(89)90038-X; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; KUJUBU DA, 1987, ONCOGENE, V1, P257; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAUTERBORN JC, 1991, J COMP NEUROL, V306, P439, DOI 10.1002/cne.903060308; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LEVIMONTALCINI R, 1985, DEV BIOL, V263, P16348; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MOCCHETTI I, 1989, P NATL ACAD SCI USA, V86, P3891, DOI 10.1073/pnas.86.10.3891; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; THANOS S, 1989, EUR J NEUROSCI, V1, P19, DOI 10.1111/j.1460-9568.1989.tb00770.x; THOENEN H, 1987, REV PHYSIOL BIOCH P, V109, P145, DOI 10.1007/BFb0031026; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; WHITTEMORE SR, 1988, J NEUROSCI RES, V20, P403, DOI 10.1002/jnr.490200402; WILLIAMS LR, 1990, J NEUROCHEM, V55, P1042, DOI 10.1111/j.1471-4159.1990.tb04594.x; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	43	603	618	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1991	6	6					937	948		10.1016/0896-6273(91)90234-Q	http://dx.doi.org/10.1016/0896-6273(91)90234-Q			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	2054188				2022-12-28	WOS:A1991FT94900009
J	RAO, MS; LANDIS, SC				RAO, MS; LANDIS, SC			CHARACTERIZATION OF A TARGET-DERIVED NEURONAL CHOLINERGIC DIFFERENTIATION FACTOR	NEURON			English	Article							CULTURED SYMPATHETIC NEURONS; CILIARY NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; RAT SWEAT GLANDS; NEUROTRANSMITTER PLASTICITY INVIVO; PERIPHERAL NORADRENERGIC NEURONS; Y (NPY)-LIKE IMMUNOREACTIVITY; TYROSINE-HYDROXYLASE ACTIVITY; MUSCLE-CONDITIONED MEDIUM; NEUROPEPTIDE-Y	The sympathetic innervation of rat sweat glands undergoes a target-induced switch from a noradrenergic to a cholinergic and peptidergic phenotype during development. Treatment of cultured sympathetic neurons with sweat gland extracts mimics many of the changes seen in vivo. Extracts induced choline acetyltransferase activity and vasoactive intestinal peptide expression in the neurons in a dose-dependent fashion while reducing catecholaminergic properties and neuropeptide Y. The cholinergic differentiation activity appears in developing glands of postnatal day 5 rats and is maintained in adult glands. It is a heat-labile, trypsin-sensitive, acidic protein that does not bind to heparin-agarose. Immunoprecipitation experiments with an antiserum directed against an N-terminal peptide of a cholinergic differentiation factor (CDF/LIF) from heart cells suggest that the sweat gland differentiation factor is not CDF/LIF. The sweat gland activity is a likely candidate for mediating the target-directed change in sympathetic neurotransmitter function observed in vivo.	CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,CLEVELAND,OH 44106	Case Western Reserve University	RAO, MS (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.							ADLER JE, 1986, DEV BRAIN RES, V30, P237, DOI 10.1016/0165-3806(86)90114-8; ADLER JE, 1989, P NATL ACAD SCI USA, V86, P1080, DOI 10.1073/pnas.86.3.1080; ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; BARBIN G, 1984, J NEUROCHEM, V43, P1468, DOI 10.1111/j.1471-4159.1984.tb05410.x; BOCCHINI V, 1969, P NATL ACAD SCI USA, V64, P787, DOI 10.1073/pnas.64.2.787; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FONNUM F, 1969, BIOCHEM J, V115, P465, DOI 10.1042/bj1150465; FUKADA K, 1985, P NATL ACAD SCI USA, V82, P8795, DOI 10.1073/pnas.82.24.8795; Hawrot E, 1979, Methods Enzymol, V58, P574; HILTON DJ, 1988, ANAL BIOCHEM, V173, P359, DOI 10.1016/0003-2697(88)90200-X; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; JARVI R, 1986, NEUROSCI LETT, V67, P223, DOI 10.1016/0304-3940(86)90402-7; JOHNSON M, 1976, NATURE, V262, P308, DOI 10.1038/262308a0; JOHNSON MI, 1980, J CELL BIOL, V84, P680, DOI 10.1083/jcb.84.3.680; KESSLER JA, 1986, P NATL ACAD SCI USA, V83, P3528, DOI 10.1073/pnas.83.10.3528; LAMOUROUX A, 1982, P NATL ACAD SCI-BIOL, V79, P3881, DOI 10.1073/pnas.79.12.3881; LANDIS SC, 1988, DEV BIOL, V126, P129, DOI 10.1016/0012-1606(88)90246-1; LANDIS SC, 1986, BRAIN RES, V377, P177, DOI 10.1016/0006-8993(86)91205-9; LANDIS SC, 1983, DEV BIOL, V98, P349, DOI 10.1016/0012-1606(83)90365-2; LEBLANC G, 1986, J NEUROSCI, V6, P260; LEE JM, 1990, EXP NEUROL, V108, P109, DOI 10.1016/0014-4886(90)90016-L; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LINDH B, 1989, CELL TISSUE RES, V256, P259; LUNDBERG JM, 1983, NEUROSCI LETT, V42, P167, DOI 10.1016/0304-3940(83)90401-9; LUNDBERG JM, 1982, ACTA PHYSIOL SCAND, V116, P477, DOI 10.1111/j.1748-1716.1982.tb07171.x; LUNDBERG JM, 1979, NEUROSCIENCE, V4, P1539, DOI 10.1016/0306-4522(79)90018-6; MANTHORPE M, 1986, BRAIN RES, V367, P282, DOI 10.1016/0006-8993(86)91603-3; MANTHORPE M, 1980, J NEUROCHEM, V34, P69, DOI 10.1111/j.1471-4159.1980.tb04622.x; MAREK KL, 1989, J NEUROCHEM, V52, P1807, DOI 10.1111/j.1471-4159.1989.tb07261.x; MCMAHON SB, 1987, NEUROSCI LETT, V73, P9, DOI 10.1016/0304-3940(87)90022-X; MCMANAMAN JL, 1988, J BIOL CHEM, V263, P5890; NAWA H, 1990, NEURON, V4, P279, DOI 10.1016/0896-6273(90)90102-L; NAWA H, 1990, NEURON, V4, P269, DOI 10.1016/0896-6273(90)90101-K; PATTERSON PH, 1977, DEV BIOL, V60, P473, DOI 10.1016/0012-1606(77)90144-0; PATTERSON PH, 1977, DEV BIOL, V56, P263, DOI 10.1016/0012-1606(77)90269-X; POTTER DD, 1986, J NEUROSCI, V6, P1080; QUICK DC, 1984, ANAT REC, V208, P491, DOI 10.1002/ar.1092080404; RAO MS, 1990, DEV BIOL, V139, P65, DOI 10.1016/0012-1606(90)90279-R; RATHJEN FG, 1984, EMBO J, V3, P1; RAYNAUD B, 1987, DEV BIOL, V121, P548, DOI 10.1016/0012-1606(87)90190-4; RITTENHOUSE AR, 1988, NEUROSCIENCE, V25, P207, DOI 10.1016/0306-4522(88)90019-X; ROHRER H, 1986, J NEUROSCI, V6, P2616; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SCHOTZINGER RJ, 1988, NATURE, V335, P637, DOI 10.1038/335637a0; SCHOTZINGER RJ, 1990, CELL TISSUE RES, V260, P575, DOI 10.1007/BF00297238; SCHOTZINGER RJ, 1990, NEURON, V5, P91, DOI 10.1016/0896-6273(90)90037-G; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; STEVENS LM, 1990, DEV BIOL, V137, P109, DOI 10.1016/0012-1606(90)90012-8; STEVENS LM, 1987, DEV BIOL, V123, P179, DOI 10.1016/0012-1606(87)90440-4; STEVENS LM, 1988, DEV BIOL, V130, P703, DOI 10.1016/0012-1606(88)90362-4; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; UNO H, 1975, CELL TISSUE RES, V158, P1; VIDAL S, 1987, DEVELOPMENT, V101, P617; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; WOLINSKY E, 1983, J NEUROSCI, V3, P1495; WOLINSKY EJ, 1985, J NEUROSCI, V5, P1497; WONG V, 1987, P NATL ACAD SCI USA, V84, P8726, DOI 10.1073/pnas.84.23.8726; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641	58	90	90	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1990	5	6					899	910		10.1016/0896-6273(90)90350-O	http://dx.doi.org/10.1016/0896-6273(90)90350-O			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ381	1980070				2022-12-28	WOS:A1990EQ38100018
J	SIGEL, E; BAUR, R; TRUBE, G; MOHLER, H; MALHERBE, P				SIGEL, E; BAUR, R; TRUBE, G; MOHLER, H; MALHERBE, P			THE EFFECT OF SUBUNIT COMPOSITION OF RAT-BRAIN GABA-A RECEPTORS ON CHANNEL FUNCTION	NEURON			English	Article									F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES,CH-4002 BASEL,SWITZERLAND; UNIV ZURICH,DEPT PHARMACOL,CH-8006 ZURICH,SWITZERLAND	Roche Holding; University of Zurich	SIGEL, E (corresponding author), UNIV BERN,DEPT PHARMACOL,CH-3000 BERN,SWITZERLAND.		Sigel, Erwin/F-7736-2015					AKAIKE N, 1990, AM J PHYSIOL, V258, pC452, DOI 10.1152/ajpcell.1990.258.3.C452; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P125, DOI 10.1113/jphysiol.1982.sp014256; BLAIR LAC, 1988, SCIENCE, V242, P577, DOI 10.1126/science.2845583; BULLER AL, 1990, MOL PHARMACOL, V37, P423; KHRESTCHATISKY M, 1989, NEURON, V3, P745, DOI 10.1016/0896-6273(89)90243-2; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LEVITAN ES, 1988, NEURON, V1, P773, DOI 10.1016/0896-6273(88)90125-0; LOLAIT SJ, 1989, FEBS LETT, V246, P145, DOI 10.1016/0014-5793(89)80271-6; MALHERBE P, 1990, FEBS LETT, V260, P261, DOI 10.1016/0014-5793(90)80118-3; MALHERBE P, 1990, J NEUROSCI, V10, P2330; MALHERBE P, 1990, IN PRESS MOL BRAIN R; MILEDI R, 1982, PROC R SOC SER B-BIO, V216, P509, DOI 10.1098/rspb.1982.0089; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; OSMANOVIC SS, 1990, J PHYSIOL-LONDON, V421, P151, DOI 10.1113/jphysiol.1990.sp017938; PARKER I, 1986, J NEUROSCI, V6, P2290; PRICHETT DB, 1989, NATURE, V338, P582; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; RICHTER JD, 1983, J BIOL CHEM, V258, P2614; SCHOFIELD PR, 1989, TRENDS PHARMACOL SCI, V10, P476, DOI 10.1016/0165-6147(89)90041-2; SCHOFIELD PR, 1989, FEBS LETT, V244, P361, DOI 10.1016/0014-5793(89)80563-0; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SIEGHART W, 1989, TRENDS PHARMACOL SCI, V10, P407, DOI 10.1016/0165-6147(89)90189-2; SIGEL E, 1988, J NEUROSCI, V8, P289; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; SIGEL E, 1984, J BIOL CHEM, V259, P7219; SIGEL E, 1989, FEBS LETT, V257, P377, DOI 10.1016/0014-5793(89)81576-5; SIGEL E, 1983, J BIOL CHEM, V258, P6965; STEPHENSON FA, 1989, FEBS LETT, V243, P358, DOI 10.1016/0014-5793(89)80161-9; YAKUSHIJI T, 1989, BRIT J PHARMACOL, V98, P735, DOI 10.1111/j.1476-5381.1989.tb14600.x; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x; YMER S, 1989, FEBS LETT, V258, P119, DOI 10.1016/0014-5793(89)81630-8	33	573	580	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1990	5	5					703	711		10.1016/0896-6273(90)90224-4	http://dx.doi.org/10.1016/0896-6273(90)90224-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ868	1699569				2022-12-28	WOS:A1990EJ86800014
J	HEMPSTEAD, BL; RABIN, SJ; KAPLAN, L; REID, S; PARADA, LF; KAPLAN, DR				HEMPSTEAD, BL; RABIN, SJ; KAPLAN, L; REID, S; PARADA, LF; KAPLAN, DR			OVEREXPRESSION OF THE TRK TYROSINE KINASE RAPIDLY ACCELERATES NERVE GROWTH FACTOR-INDUCED DIFFERENTIATION	NEURON			English	Article							INTERMEDIATE FILAMENT PROTEIN; FOS-INDEPENDENT PATHWAYS; TRANSIN GENE-EXPRESSION; PHOSPHOLIPASE-C-GAMMA; HUMAN NGF RECEPTOR; PC12 CELLS; HIGH-AFFINITY; PHEOCHROMOCYTOMA CELLS; PROTOONCOGENE PRODUCT; NEURONAL DIFFERENTIATION	To investigate the role of the gp140trk receptor tyrosine kinase in nerve growth factor (NGF)-induced differentiation, we have overexpressed gp140trk in the NGF-responsive PC12 cell line. Here we demonstrate that overexpression of gp140trk results in marked changes in NGF-induced differentiation. Whereas PC12 cells elaborated neurites after 2 days of continuous exposure to NGF, PC12 cells overexpressing gp140trk by 20-fold (trk-PC12) began this process within hours. Compared with wild-type PC12 cells, trk-PC12 exhibited an increase in both high and low affinity NGF-binding sites. Furthermore, trk-PC12 cells displayed an enhanced level of NGF-dependent gp140trk autophosphorylation, and this activity was sustained for many hours following ligand binding. The tyrosine phosphorylation or activity of several cellular proteins, such as PLC-gamma1, PI-3 kinase, and Erk1 and the expression of the mRNA for the late response gene transin were also sustained as a consequence of gp140trk overexpression. The data indicate that overexpression of gp140trk in PC12 cells markedly accelerates NGF-induced differentiation pathways, possibly through the elevation of gp140trk tyrosine kinase activity.	NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, FREDERICK, MD 21701 USA; NCI, FREDERICK CANC RES & DEV CTR, MMCL, EUKARYOT SIGNAL TRANSDUCT GRP, FREDERICK, MD 21701 USA; NCI, FREDERICK CANC RES & DEV CTR, MGL, MOLEC EMBRYOL SECT, FREDERICK, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	HEMPSTEAD, BL (corresponding author), CORNELL UNIV, SCH MED, DIV HEMATOL, NEW YORK, NY 10021 USA.		Parada, luis F/B-9400-2014		NCI NIH HHS [N01-CO-74101] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BERG MM, 1991, P NATL ACAD SCI USA, V88, P7106, DOI 10.1073/pnas.88.16.7106; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; Black I.B., 1990, Current Topics in Developmental Biology, V24, P161; BLENIS J, 1986, EMBO J, V5, P3441, DOI 10.1002/j.1460-2075.1986.tb04667.x; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; CURRAN T, 1986, P NATL ACAD SCI USA, V83, P8521, DOI 10.1073/pnas.83.22.8521; DAMON DH, 1990, J CELL BIOL, V110, P1333, DOI 10.1083/jcb.110.4.1333; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; GIZANGGINSBERG E, 1990, GENE DEV, V4, P477, DOI 10.1101/gad.4.4.477; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; GRANT AJ, 1992, P NATL ACAD SCI USA, V89, P2165, DOI 10.1073/pnas.89.6.2165; GREEN SH, 1986, J BIOL CHEM, V261, P5316; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1982, DEV BIOL, V91, P305, DOI 10.1016/0012-1606(82)90037-9; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1977, BRAIN RES, V133, P350, DOI 10.1016/0006-8993(77)90770-3; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HAMA T, 1986, P NATL ACAD SCI USA, V83, P2353, DOI 10.1073/pnas.83.8.2353; HEASLEY LE, 1989, J BIOL CHEM, V264, P8646; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KERR LD, 1988, SCIENCE, V242, P1424, DOI 10.1126/science.2462278; KIM UH, 1991, J BIOL CHEM, V266, P1359; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KNUSEL B, 1992, IN PRESS J NEUROCHEM; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEONARD DGB, 1988, J CELL BIOL, V106, P181, DOI 10.1083/jcb.106.1.181; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIVNEH E, 1986, J BIOL CHEM, V261, P2490; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MACHIDA CM, 1991, J CELL BIOL, V114, P1037, DOI 10.1083/jcb.114.5.1037; MACHIDA CM, 1989, NEURON, V2, P1587, DOI 10.1016/0896-6273(89)90047-0; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MATSUSHIMA H, 1990, MOL CELL BIOL, V10, P5015, DOI 10.1128/MCB.10.9.5015; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MIYASAKA T, 1991, P NATL ACAD SCI USA, V88, P2653, DOI 10.1073/pnas.88.7.2653; MORRISON DK, 1990, MOL CELL BIOL, V10, P2359, DOI 10.1128/MCB.10.5.2359; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MUTOH T, 1988, J BIOL CHEM, V263, P15853; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; POSSENTI R, 1989, EMBO J, V8, P2217, DOI 10.1002/j.1460-2075.1989.tb08345.x; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; SALTON SRJ, 1991, MOL CELL BIOL, V11, P2335, DOI 10.1128/MCB.11.5.2335; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SOLTOFF SP, 1992, J BIOL CHEM, V267, P17472; SONNENFELD KH, 1985, J NEUROSCI, V5, P1717; SUH PG, 1988, J BIOL CHEM, V263, P14497; SUTTER A, 1979, J BIOL CHEM, V254, P5972; THOMPSON MA, 1989, NEURON, V2, P1043, DOI 10.1016/0896-6273(89)90228-6; TSAO H, 1990, J BIOL CHEM, V265, P15471; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551	73	313	317	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1992	9	5					883	896		10.1016/0896-6273(92)90241-5	http://dx.doi.org/10.1016/0896-6273(92)90241-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1384575				2022-12-28	WOS:A1992JY55200008
J	LUO, LQ; TULLY, T; WHITE, K				LUO, LQ; TULLY, T; WHITE, K			HUMAN AMYLOID PRECURSOR PROTEIN AMELIORATES BEHAVIORAL DEFICIT OF FLIES DELETED FOR APPL GENE	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; DROSOPHILA-MELANOGASTER; MESSENGER-RNA; TYROSINE KINASE; NEXIN-II; EXPRESSION PATTERN; CELL-ADHESION; SECRETED FORM; PERIOD GENE	Drosophila amyloid precursor protein-like (Appl) gene encodes a protein product (APPL) similar to beta-amyloid precursor protein (APP) associated with Alzheimer's disease. To understand the in vivo function of APPL protein, we have generated flies deleted for the Appl gene. These flies are viable, fertile, and morphologically normal, yet they exhibit subtle behavioral deficits. We show that a fast phototaxis defect in Appl- flies is partially rescued by transgenes expressing the wild-type, but not a mutant, APPL protein. We further demonstrate a functional homology between APPL and APP, since transgenes expressing human APP show a similar level of rescue as transgenes expressing fly APPL.	BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254; BRANDEIS UNIV,CTR COMPLEX SYST,WALTHAM,MA 02254	Brandeis University; Brandeis University					NINDS NIH HHS [NS 25621, NS 29826] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029826, R29NS025621] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASLER K, 1989, EMBO J, V8, P2381, DOI 10.1002/j.1460-2075.1989.tb08367.x; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; BOSSY B, 1984, EMBO J, V3, P2537, DOI 10.1002/j.1460-2075.1984.tb02169.x; BOYNTON S, 1992, GENETICS, V131, P655; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; EWER J, 1988, NATURE, V333, P82, DOI 10.1038/333082a0; GAILEY DA, 1991, J COMP PHYSIOL A, V169, P685; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOEBL MG, 1986, CELL, V46, P983, DOI 10.1016/0092-8674(86)90697-5; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GREENSPAN RJ, 1980, J COMP NEUROL, V189, P741, DOI 10.1002/cne.901890409; HARLOW E, 1988, ANTIBODIES LABORATOR; Heisenberg M., 1984, STUDIES BRAIN FUNCTI, V12; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LIU X, 1991, NEURON, V6, P753, DOI 10.1016/0896-6273(91)90172-V; LOWERY DE, 1991, J BIOL CHEM, V266, P19842; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; MARTINMORRIS LE, 1990, DEVELOPMENT, V110, P185; MEEHAN MJ, 1987, BEHAV GENET, V17, P503, DOI 10.1007/BF01073117; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NEVE RL, 1988, NEURON, V1, P669, DOI 10.1016/0896-6273(88)90166-3; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; PEREIRA A, 1992, J CELL BIOL, V116, P377, DOI 10.1083/jcb.116.2.377; Pirrotta V, 1988, VECTORS SURVEY MOL C, P437; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; RENDAHL KG, 1992, J NEUROSCI, V12, P390; RESTIFO LL, 1991, DEV BIOL, V148, P174, DOI 10.1016/0012-1606(91)90328-Z; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROMAS RGP, 1989, GENETICS, V323, P337; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SALZ HK, 1982, GENETICS, V100, P587; SCHUBERT D, 1989, NEURON, V3, P689, DOI 10.1016/0896-6273(89)90237-7; SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066; SEEGER MA, 1988, CELL, V55, P589, DOI 10.1016/0092-8674(88)90217-6; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SHIVERS BD, 1988, EMBO J, V7, P1365, DOI 10.1002/j.1460-2075.1988.tb02952.x; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; SPRADLING AC, 1982, SCIENCE, V218, P348; STELLER H, 1985, EMBO J, V4, P3765, DOI 10.1002/j.1460-2075.1985.tb04146.x; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; VANNOSTRAND WE, 1989, NATURE, V341, P546; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; YAMADA T, 1987, BIOCHEM BIOPH RES CO, V149, P665, DOI 10.1016/0006-291X(87)90419-0; YOUNG MW, 1978, GENETICS, V88, P723; [No title captured]	70	220	233	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					595	605		10.1016/0896-6273(92)90024-8	http://dx.doi.org/10.1016/0896-6273(92)90024-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1389179				2022-12-28	WOS:A1992JT51600002
J	SCHECTERSON, LC; BOTHWELL, M				SCHECTERSON, LC; BOTHWELL, M			NOVEL ROLES FOR NEUROTROPHINS ARE SUGGESTED BY BDNF AND NT-3 MESSENGER-RNA EXPRESSION IN DEVELOPING NEURONS	NEURON			English	Article							NERVE GROWTH-FACTOR; SPINAL-CORD MOTONEURONS; AFFINITY NGF RECEPTOR; TRK PROTOONCOGENE; SCHWANN-CELLS; MOLECULAR-CLONING; INSITU HYBRIDIZATION; RETROGRADE TRANSPORT; SENSORY NEURONS; TYROSINE KINASE	The results of our in situ hybridization experiments demonstrate that sensory neurons, sympathetic neurons, and motoneurons express brain-derived neurotrophic factor and/or neurotrophin-3 mRNAs during development in mouse. In accordance with previous data, we also find neurotrophins in the targets of sensory neurons (skin) and motoneurons (muscle) and the neurotrophin receptors p75, trkA, and trkB in sensory and sympathetic ganglia. These results suggest that neurotrophins have roles other than being target-derived factors that support neuron survival during developmental cell death (neurotrophic hypothesis), but may be transported in an orthograde fashion in neurons and released from axon terminals. We discuss several novel roles for neurotrophins, including autocrine/paracrine regulation of neuron survival, regulation of Schwann cell activity, and neuron to target signaling.			SCHECTERSON, LC (corresponding author), UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS SJ-40,SEATTLE,WA 98195, USA.			SCHECTERSON, LESLAYANN/0000-0002-3896-998X	NINDS NIH HHS [NS-23343, NS-07332] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023343] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BANDTLOW CE, 1987, EMBO J, V6, P891, DOI 10.1002/j.1460-2075.1987.tb04835.x; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; BYERS MR, 1990, DEVELOPMENT, V109, P461; COHEN S, 1960, P NATL ACAD SCI USA, V46, P302, DOI 10.1073/pnas.46.3.302; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; DAMICOMARTEL A, 1980, J EMBRYOL EXP MORPH, V55, P167; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DESPRES G, 1988, NEUROSCI LETT, V85, P5, DOI 10.1016/0304-3940(88)90418-1; EDWARDS RH, 1988, MOL CELL BIOL, V8, P2456, DOI 10.1128/MCB.8.6.2456; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEUER JG, 1990, DEV BIOL, V137, P287, DOI 10.1016/0012-1606(90)90255-H; HEUMANN R, 1984, EMBO J, V3, P3138; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON EM, 1983, NEUROSCIENCE, V8, P631, DOI 10.1016/0306-4522(83)90204-X; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEFEBVRE PP, 1990, BRAIN RES, V507, P254, DOI 10.1016/0006-8993(90)90279-K; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LINDSAY RM, 1985, DEV BIOL, V112, P30, DOI 10.1016/0012-1606(85)90116-2; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; NODEN DM, 1978, DEV BIOL, V67, P313, DOI 10.1016/0012-1606(78)90202-6; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCHATTEMAN GC, 1988, J NEUROSCI, V8, P860; SEILHEIMER B, 1987, EMBO J, V6, P1611, DOI 10.1002/j.1460-2075.1987.tb02408.x; SHELTON DL, 1984, P NATL ACAD SCI-BIOL, V81, P7951, DOI 10.1073/pnas.81.24.7951; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; TANIUCHI M, 1988, J NEUROSCI, V8, P664; VONBARTHELD CS, 1991, DEVELOPMENT, V113, P455; WAYNE DB, 1988, DEV BIOL, V127, P220, DOI 10.1016/0012-1606(88)90203-5; WHEELER EF, 1992, J NEUROSCI, V12, P930; YAN Q, 1988, NEURON, V1, P335; YAN Q, 1988, J NEUROSCI, V8, P3481; YANCOPOULOS GD, 1990, SCIENCE, V247, P1446	57	498	507	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					449	463		10.1016/0896-6273(92)90183-E	http://dx.doi.org/10.1016/0896-6273(92)90183-E			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1345671				2022-12-28	WOS:A1992JM57100007
J	CLARK, JA; DEUTCH, AY; GALLIPOLI, PZ; AMARA, SG				CLARK, JA; DEUTCH, AY; GALLIPOLI, PZ; AMARA, SG			FUNCTIONAL EXPRESSION AND CNS DISTRIBUTION OF A BETA-ALANINE-SENSITIVE NEURONAL GABA TRANSPORTER	NEURON			English	Article							GAMMA-AMINOBUTYRIC-ACID; HIGH-AFFINITY UPTAKE; RAT-BRAIN; AMINO-ACIDS; PRIMARY CULTURES; GLIAL CELLS; SELECTIVE UPTAKE; CARBOXYLIC-ACID; MESSENGER-RNAS; NERVOUS-SYSTEM	The synaptic action of gamma-aminobutyric acid (GABA) is terminated by high affinity, Na+-dependent transport processes in both neurons and glia. We have isolated a novel GABA transporter cDNA, GAT-B, which encodes a high affinity (K(m) = 2.3-mu-M), Na+- and Cl--dependent GABA transport protein that is potently blocked by beta-alanine, a compound generally considered a selective inhibitor of glial transport. However, in situ hybridization studies indicate that GAT-B mRNA is expressed predominantly within neurons. These data indicate that the neuronal-glial distinction of GABA transporters based on inhibitor sensitivities must be reconsidered and suggest a greater diversity of GABA transporters than has been predicted by previous pharmacologic studies.	YALE UNIV,SCH MED,DEPT PSYCHIAT,NEW HAVEN,CT 06510; OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201	Yale University; Oregon Health & Science University	CLARK, JA (corresponding author), YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510, USA.		Gallipoli, Paolo/AAA-7094-2019; Clark, Janet/P-4896-2018	Gallipoli, Paolo/0000-0001-7254-2253; Amara, Susan/0000-0001-8914-1106	NIMH NIH HHS [MH-14092] Funding Source: Medline; PHS HHS [278-90-0007] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH014092, R37MH014092] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AOKI E, 1989, BRAIN RES, V502, P245, DOI 10.1016/0006-8993(89)90619-7; BALCAR VJ, 1979, NEUROCHEM RES, V4, P339, DOI 10.1007/BF00963804; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; BENES FM, 1992, J NEUROSCI, V12, P924; BLAKELY RD, 1991, J NEUROCHEM, V56, P860, DOI 10.1111/j.1471-4159.1991.tb02002.x; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BONNANO G, 1987, J NEURAL TRANSM, V69, P59; BORG J, 1980, J NEUROCHEM, V34, P1113, DOI 10.1111/j.1471-4159.1980.tb09949.x; BOUHADDI K, 1988, NEUROCHEM RES, V13, P1119, DOI 10.1007/BF00971628; BOWERY NG, 1976, NATURE, V264, P281, DOI 10.1038/264281a0; BRANDL CJ, 1986, P NATL ACAD SCI USA, V83, P917, DOI 10.1073/pnas.83.4.917; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COX JV, 1988, MOL CELL BIOL, V8, P1327, DOI 10.1128/MCB.8.3.1327; CUMMINS CJ, 1982, BRAIN RES, V239, P299, DOI 10.1016/0006-8993(82)90856-3; DEUTCH AY, 1985, BRAIN RES, V333, P143, DOI 10.1016/0006-8993(85)90134-9; FAHN S, 1968, J NEUROCHEM, V15, P209, DOI 10.1111/j.1471-4159.1968.tb06198.x; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GAVRILOVIC J, 1984, BRAIN RES, V303, P183, DOI 10.1016/0006-8993(84)90226-9; GOMEZA J, 1991, BIOCHEM J, V275, P435, DOI 10.1042/bj2750435; GOTTESFELD Z, 1971, J NEUROCHEM, V18, P683, DOI 10.1111/j.1471-4159.1971.tb11998.x; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; HANSSON E, 1991, BRAIN RES, V548, P215, DOI 10.1016/0006-8993(91)91124-J; HANSSON E, 1991, LIFE SCI, V548, P215; HEDIGER MA, 1989, P NATL ACAD SCI USA, V86, P5748, DOI 10.1073/pnas.86.15.5748; HOLOPAINEN I, 1986, NEUROCHEM RES, V11, P207, DOI 10.1007/BF00967969; IVERSEN LL, 1975, BIOCHEM PHARMACOL, V24, P933, DOI 10.1016/0006-2952(75)90422-0; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; IVERSEN LL, 1971, J NEUROCHEM, V18, P1939, DOI 10.1111/j.1471-4159.1971.tb09600.x; IVERSEN LL, 1968, J NEUROCHEM, V15, P1141, DOI 10.1111/j.1471-4159.1968.tb06831.x; JENNINGS ML, 1989, ANNU REV BIOCHEM, V58, P999; KACZMAREK LK, 1972, J NEUROCHEM, V19, P2355, DOI 10.1111/j.1471-4159.1972.tb01289.x; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KILTY JE, 1991, SCIENCE, V254, P578, DOI 10.1126/science.1948035; KOHLER C, 1983, NEUROSCIENCE, V8, P819, DOI 10.1016/0306-4522(83)90013-1; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KROGSGAARDLARSEN P, 1987, EPILEPSY RES, V1, P77, DOI 10.1016/0920-1211(87)90012-X; KROGSGAARDLARSEN P, 1980, MOL CELL BIOCHEM, V31, P105; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARSSON OM, 1983, BRAIN RES, V260, P279, DOI 10.1016/0006-8993(83)90681-9; LEVI G, 1983, DEV BRAIN RES, V10, P227, DOI 10.1016/0165-3806(83)90139-6; LOSCHER W, 1986, J NEUROCHEM, V46, P1322, DOI 10.1111/j.1471-4159.1986.tb00658.x; MARTIN DL, 1979, J BIOL CHEM, V254, P7076; Meldrum B S, 1975, Int Rev Neurobiol, V17, P1, DOI 10.1016/S0074-7742(08)60205-6; Mugnaini E, 1985, HDB CHEM NEUROANATOM, P436; OGDEN RC, 1987, METHOD ENZYMOL, V152, P61; ONTENIENTE B, 1986, J COMP NEUROL, V248, P422, DOI 10.1002/cne.902480310; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; PERRY TL, 1971, J NEUROCHEM, V18, P513, DOI 10.1111/j.1471-4159.1971.tb11979.x; RADIAN R, 1990, J NEUROSCI, V10, P1319; REYNOLDS GP, 1990, BIOL PSYCHIAT, V27, P1038, DOI 10.1016/0006-3223(90)90039-5; REYNOLDS R, 1986, BRAIN RES, V371, P253, DOI 10.1016/0006-8993(86)90361-6; RHOADS DE, 1984, BIOCHEM BIOPH RES CO, V119, P1198, DOI 10.1016/0006-291X(84)90903-3; RIBAK CE, 1979, SCIENCE, V205, P211, DOI 10.1126/science.109922; SAMBROOK J, 1989, MOL CLONING LABORATO, V1; SCHON F, 1975, BRAIN RES, V86, P243, DOI 10.1016/0006-8993(75)90700-3; SCHON F, 1974, BRAIN RES, V66, P289, DOI 10.1016/0006-8993(74)90147-4; SCHOUSBOE A, 1977, NEUROCHEM RES, V2, P217, DOI 10.1007/BF00964098; SCHRIER BK, 1974, J BIOL CHEM, V249, P1769; SUZDAK PD, 1992, IN PRESS EUR J PHARM; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WILKIN GP, 1983, DEV BRAIN RES, V10, P265, DOI 10.1016/0165-3806(83)90143-8; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649	63	203	208	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					337	348		10.1016/0896-6273(92)90172-A	http://dx.doi.org/10.1016/0896-6273(92)90172-A			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1497897				2022-12-28	WOS:A1992JJ33200015
J	IMREDY, JP; YUE, DT				IMREDY, JP; YUE, DT			SUBMICROSCOPIC CA2+ DIFFUSION MEDIATES INHIBITORY COUPLING BETWEEN INDIVIDUAL CA2+ CHANNELS	NEURON			English	Article							SINGLE CALCIUM CHANNELS; TRANSMITTER RELEASE; ACTIVE ZONES; CELLS; INACTIVATION; VOLTAGE; CA-2+; SELECTIVITY; DEPENDENCE; CURRENTS	Dihydropyridine-sensitive Ca2+ channels in heart demonstrate an important negative feedback property: they close, or inactivate, in response to prior Ca2+ entry. We now find that Ca2+ influx through one channel can selectively contribute to the inactivation of another adjacent channel, without a generalized elevation of bulk intracellular Ca2+ concentration. Intracellular application of the Ca2+ chelator BAPTA greatly diminishes such negative interactions within Ca2+ channel pairs. These findings demonstrate that Ca2+ currents are controlled not only by intrinsic channel properties, but also by local diffusive interactions among neighboring channels. Such inhibitory coupling among channels provides a concrete example of localized Ca2+ signaling, long proposed to exist on the basis of theoretical calculations.			IMREDY, JP (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT BIOMED ENGN,BALTIMORE,MD 21205, USA.				NHLBI NIH HHS [R29 HL43307] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07057] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL043307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007057] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; CAVALIE A, 1986, PFLUG ARCH EUR J PHY, V406, P241, DOI 10.1007/BF00640910; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; GURNEY AM, 1989, NATURE, V341, P65, DOI 10.1038/341065a0; GUTNICK MJ, 1989, J PHYSIOL-LONDON, V412, P197, DOI 10.1113/jphysiol.1989.sp017611; HAGIWARA S, 1983, J PHYSIOL-LONDON, V336, P649, DOI 10.1113/jphysiol.1983.sp014603; HILLE B, 1984, IONIC CHANNELS EXCIT, P186; JOHNSON EA, 1991, SCIENCE, V251, P1370, DOI 10.1126/science.1848371; KAY AR, 1991, J PHYSIOL-LONDON, V437, P27, DOI 10.1113/jphysiol.1991.sp018581; KOKUBUN S, 1984, JPN J PHYSIOL, V34, P599, DOI 10.2170/jjphysiol.34.599; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LUX HD, 1984, SCIENCE, V225, P432, DOI 10.1126/science.6330896; MAZZANTI M, 1991, J PHYSIOL-LONDON, V443, P307, DOI 10.1113/jphysiol.1991.sp018835; MAZZANTI M, 1990, BIOPHYS J, V58, P1059, DOI 10.1016/S0006-3495(90)82448-6; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; SHAM JSK, 1992, SCIENCE, V255, P850, DOI 10.1126/science.1311127; SHERMAN A, 1990, BIOPHYS J, V58, P985, DOI 10.1016/S0006-3495(90)82443-7; SIGWORTH FJ, 1981, BIOPHYS J, V34, P111, DOI 10.1016/S0006-3495(81)84840-0; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; STANDEN NB, 1982, PROC R SOC SER B-BIO, V217, P101, DOI 10.1098/rspb.1982.0097; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; WIER WG, 1987, SCIENCE, V235, P325, DOI 10.1126/science.3798114; WILLIAMS DA, 1985, NATURE, V318, P558, DOI 10.1038/318558a0; YUE DT, 1990, J GEN PHYSIOL, V95, P911, DOI 10.1085/jgp.95.5.911; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032	32	106	107	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					197	207		10.1016/0896-6273(92)90159-B	http://dx.doi.org/10.1016/0896-6273(92)90159-B			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1323309				2022-12-28	WOS:A1992JJ33200002
J	TORO, L; STEFANI, E; LATORRE, R				TORO, L; STEFANI, E; LATORRE, R			INTERNAL BLOCKADE OF A CA2+-ACTIVATED K+ CHANNEL BY SHAKER-B INACTIVATING BALL PEPTIDE	NEURON			English	Article							PLANAR LIPID BILAYERS; ACTIVATED POTASSIUM CHANNELS; QUATERNARY AMMONIUM-IONS; SODIUM-CHANNELS; SKELETAL-MUSCLE; SQUID AXON; CONDUCTANCE; TETRAETHYLAMMONIUM; RECONSTITUTION; SELECTIVITY	Shaker B inactivating peptide ("ball peptide", BP) interacts with Ca2+-activated K+ (K(Ca)) channels from the cytoplasmic side only, producing inhibition of channel activity. This effect was reversible and dose and voltage dependent (stronger at depolarized potentials). The inhibition of K(Ca) channels by BP cannot be mimicked by an inactive point mutation of the BP, L7E. BP binds to K(Ca) channels in a bimolecular reaction (dissociation constant of 95-mu-M at +40 mV). The binding site is probably located in the internal "mouth" or conduction pathway, since both external K+ and internal tetraethylammonium relieve BP-induced inhibition. These results suggest that K(Ca) channels possess a binding site for the BP with some properties similar to the ball receptor found in Shaker B K+ channels.	CTR ESTUDIOS CIENT SANTIAGO,CASILLA 16443,SPAIN; UNIV CHILE,FAC CIENCIAS,DEPT BIOL,SANTIAGO,CHILE	Universidad de Chile	TORO, L (corresponding author), BAYLOR COLL MED,DEPT MOLEC PHYSIOL & BIOPHYS,HOUSTON,TX 77030, USA.				NHLBI NIH HHS [HL-37044] Funding Source: Medline; NICHD NIH HHS [HD-25616] Funding Source: Medline; NIGMS NIH HHS [GM35981] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025616] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035981] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armstrong C M, 1975, Membranes, V3, P325; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; BLATZ AL, 1984, J GEN PHYSIOL, V84, P1, DOI 10.1085/jgp.84.1.1; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; FOSTER CD, 1992, NEURON, V9, P229, DOI 10.1016/0896-6273(92)90162-7; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; FRENCH RJ, 1984, BIOPHYS J, V45, P301, DOI 10.1016/S0006-3495(84)84156-9; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HAMILTON SL, 1989, ANAL BIOCHEM, V183, P31, DOI 10.1016/0003-2697(89)90167-X; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; LATORRE R, 1982, P NATL ACAD SCI-BIOL, V79, P805, DOI 10.1073/pnas.79.3.805; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; MACKINNON R, 1991, J BIOENERG BIOMEMBR, V23, P647, DOI 10.1007/BF00785815; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; MOCZYDLOWSKI E, 1984, J GEN PHYSIOL, V84, P665, DOI 10.1085/jgp.84.5.665; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SCHURR JM, 1970, BIOPHYS J, V10, P700, DOI 10.1016/S0006-3495(70)86330-5; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SWENSON RP, 1981, J GEN PHYSIOL, V77, P255, DOI 10.1085/jgp.77.3.255; TORO L, 1991, AM J PHYSIOL, V260, pH1779, DOI 10.1152/ajpheart.1991.260.6.H1779; VILLARROEL A, 1988, PFLUG ARCH EUR J PHY, V413, P118, DOI 10.1007/BF00582521; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YELLEN G, 1987, ANNU REV BIOPHYS BIO, V16, P227; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1984, J GEN PHYSIOL, V84, P157, DOI 10.1085/jgp.84.2.157; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	33	55	56	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					237	245		10.1016/0896-6273(92)90163-8	http://dx.doi.org/10.1016/0896-6273(92)90163-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1497893				2022-12-28	WOS:A1992JJ33200006
J	EKKER, M; AKIMENKO, MA; BREMILLER, R; WESTERFIELD, M				EKKER, M; AKIMENKO, MA; BREMILLER, R; WESTERFIELD, M			REGIONAL EXPRESSION OF 3 HOMEOBOX TRANSCRIPTS IN THE INNER-EAR OF ZEBRAFISH EMBRYOS	NEURON			English	Article							NEURAL CREST; CONTAINING GENES; DROSOPHILA; PATTERN; MURINE; ORGANIZATION; HOMEODOMAIN; HINDBRAIN; FAMILY	The inner ear of all jawed vertebrates arises from the epithelium of the otic vesicle and contains three semicircular canals, otoliths, and sets of sensory neurons, all positioned precisely within the cranium to detect head orientation and movement. The msh-C gene and two new homeobox genes, msh-D and a gene related to distal-less, dlx-3, are each expressed in distinct regions of the otic vesicle during its early development in zebrafish embryos. Cells in the ectoderm express dlx-3 before induction of the otic vesicle, suggesting that dlx-3 has an early function in this process. Later, cells aligned with the future axes of the semicircular canals specifically express either dlx-3 or msh-D. Even later, sensory hair cells express msh-C and msh-D, while other cells of the epithelium express dlx-3. The early expression of these genes could specify the orientation and morphogenesis of the inner ear, whereas their later expression could specify the fates of particular cell types.	UNIV OREGON,FAC NEUROSCI,EUGENE,OR 97403	University of Oregon					NICHD NIH HHS [HD22486] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AKAM M, 1987, DEVELOPMENT, V101, P1; AKIMENKO MA, 1991, NATO ASI SER, P61; COELHO CND, 1991, MECH DEVELOP, V34, P143, DOI 10.1016/0925-4773(91)90051-7; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HILL RE, 1989, GENE DEV, V3, P26, DOI 10.1101/gad.3.1.26; HOLLAND PWH, 1991, GENE, V98, P253, DOI 10.1016/0378-1119(91)90182-B; HUNT P, 1991, CELL, V66, P1075, DOI 10.1016/0092-8674(91)90029-X; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; HUNT P, 1991, DEVELOPMENT S, V1, P187; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; IVENS A, 1990, HUM GENET, V84, P473; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LANGILLE RM, 1988, ANAT EMBRYOL, V177, P297, DOI 10.1007/BF00315836; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MONAGHAN AP, 1991, DEVELOPMENT, V112, P1053; MOORE R, 1986, EMBO J, V5, P919, DOI 10.1002/j.1460-2075.1986.tb04304.x; Noden, 1980, CURRENT RES TRENDS P, P3; NODEN DM, 1978, DEV BIOL, V67, P296, DOI 10.1016/0012-1606(78)90201-4; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; REPRESA J, 1991, NATURE, V353, P561, DOI 10.1038/353561a0; REPRESA J, 1990, DEVELOPMENT, V110, P1081; ROBERT B, 1989, EMBO J, V8, P91, DOI 10.1002/j.1460-2075.1989.tb03352.x; ROBERT B, 1991, GENE DEV, V5, P2363, DOI 10.1101/gad.5.12b.2363; ROBINSON GW, 1991, NEW BIOL, V3, P1183; SASSOON DA, 1988, DEVELOPMENT, V104, P155; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SU MW, 1991, DEVELOPMENT, V111, P1179; SUZUKI HR, 1991, DEV BIOL, V148, P375, DOI 10.1016/0012-1606(91)90345-4; TAKAHASHI Y, 1990, P NATL ACAD SCI USA, V87, P7482, DOI 10.1073/pnas.87.19.7482; Waddington CH, 1937, J EXP BIOL, V14, P232; WATERMAN RE, 1984, ANAT REC, V210, P101, DOI 10.1002/ar.1092100113; WESTERFIELD M, 1989, ZEBRAFISH BOOK GUIDE; WILKINSON DG, 1990, TRENDS NEUROSCI, V13, P335, DOI 10.1016/0166-2236(90)90145-Z; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1987, DEVELOPMENT, V99, P493	39	161	165	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					27	35		10.1016/0896-6273(92)90217-2	http://dx.doi.org/10.1016/0896-6273(92)90217-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1352984				2022-12-28	WOS:A1992JE75600003
J	MORI, N; SCHOENHERR, C; VANDENBERGH, DJ; ANDERSON, DJ				MORI, N; SCHOENHERR, C; VANDENBERGH, DJ; ANDERSON, DJ			A COMMON SILENCER ELEMENT IN THE SCG-10 AND TYPE-II NA+ CHANNEL GENES BINDS A FACTOR PRESENT IN NONNEURONAL CELLS BUT NOT IN NEURONAL CELLS	NEURON			English	Article							TRANSCRIPTION FACTOR; REGULATORY ELEMENTS; NERVOUS-SYSTEM; SODIUM-CHANNEL; SCG10 GENE; EXPRESSION; PROTEIN; GROWTH; DNA; CLONING	We have localized a cell type-specific silencer element in the SCG10 gene by deletion analysis. This neural-restrictive silencer element (NRSE) selectively represses SCG10 expression in nonneuronal cells and tissues. The NRSE contains a 21 bp region with striking homology to a sequence present in a silencer domain of the rat type II sodium channel (NaII), another neuron-specific gene. We have identified a sequence-specific protein(s) that binds the SCG10 NRSE, as well as the homologous element in the NaII gene. A point mutation in the NRSE that abolishes binding of this neural-restrictive silencer-binding factor (NRSBF) in vitro also eliminates silencing activity in vivo. NRSBF is present in nuclear extracts from nonneuronal cells but not in extracts from neuronal cells, suggesting that the neuron-specific expression of SCG10 reflects, at least in part, the absence or inactivity of this protein. These data identify the NRSE as a potentially general DNA element for the control of neuron-specific gene expression in vertebrates.	CALTECH,DIV BIOL,PASADENA,CA 91125; CALTECH,HOWARD HUGHES MED INST,PASADENA,CA 91125	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute				Vandenbergh, David/0000-0002-5620-2870	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023476] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23476] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON DJ, 1985, CELL, V42, P649, DOI 10.1016/0092-8674(85)90122-9; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BASI GS, 1987, CELL, V49, P785, DOI 10.1016/0092-8674(87)90616-7; BENOWITZ LI, 1987, TRENDS NEUROSCI, V10, P527, DOI 10.1016/0166-2236(87)90135-4; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; CALZONE FJ, 1991, DEVELOPMENT, V112, P335; CAMPER SA, 1989, GENE DEV, V3, P537, DOI 10.1101/gad.3.4.537; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; DIFFLEY JFX, 1989, SCIENCE, V246, P1034, DOI 10.1126/science.2511628; DOYE V, 1989, J BIOL CHEM, V264, P12134; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; GHYSEN A, 1989, TRENDS GENET, V5, P251, DOI 10.1016/0168-9525(89)90097-8; HARSHMAN KD, 1988, CELL, V53, P321, DOI 10.1016/0092-8674(88)90393-5; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOOG C, 1991, DEVELOPMENT, V112, P351; HOUGHEVANS BR, 1990, DEVELOPMENT, V110, P41; IBANEZ CF, 1991, J NEUROSCI, V3, P1309; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JAN YN, 1990, TRENDS NEUROSCI, V13, P493, DOI 10.1016/0166-2236(90)90083-M; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; KARNS LR, 1987, SCIENCE, V236, P597, DOI 10.1126/science.2437653; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y; MORI N, 1990, NEURON, V4, P583, DOI 10.1016/0896-6273(90)90116-W; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; RENKAWITZ R, 1990, TRENDS GENET, V6, P192, DOI 10.1016/0168-9525(90)90176-7; SAUERWALD A, 1990, J BIOL CHEM, V265, P14932; SAVAGNER P, 1990, J BIOL CHEM, V265, P6669; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHEN RQ, 1991, MOL CELL BIOL, V11, P1676, DOI 10.1128/MCB.11.3.1676; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; SHUBART UK, 1989, DNA CELL BIOL, V8, P389; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; SUDHOF TC, 1990, J BIOL CHEM, V265, P7849; TADA H, 1991, VIROLOGY, V180, P327, DOI 10.1016/0042-6822(91)90037-C; THIEL G, 1991, P NATL ACAD SCI USA, V88, P3431, DOI 10.1073/pnas.88.8.3431; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; VANDENBERGH DJ, 1989, NEURON, V3, P507, DOI 10.1016/0896-6273(89)90209-2; WEINBERGER J, 1988, MOL CELL BIOL, V8, P988, DOI 10.1128/MCB.8.2.988; WEISSMAN JD, 1991, MOL CELL BIOL, V11, P4217, DOI 10.1128/MCB.11.8.4217; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WUENSCHELL CW, 1990, NEURON, V4, P595, DOI 10.1016/0896-6273(90)90117-X	46	363	370	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					45	54		10.1016/0896-6273(92)90219-4	http://dx.doi.org/10.1016/0896-6273(92)90219-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1321646				2022-12-28	WOS:A1992JE75600005
J	BASCOM, RA; MANARA, S; COLLINS, L; MOLDAY, RS; KALNINS, VI; MCINNES, RR				BASCOM, RA; MANARA, S; COLLINS, L; MOLDAY, RS; KALNINS, VI; MCINNES, RR			CLONING OF THE CDNA FOR A NOVEL PHOTORECEPTOR MEMBRANE-PROTEIN (ROM-1) IDENTIFIES A DISK RIM PROTEIN FAMILY IMPLICATED IN HUMAN RETINOPATHIES	NEURON			English	Article							ROD OUTER SEGMENT; RDS MUTANT MICE; DEGENERATION SLOW RDS; TERMINAL LOOP REGION; RETINAL DEGENERATION; IMMUNOCYTOCHEMICAL LOCALIZATION; STRUCTURAL FEATURES; HUMAN-LYMPHOCYTES; CLONED CDNA; OPSIN	The molecules essential to the continual morphogenesis and shedding of the opsin-containing disks of vertebrate photoreceptors are largely unknown. We describe a 37 kd protein, rom-1, which is 35% identical and structurally similar to peripherin/retinal degeneration slow (rds). Like peripherin, rom-1 is a retina-specific integral membrane protein localized to the photoreceptor disk rim. The two proteins are similarly oriented in the membrane, and each has a highly conserved (15/16 residues) cysteine- and proline-rich domain in the disk lumen. Although both rom-1 and peripherin form disulfide-linked dimers, they do not form heterodimers with each other, but appear to associate noncovalently. These results suggest both that rom-1 and peripherin are functionally related members of a new photoreceptor-specific protein family and that rom-1, like peripherin, is likely to be important to outer segment morphogenesis. The association of mutations in RDS with retinitis pigmentosa indicates that ROM1 is a strong candidate gene for human retinopathies.	UNIV TORONTO, DEPT MED GENET, TORONTO M5S 1A8, ONTARIO, CANADA; UNIV TORONTO, DEPT ANAT, TORONTO M5S 1A8, ONTARIO, CANADA; UNIV BRITISH COLUMBIA, DEPT BIOCHEM, VANCOUVER V6T 1W5, BC, CANADA	University of Toronto; University of Toronto; University of British Columbia	BASCOM, RA (corresponding author), HOSP SICK CHILDREN, DEPT GENET, RES INST, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA.			Bascom, Roger/0000-0002-9106-8224				AGARWAL N, 1990, J NEUROSCI, V10, P3275; ANDERSON DH, 1978, INVEST OPHTH VIS SCI, V17, P117; ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; BESHARSE JC, 1986, RETINA 1, P314; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BOROVJAGIN VL, 1973, VISION RES, V13, P753, DOI 10.1016/0042-6989(73)90039-4; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; COHEN AI, 1983, INVEST OPHTH VIS SCI, V24, P832; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; CONNELL GJ, 1990, BIOCHEMISTRY-US, V29, P4691, DOI 10.1021/bi00471a025; CORLESS JM, 1987, J COMP NEUROL, V257, P1, DOI 10.1002/cne.902570102; CORLESS JM, 1987, J COMP NEUROL, V257, P24, DOI 10.1002/cne.902570104; CORLESS JM, 1989, J COMP NEUROL, V287, P531, DOI 10.1002/cne.902870410; CRAMPTON J, 1980, NUCLEIC ACIDS RES, V8, P6007, DOI 10.1093/nar/8.24.6007; CRAMPTON JM, 1981, NUCLEIC ACIDS RES, V9, P3821, DOI 10.1093/nar/9.15.3821; DOGGENWEILER CF, 1972, REV LATINOAM MICROSC, V1, P146; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; FALK G, 1969, J ULTRA MOL STRUCT R, V28, P41, DOI 10.1016/S0022-5320(69)90005-7; Falk J.D., 1988, PROGR RETINAL RES, V7, P89; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; HELMS C, 1987, METHOD ENZYMOL, V153, P69; JANSEN HG, 1984, J COMP NEUROL, V224, P71, DOI 10.1002/cne.902240107; JANSEN HG, 1987, EXP EYE RES, V44, P347, DOI 10.1016/S0014-4835(87)80170-7; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIN B, 1990, GENES, V4, P479; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MIZUNO K, 1977, AM J OPHTHALMOL, V83, P32, DOI 10.1016/0002-9394(77)90188-X; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NIR I, 1986, INVEST OPHTH VIS SCI, V27, P836; NIR I, 1990, EXP EYE RES, V51, P257, DOI 10.1016/0014-4835(90)90022-M; PAPERMASTER DS, 1978, J CELL BIOL, V78, P415, DOI 10.1083/jcb.78.2.415; PAPERMASTER DS, 1982, VISION RES, V22, P1417, DOI 10.1016/0042-6989(82)90204-8; ROOF DJ, 1982, J CELL BIOL, V95, P487, DOI 10.1083/jcb.95.2.487; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAVIS GH, 1991, GENOMICS, V10, P733, DOI 10.1016/0888-7543(91)90457-P; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; USUKURA J, 1981, BIOMED RES-TOKYO, V2, P177, DOI 10.2220/biomedres.2.177; USUKURA J, 1980, J ELECTRON MICROSC, V29, P376; USUKURA J, 1987, EXP EYE RES, V45, P501, DOI 10.1016/S0014-4835(87)80061-1; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VONHEIJNE G, 1988, BIOCHIM BIOPHYS ACTA, V947, P307, DOI 10.1016/0304-4157(88)90013-5; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WILLIAMS DS, 1988, J COMP NEUROL, V272, P161, DOI 10.1002/cne.902720202; YOST CS, 1990, NATURE, V343, P669, DOI 10.1038/343669a0; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700	66	201	203	2	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1992	8	6					1171	1184		10.1016/0896-6273(92)90137-3	http://dx.doi.org/10.1016/0896-6273(92)90137-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1610568				2022-12-28	WOS:A1992JA42900016
J	NORENBERG, U; WILLE, H; WOLFF, JM; FRANK, R; RATHJEN, FG				NORENBERG, U; WILLE, H; WOLFF, JM; FRANK, R; RATHJEN, FG			THE CHICKEN NEURAL EXTRACELLULAR-MATRIX MOLECULE RESTRICTIN - SIMILARITY WITH EGF-LIKE, FIBRONECTIN TYPE-III-LIKE, AND FIBRINOGEN-LIKE MOTIFS	NEURON			English	Article							SUBSTRATUM-BOUND FIBRONECTIN; IMMUNOGLOBULIN SUPERFAMILY; NEURITE OUTGROWTH; HEXABRACHION PROTEINS; NERVOUS-SYSTEM; TENASCIN; MEMBER; DOMAINS; PHOSPHATIDYLINOSITOL; GLYCOPROTEINS	Restrictin is a chick neural extracellular matrix protein implicated in neural cell attachment and found to be associated with the cell surface recognition protein F11. Here we show by cDNA cloning that restrictin is a large multidomain protein composed of 4 structural motifs. At the N-terminus restrictin contains a cysteine-rich segment of about 140 aa that might link restrictin monomers into oligomers. This region is followed by 4.5 epidermal growth factor-like repeats and then by 9 consecutive motifs that are similar to fibronectin type III motifs. At the C-terminus restrictin is related to the beta and gamma-chains of fibrinogen, including similarity to a calcium-binding segment. Restrictin shows substantial sequence similarity with tenascin (cytotactin) throughout the polypeptide, and like tenascin, it forms oligomeric structures, as revealed by electron microscopy of immunoaffinity-purified restrictin. The cell attachment site of restrictin is mapped to the C-terminal region by antibody perturbation experiments.	MAX PLANCK ARBEITSGRUPPEN STRUKT MOLEK, O-2000 HAMBURG 52, GERMANY; MAX PLANCK INST ENTWICKLUNGSBIOL, O-7400 TUBINGEN, GERMANY; ZENTRUM MOLEK BIOL, O-6900 HEIDELBERG, GERMANY	Max Planck Society; Max Planck Society; Ruprecht Karls University Heidelberg	NORENBERG, U (corresponding author), ZENTRUM MOLEK NEUROBIOL, O-2000 HAMBURG 20, GERMANY.		Wille, Holger/C-2280-2008	Wille, Holger/0000-0001-5102-8706				AKERS RM, 1981, DEV BIOL, V86, P179, DOI 10.1016/0012-1606(81)90328-6; ANSORGE W, 1985, J BIOCHEM BIOPH METH, V11, P13, DOI 10.1016/0165-022X(85)90037-5; AVIS H, 1972, P NATL ACAD SCI USA, V69, P1408; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; BURGOON MP, 1991, J CELL BIOL, V112, P1017, DOI 10.1083/jcb.112.5.1017; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CHIQUET M, 1984, J CELL BIOL, V98, P1937, DOI 10.1083/jcb.98.6.1937; CHIQUETEHRISMANN R, 1990, FASEB J, V4, P2598, DOI 10.1096/fasebj.4.9.1693347; DAVIS C G, 1990, New Biologist, V2, P410; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DOOLITTLE RF, 1978, J MOL BIOL, V120, P311, DOI 10.1016/0022-2836(78)90070-0; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; ENGLE J, 1986, MULTIDOMAIN PROTEINS, P89; ERICKSON HP, 1984, NATURE, V311, P267, DOI 10.1038/311267a0; ERICKSON HP, 1987, J CELL BIOL, V105, P1387, DOI 10.1083/jcb.105.3.1387; ERICKSON HP, 1989, ANNU REV CELL BIOL, V5, P71, DOI 10.1146/annurev.cb.05.110189.000443; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; FUSS B, 1991, J NEUROSCI RES, V29, P299, DOI 10.1002/jnr.490290305; GAUSEPOHL H, 1986, ADV METHODS PROTEIN, P149; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; JONES FS, 1989, P NATL ACAD SCI USA, V86, P1905, DOI 10.1073/pnas.86.6.1905; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LOCHTER A, 1991, J CELL BIOL, V113, P1159, DOI 10.1083/jcb.113.5.1159; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MURPHYULLRICH JE, 1991, J CELL BIOL, V115, P1127, DOI 10.1083/jcb.115.4.1127; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; NIES DE, 1991, J BIOL CHEM, V266, P2818; NORTON PA, 1990, CELL, V61, P15, DOI 10.1016/0092-8674(90)90209-W; OSHEA KS, 1991, NEURON, V7, P231, DOI 10.1016/0896-6273(91)90261-W; PANAYOTOU G, 1989, CELL, V56, P93, DOI 10.1016/0092-8674(89)90987-2; PARRY DAD, 1982, BIOSCIENCE REP, V2, P1017, DOI 10.1007/BF01122170; PATTHY L, 1990, CELL, V61, P13, DOI 10.1016/0092-8674(90)90208-V; PESHEVA P, 1989, J CELL BIOL, V109, P1765, DOI 10.1083/jcb.109.4.1765; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; Rathjen F. G, 1991, SEMIN NEUROSCI, V3, P297, DOI 10.1016/1044-5765(91)90047-R; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; RATHJEN FG, 1991, DEVELOPMENT, V113, P151; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; Rathjen FG, 1991, CURR OPIN CELL BIOL, V3, P992, DOI 10.1016/0955-0674(91)90119-J; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0; SAGA Y, 1991, GENE, V104, P177, DOI 10.1016/0378-1119(91)90248-A; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIRI A, 1991, NUCLEIC ACIDS RES, V19, P525, DOI 10.1093/nar/19.3.525; SPRING J, 1989, CELL, V59, P325, DOI 10.1016/0092-8674(89)90294-8; STOECKLI ET, 1991, J CELL BIOL, V112, P449, DOI 10.1083/jcb.112.3.449; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TAYLOR HC, 1989, J CELL BIOCHEM, V41, P71, DOI 10.1002/jcb.240410204; TYLER JM, 1980, J ULTRA MOL STRUCT R, V71, P95, DOI 10.1016/S0022-5320(80)90098-2; ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WEHRLE B, 1990, DEVELOPMENT, V110, P401; WELLER A, 1991, J CELL BIOL, V112, P355, DOI 10.1083/jcb.112.2.355; WOLFF JM, 1989, BIOCHEM BIOPH RES CO, V161, P931, DOI 10.1016/0006-291X(89)92688-0; WOLFF JM, 1987, EUR J BIOCHEM, V168, P551, DOI 10.1111/j.1432-1033.1987.tb13453.x; XUN X, 1990, P NATL ACAD SCI USA, V87, P2097, DOI 10.1073/pnas.87.6.2097; YAMAGATA M, 1991, J CELL BIOL, V115, P209, DOI 10.1083/jcb.115.1.209	66	160	165	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1992	8	5					849	863		10.1016/0896-6273(92)90199-N	http://dx.doi.org/10.1016/0896-6273(92)90199-N			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1375037				2022-12-28	WOS:A1992HV46700004
J	TAO, W; LAI, E				TAO, W; LAI, E			TELENCEPHALON-RESTRICTED EXPRESSION OF BF-1, A NEW MEMBER OF THE HNF-3 FORK HEAD GENE FAMILY, IN THE DEVELOPING RAT-BRAIN	NEURON			English	Article							GLUTAMINE-SYNTHETASE EXPRESSION; PHENOL-CHLOROFORM EXTRACTION; SEGMENT-SPECIFIC EXPRESSION; SINGLE-STEP METHOD; DEVELOPMENTAL REGULATION; DROSOPHILA EMBRYO; MOUSE HINDBRAIN; NERVOUS-SYSTEM; RNA-POLYMERASE; HOMEO BOX	We have previously characterized a novel transcription factor family in mammals, the HNF-3 family, by the members' homology to one another and to the Drosophila homeotic gene fork head. The expression of fork head is restricted to the anterior and posterior termini of the early fly embryo. Brain factor 1 (BF-1) is a new member of this family isolated from rat brain with an expression pattern and DNA binding specificity distinct from the HNF-3 genes. Expression is highly restricted in the developing neural tube to its rostral end, which gives rise to the telencephalon. These results suggest that BF-1 plays an important role in the establishment of the regional subdivision of the developing brain and in the development of the telencephalon.	MEM SLOAN KETTERING CANC CTR, PROGRAM CELL BIOL & GENET, NEW YORK, NY 10021 USA	Memorial Sloan Kettering Cancer Center	TAO, W (corresponding author), MEM SLOAN KETTERING CANC CTR, DIV ENDOCRINOL, NEW YORK, NY 10021 USA.							BERGQUIST H, 1954, J COMP NEUROL, V100, P627, DOI 10.1002/cne.901000308; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COSTA RH, 1986, MOL CELL BIOL, V6, P4697, DOI 10.1128/MCB.6.12.4697; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DAVIS CA, 1988, GENE DEV, V2, P361, DOI 10.1101/gad.2.3.361; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; EHRLICH ME, 1990, J MOL NEUROSCI, V2, P1, DOI 10.1007/BF02896920; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HE X, 1991, NEURON, V7, P183, DOI 10.1016/0896-6273(91)90257-Z; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; JURGENS G, 1988, ROUX ARCH DEV BIOL, V197, P345, DOI 10.1007/BF00375954; Kandel E.R., 1991, PRINC NEUROSCI, V3rd ed.; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KUO CF, 1988, MOL CELL BIOL, V8, P4966, DOI 10.1128/MCB.8.11.4966; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; LAI E, 1990, GENE DEV, V4, P1427, DOI 10.1101/gad.4.8.1427; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; LI C, 1991, P NATL ACAD SCI USA, V88, P7739, DOI 10.1073/pnas.88.17.7739; LIU JK, 1991, MOL CELL BIOL, V11, P773, DOI 10.1128/MCB.11.2.773; Mangold O, 1933, NATURWISSENSCHAFTEN, V21, P761, DOI 10.1007/BF01503740; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MORI K, 1987, P NATL ACAD SCI USA, V84, P3921, DOI 10.1073/pnas.84.11.3921; MURPHY P, 1989, NATURE, V341, P156, DOI 10.1038/341156a0; PLACZEK M, 1990, SCIENCE, V250, P985, DOI 10.1126/science.2237443; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; RUGH R, 1968, MOUSE ITS REPRODUCTI; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Spemann H., 1938, EMBRYONIC DEV INDUCT; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V	42	354	356	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1992	8	5					957	966		10.1016/0896-6273(92)90210-5	http://dx.doi.org/10.1016/0896-6273(92)90210-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1350202				2022-12-28	WOS:A1992HV46700015
J	LERMA, J				LERMA, J			SPERMINE REGULATES N-METHYL-D-ASPARTATE RECEPTOR DESENSITIZATION	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; HYPOXIA-INDUCED NEURODEGENERATION; POLYAMINE RECOGNITION SITE; CORTICAL CELL-CULTURES; NMDA RECEPTOR; XENOPUS-OOCYTES; REGIONAL DISTRIBUTION; NERVOUS-SYSTEM; GLYCINE; RESPONSES	The action of the endogenous polyamine spermine on NMDA-induced responses (in the presence of glycine) was evaluated in cultured spinal cord neurons under voltage- and concentration-clamp conditions. Spermine potentiated NMDA-induced responses in a dose-dependent manner. It was more effective in potentiating steady-state currents (i.e., desensitized response) than the peak phase of the response, indicating that the degree of desensitization was reduced in the presence of the polyamine. Kinetic analysis revealed that the desensitization onset rate, but not recovery rate, was affected by spermine. The effect was voltage independent and was seen in thoroughly dialyzed cells, in which desensitization becomes independent of glycine. Spermine potentiation showed fast on-off kinetics, and intracellular spermine, loaded in the recording pipette, did not occlude potentiation by extracellularly applied spermine. These results are consistent with the existence of a modulatory site for polyamines in the extracellular domain of the NMDA receptor, the activation of which potentiates NMDA receptor function by regulating its desensitization kinetics.			LERMA, J (corresponding author), CONSEJO SUPER INVEST CIENTIFICAS,INST CAJAL,E-28002 MADRID,SPAIN.		Lerma, Juan/G-7907-2015	Lerma, Juan/0000-0001-7838-5199				AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; ASCHER P, 1989, NMDA RECEPTOR, P109; BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; BRACKLEY P, 1990, NEUROSCI LETT, V114, P51, DOI 10.1016/0304-3940(90)90427-B; BREWER GJ, 1989, NEUROSCI LETT, V99, P268, DOI 10.1016/0304-3940(89)90458-8; CARTER CJ, 1990, J PHARMACOL EXP THER, V253, P475; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; CHOI DW, 1990, J NEUROSCI, V10, P2493; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; FONNUM F, 1973, BRAIN RES, V54, P115, DOI 10.1016/0006-8993(73)90038-3; GILAD GM, 1991, EUR J PHARMACOL, V193, P41, DOI 10.1016/0014-2999(91)90198-Y; Gutfreund H., 1972, ENZYMES PHYSICAL PRI; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARMAN RJ, 1981, J NEUROCHEM, V36, P1609, DOI 10.1111/j.1471-4159.1981.tb00409.x; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; LERMA J, 1991, NEUROSCI LETT, V123, P187, DOI 10.1016/0304-3940(91)90927-L; LERMA J, 1990, P NATL ACAD SCI USA, V87, P2354, DOI 10.1073/pnas.87.6.2354; LERMA J, 1989, P NATL ACAD SCI USA, V86, P1708, DOI 10.1073/pnas.86.5.1708; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McDonald JF, 1991, J PHYSL, V432, P483; MCGURK JF, 1990, P NATL ACAD SCI USA, V87, P9971, DOI 10.1073/pnas.87.24.9971; MCNAMARA D, 1990, J NEUROSCI, V10, P3970, DOI 10.1523/JNEUROSCI.10-12-03970.1990; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; PRIESTLEY T, 1990, BRAIN RES, V531, P183, DOI 10.1016/0006-8993(90)90772-4; RANSCHECKER JP, 1987, NATURE, V326, P183; RANSOM RW, 1990, SYNAPSE, V5, P294, DOI 10.1002/syn.890050406; RANSOM RW, 1988, J NEUROCHEM, V51, P830, DOI 10.1111/j.1471-4159.1988.tb01818.x; SACAAN AI, 1990, J PHARMACOL EXP THER, V255, P1060; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; SEILER N, 1975, J NEUROCHEM, V24, P791, DOI 10.1111/j.1471-4159.1975.tb03866.x; SHAW GG, 1979, BIOCHEM PHARMACOL, V28, P1, DOI 10.1016/0006-2952(79)90261-2; SHAW GG, 1973, J NEUROCHEM, V20, P1225, DOI 10.1111/j.1471-4159.1973.tb00091.x; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SPROSEN TS, 1990, EUR J PHARMACOL, V179, P477, DOI 10.1016/0014-2999(90)90193-A; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; WEDGWOOD MA, 1977, NEUROPHARMACOLOGY, V16, P445, DOI 10.1016/0028-3908(77)90087-9; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; WILLIAMS K, 1989, MOL PHARMACOL, V36, P575; WILLIAMS K, 1990, NEURON, V5, P199, DOI 10.1016/0896-6273(90)90309-4; WILLIAMS K, 1991, LIFE SCI, V48, P469, DOI 10.1016/0024-3205(91)90463-L; ZEEVALK GD, 1990, BRAIN RES, V522, P135, DOI 10.1016/0006-8993(90)91588-8; ZORUMSKI CF, 1990, NEURON, V5, P61, DOI 10.1016/0896-6273(90)90033-C	51	111	114	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1992	8	2					343	352		10.1016/0896-6273(92)90300-3	http://dx.doi.org/10.1016/0896-6273(92)90300-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1531415				2022-12-28	WOS:A1992HE93000014
J	FILBIN, MT; TENNEKOON, GI				FILBIN, MT; TENNEKOON, GI			THE ROLE OF COMPLEX CARBOHYDRATES IN ADHESION OF THE MYELIN PROTEIN, PO	NEURON			English	Article							PERIPHERAL-NERVE MYELIN; HAMSTER OVARY CELLS; NEURITE OUTGROWTH; NEURAL ADHESION; SCIATIC-NERVE; SCHWANN-CELLS; MAJOR MYELIN; FATTY-ACID; P0 PROTEIN; N-CAM	The most abundant protein of peripheral nerve myelin, a glycoprotein termed P0, is believed to be involved in the compaction of the myelin sheath and is postulated to be the closest relative to the ancestral gene for the immunoglobulin superfamily. Recently, P0 has indeed been shown to behave like a homophilic adhesion molecule via interactions of its extracellular domains. Here we demonstrate the importance of the oligosaccharide moieties of P0 in its functioning as a homophilic adhesion molecule. Expression of the complex form of P0 glycoprotein in transfected Chinese hamster ovary cells greatly increased the adhesiveness of those cells, whereas expression of the high-mannose form of P0 glycoprotein did not. This is the first step in the dissection of P0-P0 interaction at the molecular level.	JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA	Johns Hopkins University					NINDS NIH HHS [NS 26242, NS-21700] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021700, R01NS026242, R29NS026242] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGRAWAL HC, 1983, J BIOL CHEM, V258, P6556; BOLLENSEN E, 1987, NEUROSCI LETT, V82, P77, DOI 10.1016/0304-3940(87)90174-1; BRAUN PE, 1984, MYELIN, P97; BRUNDEN KR, 1987, J CELL BIOL, V104, P661, DOI 10.1083/jcb.104.3.661; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; CROWLEY JF, 1984, ARCH BIOCHEM BIOPHYS, V231, P524, DOI 10.1016/0003-9861(84)90417-X; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; EVERLY JL, 1973, J NEUROCHEM, V21, P329, DOI 10.1111/j.1471-4159.1973.tb04253.x; FILBIN MT, 1986, NEUROCHEM INT, V9, P517, DOI 10.1016/0197-0186(86)90144-0; FILBIN MT, 1990, J NEUROCHEM, V55, P500, DOI 10.1111/j.1471-4159.1990.tb04163.x; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; FROST E, 1978, VIROLOGY, V91, P39, DOI 10.1016/0042-6822(78)90353-7; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; GOTTLIEB C, 1975, J BIOL CHEM, V250, P3303; GOTTLIEB C, 1974, P NATL ACAD SCI USA, V71, P1078, DOI 10.1073/pnas.71.4.1078; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRUMET M, 1988, J CELL BIOL, V106, P487, DOI 10.1083/jcb.106.2.487; HARLOW E, 1988, ANTIBODIES LABORATOR; HOLT GD, 1985, J IMMUNOL, V135, P399; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; ISHAQUE A, 1980, CAN J BIOCHEM CELL B, V58, P913, DOI 10.1139/o80-125; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; KITAMURA K, 1976, BIOCHIM BIOPHYS ACTA, V455, P806, DOI 10.1016/0005-2736(76)90050-X; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LEBLANC AC, 1987, MOL BRAIN RES, V2, P57, DOI 10.1016/0169-328X(87)90021-0; LEE SJ, 1988, J BIOL CHEM, V263, P3521; Lees M., 1984, MYELIN, P197; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1988, DEVELOPMENT, V102, P499; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LERNER RA, 1981, P NATL ACAD SCI-BIOL, V78, P3403, DOI 10.1073/pnas.78.6.3403; MATTHIEU JM, 1975, BIOCHIM BIOPHYS ACTA, V392, P167, DOI 10.1016/0304-4165(75)90177-4; NUNN DJ, 1984, J NEUROCHEM, V42, P158, DOI 10.1111/j.1471-4159.1984.tb09712.x; PODUSLO JF, 1985, J NEUROCHEM, V44, P388, DOI 10.1111/j.1471-4159.1985.tb05428.x; ROBERTSON MA, 1978, CELL, V13, P515, DOI 10.1016/0092-8674(78)90325-2; ROOMI MW, 1978, BIOCHIM BIOPHYS ACTA, V536, P112, DOI 10.1016/0005-2795(78)90057-0; SAKAMOTO Y, 1987, J BIOL CHEM, V262, P4208; SAKAMOTO Y, 1986, BIOMED RES-TOKYO, V7, P261; SCHNEIDERSCHAULIES J, 1990, J NEUROSCI RES, V27, P286, DOI 10.1002/jnr.490270307; SHIBUYA N, 1988, J BIOL CHEM, V263, P728; SINGH H, 1976, BIOCHIM BIOPHYS ACTA, V448, P325, DOI 10.1016/0005-2736(76)90246-7; STANLEY P, 1987, TRENDS GENET, V3, P77, DOI 10.1016/0168-9525(87)90180-6; TRAPP BD, 1988, J NEUROSCI, V8, P3515; TRIMBLE RB, 1984, ANAL BIOCHEM, V141, P515, DOI 10.1016/0003-2697(84)90080-0; UYEMURA K, 1991, COMP BIOCHEM PHYS C, V98, P63; WIGGINS RC, 1980, J NEUROCHEM, V34, P627, DOI 10.1111/j.1471-4159.1980.tb11190.x; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	53	71	71	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1991	7	5					845	855		10.1016/0896-6273(91)90286-9	http://dx.doi.org/10.1016/0896-6273(91)90286-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1720626	hybrid			2022-12-28	WOS:A1991GT93900014
J	LINSTEDT, AD; KELLY, RB				LINSTEDT, AD; KELLY, RB			SYNAPTOPHYSIN IS SORTED FROM ENDOCYTOTIC MARKERS IN NEUROENDOCRINE PC12-CELLS BUT NOT TRANSFECTED FIBROBLASTS	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLE MEMBRANE; TEMPERATURE-SENSITIVE MUTANT; TRANSMITTER RELEASE; FUSION PORE; CELL-LINE; DROSOPHILA-MELANOGASTER; REVERSIBLE BLOCKAGE; SECRETORY VESICLE; COATED VESICLES	The targeting of synaptophysin, a major synaptic vesicle protein, in transfected nonneuronal cells has important implications for synaptic vesicle biogenesis, but has proved controversial. We have analyzed four transfected cell types by differential centrifugation and velocity gradient sedimentation to determine whether synaptophysin is targeted to endosomes or to synaptic vesicle-like structures. Synaptophysin was recovered only in vesicles that sedimented more rapidly than synaptic vesicles. The synaptophysin-containing vesicles were labeled if a surface-labeled cell was warmed to 37-degrees-C, comigrated with transferrin receptor-containing vesicles on velocity and density gradients, and could be completely immunoadsorbed by anti-LDL receptor tail antibodies. These data demonstrate that synaptophysin was targeted to the early endocytotic pathway in the transfected cells and are inconsistent with the suggestion that synaptophysin expression induces a novel population of vesicles. Targeting of synaptophysin to early endosomes implicates their role in synaptic vesicle biogenesis.	UNIV CALIF SAN FRANCISCO,HORMONE RES INST,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	LINSTEDT, AD (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,DIV NEUROSCI,SAN FRANCISCO,CA 94143, USA.				NIDDK NIH HHS [DK33937] Funding Source: Medline; NINDS NIH HHS [NS09878, NS15927] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015927, R01NS009878] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMERS W, 1990, NEURON, V4, P813, DOI 10.1016/0896-6273(90)90134-2; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; CECCARELLI B, 1980, PHYSIOL REV, V60, P396, DOI 10.1152/physrev.1980.60.2.396; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CLIFTOGRADY L, 1990, J CELL BIOL, V110, P1693, DOI 10.1083/jcb.110.5.1693; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; GEUZE HJ, 1984, CELL, V37, P195, DOI 10.1016/0092-8674(84)90315-5; GUMBINER B, 1981, P NATL ACAD SCI-BIOL, V78, P318, DOI 10.1073/pnas.78.1.318; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JOHNSTON PA, 1989, EMBO J, V8, P2863, DOI 10.1002/j.1460-2075.1989.tb08434.x; KIRSCHMEIER PT, 1988, DNA-J MOLEC CELL BIO, V7, P219, DOI 10.1089/dna.1988.7.219; KOENIG JH, 1989, J NEUROSCI, V9, P1937; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; LEBIVIC A, 1990, J CELL BIOL, V110, P1533, DOI 10.1083/jcb.110.5.1533; LEUBE RE, 1989, CELL, V59, P433, DOI 10.1016/0092-8674(89)90028-7; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; MATTER K, 1990, CELL, V60, P429, DOI 10.1016/0092-8674(90)90594-5; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; PERKINS AS, 1983, MOL CELL BIOL, V3, P1123, DOI 10.1128/MCB.3.6.1123; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; SULZER D, 1989, J NEUROCYTOL, V18, P529, DOI 10.1007/BF01474548; THOMPSON JA, 1987, BIOCHEMISTRY-US, V26, P743, DOI 10.1021/bi00377a014; TORRITARELLI F, 1987, J NEUROCYTOL, V16, P205, DOI 10.1007/BF01795304; TSURUHARA T, 1990, CELL TISSUE RES, V259, P199, DOI 10.1007/BF00318441; VALTORTA F, 1988, J CELL BIOL, V107, P2717, DOI 10.1083/jcb.107.6.2717; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; VONWEDEL RJ, 1981, P NATL ACAD SCI-BIOL, V78, P1014; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WILEY RG, 1987, J NEUROCYTOL, V16, P359, DOI 10.1007/BF01611347	34	121	121	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					309	317		10.1016/0896-6273(91)90269-6	http://dx.doi.org/10.1016/0896-6273(91)90269-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1908253				2022-12-28	WOS:A1991GB93300014
J	UCHIDA, Y; TAKIO, K; TITANI, K; IHARA, Y; TOMONAGA, M				UCHIDA, Y; TAKIO, K; TITANI, K; IHARA, Y; TOMONAGA, M			THE GROWTH INHIBITORY FACTOR THAT IS DEFICIENT IN THE ALZHEIMERS-DISEASE BRAIN IS A 68-AMINO ACID METALLOTHIONEIN-LIKE PROTEIN	NEURON			English	Article							PAIRED HELICAL FILAMENTS; MICROTUBULE-ASSOCIATED PROTEINS; CEREBRAL CORTICAL-NEURONS; SENILE DEMENTIA; NEUROFIBRILLARY TANGLES; FIBROUS ASTROCYTES; ANTIGENIC DETERMINANTS; NEURITIC PLAQUES; GENE-EXPRESSION; BASAL FOREBRAIN	We have purified and characterized the growth inhibitory factor (GIF) that is abundant in the normal human brain, but greatly reduced in the Alzheimer's disease (AD) brain. GIF inhibited survival and neurite formation of cortical neurons in vitro. Purified GIF is a 68 amino acid small protein, and its amino acid sequence is 70% identical to that of human metallothionein 11 with a 1 amino acid insert and a unique 6 amino acid insert in the NH2-terminal and the COOH-terminal portions, respectively. The antibodies to the unique sequence of GIF revealed a distinct subset of astrocytes in the gray matter that appears to be closely associated with neuronal perikarya and dendrites. In the AD cortex, the number of GIF-positive astrocytes was drastically reduced, suggesting that GIF is down-regulated in the subset of astrocytes during AD.	TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT NEUROPHYSIOL,TOKYO 173,JAPAN; INST PHYS & NUCL ENGN,AGING PROC RES LAB,FRONTIER RES PROGRAM,SAITAMA 35101,JAPAN; UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROPATHOL,BUNKYO KU,TOKYO 113,JAPAN	Tokyo Metropolitan Institute of Gerontology; University of Tokyo	UCHIDA, Y (corresponding author), TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT NEUROPATHOL,35-2 SAKAECHO,ITABASHI KU,TOKYO 173,JAPAN.							ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602; ARENDT T, 1986, NEUROSCIENCE, V19, P1265, DOI 10.1016/0306-4522(86)90141-7; BALL MJ, 1977, ACTA NEUROPATHOL, V37, P111, DOI 10.1007/BF00692056; BANERJEE D, 1982, TOXICOLOGY, V24, P95, DOI 10.1016/0300-483X(82)90048-8; BONDAREFF W, 1982, NEUROLOGY, V32, P164, DOI 10.1212/WNL.32.2.164; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; BRAAK H, 1988, NEUROPATH APPL NEURO, V14, P39, DOI 10.1111/j.1365-2990.1988.tb00864.x; BRION JP, 1985, ADV APPLIED NEUROLOG, P164; BRUGG B, 1988, J CELL BIOL, V107, P643, DOI 10.1083/jcb.107.2.643; BUTCHER LL, 1989, NEUROBIOL AGING, V10, P557, DOI 10.1016/0197-4580(89)90130-9; CRYSTAL H, 1988, NEUROLOGY, V38, P1682, DOI 10.1212/WNL.38.11.1682; DANIELSON KG, 1982, P NATL ACAD SCI-BIOL, V79, P2301, DOI 10.1073/pnas.79.7.2301; DAVIES L, 1988, NEUROLOGY, V38, P1688, DOI 10.1212/WNL.38.11.1688; DELACOURTE A, 1990, NEUROLOGY, V40, P33, DOI 10.1212/WNL.40.1.33; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; DINARELLO CA, 1988, FASEB J, V2, P108, DOI 10.1096/fasebj.2.2.3277884; DUFFY PE, 1980, NEUROLOGY, V30, P778, DOI 10.1212/WNL.30.7.778; DUGUID JR, 1989, P NATL ACAD SCI USA, V86, P7260, DOI 10.1073/pnas.86.18.7260; DUNN MA, 1987, P SOC EXP BIOL MED, V185, P107; EBADI M, 1986, BIOL TRACE ELEM RES, V11, P101, DOI 10.1007/BF02795528; EMORY CR, 1987, NEUROLOGY, V37, P768, DOI 10.1212/WNL.37.5.768; FERRER I, 1983, ACTA NEUROPATHOL, V59, P167, DOI 10.1007/BF00703200; FERRER I, 1990, NEUROSCI LETT, V114, P11, DOI 10.1016/0304-3940(90)90420-E; FUREY WF, 1986, SCIENCE, V231, P704, DOI 10.1126/science.3945804; GARVEY JS, 1981, SCIENCE, V214, P805, DOI 10.1126/science.7292012; GOULD E, 1989, J NEUROSCI, V9, P3347; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; HANSEN LA, 1987, NEUROBIOL AGING, V8, P1, DOI 10.1016/0197-4580(87)90051-0; HASEGAWA M, 1990, NEURON, V4, P909, DOI 10.1016/0896-6273(90)90144-5; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; IHARA Y, 1983, NATURE, V304, P727, DOI 10.1038/304727a0; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; IHARA Y, 1989, NEUROBIOL AGING, V10, P573, DOI 10.1016/0197-4580(89)90132-2; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; KANEMARU K, 1990, AM J PATHOL, V137, P677; KARIN M, 1985, CELL, V41, P9, DOI 10.1016/0092-8674(85)90051-0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KITAMOTO T, 1987, LAB INVEST, V57, P230; KITAMURA T, 1987, BRAIN RES, V423, P189, DOI 10.1016/0006-8993(87)90839-0; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; Kuzuhara S, 1989, No To Shinkei, V41, P465; KUZUHARA S, 1990, IN PRESS ALZHEIMERS; MANCARDI GL, 1983, ACTA NEUROPATHOL, V61, P76, DOI 10.1007/BF00688390; MANN DMA, 1988, NEUROPATH APPL NEURO, V14, P177, DOI 10.1111/j.1365-2990.1988.tb00880.x; MANN DMA, 1989, NEUROBIOL AGING, V10, P397, DOI 10.1016/0197-4580(89)90073-0; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; MOUNTJOY CQ, 1983, NEUROBIOL AGING, V4, P1, DOI 10.1016/0197-4580(83)90048-9; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; NUKINA N, 1983, P JAPAN ACAD, V259, P288; OH TH, 1982, J NEUROSCI RES, V8, P535, DOI 10.1002/jnr.490080239; PALIWAL VK, 1988, EXP BRAIN RES, V5, P477; PAULABARBOSA MM, 1980, J NEUROL SCI, V45, P129, DOI 10.1016/S0022-510X(80)80014-1; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; PROBST A, 1983, BRAIN RES, V268, P249, DOI 10.1016/0006-8993(83)90490-0; SAITO Y, 1989, J BIOCHEM, V106, P1035, DOI 10.1093/oxfordjournals.jbchem.a122960; SATO SM, 1984, J NEUROSCI, V4, P1652; SCHECHTER R, 1981, J NEUROPATH EXP NEUR, V40, P95, DOI 10.1097/00005072-198103000-00002; SCHEIBEL AB, 1978, EXP NEUROL, V60, P1, DOI 10.1016/0014-4886(78)90164-4; SCHULTZE P, 1988, J MOL BIOL, V203, P251, DOI 10.1016/0022-2836(88)90106-4; TERRY RD, 1981, ANN NEUROL, V10, P184, DOI 10.1002/ana.410100209; TOMLINSON BE, 1981, J NEUROL SCI, V49, P419, DOI 10.1016/0022-510X(81)90031-9; UCHIDA Y, 1989, BRAIN RES, V481, P190, DOI 10.1016/0006-8993(89)90503-9; UCHIDA Y, 1988, BIOCHEM BIOPH RES CO, V150, P1263, DOI 10.1016/0006-291X(88)90765-6; VIERECK C, 1989, J NEUROSCI, V9, P3547; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; WHITSON JS, 1989, SCIENCE, V243, P1488, DOI 10.1126/science.2928783; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V77, P113; YAMAMOTO T, 1985, ANN NEUROL, V17, P573, DOI 10.1002/ana.410170608; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YEN SH, 1983, AM J PATHOL, V113, P373	78	664	688	0	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					337	347		10.1016/0896-6273(91)90272-2	http://dx.doi.org/10.1016/0896-6273(91)90272-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1873033				2022-12-28	WOS:A1991GB93300017
J	GRILLNER, S; MATSUSHIMA, T				GRILLNER, S; MATSUSHIMA, T			THE NEURAL NETWORK UNDERLYING LOCOMOTION IN LAMPREY SYNAPTIC AND CELLULAR MECHANISMS	NEURON			English	Review							SPINAL-CORD INVITRO; EXCITATORY AMINO-ACIDS; D-ASPARTATE NMDA; MEMBRANE-POTENTIAL OSCILLATIONS; ELICITS FICTIVE LOCOMOTION; CENTRAL NERVOUS-SYSTEM; BRAIN-STEM; RETICULOSPINAL NEURONS; PATTERN GENERATORS; XENOPUS EMBRYOS				GRILLNER, S (corresponding author), KAROLINSKA INST, NOBEL INST NEUROPHYSIOL, S-10401 STOCKHOLM 60, SWEDEN.							ALFORD S, 1990, BRAIN RES, V506, P297, DOI 10.1016/0006-8993(90)91266-J; ALFORD S, 1991, EUR J NEUROSCI, V3, P107, DOI 10.1111/j.1460-9568.1991.tb00071.x; ALFORD S, 1989, J NEUROSCI, V9, P2792; ALFORD S, 1991, IN PRESS J NEUROSCI; ANDREWS PC, 1988, J BIOL CHEM, V263, P15809; Arshavsky Y.I., 1986, NEUROBIOLOGY VERTEBR, P677; ARSHAVSKY YI, 1991, IN PRESS DEV TIMING; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BRODIN L, 1988, BRAIN RES, V458, P166, DOI 10.1016/0006-8993(88)90511-2; BRODIN L, 1985, BRAIN RES, V360, P149, DOI 10.1016/0006-8993(85)91230-2; BRODIN L, 1985, BRAIN RES, V360, P139, DOI 10.1016/0006-8993(85)91229-6; BRODIN L, 1990, BRAIN RES, V508, P172, DOI 10.1016/0006-8993(90)91134-3; BRODIN L, 1985, BRAIN RES, V325, P302, DOI 10.1016/0006-8993(85)90328-2; BRODIN L, 1986, NEUROSCI LETT, V67, P53, DOI 10.1016/0304-3940(86)90207-7; BRODIN L, 1989, J COMP NEUROL, V281, P225, DOI 10.1002/cne.902810206; BRODIN L, 1986, BRAIN RES, V380, P244, DOI 10.1016/0006-8993(86)90219-2; BRODIN L, 1989, J NEUROSCI, V9, P3428; BRODIN L, 1989, THESIS KAROLINSKA I; Brodin L, 1990, PREPARATIONS VERTEBR, P103; BRODIN L, 1991, IN PRESS J NEUROPHYS; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; BUCHANAN JT, 1989, J NEUROPHYSIOL, V62, P59, DOI 10.1152/jn.1989.62.1.59; BUCHANAN JT, 1988, BRAIN RES, V438, P404, DOI 10.1016/0006-8993(88)91373-X; BUCHANAN JT, 1991, NEUROSCI LETT, V122, P71, DOI 10.1016/0304-3940(91)90196-Z; BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P961, DOI 10.1152/jn.1982.47.5.961; BUCHANAN JT, 1987, SCIENCE, V236, P312, DOI 10.1126/science.3563512; CAZALETS JR, 1990, NEUROSCI LETT, V111, P116, DOI 10.1016/0304-3940(90)90354-C; CHRISTENSON J, 1990, BRAIN RES, V512, P201, DOI 10.1016/0006-8993(90)90627-N; CHRISTENSON J, 1991, BRAIN RES, V538, P313, DOI 10.1016/0006-8993(91)90446-3; CHRISTENSON J, 1989, NEUROSCI LETT, V100, P188, DOI 10.1016/0304-3940(89)90682-4; CHRISTENSON J, 1991, IN PRESS J NEUROPHYS; Cohen A., 1988, NEURAL CONTROL RHYTH; COHEN AH, 1984, BRAIN RES, V293, P164, DOI 10.1016/0006-8993(84)91464-1; CRONE C, 1988, J PHYSIOL-LONDON, V405, P321, DOI 10.1113/jphysiol.1988.sp017335; DALE N, 1985, J PHYSIOL-LONDON, V363, P35, DOI 10.1113/jphysiol.1985.sp015694; DALE N, 1986, J NEUROSCI, V6, P2662, DOI 10.1523/jneurosci.06-09-02662.1986; DALE N, 1986, J NEUROSCI, V6, P2653; DICKINSON PS, 1990, NATURE, V344, P155, DOI 10.1038/344155a0; DIPRISCO GV, 1990, BRAIN RES, V530, P161; DUBUC R, 1989, BRAIN RES, V483, P196, DOI 10.1016/0006-8993(89)90055-3; EKEBERG O, 1991, IN PRESS BIO CYBERNE; GARCIARILL E, 1986, BRAIN RES REV, V11, P47, DOI 10.1016/0165-0173(86)90009-3; Gelfand I., 1988, NEURAL CONTROL RHYTH, P167; GEORGOPOULOS AP, 1988, FASEB J, V2, P2849, DOI 10.1096/fasebj.2.13.3139485; GRILLNER P, 1991, ACTA PHYSIOL SCAND, V141, P131, DOI 10.1111/j.1748-1716.1991.tb09055.x; GRILLNER S, 1989, CELL TO CELL SIGNALLING : FROM EXPERIMENTS TO THEORETICAL MODELS, P77; GRILLNER S, 1981, ACTA PHYSIOL SCAND, V113, P549, DOI 10.1111/j.1748-1716.1981.tb06937.x; GRILLNER S, 1975, PHYSIOL REV, V55, P247, DOI 10.1104/pp.55.2.247; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; GRILLNER S, 1991, ANNU REV NEUROSCI, V14, P169, DOI 10.1146/annurev.neuro.14.1.169; GRILLNER S, 1980, ACTA PHYSIOL SCAND, V110, P103, DOI 10.1111/j.1748-1716.1980.tb06637.x; GRILLNER S, 1982, J EXP BIOL, V98, P1; GRILLNER S, 1982, BRAIN RES, V235, P169, DOI 10.1016/0006-8993(82)90208-6; GRILLNER S, 1984, SCIENCE, V223, P500, DOI 10.1126/science.6691161; GRILLNER S, 1974, EXP BRAIN RES, V20, P459; GRILLNER S, 1985, NEUROSCI LETT, V60, P289, DOI 10.1016/0304-3940(85)90592-0; GRILLNER S, 1981, BRAIN RES, V217, P380, DOI 10.1016/0006-8993(81)90015-9; GRILLNER S, 1990, NEUROSCI IN, P187; GRILLNER S, 1981, PHYSIOL REV, P1179; Grillner S., 1988, NEURAL CONTROL RHYTH, P1; HARRISWARRICK RM, 1985, J EXP BIOL, V116, P27; HARRISWARRICK RM, 1985, NEUROSCIENCE, V14, P1127, DOI 10.1016/0306-4522(85)90282-9; HEADLEY PM, 1990, TRENDS PHARMACOL SCI, V11, P205, DOI 10.1016/0165-6147(90)90116-P; HILL RH, 1989, BRAIN RES, V499, P388, DOI 10.1016/0006-8993(89)90790-7; HOUNSGAARD J, 1985, EXP BRAIN RES, V57, P422; JAHR CE, 1990, J NEUROSCI, V10, P3178; JORDAN LM, 1986, NEUROBIOLOGY VERTEBR, P21; KASICKI S, 1989, BRAIN RES, V484, P203, DOI 10.1016/0006-8993(89)90363-6; KIEHN O, 1991, TRENDS NEUROSCI, V14, P68, DOI 10.1016/0166-2236(91)90023-N; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; LARHAMMAR D, 1991, IN PRESS NEUROBIOLOG; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Matsushima T, 1990, Neuroreport, V1, P97, DOI 10.1097/00001756-199010000-00003; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MCCLELLAN AD, 1984, BRAIN RES, V300, P357, DOI 10.1016/0006-8993(84)90846-1; MCCLELLAN AD, 1988, BRAIN RES, V457, P338, DOI 10.1016/0006-8993(88)90704-4; MCCLELLAN AD, 1988, J NEUROSCI, V8, P133; MCCLELLAN AD, 1985, BRAIN RES, V332, P119, DOI 10.1016/0006-8993(85)90395-6; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; ODONOVAN MJ, 1986, NEUROBIOLOGY VERTEBR, P415; OHTA Y, 1989, J NEUROPHYSIOL, V62, P1079, DOI 10.1152/jn.1989.62.5.1079; OHTA Y, 1988, BRAIN RES, V445, P400, DOI 10.1016/0006-8993(88)91207-3; ORLOVSKY GM, 1976, INT REV PHYSL NEUROP, V10, P281; Pearson K.G., 1985, P307; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; POON MLT, 1980, J COMP PHYSIOL, V136, P337, DOI 10.1007/BF00657354; ROBERTS A, 1990, EUR J NEUROSCI, V2, P11, DOI 10.1111/j.1460-9568.1990.tb00377.x; Rossignol SLJ, 1988, NEURAL CONTROL RHYTH, P201; ROVAINEN CM, 1974, J COMP NEUROL, V154, P207, DOI 10.1002/cne.901540207; ROVAINEN CM, 1979, PHYSIOL REV, V59, P1007, DOI 10.1152/physrev.1979.59.4.1007; ROVAINEN CM, 1979, J NEUROPHYSIOL, V42, P745, DOI 10.1152/jn.1979.42.3.745; ROVAINEN CM, 1983, BIOL LAMPREY, V3, P1; RUSSELL DF, 1983, ACTA PHYSIOL SCAND, V117, P161, DOI 10.1111/j.1748-1716.1983.tb07193.x; SCHMIDT BJ, 1988, EXP BRAIN RES, V71, P568, DOI 10.1007/BF00248749; SCHROEDER DM, 1990, J COMP NEUROL, V301, P93, DOI 10.1002/cne.903010109; SELVERSTON AI, 1985, ANNU REV PHYSIOL, V47, P29; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIK ML, 1976, PHYSIOL REV, V56, P465, DOI 10.1152/physrev.1976.56.3.465; SIGVARDT KA, 1985, BRAIN RES, V336, P390, DOI 10.1016/0006-8993(85)90676-6; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; SOFFE SR, 1989, EUR J NEUROSCI, V1, P507, DOI 10.1111/j.1460-9568.1989.tb00357.x; Stein PSG, 1986, NEUROBIOLOGY VERTEBR, P201; THOMSON AM, 1989, TRENDS NEUROSCI, V12, P349, DOI 10.1016/0166-2236(89)90042-8; VANDONGEN PAM, 1985, J COMP NEUROL, V234, P501, DOI 10.1002/cne.902340408; von Holst E, 1935, PFLUG ARCH GES PHYS, V236, P149; WALLEN P, 1984, J PHYSIOL-LONDON, V347, P225, DOI 10.1113/jphysiol.1984.sp015063; WALLEN P, 1989, PROG BRAIN RES, V80, P321; WALLEN P, 1989, J NEUROPHYSIOL, V61, P759, DOI 10.1152/jn.1989.61.4.759; WALLEN P, 1987, J NEUROSCI, V7, P2745; WALLEN P, 1985, NEUROSCI LETT, V56, P87, DOI 10.1016/0304-3940(85)90112-0; WICKELGREN WO, 1985, J NEUROSCI, V5, P1188; WILLIAMS TL, 1990, J NEUROPHYSIOL, V64, P862, DOI 10.1152/jn.1990.64.3.862	113	117	118	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1991	7	1					1	15		10.1016/0896-6273(91)90069-C	http://dx.doi.org/10.1016/0896-6273(91)90069-C			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1676892				2022-12-28	WOS:A1991FY48100001
J	DOSTER, SK; LOZANO, AM; AGUAYO, AJ; WILLARD, MB				DOSTER, SK; LOZANO, AM; AGUAYO, AJ; WILLARD, MB			EXPRESSION OF THE GROWTH-ASSOCIATED PROTEIN GAP-43 IN ADULT-RAT RETINAL GANGLION-CELLS FOLLOWING AXON INJURY	NEURON			English	Article							PERIPHERAL-NERVE GRAFTS; CALMODULIN-BINDING-PROTEIN; KINASE-C SUBSTRATE; TRANSPORTED PROTEINS; OPTIC-NERVE; POLYACRYLAMIDE GELS; BRAIN; REGENERATION; B-50; PHOSPHORYLATION	We have studied the expression of the growth-associated protein GAP-43 after injury to the axons of adult rat retinal ganglion cells (CNS neurons that do not normally regenerate injured axons). Both the biosynthetic labeling of GAP-43 and the GAP-43 immunoreactivity of the retina increased after axotomy, but only when the injury was within 3 mm of the eye. These results suggest the following conclusions: First, axon injury is sufficient to alter GAP-43 expression in CNS neurons, even in the absence of regeneration. Second, mechanisms that regulate GAP-43 expression are sensitive to the length of uninterrupted axon remaining after injury. Finally, the conditions that favor increased GAP-43 are similar to those that favor regrowth of injured CNS axons into grafts of peripheral nerve, suggesting that GAP-43 induction is accompanied by an increased potential of injured CNS neurons to regenerate.	WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110; MONTREAL GEN HOSP,NEUROSCI UNIT,MONTREAL H3G 1A4,QUEBEC,CANADA; MCGILL UNIV,MONTREAL H3G 1A4,QUEBEC,CANADA	Washington University (WUSTL); McGill University; McGill University			Lozano, Andres M/A-5058-2012	Lozano, Andres M./0000-0001-8257-3694	NEI NIH HHS [EYO6082] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006082] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aguayo A.J., 1985, SYNAPTIC PLASTICITY, P457; AGUAYO AJ, 1990, BRAIN REPAIR, P251; ANDREASEN TJ, 1983, BIOCHEMISTRY-US, V22, P4615, DOI 10.1021/bi00289a001; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; BENOWITZ LI, 1987, TRENDS NEUROSCI, V10, P527, DOI 10.1016/0166-2236(87)90135-4; BENOWITZ LI, 1988, J NEUROSCI, V8, P339; BENOWITZ LI, 1983, J NEUROSCI, V3, P2153; BENOWITZ LI, 1987, J NEUROCHEM, V48, P1640, DOI 10.1111/j.1471-4159.1987.tb05713.x; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BIFFO S, 1990, EUR J NEUROSCI, V2, P487, DOI 10.1111/j.1460-9568.1990.tb00440.x; CARBONETTO S, 1987, J NEUROSCI, V7, P610; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; CHANGELIAN PS, 1990, BRAIN RES, V510, P259, DOI 10.1016/0006-8993(90)91376-R; CIMLER BM, 1987, J BIOL CHEM, V262, P12158; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DAVID S, 1985, J NEUROCYTOL, V14, P1, DOI 10.1007/BF01150259; DEGRAAN PNE, 1985, NEUROSCI LETT, V61, P235, DOI 10.1016/0304-3940(85)90470-7; DEKKER LV, 1989, J NEUROCHEM, V52, P24, DOI 10.1111/j.1471-4159.1989.tb10893.x; Freeman JA, 1986, EXP BRAIN RES S, V13, P34; GISPEN WH, 1985, BRAIN RES, V328, P381, DOI 10.1016/0006-8993(85)91054-6; GISPEN WH, 1985, INOSITOL PHOSPHOINOS, P399; Grafstein B, 1987, PROG BRAIN RES <D>, V71, P113; JACOBSON RD, 1986, J NEUROSCI, V6, P1843; KALIL K, 1986, J NEUROSCI, V6, P2563; KATZ F, 1985, J NEUROSCI, V5, P1402; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LOVINGER DM, 1985, BRAIN RES, V343, P137, DOI 10.1016/0006-8993(85)91167-9; MCGUIRE CB, 1988, DEV BRAIN RES, V41, P277, DOI 10.1016/0165-3806(88)90189-7; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; MERRIL CR, 1981, ANAL BIOCHEM, V110, P201, DOI 10.1016/0003-2697(81)90136-6; MOYA KL, 1988, J NEUROSCI, V8, P4445; NELSON RB, 1985, EXP NEUROL, V89, P213, DOI 10.1016/0014-4886(85)90277-8; NG SC, 1988, NEURON, V1, P133, DOI 10.1016/0896-6273(88)90197-3; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PERRY GW, 1987, J NEUROSCI, V7, P792; REH TA, 1987, MOL BRAIN RES, V2, P1, DOI 10.1016/0169-328X(87)90014-3; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; RICHARDSON PM, 1982, J NEUROCYTOL, V11, P949, DOI 10.1007/BF01148310; RICHARDSON PM, 1984, J NEUROCYTOL, V13, P165, DOI 10.1007/BF01148324; SCHWAB ME, 1985, J NEUROSCI, V5, P2415; SCHWAB ME, 1990, MENTAL NEUROL, V109, P2; SKENE JHP, 1986, SCIENCE, V233, P783, DOI 10.1126/science.3738509; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; SKENE JHP, 1981, J CELL BIOL, V89, P86, DOI 10.1083/jcb.89.1.86; SKENE JHP, 1981, J CELL BIOL, V89, P96, DOI 10.1083/jcb.89.1.96; SO KF, 1985, BRAIN RES, V328, P349, DOI 10.1016/0006-8993(85)91047-9; STRITTMATTER SM, 1990, NATURE, V344, P836, DOI 10.1038/344836a0; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WILLARD M, 1974, P NATL ACAD SCI USA, V71, P2183, DOI 10.1073/pnas.71.6.2183; WILLARD MB, 1985, MOL BASES NEURAL DEV, P341; WOOLF CJ, 1990, NEUROSCIENCE, V34, P465, DOI 10.1016/0306-4522(90)90155-W; ZWIERS H, 1976, NEUROCHEM RES, V1, P669, DOI 10.1007/BF00965607	55	296	300	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					635	647		10.1016/0896-6273(91)90066-9	http://dx.doi.org/10.1016/0896-6273(91)90066-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	1826603				2022-12-28	WOS:A1991FH80200015
J	FOSSIER, P; BAUX, G; TAUC, L				FOSSIER, P; BAUX, G; TAUC, L			ACTIVATION OF PROTEIN-KINASE-C BY PRESYNAPTIC FLRFAMIDE RECEPTORS FACILITATES TRANSMITTER RELEASE AT AN APLYSIA CHOLINERGIC SYNAPSE	NEURON			English	Article											FOSSIER, P (corresponding author), CNRS,NEUROBIOL CELLULAIRE & MOLEC LAB,F-91198 GIF SUR YVETTE,FRANCE.							ALLGAIER C, 1988, BRIT J PHARMACOL, V93, P525, DOI 10.1111/j.1476-5381.1988.tb10307.x; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V369, P163; BAUX G, 1987, J PHYSIOL-LONDON, V388, P665, DOI 10.1113/jphysiol.1987.sp016637; BAUX G, 1990, IN PRESS J PHYSL; BELARDETTI F, 1987, NATURE, V325, P153, DOI 10.1038/325153a0; BOYD PJ, 1985, COMP BIOCHEM PHYS C, V81, P379, DOI 10.1016/0742-8413(85)90023-4; BREZINA V, 1987, J PHYSIOL-LONDON, V388, P565, DOI 10.1113/jphysiol.1987.sp016632; BREZINA V, 1987, J PHYSIOL-LONDON, V382, P267, DOI 10.1113/jphysiol.1987.sp016367; BUTTNER N, 1989, NATURE, V342, P553, DOI 10.1038/342553a0; CARATSCH CG, 1989, N-S ARCH PHARMACOL, V340, P82; CARATSCH CG, 1988, N-S ARCH PHARMACOL, V337, P9; CARATSCH CG, 1986, PFLUG ARCH EUR J PHY, V407, P409, DOI 10.1007/BF00652626; COLOMBAIONI L, 1985, J NEUROSCI, V5, P2533; CONN PJ, 1989, J NEUROSCI, V9, P473; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; COTTRELL GA, 1987, J PHYSIOL-LONDON, V382, P51, DOI 10.1113/jphysiol.1987.sp016355; COTTRELL GA, 1984, J PHYSIOL-LONDON, V356, P315, DOI 10.1113/jphysiol.1984.sp015467; DALE N, 1990, J PHYSIOL-LONDON, V421, P203, DOI 10.1113/jphysiol.1990.sp017941; DERIEMER SA, 1985, J NEUROSCI, V5, P2672; DIXON D, 1989, J NEUROPHYSIOL, V62, P239, DOI 10.1152/jn.1989.62.1.239; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; EUSEBI F, 1985, J CELL BIOL, V100, P1339, DOI 10.1083/jcb.100.4.1339; FOSSIER P, 1983, PFLUG ARCH EUR J PHY, V396, P15, DOI 10.1007/BF00584692; FOSSIER P, 1988, PFLUG ARCH EUR J PHY, V411, P345, DOI 10.1007/BF00587712; GARDNER D, 1977, J NEUROPHYSIOL, V40, P333, DOI 10.1152/jn.1977.40.2.333; GREGA DS, 1987, SCIENCE, V235, P345, DOI 10.1126/science.2432663; HERMANN A, 1981, J GEN PHYSIOL, V78, P63, DOI 10.1085/jgp.78.1.63; HERMANN A, 1981, J GEN PHYSIOL, V78, P87, DOI 10.1085/jgp.78.1.87; HUGANIR RL, 1987, J RECEPTOR RES, V7, P241, DOI 10.3109/10799898709054988; ICHINOSE M, 1988, J NEUROSCI, V8, P3891; KACZMAREK LK, 1987, TRENDS NEUROSCI, V10, P30, DOI 10.1016/0166-2236(87)90122-6; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; MADISON DV, 1986, NATURE, V321, P695, DOI 10.1038/321695a0; MALENKA RC, 1987, BRAIN RES, V403, P198, DOI 10.1016/0006-8993(87)90145-4; MATTHIES HJG, 1987, J NEUROSCI, V7, P1198; MURPHY RLW, 1987, BRIT J PHARMACOL, V90, P327, DOI 10.1111/j.1476-5381.1987.tb08962.x; NEHER E, 1971, J GEN PHYSIOL, V58, P36, DOI 10.1085/jgp.58.1.36; NICHOLS RA, 1987, J NEUROCHEM, V48, P615, DOI 10.1111/j.1471-4159.1987.tb04137.x; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; POULAIN B, 1987, BRAIN RES, V435, P63, DOI 10.1016/0006-8993(87)91587-3; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RANE SG, 1986, P NATL ACAD SCI USA, V83, P184, DOI 10.1073/pnas.83.1.184; RUBEN P, 1986, J NEUROSCI, V6, P252; SAWADA M, 1989, J NEUROSCI RES, V22, P158, DOI 10.1002/jnr.490220208; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; SIMONNEAU M, 1980, P NATL ACAD SCI-BIOL, V77, P1661, DOI 10.1073/pnas.77.3.1661; SOSSIN WS, 1987, J NEUROSCI, V7, P671; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; SUSSWEIN AJ, 1988, J NEUROSCI, V8, P2049; SWEATT JD, 1989, NATURE, V342, P275, DOI 10.1038/342275a0; TAUC L, 1974, NATURE, V250, P496, DOI 10.1038/250496a0; TAUC L, 1962, J NEUROPHYSIOL, V25, P236, DOI 10.1152/jn.1962.25.2.236; TAUSSIG R, 1989, J NEUROSCI, V9, P3218; THOMPSON S, 1988, J NEUROSCI, V8, P3200; WERZ MA, 1987, J NEUROSCI, V7, P1639; YAMAMOTO D, 1988, J PHYSIOL-LONDON, V400, P691, DOI 10.1113/jphysiol.1988.sp017144; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032; ZURGIL N, 1986, NEUROSCIENCE, V19, P1255, DOI 10.1016/0306-4522(86)90140-5	59	29	29	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1990	5	4					479	486		10.1016/0896-6273(90)90087-V	http://dx.doi.org/10.1016/0896-6273(90)90087-V			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED517	1976320				2022-12-28	WOS:A1990ED51700011
J	DRAPEAU, P				DRAPEAU, P			LOSS OF CHANNEL MODULATION BY TRANSMITTER AND PROTEIN KINASE-C DURING INNERVATION OF AN IDENTIFIED LEECH NEURON	NEURON			English	Article											DRAPEAU, P (corresponding author), MONTREAL GEN HOSP,CTR RES NEUROSCI,MONTREAL H3G 1A4,QUEBEC,CANADA.							BERG DK, 1989, TRENDS NEUROSCI, V12, P16, DOI 10.1016/0166-2236(89)90151-3; BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; CAMARDO J, 1983, J NEUROSCI, V3, P2614; COHEN MW, 1987, J NEUROSCI, V7, P2849; COOPER E, 1984, J PHYSIOL-LONDON, V351, P263, DOI 10.1113/jphysiol.1984.sp015244; COOPER E, 1987, J PHYSIOL-LONDON, V377, P409; DAGAN D, 1981, J NEUROSCI, V7, P736; DIETZEL ID, 1986, J PHYSIOL-LONDON, V372, P191, DOI 10.1113/jphysiol.1986.sp016004; DRAPEAU P, 1989, J NEUROBIOL, V20, P312, DOI 10.1002/neu.480200505; DRAPEAU P, 1989, J NEUROSCI, V9, P2502; DRAPEAU P, 1988, J NEUROSCI, V8, P4718; FUCHS PA, 1981, J PHYSIOL-LONDON, V316, P203, DOI 10.1113/jphysiol.1981.sp013783; FUCHS PA, 1982, J PHYSIOL-LONDON, V323, P195, DOI 10.1113/jphysiol.1982.sp014068; GERSCHENFELD HM, 1973, PHYSIOL REV, V53, P1, DOI 10.1152/physrev.1973.53.1.1; HADLEY RD, 1983, SCIENCE, V221, P466, DOI 10.1126/science.6867723; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HENDERSON LP, 1983, J PHYSIOL-LONDON, V340, P347, DOI 10.1113/jphysiol.1983.sp014766; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kaczmarek LK, 1987, NEUROMODULATION BIOC; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; KRISTAN WB, 1982, J PHYSIOL-PARIS, V78, P743; KUFFLER DP, 1987, J COMP NEUROL, V256, P516, DOI 10.1002/cne.902560404; LIU Y, 1989, PROC R SOC SER B-BIO, V236, P253, DOI 10.1098/rspb.1989.0023; MARGIOTTA JF, 1987, P NATL ACAD SCI USA, V84, P8155, DOI 10.1073/pnas.84.22.8155; MARGIOTTA JF, 1987, J NEUROSCI, V7, P3612; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; NEHER E, 1976, J PHYSIOL-LONDON, V258, P705, DOI 10.1113/jphysiol.1976.sp011442; Nicholls JG, 1987, MAGNES LECTURE SERIE, V2, P1; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PURVES D, 1985, PRINCIPLES NEURAL DE; READY DF, 1979, NATURE, V281, P67, DOI 10.1038/281067a0; SAKMANN B, 1983, SINGLE CHANNEL RECOR; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703	38	22	22	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1990	4	6					875	882		10.1016/0896-6273(90)90140-B	http://dx.doi.org/10.1016/0896-6273(90)90140-B			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK185	1694445				2022-12-28	WOS:A1990DK18500007
J	TANAKA, K; MASU, M; NAKANISHI, S				TANAKA, K; MASU, M; NAKANISHI, S			STRUCTURE AND FUNCTIONAL EXPRESSION OF THE CLONED RAT NEUROTENSIN RECEPTOR	NEURON			English	Article											TANAKA, K (corresponding author), KYOTO UNIV,FAC MED,INST IMMUNOL,KYOTO 606,JAPAN.							AMAR S, 1985, BIOCHEM BIOPH RES CO, V129, P117, DOI 10.1016/0006-291X(85)91411-1; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BOZOU JC, 1986, MOL PHARMACOL, V29, P489; COTECCHIA S, 1988, P NATL ACAD SCI USA, V85, P7159, DOI 10.1073/pnas.85.19.7159; DIXON RAF, 1988, ANNU REP MED CHEM, V23, P221; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; DOBNER PR, 1987, P NATL ACAD SCI USA, V84, P3516, DOI 10.1073/pnas.84.10.3516; GILBERT JA, 1984, EUR J PHARMACOL, V99, P245, DOI 10.1016/0014-2999(84)90248-6; GOEDERT M, 1984, BRAIN RES, V323, P193, DOI 10.1016/0006-8993(84)90288-9; HARADA Y, 1987, J NEUROSCI, V7, P3265; HIRONO C, 1987, J PHYSIOL-LONDON, V382, P523, DOI 10.1113/jphysiol.1987.sp016382; KITABGI P, 1985, Reviews in Clinical and Basic Pharmacology, V5, P397; KITABGI P, 1977, P NATL ACAD SCI USA, V74, P1846, DOI 10.1073/pnas.74.5.1846; KITABGI P, 1987, EUR J PHARMACOL, V140, P285, DOI 10.1016/0014-2999(87)90285-8; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUBO T, 1988, FEBS LETT, V241, P119, DOI 10.1016/0014-5793(88)81043-3; LEEMAN SE, 1982, ANN NY ACAD SCI, V400, P1, DOI 10.1111/j.1749-6632.1982.tb31557.x; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MAZELLA J, 1985, J BIOL CHEM, V260, P508; MAZELLA J, 1989, J BIOL CHEM, V264, P5559; MILLS A, 1988, J BIOL CHEM, V263, P13; MINAMINO N, 1984, BIOCHEM BIOPH RES CO, V122, P542, DOI 10.1016/S0006-291X(84)80067-4; NAKANISHI S, 1990, IN PRESS RECENT PROG, V46; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; PARKER I, 1986, PROC R SOC SER B-BIO, V229, P151, DOI 10.1098/rspb.1986.0079; PRITCHETT DB, 1988, EMBO J, V7, P4135, DOI 10.1002/j.1460-2075.1988.tb03308.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAI Y, 1989, BIOCHEM BIOPH RES CO, V165, P695, DOI 10.1016/S0006-291X(89)80022-1; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SHIGEMOTO R, 1990, J BIOL CHEM, V265, P623; SNIDER RM, 1986, J NEUROCHEM, V47, P1214; SNUTCH TP, 1988, TRENDS NEUROSCI, V11, P250, DOI 10.1016/0166-2236(88)90102-6; STRADER CD, 1987, J BIOL CHEM, V262, P16439; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649	36	497	516	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1990	4	6					847	854		10.1016/0896-6273(90)90137-5	http://dx.doi.org/10.1016/0896-6273(90)90137-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK185	1694443				2022-12-28	WOS:A1990DK18500004
J	MA, YJ; JUNIER, MP; COSTA, ME; OJEDA, SR				MA, YJ; JUNIER, MP; COSTA, ME; OJEDA, SR			TRANSFORMING GROWTH FACTOR-ALPHA GENE-EXPRESSION IN THE HYPOTHALAMUS IS DEVELOPMENTALLY REGULATED AND LINKED TO SEXUAL-MATURATION	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; HORMONE-RELEASING HORMONE; MESSENGER RIBONUCLEIC-ACID; HUMAN-BREAST CANCER; FEMALE RAT; CELL-PROLIFERATION; CULTURED NEURONS; ESTROUS-CYCLE; EGF RECEPTOR; BRAIN	Hypothalamic injury causes female sexual precocity by activating luteinizing hormone-releasing hormone (LHRH) neurons, which control sexual development. Transforming growth factor-alpha (TGF-alpha) has been implicated in this process, but its involvement in normal sexual maturation is unknown. The present study addresses this issue. TGF-alpha mRNA and protein were found mostly in astroglia, in regions of the hypothalamus concerned with LHRH control. Hypothalamic TGF-alpha mRNA levels increased at times when secretion of pituitary gonadotropins-an LHRH-dependent event-was elevated, particularly at the time of puberty. Gonadal steroids involved in the control of LHRH secretion increased TGF-alpha mRNA levels. Blockade of TGF-alpha action in the median eminence, a site of glial-LHRH nerve terminal association, delayed puberty. These results suggest that TGF-alpha of glial origin is a component of the developmental program by which the brain controls mammalian sexual maturation.	OREGON HLTH SCI UNIV,DEPT PHYSIOL,PORTLAND,OR 97201	Oregon Health & Science University	MA, YJ (corresponding author), OREGON REG PRIMATE RES CTR,DIV NEUROSCI,BEAVERTON,OR 97006, USA.				NCRR NIH HHS [RR00163] Funding Source: Medline; NICHD NIH HHS [HD25123] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABE K, 1990, JPN J PHARMACOL, V54, P45, DOI 10.1254/jjp.54.45; ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; ANDREWS WW, 1981, ENDOCRINOLOGY, V109, P1404, DOI 10.1210/endo-109-5-1404; BATES SE, 1988, MOL ENDOCRINOL, V2, P543, DOI 10.1210/mend-2-6-543; BROWNGRANT K, 1977, PROC R SOC SER B-BIO, V198, P279, DOI 10.1098/rspb.1977.0098; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CODE RA, 1987, BRAIN RES, V421, P401, DOI 10.1016/0006-8993(87)91317-5; COTMAN CW, 1984, SCIENCE, V225, P1287, DOI 10.1126/science.6382610; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DERYNCK R, 1988, CELL, V54, P593, DOI 10.1016/S0092-8674(88)80001-1; ERNSBERGER P, 1990, BRAIN RES, V517, P202, DOI 10.1016/0006-8993(90)91027-E; Fallon JH, 1990, GROWTH FACTORS, V2, P241, DOI 10.3109/08977199009071510; FALLON JH, 1984, SCIENCE, V224, P1107, DOI 10.1126/science.6144184; GENTRY LE, 1987, MOL CELL BIOL, V7, P1585, DOI 10.1128/MCB.7.5.1585; GILMAN M, 1989, CURRENT PROTOCOLS MO; HILL DF, 1992, METHODS NEUROSCIENCE, V9, P179; HOMPES PGA, 1982, NEUROENDOCRINOLOGY, V35, P8, DOI 10.1159/000123347; JUNGTESTAS I, 1991, EXP CELL RES, V193, P12, DOI 10.1016/0014-4827(91)90532-Y; JUNIER MP, 1991, P NATL ACAD SCI USA, V88, P9743, DOI 10.1073/pnas.88.21.9743; JUNIER MP, 1992, ENDOCRINOLOGY, V131, P77; JUNIER MP, 1992, IN PRESS J NEUROSCI; KALRA SP, 1986, FRONT NEUROENDOCRIN, V9, P31; KIM KJ, 1989, MOL BRAIN RES, V6, P151, DOI 10.1016/0169-328X(89)90049-1; Knowles F, 1972, Prog Brain Res, V38, P255; KORNBLUM HI, 1990, BRAIN RES, V535, P255, DOI 10.1016/0006-8993(90)91608-J; KOZLOWSKI GP, 1985, CELL TISSUE RES, V242, P301; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; KUDLOW JE, 1989, J BIOL CHEM, V264, P3880; LAKOS S, 1986, J HISTOCHEM CYTOCHEM, V34, P1047, DOI 10.1177/34.8.2426333; LANGUB MC, 1992, ENDOCRINOLOGY, V130, P364, DOI 10.1210/en.130.1.364; LARA HE, 1990, ENDOCRINOLOGY, V126, P357, DOI 10.1210/endo-126-1-357; LAZAR LM, 1992, J NEUROSCI, V12, P1688; LEE DC, 1985, NATURE, V313, P489, DOI 10.1038/313489a0; LEUTZ A, 1981, CELL TISSUE RES, V220, P393; LUGER A, 1988, J CLIN ENDOCR METAB, V66, P334, DOI 10.1210/jcem-66-2-334; LYALL RM, 1989, J BIOL CHEM, V264, P14503; MA YJ, 1990, ENDOCRINOLOGY, V127, P2654, DOI 10.1210/endo-127-6-2654; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; MASSAGUE J, 1990, J BIOL CHEM, V265, P21393; MEIJER JH, 1989, PHYSIOL REV, V69, P671, DOI 10.1152/physrev.1989.69.3.671; MORRISON RS, 1987, SCIENCE, V238, P72, DOI 10.1126/science.3498986; MURPHY LC, 1989, MOL ENDOCRINOL, V3, P611, DOI 10.1210/mend-3-4-611; Ojeda S R, 1980, Endocr Rev, V1, P228; OJEDA SR, 1972, ENDOCRINOLOGY, V90, P466, DOI 10.1210/endo-90-2-466; OJEDA SR, 1990, P NATL ACAD SCI USA, V87, P9698, DOI 10.1073/pnas.87.24.9698; OJEDA SR, 1991, MOL BRAIN RES, V9, P47, DOI 10.1016/0169-328X(91)90129-L; OJEDA SR, 1969, ENDOCRINOLOGY, V84, P786, DOI 10.1210/endo-84-4-786; OJEDA SR, 1988, PHYSL REPRODUCTION, V2, P1699; PARK OK, 1990, ENDOCRINOLOGY, V127, P365, DOI 10.1210/endo-127-1-365; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; RONNEKLEIV OK, 1986, NEUROENDOCRINOLOGY, V43, P564, DOI 10.1159/000124583; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SAEKI T, 1991, MOL ENDOCRINOL, V5, P1955, DOI 10.1210/mend-5-12-1955; Salomon D S, 1989, Recent Results Cancer Res, V113, P57; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SEROOGY KB, 1991, NEUROSCI LETT, V125, P241, DOI 10.1016/0304-3940(91)90039-V; SHINODA H, 1989, SCIENCE, V245, P415, DOI 10.1126/science.2569236; SHIVERS BD, 1983, NATURE, V304, P345, DOI 10.1038/304345a0; SILVERMAN RC, 1991, EXP NEUROL, V114, P259, DOI 10.1016/0014-4886(91)90152-3; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SIMPSON DL, 1982, J NEUROSCI RES, V8, P453, DOI 10.1002/jnr.490080233; SPRANGER M, 1990, EUR J NEUROSCI, V2, P69, DOI 10.1111/j.1460-9568.1990.tb00382.x; UGRUMOV M, 1989, NEUROSCI LETT, V102, P159, DOI 10.1016/0304-3940(89)90072-4; WEINER RI, 1988, PHYSL REPRODUCTION, V1, P1235; WIEGAND SJ, 1982, NEUROENDOCRINOLOGY, V34, P395, DOI 10.1159/000123335; WILCOX JN, 1988, J NEUROSCI, V8, P1901; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702	67	171	172	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					657	670						14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1327011				2022-12-28	WOS:A1992JT51600007
J	MILWARD, EA; PAPADOPOULOS, R; FULLER, SJ; MOIR, RD; SMALL, D; BEYREUTHER, K; MASTERS, CL				MILWARD, EA; PAPADOPOULOS, R; FULLER, SJ; MOIR, RD; SMALL, D; BEYREUTHER, K; MASTERS, CL			THE AMYLOID PROTEIN-PRECURSOR OF ALZHEIMERS-DISEASE IS A MEDIATOR OF THE EFFECTS OF NERVE GROWTH-FACTOR ON NEURITE OUTGROWTH	NEURON			English	Article							BETA-PROTEIN; MESSENGER-RNA; HUMAN-BRAIN; SOLUBLE DERIVATIVES; PRION PROTEIN; SECRETED FORM; NEXIN-II; EXPRESSION; GENE; CELLS	The beta-A4 protein, the major component of the amyloid deposition characterizing Alzheimer's disease, derives from the amyloid protein precursor (APP), an integral membrane protein with soluble derivatives. The function of APP is unknown. Both soluble and membrane-associated human brain APP (10(-10) M) significantly increased (P < 0.025) neurite length and branching in pheochromocytoma PC12 cells, but did not affect the number of neurites per cell. At higher concentrations, APP was cytotoxic, with a half-maximal concentration of 5 x 10(-9) M. Nerve growth factor (NGF) is known to affect APP expression in vivo and in vitro. Antibodies to APP specifically diminished the effects of NGF on neurite length and branching. Thus APP may act to mediate neurite outgrowth promotion by NGF.	UNIV HEIDELBERG,CTR MOLEC BIOL,W-6900 HEIDELBERG,GERMANY; MENTAL HLTH RES INST,PARKVILLE,VIC 3052,AUSTRALIA	Ruprecht Karls University Heidelberg; Florey Institute of Neuroscience & Mental Health	MILWARD, EA (corresponding author), UNIV MELBOURNE,DEPT PATHOL,PARKVILLE,VIC 3052,AUSTRALIA.		Moir, Robert D./M-7612-2017	Moir, Robert D./0000-0001-5431-3553; Milward, Adrienne/0000-0002-1023-7795				BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; CHEN M, 1991, NEUROSCI LETT, V125, P223, DOI 10.1016/0304-3940(91)90034-Q; COHEN ML, 1988, P NATL ACAD SCI USA, V85, P1227, DOI 10.1073/pnas.85.4.1227; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GEDDES JW, 1986, EXP NEUROL, V94, P767, DOI 10.1016/0014-4886(86)90254-2; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; JOHNSON SA, 1990, SCIENCE, V248, P854, DOI 10.1126/science.2111579; JOHNSON SA, 1989, NEUROBIOL AGING, V10, P267, DOI 10.1016/0197-4580(89)90061-4; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KLIER FG, 1990, BRAIN RES, V515, P336, DOI 10.1016/0006-8993(90)90619-M; KONIG G, 1991, MOL BRAIN RES, V9, P259, DOI 10.1016/0169-328X(91)90010-U; KONIG G, 1990, FEBS LETT, V269, P305, DOI 10.1016/0014-5793(90)81181-M; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6; MASLIAH E, 1991, NEURON, V6, P729, DOI 10.1016/0896-6273(91)90170-5; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; NEVE RL, 1990, NEURON, V5, P329, DOI 10.1016/0896-6273(90)90169-G; NEVE RL, 1988, NEURON, V1, P669, DOI 10.1016/0896-6273(88)90166-3; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; PALMERT MR, 1988, SCIENCE, V241, P1080, DOI 10.1126/science.2457949; PALMERT MR, 1989, BIOCHEM BIOPH RES CO, V165, P182, DOI 10.1016/0006-291X(89)91052-8; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; QUON D, 1990, BIOCHEM BIOPH RES CO, V167, P96, DOI 10.1016/0006-291X(90)91735-B; REFOLO LM, 1989, BIOCHEM BIOPH RES CO, V164, P664, DOI 10.1016/0006-291X(89)91511-8; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SALBAUM JM, 1988, EMBO J, V7, P2807, DOI 10.1002/j.1460-2075.1988.tb03136.x; SCHUBERT D, 1989, BIOCHEM BIOPH RES CO, V162, P83, DOI 10.1016/0006-291X(89)91965-7; SCHUBERT D, 1989, NEURON, V3, P689, DOI 10.1016/0896-6273(89)90237-7; SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066; SCHUBERT D, 1978, BRAIN RES, V155, P196, DOI 10.1016/0006-8993(78)90325-6; SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P4055, DOI 10.1073/pnas.74.9.4055; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMALL DH, 1991, BIOCHEMISTRY-US, V30, P10795, DOI 10.1021/bi00108a027; SMITH CJ, 1991, MOL BRAIN RES, V10, P351, DOI 10.1016/0169-328X(91)90095-F; SPILLANTINI MG, 1989, MOL BRAIN RES, V6, P143, DOI 10.1016/0169-328X(89)90048-X; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; VANNOSTRAND WE, 1989, NATURE, V341, P546; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WHITSON JS, 1990, NEUROSCI LETT, V110, P319, DOI 10.1016/0304-3940(90)90867-9; WHITSON JS, 1989, SCIENCE, V243, P1488, DOI 10.1126/science.2928783; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WION D, 1988, INT J DEV NEUROSCI, V6, P387, DOI 10.1016/0736-5748(88)90021-4; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YANKNER BA, 1990, P NATL ACAD SCI USA, V87, P9020, DOI 10.1073/pnas.87.22.9020	63	409	415	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					129	137		10.1016/0896-6273(92)90228-6	http://dx.doi.org/10.1016/0896-6273(92)90228-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1632967				2022-12-28	WOS:A1992JE75600014
J	LAGNADO, L; BAYLOR, D				LAGNADO, L; BAYLOR, D			SIGNAL FLOW IN VISUAL TRANSDUCTION	NEURON			English	Review							ROD OUTER SEGMENTS; GMP PHOSPHODIESTERASE ACTIVATION; MONKEY MACACA-FASCICULARIS; CYCLIC-GMP; RETINAL RODS; CALCIUM-CONCENTRATION; LIGHT ADAPTATION; 48-KDA PROTEIN; TOAD RODS; PHOTOTRANSDUCTION				LAGNADO, L (corresponding author), STANFORD UNIV,MED CTR,SCH MED,SHERMAN FAIRCHILD SCI CTR,DEPT NEUROBIOL,STANFORD,CA 94305, USA.				NATIONAL EYE INSTITUTE [R01EY001543, R37EY001543, R01EY005750] Funding Source: NIH RePORTER; NEI NIH HHS [EY05750, EY01543] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARSHAVSKY VY, 1991, J BIOL CHEM, V266, P18530; ARSHAVSKY VY, 1992, IN PRESS NATURE; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; BENNETT N, 1988, BIOCHEMISTRY-US, V27, P1710, DOI 10.1021/bi00405a049; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FORTI S, 1989, J PHYSIOL-LONDON, V419, P265, DOI 10.1113/jphysiol.1989.sp017873; FOWLES C, 1989, BIOCHEMISTRY-US, V28, P9385, DOI 10.1021/bi00450a020; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; HODGKIN AL, 1985, J PHYSIOL-LONDON, V358, P447, DOI 10.1113/jphysiol.1985.sp015561; HUPPERTZ B, 1990, J BIOL CHEM, V265, P9470; HURLEY JB, 1987, ANNU REV PHYSIOL, V49, P793; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; LAGNADO L, 1992, IN PRESS J PHYSL; Lamb T.D., 1990, Seminars in the Neurosciences, V2, P3; LAMB TD, 1988, J PHYSIOL-LONDON, V407, P463, DOI 10.1113/jphysiol.1988.sp017426; LAMB TD, 1984, J PHYSIOL-LONDON, V346, P557, DOI 10.1113/jphysiol.1984.sp015041; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; LAMB TD, 1986, J PHYSIOL-LONDON, V372, P315, DOI 10.1113/jphysiol.1986.sp016011; LAMB TD, 1980, NATURE, V287, P349, DOI 10.1038/287349a0; LAMBRECHT HG, 1991, EMBO J, V10, P793, DOI 10.1002/j.1460-2075.1991.tb08011.x; LAMBRECHT HG, 1991, FEBS LETT, V294, P207, DOI 10.1016/0014-5793(91)80670-X; LIEBMAN PA, 1980, NATURE, V287, P734, DOI 10.1038/287734a0; LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001; LOLLEY RN, 1982, VISION RES, V22, P1481, DOI 10.1016/0042-6989(82)90213-9; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MCNAUGHTON PA, 1986, NATURE, V322, P261, DOI 10.1038/322261a0; MCNAUGHTON PA, 1990, PHYSIOL REV, V70, P847, DOI 10.1152/physrev.1990.70.3.847; MILLER JL, 1984, VISION RES, V24, P1509, DOI 10.1016/0042-6989(84)90313-4; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P731, DOI 10.1113/jphysiol.1988.sp016943; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; NATHANS J, 1987, ANNU REV NEUROSCI, V10, P163; OHGURO H, 1991, EMBO J, V10, P3669, DOI 10.1002/j.1460-2075.1991.tb04934.x; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; PALCZEWSKI K, 1992, NEURON, V8, P117, DOI 10.1016/0896-6273(92)90113-R; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P4201; PEREZSALA D, 1991, P NATL ACAD SCI USA, V88, P3043, DOI 10.1073/pnas.88.8.3043; RAY S, 1992, IN PRESS P NATL ACAD; SATHER WA, 1987, P NATL ACAD SCI USA, V84, P9290, DOI 10.1073/pnas.84.24.9290; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; SITARAMAYYA A, 1983, J BIOL CHEM, V258, P2106; SNEYD J, 1989, B MATH BIOL, V51, P749, DOI 10.1007/BF02459659; STRYER L, 1991, J BIOL CHEM, V266, P10711; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; VUONG TM, 1990, NATURE, V346, P71, DOI 10.1038/346071a0; VUONG TM, 1991, P NATL ACAD SCI USA, V88, P9813, DOI 10.1073/pnas.88.21.9813; YAU KW, 1985, NATURE, V313, P579, DOI 10.1038/313579a0; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; ZIMMERMAN AL, 1985, P NATL ACAD SCI USA, V82, P8813, DOI 10.1073/pnas.82.24.8813	55	188	190	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					995	1002		10.1016/0896-6273(92)90122-T	http://dx.doi.org/10.1016/0896-6273(92)90122-T			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1377000				2022-12-28	WOS:A1992JA42900001
J	ATASHI, JR; KLINZ, SG; INGRAHAM, CA; MATTEN, WT; SCHACHNER, M; MANESS, PF				ATASHI, JR; KLINZ, SG; INGRAHAM, CA; MATTEN, WT; SCHACHNER, M; MANESS, PF			NEURAL CELL-ADHESION MOLECULES MODULATE TYROSINE PHOSPHORYLATION OF TUBULIN IN NERVE GROWTH CONE MEMBRANES	NEURON			English	Article							SRC GENE-PRODUCT; MYELIN-ASSOCIATED GLYCOPROTEIN; IMMUNOELECTRON MICROSCOPIC LOCALIZATION; PROTEIN-KINASE ACTIVITY; EXPRESS HIGH-LEVELS; ROUS-SARCOMA VIRUS; FETAL-RAT-BRAIN; N-CAM; NEURITE OUTGROWTH; DEVELOPMENTAL REGULATION	Triggering neural cell adhesion molecules of the immunoglobulin superfamily with specific ligands or antibodies inhibited the phosphorylation of tyrosyl residues in a subpopulation of alpha- and beta-tubulin associated with membranes from a subcellular fraction of nerve growth cones from fetal rat brain. Preincubation of these membranes with purified extracellular fragments of L1, N-CAM, or myelin-associated glycoprotein, or with antibodies directed against the extracellular domains of L1 or N-CAM, inhibited pp60c-src-dependent phosphorylation of tubulin in an endogenous membrane kinase reaction. Other proteins that affect neurite outgrowth (fibronectin, laminin, antibodies against N-cadherin) had no effect. The results suggest that cell adhesion molecules transduce cell surface events to intracellular signals by modulating the activity of protein tyrosine kinases or phosphatases in axonal membranes to influence cytoskeletal dynamics at the growth cone.	SWISS FED INST TECHNOL, DEPT NEUROBIOL, CH-8093 ZURICH, SWITZERLAND	ETH Zurich	ATASHI, JR (corresponding author), UNIV N CAROLINA, SCH MED, DEPT BIOCHEM & BIOPHYS, CHAPEL HILL, NC 27599 USA.				NINDS NIH HHS [NS26620] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026620] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; BARONVANEVERCOOREN A, 1982, J NEUROSCI RES, V8, P179, DOI 10.1002/jnr.490080208; BARTHELS D, 1987, EMBO J, V6, P907, DOI 10.1002/j.1460-2075.1987.tb04837.x; BARTSCH U, 1989, J COMP NEUROL, V284, P451, DOI 10.1002/cne.902840310; BEST D, 1981, ANAL BIOCHEM, V114, P281, DOI 10.1016/0003-2697(81)90481-4; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BLASCHUK OW, 1989, DEV BIOL, V136, P564, DOI 10.1016/0012-1606(89)90283-2; BOLEN JB, 1985, P NATL ACAD SCI USA, V82, P7275, DOI 10.1073/pnas.82.21.7275; BRONNERFRASER M, 1985, J CELL BIOL, V101, P610, DOI 10.1083/jcb.101.2.610; BROWN PJ, 1986, J CELL BIOL, V103, P1595, DOI 10.1083/jcb.103.4.1595; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; BUSS JE, 1984, MOL CELL BIOL, V4, P2697, DOI 10.1128/MCB.4.12.2697; COLE GJ, 1985, J CELL BIOL, V100, P1192, DOI 10.1083/jcb.100.4.1192; COLLETT MS, 1978, P NATL ACAD SCI USA, V75, P2021, DOI 10.1073/pnas.75.4.2021; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COTTON PC, 1983, MOL CELL BIOL, V3, P1157, DOI 10.1128/MCB.3.6.1157; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; DOHERTY P, 1991, NEURON, V6, P247, DOI 10.1016/0896-6273(91)90360-C; DRAZBA J, 1990, DEV BIOL, V138, P82, DOI 10.1016/0012-1606(90)90178-L; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; ELLIS L, 1985, J CELL BIOL, V101, P1977, DOI 10.1083/jcb.101.5.1977; FULTS DW, 1985, MOL CELL BIOL, V5, P27, DOI 10.1128/MCB.5.1.27; GARBER EA, 1985, MOL CELL BIOL, V5, P2781, DOI 10.1128/MCB.5.10.2781; GARD DL, 1985, J CELL BIOL, V100, P764, DOI 10.1083/jcb.100.3.764; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; IGNELZI MA, 1991, J COMP NEUROL, V314, P1; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBEAU JM, 1991, J NEUROSCI RES, V28, P299, DOI 10.1002/jnr.490280217; LEVY BT, 1984, DEV BIOL, V104, P9, DOI 10.1016/0012-1606(84)90031-9; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LINNEMANN D, 1989, DEV NEUROSCI-BASEL, V11, P149, DOI 10.1159/000111896; LOCKERBIE RO, 1991, IN PRESS J CELL BIOL; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANESS PF, 1986, J NEUROSCI RES, V16, P127, DOI 10.1002/jnr.490160113; MANESS PF, 1990, CIBA F SYMP, V150, P57; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; MANESS PF, 1991, SEM CELL BIOL, V2; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MATTEN WT, 1990, J CELL BIOL, V111, P1959, DOI 10.1083/jcb.111.5.1959; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; PERSOHN E, 1987, J CELL BIOL, V105, P569, DOI 10.1083/jcb.105.1.569; PFENNINGER KH, 1983, CELL, V35, P573, DOI 10.1016/0092-8674(83)90191-5; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; POLTORAK M, 1987, J CELL BIOL, V105, P1893, DOI 10.1083/jcb.105.4.1893; POULIOT Y, 1990, DEV BIOL, V141, P292, DOI 10.1016/0012-1606(90)90385-V; PROBSTMEIER R, 1989, J NEUROCHEM, V53, P1794, DOI 10.1111/j.1471-4159.1989.tb09245.x; PROBSTMEIER R, IN PRESS J CELL BIOL; RATHJEN FG, 1984, EMBO J, V3, P1; ROGERS SL, 1985, J NEUROSCI, V5, P369; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; SADOUL R, 1989, J NEUROCHEM, V53, P1471, DOI 10.1111/j.1471-4159.1989.tb08540.x; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SCHUCH U, 1991, THESIS U HEIDELBERG; SCOTT JD, 1985, P NATL ACAD SCI USA, V82, P4379, DOI 10.1073/pnas.82.13.4379; SIMKOWITZ P, 1989, J NEUROSCI, V9, P1004; SORGE LK, 1984, CELL, V36, P249, DOI 10.1016/0092-8674(84)90218-6; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Stephens R.E., 1990, P217; SUGRUE MM, 1990, J NEUROSCI, V10, P2513; SUNSHINE J, 1987, P NATL ACAD SCI USA, V84, P5986, DOI 10.1073/pnas.84.16.5986; SWEADNER KJ, 1985, J BIOL CHEM, V260, P9016; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TONKS NK, 1990, J BIOL CHEM, V265, P10674; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WANG JYJ, 1985, MOL CELL BIOL, V5, P3640, DOI 10.1128/MCB.5.12.3640; WERZ W, 1988, DEV BRAIN RES, V43, P225, DOI 10.1016/0165-3806(88)90101-0	78	192	193	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1992	8	5					831	842		10.1016/0896-6273(92)90197-L	http://dx.doi.org/10.1016/0896-6273(92)90197-L			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1375036				2022-12-28	WOS:A1992HV46700002
J	LIVSEY, CT; VICINI, S				LIVSEY, CT; VICINI, S			SLOWER SPONTANEOUS EXCITATORY POSTSYNAPTIC CURRENTS IN SPINY VERSUS ASPINY HILAR NEURONS	NEURON			English	Article							DENTATE GYRUS; PATCH-CLAMP; SYNAPTIC TRANSMISSION; ELECTRICAL-PROPERTIES; HIPPOCAMPAL SLICES; FASCIA-DENTATA; MOSSY CELLS; TIME COURSE; RAT; GLUTAMATE	In the hilar region of the rat hippocampus, large spontaneous excitatory postsynaptic currents (sEPSCs) mediated by non-NMDA glutamate receptors are present in both excitatory spiny mossy cells and inhibitory aspiny hilar interneurons, making these neurons ideal candidates for a comparative study using the tight seal whole-cell recording technique. Although sEPSCs have similar amplitude distributions, the rise and decay times are significantly slower in spiny versus aspiny neurons. Similar kinetic differences are observed in synaptic currents evoked by mossy fiber stimulation. These results demonstrate a physiological difference between the excitatory drive to excitatory and inhibitory neurons in the hilus that certainly contributes to differences in synaptic strength and that may be applicable to other brain regions. Furthermore, since the development or modification of individual spines or groups of spines may affect synaptic strength, these results may be pivotal in establishing a role for spines in modulating synaptic activity.			LIVSEY, CT (corresponding author), GEORGETOWN UNIV,SCH MED,FIDIA,GEORGETOWN INST NEUROSCI,WASHINGTON,DC 20007, USA.			Vicini, Stefano/0000-0001-8671-5194	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS028130] Funding Source: NIH RePORTER; NINDS NIH HHS [P01-NS-28130] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARAL DG, 1978, J COMP NEUROL, V182, P851, DOI 10.1002/cne.901820508; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BLACKSTAD TW, 1956, J COMP NEUROL, V105, P417, DOI 10.1002/cne.901050305; BROWN T H, 1988, P201; CACECI MS, 1984, BYTE, V9, P340; CHANG HT, 1952, COLD SPRING HARB SYM, V17, P189, DOI 10.1101/SQB.1952.017.01.019; DAVIES J, 1986, BRAIN RES, V382, P169, DOI 10.1016/0006-8993(86)90127-7; DEADWYLER SA, 1974, J NEUROPHYSIOL, V38, P167; DESMOND NL, 1983, BRAIN RES, V265, P21, DOI 10.1016/0006-8993(83)91329-X; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FATT P, 1951, J PHYSIOL-LONDON, V115, P320, DOI 10.1113/jphysiol.1951.sp004675; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; FISCHER BO, 1986, EXP BRAIN RES, V63, P620, DOI 10.1007/BF00237484; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; JACK JJB, 1975, ELECT CURRENT FLOW E, P131; KAWATO M, 1984, BIOPHYS J, V46, P155, DOI 10.1016/S0006-3495(84)84008-4; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOCH C, 1983, PROC R SOC SER B-BIO, V218, P455, DOI 10.1098/rspb.1983.0051; LAURBERG S, 1981, BRAIN RES, V212, P287, DOI 10.1016/0006-8993(81)90463-7; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; NELSON PG, 1986, J PHYSIOL-LONDON, V372, P169, DOI 10.1113/jphysiol.1986.sp016003; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; RALL W, 1971, BIOPHYS J, V9, P466; Rall W, 1988, CELLULAR MECH CONDIT, P221; RIBAK CE, 1985, J NEUROCYTOL, V14, P835, DOI 10.1007/BF01170832; RIBAK CE, 1983, J NEUROCYTOL, V12, P577, DOI 10.1007/BF01181525; SAH P, 1990, J PHYSIOL-LONDON, V430, P605, DOI 10.1113/jphysiol.1990.sp018310; SCHARFMAN HE, 1991, J NEUROSCI, V11, P1660; SCHARFMAN HE, 1988, J NEUROSCI, V8, P3812; SCHARFMAN HE, 1990, NEUROSCIENCE, V37, P693, DOI 10.1016/0306-4522(90)90100-I; SCHARFMAN HE, 1990, NEUROSCIENCE, V35, P505, DOI 10.1016/0306-4522(90)90325-X; SEGEV I, 1988, J NEUROPHYSIOL, V60, P499, DOI 10.1152/jn.1988.60.2.499; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Storm-Mathisen J, 1989, NEUROTRANSMITTERS CO, P39; STORMMATHISEN J, 1983, NATURE, V301, P517, DOI 10.1038/301517a0; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VICINI S, 1985, J NEUROSCI, V5, P2212; Xiao P, 1991, Hippocampus, V1, P373, DOI 10.1002/hipo.450010405; ZIMMER J, 1971, J COMP NEUROL, V142, P393, DOI 10.1002/cne.901420402	51	55	55	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					745	755		10.1016/0896-6273(92)90095-U	http://dx.doi.org/10.1016/0896-6273(92)90095-U			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1314622				2022-12-28	WOS:A1992HQ18800013
J	VIJAYARAGHAVAN, S; PUGH, PC; ZHANG, ZW; RATHOUZ, MM; BERG, DK				VIJAYARAGHAVAN, S; PUGH, PC; ZHANG, ZW; RATHOUZ, MM; BERG, DK			NICOTINIC RECEPTORS THAT BIND ALPHA-BUNGAROTOXIN ON NEURONS RAISE INTRACELLULAR FREE CA2+	NEURON			English	Article							CILIARY GANGLION NEURONS; ACETYLCHOLINE-RECEPTOR; CELL-CULTURE; SYMPATHETIC NEURONS; CALCIUM CHANNELS; PARASYMPATHETIC GANGLIA; GLUTAMATE NEUROTOXICITY; CHROMAFFIN CELLS; CHICK; SITES	Many populations of vertebrate neurons have a membrane component that binds alpha-bungarotoxin and cholinergic ligands. Despite the abundance of this component and its similarities to nicotinic receptors, its function has remained controversial. Using a fluorescence assay, we show here that activation of the component elevates the intracellular concentration of free Ca2+, demonstrating a receptor function for the toxin-binding component. Whole-cell voltage-clamp and intracellular recordings did not detect a significant current resulting from receptor activation, possibly because the currents were small or the receptors rapidly desensitized. The rise in intracellular free Ca2+ caused by the receptor was prevented by Ca2+ channel blockers. This suggests a signaling cascade likely to have important regulatory consequences for the neuron.			VIJAYARAGHAVAN, S (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA.			Pugh, Phyllis/0000-0001-7500-7117	NINDS NIH HHS [R01 NS12601, P01 NS25916] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012601, P01NS025916] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKASU T, 1990, J PHYSIOL-LONDON, V422, P303, DOI 10.1113/jphysiol.1990.sp017985; AKASU T, 1990, J PHYSIOL-LONDON, V426, P439, DOI 10.1113/jphysiol.1990.sp018148; ASCHER P, 1979, J PHYSIOL-LONDON, V295, P139, DOI 10.1113/jphysiol.1979.sp012958; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BETZ H, 1981, EUR J BIOCHEM, V117, P131; BROWN DA, 1977, BRAIN RES, V129, P165, DOI 10.1016/0006-8993(77)90981-7; CARBONETTO ST, 1978, P NATL ACAD SCI USA, V75, P1016, DOI 10.1073/pnas.75.2.1016; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHIAPPINELLI VA, 1978, NEUROCHEM RES, V3, P465, DOI 10.1007/BF00966328; CHIAPPINELLI VA, 1985, PHARMACOL THERAPEUT, V31, P1, DOI 10.1016/0163-7258(85)90035-X; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1987, J NEUROSCI, V7, P369; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DUGGAN AW, 1976, BRAIN RES, V107, P166, DOI 10.1016/0006-8993(76)90106-2; GOTTMANN K, 1988, J NEUROSCI, V8, P3722; GRAY DB, 1990, J NEUROSCI, V10, P2687; HALVORSEN SW, 1987, J NEUROSCI, V7, P2547; HALVORSEN SW, 1990, J NEUROSCI, V10, P1711; HALVORSEN SW, 1991, J NEUROSCI, V11, P2177; HALVORSEN SW, 1986, J NEUROSCI, V6, P3405; HALVORSEN SW, 1989, J NEUROSCI, V9, P3673; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYDON PG, 1984, SCIENCE, V226, P561, DOI 10.1126/science.6093252; HIGGINS LS, 1987, J NEUROSCI, V7, P1792; JACOB MH, 1984, P NATL ACAD SCI-BIOL, V81, P3223, DOI 10.1073/pnas.81.10.3223; JACOB MH, 1983, J NEUROSCI, V3, P260; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KATER SB, 1991, J NEUROSCI, V11, P891; LANDMESSER L, 1974, J PHYSIOL-LONDON, V241, P737, DOI 10.1113/jphysiol.1974.sp010681; Lindstrom J, 1981, Methods Enzymol, V74 Pt C, P432; LINDSTROM J, 1987, MOL NEUROBIOL, V1, P281, DOI 10.1007/BF02935740; LIPTON SA, 1987, PFLUG ARCH EUR J PHY, V410, P37, DOI 10.1007/BF00581893; LORING RH, 1987, J NEUROSCI, V7, P2153; LORING RH, 1985, NEUROSCIENCE, V14, P645, DOI 10.1016/0306-4522(85)90316-1; LORING RH, 1984, NEUROSCIENCE, V11, P989, DOI 10.1016/0306-4522(84)90209-4; MARGIOTTA JF, 1982, NATURE, V296, P152, DOI 10.1038/296152a0; MARGIOTTA JF, 1987, J NEUROSCI, V7, P3612; MATTSON MP, 1988, NEURON, V1, P865, DOI 10.1016/0896-6273(88)90134-1; MCCOBB DP, 1988, NEURON, V1, P377, DOI 10.1016/0896-6273(88)90187-0; MERINEY SD, 1987, J NEUROSCI, V7, P3840; MESSING A, 1984, BRAIN RES, V303, P241, DOI 10.1016/0006-8993(84)91210-1; MESSING A, 1982, BRAIN RES, V232, P479, DOI 10.1016/0006-8993(82)90292-X; NISHI R, 1981, J NEUROSCI, V1, P505; NORONHABLOB L, 1989, BIOCHEM BIOPH RES CO, V162, P1230, DOI 10.1016/0006-291X(89)90805-X; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; NURSE CA, 1975, P NATL ACAD SCI USA, V72, P1955, DOI 10.1073/pnas.72.5.1955; PATRICK J, 1977, P NATL ACAD SCI USA, V74, P4689, DOI 10.1073/pnas.74.10.4689; PURVES D, 1987, J NEUROSCI, V7, P1492; RAVDIN PM, 1979, P NATL ACAD SCI USA, V76, P2072, DOI 10.1073/pnas.76.4.2072; RAVDIN PM, 1981, J NEUROSCI, V1, P849; SASAKAWA N, 1986, NEUROSCI LETT, V63, P275, DOI 10.1016/0304-3940(86)90369-1; SCHMIDT J, 1988, INT REV NEUROBIOL, V30, P1; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; SMITH MA, 1986, J NEUROSCI, V6, P946; SMITH MA, 1985, J NEUROSCI, V5, P2726; SWANDULLA D, 1991, TRENDS NEUROSCI, V14, P46, DOI 10.1016/0166-2236(91)90018-P; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; WARD JM, 1990, FEBS LETT, V270, P45, DOI 10.1016/0014-5793(90)81231-C	59	252	258	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1992	8	2					353	362		10.1016/0896-6273(92)90301-S	http://dx.doi.org/10.1016/0896-6273(92)90301-S			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1310863				2022-12-28	WOS:A1992HE93000015
J	SUGITA, S; SHEN, KZ; NORTH, RA				SUGITA, S; SHEN, KZ; NORTH, RA			5-HYDROXYTRYPTAMINE IS A FAST EXCITATORY TRANSMITTER AT 5-HT3 RECEPTORS IN RAT AMYGDALA	NEURON			English	Article								A fast excitatory synaptic potential mediated by 5-hydroxytryptamine (5-HT) was recorded in rat lateral amygdala neurons in brain slices. The synaptic potential has brief duration (tens of milliseconds), is mimicked by 5-HT, is potentiated by a 5-HT uptake inhibitor, and is blocked by selective 5-HT3 receptor antagonists. The underlying synaptic current reversed polarity at about 0 mV. This is an example of fast neurotransmission in the mammalian brain mediated by an amine rather than an amino acid. The antiemetic, anxiolytic, and perhaps anti-psychotic actions of 5-HT3 antagonists might result from blockade of such synapses.	OREGON HLTH SCI UNIV, INST VOLLUM, PORTLAND, OR 97201 USA	Oregon Health & Science University			North, Richard/GQA-6156-2022					BUTLER A, 1988, BRIT J PHARMACOL, V94, P397, DOI 10.1111/j.1476-5381.1988.tb11542.x; CALABRESI P, 1989, BRIT J PHARMACOL, V98, P135, DOI 10.1111/j.1476-5381.1989.tb16873.x; COSTALL B, 1987, BRIT J PHARMACOL, V92, P881, DOI 10.1111/j.1476-5381.1987.tb11394.x; CUNNINGHAM D, 1987, LANCET, V1, P1461, DOI 10.1016/S0140-6736(87)92208-2; DERKACH V, 1989, NATURE, V339, P706, DOI 10.1038/339706a0; EGAN TM, 1986, NEUROSCIENCE, V19, P565, DOI 10.1016/0306-4522(86)90281-2; GEPNER JI, 1978, NATURE, V276, P188, DOI 10.1038/276188a0; GERSCHENFELD HM, 1973, PHYSIOL REV, V53, P1, DOI 10.1152/physrev.1973.53.1.1; GERSCHENFELD HM, 1974, J PHYSIOL-LONDON, V243, P427, DOI 10.1113/jphysiol.1974.sp010761; GERSCHENFELD HM, 1974, J PHYSIOL-LONDON, V243, P457, DOI 10.1113/jphysiol.1974.sp010762; HAGAN RM, 1990, BRIT J PHARMACOL, V99, P227, DOI 10.1111/j.1476-5381.1990.tb14685.x; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HIGASHI H, 1982, J PHYSIOL-LONDON, V323, P543, DOI 10.1113/jphysiol.1982.sp014091; JONES BJ, 1988, BRIT J PHARMACOL, V93, P985, DOI 10.1111/j.1476-5381.1988.tb11489.x; KILPATRICK GJ, 1990, N-S ARCH PHARMACOL, V342, P22; KILPATRICK GJ, 1987, NATURE, V330, P746, DOI 10.1038/330746a0; LAMBERT JJ, 1989, BRIT J PHARMACOL, V97, P27, DOI 10.1111/j.1476-5381.1989.tb11920.x; LI YQ, 1990, NEUROSCI LETT, V120, P124, DOI 10.1016/0304-3940(90)90184-B; NEIJT HC, 1988, NEUROPHARMACOLOGY, V27, P301, DOI 10.1016/0028-3908(88)90048-2; NORTH RA, 1989, J PHYSIOL-LONDON, V417, P1; PEROUTKA SJ, 1988, TRENDS NEUROSCI, V11, P496, DOI 10.1016/0166-2236(88)90011-2; PRATT GD, 1989, NEUROPHARMACOLOGY, V28, P1367, DOI 10.1016/0028-3908(89)90012-9; REYNOLDS DJM, 1989, EUR J PHARMACOL, V174, P127, DOI 10.1016/0014-2999(89)90884-4; RICHARDSON BP, 1986, TRENDS NEUROSCI, V9, P424, DOI 10.1016/0166-2236(86)90137-2; RICHARDSON BP, 1985, NATURE, V316, P126, DOI 10.1038/316126a0; SUGITA S, 1991, P NATL ACAD SCI USA, V88, P2608, DOI 10.1073/pnas.88.6.2608; SURPRENANT A, 1988, NEUROSCIENCE, V24, P283, DOI 10.1016/0306-4522(88)90331-4; TYERS MB, 1990, ANN NY ACAD SCI, V600, P194, DOI 10.1111/j.1749-6632.1990.tb16882.x; VANNER S, 1990, BRIT J PHARMACOL, V99, P840, DOI 10.1111/j.1476-5381.1990.tb13017.x; WAEBER C, 1989, NEUROSCIENCE, V31, P393, DOI 10.1016/0306-4522(89)90382-5; WALLIS DI, 1978, NEUROPHARMACOLOGY, V17, P1023, DOI 10.1016/0028-3908(78)90028-X; WONG DT, 1974, LIFE SCI, V15, P471, DOI 10.1016/0024-3205(74)90345-2; YAKEL JL, 1988, NEURON, V1, P615, DOI 10.1016/0896-6273(88)90111-0; YAKEL JL, 1991, J PHYSIOL-LONDON, V436, P293, DOI 10.1113/jphysiol.1991.sp018551; YAKEL JL, 1988, J NEUROSCI, V8, P1273; YANG J, 1990, J GEN PHYSIOL, V96, P1177, DOI 10.1085/jgp.96.6.1177; YANG J, 1991, IN PRESS J PHYSL	37	166	168	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1992	8	1					199	203		10.1016/0896-6273(92)90121-S	http://dx.doi.org/10.1016/0896-6273(92)90121-S			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1346089				2022-12-28	WOS:A1992HB18500018
J	WEST, JW; SCHEUER, T; MAECHLER, L; CATTERALL, WA				WEST, JW; SCHEUER, T; MAECHLER, L; CATTERALL, WA			EFFICIENT EXPRESSION OF RAT-BRAIN TYPE-IIA NA+ CHANNEL ALPHA-SUBUNITS IN A SOMATIC-CELL LINE	NEURON			English	Article							FUNCTIONAL SODIUM-CHANNELS; XENOPUS-OOCYTES; MESSENGER-RNA; GATING PROPERTIES; MAMMALIAN-CELLS; NEURONS; CDNA; TRANSFORMATION; PURIFICATION; INACTIVATION	Type IIA rat brain Na+ channel alpha-subunits were expressed in CHO cells by nuclear microinjection or by transfection using a vector containing both metallothionein and bacteriophage SP6 promoters. Stable cell lines expressing Na+ channels were isolated, and whole-cell Na+ currents of 0.9-14 nA were recorded. The mean level of whole-cell Na+ current (4.5 nA) corresponds to a cell surface density of approximately 2 channels active at the peak of the Na+ current per mu-m2, a density comparable to that observed in the cell bodies of central neurons. The expressed Na+ channels had the voltage dependence, rapid activation and inactivation, and rapid recovery from inactivation characteristic of Na+ channels in brain neurons, bound toxins at neurotoxin receptor sites 1 and 3 with normal properties, and were posttranslationally processed to a normal mature size of 260 kd. Expression of Na+ channel cDNA in CHO cells driven by the metallothionein promoter accurately and efficiently reproduces native Na+ channel properties and provides a method for combined biochemical and physiological analysis of Na+ channel structure and function.			WEST, JW (corresponding author), UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025704, R01NS015751] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-07270] Funding Source: Medline; NINDS NIH HHS [NS-25704, NS-15751] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; CAPECCHI MR, 1980, CELL, V22, P479, DOI 10.1016/0092-8674(80)90358-X; CATTERALL WA, 1976, J BIOL CHEM, V251, P5528; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; GLANVILLE N, 1981, NATURE, V292, P267, DOI 10.1038/292267a0; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GOLDIN AL, 1986, P NATL ACAD SCI USA, V83, P7503, DOI 10.1073/pnas.83.19.7503; GORDON D, 1988, BIOCHEMISTRY-US, V27, P7032, DOI 10.1021/bi00418a054; GORDON DA, 1987, P NATL ACAD SCI USA, V86, P8682; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; Hille B, 1984, IONIC CHANNELS EXCIT; HORN R, 1984, J GEN PHYSIOL, V84, P505, DOI 10.1085/jgp.84.4.505; JOHO RH, 1990, MOL BRAIN RES, V7, P105, DOI 10.1016/0169-328X(90)90087-T; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; KIMITSUKI T, 1990, PFLUG ARCH EUR J PHY, V416, P493, DOI 10.1007/BF00382681; KRAFTE DS, 1988, J NEUROSCI, V8, P2859; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANDEL G, 1988, P NATL ACAD SCI USA, V85, P924, DOI 10.1073/pnas.85.3.924; MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; RITCHIE JM, 1976, J PHYSIOL-LONDON, V261, P477, DOI 10.1113/jphysiol.1976.sp011569; RITCHIE JM, 1977, REV PHYSIOL BIOCH P, V79, P1, DOI 10.1007/BFb0037088; SAH P, 1988, J GEN PHYSIOL, V91, P373, DOI 10.1085/jgp.91.3.373; SCHEINMAN RI, 1989, J BIOL CHEM, V264, P10660; SCHEUER T, 1990, SCIENCE, V247, P854, DOI 10.1126/science.2154850; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; STRICHARTZ G, 1987, ANNU REV NEUROSCI, V10, P237; STUHMER W, 1987, EUR BIOPHYS J BIOPHY, V14, P131, DOI 10.1007/BF00253837; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAECHTER CJ, 1983, J BIOL CHEM, V258, P5117; WANG GK, 1982, MOL PHARMACOL, V23, P519; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9	43	120	122	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1992	8	1					59	70		10.1016/0896-6273(92)90108-P	http://dx.doi.org/10.1016/0896-6273(92)90108-P			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1309650				2022-12-28	WOS:A1992HB18500005
J	CARD, JP; WHEALY, ME; ROBBINS, AK; MOORE, RY; ENQUIST, LW				CARD, JP; WHEALY, ME; ROBBINS, AK; MOORE, RY; ENQUIST, LW			2 ALPHA-HERPESVIRUS STRAINS ARE TRANSPORTED DIFFERENTIALLY IN THE RODENT VISUAL-SYSTEM	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; SIMPLEX VIRUS TYPE-1; HYPOTHALAMIC SUPRACHIASMATIC NUCLEUS; COLI BETA-GALACTOSIDASE; TRANS-NEURONAL TRANSFER; RETINAL GANGLION-CELLS; PSEUDORABIES VIRUS; AXONAL-TRANSPORT; RETINOHYPOTHALAMIC PROJECTION; SYMPATHETIC OUTFLOW	Uptake and transneuronal passage of wild-type and attenuated strains of a swine alpha-herpesvirus (pseudorabies [PRV]) were examined in rat visual projections. Both strains of virus infected subpopulations of retinal ganglion cells and passed transneuronally to infect retino-recipient neurons in the forebrain. However, the location of infected forebrain neurons varied with the strain of virus. Intravitreal injection of wild-type virus produced two temporally separated waves of infection that eventually reached all known retino-recipient regions of the central neuraxis. By contrast, the attenuated strain of PRV selectively infected a functionally distinct subset of retinal ganglion cells with restricted central projections. The data indicate that projection-specific groups of ganglion cells are differentially susceptible to the two strains of virus and suggest that this sensitivity may be receptor mediated.	UNIV PITTSBURGH, DEPT PSYCHIAT, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, DEPT NEUROL, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, DEPT BEHAV SCI, PITTSBURGH, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	CARD, JP (corresponding author), DUPONT MERCK PHARMACEUT CO, VIRAL DIS GRP, WILMINGTON, DE 19880 USA.			Robbins, Alan/0000-0001-8995-0683; Card, John/0000-0002-6148-7364				BAK IJ, 1977, BRAIN RES, V136, P415; Bartha A., 1961, Magyar Allatorvosok Lapja, V16, P42; BECKER CH, 1967, EXPERIENTIA, V23, P209, DOI 10.1007/BF02136291; BREAKEFIELD XO, 1987, MOL NEUROBIOL, V1, P339, DOI 10.1007/BF02935741; CARD JP, 1981, J NEUROSCI, V1, P1289; CARD JP, 1990, J NEUROSCI, V10, P1974; CHIOCCA E A, 1990, New Biologist, V2, P739; DOBSON AT, 1990, NEURON, V5, P353, DOI 10.1016/0896-6273(90)90171-B; DOLIVO M, 1978, BRAIN RES, V140, P111, DOI 10.1016/0006-8993(78)90241-X; EHINGER B, 1987, HDB CHEM NEUROANATOM, V5, P389; FERGUSON IA, 1990, J NEUROSCI, V10, P2176; FIELD HJ, 1975, J GEN VIROL, V26, P145, DOI 10.1099/0022-1317-26-1-145; FULLER AO, 1987, P NATL ACAD SCI USA, V84, P5454, DOI 10.1073/pnas.84.15.5454; GELLER AI, 1990, P NATL ACAD SCI USA, V87, P1149, DOI 10.1073/pnas.87.3.1149; GELLER AI, 1990, P NATL ACAD SCI USA, V87, P8950, DOI 10.1073/pnas.87.22.8950; GELLER AI, 1988, SCIENCE, V241, P1667, DOI 10.1126/science.2843986; HAMPL H, 1984, J VIROL, V52, P583, DOI 10.1128/JVI.52.2.583-590.1984; HO DY, 1988, VIROLOGY, V167, P279, DOI 10.1016/0042-6822(88)90079-7; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; JOHNSON DC, 1990, J VIROL, V64, P2569, DOI 10.1128/JVI.64.6.2569-2576.1990; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; KANER RJ, 1990, SCIENCE, V248, P1410, DOI 10.1126/science.2162560; KRISTENSSON K, 1974, BRAIN RES, V69, P189, DOI 10.1016/0006-8993(74)90001-8; KUCERA P, 1985, J VIROL, V55, P158, DOI 10.1128/JVI.55.1.158-162.1985; KUYPERS HGJM, 1990, TRENDS NEUROSCI, V13, P71, DOI 10.1016/0166-2236(90)90071-H; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; LITTLE SP, 1981, VIROLOGY, V115, P149, DOI 10.1016/0042-6822(81)90097-0; LOMNICZI B, 1984, J VIROL, V52, P198, DOI 10.1128/JVI.52.1.198-205.1984; LOMNICZI B, 1984, J VIROL, V49, P970, DOI 10.1128/JVI.49.3.970-979.1984; LOMNICZI B, 1987, J VIROL, V61, P796, DOI 10.1128/JVI.61.3.796-801.1987; MANSERVIGI R, 1990, J VIROL, V64, P431, DOI 10.1128/JVI.64.1.431-436.1990; MARCHAND CF, 1986, BRAIN RES, V383, P262, DOI 10.1016/0006-8993(86)90024-7; MARGOLIS T, 1987, CURR EYE RES, V6, P119, DOI 10.3109/02713688709020078; MARGOLIS TP, 1989, J VIROL, V63, P4756, DOI 10.1128/JVI.63.11.4756-4761.1989; MARTIN X, 1983, BRAIN RES, V273, P253, DOI 10.1016/0006-8993(83)90850-8; MCLEAN JH, 1989, BRAIN RES BULL, V22, P867, DOI 10.1016/0361-9230(89)90032-4; METTENLEITER TC, 1990, J VIROL, V64, P278, DOI 10.1128/JVI.64.1.278-286.1990; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; NORGREN RB, 1989, BRAIN RES, V479, P374, DOI 10.1016/0006-8993(89)91644-2; Parnavelas J.G., 1989, Handbook of Chemical Neuroanatomy, V7, P1; PETROVSKIS EA, 1986, J VIROL, V60, P1166, DOI 10.1128/JVI.60.3.1166-1169.1986; PICKARD GE, 1982, J COMP NEUROL, V211, P65, DOI 10.1002/cne.902110107; PICKARD GE, 1985, NEUROSCI LETT, V55, P211, DOI 10.1016/0304-3940(85)90022-9; ROBBINS AK, 1989, J VIROL, V63, P250, DOI 10.1128/JVI.63.1.250-258.1989; RODIECK RW, 1979, ANNU REV NEUROSCI, V2, P193, DOI 10.1146/annurev.ne.02.030179.001205; ROIZMAN B, 1990, VIROLOGY 1990, P1795; ROIZMAN B, 1990, VIROLOGY, P1787; ROUILLER EM, 1986, NEUROSCI LETT, V72, P247, DOI 10.1016/0304-3940(86)90521-5; ROUILLER EM, 1989, BRAIN RES, V476, P21, DOI 10.1016/0006-8993(89)91532-1; SARMIENTO M, 1979, J VIROL, V29, P1149, DOI 10.1128/JVI.29.3.1149-1158.1979; STRACK AM, 1990, J NEUROSCI, V10, P2139; STRACK AM, 1989, BRAIN RES, V491, P274, DOI 10.1016/0006-8993(89)90063-2; STRACK AM, 1989, BRAIN RES, V491, P156, DOI 10.1016/0006-8993(89)90098-X; UGOLINI G, 1987, BRAIN RES, V422, P242, DOI 10.1016/0006-8993(87)90931-0; UGOLINI G, 1989, SCIENCE, V243, P89, DOI 10.1126/science.2536188; VAHLNE A, 1980, INFECT IMMUN, V28, P675; VAHLNE A, 1979, J GEN VIROL, V44, P217, DOI 10.1099/0022-1317-44-1-217; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; Wittmann G., 1989, DEV VET VIROL, P230, DOI [DOI 10.1007/978-1-4613-1587-2, DOI 10.1007/978-1-4613-1587-2_7]; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; ZIEGLER RJ, 1981, INFECT IMMUN, V34, P588, DOI 10.1128/IAI.34.2.588-595.1981; ZUCKERMANN F, 1989, J VIROL, V63, P3323, DOI 10.1128/JVI.63.8.3323-3329.1989	63	201	203	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1991	6	6					957	969		10.1016/0896-6273(91)90236-S	http://dx.doi.org/10.1016/0896-6273(91)90236-S			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	1711350				2022-12-28	WOS:A1991FT94900011
J	SIEBERBLUM, M				SIEBERBLUM, M			ROLE OF THE NEUROTROPHIC FACTORS BDNF AND NGF IN THE COMMITMENT OF PLURIPOTENT NEURAL CREST CELLS	NEURON			English	Article							CILIARY GANGLION NEURONS; DORSAL-ROOT GANGLIA; MONOCLONAL-ANTIBODIES; SENSORY NEURONS; CHICK-EMBRYO; BRAIN; LINEAGE; DIFFERENTIATION; SURVIVAL; RECEPTOR	Since trophic factors are increasingly recognized as playing a role in some decision-making steps during development, the influence of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) on the commitment of pluripotent neural crest cells was investigated by in vitro clonal analysis. BDNF caused an increase of up to 21-fold in the number of sensory neuron precursors per colony without a corresponding increase in the total number of cells. By contrast, BDNF treatment caused an equivalent decrease in the number of undifferentiated cells per colony. The data suggest that BDNF, but not NGF, directs pluripotent neural crest cells to differentiate along the primary sensory neuron lineage.			SIEBERBLUM, M (corresponding author), MED COLL WISCONSIN, DEPT ANAT & CELLULAR BIOL, MILWAUKEE, WI 53226 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021423] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21423] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACHESON A, 1987, EXP CELL RES, V170, P56, DOI 10.1016/0014-4827(87)90116-9; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BARALD KF, 1988, J NEUROSCI RES, V21, P107, DOI 10.1002/jnr.490210204; BARALD KF, 1988, J NEUROSCI RES, V21, P119, DOI 10.1002/jnr.490210205; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNSBERGER U, 1988, DEV BIOL, V126, P420, DOI 10.1016/0012-1606(88)90151-0; GIRDLESTONE J, 1985, DEV BIOL, V109, P274, DOI 10.1016/0012-1606(85)90455-5; GODFREY EW, 1986, J NEUROSCI, V6, P2543; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HEUER JG, 1990, DEV BIOL, V137, P287, DOI 10.1016/0012-1606(90)90255-H; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; JOHNSON EM, 1989, BRAIN RES, V478, P166, DOI 10.1016/0006-8993(89)91491-1; KALCHEIM C, 1988, DEV BRAIN RES, V41, P79, DOI 10.1016/0165-3806(88)90171-X; KALCHEIM C, 1986, DEV BIOL, V116, P451, DOI 10.1016/0012-1606(86)90146-6; KALCHEIM C, 1987, EMBO J, V6, P2871, DOI 10.1002/j.1460-2075.1987.tb02589.x; LALLIER TE, 1988, DEV BIOL, V127, P99, DOI 10.1016/0012-1606(88)90192-3; Le Douarin N.M., 1982, NEURAL CREST; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; NODEN DM, 1978, SPECIFICITY EMBRYOLO, P3; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SIEBERBLUM M, 1989, DEV BIOL, V136, P372, DOI 10.1016/0012-1606(89)90263-7; SIEBERBLUM M, 1989, SCIENCE, V243, P1608, DOI 10.1126/science.2564699; SIEBERBLUM M, 1989, DEV BIOL, V134, P362, DOI 10.1016/0012-1606(89)90108-5; SIEBERBLUM M, 1980, DEV BIOL, V80, P96, DOI 10.1016/0012-1606(80)90501-1; SIEBERBLUM M, 1984, DEV BRAIN RES, V14, P241, DOI 10.1016/0165-3806(84)90308-0; SIEBERBLUM M, 1985, CELL CULTURE NEUROSC, P193; SIEBERBLUM M, 1990, DEV BRAIN RES, V1, P225; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; TEILLET MA, 1983, DEV BIOL, V98, P192, DOI 10.1016/0012-1606(83)90349-4; THOENEN H, 1987, CIBA F SYMP, V126, P82; VOGEL KS, 1988, NEURON, V1, P569, DOI 10.1016/0896-6273(88)90106-7; Weston J A, 1970, Adv Morphog, V8, P41	38	173	178	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1991	6	6					949	955		10.1016/0896-6273(91)90235-R	http://dx.doi.org/10.1016/0896-6273(91)90235-R			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	1711349				2022-12-28	WOS:A1991FT94900010
J	HODGKIN, J				HODGKIN, J			SEX DETERMINATION AND THE GENERATION OF SEXUALLY DIMORPHIC NERVOUS SYSTEMS	NEURON			English	Review							NEMATODE CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; C-ELEGANS; GENETIC-CONTROL; CELL LINEAGES; BEHAVIOR; EXPRESSION; COURTSHIP; DIFFERENTIATION; REPTILES				HODGKIN, J (corresponding author), MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND.							ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; BAKER BS, 1989, NATURE, V340, P521, DOI 10.1038/340521a0; BARDIN CW, 1981, SCIENCE, V211, P1285, DOI 10.1126/science.7010603; BASS AH, 1986, J NEUROBIOL, V17, P131, DOI 10.1002/neu.480170303; BEHRINGER RR, 1990, NATURE, V345, P167, DOI 10.1038/345167a0; BELL LR, 1988, CELL, V55, P1037, DOI 10.1016/0092-8674(88)90248-6; BELOTE JM, 1985, CELL, V40, P339, DOI 10.1016/0092-8674(85)90148-5; BELOTE JM, 1987, P NATL ACAD SCI USA, V84, P8026, DOI 10.1073/pnas.84.22.8026; BULL JJ, 1980, Q REV BIOL, V55, P3, DOI 10.1086/411613; BURGOYNE PS, 1988, DEVELOPMENT, V102, P443; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; CHALFIE M, 1988, NENATODE CAENORHABDI; CHAPMAN KB, 1988, DEV BIOL, V126, P195, DOI 10.1016/0012-1606(88)90253-9; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; CLINE TW, 1984, GENETICS, V107, P231; COSTA M, 1988, CELL, V55, P747, DOI 10.1016/0092-8674(88)90131-6; DEEMING DC, 1988, PHILOS T ROY SOC B, V322, P19, DOI 10.1098/rstb.1988.0111; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; FISHMAN RB, 1990, J NEUROBIOL, V21, P694, DOI 10.1002/neu.480210504; GAILEY DA, 1989, GENETICS, V121, P773; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; GURNEY ME, 1981, J NEUROSCI, V1, P658; HARDIE RC, 1986, TRENDS NEUROSCI, V9, P419, DOI 10.1016/0166-2236(86)90136-0; HODGKIN J, 1987, GENE DEV, V1, P731, DOI 10.1101/gad.1.7.731; HODGKIN J, 1990, NATURE, V344, P721, DOI 10.1038/344721a0; HOTTA Y, 1976, P NATL ACAD SCI USA, V73, P4154, DOI 10.1073/pnas.73.11.4154; HUNTER CP, 1990, CELL, V63, P1193, DOI 10.1016/0092-8674(90)90415-B; IMPERATOMCGINLEY J, 1986, TRENDS GENET, V2, P130, DOI 10.1016/0168-9525(86)90202-7; KELLEY DB, 1986, J NEUROBIOL, V17, P231, DOI 10.1002/neu.480170307; KELLEY DB, 1988, ANNU REV NEUROSCI, V11, P225; KENYON C, 1986, CELL, V46, P477, DOI 10.1016/0092-8674(86)90668-9; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; KONISHI M, 1985, NATURE, V315, P145, DOI 10.1038/315145a0; LAWRENCE PA, 1986, CELL, V45, P505, DOI 10.1016/0092-8674(86)90282-5; LI C, 1990, NEURON, V4, P681, DOI 10.1016/0896-6273(90)90195-L; MCKEOWN M, 1988, CELL, V53, P887, DOI 10.1016/S0092-8674(88)90369-8; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PALMER MS, 1989, NATURE, V342, P937, DOI 10.1038/342937a0; RENFREE MB, 1988, PHILOS T ROY SOC B, V322, P41, DOI 10.1098/rstb.1988.0112; SCOTT D, 1988, GENETICS, V119, P639; SHEN MM, 1988, CELL, V54, P1019, DOI 10.1016/0092-8674(88)90117-1; SIEGEL RW, 1984, BEHAV GENET, V14, P383, DOI 10.1007/BF01065442; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; STERNBERG PW, 1982, DEV BIOL, V93, P181, DOI 10.1016/0012-1606(82)90251-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Technau GM, 1984, J NEUROGENET, V1, P113, DOI 10.3109/01677068409107077; THOMAS JH, 1990, CELL, V62, P1041, DOI 10.1016/0092-8674(90)90382-O; TOMPKINS L, 1986, TRENDS GENET, V2, P14, DOI 10.1016/0168-9525(86)90162-9; TRENT C, 1983, GENETICS, V104, P619; Villeneuve A.M., 1990, Advances in Genetics, V27, P117; VILLENEUVE AM, 1990, GENETICS, V124, P91; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WOOD WB, 1985, COLD SPRING HARB SYM, V50, P575, DOI 10.1101/SQB.1985.050.01.070; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	57	13	35	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1991	6	2					177	185		10.1016/0896-6273(91)90354-3	http://dx.doi.org/10.1016/0896-6273(91)90354-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1899579				2022-12-28	WOS:A1991EY70900001
J	COUTURIER, S; BERTRAND, D; MATTER, JM; HERNANDEZ, MC; BERTRAND, S; MILLAR, N; VALERA, S; BARKAS, T; BALLIVET, M				COUTURIER, S; BERTRAND, D; MATTER, JM; HERNANDEZ, MC; BERTRAND, S; MILLAR, N; VALERA, S; BARKAS, T; BALLIVET, M			A NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR SUBUNIT (ALPHA-7) IS DEVELOPMENTALLY REGULATED AND FORMS A HOMOOLIGOMERIC CHANNEL BLOCKED BY ALPHA-BTX	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; BUNGAROTOXIN-BINDING-SITES; IMMUNOHISTOCHEMICAL LOCALIZATION; FUNCTIONAL EXPRESSION; MONOCLONAL-ANTIBODIES; XENOPUS OOCYTES; HIGH-AFFINITY; GENE FAMILY; MUSCLE; BRAIN	cDNA and genomic clones encoding alpha-7, a novel neuronal nicotinic acetylcholine receptor (nAChR) alpha subunit, were isolated and sequenced. The mature alpha-7 protein (479 residues) has moderate homology with all other alpha and non-alpha nAChR subunits and probably assumes the same transmembrane topology. Alpha-7 transcripts transiently accumulate in the developing optic tectum between E5 and E16. They are present in both the deep and the superficial layers of E12 tectum. In Xenopus oo-cytes, the alpha-7 protein assembles into a homo-oligomeric channel responding to acetylcholine and nicotine. The alpha-7 channel desensitizes very rapidly, rectifies strongly above -20 mV, and is blocked by alpha-bungarotoxin. A bacterial fusion protein encompassing residues 124-239 of alpha-7 binds labeled alpha-bungarotoxin. We conclude that alpha-bungarotoxin binding proteins in the vertebrate nervous system can function as nAChRs.	UNIV GENEVA, SCH MED, DEPT PHYSIOL, CH-1211 GENEVA 4, SWITZERLAND; UNIV NEWCASTLE UPON TYNE, DEPT BIOCHEM & GENET, NEWCASTLE UPON TYNE NE1 7RU, TYNE & WEAR, ENGLAND	University of Geneva; Newcastle University - UK	COUTURIER, S (corresponding author), UNIV GENEVA, DEPT BIOCHEM, CH-1211 GENEVA 4, SWITZERLAND.		Hernandez, María/GYU-3543-2022					AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BALLIVET M, 1988, NEURON, V1, P847, DOI 10.1016/0896-6273(88)90132-8; BARKAS T, 1984, BIOCHEM SOC T, V12, P813, DOI 10.1042/bst0120813; BARKAS T, 1988, J BIOL CHEM, V263, P5916; BERTRAND D, 1990, P NATL ACAD SCI USA, V87, P1993, DOI 10.1073/pnas.87.5.1993; BERTRAND D, 1990, IN PRESS METH NEUROS; BOSSY B, 1988, EMBO J, V7, P611, DOI 10.1002/j.1460-2075.1988.tb02854.x; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; BOULTER J, 1990, J BIOL CHEM, V265, P4472; BULLER AL, 1990, MOL PHARMACOL, V37, P423; BUONANNO A, 1989, J BIOL CHEM, V264, P7611; CHIAPPINELLI VA, 1983, BRAIN RES, V277, P9, DOI 10.1016/0006-8993(83)90902-2; CONTITRONCONI BM, 1985, P NATL ACAD SCI USA, V82, P5208, DOI 10.1073/pnas.82.15.5208; COUTURIER S, 1990, IN PRESS J BIOL CHEM; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; FERAMISCO JR, 1982, J BIOL CHEM, V257, P1024; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GOLDMAN D, 1987, CELL, V48, P965, DOI 10.1016/0092-8674(87)90705-7; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOTTI C, 1989, NEUROSCIENCE, V32, P759, DOI 10.1016/0306-4522(89)90296-0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; HAMBURGER V, 1951, J MORPHOL, V48, P4949; HARTMAN DS, 1990, NATURE, V343, P372, DOI 10.1038/343372a0; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; Hunt S.P., 1984, P619; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; KHANDJIAN EW, 1986, MOL BIOL REP, V11, P107, DOI 10.1007/BF00364822; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; LINDSTROM J, 1987, MOL NEUROBIOL, V1, P281, DOI 10.1007/BF02935740; LORING RH, 1988, TRENDS NEUROSCI, V11, P73, DOI 10.1016/0166-2236(88)90168-3; MATTER JM, 1990, EMBO J, V9, P1021, DOI 10.1002/j.1460-2075.1990.tb08205.x; MEEKER RB, 1986, J NEUROSCI, V6, P1866; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; NEF P, 1984, P NATL ACAD SCI-BIOL, V81, P7975, DOI 10.1073/pnas.81.24.7975; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; NODA M, 1983, NATURE, V305, P818, DOI 10.1038/305818a0; PAPKE RL, 1989, NEURON, V3, P589, DOI 10.1016/0896-6273(89)90269-9; POLZTEJERA G, 1975, NATURE, V258, P349, DOI 10.1038/258349a0; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; RAVDIN PM, 1979, P NATL ACAD SCI USA, V76, P2072, DOI 10.1073/pnas.76.4.2072; REINER A, 1982, J COMP NEUROL, V208, P16, DOI 10.1002/cne.902080103; SCHMIDT J, 1988, INT REV NEUROBIOL, V30, P1; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; SORENSON EM, 1989, J COMP NEUROL, V281, P641, DOI 10.1002/cne.902810412; SWANSON LW, 1983, P NATL ACAD SCI-BIOL, V80, P4532, DOI 10.1073/pnas.80.14.4532; SWANSON LW, 1987, J NEUROSCI, V7, P3334; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952; WANG GK, 1978, J BIOL CHEM, V253, P8507; WANG GK, 1976, BRAIN RES, V114, P524, DOI 10.1016/0006-8993(76)90976-8; WHITING P, 1987, P NATL ACAD SCI USA, V84, P595, DOI 10.1073/pnas.84.2.595	54	846	868	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1990	5	6					847	856		10.1016/0896-6273(90)90344-F	http://dx.doi.org/10.1016/0896-6273(90)90344-F			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ381	1702646	Green Published			2022-12-28	WOS:A1990EQ38100012
J	CACERES, A; MAUTINO, J; KOSIK, KS				CACERES, A; MAUTINO, J; KOSIK, KS			SUPPRESSION OF MAP2 IN CULTURED CEREBELLAR MACRONEURONS INHIBITS MINOR NEURITE FORMATION	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; TAU-ANTISENSE OLIGONUCLEOTIDES; HIPPOCAMPAL-NEURONS; SELECTIVE INDUCTION; DEVELOP INVITRO; ACTIN-FILAMENTS; RAT CEREBELLUM; NERVOUS-SYSTEM; PC12 CELLS; GROWTH	We show here that antisense MAP2 oligonucleotides inhibit neurite outgrowth in cultured cerebellar macroneurons. Unlike control neurons, which first extend a lamellipodial veil followed by a consolidation phase during which the cells extend minor neurites, MAP2-suppressed cells persist with lamellipodia and later become rounded. The induction of microtubules containing tyrosinated tubulin, which parallels neurite outgrowth in control neurons, was blocked under antisense conditions. The small but significant increase in acetylated microtubules was not affected. In contrast, the suppression of tau, which selectively blocks axonal elongation, completely prevented the increase of acetylated microtubules, but did not modify the induction of labile microtubules. These results suggest that MAP2 and tau have different functions: the initial establishment of neurites depends upon MAP2, whereas further neurite elongation depends upon tau and microtubule stabilization.	HARVARD UNIV,SCH MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,DEPT MED,DIV NEUROL,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	CACERES, A (corresponding author), INST INVEST MED M&M FERREYRA,CORDOBA,ARGENTINA.				NIA NIH HHS [AG06601] Funding Source: Medline; NINDS NIH HHS [NS29031] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006601] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BERNHARDT R, 1982, J CELL BIOL, V92, P589, DOI 10.1083/jcb.92.2.589; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BERNHARDT R, 1985, J NEUROSCI, V5, P977; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BLACK MM, 1986, J CELL BIOL, V103, P545, DOI 10.1083/jcb.103.2.545; BRION JP, 1988, NEUROSCIENCE, V25, P139, DOI 10.1016/0306-4522(88)90013-9; BRUGG B, 1988, J CELL BIOL, V107, P643, DOI 10.1083/jcb.107.2.643; CACERES A, 1991, J NEUROSCI, V11, P1515; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; CACERES A, 1984, J NEUROSCI, V4, P394; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DINSMORE JH, 1991, CELL, V64, P817, DOI 10.1016/0092-8674(91)90510-6; DOLL T, 1990, NUCLEIC ACIDS RES, V18, P361, DOI 10.1093/nar/18.2.361; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; FERREIRA A, 1987, DEV BRAIN RES, V34, P9, DOI 10.1016/0165-3806(87)90191-X; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; FERREIRA A, 1991, J NEUROSCI, V11, P392; FERREIRA A, 1989, DEV BRAIN RES, V49, P215, DOI 10.1016/0165-3806(89)90023-0; FERREIRA A, 1990, J NEUROSCI, V10, P293; FERREIRA A, 1989, DEV BRAIN RES, V49, P205, DOI 10.1016/0165-3806(89)90022-9; GOLDBERG DJ, 1989, TRENDS NEUROSCI, V12, P503, DOI 10.1016/0166-2236(89)90110-0; GRIFFITH LM, 1982, J BIOL CHEM, V257, P9143; GRIFFITH LM, 1978, J CELL BIOL, V78, P958, DOI 10.1083/jcb.78.3.958; KINDLER S, 1990, NUCLEIC ACIDS RES, V18, P2822, DOI 10.1093/nar/18.9.2822; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; KOSIK KS, 1987, J NEUROSCI, V7, P3142; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; LEE G, 1990, CELL MOTIL CYTOSKEL, V15, P199, DOI 10.1002/cm.970150402; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MIGHELI A, 1988, J NEUROSCI, V8, P1846; MILLER P, 1982, P NATL ACAD SCI-BIOL, V79, P5562, DOI 10.1073/pnas.79.18.5562; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; NISHIDA E, 1981, J BIOCHEM-TOKYO, V90, P575, DOI 10.1093/oxfordjournals.jbchem.a133510; PENG I, 1986, J CELL BIOL, V102, P252, DOI 10.1083/jcb.102.1.252; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; SANDOVAL IV, 1981, J BIOL CHEM, V256, P8795; SATTILARO RF, 1981, J CELL BIOL, V90, P467, DOI 10.1083/jcb.90.2.467; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; SWANSON JA, 1982, CELL, V28, P225, DOI 10.1016/0092-8674(82)90340-3; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; TUCKER RP, 1988, J COMP NEUROL, V271, P44, DOI 10.1002/cne.902710106; VALLEE RB, 1990, CELL MOTIL CYTOSKEL, V15, P204, DOI 10.1002/cm.970150403; WEBSTER DR, 1989, J CELL SCI, V92, P57	47	235	240	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					607	618		10.1016/0896-6273(92)90025-9	http://dx.doi.org/10.1016/0896-6273(92)90025-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1389180				2022-12-28	WOS:A1992JT51600003
J	COLLAZO, D; TAKAHASHI, H; MCKAY, RDG				COLLAZO, D; TAKAHASHI, H; MCKAY, RDG			CELLULAR TARGETS AND TROPHIC FUNCTIONS OF NEUROTROPHIN-3 IN THE DEVELOPING RAT HIPPOCAMPUS	NEURON			English	Article							NERVE GROWTH-FACTOR; CALCIUM-BINDING PROTEIN; FACTOR MESSENGER-RNA; SEPTAL CHOLINERGIC NEURONS; TRK PROTOONCOGENE PRODUCT; TYROSINE KINASE RECEPTOR; AFFINITY NGF RECEPTOR; FACTOR FAMILY; MOLECULAR-CLONING; BIOLOGICAL-ACTIVITY	The expression of the neurotrophins and trk receptors in the hippocampus has directed attention toward their roles in the development and maintenance of this region. We have examined the effects of the neurotrophins NT-3, BDNF, and NGF in cultures of developing rat hippocampal cells by two criteria: rapid induction of c-fos and neurotrophic responses. The selective induction of c-fos mRNA suggests the presence of functional receptors for NT-3 and BDNF, but not NGF, in embryonic hippocampal cultures. The NT-3-responsive cells were localized in pyramidal neurons of areas CA1 through CA3 and dentate granular and hilar cells of postnatal organotypic slices, as detected by c-Fos immunocytochemistry. In addition to immediate early responses, NT-3 caused a 10-fold increase in the number of cells expressing the neuronal antigen calbindin-D28k. This increase was dose dependent, with maximal stimulation at 10 ng/ml. In contrast, BDNF elicited small but significant calbindin responses. These results indicate biological responses to NT-3 in the CNS and suggest roles for for this neurotrophin during hippocampal neurogenesis.	MIT,DEPT BRAIN & COGNIT SCI,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	COLLAZO, D (corresponding author), HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115, USA.							ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; AMARAL DG, 1985, NEUROSCI LETT, V59, P33, DOI 10.1016/0304-3940(85)90211-3; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BAIMBRIDGE KG, 1982, BRAIN RES, V239, P519, DOI 10.1016/0006-8993(82)90526-1; BAIMBRIDGE KG, 1982, BRAIN RES, V245, P223, DOI 10.1016/0006-8993(82)90804-6; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; FRIEDMAN WJ, 1991, J NEUROSCI, V11, P1577; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078; IP NY, 1991, J NEUROSCI, V11, P3124; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LYNCH G, 1986, SYNAPSES CIRCUITS BE, P122; MADL JE, 1986, J HISTOCHEM CYTOCHEM, V34, P317, DOI 10.1177/34.3.2419390; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MARAGOS WF, 1987, TRENDS NEUROSCI, V10, P65, DOI 10.1016/0166-2236(87)90025-7; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; PATTERSON PH, 1978, ANNU REV NEUROSCI, V1, P1, DOI 10.1146/annurev.ne.01.030178.000245; PERSECHINI A, 1989, TRENDS NEUROSCI, V12, P462, DOI 10.1016/0166-2236(89)90097-0; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; PURVES D, 1988, BODY BRAIN TROPHIC T, P123; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCHARFMAN HE, 1989, SCIENCE, V246, P257, DOI 10.1126/science.2508225; SCHEIBEL ME, 1974, EPILEPSIA, V15, P55, DOI 10.1111/j.1528-1157.1974.tb03997.x; SEGAL RA, 1993, IN PRESS NEURON; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; SQUINTO SP, 1990, NEURON, V5, P757, DOI 10.1016/0896-6273(90)90334-C; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P817; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WHITTEMORE SR, 1986, P NATL ACAD SCI USA, V83, P817, DOI 10.1073/pnas.83.3.817; Witter MP, 1989, HIPPOCAMPUS NEW VIST, P53; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZIMMER J, 1984, J COMP NEUROL, V228, P432, DOI 10.1002/cne.902280310	88	213	218	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					643	656		10.1016/0896-6273(92)90028-C	http://dx.doi.org/10.1016/0896-6273(92)90028-C			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1389181				2022-12-28	WOS:A1992JT51600006
J	HUANG, CF; TONG, J; SCHMIDT, J				HUANG, CF; TONG, J; SCHMIDT, J			PROTEIN-KINASE-C COUPLES MEMBRANE EXCITATION TO ACETYLCHOLINE-RECEPTOR GENE INACTIVATION IN CHICK SKELETAL-MUSCLE	NEURON			English	Article							ALPHA-SUBUNIT GENE; ELECTRICAL-ACTIVITY; PHORBOL ESTERS; MESSENGER-RNAS; BETA-TUBULIN; EXPRESSION; INNERVATION; SENSITIVITY; STIMULATION; NUCLEOTIDE	The signaling pathway connecting membrane depolarization and gene activity in skeletal muscle remains largely unknown. Using transcription elongation (run-on) analysis we have found that electrical stimulation of denervated chick skeletal muscle in vivo rapidly and selectively results in inactivation of acetylcholine receptor (AChR) subunit genes. We have studied the possible involvement of protein kinase C (PKC) in this response and have observed that electrical stimulation increases the activity of PKC in the nucleus by over two orders of magnitude within 10 min; phorbol esters, within minutes after intramuscular application, block AChR subunit genes in the absence of electrical activity; and the activity-triggered gene inactivation is blocked by the protein kinase inhibitor staurosporine or by enzyme depletion resulting from chronic pretreatment of muscle with phorbol esters. We conclude that PKC is an integral component of the pathway coupling membrane excitation and AChR gene control.			HUANG, CF (corresponding author), SUNY STONY BROOK,DEPT BIOCHEM & CELL BIOL,STONY BROOK,NY 11794, USA.				NINDS NIH HHS [NS20233] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020233] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AXELSSON J, 1959, J PHYSIOL-LONDON, V147, P1789; BURSZTAJN S, 1988, BIOL CELL, V63, P57, DOI 10.1016/0248-4900(88)90108-6; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; DRACHMAN DB, 1972, SCIENCE, V176, P514, DOI 10.1126/science.176.4034.514; DUCLERT A, 1990, P NATL ACAD SCI USA, V87, P1391, DOI 10.1073/pnas.87.4.1391; DUCLERT A, 1991, NEUROREPORT, V2, P25, DOI 10.1097/00001756-199101000-00006; EFTIMIE R, 1991, P NATL ACAD SCI USA, V88, P1349, DOI 10.1073/pnas.88.4.1349; FAMBROUGH DM, 1970, SCIENCE, V168, P372, DOI 10.1126/science.168.3929.372; FIELDS AP, 1988, J BIOL CHEM, V263, P8253; GOLDMAN D, 1988, NEURON, V1, P329, DOI 10.1016/0896-6273(88)90081-5; GOODING C, 1987, NUCLEIC ACIDS RES, V15, P8105, DOI 10.1093/nar/15.19.8105; HALL ZW, 1975, NATURE, V268, P655; HEILMANN C, 1979, EUR J BIOCHEM, V93, P437, DOI 10.1111/j.1432-1033.1979.tb12841.x; JOLESZ F, 1981, ANNU REV PHYSIOL, V43, P531, DOI 10.1146/annurev.ph.43.030181.002531; KANG JJ, 1991, ARCH BIOCHEM BIOPHYS, V290, P214, DOI 10.1016/0003-9861(91)90611-L; KLARSFELD A, 1989, NEURON, V2, P1229, DOI 10.1016/0896-6273(89)90307-3; LOMO T, 1975, J PHYSIOL-LONDON, V252, P603, DOI 10.1113/jphysiol.1975.sp011161; MCARDLE CA, 1989, NEUROENDOCRINE PEPTI, P349; MOLDERS H, 1987, ONCOGENE, V1, P377; NAKANO H, 1984, P NATL ACAD SCI-BIOL, V81, P71, DOI 10.1073/pnas.81.1.71; NEVILLE C, 1991, NEUROREPORT, V2, P655, DOI 10.1097/00001756-199111000-00005; NEVILLE CM, 1992, IN PRESS CELL MOL NE; NIEDEL JE, 1986, PHOSPHOINOSITIDES RE, V7, P47; PETTE D, 1976, PFLUG ARCH EUR J PHY, V364, P103, DOI 10.1007/BF00585177; PEZZEMENTI L, 1981, J BIOL CHEM, V256, P2651; Sambrook J, 1989, MOL CLONING LABORATO; SHAINBERG A, 1976, NATURE, V264, P368, DOI 10.1038/264368a0; SHIEH BH, 1988, NEUROSCIENCE, V24, P175, DOI 10.1016/0306-4522(88)90321-1; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; TSAY HJ, 1990, FEBS LETT, V274, P69, DOI 10.1016/0014-5793(90)81331-H; TSAY HJ, 1989, J CELL BIOL, V108, P1523, DOI 10.1083/jcb.108.4.1523; VALENZUELA P, 1981, NATURE, V289, P650, DOI 10.1038/289650a0; WAKADE TD, 1991, J BIOL CHEM, V266, P6424; WANG Y, 1988, NEURON, V1, P527, DOI 10.1016/0896-6273(88)90183-3; ZHU YY, 1991, J CELL BIOL, V115, P745, DOI 10.1083/jcb.115.3.745	36	79	85	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					671	678		10.1016/0896-6273(92)90030-H	http://dx.doi.org/10.1016/0896-6273(92)90030-H			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1389182				2022-12-28	WOS:A1992JT51600008
J	ADELMAN, JP; SHEN, KZ; KAVANAUGH, MP; WARREN, RA; WU, YN; LAGRUTTA, A; BOND, CT; NORTH, RA				ADELMAN, JP; SHEN, KZ; KAVANAUGH, MP; WARREN, RA; WU, YN; LAGRUTTA, A; BOND, CT; NORTH, RA			CALCIUM-ACTIVATED POTASSIUM CHANNELS EXPRESSED FROM CLONED COMPLEMENTARY DNAS	NEURON			English	Article							K+-CHANNEL; XENOPUS-OOCYTES; PROTEIN-KINASE; ION CHANNELS; RAT-BRAIN; SHAKER LOCUS; TEA BLOCKADE; DROSOPHILA; CURRENTS; NEURONS	Calcium-activated potassium channels were expressed in Xenopus oocytes by injection of RNA transcribed in vitro from complementary DNAs derived from the slo locus of Drosophila melanogaster. Many cDNAs were found that encode closely related proteins of about 1200 aa. The predicted sequences of these proteins differ by the substitution of blocks of amino acids at five identified positions within the putative intracellular region between residues 327 and 797. Excised inside-out membrane patches showed potassium channel openings only with micromolar calcium present at the cytoplasmic side; activity increased steeply both with depolarization and with increasing calcium concentration. The single-channel conductance was 126 pS with symmetrical potassium concentrations. The mean open time of the channels was clearly different for channels having different subsituent blocks of amino acids. The results suggest that alternative splicing gives rise to a large family of functionally diverse, calcium-activated potassium channels.			ADELMAN, JP (corresponding author), OREGON HLTH SCI UNIV, VOLLUM INST, PORTLAND, OR 97201 USA.		North, Richard/GQA-6156-2022					ADAMS PR, 1982, NATURE, V296, P746, DOI 10.1038/296746a0; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BLATZ AL, 1987, TRENDS NEUROSCI, V10, P463, DOI 10.1016/0166-2236(87)90101-9; BOND CT, 1991, MOL ENDOCRINOL, V5, P931, DOI 10.1210/mend-5-7-931; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; DASWSON RMC, 1969, DATA BIOCH RES; DERKACH V, 1989, NATURE, V339, P706, DOI 10.1038/339706a0; DURELL SR, 1992, IN PRESS BIOPHYS J; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; Ewald D, 1987, NEUROMODULATION BIOC, P138; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; GARDOS G, 1958, BIOCHIM BIOPHYS ACTA, V30, P653, DOI 10.1016/0006-3002(58)90124-0; GHO M, 1986, PFLUG ARCH EUR J PHY, V407, P526, DOI 10.1007/BF00657511; GORMAN ALF, 1979, J PHYSIOL-LONDON, V296, P393, DOI 10.1113/jphysiol.1979.sp013012; GORMAN ALF, 1978, J PHYSIOL-LONDON, V275, P357, DOI 10.1113/jphysiol.1978.sp012194; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HAYLETT DG, 1990, POTASSIUM CHANNELS S, P70; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; JENKINSON DH, 1983, CELL CALCIUM, V4, P429, DOI 10.1016/0143-4160(83)90019-2; KAMPS MP, 1984, NATURE, V310, P589, DOI 10.1038/310589a0; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; KOMATSU A, 1990, NEURON, V4, P313, DOI 10.1016/0896-6273(90)90105-O; KRNJEVIC K, 1972, J PHYSIOL-LONDON, V225, P363, DOI 10.1113/jphysiol.1972.sp009945; KUME H, 1989, NATURE, V341, P152, DOI 10.1038/341152a0; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MARTY A, 1989, TRENDS NEUROSCI, V12, P420, DOI 10.1016/0166-2236(89)90090-8; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MARTY A, 1974, TRENDS NEUROSCI, V237, P256; MEECH RW, 1974, J PHYSIOL-LONDON, V237, P259, DOI 10.1113/jphysiol.1974.sp010481; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; REINHART PH, 1991, J NEUROSCI, V11, P1627; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SAITO M, 1991, J NEUROSCI, V11, P2135; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SHEN KZ, 1992, J PHYSIOL-LONDON, V445, P581, DOI 10.1113/jphysiol.1992.sp018941; SINGH S, 1989, NEURON, V2, P1325, DOI 10.1016/0896-6273(89)90070-6; SMITH SJ, 1987, J PHYSIOL-LONDON, V382, P425, DOI 10.1113/jphysiol.1987.sp016376; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1984, J GEN PHYSIOL, V84, P157, DOI 10.1085/jgp.84.2.157; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	56	443	450	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1992	9	2					209	216		10.1016/0896-6273(92)90160-F	http://dx.doi.org/10.1016/0896-6273(92)90160-F			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1497890				2022-12-28	WOS:A1992JJ33200003
J	GLASGOW, E; DRUGER, RK; LEVINE, EM; FUCHS, C; SCHECHTER, N				GLASGOW, E; DRUGER, RK; LEVINE, EM; FUCHS, C; SCHECHTER, N			PLASTICIN, A NOVEL TYPE-III NEUROFILAMENT PROTEIN FROM GOLDFISH RETINA - INCREASED EXPRESSION DURING OPTIC-NERVE REGENERATION	NEURON			English	Article							INTERMEDIATE FILAMENT PROTEIN; MESSENGER-RNA; MOUSE EMBRYO; SPINAL-CORD; RAT EMBRYO; CELLS; GENE; PERIPHERIN; VIMENTIN; SYSTEM	The goldfish visual pathway displays a remarkable capacity for continued development and plasticity. The intermediate filament proteins in this pathway are unexpected and atypical, suggesting these proteins provide a structure that supports growth and plasticity. Using a goldfish retina lambda-gt10 library, we have isolated a full-length cDNA clone that encodes a novel type III intermediate filament protein. The mRNA for this protein is located in retinal ganglion cells, and its level dramatically increases during optic nerve regeneration. The protein is transported into the optic nerve within the slow phase of axonal transport. We have named this protein plasticin because it was isolated from a neuronal pathway well known for its plasticity.	SUNY STONY BROOK,HLTH SCI CTR,DEPT PSYCHIAT & BEHAV SCI,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	GLASGOW, E (corresponding author), SUNY STONY BROOK,HLTH SCI CTR,DEPT BIOCHEM & CELL BIOL,STONY BROOK,NY 11794, USA.		Levine, Edward/N-3878-2015	Levine, Edward/0000-0003-1725-2805; Glasgow, Eric/0000-0001-7729-3954	NEI NIH HHS [EY05212] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENOWITZ LI, 1983, J NEUROSCI, V3, P2153; BIGNAMI A, 1982, DEV BIOL, V91, P286, DOI 10.1016/0012-1606(82)90035-5; CARDEN MJ, 1987, J NEUROSCI, V7, P3489; CHIU FC, 1989, NEURON, V2, P1435, DOI 10.1016/0896-6273(89)90189-X; COCHARD P, 1984, J NEUROSCI, V4, P2080; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EASTER SS, 1984, J NEUROSCI, V4, P1052; FLIEGNER KH, 1991, INT REV CYTOL, V131, P109, DOI 10.1016/S0074-7696(08)62018-5; GIORDANO S, 1989, NEURON, V2, P1507, DOI 10.1016/0896-6273(89)90197-9; GIORDANO S, 1990, DIFFERENTIATION, V44, P163, DOI 10.1111/j.1432-0436.1990.tb00614.x; GOLDMAN RD, 1990, CELLULAR MOL BIOL IN; GORHAM JD, 1990, DEV BRAIN RES, V57, P235, DOI 10.1016/0165-3806(90)90049-5; HALL CM, 1990, J NEUROCHEM, V55, P1671, DOI 10.1111/j.1471-4159.1990.tb04955.x; HEACOCK AM, 1976, P NATL ACAD SCI USA, V73, P828, DOI 10.1073/pnas.73.3.828; JACKSON BW, 1981, DIFFERENTIATION, V20, P203, DOI 10.1111/j.1432-0436.1981.tb01177.x; JOHNS PR, 1977, J COMP NEUROL, V176, P331, DOI 10.1002/cne.901760303; JONES P S, 1986, Journal of Histotechnology, V9, P181; JONES PS, 1986, J NEUROCHEM, V47, P1226; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; KLYMKOWSKY MW, 1989, CELL MOTIL CYTOSKEL, V14, P309, DOI 10.1002/cm.970140302; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEONARD DGB, 1988, J CELL BIOL, V106, P181, DOI 10.1083/jcb.106.1.181; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MEYER RL, 1978, EXP NEUROL, V59, P99, DOI 10.1016/0014-4886(78)90204-2; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OSBORN M, 1986, TRENDS BIOCHEM SCI, V11, P469, DOI 10.1016/0968-0004(86)90249-5; PARYSEK LM, 1988, NEURON, V1, P395, DOI 10.1016/0896-6273(88)90189-4; PERRY GW, 1987, J NEUROSCI, V7, P792; QUAX W, 1985, CELL, V43, P327, DOI 10.1016/0092-8674(85)90038-8; QUAX W, 1983, CELL, V35, P215, DOI 10.1016/0092-8674(83)90224-6; QUITSCHKE W, 1985, J NEUROCHEM, V44, P1465, DOI 10.1111/j.1471-4159.1985.tb08784.x; QUITSCHKE W, 1983, BRAIN RES, V2581, P6947; SAMBROOK J, 1989, MOL CLONING LABOARAT; SHAW G, 1983, EUR J CELL BIOL, V30, P219; SKALLI O, 1991, CELL MOTIL CYTOSKEL, V19, P67, DOI 10.1002/cm.970190202; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STEINERT PM, 1990, CELL, V60, P521, DOI 10.1016/0092-8674(90)90651-T; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; STERNINI C, 1989, GASTROENTEROLOGY, V97, P348, DOI 10.1016/0016-5085(89)90070-X; TAPSCOTT SJ, 1981, DEV BIOL, V86, P40, DOI 10.1016/0012-1606(81)90313-4; THOMPSON MA, 1989, NEURON, V2, P1043, DOI 10.1016/0896-6273(89)90228-6; TROY CM, 1990, NEUROSCIENCE, V36, P217, DOI 10.1016/0306-4522(90)90364-A; VIKSTROM KL, 1989, P NATL ACAD SCI USA, V86, P549, DOI 10.1073/pnas.86.2.549	45	50	52	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					373	381		10.1016/0896-6273(92)90175-D	http://dx.doi.org/10.1016/0896-6273(92)90175-D			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1379821				2022-12-28	WOS:A1992JJ33200018
J	PARK, CS; MILLER, C				PARK, CS; MILLER, C			INTERACTION OF CHARYBDOTOXIN WITH PERMEANT IONS INSIDE THE PORE OF A K+ CHANNEL	NEURON			English	Article							HIGH-CONDUCTANCE; SCORPION TOXINS; BLOCK	Charybdotoxin (CTX) blocks high conductance Ca2+-activated K+ channels by binding to a receptor site in the externally facing "mouth." Toxin bound to the channel can be destabilized from its site by K+ entering the channel from the opposite, internal, solution. By analyzing point mutants of CTX expressed in E. coli, assayed with single Ca2+-activated K+ channels reconstituted into planar lipid bilayers, we show that a single positively charged residue of the peptide, Lys-27, wholly mediates this interaction of K+ with CTX. If position 27 carries a positively charged residue, internal K+ accelerates the dissociation rate of CTX in a voltage-dependent manner; however, if a neutral Asn or Gln is substituted at this position, the dissociation rate is completely insensitive to either internal K+ or applied voltage. Position 27 is unique in this respect; charge-neutral substitutions made at other positions fail to eliminate the K+ destabilization phenomenon. The results argue that CTX bound to the channel positions Lys-27 physically close to a K+-specific binding site on the external end of the conduction pathway and that a K+ ion occupying this site destabilizes CTX via direct electrostatic repulsion with the epsilon-amino group of Lys-27.			PARK, CS (corresponding author), BRANDEIS UNIV,HOWARD HUGHES MED INST,GRAD DEPT BIOCHEM,WALTHAM,MA 02254, USA.			Park, Chul-Seung/0000-0003-0209-1412	NIGMS NIH HHS [GM-31768] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031768, R01GM031768] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; BONTEMS F, 1991, EUR J BIOCHEM, V196, P19, DOI 10.1111/j.1432-1033.1991.tb15780.x; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; BONTEMS F, 1992, IN PRESS BIOCHEMISTR; GOLDSTEIN SAN, 1992, BIOPHYS J, V62, P5, DOI 10.1016/S0006-3495(92)81760-5; Hille B., 1991, IONIC CHANNELS EXCIT; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; PARK CS, 1992, IN PRESS BIOCHEMISTR; STAMPE P, 1992, BIOPHYS J, V62, P8, DOI 10.1016/S0006-3495(92)81761-7	12	170	174	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					307	313		10.1016/0896-6273(92)90169-E	http://dx.doi.org/10.1016/0896-6273(92)90169-E			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1379820				2022-12-28	WOS:A1992JJ33200012
J	CHRISTIE, BR; ABRAHAM, WC				CHRISTIE, BR; ABRAHAM, WC			PRIMING OF ASSOCIATIVE LONG-TERM DEPRESSION IN THE DENTATE GYRUS BY THETA FREQUENCY SYNAPTIC ACTIVITY	NEURON			English	Article							POTENTIATION; HIPPOCAMPUS; SYNAPSES; STIMULATION; MEMORY	Associative long-term synaptic depression (LTD) was investigated utilizing negatively correlated activity patterns in the medial and lateral perforant path inputs to the dentate gyrus in anesthetized rats. Normally only nonassociative, or heterosynaptic, LTD is elicited in naive pathways. We report here, however, that associative LTD in the lateral path is readily induced after being "primed" by a brief period of lateral path synaptic activity at a theta-rhythm frequency (5 Hz). Priming of associative LTD lasts at least 2 hr and is not seen following priming activity at non-theta frequencies (1 and 15 Hz). N-methyl-D-aspartate receptor activation is critical for establishing the priming effect, but not for the subsequent induction of the associative LTD. These data suggest that theta-rhythm activity in the dentate gyrus may predispose the system to a specific form of synaptic plasticity, associative LTD.	UNIV OTAGO,NEUROSCI RES CTR,DUNEDIN,NEW ZEALAND	University of Otago	CHRISTIE, BR (corresponding author), UNIV OTAGO,DEPT PSYCHOL,DUNEDIN,NEW ZEALAND.		Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160				ABRAHAM WC, 1991, BRAIN RES, V546, P336, DOI 10.1016/0006-8993(91)91498-P; ABRAHAM WC, 1984, BRAIN RES, V303, P251, DOI 10.1016/0006-8993(84)91211-3; ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BERRY SD, 1979, SCIENCE, V205, P209, DOI 10.1126/science.451592; BERRY SD, 1978, SCIENCE, V200, P1298, DOI 10.1126/science.663612; BLAND BH, 1986, PROG NEUROBIOL, V26, P199; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; BUSZAKI G, 1991, MEMORY MECHANISMS, P79; CHATTARJI S, 1989, BRAIN RES, V495, P145, DOI 10.1016/0006-8993(89)91228-6; CHRISTIE BR, 1992, SYNAPSE, V10, P1, DOI 10.1002/syn.890100102; DESMOND NL, 1991, BRAIN RES, V552, P93, DOI 10.1016/0006-8993(91)90664-H; EAST SJ, 1991, NEUROSCI LETT, V123, P17, DOI 10.1016/0304-3940(91)90147-L; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HASHEMZADEHGARGARI H, 1991, NEUROSCI LETT, V126, P37, DOI 10.1016/0304-3940(91)90365-Z; HEBB DO, 1949, ORG BEHAVIOR; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; Kohonen T, 1984, SELF ORG ASS MEMORY; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; MCNAUGHTON BL, 1977, J COMP NEUROL, V175, P439, DOI 10.1002/cne.901750404; MCNAUGHTON N, 1991, MEMORY MECHANISMS TR, P129; Sejnowski T.J., 1989, NEURAL MODELS PLASTI, P94; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; STANTON PK, 1991, NEUROSCI LETT, V127, P61, DOI 10.1016/0304-3940(91)90895-Z; WICKENS JR, 1991, NEUROSCI LETT, V130, P128, DOI 10.1016/0304-3940(91)90244-N; WIGSTROM H, 1986, ACTA PHYSIOL SCAND, V126, P317, DOI 10.1111/j.1748-1716.1986.tb07822.x	30	165	167	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					79	84		10.1016/0896-6273(92)90222-Y	http://dx.doi.org/10.1016/0896-6273(92)90222-Y			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1321647				2022-12-28	WOS:A1992JE75600008
J	TRAVIS, GH; GROSHAN, KR; LLOYD, M; BOK, D				TRAVIS, GH; GROSHAN, KR; LLOYD, M; BOK, D			COMPLETE RESCUE OF PHOTORECEPTOR DYSPLASIA AND DEGENERATION IN TRANSGENIC RETINAL DEGENERATION SLOW (RDS) MICE	NEURON			English	Article							MUTANT MICE; MOUSE; OPSIN; GENE; LOCALIZATION; IDENTIFICATION; FRAGMENTS; MUTATION; CDNA; RNA	retinal degeneration slow (rds) is a semidominant mutation of mice with the phenotype of abnormal development of rod and cone photoreceptors, followed by their slow degeneration. The rds gene has been putatively cloned and its novel protein product initially characterized biochemically. In the present study we undertook to correct in vivo the retinal phenotype of mice with the rds mutation. We assembled a transgene containing a regulatory segment of the opsin gene positioned upstream of the wild-type rds coding region. Mice from three transgenic lines, homozygous for the rds mutation, were analyzed for expression of the transgene and for their retinal phenotypes. In two high expressing lines, we observed complete reversion to wild-type retinal morphology. In a third, low expressing line, we observed a retinal phenotype intermediate between wild type and rds/rds, suggesting partial rescue of the mutation. These results constitute formal proof that we have cloned the rds gene.	JULES STEIN EYE INST,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT ANAT & CELL BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	TRAVIS, GH (corresponding author), UNIV TEXAS,SW MED CTR,DEPT PSYCHIAT,DALLAS,TX 75235, USA.		Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493				ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; BAEHR W, 1988, FEBS LETT, V238, P253, DOI 10.1016/0014-5793(88)80490-3; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; COHEN AI, 1983, INVEST OPHTH VIS SCI, V24, P832; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; HOGAN B, 1986, MANIPULATING MOUSE E, P153; JANSEN HG, 1984, J COMP NEUROL, V224, P71, DOI 10.1002/cne.902240107; JANSEN HG, 1987, EXP EYE RES, V44, P347, DOI 10.1016/S0014-4835(87)80170-7; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; NIR I, 1986, INVEST OPHTH VIS SCI, V27, P836; REUTER JH, 1984, NEUROSCI LETT, V46, P231; RUTHER U, 1983, EMBO J, V2, P1791, DOI 10.1002/j.1460-2075.1983.tb01659.x; SANYAL S, 1987, DEGENERATIVE RETINAL, P175; SUBRAMANI S, 1983, ANAL BIOCHEM, V135, P1, DOI 10.1016/0003-2697(83)90723-6; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TRAVIS GH, 1991, GENOMICS, V10, P733, DOI 10.1016/0888-7543(91)90457-P; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; USUKURA J, 1987, EXP EYE RES, V45, P501, DOI 10.1016/S0014-4835(87)80061-1; VANNIE R, 1978, TISSUE ANTIGENS, V12, P106, DOI 10.1111/j.1399-0039.1978.tb01305.x; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4	26	106	110	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					113	119		10.1016/0896-6273(92)90226-4	http://dx.doi.org/10.1016/0896-6273(92)90226-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1385966				2022-12-28	WOS:A1992JE75600012
J	FERNS, M; HOCH, W; CAMPANELLI, JT; RUPP, F; HALL, ZW; SCHELLER, RH				FERNS, M; HOCH, W; CAMPANELLI, JT; RUPP, F; HALL, ZW; SCHELLER, RH			RNA SPLICING REGULATES AGRIN-MEDIATED ACETYLCHOLINE-RECEPTOR CLUSTERING ACTIVITY ON CULTURED MYOTUBES	NEURON			English	Article							TORPEDO ELECTRIC ORGAN; GENE-RELATED PEPTIDE; HEPARAN-SULFATE; MOTOR NEURONS; MUSCLE-CELLS; COMPONENTS; MOLECULES; ACCUMULATION; AGGREGATION; PROTEIN	Agrin is a component of the synaptic basal lamina that induces the clustering of acetylcholine receptors (AChRs) on muscle fibers. A region near the carboxyl terminus of the protein exists in four forms that are generated by alternative RNA splicing. All four alternatively spliced forms of agrin are active in inducing AChR clusters on rat primary and C2-derived muscle fibers. In contrast, only two forms of the protein, each containing an 8 amino acid insert, are capable of inducing clusters on myotubes of S27 cells, a C2 variant that has defective proteoglycans. These two forms are also most active in inducing clusters on chick myotubes. This pattern of differential activity suggests that RNA splicing of agrin transcripts and interactions with proteoglycans or other components of basal lamina have important roles in regulating the localization of neurotransmitter receptors at synaptic sites.	STANFORD UNIV,HOWARD HUGHES MED INST,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University	FERNS, M (corresponding author), UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PHYSIOL,SAN FRANCISCO,CA 94143, USA.			Ferns, Michael/0000-0002-1545-3024	NIGMS NIH HHS [GM07276] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; DENNIS MJ, 1981, ANNU REV NEUROSCI, V4, P43, DOI 10.1146/annurev.ne.04.030181.000355; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FONTAINE B, 1987, J CELL BIOL, V105, P1337, DOI 10.1083/jcb.105.3.1337; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; GODFREY EW, 1991, EXP CELL RES, V195, P99, DOI 10.1016/0014-4827(91)90504-N; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; GODON H, 1992, IN PESS P NATL ACAD; GORDON H, 1989, DEV BIOL, V135, P1, DOI 10.1016/0012-1606(89)90152-8; GU Y, 1990, NEURON, V5, P147, DOI 10.1016/0896-6273(90)90305-Y; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; HIRANO Y, 1989, J NEUROSCI, V9, P1555; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; MAGILLSOLC C, 1990, J EXP BIOL, V153, P1; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; NEW HV, 1986, NATURE, V323, P809, DOI 10.1038/323809a0; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PENG HB, 1991, NEURON, V6, P237; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; RUPP F, 1992, IN PRESS J NEUROSCI; SCHUETZE SM, 1987, ANNU REV NEUROSCI, V10, P403, DOI 10.1146/annurev.ne.10.030187.002155; USDIN TB, 1986, J CELL BIOL, V103, P493, DOI 10.1083/jcb.103.2.493; WALLACE BG, 1990, J NEUROSCI, V10, P3576; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1989, J NEUROSCI, V9, P1294; WALLACE BG, 1986, J CELL BIOL, V102, P783, DOI 10.1083/jcb.102.3.783; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	37	197	199	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1079	1086		10.1016/0896-6273(92)90129-2	http://dx.doi.org/10.1016/0896-6273(92)90129-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1319184				2022-12-28	WOS:A1992JA42900008
J	ARAMORI, I; NAKANISHI, S				ARAMORI, I; NAKANISHI, S			SIGNAL TRANSDUCTION AND PHARMACOLOGICAL CHARACTERISTICS OF A METABOTROPIC GLUTAMATE RECEPTOR, MGLUR1, IN TRANSFECTED CHO CELLS	NEURON			English	Article							AMINO-ACID RECEPTORS; INOSITOL PHOSPHOLIPID-METABOLISM; PROTEIN KINASE-C; PHOSPHOINOSITIDE HYDROLYSIS; RAT HIPPOCAMPUS; QUISQUALATE RECEPTORS; STRIATAL NEURONS; XENOPUS OOCYTES; PHORBOL ESTERS; ANTAGONIST	The signal transduction and pharmacological properties of a metabotropic glutamate receptor, mGluR1, were studied in CHO cells permanently expressing the cloned receptor. mGluR1 stimulated phosphatidylinositol (PI) hydrolysis in the potency rank order of quisqualate > L-glutamate greater-than-or-equal-to ibotenate > L-homocysteine sulfinate greater-than-or-equal-to trans-ACPD. This receptor also evoked the stimulation of cAMP formation and arachidonic acid release with comparable agonist potencies. DL-AP3 and L-AP4, the effective antagonists reported for glutamate-stimulated PI hydrolysis in brain slices, showed no appreciable effects on mGluR1, suggesting the existence of an additional subtype of this receptor family. Pertussis toxin and phorbol ester produced distinct effects on the three transduction cascades, implying that mGluR1 independently links to the multiple transduction pathways probably through different G proteins.			ARAMORI, I (corresponding author), KYOTO UNIV,FAC MED,INST IMMUNOL,KYOTO 606,JAPAN.							AKAIKE N, 1987, NEUROSCI LETT, V79, P326, DOI 10.1016/0304-3940(87)90453-8; ASHKENAZI A, 1989, CELL, V56, P487, DOI 10.1016/0092-8674(89)90251-1; BASKYS A, 1991, EUR J PHARMACOL, V193, P131, DOI 10.1016/0014-2999(91)90213-A; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BLAKE JF, 1989, BRIT J PHARMACOL, V97, P71, DOI 10.1111/j.1476-5381.1989.tb11925.x; BONNER TI, 1989, TRENDS NEUROSCI, V12, P148, DOI 10.1016/0166-2236(89)90054-4; CANONICO PL, 1988, J NEUROCHEM, V51, P1049, DOI 10.1111/j.1471-4159.1988.tb03067.x; CHARPAK S, 1990, NATURE, V347, P765, DOI 10.1038/347765a0; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; DESAI MA, 1990, NEUROSCI LETT, V109, P157, DOI 10.1016/0304-3940(90)90555-N; DUMUIS A, 1990, NATURE, V347, P182, DOI 10.1038/347182a0; FELDER CC, 1989, J BIOL CHEM, V264, P20356; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRIMWOOD S, 1991, BRIT J PHARMACOL, V103, P1385, DOI 10.1111/j.1476-5381.1991.tb09799.x; GUPTA SK, 1990, SCIENCE, V249, P662, DOI 10.1126/science.2166341; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; ITO S, 1991, J NEUROCHEM, V56, P531, DOI 10.1111/j.1471-4159.1991.tb08182.x; KANTERMAN RY, 1991, MOL PHARMACOL, V39, P364; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; LIGGETT SB, 1991, J BIOL CHEM, V266, P4816; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; MANZONI OJJ, 1990, NEUROSCI LETT, V109, P146, DOI 10.1016/0304-3940(90)90553-L; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MILLER RJ, 1991, TRENDS PHARMACOL SCI, V12, P365, DOI 10.1016/0165-6147(91)90604-Q; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; NAKAJIMA Y, 1992, J BIOL CHEM, V267, P2437; NICOLETTI F, 1986, J NEUROCHEM, V46, P40, DOI 10.1111/j.1471-4159.1986.tb12922.x; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; OIKAWA S, 1989, BIOCHEM BIOPH RES CO, V164, P39, DOI 10.1016/0006-291X(89)91679-3; PALMER E, 1989, EUR J PHARMACOL, V166, P585, DOI 10.1016/0014-2999(89)90383-X; PEARCE B, 1986, NEUROSCI LETT, V72, P335, DOI 10.1016/0304-3940(86)90537-9; SCHOEPP D, 1990, TRENDS PHARMACOL SCI, V11, P508, DOI 10.1016/0165-6147(90)90052-A; SCHOEPP DD, 1989, J NEUROCHEM, V53, P273, DOI 10.1111/j.1471-4159.1989.tb07324.x; SCHOEPP DD, 1988, J NEUROCHEM, V50, P1605, DOI 10.1111/j.1471-4159.1988.tb03050.x; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; URLAUB G, 1980, P NATL ACAD SCI-BIOL, V77, P4216, DOI 10.1073/pnas.77.7.4216; VANSANDE J, 1990, MOL CELL ENDOCRINOL, V74, pR1, DOI 10.1016/0303-7207(90)90209-Q; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; YOUNG AB, 1990, TRENDS PHARMACOL SCI, V11, P126, DOI 10.1016/0165-6147(90)90199-I	47	560	577	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					757	765		10.1016/0896-6273(92)90096-V	http://dx.doi.org/10.1016/0896-6273(92)90096-V			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1314623				2022-12-28	WOS:A1992HQ18800014
J	PHILLIPS, AM; BULL, A; KELLY, LE				PHILLIPS, AM; BULL, A; KELLY, LE			IDENTIFICATION OF A DROSOPHILA GENE ENCODING A CALMODULIN-BINDING PROTEIN WITH HOMOLOGY TO THE TRP PHOTOTRANSDUCTION GENE	NEURON			English	Article							LIMULUS VENTRAL PHOTORECEPTORS; CA2+-DEPENDENT REGULATOR PROTEIN; BRAIN ADENYLATE-CYCLASE; SODIUM-CHANNEL; NEUROTRANSMITTER RELEASE; NEUROGENIC LOCUS; PHOSPHOLIPASE-C; BOVINE BRAIN; SYNAPSIN-I; RAT-BRAIN	We have isolated a number of Drosophila cDNAs on the basis of their encoding calmodulin-binding proteins. A full-length cDNA clone corresponding to one of these genes has been cloned and sequenced. Conservation of amino acid sequence and tissue-specific expression are observed between this gene and the transient receptor potential (trp) gene. We propose the name transient receptor potential-like (trpl) to describe this newly isolated gene. The trpl protein contains two possible calmodulin-binding sites, six transmembrane regions, and a sequence homologous to an ankyrin-like repeat. Structurally, the trpl and trp proteins resemble cation channel proteins, particularly the brain isoform of the voltage-sensitive Ca2+ channel. The identification of a protein similar to the trp gene product, yet also able to bind Ca2+/calmodulin, allows for a reinterpretation of the phenotype of the trp mutation and suggests that both genes may encode light-sensitive ion channels.			PHILLIPS, AM (corresponding author), UNIV MELBOURNE,DEPT GENET,PARKVILLE,VIC 3052,AUSTRALIA.			Bull, Ann/0000-0001-5725-7067				ACEVESPINA EO, 1983, COLD SPRING HARB SYM, V48, P831, DOI 10.1101/SQB.1983.048.01.086; BACIGALUPO J, 1986, J GEN PHYSIOL, V87, P73, DOI 10.1085/jgp.87.1.73; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BLUMENFELD A, 1985, P NATL ACAD SCI USA, V82, P7116, DOI 10.1073/pnas.82.20.7116; BROSTROM CO, 1975, P NATL ACAD SCI USA, V72, P64, DOI 10.1073/pnas.72.1.64; BUSCHMEIER B, 1987, J BIOL CHEM, V262, P9454; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHEUNG WY, 1975, BIOCHEM BIOPH RES CO, V66, P1055, DOI 10.1016/0006-291X(75)90747-0; CHEUNG WY, 1971, J BIOL CHEM, V246, P2859; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; DEDMAN JR, 1977, J BIOL CHEM, V252, P8415; DELORENZO RJ, 1979, P NATL ACAD SCI USA, V76, P1838, DOI 10.1073/pnas.76.4.1838; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6934; DUDAI Y, 1984, NEUROSCI LETT, V47, P119, DOI 10.1016/0304-3940(84)90416-6; ENGELS WR, 1986, FOCUS, V8, P6; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARTLEY DA, 1988, CELL, V55, P785, DOI 10.1016/0092-8674(88)90134-1; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; INGHAM PW, 1985, NATURE, V318, P439, DOI 10.1038/318439a0; INOUE H, 1988, J BIOCHEM-TOKYO, V103, P91, DOI 10.1093/oxfordjournals.jbchem.a122246; ITOH N, 1985, DROS INF SERVICE, V61, P89; JOHNSON EC, 1986, NATURE, V324, P468, DOI 10.1038/324468a0; KAUVAR LM, 1982, J NEUROSCI, V2, P1347; KELLY LE, 1990, BIOCHEM J, V271, P661, DOI 10.1042/bj2710661; KELLY LE, 1983, CELL MOL NEUROBIOL, V3, P127, DOI 10.1007/BF00735277; KENNEDY MB, 1983, J NEUROSCI, V3, P818; KIRSCHFELD K, 1980, NATURWISSENSCHAFTEN, V67, P516, DOI 10.1007/BF01047639; KLEE CB, 1977, BIOCHEMISTRY-US, V16, P1017, DOI 10.1021/bi00624a033; KRETSINGER RH, 1980, CRC CR REV BIOCH MOL, V8, P119, DOI 10.3109/10409238009105467; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LISMAN JE, 1975, J GEN PHYSIOL, V66, P489, DOI 10.1085/jgp.66.4.489; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LO MVC, 1981, J GEN PHYSIOL, V77, P155, DOI 10.1085/jgp.77.2.155; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Maniatis T., 1982, MOL CLONING; MARCHALONIS JJ, 1969, BIOCHEM J, V113, P29; MINKE B, 1982, J GEN PHYSIOL, V79, P361, DOI 10.1085/jgp.79.3.361; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NAGY K, 1991, Q REV BIOPHYS, V24, P165, DOI 10.1017/S0033583500003401; NAIRN AC, 1987, J BIOL CHEM, V262, P7273; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; ORGAD S, 1987, EUR J BIOCHEM, V164, P31, DOI 10.1111/j.1432-1033.1987.tb10988.x; PAK WL, 1979, NEUROGENETICS GENETI, V10, P67; PAYNE R, 1986, J GEN PHYSIOL, V88, P127, DOI 10.1085/jgp.88.1.127; PIASCIK MT, 1980, J BIOL CHEM, V255, P4176; RANGANATHAN R, 1991, TRENDS NEUROSCI, V14, P486, DOI 10.1016/0166-2236(91)90060-8; ROSS EM, 1980, ANNU REV BIOCHEM, V49, P533; SALKOFF L, 1987, SCIENCE, V237, P744, DOI 10.1126/science.2441469; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; SEAMON KB, 1980, BIOCHEMISTRY-US, V19, P207, DOI 10.1021/bi00542a031; SIKELA JM, 1987, P NATL ACAD SCI USA, V84, P3038, DOI 10.1073/pnas.84.9.3038; STEWART AA, 1983, EUR J BIOCHEM, V132, P285; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; WANG CLA, 1989, BIOCHEM BIOPH RES CO, V162, P746, DOI 10.1016/0006-291X(89)92373-5; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; WOLFF DJ, 1977, J BIOL CHEM, V252, P4108; WONG F, 1989, NEURON, V3, P81, DOI 10.1016/0896-6273(89)90117-7; YAMANAKA MK, 1987, NUCLEIC ACIDS RES, V15, P3335, DOI 10.1093/nar/15.8.3335; YAMANKA MK, 1981, BIOCH BIPHYS ACTA, V647, P277; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359	73	375	382	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					631	642		10.1016/0896-6273(92)90085-R	http://dx.doi.org/10.1016/0896-6273(92)90085-R			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1314616				2022-12-28	WOS:A1992HQ18800003
J	BECKER, CM; SCHMIEDEN, V; TARRONI, P; STRASSER, U; BETZ, H				BECKER, CM; SCHMIEDEN, V; TARRONI, P; STRASSER, U; BETZ, H			ISOFORM-SELECTIVE DEFICIT OF GLYCINE RECEPTORS IN THE MOUSE MUTANT SPASTIC	NEURON			English	Article							POLL HEREFORD CALVES; RAT SPINAL-CORD; CHLORIDE CHANNEL; POSTNATAL-DEVELOPMENT; SUBUNIT; EXPRESSION; PROTEIN; COMPLEX	The mutant mouse spastic (spa) develops a characteristic motor disorder about 2 weeks after birth, with symptoms resembling sublethal poisoning by the glycinergic antagonist strychnine. Correspondingly, adult homozygotic mutants (spa/spa) exhibit a severe reduction of inhibitory glycine receptors in spinal cord and brain. Here we show that the spastic mutation selectively interferes with the postnatal accumulation of the adult isoform of the glycine receptor protein, whereas perinatal expression of the neonatal receptor isoform is not detectably affected. Heterologous expression in X. laevis oocytes of poly(A)+ RNA and Northern blot analysis indicate normal levels of glycine receptor alpha-1 subunit transcripts in spinal cord of adult spastic mutants. Thus, the age-dependent manifestation of spastic symptoms after birth reflects a selective effect of the mutation on the developmental expression of the adult glycine receptor isoform.	UNIV HEIDELBERG,NEUROL KLIN,W-6900 HEIDELBERG,GERMANY; MAX PLANCK INST HIRNFORSCH,W-6000 FRANKFURT 71,GERMANY; UNIV MILAN,CTR FARMACOL CELLULARE,DIPARTIMENTO FARMACOL MED,I-20129 MILAN,ITALY	Ruprecht Karls University Heidelberg; Max Planck Society; University of Milan	BECKER, CM (corresponding author), UNIV HEIDELBERG,ZENTRUM MOLEK BIOL,NEUENHEIMER FELD 282,W-6900 HEIDELBERG,GERMANY.			Tarroni, Paola/0000-0001-7398-0722				BECKER CM, 1989, J NEUROCHEM, V53, P124, DOI 10.1111/j.1471-4159.1989.tb07303.x; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; BECKER CM, 1990, FASEB J, V4, P2767, DOI 10.1096/fasebj.4.10.2165011; BECKER CM, 1986, J NEUROSCI, V6, P1358; BENAVIDES J, 1981, J NEUROCHEM, V37, P315, DOI 10.1111/j.1471-4159.1981.tb00457.x; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BETZ H, 1988, NEUROCHEM INT, V13, P137, DOI 10.1016/0197-0186(88)90048-4; BISCOE TJ, 1986, J PHYSIOL-LONDON, V379, P275, DOI 10.1113/jphysiol.1986.sp016253; CHAI CK, 1962, P SOC EXP BIOL MED, V109, P491; CHAI CK, 1961, J HERED, V52, P241, DOI 10.1093/oxfordjournals.jhered.a107083; DRACHMAN DB, 1978, P NATL ACAD SCI USA, V75, P3422, DOI 10.1073/pnas.75.7.3422; EICHER EM, 1980, J HERED, V71, P315, DOI 10.1093/oxfordjournals.jhered.a109378; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GUNDLACH AL, 1990, FASEB J, V4, P2761, DOI 10.1096/fasebj.4.10.2165010; HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P871, DOI 10.1136/jnnp.44.10.871; HEALY PJ, 1985, RES VET SCI, V38, P96, DOI 10.1016/S0034-5288(18)31854-X; HELLER AH, 1982, BRAIN RES, V234, P299, DOI 10.1016/0006-8993(82)90870-8; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; KUHSE J, 1991, FEBS LETT, V283, P73, DOI 10.1016/0014-5793(91)80557-J; KUHSE J, 1990, J BIOL CHEM, V265, P22317; LANGOSCH D, 1990, EUR J BIOCHEM, V194, P1, DOI 10.1111/j.1432-1033.1990.tb19419.x; LARSON E, 1986, ANAL BIOCHEM, V155, P243, DOI 10.1016/0003-2697(86)90432-X; MALOSIO ML, 1991, J BIOL CHEM, V266, P2048; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; RIENITZ A, 1987, NEUROSCI LETT, V76, P91, DOI 10.1016/0304-3940(87)90198-4; SAENZLOPE E, 1984, ANN NEUROL, V15, P36, DOI 10.1002/ana.410150107; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SCHMITT B, 1987, BIOCHEMISTRY-US, V26, P805, DOI 10.1021/bi00377a022; SCHRODER S, 1991, BIOCHEMISTRY-US, V30, P42, DOI 10.1021/bi00215a007; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; WEATHERALL DJ, 1982, CELL, V29, P7, DOI 10.1016/0092-8674(82)90084-8; WHITE WF, 1982, NATURE, V298, P655, DOI 10.1038/298655a0; WHITE WF, 1985, BRAIN RES, V329, P1	36	88	91	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1992	8	2					283	289		10.1016/0896-6273(92)90295-O	http://dx.doi.org/10.1016/0896-6273(92)90295-O			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1371219				2022-12-28	WOS:A1992HE93000009
J	REED, RR				REED, RR			SIGNALING PATHWAYS IN ODORANT DETECTION	NEURON			English	Review							GTP-BINDING PROTEINS; OLFACTORY CILIA; ADENYLATE-CYCLASE; FUNCTIONAL EXPRESSION; ION CHANNELS; RECEPTOR; IDENTIFICATION; PURIFICATION; TRANSDUCTION; GOLF		JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205	Johns Hopkins University	REED, RR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205, USA.							ALTENHOFEN W, 1991, P NATL ACAD SCI USA, V88, P9868, DOI 10.1073/pnas.88.21.9868; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BIGNETTI E, 1985, EUR J BIOCHEM, V149, P227, DOI 10.1111/j.1432-1033.1985.tb08916.x; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BOEKHOFF I, 1992, IN PRESS P NATL ACAD; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BRUCH RC, 1987, J BIOL CHEM, V262, P2401; BRUCH RC, 1990, CHEM SENSES, V15, P419, DOI 10.1093/chemse/15.4.419; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; COUSSEN F, 1985, P NATL ACAD SCI USA, V82, P6736, DOI 10.1073/pnas.82.20.6736; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; HUQUE T, 1986, BIOCHEM BIOPH RES CO, V137, P36, DOI 10.1016/0006-291X(86)91172-1; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; JONES DT, 1990, J BIOL CHEM, V265, P2671; JONES DT, 1990, CHEM SENSES, V15, P333, DOI 10.1093/chemse/15.3.333; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KRUEGER JM, 1976, J BIOL CHEM, V251, P88; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LEE KH, 1987, SCIENCE, V235, P1053, DOI 10.1126/science.3493528; LEVY NS, 1991, STER BIOCH MOL BIOL, V39, P633; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; PEVSNER J, 1985, P NATL ACAD SCI USA, V82, P3050, DOI 10.1073/pnas.82.9.3050; PEVSNER J, 1988, SCIENCE, V241, P336, DOI 10.1126/science.3388043; PFEUFFER E, 1989, J BIOL CHEM, V264, P18803; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; STEINLEN S, 1990, BIOCHIM BIOPHYS ACTA, V1054, P69, DOI 10.1016/0167-4889(90)90206-S; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445	35	195	203	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1992	8	2					205	209		10.1016/0896-6273(92)90287-N	http://dx.doi.org/10.1016/0896-6273(92)90287-N			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1739458				2022-12-28	WOS:A1992HE93000001
J	SCHILLING, K; DICKINSON, MH; CONNOR, JA; MORGAN, JI				SCHILLING, K; DICKINSON, MH; CONNOR, JA; MORGAN, JI			ELECTRICAL-ACTIVITY IN CEREBELLAR CULTURES DETERMINES PURKINJE-CELL DENDRITIC GROWTH-PATTERNS	NEURON			English	Article							BRAIN-SPECIFIC POLYPEPTIDE; CENTRAL NERVOUS-SYSTEM; MUTANT MOUSE; NEURONS; RAT; DIFFERENTIATION; PEP-19; LOCALIZATION; MATURATION; ACTIVATION	In primary dissociated cultures of mouse cerebellum a number of Purkinje cell-specific marker proteins and characteristic ionic currents appear at the appropriate developmental time. During the first week after plating, Purkinje cell dendrites elongate, but as electrical activity emerges the dendrites stop growing and branch. If endogenous electrical activity is inhibited by chronic tetrodotoxin or high magnesium treatment, dendrites continue to elongate, as if they were still immature. At the time that branching begins, intracellular calcium levels become sensitive to tetrodotoxin, suggesting that this cation may be involved in dendrite growth. Even apparently mature Purkinje cells alter their dendritic growth in response to changes in activity, suggesting long-term plasticity.			SCHILLING, K (corresponding author), ROCHE RES CTR,ROCHE INST MOLEC BIOL,DEPT NEUROSCI,NUTLEY,NJ 07110, USA.		Morgan, James/GRO-2905-2022; Morgan, James/N-8104-2018	Morgan, James/0000-0002-8920-1065; 				BALABAN CD, 1989, J NEUROSCI, V9, P2374; BERRY M, 1976, BRAIN RES, V116, P361, DOI 10.1016/0006-8993(76)90487-X; BERRY M, 1976, BRAIN RES, V112, P1, DOI 10.1016/0006-8993(76)90331-0; BLACK IB, 1984, SCIENCE, V225, P1266, DOI 10.1126/science.6147894; BRADLEY P, 1978, BRAIN RES, V142, P135, DOI 10.1016/0006-8993(78)90182-8; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CONNOR JA, 1986, P NATL ACAD SCI USA, V83, P6179, DOI 10.1073/pnas.83.16.6179; CURRAN T, 1990, COLD SPRING HARB SYM, V55, P225; FISCHER G, 1982, NEUROSCI LETT, V28, P325, DOI 10.1016/0304-3940(82)90079-9; GRUOL DL, 1987, J NEUROSCI, V7, P1271; HECKROTH JA, 1990, J COMP NEUROL, V291, P415, DOI 10.1002/cne.902910308; HOCKBERGER PE, 1989, J NEUROSCI, V9, P2272; HOLLIDAY J, 1990, DEV BIOL, V141, P13, DOI 10.1016/0012-1606(90)90098-4; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; JANDE SS, 1981, HISTOCHEMISTRY, V71, P99, DOI 10.1007/BF00592574; KATER SB, 1991, J NEUROSCI, V11, P891; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Llinas R, 1979, Prog Brain Res, V51, P323; MARIANI J, 1977, PHILOS T R SOC B, V281, P1, DOI 10.1098/rstb.1977.0121; MATTSON MP, 1988, BRAIN RES REV, V13, P179, DOI 10.1016/0165-0173(88)90020-3; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MUGNAINI E, 1987, ARCH ITAL BIOL, V126, P41; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; PRIVAT A, 1976, J COMP NEUROL, V166, P201, DOI 10.1002/cne.901660207; SANGAMESWARAN L, 1989, P NATL ACAD SCI USA, V86, P5651, DOI 10.1073/pnas.86.14.5651; SCHILLING K, 1989, J NEUROSCI RES, V24, P347, DOI 10.1002/jnr.490240302; SCHILLING K, 1988, FEBS LETT, V233, P22, DOI 10.1016/0014-5793(88)81348-6; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SLEMMON JR, 1984, P NATL ACAD SCI-BIOL, V81, P6866, DOI 10.1073/pnas.81.21.6866; SLEMMON JR, 1988, J NEUROSCI, V8, P4603; SMEYNE RJ, 1991, SCIENCE, V254, P719, DOI 10.1126/science.1948052; Sokal R. R, 1981, BIOMETRY; SOTELO C, 1987, NATURE, V327, P421, DOI 10.1038/327421a0; THOMASSET M, 1982, AM J PHYSIOL, V243, pE483, DOI 10.1152/ajpendo.1982.243.6.E483; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; WOODWARD DJ, 1971, BRAIN RES, V34, P73, DOI 10.1016/0006-8993(71)90352-0; ZIAI MR, 1988, J NEUROCHEM, V51, P1771, DOI 10.1111/j.1471-4159.1988.tb01158.x; ZIAI R, 1986, P NATL ACAD SCI USA, V83, P8420, DOI 10.1073/pnas.83.21.8420	43	189	192	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					891	902		10.1016/0896-6273(91)90335-W	http://dx.doi.org/10.1016/0896-6273(91)90335-W			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1684902				2022-12-28	WOS:A1991GY43800003
J	SAH, P; MCLACHLAN, EM				SAH, P; MCLACHLAN, EM			CA2+-ACTIVATED K+-CURRENTS UNDERLYING THE AFTERHYPERPOLARIZATION IN GUINEA-PIG VAGAL NEURONS - A ROLE FOR CA2+-ACTIVATED CA2+ RELEASE	NEURON			English	Article							ACTIVATED POTASSIUM CONDUCTANCES; HIPPOCAMPAL PYRAMIDAL CELLS; SYMPATHETIC-GANGLION CELLS; CALCIUM-RELEASE; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; AFTER-HYPERPOLARIZATION; RYANODINE RECEPTOR; PLASMA-MEMBRANES; CA-2+ TRANSIENTS	We examined the possibility that Ca2+ released from intracellular stores could activate K+ currents underlying the afterhyperpolarization (AHP) in neurons. In neurons of the dorsal motor nucleus of the vagus, the current underlying the AHP had two components: a rapidly decaying component that was maximal following the action potential (Gk(Ca,1)) and a slower component that had a distinct rising phase (Gk(Ca,2)). Both components required influx of extracellular Ca2+ for their activation, and neither was blocked by extracellular TEA (10 mM). Gk(Ca,1) was selectively blocked by apamin, whereas Gk(Ca,2) was selectively reduced by noradrenaline. The time course of Gk(Ca,2) was markedly temperature sensitive. Gk(Ca,2) was selectively blocked by application of ryanodine or sodium dantrolene, or by loading cells with ruthenium red. These results suggest that influx of Ca2+ directly gates one class of K+ channels and leads to release of Ca2+ from intracellular stores, which activates a different class of K+ channel.			SAH, P (corresponding author), UNIV QUEENSLAND,DEPT PHYSIOL & PHARMACOL,ST LUCIA,QLD 4072,AUSTRALIA.		McLachlan, Elspeth M/A-1844-2013; Sah, Pankaj/C-8175-2009	McLachlan, Elspeth M/0000-0003-0755-8747; Sah, Pankaj/0000-0001-5063-1589				ASHLEY RH, 1989, J MEMBRANE BIOL, V111, P179, DOI 10.1007/BF01871781; BARISH ME, 1983, J PHYSIOL-LONDON, V337, P201, DOI 10.1113/jphysiol.1983.sp014620; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; BLATZ AL, 1987, TRENDS NEUROSCI, V10, P463, DOI 10.1016/0166-2236(87)90101-9; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; BOURQUE CW, 1987, NEUROSCI LETT, V82, P185, DOI 10.1016/0304-3940(87)90127-3; CAPIOD T, 1989, J PHYSIOL-LONDON, V409, P285, DOI 10.1113/jphysiol.1989.sp017497; CARAFOLI E, 1982, BIOCHIM BIOPHYS ACTA, V683, P279, DOI 10.1016/0304-4173(82)90004-0; CASSELL JF, 1987, J PHYSIOL-LONDON, V394, P331, DOI 10.1113/jphysiol.1987.sp016873; CASSELL JF, 1986, J PHYSIOL-LONDON, V372, P457, DOI 10.1113/jphysiol.1986.sp016020; CASTLE NA, 1989, TRENDS NEUROSCI, V12, P59, DOI 10.1016/0166-2236(89)90137-9; CONSTANTI A, 1987, J PHYSIOL-LONDON, V387, P173, DOI 10.1113/jphysiol.1987.sp016569; ELLISMAN MH, 1990, NEURON, V5, P135, DOI 10.1016/0896-6273(90)90304-X; FELDMAN JL, 1988, ANNU REV PHYSIOL, V50, P593; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; GOLA M, 1990, J PHYSIOL-LONDON, V420, P73, DOI 10.1113/jphysiol.1990.sp017902; HENKART M, 1976, J CELL BIOL, V70, P338, DOI 10.1083/jcb.70.2.338; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HIRST GDS, 1985, J PHYSIOL-LONDON, V361, P315, DOI 10.1113/jphysiol.1985.sp015648; HODGKIN AL, 1957, J PHYSIOL-LONDON, V138, P253, DOI 10.1113/jphysiol.1957.sp005850; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; KAWAI T, 1986, BRIT J PHARMACOL, V87, P225, DOI 10.1111/j.1476-5381.1986.tb10175.x; KAWAI T, 1989, PFLUG ARCH EUR J PHY, V413, P470, DOI 10.1007/BF00594175; KING MA, 1989, BRAIN RES, V497, P361, DOI 10.1016/0006-8993(89)90281-3; KUBA K, 1980, J PHYSIOL-LONDON, V298, P251, DOI 10.1113/jphysiol.1980.sp013079; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LANCASTER B, 1991, J NEUROSCI, V11, P23; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; LANG DG, 1990, J PHYSIOL-LONDON, V425, P117, DOI 10.1113/jphysiol.1990.sp018095; LANG DG, 1987, PFLUG ARCH EUR J PHY, V410, P614, DOI 10.1007/BF00581321; LEDERER WJ, 1990, SCIENCE, V248, P283, DOI 10.1126/science.2326638; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MARTY A, 1989, TRENDS NEUROSCI, V12, P420, DOI 10.1016/0166-2236(89)90090-8; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; MORITA K, 1989, PFLUG ARCH EUR J PHY, V414, P171, DOI 10.1007/BF00580960; NAKAI J, 1990, FEBS LETT, V271, P169, DOI 10.1016/0014-5793(90)80399-4; NEERING JR, 1984, NATURE, V309, P158; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; PENNEFATHER P, 1985, P NATL ACAD SCI USA, V82, P3040, DOI 10.1073/pnas.82.9.3040; PETERSEN OH, 1990, J MEMBRANE BIOL, V118, P93, DOI 10.1007/BF01868467; PIETROBON D, 1990, EUR J BIOCHEM, V193, P599, DOI 10.1111/j.1432-1033.1990.tb19378.x; Rall T, 1982, PHARMACOLOGIST, V24, P277; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; SCHWINDT PC, 1988, J NEUROPHYSIOL, V59, P424, DOI 10.1152/jn.1988.59.2.424; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; SMITH SJ, 1983, NATURE, V304, P350, DOI 10.1038/304350a0; STOCKBRIDGE N, 1984, NATURE, V309, P266, DOI 10.1038/309266a0; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; SUTKO JL, 1985, FED PROC, V44, P2984; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; VANWINKLE WB, 1976, SCIENCE, V193, P1130, DOI 10.1126/science.959824; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; Yamada WM, 1989, METHODS NEURONAL MOD, P97; YAROM Y, 1985, NEUROSCIENCE, V16, P719, DOI 10.1016/0306-4522(85)90090-9	58	174	174	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					257	264		10.1016/0896-6273(91)90264-Z	http://dx.doi.org/10.1016/0896-6273(91)90264-Z			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1873029				2022-12-28	WOS:A1991GB93300009
J	LINDEN, DJ; DICKINSON, MH; SMEYNE, M; CONNOR, JA				LINDEN, DJ; DICKINSON, MH; SMEYNE, M; CONNOR, JA			A LONG-TERM DEPRESSION OF AMPA CURRENTS IN CULTURED CEREBELLAR PURKINJE NEURONS	NEURON			English	Article							PROTEIN KINASE-C; CLIMBING FIBER IMPULSES; EXCITATORY AMINO-ACIDS; METHYL-D-ASPARTATE; GLUTAMATE RECEPTOR; GRANULE CELL; GUINEA-PIG; QUISQUALATE RECEPTORS; SYNAPTIC TRANSMISSION; ARACHIDONIC-ACID	Cerebellar long-term depression (LTD) is a model of synaptic plasticity in which conjunctive stimulation of parallel fiber and climbing fiber inputs to a Purkinje neuron induces a persistent depression of the parallel fiber-Purkinje neuron synapse. We report that an analogous phenomenon may be elicited in the cultured mouse Purkinje neuron when iontophoretic glutamate application and depolarization of the Purkinje neurons are substituted for parallel fiber and climbing fiber stimulation, respectively. The induction of LTD in these cerebellar cultures requires activation of both ionotropic (AMPA) and metabotropic quisqualate receptors, together with depolarization in the presence of external Ca2+. This postsynaptic alteration is manifest as a depression of glutamate or AMPA currents, but not aspartate or NMDA currents. These results strengthen the contention that the expression of cerebellar LTD is at least in part postsynaptic and provide evidence that activation of both ionotropic and metabotropic quisqualate receptors are necessary for LTD induction.			LINDEN, DJ (corresponding author), ROCHE INST MOLEC BIOL,DEPT NEUROSCI,ROCHE RES CTR,NUTLEY,NJ 07110, USA.							ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; AUDINAT E, 1990, J PHYSIOL-LONDON, V430, P297, DOI 10.1113/jphysiol.1990.sp018292; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; CAMPBELL NC, 1983, J PHYSIOL-LONDON, V340, P225, DOI 10.1113/jphysiol.1983.sp014760; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; DUMUIS A, 1990, NATURE, V347, P182, DOI 10.1038/347182a0; DUPONT JL, 1987, DEV BRAIN RES, V34, P59, DOI 10.1016/0165-3806(87)90195-7; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; EKEROT CF, 1981, J PHYSIOL-LONDON, V318, P207; FISCHER G, 1982, NEUROSCI LETT, V28, P325, DOI 10.1016/0304-3940(82)90079-9; GARTHWAITE G, 1987, DEV BRAIN RES, V36, P288, DOI 10.1016/0165-3806(87)90034-4; HIDAKA H, 1988, J BIOL CHEM, V263, P4523; HIRANO T, 1990, NEUROSCI LETT, V119, P141, DOI 10.1016/0304-3940(90)90818-T; HIRANO T, 1990, NEUROSCI LETT, V119, P145, DOI 10.1016/0304-3940(90)90819-U; HIRANO T, 1988, P NATL ACAD SCI USA, V85, P934, DOI 10.1073/pnas.85.3.934; HOCKBERGER PE, 1989, J NEUROSCI, V9, P2272; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; KANO M, 1988, NEUROSCI RES, V5, P544, DOI 10.1016/0168-0102(88)90041-7; KANO M, 1988, NEUROSCI RES, V5, P325, DOI 10.1016/0168-0102(88)90034-X; KIMURA H, 1985, J PHYSIOL-LONDON, V365, P103, DOI 10.1113/jphysiol.1985.sp015761; KNOPFEL T, 1990, EUR J NEUROSCI, V2, P726, DOI 10.1111/j.1460-9568.1990.tb00463.x; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KRUPA M, 1990, EUR J NEUROSCI, V2, P312, DOI 10.1111/j.1460-9568.1990.tb00423.x; LEVI G, 1982, BRAIN RES, V239, P425, DOI 10.1016/0006-8993(82)90520-0; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MANZONI OJJ, 1990, NEUROSCI LETT, V109, P146, DOI 10.1016/0304-3940(90)90553-L; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MCPHAIL LC, 1984, SCIENCE, V224, P622, DOI 10.1126/science.6231726; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; NICOLETTI F, 1988, NEUROPHARMACOLOGY, V27, P551, DOI 10.1016/0028-3908(88)90174-8; PALMER E, 1989, EUR J PHARMACOL, V166, P585, DOI 10.1016/0014-2999(89)90383-X; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SANDOVAL ME, 1978, NEUROSCIENCE, V3, P199, DOI 10.1016/0306-4522(78)90101-X; SANGAMESWARAN L, 1989, P NATL ACAD SCI USA, V86, P5651, DOI 10.1073/pnas.86.14.5651; SCHILLING KL, 1988, J NEUROSCI RES, V19, P27, DOI 10.1002/jnr.490190105; SCHOEPP D, 1990, TRENDS PHARMACOL SCI, V11, P508, DOI 10.1016/0165-6147(90)90052-A; SCHOEPP DD, 1990, MOL PHARMACOL, V38, P222; SHEARMAN MS, 1989, FEBS LETT, V243, P177, DOI 10.1016/0014-5793(89)80125-5; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SLADECZEK F, 1988, TRENDS NEUROSCI, V11, P545, DOI 10.1016/0166-2236(88)90183-X; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; WIKLUND L, 1982, SCIENCE, V216, P78, DOI 10.1126/science.6121375	47	358	368	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1991	7	1					81	89		10.1016/0896-6273(91)90076-C	http://dx.doi.org/10.1016/0896-6273(91)90076-C			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1676895				2022-12-28	WOS:A1991FY48100008
J	EISEN, JS; PIKE, SH				EISEN, JS; PIKE, SH			THE SPT-1 MUTATION ALTERS SEGMENTAL ARRANGEMENT AND AXONAL DEVELOPMENT OF IDENTIFIED NEURONS IN THE SPINAL-CORD OF THE EMBRYONIC ZEBRAFISH	NEURON			English	Article							GROWTH CONES; LEECH NEUROGENESIS; MOTONEURONS; DROSOPHILA; FATE; EXPRESSION; HINDBRAIN; RELEASE	We examined the arrangement and development of identified neurons in zebrafish embryos homozygous for the mutation spt-1, which acts autonomously and specifically to alter the development of precursors of trunk segmented mesoderm, resulting in muscle-deficient myotomes. We found that the mutation alters the morphology, number, and arrangement of identified motoneurons. By transplanting identified motoneurons between wild-type and mutant embryos, we found that the effect of the mutation was nonautonomous. We suggest that the segmental arrangement and proper axonal development of motoneurons may result from interactions with segmented mesoderm.			EISEN, JS (corresponding author), UNIV OREGON, INST NEUROSCI, EUGENE, OR 97403 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023915, R56NS023915] Funding Source: NIH RePORTER; NICHD NIH HHS [HD22486] Funding Source: Medline; NINDS NIH HHS [NS23915] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARIAS AM, 1988, DEVELOPMENT, V103, P157; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; EISEN JS, 1990, J NEUROSCI, V10, P34; EISEN JS, 1989, NEURON, V2, P1097, DOI 10.1016/0896-6273(89)90234-1; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; GRUNWALD DJ, 1988, DEV BIOL, V126, P115, DOI 10.1016/0012-1606(88)90245-X; HANNEMAN E, 1989, J COMP NEUROL, V284, P350, DOI 10.1002/cne.902840303; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; HATTA K, 1991, IN PRESS DEVELOPMENT; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1989, NATURE, V337, P358, DOI 10.1038/337358a0; KIMMEL CB, 1988, DEVELOPMENT, V104, P197; KIMMEL CB, 1989, TRENDS GENET, V5, P283, DOI 10.1016/0168-9525(89)90103-0; KUWADA JY, 1990, J NEUROSCI, V10, P1299; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P39, DOI 10.1113/jphysiol.1986.sp016104; METCALFE WK, 1990, DEVELOPMENT, V110, P491; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; MORRISONGRAHAM K, 1989, TRENDS GENET, V5, P116, DOI 10.1016/0168-9525(89)90042-5; MYERS PZ, 1986, J NEUROSCI, V6, P2278; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OPPENHEIM RW, 1988, SCIENCE, V240, P919, DOI 10.1126/science.3363373; Purves D, 1985, PRINCIPLES NEURAL DE, P131; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; STUART DK, 1989, DEV BIOL, V136, P17, DOI 10.1016/0012-1606(89)90128-0; TORRENCE SA, 1989, DEV BIOL, V136, P40, DOI 10.1016/0012-1606(89)90129-2; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; WESTERFIELD M, 1990, NEURON, V4, P867, DOI 10.1016/0896-6273(90)90139-7; WESTERFIELD M, 1985, DEV BIOL, V109, P96, DOI 10.1016/0012-1606(85)90349-5; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0	33	68	68	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1991	6	5					767	776		10.1016/0896-6273(91)90173-W	http://dx.doi.org/10.1016/0896-6273(91)90173-W			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	2025428				2022-12-28	WOS:A1991FM52200009
J	KSIEZAKREDING, H; YEN, SH				KSIEZAKREDING, H; YEN, SH			STRUCTURAL STABILITY OF PAIRED HELICAL FILAMENTS REQUIRES MICROTUBULE-BINDING DOMAINS OF TAU - A MODEL FOR SELF-ASSOCIATION	NEURON			English	Article							ALZHEIMERS-DISEASE; PROTEIN-TAU; NEUROFIBRILLARY TANGLES; ABNORMAL PHOSPHORYLATION; ANTIGENIC DETERMINANTS; NERVOUS-SYSTEM; EPITOPES; LOCALIZATION; SOLUBILITY; COMPONENT	Highly purified and SDS-soluble paired helical filaments (PHFs) were immunogold labeled and immunoblotted with antibodies to tau: Tau 14 (N-terminal half), AH-1 (microtubule-binding domain), and Tau 46 (C-terminal end). The main component of PHFs was modified tau of 68, 64, and 60 kd, also called A68 or PHF-tau. Trypsin digestion reduced the maximum width of PHFs by 10%-20%, increased aggregation of filaments, and abolished the binding of Tau 14, but had no effect on the binding of AH-1. The smallest tau-reactive tryptic fragments were 13 and 7-8 kd, positive with AH-1, and negative with Tau 46. Our results and the model of Crowther and Wischik suggest that by self-association and anti-parallel arrangement of the microtubule-binding domains, PHF-tau forms the backbone of PHFs.			KSIEZAKREDING, H (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PATHOL,BRONX,NY 10461, USA.				NATIONAL INSTITUTE ON AGING [P01AG006803, R01AG004145, R37AG001136, R01AG001136] Funding Source: NIH RePORTER; NIA NIH HHS [AG4145, AG1136, AG06803] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BONDAREFF W, 1990, AM J PATHOL, V137, P711; Brion J. P., 1985, ARCH BIOL BRUX, V95, P229; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; CROWTHER RA, 1985, EMBO J, V4, P3661, DOI 10.1002/j.1460-2075.1985.tb04132.x; CROWTHER T, 1989, ANN MED, V21, P127, DOI 10.3109/07853898909149199; DEGARCINI EM, 1987, J BIOCHEM-TOKYO, V102, P1415, DOI 10.1093/oxfordjournals.jbchem.a122187; DICKSON DW, 1987, ALTERATIONS NEURONAL, P165; FLAMENT S, 1989, CR ACAD SCI III-VIE, V308, P77; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389, DOI 10.1128/MCB.9.4.1389; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; IQBAL K, 1986, LANCET, V2, P421; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; IQBAL K, 1984, ACTA NEUROPATHOL, V62, P167, DOI 10.1007/BF00691849; IQBAL K, 1986, LIFE SCI, V38, P1695, DOI 10.1016/0024-3205(86)90414-5; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KSIEZAKREDING H, 1990, J NEUROSCI RES, V25, P420, DOI 10.1002/jnr.490250320; KSIEZAKREDING H, 1990, J NEUROSCI RES, V25, P412, DOI 10.1002/jnr.490250319; KSIEZAKREDING H, 1988, J BIOL CHEM, V263, P7943; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LICHTENBERG B, 1988, NATURE, V334, P359, DOI 10.1038/334359a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NIETO A, 1988, BIOCHEM BIOPH RES CO, V154, P660, DOI 10.1016/0006-291X(88)90190-8; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; PAPASOZOMENOS SC, 1987, CELL MOTIL CYTOSKEL, V8, P210, DOI 10.1002/cm.970080303; RUBENSTEIN R, 1986, BRAIN RES, V372, P80, DOI 10.1016/0006-8993(86)91460-5; SCHMIDT ML, 1990, AM J PATHOL, V136, P1069; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; VOGELSANG GD, 1990, J NEUROCHEM, V54, P148, DOI 10.1111/j.1471-4159.1990.tb13295.x; WISCHIK CM, 1985, J CELL BIOL, V100, P1905, DOI 10.1083/jcb.100.6.1905; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WISNIEWSKI HM, 1987, NEUROCHEM RES, V12, P93, DOI 10.1007/BF00971370; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040; YEN SH, 1987, AM J PATHOL, V126, P81; YEN SH, 1991, IN PRESS NIIGATA INT; YEN SH, 1983, BANBURY REPORT, V15, P155	45	134	140	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					717	728		10.1016/0896-6273(91)90169-Z	http://dx.doi.org/10.1016/0896-6273(91)90169-Z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1709023				2022-12-28	WOS:A1991FM52200005
J	LIU, X; YU, Q; HUANG, Z; ZWIEBEL, LJ; HALL, JC; ROSBASH, M				LIU, X; YU, Q; HUANG, Z; ZWIEBEL, LJ; HALL, JC; ROSBASH, M			THE STRENGTH AND PERIODICITY OF DROSOPHILA-MELANOGASTER CIRCADIAN-RHYTHMS ARE DIFFERENTIALLY AFFECTED BY ALTERATIONS IN PERIOD GENE-EXPRESSION	NEURON			English	Article							DROSOPHILA-MELANOGASTER; REGULATORY ELEMENTS; BIOLOGICAL RHYTHMS; VISUAL-SYSTEM; COMPLEX PATTERN; MESSENGER-RNA; CLOCK GENE; LOCUS; PRODUCT; MUTANT	The per gene of D. melanogaster influences or participates in the generation of biological rhythms. Previous experiments have identified the head as the location from which per exerts its effect on circadian rhythms. To localize further this region and to examine the effects of altered levels and altered spatial expression patterns of the per gene on circadian rhythms of locomotor activity, we have characterized transformed lines containing per gene constructs missing substantial cis-acting regulatory information. The data suggest that wild-type levels of per gene expression are necessary in only a small fraction of the nervous system for near wild-type periods, whereas a larger fraction of per-expressing cells in the brain contributes to the strength of the circadian rhythms.	BRANDEIS UNIV, DEPT BIOL, WALTHAM, MA 02254 USA	Brandeis University	LIU, X (corresponding author), BRANDEIS UNIV, HOWARD HUGHES MED INST, WALTHAM, MA 02254 USA.			Zwiebel, Laurence/0000-0001-6686-7289; Huang, Z. Josh/0000-0003-0592-028X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM033205] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33205] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BOWTELL DDL, 1989, P NATL ACAD SCI USA, V86, P6245, DOI 10.1073/pnas.86.16.6245; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; BRUHAT A, 1990, NUCLEIC ACIDS RES, V18, P2861, DOI 10.1093/nar/18.10.2861; BUCHNER E, 1988, CELL TISSUE RES, V253, P357, DOI 10.1007/BF00222292; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; COLOT HV, 1982, DEV BIOL, V94, P79, DOI 10.1016/0012-1606(82)90070-7; COTE GG, 1986, J THEOR BIOL, V121, P487, DOI 10.1016/S0022-5193(86)80104-7; EWER J, 1988, NATURE, V333, P82, DOI 10.1038/333082a0; EWER J, 1990, J NEUROGENET, V7, P31, DOI 10.3109/01677069009084151; GEYER PK, 1987, GENE DEV, V1, P996, DOI 10.1101/gad.1.9.996; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; HALL JC, 1984, DEV GENET, V4, P355; HALL JC, 1988, ANNU REV NEUROSCI, V11, P373, DOI 10.1146/annurev.ne.11.030188.002105; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HAYDAY AC, 1984, NATURE, V307, P334, DOI 10.1038/307334a0; HOYLE G, 1986, J COMP NEUROL, V246, P85, DOI 10.1002/cne.902460106; JACKSON FR, 1986, NATURE, V320, P185, DOI 10.1038/320185a0; JAMES AA, 1986, EMBO J, V5, P2313, DOI 10.1002/j.1460-2075.1986.tb04499.x; KONOPKA R, 1983, MOL GEN GENET, V190, P284, DOI 10.1007/BF00330652; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1987, ANNU REV GENET, V21, P227, DOI 10.1146/annurev.genet.21.1.227; LIU X, 1988, GENE DEV, V2, P228, DOI 10.1101/gad.2.2.228; MURPHY W, 1986, P NATL ACAD SCI USA, V83, P2939, DOI 10.1073/pnas.83.9.2939; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PETERSEN G, 1988, EMBO J, V7, P3939, DOI 10.1002/j.1460-2075.1988.tb03280.x; REDDY P, 1984, CELL, V38, P701, DOI 10.1016/0092-8674(84)90265-4; ROSBASH M, 1989, NEURON, V3, P387, DOI 10.1016/0896-6273(89)90199-2; RUBIN GM, 1988, SCIENCE, V240, P1453, DOI 10.1126/science.3131880; SAEZ L, 1988, MOL CELL BIOL, V8, P5378, DOI 10.1128/MCB.8.12.5378; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; SMITH RF, 1982, MOL GEN GENET, V185, P30, DOI 10.1007/BF00333786; SMITH RF, 1981, MOL GEN GENET, V183, P243, DOI 10.1007/BF00270625; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WIGGLESWORTH VB, 1959, Q J MICROSC SCI, V100, P299; YOUNG MW, 1989, MOL BIOL DROSOPHILA, P529; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784; YU Q, 1987, NATURE, V326, P765, DOI 10.1038/326765a0; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1; ZERR DM, 1990, J NEUROSCI, V10, P2749; ZWIEBEL LJ, 1991, IN PRESS P NATL ACAD; [No title captured]; [No title captured]	46	50	50	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1991	6	5					753	766		10.1016/0896-6273(91)90172-V	http://dx.doi.org/10.1016/0896-6273(91)90172-V			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1902699				2022-12-28	WOS:A1991FM52200008
J	MASLIAH, E; MALLORY, M; HANSEN, L; ALFORD, M; ALBRIGHT, T; DETERESA, R; TERRY, R; BAUDIER, J; SAITOH, T				MASLIAH, E; MALLORY, M; HANSEN, L; ALFORD, M; ALBRIGHT, T; DETERESA, R; TERRY, R; BAUDIER, J; SAITOH, T			PATTERNS OF ABERRANT SPROUTING IN ALZHEIMERS-DISEASE	NEURON			English	Article							PROTEIN-KINASE-C; GROWTH-ASSOCIATED PROTEIN; ADULT-RAT BRAIN; CALMODULIN-BINDING PROTEIN; LONG-TERM POTENTIATION; B-50 GAP-43; IMMUNOCYTOCHEMICAL DISTRIBUTION; AXONAL REGENERATION; NEURONAL POLARITY; SENILE DEMENTIA	Alzheimer's disease (AD) is characterized by extensive synaptic and neuronal loss and by plaque formation in the cortex, but the mechanisms responsible for synaptic plasticity in the neocortex are still not completely understood. To analyze the sprouting response in AD cortex, we compared the patterns of GAP-43 with synaptophysin immunoreactivity. In AD, GAP-43 immunohistochemistry revealed extensive sprouting in the hippocampal molecular layer, stratum polymorphous, CA1 region, and prosubiculum. These regions presented abundant anti-GAP-43-immunoreactive coiled fibers and dystrophic neurites in association with plaques. Some of these sprouting structures were colocalized with anti-synaptophysin- and anti-neurofilament-positive neurites. The AD neocortex was characterized by an overall decrease in GAP-43 immunoreactivity accompanied by sprouting neurites in the areas of synaptic pahtology. We conclude that GAP-43 might be involved in the mechanisms of synaptic plasticity in the AD cortex, as well as in the process of aberrant sprouting in the neuritic plaques.	LAB BIOL MOLEC CYCLE CELLULAIRE,F-38041 GRENOBLE,FRANCE		MASLIAH, E (corresponding author), UNIV CALIF SAN DIEGO,SCH MED,DEPT NEUROSCI,LA JOLLA,CA 92093, USA.		jacques, baudier/T-3300-2019	jacques, baudier/0000-0001-8427-4444	NATIONAL INSTITUTE ON AGING [R01AG008201, R01AG008205, P50AG005131] Funding Source: NIH RePORTER; NIA NIH HHS [AG05131, AG08201, AG08205] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALEXANDER KA, 1988, J BIOL CHEM, V263, P7544; BAUDIER J, 1989, J BIOL CHEM, V264, P1824; BENOWITZ LI, 1990, MOL BRAIN RES, V8, P17, DOI 10.1016/0169-328X(90)90004-W; BENOWITZ LI, 1989, J NEUROSCI, V9, P990; BENOWITZ LI, 1987, TRENDS NEUROSCI, V10, P527, DOI 10.1016/0166-2236(87)90135-4; BENOWITZ LI, 1988, J NEUROSCI, V8, P339; BENOWITZ LI, 1987, J NEUROCHEM, V48, P1640, DOI 10.1111/j.1471-4159.1987.tb05713.x; CHAN SY, 1986, J NEUROSCI, V6, P3618; CLARK EA, 1991, LAB INVEST, V64, P35; COLE G, 1988, BRAIN RES, V452, P165, DOI 10.1016/0006-8993(88)90021-2; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; DELAMONTE SM, 1989, DEV BRAIN RES, V46, P161, DOI 10.1016/0165-3806(89)90279-4; GISPEN WH, 1985, BRAIN RES, V328, P381, DOI 10.1016/0006-8993(85)91054-6; GORGELS TGMF, 1987, NEUROSCI LETT, V83, P59, DOI 10.1016/0304-3940(87)90216-3; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; GOSLIN K, 1990, J NEUROSCI, V10, P588; HAMA T, 1986, P NATL ACAD SCI USA, V83, P2353, DOI 10.1073/pnas.83.8.2353; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; HESSELMANS LFGM, 1989, J NEUROL SCI, V89, P301, DOI 10.1016/0022-510X(89)90031-2; IIMOTO DS, 1990, BRAIN RES, V507, P273, DOI 10.1016/0006-8993(90)90282-G; JACOBSON RD, 1986, J NEUROSCI, V6, P1843; KALIL K, 1986, J NEUROSCI, V6, P2563; LABATE ME, 1989, NEURON, V3, P299, DOI 10.1016/0896-6273(89)90254-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARRIVEE DC, 1987, J NEUROCHEM, V48, P279, DOI 10.1111/j.1471-4159.1987.tb13159.x; LINDEN DJ, 1989, BRAIN RES REV, V14, P279, DOI 10.1016/0165-0173(89)90004-0; LOVINGER DM, 1988, J PHYSIOL-LONDON, V400, P321, DOI 10.1113/jphysiol.1988.sp017122; LOVINGER DM, 1986, BRAIN RES, V399, P205, DOI 10.1016/0006-8993(86)91510-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASLIAH E, 1991, AM J PATHOL, V138, P235; MASLIAH E, 1990, AM J PATHOL, V137, P1293; MASLIAH E, 1990, J NEUROSCI, V10, P2113; MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; MASLIAH E, 1990, J HISTOCHEM CYTOCHEM, V38, P837, DOI 10.1177/38.6.2110586; MASLIAH E, 1990, BRAIN RES, V531, P36, DOI 10.1016/0006-8993(90)90755-Z; MCINTOSH H, 1990, BRAIN RES, V518, P324, DOI 10.1016/0006-8993(90)90991-J; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; NG SC, 1988, NEURON, V1, P133, DOI 10.1016/0896-6273(88)90197-3; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OESTREICHER AB, 1986, BRAIN RES, V375, P267, DOI 10.1016/0006-8993(86)90747-X; PERRONEBIZZOZERO NI, 1987, J NEUROCHEM, V48, P644, DOI 10.1111/j.1471-4159.1987.tb04141.x; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PISANO MR, 1988, BIOCHEM BIOPH RES CO, V155, P1207, DOI 10.1016/S0006-291X(88)81268-3; SAITOH T, 1991, IN PRESS LAB INVEST; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; SHEU FS, 1990, BRAIN RES, V524, P144, DOI 10.1016/0006-8993(90)90503-4; SHEU FS, 1990, BIOCHEM BIOPH RES CO, V171, P1236, DOI 10.1016/0006-291X(90)90818-8; SKENE JHP, 1986, SCIENCE, V233, P783, DOI 10.1126/science.3738509; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; SKENE JHP, 1981, J CELL BIOL, V89, P86, DOI 10.1083/jcb.89.1.86; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; STRITTMATTER SM, 1990, NATURE, V344, P836, DOI 10.1038/344836a0; TERRY RD, 1981, ANN NEUROL, V10, P184, DOI 10.1002/ana.410100209; TERRY RD, 1983, ANN NEUROL, V14, P497, DOI 10.1002/ana.410140502; TETZLAFF W, 1989, J NEUROSCI, V9, P1303; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERNEUT R, 1990, NEUROSCI LETT, V109, P36, DOI 10.1016/0304-3940(90)90534-G; VANHOOFF COM, 1986, BIOCHEM BIOPH RES CO, V139, P644, DOI 10.1016/S0006-291X(86)80039-0; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; VERHAAGEN J, 1986, BRAIN RES BULL, V17, P737, DOI 10.1016/0361-9230(86)90084-5; WEIDENMANN B, 1985, CELL, V45, P1017; WEILER R, 1990, FEBS LETT, V263, P337, DOI 10.1016/0014-5793(90)81408-G; WOOLF CJ, 1990, NEUROSCIENCE, V34, P465, DOI 10.1016/0306-4522(90)90155-W; YAMAGUCHI H, 1990, BRAIN RES, V508, P320, DOI 10.1016/0006-8993(90)90416-9	67	240	240	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					729	739		10.1016/0896-6273(91)90170-5	http://dx.doi.org/10.1016/0896-6273(91)90170-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1827266				2022-12-28	WOS:A1991FM52200006
J	CLINE, HT; TSIEN, RW				CLINE, HT; TSIEN, RW			GLUTAMATE-INDUCED INCREASES IN INTRACELLULAR CA2+ IN CULTURED FROG TECTAL CELLS MEDIATED BY DIRECT ACTIVATION OF NMDA RECEPTOR CHANNELS	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; MOUSE CENTRAL NEURONS; SPINAL-CORD NEURONS; ANTICONVULSANT MK-801; HIPPOCAMPAL-NEURONS; DIVALENT-CATIONS; CALCIUM; INVITRO; BLOCK; QUISQUALATE	Influx of Ca2+ through NMDA channels may initiate the stabilization of coactive synapses during development of the retinotectal projection in frogs. Ca2+ imaging techniques were applied to cultured tectal cells to investigate whether excitatory amino acids cause a rise in [Ca2+]i. High [K+], NMDA, and glutamate increase [Ca2+]i in about 75% of the cells. NMDA and glutamate responses were completely blocked in the absence of extracellular Ca2+ and by the NMDA receptor or channel blockers APV and MK-801. The NMDA response was also blocked by Mg2+. Quisqualate and kainate produced little or no rise in [Ca2+]i. These studies indicate that when tectal cells are exposed to the retinal ganglion cell transmitter glutamate, the prodominant means of Ca2+ entry is through NMDA channels.	STANFORD UNIV, MED CTR, SCH MED, DEPT MOLEC & CELLULAR PHYSIOL, STANFORD, CA 94305 USA	Stanford University					NINDS NIH HHS [NS24067] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BEAR MF, 1990, J NEUROSCI, V10, P909; BLANTON MG, 1990, P NATL ACAD SCI USA, V87, P8027, DOI 10.1073/pnas.87.20.8027; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; CLINE HT, 1990, J NEUROSCI, V10, P1197; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; CLINE HT, 1991, IN PRESS TRENDS NEUR; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; FOX K, 1989, J NEUROSCI, V9, P2443; FURUYA S, 1989, J PHYSIOL-LONDON, V414, P539, DOI 10.1113/jphysiol.1989.sp017702; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; KING AE, 1987, NEUROSCI LETT, V76, P179, DOI 10.1016/0304-3940(87)90712-9; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MATSUMOTO N, 1980, BRAIN RES, V192, P39, DOI 10.1016/0006-8993(80)91006-9; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCDONALD JW, 1989, BRAIN RES, V482, P155, DOI 10.1016/0006-8993(89)90553-2; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; MURPHY SN, 1987, J NEUROSCI, V7, P4145; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; MURPHY SN, 1989, MOL PHARMACOL, V35, P671; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; POENIE M, 1986, SCIENCE, V233, P886, DOI 10.1126/science.3755550; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; SCHERER WJ, 1989, J NEUROSCI, V9, P3837; SCHMIDT JT, 1985, CELL MOL NEUROBIOL, V5, P5, DOI 10.1007/BF00711083; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; SLADECZEK F, 1988, TRENDS NEUROSCI, V11, P545, DOI 10.1016/0166-2236(88)90183-X; STEEN P, 1989, J COMP NEUROL, V289, P467, DOI 10.1002/cne.902890311; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; TAYLOR AC, 1946, ANAT REC, V94, P7, DOI 10.1002/ar.1090940103; THAYER SA, 1988, J NEUROSCI, V8, P4089; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P2834, DOI 10.1073/pnas.85.8.2834; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	43	45	45	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1991	6	2					259	267		10.1016/0896-6273(91)90361-3	http://dx.doi.org/10.1016/0896-6273(91)90361-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1704244				2022-12-28	WOS:A1991EY70900008
J	LEM, J; APPLEBURY, ML; FALK, JD; FLANNERY, JG; SIMON, MI				LEM, J; APPLEBURY, ML; FALK, JD; FLANNERY, JG; SIMON, MI			TISSUE-SPECIFIC AND DEVELOPMENTAL REGULATION OF ROD OPSIN CHIMERIC GENES IN TRANSGENIC MICE	NEURON			English	Article							ALPHA-SUBUNIT; MOUSE RETINA; VERTEBRATE RETINA; PINEAL ORGANS; CELL LINEAGE; FROG RETINA; S-ANTIGEN; G-PROTEIN; TRANSDUCIN; DIFFERENTIATION	Chimeric gene fusions between 4.4 kb of rod opsin 5' flanking sequence fused to a diphtheria toxin gene and 4.4 kb or 500 bp of rod opsin 5' flanking sequence fused to the E. coli IacZ gene were used to generate transgenic mice for analysis of cell type-specific expression and temporal and spatial distribution of reporter gene product during retinal development. Opsin-diphtheria toxin transgene expression evoked photoreceptor-specific cell death. The 4.4 kb opsin-IacZ transgene followed temporal and spatial gradients of expression that approximate opsin expression. The 500 bp opsin fragment targeted expression to photoreceptors, but expression was weaker and nonuniform, suggesting that elements located upstream may be required for enhanced and uniform spatial expression.	UNIV CHICAGO,EYE RES INST,CHICAGO,IL 60637; UNIV CALIF LOS ANGELES,SCH MED,JULES STEIN EYE INST,LOS ANGELES,CA 90024	University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	LEM, J (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.			Flannery, John/0000-0002-0720-8897	NEI NIH HHS [EY04801] Funding Source: Medline; NIA NIH HHS [AG 97687] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004801] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAEHR W, 1988, FEBS LETT, V238, P253, DOI 10.1016/0014-5793(88)80490-3; BLANKS JC, 1977, J COMP NEUROL, V174, P317, DOI 10.1002/cne.901740208; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; ERICKSON PA, 1987, J ELECTRON MICR TECH, V5, P303, DOI 10.1002/jemt.1060050403; FALK JD, 1987, PROGR RETINAL RES, V7, P89; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GORING DR, 1987, SCIENCE, V235, P456, DOI 10.1126/science.3099390; GRUN G, 1982, ADV ANAT EMBRYOL CEL, V78, P1; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HICKS D, 1989, EXP EYE RES, V49, P13, DOI 10.1016/0014-4835(89)90072-9; HOGAN B, 1986, MANIPULATING MOUSE E; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; ISHIGURO SI, 1987, CELL STRUCT FUNCT, V123, P141; JOHNSON LV, 1984, CURR EYE RES, V3, P969, DOI 10.3109/02713688409167215; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KORF B, 1989, CELL TISSUE RES, V258, P319; KORF HW, 1985, CELL TISSUE RES, V239, P81, DOI 10.1007/BF00214906; KORF HW, 1985, CELL TISSUE RES, V242, P645; LEREA CL, 1986, SCIENCE, V234, P77, DOI 10.1126/science.3529395; LI T, 1990, P NATL ACAD SCI USA, V87, P293, DOI 10.1073/pnas.87.1.293; LIPKIN VM, 1990, J BIOL CHEM, V265, P12955; LOCHRIE MA, 1985, SCIENCE, V228, P96, DOI 10.1126/science.3856323; LOCHRIE MA, 1988, BIOCHEMISTRY-US, V27, P4959; MACGREGOR GR, 1991, GENE EXPRESSION INVI, V7; MOSCONA AA, 1987, AM ZOOL, V27, P137; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NIR I, 1984, J CELL BIOL, V98, P1788, DOI 10.1083/jcb.98.5.1788; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; POLLEY EH, 1989, DEVVERTEBRATE RETINA; RAMONYCAJAL S, 1972, RETINA WIRBELTIERE; RAMONYCAJAL S, 1960, ETUDES NEUROGENESE Q; RAPORT CJ, 1989, J BIOL CHEM, V264, P7122; REH TA, 1986, DEV BIOL, V114, P463, DOI 10.1016/0012-1606(86)90210-1; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; TANABE T, 1985, NATURE, V315, P242, DOI 10.1038/315242a0; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VANVEEN T, 1986, P NATL ACAD SCI USA, V83, P912; VANVEEN T, 1986, FEBS LETT, V208, P133, DOI 10.1016/0014-5793(86)81547-2; VIGHTEICHMANN I, 1986, PINEAL RETINAL RELAT, P401; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; ZACK DJ, 1991, NEURON, V6; ZIMMERMAN RP, 1988, J COMP NEUROL, V274, P77, DOI 10.1002/cne.902740108	51	166	170	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1991	6	2					201	210		10.1016/0896-6273(91)90356-5	http://dx.doi.org/10.1016/0896-6273(91)90356-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1825171				2022-12-28	WOS:A1991EY70900003
J	DRAGUHN, A; VERDORN, TA; EWERT, M; SEEBURG, PH; SAKMANN, B				DRAGUHN, A; VERDORN, TA; EWERT, M; SEEBURG, PH; SAKMANN, B			FUNCTIONAL AND MOLECULAR DISTINCTION BETWEEN RECOMBINANT RAT GABA-A RECEPTOR SUBTYPES BY ZN-2+	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR; ZINC; EXPRESSION; RELEASE; SUBUNITS; NEURONS; CELLS; HETEROGENEITY; RESPONSES; CHANNELS	Gamma-Aminobutyric acid receptor (GABA(A)R) channels in different neurons display heterogeneous functional properties. Molecular cloning revealed a large number of GABA(A)R subunits that assemble into GABA(A)R subtypes with different functional properties, suggesting that the subunit combination determines the functional properties of the receptor. In this study, the subunit composition of GABA(A)Rs is related to a functional distinction between Zn2+-sensitive and Zn2+-insensitive receptor subtypes. GABA(A)Rs reconstituted in transiently transfected fibroblasts from combinations of cDNAs encoding alpha and beta subunits are potently blocked by Zn2+. The presence of a gamma subunit in any combination with the other subunits leads to the formation of GABA(A)Rs that are almost insensitive to Zn2+. These data provide a structural correlate to the functional heterogeneity of the action of Zn2+ on GABA(A)Rs in native membranes and show that Zn2+ insensitivity of GABA-activated currents indicates the presence of a gamma-subunit in the assembled GABA(A)R channel.	UNIV HEIDELBERG,CTR MOLEC BIOL,MOLEC NEUROENDOCRINOL LAB,W-6900 HEIDELBERG,GERMANY	Ruprecht Karls University Heidelberg	DRAGUHN, A (corresponding author), MAX PLANCK INST MED RES,ZELLPHYSIOL ABT,W-6900 HEIDELBERG 1,GERMANY.							AKAIKE N, 1987, CELL MOL NEUROBIOL, V7, P97, DOI 10.1007/BF00734993; ANIKSZTEJN L, 1987, BRAIN RES, V404, P58, DOI 10.1016/0006-8993(87)91355-2; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BLAIR LAC, 1988, SCIENCE, V242, P577, DOI 10.1126/science.2845583; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CURTIS DR, 1987, BRAIN RES, V422, P192, DOI 10.1016/0006-8993(87)90558-0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAUG FMS, 1967, HISTOCHEMISTRY, V8, P355, DOI 10.1007/BF00401978; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; KANEKO A, 1986, J PHYSIOL-LONDON, V373, P463, DOI 10.1113/jphysiol.1986.sp016058; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MALHERBE P, 1990, FEBS LETT, V260, P261, DOI 10.1016/0014-5793(90)80118-3; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P351, DOI 10.1113/jphysiol.1989.sp017725; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MOHLER H, 1990, NEUROCHEM RES, V15, P199, DOI 10.1007/BF00972210; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; PEREZCLAUSELL J, 1986, BRAIN RES, V362, P358, DOI 10.1016/0006-8993(86)90463-4; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SMART TG, 1983, NEUROSCI LETT, V40, P205, DOI 10.1016/0304-3940(83)90303-8; SMART TG, 1982, PROC R SOC SER B-BIO, V215, P327, DOI 10.1098/rspb.1982.0045; SMART TG, 1990, BRIT J PHARMACOL, V99, P643, DOI 10.1111/j.1476-5381.1990.tb12984.x; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; WINEGAR BD, 1990, J PHYSIOL-LONDON, V425, P563, DOI 10.1113/jphysiol.1990.sp018118; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x; YMER S, 1989, FEBS LETT, V258, P119, DOI 10.1016/0014-5793(89)81630-8; YMER S, 1990, IN PRESS EMBO J	40	387	390	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1990	5	6					781	788		10.1016/0896-6273(90)90337-F	http://dx.doi.org/10.1016/0896-6273(90)90337-F			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ381	1702644				2022-12-28	WOS:A1990EQ38100005
J	WESTENBROEK, RE; HELL, JW; WARNER, C; DUBEL, SJ; SNUTCH, TP; CATTERALL, WA				WESTENBROEK, RE; HELL, JW; WARNER, C; DUBEL, SJ; SNUTCH, TP; CATTERALL, WA			BIOCHEMICAL-PROPERTIES AND SUBCELLULAR-DISTRIBUTION OF AN N-TYPE CALCIUM CHANNEL-ALPHA-1 SUBUNIT	NEURON			English	Article							OMEGA-CONOTOXIN GVIA; CENTRAL-NERVOUS-SYSTEM; 2 SIZE FORMS; SKELETAL-MUSCLE; BETA-SUBUNIT; CA-2+ CHANNELS; RAT-BRAIN; FUNCTIONAL EXPRESSION; CA2+ CHANNELS; DIFFERENTIAL SENSITIVITY	A site-directed anti-peptide antibody, CNB-1, that recognizes the alpha1 subunit of rat brain class B calcium channels (rbB) immunoprecipitated 43% of the N-type calcium channels labeled by [I-125]omega-conotoxin. CNB-1 recognized proteins of 240 and 210 kd, suggesting the presence of two size forms of this alpha1 subunit. Calcium channels recognized by CNB-1 were localized predominantly in dendrites; both dendritic shafts and punctate synaptic structures upon the dendrites were labeled. The large terminals of the mossy fibers of the dentate gyrus granule neurons were heavily labeled, suggesting that the punctate labeling pattern represents calcium channels in nerve terminals. The pattern of immunostaining was cell specific. The cell bodies of some pyramidal cells in layers II, III, and V of the dorsal cortex, Purkinje cells, and scattered cell bodies elsewhere in the brain were also labeled at a low level. The results define complementary distributions of N- and L-type calcium channels in dendrites, nerve terminals, and cell bodies of most central neurons and support distinct functional roles in calcium-dependent electrical activity, intracellular calcium regulation, and neurotransmitter release for these two channel types.	UNIV BRITISH COLUMBIA,DEPT ZOOL,BIOTECHNOL LAB,VANCOUVER V6T 1Z3,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT NEUROSCI,VANCOUVER V6T 1Z3,BC,CANADA	University of British Columbia; University of British Columbia	WESTENBROEK, RE (corresponding author), UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195, USA.		Snutch, Terrance P/L-3464-2019; Hell, Johannes W./P-5085-2019	Snutch, Terrance P/0000-0001-5182-1296; 	NINDS NIH HHS [P01 NS20484] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLIJANIAN MK, 1991, J BIOL CHEM, V266, P20192; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CATTERALL WA, 1988, J BIOL CHEM, V263, P3535; COHEN MW, 1991, J NEUROSCI, V11, P1032; CRILL WE, 1983, TRENDS NEUROSCI, V6, P236, DOI 10.1016/0166-2236(83)90101-7; DAYANITHI G, 1988, BIOCHEM BIOPH RES CO, V156, P255, DOI 10.1016/S0006-291X(88)80833-7; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DEJONGH KS, 1991, P NATL ACAD SCI USA, V88, P10778, DOI 10.1073/pnas.88.23.10778; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; DUTAR P, 1989, EUR J PHARMACOL, V174, P261, DOI 10.1016/0014-2999(89)90318-X; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; ELLISMAN MH, 1990, NEURON, V5, P135, DOI 10.1016/0896-6273(90)90304-X; FORTIER LP, 1991, MOL BRAIN RES, V9, P209, DOI 10.1016/0169-328X(91)90004-H; GRINNELL AD, 1989, J PHYSIOL-LONDON, V418, P397, DOI 10.1113/jphysiol.1989.sp017848; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; JAY SD, 1991, J BIOL CHEM, V266, P3287; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; JONES OT, 1989, SCIENCE, V244, P1189, DOI 10.1126/science.2543080; KERR LM, 1988, EUR J PHARMACOL, V146, P181, DOI 10.1016/0014-2999(88)90501-8; KERR LM, 1984, NATURE, V308, P282, DOI 10.1038/308282a0; KIM HL, 1992, P NATL ACAD SCI USA, V89, P3251, DOI 10.1073/pnas.89.8.3251; KOYANO K, 1987, EUR J PHARMACOL, V135, P337, DOI 10.1016/0014-2999(87)90683-2; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LAI Y, 1990, J BIOL CHEM, V265, P20839; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; Llinas R, 1979, Prog Brain Res, V51, P323; LLINAS R, 1984, BRAIN SLICES, P7; LUNDY PM, 1988, EUR J PHARMACOL, V156, P325, DOI 10.1016/0014-2999(88)90277-4; MAGGI CA, 1990, NEUROSCI LETT, V114, P203, DOI 10.1016/0304-3940(90)90072-H; MCENERY MW, 1991, P NATL ACAD SCI USA, V88, P11095, DOI 10.1073/pnas.88.24.11095; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Orth DN, 1979, METHOD HORM RADIOIMM, P245; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; PROTTI DA, 1991, BRAIN RES, V557, P336, DOI 10.1016/0006-8993(91)90156-P; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; REYNOLDS IJ, 1986, P NATL ACAD SCI USA, V83, P8804, DOI 10.1073/pnas.83.22.8804; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; ROTMAN EI, 1992, J BIOL CHEM, V267, P16100; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SAKAMOTO J, 1991, J BIOL CHEM, V266, P18914; SANO K, 1987, EUR J PHARMACOL, V141, P235, DOI 10.1016/0014-2999(87)90268-8; SEABROOK GR, 1989, BRIT J PHARMACOL, V97, P1125, DOI 10.1111/j.1476-5381.1989.tb12570.x; SEINO S, 1992, P NATL ACAD SCI USA, V89, P584, DOI 10.1073/pnas.89.2.584; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; STANLEY EF, 1991, J NEUROSCI, V11, P985; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; Sternberger LA, 1979, IMMUNOCYTOCHEMISTRY, P104; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TAKEMURA M, 1988, BRAIN RES, V451, P386, DOI 10.1016/0006-8993(88)90790-1; TAKEMURA M, 1989, NEUROSCIENCE, V32, P405, DOI 10.1016/0306-4522(89)90089-4; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; UCHITEL OD, 1992, P NATL ACAD SCI USA, V89, P3330, DOI 10.1073/pnas.89.8.3330; USOWICZ MM, 1990, J PHYSIOL-LONDON, V426, P95, DOI 10.1113/jphysiol.1990.sp018128; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; VENEMA VJ, 1992, J BIOL CHEM, V267, P2610; VONSPRECKELSEN S, 1990, BRAIN RES, V514, P68, DOI 10.1016/0006-8993(90)90436-F; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; WEI XY, 1991, J BIOL CHEM, V266, P21943; WESSLER I, 1990, NEUROSCI LETT, V108, P173, DOI 10.1016/0304-3940(90)90726-P; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; WOODWARD JJ, 1988, BRAIN RES, V475, P141, DOI 10.1016/0006-8993(88)90207-7; XIANG JZ, 1990, NEUROPHARMACOLOGY, V29, P439, DOI 10.1016/0028-3908(90)90165-N	84	497	505	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1099	1115		10.1016/0896-6273(92)90069-P	http://dx.doi.org/10.1016/0896-6273(92)90069-P			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1334419				2022-12-28	WOS:A1992KD71600009
J	KRAMER, RH; SIEGELBAUM, SA				KRAMER, RH; SIEGELBAUM, SA			INTRACELLULAR CA2+ REGULATES THE SENSITIVITY OF CYCLIC NUCLEOTIDE-GATED CHANNELS IN OLFACTORY RECEPTOR NEURONS	NEURON			English	Article							GMP-ACTIVATED CONDUCTANCE; ADENYLATE-CYCLASE; RETINAL RODS; CALCIUM; CELLS; ODORANTS; PROTEIN; CILIA; NEWT; PHOSPHODIESTERASE	In olfactory receptor neurons, odorants stimulate production of cAMP, which directly activates cyclic nucleotide-gated (CNG) channels. Olfactory adaptation is thought to result from a rise in intracellular Ca2+. To determine whether inhibition of CNG channels plays a role in adaptation, we have investigated the action of Ca2+ on these channels in inside-out "macro" patches from the dendrite and cilia of catfish olfactory neurons. Internal Ca2+, with a K1/2 of 3 muM, profoundly inhibits CNG channels by shifting the dose-response relationship to higher cAMP levels without altering the maximal response. The inhibition does not appear to result from a direct interaction of Ca2+ with the CNG channel. Thus, the inhibition washes out after excision of the inside-out patch, and Ca2+ does not inhibit the cloned catfish CNG channel expressed in Xenopus oocytes. Hence we propose that a regulatory Ca2+-binding protein, distinct from the CNG channel, controls the gain of signal transduction and contributes to olfactory adaptation by decreasing the sensitivity of the CNG channel to cAMP.	COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; Howard Hughes Medical Institute	KRAMER, RH (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,DEPT PHARMACOL,NEW YORK,NY 10032, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030685] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30685] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; ALTENHOFENW, 1991, P NATL ACAD SCI USA, V88, P9868; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BLATTER LA, 1989, J PHYSIOL-LONDON, V418, pP154; BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P471, DOI 10.1073/pnas.89.2.471; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BORISY FF, 1992, JJ NEUUROSCI, V12, P9115; BRAUMANN T, 1986, BIOCHIM BIOPHYS ACTA, V871, P199, DOI 10.1016/0167-4838(86)90174-3; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; COLOMARTINO G, 1991, J PHYSL, V440, P189; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; FIRESTEIN S, 1991, J NEUROSCI, V11, P3565; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HAYNES LW, 1990, J PHYSIOL-LONDON, V429, P451, DOI 10.1113/jphysiol.1990.sp018267; HELDMAN J, 1986, J NEUROCHEM, V47, P1527, DOI 10.1111/j.1471-4159.1986.tb00790.x; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KURAHASHI T, 1989, J PHYSIOL-LONDON, V419, P177, DOI 10.1113/jphysiol.1989.sp017868; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MIYAMOTO T, 1992, J GEN PHYSIOL, V99, P505, DOI 10.1085/jgp.99.4.505; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NAKAYAMA S, 1991, J PHYSIOL-LONDON, V435, P559, DOI 10.1113/jphysiol.1991.sp018525; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; RESTREPO D, 1990, AM J PHYSIOL, V258, pC1051, DOI 10.1152/ajpcell.1990.258.6.C1051; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; SHIRLEY SG, 1986, BIOCHEM J, V240, P605, DOI 10.1042/bj2400605; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; ZUFALL F, 1991, J NEUROSCI, V11, P3573; ZUFALL F, 1991, P ROY SOC LOND B BIO, P225	42	111	112	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1992	9	5					897	906		10.1016/0896-6273(92)90242-6	http://dx.doi.org/10.1016/0896-6273(92)90242-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1384576				2022-12-28	WOS:A1992JY55200009
J	HEMMATIBRIVANLOU, A; MANN, RW; HARLAND, RM				HEMMATIBRIVANLOU, A; MANN, RW; HARLAND, RM			A PROTEIN EXPRESSED IN THE GROWTH CONES OF EMBRYONIC VERTEBRATE NEURONS DEFINES A NEW CLASS OF INTERMEDIATE FILAMENT PROTEIN	NEURON			English	Article							XENOPUS-LAEVIS; MESSENGER-RNAS; SEQUENCE; OOCYTES; CELL; GENE; CYTOKERATINS; LOCALIZATION; MORPHOLOGY; MOTILITY	We have isolated and characterized cDNAs that encode a protein expressed in the axons and growth cones of a subset of Xenopus embryonic neurons. The protein is also expressed in a subset of cells of the brain, including cells in even-numbered rhombomeres, the eye, and the heart. The sequence of the cDNA suggests that the protein belongs to a new class of neural-specific intermediate filaments. Both the RNA and the protein are expressed in the neurula and persist during embryogenesis in the brain, cranial nerves, and spinal cord. Because of the predicted structure of the protein, we have named it tanabin (from the Persian word for rope).	UNIV CALIF BERKELEY,DEPT MOLEC & CELLULAR BIOL,DIV BIOCHEM & MOLEC BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley								BENAVENTE R, 1985, CELL, V41, P177, DOI 10.1016/0092-8674(85)90072-8; BENAVENTE R, 1985, P NATL ACAD SCI USA, V82, P6176, DOI 10.1073/pnas.82.18.6176; BENNETT GS, 1979, J CELL BIOL, V82, P577, DOI 10.1083/jcb.82.2.577; BOVOLENTA P, 1987, J NEUROSCI, V7, P1447; BRAY D, 1988, ANNU REV CELL BIOL, V4, P43, DOI 10.1146/annurev.cb.04.110188.000355; BRUTLAG DL, 1990, COMPUT APPL BIOSCI, V6, P237; CARLSON BM, 1988, PATTENS F EMBRYOLOGY, P4422; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; CONDIE BG, 1987, DEVELOPMENT, V101, P93; DAVIES SN, 1982, J EMBRYOL EXP MORPH, V70, P215; FLIEGNER KH, 1991, INT REV CYTOL, V131, P109, DOI 10.1016/S0074-7696(08)62018-5; FOUQUET B, 1988, DEVELOPMENT, V104, P533; FRANK D, 1991, DEVELOPMENT, V113, P1387; FRANZ JK, 1983, P NATL ACAD SCI-BIOL, V80, P6254, DOI 10.1073/pnas.80.20.6254; FRANZ JK, 1986, P NATL ACAD SCI USA, V83, P6475, DOI 10.1073/pnas.83.17.6475; HARLAND RM, 1991, METHOD CELL BIOL, V36, P675; HASHIMOTO C, 1991, DEVELOPMENT, V111, P1021; HEMMATIBRIVANLO.A, 1989, DEVELOPMENT, V106, P611; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HOLT CE, 1984, J NEUROSCI, V4, P1130; JAMRICH M, 1987, GENE DEV, V1, P124, DOI 10.1101/gad.1.2.124; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; KLYMKOWSKY MW, 1987, DEVELOPMENT, V100, P543; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; MIYATANI S, 1986, J CELL BIOL, V103, P1957, DOI 10.1083/jcb.103.5.1957; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; PAPALOPULU N, 1991, DEVELOPMENT, V113, P1145; QUINLAN RA, 1982, P NATL ACAD SCI-BIOL, V79, P3452, DOI 10.1073/pnas.79.11.3452; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHARPE CR, 1988, DEVELOPMENT, V103, P269; SHARPE CR, 1989, DEVELOPMENT, V107, P701; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; STICK R, 1985, CELL, V41, P191, DOI 10.1016/0092-8674(85)90073-X; SZARO BG, 1989, DEV BRAIN RES, V48, P87, DOI 10.1016/0165-3806(89)90095-3; TANAKA EM, 1991, J CELL BIOL, V115, P345, DOI 10.1083/jcb.115.2.345; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; WYLIE CC, 1985, J EMBRYOL EXP MORPH, V89, P1	45	55	57	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					417	428		10.1016/0896-6273(92)90180-L	http://dx.doi.org/10.1016/0896-6273(92)90180-L			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1524825				2022-12-28	WOS:A1992JM57100004
J	MARTINEZ, S; WASSEF, M; ALVARADOMALLART, RM				MARTINEZ, S; WASSEF, M; ALVARADOMALLART, RM			INDUCTION OF A MESENCEPHALIC PHENOTYPE IN THE 2-DAY-OLD CHICK PROSENCEPHALON IS PRECEDED BY THE EARLY EXPRESSION OF THE HOMEOBOX GENE EN	NEURON			English	Article							PROTO-ONCOGENE INT-1; DROSOPHILA ENGRAILED GENE; SEQUENCE HOMOLOGY; NERVOUS-SYSTEM; QUAIL CHIMERAS; MOUSE-BRAIN; NEURAL-TUBE; EMBRYOS; DIFFERENTIATION; EMBRYOGENESIS	The homeobox gene en, homologous to the gene engrailed of Drosophila, is expressed in the metencephalic-mesencephalic segment of the vertebrate neural tube. Using quail-chick chimeras, an antibody against en proteins, and cytoarchitectonic techniques, we demonstrate that metencephalon transplanted to prosencephalon, at E2, maintains a high level of en proteins and its presumptive cerebellar fate. The ectopic metencephalon induces in the contiguous host prosencephalon the expression of en and, subsequently, a mesencephalic phenotype. These related genetic and phenotypic expressions indicate that the transcriptional regulatory en gene is involved in cerebellar and mesencephalic cytodifferentiation. The expression of en can also be induced in chick prosencephalon by a mammalian metencephalic graft, indicating that the factors regulating the transcription of en are phylogenetically well conserved.	HOP LA PITIE SALPETRIERE,INSERM,U106,F-75651 PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite			Mratinez, Salvador/L-4896-2014	Mratinez, Salvador/0000-0002-9320-4103; Martinez, Salvador/0000-0002-2910-8926				ALVARADOMALLART RM, 1990, DEV BIOL, V139, P75, DOI 10.1016/0012-1606(90)90280-V; ALVARADOMALLART RM, 1984, DEV BIOL, V103, P378, DOI 10.1016/0012-1606(84)90326-9; ALVARADOMALLART RM, 1990, AVIAN MODEL IN DEVELOPMENT BIOLOGY : FROM ORGANISM TO GENES, P93; BRIVANLOU AH, 1989, DEVELOPMENT, V106, P611; BRIVANLOU AH, 1990, SCIENCE, V250, P800; COOKE J, 1985, TRENDS NEUROSCI, V8, P58, DOI 10.1016/0166-2236(85)90027-X; DAVIDSON D, 1988, DEVELOPMENT, V104, P305; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DAVIS CA, 1988, GENE DEV, V2, P361, DOI 10.1101/gad.2.3.361; DESPLAN C, 1985, NATURE, V318, P630, DOI 10.1038/318630a0; Feulgen R, 1924, H-S Z PHYSIOL CHEM, V135, P203, DOI 10.1515/bchm2.1924.135.5-6.203; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; GARCIABELLIDO A, 1976, DEV BIOL, V48, P132, DOI 10.1016/0012-1606(76)90052-X; GARDNER CA, 1988, J NEUROSCI RES, V21, P426, DOI 10.1002/jnr.490210234; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOLLAND PWH, 1989, TRENDS NEUROSCI, V12, P206, DOI 10.1016/0166-2236(89)90122-7; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; JOYNER AL, 1985, CELL, V43, P29, DOI 10.1016/0092-8674(85)90009-1; LANCEJONES CC, 1987, J HISTOCHEM CYTOCHEM, V35, P771, DOI 10.1177/35.7.3295031; LAWRENCE PA, 1990, NATURE, V344, P382, DOI 10.1038/344382a0; LEDOUARIN N, 1969, B BIOL FR BELG, V103, P436; LEDOUARIN NM, 1982, DEV CELL BIOL 12; MARTINEZ S, 1990, DEV BIOL, V139, P432, DOI 10.1016/0012-1606(90)90312-7; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; NAKAMURA H, 1986, CELL DIFFER DEV, V19, P187, DOI 10.1016/0045-6039(86)90095-3; NAKAMURA H, 1990, BRAIN RES, V511, P122, DOI 10.1016/0006-8993(90)90231-Y; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PUELLES L, 1987, J COMP NEUROL, V266, P247, DOI 10.1002/cne.902660210; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; Spemann H., 1938, EMBRYONIC DEV INDUCT; STERNBER.LA, 1970, J HISTOCHEM CYTOCHEM, V18, P315, DOI 10.1177/18.5.315; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7	38	284	285	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1991	6	6					971	981		10.1016/0896-6273(91)90237-T	http://dx.doi.org/10.1016/0896-6273(91)90237-T			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	1675863				2022-12-28	WOS:A1991FT94900012
J	HALLBOOK, F; IBANEZ, CF; PERSSON, H				HALLBOOK, F; IBANEZ, CF; PERSSON, H			EVOLUTIONARY STUDIES OF THE NERVE GROWTH-FACTOR FAMILY REVEAL A NOVEL MEMBER ABUNDANTLY EXPRESSED IN XENOPUS OVARY	NEURON			English	Article							RECEPTOR MESSENGER-RNA; POLYMERASE CHAIN-REACTION; HIGH-AFFINITY RECEPTORS; NEUROTROPHIC FACTOR; MOLECULAR-CLONING; FACTOR GENE; NGF-RECEPTOR; PC12 CELLS; DEVELOPMENTAL EXPRESSION; PHEOCHROMOCYTOMA CELLS	Evolutionary conservation of members of the NGF family in vertebrates was studied by DNA sequence analysis of PCR fragments for NGF, BDNF, and NT-3 from human, rat, chicken, viper, Xenopus, salmon, and ray. The results showed that the three factors are highly conserved from fishes to mammals. Phylogenetic trees reflecting the evolution and speciation of the members of the NGF family were constructed. In addition, the gene for a fourth member of the family, neurotrophin-4 (NT-4), was isolated from Xenopus and viper. The NT-4 gene encodes a precursor protein of 236 amino acids, which is processed into a 123 amino acid mature NT-4 protein with 50%-60% amino acid identity to NGF, BDNF, and NT-3. The NT-4 protein was shown to interact with the low affinity NGF receptor and elicited neurite outgrowth from explanted dorsal root ganglia with no and lower activity in sympathetic and nodose ganglia, respectively. Northern blot analysis of different tissues from Xenopus showed NT-4 mRNA only in ovary, where it was present at levels over 100-fold higher than those of NGF mRNA in heart.			HALLBOOK, F (corresponding author), KAROLINSKA INST,DEPT MED CHEM,MOLEC ENDOCRINOL LAB,S-10401 STOCKHOLM 60,SWEDEN.			Hallbook, Finn/0000-0001-7552-187X	NIA NIH HHS [AG 04418] Funding Source: Medline; NINDS NIH HHS [NS 09199] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS009199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; ANGELETT.RH, 1973, BIOCHEMISTRY-US, V12, P100, DOI 10.1021/bi00725a018; [Anonymous], 1982, EVOLUTION DEV; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; AYERLELIEVRE C, 1988, P NATL ACAD SCI USA, V85, P2628, DOI 10.1073/pnas.85.8.2628; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Battey, 1986, BASIC METHODS MOL BI; BERND P, 1984, J BIOL CHEM, V259, P5509; BRADSHAW RA, 1978, ANNU REV BIOCHEM, V47, P191, DOI 10.1146/annurev.bi.47.070178.001203; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRUTCHER KA, 1982, SCIENCE, V217, P67, DOI 10.1126/science.7089542; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Dickerson R E., 1971, Journal Molec Evol, V1, P26, DOI 10.1007/BF01659392; Ebendal T, 1989, Prog Growth Factor Res, V1, P143, DOI 10.1016/0955-2235(89)90008-2; EBENDAL T, 1986, EMBO J, V5, P1483, DOI 10.1002/j.1460-2075.1986.tb04386.x; EBENDAL T, 1988, DEVELOPMENT, V102, P101; EBENDAL T, 1989, NERVE GROWTH FACTORS, P81; EBENDAL T, 1984, ORGANIZING PRINCIPLE, P93; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; ERNFORS P, 1991, INT J DEV NEUROSCI, V9, P57, DOI 10.1016/0736-5748(91)90073-U; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; HALLBOOK F, 1988, MOL CELL BIOL, V8, P452, DOI 10.1128/MCB.8.1.452; HALLBOOK F, 1990, DEVELOPMENT, V108, P693; HARPER GP, 1981, ANNU REV PHARMACOL, V21, P205, DOI 10.1146/annurev.pa.21.040181.001225; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HEUER JG, 1990, DEV BIOL, V137, P287, DOI 10.1016/0012-1606(90)90255-H; HEUER JG, 1990, NEURON, V5, P283, DOI 10.1016/0896-6273(90)90165-C; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HOSANG M, 1987, EMBO J, V6, P1197, DOI 10.1002/j.1460-2075.1987.tb02354.x; IBANEZ CF, 1990, EMBO J, V9, P1477, DOI 10.1002/j.1460-2075.1990.tb08265.x; IBANEZ CF, 1991, IN PRESS J NEUROCHEM; IBANEZ CF, 1991, IN PRESS EMBO J; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KALCHEIM C, 1988, DEV BRAIN RES, V41, P79, DOI 10.1016/0165-3806(88)90171-X; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; Kimura M., 1983, P208; KIMURA M, 1973, NATURE-NEW BIOL, V13, P199; KNOTH K, 1988, NUCLEIC ACIDS RES, V16, P10932, DOI 10.1093/nar/16.22.10932; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Li W.-H., 1983, P14; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MALLETT S, 1990, EMBO J, V9, P1063, DOI 10.1002/j.1460-2075.1990.tb08211.x; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MEIER R, 1986, EMBO J, V5, P1489, DOI 10.1002/j.1460-2075.1986.tb04387.x; NUNBERG JH, 1989, J VIROL, V63, P3240, DOI 10.1128/JVI.63.8.3240-3249.1989; OLENDER EJ, 1980, J BIOL CHEM, V255, P9338; OLSON L, 1987, CELL TISSUE RES, V248, P275; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; PERSSON H, 1990, SCIENCE, V247, P704, DOI 10.1126/science.2154035; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROMER AS, 1976, VERTEBRATE BODY; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SCHWARZ MA, 1989, J NEUROCHEM, V52, P1203, DOI 10.1111/j.1471-4159.1989.tb01867.x; SCHWARZ MA, 1979, ATLAS PROTEIN SEQUEN, P353; SCOTT J, 1983, NATURE, V302, P538, DOI 10.1038/302538a0; SELBY MJ, 1987, J NEUROSCI RES, V18, P293, DOI 10.1002/jnr.490180205; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; SUTTER A, 1979, J BIOL CHEM, V254, P5972; Swofford David L., 1990, P411; THOENEN H, 1987, REV PHYSIOL BIOCH P, V109, P145, DOI 10.1007/BFb0031026; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; ULLRICH A, 1983, NATURE, V303, P821, DOI 10.1038/303821a0; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WHITTEMORE SR, 1987, BRAIN RES REV, V12, P439, DOI 10.1016/0165-0173(87)90008-7; WHITTEMORE SR, 1988, J NEUROSCI RES, V20, P403, DOI 10.1002/jnr.490200402; WION D, 1986, FEBS LETT, V203, P82, DOI 10.1016/0014-5793(86)81441-7; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0; Young JZ, 1981, LIFE VERTEBRATES	94	697	758	0	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					845	858		10.1016/0896-6273(91)90180-8	http://dx.doi.org/10.1016/0896-6273(91)90180-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	2025430				2022-12-28	WOS:A1991FM52200016
J	RUPP, F; PAYAN, DG; MAGILLSOLC, C; COWAN, DM; SCHELLER, RH				RUPP, F; PAYAN, DG; MAGILLSOLC, C; COWAN, DM; SCHELLER, RH			STRUCTURE AND EXPRESSION OF A RAT AGRIN	NEURON			English	Article							CULTURED MUSCLE-CELLS; GENE-RELATED PEPTIDE; NICOTINIC ACETYLCHOLINE-RECEPTORS; TORPEDO ELECTRIC ORGAN; AMINO-ACID SEQUENCE; NEURITE OUTGROWTH; BRAIN EXTRACT; BASAL LAMINA; NEUROMUSCULAR-JUNCTIONS; SKELETAL-MUSCLE	Agrin is a component of the basal lamina that causes the aggregation of acetylcholine receptors on cultured muscle fibers. An agrin cDNA clone isolated from electromotor neurons of a marine ray was used to characterize the corresponding cDNAs from a rat embryonic spinal cord library. Analysis of a set of clones predicts a 1940 amino acid protein containing 141 cysteine residues. The predicted protein has nine domains homologous to protease inhibitors, a region similar to domain III of laminin, and four epidermal growth factor repeats. The agrin gene is expressed in rat embryonic nervous system and muscle. The rat agrin protein is concentrated at synapses, where it may play a role in development and regeneration.			RUPP, F (corresponding author), STANFORD UNIV,BECKMAN CTR,HOWARD HUGHES MED INST,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021710] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21710] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; ANGERER LM, 1987, IN SITU HYBRIDIZATIO, P42; ANGLISTER L, 1985, J CELL BIOL, V101, P735, DOI 10.1083/jcb.101.3.735; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BEVAN S, 1977, J PHYSIOL-LONDON, V267, P195, DOI 10.1113/jphysiol.1977.sp011808; BUCCARON MH, 1983, DEV BIOL, V95, P378, DOI 10.1016/0012-1606(83)90039-8; DAVIS C G, 1990, New Biologist, V2, P410; DENNIS MJ, 1981, ANNU REV NEUROSCI, V4, P43, DOI 10.1146/annurev.ne.04.030181.000355; DUBINSKY JM, 1989, J CELL BIOL, V109, P1733, DOI 10.1083/jcb.109.4.1733; EDGAR D, 1984, EMBO J, V3, P1463, DOI 10.1002/j.1460-2075.1984.tb01997.x; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; FALLON JR, 1985, NATURE, V315, P571, DOI 10.1038/315571a0; FONTAINE B, 1987, J CELL BIOL, V105, P1337, DOI 10.1083/jcb.105.3.1337; FONTAINE B, 1986, NEUROSCI LETT, V71, P59, DOI 10.1016/0304-3940(86)90257-0; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GLOOR S, 1986, CELL, V47, P687; GODFREY EW, 1988, J CELL BIOL, V106, P1263, DOI 10.1083/jcb.106.4.1263; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HARLOW E, 1988, ANTIBODIES LABORATOR; HARRIS DA, 1988, P NATL ACAD SCI USA, V85, P1983, DOI 10.1073/pnas.85.6.1983; HAWKINS RL, 1986, BRAIN RES, V398, P63, DOI 10.1016/0006-8993(86)91250-3; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; HUNTER DD, 1989, CELL, V59, P905, DOI 10.1016/0092-8674(89)90613-2; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; JESSELL TM, 1979, P NATL ACAD SCI USA, V76, P5397, DOI 10.1073/pnas.76.10.5397; KAZAL LA, 1948, J AM CHEM SOC, V70, P3034, DOI 10.1021/ja01189a060; KNAACK D, 1985, P NATL ACAD SCI USA, V82, P575, DOI 10.1073/pnas.82.2.575; KOERNER TJ, 1990, IN PRESS METH ENZYMO; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LIESI P, 1989, FEBS LETT, V244, P141, DOI 10.1016/0014-5793(89)81180-9; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MARKELONIS GJ, 1982, DEV BIOL, V89, P353, DOI 10.1016/0012-1606(82)90324-4; MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cellbio.3.1.57; MCMAHAN UJ, 1984, J CELL BIOL, V98, P1453, DOI 10.1083/jcb.98.4.1453; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8; MONTELL DJ, 1988, CELL, V53, P463, DOI 10.1016/0092-8674(88)90166-3; NEUGEBAUER K, 1985, BRAIN RES, V346, P58, DOI 10.1016/0006-8993(85)91094-7; NEW HV, 1986, NATURE, V323, P809, DOI 10.1038/323809a0; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; OLEK AJ, 1983, CELL, V34, P255, DOI 10.1016/0092-8674(83)90156-3; PANAYOTOU G, 1989, CELL, V56, P93, DOI 10.1016/0092-8674(89)90987-2; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; PIKKARAINEN T, 1987, J BIOL CHEM, V262, P10454; PIKKARAINEN T, 1988, J BIOL CHEM, V263, P6751; PODLESKI TR, 1978, P NATL ACAD SCI USA, V75, P2035, DOI 10.1073/pnas.75.4.2035; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; ROLE LW, 1985, J NEUROSCI, V5, P2197; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; SALPETER MM, 1982, J CELL BIOL, V93, P417, DOI 10.1083/jcb.93.2.417; Sambrook J, 1989, MOL CLONING LABORATO; SCHUETZE SM, 1987, ANNU REV NEUROSCI, V10, P403, DOI 10.1146/annurev.ne.10.030187.002155; SMALL DH, 1990, TRENDS BIOCHEM SCI, V15, P213, DOI 10.1016/0968-0004(90)90027-9; SMITH MA, 1987, J EXP BIOL, V132, P223; USDIN TB, 1986, J CELL BIOL, V103, P493, DOI 10.1083/jcb.103.2.493; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5; ZISKINDCONHAIM L, 1984, J NEUROSCI, V4, P2346	62	272	279	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					811	823		10.1016/0896-6273(91)90177-2	http://dx.doi.org/10.1016/0896-6273(91)90177-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1851019				2022-12-28	WOS:A1991FM52200013
J	SUDHOF, TC; JAHN, R				SUDHOF, TC; JAHN, R			PROTEINS OF SYNAPTIC VESICLES INVOLVED IN EXOCYTOSIS AND MEMBRANE RECYCLING	NEURON			English	Review							GTP-BINDING PROTEIN; FROG NEUROMUSCULAR-JUNCTION; TERMINAL-SPECIFIC PHOSPHOPROTEIN; CLATHRIN-COATED VESICLES; CENTRAL NERVOUS-SYSTEM; AMINO-ACID SEQUENCES; VACUOLAR H+-ATPASE; SYNAPSIN-I; CHROMAFFIN GRANULES; BOVINE BRAIN		MAX PLANCK INST PSYCHIAT,NEUROCHEM ABT,W-8033 PLANEGG,GERMANY	Max Planck Society	SUDHOF, TC (corresponding author), UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DEPT MOLEC GENET,DALLAS,TX 75235, USA.			Jahn, Reinhard/0000-0003-1542-3498				AHLE S, 1990, J CELL BIOL, V111, P19, DOI 10.1083/jcb.111.1.19; AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; ALMERS W, 1990, NEURON, V4, P813, DOI 10.1016/0896-6273(90)90134-2; ARAKI S, 1990, J BIOL CHEM, V265, P13007; ARCHER BT, 1990, J BIOL CHEM, V265, P17267; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BAHLER M, 1989, J CELL BIOL, V108, P1841, DOI 10.1083/jcb.108.5.1841; BAINES AJ, 1986, NATURE, V319, P145, DOI 10.1038/319145a0; BAINES AJ, 1985, NATURE, V315, P410, DOI 10.1038/315410a0; BAJJALIEH SM, 1989, J BIOL CHEM, V264, P14354; BARKER LA, 1972, BIOCHEM J, V130, P1063, DOI 10.1042/bj1301063; BAUMERT M, 1990, J CELL BIOL, V110, P1285, DOI 10.1083/jcb.110.4.1285; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BENFENATI F, 1990, J BIOL CHEM, V265, P12584; BERNASCONI P, 1990, J BIOL CHEM, V265, P17428; BERNSTEIN BW, 1989, NEURON, V3, P257, DOI 10.1016/0896-6273(89)90039-1; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BRODSKY FM, 1983, J MOL BIOL, V167, P197, DOI 10.1016/S0022-2836(83)80041-2; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; FISCHER, 1990, P NATL ACAD SCI USA, V87, P1988; GOELZ SE, 1981, P NATL ACAD SCI USA, V78, P63; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HALL FL, 1990, J BIOL CHEM, V265, P6944; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; HIRSCH S, 1988, P NATL ACAD SCI USA, V85, P3004, DOI 10.1073/pnas.85.9.3004; HUANG CK, 1982, J BIOL CHEM, V257, P6524; HUTTNER WB, 1981, J BIOL CHEM, V256, P1482; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSON EM, 1972, J BIOL CHEM, V247, P5650; JOHNSON RG, 1988, PHYSIOL REV, V68, P232, DOI 10.1152/physrev.1988.68.1.232; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; JOHNSTON PA, 1989, EMBO J, V8, P2863, DOI 10.1002/j.1460-2075.1989.tb08434.x; JOHNSTON PA, 1991, IN PRESS NEURON; JOHNSTON PA, 1990, J BIOL CHEM, V265, P7849; Katz B., 1966, NERVE MUSCLE SYNAPSE; KENNEDY MB, 1981, P NATL ACAD SCU US, V72, P3488; KNAUS P, 1990, NEURON, V5, P453, DOI 10.1016/0896-6273(90)90084-S; KOHTZ DS, 1988, J BIOL CHEM, V263, P7418; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; LEUBE RE, 1989, CELL, V59, P433, DOI 10.1016/0092-8674(89)90028-7; LINIAL M, 1989, NEURON, V2, P1265, DOI 10.1016/0896-6273(89)90311-5; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MATSUI Y, 1988, J BIOL CHEM, V263, P11071; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Nestler E. J., 1984, PROTEIN PHOSPHORYLAT; NICHOLS RA, 1990, NATURE, V343, P647, DOI 10.1038/343647a0; NISHIZUKA Y, 1989, JAMA-J AM MED ASSOC, V262, P1826, DOI 10.1001/jama.262.13.1826; OZCELIK T, 1990, AM J HUM GENET, V47, P551; PANG DT, 1988, P NATL ACAD SCI USA, V85, P762, DOI 10.1073/pnas.85.3.762; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PERIN MS, 1988, EMBO J, V7, P2697, DOI 10.1002/j.1460-2075.1988.tb03123.x; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PERIN MS, 1991, IN PRESS J BIOL CHEM; PETRUCCI TC, 1988, J CELL BIOCHEM, V36, P25, DOI 10.1002/jcb.240360104; PETRUCCI TC, 1987, J CELL BIOL, V105, P1355, DOI 10.1083/jcb.105.3.1355; PFEFFER SR, 1985, CELL, V40, P949, DOI 10.1016/0092-8674(85)90355-1; PFENNINGER K, 1972, J NEUROCYTOL, V1, P129, DOI 10.1007/BF01099180; POW DV, 1989, NEUROSCIENCE, V32, P435, DOI 10.1016/0306-4522(89)90091-2; RAHAMIMOFF R, 1988, P NATL ACAD SCI USA, V85, P5310, DOI 10.1073/pnas.85.14.5310; REHM H, 1986, EMBO J, V5, P535, DOI 10.1002/j.1460-2075.1986.tb04243.x; SALKOFF L, 1978, NATURE, V273, P156, DOI 10.1038/273156a0; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SASAKI T, 1990, J BIOL CHEM, V265, P2333; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; SIHRA TS, 1989, P NATL ACAD SCI USA, V86, P8108, DOI 10.1073/pnas.86.20.8108; STADLER H, 1982, EMBO J, V1, P1381, DOI 10.1002/j.1460-2075.1982.tb01326.x; Steinbach J.H., 1976, P33; STEINER JP, 1987, BRAIN RES BULL, V18, P777, DOI 10.1016/0361-9230(87)90216-4; STERNBACH Y, 1990, J BIOL CHEM, V265, P3961; STONE DK, 1989, J BIOENERG BIOMEMBR, V21, P605, DOI 10.1007/BF00808116; SUDHOF TC, 1990, J BIOL CHEM, V265, P7849; SUDHOF TC, 1989, P NATL ACAD SCI USA, V86, P6067, DOI 10.1073/pnas.86.16.6067; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Sudhof TC, 1989, CURR OPIN CELL BIOL, V1, P655, DOI 10.1016/0955-0674(89)90030-6; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; THOMAS L, 1990, J CELL BIOL, V111, P2041, DOI 10.1083/jcb.111.5.2041; THURESONKLEIN A, 1983, NEUROSCIENCE, V10, P245, DOI 10.1016/0306-4522(83)90132-X; TRIFARO JM, 1989, NEUROSCIENCE, V29, P1, DOI 10.1016/0306-4522(89)90327-8; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WANG SY, 1988, J BIOL CHEM, V263, P17638; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; XIE XS, 1989, J BIOL CHEM, V264, P18870; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394	107	497	500	1	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					665	677		10.1016/0896-6273(91)90165-V	http://dx.doi.org/10.1016/0896-6273(91)90165-V			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1673848				2022-12-28	WOS:A1991FM52200001
J	LLEDO, PM; SOMASUNDARAM, B; MORTON, AJ; EMSON, PC; MASON, WT				LLEDO, PM; SOMASUNDARAM, B; MORTON, AJ; EMSON, PC; MASON, WT			STABLE TRANSFECTION OF CALBINDIN-D28K INTO THE GH3 CELL-LINE ALTERS CALCIUM CURRENTS AND INTRACELLULAR CALCIUM HOMEOSTASIS	NEURON			English	Article							CLONAL PITUITARY-CELLS; SQUID GIANT SYNAPSE; BINDING PROTEIN; CYTOSOLIC CA-2+; MOLLUSCAN NEURONS; ACTION-POTENTIALS; NERVOUS-SYSTEM; IONIC CURRENTS; WHOLE-CELL; K+ CURRENT	Previous work demonstrating the presence and differential distribution of Ca2+-binding proteins in the CNS has led to the proposal that cytosolic proteins, such as calbindin-D28k (CB), may play a pivotal role in neurons. We have used a retrovirus containing the full-length cDNA for CB to transfect the pituitary tumor cell line GH3, to generate CB-expressing GH3 cells and to investigate whether ionic channel activities as well as the concentration of intracellular free Ca2+ ([Ca2+]i) homeostasis could be altered by the presence of this Ca2+-binding protein. We show that CB-transfected GH3 cells exhibited lower Ca2+ entry through voltage-dependent Ca2+ channels and were better able to reduce [Ca2+]i transients evoked by voltage depolarizations than the wild-type parent cell line. These observations provide a mechanism by which CB may protect tissues against Ca2+-mediated excitotoxicity.	INST ANIM PHYSIOL & GENET RES,MED RES COUNCIL GRP,CAMBRIDGE CB2 4AT,ENGLAND; INST ANIM PHYSIOL & GENET RES,AGR FOOD RES COUNCIL,CAMBRIDGE CB2 4AT,ENGLAND	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	LLEDO, PM (corresponding author), INST ANIM PHYSIOL & GENET RES,DEPT NEUROBIOL,CAMBRIDGE CB2 4AT,ENGLAND.		Morton, Jenny/AAT-8642-2020	Morton, Jenny/0000-0003-0181-6346	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADLER EM, 1991, J NEUROSCI, V11, P1496; AHMED Z, 1988, CELL CALCIUM, V9, P57, DOI 10.1016/0143-4160(88)90025-5; ARMSTRONG D, 1987, P NATL ACAD SCI USA, V84, P2518, DOI 10.1073/pnas.84.8.2518; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BENHAM CD, 1989, J PHYSIOL-LONDON, V415, P143, DOI 10.1113/jphysiol.1989.sp017716; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; BURGOYNE RD, 1989, NATURE, V342, P72, DOI 10.1038/342072a0; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CHRISTAKOS S, 1989, ENDOCR REV, V10, P3, DOI 10.1210/edrv-10-1-3; COHEN CJ, 1987, J PHYSIOL-LONDON, V387, P195, DOI 10.1113/jphysiol.1987.sp016570; DUBINSKY JM, 1984, J GEN PHYSIOL, V83, P309, DOI 10.1085/jgp.83.3.309; DUTAR P, 1991, EUR J NEUROSCI, V3, P839, DOI 10.1111/j.1460-9568.1991.tb00095.x; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; FORSCHER P, 1985, J GEN PHYSIOL, V85, P743, DOI 10.1085/jgp.85.5.743; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEIZMANN CW, 1987, CELL CALCIUM, V8, P11; HERRINGTON J, 1991, NEUROSCIENCE, V11, P2226; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; HINRICHSEN RD, 1986, SCIENCE, V232, P503, DOI 10.1126/science.2421410; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078; ICHIMIYA Y, 1989, BRAIN RES, V499, P402, DOI 10.1016/0006-8993(89)90793-2; JACKSON AP, 1987, FEBS LETT, V216, P35, DOI 10.1016/0014-5793(87)80752-4; KALMAN D, 1988, J GEN PHYSIOL, V92, P531, DOI 10.1085/jgp.92.4.531; KATZ B, 1967, J PHYSIOL-LONDON, V192, P407, DOI 10.1113/jphysiol.1967.sp008307; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; KIMURA J, 1987, J PHYSIOL-LONDON, V384, P199, DOI 10.1113/jphysiol.1987.sp016450; KOHR G, 1991, J GEN PHYSIOL, V98, P941, DOI 10.1085/jgp.98.5.941; KORN SJ, 1989, J GEN PHYSIOL, V94, P789, DOI 10.1085/jgp.94.5.789; KRAMER RH, 1991, NEURON, V6, P557, DOI 10.1016/0896-6273(91)90058-8; LEATHERS VL, 1990, J BIOL CHEM, V265, P9838; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; LLEDO PM, 1991, J PHYSIOL-LONDON, V437, P477, DOI 10.1113/jphysiol.1991.sp018607; LLEDO PM, 1992, J PHYSL, V452, P218; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MATTESON DR, 1986, J GEN PHYSIOL, V87, P161, DOI 10.1085/jgp.87.1.161; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; MEECH RW, 1978, ANNU REV BIOPHYS BIO, V7, P1, DOI 10.1146/annurev.bb.07.060178.000245; MOLLARD P, 1991, EUR J PHARM-MOLEC PH, V206, P271, DOI 10.1016/0922-4106(91)90109-U; MORGAN DW, 1986, BIOCHEM BIOPH RES CO, V138, P547, DOI 10.1016/S0006-291X(86)80531-9; MORGAN JI, 1988, CELL CALCIUM, V9, P303, DOI 10.1016/0143-4160(88)90011-5; MORTON AJ, 1990, BRAIN RES, V533, P161, DOI 10.1016/0006-8993(90)91811-T; MORTON AJ, 1992, J PHYSIOL-LONDON, V446, pP306; OBERHOLTZER JC, 1988, P NATL ACAD SCI USA, V85, P3387, DOI 10.1073/pnas.85.10.3387; OKANO T, 1988, J CHROMATOGR, V448, P145, DOI 10.1016/S0021-9673(01)84573-8; OXFORD GS, 1989, J PHYSIOL-LONDON, V410, P587, DOI 10.1113/jphysiol.1989.sp017550; PERSECHINI A, 1989, TRENDS NEUROSCI, V12, P462, DOI 10.1016/0166-2236(89)90097-0; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; RASMUSSEN H, 1984, PHYSIOL REV, V64, P939; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; SCHLEGEL W, 1987, NATURE, V329, P719, DOI 10.1038/329719a0; SETOOHSHIMA A, 1988, LANCET, V1, P1252; SIMASKO SM, 1988, AM J PHYSIOL, V254, pE328, DOI 10.1152/ajpendo.1988.254.3.E328; SMITH SJ, 1980, J PHYSIOL-LONDON, V300, P167, DOI 10.1113/jphysiol.1980.sp013157; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; TIXIERVIDAL A, 1975, INT REV CYTOL, V41, P173, DOI 10.1016/S0074-7696(08)60968-7; VANELDIK LJ, 1982, INT REV CYTOL, V77, P1, DOI 10.1016/S0074-7696(08)62463-8; WASSERMA.RH, 1966, SCIENCE, V152, P791, DOI 10.1126/science.152.3723.791; WOOD JG, 1980, J CELL BIOL, V84, P66, DOI 10.1083/jcb.84.1.66; YAMAGUCHI T, 1991, NEUROSCI LETT, V131, P79, DOI 10.1016/0304-3940(91)90341-P	65	179	180	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1992	9	5					943	954		10.1016/0896-6273(92)90246-A	http://dx.doi.org/10.1016/0896-6273(92)90246-A			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1329864				2022-12-28	WOS:A1992JY55200013
J	SCANZIANI, M; CAPOGNA, M; GAHWILER, BH; THOMPSON, SM				SCANZIANI, M; CAPOGNA, M; GAHWILER, BH; THOMPSON, SM			PRESYNAPTIC INHIBITION OF MINIATURE EXCITATORY SYNAPTIC CURRENTS BY BACLOFEN AND ADENOSINE IN THE HIPPOCAMPUS	NEURON			English	Article							GAMMA-AMINOBUTYRIC-ACID; CHICK SENSORY NEURONS; GUINEA-PIG HIPPOCAMPUS; ROOT GANGLION NEURONS; RAT HIPPOCAMPUS; CALCIUM CURRENTS; TRANSMITTER RELEASE; SLICE CULTURES; PHARMACOLOGICAL PROPERTIES; PYRAMIDAL NEURONS	Presynaptic inhibition of neurotransmitter release is thought to be mediated by a reduction of axon terminal Ca2+ current. We have compared the actions of several known inhibitors of evoked glutamate release with the actions of the Ca2+ channel antagonist Cd2+ on action potential-independent synaptic currents recorded from CA3 neurons in hippocampal slice cultures. Baclofen and adenosine decreased the frequency of miniature excitatory postsynaptic currents (mEPSCs) without affecting the distribution of their amplitudes. Cd2+ blocked evoked synaptic transmission, but had no effect on the frequency or amplitude of either mEPSCs or inhibitory postsynaptic currents (IPSCs). Inhibition of presynaptic Ca2+ current therefore appears not to be required for the inhibition of glutamate release by adenosine and baclofen. Baclofen had no effect on the frequency of miniature IPSCs, indicating that gamma-aminobutyric acid B-type receptors exert distinct presynaptic actions at excitatory and inhibitory synapses.			SCANZIANI, M (corresponding author), UNIV ZURICH,BRAIN RES INST,AUGUST FOREL STR 1,CH-8029 ZURICH,SWITZERLAND.		Thompson, Scott M/K-8921-2015	Capogna, Marco/0000-0002-2742-5485				ALFORD S, 1991, J NEUROSCI, V11, P3718; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BASKYS A, 1991, J PHYSIOL-LONDON, V444, P687, DOI 10.1113/jphysiol.1991.sp018901; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; COTMAN CW, 1986, J PHYSIOL-LONDON, V378, P403, DOI 10.1113/jphysiol.1986.sp016227; DALE N, 1990, J PHYSIOL-LONDON, V421, P203, DOI 10.1113/jphysiol.1990.sp017941; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; DEISZ RA, 1985, NEUROSCI LETT, V56, P205, DOI 10.1016/0304-3940(85)90130-2; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P553, DOI 10.1113/jphysiol.1954.sp005128; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DOLPHIN AC, 1985, NATURE, V316, P148, DOI 10.1038/316148a0; DOLPHIN AC, 1986, BRIT J PHARMACOL, V88, P213, DOI 10.1111/j.1476-5381.1986.tb09489.x; DOLPHIN AC, 1986, J PHYSIOL-LONDON, V373, P47, DOI 10.1113/jphysiol.1986.sp016034; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; DUTAR P, 1988, J NEUROSCI, V8, P4214; DUTAR P, 1988, NEURON, V1, P585, DOI 10.1016/0896-6273(88)90108-0; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; FINCH DM, 1990, BRAIN RES, V518, P269, DOI 10.1016/0006-8993(90)90979-L; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FREDHOLM BB, 1989, EUR J PHARM-MOLEC PH, V172, P249, DOI 10.1016/0922-4106(89)90055-2; FROTSCHER M, 1988, NEUROSCIENCE, V24, P541, DOI 10.1016/0306-4522(88)90348-X; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; GAHWILER BH, 1984, NEUROSCIENCE, V11, P751, DOI 10.1016/0306-4522(84)90192-1; GAHWILER BH, 1985, P NATL ACAD SCI USA, V82, P1558, DOI 10.1073/pnas.82.5.1558; GERBER U, 1989, J PHYSIOL-LONDON, V417, P567, DOI 10.1113/jphysiol.1989.sp017819; HALLIWELL JV, 1984, NEUROSCI LETT, V50, P13, DOI 10.1016/0304-3940(84)90454-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISON NL, 1990, J PHYSIOL-LONDON, V422, P433, DOI 10.1113/jphysiol.1990.sp017993; HHORI Y, 1992, J PHYSL, V450, P673; JAROLIMEK W, 1992, J PHYSIOL-LONDON, V451, P419, DOI 10.1113/jphysiol.1992.sp019171; KATZ B, 1963, J PHYSIOL-LONDON, V168, P389, DOI 10.1113/jphysiol.1963.sp007199; KAY AR, 1986, J NEUROSCI, V6, P2915; LAMBERT NA, 1991, NEUROSCI LETT, V122, P50, DOI 10.1016/0304-3940(91)90190-5; LANTHORN TH, 1981, BRAIN RES, V225, P171, DOI 10.1016/0006-8993(81)90326-7; LIN JW, 1990, P NATL ACAD SCI USA, V87, P8257, DOI 10.1073/pnas.87.21.8257; MALENKA RC, 1987, BRAIN RES, V403, P198, DOI 10.1016/0006-8993(87)90145-4; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MISGELD U, 1989, PFLUG ARCH EUR J PHY, V414, P139, DOI 10.1007/BF00580955; MISGELD U, 1984, NEUROSCI LETT, V47, P307, DOI 10.1016/0304-3940(84)90531-7; NEWBERRY NR, 1984, NATURE, V308, P450, DOI 10.1038/308450a0; PROCTOR WR, 1987, BRAIN RES, V426, P187, DOI 10.1016/0006-8993(87)90441-0; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V435, P373, DOI 10.1113/jphysiol.1991.sp018515; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; STREIT P, 1989, EUR J NEUROSCI, V1, P603, DOI 10.1111/j.1460-9568.1989.tb00366.x; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P524, DOI 10.1152/jn.1989.61.3.524; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P329, DOI 10.1113/jphysiol.1992.sp019167; TRIMBLE WS, 1991, ANNU REV NEUROSCI, V14, P93, DOI 10.1146/annurev.ne.14.030191.000521; VANDERKLOOT W, 1991, PROG NEUROBIOL, V36, P93, DOI 10.1016/0301-0082(91)90019-W; YOON KW, 1991, J PHYSIOL-LONDON, V442, P377, DOI 10.1113/jphysiol.1991.sp018798; ZIMMER J, 1984, J COMP NEUROL, V228, P432, DOI 10.1002/cne.902280310	58	348	353	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1992	9	5					919	927		10.1016/0896-6273(92)90244-8	http://dx.doi.org/10.1016/0896-6273(92)90244-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1358131				2022-12-28	WOS:A1992JY55200011
J	YAMAMOTO, N; YAMADA, K; KUROTANI, T; TOYAMA, K				YAMAMOTO, N; YAMADA, K; KUROTANI, T; TOYAMA, K			LAMINAR SPECIFICITY OF EXTRINSIC CORTICAL CONNECTIONS STUDIED IN COCULTURE PREPARATIONS	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; POSITION-SPECIFIC PROPERTIES; CENTRAL NERVOUS-SYSTEM; TECTAL CELL-MEMBRANES; RETINAL AXONS; RAT NEOCORTEX; POSTNATAL-DEVELOPMENT; CALLOSAL CONNECTIONS; SUBPLATE NEURONS	The formation of specific neural connections in the cerebral cortex was studied using organotypic coculture preparations composed of subcortical and cortical regions. Morphological and electrophysiological analysis indicated that several cortical efferent and afferent connections, such as the corticothalamic, thalamocortical, corticocortical, and corticotectal connections, were established in the cocultures with essentially the same laminar specificity as that found in the adult cerebral cortex, but without specificity of sensory modality. This suggests the existence of a cell-cell recognition system between cortical or subcortical neurons and their final targets. This interaction produces lamina-specific connections, but is probably insufficient for the formation of the modality-specific connections.			YAMAMOTO, N (corresponding author), KYOTO PREFECTURAL UNIV MED,DEPT PHYSIOL,KAMIGYO KU,KYOTO 602,JAPAN.			Yamamoto, Nobuhiko/0000-0002-1916-932X				BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; BRUCKNER G, 1976, J COMP NEUROL, V166, P245, DOI 10.1002/cne.901660208; BRUNNER G, 1982, DEV BRAIN RES, V2, P563; CAESER M, 1989, EXP BRAIN RES, V77, P234, DOI 10.1007/BF00274981; COGGESHALL RE, 1964, J COMP NEUROL, V122, P241, DOI 10.1002/cne.901220208; DELRIO JA, 1989, DEV BRAIN RES, V49, P311, DOI 10.1016/0165-3806(89)90033-3; EBENDAL T, 1977, EXP CELL RES, V105, P379, DOI 10.1016/0014-4827(77)90135-5; FUJISAWA H, 1989, DEV BIOL, V135, P231, DOI 10.1016/0012-1606(89)90175-9; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GILBERT CD, 1975, J COMP NEUROL, V163, P81, DOI 10.1002/cne.901630106; GODEMENT P, 1987, DEVELOPMENT, V101, P697; HAMASAKI T, 1987, BRAIN RES, V422, P172, DOI 10.1016/0006-8993(87)90554-3; HARRIS WA, 1989, NATURE, V339, P218, DOI 10.1038/339218a0; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HERKENHAM M, 1980, SCIENCE, V207, P532, DOI 10.1126/science.7352263; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HUGHES HC, 1977, J COMP NEUROL, V175, P311, DOI 10.1002/cne.901750306; INNOCENTI GM, 1981, SCIENCE, V212, P824, DOI 10.1126/science.7221566; JACOBSON S, 1970, EXP NEUROL, V28, P193, DOI 10.1016/0014-4886(70)90229-3; Jones EG, 1981, ORG CEREBRAL CORTEX, P199; KATZ LC, 1991, EUR J NEUROSCI, V3, P1, DOI 10.1111/j.1460-9568.1991.tb00805.x; KOMATSU Y, 1988, J NEUROPHYSIOL, V59, P124, DOI 10.1152/jn.1988.59.1.124; KRIEG WJS, 1946, J COMP NEUROL, V84, P221, DOI 10.1002/cne.900840205; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; MASON R, 1981, NEUROSCI LETT, V25, P107, DOI 10.1016/0304-3940(81)90316-5; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; MILLER MW, 1984, BRAIN RES, V297, P75, DOI 10.1016/0006-8993(84)90544-4; MITZDORF U, 1978, EXP BRAIN RES, V33, P3711; MOLNAR Z, 1991, NATURE, V351, P475, DOI 10.1038/351475a0; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Paxinos G., 1991, ATLAS DEV RAT BRAIN; PETERS A, 1976, J NEUROCYTOL, V5, P63, DOI 10.1007/BF01176183; PRICE DJ, 1985, NATURE, V316, P721, DOI 10.1038/316721a0; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1977, PHILOS T R SOC B, V278, P245, DOI 10.1098/rstb.1977.0040; Ramon y Cajal S., 1972, STRUCTURE RETINA; RIBAK CE, 1975, BRAIN RES, V92, P341, DOI 10.1016/0006-8993(75)90322-4; ROMIJN HJ, 1988, J NEUROSCI METH, V23, P75, DOI 10.1016/0165-0270(88)90025-8; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SEFTON AJ, 1981, BRAIN RES, V215, P1, DOI 10.1016/0006-8993(81)90487-X; SHATZ CJ, 1986, J NEUROSCI, V6, P3655; STANFIELD BB, 1982, NATURE, V298, P371, DOI 10.1038/298371a0; TANAKA H, 1989, DEV BIOL, V132, P419, DOI 10.1016/0012-1606(89)90238-8; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TOYAMA K, 1974, EXP BRAIN RES, V21, P45; VIELMETTER J, 1989, NEURON, V2, P1331, DOI 10.1016/0896-6273(89)90071-8; WALTER J, 1987, DEVELOPMENT, V101, P685; YAMAMOTO N, 1989, SCIENCE, V245, P192, DOI 10.1126/science.2749258	52	175	178	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					217	228		10.1016/0896-6273(92)90161-6	http://dx.doi.org/10.1016/0896-6273(92)90161-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1497891				2022-12-28	WOS:A1992JJ33200004
J	SAHA, MS; GRAINGER, RM				SAHA, MS; GRAINGER, RM			A LABILE PERIOD IN THE DETERMINATION OF THE ANTERIOR POSTERIOR AXIS DURING EARLY NEURAL DEVELOPMENT IN XENOPUS	NEURON			English	Article							HOMEOBOX GENE XHOX3; MESSENGER-RNA; RETINOIC ACID; PROSPECTIVE AREAS; NERVOUS-SYSTEM; GROWTH-FACTORS; ACTIN GENES; LAEVIS; INDUCTION; EXPRESSION	The process by which the vertebrate central nervous system acquires its regional properties remains a central problem in developmental biology. It is generally argued that at early gastrula stages the dorsal mesoderm possesses precise anterior-posterior positional information, which is subsequently imparted to the overlying ectoderm. However, using regionally specific gene probes to monitor regional responses in Xenopus embryos, we find that anterior-posterior properties are not fixed until early neurula stages. During gastrulation the regional inducing capacities of the dorsal mesoderm as well as the regional responses of the presumptive neural ectoderm are activated along the entire anterior-posterior axis when these properties are assayed in recombinant and explant experiments, respectively. Restriction of regional inducing capacity in the mesoderm and responsiveness in the neural ectoderm occur only at neural plate stages.			SAHA, MS (corresponding author), UNIV VIRGINIA, DEPT BIOL, CHARLOTTESVILLE, VA 22901 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007192] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006675, R01EY005542] Funding Source: NIH RePORTER; NEI NIH HHS [EY-06675, EY-05542] Funding Source: Medline; NICHD NIH HHS [5-T32HD07192] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTABA AR, 1989, CELL, V57, P317, DOI 10.1016/0092-8674(89)90969-0; ALTABA AR, 1989, NATURE, V341, P33; ALTABA ARI, 1991, GENE DEV, V5, P175, DOI 10.1101/gad.5.2.175; ALTABA ARI, 1989, DEVELOPMENT, V106, P173; APPLEBURY ML, 1986, VISION RES, V26, P1881, DOI 10.1016/0042-6989(86)90115-X; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BAEHR W, 1984, VISION RES, V24, P1695, DOI 10.1016/0042-6989(84)90339-0; CHO KWY, 1990, GENE DEV, V4, P1910, DOI 10.1101/gad.4.11.1910; CHUONG CM, 1990, DEVELOPMENT, V110, P1021; DEROBERTIS EM, 1991, DEVELOPMENT, V112, P669; DEUCHAR EM, 1953, J EXP BIOL, V30, P18; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; EYAL-GILADI H., 1954, ARCH BIOL [PARIS], V65, P179; GERHART J, 1986, ANNU REV CELL BIOL, V2, P201, DOI 10.1146/annurev.cb.02.110186.001221; Gerhart J.C., 1980, Biological Regulation and Development, V2, P133; GREEN JBA, 1990, DEVELOPMENT, V108, P173; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Gurdon J.B., 1977, Methods Cell Biol, V16, P125; GURDON JB, 1985, CELL, V41, P913, DOI 10.1016/S0092-8674(85)80072-6; Hamburger V, 1988, HERITAGE EXPT EMBRYO; HARVEY RP, 1990, DEVELOPMENT, V108, P669; HEMMATIBRIVANLOU A, 1990, SCIENCE, V250, P800, DOI 10.1126/science.1978411; HENRY JJ, 1987, DEV BIOL, V124, P200, DOI 10.1016/0012-1606(87)90472-6; HILDAGO A, 1990, DEVELOPMENT, V110, P291; HOLTFRETER J., 1938, WILHELM ROUX ARCH ENTWICKLUNGSMECH ORGAN, V138, P657, DOI 10.1007/BF00573815; Holtfreter J, 1936, Wilhelm Roux Arch Entwickl Mech Org, V134, P466, DOI 10.1007/BF01381161; HOLTFRETER J, 1965, THESIS U ROCHESTER R; HOLTPRETER J., 1938, WILHELM RAUX ARCH ENTWICKLUNGSMECH ORGAN, V138, P522, DOI 10.1007/BF00573814; IRISH V, 1989, NATURE, V338, P646, DOI 10.1038/338646a0; KANEDA T, 1979, ROUX ARCH DEV BIOL, V187, P25, DOI 10.1007/BF00848164; KELLER R, 1989, DEV BIOL, V131, P539, DOI 10.1016/S0012-1606(89)80024-7; Keller R.E., 1986, P241; KELLER RE, 1976, DEV BIOL, V51, P118, DOI 10.1016/0012-1606(76)90127-5; KELLER RE, 1975, DEV BIOL, V42, P222, DOI 10.1016/0012-1606(75)90331-0; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Mangold O, 1933, NATURWISSENSCHAFTEN, V21, P761, DOI 10.1007/BF01503740; MOHUN TJ, 1984, NATURE, V311, P716, DOI 10.1038/311716a0; MOLVEN A, 1990, DEVELOPMENT, V109, P279; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nieuwkoop PD, 1985, EPIGENETIC NATURE EA, P150; REPRESA J, 1989, International Journal of Developmental Biology, V33, P397; RICHTER K, 1988, P NATL ACAD SCI USA, V85, P8086, DOI 10.1073/pnas.85.21.8086; Rugh R, 1962, EXPT EMBRYOLOGY; RUPP RAW, 1991, CELL, V65, P927, DOI 10.1016/0092-8674(91)90545-A; SAMBROOK J, 1989, MOL CLONICNG LABORAT; SATER AK, 1990, DEV BIOL, V140, P328, DOI 10.1016/0012-1606(90)90083-U; SAXEN L, 1961, J EMBRYOL EXP MORPH, V9, P514; SHARPE CR, 1987, CELL, V50, P749, DOI 10.1016/0092-8674(87)90333-3; SHARPE CR, 1990, DEVELOPMENT, V109, P765; SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Slack J. M. W, 1991, EGG EMBRYON REGIONAL; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Spemann H., 1938, EMBRYONIC DEV INDUCT; Spemann H, 1931, W ROUX ARCH ENTWICKL, V123, P390; Tondury Gian, 1936, Wilhelm Roux Arch Entwickl Mech Org, V134, P1, DOI 10.1007/BF00573465; WADDINGTON CH, 1950, J EXP BIOL, V27, P126; WEISS P, 1939, PRINCIPLES DEV; WRIGHT CVE, 1990, DEVELOPMENT, V109, P225	61	92	93	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1992	8	6					1003	1014		10.1016/0896-6273(92)90123-U	http://dx.doi.org/10.1016/0896-6273(92)90123-U			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1610562				2022-12-28	WOS:A1992JA42900002
J	HERB, A; BURNASHEV, N; WERNER, P; SAKMANN, B; WISDEN, W; SEEBURG, PH				HERB, A; BURNASHEV, N; WERNER, P; SAKMANN, B; WISDEN, W; SEEBURG, PH			THE KA-2 SUBUNIT OF EXCITATORY AMINO-ACID RECEPTORS SHOWS WIDESPREAD EXPRESSION IN BRAIN AND FORMS ION CHANNELS WITH DISTANTLY RELATED SUBUNITS	NEURON			English	Article								A new ionotropic glutamate receptor subunit termed KA-2, cloned from rat brain cDNA, exhibits high affinity for [H-3]kainate (K(D) almost-equal-to 15 nM). KA-2 mRNA is widely expressed in embryonic and adult brain. Homomeric KA-2 expression does not generate agonist-sensitive channels, but currents are observed when KA-2 is coexpressed with GluR5 or GluR6 subunits. Specifically, coexpression of GluR5(R) and KA-2 produces channel activity, whereas homomeric expression of either subunit does not. Currents through heteromeric GluR5(Q)/KA-2 channels show more rapid desensitization and different current-voltage relations when compared with GluR5(Q) currents. GluR6/KA-2 channels are gated by AMPA, which fails to gate homomeric GluR6 receptor channels. These results suggest possible in vivo partnership relations for high affinity kainate receptors.	MAX PLANCK INST MED RES, ZELLPHYSIOL ABT, W-6900 HEIDELBERG 1, GERMANY	Max Planck Society	HERB, A (corresponding author), UNIV HEIDELBERG, CTR MOLEC BIOL, INF 282, W-6900 HEIDELBERG, GERMANY.		Burnashev, Nail/G-4056-2013; Wisden, William/A-4071-2011	Wisden, William/0000-0003-4743-0334				AMBROSINI A, 1991, FEBS LETT, V281, P27, DOI 10.1016/0014-5793(91)80350-C; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DAWSON TL, 1990, MOL PHARMACOL, V38, P779; DINGLEDINE R, 1991, TRENDS PHARMACOL SCI, V12, P360, DOI 10.1016/0165-6147(91)90602-O; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; FOSTER AC, 1981, NATURE, V289, P73, DOI 10.1038/289073a0; Gasic G P, 1991, Curr Opin Neurobiol, V1, P20, DOI 10.1016/0959-4388(91)90006-S; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GU YP, 1991, NEURON, V6, P777, DOI 10.1016/0896-6273(91)90174-X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMPSON DR, 1987, J NEUROCHEM, V49, P1209, DOI 10.1111/j.1471-4159.1987.tb10012.x; HENLEY J M, 1989, New Biologist, V1, P153; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1990, COLD SH Q B, V55, P41; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; JONAS P, 1991, J PHYSIOL-LONDON, V438, pP321; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; LONDON ED, 1979, MOL PHARMACOL, V15, P492; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MILLER LP, 1990, NEUROSCIENCE, V35, P45, DOI 10.1016/0306-4522(90)90118-N; MILLER RJ, 1991, TRENDS NEUROSCI, V14, P477, DOI 10.1016/0166-2236(91)90054-X; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; Paxinos G., 1991, ATLAS DEV RAT BRAIN; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PRUSS RM, 1991, NEURON, V7, P509, DOI 10.1016/0896-6273(91)90302-G; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; ROBINSON JH, 1981, BRAIN RES, V221, P117, DOI 10.1016/0006-8993(81)91067-2; ROGERS SW, 1991, J NEUROSCI, V11, P2713; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEEBURG PH, 1990, COLD SH Q B, V55, P29; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SOMMER B, 1992, IN PRESS EMBO J; UNNERSTALL JR, 1983, EUR J PHARMACOL, V86, P361, DOI 10.1016/0014-2999(83)90185-1; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VERDOORN TA, 1989, MOL PHARMACOL, V35, P360; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WENTHOLD RJ, 1990, FEBS LETT, V276, P147, DOI 10.1016/0014-5793(90)80529-R; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; WISDEN W, 1991, MOL NEUROBIOLOGY PRA, P205; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YOUNG AB, 1990, TRENDS PHARMACOL SCI, V11, P126, DOI 10.1016/0165-6147(90)90199-I	58	493	499	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1992	8	4					775	785		10.1016/0896-6273(92)90098-X	http://dx.doi.org/10.1016/0896-6273(92)90098-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1373632				2022-12-28	WOS:A1992HQ18800016
J	WANG, LS; DENBURG, JL				WANG, LS; DENBURG, JL			A ROLE FOR PROTEOGLYCANS IN THE GUIDANCE OF A SUBSET OF PIONEER AXONS IN CULTURED EMBRYOS OF THE COCKROACH	NEURON			English	Article								Several molecules involved in the development of the nervous system have specific binding sites for the glycosaminoglycan (GAG) side chains of proteoglycans. Exogenous GAGs should bind to these sites, competitively inhibit interactions with proteoglycans, and perturb development. GAGs added to the culture medium perturb the in situ growth of pioneer axons in cultured cockroach embryos by producing axon defasciculation and growth in incorrect directions. The specificity of this phenomenon is evident from the following observations: Of all the GAGs tested only heparin and heparan sulfate produced perturbation; of the six axon tracts being pioneered during the culture period only two of them are perturbed by the GAGs; and similar perturbations are produced when embryos are cultured in the presence of heparinase II and heparitinase.			WANG, LS (corresponding author), UNIV IOWA, DEPT BIOL, IOWA CITY, IA 52242 USA.				NINDS NIH HHS [NS 15350, NS 14295] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014295] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKESON R, 1986, EXP CELL RES, V162, P347, DOI 10.1016/0014-4827(86)90340-X; ANDERSON H, 1988, DEVELOPMENT, V104, P601; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BATE CM, 1976, NATURE, V260, P54, DOI 10.1038/260054a0; BENTLEY D, 1983, NATURE, V304, P62, DOI 10.1038/304062a0; BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082; BRANDAN E, 1987, FEBS LETT, V213, P159, DOI 10.1016/0014-5793(87)81483-7; BROWER DL, 1987, DEV BIOL, V119, P373, DOI 10.1016/0012-1606(87)90042-X; BURG M, 1990, ARCH BIOCHEM BIOPHYS, V276, P396, DOI 10.1016/0003-9861(90)90738-K; CAMPBELL AG, 1987, J BIOL CHEM, V262, P17605; CARBONETTO S, 1983, J NEUROSCI, V3, P2324; CASSARO CMF, 1977, J BIOL CHEM, V252, P2254; CAUDY M, 1986, J NEUROSCI, V6, P364; COLE GJ, 1986, NATURE, V320, P445, DOI 10.1038/320445a0; COLE GJ, 1985, J CELL BIOL, V100, P1192, DOI 10.1083/jcb.100.4.1192; CONDIC ML, 1989, NEURON, V3, P427, DOI 10.1016/0896-6273(89)90202-X; DENBURG JL, 1989, DEV BIOL, V135, P99, DOI 10.1016/0012-1606(89)90161-9; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DOW KE, 1991, CELL TISSUE RES, V265, P345, DOI 10.1007/BF00398082; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; GOODMAN CS, 1981, J NEUROSCI, V1, P94, DOI 10.1523/JNEUROSCI.01-01-00094.1981; GORDON MY, 1987, NATURE, V326, P403, DOI 10.1038/326403a0; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HERNDON ME, 1990, NEURON, V4, P949, DOI 10.1016/0896-6273(90)90148-9; Hockfield S., 1990, Seminars in Developmental Biology, V1, P55; HOFFMAN S, 1988, J CELL BIOL, V106, P519, DOI 10.1083/jcb.106.2.519; HU GF, 1991, P NATL ACAD SCI USA, V88, P2227, DOI 10.1073/pnas.88.6.2227; JAY DG, 1990, NATURE, V348, P548, DOI 10.1038/348548a0; KESHISHIAN H, 1980, DEV BIOL, V80, P388, DOI 10.1016/0012-1606(80)90413-3; Klagsbrun M, 1990, CURR OPIN CELL BIOL, V2, P857, DOI 10.1016/0955-0674(90)90084-R; LANDER AD, 1989, TRENDS NEUROSCI, V12, P189, DOI 10.1016/0166-2236(89)90070-2; LENOIR-ROUSSEAUX J J, 1970, Bulletin de la Societe Zoologique de France, V95, P737; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; MERENMIES J, 1990, J BIOL CHEM, V265, P16721; MEYER MR, 1988, DEV BIOL, V130, P374, DOI 10.1016/0012-1606(88)90443-5; MORRISS GM, 1978, J EMBRYOL EXP MORPH, V46, P37; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; NORBECK BA, 1991, ROUX ARCH DEV BIOL, V199, P476, DOI 10.1007/BF01705784; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; SCOTT JE, 1965, HISTOCHEMISTRY, V5, P221, DOI 10.1007/BF00306130; WALICKE PA, 1989, ANNU REV NEUROSCI, V12, P103, DOI 10.1146/annurev.neuro.12.1.103	45	81	83	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1992	8	4					701	714		10.1016/0896-6273(92)90091-Q	http://dx.doi.org/10.1016/0896-6273(92)90091-Q			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1567620				2022-12-28	WOS:A1992HQ18800009
J	DANI, JW; CHERNJAVSKY, A; SMITH, SJ				DANI, JW; CHERNJAVSKY, A; SMITH, SJ			NEURONAL-ACTIVITY TRIGGERS CALCIUM WAVES IN HIPPOCAMPAL ASTROCYTE NETWORKS	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; EXCITATORY AMINO-ACIDS; BLOOD-BRAIN-BARRIER; CULTURED ASTROCYTES; RAT ASTROCYTES; INTRACELLULAR CA-2+; SLICE CULTURES; ORGANOTYPIC CULTURES; GENE-EXPRESSION; KYNURENIC ACID	The recent discovery that the neurotransmitter glutamate can trigger actively propagating Ca2+ waves in the cytoplasm of cultured astrocytes suggests the possibility that synaptically released glutamate may trigger similar Ca2+ waves in brain astrocytes in situ. To explore this possibility, we used confocal microscopy and the Ca2+ indicator fluo-3 to study organotypically cultured slices of rat hippocampus, where astrocytic and neuronal networks are intermingled in their normal tissue relationships. We find that astrocytic Ca2+ waves are present under these circumstances and that these waves can be triggered by the firing of glutamatergic neuronal afferents with latencies as short as 2 s. The Ca2+ waves closely resemble those previously observed in cultured astrocytes: they propagate both within and between astrocytes at velocities of 7-27-mu-m/s at 21-degrees-C. The ability of tissue astrocyte networks to respond to neuronal network activity suggests that astrocytes may have a much more dynamic and active role in brain function than has been generally recognized.			DANI, JW (corresponding author), STANFORD UNIV, MED CTR, SCH MED, BECKMAN CTR, DEPT MOLEC & CELLULAR PHYSIOL, STANFORD, CA 94305 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028587] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS 28587] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED Z, 1990, BRAIN RES, V516, P165, DOI 10.1016/0006-8993(90)90914-W; ALBERTS B, 1989, MOL BIOL CELL, P708; ARBONES L, 1990, MOL PHARMACOL, V37, P921; ARENANDER AT, 1989, J NEUROSCI RES, V24, P107, DOI 10.1002/jnr.490240115; BARBOUR B, 1989, NATURE, V342, P918, DOI 10.1038/342918a0; BARRES BA, 1989, NATURE, V339, P343, DOI 10.1038/339343a0; BARRES BA, 1990, NEURON, V5, P527, DOI 10.1016/0896-6273(90)90091-S; BEACH RL, 1982, DEV BRAIN RES, V3, P3, DOI 10.1016/0165-3806(82)90071-2; BENJAMIN AM, 1987, J NEUROCHEM, V48, P1157, DOI 10.1111/j.1471-4159.1987.tb05641.x; BENVENISTE EN, 1990, J NEUROIMMUNOL, V30, P201, DOI 10.1016/0165-5728(90)90104-U; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; Bevan S., 1990, SEMIN NEUROSCI, V2, P467; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BRADBURY MWB, 1985, CIRC RES, V57, P213, DOI 10.1161/01.RES.57.2.213; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; CIARDO A, 1990, EUR J PHARM-MOLEC PH, V188, P417, DOI 10.1016/0922-4106(90)90204-B; CONDORELLI DF, 1989, J NEUROSCI RES, V23, P234, DOI 10.1002/jnr.490230214; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CORNELLBELL AH, 1991, CELL CALCIUM, V12, P185, DOI 10.1016/0143-4160(91)90020-F; DELRIO JA, 1991, NEUROSCIENCE, V43, P335, DOI 10.1016/0306-4522(91)90298-3; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; EHRENREICH H, 1991, BRAIN RES, V538, P54, DOI 10.1016/0006-8993(91)90375-6; ENKVIST MOK, 1989, GLIA, V2, P397, DOI 10.1002/glia.440020602; FADDIS BT, 1988, AM J ANAT, V183, P316, DOI 10.1002/aja.1001830405; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FOWLER J, 1986, BRAIN RES, V378, P398, DOI 10.1016/0006-8993(86)90945-5; GAHWILER BH, 1984, EXPERIENTIA, V40, P235, DOI 10.1007/BF01947561; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; GAHWILER BH, 1988, TRENDS NEUROSCI, V11, P484, DOI 10.1016/0166-2236(88)90007-0; GALAMBOS R, 1961, P NATL ACAD SCI USA, V47, P129, DOI 10.1073/pnas.47.1.129; GLAUM SR, 1990, P NATL ACAD SCI USA, V87, P3454, DOI 10.1073/pnas.87.9.3454; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; INAGAKI N, 1991, P NATL ACAD SCI USA, V88, P4215, DOI 10.1073/pnas.88.10.4215; JACOB R, 1990, BIOCHIM BIOPHYS ACTA, V1052, P427, DOI 10.1016/0167-4889(90)90152-4; JAFFE LF, 1983, DEV BIOL, V99, P265, DOI 10.1016/0012-1606(83)90276-2; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; JENSEN AM, 1991, J NEUROSCI, V11, P1674; JENSEN AM, 1990, J NEUROSCI, V10, P1165; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KARWOSKI CJ, 1989, SCIENCE, V244, P578, DOI 10.1126/science.2785716; KETTENMANN H, 1988, GLIA, V1, P64, DOI 10.1002/glia.440010108; KIMELBERG HK, 1989, SCI AM, V260, P66, DOI 10.1038/scientificamerican0489-66; LAMING PR, 1989, COMP BIOCHEM PHYS A, V94, P555, DOI 10.1016/0300-9629(89)90594-X; LLANO I, 1988, P NATL ACAD SCI USA, V85, P3221, DOI 10.1073/pnas.85.9.3221; MACVICAR BA, 1988, GLIA, V1, P359, DOI 10.1002/glia.440010602; MARRERO H, 1989, NATURE, V339, P378, DOI 10.1038/339378a0; MCBAIN CJ, 1989, J NEUROSCI METH, V27, P35, DOI 10.1016/0165-0270(89)90051-4; MEYER T, 1991, CELL, V64, P675, DOI 10.1016/0092-8674(91)90496-L; MINTA A, 1989, J BIOL CHEM, V264, P8171; MORGAN JI, 1988, CELL CALCIUM, V9, P303, DOI 10.1016/0143-4160(88)90011-5; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MULLER CM, 1989, NATURE, V342, P427, DOI 10.1038/342427a0; MURPHY S, 1988, GLIA, V1, P241, DOI 10.1002/glia.440010402; MURPHY S, 1990, J NEUROCHEM, V55, P349, DOI 10.1111/j.1471-4159.1990.tb08860.x; NEARY JT, 1987, BRAIN RES, V410, P164, DOI 10.1016/S0006-8993(87)80040-9; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; OLSON JE, 1990, GLIA, V3, P405, DOI 10.1002/glia.440030512; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; PASANTESMORALES H, 1990, GLIA, V3, P427, DOI 10.1002/glia.440030514; PEARCE B, 1986, NEUROSCI LETT, V72, P335, DOI 10.1016/0304-3940(86)90537-9; PEARCE B, 1988, NEUROSCI LETT, V90, P191, DOI 10.1016/0304-3940(88)90810-5; PETERS A, 1991, FINE STRUCTURE NERVO, P276; QUANDT FN, 1986, NEUROSCIENCE, V19, P29, DOI 10.1016/0306-4522(86)90003-5; RAFF MC, 1988, J CELL SCI, P77; ROBINSON MB, 1985, BRAIN RES, V361, P19, DOI 10.1016/0006-8993(85)91270-3; ROBINSON MB, 1984, BRAIN RES, V309, P119, DOI 10.1016/0006-8993(84)91015-1; SALM AK, 1990, GLIA, V3, P529, DOI 10.1002/glia.440030612; SANDERSON MJ, 1990, CELL REGUL, V1, P585, DOI 10.1091/mbc.1.8.585; Sastry B R, 1990, Adv Exp Med Biol, V268, P377; SCHIEREN I, 1988, J NEUROSCI METH, V26, P35, DOI 10.1016/0165-0270(88)90127-6; SHEPHERD GM, 1974, SYNAPTIC ORG BRAIN, P260; SHINODA H, 1989, SCIENCE, V245, P415, DOI 10.1126/science.2569236; Stewart R M, 1979, Int Rev Neurobiol, V21, P275; STRYER L, 1988, BIOCHEMISTRY-US, P988; SUGINO H, 1984, BRAIN RES, V322, P127, DOI 10.1016/0006-8993(84)91190-9; THOMSON AM, 1989, TRENDS NEUROSCI, V12, P349, DOI 10.1016/0166-2236(89)90042-8; TRACHTENBERG M C, 1970, Science (Washington D C), V167, P1248, DOI 10.1126/science.167.3922.1248; TSIEN RY, 1988, TRENDS NEUROSCI, V11, P419, DOI 10.1016/0166-2236(88)90192-0; VERNADAKIS A, 1988, INT REV NEUROBIOL, V30, P149; WOOD PL, 1990, NEUROCHEM RES, V15, P217, DOI 10.1007/BF00972212; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; ZHABOTINSKI YM, 1979, NEUROSCIENCE, V4, P913, DOI 10.1016/0306-4522(79)90175-1; ZIMMER J, 1984, J COMP NEUROL, V228, P432, DOI 10.1002/cne.902280310	84	653	663	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1992	8	3					429	440		10.1016/0896-6273(92)90271-E	http://dx.doi.org/10.1016/0896-6273(92)90271-E			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1347996				2022-12-28	WOS:A1992HK67500003
J	HEGINBOTHAM, L; MACKINNON, R				HEGINBOTHAM, L; MACKINNON, R			THE AROMATIC BINDING-SITE FOR TETRAETHYLAMMONIUM ION ON POTASSIUM CHANNELS	NEURON			English	Article							MOLECULAR RECOGNITION; K+ CHANNELS; EXPRESSION; DIVERSITY; RECEPTOR; BRAIN; MEDIA	K+ channels are quite variable in their sensitivity to the pore-blocking agent tetraethylammonium ion (TEA) when it is applied to the extracellular side of the membrane. A Shaker K+ channel can be made highly sensitive by introducing a tyrosine (or phenylalanine) at residue 449 in each of the four subunits. A shift in the voltage dependence of blockade indicates that TEA senses a smaller fraction of the transmembrane electric field in the highly sensitive channels. There is a linear relationship between the free energy for TEA blockade and the number of subunits (zero, two, or four) containing tyrosine at 449, as if these four residues interact simultaneously with a TEA molecule to produce a high affinity binding site. The temperature dependence of blockade suggests that the interaction is not purely hydrophobic. These findings are consistent with a TEA-binding site formed by a bracelet of pore-lining aromatic residues. The center of the bracelet could bind a TEA molecule through a cation-pi-orbital interaction.			HEGINBOTHAM, L (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.				NIGMS NIH HHS [GM43949] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG CM, 1965, J GEN PHYSIOL, V48, P859, DOI 10.1085/jgp.48.5.859; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; CANTOR CR, 1980, BIOPHYSICAL CHEM 1, P287; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; HILLE B, 1967, J GEN PHYSIOL, V50, P1287, DOI 10.1085/jgp.50.5.1287; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; MILLER C, 1982, J GEN PHYSIOL, V79, P869, DOI 10.1085/jgp.79.5.869; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEPODD TJ, 1988, J AM CHEM SOC, V110, P1983, DOI 10.1021/ja00214a063; STAUFFER DA, 1988, TETRAHEDRON LETT, V29, P6039, DOI 10.1016/S0040-4039(00)82259-5; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SUNNER J, 1981, J PHYS CHEM-US, V85, P1814, DOI 10.1021/j150613a011; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; VILLARROEL A, 1988, PFLUG ARCH EUR J PHY, V413, P118, DOI 10.1007/BF00582521; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7	27	421	424	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					483	491		10.1016/0896-6273(92)90276-J	http://dx.doi.org/10.1016/0896-6273(92)90276-J			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550673				2022-12-28	WOS:A1992HK67500008
J	MESSING, A; BEHRINGER, RR; HAMMANG, JP; PALMITER, RD; BRINSTER, RL; LEMKE, G				MESSING, A; BEHRINGER, RR; HAMMANG, JP; PALMITER, RD; BRINSTER, RL; LEMKE, G			PO PROMOTER DIRECTS EXPRESSION OF REPORTER AND TOXIN GENES TO SCHWANN-CELLS OF TRANSGENIC MICE	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; RAT SCIATIC-NERVE; HEREDITARY HYPERTROPHIC NEUROPATHY; MYELIN-SPECIFIC PROTEINS; TREMBLER MOUSE; CONGENITAL HYPOMYELINATION; UNMYELINATED FIBERS; TWITCHER MOUSE; GROWTH-FACTOR; MAJOR MYELIN	We generated transgenic mice that specifically express foreign genes in myelinating Schwann cells. A 1.1 kb segment of 5' flanking sequence from the rat P0 gene was used to drive expression of the genes encoding human growth hormone (hGH) and bacterial diphtheria toxin A chain (DT-A). The P0-hGH mice expressed hGH in myelinating Schwann cells, but not in nonmyelinating Schwann cells, the central nervous system, or any other tissue assayed. This expression was activated on a developmental schedule comparable to that of endogenous myelin gene expression. One line of P0-DT-A mice developed a generalized hypomyelinating peripheral neuropathy, with Schwann cell deficiency apparent in newborn animals. Peripheral nerves from adult mice of this line displayed morphological alterations ranging from completely denuded axons to myelinated Schwann cells undergoing degeneration, although occasional Schwann cells were able to form apparently normal myelin sheaths. Pronounced secondary changes, including proliferation and retraction of processes, occurred in the nonmyelinating Schwann cells of these P0-DT-A mice.	UNIV PENN, SCH VET MED, REPROD PHYSIOL LAB, PHILADELPHIA, PA 19104 USA; UNIV WASHINGTON, HOWARD HUGHES MED INST, DEPT BIOCHEM, SEATTLE, WA 98195 USA; SALK INST BIOL STUDIES, MOLEC NEUROBIOL LAB, LA JOLLA, CA 92037 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Salk Institute	MESSING, A (corresponding author), UNIV WISCONSIN, SCH VET MED, DEPT PATHOBIOL SCI, MADISON, WI 53706 USA.			Messing, Albee/0000-0001-6049-0521; Brinster, Ralph/0000-0003-1408-7656	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD009172, R01HD009172] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA038635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022475] Funding Source: NIH RePORTER; NCI NIH HHS [CA-38635] Funding Source: Medline; NICHD NIH HHS [HD-09172] Funding Source: Medline; NINDS NIH HHS [NS-22475] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERCROMBIE M, 1946, J ANAT, V80, P37; AGUAYO AJ, 1977, NATURE, V265, P73, DOI 10.1038/265073a0; AYERS MM, 1973, ACTA NEUROPATHOL, V25, P54, DOI 10.1007/BF00686858; BEHRINGER RR, 1988, GENE DEV, V2, P453, DOI 10.1101/gad.2.4.453; BLACK JA, 1990, TRENDS NEUROSCI, V13, P48, DOI 10.1016/0166-2236(90)90068-L; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; BROCKES JP, 1980, J NEUROCYTOL, V9, P67, DOI 10.1007/BF01205227; CHARNAS L, 1988, NEUROLOGY, V38, P966, DOI 10.1212/WNL.38.6.966; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEMENCE A, 1989, J NEUROCYTOL, V18, P185, DOI 10.1007/BF01206661; DEWAEGH S, 1990, J NEUROSCI, V10, P1855; EVANS GA, 1989, GENE DEV, V3, P259, DOI 10.1101/gad.3.3.259; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; GREENFIELD S, 1973, J NEUROCHEM, V20, P1207, DOI 10.1111/j.1471-4159.1973.tb00089.x; GRIFFIN JW, 1987, J NEUROSCI, V7, P682; GRIFFIN JW, 1990, J NEUROCYTOL, V19, P367, DOI 10.1007/BF01188405; GUZZETTA F, 1982, BRAIN, V105, P395, DOI 10.1093/brain/105.2.395; HAHN AF, 1987, J COMP NEUROL, V260, P501, DOI 10.1002/cne.902600404; HALL SM, 1975, NEUROPATH APPL NEURO, V1, P149, DOI 10.1111/j.1365-2990.1975.tb00386.x; HALL SM, 1978, NEUROPATH APPL NEURO, V4, P165, DOI 10.1111/j.1365-2990.1978.tb00533.x; HALL SM, 1986, NEUROPATH APPL NEURO, V12, P401, DOI 10.1111/j.1365-2990.1986.tb00151.x; HARATI Y, 1985, J NEUROL NEUROSUR PS, V48, P1269, DOI 10.1136/jnnp.48.12.1269; HENRY EW, 1988, SCIENCE, V241, P344, DOI 10.1126/science.3388045; JESSEN KR, 1990, DEVELOPMENT, V109, P91; KENNEDY WR, 1977, ARCH NEUROL-CHICAGO, V34, P337, DOI 10.1001/archneur.1977.00500180031007; KOBAYASHI S, 1988, AM J PATHOL, V131, P308; LEBLANC AC, 1987, MOL BRAIN RES, V2, P57, DOI 10.1016/0169-328X(87)90021-0; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; LEMKE G, 1988, DEVELOPMENT, V102, P499; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LOW PA, 1976, J NEUROL SCI, V30, P343, DOI 10.1016/0022-510X(76)90139-8; LOW PA, 1976, J NEUROL SCI, V30, P327, DOI 10.1016/0022-510X(76)90138-6; LOW PA, 1975, J NEUROL SCI, V26, P565, DOI 10.1016/0022-510X(75)90057-X; MARTINI R, 1988, DEV BIOL, V129, P330, DOI 10.1016/0012-1606(88)90380-6; MIRSKY R, 1980, J CELL BIOL, V84, P483, DOI 10.1083/jcb.84.3.483; MOKUNO K, 1989, J NEUROSCI RES, V23, P396, DOI 10.1002/jnr.490230405; MUIR D, 1989, NEUROCHEM RES, V14, P1003, DOI 10.1007/BF00965935; OAKLANDER AL, 1987, BRAIN RES, V419, P39, DOI 10.1016/0006-8993(87)90566-X; ONO J, 1982, EUR J PEDIATR, V138, P265, DOI 10.1007/BF00441215; ORNITZ DM, 1985, NATURE, V313, P600, DOI 10.1038/313600a0; OWENS GC, 1990, J CELL BIOL, V111, P1171, DOI 10.1083/jcb.111.3.1171; OWENS GC, 1991, DEVELOPMENT, V112, P639; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363; PELLEGRINO RG, 1986, J NEUROCYTOL, V15, P17, DOI 10.1007/BF02057901; PODUSLO JF, 1985, P NATL ACAD SCI USA, V82, P5987, DOI 10.1073/pnas.82.17.5987; POLITIS MJ, 1982, J NEUROSCI, V2, P1252; RAINE CS, 1982, J NEUROCYTOL, V11, P109, DOI 10.1007/BF01258007; SAIDA K, 1986, ACTA NEUROPATHOL, V71, P251, DOI 10.1007/BF00688047; TANAKA K, 1989, BRAIN RES, V503, P160, DOI 10.1016/0006-8993(89)91719-8; TANIUCHI M, 1988, J NEUROSCI, V8, P664; TRAPP BD, 1981, J CELL BIOL, V90, P1, DOI 10.1083/jcb.90.1.1; TRAPP BD, 1988, J NEUROSCI, V8, P3515; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; URSCHEL BA, 1990, J COMP NEUROL, V296, P114, DOI 10.1002/cne.902960107; VITAL A, 1987, ACTA NEUROPATHOL, V73, P295, DOI 10.1007/BF00686625; WEINMASTER G, 1990, EMBO J, V9, P915, DOI 10.1002/j.1460-2075.1990.tb08189.x; WILKIE TM, 1986, DEV BIOL, V118, P9, DOI 10.1016/0012-1606(86)90068-0; WINTER J, 1982, J NEUROCYTOL, V11, P351, DOI 10.1007/BF01257982; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5	62	98	112	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1992	8	3					507	520		10.1016/0896-6273(92)90279-M	http://dx.doi.org/10.1016/0896-6273(92)90279-M			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1372510				2022-12-28	WOS:A1992HK67500011
J	NOWAK, LM; WRIGHT, JM				NOWAK, LM; WRIGHT, JM			SLOW VOLTAGE-DEPENDENT CHANGES IN CHANNEL OPEN-STATE PROBABILITY UNDERLIE HYSTERESIS OF NMDA RESPONSES IN MG2+-FREE SOLUTIONS	NEURON			English	Article								Many single-channel studies rely on the assumption that the channels are functioning under steady-state conditions. In examining the basis for nonlinear whole-cell current-voltage curves in Mg2+-free solutions we discovered that N-methyl-D-aspartate (NMDA) channels in excised patches reversibly shifted their open-state probability (P(o)) in a voltage-dependent way, exhibiting approximately 3- to 4-fold greater P(o) at positive potentials than at rest. Changes in P(o) were mainly attributable to shifts in frequency of channel opening. P(o) changed remarkably slowly (2-15 min), explaining the hysteresis of whole-cell current-voltage curves obtained in nonequilibrium conditions. The slow increase in P(o) provides a mechanism by which NMDA channels can substantially increase Ca2+ influx in cells depolarized for prolonged periods of time and may play a role in excitotoxicity.			NOWAK, LM (corresponding author), CORNELL UNIV, COLL VET MED, DEPT PHARMACOL, ITHACA, NY 14853 USA.			Nowak, Linda/0000-0003-2249-4905	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024467] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24467] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P207; CHOI DW, 1987, J NEUROSCI, V7, P369; CLARK GD, 1990, NEUROSCIENCE, V39, P787, DOI 10.1016/0306-4522(90)90261-2; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; HARTLEY DM, 1989, J PHARMACOL EXP THER, V250, P752; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; JACKSON MB, 1985, BIOPHYS J, V47, P129, DOI 10.1016/S0006-3495(85)83886-8; JAHR CE, 1990, J NEUROSCI, V10, P1830; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; KONNERTH A, 1990, EXP BRAIN RES, V81, P209; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MACDONALD JF, 1990, TRENDS PHARMACOL SCI, V11, P167, DOI 10.1016/0165-6147(90)90070-O; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1985, J PHYSIOL-LONDON, V361, P65, DOI 10.1113/jphysiol.1985.sp015633; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; SACHS F, 1982, PFLUG ARCH EUR J PHY, V395, P331, DOI 10.1007/BF00580798; STRECKER GJ, 1990, BIOPHYS J, V57, pA121; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; WRIGHT JM, 1991, J PHYSIOL-LONDON, V439, P579, DOI 10.1113/jphysiol.1991.sp018683	28	50	50	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1992	8	1					181	187		10.1016/0896-6273(92)90119-X	http://dx.doi.org/10.1016/0896-6273(92)90119-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1370371				2022-12-28	WOS:A1992HB18500016
J	GLANZMAN, DL; KANDEL, ER; SCHACHER, S				GLANZMAN, DL; KANDEL, ER; SCHACHER, S			TARGET-DEPENDENT MORPHOLOGICAL SEGREGATION OF APLYSIA SENSORY OUTGROWTH INVITRO	NEURON			English	Article							OCULAR DOMINANCE COLUMNS; GANGLION-CELLS; PRENATAL DEVELOPMENT; NEIGHBORING HOMOLOGS; SYNAPSE ELIMINATION; PREGANGLIONIC AXONS; DEVELOPING NEURONS; SKELETAL-MUSCLE; LEECH DEPENDS; COMPETITION	The adult nervous system is characterized by partial or complete morphological segregation of terminals from different afferent neurons innervating the same postsynaptic target. This segregation is thought to result, in part, from competition between the afferent terminals. To explore the role of the target cell in the spatial distribution of presynaptic inputs, the sensory neurons of Aplysia were cultured either with or without a common target motor neuron. In the presence of a common target, the outgrowth f rom two different sensory neurons tends to occupy separate postsynaptic regions. When cultured without a target motor neuron, processes from different sensory neurons do not segregate, but rather grow freely along one another. Thus, morphological segregation of sensory outgrowth requires interaction with a target neuron and may reflect competition between presynaptic terminals for a limited number of synaptic sites on the motor neuron, or for a postsynaptic trophic factor.	COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY 10032	Columbia University; Howard Hughes Medical Institute; Columbia University; New York State Psychiatry Institute					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027541] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 32099] Funding Source: Medline; NINDS NIH HHS [NS 27541] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], [No title captured]; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BIXBY JL, 1979, NATURE, V282, P726, DOI 10.1038/282726a0; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; CALLAWAY EM, 1987, NATURE, V328, P422, DOI 10.1038/328422a0; FOREHAND CJ, 1984, J NEUROSCI, V4, P1; FOREHAND CJ, 1987, J NEUROSCI, V7, P3274; GAO WQ, 1987, J NEUROBIOL, V18, P295, DOI 10.1002/neu.480180305; GAO WQ, 1987, J NEUROBIOL, V18, P43, DOI 10.1002/neu.480180105; GLANZMAN DL, 1989, NEURON, V3, P441, DOI 10.1016/0896-6273(89)90203-1; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; HUME RI, 1981, NATURE, V293, P469, DOI 10.1038/293469a0; KRASNE FB, 1987, J NEUROBIOL, V18, P61, DOI 10.1002/neu.480180106; LAW MI, 1981, J NEUROSCI, V1, P741, DOI 10.1523/JNEUROSCI.01-07-00741.1981; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; LICHTMAN JW, 1980, J PHYSIOL-LONDON, V302, P121; LICHTMAN JW, 1980, J PHYSIOL-LONDON, V301, P213, DOI 10.1113/jphysiol.1980.sp013200; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTAROLO PG, 1988, NATURE, V333, P171, DOI 10.1038/333171a0; MURPHEY RK, 1984, SCIENCE, V224, P1352, DOI 10.1126/science.6729457; PURVES D, 1981, J NEUROSCI, V1, P441; RAKIC P, 1981, SCIENCE, V214, P928, DOI 10.1126/science.7302569; RAKIC P, 1977, PHILOS T R SOC B, V278, P245, DOI 10.1098/rstb.1977.0040; RAYPORT SG, 1986, J NEUROSCI, V6, P759; REDFERN PA, 1970, J PHYSIOL-LONDON, V209, P701, DOI 10.1113/jphysiol.1970.sp009187; REH TA, 1984, J NEUROSCI, V4, P442; SCHACHER S, 1991, NEURON, V6, P679, DOI 10.1016/0896-6273(91)90166-W; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978	35	20	20	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					903	913		10.1016/0896-6273(91)90336-X	http://dx.doi.org/10.1016/0896-6273(91)90336-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1764244				2022-12-28	WOS:A1991GY43800004
J	ZHOU, JY; POTTS, JF; TRIMMER, JS; AGNEW, WS; SIGWORTH, FJ				ZHOU, JY; POTTS, JF; TRIMMER, JS; AGNEW, WS; SIGWORTH, FJ			MULTIPLE GATING MODES AND THE EFFECT OF MODULATING FACTORS ON THE MU-I SODIUM-CHANNEL	NEURON			English	Article							RAT-BRAIN; XENOPUS OOCYTES; SKELETAL-MUSCLE; MESSENGER-RNA; FUNCTIONAL EXPRESSION; ALPHA-SUBUNIT; INACTIVATION; ACTIVATION; BEHAVIOR; RECEPTOR	Macroscopic current from the mu-l skeletal muscle sodium channel expressed in Xenopus oocytes shows inactivation with two exponential components. The major, slower component's amplitude decreases with rapid pulsing. When mu-l cRNA is coinjected with rat skeletal muscle or brain mRNA the faster component becomes predominant. Individual mu-l channels switch between two principal gating modes, opening either only once per depolarization, or repeatedly in long bursts. These two modes differ in both activation and inactivation kinetics. There is also evidence for additional gating modes. It appears that the equilibrium among gating modes is influenced by a modulating factor encoded in rat skeletal muscle and brain mRNA. The modal gating is similar to that observed in hyperkalemic periodic paralysis.	SUNY STONY BROOK,DEPT BIOCHEM & CELL BIOL,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	ZHOU, JY (corresponding author), YALE UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,NEW HAVEN,CT 06510, USA.				NHLBI NIH HHS [HL38156] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL038156] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Colman A., 1984, TRANSCRIPTION TRANSL; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; JOHO RH, 1990, MOL BRAIN RES, V7, P105, DOI 10.1016/0169-328X(90)90087-T; KRAFTE DS, 1988, J NEUROSCI, V8, P2859; KRAFTE DS, 1990, J GEN PHYSIOL, V96, P689, DOI 10.1085/jgp.96.4.689; MANIATIS T, 1982, MOL CLONING LABORATO, P468; MCMANUS OB, 1988, J PHYSIOL-LONDON, V402, P79, DOI 10.1113/jphysiol.1988.sp017195; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; MOORMAN JR, 1990, SCIENCE, V250, P688; NILIUS B, 1988, BIOPHYS J, V53, P857, DOI 10.1016/S0006-3495(88)83166-7; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PATLAK JB, 1986, J GEN PHYSIOL, V87, P305, DOI 10.1085/jgp.87.2.305; PATLAK JB, 1989, J GEN PHYSIOL, V94, P279, DOI 10.1085/jgp.94.2.279; PATLAK JB, 1979, NATURE, V278, P643, DOI 10.1038/278643a0; PIETROBON D, 1990, NATURE, V346, P651, DOI 10.1038/346651a0; PLUMMER MR, 1991, NATURE, V351, P657, DOI 10.1038/351657a0; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; STUHMER W, 1987, EUR BIOPHYS J BIOPHY, V14, P131, DOI 10.1007/BF00253837; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X	31	129	130	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1991	7	5					775	785		10.1016/0896-6273(91)90280-D	http://dx.doi.org/10.1016/0896-6273(91)90280-D			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1660285	hybrid			2022-12-28	WOS:A1991GT93900008
J	ANCHAN, RM; REH, TA; ANGELLO, J; BALLIET, A; WALKER, M				ANCHAN, RM; REH, TA; ANGELLO, J; BALLIET, A; WALKER, M			EGF AND TGF-ALPHA STIMULATE RETINAL NEUROEPITHELIAL CELL-PROLIFERATION INVITRO	NEURON			English	Article							EPIDERMAL GROWTH-FACTOR; FACTOR IMMUNOREACTIVE MATERIAL; SERIAL SECTION ANALYSIS; NEURON-SPECIFIC ENOLASE; EMBRYONIC MOUSE RETINA; CENTRAL NERVOUS-SYSTEM; LARVAL FROG RETINA; RAT RETINA; NEUROTOXIC DESTRUCTION; MONOCLONAL-ANTIBODIES	Peptide growth factors have been shown to have diverse effects on cells of the CNS, such as promoting neuronal survival, neurite outgrowth, and several other aspects of neuronal differentiation. In addition, some of these factors have been shown to be mitogenic for particular classes of glial cells within the brain and optic nerve, and recently two peptide growth factors, fibroblast growth factor and nerve growth factor, have been shown to have mitogenic activity on the CNS neuronal progenitors. We now report that two members of another peptide growth factor, epidermal growth factor and transforming growth factor-alpha, are mitogenic for retinal neuroepithelial cells in primary cultures and provide evidence for the presence of both of these factors in normal developing rat retina.			ANCHAN, RM (corresponding author), UNIV WASHINGTON,DEPT BIOL STRUCT,SM-20,SEATTLE,WA 98195, USA.				NINDS NIH HHS [R01 NS23808] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023808] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; AKAGAWA K, 1986, BRAIN RES, V383, P110, DOI 10.1016/0006-8993(86)90012-0; ARAKI M, 1987, DEV BIOL, V124, P239, DOI 10.1016/0012-1606(87)90475-1; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; BENNETT GS, 1987, CURR TOP DEV BIOL, V21, P151; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHANDLER LP, 1985, J BIOL CHEM, V260, P3360; COHEN S, 1982, J BIOL CHEM, V257, P1523; COULOMBRE JL, 1965, DEV BIOL, V12, P79, DOI 10.1016/0012-1606(65)90022-9; DELEEUW AM, 1990, J NEUROCYTOL, V19, P253, DOI 10.1007/BF01217303; DICICCOBLOOM E, 1990, J CELL BIOL, V110, P2073, DOI 10.1083/jcb.110.6.2073; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; DRAGER UC, 1983, NATURE, V336, P672; EDELMAN GM, 1987, P NATL ACAD SCI USA, V84, P8502, DOI 10.1073/pnas.84.23.8502; FALLON JH, 1984, SCIENCE, V224, P1107, DOI 10.1126/science.6144184; FASSIO JB, 1989, INVEST OPHTH VIS SCI, V30, P1916; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; GOMEZPINILLA F, 1988, BRAIN RES, V438, P385, DOI 10.1016/0006-8993(88)91369-8; GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0; HEUER JG, 1990, NEURON, V5, P283, DOI 10.1016/0896-6273(90)90165-C; HICKS D, 1987, J HISTOCHEM CYTOCHEM, V35, P1317, DOI 10.1177/35.11.3655327; HINDS JW, 1979, J COMP NEUROL, V187, P495, DOI 10.1002/cne.901870303; HINDS JW, 1978, J COMP NEUROL, V179, P277, DOI 10.1002/cne.901790204; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LEE DC, 1985, NATURE, V313, P489, DOI 10.1038/313489a0; LOPASHOV GV, 1964, DEV EYE EXPT STUDIES; MASSAGUE J, 1983, J BIOL CHEM, V258, P3614; MESSERSMITH EK, 1990, INT J DEV NEUROSCI, V8, P447, DOI 10.1016/0736-5748(90)90077-F; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MORRISON RS, 1987, SCIENCE, V238, P72, DOI 10.1126/science.3498986; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; NEGISHI K, 1982, SCIENCE, V216, P747, DOI 10.1126/science.7079736; NEGISHI K, 1985, DEV BRAIN RES, V20, P291, DOI 10.1016/0165-3806(85)90117-8; NEGISHI K, 1987, DEV BRAIN RES, V33, P76; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; PINCUS DW, 1990, BRAIN RES, V514, P355, DOI 10.1016/0006-8993(90)91433-H; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; REH TA, 1989, J NEUROSCI, V9, P4179; REH TA, 1987, J NEUROSCI, V7, P3317; REH TA, 1986, DEV BIOL, V114, P463, DOI 10.1016/0012-1606(86)90210-1; REH TA, 1989, DEV VERTEBRATE RETIN, P43; REH TA, 1991, IN PRESS DETERMINANT; REISERT I, 1982, NEUROSCIENCE, V7, P1317, DOI 10.1016/0306-4522(82)91137-X; REYER RW, 1977, AMPHIBIAN EYE DEV RE, P309; RUGH R, 1955, ARCH OPHTHALMOL-CHIC, V54, P351; RUGH R, 1955, P SOC EXP BIOL MED, V89, P248; SCHAUDIES RP, 1989, J BIOL CHEM, V264, P10447; SCHILLING K, 1988, HISTOCHEMISTRY, V89, P295, DOI 10.1007/BF00493155; SCHUBERT D, 1986, DEV BIOL CULTURED NE; SHAW G, 1983, EUR J CELL BIOL, V30, P219; Sidman RL, 1961, STRUCTURE EYE, P487; SIMPSON DL, 1982, J NEUROSCI RES, V8, P453, DOI 10.1002/jnr.490080233; STONE LEON S., 1960, YALE JOUR BIOL AND MED, V32, P464; STONE LS, 1950, ANAT REC, V106, P89, DOI 10.1002/ar.1091060108; STONE LS, 1950, J EXP ZOOL, V113, P9, DOI 10.1002/jez.1401130103; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WERNER MH, 1988, J HISTOCHEM CYTOCHEM, V36, P81, DOI 10.1177/36.1.3275713; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILCOX JN, 1988, J NEUROSCI, V8, P1901	66	255	272	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1991	6	6					923	936		10.1016/0896-6273(91)90233-P	http://dx.doi.org/10.1016/0896-6273(91)90233-P			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	1711348				2022-12-28	WOS:A1991FT94900008
J	LOWENSTEIN, DH; MILES, MF; HATAM, F; MCCABE, T				LOWENSTEIN, DH; MILES, MF; HATAM, F; MCCABE, T			UP REGULATION OF CALBINDIN-D28K MESSENGER-RNA IN THE RAT HIPPOCAMPUS FOLLOWING FOCAL STIMULATION OF THE PERFORANT PATH	NEURON			English	Article							CALCIUM-BINDING PROTEIN; CYTOSOLIC FREE CALCIUM; SUSTAINED ELECTRICAL-STIMULATION; GENE-EXPRESSION; STATUS EPILEPTICUS; ALZHEIMER DONORS; BRAIN; 1,25-DIHYDROXYVITAMIN-D3; NEURONS; CELLS	Calbindin-D28K is a constitutive Ca2+-binding protein expressed in hippocampal neurons that are resistant to various forms of excitotoxic injury. However, the local factors controlling calbindin-D28K expression within the central nervous system are unknown. We report that neuronal excitation via the perforant path leads to an increased expression of calbindin-D28K mRNA within dentate granule cells. This response is related specifically to stimulation that induces prolonged periods of bursting afterdischarges and precedes cellular injury. The up regulation of calbindin-D28K mRNA occurs during the type of neuronal activation associated with elevated cytosolic Ca2+ and suggests that the maintenance of Ca2+ homeostasis includes a system of feedback control at the level of gene expression.	UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,ERNEST GALLO CLIN & RES CTR,SAN FRANCISCO,CA 94110	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	LOWENSTEIN, DH (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT NEUROL,EPILEPSY RES LAB,SAN FRANCISCO,CA 94143, USA.				NIAAA NIH HHS [AA07750] Funding Source: Medline; NINDS NIH HHS [NS01424] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R29AA007750, R01AA007750] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Andersen P, 1967, Prog Brain Res, V27, P400; BAIMBRIDGE KG, 1982, BRAIN RES, V239, P519, DOI 10.1016/0006-8993(82)90526-1; BOWMAN LH, 1981, NUCLEIC ACIDS RES, V9, P4951, DOI 10.1093/nar/9.19.4951; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHRISTAKOS S, 1989, ENDOCR REV, V10, P3, DOI 10.1210/edrv-10-1-3; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FULLMER CS, 1987, P NATL ACAD SCI USA, V84, P4772, DOI 10.1073/pnas.84.14.4772; GLOOR P, 1989, CAN J NEUROL SCI, V16, P8, DOI 10.1017/S0317167100028468; GONZALEZ MF, 1989, MOL BRAIN RES, V6, P93, DOI 10.1016/0169-328X(89)90033-8; GREENBERG DA, 1987, ANN NEUROL, V21, P317, DOI 10.1002/ana.410210402; GRIFFITHS T, 1983, NEUROSCIENCE, V10, P385, DOI 10.1016/0306-4522(83)90141-0; GRIFFITHS T, 1984, NEUROSCIENCE, V12, P557, DOI 10.1016/0306-4522(84)90073-3; HALL AK, 1987, MOL CELL ENDOCRINOL, V51, P25, DOI 10.1016/0303-7207(87)90115-8; HUANG YC, 1988, MOL ENDOCRINOL, V2, P928, DOI 10.1210/mend-2-10-928; HUANG YC, 1989, J BIOL CHEM, V264, P17454; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; IACOPINO AM, 1990, J BIOL CHEM, V265, P10177; IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078; ICHIMIYA Y, 1989, BRAIN RES, V499, P402, DOI 10.1016/0006-8993(89)90793-2; INGERSOLL RJ, 1971, J BIOL CHEM, V246, P2808; JANDE SS, 1981, NATURE, V294, P765, DOI 10.1038/294765a0; LEATHERS VL, 1990, J BIOL CHEM, V265, P9838; LOGSDON CD, 1987, ENDOCRINOLOGY, V121, P1242, DOI 10.1210/endo-121-4-1242; LOMO T, 1971, EXP BRAIN RES, V12, P18; LOWENSTEIN DH, 1990, BRAIN RES, V531, P173, DOI 10.1016/0006-8993(90)90771-3; MINGHETTI PP, 1989, BIOCHEM BIOPH RES CO, V162, P869, DOI 10.1016/0006-291X(89)92390-5; MINGHETTI PP, 1988, MOL ENDOCRINOL, V2, P355, DOI 10.1210/mend-2-4-355; NEVANDER G, 1985, ANN NEUROL, V18, P281, DOI 10.1002/ana.410180303; PETERSON C, 1986, P NATL ACAD SCI USA, V83, P7999, DOI 10.1073/pnas.83.20.7999; PETERSON C, 1988, NEUROBIOL AGING, V9, P261, DOI 10.1016/S0197-4580(88)80063-0; RAMI A, 1989, BRAIN RES, V485, P20, DOI 10.1016/0006-8993(89)90664-1; SCHARFMAN HE, 1989, SCIENCE, V246, P257, DOI 10.1126/science.2508225; SEQUIER JM, 1988, NEUROSCI LETT, V86, P155, DOI 10.1016/0304-3940(88)90563-0; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SIMON R, 1991, IN PRESS J NEUROSCI; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; SLOVITER RS, 1981, NEUROSCI LETT, V24, P279, DOI 10.1016/0304-3940(81)90171-3; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; UEMATSU D, 1989, J CEREBR BLOOD F MET, V9, P149, DOI 10.1038/jcbfm.1989.22; VARGHESE S, 1988, J BIOL CHEM, V263, P9776; VARGHESE S, 1989, MOL ENDOCRINOL, V3, P495, DOI 10.1210/mend-3-3-495; VASS K, 1989, NEUROSCI LETT, V100, P259, DOI 10.1016/0304-3940(89)90695-2; WASSERMA.RH, 1966, SCIENCE, V152, P791, DOI 10.1126/science.152.3723.791; WASSERMAN RH, 1968, J BIOL CHEM, V243, P3978; WOOD TL, 1988, DNA-J MOLEC CELL BIO, V7, P585, DOI 10.1089/dna.1988.7.585	48	100	100	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					627	633		10.1016/0896-6273(91)90065-8	http://dx.doi.org/10.1016/0896-6273(91)90065-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	2015095				2022-12-28	WOS:A1991FH80200014
J	NIGHORN, A; HEALY, MJ; DAVIS, RL				NIGHORN, A; HEALY, MJ; DAVIS, RL			THE CYCLIC-AMP PHOSPHODIESTERASE ENCODED BY THE DROSOPHILA DUNCE GENE IS CONCENTRATED IN THE MUSHROOM BODY NEUROPIL	NEURON			English	Article							ADENOSINE 3'-5'-MONOPHOSPHATE PHOSPHODIESTERASE; SHORT-TERM-MEMORY; MUTANT DROSOPHILA; LEARNING MUTANTS; APIS-MELLIFERA; CDNA CLONES; MELANOGASTER; BRAIN; IDENTIFICATION; SEQUENCES	Drosophila dunce (dnc) flies are defective in learning and memory as a result of lesions in the gene that codes for a cAMP-specific phosphodiesterase (PDE). Antibodies to the dnc PDE showed that the most intensely stained regions in the adult brain were the mushroom body neurophil-areas previously implicated in learning and memory. In situ hybridization demonstrated that dnc RNA was enriched in the mushroom body perikarya. The mushroom bodies of third instar larval brains were also stained intensely by the antibody, suggesting that the dnc PDE plays an important role in these neurons throughout their development. The role of the dnc PDE in mushroom body physiology is discussed, and a circuit model describing a possible role of the mushroom bodies in mediating olfactory learning and memory is presented.	CSIRO,DIV ENTOMOL,CANBERRA,ACT 2601,AUSTRALIA; BAYLOR UNIV,DIV NEUROSCI,HOUSTON,TX 77030	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Baylor University	NIGHORN, A (corresponding author), BAYLOR UNIV,DEPT CELL BIOL,HOUSTON,TX 77030, USA.		Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608				BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; BELLEN HJ, 1987, DEV BIOL, V121, P432, DOI 10.1016/0012-1606(87)90180-1; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BOOKER R, 1981, P NATL ACAD SCI-BIOL, V78, P3940, DOI 10.1073/pnas.78.6.3940; BYRNE JH, 1987, PHYSIOL REV, V67, P329, DOI 10.1152/physrev.1987.67.2.329; CHARBONNEAU H, 1986, P NATL ACAD SCI USA, V83, P9308, DOI 10.1073/pnas.83.24.9308; CHEN CN, 1986, P NATL ACAD SCI USA, V83, P9313, DOI 10.1073/pnas.83.24.9313; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; DAVIS RL, 1984, MOL CELL BIOL, V4, P358, DOI 10.1128/MCB.4.2.358; DAVIS RL, 1984, ADV CYCLIC NUCL PROT, V16, P393; DAVIS RL, 1989, P NATL ACAD SCI USA, V86, P3604, DOI 10.1073/pnas.86.10.3604; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; DUDAI Y, 1983, P NATL ACAD SCI-BIOL, V80, P5445, DOI 10.1073/pnas.80.17.5445; DUDAI Y, 1988, ANNU REV NEUROSCI, V11, P537, DOI 10.1146/annurev.ne.11.030188.002541; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; HALL JC, 1986, TRENDS NEUROSCI, V9, P414, DOI 10.1016/0166-2236(86)90135-9; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HEISENBERG M, 1978, Z NATURFORSCH, V34, P143; HUBER F, 1974, PHYSL INSECTA, P4; HUBER F, 1967, INVERTEBRATE NERVOUS, P333; KATZ F, 1988, EMBO J, V7, P3471, DOI 10.1002/j.1460-2075.1988.tb03222.x; KAUVAR LM, 1982, J NEUROSCI, V2, P1347; KIGER JA, 1985, ADV INSECT PHYSIOL, V18, P141; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; Power ME, 1943, J MORPHOL, V72, P517, DOI 10.1002/jmor.1050720306; POWER ME, 1946, J COMP NEUROL, V85, P485, DOI 10.1002/cne.900850307; QIU Y, 1991, IN PRESS J MOL BIOLS; SCHILDBERGER K, 1984, J COMP PHYSIOL, V154, P71, DOI 10.1007/BF00605392; SCHWARZ TL, 1990, NEURON, V4, P119, DOI 10.1016/0896-6273(90)90448-O; SHOTWELL SL, 1983, J NEUROSCI, V3, P739; STANLEY KK, 1984, EMBO J, V3, P1429, DOI 10.1002/j.1460-2075.1984.tb01988.x; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; WADEPUHL M, 1979, NATURWISSENSCHAFTEN, V66, P320, DOI 10.1007/BF00441284; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301	39	216	218	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					455	467		10.1016/0896-6273(91)90253-V	http://dx.doi.org/10.1016/0896-6273(91)90253-V			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1848082				2022-12-28	WOS:A1991FC47000013
J	GRAY, GE; SANES, JR				GRAY, GE; SANES, JR			MIGRATORY PATHS AND PHENOTYPIC CHOICES OF CLONALLY RELATED CELLS IN THE AVIAN OPTIC TECTUM	NEURON			English	Article							RECOMBINANT RETROVIRUS; CHICK-EMBRYO; NERVOUS-SYSTEM; LINEAGE ANALYSIS; CEREBRAL-CORTEX; RADIAL GLIA; NEURONS; MOUSE; DIFFERENTIATION; PATHWAYS	We used retrovirus-mediated gene transfer to study the migration of clonally related cells in the developing chicken optic tectum. Clonal cohorts initially form radial arrays in the ventricular zone (approximately E5), but eventually divide into three separate migratory streams. In the first migration, a minor population of cells migrates tangentially along axon fascicles in medio-laterally directed files (approximately E6-E7); these eventually differentiate into multipolar efferent cells. After E7, the majority of cells in each clone migrate radially along fascicles of radial glia to form the tectal plate, wherein they differentiate into neurons and astrocytes. Around E9, a set of small cells leaves the radial arrays in superficial layers to form a second tangential migration; at least some of these differentiate into astrocytes. Thus, as the tectum develops, cells derived from a single multipotential precursor migrate along three separate pathways, follow separate guidance cues, and adopt distinct phenotypes.			GRAY, GE (corresponding author), WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110, USA.							ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BENNETT GS, 1984, BRAIN RES, V304, P291, DOI 10.1016/0006-8993(84)90333-0; BITNER C, 1987, DEV BRAIN RES, V37, P167, DOI 10.1016/0165-3806(87)90238-0; BOOK KJ, 1990, J COMP NEUROL, V297, P55, DOI 10.1002/cne.902970105; BOURRAT F, 1988, DEV BRAIN RES, V39, P19, DOI 10.1016/0165-3806(88)90064-8; CAJAL SRY, 1960, ETUDES NEUROGENESIS; DOMESICK VB, 1977, NEUROSCIENCE, V2, P459, DOI 10.1016/0306-4522(77)90011-2; DRAGER UC, 1984, J NEUROSCI, V4, P2025; DUPOUEY P, 1985, DEV NEUROSCI-BASEL, V7, P81, DOI 10.1159/000112279; FUJITA S, 1964, J COMP NEUROL, V122, P311, DOI 10.1002/cne.901220303; GADISSEUX JF, 1985, DEV NEUROSCI-BASEL, V7, P12, DOI 10.1159/000112273; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GOLDBERG S, 1974, DEV BIOL, V36, P24, DOI 10.1016/0012-1606(74)90188-2; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; GRAY GE, 1988, P NATL ACAD SCI USA, V85, P7356, DOI 10.1073/pnas.85.19.7356; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAMDI FA, 1954, Q J EXP PHYSIOL CMS, V39, P111, DOI 10.1113/expphysiol.1954.sp001053; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HYNES RO, 1986, J NEUROSCI, V6, P867; Jassik-Gerschenfeld D., 1984, P649; KROGER S, 1990, J NEUROSCI, V10, P3118; LAVAIL JH, 1971, BRAIN RES, V28, P421; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; LEBER SM, 1990, J NEUROSCI, V10, P2451; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LINSER PJ, 1985, J NEUROSCI, V5, P2388; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MOODY SA, 1983, J COMP NEUROL, V216, P20, DOI 10.1002/cne.902160104; ONO K, 1989, EXP BRAIN RES, V78, P290; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; PUELLES L, 1978, NEUROSCIENCE, V3, P307, DOI 10.1016/0306-4522(78)90079-9; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAGER G, 1979, EXP BRAIN RES, V35, P213, DOI 10.1007/BF00236612; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Rakic P, 1985, CELL CONTACT ADHESIO, P67; REINER A, 1982, J COMP NEUROL, V204, P165, DOI 10.1002/cne.902040206; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SANES JR, 1990, IN PRESS AVIAN MODEL; SENUT MC, 1987, DEV BRAIN RES, V32, P187, DOI 10.1016/0165-3806(87)90100-3; STENT GS, 1985, PHILOS T R SOC B, V312, P3, DOI 10.1098/rstb.1985.0174; VANSELOW J, 1989, DEV BRAIN RES, V45, P15, DOI 10.1016/0165-3806(89)90003-5; WEIKERT T, 1990, J NEUROBIOL, V21, P482, DOI 10.1002/neu.480210309; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILSON DB, 1973, J EMBRYOL EXP MORPH, V29, P745	50	140	141	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1991	6	2					211	225		10.1016/0896-6273(91)90357-6	http://dx.doi.org/10.1016/0896-6273(91)90357-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1704243				2022-12-28	WOS:A1991EY70900004
J	ALLEN, F; WARNER, A				ALLEN, F; WARNER, A			GAP JUNCTIONAL COMMUNICATION DURING NEUROMUSCULAR-JUNCTION FORMATION	NEURON			English	Article							CULTURED MUSCLE-CELLS; ORIGINAL SYNAPTIC SITES; ACETYLCHOLINE-RECEPTORS; SKELETAL-MUSCLE; BASAL LAMINA; POSTSYNAPTIC MEMBRANES; REGENERATING MUSCLE; NERVE; CHOLINESTERASE; PROTEIN	We have tested whether gap junctions form between nerve and muscle during their initial contact, before establishing the chemical synapse. Embryonic Xenopus stage 18-20 myotomes and neural tubes were permeabilized with DMSO to load appropriate reagents, dissociated, and cocultured. When myotomes, loaded with Lucifer yellow, were cocultured with unlabeled neural tube cells, 23% of the neurons contained dye after 24 hr. Affinity-purified gap junction antibodies loaded into myocytes or neurons reduced neuronal labeling significantly to 5%. [H-3]uridine nucleotide transfer was observed in both directions between myocytes and neurons. Again gap junction antibodies substantially reduced recipient label. In all cases preimmune IgGs did not reduce transfer. When acetylcholine receptor clustering was examined in cultures containing gap junction antibodies, no difference in the number of neuronally induced AChR clusters was observed. This suggests that the cluster-inducing signal between nerve and muscle does not pass through gap junctions.	UNIV LONDON UNIV COLL,DEPT ANAT & DEV BIOL,LONDON WC1E 6BT,ENGLAND	University of London; University College London					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037904, R01GM037904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 37904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN F, 1990, DEVELOPMENT, V108, P623; ALLEN FLG, 1988, THESIS U LONDON LOND; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; ANDERSON MJ, 1983, J CELL BIOL, V97, P1396, DOI 10.1083/jcb.97.5.1396; BAUER HC, 1981, BRAIN RES, V709, P395; BETZ W, 1973, J PHYSIOL-LONDON, V230, P673, DOI 10.1113/jphysiol.1973.sp010211; BLOCH RJ, 1983, J CELL BIOL, V97, P217, DOI 10.1083/jcb.97.1.217; BLOCH RJ, 1980, CELL, V21, P25, DOI 10.1016/0092-8674(80)90111-7; BONNER PH, 1989, EXP CELL RES, V181, P205, DOI 10.1016/0014-4827(89)90194-8; BURDEN S, 1982, J CELL BIOL, V94, P521, DOI 10.1083/jcb.94.3.521; BURDEN SJ, 1979, J CELL BIOL, V82, P412, DOI 10.1083/jcb.82.2.412; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; CHRISTIAN CN, 1978, P NATL ACAD SCI USA, V75, P4011, DOI 10.1073/pnas.75.8.4011; COHEN MW, 1984, J PHYSIOL-LONDON, V348, P57, DOI 10.1113/jphysiol.1984.sp015099; COHEN MW, 1980, J CELL BIOL, V86, P388, DOI 10.1083/jcb.86.2.388; COHEN SA, 1977, DEV BIOL, V59, P24, DOI 10.1016/0012-1606(77)90237-8; DAVEY DF, 1986, J NEUROSCI, V6, P673; FISCHBACH GD, 1972, DEV BIOL, V28, P407, DOI 10.1016/0012-1606(72)90023-1; FRASER SE, 1987, SCIENCE, V237, P49, DOI 10.1126/science.3037697; FREUND JE, 1960, MANUAL EXPT STATISTI, P22; FROEHNER SC, 1984, J CELL BIOL, V99, P88, DOI 10.1083/jcb.99.1.88; HALL ZW, 1981, J CELL BIOL, V90, P789, DOI 10.1083/jcb.90.3.789; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; JESSELL TM, 1979, P NATL ACAD SCI USA, V76, P5397, DOI 10.1073/pnas.76.10.5397; LEE S, 1987, CELL, V51, P851, DOI 10.1016/0092-8674(87)90108-5; MARKELONIS GJ, 1982, DEV BIOL, V89, P353, DOI 10.1016/0012-1606(82)90324-4; MARSHALL LM, 1977, P NATL ACAD SCI USA, V74, P3073, DOI 10.1073/pnas.74.7.3073; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P39, DOI 10.1113/jphysiol.1986.sp016104; MCMAHAN UJ, 1978, NATURE, V271, P172, DOI 10.1038/271172a0; MCMAHAN UJ, 1984, J CELL BIOL, V98, P1453, DOI 10.1083/jcb.98.4.1453; MESSENGER EA, 1979, J PHYSIOL-LONDON, V292, P85, DOI 10.1113/jphysiol.1979.sp012840; MOODYCORBETT F, 1982, J NEUROSCI, V2, P633; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; PEACOCK HA, 1950, ELEMENTARY MICROTECH; PENG HB, 1980, BRAIN RES, V196, P11; PODLESKI TR, 1978, P NATL ACAD SCI USA, V75, P2035, DOI 10.1073/pnas.75.4.2035; RIEGER F, 1985, J CELL BIOL, V101, P285, DOI 10.1083/jcb.101.1.285; STJOHN PA, 1982, J CELL BIOL, V92, P333, DOI 10.1083/jcb.92.2.333; WARNER A, 1987, J CELL BIOL, V104, P557, DOI 10.1083/jcb.104.3.557; WARNER AE, 1984, NATURE, V311, P127, DOI 10.1038/311127a0	41	30	30	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1991	6	1					101	111		10.1016/0896-6273(91)90125-J	http://dx.doi.org/10.1016/0896-6273(91)90125-J			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1986772				2022-12-28	WOS:A1991EU27800010
J	BAETGE, EE; HAMMANG, JP				BAETGE, EE; HAMMANG, JP			NEURITE OUTGROWTH IN PC12 CELLS DEFICIENT IN GAP-43	NEURON			English	Article							NERVE GROWTH-FACTOR; KINASE-C SUBSTRATE; CALMODULIN-BINDING-PROTEIN; LONG-TERM POTENTIATION; DEVELOPMENTAL REGULATION; PHEOCHROMOCYTOMA CELLS; SYNAPTIC PLASTICITY; SELECTIVE INCREASE; CEREBRAL-CORTEX; GENE-EXPRESSION	The neuronal cell line PC12 undergoes a well-documented morphological and biochemical differentiation when treated with NGF and other growth factors. A hallmark of this growth factor-mediated differentiation is the induction of the growth-associated protein, GAP-43. Here we show that a PC12 cell line which is capable of NGF-, bFGF-, and cAMP-mediated neurite outgrowth is deficient in GAP-43 protein and full-length mRNA, as measured by immunocytochemistry, Western blot, Northern blot, and PCR analyses, respectively. We propose that the GAP-43 protein may not be essential for the initial extension and maintenance of neurites induced by these neuritogenic factors; rather, its role may lie predominantly in growth cone function and in the operation of the presynaptic terminal.	UNIV WISCONSIN, SCH VET MED, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	BAETGE, EE (corresponding author), BRISTOL MYERS SQUIBB CO, CNS MOLEC BIOL, WALLINGFORD, CT 06492 USA.				PHS HHS [22475] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AKERS RF, 1987, J NEUROSCI, V7, P3976; ALEXANDER KA, 1988, J BIOL CHEM, V263, P7544; ANDREASEN TJ, 1983, BIOCHEMISTRY-US, V22, P4615, DOI 10.1021/bi00289a001; BASI GS, 1987, CELL, V49, P785, DOI 10.1016/0092-8674(87)90616-7; BENOWITZ LI, 1989, J NEUROSCI, V9, P990; BENOWITZ LI, 1988, J NEUROSCI, V8, P339; BOTHWELL MA, 1980, CELL, V21, P857, DOI 10.1016/0092-8674(80)90449-3; BRUGG B, 1988, J CELL BIOL, V107, P643, DOI 10.1083/jcb.107.2.643; CAMPAGNE MV, 1989, J NEUROCYTOL, V18, P479, DOI 10.1007/BF01474544; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; CIMLER BM, 1985, J BIOL CHEM, V260, P784; CIMLER BM, 1987, J BIOL CHEM, V262, P12158; COSTELLO B, 1990, J NEUROSCI, V10, P1398; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DEGRAAN PNE, 1988, NEUROSCI RES COMMUN, V3, P175; DEKKER LV, 1990, J NEUROCHEM, V54, P1645, DOI 10.1111/j.1471-4159.1990.tb01217.x; DEKKER LV, 1989, NATURE, V342, P74, DOI 10.1038/342074a0; DELAMONTE SM, 1989, DEV BRAIN RES, V46, P161, DOI 10.1016/0165-3806(89)90279-4; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FEDEROFF HJ, 1988, J BIOL CHEM, V263, P19290; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; GOSLIN K, 1990, J NEUROSCI, V10, P588; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1980, ANNU REV NEUROSCI, V3, P353, DOI 10.1146/annurev.ne.03.030180.002033; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HEEMSKERK FMJ, 1990, J NEUROCHEM, V54, P863, DOI 10.1111/j.1471-4159.1990.tb02331.x; HEIDEMANN SR, 1985, J CELL BIOL, V100, P916, DOI 10.1083/jcb.100.3.916; HOFFMAN PN, 1989, J NEUROSCI, V9, P893; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; KALIL K, 1986, J NEUROSCI, V6, P2563; KARNS LR, 1987, SCIENCE, V236, P597, DOI 10.1126/science.2437653; KATZ F, 1985, J NEUROSCI, V5, P1402; KAWASAKI ES, 1989, PCR TECHNOLOGY PRINC, P89; KGUROFF G, 1985, CELL CULTURE NEUROSC, P245; LABATE ME, 1989, NEURON, V3, P299, DOI 10.1016/0896-6273(89)90254-7; LOVINGER DM, 1985, BRAIN RES, V343, P137, DOI 10.1016/0006-8993(85)91167-9; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; MEIRI KF, 1988, J NEUROSCI, V8, P2571; MEIRI KF, 1990, J NEUROSCI, V10, P256; MOSS DJ, 1990, J NEUROCHEM, V54, P729, DOI 10.1111/j.1471-4159.1990.tb02312.x; NELSON RB, 1985, EXP NEUROL, V89, P213, DOI 10.1016/0014-4886(85)90277-8; NEVE RL, 1988, P NATL ACAD SCI USA, V85, P3638, DOI 10.1073/pnas.85.10.3638; NEVE RL, 1987, MOL BRAIN RES, V2, P177, DOI 10.1016/0169-328X(87)90012-X; NG SC, 1988, NEURON, V1, P133, DOI 10.1016/0896-6273(88)90197-3; RIEDERER B, 1986, J NEUROCYTOL, V15, P763, DOI 10.1007/BF01625193; ROSENTHAL A, 1987, EMBO J, V6, P3641, DOI 10.1002/j.1460-2075.1987.tb02696.x; ROUTTENBERG A, 1985, BEHAV NEURAL BIOL, V43, P3, DOI 10.1016/S0163-1047(85)91426-8; RUZZIER F, 1988, PROC R SOC SER B-BIO, V234, P1, DOI 10.1098/rspb.1988.0035; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SCHRAMA LH, 1986, PROG BRAIN RES, V69, P245; SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P2579, DOI 10.1073/pnas.74.6.2579; SKENE JHP, 1986, SCIENCE, V233, P783, DOI 10.1126/science.3738509; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; SKENE JHP, 1981, J CELL BIOL, V89, P86, DOI 10.1083/jcb.89.1.86; SKENE JHP, 1981, J CELL BIOL, V89, P96, DOI 10.1083/jcb.89.1.96; SNIPES GJ, 1987, J NEUROSCI, V7, P4066; STRITTMATTER SM, 1990, NATURE, V344, P836, DOI 10.1038/344836a0; TOGARI A, 1983, BIOCHEM BIOPH RES CO, V114, P1189, DOI 10.1016/0006-291X(83)90688-5; VANDONGEN AMJ, 1988, SCIENCE, V242, P1433, DOI 10.1126/science.3144040; VANHOOFF COM, 1986, BIOCHEM BIOPH RES CO, V139, P644, DOI 10.1016/S0006-291X(86)80039-0; VERHAAGEN J, 1988, J NEUROSCI, V8, P1759; WOOLF CJ, 1990, NEUROSCIENCE, V34, P465, DOI 10.1016/0306-4522(90)90155-W; YANKNER BA, 1990, MOL BRAIN RES, V7, P39, DOI 10.1016/0169-328X(90)90071-K; ZUBER MX, 1989, SCIENCE, V244, P1193, DOI 10.1126/science.2658062; ZUBER MX, 1989, NATURE, V341, P345, DOI 10.1038/341345a0	67	116	120	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1991	6	1					21	30		10.1016/0896-6273(91)90118-J	http://dx.doi.org/10.1016/0896-6273(91)90118-J			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1824753				2022-12-28	WOS:A1991EU27800003
J	SIMMONS, LK; SCHUETZE, SM; ROLE, LW				SIMMONS, LK; SCHUETZE, SM; ROLE, LW			SUBSTANCE-P MODULATES SINGLE-CHANNEL PROPERTIES OF NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS	NEURON			English	Article									COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,DEPT ANAT & CELL BIOL,NEW YORK,NY 10032	Columbia University			Role, LW/Q-7371-2018	Role, LW/0000-0001-5851-212X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022061] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 22061] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELCHER G, 1977, J PHYSIOL-LONDON, V272, P105, DOI 10.1113/jphysiol.1977.sp012036; BERUBE A, 1978, CAN J PHYSIOL PHARM, V56, P603, DOI 10.1139/y78-096; BOKSA P, 1982, BRAIN RES, V245, P275, DOI 10.1016/0006-8993(82)90810-1; BOYD ND, 1987, J PHYSIOL-LONDON, V389, P69, DOI 10.1113/jphysiol.1987.sp016647; CHOI DW, 1981, J NEUROPHYSIOL, V45, P605, DOI 10.1152/jn.1981.45.4.605; CLAPHAM DE, 1984, J PHYSIOL-LONDON, V347, P255, DOI 10.1113/jphysiol.1984.sp015065; DOWNING JEG, 1987, P NATL ACAD SCI USA, V84, P7739, DOI 10.1073/pnas.84.21.7739; EARDLEY D, 1985, EUR J PHARMACOL, V114, P101, DOI 10.1016/0014-2999(85)90529-1; EUSEBI F, 1988, PROC R SOC SER B-BIO, V234, P333, DOI 10.1098/rspb.1988.0052; GREENGARD P, 1987, MOL NEUROBIOL, V1, P81, DOI 10.1007/BF02935265; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HANLEY MR, 1980, MOL PHARMACOL, V18, P78; HAYASHI M, 1983, NEUROSCIENCE, V10, P31, DOI 10.1016/0306-4522(83)90078-7; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HORWITZ J, 1986, J PHARMACOL EXP THER, V237, P313; HUGANIR RL, 1986, NATURE, V321, P774, DOI 10.1038/321774a0; JARAMILLO F, 1988, J PHYSIOL-LONDON, V396, P267, DOI 10.1113/jphysiol.1988.sp016962; Kaczmarek LK, 1987, NEUROMODULATION BIOC; LEE CM, 1986, EUR J PHARMACOL, V130, P209, DOI 10.1016/0014-2999(86)90270-0; LEVITAN IB, 1985, J MEMBRANE BIOL, V87, P177, DOI 10.1007/BF01871217; LLIANG T, 1979, MOL CELL ENDOCRINOL, V15, P151; MAGGIO JE, 1986, NEUROSCIENCE, V18, P175; MARGIOTTA JF, 1987, J NEUROSCI, V7, P3612; MIDDLETON P, 1988, J NEUROSCI, V8, P3405; MILES K, 1989, NEURON, V2, P1517, DOI 10.1016/0896-6273(89)90198-0; MILES K, 1988, MOL NEUROBIOL, V2, P91, DOI 10.1007/BF02935341; MIZOBE F, 1979, BRAIN RES, V178, P555, DOI 10.1016/0006-8993(79)90714-5; MOSS BL, 1989, NEURON, V3, P597, DOI 10.1016/0896-6273(89)90270-5; MULLE C, 1988, P NATL ACAD SCI USA, V85, P5728, DOI 10.1073/pnas.85.15.5728; NEW HV, 1986, DEV BIOL, V116, P337, DOI 10.1016/0012-1606(86)90137-5; RAMIREZ OA, 1987, BRAIN RES, V414, P228, DOI 10.1016/0006-8993(87)90003-5; ROLE LW, 1981, NEUROSCIENCE, V6, P1813, DOI 10.1016/0306-4522(81)90215-3; ROLE LW, 1984, P NATL ACAD SCI-BIOL, V81, P2924, DOI 10.1073/pnas.81.9.2924; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; SIEGELBAUM SA, 1983, TRENDS NEUROSCI, V6, P307, DOI 10.1016/0166-2236(83)90145-5; SIMASKO SM, 1985, J PHARMACOL EXP THER, V235, P601; SIMASKO SM, 1987, J NEUROCHEM, V49, P253, DOI 10.1111/j.1471-4159.1987.tb03423.x; SMITH CD, 1988, BIOCHEM BIOPH RES CO, V156, P1250, DOI 10.1016/S0006-291X(88)80767-8; STALLCUP WB, 1980, P NATL ACAD SCI-BIOL, V77, P634, DOI 10.1073/pnas.77.1.634; STEINACKER A, 1976, BRAIN RES, V114, P128, DOI 10.1016/0006-8993(76)91013-1; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; WEISS SJ, 1982, BIOCHEM J, V206, P555, DOI 10.1042/bj2060555	42	47	47	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1990	4	3					393	403		10.1016/0896-6273(90)90051-G	http://dx.doi.org/10.1016/0896-6273(90)90051-G			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX032	1690566				2022-12-28	WOS:A1990CX03200007
J	GALILEO, DS; MAJORS, J; HORWITZ, AF; SANES, JR				GALILEO, DS; MAJORS, J; HORWITZ, AF; SANES, JR			RETROVIRALLY INTRODUCED ANTISENSE INTEGRIN RNA INHIBITS NEUROBLAST MIGRATION INVIVO	NEURON			English	Article							CLONALLY RELATED CELLS; CHICKEN OPTIC TECTUM; NEURONAL MIGRATION; RECOMBINANT RETROVIRUS; ADHESION MOLECULES; LINEAGE ANALYSIS; NERVOUS-SYSTEM; EXPRESSION; ANTIBODIES; FIBRONECTIN	We used retrovirus-mediated gene transfer to ask whether integrins are involved in the development of neuroblasts in the chicken optic tectum. Vectors were constructed with the E. coli lacZ gene in the sense orientation and beta1 integrin sequences in the antisense orientation. Tests in culture showed that the progeny of cells infected by these vectors were identifiable by expression of LacZ and had reduced levels of beta1 integrins on their surfaces. We then injected these vectors into optic tecta on E3, at the height of neuronal production. Clones of LacZ-positive cells were analyzed 3-9 days later, as they migrated along radial glia to form the tectal plate. Antisense sequences had little effect on the proliferation of progenitors, or on the radial stacking of their progeny in the ventricular zone (E6). However, many antisense-bearing cells accumulated in the ventricular zone and failed to migrate into the tectal plate (E7.5 and E9). At later stages (E12), few antisense-bearing cells could be found. Thus, integrin appears to be required in the migratory process, and cells that fail to engage in integrin-mediated interactions may die.	WASHINGTON UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63110; UNIV ILLINOIS,DEPT CELL & STRUCT BIOL,URBANA,IL 61801	Washington University (WUSTL); University of Illinois System; University of Illinois Urbana-Champaign	GALILEO, DS (corresponding author), WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110, USA.							ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; BENNETT GS, 1984, BRAIN RES, V304, P291, DOI 10.1016/0006-8993(84)90333-0; BOUCAUT JC, 1984, J CELL BIOL, V99, P1822, DOI 10.1083/jcb.99.5.1822; BOZYCZKO D, 1986, J NEUROSCI, V6, P1241; BRONNERFRASER M, 1986, DEV BIOL, V117, P528, DOI 10.1016/0012-1606(86)90320-9; CHANG EH, 1991, BIOCHEMISTRY-US, V30, P8283, DOI 10.1021/bi00098a001; CHUONG CM, 1987, J CELL BIOL, V104, P331, DOI 10.1083/jcb.104.2.331; COLMAN A, 1990, J CELL SCI, V97, P399; CONDREAY LD, 1990, J VIROL, V64, P3249, DOI 10.1128/JVI.64.7.3249-3258.1990; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; EMMERMAN M, 1984, CELL, V39, P459; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; GRAY GE, 1992, DEVELOPMENT, V114, P271; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; GRAY GE, 1988, P NATL ACAD SCI USA, V85, P7356, DOI 10.1073/pnas.85.19.7356; GREVE JM, 1982, J CELL BIOCHEM, V18, P221, DOI 10.1002/jcb.1982.240180209; HAINES DS, 1991, J CELL BIOCHEM, V46, P9, DOI 10.1002/jcb.240460104; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; HAYASHI Y, 1990, J CELL BIOL, V110, P175, DOI 10.1083/jcb.110.1.175; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HUSMANN K, 1992, J CELL BIOL, V116, P1475, DOI 10.1083/jcb.116.6.1475; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JAFFREDO T, 1988, DEVELOPMENT, V103, P431; KATSUKI M, 1988, SCIENCE, V241, P593, DOI 10.1126/science.2456614; LAVAIL JH, 1971, BRAIN RES, V28, P421; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LEHMANN S, 1990, P NATL ACAD SCI USA, V87, P6455, DOI 10.1073/pnas.87.16.6455; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; Melton DA, 1988, ANTISENSE RNA DNA; MOONEN G, 1982, NATURE, V298, P753, DOI 10.1038/298753a0; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; PEPIN MC, 1992, NATURE, V355, P725, DOI 10.1038/355725a0; PETROPOULOS CJ, 1991, J VIROL, V65, P3728, DOI 10.1128/JVI.65.7.3728-3737.1991; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; RESZKA AA, 1992, IN PRESS J CELL BIOL; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SHEPPARD AM, 1991, J NEUROSCI, V11, P3928; SOLOWSKA J, 1989, J CELL BIOL, V109, P853, DOI 10.1083/jcb.109.2.853; STITT TN, 1990, NEURON, V5, P639, DOI 10.1016/0896-6273(90)90218-5; SWANSTROM R, 1981, P NATL ACAD SCI-BIOL, V78, P124, DOI 10.1073/pnas.78.1.124; TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0; THANOS S, 1984, P NATL ACAD SCI-BIOL, V81, P1906, DOI 10.1073/pnas.81.6.1906; TOMINAGA S, 1988, FEBS LETT, V238, P315, DOI 10.1016/0014-5793(88)80503-9; van der Eb A J, 1980, Methods Enzymol, V65, P826; VANDERKROL AR, 1988, BIOTECHNIQUES, V6, P958; ZIMMER A, 1992, ANN REV NEUROSCI, V15, P1115	56	128	132	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1117	1131		10.1016/0896-6273(92)90070-T	http://dx.doi.org/10.1016/0896-6273(92)90070-T			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1463609				2022-12-28	WOS:A1992KD71600010
J	HAN, PL; LEVIN, LR; REED, RR; DAVIS, RL				HAN, PL; LEVIN, LR; REED, RR; DAVIS, RL			PREFERENTIAL EXPRESSION OF THE DROSOPHILA RUTABAGA GENE IN MUSHROOM BODIES, NEURAL CENTERS FOR LEARNING IN INSECTS	NEURON			English	Article							CYCLIC-AMP PHOSPHODIESTERASE; MEDIATED ENHANCER DETECTION; SHORT-TERM-MEMORY; MUTANT DROSOPHILA; ADENYLATE-CYCLASE; DUNCE; MELANOGASTER; DISSECTION; DEFICIENT; SYSTEM	Seven lines were isolated with P element insertions in the cytogenetic vicinity of the learning and memory gene, rutabaga, from an enhancer detector screen designed to mark genes preferentially expressed in mushroom bodies. Six of these lines performed poorly in learning and memory tests, and several failed to complement an existing rutabaga allele. Molecular cloning revealed that the P elements were inserted in the putative promoter of the rutabaga gene. RNA in situ hybridization and immunohistochemistry demonstrated that the expression of the rutabaga gene, which encodes a Ca2+/calmodulin-responsive adenylyl cyclase, is markedly elevated in the mushroom bodies of normal flies and that the insertion elements compromised its expression in the new rutabaga mutants. The reisolation of a known learning and memory gene, but with a heretofore unknown expression pattern, strongly supports the postulate that mushroom bodies are principal sites mediating olfactory learning and memory.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205	Baylor College of Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	HAN, PL (corresponding author), BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030, USA.		Reed, Russell/HGU-0528-2022; Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608; Levin, Lonny/0000-0002-5204-6356; Han, Pyung-Lim/0000-0002-1735-6746				ABRAMS TW, 1988, TRENDS NEUROSCI, V11, P128, DOI 10.1016/0166-2236(88)90137-3; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CHEN CN, 1986, P NATL ACAD SCI USA, V83, P9313, DOI 10.1073/pnas.83.24.9313; CORFAS G, 1989, J NEUROSCI, V9, P56; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; DELGADO R, 1991, P NATL ACAD SCI USA, V88, P557, DOI 10.1073/pnas.88.2.557; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; DUDAI Y, 1983, P NATL ACAD SCI-BIOL, V80, P5445, DOI 10.1073/pnas.80.17.5445; DUDAI Y, 1988, ANNU REV NEUROSCI, V11, P537, DOI 10.1146/annurev.ne.11.030188.002541; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Heisenberg M., 1989, Progress in Zoology, V37, P3; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIVINGSTONE MS, 1985, P NATL ACAD SCI USA, V82, P5992, DOI 10.1073/pnas.82.17.5992; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; QIU YH, 1991, J MOL BIOL, V222, P553, DOI 10.1016/0022-2836(91)90496-S; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	22	214	216	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					619	627		10.1016/0896-6273(92)90026-A	http://dx.doi.org/10.1016/0896-6273(92)90026-A			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1382471				2022-12-28	WOS:A1992JT51600004
J	QIU, MS; GREEN, SH				QIU, MS; GREEN, SH			PC12 CELL NEURONAL DIFFERENTIATION IS ASSOCIATED WITH PROLONGED P21(RAS) ACTIVITY AND CONSEQUENT PROLONGED ERK ACTIVITY	NEURON			English	Article							NERVE GROWTH-FACTOR; PROTEIN-KINASE-C; LIGAND-INDUCED INTERNALIZATION; SERINE THREONINE KINASES; SIGNAL-REGULATED KINASES; SERUM-RESPONSE ELEMENT; TYROSINE PHOSPHORYLATION; NEURITE OUTGROWTH; FACTOR RECEPTOR; PHEOCHROMOCYTOMA CELLS	Expression of oncogenic ras in PC12 cells causes neuronal differentiation 'and sustained protein tyrosine phosphorylation and activity of extracellular signal-regulated kinases (ERKs), p42erk2 and p44erk1. Oncogenic N-ras-induced neuronal differentiation is inhibited by compounds that block ERK protein tyrosine phosphorylation or ERK activity, indicating that ERKs are not only activated by p21ras but serve as the primary downstream effectors of p21ras. Treatment of PC12 cells with nerve growth factor or fibroblast growth factor results in neuronal differentiation and in a sustained elevation of p21ras activity, of ERK activity, and of ERK tyrosine phosphorylation. Epidermal growth factor, which does not cause neuronal differentiation, stimulates only transient (< 1 hr) activation of p21ras and ERKs. These data indicate that transient activation of p21ras and, consequently, ERKs is not sufficient for induction of neuronal differentiation. Prolonged ERK activity is required: a consequence of sustained activation of p21ras by the growth factor receptor protein tyrosine kinase.			QIU, MS (corresponding author), UNIV IOWA,DEPT BIOL,IOWA CITY,IA 52242, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026538] Funding Source: NIH RePORTER; NINDS NIH HHS [NS26538] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHN NG, 1991, J BIOL CHEM, V266, P4220; AHN NG, 1990, J BIOL CHEM, V265, P11487; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ANDERSON NG, 1991, BIOCHEM J, V277, P573, DOI 10.1042/bj2770573; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Ausubel FM, 1988, MOL REPROD DEV; BALLESTER R, 1985, J BIOL CHEM, V260, P5194; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BERGER FG, 1984, J BIOL CHEM, V259, P7941; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BURSTEIN DE, 1982, DEV BIOL, V94, P477, DOI 10.1016/0012-1606(82)90364-5; CAMPOSGONZALEZ R, 1991, CELL REGUL, V2, P663, DOI 10.1091/mbc.2.8.663; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; CHO KO, 1989, MOL CELL BIOL, V9, P135, DOI 10.1128/MCB.9.1.135; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUNG J, 1991, P NATL ACAD SCI USA, V88, P4981, DOI 10.1073/pnas.88.11.4981; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; DECKER SJ, 1990, J BIOL CHEM, V265, P7009; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; FUKUMOTO Y, 1990, J BIOL CHEM, V265, P774; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GAUTHIERROUVIERE C, 1990, EMBO J, V9, P171, DOI 10.1002/j.1460-2075.1990.tb08093.x; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1978, NATURE, V276, P191, DOI 10.1038/276191a0; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1990, J NEUROSCI, V10, P1479; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; GUERRERO I, 1988, BIOCHEM BIOPH RES CO, V150, P1185, DOI 10.1016/0006-291X(88)90754-1; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HEISERMANN GJ, 1990, J BIOL CHEM, V265, P12820; HUFF KR, 1979, BIOCHEM BIOPH RES CO, V89, P176; KAZLAUSKAS A, 1988, J CELL BIOL, V106, P1395, DOI 10.1083/jcb.106.4.1395; KIM UH, 1991, J BIOL CHEM, V266, P1359; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LACAL JC, 1987, MOL CELL BIOL, V7, P4146, DOI 10.1128/MCB.7.11.4146; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALLEMAIN G, 1991, CELL REGUL, V2, P675, DOI 10.1091/mbc.2.8.675; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LI P, 1991, CELL, V64, P479, DOI 10.1016/0092-8674(91)90228-Q; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LUND KA, 1990, J BIOL CHEM, V265, P20517; MAHER PA, 1989, J NEUROSCI RES, V24, P29, DOI 10.1002/jnr.490240106; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MIYASAKA T, 1991, P NATL ACAD SCI USA, V88, P2653, DOI 10.1073/pnas.88.7.2653; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MORRIS JDH, 1989, ONCOGENE, V4, P27; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; NJA A, 1978, J PHYSIOL-LONDON, V277, P53; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; POSADA J, 1991, MOL CELL BIOL, V11, P2517, DOI 10.1128/MCB.11.5.2517; POSADA J, 1992, SCIENCE, V255, P212, DOI 10.1126/science.1313186; PRESTA M, 1991, CELL REGUL, V2, P719, DOI 10.1091/mbc.2.9.719; PURVES D, 1976, J PHYSIOL-LONDON, V259, P159, DOI 10.1113/jphysiol.1976.sp011459; QIU MS, 1991, J CELL BIOL, V115, P795, DOI 10.1083/jcb.115.3.795; QIU MS, 1991, NEURON, V7, P937, DOI 10.1016/0896-6273(91)90339-2; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SCHANENKING C, 1991, NEURON, V6, P915, DOI 10.1016/0896-6273(91)90232-O; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; SIGMUND O, 1990, J BIOL CHEM, V265, P2257; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TOGARI A, 1985, J NEUROSCI, V5, P307; TROTTA RJ, 1990, J CELL PHYSIOL, V143, P68, DOI 10.1002/jcp.1041430109; TSAO H, 1991, J BIOL CHEM, V266, P12981; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; VOLONTE C, 1989, J CELL BIOL, V109, P2395, DOI 10.1083/jcb.109.5.2395; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; ZINN K, 1988, SCIENCE, V240, P210, DOI 10.1126/science.3281258	90	452	458	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					705	717		10.1016/0896-6273(92)90033-A	http://dx.doi.org/10.1016/0896-6273(92)90033-A			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1382473				2022-12-28	WOS:A1992JT51600011
J	WRIGHT, EM; VOGEL, KS; DAVIES, AM				WRIGHT, EM; VOGEL, KS; DAVIES, AM			NEUROTROPHIC FACTORS PROMOTE THE MATURATION OF DEVELOPING SENSORY NEURONS BEFORE THEY BECOME DEPENDENT ON THESE FACTORS FOR SURVIVAL	NEURON			English	Article							NERVE GROWTH-FACTOR; RECEPTOR MESSENGER-RNA; DORSAL-ROOT GANGLIA; NEURAL CREST; NGF RECEPTOR; MOLECULAR-CLONING; DEVELOPMENTAL EXPRESSION; SYMPATHETIC NEURONS; GENE-TRANSFER; FACTOR FAMILY	We have studied the early development of chicken embryo sensory neurons in culture before they become dependent on neurotrophic factors for survival. During this period, they undergo a distinct change in morphology: initially they have small, spindle-shaped, phase-dark cell bodies, which become spherical and phase bright and extend long neurites. Although this maturational change occurs in isolated cells grown in chemically defined medium, it is accelerated by brain-derived neurotrophic factor (BDNF) or neurotrophin-3 and is retarded by antisense oligonucleotides that inhibit expression of the common, low affinity neurotrophic factor receptor (gp75(NGFR)) and by antisense BDNF oligonucleotides. We conclude that neurotrophic factors play a role in the earliest stages of sensory neuron development and suggest that they operate by an autocrine mechanism at this time.			WRIGHT, EM (corresponding author), ST GEORGE HOSP,SCH MED,DEPT ANAT,CRANMER TERRACE,LONDON SW17 0RE,ENGLAND.		Davies, Alun M/A-4334-2010	Davies, Alun M/0000-0001-5841-8176	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BOCCHINI V, 1969, P NATL ACAD SCI USA, V64, P787, DOI 10.1073/pnas.64.2.787; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P1565; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; COUGHLIN MD, 1985, DEV BIOL, V110, P392, DOI 10.1016/0012-1606(85)90098-3; DAVIES A, 1984, J COMP NEUROL, V223, P124, DOI 10.1002/cne.902230110; DAVIES AM, 1984, DEV BRAIN RES, V14, P121, DOI 10.1016/0165-3806(84)90015-4; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DAVIES AM, 1986, NATURE, V319, P497, DOI 10.1038/319497a0; DAVIES AM, 1985, DEV BIOL, V111, P62, DOI 10.1016/0012-1606(85)90435-X; DAVIES AM, 1987, DEVELOPMENT, V101, P185; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DAVIES AM, 1987, NEUROSCIENCE, V20, P37, DOI 10.1016/0306-4522(87)90004-2; DAVIES AM, 1989, NATURE, V337, P553, DOI 10.1038/337553a0; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; ERNSBERGER U, 1989, DEV BIOL, V135, P250, DOI 10.1016/0012-1606(89)90177-2; ERNSBERGER U, 1988, DEV BIOL, V126, P420, DOI 10.1016/0012-1606(88)90151-0; ERNSFORS P, 1990, NEURON, V5, P511; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; HALLBOOK F, 1990, DEVELOPMENT, V108, P693; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HEUER JG, 1990, DEV BIOL, V137, P287, DOI 10.1016/0012-1606(90)90255-H; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KALCHEIM C, 1988, DEV BRAIN RES, V41, P79, DOI 10.1016/0165-3806(88)90171-X; KALCHEIM C, 1987, EMBO J, V6, P2871, DOI 10.1002/j.1460-2075.1987.tb02589.x; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MATSUSHIMA H, 1990, MOL CELL BIOL, V10, P5015, DOI 10.1128/MCB.10.9.5015; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RAIVICH G, 1985, EMBO J, V4, P637, DOI 10.1002/j.1460-2075.1985.tb03677.x; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1989, DEV BIOL, V136, P296, DOI 10.1016/0012-1606(89)90256-X; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; ROHRER H, 1985, EMBO J, V4, P1709, DOI 10.1002/j.1460-2075.1985.tb03840.x; ROHRER H, 1982, DEV BIOL, V89, P309, DOI 10.1016/0012-1606(82)90320-7; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SEHGAL A, 1988, MOL CELL BIOL, V8, P2242, DOI 10.1128/MCB.8.5.2242; SIEBERBLUM M, 1991, NEURON, V6, P949, DOI 10.1016/0896-6273(91)90235-R; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; SUTTER A, 1979, J BIOL CHEM, V254, P5972; VOGEL KS, 1991, NEURON, V7, P819, DOI 10.1016/0896-6273(91)90284-7; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WYATT S, 1990, NEURON, V4, P421, DOI 10.1016/0896-6273(90)90054-J; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551	64	199	200	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					139	150		10.1016/0896-6273(92)90229-7	http://dx.doi.org/10.1016/0896-6273(92)90229-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1321644				2022-12-28	WOS:A1992JE75600015
J	KNOX, RJ; QUATTROCKI, EA; CONNOR, JA; KACZMAREK, LK				KNOX, RJ; QUATTROCKI, EA; CONNOR, JA; KACZMAREK, LK			RECRUITMENT OF CA2+ CHANNELS BY PROTEIN-KINASE-C DURING RAPID FORMATION OF PUTATIVE NEUROPEPTIDE RELEASE SITES IN ISOLATED APLYSIA NEURONS	NEURON			English	Article							BAG CELL NEURONS; GROWTH CONES; CALCIUM CHANNELS; NERVOUS-SYSTEM; STIMULATION; MODULATION; CULTURE	Activation of protein kinase C (PKC) in Aplysia bag cell neurons causes the recruitment of voltage-dependent calcium channels. Using imaging techniques on isolated cells, we have now found that an activator of PKC, 12-O-tetradecanoyl-phorbol-13-acetate (TPA), promotes the rapid appearance of new sites of calcium influx associated with a change in the morphology of neurite endings. In untreated cells, calcium influx triggered by action potentials occurs along neurites and in the central region of growth cones, but does not usually occur at the leading edge of lamellipodia. TPA produces extension of the lamellipodium, and action potentials now trigger calcium influx at the distal edge of the newly extended endings. Cotreatment with TPA and a cyclic AMP analog promotes movement of secretory organelles toward the new sites of calcium influx. Our results suggest that these second messenger systems promote the rapid formation of morphological structures that contribute to the potentiation of peptide release.	ROCHE INST MOLEC BIOL,ROCHE RES CTR,NUTLEY,NJ 07110; YALE UNIV,SCH MED,DEPT MOLEC & CELLULAR PHYSIOL,NEW HAVEN,CT 06510	Roche Holding; Yale University	KNOX, RJ (corresponding author), YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510, USA.		Quattrocki, Elizabeth/D-5263-2016	Quattrocki, Elizabeth/0000-0003-1164-8606; Smith, Peter/0000-0003-4400-6853				ARCH S, 1976, AM ZOOL, V16, P167; BAILEY CH, 1989, J NEUROSCI, V9, P1774; BIXBY JL, 1989, NEURON, V3, P287, DOI 10.1016/0896-6273(89)90253-5; BRIDGMAN PC, 1986, J CELL BIOL, V102, P1510, DOI 10.1083/jcb.102.4.1510; BRUEHL CL, 1985, J NEUROSCI, V5, P1233; COHAN CS, 1987, J NEUROSCI, V7, P3588; COHEN CS, 1986, SCIENCE, V232, P1638; CONN PJ, 1989, J NEUROSCI, V9, P480; CONN PJ, 1989, J NEUROSCI, V9, P473; CONN PJ, 1989, MOL NEUROBIOL, V3, P237, DOI 10.1007/BF02740607; CONNOR JA, 1986, P NATL ACAD SCI USA, V83, P6179, DOI 10.1073/pnas.83.16.6179; DERIEMER SA, 1985, NATURE, V313, P313, DOI 10.1038/313313a0; DERIEMER SA, 1985, J NEUROSCI, V5, P2672; DUDEK FE, 1976, SCIENCE, V192, P1009, DOI 10.1126/science.1273581; FINK LA, 1988, J NEUROSCI, V8, P2544; FORSCHER P, 1987, J NEUROSCI, V7, P3600; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; FRAZIER WT, 1967, J NEUROPHYSIOL, V30, P1288, DOI 10.1152/jn.1967.30.6.1288; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; JENNINGS KR, 1982, J NEUROSCI, V2, P158; JONES PG, 1987, BRAIN RES, V437, P56, DOI 10.1016/0006-8993(87)91526-5; Kaczmarek L.K., 1985, P80; KACZMAREK LK, 1978, P NATL ACAD SCI USA, V75, P5200, DOI 10.1073/pnas.75.10.5200; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KACZMAREK LK, 1979, J NEUROBIOL, V10, P535, DOI 10.1002/neu.480100604; KACZMAREK LK, 1982, BRAIN RES, V238, P105, DOI 10.1016/0006-8993(82)90774-0; KACZMAREK LK, 1983, J NEUROSCI, V3, P2230; KACZMAREK LK, 1984, J NEUROPHYSIOL, V52, P430; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; LOECHNER KJ, 1990, J NEUROPHYSIOL, V63, P738, DOI 10.1152/jn.1990.63.4.738; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0	33	56	58	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					883	889		10.1016/0896-6273(92)90202-O	http://dx.doi.org/10.1016/0896-6273(92)90202-O			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1316764				2022-12-28	WOS:A1992HV46700007
J	LOPEZ, HS				LOPEZ, HS			KINETICS OF G-PROTEIN MEDIATED MODULATION OF THE POTASSIUM M-CURRENT IN BULLFROG SYMPATHETIC NEURONS	NEURON			English	Article							GUANINE-NUCLEOTIDE BINDING; MUSCARINIC RECEPTOR; VOLTAGE-CLAMP; ATRIAL CELLS; FROG; INHIBITION; MECHANISM; GTP; ACTIVATION; CHANNEL	The inhibition of the voltage-dependent, K+ M-current (I(M)) following receptor-independent G protein activation with controlled intracellular perfusion of nonhydrolyzable GTP analogs had an exponential time course, with rates hyperbolically dependent on GTP analog concentration, and a limiting value of 0.53 min-1. The inhibitory agonist muscarine caused a concentration-dependent acceleration of the rate of nucleotide-induced inhibition, with a plateau of about 20 min-1 and an exponential time course. In neurons not treated with nucleotide analogs the I(M) recovery rate following agonist removal was 3-7 min-1. It is proposed that the overall kinetics of the transduction pathway for I(M) modulation is governed by the agonist-dependent kinetics of nucleotide interaction with G proteins. A simple model of I(M) modulation based on G proteins' kinetics has been developed. These data suggest a possible cellular process responsible for the time course of slow synaptic potentials caused by I(M) inhibition in sympathetic neurons.			LOPEZ, HS (corresponding author), SUNY STONY BROOK,HOWARD HUGHES MED INST,DEPT NEUROBIOL & BEHAV,STONY BROOK,NY 11794, USA.							ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P263, DOI 10.1113/jphysiol.1982.sp014412; ADAMS PR, 1982, J PHYSIOL-LONDON, V330, P537, DOI 10.1113/jphysiol.1982.sp014357; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; AKASU T, 1984, J PHYSIOL-LONDON, V351, P583, DOI 10.1113/jphysiol.1984.sp015264; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; BROWN DA, 1989, J PHYSIOL-LONDON, V413, P469, DOI 10.1113/jphysiol.1989.sp017664; CASEY PJ, 1988, J BIOL CHEM, V263, P2577; DODD J, 1983, J PHYSIOL-LONDON, V334, P255, DOI 10.1113/jphysiol.1983.sp014493; DOLPHIN AC, 1988, PFLUG ARCH EUR J PHY, V411, P628, DOI 10.1007/BF00580858; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; FINKEL AS, 1984, J NEUROSCI METH, V11, P101, DOI 10.1016/0165-0270(84)90029-3; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; JAN YN, 1979, P NATL ACAD SCI USA, V76, P1501, DOI 10.1073/pnas.76.3.1501; JAN YN, 1980, P NATL ACAD SCI-BIOL, V77, P5008, DOI 10.1073/pnas.77.8.5008; JONES SW, 1991, BIOPHYS J, V60, P502, DOI 10.1016/S0006-3495(91)82077-X; JONES SW, 1987, J PHYSIOL-LONDON, V389, P605, DOI 10.1113/jphysiol.1987.sp016674; JONES SW, 1985, J PHYSIOL-LONDON, V366, P63, DOI 10.1113/jphysiol.1985.sp015785; KATAYAMA Y, 1982, J PHYSIOL-LONDON, V333, P305, DOI 10.1113/jphysiol.1982.sp014455; KUFFLER SW, 1983, J PHYSIOL-LONDON, V341, P257, DOI 10.1113/jphysiol.1983.sp014805; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; KUROSE H, 1986, J BIOL CHEM, V261, P6423; LOCHRIE MA, 1988, BIOCHEMISTRY-US, V27, P4957, DOI 10.1021/bi00414a001; LOEB JN, 1987, MOL ENDOCRINOL, V1, P75, DOI 10.1210/mend-1-1-75; LOPEZ HS, 1989, EUR J NEUROSCI, V1, P529, DOI 10.1111/j.1460-9568.1989.tb00360.x; MARRION NV, 1991, NEURON, V6, P533, DOI 10.1016/0896-6273(91)90056-6; MARRION NV, 1989, BRIT J PHARMACOL, V98, P557, DOI 10.1111/j.1476-5381.1989.tb12630.x; MARUYAMA Y, 1988, J PHYSIOL-LONDON, V406, P299, DOI 10.1113/jphysiol.1988.sp017381; OLIVA C, 1988, BIOPHYS J, V54, P791, DOI 10.1016/S0006-3495(88)83017-0; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SCHRAMM M, 1975, J BIOL CHEM, V250, P2232; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; TOTA MR, 1987, BIOCHEMISTRY-US, V26, P8175, DOI 10.1021/bi00399a023; UHL R, 1990, TRENDS NEUROSCI, V13, P64, DOI 10.1016/0166-2236(90)90070-Q; YATANI A, 1987, SCIENCE, V235, P207, DOI 10.1126/science.2432660	42	22	22	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					725	736		10.1016/0896-6273(92)90093-S	http://dx.doi.org/10.1016/0896-6273(92)90093-S			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1567621				2022-12-28	WOS:A1992HQ18800011
J	HUNTER, DD; MURPHY, MD; OLSSON, CV; BRUNKEN, WJ				HUNTER, DD; MURPHY, MD; OLSSON, CV; BRUNKEN, WJ			S-LAMININ EXPRESSION IN ADULT AND DEVELOPING RETINAE - A POTENTIAL CUE FOR PHOTORECEPTOR MORPHOGENESIS	NEURON			English	Article							EMBRYONIC MOUSE RETINA; NEUROMUSCULAR-JUNCTION; GANGLION-CELLS; SKATE RETINA; RAT RETINA; DIFFERENTIATION; PROTEIN; LOCALIZATION; MOLECULES; ANTIBODY	The development of the neural retina follows a stereo-typed time course that begins with an undifferentiated neuroepithelium populated by multipotential progenitor cells and ends with a highly differentiated tissue containing diverse cell types. The identities of the factors that guide this differentiation have remained elusive; a likely location for such factors, however, is the extracellular environment. Here, we show that the extracellular matrix component s-laminin is present in the neural retina, that s-laminin expression parallels the differentiation of rod photoreceptors, that photoreceptors interact with s-laminin in vitro, and that antibodies to s-laminin profoundly reduce the appearance of cells that express rhodopsin in vitro. These data suggest that s-laminin plays a role in the differentiation of the neural retina and provide evidence that the composition of the extracellular matrix may be an important determinant of retinal differentiation.	BOSTON COLL,DEPT BIOL,CHESTNUT HILL,MA 02167	Boston College	HUNTER, DD (corresponding author), TUFTS UNIV,SCH MED,NEUROSCI PROGRAM,BOSTON,MA 02111, USA.			Brunken, William J/0000-0001-7330-1814	NATIONAL EYE INSTITUTE [R01EY006776] Funding Source: NIH RePORTER; NEI NIH HHS [EY 06776] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; ADLER R, 1985, DEV BIOL, V112, P100, DOI 10.1016/0012-1606(85)90124-1; ALLEN F, 1991, NEURON, V6, P101, DOI 10.1016/0896-6273(91)90125-J; CAMPBELL M, 1988, OPHTHALM PAEDIAT GEN, V3, P171; COHEN J, 1986, NATURE, V322, P465, DOI 10.1038/322465a0; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; ENGVALL E, 1990, CELL REGUL, V1, P731, DOI 10.1091/mbc.1.10.731; FEKETE DM, 1983, J NEUROCYTOL, V12, P785, DOI 10.1007/BF01258151; Fernald R.D., 1989, P31; GONZALEZFERNANDEZ F, 1990, J CELL BIOL, V111, P2775, DOI 10.1083/jcb.111.6.2775; GREEN TL, 1992, IN PRESS J BIOL CHEM; HAGEMAN GS, 1991, P NATL ACAD SCI USA, V88, P6706, DOI 10.1073/pnas.88.15.6706; HALL DE, 1987, J CELL BIOL, V104, P623, DOI 10.1083/jcb.104.3.623; HEWITT AT, 1990, EXP EYE RES, V50, P79; HINDS JW, 1979, J COMP NEUROL, V187, P495, DOI 10.1002/cne.901870303; HINDS JW, 1983, J COMP NEUROL, V213, P1, DOI 10.1002/cne.902130102; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUNTER DD, 1989, CELL, V59, P905, DOI 10.1016/0092-8674(89)90613-2; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; HUNTER DD, 1991, J NEUROSCI, V11, P3960; KLJAVIN IJ, 1991, J NEUROSCI, V11, P2985; KNIGHT JK, 1990, DEVELOPMENT, V110, P1115; KOHNO T, 1987, INVEST OPHTH VIS SCI, V28, P506; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LASATER EM, 1984, J NEUROSCI, V4, P1966; LILLIEN LE, 1990, J CELL BIOL, V111, P635, DOI 10.1083/jcb.111.2.635; MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cellbio.3.1.57; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; OWEN WG, 1985, J COMP NEUROL, V240, P423, DOI 10.1002/cne.902400410; Polley E.H., 1989, P3; RAYMONDJOHNS P, 1981, NATURE, V293, P141; REH TA, 1989, J NEUROSCI, V9, P4179; SANES JR, 1990, COLD SH Q B, V55, P419; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SARTHY PV, 1990, J CELL BIOL, V110, P2099, DOI 10.1083/jcb.110.6.2099; SZAMIER RB, 1983, J COMP NEUROL, V215, P51, DOI 10.1002/cne.902150105; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732	41	123	124	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					399	413		10.1016/0896-6273(92)90269-J	http://dx.doi.org/10.1016/0896-6273(92)90269-J			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550669				2022-12-28	WOS:A1992HK67500001
J	KIRSCH, GE; DREWE, JA; HARTMANN, HA; TAGLIALATELA, M; DEBIASI, M; BROWN, AM; JOHO, RH				KIRSCH, GE; DREWE, JA; HARTMANN, HA; TAGLIALATELA, M; DEBIASI, M; BROWN, AM; JOHO, RH			DIFFERENCES BETWEEN THE DEEP PORES OF K+ CHANNELS DETERMINED BY AN INTERACTING PAIR OF NONPOLAR AMINO-ACIDS	NEURON			English	Article							POTASSIUM CHANNELS; RAT-BRAIN; EXPRESSION; MUTATIONS	The pore of a chimeric K+ channel, CHM, differed from its parental host channel, Kv2.1, by 9 amino acids. Four were located in a putative deep region and 5 in a nearby outer mouth. Point reversions were without restorative effects, and reversions V369I or L374V in the deep pore produced novel phenotypes. Among double mutations, only V369I and L374V were effective in restoring the Kv2.1 pore phenotype. Adding a change in charge at Q382K in the outer pore fully restored the parental phenotype. Thus, the pore appears to have an inner, deep region where ions such as K+ and TEA+ may be regulated by nonpolar residues and an outer region where ions may be regulated by charged residues.	BAYLOR COLL MED,DEPT MOLEC PHYSIOL & BIOPHYS,HOUSTON,TX 77030	Baylor College of Medicine	KIRSCH, GE (corresponding author), BAYLOR COLL MED,DEPT ANESTHESIOL,HOUSTON,TX 77030, USA.		Taglialatela, Maurizio/AAB-8621-2022; Taglialatela, Maurizio/K-1840-2013; Taglialatela, Maurizio/ABH-4262-2020; De Biasi, Mariella/M-7646-2017; Taglialatela, Maurizio/A-2062-2019	Taglialatela, Maurizio/0000-0002-8202-0560; Taglialatela, Maurizio/0000-0002-8202-0560; De Biasi, Mariella/0000-0002-0687-8872; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS008805, R01NS029473, R01NS028407] Funding Source: NIH RePORTER; NINDS NIH HHS [NS08805, NS28407, NS29473] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN OS, 1984, ANNU REV PHYSIOL, V46, P531; CHANDY KG, 1991, NATURE, V352, P26, DOI 10.1038/352026b0; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HILLE B, 1984, IONIC CHANNELS EXCIT, P184; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; JOHO RH, 1990, MOL BRAIN RES, V7, P105, DOI 10.1016/0169-328X(90)90087-T; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7584; KIRSCH GE, 1992, IN PRESS BIOPHYS J; LICHTINGHAGEN R, 1990, EMBO J, V9, P4399, DOI 10.1002/j.1460-2075.1990.tb07890.x; LODISH HF, 1988, TRENDS BIOCHEM SCI, V7, P105; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MOORMAN JR, 1990, SCIENCE, V250, P688; ROUX B, 1991, BIOPHYS J, V59, P961, DOI 10.1016/S0006-3495(91)82311-6; Sambrook J, 1989, MOL CLONING LABORATO; TAGLIALATELA M, 1991, MOL PHARMACOL, V40, P299; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	24	101	101	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					499	505		10.1016/0896-6273(92)90278-L	http://dx.doi.org/10.1016/0896-6273(92)90278-L			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550675				2022-12-28	WOS:A1992HK67500010
J	MCINTIRE, SL; GARRIGA, G; WHITE, J; JACOBSON, D; HORVITZ, HR				MCINTIRE, SL; GARRIGA, G; WHITE, J; JACOBSON, D; HORVITZ, HR			GENES NECESSARY FOR DIRECTED AXONAL ELONGATION OR FASCICULATION IN C-ELEGANS	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; TEMPERATURE-SENSITIVE MUTANT; DROSOPHILA-MELANOGASTER; REVERSIBLE BLOCKAGE; ADHESION MOLECULE; FASCICLIN-I; NEURONS; EXPRESSION; MUTATIONS; PATHWAYS	The outgrowth of single axons through different cellular environments requires distinct sets of genes in the nematode C. elegans. Three genes are required for the pioneering circumferential outgrowth of identified motor neuron axons between the lateral hypodermal cell membrane and the basal lamina. Three other genes are required for the longitudinal outgrowth of these axons along preexisting axon bundles as well as for the fasciculation of axons within these neuron bundles. Five additional genes are required for circumferential outgrowth, longitudinal outgrowth, and fasciculation; mutations in three of these genes disrupt axon ultrastructure, suggesting that they function in axon formation rather than in axon guidance.	HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND	Harvard University; Harvard Medical School; MRC Laboratory Molecular Biology	MCINTIRE, SL (corresponding author), MIT,HOWARD HUGHES MED INST,DEPT BIOL,CAMBRIDGE,MA 02139, USA.				NIGMS NIH HHS [GM24663] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024663, R01GM024663] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BRENNER S, 1974, GENETICS, V77, P71; BRENNER S, 1973, BRIT MED BULL, V29, P269, DOI 10.1093/oxfordjournals.bmb.a071019; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; COSTELLO WJ, 1986, J NEUROSCI, V6, P3634; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DURBIN RM, 1987, THESIS KINGS COLLEGE; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; EMMONS SW, 1988, NEMATODE CAENORHABDI, P47; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HERMAN RK, 1988, NEMATODE CAENORHABDI, P17; HODGKIN J, 1988, NEMATODE CAENORHABDI, P502; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; KIM YT, 1987, J NEUROSCI, V7, P3245; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; LANDER AD, 1983, COLD SPRING HARB SYM, V48, P611, DOI 10.1101/SQB.1983.048.01.065; PARK EC, 1986, GENETICS, V113, P821; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WHITE JG, 1985, TRENDS NEUROSCI, V8, P277, DOI 10.1016/0166-2236(85)90102-X	30	229	249	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1992	8	2					307	322		10.1016/0896-6273(92)90297-Q	http://dx.doi.org/10.1016/0896-6273(92)90297-Q			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1739461				2022-12-28	WOS:A1992HE93000011
J	THOR, S; ERICSON, J; BRANNSTROM, T; EDLUND, T				THOR, S; ERICSON, J; BRANNSTROM, T; EDLUND, T			THE HOMEODOMAIN LIM PROTEIN ISL-1 IS EXPRESSED IN SUBSETS OF NEURONS AND ENDOCRINE-CELLS IN THE ADULT-RAT	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; HOMEOBOX-CONTAINING GENE; CAENORHABDITIS-ELEGANS; TRANSGENIC MICE; MESSENGER-RNAS; POU-DOMAIN; PITUITARY; LINEAGE; PIT-1; PRODUCT	We have used immunocytochemical methods to localize the homeodomain LIM protein Isl-1 in the adult rat. Isl-1 immunoreactivity is expressed in polypeptide hormone-producing cells of the endocrine system, in neurons of the peripheral nervous system, and in a subset of brain nuclei. Isl-1 is also expressed in a subset of motoneurons in the spinal cord and brain stem, but not in regions of the central nervous system involved in sensory function or in neocortical areas. The pattern of expression of Isl-1 suggests that this gene may be involved in the specification and maintenance of differentiated phenotypical properties of these cells.	UMEA UNIV, DEPT ANAT, S-90187 UMEA, SWEDEN	Umea University	THOR, S (corresponding author), UMEA UNIV, DEPT MICROBIOL, S-90187 UMEA, SWEDEN.		Thor, Stefan/Y-5804-2019	Thor, Stefan/0000-0001-5095-541X; Ericson, Johan/0000-0002-8019-7127				ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; ATWATER I, 1986, ADV EXP MED, V211; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BALLING R, 1989, CELL, V58, P337, DOI 10.1016/0092-8674(89)90848-9; BARASCH JM, 1987, J NEUROSCI, V7, P2874; BIRKENMEIER EH, 1986, P NATL ACAD SCI USA, V83, P2516, DOI 10.1073/pnas.83.8.2516; BOEHM T, 1990, EMBO J, V9, P857, DOI 10.1002/j.1460-2075.1990.tb08183.x; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; CLAUDE P, 1988, NEURON, V1, P783, DOI 10.1016/0896-6273(88)90126-2; COULY GF, 1985, DEV BIOL, V110, P422, DOI 10.1016/0012-1606(85)90101-0; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; ERLICH SS, 1985, J NEUROSURG, V63, P321, DOI 10.3171/jns.1985.63.3.0321; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; IZPISUABELMONTE JC, 1991, NATURE, V350, P585, DOI 10.1038/350585a0; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KELLY RB, 1988, NEURON, V1, P431, DOI 10.1016/0896-6273(88)90174-2; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; Le Douarin N.M., 1982, NEURAL CREST; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; MOOREEDE MC, 1982, PHYSL CIRCADIAN TIMI; NALIK P, 1989, MOL CELL ENDOCRINOL, V62, P235, DOI 10.1016/0303-7207(89)90010-5; NOHNO T, 1991, CELL, V64, P1197, DOI 10.1016/0092-8674(91)90274-3; OHLSSON H, 1991, MOL ENDOCRINOL, V5, P897, DOI 10.1210/mend-5-7-897; PALKOVITIS M, 1988, PEPTIDES HORMONES EF, V1, P3; PATTERSON PH, 1990, CELL, V62, P1035, DOI 10.1016/0092-8674(90)90379-S; PEARSE AGE, 1976, CLIN ENDOCRINOL, V5, pS229, DOI 10.1111/j.1365-2265.1976.tb03832.x; PEARSE AGE, 1977, MED BIOL, V55, P115; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAKORTAKOR T, 1975, J EMBRYOL EXP MORPH, V34, P311; TEITELMAN G, 1990, DEV BIOL, V142, P368, DOI 10.1016/0012-1606(90)90357-O; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; WOLGEMUTH DJ, 1989, NATURE, V337, P464, DOI 10.1038/337464a0; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	40	319	326	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1991	7	6					881	889		10.1016/0896-6273(91)90334-V	http://dx.doi.org/10.1016/0896-6273(91)90334-V			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1764243				2022-12-28	WOS:A1991GY43800002
J	TANAKA, H; MATSUI, T; AGATA, A; TOMURA, M; KUBOTA, I; MCFARLAND, KC; KOHR, B; LEE, A; PHILLIPS, HS; SHELTON, DL				TANAKA, H; MATSUI, T; AGATA, A; TOMURA, M; KUBOTA, I; MCFARLAND, KC; KOHR, B; LEE, A; PHILLIPS, HS; SHELTON, DL			MOLECULAR-CLONING AND EXPRESSION OF A NOVEL ADHESION MOLECULE, SC1	NEURON			English	Article							AMINO-ACID SEQUENCE; IMMUNOGLOBULIN SUPERFAMILY; CARCINOEMBRYONIC ANTIGEN; MONOCLONAL-ANTIBODIES; PROTEIN SEQUENCES; RNA; DOMAINS; MEMBER; GLYCOPROTEINS; RECOGNITION	SC1, an integral membrane glycoprotein of 100 kd, is uniquely and transiently expressed on spinal cord motoneurons early in development and appears in peripheral neurons and several other tissues during development. SC1 has been purified by immunoaffinity techniques, and SC1 cDNA clones have been obtained by screening an E4 chick embryo phage expression library with a rabbit polyclonal antibody produced against purified SC1. The deduced protein sequence of 588 amino acids consists of a signal peptide, five immunoglobulin-like domains, a transmembrane region, and a short cytoplasmic tail. The sequence is most similar to MUC18, reported as a tumor progression marker in human melanoma. Transfection of SC1 cDNA into mammalian cells leads to cell surface expression of SC1 antigen and a subsequent increase in cell-cell adhesion. SC1 molecules bind to each other via a homophilic adhesion mechanism, independently of calcium or magnesium ions. SC1 may have a role in lateral motor column formation or neurite growth or fasciculation.	GENENTECH INC, DEPT RES TECHNOL, S SAN FRANCISCO, CA 94080 USA; SUNTORY LTD, CTR BIOL & PHARMACOL TECH, CHIYODA, OHRA 37005, JAPAN; GENENTECH INC, DEPT DEV BIOL, S SAN FRANCISCO, CA 94080 USA	Roche Holding; Genentech; Suntory Holdings Ltd; Roche Holding; Genentech	TANAKA, H (corresponding author), GUNMA UNIV, SCH MED, DEPT PHARMACOL, MAEBASHI, GUNMA 371, JAPAN.							AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARTON CH, 1988, DEVELOPMENT, V104, P165; BEAUCHEMIN N, 1989, CANCER RES, V49, P2017; BENNETT MR, 1983, PHYSIOL REV, V63, P915, DOI 10.1152/physrev.1983.63.3.915; BLOCHGALLEGO E, 1991, DEVELOPMENT, V111, P221; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; FENG DF, 1990, METHOD ENZYMOL, V183, P375; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; FITCH WM, 1983, P NATL ACAD SCI-BIOL, V80, P1382, DOI 10.1073/pnas.80.5.1382; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LIPKIN VM, 1989, FEBS LETT, V254, P69, DOI 10.1016/0014-5793(89)81011-7; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHELTON DL, 1984, P NATL ACAD SCI-BIOL, V81, P7951, DOI 10.1073/pnas.81.24.7951; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; TANAKA H, 1991, J COMP NEUROL, V303, P329, DOI 10.1002/cne.903030213; TANAKA H, 1989, DEV BIOL, V132, P419, DOI 10.1016/0012-1606(89)90238-8; TANAKA H, 1990, DEVELOPMENT, V110, P565; TANAKA H, 1984, DEV BIOL, V106, P26, DOI 10.1016/0012-1606(84)90057-5; TAWARAGI Y, 1988, BIOCHEM BIOPH RES CO, V150, P89, DOI 10.1016/0006-291X(88)90490-1; THIERY JP, 1982, P NATL ACAD SCI-BIOL, V79, P6737, DOI 10.1073/pnas.79.21.6737; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; URUSHIHARA H, 1979, DEV BIOL, V70, P206, DOI 10.1016/0012-1606(79)90017-4; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	44	202	205	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1991	7	4					535	545		10.1016/0896-6273(91)90366-8	http://dx.doi.org/10.1016/0896-6273(91)90366-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1931049				2022-12-28	WOS:A1991GM95400002
J	TAKAGI, S; HIRATA, T; AGATA, K; MOCHII, M; EGUCHI, G; FUJISAWA, H				TAKAGI, S; HIRATA, T; AGATA, K; MOCHII, M; EGUCHI, G; FUJISAWA, H			THE A5-ANTIGEN, A CANDIDATE FOR THE NEURONAL RECOGNITION MOLECULE, HAS HOMOLOGIES TO COMPLEMENT COMPONENTS AND COAGULATION-FACTORS	NEURON			English	Article							AMINO-ACID SEQUENCE; PSEUDOMONAS-AERUGINOSA; NUCLEOTIDE-SEQUENCE; ADHESION MOLECULES; CHICKEN EMBRYOS; VISUAL CENTERS; COMPLETE CDNA; GROWTH CONE; EXPRESSION; XENOPUS	The A5 antigen is a neuronal cell surface protein of Xenopus presumed to be involved in the neuronal recognition between the optic nerve fibers and the visual centers. Analyses of cDNA clones revealed that the A5 antigen is a class I membrane protein containing two different internal repeats in the extracellular segment. The first repeat bears homology to domain III of complement components C1r and C1s, and the second repeat is homologous to the C1 and C2 domains of coagulation factors V and VIII. The mRNA for the A5 antigen was present in retinal ganglion cells and visual center neurons. Nonneuronal cells in the peripheral and central nervous systems did not express the mRNA for the A5 antigen.	KYOTO PREFECTURAL UNIV MED,DEPT ANAT,KAMIKYO KU,KYOTO 602,JAPAN; NATL INST BASIC BIOL,MORPHOGENESIS LAB,OKAZAKI,AICHI 444,JAPAN	Kyoto Prefectural University of Medicine; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	TAKAGI, S (corresponding author), NAGOYA UNIV,FAC SCI,DEPT MOLEC BIOL,FURO CHO,CHIGUSA KU,NAGOYA 46401,JAPAN.			Agata, Kiyokazu/0000-0002-5195-2576				AGATA K, 1983, DEV BIOL, V100, P222, DOI 10.1016/0012-1606(83)90214-2; ARLAUD GJ, 1987, IMMUNOL TODAY, V8, P106, DOI 10.1016/0167-5699(87)90860-7; ARLAUD GJ, 1987, BIOCHEM J, V241, P711, DOI 10.1042/bj2410711; BASTIANI MJ, 1985, TRENDS NEUROSCI, V8, P257, DOI 10.1016/0166-2236(85)90099-2; EDELMAN GM, 1988, MASSAGE MIND, P4; FRITZ AF, 1989, DEV BIOL, V131, P584, DOI 10.1016/S0012-1606(89)80029-6; FUJISAWA H, 1980, BRAIN RES, V194, P431, DOI 10.1016/0006-8993(80)91223-8; FUJISAWA H, 1989, DEV BIOL, V135, P231, DOI 10.1016/0012-1606(89)90175-9; FUJISAWA H, 1987, DEV GROWTH DIFFER, V29, P105; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; JOHNSON K, 1986, J BIOL CHEM, V261, P5703; KATOH K, 1987, CELL STRUCT FUNCT, V12, P575, DOI 10.1247/csf.12.575; KEMBALLCOOK G, 1988, THROMB HAEMOSTASIS, V60, P422; KEYNES R, 1990, CELL, V62, P609, DOI 10.1016/0092-8674(90)90103-L; KOBEL HR, 1986, TRENDS GENET, V2, P310, DOI 10.1016/0168-9525(86)90286-6; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDER AD, 1989, TRENDS NEUROSCI, V12, P19; LANDMESSER L, 1984, TRENDS NEUROSCI, V7, P336, DOI 10.1016/S0166-2236(84)80083-1; LEYTUS SP, 1986, BIOCHEMISTRY-US, V25, P4855, DOI 10.1021/bi00365a020; MACKINNON CM, 1987, EUR J BIOCHEM, V169, P547, DOI 10.1111/j.1432-1033.1987.tb13644.x; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; POOLE S, 1981, J MOL BIOL, V153, P273, DOI 10.1016/0022-2836(81)90278-3; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHACHNER M, 1983, COLD SPRING HARB SYM, V48, P557, DOI 10.1101/SQB.1983.048.01.060; SOUSSI T, 1987, ONCOGENE, V1, P71; STOFFEL W, 1984, P NATL ACAD SCI-BIOL, V81, P5012, DOI 10.1073/pnas.81.16.5012; SUEMORI H, 1990, CELL DIFFER DEV, V29, P181, DOI 10.1016/0922-3371(90)90120-L; TAKAGI S, 1987, DEV BIOL, V122, P90, DOI 10.1016/0012-1606(87)90335-6; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; TOSI M, 1987, BIOCHEMISTRY-US, V26, P8516, DOI 10.1021/bi00400a004; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; WOODS DE, 1980, INFECT IMMUN, V29, P1146	45	187	202	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					295	307		10.1016/0896-6273(91)90268-5	http://dx.doi.org/10.1016/0896-6273(91)90268-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1908252				2022-12-28	WOS:A1991GB93300013
J	RADEKE, MJ; FEINSTEIN, SC				RADEKE, MJ; FEINSTEIN, SC			ANALYTICAL PURIFICATION OF THE SLOW, HIGH-AFFINITY NGF RECEPTOR - IDENTIFICATION OF A NOVEL 135 KD POLYPEPTIDE	NEURON			English	Article							NERVE GROWTH-FACTOR; SYMPATHETIC-GANGLIA MEMBRANES; PC12 CELLS; RAT PHEOCHROMOCYTOMA; NEUROTROPHIC FACTOR; MOLECULAR-CLONING; MELANOMA-CELLS; BINDING-SITES; GENE-TRANSFER; II FAST	Although nerve growth factor (NGF) action is mediated by the slow, high affinity NGF receptor, little is known regarding its molecular composition or mode of action. We have used reversible chemical cross-linkers and affinity chromatography strategies to purify the slow NGF receptor covalently cross-linked to its NGF ligand. Subsequent uncoupling of the cross-links reveals that the receptor-ligand complex is composed of only a novel 135 kd polypeptide interacting with NGF. The previously characterized 85 kd fast, low affinity NGF receptor is not a component of the cross-linked slow receptor-ligand complex. This newly identified 135 kd polypeptide is either the entire slow NGF receptor, or it might be one component of a larger, multisubunit slow NGF holo-receptor.	UNIV CALIF SANTA BARBARA,DEPT BIOL SCI,SANTA BARBARA,CA 93106	University of California System; University of California Santa Barbara	RADEKE, MJ (corresponding author), UNIV CALIF SANTA BARBARA,NEUROSCI RES INST,SANTA BARBARA,CA 93106, USA.							BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BUXSER S, 1990, J BIOL CHEM, V265, P12701; BUXSER SE, 1983, J CELL BIOCHEM, V22, P219, DOI 10.1002/jcb.240220404; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; COHEN S, 1960, P NATL ACAD SCI USA, V46, P302, DOI 10.1073/pnas.46.3.302; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; EVELETH DD, 1988, NEURON, V1, P929, DOI 10.1016/0896-6273(88)90150-X; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GROB PM, 1983, P NATL ACAD SCI-BIOL, V80, P6819, DOI 10.1073/pnas.80.22.6819; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HOSANG M, 1985, J BIOL CHEM, V260, P655; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KOIZUMI S, 1988, J NEUROSCI, V8, P715; KORSCHING S, 1983, NEUROSCI LETT, V39, P1, DOI 10.1016/0304-3940(83)90155-6; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; KOUCHALAKOS RN, 1986, J BIOL CHEM, V261, P6054; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MASSAGUE J, 1981, J BIOL CHEM, V256, P9419; MATSUSHIMA H, 1990, MOL CELL BIOL, V10, P5015, DOI 10.1128/MCB.10.9.5015; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; SAITO Y, 1988, J EXP MED, V168, P1563, DOI 10.1084/jem.168.5.1563; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SHELTON DL, 1984, P NATL ACAD SCI-BIOL, V81, P7951, DOI 10.1073/pnas.81.24.7951; SMITH AP, 1968, BIOCHEMISTRY-US, V7, P3529; SONNENFELD KH, 1985, J NEUROSCI, V5, P1717; SUTTER A, 1979, J BIOL CHEM, V254, P5972; VALE RD, 1985, DEV NEUROSCI-BASEL, V7, P55, DOI 10.1159/000112276; VALE RD, 1985, J NEUROSCI, V5, P2762	38	26	27	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1991	7	1					141	150		10.1016/0896-6273(91)90082-B	http://dx.doi.org/10.1016/0896-6273(91)90082-B			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1648937				2022-12-28	WOS:A1991FY48100014
J	GU, Y; CAMACHO, P; GARDNER, P; HALL, ZW				GU, Y; CAMACHO, P; GARDNER, P; HALL, ZW			IDENTIFICATION OF 2 AMINO-ACID-RESIDUES IN THE EPSILON SUBUNIT THAT PROMOTE MAMMALIAN MUSCLE ACETYLCHOLINE-RECEPTOR ASSEMBLY IN COS CELLS	NEURON			English	Article							MONOCLONAL-ANTIBODIES; MESSENGER-RNAS; ALPHA-SUBUNIT; GAMMA-SUBUNIT; BETA-SUBUNIT; RAT MUSCLE; SITE; GLYCOSYLATION; MUTAGENESIS; EXPRESSION	We have used a species difference in epsilon-subunits of the acetylcholine receptor (AChR) to investigate regions of the subunit protein that are important in receptor assembly. Upon transient transfection of COS cells, mouse epsilon-subunit cDNA is approximately 10 times more effective than that of the rat in supporting expression of surface AChRs when the other subunits are from either mouse or rat. In cells transfected with only alpha-and epsilon-subunit cDNAs, the formation of an alpha-epsilon-heterodimer, a presumed assembly intermediate, is also less efficient with rat than with mouse epsilon-subunit. By site-directed mutagenesis, we have found that these differences can be accounted for by 2 amino acid differences in the N-terminal domain at positions 106 and 115 of the rat and mouse epsilon-subunits, suggesting that the region near these 2 amino acid residues is important for AChR assembly.	TUFTS UNIV, SCH MED, DEPT PHYSIOL, BOSTON, MA 02111 USA; DARTMOUTH COLL, HITCHCOCK MED CTR, DARTMOUTH MED SCH, DEPT BIOCHEM, HANOVER, NH 03756 USA	Tufts University; Dartmouth College	GU, Y (corresponding author), UNIV CALIF SAN FRANCISCO, SCH MED, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA.							ANDERSON DJ, 1981, P NATL ACAD SCI-BIOL, V78, P5598, DOI 10.1073/pnas.78.9.5598; BLOUNT P, 1990, J CELL BIOL, V111, P2601, DOI 10.1083/jcb.111.6.2601; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; BRODSKY MH, 1990, J IMMUNOL, V144, P3078; BUONANNO A, 1986, J BIOL CHEM, V261, P6451; BUONANNO A, 1989, J BIOL CHEM, V264, P7611; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FROEHNER SC, 1983, J BIOL CHEM, V258, P7112; GEISSELSODER J, 1987, BIOTECHNIQUES, V5, P786; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; GU Y, 1989, J BIOL CHEM, V264, P11952; GU Y, 1988, J BIOL CHEM, V263, P12878; GU Y, 1990, NEURON, V5, P147, DOI 10.1016/0896-6273(90)90305-Y; GU Y, 1991, IN PRESS J CELL BIOL; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; ISENBERG KE, 1986, NUCLEIC ACIDS RES, V14, P5111, DOI 10.1093/nar/14.12.5111; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPOLLA RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7970, DOI 10.1073/pnas.81.24.7970; MCCARTHY MP, 1986, ANNU REV NEUROSCI, V9, P383; MERLIE JP, 1983, COLD SPRING HARB SYM, V48, P135, DOI 10.1101/SQB.1983.048.01.016; MERLIE JP, 1982, J BIOL CHEM, V257, P2694; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; NODA M, 1983, NATURE, V302, P528, DOI 10.1038/302528a0; NUMA S, 1983, COLD SPRING HARB SYM, V48, P57, DOI 10.1101/SQB.1983.048.01.008; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; SMITH MM, 1987, J BIOL CHEM, V262, P4367; TZARTOS SJ, 1981, J BIOL CHEM, V256, P8635; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; WITZEMANN V, 1987, FEBS LETT, V223, P104, DOI 10.1016/0014-5793(87)80518-5; WITZEMANN V, 1989, FEBS LETT, V242, P419, DOI 10.1016/0014-5793(89)80514-9; YONG G, 1989, J CELL BIOL, V109, P729, DOI 10.1083/jcb.109.2.729; YU L, 1986, NUCLEIC ACIDS RES, V14, P3539, DOI 10.1093/nar/14.8.3539	35	72	73	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1991	6	6					879	887		10.1016/0896-6273(91)90228-R	http://dx.doi.org/10.1016/0896-6273(91)90228-R			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	2054186				2022-12-28	WOS:A1991FT94900003
J	WALLACE, BG; QU, ZC; HUGANIR, RL				WALLACE, BG; QU, ZC; HUGANIR, RL			AGRIN INDUCES PHOSPHORYLATION OF THE NICOTINIC ACETYLCHOLINE-RECEPTOR	NEURON			English	Article							TORPEDO ELECTRIC ORGAN; PROTEIN KINASE-C; CHICK MUSCLE-CELLS; PHORBOL ESTER; RAT MYOTUBES; TYROSINE PHOSPHORYLATION; CULTURED MYOTUBES; DESENSITIZATION; CAMP; AGGREGATION	Agrin causes acetylcholine receptors (AChRs) on chick myotubes in culture to aggregate, forming specializations that resemble the postsynaptic apparatus at the vertebrate skeletal neuromuscular junction. Here we report that treating chick myotubes with agrin caused an increase in phosphorylation of the AChR beta, gamma, and delta subunits. H-7, a potent inhibitor of several protein serine kinases, blocked agrin-induced phosphorylation of the gamma and delta-subunits, but did not prevent either agrin-induced AChR aggregation or phosphorylation of the beta-subunit. Experiments with anti-phosphotyrosine antibodies demonstrated that agrin caused an increase in tyrosine phosphorylation of the beta-subunit that began within 30 min of adding agrin to the myotube cultures, reached a plateau by 3 hr, and was blocked by treatments known to block agrin-induced AChR aggregation. Anti-phosphotyrosine antibodies labeled agrin-induced specializations as they do the postsynaptic apparatus. These results suggest that agrin-induced tyrosine phosphorylation of the beta-subunit may play a role in regulating AChR distribution.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205	Howard Hughes Medical Institute; Johns Hopkins University	WALLACE, BG (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT PHYSIOL,DENVER,CO 80262, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014506, R01NS024418] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24418, NS14506] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBUQUERQUE EX, 1986, FEBS LETT, V190, P161; ANTHONY DT, 1988, J CELL BIOL, V106, P1713, DOI 10.1083/jcb.106.5.1713; ANTHONY DT, 1984, P NATL ACAD SCI-BIOL, V81, P2265, DOI 10.1073/pnas.81.7.2265; BLUMBERG PM, 1981, CRC CR REV TOXICOL, V8, P199, DOI 10.3109/10408448109109658; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; CHANGEUX JP, 1984, SCIENCE, V225, P1333; CROOP J, 1982, DEV BIOL, V89, P460, DOI 10.1016/0012-1606(82)90334-7; EUSEBI F, 1985, J CELL BIOL, V100, P1339, DOI 10.1083/jcb.100.4.1339; FISCHBACH GD, 1972, DEV BIOL, V28, P407, DOI 10.1016/0012-1606(72)90023-1; FROEHNER SC, 1986, TRENDS NEUROSCI, V9, P37, DOI 10.1016/0166-2236(86)90013-5; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HUGANIR RL, 1986, NATURE, V321, P774, DOI 10.1038/321774a0; HUGANIR RL, 1980, J SUPRAMOL STR CELL, V14, P13, DOI 10.1002/jss.400140103; HUGANIR RL, 1989, CRIT REV BIOCHEM MOL, V24, P183, DOI 10.3109/10409238909082553; HUGANIR RL, 1983, P NATL ACAD SCI-BIOL, V80, P1130, DOI 10.1073/pnas.80.4.1130; HUGANIR RL, 1984, P NATL ACAD SCI-BIOL, V81, P6968, DOI 10.1073/pnas.81.22.6968; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; JEN G, 1982, J VIROL, V43, P250, DOI 10.1128/JVI.43.1.250-261.1982; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MAGILLSOLC C, 1989, J PHYSL PARIS, V83, P18; MARAZZI G, 1989, J CELL BIOL, V109, P2337, DOI 10.1083/jcb.109.5.2337; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; MEIGS JB, 1986, J CELL BIOL, V102, P1430, DOI 10.1083/jcb.102.4.1430; MERLIE JP, 1981, J BIOL CHEM, V256, P3605; MIDDLETON P, 1988, J NEUROSCI, V8, P3405; MIDDLETON P, 1986, P NATL ACAD SCI USA, V83, P4967, DOI 10.1073/pnas.83.13.4967; MILES K, 1989, NEURON, V2, P1517, DOI 10.1016/0896-6273(89)90198-0; MILES K, 1987, P NATL ACAD SCI USA, V84, P6591, DOI 10.1073/pnas.84.18.6591; MISHKIN T, 1978, CELL, V15, P1287; MULLE C, 1988, P NATL ACAD SCI USA, V85, P5728, DOI 10.1073/pnas.85.15.5728; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; PENG HB, 1991, NEURON, V6, P237; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; ROSS A, 1988, J CELL BIOL, V107, P1139, DOI 10.1083/jcb.107.3.1139; ROSS AF, 1987, J BIOL CHEM, V262, P14640; SAFRAN A, 1987, J BIOL CHEM, V262, P10506; SCHLIWA M, 1984, J CELL BIOL, V99, P1045, DOI 10.1083/jcb.99.3.1045; SMITH MM, 1987, P NATL ACAD SCI USA, V84, P6601, DOI 10.1073/pnas.84.18.6601; SMITH MM, 1989, J BIOL CHEM, V264, P12813; VANDLEN RL, 1979, BIOCHEMISTRY-US, V18, P1845, DOI 10.1021/bi00577a001; WALKER JH, 1984, EMBO J, V3, P2287, DOI 10.1002/j.1460-2075.1984.tb02127.x; WALLACE BG, 1990, J NEUROSCI, V10, P3576; WALLACE BG, 1989, J NEUROSCI, V9, P1294; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; WALLACE BG, 1986, J CELL BIOL, V102, P783, DOI 10.1083/jcb.102.3.783; WALLACE BG, 1991, IN PRESS PHIL T RO B; WANG JYJ, 1988, ANAL BIOCHEM, V172, P1, DOI 10.1016/0003-2697(88)90403-4	51	238	240	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1991	6	6					869	878		10.1016/0896-6273(91)90227-Q	http://dx.doi.org/10.1016/0896-6273(91)90227-Q			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	1711347				2022-12-28	WOS:A1991FT94900002
J	HARRIS, WA; HARTENSTEIN, V				HARRIS, WA; HARTENSTEIN, V			NEURONAL DETERMINATION WITHOUT CELL-DIVISION IN XENOPUS EMBRYOS	NEURON			English	Article							SPINAL-CORD; CAENORHABDITIS ELEGANS; SECONDARY MOTONEURONS; DIFFERENTIATION; DROSOPHILA; LINEAGES; RETINA; LAEVIS; PATTERN; GABA	Cell division in the Xenopus CNS was blocked by incubating embryos in a mixture of the DNA synthesis inhibitors hydroxyurea and aphidicolin. Surprisingly, embryos treated at the beginning of gastrulation proceeded normally through neurulation, neural tube closure, and CNS subdivision. Thus, cell division is not critical for neural induction or early morphogenetic events in the CNS. Neuroblasts in treated embryos differentiated into neurons of many classes, indicating that cellular determination in the CNS can be dissociated from lineage and birth date. Axonal tracts and embryonic reflexes also developed. The remarkable amount of normal CNS development that occurs in these animals may be explained by a series of sequential inductions that are largely independent of cell proliferation.			HARRIS, WA (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.							[Anonymous], [No title captured]; ARTAVANISTSAKONAS S, 1988, TRENDS GENET, V4, P95, DOI 10.1016/0168-9525(88)90096-0; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; BLIGHT AR, 1978, J COMP NEUROL, V180, P679, DOI 10.1002/cne.901800403; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; COGHILL GE, 1964, ANATOMY PROBLEM BEHA; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; COWAN AE, 1985, CELL, V41, P923, DOI 10.1016/S0092-8674(85)80073-8; DALE N, 1987, PROC R SOC SER B-BIO, V232, P193, DOI 10.1098/rspb.1987.0068; DALE N, 1986, NATURE, V324, P255, DOI 10.1038/324255a0; Dowling J. E., 1987, RETINA APPROACHABLE; EAGLESON GW, 1990, J NEUROBIOL, V21, P427, DOI 10.1002/neu.480210305; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; FOE VE, 1989, DEVELOPMENT, V107, P1; FOREHAND CJ, 1982, J COMP NEUROL, V209, P386, DOI 10.1002/cne.902090408; Gilman AG, 1980, PHARM BASIS THERAPEU; GRUNWALD DJ, 1988, DEV BIOL, V126, P115, DOI 10.1016/0012-1606(88)90245-X; HARTENSTEIN V, 1989, NEURON, V3, P399, DOI 10.1016/0896-6273(89)90200-6; HARTENSTEIN V, 1990, DEV BIOL, V138, P146; HIRANO T, 1984, J PHYSIOL-LONDON, V347, P301, DOI 10.1113/jphysiol.1984.sp015067; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HOLTZER H, 1975, Q REV BIOPHYS, V8, P523, DOI 10.1017/S0033583500001980; HUGHES A, 1959, J EMBRYOL EXP MORPH, V7, P128; HUGHES AF, 1957, J ANAT, V91, P3; IKEGAMI S, 1978, NATURE, V275, P258; JENSEN LM, 1987, DEV BIOL, V120, P56, DOI 10.1016/0012-1606(87)90103-5; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KEYNES R, 1990, NEURON, V4, P1, DOI 10.1016/0896-6273(90)90438-L; KIMMEL CB, 1986, SCIENCE, V231, P365, DOI 10.1126/science.231.4736.365; LAMBORGHINI JE, 1980, J COMP NEUROL, V189, P323, DOI 10.1002/cne.901890208; LAUFER JS, 1980, CELL, V19, P569, DOI 10.1016/S0092-8674(80)80033-X; LIU L, 1986, CELL TISSUE RES, V244, P501; MAURERSCHULTZE B, 1988, EXP CELL RES, V174, P230, DOI 10.1016/0014-4827(88)90157-7; NEWPORT J, 1989, J CELL SCI S, V12, P149; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; NORDLANDER RH, 1986, J COMP NEUROL, V253, P403, DOI 10.1002/cne.902530308; NORDLANDER RH, 1984, J COMP NEUROL, V228, P117, DOI 10.1002/cne.902280111; PRICE J, 1989, TRENDS NEUROSCI, V12, P276, DOI 10.1016/0166-2236(89)90002-7; REH TA, 1989, J NEUROSCI, V9, P4179; REH TA, 1988, DEV BIOL, V129, P283, DOI 10.1016/0012-1606(88)90375-2; ROBERTS A, 1987, J COMP NEUROL, V261, P435, DOI 10.1002/cne.902610308; ROBERTS A, 1982, PHILOS T R SOC B, V296, P195, DOI 10.1098/rstb.1982.0002; Rugh R, 1962, EXPT EMBRYOLOGY; SCHROEDER TE, 1970, J EMBRYOL EXP MORPH, V23, P427; Sidman RL, 1961, STRUCTURE EYE, P487; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VANMIER P, 1986, INT J DEV NEUROSCI, V4, P465, DOI 10.1016/0736-5748(86)90028-6; VANMIER P, 1985, ANAT EMBRYOL, V172, P311; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WETZEL DM, 1989, J NEUROBIOL, V20, P255, DOI 10.1002/neu.480200407; WHITTAKER JR, 1987, AM ZOOL, V27, P607; Wood W B, 1988, Dev Biol (N Y 1985), V5, P57; WU CF, 1990, J NEUROBIOL, V21, P499, DOI 10.1002/neu.480210310	59	217	220	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					499	515		10.1016/0896-6273(91)90053-3	http://dx.doi.org/10.1016/0896-6273(91)90053-3			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	1901716				2022-12-28	WOS:A1991FH80200002
J	NARANJO, JR; MELLSTROM, B; ACHAVAL, M; SASSONECORSI, P				NARANJO, JR; MELLSTROM, B; ACHAVAL, M; SASSONECORSI, P			MOLECULAR PATHWAYS OF PAIN - FOS JUN-MEDIATED ACTIVATION OF A NONCANONICAL AP-1 SITE IN THE PRODYNORPHIN GENE	NEURON			English	Article							RAT SPINAL-CORD; CHRONIC ARTHRITIC RATS; C-FOS; MESSENGER-RNAS; DYNORPHIN-A; EXPRESSION; NEURONS; PROTEIN; TRANSCRIPTION; ELEMENTS	Noxious stimulation provokes the activation of genes that are thought to play a crucial role in the phenomena of stress and pain. Among these is the prodynorphin gene. By double-labeling in situ hybridization/immunohistochemistry, we show that increased prodynorphin gene expression is preceded, in the same neurons, by an early induction of c-fos. Inspection of the prodynorphin promoter region revealed the presence of several AP-1-like sequences. We demonstrate that only one of these sites is a functional AP-1 element. It is constituted by the noncanonical TGACAAACA sequence, in which the palindromic structure is partly conserved by the 3' terminal CA dinucleotide. Transfection experiments in NCB20 neuroblastoma cells indicated that this site is a target of Fos/Jun trans-activation. Our results suggest that Fos/Jun oncoproteins may function as third messengers in the signal transduction mechanisms of stress/pain processes.	FAC MED STRASBOURG,INST CHIM BIOL,INSERM,U184,F-67085 STRASBOURG,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	NARANJO, JR (corresponding author), CSIC,INST CAJAL NEUROCIENCIAS,E-28002 MADRID,SPAIN.		NARANJO, Jose R/K-1950-2014	NARANJO, Jose R/0000-0002-0270-3469				AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BERRIDGE M, 1986, NATURE, V323, P294, DOI 10.1038/323294a0; BULLITT E, 1989, BRAIN RES, V493, P391, DOI 10.1016/0006-8993(89)91177-3; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; CECCATELLI S, 1989, P NATL ACAD SCI USA, V86, P9569, DOI 10.1073/pnas.86.23.9569; CHO HJ, 1988, NEUROSCI LETT, V84, P125, DOI 10.1016/0304-3940(88)90395-3; CIVELLI O, 1985, P NATL ACAD SCI USA, V82, P4291, DOI 10.1073/pnas.82.12.4291; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; CORBETT AD, 1982, NATURE, V299, P79, DOI 10.1038/299079a0; CRUZ L, 1985, J COMP NEUROL, V240, P331, DOI 10.1002/cne.902400402; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; CURRAN T, 1987, ONCOGENE, V2, P79; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DETOGNI P, 1988, MOL CELL BIOL, V8, P2251, DOI 10.1128/MCB.8.5.2251; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOUGLASS J, 1989, MOL ENDOCRINOL, V3, P2070, DOI 10.1210/mend-3-12-2070; DOUGLASS J, 1987, ENDOCRINOLOGY, V120, P707, DOI 10.1210/endo-120-2-707; DRAISCI G, 1989, MOL BRAIN RES, V6, P31, DOI 10.1016/0169-328X(89)90025-9; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GIZANGGINSBERG E, 1990, GENE DEV, V4, P477, DOI 10.1101/gad.4.4.477; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HENGERER B, 1990, P NATL ACAD SCI USA, V87, P3899, DOI 10.1073/pnas.87.10.3899; HERDEGEN T, 1991, IN PRESS 6TH P WORLD; HERMAN BH, 1985, J PHARMACOL EXP THER, V232, P27; HOLLT V, 1987, NEUROSCI LETT, V73, P90, DOI 10.1016/0304-3940(87)90037-1; HORIKAWA H, 1983, NATURE, V308, P611; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Iadarola M J, 1986, NIDA Res Monogr, V75, P406; IADAROLA MJ, 1988, BRAIN RES, V455, P205, DOI 10.1016/0006-8993(88)90078-9; KAKIDANI H, 1982, NATURE, V298, P245, DOI 10.1038/298245a0; LEAH J, 1988, NEUROSCIENCE, V24, P195; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MCMURRAY CT, 1989, ENDOCRINOLOGY, V124, P49, DOI 10.1210/endo-124-1-49; MENETREY D, 1989, J COMP NEUROL, V285, P177, DOI 10.1002/cne.902850203; MILLAN MJ, 1985, BRAIN RES, V340, P156, DOI 10.1016/0006-8993(85)90786-3; MILLER KE, 1987, J COMP NEUROL, V255, P293, DOI 10.1002/cne.902550212; MINAMI M, 1989, NEUROSCI LETT, V98, P105, DOI 10.1016/0304-3940(89)90382-0; NARANJO JR, 1991, ONCOGENE, V6, P223; NOGUCHI K, 1989, MOL BRAIN RES, V5, P227, DOI 10.1016/0169-328X(89)90039-9; PRZEWLOCKI R, 1988, MOL BRAIN RES, V4, P37, DOI 10.1016/0169-328X(88)90016-2; RUDA MA, 1988, P NATL ACAD SCI USA, V85, P622, DOI 10.1073/pnas.85.2.622; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASEK CA, 1984, NEUROSCIENCE, V12, P855, DOI 10.1016/0306-4522(84)90175-1; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SCHMAUSS C, 1984, J PHARMACOL EXP THER, V232, P1; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; STERNBERGER LA, 1979, INMMUNOCYTOCHEMISTRY; VOGT PK, 1989, TRENDS BIOCHEM SCI, V14, P172, DOI 10.1016/0968-0004(89)90268-5; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; YOUNG WS, 1986, P NATL ACAD SCI USA, V83, P9827, DOI 10.1073/pnas.83.24.9827; [No title captured]	59	278	280	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					607	617		10.1016/0896-6273(91)90063-6	http://dx.doi.org/10.1016/0896-6273(91)90063-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	1901718				2022-12-28	WOS:A1991FH80200012
J	FELDBLUM, S; ACKERMANN, RF; TOBIN, AJ				FELDBLUM, S; ACKERMANN, RF; TOBIN, AJ			LONG-TERM INCREASE OF GLUTAMATE-DECARBOXYLASE MESSENGER-RNA IN A RAT MODEL OF TEMPORAL-LOBE EPILEPSY	NEURON			English	Article									UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,BRAIN RES INST,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DIV NUCL MED & BIOPHYS,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles					NINDS NIH HHS [NS-15654, NS22256] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS015654, R01NS022256] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARAL DG, 1978, J COMP NEUROL, V182, P851, DOI 10.1002/cne.901820508; ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P608, DOI 10.1152/jn.1964.27.4.608; BABB TL, 1988, J COMP NEUROL, V278, P121, DOI 10.1002/cne.902780108; BABB TL, 1989, EPILEPSY RES, V3, P18, DOI 10.1016/0920-1211(89)90064-8; BABB TL, 1989, J NEUROSCI, V9, P2562; BAKST I, 1986, J NEUROSCI, V6, P1452; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; CAVALHEIRO EA, 1982, ELECTROEN CLIN NEURO, V53, P581, DOI 10.1016/0013-4694(82)90134-1; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; DAVENPORT CJ, 1990, IN PRESS EXP NEUROL; DOUGLAS RM, 1988, BRAIN RES, V454, P259; Engel Jr J, 1986, NEUROTRANSMITTERS SE, VIII, P1; FELDBLUM S, 1987, EXP NEUROL, V97, P255, DOI 10.1016/0014-4886(87)90087-2; FINLEY JC, 1981, NEUROSCIENCE, V11, P2173; GALL C, 1988, J NEUROSCI, V8, P1852; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GILAD GM, 1979, BRAIN RES, V178, P185, DOI 10.1016/0006-8993(79)90098-2; GOLDOWITZ D, 1982, BRAIN RES, V238, P413, DOI 10.1016/0006-8993(82)90116-0; HOUSER CR, 1986, BRAIN RES, V383, P129, DOI 10.1016/0006-8993(86)90014-4; HOUSER CR, 1990, J NEUROSCI, V10, P267; IADAROLA MJ, 1980, ADV EPILEPTOL, P449; JIRIKOWSKI G, 1984, NEUROSCI LETT, V46, P35, DOI 10.1016/0304-3940(84)90195-2; KAUFMAN DL, 1986, SCIENCE, V232, P1138, DOI 10.1126/science.3518061; KOHLER C, 1985, ANAT EMBRYOL, V173, P35, DOI 10.1007/BF00707302; KOHLER C, 1982, NEUROSCI LETT, V34, P259, DOI 10.1016/0304-3940(82)90185-9; LASALLE GL, 1983, NEUROSCI LETT, V36, P69, DOI 10.1016/0304-3940(83)90488-3; LLOYD KG, 1986, THERAP NEUROL, V36, P243; Lloyd KG, 1981, NEUROTRANSMITTERS SE, P325; LOTHMAN EW, 1987, EPILEPSY RES, V1, P313, DOI 10.1016/0920-1211(87)90055-6; MARKSTEINER J, 1988, NEUROSCIENCE, V26, P379, DOI 10.1016/0306-4522(88)90155-8; MARU E, 1987, EXP NEUROL, V96, P46, DOI 10.1016/0014-4886(87)90167-1; MASUKAWA LM, 1989, BRAIN RES, V493, P168, DOI 10.1016/0006-8993(89)91012-3; MCGEER PL, 1981, GLUTAMATE TRANSMITTE, P55; MELDRUM B, 1984, EPILEPSIA, V25, pS140, DOI 10.1111/j.1528-1157.1984.tb05646.x; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Mugnaini E, 1985, HDB CHEM NEUROANATOM, P436; NADLER JV, 1977, BRAIN RES, V131, P241; NADLER JV, 1974, EXP NEUROL, V45, P403, DOI 10.1016/0014-4886(74)90128-9; NIEOULLON A, 1981, BRAIN RES, V3224, P129; OBATATSUTO HL, 1987, BRAIN RES BULL, V18, P613, DOI 10.1016/0361-9230(87)90131-6; OLENIK C, 1989, SYNAPSE, V4, P223, DOI 10.1002/syn.890040307; OLTMANS GA, 1985, BRAIN RES, V347, P154, DOI 10.1016/0006-8993(85)90904-7; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; RIBAK CE, 1986, BRAIN RES, V363, P78, DOI 10.1016/0006-8993(86)90660-8; RIBAK CE, 1978, BRAIN RES, V140, P315, DOI 10.1016/0006-8993(78)90463-8; RIBAK CE, 1983, J NEUROCYTOL, V12, P577, DOI 10.1007/BF01181525; SAFFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795, DOI 10.1073/pnas.85.20.7795; SCHMIDT D, 1981, NEUROTRANSMITTERS SE, P315; SLOVITER RS, 1987, J COMP NEUROL, V256, P42, DOI 10.1002/cne.902560105; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; SONNENBERG JL, 1989, J NEUROSCI RES, V24, P72, DOI 10.1002/jnr.490240111; STRINGER JL, 1989, J NEUROPHYSIOL, V62, P135; TAUCK DL, 1985, J NEUROSCI, V5, P1016; VINCENT SR, 1978, BRAIN RES, V143, P168; WUENSCHELL CW, 1986, P NATL ACAD SCI USA, V83, P6193, DOI 10.1073/pnas.83.16.6193	55	112	114	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1990	5	3					361	371		10.1016/0896-6273(90)90172-C	http://dx.doi.org/10.1016/0896-6273(90)90172-C			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ279	1976015				2022-12-28	WOS:A1990DZ27900013
J	OLSSON, JE; GORDON, JW; PAWLYK, BS; ROOF, D; HAYES, A; MOLDAY, RS; MUKAI, S; COWLEY, GS; BERSON, EL; DRYJA, TP				OLSSON, JE; GORDON, JW; PAWLYK, BS; ROOF, D; HAYES, A; MOLDAY, RS; MUKAI, S; COWLEY, GS; BERSON, EL; DRYJA, TP			TRANSGENIC MICE WITH A RHODOPSIN MUTATION (PRO23HIS) - A MOUSE MODEL OF AUTOSOMAL DOMINANT RETINITIS-PIGMENTOSA	NEURON			English	Article							I HISTOCOMPATIBILITY MOLECULES; PANCREATIC BETA-CELLS; OCULAR FINDINGS; ONE FORM; GENE; EXPRESSION; HETEROGENEITY; DELETION; DEFECT; OPSIN	We inserted into the germline of mice either a mutant or wild-type allele from a patient with retinitis pigmentosa and a missense mutation (P23H) in the rhodopsin gene. All three lines of transgenic mice with the mutant allele developed photoreceptor degeneration; the one with the least severe retinal photoreceptor degeneration had the lowest transgene expression, which was one-sixth the level of endogenous murine rod opsin. Of two lines of mice with the wild-type allele, one expressed approximately equal amounts of transgenic and murine opsin and maintained normal retinal function and structure. The other expressed approximately 5 times more transgenic than murine opsin and developed a retinal degeneration similar to that found in mice carrying a mutant allele, presumably due to the overexpression of this protein. Our findings help to establish the pathogenicity of mutant human P23H rod opsin and suggest that overexpression of wild-type human rod opsin leads to a remarkably similar photoreceptor degeneration.	UNIV BRITISH COLUMBIA,DEPT BIOCHEM,VANCOUVER V6T 1Z3,BC,CANADA; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,HOWE LAB OPHTHALMOL,BOSTON,MA 02114; CUNY MT SINAI SCH MED,DEPT OBSTET & GYNECOL,NEW YORK,NY 10029	University of British Columbia; Harvard University; Harvard Medical School; Massachusetts General Hospital; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	OLSSON, JE (corresponding author), HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,BERMAN GUND LAB STUDY RETINAL DEGENERAT,BOSTON,MA 02114, USA.			Olsson, Jane/0000-0001-9546-0568	NEI NIH HHS [EY00169, EY 08683, EY06514] Funding Source: Medline; NATIONAL EYE INSTITUTE [R23EY006514, R01EY000169, R37EY000169, R01EY008683, R01EY006514] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLISON J, 1991, P NATL ACAD SCI USA, V88, P2070, DOI 10.1073/pnas.88.6.2070; ALLISON J, 1988, NATURE, V333, P529, DOI 10.1038/333529a0; ALUBAIDI MR, 1990, J BIOL CHEM, V265, P20563; Berson E L, 1991, Trans Am Ophthalmol Soc, V89, P117; BERSON EL, 1991, AM J OPHTHALMOL, V111, P614, DOI 10.1016/S0002-9394(14)73708-0; BERSON EL, 1969, ARCH OPHTHALMOL-CHIC, V81, P207; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; BERSON EL, 1968, ARCH OPHTHALMOL-CHIC, V80, P355; BHATTACHARYA SS, 1991, INVEST OPHTH VIS SCI, V32, P890; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; CHEN JD, 1989, AM J HUM GENET, V45, P401; COGAN D G, 1950, Trans Am Acad Ophthalmol Otolaryngol, V54, P629; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; EFRAT S, 1990, MOL CELL BIOL, V10, P1779, DOI 10.1128/MCB.10.4.1779; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; GAL A, 1991, GENOMICS, V11, P468, DOI 10.1016/0888-7543(91)90159-C; GILFILLAN S, 1990, P NATL ACAD SCI USA, V87, P7319, DOI 10.1073/pnas.87.18.7319; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; GORDON JW, 1981, SCIENCE, V214, P1244, DOI 10.1126/science.6272397; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; HODGES RS, 1988, J BIOL CHEM, V263, P11768; INGLEHEARN CF, 1991, AM J HUM GENET, V48, P26; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; KEEN TJ, 1991, GENOMICS, V11, P199, DOI 10.1016/0888-7543(91)90119-Y; KOLB H, 1974, INVEST OPHTH VISUAL, V13, P487; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; MCWILLIAM P, 1989, GENOMICS, V5, P619, DOI 10.1016/0888-7543(89)90031-1; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; ROOF D, 1991, INVEST OPHTH VIS SCI, V32, P582; SANDBERG MA, 1986, EXP EYE RES, V43, P781, DOI 10.1016/S0014-4835(86)80009-4; STONE EM, 1991, INVEST OPHTH VIS SCI, V32, P891; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; TURNLEY AM, 1991, NATURE, V353, P566, DOI 10.1038/353566a0; Verhoeff FH, 1931, ARCH OPHTHALMOL-CHIC, V5, P392; WASHBURN T, 1989, J BIOL CHEM, V264, P15464; WIRTH B, 1988, Genomics, V2, P263, DOI 10.1016/0888-7543(88)90011-0; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4	44	386	401	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1992	9	5					815	830		10.1016/0896-6273(92)90236-7	http://dx.doi.org/10.1016/0896-6273(92)90236-7			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1418997				2022-12-28	WOS:A1992JY55200003
J	HALLIDAY, AL; CEPKO, CL				HALLIDAY, AL; CEPKO, CL			GENERATION AND MIGRATION OF CELLS IN THE DEVELOPING STRIATUM	NEURON			English	Article							PLACENTAL ALKALINE-PHOSPHATASE; FETAL MONKEY NEOCORTEX; MEDIATED GENE-TRANSFER; RADIAL GLIAL-CELLS; CEREBRAL-CORTEX; NERVOUS-SYSTEM; BRAIN-DEVELOPMENT; PRECURSOR CELLS; MOUSE RETINA; NEURONS	The development of the rat striatum was investigated using a combination of two histochemically distinguishable retrovirus vectors. Using this method, it was possible to identify clonal boundaries within the embryonic striatum and thus determine patterns of proliferation, migration, and some lineal relationships. Several novel aspects of striatal histogenesis were discovered. Striatal progenitor cells do not exhibit a stem cell pattern of division between embryonic day 15 (E15) and E19; a progenitor-progeny relationship appears to exist for ventricular zone and subventricular zone (SVZ) cells; striatal progenitors produce a variety of clone types; some SVZ cells migrate radially, and some migrate tangentially within the SVZ; and radial glia and presumptive neurons can occur in the same clone.	MASSACHUSETTS GEN HOSP,DEPT NEUROSCI,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital	HALLIDAY, AL (corresponding author), HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023021] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23021] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUSTIN CP, 1990, DEVELOPMENT, V110, P713; BALABAN E, 1988, SCIENCE, V241, P1339, DOI 10.1126/science.3413496; BAYER SA, 1984, INT J DEV NEUROSCI, V2, P163, DOI 10.1016/0736-5748(84)90008-X; BIGNAMI A, 1982, DEV BIOL, V91, P286, DOI 10.1016/0012-1606(82)90035-5; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; CEPKO C, 1989, NEUROMETHODS, V16, P177; CEPKO CL, 1990, COLD SH Q B, V55, P265; CHUN JJM, 1988, J CELL BIOL, V106, P857, DOI 10.1083/jcb.106.3.857; CHUONG CM, 1987, J CELL BIOL, V104, P331, DOI 10.1083/jcb.104.2.331; COCHARD P, 1984, J NEUROSCI, V4, P2025; DRAGER UC, 1984, J NEUROSCI, V4, P2025; FENTRESS JC, 1981, ANAT EMBRYOL, V163, P275, DOI 10.1007/BF00315705; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; GARNER CC, 1988, J NEUROCHEM, V50, P609, DOI 10.1111/j.1471-4159.1988.tb02954.x; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; GRAY GE, 1992, DEVELOPMENT, V114, P271; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; GRUMET M, 1985, P NATL ACAD SCI USA, V82, P8075, DOI 10.1073/pnas.82.23.8075; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HYNES RO, 1986, J NEUROSCI, V6, P867; KAM W, 1985, P NATL ACAD SCI USA, V82, P8715, DOI 10.1073/pnas.82.24.8715; KNOLL BJ, 1988, J BIOL CHEM, V263, P12020; KOSIK KS, 1984, P NATL ACAD SCI-BIOL, V81, P7941, DOI 10.1073/pnas.81.24.7941; LAMMERS GJ, 1980, ANAT EMBRYOL, V158, P193, DOI 10.1007/BF00315906; LEVITT P, 1981, J NEUROSCI, V1, P27, DOI 10.1523/JNEUROSCI.01-01-00027.1981; LIESI P, 1985, EMBO J, V4, P1163, DOI 10.1002/j.1460-2075.1985.tb03755.x; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; NOWAKOWSKI RS, 1979, J NEUROCYTOL, V8, P697, DOI 10.1007/BF01206671; ONO K, 1989, EXP BRAIN RES, V78, P290; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; PRICE J, 1988, DEVELOPMENT, V104, P473; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Rakic P, 1985, CELL CONTACT ADHESIO, P67; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SMART I, 1961, J COMP NEUROL, V116, P325, DOI 10.1002/cne.901160306; SMART IHM, 1976, J ANAT, V121, P71; SMART IHM, 1979, NEOSTRIATUM, P127; STEWART GR, 1987, J NEUROSCI, V7, P3325; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VANDERKOOY D, 1987, BRAIN RES, V401, P155, DOI 10.1016/0006-8993(87)91176-0; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WAECHTER RV, 1972, BRAIN RES, V46, P235, DOI 10.1016/0006-8993(72)90018-2; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520	55	161	165	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					15	26		10.1016/0896-6273(92)90216-Z	http://dx.doi.org/10.1016/0896-6273(92)90216-Z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1632968				2022-12-28	WOS:A1992JE75600002
J	HILLYARD, DR; MONJE, VD; MINTZ, IM; BEAN, BP; NADASDI, L; RAMACHANDRAN, J; MILJANICH, G; AZIMIZOONOOZ, A; MCINTOSH, JM; CRUZ, LJ; IMPERIAL, JS; OLIVERA, BM				HILLYARD, DR; MONJE, VD; MINTZ, IM; BEAN, BP; NADASDI, L; RAMACHANDRAN, J; MILJANICH, G; AZIMIZOONOOZ, A; MCINTOSH, JM; CRUZ, LJ; IMPERIAL, JS; OLIVERA, BM			A NEW CONUS PEPTIDE LIGAND FOR MAMMALIAN PRESYNAPTIC CA2+ CHANNELS	NEURON			English	Article							CALCIUM-CHANNEL; OMEGA-CONOTOXIN; VENOM; NEUROTOXINS; ANTAGONISTS; NEURONS; TOXIN	Voltage-sensitive Ca2+ channels that control neurotransmitter release are blocked by omega-conotoxin (omega-CgTx) GVIA from the marine snail Conus geographus, the most widely used inhibitor of neurotransmitter release. However, many mammalian synapses are omega-CgTx-GVIA insensitive. We describe a new Conus peptide, omega-CgTx-MVIIC, that is an effective inhibitor of omega-CgTx-GVIA-resistant synaptic transmission. Ca2+ channel targets that are inhibited by omega-CgTx-MVIIC but not by omega-CgTx-GVIA include those mediating depolarization-induced Ca-45(2+) uptake in rat synaptosome preparations, "P" currents in cerebellar Purkinje cells, and a subset of omega-CgTx-GVIA-resistant currents in CA1 hippocampal pyramidal cells. The characterization of omega-CgTx-MVIIC by a combination of molecular genetics and chemical synthesis defines a general approach for obtaining ligands with novel receptor subtype specificity from Conus.	UNIV UTAH,DEPT PATHOL,SALT LAKE CITY,UT 84132; UNIV UTAH,DEPT PSYCHIAT,SALT LAKE CITY,UT 84132; HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115; UNIV PHILIPPINES,INST CHEM,QUEZON CITY 1107,PHILIPPINES; UNIV PHILIPPINES,INST MARINE SCI,QUEZON CITY 1107,PHILIPPINES; NEUREX CORP,MENLO PK,CA 94025	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; University of the Philippines System; University of the Philippines Diliman; University of the Philippines System; University of the Philippines Diliman	HILLYARD, DR (corresponding author), UNIV UTAH,DEPT BIOL,SALT LAKE CITY,UT 84132, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K20MH000929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS002253] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM22737] Funding Source: Medline; NIMH NIH HHS [K20 MH00929] Funding Source: Medline; NINDS NIH HHS [P01-NS02253] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLAUSTEIN MP, 1975, J PHYSIOL-LONDON, V247, P617, DOI 10.1113/jphysiol.1975.sp010950; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; CRUZ LJ, 1986, J BIOL CHEM, V261, P6230; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Katz B., 1969, RELEASE NEURAL TRANS; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LUNDY PM, 1991, EUR J PHARM-MOLEC PH, V206, P61, DOI 10.1016/0922-4106(91)90147-A; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; ODELL TJ, 1991, J PHYSIOL-LONDON, V436, P739, DOI 10.1113/jphysiol.1991.sp018577; OLIVERA BM, 1984, BIOCHEMISTRY-US, V23, P5087, DOI 10.1021/bi00317a001; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; OLIVERA BM, 1987, BIOCHEMISTRY-US, V26, P2086, DOI 10.1021/bi00382a004; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REGAN LJ, 1991, J NEUROSCI, V11, P2259; RIVIER J, 1987, J BIOL CHEM, V262, P1194; Sambrook J, 1989, MOL CLONING LABORATO; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; YOSHIKAMI D, 1989, ANN NY ACAD SCI, V560, P230, DOI 10.1111/j.1749-6632.1989.tb24100.x	24	462	475	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					69	77		10.1016/0896-6273(92)90221-X	http://dx.doi.org/10.1016/0896-6273(92)90221-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1352986				2022-12-28	WOS:A1992JE75600007
J	BUCKLES, GR; SMITH, ZDJ; KATZ, FN				BUCKLES, GR; SMITH, ZDJ; KATZ, FN			MIP CAUSES HYPERINNERVATION OF A RETINOTOPIC MAP IN DROSOPHILA BY EXCESSIVE RECRUITMENT OF R7 PHOTORECEPTOR CELLS	NEURON			English	Article							MEDIATED ENHANCER DETECTION; EARLY NEUROGENESIS; PATTERN-FORMATION; GENETIC-ANALYSIS; VISUAL-SYSTEM; COMPOUND EYE; OPTIC-LOBES; MELANOGASTER; SEVENLESS; RETINA	The two central photoreceptor neurons of the Drosophila eye, R7 and R8, form a retinotopic map in the optic lobe of the fly brain. We have developed a technique that allows us to visualize the projections of these neurons with high resolution. Using this technique, we have identified a new mutant, mip (more inner photoreceptors), in which this map shows a striking hyperinnervation. The extra terminals in the brain derive from an excessive recruitment of sevenless-independent R7 photoreceptor cells during eye development. The original R7, however, remains sevenless responsive. The behavior of this gene suggests that recruitment to the R7 pathway, and possibly to multiple programs in ommatidial assembly, is partially regulated by inhibition.			BUCKLES, GR (corresponding author), UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235, USA.				NEI NIH HHS [1 RO1 EY09298-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009298] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADAMS JC, 1981, J HISTOCHEM CYTOCHEM, V29, P775, DOI 10.1177/29.6.7252134; ASHBURNER M, 1989, DROSOPHILIA LABORATO; BALLINGER DG, 1988, P NATL ACAD SCI USA, V85, P3960, DOI 10.1073/pnas.85.11.3960; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; BANERJEE U, 1987, CELL, V51, P151, DOI 10.1016/0092-8674(87)90020-1; BASLER K, 1991, BIOESSAYS, V13, P621, DOI 10.1002/bies.950131202; BASLER K, 1988, CELL, V54, P299; BASLER K, 1989, SCIENCE, V243, P931, DOI 10.1126/science.2493159; BASLER K, 1991, CELL, V64, P1069, DOI 10.1016/0092-8674(91)90262-W; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BENZER S, 1991, DEV VISUAL SYSTEM; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BIER E, 1988, SCIENCE, V240, P913, DOI 10.1126/science.3129785; BOWTELL DDL, 1989, CELL, V56, P931, DOI 10.1016/0092-8674(89)90626-0; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; FISCHBACH KF, 1984, DEV BIOL, V104, P219, DOI 10.1016/0012-1606(84)90050-2; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FISCHBACH KF, 1983, DEV BIOL, V95, P1, DOI 10.1016/0012-1606(83)90002-7; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; FROHLICH A, 1987, J NEUROBIOL, V18, P343, DOI 10.1002/neu.480180403; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; Hodgkin N.M., 1978, GENET BIOL DROSOPHIL, V2c, P337; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; LEICHT BG, 1988, GENETICS, V119, P579; LINDSLEY DL, 1968, CARNEGIE I WASH PUBL, V627; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; MONTELL C, 1987, J NEUROSCI, V7, P1558; MULLINS MC, 1991, P NATL ACAD SCI USA, V88, P9387, DOI 10.1073/pnas.88.21.9387; MURPHEY RK, 1983, J NEUROSCI, V3, P312; MURPHEY RK, 1986, J COMP NEUROL, V251, P100, DOI 10.1002/cne.902510107; NICOL D, 1982, J COMP NEUROL, V207, P45, DOI 10.1002/cne.902070105; Poulson DF, 1937, P NATL ACAD SCI USA, V23, P133, DOI 10.1073/pnas.23.3.133; Power ME, 1943, J EXP ZOOL, V94, P33, DOI 10.1002/jez.1400940103; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; ROBERTSON HM, 1988, GENETICS, V118, P461; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; ROGGE R, 1992, IN PRESS P NATL ACAD; RUBIN GM, 1991, TRENDS GENET, V7, P372, DOI 10.1016/0168-9525(91)90258-R; SELLECK SB, 1991, NEURON, V6, P83, DOI 10.1016/0896-6273(91)90124-I; SELLECK SB, 1992, NATURE, V355, P253, DOI 10.1038/355253a0; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; STARK WS, 1987, J NEUROGENET, V4, P227, DOI 10.3109/01677068709102343; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Sved J, 1986, DROSOPH INF SERV, V63, P169; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TOMLINSON A, 1985, J EMBRYOL EXP MORPH, V89, P313; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; TOMLINSON A, 1986, SCIENCE, V231, P400, DOI 10.1126/science.231.4736.400; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; VASSIN H, 1985, J NEUROGENET, V2, P291, DOI 10.3109/01677068509102325; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; WOLFF T, 1991, DEVELOPMENT, V113, P841; WOLFF T, 1991, DEVELOPMENT, V113, P825	64	25	25	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1015	1029		10.1016/0896-6273(92)90124-V	http://dx.doi.org/10.1016/0896-6273(92)90124-V			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1610563				2022-12-28	WOS:A1992JA42900003
J	FRIEL, DD; TSIEN, RW				FRIEL, DD; TSIEN, RW			PHASE-DEPENDENT CONTRIBUTIONS FROM CA2+ ENTRY AND CA2+ RELEASE TO CAFFEINE-INDUCED [CA2+]I OSCILLATIONS IN BULLFROG SYMPATHETIC NEURONS	NEURON			English	Article							FREE CALCIUM-CONCENTRATION; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CA-2+ TRANSIENTS; CYTOSOLIC CA-2+; CELLS; RYANODINE; CHANNEL; STORES; ACTIVATION	Sympathetic neurons display robust [Ca2+]i oscillations in response to caffeine and mild depolarization. Oscillations occur at constant membrane potential, ruling out voltage-dependent changes in plasma membrane conductance. They are terminated by ryanodine, implicating Ca2+-induced Ca2+ release. Ca2+ entry is necessary for sustained oscillatory activity, but its importance varies within the oscillatory cycle: the slow interspike rise in [Ca2+]i requires Ca2+ entry, but the rapid upstroke does not, indicating that it reflects internal Ca2+ release. Sudden alterations in [Ca2+]o, [K+]o, or [caffeine]o produce immediate changes in d[Ca2+]i/dt and provide information about the relative rates of surface membrane Ca2+ transport as well as uptake and release by internal stores. Based on our results, [Ca2+]i oscillations can be explained in terms of coordinated changes in Ca2+ fluxes across surface and store membranes.			FRIEL, DD (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.				NHLBI NIH HHS [HL13156] Funding Source: Medline; NINDS NIH HHS [NS24067] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1986, J EXP BIOL, V124, P259; BERRIDGE MJ, 1979, J EXP BIOL, V81, P217; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BERRIDGE MJ, 1991, P ROY SOC B-BIOL SCI, V244, P57, DOI 10.1098/rspb.1991.0051; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; ENDO M, 1985, CURR TOP MEMBR TRANS, V25, P181; ENDO M, 1975, P JPN ACAD, V51, P479, DOI 10.2183/pjab1945.51.479; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; FILL M, 1988, TRENDS NEUROSCI, V11, P453, DOI 10.1016/0166-2236(88)90198-1; FOSKETT JK, 1991, J BIOL CHEM, V266, P14535; FOSKETT JK, 1991, J BIOL CHEM, V266, P2778; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; GORMAN ALF, 1978, J PHYSIOL-LONDON, V275, P357, DOI 10.1113/jphysiol.1978.sp012194; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GURNEY AM, 1989, NATURE, V341, P65, DOI 10.1038/341065a0; HAROOTUNIAN AT, 1988, COLD SPRING HARB SYM, V53, P935, DOI 10.1101/SQB.1988.053.01.108; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P275, DOI 10.1113/jphysiol.1988.sp017120; HUGHES AD, 1990, PFLUG ARCH EUR J PHY, V416, P462, DOI 10.1007/BF00370755; IMAGAWA T, 1987, J BIOL CHEM, V262, P16636; JACOB R, 1990, BIOCHIM BIOPHYS ACTA, V1052, P427, DOI 10.1016/0167-4889(90)90152-4; JACOB R, 1990, J PHYSIOL-LONDON, V421, P55, DOI 10.1113/jphysiol.1990.sp017933; KOSTYUK PG, 1991, EXP BRAIN RES, V83, P459; KOSTYUK PG, 1989, J MEMBRANE BIOL, V110, P11, DOI 10.1007/BF01870988; KUBA K, 1981, J THEOR BIOL, V93, P1009, DOI 10.1016/0022-5193(81)90352-0; KUBA K, 1980, J PHYSIOL-LONDON, V298, P251, DOI 10.1113/jphysiol.1980.sp013079; KUBA K, 1976, J NEUROPHYSIOL, V39, P547, DOI 10.1152/jn.1976.39.3.547; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LATTANZIO FA, 1987, J BIOL CHEM, V262, P2711; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; LOESSBERG PA, 1991, J BIOL CHEM, V266, P1363; MALGAROLI A, 1990, J BIOL CHEM, V265, P3005; MARBAN E, 1982, J PHYSIOL-LONDON, V329, P589, DOI 10.1113/jphysiol.1982.sp014321; MARBAN E, 1985, CIRC RES, V56, P133, DOI 10.1161/01.RES.56.1.133; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; MIRONOV SL, 1991, NEUROSCI LETT, V123, P200, DOI 10.1016/0304-3940(91)90930-R; NAGASAKI K, 1984, J BIOCHEM-TOKYO, V96, P1769, DOI 10.1093/oxfordjournals.jbchem.a135009; ONEILL SC, 1990, J PHYSIOL-LONDON, V425, P55, DOI 10.1113/jphysiol.1990.sp018092; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RINK TJ, 1989, CELL CALCIUM, V10, P385, DOI 10.1016/0143-4160(89)90064-X; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; SCHLEGEL W, 1987, NATURE, V329, P719, DOI 10.1038/329719a0; SUTKO JL, 1985, FED PROC, V44, P2984; TEPIKIN AV, 1991, J MEMBRANE BIOL, V123, P43, DOI 10.1007/BF01993961; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THAYER SA, 1988, MOL PHARMACOL, V34, P664; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; TSIEN RW, 1979, J EXP BIOL, V81, P205; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; WAKUI M, 1990, CELL, V63, P1025, DOI 10.1016/0092-8674(90)90505-9; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0	58	112	112	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1109	1125		10.1016/0896-6273(92)90132-W	http://dx.doi.org/10.1016/0896-6273(92)90132-W			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1610566				2022-12-28	WOS:A1992JA42900011
J	HARDIE, RC; MINKE, B				HARDIE, RC; MINKE, B			THE TRP GENE IS ESSENTIAL FOR A LIGHT-ACTIVATED CA2+ CHANNEL IN DROSOPHILA PHOTORECEPTORS	NEURON			English	Article							LIMULUS VENTRAL PHOTORECEPTORS; INVERTEBRATE PHOTORECEPTORS; PIGMENT MIGRATION; PHOSPHOLIPASE-C; CALCIUM-ION; MUTANT; EXCITATION; CELLS; FLY; PHOTOTRANSDUCTION	Invertebrate phototransduction is an important model system for studying the ubiquitous inositol-lipid signaling system. In the transient receptor potential (trp) mutant, one of the most intensively studied transduction mutants of Drosophila, the light response quickly declines to baseline during prolonged intense light. Using whole-cell recordings from Drosophila photoreceptors, we show that the wild-type response is mediated by at least two functionally distinct classes of light-sensitive channels and that both the trp mutation and a Ca2+ channel blocker (La3+) selectively abolish one class of channel with high Ca2+ permeability. Evidence is also presented that Ca2+ is necessary for excitation and that Ca2+ depletion mimics the trp phenotype. We conclude that the recently sequenced trp protein represents a class of light-sensitive channel required for inositide-mediated Ca2+ entry and suggest that this process is necessary for maintained excitation during intense illumination in fly photoreceptors.	HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT PHYSIOL,IL-91010 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH MED SCH,MINERVA CTR STUDIES VISUAL TRANSDUCT,IL-91010 JERUSALEM,ISRAEL	Hebrew University of Jerusalem; Hebrew University of Jerusalem	HARDIE, RC (corresponding author), UNIV CAMBRIDGE,DEPT ZOOL,CAMBRIDGE CB2 3EJ,ENGLAND.			Hardie, Roger/0000-0001-5531-3264				BAUMANN O, 1991, P NATL ACAD SCI USA, V88, P741, DOI 10.1073/pnas.88.3.741; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BIRD GS, 1991, NATURE, V352, P162, DOI 10.1038/352162a0; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BOLSOVER SR, 1985, J PHYSIOL-LONDON, V364, P381, DOI 10.1113/jphysiol.1985.sp015751; BROWN HM, 1988, CELL CALCIUM, V9, P105, DOI 10.1016/0143-4160(88)90014-0; BROWN JE, 1984, NATURE, V311, P160, DOI 10.1038/311160a0; BROWN JE, 1974, J GEN PHYSIOL, V64, P643, DOI 10.1085/jgp.64.6.643; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; DEVARY OO, 1987, P NATL ACAD SCI USA, V84, P6939; FEIN A, 1984, NATURE, V311, P157, DOI 10.1038/311157a0; FENG JJ, 1991, BRAIN RES, V552, P291, DOI 10.1016/0006-8993(91)90094-C; FRANK TM, 1991, J GEN PHYSIOL, V97, P697, DOI 10.1085/jgp.97.4.697; FURIUCHI T, 1989, NATURE, V342, P32; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1991, J NEUROSCI, V11, P3079; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; Hille B, 1984, IONIC CHANNELS EXCIT; HOCHSTRATE P, 1989, J COMP PHYSIOL A, V166, P179, DOI 10.1007/BF00193462; HOWARD J, 1984, J EXP BIOL, V113, P471; IRVINE RF, 1991, BIOESSAYS, V13, P419, DOI 10.1002/bies.950130810; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; JOHNSON EC, 1986, NATURE, V324, P468, DOI 10.1038/324468a0; KIRSCHFELD K, 1980, NATURWISSENSCHAFTEN, V67, P516, DOI 10.1007/BF01047639; LISMAN JE, 1972, J GEN PHYSIOL, V59, P701, DOI 10.1085/jgp.59.6.701; LO MVC, 1981, J GEN PHYSIOL, V77, P155, DOI 10.1085/jgp.77.2.155; MINKE B, 1986, VISION RES, V26, P679, DOI 10.1016/0042-6989(86)90082-9; MINKE B, 1975, NATURE, V258, P84, DOI 10.1038/258084a0; MINKE B, 1983, J COMP PHYSIOL, V151, P483, DOI 10.1007/BF00605465; MINKE B, 1982, J GEN PHYSIOL, V79, P361, DOI 10.1085/jgp.79.3.361; MINKE B, 1992, PROGR RETINAL RES, V11, P99; MINKE B, 1992, IN PRESS SENSORY TRA; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NAGY K, 1991, Q REV BIOPHYS, V24, P165, DOI 10.1017/S0033583500003401; NASI E, 1991, J GEN PHYSIOL, V97, P55, DOI 10.1085/jgp.97.1.55; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Pak W.L., 1979, P67; PAK WL, 1991, PROG CLIN BIOL RES, V362, P1; PAYNE R, 1988, PHILOS T ROY SOC B, V320, P359, DOI 10.1098/rstb.1988.0082; PAYNE R, 1986, J GEN PHYSIOL, V88, P107, DOI 10.1085/jgp.88.1.107; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; RANGANATHAN R, 1991, TRENDS NEUROSCI, V14, P486, DOI 10.1016/0166-2236(91)90060-8; SELINGER Z, 1988, COLD SPRING HARB SYM, V53, P333, DOI 10.1101/SQB.1988.053.01.040; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; SUSS E, 1989, J GEN PHYSIOL, V94, P465, DOI 10.1085/jgp.94.3.465; SUSSTOBY E, 1991, J GEN PHYSIOL, V98, P848; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; TOYOSHIMA S, 1990, J BIOL CHEM, V265, P14842; WALZ B, 1982, J ULTRA MOL STRUCT R, V81, P240, DOI 10.1016/S0022-5320(82)90079-X; WALZ B, 1992, IN PRESS J COMP PHYS; WERNER U, 1992, IN PRESS J COMP PHYS; WONG F, 1989, NEURON, V3, P81, DOI 10.1016/0896-6273(89)90117-7; YOSHIOKA T, 1985, J BIOCHEM-TOKYO, V97, P1251, DOI 10.1093/oxfordjournals.jbchem.a135171; ZIEGLER A, 1989, J COMP PHYSIOL A, V165, P697, DOI 10.1007/BF00611001	57	561	584	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					643	651		10.1016/0896-6273(92)90086-S	http://dx.doi.org/10.1016/0896-6273(92)90086-S			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1314617				2022-12-28	WOS:A1992HQ18800004
J	PRICE, M; LAZZARO, D; POHL, T; MATTEI, MG; RUTHER, U; OLIVO, JC; DUBOULE, D; DILAURO, R				PRICE, M; LAZZARO, D; POHL, T; MATTEI, MG; RUTHER, U; OLIVO, JC; DUBOULE, D; DILAURO, R			REGIONAL EXPRESSION OF THE HOMEOBOX GENE NKX-2.2 IN THE DEVELOPING MAMMALIAN FOREBRAIN	NEURON			English	Article							SEGMENT-SPECIFIC EXPRESSION; NERVOUS-SYSTEM; MOUSE; DIENCEPHALON; HOMEODOMAIN; ORIGIN; TIME; RAT; CHROMOSOME; MESODERM	A novel mouse homeobox-containing gene, Nkx-2.2, has been isolated. Nkx-2.2 is a member of a family of genes whose homeodomains are homologous to that of the Drosophila NK-2 gene. Nkx-2.2 transcripts are found in localized domains of the brain during mouse embryogenesis. Nkx-2.2 expression in the brain abuts and partially overlaps with the expression domains of two other related homeobox-containing genes, TTF-1 and Dlx. The expression domains of the three genes in the developing prosencephalon coincide with anatomical boundaries, particularly apparent in the diencephalon. This result raises the possibility that these genes may specify regional differentiation of the developing diencephalon into its anatomically and functionally defined subregions. Nkx-2.2 may be involved in specifying diencephalic neuromeric boundaries.	EUROPEAN MOLEC BIOL LAB, W-6900 HEIDELBERG, GERMANY; HOP ENFANTS LA TIMONE, INSERM, U242, F-13385 MARSEILLE 5, FRANCE	European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille			Olivo-Marin, Jean-Christophe/K-4428-2015; Di Lauro, Roberto/A-2746-2012	Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Di Lauro, Roberto/0000-0001-9493-3036; duboule, denis/0000-0001-9961-2960				ALTMAN J, 1979, J COMP NEUROL, V188, P455, DOI 10.1002/cne.901880308; ALTMAN J, 1978, J COMP NEUROL, V182, P945, DOI 10.1002/cne.901820511; ANGEVINE JB, 1970, J COMP NEUROL, V139, P129, DOI 10.1002/cne.901390202; BASTIAN H, 1990, EMBO J, V9, P1839, DOI 10.1002/j.1460-2075.1990.tb08309.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COHEN S, 1991, TRENDS GENET, V7, P267; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DOLLE P, 1989, EMBO J, V8, P1507, DOI 10.1002/j.1460-2075.1989.tb03535.x; FEATHERSTONE MS, 1988, P NATL ACAD SCI USA, V85, P4760, DOI 10.1073/pnas.85.13.4760; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; GLOVER DM, 1989, DNA CLONING PRACTICA; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; JAN YN, 1990, TRENDS NEUROSCI, V13, P493, DOI 10.1016/0166-2236(90)90083-M; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KIM YS, 1989, P NATL ACAD SCI USA, V86, P7716, DOI 10.1073/pnas.86.20.7716; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Maniatis T, 1989, MOL CLONING; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MAVILIO F, 1986, NATURE, V324, P664, DOI 10.1038/324664a0; MURPHY P, 1989, NATURE, V341, P156, DOI 10.1038/341156a0; NIMMI K, 1962, J EXP MED, V8, P203; OLIVO JC, 1990, SCANNING MICROSCOPY, V4, P825; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; PUELLES L, 1987, J COMP NEUROL, V266, P247, DOI 10.1002/cne.902660210; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; STERN CD, 1988, TRENDS NEUROSCI, V11, P190, DOI 10.1016/0166-2236(88)90120-8; TOTH LE, 1987, P NATL ACAD SCI USA, V84, P6790, DOI 10.1073/pnas.84.19.6790; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; ZAPPAVIGNA V, IN PRESS EMBO J	35	270	278	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1992	8	2					241	255		10.1016/0896-6273(92)90291-K	http://dx.doi.org/10.1016/0896-6273(92)90291-K			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1346742				2022-12-28	WOS:A1992HE93000005
J	SMEYNE, RJ; SCHILLING, K; ROBERTSON, L; LUK, D; OBERDICK, J; CURRAN, T; MORGAN, JI				SMEYNE, RJ; SCHILLING, K; ROBERTSON, L; LUK, D; OBERDICK, J; CURRAN, T; MORGAN, JI			FOS-LACZ TRANSGENIC MICE - MAPPING SITES OF GENE INDUCTION IN THE CENTRAL-NERVOUS-SYSTEM	NEURON			English	Article								A transgenic mouse line containing a fos-lacZ fusion gene was derived in which beta-galactosidase activity identified cell populations expressing fos either constitutively or after stimulation. Seizures and light pulses induced nuclear lacZ activity in defined populations of neurons in vivo, and an array of neurotransmitters, including glutamate, induced the transgene in primary brain cultures. In unstimulated mice, the major sites of fos-lacZ expression were skin, hair follicle, and bone. fos-lacZ mice provide a new avenue for activity mapping studies based on gene expression.	ROCHE RES CTR, ROCHE INST MOLEC BIOL, DEPT MOLEC ONCOL & VIROL, NUTLEY, NJ 07110 USA	Roche Holding	SMEYNE, RJ (corresponding author), ROCHE RES CTR, ROCHE INST MOLEC BIOL, DEPT NEUROSCI, NUTLEY, NJ 07110 USA.		Curran, Tom/C-1164-2008; Morgan, James/GRO-2905-2022; Curran, Tom/D-7515-2011; Curran, Tom/F-5234-2018; Morgan, James/N-8104-2018; Curran, Thomas/AAE-7631-2019	Curran, Tom/0000-0003-1444-7551; Morgan, James/0000-0002-8920-1065; Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Smeyne, Richard/0000-0002-8459-5472	PHS HHS [08680-02] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ARONIN N, 1990, P NATL ACAD SCI USA, V87, P5959, DOI 10.1073/pnas.87.15.5959; BULLITT E, 1989, BRAIN RES, V493, P391, DOI 10.1016/0006-8993(89)91177-3; CECCATELLI S, 1989, P NATL ACAD SCI USA, V86, P9569, DOI 10.1073/pnas.86.23.9569; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; COHEN DR, 1990, ONCOGENE, V5, P929; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Curran T, 1988, ONCOGENE HDB, P307; DeSouza E.B., 1990, CORTICOTROPIN RELEAS, P69; DETOGNI P, 1988, MOL CELL BIOL, V8, P2251, DOI 10.1128/MCB.8.5.2251; DONY C, 1987, NATURE, V328, P711, DOI 10.1038/328711a0; DOTTO GP, 1986, EMBO J, V5, P2853, DOI 10.1002/j.1460-2075.1986.tb04579.x; DRAGUNOW M, 1989, NEUROSCI LETT, V101, P274, DOI 10.1016/0304-3940(89)90545-4; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; FINKEL MP, 1966, SCIENCE, V151, P698, DOI 10.1126/science.151.3711.698; FISCHER G, 1982, NEUROSCI LETT, V28, P325, DOI 10.1016/0304-3940(82)90079-9; FISHER C, 1991, DEVELOPMENT, V111, P253; FRANZA BR, 1987, ONCOGENE, V1, P213; GIOVANNELLI L, 1990, BRAIN RES, V531, P299, DOI 10.1016/0006-8993(90)90789-E; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; HOGAN B, 1986, MANIPULATING MOUSE E; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; KASIK JW, 1987, MOL CELL BIOL, V7, P3349, DOI 10.1128/MCB.7.9.3349; Kerppola TK, 1991, CURR OPIN STRUC BIOL, V1, P71, DOI 10.1016/0959-440X(91)90014-K; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; MEIJER JH, 1989, PHYSIOL REV, V69, P671, DOI 10.1152/physrev.1989.69.3.671; MOORE RY, 1983, FED PROC, V42, P2783; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MULLER R, 1982, NATURE, V299, P640, DOI 10.1038/299640a0; MULLER R, 1984, NATURE, V311, P438, DOI 10.1038/311438a0; MULLER R, 1985, NATURE, V314, P546, DOI 10.1038/314546a0; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OKUNO H, 1991, ONCOGENE, V6, P1491; POPOVICI T, 1990, BRAIN RES, V536, P183, DOI 10.1016/0006-8993(90)90024-6; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; REA MA, 1989, BRAIN RES BULL, V23, P577, DOI 10.1016/0361-9230(89)90204-9; ROBERTSON HA, 1989, BRAIN RES, V503, P346, DOI 10.1016/0006-8993(89)91689-2; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; SAGAR SM, 1990, MOL BRAIN RES, V7, P17, DOI 10.1016/0169-328X(90)90068-O; SANDBERG M, 1988, DEVELOPMENT, V102, P461; SCHILLING K, 1991, P NATL ACAD SCI USA, V88, P5665, DOI 10.1073/pnas.88.13.5665; SCHILLING KL, 1988, J NEUROSCI RES, V19, P27, DOI 10.1002/jnr.490190105; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SHIN C, 1990, J NEUROCHEM, V55, P1050, DOI 10.1111/j.1471-4159.1990.tb04595.x; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; SONNENBERG JL, 1989, J NEUROSCI RES, V24, P72, DOI 10.1002/jnr.490240111; Treisman R, 1990, Semin Cancer Biol, V1, P47; TUREK FW, 1985, ANNU REV PHYSIOL, V47, P49, DOI 10.1146/annurev.ph.47.030185.000405; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; YANG G, 1989, MOL CELL ENDOCRINOL, V66, P163; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x; [No title captured]	62	229	235	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1992	8	1					13	23		10.1016/0896-6273(92)90105-M	http://dx.doi.org/10.1016/0896-6273(92)90105-M			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1730004				2022-12-28	WOS:A1992HB18500002
J	HOKFELT, T				HOKFELT, T			NEUROPEPTIDES IN PERSPECTIVE - THE LAST 10 YEARS	NEURON			English	Review							GENE-RELATED PEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE; SPINAL DORSAL HORN; NERVE GROWTH-FACTOR; GALANIN-LIKE IMMUNOREACTIVITY; RETROGRADE AXONAL-TRANSPORT; BASAL FOREBRAIN COMPLEX; PRIMARY SENSORY NEURONS; RAT FACIAL MOTONEURONS; SUBSTANCE-P RECEPTOR				HOKFELT, T (corresponding author), KAROLINSKA INST,DEPT HISTOL & NEUROBIOL,S-10401 STOCKHOLM 60,SWEDEN.				NIMH NIH HHS [NIMH-43230] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH043230] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLEN JM, 1982, NEUROPEPTIDES, V3, P71, DOI 10.1016/0143-4179(82)90001-4; ARVIDSSON U, 1990, EXP BRAIN RES, V79, P212; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Barron K, 1983, SPINAL CORD RECONSTR, P7; BARTFAI T, 1991, IN PRESS P NATL ACAD; BEAN AJ, 1991, J NEUROSCI, V11, P2694; BENARI Y, 1990, EUR J NEUROSCI, V2, P62, DOI 10.1111/j.1460-9568.1990.tb00381.x; BERSANI M, 1991, FEBS LETT, V283, P189, DOI 10.1016/0014-5793(91)80585-Q; Bjorklund A.H.T., 1988, HATLDBOOK CHEM NEURO, V6, P599; BOCK MG, 1989, J MED CHEM, V32, P13, DOI 10.1021/jm00121a004; BRADWEJN J, 1990, CAN J PSYCHIAT, V35, P83, DOI 10.1177/070674379003500115; BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0; BRENNEMAN DE, 1986, P NATL ACAD SCI USA, V83, P1159, DOI 10.1073/pnas.83.4.1159; BROWNSTEIN MJ, 1986, PROG BRAIN RES, V68, P161, DOI 10.1016/S0079-6123(08)60237-X; CASTEL MN, 1990, NEUROSCIENCE, V36, P425, DOI 10.1016/0306-4522(90)90438-A; CECCATELLI S, 1989, NEUROENDOCRINOLOGY, V49, P309, DOI 10.1159/000125133; Chan-Palay V., 1984, COEXISTENCE NEUROACT; CHANG MM, 1971, NATURE-NEW BIOL, V232, P86, DOI 10.1038/newbio232086a0; CHANPALAY V, 1988, J COMP NEUROL, V273, P543, DOI 10.1002/cne.902730409; CHANPALAY V, 1988, BRAIN RES BULL, V21, P465, DOI 10.1016/0361-9230(88)90160-8; CHRISTENSON J, 1991, IN PRESS NEUROSCI LE; CORTES R, 1990, P NATL ACAD SCI USA, V87, P7742, DOI 10.1073/pnas.87.19.7742; COSTA E, 1983, NEUROPHARMACOLOGY, V22, P1481, DOI 10.1016/0028-3908(83)90116-8; COSTA M, 1986, PROG BRAIN RES, V68, P217, DOI 10.1016/S0079-6123(08)60241-1; COTTRELL GA, 1990, PFLUG ARCH EUR J PHY, V416, P612, DOI 10.1007/BF00382698; Cuello A. C., 1982, COTRANSMISSION; Danielii J.F., 1958, GENERAL CYTOCHEMICAL, P399; DEBIASI S, 1988, P NATL ACAD SCI USA, V85, P7820; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; DEMONTIGNY C, 1989, ARCH GEN PSYCHIAT, V46, P511; DENISDONINI S, 1989, NATURE, V339, P701, DOI 10.1038/339701a0; DEWIED D, 1971, NATURE, V232, P58, DOI 10.1038/232058a0; DOURISH CT, 1989, SCIENCE, V245, P1509, DOI 10.1126/science.2781294; DOURISH CT, 1990, EUR J PHARMACOL, V176, P35, DOI 10.1016/0014-2999(90)90129-T; DUGGAN AW, 1990, NEUROSCIENCE, V35, P195, DOI 10.1016/0306-4522(90)90134-P; ECCLES JC, 1986, PROGR BRAIN RES, P3; EDWARDS AV, 1982, SYSTEMIC ROLE REGULA, P145; ELDE R, 1990, NEUROSCI LETT, V120, P134, DOI 10.1016/0304-3940(90)90187-E; EVANS BE, 1986, P NATL ACAD SCI USA, V83, P4918, DOI 10.1073/pnas.83.13.4918; FISONE G, 1987, P NATL ACAD SCI USA, V84, P7339, DOI 10.1073/pnas.84.20.7339; FITZGERALD M, 1985, BRAIN RES, V332, P131, DOI 10.1016/0006-8993(85)90396-8; FOLKERS K, 1982, ACTA CHEM SCAND B, V36, P389, DOI 10.3891/acta.chem.scand.36b-0389; FONTAINE B, 1987, J CELL BIOL, V105, P1337, DOI 10.1083/jcb.105.3.1337; FONTAINE B, 1986, NEUROSCI LETT, V71, P59, DOI 10.1016/0304-3940(86)90257-0; FRIED G, 1985, J NEUROSCI, V5, P450; FUXE K, 1991, VOLUME TRANSMISSION, P1; GESSER BP, 1985, J NEUROSCI, V5, P1412; GIAID A, 1989, P NATL ACAD SCI USA, V86, P7634, DOI 10.1073/pnas.86.19.7634; GIBBINS IL, 1987, CELL TISSUE RES, V248, P417; GIBSON SJ, 1984, J NEUROSCI, V4, P3101, DOI 10.1523/jneurosci.04-12-03101.1984; GOLDING DW, 1984, EXPERIENTIA, V40, P1277, DOI 10.1007/BF01946673; GOODMAN RR, 1980, P NATL ACAD SCI-BIOL, V77, P6239, DOI 10.1073/pnas.77.10.6239; GUILLEMIN R, 1978, HYPOTHALAMUS, P155; HAAS CA, 1990, J NEUROSCI RES, V27, P270, DOI 10.1002/jnr.490270305; HAEGERSTRAND A, 1989, P NATL ACAD SCI USA, V86, P5993, DOI 10.1073/pnas.86.15.5993; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; HENRY JL, 1975, CAN J PHYSIOL PHARM, V53, P423, DOI 10.1139/y75-061; HERSHEY AD, 1990, SCIENCE, V247, P958, DOI 10.1126/science.2154852; HILL EL, 1991, NEUROSCIENCE, V44, P747, DOI 10.1016/0306-4522(91)90094-5; HOHMANN EL, 1986, SCIENCE, V232, P868, DOI 10.1126/science.3518059; HOKFELT T, 1987, EXPERIENTIA, V43, P768; HOKFELT T, 1980, NEUROSCIENCE, V5, P2093, DOI 10.1016/0306-4522(80)90127-X; HOKFELT T, 1987, NEUROSCI LETT, V83, P217, DOI 10.1016/0304-3940(87)90088-7; HOKFELT T, 1980, NATURE, V284, P515, DOI 10.1038/284515a0; HOKFELT T, 1977, P NATL ACAD SCI USA, V74, P3587, DOI 10.1073/pnas.74.8.3587; HOKFELT T, 1986, COEXISTENCE NEURONAL; HUGHES J, 1975, NATURE, V258, P577, DOI 10.1038/258577a0; HUGHES J, 1990, P NATL ACAD SCI USA, V87, P6728, DOI 10.1073/pnas.87.17.6728; ITOH N, 1983, NATURE, V304, P547, DOI 10.1038/304547a0; IVERFELDT K, 1989, ACTA PHYSIOL SCAND, V137, P63, DOI 10.1111/j.1748-1716.1989.tb08721.x; IVERSEN LL, 1986, FAST SLOW CHEM SIGNA; JENNINGS CGB, 1989, BRAIN RES, V504, P199, DOI 10.1016/0006-8993(89)91357-7; JESSELL T, 1979, BRAIN RES, V168, P247, DOI 10.1016/0006-8993(79)90167-7; JIRIKOWSKI GF, 1990, P NATL ACAD SCI USA, V87, P7400, DOI 10.1073/pnas.87.19.7400; JONSSON G, 1982, SCIENCE, V215, P75, DOI 10.1126/science.6171883; KANEKO T, 1990, BRAIN RES, V507, P141; KANGRGA I, 1990, J NEUROSCI, V10, P2026; KASAKOV L, 1988, J AUTONOM NERV SYST, V22, P75, DOI 10.1016/0165-1838(88)90156-7; KESSLER JA, 1980, P NATL ACAD SCI-BIOL, V77, P649, DOI 10.1073/pnas.77.1.649; KOBAYASHI RM, 1977, BRAIN RES, V126, P584, DOI 10.1016/0006-8993(77)90613-8; KORDOWER JH, 1990, J COMP NEUROL, V294, P281, DOI 10.1002/cne.902940211; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; LAUFER R, 1987, EMBO J, V6, P901, DOI 10.1002/j.1460-2075.1987.tb04836.x; LAZAR P, 1991, NEUROSCI LETT, V130, P99, DOI 10.1016/0304-3940(91)90237-N; LECCI A, 1991, NEUROSCI LETT, V129, P299, DOI 10.1016/0304-3940(91)90485-C; LEE CM, 1982, N-S ARCH PHARMACOL, V318, P281, DOI 10.1007/BF00501166; LEGREVES P, 1985, EUR J PHARMACOL, V115, P309, DOI 10.1016/0014-2999(85)90706-X; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; LORD JAH, 1977, NATURE, V267, P495, DOI 10.1038/267495a0; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; LUNDBERG JM, 1983, TRENDS NEUROSCI, V6, P325, DOI 10.1016/0166-2236(83)90149-2; LUNDBERG JM, 1981, NEUROSCIENCE, V6, P1001, DOI 10.1016/0306-4522(81)90066-X; LUNDBERG JM, 1982, SYSTEMIC ROLE REGULA, P93; MAGISTRETTI PJ, 1984, NATURE, V308, P280, DOI 10.1038/308280a0; MAGISTRETTI PJ, 1981, P NATL ACAD SCI-BIOL, V78, P6535, DOI 10.1073/pnas.78.10.6535; MARLIER L, 1990, EXP BRAIN RES, V82, P40; MASTROPAOLO J, 1988, P NATL ACAD SCI USA, V85, P9841, DOI 10.1073/pnas.85.24.9841; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; MCMAHON SB, 1987, NEUROSCI LETT, V73, P9, DOI 10.1016/0304-3940(87)90022-X; MEISTER B, 1988, NEUROENDOCRINOLOGY, V48, P516, DOI 10.1159/000125058; MEISTER B, 1990, NEUROSCIENCE, V37, P603, DOI 10.1016/0306-4522(90)90094-K; MELANDER T, 1986, NEUROSCI LETT, V68, P17, DOI 10.1016/0304-3940(86)90222-3; MELANDER T, 1985, BRAIN RES, V360, P130, DOI 10.1016/0006-8993(85)91228-4; MICEVYCH P, 1988, J COMP NEUROL, V269, P381, DOI 10.1002/cne.902690306; MILETIC V, 1988, BRAIN RES, V446, P169, DOI 10.1016/0006-8993(88)91310-8; MOORE RY, 1989, J COMP NEUROL, V282, P512, DOI 10.1002/cne.902820404; NARUMI S, 1978, J NEUROCHEM, V30, P1321, DOI 10.1111/j.1471-4159.1978.tb10462.x; NEW HV, 1986, NATURE, V323, P809, DOI 10.1038/323809a0; Nicholas A P, 1990, Neuroreport, V1, P235, DOI 10.1097/00001756-199011000-00016; NILSSON J, 1985, NATURE, V315, P61, DOI 10.1038/315061a0; NOGUCHI K, 1990, MOL BRAIN RES, V7, P299, DOI 10.1016/0169-328X(90)90080-W; OKU R, 1987, BRAIN RES, V403, P350, DOI 10.1016/0006-8993(87)90074-6; OKU R, 1988, BRAIN RES, V475, P356, DOI 10.1016/0006-8993(88)90625-7; PALACIOS JM, 1981, NATURE, V294, P587, DOI 10.1038/294587a0; PALACIOS JM, 1989, BRAIN RES, V488, P369, DOI 10.1016/0006-8993(89)90733-6; PERNOW B, 1983, PHARMACOL REV, V35, P85; PIEHL F, 1991, EUR J NEUROSCI, V3, P737, DOI 10.1111/j.1460-9568.1991.tb01670.x; PINCUS DW, 1990, NATURE, V343, P564, DOI 10.1038/343564a0; POPPER P, 1989, BRAIN RES, V496, P180, DOI 10.1016/0006-8993(89)91064-0; RANDIC M, 1990, NEUROSCI LETT, V117, P74, DOI 10.1016/0304-3940(90)90122-P; ROA M, 1991, NEUROSCIENCE, V41, P563, DOI 10.1016/0306-4522(91)90349-S; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; RYU PD, 1988, BRAIN RES, V441, P357, DOI 10.1016/0006-8993(88)91414-X; SAID SI, 1970, SCIENCE, V169, P1217, DOI 10.1126/science.169.3951.1217; SALT TE, 1983, NEUROSCIENCE, V10, P1083, DOI 10.1016/0306-4522(83)90101-X; SCHALLING M, 1990, P NATL ACAD SCI USA, V87, P8427, DOI 10.1073/pnas.87.21.8427; SCHALLY AV, 1973, SCIENCE, V179, P341, DOI 10.1126/science.179.4071.341; SCHNEIDER SP, 1985, BRAIN RES, V360, P339, DOI 10.1016/0006-8993(85)91251-X; SCHULTZBERG M, 1988, HDB CHEM NEUROANATOM, V6, P297; SHEHAB SAS, 1986, BRAIN RES, V372, P37, DOI 10.1016/0006-8993(86)91456-3; SHINMI O, 1989, BIOCHEM BIOPH RES CO, V162, P340, DOI 10.1016/0006-291X(89)92001-9; SIMERLY RB, 1987, P NATL ACAD SCI USA, V84, P2087, DOI 10.1073/pnas.84.7.2087; SMULLIN DH, 1990, PAIN, V42, P93, DOI 10.1016/0304-3959(90)91095-Z; SNEDDON P, 1984, J PHYSIOL-LONDON, V347, P561, DOI 10.1113/jphysiol.1984.sp015083; SNIDER RM, 1991, SCIENCE, V251, P435, DOI 10.1126/science.1703323; SNYDER SH, 1980, SCIENCE, V209, P976, DOI 10.1126/science.6157191; SOSSIN WS, 1990, P NATL ACAD SCI USA, V87, P4845, DOI 10.1073/pnas.87.12.4845; STREIT WJ, 1989, NEUROSCI LETT, V101, P143, DOI 10.1016/0304-3940(89)90521-1; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; SUNDSTROM E, 1988, NEUROSCI LETT, V88, P331, DOI 10.1016/0304-3940(88)90233-9; SWAAB DF, 1977, J HISTOCHEM CYTOCHEM, V25, P388, DOI 10.1177/25.5.325124; SWANSON LW, 1986, PROG BRAIN RES, V68, P169, DOI 10.1016/S0079-6123(08)60238-1; TAKAHASHI T, 1974, BRAIN RES, V73, P59, DOI 10.1016/0006-8993(74)91007-5; TAKAMI K, 1986, JPN J PHARMACOL, V42, P345, DOI 10.1254/jjp.42.345; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Tatemoto K., 1988, Gastrointestinal hormones., P421; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; Thureson-Klein A K, 1990, Int Rev Cytol, V121, P67, DOI 10.1016/S0074-7696(08)60659-2; TSUJIMOTO T, 1988, J NEUROSCI, V8, P3951; VERTES Z, 1982, LIFE SCI, V31, P119, DOI 10.1016/0024-3205(82)90423-4; VILLAR MJ, 1989, NEUROSCIENCE, V33, P587, DOI 10.1016/0306-4522(89)90411-9; VILLAR MJ, 1989, EUR J NEUROSCI, V1, P269, DOI 10.1111/j.1460-9568.1989.tb00795.x; WALKER LC, 1989, J COMP NEUROL, V280, P272, DOI 10.1002/cne.902800208; WALL PD, 1974, EXP NEUROL, V43, P580, DOI 10.1016/0014-4886(74)90197-6; WALL PD, 1984, J PHYSIOL-LONDON, V356, P443, DOI 10.1113/jphysiol.1984.sp015475; WANG R, 1987, CHOLECYSTOKININ ANTA; WHIM MD, 1989, P NATL ACAD SCI USA, V86, P9034, DOI 10.1073/pnas.86.22.9034; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; WIESENFELDHALLIN Z, 1984, NEUROSCI LETT, V52, P199, DOI 10.1016/0304-3940(84)90374-4; WOODLEY SJ, 1991, BRAIN RES, V559, P17, DOI 10.1016/0006-8993(91)90281-Y; WOODRUFF GN, 1991, NEUROPEPTIDES, V19, P45, DOI 10.1016/0143-4179(91)90082-T; WOOLF C, 1986, NEUROSCI LETT, V66, P226, DOI 10.1016/0304-3940(86)90195-3; XU XJ, 1990, EUR J NEUROSCI, V2, P733, DOI 10.1111/j.1460-9568.1990.tb00464.x; XU XJ, 1989, ACTA PHYSIOL SCAND, V137, P463, DOI 10.1111/j.1748-1716.1989.tb08780.x; XU XJ, 1991, IN PRESS BR J PHARM; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649; YOUNG WS, 1979, BRAIN RES, V179, P255; ZAGON IS, 1983, SCIENCE, V221, P1179, DOI 10.1126/science.6612331	171	524	533	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					867	879		10.1016/0896-6273(91)90333-U	http://dx.doi.org/10.1016/0896-6273(91)90333-U			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1684901				2022-12-28	WOS:A1991GY43800001
J	PRUSS, RM; AKESON, RL; RACKE, MM; WILBURN, JL				PRUSS, RM; AKESON, RL; RACKE, MM; WILBURN, JL			AGONIST-ACTIVATED COBALT UPTAKE IDENTIFIES DIVALENT-CATION PERMEABLE KAINATE RECEPTORS ON NEURONS AND GLIAL-CELLS	NEURON			English	Article							METHYL-D-ASPARTATE; AMINO-ACID RECEPTORS; CEREBELLAR GRANULE CELLS; ADRENAL CHROMAFFIN CELLS; CENTRAL NERVOUS-SYSTEM; MOUSE CENTRAL NEURONS; SPINAL-CORD NEURONS; FUNCTIONAL EXPRESSION; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS	Activation of kainate receptors causes Co2+ influx into neurons, type-2 astrocytes, and O-2A progenitor cells. Agonist-activated Co2+ uptake can be performed using cultured cells or fresh tissue slices. Based on the pattern of response to kainate, glutamate, and quisqualate, three functionally different kainate-activated ion channels (K1, K2, and K3) can be discriminated. Co2+ uptake through the K1 receptor was only activated by kainate. Both kainate and glutamate activated Co2+ uptake through the K2 receptor. Co2+ uptake through the K3 receptor was activated by all three ligands: kainate, glutamate, and quisqualate. Co2+ uptake occurred through a nonselective cation entry pathway permeable to Co2+, Ca2+, and Mn2+. The agonist-dependent activation of divalent cation influx through different kainate receptors could be correlated with expression of certain kainate receptor subunit combinations. These results are indicative of kainate receptors that may contribute to excitatory amino acid-mediated neurotoxicity.			PRUSS, RM (corresponding author), MARION MERRELL DOW RES INST, 2110 E GALBRAITH RD, CINCINNATI, OH 45215 USA.							ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P227; BARNARD EA, 1990, TRENDS PHARMACOL SCI, V11, P500, DOI 10.1016/0165-6147(90)90051-9; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; GALLO V, 1989, J NEUROCHEM, V52, P1, DOI 10.1111/j.1471-4159.1989.tb10890.x; GILBERTSON TA, 1991, SCIENCE, V251, P1613, DOI 10.1126/science.1849316; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HOGAN PG, 1983, THESIS HARVARD U CAM; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KWAN CY, 1990, J BIOL CHEM, V265, P678; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1987, J NEUROSCI, V7, P3230; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MILLER RH, 1989, ANNU REV NEUROSCI, V12, P517, DOI 10.1146/annurev.ne.12.030189.002505; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MURPHY SN, 1989, J PHARMACOL EXP THER, V249, P184; MURPHY SN, 1987, J NEUROSCI, V7, P4145; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; NOVELLI A, 1988, BRAIN RES, V451, P205, DOI 10.1016/0006-8993(88)90765-2; PRUSS RM, 1979, NATURE, V280, P688, DOI 10.1038/280688a0; RANDLE JCR, 1988, MOL CELL BIOCHEM, V80, P121; ROGERS KL, 1990, EUR J PHARMACOL, V177, P195, DOI 10.1016/0014-2999(90)90270-G; SCHRAMM M, 1990, P NATL ACAD SCI USA, V87, P1193, DOI 10.1073/pnas.87.3.1193; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STAUDERMAN KA, 1989, J BIOL CHEM, V264, P18349; STAUDERMAN KA, 1990, CELL REGUL, V1, P683, DOI 10.1091/mbc.1.9.683; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; WINTER J, 1987, NEUROSCI LETT, V80, P134, DOI 10.1016/0304-3940(87)90642-2; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; WOOD JN, 1988, J NEUROSCI, V8, P3208; WROBLEWSKI JT, 1985, NEUROPHARMACOLOGY, V24, P919, DOI 10.1016/0028-3908(85)90046-2; WROBLEWSKI JT, 1989, ANNU REV PHARMACOL, V29, P441, DOI 10.1146/annurev.pa.29.040189.002301	44	217	217	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1991	7	3					509	518		10.1016/0896-6273(91)90302-G	http://dx.doi.org/10.1016/0896-6273(91)90302-G			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1716930	Bronze			2022-12-28	WOS:A1991GG88700015
J	KANEDA, N; SASAOKA, T; KOBAYASHI, K; KIUCHI, K; NAGATSU, I; KUROSAWA, Y; FUJITA, K; YOKOYAMA, M; NOMURA, T; KATSUKI, M; NAGATSU, T				KANEDA, N; SASAOKA, T; KOBAYASHI, K; KIUCHI, K; NAGATSU, I; KUROSAWA, Y; FUJITA, K; YOKOYAMA, M; NOMURA, T; KATSUKI, M; NAGATSU, T			TISSUE-SPECIFIC AND HIGH-LEVEL EXPRESSION OF THE HUMAN TYROSINE-HYDROXYLASE GENE IN TRANSGENIC MICE	NEURON			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PHEOCHROMOCYTOMA CELL-LINE; MESSENGER-RNA TYPES; CDNA CLONE; CYCLIC-AMP; NERVOUS-SYSTEM; SINGLE GENE; RAT; ACID; DNA	Transgenic mice carrying multiple copies of the human tyrosine hydroxylase (TH)gene have been produced. The transgenes were transcribed correctly and expressed specifically in brain and adrenal gland. The level of human TH mRNA in brain was about 50-fold higher than that of endogenous mouse TH mRNA. In situ hybridization demonstrated an enormous region-specific expression of the transgene in substantia nigra and ventral tegmental area. TH immunoreactivity in these regions, though not comparable to the increment of the mRNA, was definitely increased in transgenic mice. This observation was also supported by Western blot analysis and TH activity measurements. However, catecholamine levels in transgenics were not significantly different from those in nontransgenics. These results suggest unknown regulatory mechanisms for human TH gene expression and for the catecholamine levels in transgenic mice.	NAGOYA UNIV,SCH MED,DEPT BIOCHEM,NAGOYA,AICHI 466,JAPAN; NAGOYA UNIV,RADIOISOTOPE CTR,DIV MED,NAGOYA,AICHI 466,JAPAN; FUJITA HLTH UNIV,SCH MED,INST COMPREHENS MED SCI,TOYOAKE 47011,JAPAN; FUJITA HLTH UNIV,SCH MED,DEPT ANAT,TOYOAKE 47011,JAPAN; CENT INST EXPTL ANIM,DIV DEV BIOTECHNOL,KAWASAKI 213,JAPAN; TOKAI UNIV,SCH MED,DEPT DNA BIOL,ISEHARA,KANAGAWA 25911,JAPAN	Nagoya University; Nagoya University; Fujita Health University; Fujita Health University; Tokai University			, 笹岡俊邦/N-9152-2015	, 笹岡俊邦/0000-0002-7797-4394				BEROD A, 1987, P NATL ACAD SCI USA, V84, P1699, DOI 10.1073/pnas.84.6.1699; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMBI F, 1989, J NEUROCHEM, V53, P1656, DOI 10.1111/j.1471-4159.1989.tb08567.x; CHADA K, 1985, NATURE, V314, P377, DOI 10.1038/314377a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COKER GT, 1988, BIOCHEM BIOPH RES CO, V157, P1341, DOI 10.1016/S0006-291X(88)81022-2; GIZANGGINSBERG E, 1990, GENE DEV, V4, P477, DOI 10.1101/gad.4.4.477; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; GRIMA B, 1987, NATURE, V326, P707, DOI 10.1038/326707a0; HAMMANG JP, 1990, NEURON, V4, P775, DOI 10.1016/0896-6273(90)90204-S; HARRINGTON CA, 1987, NUCLEIC ACIDS RES, V15, P2363, DOI 10.1093/nar/15.5.2363; ICHINOSE H, 1989, BIOCHEM BIOPH RES CO, V164, P1024, DOI 10.1016/0006-291X(89)91772-5; KANEDA N, 1988, J BIOL CHEM, V263, P7672; KANEDA N, 1987, BIOCHEM BIOPH RES CO, V146, P971, DOI 10.1016/0006-291X(87)90742-X; KOBAYASHI K, 1988, J BIOCHEM, V103, P907, DOI 10.1093/oxfordjournals.jbchem.a122386; KOBAYASHI K, 1988, FEBS LETT, V238, P431, DOI 10.1016/0014-5793(88)80526-X; KOBAYASHI K, 1987, NUCLEIC ACIDS RES, V15, P6733, DOI 10.1093/nar/15.16.6733; KOBAYASHI K, 1989, NUCLEIC ACIDS RES, V17, P1089, DOI 10.1093/nar/17.3.1089; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBOURDELLES B, 1988, J NEUROCHEM, V50, P988; LEVINE RA, 1981, SCIENCE, V214, P919, DOI 10.1126/science.6117945; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; LEWIS EJ, 1987, MOL CELL BIOL, V7, P3332, DOI 10.1128/MCB.7.9.3332; LEWIS EJ, 1983, J BIOL CHEM, V258, P4632; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; Maniatis T., 1982, MOL CLONING; MEFFORD IN, 1980, ANAL BIOCHEM, V104, P469, DOI 10.1016/0003-2697(80)90101-3; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; NAGATSU I, 1989, BIOMED RES-TOKYO, V10, P277; NAGATSU I, 1990, BRAIN RES, V511, P55, DOI 10.1016/0006-8993(90)90224-Y; NAGATSU T, 1979, J CHROMATOGR, V163, P247, DOI 10.1016/S0378-4347(00)81411-5; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; OKA K, 1982, BIOCHIM BIOPHYS ACTA, V706, P188, DOI 10.1016/0167-4838(82)90486-1; OMALLEY KL, 1987, BIOCHEMISTRY-US, V26, P6910, DOI 10.1021/bi00396a007; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; ROSENFELD MG, 1988, ANNU REV NEUROSCI, V11, P353, DOI 10.1146/annurev.neuro.11.1.353; SASAOKA T, 1989, NEUROCHEM INT, V15, P555, DOI 10.1016/0197-0186(89)90176-9; STERNBERGER LA, 1986, IMMUNOCYTOCHEMISTRY; TANK AW, 1986, MOL PHARMACOL, V30, P497; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TOWNES TM, 1985, EMBO J, V4, P1715, DOI 10.1002/j.1460-2075.1985.tb03841.x; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	44	109	124	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					583	594		10.1016/0896-6273(91)90061-4	http://dx.doi.org/10.1016/0896-6273(91)90061-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	1673055				2022-12-28	WOS:A1991FH80200010
J	HOGER, JH; WALTER, AE; VANCE, D; YU, L; LESTER, HA; DAVIDSON, N				HOGER, JH; WALTER, AE; VANCE, D; YU, L; LESTER, HA; DAVIDSON, N			MODULATION OF A CLONED MOUSE-BRAIN POTASSIUM CHANNEL	NEURON			English	Article							PROTEIN-KINASE-C; INJECTED XENOPUS OOCYTES; MESSENGER-RNA; INTRACELLULAR CALCIUM; NEUROTRANSMITTER RESPONSES; MAMMALIAN BRAIN; 5-HT1C RECEPTOR; CA-2+ CHANNEL; K-CHANNELS; RAT	The mouse brain K+ channel (MBK), previously cloned by others, has been independently cloned and shown to express in Xenopus oocytes. This K+ current (I(K)) inactivated over a time course of seconds and was sensitive to the K+ channel-blocking reagent tetraethylammonium. When the K+ channel was coexpressed with a cloned mouse brain serotonin receptor (5HT1c) in oocytes, activation of the 5HT1c receptor by a brief application of serotonin resulted in a suppression of the I(K)) amplitude over the next 20 min. I(K)) could also be suppressed by activation of G proteins. Suppression was also caused by intracellular Ca2+ injections and was blocked by intracellular injection of EGTA. Calmodulin antagonists block the I(K)) suppression, but a known protein kinase inhibitor did not block suppression. The 5HT1c suppression was reversible; recovery from suppression was blocked by the protein kinase inhibitor H-7. These data suggest that the I(K)) suppression occurs through a novel mechanism independent of A- or C-type protein kinases; suppression is best explained as being due to the action of a Ca2+/calmodulin-activated phosphatase; recovery from suppression is due to the action of a protein kinase.	CALTECH,DIV BIOL,PASADENA,CA 91125; UNIV INDIANA,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202	California Institute of Technology; Indiana University System; Indiana University-Purdue University Indianapolis	HOGER, JH (corresponding author), CALTECH,DIV CHEM & CHEM ENGN,PASADENA,CA 91125, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029836] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-29836] Funding Source: Medline; FDA HHS [BM-10881] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FDA HHS		ACOSTAURQUIDI J, 1989, J EXP BIOL, V145, P403; AKERMAN KEO, 1988, NEUROSCI LETT, V92, P265, DOI 10.1016/0304-3940(88)90600-3; ALKON DL, 1982, BIOPHYS J, V40, P245, DOI 10.1016/S0006-3495(82)84479-2; ARMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117, DOI 10.1016/0166-2236(89)90168-9; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; BAUMANN A, 1988, EMBO J, V7, P1087; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CHUANG DM, 1989, ANNU REV PHARMACOL, V29, P71; COHEN-ARMON M, 1989, BRAIN RES, V496, P197, DOI 10.1016/0006-8993(89)91066-4; DASCAL N, 1986, MOL BRAIN RES, V1, P201, DOI 10.1016/0169-328X(86)90026-4; DASCAL N, 1986, SCIENCE, V231, P1147, DOI 10.1126/science.2418503; DOERNER D, 1988, J NEUROSCI, V8, P4069; DUBINSKY JM, 1985, P NATL ACAD SCI USA, V82, P4282, DOI 10.1073/pnas.82.12.4282; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; FUKUDA K, 1987, NATURE, V327, P623, DOI 10.1038/327623a0; GLASS DB, 1986, J BIOL CHEM, V261, P2987; GURNEY AM, 1987, P NATL ACAD SCI USA, V84, P3496, DOI 10.1073/pnas.84.10.3496; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HEVRON E, 1986, NEUROSCI LETT, V72, P87, DOI 10.1016/0304-3940(86)90624-5; Hille B, 1984, IONIC CHANNELS EXCIT; HOGER JH, 1991, IN PRESS MOL BRAIN R; HOSEY MM, 1986, P NATL ACAD SCI USA, V83, P3733, DOI 10.1073/pnas.83.11.3733; ITO I, 1988, J CELL PHYSIOL, V134, P155, DOI 10.1002/jcp.1041340120; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; JAFFE LA, 1985, J PHYSIOL-LONDON, V358, P299, DOI 10.1113/jphysiol.1985.sp015552; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Kaczmarek LK, 1987, NEUROMODULATION BIOC; KANEKO S, 1987, NEUROSCI LETT, V83, P123, DOI 10.1016/0304-3940(87)90227-8; KENNEDY MB, 1989, TRENDS NEUROSCI, V12, P417, DOI 10.1016/0166-2236(89)90089-1; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; KRAFTE DS, 1988, J NEUROSCI, V8, P2859; KUSANO K, 1982, J PHYSIOL-LONDON, V328, P143, DOI 10.1113/jphysiol.1982.sp014257; LEONARD JP, 1987, J NEUROSCI, V7, P875; LESTER HA, 1988, SCIENCE, V241, P1057, DOI 10.1126/science.2457947; LLINAS R, 1988, SCIENCE, V242, P1659; LOTAN I, 1990, IN PRESS FEBS LETT; LUBBERT H, 1987, P NATL ACAD SCI USA, V84, P4332, DOI 10.1073/pnas.84.12.4332; LUBBERT H, 1987, J NEUROSCI, V7, P1159; MALLER JL, 1979, J BIOL CHEM, V254, P579; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; MOCZYDLOWSKI E, 1988, J MEMBRANE BIOL, V105, P95, DOI 10.1007/BF02009164; MOLINEAUX SM, 1989, P NATL ACAD SCI USA, V86, P6793, DOI 10.1073/pnas.86.17.6793; MORAN O, 1989, MOL BRAIN RES, V5, P193, DOI 10.1016/0169-328X(89)90035-1; MULNER O, 1983, CELL DIFFER DEV, V12, P211, DOI 10.1016/0045-6039(83)90030-1; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PARKER I, 1990, MOL BRAIN RES, V7, P31, DOI 10.1016/0169-328X(90)90070-T; PARKER I, 1986, PROC R SOC SER B-BIO, V228, P307, DOI 10.1098/rspb.1986.0057; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; ROSSIE S, 1987, ENZYMES, V18, P335; RUDY B, 1988, NEURON, V1, P649, DOI 10.1016/0896-6273(88)90164-X; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SADLER SE, 1987, J BIOL CHEM, V262, P10644; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; SOLIVEN B, 1988, J MEMBRANE BIOL, V105, P177, DOI 10.1007/BF02009170; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SULLIVAN SK, 1990, P NATL ACAD SCI USA, V87, P4553, DOI 10.1073/pnas.87.12.4553; TAKAHASHI T, 1987, P NATL ACAD SCI USA, V84, P5063, DOI 10.1073/pnas.84.14.5063; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; WALSH KB, 1989, J GEN PHYSIOL, V93, P841, DOI 10.1085/jgp.93.5.841; WASSERMAN WJ, 1984, DEV BIOL, V101, P436, DOI 10.1016/0012-1606(84)90158-1; WASSERMAN WJ, 1981, J CELL BIOL, V89, P389, DOI 10.1083/jcb.89.3.389; YATANI A, 1987, SCIENCE, V235, P207, DOI 10.1126/science.2432660	71	64	64	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1991	6	2					227	236		10.1016/0896-6273(91)90358-7	http://dx.doi.org/10.1016/0896-6273(91)90358-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1899581				2022-12-28	WOS:A1991EY70900005
J	ZACK, DJ; BENNETT, J; WANG, YS; DAVENPORT, C; KLAUNBERG, B; GEARHART, J; NATHANS, J				ZACK, DJ; BENNETT, J; WANG, YS; DAVENPORT, C; KLAUNBERG, B; GEARHART, J; NATHANS, J			UNUSUAL TOPOGRAPHY OF BOVINE RHODOPSIN PROMOTER-LACZ FUSION GENE-EXPRESSION IN TRANSGENIC MOUSE RETINAS	NEURON			English	Article							DROSOPHILA-MELANOGASTER; OPSIN GENE; PHOTORECEPTOR CELLS; PINEAL-GLAND; RAT PINEAL; NEURONS; MICE; POSITION; SEQUENCE; GRADIENT	To define the cis-acting DNA elements required for rhodopsin expression, we generated lines of transgenic mice carrying sequences upstream of the bovine rhodopsin gene fused to the E. coli beta-galactosidase gene (IacZ). Upstream sequences extending from -2174 to +70 bp, from -734 to +70 bp, and from -222 to +70 bp direct photoreceptor-specific expression. All three -2174 lines demonstrate a superior-temporal to inferior-nasal gradient of expression across the retina, whereas lines carrying the shorter constructs demonstrate either spatially continuous expression across the retina, discrete clusters of expression, or both. As a complementary approach to defining regulatory elements, we compared DNA sequences 5' of the murine, bovine, and human rhodopsin genes. Significant homology between all three species was found just upstream of the transcription start site and at approximately 1.5 kb upstream.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,WILMER INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	ZACK, DJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205, USA.			Nathans, Jeremy/0000-0001-8106-5460; Zack, Don/0000-0002-7966-1973	NEI NIH HHS [EY00297] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER R, 1986, RETINA MODEL CELL BI; ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; BAEHR W, 1988, FEBS LETT, V238, P253, DOI 10.1016/0014-5793(88)80490-3; BAETGE EE, 1988, P NATL ACAD SCI USA, V85, P3648, DOI 10.1073/pnas.85.10.3648; BARNSTABLE CJ, 1987, IMMUNOL REV, V100, P47, DOI 10.1111/j.1600-065X.1987.tb00527.x; BRONSTEIN DM, 1987, BRAIN RES, V406, P352, DOI 10.1016/0006-8993(87)90806-7; CARR RE, 1989, DUANES CLIN OPHTHALM, V24, P21; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; DEGUCHI T, 1981, NATURE, V290, P706, DOI 10.1038/290706a0; DENTE L, 1988, GENE DEV, V2, P259, DOI 10.1101/gad.2.2.259; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; HAZELRIGG T, 1984, CELL, V36, P469, DOI 10.1016/0092-8674(84)90240-X; HICKS D, 1986, J NEUROCYTOL, V15, P219, DOI 10.1007/BF01611658; HO AK, 1986, J NEUROCHEM, V46, P1176, DOI 10.1111/j.1471-4159.1986.tb00634.x; HOGAN B, 1986, MANIPULATING MOUSE G; KORF HW, 1985, CELL TISSUE RES, V242, P645; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; LIOU GI, 1990, J BIOL CHEM, V265, P8373; MCLAUGHLIN PJ, 1972, ATLAS PROTEIN SEQUEN, P47; MISMER D, 1987, GENETICS, V116, P565; MONTELL C, 1987, J NEUROSCI, V7, P1558; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; PESCHON JJ, 1987, P NATL ACAD SCI USA, V84, P5316, DOI 10.1073/pnas.84.15.5316; POLITI LE, 1988, INVEST OPHTH VIS SCI, V29, P534; Polley E.H., 1989, P3; Sambrook J, 1989, MOL CLONING LABORATO; SPARROW JR, 1988, J NEUROSCI RES, V21, P398, DOI 10.1002/jnr.490210231; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; TAKAO M, 1988, VISION RES, V28, P471, DOI 10.1016/0042-6989(88)90169-1; Torczynski E., 1982, OCULAR ANATOMY EMBRY; TREISMAN JE, 1988, MOL CELL BIOL, V8, P570; TRISLER GD, 1981, P NATL ACAD SCI-BIOL, V78, P2145, DOI 10.1073/pnas.78.4.2145; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VANVEEN T, 1986, FEBS LETT, V208, P133, DOI 10.1016/0014-5793(86)81547-2; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WINDLE JJ, 1990, NATURE, V343, P665, DOI 10.1038/343665a0; WUENSCHELL CW, 1990, NEURON, V4, P595, DOI 10.1016/0896-6273(90)90117-X; YAN C, 1990, EMBO J, V9, P869, DOI 10.1002/j.1460-2075.1990.tb08184.x; YOKOYAMA R, 1990, VISION RES, V30, P807, DOI 10.1016/0042-6989(90)90049-Q; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; ZIMMERMAN K, 1990, MOL CELL BIOL, V10, P2096, DOI 10.1128/MCB.10.5.2096; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	51	195	200	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1991	6	2					187	199		10.1016/0896-6273(91)90355-4	http://dx.doi.org/10.1016/0896-6273(91)90355-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1899580				2022-12-28	WOS:A1991EY70900002
J	TRAVIS, GH; SUTCLIFFE, JG; BOK, D				TRAVIS, GH; SUTCLIFFE, JG; BOK, D			THE RETINAL DEGENERATION SLOW (RDS) GENE-PRODUCT IS A PHOTORECEPTOR DISK MEMBRANE-ASSOCIATED GLYCOPROTEIN	NEURON			English	Article							ROD OUTER SEGMENTS; MUTANT MICE; LOCALIZATION; MICROSCOPY; PROTEINS; MOUSE; OPSIN; IDENTIFICATION; MUTATION; CELLS	Mice homozygous for the retinal degeneration slow (rds) mutation exhibit abnormal development of photoreceptor cells, followed by their slow degeneration. We have recently cloned the rds gene and determined the structure of the wild-type rds mRNA. Here we show that the gene is expressed exclusively in photoreceptor cells. We demonstrate that it encodes a 39 kd membrane-associated glycoprotein that is restricted to photoreceptor outer segments. By electron microscopy, we show that the rds protein is distributed uniformly within outer segment discs. The developmental appearance of the rds protein coincides with outer segment disc formation. We propose that the rds protein functions as an adhesion molecule for stabilization of the outer segment discs.	Scripps Res Inst, RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA; UNIV CALIF LOS ANGELES, SCH MED, JULES STEIN EYE INST, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT ANAT & CELL BIOL, LOS ANGELES, CA 90024 USA	Scripps Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	TRAVIS, GH (corresponding author), UNIV TEXAS, SW MED CTR, DEPT PSYCHIAT, DALLAS, TX 75235 USA.		Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493				BEGY C, 1990, NUCLEIC ACIDS RES, V18, P3058, DOI 10.1093/nar/18.10.3058; BIRD AC, 1988, INVEST OPHTH VIS SCI, V29, P1028; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CHABRE M, 1975, BIOCHIM BIOPHYS ACTA, V382, P336, DOI 10.1016/0005-2736(75)90275-8; COHEN AI, 1983, INVEST OPHTH VIS SCI, V24, P832; CONNELL G, 1990, OPHTALMOL VIS SCI S, V31, P309; CONNELL GJ, 1990, BIOCHEMISTRY-US, V29, P4691, DOI 10.1021/bi00471a025; ELDER JH, 1982, P NATL ACAD SCI-BIOL, V79, P4540, DOI 10.1073/pnas.79.15.4540; FLIESLER SJ, 1985, J CELL BIOL, V100, P574, DOI 10.1083/jcb.100.2.574; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; JANSEN HG, 1984, J COMP NEUROL, V224, P71, DOI 10.1002/cne.902240107; JANSEN HG, 1987, EXP EYE RES, V44, P347, DOI 10.1016/S0014-4835(87)80170-7; JOHNSON LV, 1984, CURR EYE RES, V3, P969, DOI 10.3109/02713688409167215; KAPLAN HA, 1987, BIOCHIM BIOPHYS ACTA, V906, P161, DOI 10.1016/0304-4157(87)90010-4; KORENBROT JI, 1973, J CELL BIOL, V56, P389, DOI 10.1083/jcb.56.2.389; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MILLER RF, 1970, J NEUROPHYSIOL, V33, P323, DOI 10.1152/jn.1970.33.3.323; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; NIR I, 1986, INVEST OPHTH VIS SCI, V27, P836; REUTER JH, 1984, NEUROSCI LETT, V48, P231, DOI 10.1016/0304-3940(84)90024-7; RUTHER U, 1983, EMBO J, V2, P1791, DOI 10.1002/j.1460-2075.1983.tb01659.x; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; SANYAL S, 1985, RETINAL DEGENERATION, P239; SHUSTER TA, 1984, BIOCHEMISTRY-US, V23, P515, DOI 10.1021/bi00298a018; SIDMAN RL, 1965, J HERED, V56, P23, DOI 10.1093/oxfordjournals.jhered.a107364; STEINBERG RH, 1987, INVEST OPHTH VIS SCI, V28, P1888; STERNBERGER LA, 1979, IMMUNOCYTOCHEMISTRY, P122; SUTCLIFFE JG, 1983, CELL, V33, P671, DOI 10.1016/0092-8674(83)90010-7; TANSLEY K, 1954, J HERED, V45, P123, DOI 10.1093/oxfordjournals.jhered.a106456; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; USUKURA J, 1987, EXP EYE RES, V45, P501, DOI 10.1016/S0014-4835(87)80061-1; VANNIE R, 1978, TISSUE ANTIGENS, V12, P106, DOI 10.1111/j.1399-0039.1978.tb01305.x; WOJTKOWIAK Z, 1983, ANAL BIOCHEM, V129, P486, DOI 10.1016/0003-2697(83)90581-X; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	39	233	236	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1991	6	1					61	70		10.1016/0896-6273(91)90122-G	http://dx.doi.org/10.1016/0896-6273(91)90122-G			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1986774				2022-12-28	WOS:A1991EU27800007
J	FRIEDMAN, B; SCHERER, SS; RUDGE, JS; HELGREN, M; MORRISEY, D; MCCLAIN, J; WANG, DY; WIEGAND, SJ; FURTH, ME; LINDSAY, RM; IP, NY				FRIEDMAN, B; SCHERER, SS; RUDGE, JS; HELGREN, M; MORRISEY, D; MCCLAIN, J; WANG, DY; WIEGAND, SJ; FURTH, ME; LINDSAY, RM; IP, NY			REGULATION OF CILIARY NEUROTROPHIC FACTOR EXPRESSION IN MYELIN-RELATED SCHWANN-CELLS INVIVO	NEURON			English	Article							NERVE GROWTH-FACTOR; RAT SCIATIC-NERVE; NEURONOTROPHIC FACTOR; UNMYELINATED NERVES; SENSORY NEURONS; GENE-EXPRESSION; FACTOR CNTF; PROTEIN; PURIFICATION; REGENERATION	Adult rat sciatic nerve is known to express high levels of ciliary neurotrophic factor (CNTF) mRNA and protein. Here we examine the cellular localization of CNTF protein and mRNA in peripheral nerve and the regulation of CNTF expression by peripheral axons. In intact nerve, CNTF immunoreactivity is found predominantly in the cytoplasm of myelin-related Schwann cells. After axotomy, CNTF immunoreactivity and mRNA levels fall dramatically and do not recover unless axons regenerate. This behavior is similar to the pattern of myelin gene expression in these nerves. We conclude that the expression of CNTF in Schwann cells depends on axon-Schwann cell interactions.	UNIV PENN, SCH MED, DEPT NEUROL, PHILADELPHIA, PA 19104 USA	University of Pennsylvania	FRIEDMAN, B (corresponding author), REGENERON PHARMACEUT INC, TARRYTOWN, NY 10591 USA.		Lindsay, Ronald/GQP-8001-2022	Ip, Nancy Yuk-Yu/0000-0002-2763-8907				ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; AGUAYO AJ, 1976, J NEUROCYTOL, V5, P565, DOI 10.1007/BF01175570; AGUAYO AJ, 1976, BRAIN RES, V104, P1, DOI 10.1016/0006-8993(76)90643-0; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BANDTLOW CE, 1987, EMBO J, V6, P891, DOI 10.1002/j.1460-2075.1987.tb04835.x; BARBIN G, 1984, J NEUROCHEM, V43, P1468, DOI 10.1111/j.1471-4159.1984.tb05410.x; BOSCH EP, 1989, J NEUROSCI, V9, P3690; CARLSON J, 1979, J NEUROPATH EXP NEUR, V38, P579, DOI 10.1097/00005072-197911000-00002; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DENEEF KJ, 1982, DEV BRAIN RES, V4, P265, DOI 10.1016/0165-3806(82)90138-9; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GOLD BG, 1991, J NEUROSCI, V11, P943; GUPTA SK, 1988, MOL BRAIN RES, V4, P133, DOI 10.1016/0169-328X(88)90005-8; HANCOCK MB, 1982, NEUROSCI LETT, V31, P247, DOI 10.1016/0304-3940(82)90028-3; HAUB O, 1990, P NATL ACAD SCI USA, V87, P8022, DOI 10.1073/pnas.87.20.8022; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; LEBLANC AC, 1990, J NEUROSCI RES, V26, P317, DOI 10.1002/jnr.490260308; LEMKE G, 1988, DEVELOPMENT, V102, P499; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; LIN LFH, 1990, J BIOL CHEM, V265, P8942; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; MANTHORPE M, 1986, BRAIN RES, V367, P282, DOI 10.1016/0006-8993(86)91603-3; MANTHORPE M, 1982, J NEUROCHEM, V38, P415, DOI 10.1111/j.1471-4159.1982.tb08645.x; MANTHORPE M, 1985, GROWTH MATURATION FA, V3, P77; MASIAKOWSKI P, 1991, J NEUROCHEM, V57, P1003, DOI 10.1111/j.1471-4159.1991.tb08250.x; MCDERMOTT JR, 1977, J NEUROL SCI, V33, P81, DOI 10.1016/0022-510X(77)90184-8; MCDONALD JR, 1972, BIOCHIM BIOPHYS ACTA, V1090, P7091; MITCHELL LS, 1990, J NEUROSCI RES, V27, P125, DOI 10.1002/jnr.490270202; NIETOSAMPEDRO M, 1983, J NEUROSCI, V3, P2219; NISHI R, 1979, NATURE, V277, P232, DOI 10.1038/277232a0; NISHI R, 1977, P NATL ACAD SCI USA, V74, P5171, DOI 10.1073/pnas.74.11.5171; PENHEIM R, 1991, SCIENCE, V251, P1616; POLITIS MJ, 1982, J NEUROSCI, V2, P1252; RAMONYCAJAL S, 1928, DEGENERATION REGENER, V1; RENDE M, 1992, GLIA, V5, P25, DOI 10.1002/glia.440050105; RICH KM, 1989, J NEUROCYTOL, V18, P569, DOI 10.1007/BF01187077; SAMBROOK J, 1989, MOL COLONING LABORAT; SCHERER SS, 1992, IN PRESS MOL GENETIC; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SHAWE GDH, 1955, BRIT J SURG, V42, P474, DOI 10.1002/bjs.18004217505; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STRAUS W, 1982, J HISTOCHEM CYTOCHEM, V30, P491, DOI 10.1177/30.5.6176617; TRAPP BD, 1988, J NEUROSCI, V8, P3515; VERGE VMK, 1990, J NEUROSCI, V10, P2018; WALICKE PA, 1989, ANNU REV NEUROSCI, V12, P103, DOI 10.1146/annurev.neuro.12.1.103; WEINBERG HJ, 1976, BRAIN RES, V113, P363, DOI 10.1016/0006-8993(76)90947-1; WEST N, 1977, INT J DEV NEUROSCI, V187, P747; WILLISON HJ, 1988, BRAIN RES, V444, P10, DOI 10.1016/0006-8993(88)90907-9; YGGE J, 1989, BRAIN RES, V478, P193, DOI 10.1016/0006-8993(89)91497-2	53	313	320	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1992	9	2					295	305		10.1016/0896-6273(92)90168-D	http://dx.doi.org/10.1016/0896-6273(92)90168-D			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1497895				2022-12-28	WOS:A1992JJ33200011
J	MINTZ, IM; ADAMS, ME; BEAN, BP				MINTZ, IM; ADAMS, ME; BEAN, BP			P-TYPE CALCIUM CHANNELS IN RAT CENTRAL AND PERIPHERAL NEURONS	NEURON			English	Article							CHICK SENSORY NEURONS; HIPPOCAMPAL-NEURONS; SYMPATHETIC NEURONS; VERTEBRATE CELLS; CURRENTS; MODULATION; BLOCKING; BINDING	The peptide toxin omega-Aga-IVA blocked P-type Ca2+ channel current in rat Purkinje neurons (K(D) almost-equal-to 2 nM) but had no effect on identified T-type, L-type, or N-type currents in a variety of central and peripheral neurons. Omega-Aga-IVA blocked a substantial fraction of high threshold Ca2+ channel current in neurons from the hippocampal CA1 region (mean 26%), visual cortex (32%), spinal cord (45%), and dorsal root ganglia (23%), but less in hippocampal CA3 neurons (14%) and none in sympathetic neurons. In all cases, omega-Aga-IVA block could be reversed by a brief train of strong depolarizations. There was no overlap between current blocked by omega-Aga-IVA and the fractions blocked by dihydropyridines and omega-conotoxin GVIA, but not all current resistant to dihydropyridines and omega-conotoxin was blocked by omega-Aga-IVA. The results suggest that omega-Aga-IVA is highly selective for P-type channels and that many central neurons and some peripheral neurons possess substantial P-type current.	UNIV CALIF RIVERSIDE,DEPT ENTOMOL,RIVERSIDE,CA 92521	University of California System; University of California Riverside	MINTZ, IM (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.		Adams, Michael/ABF-6728-2020	Adams, Michael/0000-0003-0519-6113	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024472] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 35034] Funding Source: Medline; NINDS NIH HHS [NS 24472, NS 02253] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEAN BP, 1991, AM J HYPERTENS, V4, pS406, DOI 10.1093/ajh/4.7.406S; BEAN BP, 1989, J GEN PHYSIOL, V94, P65, DOI 10.1085/jgp.94.1.65; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; JONES SW, 1989, J GEN PHYSIOL, V94, P151, DOI 10.1085/jgp.94.1.151; JONES SW, 1990, J NEUROSCI, V10, P2261; KISKIN NI, 1990, EUR J NEUROSCI, V2, P461, DOI 10.1111/j.1460-9568.1990.tb00437.x; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LIN JW, 1990, P NATL ACAD SCI USA, V87, P4538, DOI 10.1073/pnas.87.12.4538; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LUNDY PM, 1991, EUR J PHARM-MOLEC PH, V206, P61, DOI 10.1016/0922-4106(91)90147-A; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MCCARTHY R, 1992, IN PRESS J NEUROSCI; MILLER RJ, 1992, J BIOL CHEM, V267, P1403; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; ODELL TJ, 1991, J PHYSIOL-LONDON, V436, P739, DOI 10.1113/jphysiol.1991.sp018577; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REGAN LJ, 1991, J NEUROSCI, V11, P2259; SAH DWY, 1990, J NEUROSCI, V10, P136; SCOTT RH, 1990, MOL PHARMACOL, V38, P711; SCROGGS RS, 1991, J NEUROSCI, V11, P1334; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; SWANDULLA D, 1991, TRENDS NEUROSCI, V14, P46, DOI 10.1016/0166-2236(91)90018-P; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q	42	725	732	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					85	95		10.1016/0896-6273(92)90223-Z	http://dx.doi.org/10.1016/0896-6273(92)90223-Z			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1321648				2022-12-28	WOS:A1992JE75600009
J	UKOMADU, C; ZHOU, JY; SIGWORTH, FJ; AGNEW, WS				UKOMADU, C; ZHOU, JY; SIGWORTH, FJ; AGNEW, WS			MU-I NA+ CHANNELS EXPRESSED TRANSIENTLY IN HUMAN EMBRYONIC KIDNEY-CELLS - BIOCHEMICAL AND BIOPHYSICAL PROPERTIES	NEURON			English	Article								We describe the transient expression of the rat skeletal muscle mu-l Na+ channel in human embryonic kidney(HEK 293) cells. Functional channels appear at a density of approximately 30 in a 10-mu-m2 patch, comparable to those of native excitable cells. Unlike mu-l currents in oocytes, inactivation gating is predominantly (approximately 97%) fast, although clear evidence is provided for noninactivating gating modes, which have been linked to anomalous behavior in the inherited disorder hyperkalemic periodic paralysis. Sequence-specific antibodies detect a approximately 230 kd glycopeptide. The majority of molecules acquire only neutral oligosaccharides and are retained within the cell. Electrophoretic mobility on SDS gels suggests the molecules may acquire covalently attached lipid. The channel is readily phosphorylated by activation of the protein kinase A and protein kinase C second messenger pathways.			UKOMADU, C (corresponding author), YALE UNIV, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, NEW HAVEN, CT 06510 USA.				NHLBI NIH HHS [HL 38156] Funding Source: Medline; NINDS NIH HHS [NS 17928] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL038156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017928] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGNEW WS, 1984, ANNU REV PHYSIOL, V46, P517; AGNEW WS, 1978, P NATL ACAD SCI USA, V75, P2606, DOI 10.1073/pnas.75.6.2606; AGNEW WS, 1980, BIOCHEM BIOPH RES CO, V92, P860, DOI 10.1016/0006-291X(80)90782-2; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BARCHI RL, 1983, J NEUROCHEM, V40, P1377, DOI 10.1111/j.1471-4159.1983.tb13580.x; CALDWELL JH, 1988, J PHYSIOL-LONDON, V401, P145, DOI 10.1113/jphysiol.1988.sp017155; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CASADEI JM, 1986, J BIOL CHEM, V261, P4318; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HAIMOVICH B, 1987, J NEUROSCI, V7, P2957; HARTSHORNE RP, 1982, J BIOL CHEM, V257, P3888; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; JOHO RH, 1990, MOL BRAIN RES, V7, P105, DOI 10.1016/0169-328X(90)90087-T; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LEVINSON SR, 1986, ANN NY ACAD SCI, V479, P162, DOI 10.1111/j.1749-6632.1986.tb15568.x; Maniatis T., 1982, MOL CLONING; MILLER JA, 1983, BIOCHEMISTRY-US, V22, P462, DOI 10.1021/bi00271a032; MOCZYDLOWSKI E, 1986, P NATL ACAD SCI USA, V83, P5321, DOI 10.1073/pnas.83.14.5321; PATLAK JB, 1986, J GEN PHYSIOL, V87, P305, DOI 10.1085/jgp.87.2.305; PTACEK LJ, 1991, AM J HUM GENET, V49, P851; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; ROBERTS RH, 1987, J BIOL CHEM, V262, P2298; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; ROSSIE S, 1987, J BIOL CHEM, V262, P17530; SCHEUER T, 1990, SCIENCE, V247, P854, DOI 10.1126/science.2154850; SCHMIDT J, 1985, P NATL ACAD SCI USA, V82, P4847, DOI 10.1073/pnas.82.14.4847; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STEPHAN M, 1991, Current Opinion in Cell Biology, V3, P676, DOI 10.1016/0955-0674(91)90041-V; THORNHILL WB, 1987, BIOCHEMISTRY-US, V26, P4381, DOI 10.1021/bi00388a029; TRIMMER JS, 1989, ANNU REV PHYSIOL, V51, P401, DOI 10.1146/annurev.physiol.51.1.401; TRIMMER JS, 1990, DEV BIOL, V142, P360, DOI 10.1016/0012-1606(90)90356-N; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; YANG J, 1990, J NEUROCHEM, V54, P954, DOI 10.1111/j.1471-4159.1990.tb02343.x; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	42	133	135	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1992	8	4					663	676		10.1016/0896-6273(92)90088-U	http://dx.doi.org/10.1016/0896-6273(92)90088-U			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1314619				2022-12-28	WOS:A1992HQ18800006
J	VERNINO, S; AMADOR, M; LUETJE, CW; PATRICK, J; DANI, JA				VERNINO, S; AMADOR, M; LUETJE, CW; PATRICK, J; DANI, JA			CALCIUM MODULATION AND HIGH CALCIUM PERMEABILITY OF NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS	NEURON			English	Article								Two properties were found to distinguish neuronal from muscle nicotinic acetylcholine receptors (nAChRs). First, neuronal nAChRs have a greater Cal+ permeability. The high Ca2+ flux through neuronal nAChRs activates a Ca2+-dependent Cl- conductance, and the Ca2+ to CS+ permeability ratio (P(Ca)/P(Cs) is 7 times greater for neuronal than for muscle nAChRs. A second difference between the receptor types is that neuronal nAChRs are potently modulated by physiological levels of external Ca2+. Neuronal nAChR currents are enhanced by external Ca2+ in a dose-dependent manner. The results indicate that changes in extracellular Ca2+ Modulate neuronal nAChRs and may modulate cholinergic synapses in the CNS. Also, activation of neuronal nAChRs produces a significant influx of Ca2+ that could be an important intracellular signal.	BAYLOR COLL MED, DEPT MOLEC PHYSIOL & BIOPHYS, HOUSTON, TX 77030 USA	Baylor College of Medicine	VERNINO, S (corresponding author), BAYLOR COLL MED, DIV NEUROSCI, HOUSTON, TX 77030 USA.		Vernino, Steven/AAD-5181-2020	Vernino, Steven/0000-0001-7799-8495				ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; AQUILONIUS SM, 1990, CHOLINERGIC NEUROTRA; ARMSTRONG CM, 1990, P NATL ACAD SCI USA, V87, P7579, DOI 10.1073/pnas.87.19.7579; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BENNINGER C, 1980, BRAIN RES, V187, P165, DOI 10.1016/0006-8993(80)90502-8; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BREGESTOVSKI PD, 1979, NATURE, V279, P638, DOI 10.1038/279638a0; CHANG HW, 1976, P NATL ACAD SCI USA, V73, P3364, DOI 10.1073/pnas.73.10.3364; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DANI JA, 1989, J NEUROSCI, V9, P884; DANI JA, 1987, J GEN PHYSIOL, V89, P959, DOI 10.1085/jgp.89.6.959; DECKER ER, 1990, J NEUROSCI, V10, P3413; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; GREENBERG A, 1982, CELL TISSUE RES, V226, P655; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HUANG LYM, 1978, J GEN PHYSIOL, V71, P397, DOI 10.1085/jgp.71.4.397; HUGANIR RL, 1988, CURR TOP MEMBR TRANS, V33, P147; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KATZ B, 1969, J PHYSIOL-LONDON, V203, P689, DOI 10.1113/jphysiol.1969.sp008887; LAUFER R, 1989, MOL NEUROBIOL, V3, P1, DOI 10.1007/BF02935587; LEONARD JP, 1990, NEURON, V4, P53, DOI 10.1016/0896-6273(90)90443-J; LEWIS CA, 1983, P NATL ACAD SCI-BIOL, V80, P6110, DOI 10.1073/pnas.80.19.6110; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; LEWIS CA, 1979, MEMBRANE TRANSPORT P, V3, P89; LIVSEY CT, 1990, VISION RES, V30, P853, DOI 10.1016/0042-6989(90)90054-O; LUETJE CW, 1990, FASEB J, V4, P2753, DOI 10.1096/fasebj.4.10.2197155; LUETJE CW, 1991, J NEUROSCI, V11, P837; MACDERMOTT AB, 1987, TRENDS NEUROSCI, V10, P280, DOI 10.1016/0166-2236(87)90173-1; MAGLEBY KL, 1980, J PHYSIOL-LONDON, V299, P203, DOI 10.1113/jphysiol.1980.sp013120; MATHIE A, 1987, PROC R SOC SER B-BIO, V232, P239, DOI 10.1098/rspb.1987.0072; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MILEDI R, 1980, J PHYSIOL-LONDON, V300, P197, DOI 10.1113/jphysiol.1980.sp013158; MILEDI R, 1984, J PHYSIOL-LONDON, V357, P173, DOI 10.1113/jphysiol.1984.sp015495; Nestler E. J., 1984, PROTEIN PHOSPHORYLAT; PAPKE RL, 1989, NEURON, V3, P589, DOI 10.1016/0896-6273(89)90269-9; PARSONS RL, 1978, CALCIUM DRUG ACTION, P289; PUMAIN R, 1985, J NEUROPHYSIOL, V53, P1; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1984, BIOPHYS J, V45, P175, DOI 10.1016/S0006-3495(84)84146-6; WHITE MM, 1990, MOL PHARMACOL, V37, P720; WONG LA, 1991, J PHYSIOL-LONDON, V436, P325, DOI 10.1113/jphysiol.1991.sp018553	43	417	423	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1992	8	1					127	134		10.1016/0896-6273(92)90114-S	http://dx.doi.org/10.1016/0896-6273(92)90114-S			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1370370				2022-12-28	WOS:A1992HB18500011
J	WILLIAMS, ME; FELDMAN, DH; MCCUE, AF; BRENNER, R; VELICELEBI, G; ELLIS, SB; HARPOLD, MM				WILLIAMS, ME; FELDMAN, DH; MCCUE, AF; BRENNER, R; VELICELEBI, G; ELLIS, SB; HARPOLD, MM			STRUCTURE AND FUNCTIONAL EXPRESSION OF ALPHA-1-SUBUNIT, ALPHA-2-SUBUNIT, AND BETA-SUBUNIT OF A NOVEL HUMAN NEURONAL CALCIUM-CHANNEL SUBTYPE	NEURON			English	Article								The primary structures of human neuronal alpha-1, alpha-2, and beta-subunits of a voltage-dependent Ca2+ channel were deduced by characterizing cDNAs. The alpha-subunit (alpha-1D) directs the recombinant expression of a dihydropyridine-sensitive L-type Ca2+ channel when coexpressed with the beta-(beta-2) and the alpha-2 (alpha-2b) subunits in Xenopus oocytes. The recombinant channel is also reversibly blocked by 10-15-mu-M omega-conotoxin. Expression of the alpha-1D Subunit alone, or coexpression with the alpha-2b subunit, did not elicit functional Ca2+ channel activity. Thus, the beta-2 subunit appears to serve an obligatory function, whereas the alpha-2b subunit appears to play an accessory role that potentiates expression of the channel. The primary transcripts encoding the alpha-1D, alpha-2, and beta-subunits are differentially processed. At least two forms of neuronal alpha-1D were identified. Different forms of alpha-2 and beta-transcripts were also identified in CNS, skeletal muscle, and aorta tissues.			WILLIAMS, ME (corresponding author), SALK INST BIOTECHNOL IND ASSOCIATES INC, 505 COAST BLVD S, LA JOLLA, CA 92037 USA.			Brenner, Robert/0000-0002-1036-8031				AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CARBONE E, 1990, PFLUG ARCH EUR J PHY, V416, P170, DOI 10.1007/BF00370239; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; DASCAL N, 1986, SCIENCE, V231, P1147, DOI 10.1126/science.2418503; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FELDMAN DH, 1987, FEBS LETT, V214, P295, DOI 10.1016/0014-5793(87)80073-X; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; GLASS DB, 1986, J BIOL CHEM, V261, P2987; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HOLZ GG, 1988, J NEUROSCI, V8, P463; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; JAY SD, 1991, J BIOL CHEM, V266, P3287; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; JONES SW, 1990, J NEUROSCI, V10, P2261; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NUMA S, 1986, ANN NY ACAD SCI, V479, P338, DOI 10.1111/j.1749-6632.1986.tb15580.x; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REGULLA S, 1991, EMBO J, V10, P45, DOI 10.1002/j.1460-2075.1991.tb07919.x; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; Sambrook J, 1989, MOL CLONING LABORATO; SANGUINETTI MC, 1984, CIRC RES, V55, P336, DOI 10.1161/01.RES.55.3.336; SCROGGS RS, 1991, J NEUROSCI, V11, P1334; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SUZUKI N, 1987, NEUROSCI LETT, V75, P235, DOI 10.1016/0304-3940(87)90303-X; SWANDULLA D, 1991, TRENDS NEUROSCI, V14, P46, DOI 10.1016/0166-2236(91)90018-P; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x; YEAGER RE, 1987, J NEUROSCI, V7, P2390	48	494	529	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1992	8	1					71	84		10.1016/0896-6273(92)90109-Q	http://dx.doi.org/10.1016/0896-6273(92)90109-Q			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1309651				2022-12-28	WOS:A1992HB18500006
J	SCHNEIDERSCHAULIES, J; KIRCHHOFF, F; ARCHELOS, J; SCHACHNER, M				SCHNEIDERSCHAULIES, J; KIRCHHOFF, F; ARCHELOS, J; SCHACHNER, M			DOWN-REGULATION OF MYELIN-ASSOCIATED GLYCOPROTEIN ON SCHWANN-CELLS BY INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA AFFECTS NEURITE OUTGROWTH	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; NEURONAL PROCESS OUTGROWTH; MOUSE SCIATIC-NERVE; IMMUNOELECTRON MICROSCOPIC LOCALIZATION; MULTIPLE-SCLEROSIS LESIONS; ADHESION MOLECULES L1; N-CAM; GROWTH-FACTOR; NEURAL ADHESION; BASIC-PROTEIN	To investigate the influence of inflammatory cytokines on the potential of peripheral nerves to regenerate, we analyzed the effect of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) on the ability of immortalized Schwann cells to mediate outgrowth of neurites from primary DRG neurons. We found that IFN-gamma and TNF-alpha synergistically inhibited the neurite outgrowth-promoting properties of the Schwann cells by specifically down-regulating myelin-associated glycoprotein (MAG) at the levels of mRNA and cell surface protein by approximately 60%. Antibodies to MAG inhibited the outgrowth of neurites on Schwann cells to the same extent as treatment with the two cytokines. Since MAG appears to be involved in both neurite outgrowth and myelination, our findings may provide evidence for a mechanism, by which inflammatory cytokines interfere with Schwann cell-neuron interactions.	UNIV HEIDELBERG,DEPT NEUROBIOL,W-6900 HEIDELBERG,GERMANY; SWISS FED INST TECHNOL,DEPT NEUROBIOL,CH-8093 ZURICH,SWITZERLAND	Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich			Kirchhoff, Frank/B-9335-2008	Kirchhoff, Frank/0000-0002-2324-2761				BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BROSNAN CF, 1988, J NEUROIMMUNOL, V18, P87, DOI 10.1016/0165-5728(88)90137-3; BROSTOFF SW, 1984, MYELIN, P405; BROWN MC, 1991, NEURON, V6, P359, DOI 10.1016/0896-6273(91)90245-U; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; DOHERTY P, 1989, J CELL BIOL, V109, P789, DOI 10.1083/jcb.109.2.789; DOHERTY P, 1991, NEURON, V6, P247, DOI 10.1016/0896-6273(91)90360-C; FAISSNER A, 1984, EMBO J, V3, P733, DOI 10.1002/j.1460-2075.1984.tb01876.x; FIELDS KL, 1985, NEUROSCIENCE, V15, P877, DOI 10.1016/0306-4522(85)90085-5; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GORIDIS C, 1985, EMBO J, V4, P631, DOI 10.1002/j.1460-2075.1985.tb03676.x; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; ITOYAMA Y, 1980, ANN NEUROL, V7, P167, DOI 10.1002/ana.410070212; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; JOHNSON D, 1986, J NEUROCHEM, V46, P1086, DOI 10.1111/j.1471-4159.1986.tb00622.x; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KINGSTON AE, 1989, EUR J IMMUNOL, V19, P177, DOI 10.1002/eji.1830190128; KLEITMAN N, 1988, J NEUROSCI, V8, P653; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; MARTINI R, 1990, J NEUROCYTOL, V19, P601, DOI 10.1007/BF01257247; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; MARTINI R, 1988, DEV BIOL, V129, P330, DOI 10.1016/0012-1606(88)90380-6; MARTINI R, 1988, J CELL BIOL, V106, P1735, DOI 10.1083/jcb.106.5.1735; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MOLLER JR, 1987, ANN NEUROL, V22, P469, DOI 10.1002/ana.410220405; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; NIEKE J, 1988, DEV BRAIN RES, V39, P281, DOI 10.1016/0165-3806(88)90032-6; OWENS GC, 1989, GLIA, V2, P119, DOI 10.1002/glia.440020208; PEDEN KWC, 1989, EXP CELL RES, V185, P60, DOI 10.1016/0014-4827(89)90037-2; POLTORAK M, 1987, J CELL BIOL, V105, P1893, DOI 10.1083/jcb.105.4.1893; QUARLES RH, 1989, CRIT REV NEUROBIOL, V5, P1; ROBERTSON KA, 1985, J IMMUNOL, V135, P4095; SADOUL R, 1990, J NEUROSCI RES, V25, P1, DOI 10.1002/jnr.490250102; SAMUEL NM, 1987, J NEUROCYTOL, V16, P281, DOI 10.1007/BF01795311; SCHNEIDERSCHAULIES J, 1990, J NEUROSCI RES, V27, P286, DOI 10.1002/jnr.490270307; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SEILHEIMER B, 1989, J CELL BIOL, V109, P3095, DOI 10.1083/jcb.109.6.3095; SEILHEIMER B, 1987, EMBO J, V6, P1611, DOI 10.1002/j.1460-2075.1987.tb02408.x; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; TRAUGOTT U, 1988, ANN NEUROL, V24, P243, DOI 10.1002/ana.410240211; WEKERLE H, 1986, EUR J IMMUNOL, V16, P1551, DOI 10.1002/eji.1830161214; YU LT, 1990, J NEUROIMMUNOL, V30, P121, DOI 10.1016/0165-5728(90)90095-5	46	55	56	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					995	1005		10.1016/0896-6273(91)90344-Y	http://dx.doi.org/10.1016/0896-6273(91)90344-Y			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1722413				2022-12-28	WOS:A1991GY43800012
J	BREDT, DS; GLATT, CE; HWANG, PM; FOTUHI, M; DAWSON, TM; SNYDER, SH				BREDT, DS; GLATT, CE; HWANG, PM; FOTUHI, M; DAWSON, TM; SNYDER, SH			NITRIC-OXIDE SYNTHASE PROTEIN AND MESSENGER-RNA ARE DISCRETELY LOCALIZED IN NEURONAL POPULATIONS OF THE MAMMALIAN CNS TOGETHER WITH NADPH DIAPHORASE	NEURON			English	Article							L-ARGININE; MACROPHAGE OXIDATION; HUNTINGTONS-DISEASE; NERVOUS-SYSTEM; RAT-BRAIN; CELLS; ACTIVATION; COFACTOR; NITRATE; ENZYME	Nitric oxide is a free radical that has been recently recognized as a neural messenger molecule. Nitric oxide synthase has now been purified and molecularly cloned from brain. Using specific antibodies and oligonucleotide probes, we have localized brain nitric oxide synthase to discrete neuronal populations in the rat and primate brain. Nitric oxide synthase is exclusively neuronal, and its localization is absolutely coincident with NADPH diaphorase staining in both rat and primate.	JOHNS HOPKINS UNIV,SCH MED,DEPT PHARMACOL & MOLEC SCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University	BREDT, DS (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.			Fotuhi, Majid/0000-0002-0980-1176	NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00266, DA-00074] Funding Source: Medline; NIGMS NIH HHS [GM-07309] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; DAWSON TM, 1991, IN PRESS P NATL ACAD; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; GARG UC, 1991, J BIOL CHEM, V266, P9; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1989, EUR J PHARM-MOLEC PH, V172, P413, DOI 10.1016/0922-4106(89)90023-0; HIBBS JB, 1987, J IMMUNOL, V138, P550; HIBBS JB, 1989, NITRIC OXIDE L ARGIN, P189; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; KOH JY, 1986, SCIENCE, V234, P73, DOI 10.1126/science.2875522; KWON NS, 1989, J BIOL CHEM, V264, P20496; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; MIZUKAWA K, 1989, J COMP NEUROL, V279, P281, DOI 10.1002/cne.902790210; MONCADA S, 1989, BIOCHEM PHARMACOL, V38, P1709, DOI 10.1016/0006-2952(89)90403-6; MURPHY TH, 1991, J NEUROCHEM, V56, P990, DOI 10.1111/j.1471-4159.1991.tb02019.x; NAKANE M, 1983, BRAIN RES, V273, P9, DOI 10.1016/0006-8993(83)91088-0; PALMER RMJ, 1989, BIOCHEM BIOPH RES CO, V158, P348, DOI 10.1016/S0006-291X(89)80219-0; ROSS CA, 1989, P NATL ACAD SCI USA, V86, P2923, DOI 10.1073/pnas.86.8.2923; SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125, DOI 10.1016/0165-6147(91)90526-X; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; THOMAS E., 1964, ACTA NEUROPATHOL, V3, P238; UEMURA Y, 1990, ANN NEUROL, V27, P620, DOI 10.1002/ana.410270606	30	1316	1335	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1991	7	4					615	624		10.1016/0896-6273(91)90374-9	http://dx.doi.org/10.1016/0896-6273(91)90374-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1718335				2022-12-28	WOS:A1991GM95400010
J	GREEN, WN; ROSS, AF; CLAUDIO, T				GREEN, WN; ROSS, AF; CLAUDIO, T			ACETYLCHOLINE-RECEPTOR ASSEMBLY IS STIMULATED BY PHOSPHORYLATION OF ITS GAMMA SUBUNIT	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; MONOCLONAL-ANTIBODIES; TORPEDO-CALIFORNICA; DELTA-SUBUNIT; MUSCLE-CELLS; DESENSITIZATION; CAMP; IDENTIFICATION; FIBROBLASTS	Different combinations of Torpedo acetylcholine receptor (AChR) subunits stably expressed in mouse fibroblasts were used to establish a role for phosphorylation in AChR biogenesis. When cell lines expressing fully functional AChR complexes (alpha-2-beta-gamma-delta) were labeled with P-32, only gamma and delta-subunits were phosphorylated. Forskolin, which causes a 2- to 3-fold increase in AChR expression by stimulating subunit assembly, increased unassembled gamma-phosphorylation, but had little effect on unassembled-delta. The forskolin effect on subunit phosphorylation was rapid, significantly preceding its effect on expression. The pivotal role of the gamma-subunit was established by treating alpha-beta-gamma and alpha-beta-delta-cell lines with forskolin and observing increased expression of only alpha-beta-gamma-complexes. This effect was also observed in alpha-gamma, but not alpha-delta-cells. We conclude that the cAMP-induced increase in expression of cell surface AChRs is due to phosphorylation of unassembled gamma-subunits, which leads to increased efficiency of assembly of all four subunits.			GREEN, WN (corresponding author), YALE UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,NEW HAVEN,CT 06510, USA.				NHLBI NIH HHS [HL38156] Funding Source: Medline; NINDS NIH HHS [NS21714] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL038156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021714] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BREHM P, 1988, DEV BIOL, V129, P1, DOI 10.1016/0012-1606(88)90156-X; CLAUDIO T, 1989, J CELL BIOL, V108, P2277, DOI 10.1083/jcb.108.6.2277; CLAUDIO T, 1977, ARCH BIOCHEM BIOPHYS, V181, P484, DOI 10.1016/0003-9861(77)90254-5; CLAUDIO T, 1987, SCIENCE, V238, P1688, DOI 10.1126/science.3686008; CLAUDIO T, 1989, FRONTIERS MOL BIOL M, P63; GREEN WN, 1991, P NATL ACAD SCI USA, V88, P854, DOI 10.1073/pnas.88.3.854; GULLICK WJ, 1983, BIOCHEMISTRY-US, V22, P3312, DOI 10.1021/bi00283a003; HARTMAN DS, 1990, J PHYSIOLOGY PARIS, V84, P42; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HUGANIR RL, 1986, NATURE, V321, P774, DOI 10.1038/321774a0; HUGANIR RL, 1983, P NATL ACAD SCI-BIOL, V80, P1130, DOI 10.1073/pnas.80.4.1130; HUGANIR RL, 1984, P NATL ACAD SCI-BIOL, V81, P6968, DOI 10.1073/pnas.81.22.6968; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; NIGAM SK, 1989, J BIOL CHEM, V264, P16927; PAULSON HL, 1990, J CELL BIOL, V110, P1705, DOI 10.1083/jcb.110.5.1705; PAULSON HL, 1991, J CELL BIOL, V113, P623; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; ROSS AF, 1991, J CELL BIOL, V113, P623, DOI 10.1083/jcb.113.3.623; ROSS AF, 1987, J BIOL CHEM, V262, P14640; SAFRAN A, 1990, BIOCHEMISTRY-US, V29, P6730, DOI 10.1021/bi00480a024; SAFRAN A, 1987, J BIOL CHEM, V262, P10506; SAITOH T, 1981, P NATL ACAD SCI-BIOL, V78, P4430, DOI 10.1073/pnas.78.7.4430; SALPETER MM, 1987, NEUROLOGY NEUROBIOLO, V23, P55; SCHEUTZE SM, 1987, ANNU REV NEUROSCI, V10, P403; SCHROEDER W, 1990, FEBS LETT, V273, P31, DOI 10.1016/0014-5793(90)81044-O; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; WAGONER PK, 1988, SCIENCE, V240, P1655, DOI 10.1126/science.2454507; WAN KK, 1985, BIOCHEMISTRY-US, V24, P1212, DOI 10.1021/bi00326a024; WITZEMANN V, 1989, FEBS LETT, V242, P419, DOI 10.1016/0014-5793(89)80514-9; YEE GH, 1987, J BIOL CHEM, V262, P16748	30	41	41	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1991	7	4					659	666		10.1016/0896-6273(91)90378-D	http://dx.doi.org/10.1016/0896-6273(91)90378-D			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1931053				2022-12-28	WOS:A1991GM95400014
J	JARAMILLO, F; HUDSPETH, AJ				JARAMILLO, F; HUDSPETH, AJ			LOCALIZATION OF THE HAIR-CELLS TRANSDUCTION CHANNELS AT THE HAIR BUNDLES TOP BY IONTOPHORETIC APPLICATION OF A CHANNEL BLOCKER	NEURON			English	Article							MECHANOELECTRICAL TRANSDUCTION; BULLFROGS SACCULUS; MECHANICAL STIMULATION; WHOLE-CELL; ADAPTATION; CURRENTS; ACETYLCHOLINE; STEREOCILIA; ANTIBIOTICS; SENSITIVITY	In order to understand how the hair cell's mechanoelectrical transduction channels are gated during mechanical stimulation, it is essential to determine their location with respect to the hair bundle's constituent stereocilia. We localized the transduction channels by focally blocking receptor currents with iontophoretically ejected gentamicin, an aminoglycoside antibiotic that acts as a reversible channel blocker. The drug was most effective when directed at the top of a hair bundle, whereas application at the bundle's bottom or at the cuticular plate had little or no effect. Computer simulations of blocking agreed with experimental data only when the transduction channels were hypothesized to occur near the bundle's top. These results confirm that the hair cell's transduction channels are located near the stereociliary tips.			JARAMILLO, F (corresponding author), UNIV TEXAS, SW MED CTR, DEPT CELL BIOL & NEUROSCI, DALLAS, TX 75235 USA.				NIDCD NIH HHS [DC00317] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; BRG HC, 1983, RANDOM WALKS BIOL, P22; CACECI MS, 1984, BYTE, V9, P340; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P557; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; COREY DP, 1983, J NEUROSCI, V3, P942; COREY DP, 1980, J NEUROSCI METH, V3, P183, DOI 10.1016/0165-0270(80)90025-4; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; DANIELS PJL, 1978, ENCY CHEM TECHNOLOGY, V2, P819; DENK W, 1989, THESIS CORNELL U ITH; DIONNE VE, 1976, BIOPHYS J, V16, P705, DOI 10.1016/S0006-3495(76)85723-2; EATOCK RA, 1987, J NEUROSCI, V7, P2821; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; HACOHEN N, 1989, J NEUROSCI, V9, P3988; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILLSMITH I, 1978, J PHYSIOL-LONDON, V279, P31, DOI 10.1113/jphysiol.1978.sp012329; HOLTON T, 1986, J PHYSIOL-LONDON, V375, P195, DOI 10.1113/jphysiol.1986.sp016113; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1979, P NATL ACAD SCI USA, V76, P1506, DOI 10.1073/pnas.76.3.1506; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; HUDSPETH AJ, 1978, AM J PHYSIOL, V234, pC56, DOI 10.1152/ajpcell.1978.234.1.C56; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; JARAMILLO F, 1990, LECT NOTES BIOMATH, V87, P26; JORGENSEN F, 1988, J PHYSIOL-LONDON, V403, P577, DOI 10.1113/jphysiol.1988.sp017265; KORN SJ, 1989, J GEN PHYSIOL, V94, P789, DOI 10.1085/jgp.94.5.789; KROESE ABA, 1982, HEARING RES, V6, P183, DOI 10.1016/0378-5955(82)90053-3; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; KUFFLER SW, 1975, J PHYSIOL-LONDON, V251, P465, DOI 10.1113/jphysiol.1975.sp011103; KUFFLER SW, 1975, J PHYSIOL-LONDON, V244, P703, DOI 10.1113/jphysiol.1975.sp010821; LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065; OGDEN DC, 1985, PROC R SOC SER B-BIO, V225, P329, DOI 10.1098/rspb.1985.0065; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; OHMORI H, 1988, J PHYSIOL-LONDON, V399, P115; PEPER K, 1972, PROC R SOC SER B-BIO, V181, P431, DOI 10.1098/rspb.1972.0060; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; PURVES RD, 1977, J THEOR BIOL, V66, P789, DOI 10.1016/0022-5193(77)90246-6; PURVES RD, 1977, J THEOR BIOL, V65, P327, DOI 10.1016/0022-5193(77)90328-9; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cb.04.110188.000431; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; SANTI PA, 1987, HEARING RES, V27, P47, DOI 10.1016/0378-5955(87)90025-6; SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973; SHOTWELL SL, 1981, ANN NY ACAD SCI, V374, P1, DOI 10.1111/j.1749-6632.1981.tb30854.x; WILLIAMS DA, 1985, NATURE, V318, P558, DOI 10.1038/318558a0	49	126	130	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1991	7	3					409	420		10.1016/0896-6273(91)90293-9	http://dx.doi.org/10.1016/0896-6273(91)90293-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1716929	Bronze			2022-12-28	WOS:A1991GG88700006
J	BURGER, PM; HELL, J; MEHL, E; KRASEL, C; LOTTSPEICH, F; JAHN, R				BURGER, PM; HELL, J; MEHL, E; KRASEL, C; LOTTSPEICH, F; JAHN, R			GABA AND GLYCINE IN SYNAPTIC VESICLES - STORAGE AND TRANSPORT CHARACTERISTICS	NEURON			English	Article							GAMMA-AMINOBUTYRIC ACID; FREE AMINO-ACIDS; CEREBRAL CORTICAL SYNAPTOSOMES; RAT-BRAIN; GLUTAMATE UPTAKE; FUNCTIONAL RECONSTITUTION; ENERGY-DEPENDENCE; SPINAL-CORD; PROTEIN-I; RELEASE	Gamma-Aminobutyric acid (GABA) and glycine are major inhibitory neurotransmitters that are released from nerve terminals by exocytosis via synaptic vesicles. Here we report that synaptic vesicles immunoisolated from rat cerebral cortex contain high amounts of GABA in addition to glutamate. Synaptic vesicles from the rat medulla oblongata also contain glycine and exhibit a higher GABA and a lower glutamate concentration than cortical vesicles. No other amino acids were detected. In addition, the uptake activities of synaptic vesicles for GABA and glycine were compared. Both were very similar with respect to substrate affinity and specificity, bioenergetic properties, and regional distribution. We conclude that GABA, glycine, and glutamate are the only major amino acid neurotransmitters stored in synaptic vesicles and that GABA and glycine are transported by similar, if not identical, transporters.	MAX PLANCK INST BIOCHEM, W-8033 MARTINSRIED, GERMANY	Max Planck Society	BURGER, PM (corresponding author), MAX PLANCK INST PSYCHIAT, DEPT NEUROCHEM, W-8033 MARTINSRIED, GERMANY.		Hell, Johannes W./P-5085-2019; Jansen, Heiko T./A-5770-2008; Krasel, Cornelius/AAH-7074-2019	Jansen, Heiko T./0000-0003-0178-396X; Krasel, Cornelius/0000-0001-8309-8696; Jahn, Reinhard/0000-0003-1542-3498				ANGEL I, 1983, NEUROCHEM INT, V5, P697, DOI 10.1016/0197-0186(83)90095-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; CHRISTENSEN H, 1990, J NEUROCHEM, V54, P1142, DOI 10.1111/j.1471-4159.1990.tb01941.x; DEBELLEROCHE JS, 1973, J NEUROCHEM, V21, P441, DOI 10.1111/j.1471-4159.1973.tb04264.x; DISBROW JK, 1982, BIOCHEM BIOPH RES CO, V108, P1221, DOI 10.1016/0006-291X(82)92130-1; FYKSE EM, 1989, NEUROSCI LETT, V99, P300, DOI 10.1016/0304-3940(89)90463-1; FYKSE EM, 1988, J NEUROCHEM, V50, P1237, DOI 10.1111/j.1471-4159.1988.tb10599.x; GODEL H, 1984, J CHROMATOGR, V297, P49, DOI 10.1016/S0021-9673(01)89028-2; HELL JW, 1990, J BIOL CHEM, V265, P2111; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; HONEGGER CG, 1989, J NEUROCHEM, V53, P423, DOI 10.1111/j.1471-4159.1989.tb07351.x; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JAHN R, 1984, P NATL ACAD SCI-BIOL, V81, P1684, DOI 10.1073/pnas.81.6.1684; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KISH PE, 1989, P NATL ACAD SCI USA, V86, P3877, DOI 10.1073/pnas.86.10.3877; KISH PE, 1989, METHOD ENZYMOL, V174, P9; KONTRO P, 1980, BRAIN RES, V184, P129, DOI 10.1016/0006-8993(80)90592-2; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; MCMAHON HT, 1990, J NEUROCHEM, V54, P373, DOI 10.1111/j.1471-4159.1990.tb01883.x; NAITO S, 1983, J BIOL CHEM, V258, P696; NAITO S, 1985, J NEUROCHEM, V44, P99, DOI 10.1111/j.1471-4159.1985.tb07118.x; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; NICHOLLS DG, 1989, J NEUROCHEM, V52, P331, DOI 10.1111/j.1471-4159.1989.tb09126.x; OORREGO F, 1986, GABA ENDOCRINE FUNCT, P39; Ottersen OP, 1984, HDB CHEM NEUROANATOM, V3, P141; PHILIPPU A, 1988, HDB EXP PHARM, V90, P1; RIVEROS N, 1986, BRAIN RES, V386, P405, DOI 10.1016/0006-8993(86)90181-2; SANCHEZPRIETO J, 1987, J NEUROCHEM, V49, P58, DOI 10.1111/j.1471-4159.1987.tb03394.x; SIHRA TS, 1987, J NEUROCHEM, V49, P261, DOI 10.1111/j.1471-4159.1987.tb03424.x; STORMMATHISEN J, 1983, NATURE, V301, P517, DOI 10.1038/301517a0; STORMMATHISEN J, 1990, J HISTOCHEM CYTOCHEM, V38, P1733, DOI 10.1177/38.12.1979340; VALCANA T, 1984, NEUROCHEM RES, V9, P1533, DOI 10.1007/BF00964679; VILLANUEVA S, 1988, BRAIN RES, V440, P363, DOI 10.1016/0006-8993(88)91008-6; WHITTAKER VP, 1982, FED PROC, V41, P2759; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9	38	162	165	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1991	7	2					287	293		10.1016/0896-6273(91)90267-4	http://dx.doi.org/10.1016/0896-6273(91)90267-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1678614				2022-12-28	WOS:A1991GB93300012
J	HUI, A; ELLINOR, PT; KRIZANOVA, O; WANG, JJ; DIEBOLD, RJ; SCHWARTZ, A				HUI, A; ELLINOR, PT; KRIZANOVA, O; WANG, JJ; DIEBOLD, RJ; SCHWARTZ, A			MOLECULAR-CLONING OF MULTIPLE SUBTYPES OF A NOVEL RAT-BRAIN ISOFORM OF THE ALPHA-1 SUBUNIT OF THE VOLTAGE-DEPENDENT CALCIUM-CHANNEL	NEURON			English	Article							SENSITIVE ION CHANNELS; SKELETAL-MUSCLE; DIHYDROPYRIDINE RECEPTOR; FUNCTIONAL EXPRESSION; BINDING POLYPEPTIDE; MESSENGER-RNAS; BETA-SUBUNIT; PHOSPHORYLATION; SITE; ALPHA-1-SUBUNIT	Several cDNAs encoding an isoform of the alpha-1 subunit of the voltage-dependent calcium channel were isolated from rat brain cDNA libraries. The complete nucleotide sequence of 6975 bp encodes a protein of 1634 amino acids, which corresponds to an M(r) of 186,968. The protein exhibits 71% and 76% homology to skeletal and cardiac alpha-1 subunits, respectively. When compared with skeletal and cardiac alpha-1 isoforms, the rat brain protein is intermediate in size at the amino terminus and shorter at the carboxyl terminus. Multiple subtypes of this alpha-1 isoform cDNA were characterized. These are indicative of alternative splicing of a primary transcript and encode three variants between motif I and motif II and two within the S3 region of motif IV. Thus, multiple isoforms of this rat brain alpha-1 subunit are possible.			HUI, A (corresponding author), UNIV CINCINNATI,COLL MED,DEPT PHARMACOL & CELL BIOPHYS,CINCINNATI,OH 45267, USA.			Ellinor, Patrick/0000-0002-2067-0533	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022619, R37HL043231, P01HL041496] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37-HL43231-01, P01-HL22619-12, HL41496] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREADIS A, 1987, ANNU REV CELL BIOL, V3, P207, DOI 10.1146/annurev.cellbio.3.1.207; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FEDULOVA SA, 1985, J PHYSIOL-LONDON, V359, P431, DOI 10.1113/jphysiol.1985.sp015594; GLOSSMANN H, 1988, ISI ATLAS-PHARMACOL, V2, P202; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HOFMANN F, 1987, TRENDS PHARMACOL SCI, V8, P393, DOI 10.1016/0165-6147(87)90103-9; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; JAY SD, 1991, J BIOL CHEM, V266, P3287; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; JOHN H, 1988, EUR J BIOCHEM, V178, P535; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; KOCH WJ, 1989, FEBS LETT, V250, P386, DOI 10.1016/0014-5793(89)80761-6; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LAI Y, 1990, J BIOL CHEM, V265, P20839; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; MANITIS T, 1982, MOL CLONING LABORATO; MCKENNA E, 1990, BIOCHEM PHARMACOL, V39, P1145, DOI 10.1016/0006-2952(90)90255-J; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MONTAL M, 1990, FASEB J, V4, P2623, DOI 10.1096/fasebj.4.9.1693348; NAITO K, 1989, J BIOL CHEM, V264, P21211; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; REGULLA S, 1991, EMBO J, V10, P45, DOI 10.1002/j.1460-2075.1991.tb07919.x; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SLISH DF, 1989, FEBS LETT, V250, P509, DOI 10.1016/0014-5793(89)80786-0; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; STRIESSNIG J, 1990, J BIOL CHEM, V265, P363; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; VAGHY PL, 1988, TRENDS PHARMACOL SCI, V9, P398, DOI 10.1016/0165-6147(88)90066-1; VAGHY PL, 1987, J BIOL CHEM, V262, P14337; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q	47	186	196	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1991	7	1					35	44		10.1016/0896-6273(91)90072-8	http://dx.doi.org/10.1016/0896-6273(91)90072-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1648940				2022-12-28	WOS:A1991FY48100004
J	LO, DC; PINKHAM, JL; STEVENS, CF				LO, DC; PINKHAM, JL; STEVENS, CF			INFLUENCE OF THE GAMMA-SUBUNIT AND EXPRESSION SYSTEM ON ACETYLCHOLINE-RECEPTOR GATING	NEURON			English	Article							SINGLE-CHANNEL CURRENTS; MAMMALIAN BC3H-1 CELLS; END-PLATE CURRENTS; DIRECTED MUTAGENESIS; BURST-KINETICS; ALPHA-SUBUNIT; ION CHANNELS; RAT MUSCLE; ACTIVATION; AGONIST	We have developed a partial kinetic theory for the gating of murine nicotinic acetylcholine receptors (AChRs) expressed in Xenopus oocytes and have used this theory to characterize the role of gamma subunit in single-channel behavior. Permeation and gating were found to be largely unaffected in AChRs produced in oocytes when the gamma subunit transcript was omitted from microinjections of AChR subunit RNAs. In contrast, marked changes in gating kinetics resulted when even very conservative single amino acid substitutions were introduced into the gamma subunit, indicating that the gamma subunit can have a large effect on AChR gating. We also found that channel openings were much prolonged when murine AChRs were expressed in oocytes compared with native AChRs expressed in BC3H-1 cells.	YALE UNIV,SCH MED,MOLEC NEUROBIOL SECT,NEW HAVEN,CT 06510; SALK INST,SAN DIEGO,CA 92186	Yale University; Salk Institute					NINDS NIH HHS [NS12961] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON CR, 1973, J PHYSIOL-LONDON, V235, P655, DOI 10.1113/jphysiol.1973.sp010410; AUERBACH A, 1984, BIOPHYS J, V45, P187, DOI 10.1016/S0006-3495(84)84147-8; BOULTER J, 1985, J NEUROSCI, V5, P2545; BOULTER J, 1986, J NEUROSCI RES, V16, P37, DOI 10.1002/jnr.490160106; BREHM P, 1989, TRENDS NEUROSCI, V12, P174, DOI 10.1016/0166-2236(89)90064-7; BULLER AL, 1990, MOL PHARMACOL, V37, P423; COLQUHOUN D, 1988, J PHYSIOL-LONDON, V395, P131, DOI 10.1113/jphysiol.1988.sp016912; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; GU Y, 1988, J BIOL CHEM, V263, P12878; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JAHR CE, 1990, J NEUROSCI, V10, P1830; KUROSAKI T, 1987, FEBS LETT, V214, P253, DOI 10.1016/0014-5793(87)80065-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LO DC, 1990, IN PRESS NEURON; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MAGLEBY KL, 1983, J PHYSIOL-LONDON, V344, P605, DOI 10.1113/jphysiol.1983.sp014958; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; PATRICK J, 1972, P NATL ACAD SCI USA, V69, P2762, DOI 10.1073/pnas.69.10.2762; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; SAKMANN B, 1985, NATURE, V318, P538, DOI 10.1038/318538a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUBERT D, 1974, J CELL BIOL, V61, P398, DOI 10.1083/jcb.61.2.398; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SINE SM, 1987, J PHYSIOL-LONDON, V385, P325, DOI 10.1113/jphysiol.1987.sp016496; SINE SM, 1986, J PHYSIOL-LONDON, V373, P129, DOI 10.1113/jphysiol.1986.sp016039; SINE SM, 1984, BIOPHYS J, V45, P175, DOI 10.1016/S0006-3495(84)84146-6; SINE SM, 1986, J PHYSIOL-LONDON, V370, P357, DOI 10.1113/jphysiol.1986.sp015939; STEINBACH JH, 1987, PROTEINS EXCITABLE M, P19; STEINBACH JH, 1989, J GEN PHYSIOL, V93, P765; WHITE MM, 1985, P NATL ACAD SCI USA, V82, P4853; WITZEMANN V, 1987, FEBS LETT, V223, P104, DOI 10.1016/0014-5793(87)80518-5; YELLEN G, 1982, NATURE, V296, P357, DOI 10.1038/296357a0; YOSHII K, 1987, J GEN PHYSIOL, V90, P443	41	22	22	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1990	5	6					857	866		10.1016/0896-6273(90)90345-G	http://dx.doi.org/10.1016/0896-6273(90)90345-G			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ381	1702647				2022-12-28	WOS:A1990EQ38100013
J	FROEHNER, SC; LUETJE, CW; SCOTLAND, PB; PATRICK, J				FROEHNER, SC; LUETJE, CW; SCOTLAND, PB; PATRICK, J			THE POSTSYNAPTIC 43K PROTEIN CLUSTERS MUSCLE NICOTINIC ACETYLCHOLINE-RECEPTORS IN XENOPUS OOCYTES	NEURON			English	Article									DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,PROGRAM MOLEC & CELLULAR NEUROSCI,HANOVER,NH 03756; BAYLOR UNIV,DIV NEUROSCI,HOUSTON,TX 77030	Dartmouth College; Baylor University	FROEHNER, SC (corresponding author), DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT BIOCHEM,HANOVER,NH 03756, USA.							BALDWIN TJ, 1988, DEVELOPMENT, V104, P557; BARRANTES FJ, 1980, FEBS LETT, V112, P73, DOI 10.1016/0014-5793(80)80131-1; BEVAN S, 1977, J PHYSIOL-LONDON, V267, P195, DOI 10.1113/jphysiol.1977.sp011808; BLOCH RJ, 1989, J CELL BIOL, V108, P481, DOI 10.1083/jcb.108.2.481; BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; BLOCH RJ, 1986, J CELL BIOL, V104, P645; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BOULTER J, 1986, MOL ASPECTS NEUROBIO; BRIDGMAN PC, 1987, J CELL BIOL, V105, P1829, DOI 10.1083/jcb.105.4.1829; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; CARR C, 1989, J CELL BIOL, V109, P1753, DOI 10.1083/jcb.109.4.1753; CARR C, 1987, BIOCHEMISTRY-US, V26, P7090, DOI 10.1021/bi00396a034; CARTAUD J, 1981, J CELL BIOL, V90, P418, DOI 10.1083/jcb.90.2.418; CLAUDIO T, 1989, NATO ASI SERIES H, V32, P469; FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376; FLUCHER BE, 1989, NEURON, V3, P163, DOI 10.1016/0896-6273(89)90029-9; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FRAIL DE, 1987, P NATL ACAD SCI USA, V84, P6302, DOI 10.1073/pnas.84.17.6302; FROEHNER SC, 1986, TRENDS NEUROSCI, V9, P37, DOI 10.1016/0166-2236(86)90013-5; FROEHNER SC, 1981, P NATL ACAD SCI-BIOL, V78, P5230, DOI 10.1073/pnas.78.8.5230; FROEHNER SC, 1987, J CELL BIOL, V104, P1633, DOI 10.1083/jcb.104.6.1633; FROEHNER SC, 1989, FEBS LETT, V249, P229, DOI 10.1016/0014-5793(89)80629-5; FROEHNER SC, 1984, J CELL BIOL, V99, P88, DOI 10.1083/jcb.99.1.88; HARTMAN DS, 1990, NATURE, V343, P372, DOI 10.1038/343372a0; KORDELI E, 1989, J CELL BIOL, V108, P127, DOI 10.1083/jcb.108.1.127; LAROCHELLE WJ, 1987, J BIOL CHEM, V262, P8190; LAROCHELLE WJ, 1989, DEV BIOL, V132, P130, DOI 10.1016/0012-1606(89)90211-X; LAROCHELLE WJ, 1986, J BIOL CHEM, V261, P5270; LAROCHELLE WJ, 1990, IN PRESS J NEUROSCI; LO MMS, 1980, FEBS LETT, V111, P407, DOI 10.1016/0014-5793(80)80838-6; LUETJE CW, 1990, IN PRESS J NEUROCHEM; MITRA AK, 1989, J CELL BIOL, V109, P755, DOI 10.1083/jcb.109.2.755; MUSIL LS, 1989, J CELL BIOL, V108, P1833, DOI 10.1083/jcb.108.5.1833; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; PORTER S, 1983, J BIOL CHEM, V258, P34; ROLE LW, 1985, J NEUROSCI, V5, P2197; ROUSSELET A, 1982, EMBO J, V1, P439, DOI 10.1002/j.1460-2075.1982.tb01188.x; SEALOCK R, 1984, J CELL BIOL, V98, P2239, DOI 10.1083/jcb.98.6.2239; SOBEL A, 1977, EUR J BIOCHEM, V80, P215, DOI 10.1111/j.1432-1033.1977.tb11874.x; STEINBACH JH, 1981, DEV BIOL, V84, P267, DOI 10.1016/0012-1606(81)90394-8; TOYOSHIMA C, 1988, NATURE, V336, P247, DOI 10.1038/336247a0; WALKER JH, 1984, EMBO J, V3, P2287, DOI 10.1002/j.1460-2075.1984.tb02127.x; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; WOODRUFF ML, 1987, J CELL BIOL, V104, P939, DOI 10.1083/jcb.104.4.939	44	227	228	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1990	5	4					403	410		10.1016/0896-6273(90)90079-U	http://dx.doi.org/10.1016/0896-6273(90)90079-U			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED517	1698395				2022-12-28	WOS:A1990ED51700003
J	LEONARD, JP; KELSO, SR				LEONARD, JP; KELSO, SR			APPARENT DESENSITIZATION OF NMDA RESPONSES IN XENOPUS OOCYTES INVOLVES CALCIUM-DEPENDENT CHLORIDE CURRENT	NEURON			English	Article											LEONARD, JP (corresponding author), UNIV ILLINOIS,DEPT BIOL SCI,CHICAGO,IL 60607, USA.		Leonard, John/M-4379-2014	Leonard, John/0000-0002-5083-1115	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS026432, R01NS024591] Funding Source: NIH RePORTER; NINDS NIH HHS [NS26432, NS24591] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BOTON R, 1989, J PHYSIOL-LONDON, V408, P511, DOI 10.1113/jphysiol.1989.sp017473; BURGOYNE RD, 1988, NEUROSCI LETT, V91, P47, DOI 10.1016/0304-3940(88)90247-9; DIERKS P, 1981, P NATL ACAD SCI-BIOL, V78, P1411, DOI 10.1073/pnas.78.3.1411; FONG TM, 1988, SYNAPSE, V2, P657, DOI 10.1002/syn.890020613; HORI N, 1985, BRAIN RES, V358, P380, DOI 10.1016/0006-8993(85)90989-8; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; ITO I, 1988, J CELL PHYSIOL, V134, P155, DOI 10.1002/jcp.1041340120; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; KUSHNER L, 1988, P NATL ACAD SCI USA, V85, P3250, DOI 10.1073/pnas.85.9.3250; LERMA J, 1989, P NATL ACAD SCI USA, V86, P1708, DOI 10.1073/pnas.86.5.1708; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MACDONALD JF, 1987, J NEUROPHYSIOL, V58, P251, DOI 10.1152/jn.1987.58.2.251; Maniatis T., 1982, MOL CLONING; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1988, J NEUROPHYSIOL, V60, P645, DOI 10.1152/jn.1988.60.2.645; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MILEDI R, 1982, PROC R SOC SER B-BIO, V215, P491, DOI 10.1098/rspb.1982.0056; MILEDI R, 1984, J PHYSIOL-LONDON, V357, P173, DOI 10.1113/jphysiol.1984.sp015495; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OOSAWA Y, 1989, J PHYSIOL-LONDON, V408, P223, DOI 10.1113/jphysiol.1989.sp017456; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; ROBINSON KR, 1979, P NATL ACAD SCI USA, V76, P837, DOI 10.1073/pnas.76.2.837; SNUTCH TP, 1986, SOC GEN PHYSL SER, V42, P154; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; VERDOORN TA, 1988, MOL PHARMACOL, V34, P298; VERDOORN TA, 1987, SCIENCE, V238, P1114, DOI 10.1126/science.2825347; VERDOORN TA, 1989, MOL PHARMACOL, V35, P360; WATKINS JC, 1987, TRENDS NEUROSCI, V10, P265, DOI 10.1016/0166-2236(87)90171-8; WATSON GB, 1989, EUR J PHARMACOL, V167, P291, DOI 10.1016/0014-2999(89)90590-6; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0	35	124	127	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1990	4	1					53	60		10.1016/0896-6273(90)90443-J	http://dx.doi.org/10.1016/0896-6273(90)90443-J			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM297	1690016				2022-12-28	WOS:A1990CM29700006
J	BERNARD, O; DRAGO, J; SHENG, H				BERNARD, O; DRAGO, J; SHENG, H			L-MYC AND N-MYC INFLUENCE LINEAGE DETERMINATION IN THE CENTRAL-NERVOUS-SYSTEM	NEURON			English	Article							DNA-BINDING; TRANSCRIPTIONAL REGULATION; LEUCINE ZIPPER; C-MYC; GENE; EXPRESSION; MURINE; DIMERIZATION; ONCOGENES; IMMORTALIZATION	The N-myc and the L-myc proto-oncogenes are expressed during embryonal development mainly in the developing brain. Studies of their expression in single neuroepithelial cells revealed that neural precursors not yet committed to the glial or the neuronal lineage expressed both genes, but after lineage commitment they expressed either N-myc or L-myc. Moreover, enforced expression of L-mycin the neural precursor cell line 2.3D caused neuronal differentiation, while the expression of N-myc promoted glial differentiation. These results indicate that L-myc and N-myc play critical roles in lineage determination for the central nervous system.			BERNARD, O (corresponding author), ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA.		Bernard, Olivier/J-1133-2014	Bernard, Olivier/0000-0003-2539-9014				ALT FW, 1986, COLD SPRING HARB SYM, V51, P931, DOI 10.1101/SQB.1986.051.01.106; BARTLETT PF, 1988, P NATL ACAD SCI USA, V85, P3255, DOI 10.1073/pnas.85.9.3255; BECKMANN H, 1991, GENE DEV, V5, P1057, DOI 10.1101/gad.5.6.1057; BERNARD O, 1989, J NEUROSCI RES, V24, P9, DOI 10.1002/jnr.490240104; BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; BLOCHLINGER K, 1984, MOL CELL BIOL, V4, P2929, DOI 10.1128/MCB.4.12.2929; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DEPINHO RA, 1986, P NATL ACAD SCI USA, V83, P1827, DOI 10.1073/pnas.83.6.1827; GONDA TJ, 1982, MOL CELL BIOL, V2, P617, DOI 10.1128/MCB.2.6.617; Hariharan I K, 1988, Oncogene Res, V3, P387; JONES N, 1990, CELL, V61, P9, DOI 10.1016/0092-8674(90)90207-U; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEGOUY E, 1987, EMBO J, V6, P3359, DOI 10.1002/j.1460-2075.1987.tb02657.x; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Maniatis T., 1982, MOL CLONING; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; PRENDERGAST GC, 1989, NATURE, V341, P392, DOI 10.1038/341392a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	27	28	28	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1217	1224		10.1016/0896-6273(92)90079-S	http://dx.doi.org/10.1016/0896-6273(92)90079-S			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1281420				2022-12-28	WOS:A1992KD71600019
J	MELLERICK, DM; KASSIS, JA; ZHANG, SD; ODENWALD, WF				MELLERICK, DM; KASSIS, JA; ZHANG, SD; ODENWALD, WF			CASTOR ENCODES A NOVEL ZINC FINGER PROTEIN REQUIRED FOR THE DEVELOPMENT OF A SUBSET OF CNS NEURONS IN DROSOPHILA	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; MEDIATED ENHANCER DETECTION; GROWTH CONE GUIDANCE; GENE FUSHI-TARAZU; EARLY NEUROGENESIS; NUCLEAR-PROTEIN; MESSENGER-RNA; NOTCH LOCUS; CELL FATES; MELANOGASTER	Using an enhancer detection screen, we have identified castor, a new gene required for embryonic CNS development in Drosophila. Embryos that lack castor expression have a diminished CNS axonal network and express engrailed aberrantly late in CNS development. castor is unique among the previously described genes involved in Drosophila neurogenesis in that its expression is restricted to a subset of delaminated CNS neuroblasts and to ventral midline glial precursor cells. The putative castor gene product contains a novel zinc-binding domain and multiple transcriptional activation domains, suggesting that it acts as a transcription factor necessary for the development of a subset of CNS neuronal precursors.	US FDA, CTR BIOL EVALUAT & RES, BETHESDA, MD 20205 USA	US Food & Drug Administration (FDA)	MELLERICK, DM (corresponding author), NINCDS, NEUROCHEM LAB, NEUROGENET UNIT, BETHESDA, MD 20892 USA.			Kassis, Judith/0000-0001-9268-3213				ALBERGA A, 1991, DEVELOPMENT, V111, P983; ARTAVANISTSAKONAS S, 1988, TRENDS GENET, V4, P95, DOI 10.1016/0168-9525(88)90096-0; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BOULAY JL, 1987, NATURE, V330, P395, DOI 10.1038/330395a0; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAMPOSORTEGA JA, 1991, INT REV CYTOL, V124, P1; CAMPOSORTEGA JA, 1991, ANNU REV NEUROSCI, V14, P399, DOI 10.1146/annurev.ne.14.030191.002151; CAMPOSORTEGA JA, 1988, TRENDS NEUROSCI, V11, P400, DOI 10.1016/0166-2236(88)90077-X; CAVENER DR, 1987, NUCLEIC ACIDS RES, V25, P1361; CHRISTIAN A, 1991, EMSA B, V16, P70; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DOE CQ, 1985, DEV BIOL, V111, P206, DOI 10.1016/0012-1606(85)90446-4; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FASANO L, 1991, CELL, V64, P63, DOI 10.1016/0092-8674(91)90209-H; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GILL G, 1987, CELL, V51, P121, DOI 10.1016/0092-8674(87)90016-X; GONZALEZ F, 1989, EMBO J, V8, P3553, DOI 10.1002/j.1460-2075.1989.tb08527.x; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P473, DOI 10.1007/BF00399871; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; HARTENSTEIN V, 1985, Wilhelm Roux's Archives of Developmental Biology, V194, P213, DOI 10.1007/BF00848248; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; JACOBS G, 1990, New Biologist, V2, P583; JACOBS JR, 1989, NEURON, V2, P1625; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JAN YN, 1990, TRENDS NEUROSCI, V13, P493, DOI 10.1016/0166-2236(90)90083-M; KANIA MA, 1990, GENE DEV, V4, P1701, DOI 10.1101/gad.4.10.1701; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KASSIS JA, 1991, GENETICS, V128, P751; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; LINDSLEY DL, 1987, DROS INF SERV, V65, P25; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; NAMBU JR, 1990, CELL, V63, P63, DOI 10.1016/0092-8674(90)90288-P; OCHMAN H, 1988, GENETICS, V120, P621; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; ROBERTSON HM, 1988, GENETICS, V118, P461; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEARLES LL, 1982, CELL, V31, P585, DOI 10.1016/0092-8674(82)90314-2; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VALLEE BL, 1991, P NATL ACAD SCI USA, V88, P999, DOI 10.1073/pnas.88.3.999; VOELKER RA, 1984, GENETICS, V107, P279; WHARTON KA, 1985, CELL, V40, P55, DOI 10.1016/0092-8674(85)90308-3; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; ZAKANY J, 1988, NEURON, V1, P679, DOI 10.1016/0896-6273(88)90167-5	67	97	98	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1992	9	5					789	803		10.1016/0896-6273(92)90234-5	http://dx.doi.org/10.1016/0896-6273(92)90234-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1418995				2022-12-28	WOS:A1992JY55200001
J	DEWAARD, M; SEAGAR, M; FELTZ, A; COURAUD, F				DEWAARD, M; SEAGAR, M; FELTZ, A; COURAUD, F			INOSITOL PHOSPHATE REGULATION OF VOLTAGE-DEPENDENT CALCIUM CHANNELS IN CEREBELLAR GRANULE NEURONS	NEURON			English	Article							EXCITATORY AMINO-ACIDS; OMEGA-CONOTOXIN; RECEPTOR ACTIVATION; PERIPHERAL NEURONS; 2ND MESSENGERS; CELLS; TRISPHOSPHATE; INFLUX; CA-2+; GLUTAMATE	The effects of intracellularly applied inositol phosphates on voltage-dependent calcium channel currents were assessed in rat cerebellar neurons using the whole-cell recording configuration of the patch-clamp technique. Intraneuronal perfusion of 10-mu-M inositol 1,4,5-trisphosphate (IP3) increased the amplitude of currents elicited by depolarization from a holding potential of -40 mV. IP3 did not modify current activation, but shifted the steady-state inactivation curve toward more positive values. The dose-response curve indicated an EC50 of 0.5-mu-M for IP3. Inositol 1,3,4,5,-tetrakisphosphate (IP4), but not inositol 4,5,-bisphosphate, mimicked the effect of IP3. The effect of IP3 persisted in the presence of 100-mu-g/ml heparin and did not depend on intracellular calcium mobilization, as similar responses were not produced by 10 mM caffeine or by intrapipette calcium buffering at pCa 6 instead of pCa 7.7. Preincubation with omega-conotoxin led to a 55% inhibition of barium current; however, inhibition was reversed by IP3, which reestablished the control current amplitude. These results imply that IP3 and IP4 can elicit calcium entry by modifying both the gating characteristics and the pharmacological properties of voltage-dependent calcium channels.	LAB ETUDE REGULAT PHYSIOL,CNRS,UPR 23,F-67087 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	DEWAARD, M (corresponding author), FAC MED NORD,NEUROBIOL CANAUX ION LAB,INSERM,CJF 9016,BLVD PIERRE DRAMARD,F-13326 MARSEILLE 15,FRANCE.		De Waard, Michel/G-7406-2014	De Waard, Michel/0000-0002-2782-9615				ABDELLATIF AA, 1986, PHARMACOL REV, V38, P227; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P221, DOI 10.1113/jphysiol.1989.sp017612; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERTA P, 1986, FEBS LETT, V197, P349, DOI 10.1016/0014-5793(86)80355-6; BIRD GS, 1991, NATURE, V352, P162, DOI 10.1038/352162a0; BOUCHELOUCHE P, 1989, EXP BRAIN RES, V76, P281; CARBONE E, 1988, PFLUG ARCH EUR J PHY, V413, P14, DOI 10.1007/BF00581223; CIARDO A, 1991, J NEUROCHEM, V56, P184, DOI 10.1111/j.1471-4159.1991.tb02579.x; DEWAARD M, 1991, EUR J NEUROSCI, V3, P771; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GALLO V, 1987, J NEUROCHEM, V49, P1801, DOI 10.1111/j.1471-4159.1987.tb02439.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLOPAINEN I, 1990, J NEUROSCI RES, V25, P187, DOI 10.1002/jnr.490250206; KRISHTAL OA, 1989, NEUROSCI LETT, V102, P197, DOI 10.1016/0304-3940(89)90078-5; MANEV H, 1989, MOL PHARMACOL, V36, P106; MARSDEN PA, 1989, BIOCHEM BIOPH RES CO, V158, P86, DOI 10.1016/S0006-291X(89)80180-9; MELDOLESI J, 1991, TRENDS PHARMACOL SCI, V12, P289, DOI 10.1016/0165-6147(91)90577-F; MEYER T, 1990, BIOCHEMISTRY-US, V29, P32, DOI 10.1021/bi00453a004; MORRIS AP, 1987, NATURE, V330, P653, DOI 10.1038/330653a0; NICOLETTI F, 1986, J NEUROSCI, V6, P1905; PALADE P, 1989, MOL PHARMACOL, V36, P664; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANA RS, 1990, PHYSIOL REV, V70, P115, DOI 10.1152/physrev.1990.70.1.115; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; SCHOEPP D, 1990, TRENDS PHARMACOL SCI, V11, P508, DOI 10.1016/0165-6147(90)90052-A; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TAKAHASHI M, 1982, J BIOL CHEM, V257, P7287; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; VILVEN J, 1988, NATURE, V336, P587, DOI 10.1038/336587a0; YANGISAWA M, 1988, NATURE, V332, P411	31	28	28	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					497	503		10.1016/0896-6273(92)90187-I	http://dx.doi.org/10.1016/0896-6273(92)90187-I			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1326296				2022-12-28	WOS:A1992JM57100011
J	LARMET, Y; DOLPHIN, AC; DAVIES, AM				LARMET, Y; DOLPHIN, AC; DAVIES, AM			INTRACELLULAR CALCIUM REGULATES THE SURVIVAL OF EARLY SENSORY NEURONS BEFORE THEY BECOME DEPENDENT ON NEUROTROPHIC FACTORS	NEURON			English	Article							NERVE GROWTH-FACTOR; DORSAL-ROOT-GANGLIA; ADRENAL CHROMAFFIN CELLS; HIGH K+ CONCENTRATIONS; SYMPATHETIC NEURONS; NEURAL CREST; SARCOPLASMIC-RETICULUM; CILIARY GANGLION; PRECURSOR CELLS; TUMOR PROMOTER	To investigate the role of intracellular Ca2+ in the survival of developing neurons before they become neurotrophic factor dependent, we have studied chick embryo nodose neurons, which have a particularly protracted period of neurorophic factor independence. Pharmacological reduction of intracellular free Ca2+ or depletion of either Ca2+-regulated or inositol trisphosphate-regulated intracellular Ca2+ stores kills early neurotrophic factor-independent neurons, but has a negligible effect on older neurons growing in the presence of brain-derived neutrotrophic factor. Shortly before they become dependent on brain-derived neurotrophic factor, nodose neurons express L-type Ca2+ channels and their survival can be enhanced by depolarization-induced Ca2+ influx. We conclude that intracellular Ca2+ plays a role in regulating neuronal survival both prior to and after the onset of neurotrophic factor dependence, but does not mediate the survival-promoting effects of neurotrophic factors.	ST GEORGE HOSP,SCH MED,DEPT ANAT,LONDON SW17 0RE,ENGLAND; ROYAL FREE HOSP,SCH MED,DEPT PHARMACOL,LONDON NW3 2PF,ENGLAND	St Georges University London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School			Tuluc, Petronel/C-2527-2011; Davies, Alun M/A-4334-2010	Davies, Alun M/0000-0001-5841-8176	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACHESON A, 1987, EXP CELL RES, V170, P56, DOI 10.1016/0014-4827(87)90116-9; AYERLELIEVRE CS, 1982, DEV BIOL, V4, P291; BADER CR, 1983, NATURE, V305, P808, DOI 10.1038/305808a0; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BENNETT MR, 1979, BRAIN RES, V173, P549, DOI 10.1016/0006-8993(79)90250-6; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; BIAN JH, 1991, J BIOL CHEM, V266, P8801; BURGOYNE RD, 1989, NATURE, V342, P72, DOI 10.1038/342072a0; BUTCHER RW, 1965, J BIOL CHEM, V240, P4515; CARR VM, 1978, J COMP NEUROL, V182, P727; CHALAZONITIS A, 1980, DEV BIOL, V78, P173, DOI 10.1016/0012-1606(80)90327-9; COHENCORY S, 1991, J NEUROSCI, V11, P462; COLLINS F, 1989, BRAIN RES, V502, P99, DOI 10.1016/0006-8993(89)90465-4; COLLINS F, 1991, J NEUROSCI, V11, P2582; COUGHLIN MD, 1985, DEV BIOL, V110, P392, DOI 10.1016/0012-1606(85)90098-3; DAMICOMARTEL A, 1982, AM J ANAT, V163, P351, DOI 10.1002/aja.1001630407; DAVIES A, 1984, J COMP NEUROL, V223, P124, DOI 10.1002/cne.902230110; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DAVIES AM, 1986, NATURE, V319, P497, DOI 10.1038/319497a0; DAVIES AM, 1985, DEV BIOL, V111, P62, DOI 10.1016/0012-1606(85)90435-X; DAVIES AM, 1987, DEVELOPMENT, V101, P185; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DAVIES AM, 1987, NEUROSCIENCE, V20, P37, DOI 10.1016/0306-4522(87)90004-2; DAVIES AM, 1989, NATURE, V337, P553, DOI 10.1038/337553a0; EICHLER ME, 1992, J NEUROCHEM, V58, P263, DOI 10.1111/j.1471-4159.1992.tb09305.x; ENDO M, 1975, P JPN ACAD, V51, P479, DOI 10.2183/pjab1945.51.479; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNSBERGER U, 1989, DEV BIOL, V135, P250, DOI 10.1016/0012-1606(89)90177-2; ERNSBERGER U, 1988, DEV BIOL, V126, P420, DOI 10.1016/0012-1606(88)90151-0; GALLO V, 1987, J NEUROSCI, V7, P2203; GOTTMANN K, 1988, J NEUROSCI, V8, P3722; GOTTMANN K, 1991, J NEUROSCI, V11, P3371; HAKII H, 1986, J CANCER RES CLIN, V111, P177, DOI 10.1007/BF00389230; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HENZI V, 1992, NEUROSCIENCE, V46, P251, DOI 10.1016/0306-4522(92)90049-8; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; KALCHEIM C, 1987, EMBO J, V6, P2871, DOI 10.1002/j.1460-2075.1987.tb02589.x; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; KOIKE T, 1991, P NATL ACAD SCI USA, V88, P3892, DOI 10.1073/pnas.88.9.3892; KUBA K, 1980, J PHYSIOL-LONDON, V298, P251, DOI 10.1113/jphysiol.1980.sp013079; LASHER RS, 1972, BRAIN RES, V41, P482, DOI 10.1016/0006-8993(72)90521-5; LAW GJ, 1990, BIOCHEM J, V267, P359, DOI 10.1042/bj2670359; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; LITTON J, 1991, J BIOL CHEM, V266, P17067; MADERDRUT JL, 1988, BRAIN RES, V444, P189, DOI 10.1016/0006-8993(88)90928-6; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MCCOBB DP, 1989, NEURON, V2, P1633, DOI 10.1016/0896-6273(89)90052-4; MERINEY SD, 1987, J NEUROSCI, V7, P3840; NISHI R, 1981, DEV BIOL, V87, P301, DOI 10.1016/0012-1606(81)90153-6; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; ODOWD DK, 1988, J NEUROSCI, V8, P792; RANE SG, 1987, PFLUG ARCH EUR J PHY, V409, P361, DOI 10.1007/BF00583789; ROBINSON IM, 1991, J NEUROCHEM, V56, P1587, DOI 10.1111/j.1471-4159.1991.tb02055.x; RODRIGUEZTEBAR A, 1989, DEV BIOL, V136, P296, DOI 10.1016/0012-1606(89)90256-X; ROHRER H, 1985, EMBO J, V4, P1709, DOI 10.1002/j.1460-2075.1985.tb03840.x; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; SCOTT BS, 1977, J CELL PHYSIOL, V91, P305, DOI 10.1002/jcp.1040910215; SIMONNEAU M, 1985, J PHYSIOLOGY PARIS, V80, P312; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; SPITZER NC, 1979, ANNU REV NEUROSCI, V2, P363, DOI 10.1146/annurev.ne.02.030179.002051; STRIESSNIG J, 1986, FEBS LETT, V197, P204, DOI 10.1016/0014-5793(86)80327-1; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; Tello J. F., 1923, Travaux du Laboratoire de Recherches Biologiques Universite de Madrid, V21, P1; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THAYER SA, 1988, MOL PHARMACOL, V34, P664; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; VERMA A, 1990, BIOCHEM BIOPH RES CO, V172, P811, DOI 10.1016/0006-291X(90)90747-B; VOGEL KS, 1991, NEURON, V7, P819, DOI 10.1016/0896-6273(91)90284-7; WAKADE AR, 1983, EXP CELL RES, V144, P377, DOI 10.1016/0014-4827(83)90417-2; Windle WF, 1936, J COMP NEUROL, V63, P431, DOI 10.1002/cne.900630304; WRIGHT L, 1981, DEV BRAIN RES, V1, P283, DOI 10.1016/0165-3806(81)90114-0	80	76	76	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					563	574		10.1016/0896-6273(92)90193-H	http://dx.doi.org/10.1016/0896-6273(92)90193-H			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1524830				2022-12-28	WOS:A1992JM57100017
J	MICHELSOHN, AM; ANDERSON, DJ				MICHELSOHN, AM; ANDERSON, DJ			CHANGES IN COMPETENCE DETERMINE THE TIMING OF 2 SEQUENTIAL GLUCOCORTICOID EFFECTS ON SYMPATHOADRENAL PROGENITORS	NEURON			English	Article							NERVE GROWTH-FACTOR; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; ADRENAL CHROMAFFIN CELLS; NEURAL CREST DERIVATIVES; TISSUE-CULTURE CELLS; NEURONAL DIFFERENTIATION; OPTIC-NERVE; PC12 CELLS; C-JUN; RAT	We have studied the control of adrenal chromaffin cell development by glucocorticoids (GCs), in a reconstituted in vitro system. The development of the chromaffin phenotype involves two sequential, GC-dependent events: the decision not to become a sympathetic neuron, and the decision to express the epinephrine-synthesizing enzyme, phenylethanolamine-N-methyltransferase (PNMT). Both decisions appear to be mediated by the type II GC receptor. Competence to express PNMT develops on a schedule in vitro which parallels that seen in vivo, but only in progenitors that have first failed to undergo neuronal differentiation. The schedule of PNMT induction is thus controlled by the time of appearance of neither the inducing signal nor its receptor, as previously suggested, but rather by a cell-intrinsic timed process in chromaffin precursors. The two effects of GCs are pharmacologically distinct, suggesting that the GC receptor may interact differently with different genes in the same cell, in a manner that changes with development.	CALTECH,HOWARD HUGHES MED INST,PASADENA,CA 91125	California Institute of Technology; Howard Hughes Medical Institute	MICHELSOHN, AM (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023476] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23476] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABO T, 1981, J IMMUNOL, V127, P1024; ABRAHAM GE, 1971, J CLIN ENDOCR METAB, V32, P619, DOI 10.1210/jcem-32-5-619; ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; ANDERSON DJ, 1989, TRENDS NEUROSCI, V12, P83, DOI 10.1016/0166-2236(89)90160-4; ANDERSON DJ, 1991, J NEUROSCI, V11, P3507; ANDERSON DJ, 1988, NATO ASI SER H, V22, P188; ANTONIPILLAI I, 1983, J CLIN ENDOCR METAB, V56, P93, DOI 10.1210/jcem-56-1-93; BAETGE EE, 1986, P NATL ACAD SCI USA, V83, P5454, DOI 10.1073/pnas.83.15.5454; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; BOHN MC, 1982, DEV BIOL, V89, P299, DOI 10.1016/0012-1606(82)90319-0; BOHN MC, 1981, DEV BIOL, V82, P1, DOI 10.1016/0012-1606(81)90423-1; BRONNERFRASER M, 1989, NEURON, V3, P755, DOI 10.1016/0896-6273(89)90244-4; CARNAHAN JF, 1991, J NEUROSCI, V11, P3520; CARNAHAN JF, 1991, J NEUROSCI, V11, P3493; CECCATELLI S, 1989, ACTA PHYSIOL SCAND, V137, P559, DOI 10.1111/j.1748-1716.1989.tb08800.x; CLAUDE P, 1988, NEURON, V1, P783, DOI 10.1016/0896-6273(88)90126-2; DAY RN, 1990, MOL ENDOCRINOL, V4, P1964, DOI 10.1210/mend-4-12-1964; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DOUPE AJ, 1985, J NEUROSCI, V5, P2143; DOUPE AJ, 1985, J NEUROSCI, V5, P2119; EHRLICH ME, 1989, DEV BRAIN RES, V50, P129, DOI 10.1016/0165-3806(89)90132-6; ERANKO O, 1955, NATURE, V175, P88, DOI 10.1038/175088a0; EVANS RM, 1989, NEURON, V2, P1105, DOI 10.1016/0896-6273(89)90177-3; FEDEROFF HJ, 1988, J BIOL CHEM, V263, P19290; GUSTAFSSON JA, 1983, STEROID HORMONE RECE, P355; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; HILLARP NA, 1953, ACTA PHYSIOL SCAND, V30, P55; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; JIANG W, 1989, INT J DEV NEUROSCI, V7, P513, DOI 10.1016/0736-5748(89)90010-5; JUNGTESTAS I, 1983, EXP CELL RES, V147, P177, DOI 10.1016/0014-4827(83)90282-3; LEONARD DGB, 1987, MOL CELL BIOL, V7, P3156, DOI 10.1128/MCB.7.9.3156; LILLIEN LE, 1990, NEURON, V5, P111, DOI 10.1016/0896-6273(90)90301-U; MERCIER L, 1983, ENDOCRINOLOGY, V112, P601, DOI 10.1210/endo-112-2-601; MERCIER L, 1986, J STEROID BIOCHEM, V25, P11, DOI 10.1016/0022-4731(86)90275-X; MICHELSOHN AM, 1992, THESIS CALTECH PASAD; MOGUILEWSKY M, 1984, J STEROID BIOCHEM, V20, P271, DOI 10.1016/0022-4731(84)90216-4; NABORS CJ, 1974, STEROIDS, V23, P363, DOI 10.1016/0039-128X(74)90088-9; NAWATA H, 1988, J STEROID BIOCHEM, V29, P63; PAIVARINTA H, 1989, J ELECTRON MICR TECH, V12, P389, DOI 10.1002/jemt.1060120411; PATTERSON PH, 1990, CELL, V62, P1035, DOI 10.1016/0092-8674(90)90379-S; PATTERSON PH, 1978, ANNU REV NEUROSCI, V1, P1, DOI 10.1146/annurev.ne.01.030178.000245; PHILIBERT D, 1973, STEROIDS, V22, P89, DOI 10.1016/0039-128X(73)90073-1; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RATKA A, 1989, NEUROENDOCRINOLOGY, V50, P117, DOI 10.1159/000125210; ROOS TB, 1967, ENDOCRINOLOGY, V81, P716, DOI 10.1210/endo-81-4-716; ROSS ME, 1990, J NEUROSCI, V10, P520; SAMUELS HH, 1970, J MOL BIOL, V52, P57, DOI 10.1016/0022-2836(70)90177-4; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SEIDL K, 1989, DEV BIOL, V136, P481, DOI 10.1016/0012-1606(89)90273-X; SEIDL K, 1989, INT J DEV NEUROSCI, V7, P465, DOI 10.1016/0736-5748(89)90006-3; SIMONS SS, 1989, CANCER RES, V49, pS2244; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; TEITELMAN G, 1982, DEV BIOL, V80, P450; TEUTSCH G, 1981, STEROIDS, V38, P651, DOI 10.1016/0039-128X(81)90084-2; TOMLINSON A, 1987, NEUROSCIENCE, V20, P895, DOI 10.1016/0306-4522(87)90250-8; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WURTMAN RJ, 1966, J BIOL CHEM, V241, P2301; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	64	99	100	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					589	604		10.1016/0896-6273(92)90285-L	http://dx.doi.org/10.1016/0896-6273(92)90285-L			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1347997				2022-12-28	WOS:A1992HK67500017
J	RUIT, KG; ELLIOTT, JL; OSBORNE, PA; YAN, Q; SNIDER, WD				RUIT, KG; ELLIOTT, JL; OSBORNE, PA; YAN, Q; SNIDER, WD			SELECTIVE DEPENDENCE OF MAMMALIAN DORSAL-ROOT GANGLION NEURONS ON NERVE GROWTH-FACTOR DURING EMBRYONIC-DEVELOPMENT	NEURON			English	Article							NEONATAL CAPSAICIN TREATMENT; PRIMARY SENSORY NEURONS; LUMBAR SPINAL-CORD; NEUROTROPHIC FACTOR; PRIMARY AFFERENTS; SUBSTANCE-P; FACTOR DEPRIVATION; FACTOR RECEPTOR; DEVELOPING RAT; GUINEA-PIGS	We have investigated the NGF dependence of dorsal root ganglion (DRG) neurons in mammals using a paradigm of multiple in utero injections of a high titer anti-NGF antiserum. We have determined the specificity of our antiserum in relation to other members of the NGF neurotrophin family and found no cross-reactivity with brain-derived neurotrophic factor (BDNF) or neurotrophin-3 (NT-3). To identify various classes of DRG neurons, we have stained their characteristic central projections with Dil. We show here that the NGF dependence of DRG neurons is strikingly selective. Although a majority of DRG neurons are lost after NGF deprivation during embryonic life, these are almost exclusively small diameter neurons that project to laminae I and II of the dorsal horn and presumably subserve nociception and thermo-reception. Larger neurons that project to more ventral spinal laminae and subserve other sensory modalities do not require NGF for survival. These NGF-independent DRG neurons likely require one of the more recently identified neurotrophins, BDNF or NT-3.	WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110; AMGEN INC,THOUSAND OAKS,CA 91320	Washington University (WUSTL); Amgen	RUIT, KG (corresponding author), WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110, USA.				NINDS NIH HHS [NS 25936, NS 24679, NS 17763] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS017763, R01NS024679, R01NS025936] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; ALOE L, 1981, NATURE, V291, P413, DOI 10.1038/291413a0; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BEAL JA, 1987, NEUROSCI LETT, V74, P139, DOI 10.1016/0304-3940(87)90139-X; BHIDE PG, 1991, J NEUROSCI, V11, P485; Brown AG, 1981, ORG SPINAL CORD; DAVIES A, 1984, J COMP NEUROL, V223, P124, DOI 10.1002/cne.902230110; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; ERNFORS P, 1991, EUR J NEUROSCI, V3, P953, DOI 10.1111/j.1460-9568.1991.tb00031.x; FENTON EL, 1970, EXP CELL RES, V59, P383, DOI 10.1016/0014-4827(70)90645-2; FITZGERALD M, 1987, J COMP NEUROL, V261, P98, DOI 10.1002/cne.902610108; GODEMENT P, 1987, DEVELOPMENT, V101, P697; GOEDERT M, 1984, P NATL ACAD SCI-BIOL, V81, P1580, DOI 10.1073/pnas.81.5.1580; GOEDERT M, 1981, P NATL ACAD SCI-BIOL, V78, P5895, DOI 10.1073/pnas.78.9.5895; GORIN PD, 1979, P NATL ACAD SCI USA, V76, P5382, DOI 10.1073/pnas.76.10.5382; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HAMBURGER V, 1981, J NEUROSCI, V1, P60, DOI 10.1523/JNEUROSCI.01-01-00060.1981; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; JOHNSON EM, 1986, TRENDS NEUROSCI, V9, P33, DOI 10.1016/0166-2236(86)90012-3; JOHNSON EM, 1983, NEUROSCIENCE, V8, P631, DOI 10.1016/0306-4522(83)90204-X; JOHNSON EM, 1989, BRAIN RES, V478, P166, DOI 10.1016/0006-8993(89)91491-1; JOHNSON EM, 1980, SCIENCE, V210, P916, DOI 10.1126/science.7192014; JOHNSON EM, 1982, BRAIN RES, V240, P131, DOI 10.1016/0006-8993(82)90650-3; KALCHEIM C, 1987, EMBO J, V6, P2871, DOI 10.1002/j.1460-2075.1987.tb02589.x; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KESSLER JA, 1980, P NATL ACAD SCI-BIOL, V77, P649, DOI 10.1073/pnas.77.1.649; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KUDO N, 1987, J PHYSIOL-LONDON, V389, P441, DOI 10.1113/jphysiol.1987.sp016665; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MCCASLAND JS, 1988, J COMP NEUROL, V278, P543, DOI 10.1002/cne.902780406; MIYATA Y, 1986, J NEUROSCI, V6, P2012; NAGY JI, 1981, NEUROSCIENCE, V6, P1923, DOI 10.1016/0306-4522(81)90032-4; NAGY JI, 1983, J NEUROSCI, V3, P399; NAGY JI, 1983, J COMP NEUROL, V218, P145, DOI 10.1002/cne.902180203; OTTEN U, 1983, NATURE, V301, P515, DOI 10.1038/301515a0; OTTEN U, 1980, NATURE, V287, P158, DOI 10.1038/287158a0; RETHELYI M, 1986, NEUROSCIENCE, V18, P749, DOI 10.1016/0306-4522(86)90067-9; RICHARDSON PM, 1984, J NEUROSCI, V4, P1682; RITTER AM, 1991, NATURE, V350, P500, DOI 10.1038/350500a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSS M, 1981, J NEUROSCI, V1, P1304; RUSSELL LC, 1984, BRAIN RES REV, V8, P165, DOI 10.1016/0165-0173(84)90005-5; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555, DOI 10.1177/36.5.3356898; SCHWARTZ JP, 1982, BRAIN RES, V244, P378, DOI 10.1016/0006-8993(82)90102-0; SHORTLAND P, 1990, J COMP NEUROL, V296, P23, DOI 10.1002/cne.902960103; SIKICH L, 1986, J NEUROSCI, V6, P1227; SMITH CL, 1983, J COMP NEUROL, V220, P29, DOI 10.1002/cne.902200105; SNIDER WD, 1990, J COMP NEUROL, V297, P227, DOI 10.1002/cne.902970206; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; URSCHEL BA, 1991, EXP NEUROL, V114, P44, DOI 10.1016/0014-4886(91)90083-O; VERGE VMK, 1989, J NEUROSCI, V9, P914; Willis WD, 1991, SENSORY MECH SPINAL; WOOLF CJ, 1987, J COMP NEUROL, V261, P105, DOI 10.1002/cne.902610109; YAN Q, 1988, J NEUROSCI, V8, P3481; YIP HK, 1984, P NATL ACAD SCI-BIOL, V81, P6245, DOI 10.1073/pnas.81.19.6245; YIP HK, 1984, J NEUROSCI, V4, P2986; YIP HK, 1986, J NEUROCYTOL, V15, P789, DOI 10.1007/BF01625195	69	220	222	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					573	587		10.1016/0896-6273(92)90284-K	http://dx.doi.org/10.1016/0896-6273(92)90284-K			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550679				2022-12-28	WOS:A1992HK67500016
J	WEITZ, CJ; NATHANS, J				WEITZ, CJ; NATHANS, J			HISTIDINE-RESIDUES REGULATE THE TRANSITION OF PHOTOEXCITED RHODOPSIN TO ITS ACTIVE CONFORMATION, METARHODOPSIN-II	NEURON			English	Article							OUTER-SEGMENT MEMBRANES; SCHIFF-BASE COUNTERION; BOVINE RHODOPSIN; SEQUENCE; PIGMENT; GENE; VISION; DETERMINANTS; TEMPERATURE; ARRANGEMENT	The biologically active photoproduct of rhodopsin, metarhodopsin II (M II), exists in a pH-sensitive equilibrium with its precursor, metarhodopsin I (M I). Increasing acidity favors M II, with the midpoint of the pH titration curve at pH 6.4. To test the long-standing proposal that histidine protonation regulates this conformational transition, we characterized mutant rhodopsins in which each of the 6 histidines was replaced by phenylalanine or cysteine. Only mutants substituted at the 3 conserved histidines showed abnormal M I-M II equilibria. Those in which His-211 was replaced by phenylalanine or cysteine formed little or no M II at either extreme of pH, whereas mutants substituted at His-65 or at His-152 showed enhanced sensitivity to protons. The simplest interpretation of these results is that His-211 is the site where protonation strongly stabilizes the M II conformation and that His-65 and His-152 are sites where protonation modestly destabilizes the M II conformation.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	WEITZ, CJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205, USA.			Nathans, Jeremy/0000-0001-8106-5460				AHO AC, 1988, NATURE, V334, P348, DOI 10.1038/334348a0; APPLEBURY ML, 1974, BIOCHEMISTRY-US, V13, P3448, DOI 10.1021/bi00714a005; BAEHR W, 1988, FEBS LETT, V238, P253, DOI 10.1016/0014-5793(88)80490-3; BALDWIN PA, 1985, BIOCHEMISTRY-US, V24, P2624, DOI 10.1021/bi00332a006; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BENNETT N, 1980, EUR J BIOCHEM, V111, P99; BENNETT N, 1982, EUR J BIOCHEM, V127, P96; DAEMEN FJM, 1973, BIOCHIM BIOPHYS ACTA, V300, P255, DOI 10.1016/0304-4157(73)90006-3; DOUKAS AG, 1978, BIOCHEMISTRY-US, V17, P2432; EMEIS D, 1982, FEBS LETT, V143, P29, DOI 10.1016/0014-5793(82)80266-4; FALK G, 1968, J PHYSIOL-LONDON, V198, P647, DOI 10.1113/jphysiol.1968.sp008631; FINDLAY JBC, 1986, BIOCHEM J, V238, P625, DOI 10.1042/bj2380625; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HARGRAVE PA, 1983, BIOPHYS STRUCT MECH, V9, P235, DOI 10.1007/BF00535659; HOFFMANN W, 1978, BIOCHIM BIOPHYS ACTA, V503, P450, DOI 10.1016/0005-2728(78)90144-5; HUBBARD R, 1965, COLD SPRING HARB SYM, V30, P301, DOI 10.1101/SQB.1965.030.01.032; HUBBARD R, 1958, P NATL ACAD SCI USA, V44, P130, DOI 10.1073/pnas.44.2.130; HUBBARD R, 1959, NATURE, V183, P448; KIBELBEK J, 1991, BIOCHEMISTRY-US, V30, P6761, DOI 10.1021/bi00241a019; KING PJ, 1984, VISION RES, V24, P1471, DOI 10.1016/0042-6989(84)90308-0; KONIG B, 1989, FEBS LETT, V257, P163, DOI 10.1016/0014-5793(89)81811-3; KUWATA O, 1990, FEBS LETT, V272, P128, DOI 10.1016/0014-5793(90)80465-U; LONGSTAFF C, 1986, P NATL ACAD SCI USA, V83, P4209, DOI 10.1073/pnas.83.12.4209; MATHEWS RG, 1963, J GEN PHYSIOL, V47, P215; NATHANS J, 1989, VISION RES, V29, P907, DOI 10.1016/0042-6989(89)90105-3; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P937, DOI 10.1021/bi00456a013; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; OVCHINNIKOV YA, 1983, BIOORG KHIM+, V9, P1331; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2348; PARKES JH, 1984, BIOCHEMISTRY-US, V23, P5054, DOI 10.1021/bi00316a035; RADDING CR, 1956, J GEN PHYSIOL, V30, P909; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; STEWART JG, 1975, NATURE, V258, P89, DOI 10.1038/258089a0; STRAUME M, 1990, BIOCHEMISTRY-US, V29, P9135, DOI 10.1021/bi00491a006; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; TAKAO M, 1988, VISION RES, V28, P471, DOI 10.1016/0042-6989(88)90169-1; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; WULFF VJ, 1958, ANN NY ACAD SCI, V74, P281, DOI 10.1111/j.1749-6632.1958.tb39551.x; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	47	66	66	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					465	472		10.1016/0896-6273(92)90274-H	http://dx.doi.org/10.1016/0896-6273(92)90274-H			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1532320				2022-12-28	WOS:A1992HK67500006
J	BERKEMEIER, LR; WINSLOW, JW; KAPLAN, DR; NIKOLICS, K; GOEDDEL, DV; ROSENTHAL, A				BERKEMEIER, LR; WINSLOW, JW; KAPLAN, DR; NIKOLICS, K; GOEDDEL, DV; ROSENTHAL, A			NEUROTROPHIN-5 - A NOVEL NEUROTROPHIC FACTOR THAT ACTIVATES TRK AND TRKB	NEURON			English	Article							NERVE GROWTH-FACTOR; DORSAL-ROOT GANGLIA; MESSENGER-RNA; MOLECULAR-CLONING; FACTOR FAMILY; SYMPATHETIC INNERVATION; CHOLINERGIC NEURONS; SENSORY NEURONS; FACTOR NGF; EXPRESSION	In vertebrates, the formation and maintenance of neuronal connections are subject to regulation by multiple target-derived, diffusible (neurotrophic) factors. Here we describe the identification and characterization of a novel neurotrophic factor designated neurotrophin-5 (NT-5). NT-5 is structurally related to nerve growth factor and is expressed in embryonic as well as adult tissues. Recombinant NT-5 promotes the survival of peripheral sensory and sympathetic neurons and induces differentiation of the pheochromocytoma cell line PC12. NT-5 activates two trk-related tyrosine kinase receptors and shares these receptors with other neurotrophins. Activation of multiple receptors may permit a single neurotrophin to control target innervation by distinct neuronal populations. Receptor sharing could enable neurotrophic factors emanating from distinct targets to cooperate in regulating neurons with multiple connections.	GENENTECH INC, DEPT DEV BIOL, San Francisco, CA 94080 USA; NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, MMCL, FREDERICK, MD 21701 USA	Roche Holding; Genentech; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	BERKEMEIER, LR (corresponding author), GENENTECH INC, DEPT MOLEC BIOL, San Francisco, CA 94080 USA.				OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; [Anonymous], [No title captured]; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BLOCHGALLEGO E, 1991, DEVELOPMENT, V111, P221; BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; BRADSHAW RA, 1978, ANNU REV BIOCHEM, V47, P191, DOI 10.1146/annurev.bi.47.070178.001203; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; DAVIES AM, 1986, NATURE, V319, P497, DOI 10.1038/319497a0; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; ERNSBERGER U, 1988, DEV BIOL, V126, P420, DOI 10.1016/0012-1606(88)90151-0; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; FRIEDMAN WJ, 1991, J NEUROSCI, V11, P1577; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEUMANN R, 1984, EMBO J, V3, P3183, DOI 10.1002/j.1460-2075.1984.tb02277.x; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KALCHEIM C, 1986, DEV BIOL, V116, P451, DOI 10.1016/0012-1606(86)90146-6; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; KORSCHING S, 1985, EMBO J, V4, P1389, DOI 10.1002/j.1460-2075.1985.tb03791.x; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; OPPENHEIM RW, 1982, J COMP NEUROL, V210, P174, DOI 10.1002/cne.902100208; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCHUBERT D, 1990, NATURE, V344, P868, DOI 10.1038/344868a0; SCOTT J, 1983, NATURE, V302, P538, DOI 10.1038/302538a0; SHELTON DL, 1984, P NATL ACAD SCI-BIOL, V81, P7951, DOI 10.1073/pnas.81.24.7951; SHELTON DL, 1986, P NATL ACAD SCI USA, V83, P2714, DOI 10.1073/pnas.83.8.2714; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; THOENEN H, 1987, CIBA F SYMP, V126, P82; ULLRICH A, 1983, NATURE, V303, P821, DOI 10.1038/303821a0; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WHITTEMORE SR, 1986, P NATL ACAD SCI USA, V83, P817, DOI 10.1073/pnas.83.3.817; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YIP HK, 1984, P NATL ACAD SCI-BIOL, V81, P6245, DOI 10.1073/pnas.81.19.6245	59	758	805	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1991	7	5					857	866		10.1016/0896-6273(91)90287-A	http://dx.doi.org/10.1016/0896-6273(91)90287-A			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1742028				2022-12-28	WOS:A1991GT93900015
J	BRADY, ST				BRADY, ST			MOLECULAR MOTORS IN THE NERVOUS-SYSTEM	NEURON			English	Review							FAST AXONAL-TRANSPORT; KINESIN-LIKE PROTEIN; SQUID GIANT-AXON; BOVINE BRAIN KINESIN; URCHIN EGG KINESIN; END-DIRECTED MOTOR; CYTOPLASMIC DYNEIN; MICROTUBULES INVITRO; ORGANELLE MOVEMENT; HEAVY-CHAIN				BRADY, ST (corresponding author), UNIV TEXAS,SW MED CTR,DEPT CELL BIOL & NEUROSCI,DALLAS,TX 75235, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS023868, R01NS023320, R01NS023868] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23868, NS23320] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS RJ, 1986, NATURE, V322, P754, DOI 10.1038/322754a0; ADAMS RJ, 1982, NATURE, V297, P327, DOI 10.1038/297327a0; ADAMS RJ, 1989, NATURE, V340, P566; ALLEN RD, 1981, CELL MOTIL CYTOSKEL, V1, P291, DOI 10.1002/cm.970010303; ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; ALLEN RD, 1985, J CELL BIOL, V100, P1736, DOI 10.1083/jcb.100.5.1736; AMOS LA, 1987, J CELL SCI, V87, P1; AMOS LA, 1987, J CELL SCI, V87, P105; ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; BERAR R, 1937, P R SOC LOND B, V123, P520; BERL S, 1973, SCIENCE, V179, P441, DOI 10.1126/science.179.4072.441; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; BLOOM GS, 1984, J CELL BIOL, V98, P320, DOI 10.1083/jcb.98.1.320; BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; BRADY ST, 1985, CELL MOTIL CYTOSKEL, V5, P81, DOI 10.1002/cm.970050203; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; BRADY ST, 1985, NEUROMETHODS, V1, P419; Cajal S., 1928, DEGENERATION REGENER; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; COHN SA, 1987, NATURE, V328, P160, DOI 10.1038/328160a0; COHN SA, 1989, J BIOL CHEM, V264, P4290; CREMO CR, 1989, J BIOL CHEM, V264, P6608; CREMO CR, 1990, BIOCHEMISTRY-US, V29, P7982, DOI 10.1021/bi00486a029; CYR JL, 1991, IN PRESS P NATL ACAD; DAHLSTRO.A, 1967, ACTA PHYSIOL SCAND, V69, P158, DOI 10.1111/j.1748-1716.1967.tb03507.x; DAHLSTROM AQ, 1991, IN PRESS ACTA PHYSL; EISENBERG E, 1980, ANNU REV PHYSIOL, V42, P293, DOI 10.1146/annurev.ph.42.030180.001453; ENDOW SA, 1991, P NATL ACAD SCI USA, V88, P4424, DOI 10.1073/pnas.88.10.4424; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; ENOS AP, 1990, CELL, V60, P1019, DOI 10.1016/0092-8674(90)90350-N; EUTENEUER U, 1989, EUR J CELL BIOL, V50, P34; EUTENEUER U, 1989, CELL MOVEMENT, P155; FORMAN DS, 1983, J NEUROSCI, V3, P1279; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; GILBERT SP, 1986, J CELL BIOL, V103, P947, DOI 10.1083/jcb.103.3.947; GILBERT SP, 1985, NATURE, V315, P245, DOI 10.1038/315245a0; GILBERT SP, 1989, J CELL BIOL, V109, P2379, DOI 10.1083/jcb.109.5.2379; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; GREENGARD P, 1987, MOL MECHANISMS NEURO, P135; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; HACKNEY DD, 1989, J BIOL CHEM, V264, P15943; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; HAMMERSCHLAG R, 1982, TRENDS NEUROSCI, V5, P12, DOI 10.1016/0166-2236(82)90009-1; HAYDEN JH, 1984, J CELL BIOL, V99, P1785, DOI 10.1083/jcb.99.5.1785; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; HIROKAWA N, 1990, J CELL BIOL, V111, P1027, DOI 10.1083/jcb.111.3.1027; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; HOLLENBECK PJ, 1990, NATURE, V346, P864, DOI 10.1038/346864a0; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P2335, DOI 10.1083/jcb.108.6.2335; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; JOHNSON KA, 1985, ANNU REV BIOPHYS BIO, V14, P161, DOI 10.1146/annurev.bb.14.060185.001113; Korn ED, 1990, CURR OPIN CELL BIOL, V2, P57, DOI 10.1016/S0955-0674(05)80031-6; KORN ED, 1988, ANNU REV BIOPHYS BIO, V17, P23; KOSIK KS, 1990, J BIOL CHEM, V265, P3278; KREUTZBERG GW, 1969, P NATL ACAD SCI USA, V62, P722, DOI 10.1073/pnas.62.3.722; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; KUTZNETSOV SA, 1986, P NATL ACAD SCI USA, V83, P8530; KUTZNETSOV SA, 1989, J BIOL CHEM, V264, P589; KUTZNETSOV SA, 1988, EMBO J, V7, P353; LASEK RJ, 1985, NATURE, V316, P645, DOI 10.1038/316645a0; LASEK RJ, 1984, BIOL BULL, V167, P503; LASEK RJ, 1984, CURR TOP MEMBR TRANS, V22, P39; LASEK RJ, 1977, MECHANISMS REGULATIO, P161; LASEK RJ, 1967, NATURE, V227, P680; LASEK RJ, 1975, CELL MOTILITY, P1021; LEEEIFORD A, 1986, J BIOL CHEM, V261, P2337; LEOPOLD PL, 1990, CELL MOTIL CYTOSKEL, V15, P210, DOI 10.1002/cm.970150404; LYE RJ, 1987, CELL, V51, P309, DOI 10.1016/0092-8674(87)90157-7; MARYA PK, 1990, EUR J BIOCHEM, V193, P39, DOI 10.1111/j.1432-1033.1990.tb19301.x; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; MCGUINNESS TL, 1989, J NEUROSCI, V9, P4138; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MILLER RH, 1985, J CELL BIOL, V101, P2181, DOI 10.1083/jcb.101.6.2181; MITCHELL DR, 1981, J BIOL CHEM, V256, P2535; MIYATA H, 1989, J CELL BIOL, V109, P1519, DOI 10.1083/jcb.109.4.1519; MUROFUSHI H, 1988, J BIOL CHEM, V263, P12744; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; OGAWA K, 1991, NATURE, V352, P643, DOI 10.1038/352643a0; OKUNO M, 1981, J MUSCLE RES CELL M, V2, P131, DOI 10.1007/BF00712064; PAGGI P, 1987, J NEUROSCI, V7, P2397; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; PASCHAL BM, 1987, NATURE, V330, P672, DOI 10.1038/330672a0; PENNINGROTH SM, 1987, FEBS LETT, V222, P204, DOI 10.1016/0014-5793(87)80220-X; PFARR CM, 1990, NATURE, V345, P263, DOI 10.1038/345263a0; PFISTER KK, 1989, BIOCHEMISTRY-US, V28, P9006, DOI 10.1021/bi00449a008; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; PORTER ME, 1987, J BIOL CHEM, V262, P2794; PRATT MM, 1984, J CELL BIOCHEM, V26, P19, DOI 10.1002/jcb.240260103; PRATT MM, 1986, J BIOL CHEM, V261, P956; PUSZKIN S, 1968, SCIENCE, V161, P170, DOI 10.1126/science.161.3837.170; ROOTS BI, 1983, SCIENCE, V221, P971, DOI 10.1126/science.6192501; SAHENK Z, 1988, BRAIN RES, V460, P199, DOI 10.1016/0006-8993(88)91224-3; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; SAXTON WM, 1988, P NATL ACAD SCI USA, V85, P1109, DOI 10.1073/pnas.85.4.1109; SCHAIFE R, 1990, J CELL BIOL, V111, P3023; SCHLIWA M, 1991, J CELL BIOL, V112, P1199, DOI 10.1083/jcb.112.6.1199; SCHNAPP BJ, 1989, P NATL ACAD SCI USA, V86, P1548, DOI 10.1073/pnas.86.5.1548; SCHOLEY JM, 1985, NATURE, V318, P483, DOI 10.1038/318483a0; SCHOLEY JM, 1989, NATURE, V338, P355, DOI 10.1038/338355a0; SCHROER TA, 1985, J CELL BIOL, V101, P568, DOI 10.1083/jcb.101.2.568; SCHROER TA, 1988, J CELL BIOL, V107, P1785, DOI 10.1083/jcb.107.5.1785; SCHROER TA, 1989, CELL, V56, P937, DOI 10.1016/0092-8674(89)90627-2; Scott FH, 1906, J PHYSIOL-LONDON, V34, P145; SHIMIZU T, 1991, J CELL BIOL, V112, P1189, DOI 10.1083/jcb.112.6.1189; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; SHPETNER HS, 1988, J CELL BIOL, V107, P1001, DOI 10.1083/jcb.107.3.1001; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; SPUDICH JA, 1989, CELL REGUL, V1, P1; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1985, CELL, V43, P623, DOI 10.1016/0092-8674(85)90234-X; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; VALLEE RB, 1989, TRENDS NEUROSCI, V12, P66, DOI 10.1016/0166-2236(89)90138-0; VALLEE RB, 1991, ANNU REV NEUROSCI, V14, P59, DOI 10.1146/annurev.ne.14.030191.000423; VALLEE RB, 1990, ANNU REV BIOCHEM, V59, P909, DOI 10.1146/annurev.biochem.59.1.909; VALLEE RB, 1988, NATURE, V332, P561, DOI 10.1038/332561a0; WAGNER MC, 1989, CELL MOTIL CYTOSKEL, V12, P195, DOI 10.1002/cm.970120403; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; WEISS P, 1948, J EXP ZOOL, V107, P315, DOI 10.1002/jez.1401070302; WILLARD M, 1977, J CELL BIOL, V75, P1, DOI 10.1083/jcb.75.1.1; WRIGHT BD, 1991, J CELL BIOL, V113, P817, DOI 10.1083/jcb.113.4.817; YANG JT, 1988, P NATL ACAD SCI USA, V85, P1864, DOI 10.1073/pnas.85.6.1864; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; YANG JT, 1990, SCIENCE, V249, P42, DOI 10.1126/science.2142332; YEH E, 1991, NATURE, V349, P713, DOI 10.1038/349713a0; ZHANG P, 1990, CELL, V62, P1053, DOI 10.1016/0092-8674(90)90383-P	133	122	123	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1991	7	4					521	533		10.1016/0896-6273(91)90365-7	http://dx.doi.org/10.1016/0896-6273(91)90365-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1834098				2022-12-28	WOS:A1991GM95400001
J	GOLDMAN, D; CARLSON, BM; STAPLE, J				GOLDMAN, D; CARLSON, BM; STAPLE, J			INDUCTION OF ADULT-TYPE NICOTINIC ACETYLCHOLINE-RECEPTOR GENE-EXPRESSION IN NONINNERVATED REGENERATING MUSCLE	NEURON			English	Article							SUBUNIT MESSENGER-RNA; DENERVATED RAT MUSCLE; ALPHA-SUBUNIT; SKELETAL-MUSCLE; EPSILON-SUBUNIT; GAMMA-SUBUNIT; BETA-SUBUNIT; BASAL LAMINA; CELLS; HYBRIDIZATION	Expression of adult-type nicotinic acetylcholine receptors at the neuromuscular junction is thought to result from selective induction of their genes in endplate-associated nuclei due to local neurotrophic control. However, denervation studies indicate that endplate-specific expression can be maintained in the absence of the nerve. We investigated the role played by the basal lamina in this expression by assaying for the adult-type-specific epsilon-RNA in noninnervated regenerating muscle. We found that this RNA is locally expressed beneath the old endplates after 10 days of regeneration. At earlier times epsilon-RNA is also found in areas other than the endplate region. These results indicate that in adult muscle the basal lamina contains all the components necessary to direct nicotinic acetylcholine receptor gene expression to the endplate.	UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT ANAT & CELL BIOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	GOLDMAN, D (corresponding author), UNIV MICHIGAN,MENTAL HLTH RES INST,ANN ARBOR,MI 48109, USA.							BADER D, 1981, J CELL BIOL, V88, P338, DOI 10.1083/jcb.88.2.338; BENOIT PW, 1970, J ANAT, V107, P547; BRENNER HR, 1990, NATURE, V344, P544, DOI 10.1038/344544a0; BUONANNO A, 1989, J BIOL CHEM, V264, P7611; CARLSON BM, 1976, EXP NEUROL, V52, P421, DOI 10.1016/0014-4886(76)90214-4; CARLSON BM, 1988, EXP NEUROL, V102, P50, DOI 10.1016/0014-4886(88)90077-5; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRIADO M, 1988, NUCLEIC ACIDS RES, V16, P10920, DOI 10.1093/nar/16.22.10920; EVANS S, 1987, J BIOL CHEM, V262, P4911; FONTAINE B, 1989, J CELL BIOL, V108, P1025, DOI 10.1083/jcb.108.3.1025; GOLDMAN D, 1988, NEURON, V1, P329, DOI 10.1016/0896-6273(88)90081-5; GOLDMAN D, 1989, NEURON, V3, P219, DOI 10.1016/0896-6273(89)90035-4; GOLDMAN D, 1985, J NEUROSCI, V5, P2553; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; HARRIS DA, 1988, P NATL ACAD SCI USA, V85, P1983, DOI 10.1073/pnas.85.6.1983; HOROVITZ O, 1989, J CELL BIOL, V108, P1823, DOI 10.1083/jcb.108.5.1823; HUGHES SM, 1990, NATURE, V345, P350, DOI 10.1038/345350a0; KLARSFELD A, 1985, P NATL ACAD SCI USA, V82, P4558, DOI 10.1073/pnas.82.13.4558; KLARSFELD A, 1991, EMBO J, V10, P625, DOI 10.1002/j.1460-2075.1991.tb07990.x; KOELLE GB, 1949, P SOC EXP BIOL MED, V70, P617; MARTINOU JC, 1991, J NEUROSCI, V11, P1291; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; OSTERLUND M, 1989, NEUROSCIENCE, V32, P279, DOI 10.1016/0306-4522(89)90078-X; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; SIEGELBAUM SA, 1984, DEV BIOL, V104, P366, DOI 10.1016/0012-1606(84)90092-7; WITZEMANN V, 1987, FEBS LETT, V223, P104, DOI 10.1016/0014-5793(87)80518-5; WITZEMANN V, 1989, FEBS LETT, V242, P419, DOI 10.1016/0014-5793(89)80514-9; WITZEMANN V, 1990, EUR J BIOCHEM, V194, P437, DOI 10.1111/j.1432-1033.1990.tb15637.x	30	59	61	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1991	7	4					649	658		10.1016/0896-6273(91)90377-C	http://dx.doi.org/10.1016/0896-6273(91)90377-C			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1931052	Green Published			2022-12-28	WOS:A1991GM95400013
J	JONES, KA; BAUGHMAN, RW				JONES, KA; BAUGHMAN, RW			BOTH NMDA AND NON-NMDA SUBTYPES OF GLUTAMATE RECEPTORS ARE CONCENTRATED AT SYNAPSES ON CEREBRAL CORTICAL-NEURONS IN CULTURE	NEURON			English	Article							LONG-TERM POTENTIATION; METHYL-D-ASPARTATE; POSTSYNAPTIC DENSITY PROTEIN; RAT VISUAL-CORTEX; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; ACETYLCHOLINE-RECEPTORS; FUNCTIONAL EXPRESSION; QUISQUALATE RECEPTORS; AMINO-ACIDS	N-methy-D-aspartate (NMDA) and non-NMDA receptors play a key role in synaptic transmission and plasticity in the vertebrate central nervous system. Previous studies have suggested that although both receptor types are present at synapses, the NMDA receptors may be relatively uniformly distributed. We have combined iontophoretic mapping of NMDA and non-NMDA receptors with immunohistochemical localization of synaptic vesicles along dendrites of single neocortical neurons to determine the relationship between NMDA and non-NMDA receptor distribution and the location of synapses. We find that when corrections for glutamate diffusion are made, NMDA responses are concentrated at focal "hot spots"that coincide with non-NMDA hot spots and that there is an excellent correlation between these hot spots and synapses.	HARVARD UNIV, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School			Baughman, Robert/O-9078-2014	Baughman, Robert/0000-0002-8557-9458	NEI NIH HHS [EY05810, EY3502] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY005810, R01EY003502] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; BAUGHMAN RW, 1991, IN PRESS NEURONAL CE; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BLAKE JF, 1988, NEUROSCI LETT, V89, P182, DOI 10.1016/0304-3940(88)90378-3; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DAVIES J, 1982, BRAIN RES, V235, P378, DOI 10.1016/0006-8993(82)91017-4; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; FAGG GE, 1984, P NATL ACAD SCI-BIOL, V81, P6876, DOI 10.1073/pnas.81.21.6876; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; FRANK E, 1979, J CELL BIOL, V83, P143, DOI 10.1083/jcb.83.1.143; GARTHWAITE J, 1985, BRIT J PHARMACOL, V85, P297, DOI 10.1111/j.1476-5381.1985.tb08860.x; Gray E G, 1969, Prog Brain Res, V31, P141; GU Y, 1990, NEURON, V5, P147, DOI 10.1016/0896-6273(90)90305-Y; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HUETTNER JE, 1988, J NEUROSCI, V8, P160; JONES KA, 1988, J NEUROSCI, V8, P3522; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; KUFFLER SW, 1975, J PHYSIOL-LONDON, V244, P703, DOI 10.1113/jphysiol.1975.sp010821; LAND BR, 1980, P NATL ACAD SCI-BIOL, V77, P3736, DOI 10.1073/pnas.77.6.3736; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; OBRIEN RJ, 1986, J NEUROSCI, V6, P3290; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SOMOGYI P, 1989, J NEUROSCI, V9, P2197; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; WITZEMANN V, 1990, EUR J BIOCHEM, V194, P437, DOI 10.1111/j.1432-1033.1990.tb15637.x; ZORUMSKI CF, 1990, NEURON, V5, P61, DOI 10.1016/0896-6273(90)90033-C	46	146	146	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1991	7	4					593	603		10.1016/0896-6273(91)90372-7	http://dx.doi.org/10.1016/0896-6273(91)90372-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1718334				2022-12-28	WOS:A1991GM95400008
J	PATTON, DE; GOLDIN, AL				PATTON, DE; GOLDIN, AL			A VOLTAGE-DEPENDENT GATING TRANSITION INDUCES USE-DEPENDENT BLOCK BY TETRODOTOXIN OF RAT IIA SODIUM-CHANNELS EXPRESSED IN XENOPUS OOCYTES	NEURON			English	Article							STEADY-STATE PROPERTIES; FROG MYELINATED NERVE; OXIDANT CHLORAMINE-T; NA CHANNELS; INACTIVATION PROCESS; HOLDING POTENTIALS; SKELETAL-MUSCLE; CARDIAC-MUSCLE; CRAYFISH AXONS; SEA-ANEMONE	We have utilized molecular biological techniques to demonstrate that rat IIA sodium channels expressed in Xenopus oocytes were blocked by tetrodotoxin (TTX) in a use-dependent manner. This use dependence was the result of an increased affinity of the channels for TTX upon depolarization, most likely due to a conformational change in the channel. Using a mutant with a slower macroscopic rate of inactivation, we have demonstrated that this conformational change is not the transition into the fast-inactivated state. The transition is probably one occurring during activation of the channel, as suggested by the fact that one sodium channel mutant demonstrated comparable depolarizing shifts in the voltage dependence of both activation and use-dependent block by TTX. The transition occurred at potentials more negative than those resulting in channel conductance, suggesting that the conformational change that causes use-dependent block by TTX is a closed-state voltage-dependent gating transition.			PATTON, DE (corresponding author), UNIV CALIF IRVINE, DEPT MICROBIOL & MOLEC GENET, IRVINE, CA 92717 USA.		Goldin, Alan/A-8385-2015	Goldin, Alan/0000-0001-7159-0288	NIMH NIH HHS [MH-14599] Funding Source: Medline; NINDS NIH HHS [NS-26729] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026729] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BAER M, 1976, NATURE, V263, P344, DOI 10.1038/263344a0; BARCHI RL, 1979, J PHYSIOL-LONDON, V295, P383, DOI 10.1113/jphysiol.1979.sp012975; BERGMAN C, 1976, BIOCHIM BIOPHYS ACTA, V455, P173, DOI 10.1016/0005-2736(76)90162-0; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; CLARKSON CW, 1988, J MOL CELL CARDIOL, V20, P1119, DOI 10.1016/0022-2828(88)90592-5; COHEN CJ, 1981, J GEN PHYSIOL, V78, P383, DOI 10.1085/jgp.78.4.383; COTA G, 1989, J GEN PHYSIOL, V94, P213, DOI 10.1085/jgp.94.2.213; EICKHORN R, 1990, PFLUG ARCH EUR J PHY, V416, P398, DOI 10.1007/BF00370746; GONOI T, 1987, J GEN PHYSIOL, V89, P253, DOI 10.1085/jgp.89.2.253; GONOI T, 1985, J NEUROSCI, V5, P2559; GUO XT, 1987, BIOCHEMISTRY-US, V26, P7546, DOI 10.1021/bi00398a003; HEGGENESS ST, 1986, BIOPHYS J, V49, P629, DOI 10.1016/S0006-3495(86)83690-6; HILLE B, 1971, J GEN PHYSIOL, V58, P599, DOI 10.1085/jgp.58.6.599; HILLE B, 1975, BIOPHYS J, V15, P615, DOI 10.1016/S0006-3495(75)85842-5; Hille B, 1984, IONIC CHANNELS EXCIT; KAO CY, 1982, J PHYSIOL-LONDON, V323, P619, DOI 10.1113/jphysiol.1982.sp014095; KAO CY, 1965, J PHYSIOL-LONDON, V180, P50; KEGEL DR, 1985, J NEUROSCI METH, V12, P317, DOI 10.1016/0165-0270(85)90016-0; KRAFTE DS, 1988, J NEUROSCI, V8, P2859; KRAFTE DS, 1990, J GEN PHYSIOL, V96, P689, DOI 10.1085/jgp.96.4.689; LONNENDONKER U, 1989, BIOCHIM BIOPHYS ACTA, V985, P161, DOI 10.1016/0005-2736(89)90361-1; LONNENDONKER U, 1989, BIOCHIM BIOPHYS ACTA, V985, P153, DOI 10.1016/0005-2736(89)90360-X; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MOCZYDLOWSKI E, 1984, J GEN PHYSIOL, V84, P665, DOI 10.1085/jgp.84.5.665; MOCZYDLOWSKI E, 1984, J GEN PHYSIOL, V84, P687, DOI 10.1085/jgp.84.5.687; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; NARAHASHI T, 1966, SCIENCE, V153, P765, DOI 10.1126/science.153.3737.765; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; NONNER W, 1980, NATURE, V284, P360, DOI 10.1038/284360a0; OXFORD GS, 1981, J GEN PHYSIOL, V77, P1, DOI 10.1085/jgp.77.1.1; OXFORD GS, 1978, J GEN PHYSIOL, V71, P227, DOI 10.1085/jgp.71.3.227; REED JK, 1976, BIOCHEMISTRY-US, V15, P944, DOI 10.1021/bi00650a002; RUBEN PC, 1990, BIOPHYS J, V58, P1169, DOI 10.1016/S0006-3495(90)82458-9; SALGADO VL, 1986, ANN NY ACAD SCI, V479, P84, DOI 10.1111/j.1749-6632.1986.tb15563.x; SCHWARZ JR, 1973, J PHYSIOL-LONDON, V233, P167, DOI 10.1113/jphysiol.1973.sp010304; SIGWORTH FJ, 1980, NATURE, V283, P293, DOI 10.1038/283293a0; STIMERS JR, 1985, J GEN PHYSIOL, V85, P65, DOI 10.1085/jgp.85.1.65; STRICHARTZ G, 1986, ANN NY ACAD SCI, V479, P96, DOI 10.1111/j.1749-6632.1986.tb15564.x; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; WADA A, 1987, NEUROSCIENCE, V23, P327, DOI 10.1016/0306-4522(87)90293-4; WAGNER HH, 1975, PFLUG ARCH EUR J PHY, V359, P297, DOI 10.1007/BF00581441; WANG GK, 1985, J GEN PHYSIOL, V86, P739, DOI 10.1085/jgp.86.5.739; WANG GK, 1985, J GEN PHYSIOL, V86, P289, DOI 10.1085/jgp.86.2.289; WANG GK, 1984, J PHYSIOL-LONDON, V346, P127, DOI 10.1113/jphysiol.1984.sp015011; WARASHINA A, 1983, J GEN PHYSIOL, V81, P305, DOI 10.1085/jgp.81.3.305; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; WORLEY JF, 1986, J GEN PHYSIOL, V87, P327, DOI 10.1085/jgp.87.2.327; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494	53	69	70	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1991	7	4					637	647		10.1016/0896-6273(91)90376-B	http://dx.doi.org/10.1016/0896-6273(91)90376-B			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1657057				2022-12-28	WOS:A1991GM95400012
J	OHLENDIECK, K; ERVASTI, JM; MATSUMURA, K; KAHL, SD; LEVEILLE, CJ; CAMPBELL, KP				OHLENDIECK, K; ERVASTI, JM; MATSUMURA, K; KAHL, SD; LEVEILLE, CJ; CAMPBELL, KP			DYSTROPHIN-RELATED PROTEIN IS LOCALIZED TO NEUROMUSCULAR-JUNCTIONS OF ADULT SKELETAL-MUSCLE	NEURON			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SURFACE-MEMBRANE; IDENTIFICATION; GLYCOPROTEIN; ASSOCIATION; DEFICIENCY; SUBUNIT; LOCUS	Dystrophin-related protein (DRP) is an autosomal gene product with high homology to dystrophin. We have used highly specific antibodies to the unique C-terminal peptide sequences of DRP and dystrophin to examine the subcellular localization and biochemical properties of DRP in adult skeletal muscle. DRP is enriched in isolated sarcolemma from control and mdx mouse muscle, but is much less abundant than dystrophin. Immunofluorescence microscopy localized DRP almost exclusively to the neuromuscular junction region in rabbit and mouse skeletal muscle, as well as mdx mouse muscle and denervated mouse muscle. DRP is also present in normal size and abundance and localizes to the neuromuscular junction region in muscle from the dystrophic mouse model dy/dy. Thus, DRP is a junction-specific membrane cytoskeletal protein that may play an important role in the organization of the postsynaptic membrane of the neuromuscular junction.	UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242	University of Iowa	OHLENDIECK, K (corresponding author), UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,IOWA CITY,IA 52242, USA.		Ervasti, James/AAZ-4786-2020	Campbell, Kevin/0000-0003-2066-5889; Ohlendieck, Kay/0000-0002-6266-4510; Kahl, Steven/0000-0001-7085-9556				ANDERSON MJ, 1974, J PHYSIOL-LONDON, V237, P385, DOI 10.1113/jphysiol.1974.sp010487; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; BIRKS R, 1960, J PHYSIOL-LONDON, V150, P134, DOI 10.1113/jphysiol.1960.sp006378; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; BRAY GM, 1970, ACTA NEUROPATHOL, V15, P34, DOI 10.1007/BF00690687; BUCKLE VJ, 1990, HUM GENET, V85, P324; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CHANG HW, 1989, J BIOL CHEM, V264, P20831; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FARDEAU M, 1990, J NEUROL SCI, V98, P232; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; HOFFMAN EP, 1989, LANCET, V2, P1211; ISHIURA S, 1990, J BIOCHEM-TOKYO, V107, P510, DOI 10.1093/oxfordjournals.jbchem.a123076; JASMIN BJ, 1990, P NATL ACAD SCI USA, V87, P3938, DOI 10.1073/pnas.87.10.3938; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; OHLENDIECK K, 1991, FEBS LETT, V283, P230, DOI 10.1016/0014-5793(91)80595-T; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; SANES JR, 1983, COLD SPRING HARB SYM, V48, P667, DOI 10.1101/SQB.1983.048.01.070; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SHARP AH, 1989, J BIOL CHEM, V264, P2816; TANAKA H, 1989, P JPN ACAD B-PHYS, V65, P238, DOI 10.2183/pjab.65.238; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; URAYAMA O, 1989, J BIOL CHEM, V264, P8271; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	32	338	339	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1991	7	3					499	508		10.1016/0896-6273(91)90301-F	http://dx.doi.org/10.1016/0896-6273(91)90301-F			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1654951	Bronze			2022-12-28	WOS:A1991GG88700014
J	SCHACHER, S; MONTAROLO, PG				SCHACHER, S; MONTAROLO, PG			TARGET-DEPENDENT STRUCTURAL-CHANGES IN SENSORY NEURONS OF APLYSIA ACCOMPANY LONG-TERM HETEROSYNAPTIC INHIBITION	NEURON			English	Article							SIPHON-WITHDRAWAL REFLEX; DISSOCIATED CELL-CULTURE; S-K+ CHANNELS; PRESYNAPTIC FACILITATION; TRANSMITTER RELEASE; NEURITE OUTGROWTH; ARACHIDONIC-ACID; GILL-WITHDRAWAL; SENSORIMOTOR SYNAPSES; SYNAPTIC TRANSMISSION	FMRFamide evokes both short-term and long-term inhibition of synapses between mechanosensory and motor neurons in Aplysia. We report here, using dissociated cell culture and low-light epifluorescence video microscopy, that depression lasting 24 hr of sensorimotor synapses evoked by four brief applications of FMRFamide is accompanied by a significant loss of sensory cell varicosities and neurites. These structural changes in the sensory cells require the presence of the target motor cell L7. Because the loss of structures known to contain transmitter release sites correlates significantly with the changes in the amplitude of the excitatory postsynaptic potential in L7, our results suggest that the structural changes evoked by FMRFamide reflect a loss of synaptic contacts. Thus, long-term depression parallels long-term facilitation of the sensorimotor synapse produced by serotonin in that both forms of heterosynaptic plasticity involve target-dependent modulation of the number of presynaptic varicosities.	COLUMBIA UNIV COLL PHYS & SURG, NEW YORK STATE PSYCHIAT INST, NEW YORK, NY 10032 USA	Columbia University; New York State Psychiatry Institute	SCHACHER, S (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA.				NIGMS NIH HHS [GM 32099] Funding Source: Medline; NINDS NIH HHS [NS19595] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019595] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMS TW, 1984, P NATL ACAD SCI-BIOL, V81, P7956, DOI 10.1073/pnas.81.24.7956; ALKON DL, 1990, P NATL ACAD SCI USA, V87, P1611, DOI 10.1073/pnas.87.4.1611; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1989, J NEUROSCI, V9, P1774; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BAILEY CH, 1988, J NEUROSCI, V8, P2452; BELARDETTI F, 1987, NATURE, V325, P153, DOI 10.1038/325153a0; BERNIER L, 1982, J NEUROSCI, V2, P1682; BLUMENFELD H, 1990, NEURON, V5, P487, DOI 10.1016/0896-6273(90)90088-W; BRAHA O, 1990, P NATL ACAD SCI USA, V87, P2040, DOI 10.1073/pnas.87.5.2040; BREZINA V, 1987, J PHYSIOL-LONDON, V388, P565, DOI 10.1113/jphysiol.1987.sp016632; BREZINA V, 1987, J PHYSIOL-LONDON, V382, P267, DOI 10.1113/jphysiol.1987.sp016367; BUTTNER N, 1989, NATURE, V342, P553, DOI 10.1038/342553a0; CASTELLUCCI VF, 1978, SCIENCE, V202, P1306, DOI 10.1126/science.214854; DALE N, 1990, J PHYSIOL-LONDON, V421, P203, DOI 10.1113/jphysiol.1990.sp017941; DALE N, 1988, SCIENCE, V239, P282, DOI 10.1126/science.2892269; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; EDMONDS B, 1990, SCIENCE, V250, P1142, DOI 10.1126/science.2174573; FORSCHER P, 1987, J NEUROSCI, V7, P3600; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; GLANZMAN DL, 1989, J NEUROSCI, V9, P4200; GLANZMAN DL, 1989, NEURON, V3, P441, DOI 10.1016/0896-6273(89)90203-1; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; HAYDON PG, 1984, SCIENCE, V226, P561, DOI 10.1126/science.6093252; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KELLER F, 1990, J CELL BIOL, V111, P2637, DOI 10.1083/jcb.111.6.2637; MACKEY SL, 1989, J NEUROSCI, V9, P4227; MACKEY SL, 1987, P NATL ACAD SCI USA, V84, P8730, DOI 10.1073/pnas.84.23.8730; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MATTSON MP, 1988, J NEUROSCI, V8, P1704; MATTSON MP, 1988, NEURON, V1, P865, DOI 10.1016/0896-6273(88)90134-1; MCCOBB DP, 1988, NEURON, V1, P377, DOI 10.1016/0896-6273(88)90187-0; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTAROLO PG, 1988, NATURE, V333, P171, DOI 10.1038/333171a0; NAZIF FA, 1991, BRAIN RES, V539, P324, DOI 10.1016/0006-8993(91)91638-H; OCORR KA, 1985, NEUROSCI LETT, V55, P113, DOI 10.1016/0304-3940(85)90004-7; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; RAYPORT SG, 1986, J NEUROSCI, V6, P759; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHACHER S, 1990, J NEUROSCI, V10, P3286; SCHACHER S, 1985, J NEUROSCI, V5, P2028; SCHACHER S, 1991, IN PRESS COLD SPRING; SCHOLZ KP, 1988, SCIENCE, V240, P1664, DOI 10.1126/science.2837826; VOLTERRA A, 1988, P NATL ACAD SCI USA, V85, P7810, DOI 10.1073/pnas.85.20.7810	47	56	56	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1991	6	5					679	690		10.1016/0896-6273(91)90166-W	http://dx.doi.org/10.1016/0896-6273(91)90166-W			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1673849				2022-12-28	WOS:A1991FM52200002
J	LLANO, I; LERESCHE, N; MARTY, A				LLANO, I; LERESCHE, N; MARTY, A			CALCIUM ENTRY INCREASES THE SENSITIVITY OF CEREBELLAR PURKINJE-CELLS TO APPLIED GABA AND DECREASES INHIBITORY SYNAPTIC CURRENTS	NEURON			English	Article							ELECTRO-PHYSIOLOGICAL PROPERTIES; CHLORIDE CURRENT; RECEPTOR; NEURONS; SLICES	The sensitivity to GABA of Purkinje cells in thin cerebellar slices was examined by recording either spontaneous inhibitory synaptic currents or ionic currents elicited by local GABA applications. The effects of Ca2+ entry induced by depolarizing voltage pulses were opposite for the two types of currents. Currents due to exogenous GABA applications were increased by a train of voltage pulses. This potentiation was transient with an average half recovery period of 3.7 min. Spontaneous synaptic currents were reduced by depolarizing voltage pulses, with a half recovery time of about 20 s. The inhibition was largely explained by a decrease of the frequency of synaptic events, suggesting that the primary location of the effect was presynaptic. Thus, a Ca2+ rise increases the sensitivity of Purkinje cells to GABA and induces a retrograde inhibition of presynaptic terminals. The latter effect may be due to a diffusible Ca2+-dependent messenger.			LLANO, I (corresponding author), ECOLE NORM SUPER,NEUROBIOL LAB,46 RUE ULM,F-75231 PARIS 05,FRANCE.			Leresche, Nathalie/0000-0001-6705-9769				BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; CHEN QX, 1990, J PHYSIOL-LONDON, V420, P207, DOI 10.1113/jphysiol.1990.sp017908; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; INOUE M, 1986, NATURE, V324, P156, DOI 10.1038/324156a0; Ito M, 1984, CEREBELLUM NEURAL CO; KANEDA M, 1989, AM J PHYSIOL, V256, pC1153, DOI 10.1152/ajpcell.1989.256.6.C1153; KHRESTCHATISKY M, 1989, NEURON, V3, P745, DOI 10.1016/0896-6273(89)90243-2; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; LLANO I, 1988, P NATL ACAD SCI USA, V85, P3221, DOI 10.1073/pnas.85.9.3221; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MAYER ML, 1985, J PHYSIOL-LONDON, V364, P217, DOI 10.1113/jphysiol.1985.sp015740; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; TALEB O, 1987, PFLUG ARCH EUR J PHY, V409, P620, DOI 10.1007/BF00584663; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; WISDEN W, 1988, NEURON, V1, P937, DOI 10.1016/0896-6273(88)90151-1	19	373	385	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					565	574		10.1016/0896-6273(91)90059-9	http://dx.doi.org/10.1016/0896-6273(91)90059-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	2015092				2022-12-28	WOS:A1991FH80200008
J	DISTASI, AMM; GALLO, V; CECCARINI, M; PETRUCCI, TC				DISTASI, AMM; GALLO, V; CECCARINI, M; PETRUCCI, TC			NEURONAL FODRIN PROTEOLYSIS OCCURS INDEPENDENTLY OF EXCITATORY AMINO ACID-INDUCED NEUROTOXICITY	NEURON			English	Article							CEREBELLAR GRANULE CELLS; GAMMA-AMINOBUTYRIC ACID; DEPENDENT PROTEASE-I; SPINAL-CORD NEURONS; PRIMARY CULTURES; CALPAIN-I; PURKINJE-CELLS; POSTNATAL-DEVELOPMENT; ERYTHROCYTE SPECTRIN; HIPPOCAMPAL-NEURONS	In cultured cerebellar granule cells, the total amount of fodrin alpha-subunit increased 3-fold between 0 and 10 days in vitro and fodrin mRNA increased 5-fold. The exposure of cerebellar neurons to NMDA induced the accumulation of a 150 kd proteolytic fragment of fodrin. The NMDA-induced breakdown of fodrin was time-, concentration-, and Ca2+-dependent and was inhibited by APV, Mg2+,or the calpain I inhibitor N-acetyl-Leu-Leu-norleucinal. Kainate caused fodrin proteolysis through indirect activation of NMDA receptors. Quisqualate was ineffective. The NMDA-induced degradation of fodrin occurred under conditions that did not cause degeneration of cultured cerebellar neurons. These results show that Ca2+/calpain I-dependent proteolysis of fodrin is selectively associated with NMDA receptor activation; however, fodrin proteolysis per se does not play a causal role in NMDA-induced toxicity in cerebellar granule cells.	IST SUPER SANITA,PHYSIOPATHOL LAB,I-00161 ROME,ITALY	Istituto Superiore di Sanita (ISS)	DISTASI, AMM (corresponding author), IST SUPER SANITA,CELL BIOL LAB,VIALE REGINA ELENA 299,I-00161 ROME,ITALY.		CECCARINI, MARINA/A-6637-2015	CECCARINI, MARINA/0000-0002-7021-4499				ALOISI F, 1985, J NEUROSCI, V5, P2001; ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; BAUDRY M, 1981, SCIENCE, V212, P937, DOI 10.1126/science.7015504; BENNETT V, 1982, NATURE, V299, P126, DOI 10.1038/299126a0; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BLOCH RJ, 1989, J CELL BIOL, V108, P481, DOI 10.1083/jcb.108.2.481; BURGOYNE RD, 1988, BRAIN RES REV, V13, P77, DOI 10.1016/0165-0173(88)90006-9; CARBONI E, 1988, J NEUROCHEM, V50, P1279, DOI 10.1111/j.1471-4159.1988.tb10605.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLEMAN TR, 1989, CELL MOTIL CYTOSKEL, V12, P225, DOI 10.1002/cm.970120405; CROALL DE, 1989, BIOCHEMISTRY-US, V28, P6882, DOI 10.1021/bi00443a016; CULLCANDY SG, 1989, J PHYSIOL-LONDON, V414, P179, DOI 10.1113/jphysiol.1989.sp017683; CULLCANDY SG, 1988, J PHYSIOL-LONDON, V400, P189, DOI 10.1113/jphysiol.1988.sp017117; EVANS RH, 1982, BRIT J PHARMACOL, V75, P65, DOI 10.1111/j.1476-5381.1982.tb08758.x; FAVARON M, 1988, P NATL ACAD SCI USA, V85, P7351, DOI 10.1073/pnas.85.19.7351; GALLO V, 1987, J NEUROCHEM, V49, P1801, DOI 10.1111/j.1471-4159.1987.tb02439.x; GALLO V, 1987, J NEUROSCI, V7, P2203; GALLO V, 1985, J NEUROSCI, V5, P2432; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; GALLO V, 1990, J NEUROCHEM, V54, P1619, DOI 10.1111/j.1471-4159.1990.tb01213.x; GALLO V, 1986, J NEUROSCI RES, V15, P289, DOI 10.1002/jnr.490150302; GARTHWAITE G, 1986, NEUROSCIENCE, V17, P755, DOI 10.1016/0306-4522(86)90043-6; GOODMAN SR, 1988, CRIT REV BIOCHEM MOL, V23, P171, DOI 10.3109/10409238809088319; HARRIS AS, 1985, BIOCHIM BIOPHYS ACTA, V830, P147, DOI 10.1016/0167-4838(85)90022-6; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; HARRIS AS, 1989, J BIOL CHEM, V264, P17401; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; HARRIS AS, 1988, J NEUROSCI, V8, P2640; HOCKBERGER PE, 1987, J NEUROSCI, V7, P1370; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; KINGSBURY A, 1987, EUR J PHARMACOL, V140, P275, DOI 10.1016/0014-2999(87)90284-6; KINGSBURY AE, 1985, DEV BRAIN RES, V17, P17, DOI 10.1016/0165-3806(85)90128-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZARIDES E, 1983, SCIENCE, V222, P931, DOI 10.1126/science.6356364; LAZARIDES E, 1984, CELL, V36, P269; LEVI G, 1991, J NEUROCHEM, V56, P199, DOI 10.1111/j.1471-4159.1991.tb02581.x; LEVI G, 1984, BRAIN RES, V290, P77, DOI 10.1016/0006-8993(84)90737-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MARCHESI VT, 1985, ANNU REV CELL BIOL, V1, P531, DOI 10.1146/annurev.cellbio.1.1.531; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MURACHI T, 1983, TRENDS BIOCHEM SCI, V8, P167, DOI 10.1016/0968-0004(83)90165-2; MURPHY SN, 1987, J NEUROSCI, V7, P4145; NADLER JV, 1981, NEUROSCIENCE, V6, P2505, DOI 10.1016/0306-4522(81)90096-8; NICOLETTI F, 1986, J NEUROSCI, V6, P1905; NOVELLI A, 1987, J NEUROSCI, V7, P40; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PATRIZIO M, 1989, NEUROCHEM RES, V14, P627, DOI 10.1007/BF00964871; PERRIN D, 1987, NATURE, V326, P498, DOI 10.1038/326498a0; PONTREMOLI S, 1988, P NATL ACAD SCI USA, V85, P1740, DOI 10.1073/pnas.85.6.1740; PURO DG, 1977, EXP BRAIN RES, V28, P427; RIEDERER BM, 1987, J NEUROSCI, V7, P864; Sambrook J, 1989, MOL CLONING LABORATO; SAMIS JA, 1987, BIOCHEM J, V246, P481, DOI 10.1042/bj2460481; SEUBERT P, 1988, BRAIN RES, V460, P189, DOI 10.1016/0006-8993(88)91222-X; SIMAN R, 1987, J NEUROSCI, V7, P55; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1989, J NEUROSCI, V9, P1579; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; SOBUE K, 1989, NEURON, V3, P311, DOI 10.1016/0896-6273(89)90255-9; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; THANGNIPON W, 1983, DEV BRAIN RES, V11, P177, DOI 10.1016/0165-3806(83)90215-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUJINATA T, 1988, BIOCHEM BIOPH RES CO, V253, P1201; VICINI S, 1986, NEUROPHARMACOLOGY, V25, P207, DOI 10.1016/0028-3908(86)90043-2; VITADELLO M, 1990, BRAIN RES, V509, P47, DOI 10.1016/0006-8993(90)90307-W; WOODWARD DJ, 1971, BRAIN RES, V34, P73, DOI 10.1016/0006-8993(71)90352-0; WROBLEWSKI JT, 1985, NEUROPHARMACOLOGY, V24, P919, DOI 10.1016/0028-3908(85)90046-2; ZAGON IS, 1986, J NEUROSCI, V6, P2977; ZAGON IS, 1984, J NEUROSCI, V4, P3089	75	51	52	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					445	454		10.1016/0896-6273(91)90252-U	http://dx.doi.org/10.1016/0896-6273(91)90252-U			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1848081				2022-12-28	WOS:A1991FC47000012
J	NEUGEBAUER, KM; EMMETT, CJ; VENSTROM, KA; REICHARDT, LF				NEUGEBAUER, KM; EMMETT, CJ; VENSTROM, KA; REICHARDT, LF			VITRONECTIN AND THROMBOSPONDIN PROMOTE RETINAL NEURITE OUTGROWTH - DEVELOPMENTAL REGULATION AND ROLE OF INTEGRINS	NEURON			English	Article							NEURONAL PROCESS OUTGROWTH; ARG-GLY-ASP; SERUM SPREADING FACTOR; HUMAN-MELANOMA CELLS; PLATELET THROMBOSPONDIN; SULFATED GLYCOLIPIDS; VONWILLEBRAND-FACTOR; GANGLION-CELLS; N-CADHERIN; ALPHA-V	Extracellular matrix (ECM) glycoproteins regulate neuronal development and axonal growth. In this paper, the ECM glycoprotein vitronectin was identified and localized in the embryonic chick neuroretina. To identify potentially important neurite outgrowth-promoting molecules, responses of embryonic chick retinal neurons to vitronectin and thrombospondin, another retinal ECM constituent, were examined. These neurons were shown to attach and extend neurites on either glycoprotein. Integrins containing the alpha-v or beta-1 subunits mediate both responses to vitronectin and neurite outgrowth on thrombospondin. Attachment to thrombospondin was inhibited by heparin, suggesting that neurons also utilize a proteoglycan or sulfated glycolipid as a receptor for this glycoprotein. Thus, retinal neurons use specific receptors to interact with vitronectin and thrombospondin, two glycoproteins present in the embryonic neuroretina, suggesting roles for these ligands and their receptors in retinal development.	UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco					NINDS NIH HHS [NS16033] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016033, P01NS016033] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASCH AS, 1986, P NATL ACAD SCI USA, V83, P2904, DOI 10.1073/pnas.83.9.2904; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; BARNES D, 1980, J SUPRAMOL STR CELL, V14, P47, DOI 10.1002/jss.400140106; BIXBY JL, 1990, J CELL BIOL, V111, P2725, DOI 10.1083/jcb.111.6.2725; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BODARY SC, 1989, J BIOL CHEM, V264, P18859; BODARY SC, 1990, J BIOL CHEM, V265, P5938; BOSSY B, 1990, BIOCHEMISTRY-US, V29, P10191, DOI 10.1021/bi00496a006; BOZYCZKO D, 1986, J NEUROSCI, V6, P1241; BUCK CA, 1987, J CELL SCI, P231; CARRI NG, 1988, J NEUROSCI RES, V19, P428, DOI 10.1002/jnr.490190407; CHERESH DA, 1989, CELL, V57, P59, DOI 10.1016/0092-8674(89)90172-4; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; COHEN J, 1989, DEVELOPMENT, V107, P381; COHEN J, 1987, DEV BIOL, V122, P407, DOI 10.1016/0012-1606(87)90305-8; COHEN J, 1986, NATURE, V322, P465, DOI 10.1038/322465a0; DAMSKY CH, 1985, J CELL BIOL, V100, P1528, DOI 10.1083/jcb.100.5.1528; DECURTIS I, 1991, IN PRESS J CELL BIOL, V112; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DRAZBA J, 1990, DEV BIOL, V138, P82, DOI 10.1016/0012-1606(90)90178-L; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; FREED E, 1989, EMBO J, V8, P2955, DOI 10.1002/j.1460-2075.1989.tb08445.x; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; HALFTER W, 1983, DEV BIOL, V95, P56, DOI 10.1016/0012-1606(83)90006-4; HALL DE, 1987, J CELL BIOL, V104, P623, DOI 10.1083/jcb.104.3.623; HARLOW E, 1988, ANTIBODIES LABORATOR; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; HERNDON ME, 1990, NEURON, V4, P949, DOI 10.1016/0896-6273(90)90148-9; HUDSON L, 1980, PRACTICAL IMMUNOLOGY, P156; KAESBERG PR, 1989, J CLIN INVEST, V83, P994, DOI 10.1172/JCI113986; KITAGAKIOGAWA H, 1990, BIOCHIM BIOPHYS ACTA, V1033, P49, DOI 10.1016/0304-4165(90)90193-Z; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LANDER AD, 1989, TRENDS NEUROSCI, V12, P189, DOI 10.1016/0166-2236(89)90070-2; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; NEUGEBAUER KM, 1991, IN PRESS NATURE; OSHEA KS, 1990, J CELL BIOL, V111, P2713, DOI 10.1083/jcb.111.6.2713; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; PRATER CA, 1991, IN PRESS J CELL BIOL; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; REICHARDT LF, 1990, IN PRESS COLD SPRING; ROBERTS DD, 1988, CANCER RES, V48, P6785; ROBERTS DD, 1985, J BIOL CHEM, V260, P9405; ROBERTS DD, 1987, J CELL BIOL, V104, P131, DOI 10.1083/jcb.104.1.131; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; SHEPPARD AM, 1988, DEV BRAIN RES, V40, P181, DOI 10.1016/0165-3806(88)90130-7; SHEPPARD D, 1990, J BIOL CHEM, V265, P11502; SUN XJ, 1989, J BIOL CHEM, V264, P11288; TARABOLETTI G, 1987, J CELL BIOL, V105, P2409, DOI 10.1083/jcb.105.5.2409; TARABOLETTI G, 1990, J CELL BIOL, V111, P765, DOI 10.1083/jcb.111.2.765; TOMASELLI KJ, 1986, J CELL BIOL, V103, P2659, DOI 10.1083/jcb.103.6.2659; TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; VOGEL BE, 1990, J BIOL CHEM, V265, P5934; WOODS A, 1985, J BIOL CHEM, V260, P872; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281	63	212	213	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1991	6	3					345	358		10.1016/0896-6273(91)90244-T	http://dx.doi.org/10.1016/0896-6273(91)90244-T			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1705807				2022-12-28	WOS:A1991FC47000004
J	WADA, E; WAY, J; SHAPIRA, H; KUSANO, K; LEBACQVERHEYDEN, AM; COY, D; JENSEN, R; BATTEY, J				WADA, E; WAY, J; SHAPIRA, H; KUSANO, K; LEBACQVERHEYDEN, AM; COY, D; JENSEN, R; BATTEY, J			CDNA CLONING, CHARACTERIZATION, AND BRAIN REGION SPECIFIC EXPRESSION OF A NEUROMEDIN-B PREFERRING BOMBESIN RECEPTOR	NEURON			English	Article							SWISS 3T3 CELLS; RAT-BRAIN; BINDING-SITES; PEPTIDES; DNA; LOCALIZATION; SEQUENCE; SUBTYPES; PROTEIN	Recent binding studies in the central nervous system and other tissues provide evidence that the mammalian bombesin-like peptides, gastrin-releasing peptide (GRP) and neuromedin-B (NMB), exert their numerous physiological effects through at least two different receptors. We describe the structure and expression of a cloned NMB-preferring bombesin receptor (NMB-R) with properties distinct from a GRP-preferring bombesin receptor (GRP-R) reported previously. In particular, the NMB-R shows higher affinity binding to NMB than to GRP in BALB 3T3 fibroblasts expressing the cloned NMB-R. The distinct regional distribution of NMB-R and GRP-R mRNA in the brain suggests that both bombesin receptor subtypes play independent roles in mediating many of the dramatic effects of bombesin-like peptides in the central nervous system.	CATHOLIC UNIV LOUVAIN, INST CELLULAR & MOLEC PATHOL, CELLULAR GENET UNIT, B-1200 BRUSSELS, BELGIUM; TULANE UNIV, MED CTR, DEPT MED, PEPTIDE RES LABS, NEW ORLEANS, LA 70112 USA; NIDDKD, DIGEST DIS BRANCH, BETHESDA, MD 20892 USA	Universite Catholique Louvain; Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	WADA, E (corresponding author), NINCDS, NEUROCHEM LAB, BETHESDA, MD 20892 USA.							ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; BATTEY JF, 1991, P NATL ACAD SCI USA, V88, P395, DOI 10.1073/pnas.88.2.395; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; DAVIS LG, 1986, BASIC METHODS MOL BI, P1; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; ERSPAMER GF, 1988, REGUL PEPTIDES, V21, P1; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; JENSEN RT, 1978, P NATL ACAD SCI USA, V75, P6139, DOI 10.1073/pnas.75.12.6139; KRIS RM, 1987, J BIOL CHEM, V262, P11215; LADENHEIM EE, 1990, BRAIN RES, V537, P233, DOI 10.1016/0006-8993(90)90363-G; LEBACQVERHEYDEN AM, 1990, HDB EXPT PHARM, V95, P71; LEE MC, 1991, IN PRESS MOL CELL NE; LUPUMEIRI M, 1989, PFLUG ARCH EUR J PHY, V413, P498, DOI 10.1007/BF00594180; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MCDONALD TJ, 1979, BIOCHEM BIOPH RES CO, V90, P227, DOI 10.1016/0006-291X(79)91614-0; MINAMINO N, 1983, BIOCHEM BIOPH RES CO, V114, P541, DOI 10.1016/0006-291X(83)90814-8; MOODY TW, 1988, ANN NY ACAD SCI, V547, P114, DOI 10.1111/j.1749-6632.1988.tb23880.x; MOODY TW, 1978, P NATL ACAD SCI USA, V75, P5372, DOI 10.1073/pnas.75.11.5372; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; REGOLI D, 1988, ANN NY ACAD SCI, V547, P158, DOI 10.1111/j.1749-6632.1988.tb23884.x; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P2936, DOI 10.1073/pnas.80.10.2936; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SPINDEL ER, 1990, MOL ENDOCRINOL, V4, P1956, DOI 10.1210/mend-4-12-1956; TACHE Y, 1982, TRENDS NEUROSCI, V5, P431, DOI 10.1016/0166-2236(82)90234-X; VONSCHRENCK T, 1990, AM J PHYSIOL, V259, pG468, DOI 10.1152/ajpgi.1990.259.3.G468; VONSCHRENCK T, 1989, AM J PHYSIOL, V256, pG747, DOI 10.1152/ajpgi.1989.256.4.G747; WADA E, 1990, J NEUROSCI, V10, P2917; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WANG LH, 1990, J BIOL CHEM, V265, P15695; WOLF SS, 1983, EUR J PHARMACOL, V87, P163, DOI 10.1016/0014-2999(83)90066-3; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649; ZACHARY I, 1985, P NATL ACAD SCI USA, V82, P7616, DOI 10.1073/pnas.82.22.7616; ZARBIN MA, 1985, J NEUROSCI, V5, P429	34	283	290	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1991	6	3					421	430		10.1016/0896-6273(91)90250-4	http://dx.doi.org/10.1016/0896-6273(91)90250-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1848080				2022-12-28	WOS:A1991FC47000010
J	ROBITAILLE, R; ADLER, EM; CHARLTON, MP				ROBITAILLE, R; ADLER, EM; CHARLTON, MP			STRATEGIC LOCATION OF CALCIUM CHANNELS AT TRANSMITTER RELEASE SITES OF FROG NEUROMUSCULAR SYNAPSES	NEURON			English	Article							EATON MYASTHENIC SYNDROME; ACETYLCHOLINE RECEPTORS; SKELETAL-MUSCLE; ACTIVE ZONES; OMEGA-CONOTOXIN; NERVE TERMINALS; MOTOR ENDPLATE; JUNCTIONS; MEMBRANE; PEPTIDE	The localization of CA2+ channels relative to the position of transmitter release sites was investigated at the frog neuromuscular junction (NMJ). Ca2+ channels were labeled with fluorescently tagged omega-conotoxin GVIA, an irreversible Ca2+ channel ligand, and observed with a confocal laser scanning microscope. The Ca2+ channel labeling almost perfectly matched that of acetylcholine receptors which were labeled with fluorescent alpha-bungarotoxin. This indicates that groups of Ca2+ channels are localized exclusively at the active zones of the frog NMJ. Cross sections of NMJs showed that Ca2+ channels are clustered on the presynaptic membrane adjacent to the postsynaptic membrane.			ROBITAILLE, R (corresponding author), UNIV TORONTO, DEPT PHYSIOL, TORONTO M5S 1A8, ONTARIO, CANADA.			Robitaille, Richard/0000-0001-6628-0146; Adler, Elizabeth M/0000-0001-8613-1252				ANDERSON MJ, 1974, J PHYSIOL-LONDON, V237, P385, DOI 10.1113/jphysiol.1974.sp010487; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; AUGUSTINE GJ, 1989, SECRETION ITS CONTRO, P203; BETZ W, 1971, NATURE-NEW BIOL, V232, P94, DOI 10.1038/newbio232094a0; CECCARELLI B, 1979, J CELL BIOL, V81, P163, DOI 10.1083/jcb.81.1.163; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; CHARLTON MP, 1990, BRAIN RES, V525, P133, DOI 10.1016/0006-8993(90)91328-E; COUTEAUX R, 1974, CR ACAD SCI D NAT, V278, P291; CRUZ LJ, 1988, CURR TOP MEMBR TRANS, V33, P417; DONAHUE BS, 1987, CELL CALCIUM, V8, P437, DOI 10.1016/0143-4160(87)90027-3; DREYER F, 1973, BRAIN RES, V62, P373, DOI 10.1016/0006-8993(73)90699-9; FUKUOKA T, 1987, ANN NEUROL, V22, P193, DOI 10.1002/ana.410220203; FUKUOKA T, 1987, ANN NEUROL, V22, P200, DOI 10.1002/ana.410220204; GRAY WR, 1988, ANNU REV BIOCHEM, V57, P665, DOI 10.1146/annurev.bi.57.070188.003313; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JONES OT, 1989, SCIENCE, V244, P1189, DOI 10.1126/science.2543080; Katz B., 1969, RELEASE NEURAL TRANS; KERR LM, 1984, NATURE, V308, P282, DOI 10.1038/308282a0; KIM YI, 1988, SCIENCE, V239, P405, DOI 10.1126/science.2447652; LINDGREN CA, 1989, J PHYSIOL-LONDON, V414, P201, DOI 10.1113/jphysiol.1989.sp017684; LLINAS R, 1981, BIOPHYS J, V33, P289, DOI 10.1016/S0006-3495(81)84898-9; LLINAS RR, 1977, NEUROSCI RES PROG B, V15, P563; LLINAS RR, 1977, APPROACHES CELL BIOL, P139; MATTHEWSBELLINGER J, 1978, J PHYSIOL-LONDON, V279, P197, DOI 10.1113/jphysiol.1978.sp012340; MCMAHAN UJ, 1972, PROC R SOC SER B-BIO, V181, P421, DOI 10.1098/rspb.1972.0059; MULLONEY B, 1973, INTRACELLULAR STAINI, P99; NASI E, 1985, BIOPHYS J, V47, P735, DOI 10.1016/S0006-3495(85)83972-2; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; PEPER K, 1972, PROC R SOC SER B-BIO, V181, P431, DOI 10.1098/rspb.1972.0060; PEPER K, 1974, CELL TISSUE RES, V149, P437; PUMPLIN DW, 1983, J NEUROCYTOL, V12, P317, DOI 10.1007/BF01148467; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; SANO K, 1987, EUR J PHARMACOL, V141, P235, DOI 10.1016/0014-2999(87)90268-8; SHOTTON DM, 1989, J CELL SCI, V94, P175; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; YOSHIKAMI D, 1989, ANN NY ACAD SCI, V560, P230, DOI 10.1111/j.1749-6632.1989.tb24100.x; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032	39	345	349	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1990	5	6					773	779		10.1016/0896-6273(90)90336-E	http://dx.doi.org/10.1016/0896-6273(90)90336-E			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ381	1980068				2022-12-28	WOS:A1990EQ38100004
J	FAISSNER, A; KRUSE, J				FAISSNER, A; KRUSE, J			J1-TENASCIN IS A REPULSIVE SUBSTRATE FOR CENTRAL-NERVOUS-SYSTEM NEURONS	NEURON			English	Article											FAISSNER, A (corresponding author), UNIV HEIDELBERG,DEPT NEUROBIOL,NEUENHEIMER FELD 364,W-6900 HEIDELBERG,GERMANY.		Faissner, Andreas/A-5314-2008	Faissner, Andreas/0000-0002-2211-8259				BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BOURDON MA, 1985, J CELL BIOCHEM, V28, P183, DOI 10.1002/jcb.240280302; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIQUET M, 1984, J CELL BIOL, V98, P1937, DOI 10.1083/jcb.98.6.1937; CHIQUET M, 1984, J CELL BIOL, V98, P1926, DOI 10.1083/jcb.98.6.1926; CHIQUETEHRISMANN R, 1986, CELL, V47, P131, DOI 10.1016/0092-8674(86)90374-0; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; CHUONG CM, 1987, J CELL BIOL, V104, P331, DOI 10.1083/jcb.104.2.331; COLLINS F, 1978, P NATL ACAD SCI USA, V75, P5210, DOI 10.1073/pnas.75.10.5210; CROSSIN KL, 1986, J CELL BIOL, V102, P1917, DOI 10.1083/jcb.102.5.1917; CROSSIN KL, 1989, DEV BIOL, V136, P381, DOI 10.1016/0012-1606(89)90264-9; EPPERLEIN HH, 1988, DEVELOPMENT, V103, P743; ERICKSON HP, 1984, NATURE, V311, P267, DOI 10.1038/311267a0; ERICKSON HP, 1989, ANNU REV CELL BIOL, V5, P71, DOI 10.1146/annurev.cb.05.110189.000443; FAISSNER A, 1985, EMBO J, V4, P3105, DOI 10.1002/j.1460-2075.1985.tb04052.x; FAISSNER A, 1988, DIFFERENTIATION, V37, P104, DOI 10.1111/j.1432-0436.1988.tb00802.x; FAISSNER A, 1990, J NEUROCHEM, V54, P1004, DOI 10.1111/j.1471-4159.1990.tb02350.x; FISCHER G, 1982, NEUROSCI LETT, V29, P297, DOI 10.1016/0304-3940(82)90333-0; FRIEDLANDER DR, 1988, J CELL BIOL, V107, P2329, DOI 10.1083/jcb.107.6.2329; GRUMET M, 1985, P NATL ACAD SCI USA, V82, P8075, DOI 10.1073/pnas.82.23.8075; HALFTER W, 1989, DEV BIOL, V132, P14, DOI 10.1016/0012-1606(89)90200-5; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HOFFMAN S, 1987, P NATL ACAD SCI USA, V84, P2523, DOI 10.1073/pnas.84.8.2523; HOFFMAN S, 1988, J CELL BIOL, V106, P519, DOI 10.1083/jcb.106.2.519; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; JONES FS, 1989, P NATL ACAD SCI USA, V86, P1905, DOI 10.1073/pnas.86.6.1905; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; LAGENAUR C, 1980, DEV BIOL, V79, P367, DOI 10.1016/0012-1606(80)90122-0; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LIESI P, 1983, J CELL BIOL, V96, P920, DOI 10.1083/jcb.96.3.920; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; MACKIE EJ, 1988, DEVELOPMENT, V102, P237; MERRIL CR, 1982, ELECTROPHORESIS, V3, P17, DOI 10.1002/elps.1150030104; PESHEVA P, 1989, J CELL BIOL, V109, P1765, DOI 10.1083/jcb.109.4.1765; POLTORAK M, 1987, J CELL BIOL, V105, P1893, DOI 10.1083/jcb.105.4.1893; PRICE J, 1985, J NEUROSCI, V5, P2205; PROBSTMEIER R, 1990, J NEUROCHEM, V54, P1016, DOI 10.1111/j.1471-4159.1990.tb02351.x; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RATHJEN FG, 1984, EMBO J, V3, P1; RIOU JF, 1990, DEV BIOL, V137, P305, DOI 10.1016/0012-1606(90)90256-I; ROUSSELET A, 1988, DEV BIOL, V129, P495, DOI 10.1016/0012-1606(88)90395-8; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SCHNITZER J, 1981, J NEUROIMMUNOL, V1, P429, DOI 10.1016/0165-5728(81)90022-9; SCHNITZER J, 1981, J NEUROIMMUNOL, V1, P471, DOI 10.1016/0165-5728(81)90024-2; SPRING J, 1989, CELL, V59, P325, DOI 10.1016/0092-8674(89)90294-8; STEINDLER DA, 1989, DEV BIOL, V131, P243, DOI 10.1016/S0012-1606(89)80056-9; STEINDLER DA, 1990, EXP NEUROL, V109, P35, DOI 10.1016/S0014-4886(05)80007-X; STEINDLER DA, 1989, COMMENTS DEV NEUROBI, V1, P29; STERN CD, 1989, DEVELOPMENT, V107, P309; TAN SS, 1987, P NATL ACAD SCI USA, V84, P7977, DOI 10.1073/pnas.84.22.7977; TROTTER J, 1989, J NEUROSCI RES, V22, P369, DOI 10.1002/jnr.490220402	55	366	367	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1990	5	5					627	637		10.1016/0896-6273(90)90217-4	http://dx.doi.org/10.1016/0896-6273(90)90217-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ868	1699568				2022-12-28	WOS:A1990EJ86800007
J	BANERJEE, U; ZIPURSKY, SL				BANERJEE, U; ZIPURSKY, SL			THE ROLE OF CELL-CELL INTERACTION IN THE DEVELOPMENT OF THE DROSOPHILA VISUAL-SYSTEM	NEURON			English	Review									UNIV CALIF LOS ANGELES, DEPT BIOL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT BIOL CHEM, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	BANERJEE, U (corresponding author), UNIV CALIF LOS ANGELES, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA.			Zipursky, Stephen/0000-0001-5630-7181				BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; BANERJEE U, 1987, CELL, V51, P151, DOI 10.1016/0092-8674(87)90020-1; BASLER K, 1988, CELL, V54, P299; BASLER K, 1989, SCIENCE, V243, P931, DOI 10.1126/science.2493159; BECKER HJ, 1957, Z INDUKT ABSTAMM VER, V88, P333, DOI 10.1007/BF00309128; BOWTELL DDL, 1989, CELL, V56, P931, DOI 10.1016/0092-8674(89)90626-0; BOWTELL DDL, 1988, GENE DEV, V2, P620, DOI 10.1101/gad.2.6.620; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; CAMPOSORTEGA JA, 1979, ROUX ARCH DEV BIOL, V186, P27, DOI 10.1007/BF00848106; CARROLL SB, 1989, GENE DEV, V3, P905, DOI 10.1101/gad.3.6.905; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GARCIABELLIDO A, 1969, J EXP ZOOL, V170, P61, DOI 10.1002/jez.1401700106; GURDON JB, 1987, DEVELOPMENT, V99, P285; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; Heisenberg M., 1984, VISION DROSOPHILA GE; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; JOHANSEN KM, 1989, J CELL BIOL, V109, P2427, DOI 10.1083/jcb.109.5.2427; Kankel D.R., 1980, Genetics and Biology of Drosophila, V2d, P295; KARPILOW J, 1989, GENE DEV, V3, P1834, DOI 10.1101/gad.3.12a.1834; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; LAWRENCE PA, 1979, DEV BIOL, V71, P142, DOI 10.1016/0012-1606(79)90088-5; LEBOVITZ RM, 1986, DEV BIOL, V117, P663, DOI 10.1016/0012-1606(86)90335-0; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; LOPRESTI V, 1973, P NATL ACAD SCI USA, V70, P433, DOI 10.1073/pnas.70.2.433; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MACAGNO ER, 1979, DEV BIOL, V73, P206, DOI 10.1016/0012-1606(79)90064-2; MEINERTZHAGEN IA, 1973, DEV NEUROBIOLOGY ART, P51; MELAMED J, 1975, J ULTRA MOL STRUCT R, V51, P79, DOI 10.1016/S0022-5320(75)80010-4; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; MOSES K, 1989, NATURE, V336, P489; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; OLIVER G, 1988, EMBO J, V7, P3199, DOI 10.1002/j.1460-2075.1988.tb03187.x; POODRY CA, 1973, DEV BIOL, V53, P217; POULSON D, 1987, P NATL ACAD SCI USA, V23, P133; Power ME, 1943, J EXP ZOOL, V94, P33, DOI 10.1002/jez.1400940103; PRICE J, 1988, DEVELOPMENT, V104, P473; PRICE JV, 1989, CELL, V56, P1085, DOI 10.1016/0092-8674(89)90641-7; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; READY DF, 1986, CELL DEV BIOL EYE, P97; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; SAINT R, 1988, NATURE, V334, P151, DOI 10.1038/334151a0; SCHEJTER ED, 1989, CELL, V56, P1093, DOI 10.1016/0092-8674(89)90642-9; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; TECHNAU GM, 1987, P NATL ACAD SCI USA, V84, P4500, DOI 10.1073/pnas.84.13.4500; TOMLINSON A, 1988, CELL, V55, P771, DOI 10.1016/0092-8674(88)90133-X; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; TOMLINSON A, 1985, J EMBRYOL EXP MORPH, V89, P313; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; TOMLINSON A, 1986, SCIENCE, V231, P400, DOI 10.1126/science.231.4736.400; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; ZAKANY J, 1988, NEURON, V1, P679, DOI 10.1016/0896-6273(88)90167-5	66	150	150	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1990	4	2					177	187		10.1016/0896-6273(90)90093-U	http://dx.doi.org/10.1016/0896-6273(90)90093-U			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT254	1968343				2022-12-28	WOS:A1990CT25400001
J	KENNEDY, TE; KUHL, D; BARZILAI, A; SWEATT, JD; KANDEL, ER				KENNEDY, TE; KUHL, D; BARZILAI, A; SWEATT, JD; KANDEL, ER			LONG-TERM SENSITIZATION TRAINING IN APLYSIA LEADS TO AN INCREASE IN CALRETICULIN, A MAJOR PRESYNAPTIC CALCIUM-BINDING PROTEIN	NEURON			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; SYSTEMIC LUPUS-ERYTHEMATOSUS; GILL-WITHDRAWAL REFLEX; HEAT-SHOCK PROTEINS; SENSORY NEURONS; ENDOPLASMIC-RETICULUM; HETEROSYNAPTIC FACILITATION; STRESS PROTEINS; CA-2+ STORE; SEQUENCE	Long-term memory for sensitization in Aplysia requires new protein and RNA synthesis. Here, we identify a late protein as calreticulin, the major Ca2+-binding protein of the lumen of the endoplasmic reticulum. An antiserum against Aplysia calreticulin reveals an enrichment of calreticulin immunoreactivity in presynaptic varicosities. Quantitative S1 nuclease analysis indicates that the steady-state level of calreticulin mRNA in Aplysia sensory neurons increases during the maintenance phase of long-term sensitization. The finding that this mRNA increases in expression late, some time after training, is consistent with the idea that long-term neuromodulatory changes underlying sensitization may depend on a cascade of gene expression in which the induction of early regulatory genes leads to the expression of late effector genes.	HOWARD HUGHES MED INST, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA	Howard Hughes Medical Institute; Columbia University			Kuhl, Dietmar/A-4689-2009	Kuhl, Dietmar/0000-0002-4772-6701; Sweatt, J. David/0000-0003-3567-485X				AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1979, J NEUROCYTOL, V8, P415, DOI 10.1007/BF01214801; BAKSH S, 1991, J BIOL CHEM, V266, P21458; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; BLUMENFELD H, 1990, NEURON, V5, P487, DOI 10.1016/0896-6273(90)90088-W; BRUNET JF, 1991, SCIENCE, V252, P856, DOI 10.1126/science.1840700; BURTON PR, 1985, J NEUROSCI, V11, P347; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; CASTELLUCCI VF, 1988, NEURON, V1, P321, DOI 10.1016/0896-6273(88)90080-3; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CHENG SY, 1987, J BIOL CHEM, V262, P11221; COLLINS JH, 1989, BIOCHEM BIOPH RES CO, V164, P575, DOI 10.1016/0006-291X(89)91758-0; DIERKS P, 1983, CELL, V32, P695, DOI 10.1016/0092-8674(83)90055-7; DUCE IR, 1978, NEUROSCIENCE, V3, P837, DOI 10.1016/0306-4522(78)90036-2; FINK LA, 1988, J NEUROSCI, V8, P2544; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; FLIEGEL L, 1989, BIOCHIM BIOPHYS ACTA, V982, P1, DOI 10.1016/0005-2736(89)90166-1; FREIHOFER D, 1990, HISTOCHEM J, V22, P63, DOI 10.1007/BF01885783; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; GLANZMAN DL, 1989, J NEUROSCI, V9, P4200; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GREENBERG SG, 1985, J NEUROSCI, V5, P1239; HEARING VJ, 1986, J NATL CANCER I, V77, P763, DOI 10.1093/jnci/77.3.763; HENKART MP, 1978, SCIENCE, V202, P1300, DOI 10.1126/science.725607; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; KENNEDY TE, 1988, NATURE, V336, P499, DOI 10.1038/336499a0; KENNEDY TE, 1988, P NATL ACAD SCI USA, V85, P7008, DOI 10.1073/pnas.85.18.7008; KISTLER HB, 1985, J NEUROSCI, V5, P72; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRAUSE KH, 1990, BIOCHEM J, V270, P545, DOI 10.1042/bj2700545; KUHL D, 1987, CELL, V50, P1057, DOI 10.1016/0092-8674(87)90172-3; KUHL D, 1992, J CELL BIOL, V119, P1069, DOI 10.1083/jcb.119.5.1069; LEADER DP, 1979, TRENDS BIOCHEM SCI, V4, P205, DOI 10.1016/0968-0004(79)90081-1; LEE AS, 1987, TRENDS BIOCHEM SCI, V12, P20, DOI 10.1016/0968-0004(87)90011-9; LINDSEY JD, 1985, J NEUROSCI, V5, P3135; MACER DRJ, 1988, J CELL SCI, V91, P61; Maniatis T., 1982, MOL CLONING; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; MCCAULIFFE DP, 1990, J CLIN INVEST, V86, P332, DOI 10.1172/JCI114704; MCCAULIFFE DP, 1992, J BIOL CHEM, V267, P2557; MCGRAW CF, 1980, J CELL BIOL, V85, P228, DOI 10.1083/jcb.85.2.228; MEDCALF RL, 1990, J BIOL CHEM, V265, P14618; MILNER RE, 1991, J BIOL CHEM, V266, P7155; MINOTA S, 1988, J CLIN INVEST, V81, P106, DOI 10.1172/JCI113280; MINOTA S, 1988, J EXP MED, V168, P1475, DOI 10.1084/jem.168.4.1475; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; PENG YW, 1991, NEURON, V6, P525, DOI 10.1016/0896-6273(91)90055-5; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; SOKOLOV BP, 1989, ANAL BIOCHEM, V176, P365, DOI 10.1016/0003-2697(89)90324-2; SOMLYO AP, 1985, NATURE, V314, P622, DOI 10.1038/314622a0; SOMLYO AP, 1984, NATURE, V309, P516, DOI 10.1038/309516b0; TING J, 1988, DNA-J MOLEC CELL BIO, V7, P275, DOI 10.1089/dna.1988.7.275; TREVES S, 1990, BIOCHEM J, V271, P473, DOI 10.1042/bj2710473; UNNASCH TR, 1988, J CLIN INVEST, V82, P262, DOI 10.1172/JCI113581; VANDELDEN C, 1992, BIOCHEM J, V281, P651, DOI 10.1042/bj2810651; VOLPE P, 1988, P NATL ACAD SCI USA, V85, P1091, DOI 10.1073/pnas.85.4.1091; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1543, DOI 10.1152/jn.1983.50.6.1543; WALTERS ET, 1985, J NEUROSCI, V5, P662; WATOWICH SS, 1988, MOL CELL BIOL, V8, P393, DOI 10.1128/MCB.8.1.393; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401; YOUNG RA, 1989, CELL, V59, P5, DOI 10.1016/0092-8674(89)90861-1	69	67	70	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1992	9	6					1013	1024		10.1016/0896-6273(92)90062-I	http://dx.doi.org/10.1016/0896-6273(92)90062-I			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1463604				2022-12-28	WOS:A1992KD71600002
J	RAJPARA, SM; GARCIA, PD; ROBERTS, R; ELIASSEN, JC; OWENS, DF; MALTBY, D; MYERS, RM; MAYERI, E				RAJPARA, SM; GARCIA, PD; ROBERTS, R; ELIASSEN, JC; OWENS, DF; MALTBY, D; MYERS, RM; MAYERI, E			IDENTIFICATION AND MOLECULAR-CLONING OF A NEUROPEPTIDE-Y HOMOLOG THAT PRODUCES PROLONGED INHIBITION IN APLYSIA NEURONS	NEURON			English	Article							EGG-LAYING HORMONE; BAG CELL NEURONS; AVIAN PANCREATIC-POLYPEPTIDE; AMINO-ACID-SEQUENCE; ABDOMINAL-GANGLION; MULTITRANSMITTER SYSTEM; SINGLE GENE; X-RAY; PEPTIDE; BRAIN	The neuroendocrine bag cell neurons of the marine mollusk Aplysia produce prolonged inhibition that lasts for more than 2 hr. We purified a peptide from the abdominal ganglion that mimics this inhibition. Mass spectrometry and microsequence analysis indicate that the peptide is 40 aa long and is amidated at its carboxyl terminus. It is highly homologous to vertebrate neuropeptide Y (NPY) and other members of the pancreatic polypeptide family. As determined from cloned cDNA, the gene coding for the precursor protein shares a common structural organization with genes encoding precursors of the vertebrate family. The peptides may therefore have arisen from a common ancestral gene. Bag cell neurons are immunoreactive for Aplysia NPY, and Northern blot analysis indicates that as with its vertebrate counterparts, the peptide is abundantly expressed in the CNS. This suggests that peptides related to NPY may have important functions in the nervous system of Aplysia as well as in other invertebrates.	UNIV CALIF SAN FRANCISCO,MASS SPECTROMETRY FACIL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	RAJPARA, SM (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143, USA.				NCRR NIH HHS [RR01614] Funding Source: Medline; NINDS NIH HHS [NS16490, NS16033] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016033, R01NS016490, P01NS016033] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN J, 1987, P NATL ACAD SCI USA, V84, P2532, DOI 10.1073/pnas.84.8.2532; ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; BARKER WC, 1972, ATLAS PROTEIN SEQUEN, P101; BRADBURY AF, 1991, TRENDS BIOCHEM SCI, V195, P67; BRANTON WD, 1978, P NATL ACAD SCI USA, V75, P5732, DOI 10.1073/pnas.75.11.5732; BROWN RO, 1989, J NEUROSCI, V9, P1443; BROWNELL P, 1979, SCIENCE, V204, P417, DOI 10.1126/science.35827; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; DAYHOFF R, 1972, NATIONAL BIOMEDICAL, P89; DOCKRAY GJ, 1981, NATURE, V293, P656, DOI 10.1038/293656a0; DUVE H, 1982, BIOCHEM J, V201, P429, DOI 10.1042/bj2010429; ELIASSEN JC, 1991, J NEUROBIOL, V22, P698, DOI 10.1002/neu.480220705; ERSPAMER V, 1962, EXPERIENTIA, V18, P58, DOI 10.1007/BF02138250; GLOVER I, 1983, BIOPOLYMERS, V22, P293, DOI 10.1002/bip.360220138; GLOVER ID, 1985, EUR J BIOCHEM, V142, P379; Gros E., 1967, METHOD ENZYMOL, V11, P238; HALTON DW, 1990, PARASITOL TODAY, V6, P284, DOI 10.1016/0169-4758(90)90254-2; HOMBERG U, 1990, CELL TISSUE RES, V259, P401, DOI 10.1007/BF01740767; HOUMARD J, 1972, P NATL ACAD SCI USA, V69, P3506, DOI 10.1073/pnas.69.12.3506; JANSEN RF, 1988, J NEUROSCI, V8, P3074; KIMMEL JR, 1975, J BIOL CHEM, V250, P9369; KOESTER J, 1989, J NEUROSCI, V9, P4078; KREINER T, 1989, MOL BRAIN RES, V6, P135, DOI 10.1016/0169-328X(89)90047-8; KUPFERMANN I, 1970, J NEUROPHYSIOL, V33, P877, DOI 10.1152/jn.1970.33.6.877; LUNDBERG JM, 1990, FUNDAM CLIN PHARM, V4, P373, DOI 10.1111/j.1472-8206.1990.tb00692.x; MAULE AG, 1991, PARASITOLOGY, V102, P309, DOI 10.1017/S0031182000062648; Mayeri E., 1985, P285; MAYERI E, 1979, J NEUROPHYSIOL, V42, P1165, DOI 10.1152/jn.1979.42.4.1165; MAYERI E, 1985, J NEUROSCI, V5, P2060; NAGASAWA H, 1986, P NATL ACAD SCI USA, V83, P5840, DOI 10.1073/pnas.83.16.5840; PFAFFINGER PJ, 1991, J NEUROSCI, V11, P918; PROUX JP, 1987, BIOCHEM BIOPH RES CO, V149, P180, DOI 10.1016/0006-291X(87)91621-4; PULST SM, 1986, NEUROSCI LETT, V70, P40, DOI 10.1016/0304-3940(86)90434-9; ROBERTS MH, 1987, CELL TISSUE RES, V248, P67, DOI 10.1007/BF01239964; ROTHMAN BS, 1983, P NATL ACAD SCI-BIOL, V80, P5753, DOI 10.1073/pnas.80.18.5753; Sambrook J, 1989, MOL CLONING LABORATO; SAWIN KE, 1992, J CELL SCI, V101, P303; SCHELLER RH, 1983, CELL, V32, P7, DOI 10.1016/0092-8674(83)90492-0; SCHOT LPC, 1981, CELL TISSUE RES, V216, P273, DOI 10.1007/BF00233620; SIGVARDT KA, 1986, J NEUROSCI, V6, P803; SMIT AB, 1988, NATURE, V331, P535, DOI 10.1038/331535a0; STONE KL, 1989, PRACTICAL GUIDE PROT, P33; TATEMOTO K, 1978, P NATL ACAD SCI USA, V75, P4115, DOI 10.1073/pnas.75.9.4115; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2514, DOI 10.1073/pnas.79.8.2514; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; TATEMOTO K, 1989, NEUROPEPTIDE Y, P13; Thorndyke M.C., 1989, P203; VANNOORDEN S, 1984, EVOLUTION TUMOUR PAT, P7; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WOOD SP, 1977, EUR J BIOCHEM, V78, P119, DOI 10.1111/j.1432-1033.1977.tb11720.x	50	108	119	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					505	513		10.1016/0896-6273(92)90188-J	http://dx.doi.org/10.1016/0896-6273(92)90188-J			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1524828				2022-12-28	WOS:A1992JM57100012
J	BITO, H; NAKAMURA, M; HONDA, Z; IZUMI, T; IWATSUBO, T; SEYAMA, Y; OGURA, A; KUDO, Y; SHIMIZU, T				BITO, H; NAKAMURA, M; HONDA, Z; IZUMI, T; IWATSUBO, T; SEYAMA, Y; OGURA, A; KUDO, Y; SHIMIZU, T			PLATELET-ACTIVATING-FACTOR (PAF) RECEPTOR IN RAT-BRAIN - PAF MOBILIZES INTRACELLULAR CA2+ IN HIPPOCAMPAL-NEURONS	NEURON			English	Article							ANTERIOR-PITUITARY-CELLS; ALKYL ETHER ANALOG; GUINEA-PIG; SIGNAL TRANSDUCTION; MOLECULAR-CLONING; BINDING-SITES; LIPID EXTRACT; BOVINE BRAIN; EXPRESSION; CULTURE	Platelet-activating factor (PAF), an alkylether phospholipid, is produced in the brain when it is subjected to various stimuli. Using a Xenopus oocyte expression system, we obtained evidence for functional PAF receptor mRNA expression in rat brain. The presence of the PAF receptor was confirmed and shown to be quite ubiquitous in the CNS by RNA blot and radioligand binding studies. To investigate the neuronal functions of PAF, intracellular Ca2+ increase elicited by nanomolar PAF application was analyzed in cultured rat hippocampal cells. Fractions of NMDA-responsive cells and non-NMDA-responsive cells were shown to respond to PAF, suggesting a potential role for PAF in the Ca2+ signaling pathway in the hippocampus.	UNIV TOKYO,FAC MED,DEPT NEUROL,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,FAC MED,DEPT PHYSIOL CHEM & NUTR,BUNKYO KU,TOKYO 113,JAPAN; MITSUBISHI KASEI INST LIFE SCI,DEPT NEUROSCI,MACHIDA,TOKYO 194,JAPAN	University of Tokyo; University of Tokyo	BITO, H (corresponding author), UNIV TOKYO,FAC MED,DEPT BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN.		Bito, Haruhiko/A-8635-2008	Kudo, Yoshihisa/0000-0002-5978-8264; Bito, Haruhiko/0000-0001-6315-9594				BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARNES PJ, 1991, TRENDS BIOCHEM SCI, V16, P365, DOI 10.1016/0968-0004(91)90152-L; BENVENISTE J, 1979, CR ACAD SCI D NAT, V289, P1037; BENVENISTE J, 1972, J EXP MED, V136, P1356, DOI 10.1084/jem.136.6.1356; BENVENISTE J, 1989, ADV PROSTAG THROMB L, V19, P355; BERNARDINI R, 1989, ENDOCRINOLOGY, V125, P1067, DOI 10.1210/endo-125-2-1067; BLANK ML, 1979, BIOCHEM BIOPH RES CO, V90, P1194, DOI 10.1016/0006-291X(79)91163-X; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BUSSOLINO F, 1988, AM J PHYSIOL, V255, pC559, DOI 10.1152/ajpcell.1988.255.4.C559; BUSSOLINO F, 1986, J BIOL CHEM, V261, P6502; CAMORATTO AM, 1989, ENDOCRINOLOGY, V124, P1502, DOI 10.1210/endo-124-3-1502; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DELCERRO S, 1990, BEHAV NEURAL BIOL, V54, P213, DOI 10.1016/0163-1047(90)90595-W; DEMOPOULOS CA, 1979, J BIOL CHEM, V254, P9355; DENT G, 1989, EUR J PHARMACOL, V169, P313, DOI 10.1016/0014-2999(89)90029-0; DOMINGO MT, 1988, BIOCHEM BIOPH RES CO, V151, P730, DOI 10.1016/S0006-291X(88)80341-3; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCESCANGELI E, 1989, BIOCHEM BIOPH RES CO, V161, P107, DOI 10.1016/0006-291X(89)91567-2; GRANDISON L, 1990, ENDOCRINOLOGY, V127, P1786, DOI 10.1210/endo-127-4-1786; HANAHAN DJ, 1986, ANNU REV BIOCHEM, V55, P483, DOI 10.1146/annurev.bi.55.070186.002411; HODA Z, 1992, IN PRESS NATURAL IMM; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; HWANG SB, 1990, J LIPID MEDIATOR, V2, P123; JUNIER MP, 1988, ENDOCRINOLOGY, V123, P72, DOI 10.1210/endo-123-1-72; KORNECKI E, 1988, SCIENCE, V240, P1792, DOI 10.1126/science.3381103; KUDO Y, 1986, BRIT J PHARMACOL, V89, P191, DOI 10.1111/j.1476-5381.1986.tb11135.x; KUMAR R, 1988, BIOCHIM BIOPHYS ACTA, V963, P375, DOI 10.1016/0005-2760(88)90304-9; LEE TC, 1988, J BIOL CHEM, V263, P1755; LEE TC, 1986, J BIOL CHEM, V261, P5373; MARCHESELLI VL, 1990, J BIOL CHEM, V265, P9140; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MMEGURO H, 1992, NATURE, V357, P70; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MURPHY S, 1990, EUR J PHARM-MOLEC PH, V188, P399, DOI 10.1016/0922-4106(90)90200-H; NAKAMURA M, 1991, J BIOL CHEM, V266, P20400; OGURA A, 1988, EXP BRAIN RES, V73, P447, DOI 10.1007/BF00406601; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Sambrook J, 1989, MOL CLONING LABORATO; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; SHIMIZU T, 1992, IN PRESS BIOCH PHARM; SHIMIZU T, 1992, IN PRESS PAF RECEPTO; SHUKLA SD, 1991, LIPIDS, V26, P1028, DOI 10.1007/BF02536496; SNYDER F, 1989, P SOC EXP BIOL MED, V190, P125; SOGOS V, 1990, J NEUROSCI RES, V27, P706, DOI 10.1002/jnr.490270431; SQUINTO SP, 1989, J NEUROSCI RES, V24, P558, DOI 10.1002/jnr.490240414; TAKANO T, 1991, BIOCHEM BIOPH RES CO, V177, P54, DOI 10.1016/0006-291X(91)91947-B; TOKUMURA A, 1987, BIOCHEM BIOPH RES CO, V145, P415, DOI 10.1016/0006-291X(87)91338-6; TOKUMURA A, 1989, J LIPID RES, V30, P219; YANG JP, 1991, BIOCHEM BIOPH RES CO, V174, P424, DOI 10.1016/0006-291X(91)91433-D; YE RD, 1991, BIOCHEM BIOPH RES CO, V180, P105, DOI 10.1016/S0006-291X(05)81261-6; YUE TL, 1990, J NEUROCHEM, V54, P1809, DOI 10.1111/j.1471-4159.1990.tb01239.x; YUE TL, 1991, NEUROSCIENCE, V41, P177, DOI 10.1016/0306-4522(91)90208-6	56	162	168	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					285	294		10.1016/0896-6273(92)90167-C	http://dx.doi.org/10.1016/0896-6273(92)90167-C			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1323312				2022-12-28	WOS:A1992JJ33200010
J	KRANER, SD; CHONG, JA; TSAY, HJ; MANDEL, G				KRANER, SD; CHONG, JA; TSAY, HJ; MANDEL, G			SILENCING THE TYPE-II SODIUM-CHANNEL GENE - A MODEL FOR NEURAL-SPECIFIC GENE-REGULATION	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; RAT SKELETAL-MUSCLE; MESSENGER-RNAS; NA+ CHANNEL; TRANSCRIPTIONAL REPRESSION; GROWTH-FACTOR; SCG10 GENE; EXPRESSION; NEURONS; CELLS	Neural-specific expression of a sodium channel mini-gene has been shown to be mediated by a 28 bp silencer element, RE1, located in the 5' flanking region of the gene. This element is active exclusively in cell lines that do not express the endogenous brain type II sodium channel gene, including fibroblast, skeletal muscle, and certain neuronal cell lines. All of these non-type II expressing cells contain RE1-binding complexes. On the basis of mutational analysis and in vivo "repressor trap" experiments, we propose that cell-specific RE1-binding proteins are responsible, at least in part, for restricting expression of the type II sodium channel gene to specific neurons in the vertebrate nervous system.			KRANER, SD (corresponding author), SUNY STONY BROOK, DEPT NEUROBIOL & BEHAV, STONY BROOK, NY 11794 USA.							AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; BECKH S, 1990, FEBS LETT, V262, P317, DOI 10.1016/0014-5793(90)80218-8; BOSSU JL, 1984, NEUROSCI LETT, V51, P241, DOI 10.1016/0304-3940(84)90558-5; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; COOPERMAN SS, 1987, P NATL ACAD SCI USA, V84, P8721, DOI 10.1073/pnas.84.23.8721; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GRUBMAN SA, 1988, CURR TOP MEMBR TRANS, V33, P277; JOHNSON WA, 1990, NATURE, V343, P467, DOI 10.1038/343467a0; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KEMP LM, 1990, NEURON, V4, P215, DOI 10.1016/0896-6273(90)90096-X; KOFF A, 1988, J VIROL, V62, P4096, DOI 10.1128/JVI.62.11.4096-4103.1988; KORNER M, 1989, NEURON, V3, P563, DOI 10.1016/0896-6273(89)90266-3; KOSTYUK PG, 1981, NEUROSCIENCE, V6, P2423, DOI 10.1016/0306-4522(81)90088-9; LAMB NJC, 1990, CELL, V61, P485, DOI 10.1016/0092-8674(90)90530-R; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; LIVANT DL, 1991, DEVELOPMENT, V113, P385; MANDEL G, 1992, J MEMBRANE BIOL, V125, P193; MANDEL G, 1988, P NATL ACAD SCI USA, V85, P924, DOI 10.1073/pnas.85.3.924; MANDEL G, 1992, IN PRESS ANN REV NEU; MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MORI N, 1990, NEURON, V4, P583, DOI 10.1016/0896-6273(90)90116-W; PIERCE JW, 1991, MOL CELL BIOL, V11, P1431, DOI 10.1128/MCB.11.3.1431; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; SILLS MN, 1989, J CLIN INVEST, V84, P331, DOI 10.1172/JCI114158; STRUHL K, 1991, NEURON, V7, P177, DOI 10.1016/0896-6273(91)90256-Y; TREACY MN, 1991, NATURE, V350, P577, DOI 10.1038/350577a0; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X; WUENSCHELL CW, 1990, NEURON, V4, P595, DOI 10.1016/0896-6273(90)90117-X; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	40	292	303	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1992	9	1					37	44		10.1016/0896-6273(92)90218-3	http://dx.doi.org/10.1016/0896-6273(92)90218-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1321645				2022-12-28	WOS:A1992JE75600004
J	ZHENG, F; GALLAGHER, JP				ZHENG, F; GALLAGHER, JP			METABOTROPIC GLUTAMATE RECEPTORS ARE REQUIRED FOR THE INDUCTION OF LONG-TERM POTENTIATION	NEURON			English	Article							DORSOLATERAL SEPTAL NEURONS; AMINO-ACID RECEPTOR; RAT HIPPOCAMPUS; SYNAPTIC TRANSMISSION; PHOSPHOINOSITIDE HYDROLYSIS; INDUCED HYPERPOLARIZATIONS; STRIATAL NEURONS; XENOPUS OOCYTES; LATERAL SEPTUM; TRANS-ACPD	Recent observations have led to the suggestion that the metabotropic glutamate receptor may play a role in the induction or maintenance of long-term potentiation (LTP). However, experimental evidence supporting a role for this receptor in the induction of LTP is still inconclusive and controversial. Here we report that, in rat dorsolateral septal nucleus (DLSN) neurons, which have the highest density of metabotropic receptors and show functional responses, the induction of LTP is not blocked by the NMDA receptor antagonist 2-amino-5-phosphonovalerate, but is blocked by two putative metabotropic glutamate receptor antagonists, L-2-amino-3-phosphonopropionic acid and L-2-amino-4-phosphonobutyrate. Furthermore, superfusion of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid, a selective metabotropic glutamate agonist, resulted in a long-lasting potentiation of synaptic transmission similar to that induced by tetanic stimuli. Our results demonstrated that activation of post-synaptic metabotropic receptors is both necessary and sufficient for the induction of LTP in the DLSN, and we suggest that such a mechanism may be important at other CNS synapses.			ZHENG, F (corresponding author), UNIV TEXAS, MED BRANCH, DEPT PHARMACOL & TOXICOL, GALVESTON, TX 77550 USA.		Zheng, Fang/J-1400-2016	Zheng, Fang/0000-0002-6626-1938	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039163] Funding Source: NIH RePORTER; NIMH NIH HHS [MH39163] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BASKYS A, 1991, EUR J PHARMACOL, V193, P131, DOI 10.1016/0014-2999(91)90213-A; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; CHA JHJ, 1990, NEUROSCI LETT, V113, P78, DOI 10.1016/0304-3940(90)90498-X; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DESAI MA, 1991, J NEUROPHYSIOL, V66, P40, DOI 10.1152/jn.1991.66.1.40; EVANS RH, 1982, BRIT J PHARMACOL, V75, P65, DOI 10.1111/j.1476-5381.1982.tb08758.x; FANG Z, 1992, EUR J PHARMACOL, V211, P281, DOI 10.1016/0014-2999(92)90542-C; GALLAGHER JP, 1989, J PHYSIOL-LONDON, V418, P367, DOI 10.1113/jphysiol.1989.sp017846; GOH JW, 1989, SCIENCE, V244, P980, DOI 10.1126/science.2543072; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HASUO H, 1990, J NEUROPHYSIOL, V64, P1838, DOI 10.1152/jn.1990.64.6.1838; HASUO H, 1988, NEUROSCI LETT, V86, P77, DOI 10.1016/0304-3940(88)90186-3; IRVING AJ, 1990, EUR J PHARMACOL, V186, P363, DOI 10.1016/0014-2999(90)90462-F; ITO I, 1991, NEUROREPORT, V2, P333, DOI 10.1097/00001756-199106000-00008; IZUMI Y, 1991, NEUROSCI LETT, V122, P187, DOI 10.1016/0304-3940(91)90854-M; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; LANTHORN TH, 1984, BRAIN RES, V290, P174, DOI 10.1016/0006-8993(84)90750-9; LOVINGER DM, 1991, NEUROSCI LETT, V129, P17, DOI 10.1016/0304-3940(91)90710-B; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MAILLEUX P, 1991, BRAIN RES, V539, P203, DOI 10.1016/0006-8993(91)91622-8; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MANZONI O, 1990, MOL PHARMACOL, V38, P1; MANZONI OJJ, 1991, EUR J PHARM-MOLEC PH, V207, P231; MCGUINNESS N, 1991, EUR J PHARMACOL, V197, P231, DOI 10.1016/0014-2999(91)90529-Y; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; NICOLETTI F, 1986, J NEUROCHEM, V46, P40, DOI 10.1111/j.1471-4159.1986.tb12922.x; OTANI S, 1991, EUR J PHARMACOL, V205, P325, DOI 10.1016/0014-2999(91)90920-L; PALMER E, 1989, EUR J PHARMACOL, V166, P585, DOI 10.1016/0014-2999(89)90383-X; RACINE RJ, 1983, BRAIN RES, V260, P217, DOI 10.1016/0006-8993(83)90676-5; REYMANN KG, 1989, NEUROSCI LETT, V98, P166, DOI 10.1016/0304-3940(89)90504-1; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; SCHOEPP D, 1990, TRENDS PHARMACOL SCI, V11, P508, DOI 10.1016/0165-6147(90)90052-A; SCHOEPP DD, 1989, J NEUROCHEM, V53, P1865, DOI 10.1111/j.1471-4159.1989.tb09254.x; SCHOEPP DD, 1991, J NEUROCHEM, V56, P1789, DOI 10.1111/j.1471-4159.1991.tb02082.x; SCHOEPP DD, 1991, EUR J PHARM-MOLEC PH, V207, P351, DOI 10.1016/0922-4106(91)90010-F; SCHOEPP DD, 1988, J NEUROCHEM, V50, P1605, DOI 10.1111/j.1471-4159.1988.tb03050.x; SCHOEPP DD, 1990, MOL PHARMACOL, V38, P222; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; STANTON PK, 1991, NEUROSCI LETT, V127, P61, DOI 10.1016/0304-3940(91)90895-Z; STEVENS DR, 1984, BRAIN RES, V305, P353, DOI 10.1016/0006-8993(84)90441-4; STEVENS DR, 1991, BRAIN RES, V558, P120, DOI 10.1016/0006-8993(91)90726-C; STEVENS DR, 1987, SYNAPSE, V1, P184, DOI 10.1002/syn.890010206; SWANSON LW, 1980, BRAIN RES, V197, P207, DOI 10.1016/0006-8993(80)90446-1; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; VANDENHOOFF P, 1989, BRAIN RES, V505, P181, DOI 10.1016/0006-8993(89)91440-6; WATSON GB, 1990, EUR J PHARMACOL, V179, P479, DOI 10.1016/0014-2999(90)90194-B; WONG LA, 1989, NATURE, V341, P439, DOI 10.1038/341439a0; ZHENG F, 1991, NEUROSCI LETT, V125, P147, DOI 10.1016/0304-3940(91)90013-J	51	148	153	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1992	9	1					163	172		10.1016/0896-6273(92)90231-2	http://dx.doi.org/10.1016/0896-6273(92)90231-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1352982				2022-12-28	WOS:A1992JE75600017
J	PTACEK, LJ; GEORGE, AL; BARCHI, RL; GRIGGS, RC; RIGGS, JE; ROBERTSON, M; LEPPERT, MF				PTACEK, LJ; GEORGE, AL; BARCHI, RL; GRIGGS, RC; RIGGS, JE; ROBERTSON, M; LEPPERT, MF			MUTATIONS IN AN S4 SEGMENT OF THE ADULT SKELETAL-MUSCLE SODIUM-CHANNEL CAUSE PARAMYOTONIA-CONGENITA	NEURON			English	Article							ADYNAMIA EPISODICA; MEMBRANE DEFECTS; POINT MUTATIONS; CDNA SEQUENCE; RAT-BRAIN; HUMAN DNA; MYOTONIA; POLYMORPHISMS; EXPRESSION; GENE	The periodic paralyses are a group of autosomal dominant muscle diseases sharing a common feature of episodic paralysis. In one form, paramyotonia congenita (PC), the paralysis usually occurs with muscle cooling. Electrophysiologic studies of muscle from PC patients have revealed temperature-dependent alterations in sodium channel (NaCh) function. This observation led to demonstration of genetic linkage of a skeletal muscle NaCh gene to a PC disease allele. We now report the use of the single-strand conformation polymorphism technique to define alleles specific to PC patients from three families. Sequencing of these alleles defined base pair changes within the same codon, which resulted in two distinct amino acid substitutions for a highly conserved arginine residue in the S4 helix of domain 4 in the adult skeletal muscle NaCh. These data establish the chromosome 17q NaCh locus as the PC gene and represent two mutations causing the distinctive, temperature-sensitive PC phenotype.	UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; UNIV UTAH,HLTH SCI CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84132; UNIV PENN,SCH MED,DAVID MAHONEY INST NEUROL SCI,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT MED,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104; UNIV ROCHESTER,SCH MED,DEPT NEUROL,ROCHESTER,NY 14642; W VIRGINIA UNIV,MED CTR,SCH MED,DEPT NEUROL,MORGANTOWN,WV 26506	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Rochester; West Virginia University	PTACEK, LJ (corresponding author), UNIV UTAH,HLTH SCI CTR,DEPT NEUROL,SALT LAKE CITY,UT 84132, USA.			Griggs, Robert/0000-0001-7988-4854	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018013] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-01862] Funding Source: Medline; NICHD NIH HHS [1 K11 HD00940-01] Funding Source: Medline; NINDS NIH HHS [NS-18013] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARCHI RL, 1987, TRENDS NEUROSCI, V10, P221, DOI 10.1016/0166-2236(87)90159-7; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; EBERS GC, 1991, ANN NEUROL, V30, P810, DOI 10.1002/ana.410300610; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GEORGE A L, 1992, Biophysical Journal, V61, pA108; GEORGE AL, 1991, GENOMICS, V9, P555, DOI 10.1016/0888-7543(91)90425-E; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; GRIGGS RC, 1978, ANN NEUROL, V3, P531, DOI 10.1002/ana.410030614; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KAYANO T, 1988, FEBS LETT, V228, P187, DOI 10.1016/0014-5793(88)80614-8; KOCH MC, 1991, HUM GENET, V88, P71, DOI 10.1007/BF00204932; KOCH MC, 1991, J MED GENET, V28, P583, DOI 10.1136/jmg.28.9.583; LEHMANNHORN F, 1981, MUSCLE NERVE, V4, P396, DOI 10.1002/mus.880040508; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P363, DOI 10.1002/mus.880100414; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P633, DOI 10.1002/mus.880100709; MANIATIS T, 1982, MOL CLONING LABORATO, P150; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PTACEK LJ, 1992, NEUROLOGY, V42, P431, DOI 10.1212/WNL.42.2.431; PTACEK LJ, 1991, AM J HUM GENET, V49, P851; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; RICH EC, 1894, MED NEWS, V65, P210; RIGGS JE, 1988, NEUROL CLIN, V6, P485, DOI 10.1016/S0733-8619(18)30856-9; RIGGS JE, 1977, ANN INTERN MED, V86, P169, DOI 10.7326/0003-4819-86-2-169; RIGGS JE, 1979, CLIN NEUROPHARMACOL, V4, P123; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; RUDEL R, 1989, MUSCLE NERVE, V12, P281; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X	38	227	230	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					891	897						7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1316765				2022-12-28	WOS:A1992HV46700008
J	CATARSI, S; DRAPEAU, P				CATARSI, S; DRAPEAU, P			LOSS OF EXTRASYNAPTIC CHANNEL MODULATION BY PROTEIN-KINASE-C UNDERLIES THE SELECTION OF SEROTONIN RESPONSES IN AN IDENTIFIED LEECH NEURON	NEURON			English	Article							FUNCTIONAL ACETYLCHOLINE-RECEPTORS; CILIARY GANGLION NEURONS; GENE-RELATED PEPTIDE; NEUROTRANSMITTER RECEPTORS; CHEMICAL TRANSMISSION; SENSORY NEURONS; ION CHANNELS; CULTURE; PHOSPHORYLATION; REINNERVATION	Pressure-sensitive (P) neurons contacted by serotonergic Retzius (R) neurons of the leech in culture selectively reduce a protein kinase C (PKC)-dependent cation response to serotonin and are innervated by the inhibitory, Cl--dependent synapse seen in vivo. We have examined whether the reduction of extrasynaptic cation channel modulation is due to changes in sensitivity of the channels to second messenger. In inside-out membrane patches from single, uncontacted P cells in culture, cation channel activity was increased by rat brain PKC and cofactors. In contrast, the activity of cation channels in patches isolated from P cells paired with R cells was unaffected by PKC. These results demonstrate the loss of extrasynaptic channel modulation by PKC during synapse formation.	MONTREAL GEN HOSP, RES INST, MONTREAL H3G 1A4, QUEBEC, CANADA	McGill University	CATARSI, S (corresponding author), MCGILL UNIV, CTR RES NEUROSCI, MONTREAL H3G 1A4, QUEBEC, CANADA.							AHMED S, 1990, BIOCHEM J, V272, P767, DOI 10.1042/bj2720767; BERG DK, 1989, TRENDS NEUROSCI, V12, P16, DOI 10.1016/0166-2236(89)90151-3; BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; CHANGEUX JP, 1990, COLD SH Q B, V55, P381; COHEN MW, 1987, J NEUROSCI, V7, P2849; COOPER E, 1986, J PHYSIOL-LONDON, V377, P409, DOI 10.1113/jphysiol.1986.sp016194; COOPER E, 1984, J PHYSIOL-LONDON, V351, P263, DOI 10.1113/jphysiol.1984.sp015244; DIETZEL ID, 1986, J PHYSIOL-LONDON, V372, P191, DOI 10.1113/jphysiol.1986.sp016004; DRAPEAU P, 1989, J NEUROBIOL, V20, P312, DOI 10.1002/neu.480200505; DRAPEAU P, 1989, J NEUROSCI, V9, P2502; DRAPEAU P, 1988, J NEUROSCI, V8, P4718; DRAPEAU P, 1990, NEURON, V4, P875, DOI 10.1016/0896-6273(90)90140-B; FALLS DL, 1990, COLD SPRING HARB SYM, V55, P397; FERRELL JE, 1989, J BIOL CHEM, V264, P20723; FONTAINE B, 1986, NEUROSCI LETT, V71, P59, DOI 10.1016/0304-3940(86)90257-0; FUCHS PA, 1981, J PHYSIOL-LONDON, V316, P203, DOI 10.1113/jphysiol.1981.sp013783; FUCHS PA, 1982, J PHYSIOL-LONDON, V323, P195, DOI 10.1113/jphysiol.1982.sp014068; GARCIAGIL M, 1991, COMP BIOCHEM PHYS B, V99, P65, DOI 10.1016/0305-0491(91)90008-2; GERSCHENFELD HM, 1973, PHYSIOL REV, V53, P1, DOI 10.1152/physrev.1973.53.1.1; GERSCHENFELD HM, 1974, J PHYSIOL-LONDON, V243, P457, DOI 10.1113/jphysiol.1974.sp010762; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; HWANG TC, 1989, SCIENCE, V244, P1351, DOI 10.1126/science.2472005; Kaczmarek LK, 1987, NEUROMODULATION BIOC; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; KRISTAN WB, 1983, J PHYSIOLOGY PARIS, V78, P743; LACERDA AE, 1988, NATURE, V335, P249, DOI 10.1038/335249a0; LI M, 1989, SCIENCE, V244, P1353, DOI 10.1126/science.2472006; LING BN, 1989, AM J PHYSIOL, V256, pF1094, DOI 10.1152/ajprenal.1989.256.6.F1094; LIU Y, 1989, PROC R SOC SER B-BIO, V236, P253, DOI 10.1098/rspb.1989.0023; MARGIOTTA JF, 1987, P NATL ACAD SCI USA, V84, P8155, DOI 10.1073/pnas.84.22.8155; MARGIOTTA JF, 1987, J NEUROSCI, V7, P3612; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; NEHER E, 1976, J PHYSIOL-LONDON, V258, P705, DOI 10.1113/jphysiol.1976.sp011442; NEW HV, 1986, NATURE, V323, P809, DOI 10.1038/323809a0; Nicholls JG, 1987, MAGNES LECTURE SERIE, V2, P1; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; Purves, 1985, PRINCIPLES NEURAL DE; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; SAKMANN B, 1983, SINGLE CHANNEL RECOR; SANCHEZARMASS S, 1991, J EXP BIOL, V155, P531; SCHOFIELD PR, 1990, TRENDS NEUROSCI, V13, P8, DOI 10.1016/0166-2236(90)90052-C; SHEARMAN MS, 1989, PHARMACOL REV, V41, P211; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WOLLHEIM CB, 1988, EMBO J, V7, P2443, DOI 10.1002/j.1460-2075.1988.tb03090.x	52	13	13	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1992	8	2					275	281		10.1016/0896-6273(92)90294-N	http://dx.doi.org/10.1016/0896-6273(92)90294-N			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1371218				2022-12-28	WOS:A1992HE93000008
J	RIVAS, RJ; BURMEISTER, DW; GOLDBERG, DJ				RIVAS, RJ; BURMEISTER, DW; GOLDBERG, DJ			RAPID EFFECTS OF LAMININ ON THE GROWTH CONE	NEURON			English	Article							INTERFERENCE CONTRAST MICROSCOPY; NEURONAL PROCESS OUTGROWTH; NEURITE EXTENSION; NERVOUS-SYSTEM; FIBRONECTIN; MICROTUBULES; MORPHOLOGY; INVITRO; CULTURE; AXONS	To gain insight into how laminin promotes neurite growth, high resolution video microscopy was used to determine the rapid effects of laminin on growth cone structure. Sympathetic growth cones in serum-free medium on polylysine substrate displayed extensive motility and protrusive activity and often had large lamellipodia. However, their neurites grew slowly because membranous organelles from the central region advanced into the lamellipodium only slowly. Acute addition of laminin accelerated growth severalfold and had visible effects on the growth cone within minutes. Laminin dramatically accelerated the advance of membranous organelles, which, with microtubules, rapidly filled the lamellipodium. Retraction of individual protrusions (filopodia and veils) was rapidly reduced. These effects of laminin are important in accelerating growth and suggest a mechanism for pathway selection by growing neurites.	COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032	Columbia University	RIVAS, RJ (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT PHARMACOL,NEW YORK,NY 10032, USA.				NINDS NIH HHS [NS25161] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025161] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALETTA JM, 1988, J NEUROSCI, V8, P1425; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; BANDTLOW C, 1990, J NEUROSCI, V10, P3837, DOI 10.1523/JNEUROSCI.10-12-03837.1990; BARONVANEVERCOOREN A, 1982, J NEUROSCI RES, V8, P179, DOI 10.1002/jnr.490080208; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BOVOLENTA P, 1987, J NEUROSCI, V7, P1447; BOZYCZKO D, 1986, J NEUROSCI, V6, P1241; BRAY D, 1979, J CELL SCI, V37, P391; BUNGE MB, 1981, SPINAL CORD RECONSTR, P99; BURMEISTER DW, 1991, CELL MOTIL CYTOSKEL, V19, P255, DOI 10.1002/cm.970190404; CHAMAK B, 1989, DEVELOPMENT, V106, P483; CONNOLLY JL, 1985, J NEUROSCI RES, V13, P183, DOI 10.1002/jnr.490130113; EDGAR D, 1988, J CELL BIOL, V106, P1299, DOI 10.1083/jcb.106.4.1299; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; GOLDBERG DJ, 1989, TRENDS NEUROSCI, V12, P503, DOI 10.1016/0166-2236(89)90110-0; GOLDBERG DJ, 1986, J CELL BIOL, V103, P1921, DOI 10.1083/jcb.103.5.1921; GOLDBERG DJ, 1991, NERVE GROWTH CONE, P79; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; HAMMARBACK JA, 1986, DEV BIOL, V117, P655, DOI 10.1016/0012-1606(86)90334-9; Hawrot E, 1979, Methods Enzymol, V58, P574; HAYDON PG, 1984, SCIENCE, V226, P561, DOI 10.1126/science.6093252; HEIDEMANN SR, 1990, J CELL BIOL, V111, P1949, DOI 10.1083/jcb.111.5.1949; KAPFHAMMER JP, 1986, J NEUROSCI, V6, P2527; LAMOUREUX P, 1990, J CELL BIOL, V110, P71, DOI 10.1083/jcb.110.1.71; LANDER AD, 1987, MOL NEUROBIOL, V1, P213, DOI 10.1007/BF02936609; LANDER AD, 1985, J CELL BIOL, V101, P893; LIESI P, 1985, EMBO J, V4, P2505, DOI 10.1002/j.1460-2075.1985.tb03963.x; LIM SS, 1990, J CELL BIOL, V111, P123, DOI 10.1083/jcb.111.1.123; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; ROGERS SL, 1986, DEV BIOL, V113, P429, DOI 10.1016/0012-1606(86)90177-6; ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0; SANDROCK AW, 1987, P NATL ACAD SCI USA, V84, P6934, DOI 10.1073/pnas.84.19.6934; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; TOMASELLI KJ, 1986, J CELL BIOL, V103, P2659, DOI 10.1083/jcb.103.6.2659; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; TURNER DC, 1987, DEV BIOL, V121, P510, DOI 10.1016/0012-1606(87)90187-4; [No title captured]	38	106	107	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1992	8	1					107	115		10.1016/0896-6273(92)90112-Q	http://dx.doi.org/10.1016/0896-6273(92)90112-Q			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1730003				2022-12-28	WOS:A1992HB18500009
J	QIU, MS; GREEN, SH				QIU, MS; GREEN, SH			NGF AND EGF RAPIDLY ACTIVATE P21RAS IN PC12 CELLS BY DISTINCT, CONVERGENT PATHWAYS INVOLVING TYROSINE PHOSPHORYLATION	NEURON			English	Article							NERVE GROWTH-FACTOR; RAT PHEOCHROMOCYTOMA CELLS; FACTOR RECEPTORS; PROTO-ONCOGENE; NEURONAL DIFFERENTIATION; KINASE-ACTIVITY; PROTEINS; GTPASE; GENE; INDUCTION	Activation of p21ras, demonstrated directly as an increase in p21ras-associated GTP, was induced rapidly but transiently by both nerve growth factor (NGF) and epidermal growth factor (EGF) in PC12 cells. The factors activate p21ras to equal extents and with virtually identical time courses. Growth factor-induced p21ras activation and tyrosine phosphorylation have similar time courses and sensitivities to genistein inhibition, indicating that p21ras activation is a result of tyrosine kinase activity. Furthermore, PC12 mutants lacking the Trk NGF receptor tyrosine kinase also lack NGF-inducible p21ras activation. The protein kinase inhibitor K252a and the methyltransferase inhibitor MTA abolish NGF-induced, but not EGF-induced, p21ras activation-effects correlated with inhibition only of NGF-induced tyrosine phosphorylation. In spite of differences in sensitivity to genistein, MTA, and K252a, EGF- and NGF-stimulated p21ras activation are not additive, implying that they do share at least one step in common.			QIU, MS (corresponding author), UNIV IOWA,DEPT BIOL,IOWA CITY,IA 52242, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026538] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 26538] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ANDRES RY, 1977, P NATL ACAD SCI USA, V74, P2785, DOI 10.1073/pnas.74.7.2785; Ausubel FM, 1988, MOL REPROD DEV; BADLEY JE, 1988, BIOTECHNIQUES, V6, P114; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CALISSANO P, 1980, NEUROSCIENCE, V5, P1033, DOI 10.1016/0306-4522(80)90184-0; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHO KO, 1989, MOL CELL BIOL, V9, P135, DOI 10.1128/MCB.9.1.135; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; CREMINS J, 1986, J CELL BIOL, V103, P887, DOI 10.1083/jcb.103.3.887; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DOWNWARD J, 1990, P NATL ACAD SCI USA, V87, P5998, DOI 10.1073/pnas.87.15.5998; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; GREEN SH, 1986, J BIOL CHEM, V261, P5316; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; GSCHWENDT M, 1989, BIOCHEM BIOPH RES CO, V164, P974, DOI 10.1016/0006-291X(89)91765-8; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; HASHIMOTO S, 1988, J CELL BIOL, V107, P1531, DOI 10.1083/jcb.107.4.1531; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HILL TD, 1990, SCIENCE, V248, P1660, DOI 10.1126/science.2163545; HOSANG M, 1985, J BIOL CHEM, V260, P655; HUFF KR, 1979, BIOCHEM BIOPH RES CO, V89, P176; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAMATA T, 1984, NATURE, V310, P147, DOI 10.1038/310147a0; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KIM UH, 1991, J BIOL CHEM, V266, P1359; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAROVICI P, 1989, J NEUROSCI RES, V23, P1, DOI 10.1002/jnr.490230102; LEV S, 1991, EMBO J, V10, P647, DOI 10.1002/j.1460-2075.1991.tb07993.x; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; MAHER PA, 1989, J NEUROSCI RES, V24, P29, DOI 10.1002/jnr.490240106; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; MILBRANDT J, 1986, P NATL ACAD SCI USA, V83, P4789, DOI 10.1073/pnas.83.13.4789; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MIYASAKA T, 1991, P NATL ACAD SCI USA, V88, P2653, DOI 10.1073/pnas.88.7.2653; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; QIU MS, 1991, J CELL BIOL, V115, P795, DOI 10.1083/jcb.115.3.795; RAUSCH DM, 1989, J NEUROSCI RES, V24, P49, DOI 10.1002/jnr.490240108; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SATOH T, 1988, FEBS LETT, V236, P185, DOI 10.1016/0014-5793(88)80311-9; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; SATOH T, 1990, P NATL ACAD SCI USA, V87, P7926, DOI 10.1073/pnas.87.20.7926; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; SCHANENKING C, 1991, NEURON, V6, P915, DOI 10.1016/0896-6273(91)90232-O; SEELEY PJ, 1984, J CELL BIOL, V98, P417, DOI 10.1083/jcb.98.2.417; SUTTER A, 1979, J BIOL CHEM, V254, P5972; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; THOENEN H, 1985, CIBA F SYMP, V116, P113; THOMSON TM, 1990, MOL CELL BIOL, V10, P1556, DOI 10.1128/MCB.10.4.1556; TOGARI A, 1983, BIOCHEM BIOPH RES CO, V114, P1189, DOI 10.1016/0006-291X(83)90688-5; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; TSAI MH, 1990, SCIENCE, V250, P982, DOI 10.1126/science.2237442; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; WEST M, 1990, FEBS LETT, V259, P245, DOI 10.1016/0014-5793(90)80019-F; WOLFMAN A, 1990, SCIENCE, V248, P67, DOI 10.1126/science.2181667	84	103	105	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					937	946		10.1016/0896-6273(91)90339-2	http://dx.doi.org/10.1016/0896-6273(91)90339-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1764245				2022-12-28	WOS:A1991GY43800007
J	BURNS, FR; VONKANNEN, S; GUY, L; RAPER, JA; KAMHOLZ, J; CHANG, S				BURNS, FR; VONKANNEN, S; GUY, L; RAPER, JA; KAMHOLZ, J; CHANG, S			DM-GRASP, A NOVEL IMMUNOGLOBULIN SUPERFAMILY AXONAL SURFACE PROTEIN THAT SUPPORTS NEURITE EXTENSION	NEURON			English	Article							NEURONAL GROWTH CONES; CELL-ADHESION MOLECULE; OUTGROWTH PROMOTING ACTIVITY; GRASSHOPPER EMBRYOS; POTENT SUBSTRATE; L1-LIKE MOLECULE; NERVOUS-SYSTEM; FLOOR PLATE; SPINAL-CORD; N-CADHERIN	We have identified a 95 kd cell surface protein, DM-GRASP, that is expressed on a restricted population of axons. Its expression begins early in chick embryogenesis, and within the spinal cord it is localized to axons in the dorsal funiculus, midline floorplate cells, and motorneurons. Antibodies to DM-GRASP impair neurite extension on axons, and purified DM-GRASP supports neurite extension from chick sensory neurons. We have cloned and sequenced the cDNA corresponding to this protein and find that it is a new member of the immunoglobulin superfamily of adhesion molecules. Consequently we have named this protein DM-GRASP, since it is an immunoglobulin-like restricted axonal surface protein that is expressed in the dorsal funiculus and ventral midline of the chick spinal cord.	UNIV PENN,SCH MED,DEPT ANAT,PHILADELPHIA,PA 19104	University of Pennsylvania	BURNS, FR (corresponding author), UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104, USA.			Burns, Frank/0000-0001-9528-4808	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS008075, F32NS011037, R01NS026519, P01NS011037, P01NS008075] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 26519, NS 11037, NS 08075] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS JC, 1981, J HISTOCHEM CYTOCHEM, V29, P775, DOI 10.1177/29.6.7252134; ALGAIT LK, 1968, J EMBRYOL EXP MORPH, V68, P149; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BASTIANI MJ, 1986, J NEUROSCI, V6, P3518; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; CHANG S, 1990, J NEUROSCI RES, V25, P180, DOI 10.1002/jnr.490250205; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DAVIES SN, 1982, J EMBRYOL EXP MORPH, V70, P215; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DULAC S, 1986, J NEUROSCI, V6, P3532; EDELMAN GM, 1984, ANNU REV NEUROSCI, V7, P339; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GRUMET M, 1984, J CELL BIOL, V98, P1746, DOI 10.1083/jcb.98.5.1746; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; JOHANSEN KM, 1989, J CELL BIOL, V109, P2427, DOI 10.1083/jcb.109.5.2427; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; KUWADA JY, 1990, J NEUROSCI, V10, P1299; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; LEMMON V, 1986, J NEUROSCI, V6, P2987; LOPRESTI V, 1973, P NATL ACAD SCI USA, V70, P433, DOI 10.1073/pnas.70.2.433; MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cellbio.3.1.57; MIYADA CG, 1987, METHOD ENZYMOL, V154, P94; MOZDZANOWSKI J, 1990, CURRENT RES PROTEIN, P87; OIKAWA S, 1987, BIOCHEM BIOPH RES CO, V144, P634, DOI 10.1016/S0006-291X(87)80013-X; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PLACZEK M, 1990, DEVELOPMENT, V110, P19; POURQUIE O, 1990, DEVELOPMENT, V109, P743; RAPER JA, 1984, J NEUROSCI, V4, P2329; RAPER JA, 1983, J NEUROSCI, V3, P31; RATHJEN FG, 1984, EMBO J, V3, P1; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; RUTISHAUSER U, 1984, NATURE, V310, P549, DOI 10.1038/310549a0; Speicher D.W., 1989, TECHNIQUES PROTEIN C, P24; STALLCUP WB, 1985, J NEUROSCI, V5, P1090; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TANAKA H, 1984, DEV BIOL, V106, P26, DOI 10.1016/0012-1606(84)90057-5; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1984, J NEUROSCI, V4, P2518; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	47	199	204	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					209	220		10.1016/0896-6273(91)90259-3	http://dx.doi.org/10.1016/0896-6273(91)90259-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1873027				2022-12-28	WOS:A1991GB93300004
J	KIRKWOOD, A; SIMMONS, MA; MATHER, RJ; LISMAN, J				KIRKWOOD, A; SIMMONS, MA; MATHER, RJ; LISMAN, J			MUSCARINIC SUPRESSION OF THE M-CURRENT IS MEDIATED BY A RISE IN INTERNAL CA-2+ CONCENTRATION	NEURON			English	Article							BULLFROG SYMPATHETIC NEURONS; LIMULUS VENTRAL PHOTORECEPTORS; INTRACELLULAR CALCIUM; RECEPTOR SUBTYPES; K+-CURRENT; INHIBITION; CHANNELS; CELLS; TRANSIENTS; CAFFEINE	The role of intracellular Ca2+ in the muscarinic suppression of M-current was examined. Intracellular injection of Ca2+ buffer into cells in the intact ganglion reduced the response to muscarinic agonist. In similar experiments on isolated cells, Ca2+ buffer was introduced into the cytoplasm using a perfused recording pipette. Ca2+ buffer (20 mM) with the free Ca2+ concentration set to normal resting levels produced a reversible reduction of the muscarinic response. In a second line of investigation, it was found that pharmacological procedures designed to deplete internal stores of Ca2+ produced a decrease in the muscarinic response. These results, taken together with previous work, support the hypothesis that the muscarinic suppression of M-current is mediated by the release of Ca2+ from intracellular stores.	BRANDEIS UNIV,PROGRAM BIOPHYS,WALTHAM,MA 02254; MARSHALL UNIV,DEPT PHARMACOL,NEUROPHARMACOL LAB,HUNTINGTON,WV 25755	Brandeis University; Marshall University	KIRKWOOD, A (corresponding author), BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254, USA.							ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P263, DOI 10.1113/jphysiol.1982.sp014412; ADAMS PR, 1982, J PHYSIOL-LONDON, V330, P537, DOI 10.1113/jphysiol.1982.sp014357; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; ADLER EM, 1991, IN PRESS J NEUROSCI; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P221, DOI 10.1113/jphysiol.1989.sp017612; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; Brown D A, 1988, Ion Channels, V1, P55; BROWN DA, 1987, CELL MOL NEUROBIOL, V7, P255, DOI 10.1007/BF00711303; BROWN JE, 1984, BIOCHEM BIOPH RES CO, V125, P1137, DOI 10.1016/0006-291X(84)91402-5; BUTCHER RW, 1962, J BIOL CHEM, V237, P1244; CHINN K, 1984, J GEN PHYSIOL, V84, P447, DOI 10.1085/jgp.84.3.447; DUTAR P, 1988, NEUROSCI LETT, V85, P89, DOI 10.1016/0304-3940(88)90434-X; FISCHER SK, 1983, J BIOL CHEM, V258, P7358; FISCHMEISTER R, 1987, J PHYSIOL-LONDON, V387, P453, DOI 10.1113/jphysiol.1987.sp016584; FUJIMOTO S, 1980, BRAIN RES, V202, P21, DOI 10.1016/S0006-8993(80)80031-X; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; JONES SVP, 1990, J PHYSIOL-LONDON, V421, P499, DOI 10.1113/jphysiol.1990.sp017958; KUBA K, 1980, J PHYSIOL-LONDON, V298, P251, DOI 10.1113/jphysiol.1980.sp013079; KUDO Y, 1988, NEUROSCI LETT, V85, P345, DOI 10.1016/0304-3940(88)90590-3; LEONARD RJ, 1981, SCIENCE, V212, P1273, DOI 10.1126/science.212.4500.1273; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; MARSHALL LM, 1981, P NATL ACAD SCI-BIOL, V78, P1948, DOI 10.1073/pnas.78.3.1948; NEHER E, 1988, FEBS LETT, V240, P88, DOI 10.1016/0014-5793(88)80345-4; Neher E., 1986, EXPT BRAIN RES SERIE, P80; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; NOHMI M, 1988, BRAIN RES, V438, P175, DOI 10.1016/0006-8993(88)91336-4; PARSONS WJ, 1988, MOL PHARMACOL, V34, P37; PAYNE R, 1986, J GEN PHYSIOL, V88, P127, DOI 10.1085/jgp.88.1.127; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; SELYANKO AA, 1990, J PHYSIOL-LONDON, V425, P471, DOI 10.1113/jphysiol.1990.sp018114; SIMMONS MA, 1990, NEURON, V4, P557, DOI 10.1016/0896-6273(90)90113-T; TOKIMASA T, 1985, BRAIN RES, V337, P386, DOI 10.1016/0006-8993(85)90081-2; TOKIMASA T, 1990, J AUTONOM NERV SYST, V29, P163, DOI 10.1016/0165-1838(90)90182-I; YELLEN G, 1982, NATURE, V296, P357, DOI 10.1038/296357a0	36	60	60	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1991	6	6					1009	1014		10.1016/0896-6273(91)90240-Z	http://dx.doi.org/10.1016/0896-6273(91)90240-Z			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	1905146				2022-12-28	WOS:A1991FT94900015
J	GENNARINI, G; DURBEC, P; BONED, A; ROUGON, G; GORIDIS, C				GENNARINI, G; DURBEC, P; BONED, A; ROUGON, G; GORIDIS, C			TRANSFECTED F3 F11 NEURONAL CELL-SURFACE PROTEIN MEDIATES INTERCELLULAR-ADHESION AND PROMOTES NEURITE OUTGROWTH	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; IMMUNOGLOBULIN SUPERFAMILY; N-CAM; NEURAL DEVELOPMENT; L2/HNK-1 FAMILY; NERVOUS-SYSTEM; MOLECULE L1; MEMBER; CDNA; EXPRESSION	The mouse neuronal F3 glycoprotein and its chicken homolog F11 belong to a subclass of proteins of the immunoglobulin superfamily with preferential localization on axons and neurites. We have transfected F3 cDNA into CHO cells. Biochemical analysis establishes that the cDNA we have cloned codes for a 130 kd phosphatidylinositol-anchored polypeptide. F3-expressing transfectants exhibited enhanced self-adhesive properties, aggregating with faster kinetics and forming larger aggregates than F3-negative control cells. When used as a culture substrate for sensory neurons, F3-transfected cells showed a markedly enhanced ability to promote neurite outgrowth compared with nontransfected cells. The results support the idea that F3/F11 and other closely similar proteins function as cell adhesion molecules that play a role in axonal growth and guidance.	UNIV BARI,FAC MED & CHIRURG,IST FISIOL UMANA,I-70124 BARI,ITALY; CNRS,URA 179,F-13288 MARSEILLE 9,FRANCE	Universita degli Studi di Bari Aldo Moro; Centre National de la Recherche Scientifique (CNRS)	GENNARINI, G (corresponding author), CTR IMMUNOL,CNRS,INSERM,CASE 906,F-13288 MARSEILLE 9,FRANCE.		ROUGON, Genevieve/G-2578-2013	ROUGON, Genevieve/0000-0003-1316-8200; GENNARINI, Gianfranco/0000-0002-3743-8474				BARTHELS D, 1987, EMBO J, V6, P907, DOI 10.1002/j.1460-2075.1987.tb04837.x; BARTSCH U, 1989, J COMP NEUROL, V284, P451, DOI 10.1002/cne.902840310; BASS J, 1974, ELEMENTS CALCUL PROB, P211; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; BRACKENBURY R, 1977, J BIOL CHEM, V252, P6835; BRACKENBURY R, 1981, P NATL ACAD SCI-BIOL, V78, P387, DOI 10.1073/pnas.78.1.387; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOHERTY P, 1989, J CELL BIOL, V109, P789, DOI 10.1083/jcb.109.2.789; Doherty P, 1989, CURR OPIN CELL BIOL, V1, P1102, DOI 10.1016/S0955-0674(89)80057-2; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; EDELMAN GM, 1984, TRENDS NEUROSCI, V7, P78, DOI 10.1016/S0166-2236(84)80162-9; EDELMAN GM, 1987, P NATL ACAD SCI USA, V84, P8502, DOI 10.1073/pnas.84.23.8502; FAISSNER A, 1984, DEV BRAIN RES, V15, P69, DOI 10.1016/0165-3806(84)90141-X; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; FUTERMAN AH, 1985, BIOCHEM J, V226, P369, DOI 10.1042/bj2260369; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; GENNARINI G, 1989, J NEUROSCI RES, V22, P1, DOI 10.1002/jnr.490220102; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GOWER HJ, 1988, CELL, V55, P955, DOI 10.1016/0092-8674(88)90241-3; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; LAI C, 1987, IMMUNOL REV, V100, P129, DOI 10.1111/j.1600-065X.1987.tb00530.x; Langley O K, 1983, Int J Dev Neurosci, V1, P393, DOI 10.1016/0736-5748(83)90021-7; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; PIERRES M, 1987, UCLA S MOL CELLULAR, V73, P293; PIZZEY JA, 1989, J CELL BIOL, V109, P3465, DOI 10.1083/jcb.109.6.3465; POLLARD JW, 1979, J CELL PHYSIOL, V98, P571, DOI 10.1002/jcp.1040980315; POLTORAK M, 1987, J CELL BIOL, V105, P1893, DOI 10.1083/jcb.105.4.1893; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; ROUGON G, 1983, NEUROSCIENCE, V10, P511, DOI 10.1016/0306-4522(83)90149-5; RUTISHAUSER U, 1982, P NATL ACAD SCI-BIOL, V79, P685, DOI 10.1073/pnas.79.2.685; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; SALZER JL, 1987, J CELL BIOL, V104, P957, DOI 10.1083/jcb.104.4.957; SCHACHNER M, 1985, CELL CONTACT, P257; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; SOMMER EW, 1985, BRAIN RES, V346, P310, DOI 10.1016/0006-8993(85)90865-0; STUDIER FW, 1990, METHOD ENZYMOL, V185, P61; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WOLFF JM, 1989, BIOCHEM BIOPH RES CO, V161, P931, DOI 10.1016/0006-291X(89)92688-0	51	159	161	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					595	606		10.1016/0896-6273(91)90062-5	http://dx.doi.org/10.1016/0896-6273(91)90062-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	2015094				2022-12-28	WOS:A1991FH80200011
J	CHRISTENSEN, BN; HIDA, E				CHRISTENSEN, BN; HIDA, E			PROTONATION OF HISTIDINE GROUPS INHIBITS GATING OF THE QUISQUALATE KAINATE CHANNEL PROTEIN IN ISOLATED CATFISH CONE HORIZONTAL CELLS	NEURON			English	Article											CHRISTENSEN, BN (corresponding author), UNIV TEXAS,MED BRANCH,DEPT PHYSIOL & BIOPHYS,GALVESTON,TX 77550, USA.				PHS HHS [NE1-01897] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; AKAIKE N, 1986, J PHYSIOL-LONDON, V379, P171, DOI 10.1113/jphysiol.1986.sp016246; ANTHONY BL, 1986, J NEUROCHEM, V46, P556, DOI 10.1111/j.1471-4159.1986.tb13003.x; BEGENISICH T, 1983, J GEN PHYSIOL, V82, P599, DOI 10.1085/jgp.82.5.599; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; CAMPBELL DT, 1982, NATURE, V298, P165, DOI 10.1038/298165a0; CAMPBELL DT, 1976, J GEN PHYSIOL, V67, P309, DOI 10.1085/jgp.67.3.309; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; HILLE B, 1968, J GEN PHYSIOL, V51, P221, DOI 10.1085/jgp.51.2.221; Hille B., 1984, IONIC CHANNELS EXCIT, P272; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; KISKIN NI, 1986, NEUROSCI LETT, V66, P305, DOI 10.1016/0304-3940(86)90036-4; LANDAU EM, 1981, J GEN PHYSIOL, V77, P647, DOI 10.1085/jgp.77.6.647; LASATER EM, 1990, J NEUROSCI, V10, P1654; LUNDBLAD RL, 1984, CHEM REAGENTS PROTEI, V1, P105; MAKSAY G, 1984, J NEUROCHEM, V42, P1715, DOI 10.1111/j.1471-4159.1984.tb12763.x; Means G.E., 1971, CHEM MODIFICATION PR; Miles E W, 1977, Methods Enzymol, V47, P431; MOZHAYEVA GN, 1981, BIOCHIM BIOPHYS ACTA, V643, P251, DOI 10.1016/0005-2736(81)90238-8; MOZHAYEVA GN, 1982, GEN PHYSIOL BIOPHYS, V1, P5; NORD EP, 1987, AM J PHYSIOL, V252, pC490, DOI 10.1152/ajpcell.1987.252.5.C490; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P1097, DOI 10.1152/jn.1989.61.6.1097; PRODHOM B, 1989, J GEN PHYSIOL, V94, P23, DOI 10.1085/jgp.94.1.23; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; SCHAUF CL, 1976, J GEN PHYSIOL, V67, P185, DOI 10.1085/jgp.67.2.185; SHINGAI R, 1983, NEUROSCIENCE, V10, P893, DOI 10.1016/0306-4522(83)90227-0; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687	32	32	32	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1990	5	4					471	478		10.1016/0896-6273(90)90086-U	http://dx.doi.org/10.1016/0896-6273(90)90086-U			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED517	1698396				2022-12-28	WOS:A1990ED51700010
J	KRAMER, RH				KRAMER, RH			PATCH CRAMMING - MONITORING INTRACELLULAR MESSENGERS IN INTACT-CELLS WITH MEMBRANE PATCHES CONTAINING DETECTOR ION CHANNELS	NEURON			English	Article									BRANDEIS UNIV,GRAD DEPT BIOCHEM,WALTHAM,MA 02254	Brandeis University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017910] Funding Source: NIH RePORTER; NINDS NIH HHS [NS17910] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAIKE N, 1978, J GEN PHYSIOL, V71, P509, DOI 10.1085/jgp.71.5.509; BUTTNER N, 1989, NATURE, V342, P553, DOI 10.1038/342553a0; COOK NJ, 1987, P NATL ACAD SCI USA, V84, P585, DOI 10.1073/pnas.84.2.585; COPENHAGEN DR, 1989, NATURE, V341, P536, DOI 10.1038/341536a0; COYNE MD, 1987, J MEMBRANE BIOL, V97, P205, DOI 10.1007/BF01869223; EHRLICH BE, 1988, NATURE, V336, P583, DOI 10.1038/336583a0; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; GORMAN ALF, 1978, J PHYSIOL-LONDON, V275, P357, DOI 10.1113/jphysiol.1978.sp012194; GORMAN ALF, 1980, J PHYSIOL-LONDON, V308, P287, DOI 10.1113/jphysiol.1980.sp013472; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KERKUT GA, 1975, COMP BIOCHEM PHYSIOL, V50, P1, DOI 10.1016/S0010-406X(75)80194-0; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MEECH RW, 1975, J PHYSIOL-LONDON, V249, P211, DOI 10.1113/jphysiol.1975.sp011012; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; Sakmann B, 1983, SINGLE CHANNEL RECOR, P37; WILMSEN U, 1983, PHYSICAL CHEM TRANSM, P479; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; YELLEN G, 1982, NATURE, V296, P357, DOI 10.1038/296357a0; ZIMMERMAN AL, 1986, NATURE, V321, P70, DOI 10.1038/321070a0	27	44	45	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1990	4	3					335	341		10.1016/0896-6273(90)90046-I	http://dx.doi.org/10.1016/0896-6273(90)90046-I			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX032	1690562				2022-12-28	WOS:A1990CX03200002
J	BAYLIES, MK; VOSSHALL, LB; SEHGAL, A; YOUNG, MW				BAYLIES, MK; VOSSHALL, LB; SEHGAL, A; YOUNG, MW			NEW SHORT-PERIOD MUTATIONS OF THE DROSOPHILA CLOCK GENE PER	NEURON			English	Article							CIRCADIAN-RHYTHMS; MELANOGASTER; PRODUCT; PROTEIN; LOCUS; MUTAGENESIS; EXPRESSION; MUTANTS; DOSAGE; SYSTEM	Earlier work has indicated that the period length of Drosophila circadian behavioral rhythms is dependent on the abundance of the period (per) gene product. Increased expression of this gene has been associated with period shortening for both the circadian eclosion (pupal hatching) rhythm and circadian locomotor activity rhythms of adult Drosophila. In this study it is shown that a wide variety of missense mutations, affecting a region of the per protein consisting of approximately 20 aa, predominantly generate short period phenotypes. The prevalence of such mutations suggests that short period phenotypes may result from loss or depression of function in this domain of the per protein. Possibly mutations in the region eliminate a regulatory function provided by this segment, or substantially increase stability of the mutant protein.	ROCKEFELLER UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10021; ROCKEFELLER UNIV,GENET LAB,NEW YORK,NY 10021	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University			, 机智的马小跳和机智的羊不愁/ABC-5169-2020	Vosshall, Leslie/0000-0002-6060-8099	NIGMS NIH HHS [GM07982] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; BARGIELLO TA, 1987, NATURE, V328, P686, DOI 10.1038/328686a0; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BAYLIES MK, 1991, THESIS ROCKEFELLER U; BAYLIES MK, 1993, IN PRESS MOL GENETIC; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; COLOT HV, 1988, EMBO J, V7, P3929, DOI 10.1002/j.1460-2075.1988.tb03279.x; COTE GG, 1986, J THEOR BIOL, V121, P487, DOI 10.1016/S0022-5193(86)80104-7; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HALL JC, 1984, DEV GENET, V4, P355; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HERMES JD, 1989, GENE, V84, P143, DOI 10.1016/0378-1119(89)90148-0; JACKSON FR, 1986, NATURE, V320, P185, DOI 10.1038/320185a0; JAMES AA, 1986, EMBO J, V5, P2313, DOI 10.1002/j.1460-2075.1986.tb04499.x; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KONOPKA R, 1983, MOL GEN GENET, V190, P284, DOI 10.1007/BF00330652; Konopka R. J., 1986, EVOL GENET, P215; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1987, ANNU REV GENET, V21, P227, DOI 10.1146/annurev.genet.21.1.227; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; LIU X, 1988, GENE DEV, V2, P228, DOI 10.1101/gad.2.2.228; PETERSEN G, 1988, EMBO J, V7, P3939, DOI 10.1002/j.1460-2075.1988.tb03280.x; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; RUTILA JE, 1992, J NEUROGENET, V8, P101, DOI 10.3109/01677069209084155; SAEZ L, 1988, MOL CELL BIOL, V8, P5378, DOI 10.1128/MCB.8.12.5378; SIWICI KK, 1992, NEUROGENET, V8, P33; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; SIWICKI KK, 1989, NEURON, V3, P51, DOI 10.1016/0896-6273(89)90114-1; SMITH RF, 1982, MOL GEN GENET, V185, P30, DOI 10.1007/BF00333786; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; SULZMAN FM, 1982, COMPUT BIOL MED, V12, P253, DOI 10.1016/0010-4825(82)90030-0; YOUNG MW, 1985, COLD SPRING HARB SYM, V50, P865, DOI 10.1101/SQB.1985.050.01.104; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784; YU Q, 1987, NATURE, V326, P765, DOI 10.1038/326765a0	36	61	61	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					575	581		10.1016/0896-6273(92)90194-I	http://dx.doi.org/10.1016/0896-6273(92)90194-I			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1524831				2022-12-28	WOS:A1992JM57100018
J	ZHANG, JF; ROBINSON, RB; SIEGELBAUM, SA				ZHANG, JF; ROBINSON, RB; SIEGELBAUM, SA			SYMPATHETIC NEURONS MEDIATE DEVELOPMENTAL-CHANGE IN CARDIAC SODIUM-CHANNEL GATING THROUGH LONG-TERM NEUROTRANSMITTER ACTION	NEURON			English	Article							RAT SKELETAL-MUSCLE; NICOTINIC ACETYLCHOLINE-RECEPTORS; GENE-RELATED PEPTIDE; VENTRICULAR MYOCYTES; CELLS; ELECTROPHYSIOLOGY; IDENTIFICATION; INACTIVATION; ACTIVATION; EXPRESSION	Innervation of nerve and muscle cells during development is often accompanied by changes in the expression and function of ion channels in the postsynaptic cell. However, the signaling pathways whereby the presynaptic nerve influences the properties of the postsynaptic cell are less well understood. Indirect evidence suggests that cardiac voltage-gated Na+ channels undergo important changes during development. Here, we compare directly single voltage-gated Na+ channel currents from neonatal and adult rat ventricular myocytes and report a negative shift in the voltage dependence of channel gating during development, leading to a significant speeding of channel activation and inactivation at a fixed membrane potential. These developmental changes can be mimicked in vitro by innervation of neonatal myocytes with sympathetic neurons. The effect of sympathetic neurons is blocked by the beta-adrenergic receptor antagonist propranolol and is mimicked by prolonged coculture of neonatal myocytes with a membrane-permeable cAMP analog. Thus presynaptic neurons can control the developmental phenotype of ion channels in a postsynaptic cell through a classic receptor-mediated neurotransmitter action that involves a defined second messenger pathway.	COLUMBIA UNIV,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; COLUMBIA UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; Columbia University; Howard Hughes Medical Institute	ZHANG, JF (corresponding author), COLUMBIA UNIV,DEPT PHARMACOL,NEW YORK,NY 10032, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030557, P01HL028958] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-28958, HL-30557] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERMAN MF, 1989, J PHYSIOL-LONDON, V415, P503, DOI 10.1113/jphysiol.1989.sp017734; DRUGGE ED, 1985, CIRC RES, V57, P415, DOI 10.1161/01.RES.57.3.415; EZRIN AM, 1980, DEV PHARMACOL THERAP, V1, P352, DOI 10.1159/000455555; FONTAINE B, 1986, NEUROSCI LETT, V71, P59, DOI 10.1016/0304-3940(86)90257-0; FRELIN C, 1984, PFLUG ARCH EUR J PHY, V402, P121, DOI 10.1007/BF00583323; FUJII S, 1988, J MEMBRANE BIOL, V101, P209, DOI 10.1007/BF01872836; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS J B, 1973, Nature New Biology, V243, P191; HENDERSON LP, 1986, DEV BIOL, V113, P381, DOI 10.1016/0012-1606(86)90173-9; HEWETT K, 1983, AM J PHYSIOL, V245, pH830, DOI 10.1152/ajpheart.1983.245.5.H830; IIJIMA T, 1979, CIRC RES, V44, P358, DOI 10.1161/01.RES.44.3.358; ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KRAFTE DS, 1988, J NEUROSCI, V8, P2859; LOMO T, 1972, J PHYSIOL-LONDON, V221, P493, DOI 10.1113/jphysiol.1972.sp009764; MAKIELSKI JC, 1987, BIOPHYS J, V52, P1, DOI 10.1016/S0006-3495(87)83182-X; MORIKAWA Y, 1984, CIRC RES, V55, P633, DOI 10.1161/01.RES.55.5.633; NEW HV, 1986, NATURE, V323, P809, DOI 10.1038/323809a0; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; OFFORD J, 1989, NEURON, V2, P1447, DOI 10.1016/0896-6273(89)90190-6; OWENS JL, 1989, DEV BIOL, V135, P12, DOI 10.1016/0012-1606(89)90153-X; PAPPANO AJ, 1977, PHARMACOL REV, V29, P3; ROSEN MR, 1978, CIRC RES, V43, P931, DOI 10.1161/01.RES.43.6.931; ROSSIE S, 1987, J BIOL CHEM, V262, P17530; SCHUBERT B, 1989, SCIENCE, V245, P516, DOI 10.1126/science.2547248; SCHUBERT B, 1990, AM J PHYSIOL, V258, pH977, DOI 10.1152/ajpheart.1990.258.4.H977; SCHUETZE SM, 1987, ANNU REV NEUROSCI, V10, P403, DOI 10.1146/annurev.ne.10.030187.002155; Sperelakis N., 1989, PHYSL PATHOPHYSIOLOG, P595; Spitzer N.C., 1985, P67; STEINBERG SF, 1985, SCIENCE, V230, P186, DOI 10.1126/science.2994230; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; SUN LS, 1991, AM J PHYSIOL, V261, pH969, DOI 10.1152/ajpheart.1991.261.3.H969; SUTKOWSKI EM, 1990, J BIOL CHEM, V256, P12393; USDIN TB, 1986, J CELL BIOL, V103, P493, DOI 10.1083/jcb.103.2.493; WEISS RE, 1986, SCIENCE, V233, P361, DOI 10.1126/science.2425432; XU YQ, 1991, CIRC RES, V69, P644, DOI 10.1161/01.RES.69.3.644	36	57	57	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					97	103		10.1016/0896-6273(92)90224-2	http://dx.doi.org/10.1016/0896-6273(92)90224-2			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1352987				2022-12-28	WOS:A1992JE75600010
J	LEI, SZ; PAN, ZH; AGGARWAL, SK; CHEN, HSV; HARTMAN, J; SUCHER, NJ; LIPTON, SA				LEI, SZ; PAN, ZH; AGGARWAL, SK; CHEN, HSV; HARTMAN, J; SUCHER, NJ; LIPTON, SA			EFFECT OF NITRIC-OXIDE PRODUCTION ON THE REDOX MODULATORY SITE OF THE NMDA RECEPTOR CHANNEL COMPLEX	NEURON			English	Article							VASCULAR SMOOTH-MUSCLE; AMINO-ACID RECEPTORS; RELAXING FACTOR; ORGANIC NITRATES; ADP-RIBOSYLTRANSFERASE; GLYCERYL TRINITRATE; N-ACETYLCYSTEINE; CEREBRAL-CORTEX; GANGLION-CELLS; BLOOD-FLOW	Nitric oxide (NO) is an important messenger both systemically and in the CNS. In digital Ca2+ imaging and patch-clamp experiments, clinically available nitroso compounds that generate NO are shown to inhibit responses mediated by the NMDA subtype of the glutamate receptor on rat cortical neurons in vitro. A mechanism of action for this effect was investigated by using the specific NO-generating agent S-nitrosocysteine. We propose that free sulfhydryl groups on the NMDA receptor-channel complex react to form one or more S-nitrosothiols in the presence of NO. If vicinal thiol groups react in this manner, they can form a disulfide bond(s), which is thought to constitute the redox modulatory site of the receptor, resulting in a relatively persistent blockade of NMDA responses. These reactions with NO can afford protection from NMDA receptor-mediated neurotoxicity. Our results demonstrate a new pathway for NO regulation of physiological function that is not via cGMP, but instead involves reactions with membrane-bound thiol groups on the NMDA receptor-channel complex.	HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT NEUROL,PROGRAM NEUROSCI,BOSTON,MA 02215; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT NEUROL,PROGRAM NEUROSCI,BOSTON,MA 02115; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT NEUROL,PROGRAM NEUROSCI,BOSTON,MA 02115	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	LEI, SZ (corresponding author), CHILDRENS HOSP MED CTR,DEPT NEUROL,CELLULAR & MOLEC NEUROSCI LAB,BOSTON,MA 02115, USA.			Lipton, Stuart/0000-0002-3490-1259; Sucher, Nikolaus/0000-0001-6233-1612	NEI NIH HHS [EY09024, EY05477] Funding Source: Medline; NINDS NIH HHS [NS07264] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005477, R01EY009024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007264] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIZENMAN E, 1988, J PHYSIOL-LONDON, V396, P75, DOI 10.1113/jphysiol.1988.sp016951; AIZENMAN E, 1990, NEURON, V5, P841, DOI 10.1016/0896-6273(90)90343-E; AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; BRUNE B, 1989, J BIOL CHEM, V264, P8455; BRUNE B, 1990, ARCH BIOCHEM BIOPHYS, V279, P286, DOI 10.1016/0003-9861(90)90493-I; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CURRAN RD, 1991, FASEB J, V5, P2085, DOI 10.1096/fasebj.5.7.1707021; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; DICHTER MA, 1978, BRAIN RES, V149, P279, DOI 10.1016/0006-8993(78)90476-6; DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FUNG HL, 1988, J PHARMACOL EXP THER, V245, P524; FURCHGOTT RF, 1990, ACTA PHYSIOL SCAND, V139, P257, DOI 10.1111/j.1748-1716.1990.tb08923.x; GARG UC, 1991, J BIOL CHEM, V266, P9; GARTHWAITE G, 1988, NEUROSCIENCE, V26, P321, DOI 10.1016/0306-4522(88)90148-0; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GILMAN AG, 1990, PHARMACOL BASIS THER, P768; GINSBERG MD, 1976, STROKE, V7, P125, DOI 10.1161/01.STR.7.2.125; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; IGNARRO LJ, 1990, HYPERTENSION, V16, P477, DOI 10.1161/01.HYP.16.5.477; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; IGNARRO LJ, 1989, CIRC RES, V65, P1, DOI 10.1161/01.RES.65.1.1; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; JAKOBY WB, 1987, METHOD ENZYMOL, V143; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; KOH JY, 1986, SCIENCE, V234, P73, DOI 10.1126/science.2875522; KOH JY, 1988, J NEUROSCI, V8, P2153, DOI 10.1523/jneurosci.08-06-02153.1988; LAZAREWICZ JW, 1989, NEUROSCI RES COMMUN, V4, P91; LEVY DI, 1990, NEUROSCI LETT, V110, P291, DOI 10.1016/0304-3940(90)90862-4; LEVY DI, 1991, NEUROREPORT, V2, P345, DOI 10.1097/00001756-199106000-00011; LIPTON SA, 1987, J PHYSIOL-LONDON, V385, P361, DOI 10.1113/jphysiol.1987.sp016497; LIPTON SA, 1992, TRENDS NEUROSCI, V15, P75, DOI 10.1016/0166-2236(92)90013-X; LIPTON SA, 1991, NEURON, V7, P111, DOI 10.1016/0896-6273(91)90079-F; Majewska M D, 1990, Neuroreport, V1, P194, DOI 10.1097/00001756-199011000-00004; MAJEWSKA MD, 1990, BRAIN RES, V537, P328, DOI 10.1016/0006-8993(90)90379-P; MARTIN W, 1985, J PHARMACOL EXP THER, V232, P708; MAYER ML, 1990, TRENDS PHARMACOL SCI, V11, P254, DOI 10.1016/0165-6147(90)90254-6; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MONCADA S, 1986, P NATL ACAD SCI USA, V83, P9164, DOI 10.1073/pnas.83.23.9164; MONCADA S, 1989, BIOCHEM PHARMACOL, V38, P1709, DOI 10.1016/0006-2952(89)90403-6; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULLIGAN MS, 1991, P NATL ACAD SCI USA, V88, P6338, DOI 10.1073/pnas.88.14.6338; MYERS PR, 1990, NATURE, V345, P161, DOI 10.1038/345161a0; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; NEEDLEMAN P, 1973, J PHARMACOL EXP THER, V184, P709; NEEDLEMAN P, 1973, J PHARMACOL EXP THER, V187, P324; NEEDLEMAN P, 1971, J PHARMACOL EXP THER, V179, P347; REYNOLDS IJ, 1990, BRIT J PHARMACOL, V101, P178, DOI 10.1111/j.1476-5381.1990.tb12109.x; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; SHIBUKI K, 1990, NEUROSCI RES, V9, P69, DOI 10.1016/0168-0102(90)90048-J; SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125, DOI 10.1016/0165-6147(91)90526-X; STAMLER J, 1989, CIRC RES, V65, P789, DOI 10.1161/01.RES.65.3.789; STAMLER J, 1988, AM J CARDIOL, V62, P377, DOI 10.1016/0002-9149(88)90962-9; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Sucher N J, 1990, Neuroreport, V1, P29, DOI 10.1097/00001756-199009000-00009; SUCHER NJ, 1991, J NEUROSCI RES, V30, P582, DOI 10.1002/jnr.490300316; TANAKA K, 1986, STROKE, V17, P994, DOI 10.1161/01.STR.17.5.994	62	709	726	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1087	1099		10.1016/0896-6273(92)90130-6	http://dx.doi.org/10.1016/0896-6273(92)90130-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1376999				2022-12-28	WOS:A1992JA42900009
J	BERGOLD, PJ; BEUSHAUSEN, SA; SACKTOR, TC; CHELEY, S; BAYLEY, H; SCHWARTZ, JH				BERGOLD, PJ; BEUSHAUSEN, SA; SACKTOR, TC; CHELEY, S; BAYLEY, H; SCHWARTZ, JH			A REGULATORY SUBUNIT OF THE CAMP-DEPENDENT PROTEIN-KINASE DOWN-REGULATED IN APLYSIA SENSORY NEURONS DURING LONG-TERM SENSITIZATION	NEURON			English	Article							AMINO-ACID-SEQUENCE; TRANSMITTER RELEASE; ESCHERICHIA-COLI; NERVOUS-SYSTEM; FACILITATION; ELECTROPHORESIS; EXPRESSION; PERSISTENT; INCREASE; MUTANTS	Binding of cAMP by the five neuronal isoforms (N1-5) of the regulatory (R) subunit of the Aplysia cAMP-dependent protein kinase is diminished in sensory neurons stimulated to produce long-term presynaptic facilitation. To determine how the cAMP-binding activity of the R subunits is lost, we isolated cDNAs encoding N4, which is a homolog of mammalian RI. Immunoblots with antisera raised against the R protein overexpressed in E. coli show that the diminished binding activity, which occurs in long-term facilitation, results from coordinate loss of R protein isoforms. No change was detected in the amount of transcripts for R subunits, suggesting that the down-regulation results from enhanced proteolytic turnover.	COLUMBIA UNIV,CTR NEUROBIOL & BEHAV,HOWARD HUGHES MED INST,NEW YORK,NY 10032; WORCESTER FDN EXPTL BIOL INC,SHREWSBURY,MA 01545	Columbia University; Howard Hughes Medical Institute; Worcester Foundation for Biomedical Research			Schwartz, John/AAO-8158-2021	Schwartz, John/0000-0002-1660-8681; Bayley, Hagan/0000-0003-2499-6116; Bergold, Peter/0000-0002-6335-1380	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026760] Funding Source: NIH RePORTER; NINDS NIH HHS [NS26760] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASZODI A, 1991, P NATL ACAD SCI USA, V88, P5832, DOI 10.1073/pnas.88.13.5832; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; BERGOLD PJ, 1990, P NATL ACAD SCI USA, V87, P3788, DOI 10.1073/pnas.87.10.3788; BERNIER L, 1982, J NEUROSCI, V2, P1682; BEUSHAUSEN S, 1988, NEURON, V1, P853, DOI 10.1016/0896-6273(88)90133-X; BUONOMANO DV, 1990, SCIENCE, V249, P420, DOI 10.1126/science.2165631; BYRNE JH, 1987, PHYSIOL REV, V67, P329, DOI 10.1152/physrev.1987.67.2.329; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; CLEGG CH, 1988, P NATL ACAD SCI USA, V85, P3703, DOI 10.1073/pnas.85.11.3703; DALE N, 1990, J PHYSIOL-LONDON, V421, P203, DOI 10.1113/jphysiol.1990.sp017941; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; Dudai Y., 1989, NEUROBIOLOGY MEMORY; EPPLER CM, 1986, J CELL BIOL, V102, P320, DOI 10.1083/jcb.102.1.320; EPPLER CM, 1982, J NEUROSCI, V2, P1692; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GREENBERG SM, 1987, NATURE, V329, P62, DOI 10.1038/329062a0; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; JOHNSON KE, 1987, J BIOL CHEM, V262, P8636; KALDERON D, 1988, GENE DEV, V2, P1539, DOI 10.1101/gad.2.12a.1539; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KURET J, 1988, J BIOL CHEM, V263, P9149; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUFFER L, 1985, NATURE, V318, P334, DOI 10.1038/318334a0; MULLER U, 1989, J NEUROGENET, V6, P95, DOI 10.3109/01677068909107104; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PALAZZOLO M, 1990, J NEUROBIOL, V20, P746; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; RECHSTEINER M, 1987, ANNU REV CELL BIOL, V3, P1, DOI 10.1146/annurev.cb.03.110187.000245; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Sambrook J, 1989, MOL CLONING LABORATO; SCHEFFNER M, 1990, CELL, V63, P129; SCHWARTZ JH, 1987, ANNU REV NEUROSCI, V10, P459; SCHWARTZ JH, 1987, METHOD ENZYMOL, V139, P277; SCHWARTZ JH, 1989, NEURAL MODELS PLASTI, P47; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SWANK RT, 1971, ANAL BIOCHEM, V39, P462, DOI 10.1016/0003-2697(71)90436-2; SWANSON M, 1991, J MOL BIOL, V216, P545; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4200, DOI 10.1021/bi00313a029; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TITANI K, 1984, BIOCHEMISTRY-US, V23, P4193, DOI 10.1021/bi00313a028	46	62	63	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1992	8	2					387	397		10.1016/0896-6273(92)90304-V	http://dx.doi.org/10.1016/0896-6273(92)90304-V			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1310865				2022-12-28	WOS:A1992HE93000018
J	KAWAJA, MD; GAGE, FH				KAWAJA, MD; GAGE, FH			REACTIVE ASTROCYTES ARE SUBSTRATES FOR THE GROWTH OF ADULT CNS AXONS IN THE PRESENCE OF ELEVATED LEVELS OF NERVE GROWTH-FACTOR	NEURON			English	Article							HIPPOCAMPAL-FORMATION; SYMPATHETIC AXONS; MAMMALIAN BRAIN; SEPTAL NEURONS; NEURITE GROWTH; RAT-BRAIN; REGENERATION; SYSTEM; OUTGROWTH; INVITRO	To assess the necessary parameters for the growth of axons within the adult rat CNS, we have used intracerebral grafts of primary fibroblasts genetically engineered to express nerve growth factor (NGF). Following the implantation of NGF-producing primary fibroblasts within the striatum, cholinergic axons arising from the nucleus basalis grow toward and penetrate these grafts between 1 and 8 weeks. Grafts of noninfected control cells do not elicit axon sprouting at any time. Unmyelinated axons grow into grafts of NGF-producing cells only on reactive astrocytic processes, which contribute to a surrounding glial border. From our data concerning axon growth within the adult rat CNS, we conclude that reactive astrocytes can act as conducive substrates for growing axons; and only in the presence of elevated levels of NGF will permissive substrates (e.g., astrocytes) support axon growth by NGF-sensitive neurons.	UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093	University of California System; University of California San Diego					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS028121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG008514, R01AG008514] Funding Source: NIH RePORTER; NIA NIH HHS [AGO8514] Funding Source: Medline; NINDS NIH HHS [NS28121] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAEHR M, 1990, GLIA, V3, P293, DOI 10.1002/glia.440030409; BATCHELOR PE, 1989, J COMP NEUROL, V284, P187, DOI 10.1002/cne.902840204; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; BJORKLUND A, 1975, NATURE, V253, P446, DOI 10.1038/253446a0; BJORKLUND A, 1971, BRAIN RES, V31, P21, DOI 10.1016/0006-8993(71)90631-7; BROWN JO, 1947, J COMP NEUROL, V87, P131, DOI 10.1002/cne.900870204; Cajal S., 1928, DEGENERATION REGENER; CAMPENOT RB, 1981, SCIENCE, V214, P579, DOI 10.1126/science.7292000; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; CAVANAGH JB, 1970, J ANAT, V106, P471; Clemente CD, 1955, REGENERATION CENTRAL, P147; CRUTCHER KA, 1987, BRAIN RES REV, V12, P203, DOI 10.1016/0165-0173(87)90013-0; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DAVID S, 1990, NEURON, V5, P463, DOI 10.1016/0896-6273(90)90085-T; DUNDORE M, 1988, J NEUROSCI, V8, P2844; ERNFORS P, 1989, P NATL ACAD SCI USA, V86, P4756, DOI 10.1073/pnas.86.12.4756; EVERCOOREN AB, 1982, J NEUROSCI RES, V8, P179; FALLON JR, 1985, J CELL BIOL, V100, P198, DOI 10.1083/jcb.100.1.198; GAGE FH, 1988, J COMP NEUROL, V269, P147, DOI 10.1002/cne.902690112; GAGE FH, 1988, EXP BRAIN RES, V72, P371; HAGG T, 1990, J NEUROSCI, V10, P3087; HAGG T, 1990, EXP NEUROL, V109, P153, DOI 10.1016/0014-4886(90)90069-5; KAWAJA MD, 1991, J COMP NEUROL, V307, P695, DOI 10.1002/cne.903070414; KROMER LF, 1981, BRAIN RES, V210, P153, DOI 10.1016/0006-8993(81)90892-1; KROMER LF, 1985, P NATL ACAD SCI USA, V82, P6330, DOI 10.1073/pnas.82.18.6330; LAVIE V, 1990, J COMP NEUROL, V298, P293, DOI 10.1002/cne.902980304; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; LOY R, 1980, EXP NEUROL, V67, P399, DOI 10.1016/0014-4886(80)90239-3; MANTHORPE M, 1983, J CELL BIOL, V97, P1882, DOI 10.1083/jcb.97.6.1882; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; NOBEL M, 1984, J NEUROSCI, V4, P1892; Reier P.J., 1989, NEURAL REGENERATION, P183; REIER PJ, 1983, SPINAL CORD RECONSTR, P163; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; SCHINSTINE M, 1990, EXP NEUROL, V108, P10, DOI 10.1016/0014-4886(90)90002-A; SCHWAB ME, 1990, TRENDS NEUROSCI, V13, P452, DOI 10.1016/0166-2236(90)90098-U; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; STENEVI U, 1978, NEUROSCI LETT, V7, P219; SVENDGAARD NA, 1975, NATURE, V255, P334, DOI 10.1038/255334a0; Tello F, 1911, REV CLIN MADRID, V5, P292; Tello J.F., 1911, TRAB LAB INVEST BIOL, V9, P123; TOPP KS, 1989, GLIA, V2, P201, DOI 10.1002/glia.440020309; TUSZYNSKI MH, 1990, NEUROSCIENCE, V36, P33, DOI 10.1016/0306-4522(90)90349-9; WINDLE WF, 1956, PHYSIOL REV, V36, P426	47	166	167	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					1019	1030		10.1016/0896-6273(91)90346-2	http://dx.doi.org/10.1016/0896-6273(91)90346-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1684900				2022-12-28	WOS:A1991GY43800014
J	LOPEZ, HS; BROWN, AM				LOPEZ, HS; BROWN, AM			CORRELATION BETWEEN G PROTEIN-ACTIVATION AND REBLOCKING KINETICS OF CA2+ CHANNEL CURRENTS IN RAT SENSORY NEURONS	NEURON			English	Article							GTP-BINDING PROTEIN; CARDIAC CALCIUM CHANNELS; KINASE-C ACTIVATORS; NEUROPEPTIDE-Y; CA-2+ CHANNELS; SYMPATHETIC NEURONS; POTASSIUM CHANNELS; INDUCED MODULATION; CHICK; INHIBITION	Membrane depolarization relieves the G protein-mediated inhibition or block of high threshold Ca2+ channel currents. We found that the net rate of reblocking depended on the extent of G protein activation. With low intracellular concentrations of GTP-gamma-S reblocking rates resembled inactivation rates; with higher concentrations reblocking rates increased progressively. Reblocking kinetics were fit with a sum of two exponential functions having time constants (in ms) tau(F) greater-than-or-equal-to 10 and tau(S) greater-than-or-equal-to 30. Unblock during depolarization was fit by a single exponential function with time constant tau(A) similar to tau(F). A model was developed in which unblocking followed dissociation of a blocking molecule, possibly the G protein itself, from Ca2+ channels, and reblocking occurred at rates that depended on the concentration of the blocking molecule. The time course of Ca2+ entry and thus presynaptic Ca2+ levels can be regulated by both the concentration of the G protein-dependent blocking particle and membrane potential.	BAYLOR COLL MED,DEPT ANESTHESIOL,HOUSTON,TX 77030	Baylor College of Medicine	LOPEZ, HS (corresponding author), BAYLOR COLL MED,DEPT MOLEC PHYSIOL & BIOPHYS,HOUSTON,TX 77030, USA.				NHLBI NIH HHS [HL-39262] Funding Source: Medline; NINDS NIH HHS [NS-23877] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023877] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARTALEJO CR, 1991, J PHYSIOL-LONDON, V432, P681, DOI 10.1113/jphysiol.1991.sp018406; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BILEZIKJIAN LM, 1987, MOL ENDOCRINOL, V1, P555, DOI 10.1210/mend-1-8-555; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BROWN AM, 1989, ANN NY ACAD SCI, V560, P373, DOI 10.1111/j.1749-6632.1989.tb24116.x; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P571, DOI 10.1113/jphysiol.1987.sp016552; DOERNER D, 1988, J NEUROSCI, V8, P4069; DOLPHIN AC, 1986, BRIT J PHARMACOL, V88, P213, DOI 10.1111/j.1476-5381.1986.tb09489.x; DOLPHIN AC, 1989, BRIT J PHARMACOL, V97, P263, DOI 10.1111/j.1476-5381.1989.tb11950.x; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; EWALD DA, 1988, J NEUROSCI, V8, P2447; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; FORSCHER P, 1986, J PHYSIOL-LONDON, V379, P131, DOI 10.1113/jphysiol.1986.sp016244; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; GRASSI F, 1989, NEUROSCI LETT, V105, P113, DOI 10.1016/0304-3940(89)90021-9; GROSS RA, 1990, P NATL ACAD SCI USA, V87, P7025, DOI 10.1073/pnas.87.18.7025; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISWARRICK RM, 1988, NEURON, V1, P27, DOI 10.1016/0896-6273(88)90206-1; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HIRNING LD, 1990, BRAIN RES, V532, P120, DOI 10.1016/0006-8993(90)91751-2; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; KASAI H, 1989, PFLUG ARCH EUR J PHY, V414, P145, DOI 10.1007/BF00580956; KOCAC H, 1989, DIFFERENTIAL DIFFERE; LACERDA AE, 1988, NATURE, V335, P249, DOI 10.1038/335249a0; LEWIS DL, 1988, NEUROENDOCRINOLOGY, V47, P169, DOI 10.1159/000124909; MARCHETTI C, 1989, BIOPHYS J, V56, P1267, DOI 10.1016/S0006-3495(89)82774-2; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; MARCHETTI C, 1988, AM J PHYSIOL, V254, pC206, DOI 10.1152/ajpcell.1988.254.1.C206; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; PIETROBON D, 1990, NATURE, V346, P651, DOI 10.1038/346651a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; POLLO A, 1991, NEUROSCI LETT, V123, P203, DOI 10.1016/0304-3940(91)90931-I; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; REUTER H, 1986, J EXP BIOL, V124, P191; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SWANDULLA D, 1988, J GEN PHYSIOL, V92, P197, DOI 10.1085/jgp.92.2.197; TAYLOR WR, 1988, J PHYSIOL-LONDON, V407, P405, DOI 10.1113/jphysiol.1988.sp017423; TRAUTWEIN W, 1990, ANNU REV PHYSIOL, V52, P257, DOI 10.1146/annurev.ph.52.030190.001353; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; VANDONGEN AMJ, 1988, SCIENCE, V242, P1433, DOI 10.1126/science.3144040; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390; YATANI A, 1988, J BIOL CHEM, V263, P9887; YATANI A, 1987, SCIENCE, V235, P207, DOI 10.1126/science.2432660	45	50	50	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					1061	1068		10.1016/0896-6273(91)90350-9	http://dx.doi.org/10.1016/0896-6273(91)90350-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1662518				2022-12-28	WOS:A1991GY43800018
J	LOWENSTEIN, DH; CHAN, PH; MILES, MF				LOWENSTEIN, DH; CHAN, PH; MILES, MF			THE STRESS PROTEIN RESPONSE IN CULTURED NEURONS - CHARACTERIZATION AND EVIDENCE FOR A PROTECTIVE ROLE IN EXCITOTOXICITY	NEURON			English	Article							HEAT-SHOCK PROTEIN; CEREBELLAR GRANULE CELLS; RAT-BRAIN; GLUTAMATE NEUROTOXICITY; TRANSIENT ISCHEMIA; STATUS EPILEPTICUS; HYPOXIA-ISCHEMIA; MAMMALIAN-CELLS; HYPERTHERMIA; INDUCTION	We used purified cultures of cerebellar granule cells to investigate the possible protective role of stress proteins in an in vitro model of excitotoxicity. Initial experiments used one- and two-dimensional polyacrylamide gel electrophoresis to confirm the induction of typical stress protein size classes by heat shock, sodium arsenite, and the calcium ionophore A23187. Immunoblot analysis and immunocytochemistry verified the expression of the highly inducible 72 kd heat shock protein (HSP72). Granule cell cultures exposed to glutamate showed evidence of cellular injury that was prevented by the noncompetitive NMDA antagonist MK-801, yet glutamate did not induce a detectable stress protein response. Nonetheless, preinduction of heat shock proteins was associated with protection from toxic concentrations of glutamate. These results imply that the HSP72 expression observed in in vivo models of excitotoxicity may not be directly related to the effects of excitatory amino acids. However, the ability of stress protein induction to protect against injury from glutamate may offer a novel approach toward ameliorating damage from excitotoxins.	UNIV CALIF SAN FRANCISCO,EPILEPSY RES LAB,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT NEUROSURG,SAN FRANCISCO,CA 94143; SAN FRANCISCO GEN HOSP,ERNEST GALLO CLIN & RES CTR,SAN FRANCISCO,CA 94110	University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	LOWENSTEIN, DH (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143, USA.				NINDS NIH HHS [NS 14543, NS01424, NS 25372] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS014543, P01NS014543, K08NS001424, R01NS025372] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARBE MF, 1988, SCIENCE, V241, P1817, DOI 10.1126/science.3175623; BENJAMIN IJ, 1990, P NATL ACAD SCI USA, V87, P6263, DOI 10.1073/pnas.87.16.6263; BROWN IR, 1983, J NEUROCHEM, V40, P1490, DOI 10.1111/j.1471-4159.1983.tb13596.x; BROWN IR, 1990, J NEUROSCI RES, V27, P247, DOI 10.1002/jnr.490270302; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COX JA, 1990, NEURON, V4, P941, DOI 10.1016/0896-6273(90)90147-8; DIDIER M, 1990, J NEUROSCI RES, V27, P25, DOI 10.1002/jnr.490270105; DIENEL GA, 1986, J CEREBR BLOOD F MET, V6, P505, DOI 10.1038/jcbfm.1986.86; DRUMMOND IAS, 1987, J BIOL CHEM, V262, P12801; DWYER BE, 1989, EXP NEUROL, V104, P28, DOI 10.1016/0014-4886(89)90005-8; FERRIERO DM, 1990, DEV BRAIN RES, V53, P145, DOI 10.1016/0165-3806(90)90136-M; FREEDMAN MS, 1981, BRAIN RES, V207, P129, DOI 10.1016/0006-8993(81)90683-1; GONZALEZ MF, 1991, BRAIN RES BULL, V26, P241, DOI 10.1016/0361-9230(91)90234-B; GONZALEZ MF, 1989, MOL BRAIN RES, V6, P93, DOI 10.1016/0169-328X(89)90033-8; GOWER DJ, 1989, J NEUROSURG, V70, P605, DOI 10.3171/jns.1989.70.4.0605; HAHN JS, 1988, P NATL ACAD SCI USA, V85, P6556, DOI 10.1073/pnas.85.17.6556; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P424, DOI 10.1016/0003-2697(88)90209-6; JACEWICZ M, 1986, J CEREBR BLOOD F MET, V6, P263, DOI 10.1038/jcbfm.1986.48; KIESSLING M, 1986, J CEREBR BLOOD F MET, V6, P642, DOI 10.1038/jcbfm.1986.119; KIRINO T, 1991, J CEREBR BLOOD F MET, V11, P299, DOI 10.1038/jcbfm.1991.62; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LOWENSTEIN DH, 1990, BRAIN RES, V531, P173, DOI 10.1016/0006-8993(90)90771-3; LYSKO PG, 1989, BRAIN RES, V499, P258, DOI 10.1016/0006-8993(89)90773-7; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; MARINI AM, 1990, J NEUROCHEM, V54, P1509, DOI 10.1111/j.1471-4159.1990.tb01198.x; MCCASLIN PP, 1987, BRAIN RES, V417, P380, DOI 10.1016/0006-8993(87)90469-0; MICHAELS RL, 1990, J NEUROSCI, V10, P283; MILES MF, 1991, J BIOL CHEM, V266, P2409; MIZZEN LA, 1988, J CELL BIOL, V106, P1105, DOI 10.1083/jcb.106.4.1105; NISHIMURA RN, 1991, MOL BRAIN RES, V9, P39, DOI 10.1016/0169-328X(91)90128-K; NOWAK TS, 1985, J NEUROCHEM, V45, P1635, DOI 10.1111/j.1471-4159.1985.tb07236.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; SIMON RP, 1991, J NEUROSCI, V11, P881; VASS K, 1988, ACTA NEUROPATHOL, V77, P128; VASS K, 1989, NEUROSCI LETT, V100, P259, DOI 10.1016/0304-3940(89)90695-2; WELCH WJ, 1983, J BIOL CHEM, V258, P7102; WELCH WJ, 1986, J CELL BIOL, V103, P2035, DOI 10.1083/jcb.103.5.2035; WELCH WJ, 1987, IMMUNOBIOLOGY PROTEI, P287; WELCH WJ, 1989, STRESS INDUCED PROTE, P187; YU ACH, 1986, J NEUROCHEM, V47, P1181	42	257	264	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					1053	1060		10.1016/0896-6273(91)90349-5	http://dx.doi.org/10.1016/0896-6273(91)90349-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1764242				2022-12-28	WOS:A1991GY43800017
J	SLESINGER, PA; LANSMAN, JB				SLESINGER, PA; LANSMAN, JB			REOPENING OF CA2+ CHANNELS IN MOUSE CEREBELLAR NEURONS AT RESTING MEMBRANE-POTENTIALS DURING RECOVERY FROM INACTIVATION	NEURON			English	Article							SQUID GIANT SYNAPSE; CALCIUM CHANNELS; VERTEBRATE CELLS; SENSORY NEURONS; SODIUM CHANNEL; MECHANISMS; CHICK; MODES	Recordings of single-channel activity from cerebellar granule cells show that a component of Ca2+ entry flows through L-type Ca2+ channels that are closed at negative membrane potentials following a strong depolarization, but then open after a delay. The delayed openings can be explained if membrane depolarization drives Ca2+ channels into an inactivated state and some channels return to rest through the open state after repolarization. Whole-cell recordings show that the charge carried by Ca2+ during the tail increases as inactivation progresses, whereas the current during the voltage step decreases. Voltage-dependent inactivation may be a general mechanism in central neurons for enhancing Ca2+ entry by delaying it until after repolarization, when the driving force for ion entry is large. Modifying the rate and extent of inactivation would have large effects on Ca2+ entry through those channels that recover from inactivation by passing through the open state.	UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PHARMACOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	SLESINGER, PA (corresponding author), UNIV CALIF SAN FRANCISCO,SCH MED,GRAD PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143, USA.			Lansman, Jeffry/0000-0002-8279-4064	NIGMS NIH HHS [GM07449] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P547, DOI 10.1113/jphysiol.1987.sp016551; CHANDLER WK, 1970, J PHYSIOL-LONDON, V211, P653, DOI 10.1113/jphysiol.1970.sp009298; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HOF RP, 1985, J CARDIOVASC PHARM, V7, P689, DOI 10.1097/00005344-198507000-00012; HORN R, 1984, ION CHANNELS MOL PHY, P53; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; IP NY, 1984, NATURE, V311, P472, DOI 10.1038/311472a0; KATZ B, 1967, J PHYSIOL-LONDON, V192, P407, DOI 10.1113/jphysiol.1967.sp008307; LEE KS, 1985, J PHYSIOL-LONDON, V364, P395, DOI 10.1113/jphysiol.1985.sp015752; LLINAS R, 1981, BIOPHYS J, V33, P289, DOI 10.1016/S0006-3495(81)84898-9; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; MEYER FB, 1989, BRAIN RES REV, V14, P227, DOI 10.1016/0165-0173(89)90002-7; PIETROBON D, 1990, NATURE, V346, P651, DOI 10.1038/346651a0; SCHROEDER JE, 1990, NEURON, V5, P445, DOI 10.1016/0896-6273(90)90083-R; SLESINGER PA, 1991, J PHYSIOL-LONDON, V435, P101, DOI 10.1113/jphysiol.1991.sp018500; SLESINGER PA, 1991, J PHYSIOL-LONDON, V439, P301, DOI 10.1113/jphysiol.1991.sp018668; SWANDULLA D, 1988, J GEN PHYSIOL, V92, P197, DOI 10.1085/jgp.92.2.197; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86, DOI 10.1152/jn.1981.45.1.86; YUE DT, 1990, P NATL ACAD SCI USA, V87, P753, DOI 10.1073/pnas.87.2.753; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	28	44	44	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1991	7	5					755	762		10.1016/0896-6273(91)90278-8	http://dx.doi.org/10.1016/0896-6273(91)90278-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1660284				2022-12-28	WOS:A1991GT93900006
J	ELDE, R; CAO, Y; CINTRA, A; BRELJE, TC; PELTOHUIKKO, M; JUNTTILA, T; FUXE, K; PETTERSSON, RF; HOKFELT, T				ELDE, R; CAO, Y; CINTRA, A; BRELJE, TC; PELTOHUIKKO, M; JUNTTILA, T; FUXE, K; PETTERSSON, RF; HOKFELT, T			PROMINENT EXPRESSION OF ACIDIC FIBROBLAST GROWTH-FACTOR IN MOTOR AND SENSORY NEURONS	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; NUCLEOTIDE-SEQUENCE; MESSENGER-RNA; PC12 CELLS; INSITU HYBRIDIZATION; ANGIOGENIC PROTEIN; ENDOTHELIAL-CELLS; NEURITE OUTGROWTH; TYROSINE KINASE; FACTOR FAMILY	Several growth factors originally characterized and named for their action on a variety of cells have more recently been suggested to be importantly involved in the development and maintenance of the nervous system. Acidic fibroblast growth factor (aFGF) is a member of a family of seven structurally related polypeptide growth factors. The cells responsible for expression of aFGF in the nervous system of adult rats have been identified using an affinity-purified antibody to aFGF in immunohistochemical studies and synthetic oligonucleotide probes for in situ hybridization studies. High levels of aFGF expression were observed in motoneurons, primary sensory neurons, and retinal ganglion neurons. Glial cells did not express detectable amounts of aFGF. Confocal and electron microscopic analysis suggested that a large portion of aFGF immunoreactivity was associated with the cytoplasmic face of neuronal membranes, consistent with the hypothesis that aFGF is a sequestered growth factor.	KAROLINSKA INST, LUDWIG INST CANC RES, S-10401 STOCKHOLM 60, SWEDEN; UNIV MINNESOTA, DEPT CELL BIOL & NEUROANAT, MINNEAPOLIS, MN 55455 USA; UNIV TAMPERE, DEPT BIOMED SCI, TAMPERE, FINLAND	Karolinska Institutet; Ludwig Institute for Cancer Research; University of Minnesota System; University of Minnesota Twin Cities; Tampere University	ELDE, R (corresponding author), KAROLINSKA INST, DEPT HISTOL & NEUROBIOL, S-10401 STOCKHOLM 60, SWEDEN.			Fuxe, Kjell/0000-0001-8491-4288	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH043230] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 43230] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; ALTERIO J, 1990, BIOCHEM BIOPH RES CO, V166, P1205, DOI 10.1016/0006-291X(90)90994-X; BALDIN V, 1990, EMBO J, V9, P1511, DOI 10.1002/j.1460-2075.1990.tb08269.x; BEAN AJ, 1991, IN PRESS P NATL ACAD; BOUCHE G, 1987, P NATL ACAD SCI USA, V84, P6770, DOI 10.1073/pnas.84.19.6770; BOVI PD, 1987, CELL, V50, P729, DOI 10.1016/0092-8674(87)90331-X; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Cao YH, 1990, GROWTH FACTORS, V3, DOI 10.3109/08977199009037497; CARUELLE D, 1989, J CELL BIOCHEM, V39, P117, DOI 10.1002/jcb.240390204; CORDEIRO PG, 1989, PLAST RECONSTR SURG, V83, P1013, DOI 10.1097/00006534-198906000-00014; Danielii J.F., 1958, GENERAL CYTOCHEMICAL, P399; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; DIXON M, 1989, MOL CELL BIOL, V9, P4896, DOI 10.1128/MCB.9.11.4896; ELDE R, 1976, NEUROSCIENCE, V1, P349, DOI 10.1016/0306-4522(76)90063-4; ERNFORS P, 1990, J NEUROSCI RES, V27, P10, DOI 10.1002/jnr.490270103; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; GOLDFARB M, 1990, CELL GROWTH DIFFER, V1, P439; GONZALEZ AM, 1990, J CELL BIOL, V110, P753, DOI 10.1083/jcb.110.3.753; GOODRICH SP, 1989, NUCLEIC ACIDS RES, V17, P2867, DOI 10.1093/nar/17.7.2867; GOSPODAROWICZ D, 1987, J CELL PHYSIOL, P15; GROTHE C, 1991, J COMP NEUROL, V305, P328, DOI 10.1002/cne.903050213; HEUER JG, 1990, NEURON, V5, P283, DOI 10.1016/0896-6273(90)90165-C; HOU JZ, 1991, SCIENCE, V251, P665, DOI 10.1126/science.1846977; HOUSSAINT E, 1990, P NATL ACAD SCI USA, V87, P8180, DOI 10.1073/pnas.87.20.8180; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; JACQUEMIN E, 1990, NEUROSCI LETT, V116, P23, DOI 10.1016/0304-3940(90)90380-R; JANET T, 1987, NEUROSCI LETT, V80, P153, DOI 10.1016/0304-3940(87)90645-8; JAYE M, 1986, SCIENCE, V233, P541, DOI 10.1126/science.3523756; KARDAMI E, 1989, J CELL BIOL, V109, P1865, DOI 10.1083/jcb.109.4.1865; Klagsbrun M, 1990, CURR OPIN CELL BIOL, V2, P857, DOI 10.1016/0955-0674(90)90084-R; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LIBERMANN TA, 1987, EMBO J, V6, P1627, DOI 10.1002/j.1460-2075.1987.tb02410.x; LIPTON SA, 1988, P NATL ACAD SCI USA, V85, P2388, DOI 10.1073/pnas.85.7.2388; Maizel JV, 1971, METHOD VIROL, V5, P179; MARICS I, 1989, ONCOGENE, V4, P335; MASCARELLI F, 1989, EMBO J, V8, P2265, DOI 10.1002/j.1460-2075.1989.tb08351.x; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MCNEIL PL, 1989, J CELL BIOL, V109, P811, DOI 10.1083/jcb.109.2.811; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; MOORE R, 1986, EMBO J, V5, P919, DOI 10.1002/j.1460-2075.1986.tb04304.x; MORROW NG, 1990, J CLIN INVEST, V85, P1816, DOI 10.1172/JCI114640; MUJUMDAR RB, 1989, CYTOMETRY, V10, P11, DOI 10.1002/cyto.990100104; NEUFELD G, 1986, J BIOL CHEM, V261, P5631; PARTANEN J, 1990, P NATL ACAD SCI USA, V87, P8913, DOI 10.1073/pnas.87.22.8913; PASQUALE EB, 1989, P NATL ACAD SCI USA, V86, P5449, DOI 10.1073/pnas.86.14.5449; PETTMANN B, 1986, NEUROSCI LETT, V68, P175, DOI 10.1016/0304-3940(86)90137-0; Pickel V.M., 1981, NEUROANATOMICAL TRAC, P483; PLATT JL, 1983, J HISTOCHEM CYTOCHEM, V31, P840, DOI 10.1177/31.6.6341464; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; RENKO M, 1990, J CELL PHYSIOL, V144, P108, DOI 10.1002/jcp.1041440114; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; RUTA M, 1989, P NATL ACAD SCI USA, V86, P8722, DOI 10.1073/pnas.86.22.8722; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SCHALLING M, 1990, THESIS KAROLINSKA I; SCHUBERT D, 1987, J CELL BIOL, V104, P635, DOI 10.1083/jcb.104.3.635; SOMMER A, 1989, J CELL PHYSIOL, V138, P215, DOI 10.1002/jcp.1041380129; TAIRA M, 1987, P NATL ACAD SCI USA, V84, P2980, DOI 10.1073/pnas.84.9.2980; TOGARI A, 1985, J NEUROSCI, V5, P307; TOGARI A, 1983, BIOCHEM BIOPH RES CO, V114, P1189, DOI 10.1016/0006-291X(83)90688-5; TOOYAMA I, 1991, NEUROSCIENCE, V40, P769, DOI 10.1016/0306-4522(91)90011-C; TORRESALEMAN I, 1990, DEV BRAIN RES, V52, P253, DOI 10.1016/0165-3806(90)90242-Q; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; VALLES AM, 1990, P NATL ACAD SCI USA, V87, P1124, DOI 10.1073/pnas.87.3.1124; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; WAGNER JA, 1986, J CELL BIOL, V103, P1363, DOI 10.1083/jcb.103.4.1363; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WALICKE PA, 1988, DEV BRAIN RES, V40, P71, DOI 10.1016/0165-3806(88)90009-0; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WILCOX BJ, 1991, NEURON, V6, P397, DOI 10.1016/0896-6273(91)90248-X; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K; YOUNG WSI, 1990, ANAL NEURONAL MICROC, P481; ZAMBONI L, 1967, J CELL BIOL A, V148, P35; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	76	184	186	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1991	7	3					349	364		10.1016/0896-6273(91)90288-B	http://dx.doi.org/10.1016/0896-6273(91)90288-B			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1716928	Bronze			2022-12-28	WOS:A1991GG88700001
J	LYNCH, WP; CZUB, S; MCATEE, FJ; HAYES, SF; PORTIS, JL				LYNCH, WP; CZUB, S; MCATEE, FJ; HAYES, SF; PORTIS, JL			MURINE RETROVIRUS INDUCED SPONGIFORM ENCEPHALOPATHY - PRODUCTIVE INFECTION OF MICROGLIA AND CEREBELLAR NEURONS IN ACCELERATED CNS DISEASE	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; LEUKEMIA-VIRUS-TB; C RNA VIRUS; IMMUNOHISTOCHEMICAL LOCALIZATION; PARALYTOGENIC MUTANT; SLOW DISEASE; MOUSE; MICE; PATHOGENESIS; CELLS	We have examined the pathological lesions and sites of infection in mice inoculated with a highly neurovirulent recombinant wild mouse ecotropic retrovirus (FrCas(E)). The spongiform lesions appeared initially as swollen postsynaptic neuronal processes, progressing to swelling in neuronal cell bodies, all in the absence of detectable gliosis. Infection of neurons in regions of vacuolation was not detected. However, high level infection of cerebellar granule neurons was observed in the absence of cytopathology, wherein viral protein was found associated with both axons and dendrites. Infection of ramified and amoeboid microglial cells was associated with cytopathology in the brain stem, and endothelial cell-pericyte infection was found throughout the CNS. No evidence of defective retroviral expression was observed. These results are consistent with an indirect mechanism of retrovirus-induced neuropathology.	NIAID, ROCKY MTN LABS, VECTORS & PATHOGENS LAB, HAMILTON, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	LYNCH, WP (corresponding author), NIAID, ROCKY MTN LABS, PERSISTENT VIRAL DIS LAB, HAMILTON, MT 59840 USA.							ANDREWS JM, 1974, J NEUROPATH EXP NEUR, V33, P285, DOI 10.1097/00005072-197404000-00007; BASZLER TV, 1990, LAB INVEST, V63, P612; BASZLER TV, 1991, AM J PATHOL, V138, P655; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BIGNAMI A, 1974, NATURE, V252, P55, DOI 10.1038/252055a0; BROOKS BR, 1980, LAB INVEST, V43, P480; BROWN WJ, 1984, CELL, V36, P295, DOI 10.1016/0092-8674(84)90223-X; CHESEBRO B, 1983, VIROLOGY, V127, P134, DOI 10.1016/0042-6822(83)90378-1; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CZUB M, 1991, IN PRESS J VIROL; DESGROSEILLERS L, 1984, J VIROL, V52, P356, DOI 10.1128/JVI.52.2.356-363.1984; EVANS LH, 1990, J VIROL, V64, P6176, DOI 10.1128/JVI.64.12.6176-6183.1990; EWERT DL, 1990, LAB INVEST, V62, P156; Fraser H., 1979, Slow transmissible diseases of the nervous system. Volume 1., P387; GARDNER MB, 1973, JNCI-J NATL CANCER I, V51, P1243, DOI 10.1093/jnci/51.4.1243; GIULIAN D, 1988, Brain Behavior and Immunity, V2, P352, DOI 10.1016/0889-1591(88)90040-2; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GIULIAN D, 1990, SCIENCE, V250, P1593, DOI 10.1126/science.2148832; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; HOFFMAN PM, 1981, J NEUROIMMUNOL, V1, P275, DOI 10.1016/0165-5728(81)90031-X; KAY DG, 1991, P NATL ACAD SCI USA, V88, P1281, DOI 10.1073/pnas.88.4.1281; MARGOLIS G, 1971, PROGR NEUROPATHOLOGY, P168; MCATEE FJ, 1985, J VIROL, V56, P1018, DOI 10.1128/JVI.56.3.1018-1022.1985; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MOREY MK, 1990, VIROLOGY, V178, P104, DOI 10.1016/0042-6822(90)90383-3; MORI S, 1990, MICROB PATHOGENESIS, V9, P243, DOI 10.1016/0882-4010(90)90013-G; OLDSTONE MBA, 1980, VIROLOGY, V107, P180, DOI 10.1016/0042-6822(80)90283-4; OLDSTONE MBA, 1977, AM J PATHOL, V88, P193; OLNEY JW, 1990, ANNU REV PHARMACOL, V30, P47; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Peters A., 1976, FINE STRUCTURE NERVO; PITTS OM, 1987, LAB INVEST, V56, P401; PORTIS JL, 1990, CURR TOP MICROBIOL, V160, P11; PORTIS JL, 1990, J VIROL, V64, P1648, DOI 10.1128/JVI.64.4.1648-1656.1990; PORTIS JL, 1987, J VIROL, V61, P1037, DOI 10.1128/JVI.61.4.1037-1044.1987; SHARPE AH, 1990, NATURE, V346, P181, DOI 10.1038/346181a0; SHOJAEIAN H, 1985, DEV BRAIN RES, V21, P141, DOI 10.1016/0165-3806(85)90033-1; SIDMAN R L, 1968, PHYSIOLOGICAL AND BIOCHEMICAL ASPECTS OF NERVOUS INTEGRATION, P163; SITBON M, 1986, CELL, V47, P851, DOI 10.1016/0092-8674(86)90800-7; SPENCER PS, 1987, SCIENCE, V237, P517, DOI 10.1126/science.3603037; SPRINGER T, 1978, EUR J IMMUNOL, V8, P539, DOI 10.1002/eji.1830080802; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; SWARZ JR, 1981, NEUROPATH APPL NEURO, V7, P365, DOI 10.1111/j.1365-2990.1981.tb00239.x; SZUREK PF, 1988, J VIROL, V62, P357, DOI 10.1128/JVI.62.1.357-360.1988; VAZEUX R, 1987, AM J PATHOL, V126, P403; WATKINS BA, 1990, SCIENCE, V249, P549, DOI 10.1126/science.2200125; YUEN PH, 1985, J VIROL, V54, P364, DOI 10.1128/JVI.54.2.364-373.1985; YUEN PH, 1986, J VIROL, V59, P59, DOI 10.1128/JVI.59.1.59-65.1986; ZACHARY JF, 1986, AM J PATHOL, V124, P457	49	83	83	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1991	7	3					365	379		10.1016/0896-6273(91)90289-C	http://dx.doi.org/10.1016/0896-6273(91)90289-C			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1654946	Bronze			2022-12-28	WOS:A1991GG88700002
J	CHARLES, AC; MERRILL, JE; DIRKSEN, ER; SANDERSON, MJ				CHARLES, AC; MERRILL, JE; DIRKSEN, ER; SANDERSON, MJ			INTERCELLULAR SIGNALING IN GLIAL-CELLS - CALCIUM WAVES AND OSCILLATIONS IN RESPONSE TO MECHANICAL STIMULATION AND GLUTAMATE	NEURON			English	Article							EXCITATORY AMINO-ACIDS; SPREADING DEPRESSION; INTRACELLULAR CA-2+; NERVOUS-SYSTEM; ASTROCYTES; CULTURES; PROLIFERATION; BRAIN; OLIGODENDROCYTES; COMMUNICATION	Intercellular Ca2+ signaling in primary cultures of glial cells was investigated with digital fluorescence video imaging. Mechanical stimulation of a single cell induced a wave of increased [Ca2+]i that was communicated to surrounding cells. This was followed by asynchronous Ca2+ oscillations in some cells. Similar communicated Ca2+ responses occurred in the absence of extracellular Ca2+, despite an initial decrease in [Ca2+]i in the stimulated cell. Mechanical stimulation in the presence of glutamate induced a typical communicated Ca2+ wave through cells undergoing asynchronous Ca2+ oscillations in response to glutamate. The coexistence of communicated Ca2+ waves and asynchronous Ca2+ oscilaltions suggests distinct mechanisms for intra- and intercellular Ca2+ signaling. This intercellular signaling may coordinate cooperative glial function.	UNIV CALIF LOS ANGELES,SCH MED,DEPT ANAT & CELL BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	CHARLES, AC (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT NEUROL,LOS ANGELES,CA 90024, USA.				NINDS NIH HHS [NS26983] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026983] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED Z, 1990, BRAIN RES, V516, P165, DOI 10.1016/0006-8993(90)90914-W; ANDERS JJ, 1988, GLIA, V1, P371, DOI 10.1002/glia.440010604; BARRES BA, 1989, NATURE, V339, P343, DOI 10.1038/339343a0; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BENVENISTE EN, 1986, NATURE, V321, P610, DOI 10.1038/321610a0; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DRAGUNOW M, 1990, EXP NEUROL, V107, P236, DOI 10.1016/0014-4886(90)90141-E; DUDEK FE, 1988, BRAIN RES, V439, P275; ENKVIST MOK, 1989, GLIA, V2, P397, DOI 10.1002/glia.440020602; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; GLAUM SR, 1990, P NATL ACAD SCI USA, V87, P3454, DOI 10.1073/pnas.87.9.3454; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTNICK MJ, 1981, BRAIN RES, V213, P486, DOI 10.1016/0006-8993(81)90259-6; HASELGROVE JC, 1990, BRAIN RES, V506, P109, DOI 10.1016/0006-8993(90)91205-U; JANECZKO K, 1988, BRAIN RES, V456, P280, DOI 10.1016/0006-8993(88)90229-6; JENSEN AM, 1990, J NEUROSCI, V10, P1165; KETTENMANN H, 1988, GLIA, V1, P64, DOI 10.1002/glia.440010108; KETTENMANN H, 1983, J NEUROSCI, V3, P506; KETTENMANN H, 1988, GLIAL CELL RECEPTORS, P95; KIMELBERG HK, 1986, ASTROCYTES, V3, P129; LAURITZEN M, 1988, BRAIN RES, V475, P317, DOI 10.1016/0006-8993(88)90620-8; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; MARRERO H, 1989, NATURE, V339, P378, DOI 10.1038/339378a0; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MERRILL JE, 1984, SCIENCE, V224, P1428, DOI 10.1126/science.6610212; MONCK JR, 1988, J BIOL CHEM, V263, P4569; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5; SACHS F, 1988, CRIT REV BIOMED ENG, V16, P141; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SANDERSON MJ, 1990, CELL REGUL, V1, P585, DOI 10.1091/mbc.1.8.585; SANDERSON MJ, 1986, P NATL ACAD SCI USA, V83, P7302, DOI 10.1073/pnas.83.19.7302; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0	37	547	558	0	50	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1991	6	6					983	992		10.1016/0896-6273(91)90238-U	http://dx.doi.org/10.1016/0896-6273(91)90238-U			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	1675864				2022-12-28	WOS:A1991FT94900013
J	FIRESTEIN, S; DARROW, B; SHEPHERD, GM				FIRESTEIN, S; DARROW, B; SHEPHERD, GM			ACTIVATION OF THE SENSORY CURRENT IN SALAMANDER OLFACTORY RECEPTOR NEURONS DEPENDS ON A G PROTEIN MEDIATED CAMP 2ND-MESSENGER SYSTEM	NEURON			English	Article							SENSITIVE ADENYLATE-CYCLASE; CYCLIC-GMP; CHEMOSENSORY NEURONS; ODORANTS; CELLS; CONDUCTANCE; AMP; TRANSDUCTION; MEMBRANE; CHANNEL	Olfactory receptor neurons respond to odor stimulation with an inward cationic current. Under whole-cell patch clamp, individual, isolated olfactory receptors were exposed to pharmacological agents known to interact with distinct enzymes in a putative second messenger cascade, and their response to odors was measured. IBMX prolonged the odor-evoked current and also reduced its amplitude. cAMP and cGMP induced a current electrically identical to the odor current, but the current showed desensitization only with cAMP. GTP-gamma-s prolonged and GDP-beta-s interfered with the odor-evoked current. The long latency seen in the odor response appears to be mainly due to the loading of the G protein and secondarily to the requirement for cAMP accumulation. The main source of the response decay appears to be cyclic nucleotide hydrolysis.			FIRESTEIN, S (corresponding author), YALE UNIV,SCH MED,NEUROBIOL SECT,NEW HAVEN,CT 06510, USA.				NIDCD NIH HHS [DC00086-23] Funding Source: Medline; NINDS NIH HHS [NS10174-18] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS010174] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FIRESTEIN S, 1990, J PHYSIOL-LONDON, V430, P135, DOI 10.1113/jphysiol.1990.sp018286; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTZELL HC, 1986, NATURE, V323, P273, DOI 10.1038/323273a0; HELDMAN J, 1986, J NEUROCHEM, V47, P1527, DOI 10.1111/j.1471-4159.1986.tb00790.x; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; KURAHASHI T, 1989, J PHYSIOL-LONDON, V419, P177, DOI 10.1113/jphysiol.1989.sp017868; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; LANCET D, 1989, CHEM SENSES, V1, P283; LEVITZKI A, 1988, SCIENCE, V241, P800, DOI 10.1126/science.2841758; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; MATTHEWS HR, 1988, J PHYSL, V403, P389; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; PACE U, 1986, P NATL ACAD SCI USA, V83, P4947, DOI 10.1073/pnas.83.13.4947; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; SHIRLEY SG, 1986, BIOCHEM J, V240, P605, DOI 10.1042/bj2400605; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; SUZUKI N, 1989, CHEM SENSES, V1, P469; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445	26	151	154	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					825	835		10.1016/0896-6273(91)90178-3	http://dx.doi.org/10.1016/0896-6273(91)90178-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1709025				2022-12-28	WOS:A1991FM52200014
J	MONYER, H; SEEBURG, PH; WISDEN, W				MONYER, H; SEEBURG, PH; WISDEN, W			GLUTAMATE-OPERATED CHANNELS - DEVELOPMENTALLY EARLY AND MATURE FORMS ARISE BY ALTERNATIVE SPLICING	NEURON			English	Article							AMINO-ACID RECEPTORS; CENTRAL-NERVOUS-SYSTEM; NMDA RECEPTORS; ACETYLCHOLINE-RECEPTOR; HIPPOCAMPAL-NEURONS; RAT HIPPOCAMPUS; AREA CA1; KAINATE; CORTEX; NEUROTOXICITY	The expression of two alternative splice variants, Flip and Flop, in mRNAs encoding the four AMPA-selective glutamate receptors (GluR-A, -B, -C, and -D) was studied in the developing brain by in situ hybridization. These receptors are expressed prominently before birth, and patterns of distribution for Flip versions remain largely invariant during postnatal brain development. In contrast, the Flop versions are expressed at low levels prior to postnatal day 8. Around this time, the expression of Flop mRNAs increases throughout the brain, reaching adult levels by postnatal day 14. Thus, receptors carrying the Flop module appear to participate in mature receptor forms.			MONYER, H (corresponding author), UNIV HEIDELBERG, CTR MOLEC BIOL HEIDELBERG, MOLEC NEUROENDOCRINOL LAB, W-6900 HEIDELBERG, GERMANY.		Wisden, William/A-4071-2011	Wisden, William/0000-0003-4743-0334; Monyer, Hannah/0000-0002-9332-5749				AGHAJANIAN G. K., 1967, BRAIN RES, V6, P716, DOI 10.1016/0006-8993(67)90128-X; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BOULTER I, 1990, SCIENCE, V29, P1033; CAMBRAYDEAKIN MA, 1990, DEV BRAIN RES, V54, P265, DOI 10.1016/0165-3806(90)90149-S; CAMPOCHIARO P, 1978, P NATL ACAD SCI USA, V75, P2025, DOI 10.1073/pnas.75.4.2025; CARPENTER MK, 1990, DEV BIOL, V138, P313, DOI 10.1016/0012-1606(90)90199-S; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; GREENAMYRE T, 1987, J NEUROSCI, V7, P1022; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; HAMON B, 1988, DEV BRAIN RES, V38, P286, DOI 10.1016/0165-3806(88)90054-5; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; HEADLEY PM, 1990, TRENDS PHARMACOL SCI, V11, P205, DOI 10.1016/0165-6147(90)90116-P; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; INSEL TR, 1990, NEUROSCIENCE, V35, P31, DOI 10.1016/0306-4522(90)90117-M; JARAMILLO F, 1988, NATURE, V335, P66, DOI 10.1038/335066a0; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; MATTSON MP, 1988, NEURON, V1, P865, DOI 10.1016/0896-6273(88)90134-1; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MILLER LP, 1990, NEUROSCIENCE, V35, P45, DOI 10.1016/0306-4522(90)90118-N; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PEARCE IA, 1987, FEBS LETT, V223, P143, DOI 10.1016/0014-5793(87)80525-2; ROGERS JH, 1987, NEUROSCIENCE, V23, P343, DOI 10.1016/0306-4522(87)90295-8; SILVERSTEIN FS, 1986, NEUROSCI LETT, V71, P13, DOI 10.1016/0304-3940(86)90249-1; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SOMOGYI P, 1990, NEUROSCIENCE, V35, P9, DOI 10.1016/0306-4522(90)90116-L; STANFIELD BB, 1988, CEREB CORTEX, V7, P91; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; WISDEN W, 1991, MOL NEUROBIOLOGY PRA, V2, P205; WOLF G, 1984, DEV BRAIN RES, V14, P15, DOI 10.1016/0165-3806(84)90004-X; YOUNG AB, 1990, TRENDS PHARMACOL SCI, V11, P126, DOI 10.1016/0165-6147(90)90199-I	36	469	481	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					799	810		10.1016/0896-6273(91)90176-Z	http://dx.doi.org/10.1016/0896-6273(91)90176-Z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1673851				2022-12-28	WOS:A1991FM52200012
J	PENG, YW; SHARP, AH; SNYDER, SH; YAU, KW				PENG, YW; SHARP, AH; SNYDER, SH; YAU, KW			LOCALIZATION OF THE INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR IN SYNAPTIC TERMINALS IN THE VERTEBRATE RETINA	NEURON			English	Article							PROTEIN KINASE-C; ROD OUTER SEGMENTS; GANGLION-CELLS; TRISPHOSPHATE RECEPTOR; ENDOGENOUS PHOSPHORYLATION; HORIZONTAL CELLS; 2ND MESSENGERS; CAT RETINA; ON-CENTER; CALCIUM	Inositol 1,4,5-trisphosphate (InsP3) mobilizes internal Ca2+ in cells by binding to a receptor protein, which has recently been purified and molecularly cloned. To clarify those neuronal functions that are regulated by InsP3, we have localized this InsP3 receptor protein immunocytochemically in the retina, a neural tissue of well-defined structure and function. Positive staining in neurons is confined almost exclusively to the synaptic layers. Using dissociated retinal neurons, we have further localized the receptor to presynaptic terminals of photoreceptors and bipolar cells, as well as the synaptic processes of amacrine cells. The specific association of InsP3 receptors with synaptic terminals suggests a role for InsP3 in synaptic modulation, especially with respect to transmitter release.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205	Johns Hopkins University	PENG, YW (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205, USA.				NATIONAL EYE INSTITUTE [R37EY006837, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T01MH018531] Funding Source: NIH RePORTER; NEI NIH HHS [EY06837] Funding Source: Medline; NIDA NIH HHS [DA00074] Funding Source: Medline; NIMH NIH HHS [MH18531] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson R.E., 1988, Progress in Retinal Research, V8, P211, DOI 10.1016/0278-4327(88)90026-0; ANDERSON RE, 1981, BIOCHIM BIOPHYS ACTA, V665, P619, DOI 10.1016/0005-2760(81)90280-0; ANDERSON RE, 1983, J NEUROCHEM, V41, P764, DOI 10.1111/j.1471-4159.1983.tb04806.x; ANDERSON RE, 1984, J CELL BIOL, V99, P686, DOI 10.1083/jcb.99.2.686; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BINDER BM, 1989, J BIOL CHEM, V264, P8857; BRECHA N, 1983, CHEM NEUROANATOMY, P85; BROWN JE, 1987, BIOCHEM BIOPH RES CO, V146, P1392, DOI 10.1016/0006-291X(87)90804-7; DAW NW, 1989, ANNU REV NEUROSCI, V12, P205, DOI 10.1146/annurev.ne.12.030189.001225; Dowling J. E., 1987, RETINA APPROACHABLE; EHRLICH BE, 1988, NATURE, V336, P583, DOI 10.1038/336583a0; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; FAMIGLIETTI EV, 1977, SCIENCE, V198, P1267, DOI 10.1126/science.73223; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GHALAYINI A, 1984, BIOCHEM BIOPH RES CO, V124, P503, DOI 10.1016/0006-291X(84)91582-1; HARE WA, 1986, J COMP NEUROL, V252, P130, DOI 10.1002/cne.902520108; KANEKO A, 1979, ANNU REV NEUROSCI, V2, P169, DOI 10.1146/annurev.ne.02.030179.001125; KAPOOR CL, 1987, EXP EYE RES, V45, P545, DOI 10.1016/S0014-4835(87)80065-9; KAPOOR CL, 1984, BIOCHEM BIOPH RES CO, V122, P1397, DOI 10.1016/0006-291X(84)91246-4; KELLEHER DJ, 1985, J CYCLIC NUCL PROT, V10, P579; KELLEHER DJ, 1986, J BIOL CHEM, V261, P4749; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARCHIAFAVA PL, 1980, PROC R SOC SER B-BIO, V208, P103, DOI 10.1098/rspb.1980.0044; MASSEY SC, 1987, PROG NEUROBIOL, V28, P55, DOI 10.1016/0301-0082(87)90005-0; MEYER T, 1988, SCIENCE, V240, P653, DOI 10.1126/science.2452482; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; NISHIZUKA Y, 1984, SCIENCE, V225, P1365, DOI 10.1126/science.6147898; OSBORNE NN, 1990, PROGR RETINAL RES, V10, P101; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; STERLING P, 1983, ANNU REV NEUROSCI, V6, P149, DOI 10.1146/annurev.ne.06.030183.001053; STREB H, 1984, J MEMBRANE BIOL, V81, P241, DOI 10.1007/BF01868717; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEILER R, 1981, J COMP PHYSIOL, V144, P459, DOI 10.1007/BF01326831; WORLEY PF, 1987, NATURE, V325, P159, DOI 10.1038/325159a0; WORLEY PF, 1987, J BIOL CHEM, V262, P12132	44	107	107	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					525	531		10.1016/0896-6273(91)90055-5	http://dx.doi.org/10.1016/0896-6273(91)90055-5			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	1849721				2022-12-28	WOS:A1991FH80200004
J	ABELE, AE; SCHOLZ, KP; SCHOLZ, WK; MILLER, RJ				ABELE, AE; SCHOLZ, KP; SCHOLZ, WK; MILLER, RJ			EXCITOTOXICITY INDUCED BY ENHANCED EXCITATORY NEUROTRANSMISSION IN CULTURED HIPPOCAMPAL PYRAMIDAL NEURONS	NEURON			English	Article											ABELE, AE (corresponding author), UNIV CHICAGO, DEPT PHARMACOL & PHYSIOL SCI, CHICAGO, IL 60637 USA.		Abele, Andrea E./AFL-3996-2022	Abele, Andrea E./0000-0002-0237-8774	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040165, R37MH040165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002575, R01DA002121] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-02121, DA-02575] Funding Source: Medline; NIMH NIH HHS [MH-40165] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1987, J NEUROSCI, V7, P357; COLMERS WF, 1988, J NEUROSCI, V8, P3827; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; FAVARON M, 1988, P NATL ACAD SCI USA, V85, P7351, DOI 10.1073/pnas.85.19.7351; FORSYTHE ID, 1988, J NEUROSCI, V8, P3733; FREDHOLM BB, 1989, EUR J PHARM-MOLEC PH, V172, P249, DOI 10.1016/0922-4106(89)90055-2; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISON NL, 1988, NEUROSCI LETT, V85, P105, DOI 10.1016/0304-3940(88)90437-5; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MAYER ML, 1987, J NEUROSCI, V7, P3230; MAYER ML, 1990, IN PRESS TRENDS PHAR; MURPHY SN, 1989, J PHARMACOL EXP THER, V249, P184; MURPHY SN, 1987, J NEUROSCI, V7, P4145; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; MURPHY SN, 1989, MOL PHARMACOL, V35, P671; NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x; NICHOLLS DG, 1989, J NEUROCHEM, V52, P331, DOI 10.1111/j.1471-4159.1989.tb09126.x; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; Olney J W, 1986, Adv Exp Med Biol, V203, P631; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SANCHEZPRIETO J, 1988, J NEUROCHEM, V50, P1322, DOI 10.1111/j.1471-4159.1988.tb10611.x; SCHOLZ WK, 1988, J NEUROSCI, V8, P1039; SIESJO BK, 1988, ANN NY ACAD SCI, V522, P638; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; THAYER SA, 1988, PFLUG ARCH EUR J PHY, V412, P216, DOI 10.1007/BF00583753; THAYER SA, 1990, IN PRESS J PHYSL	35	134	135	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1990	4	3					413	419		10.1016/0896-6273(90)90053-I	http://dx.doi.org/10.1016/0896-6273(90)90053-I			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX032	1690567				2022-12-28	WOS:A1990CX03200009
J	JING, SQ; TAPLEY, P; BARBACID, M				JING, SQ; TAPLEY, P; BARBACID, M			NERVE GROWTH-FACTOR MEDIATES SIGNAL TRANSDUCTION THROUGH TRK HOMODIMER RECEPTORS	NEURON			English	Article							TUMOR-NECROSIS-FACTOR; TYROSINE PROTEIN-KINASE; HIGH-AFFINITY RECEPTORS; MOLECULAR-CLONING; NGF RECEPTOR; PROTOONCOGENE PRODUCT; NEUROTROPHIC FACTOR; NEURONAL DIFFERENTIATION; PHEOCHROMOCYTOMA CELLS; GENE-TRANSFER	We have investigated the molecular nature of the high affinity nerve growth factor (NGF) receptors by using cell lines expressing gp75LNGFR and gp140trk. Our results suggest that gp75LNGFR and gp140trk interact with NGF independently and that only gp140trk mediates NGF signaling. NGF binds to gp140trk with picomolar affinity and induces its phosphorylation on tyrosine residues regardless of the presence of gp75LNGFR. NGF-gp140trk complexes display the slow dissociation rate and rapid internalization characteristics of high affinity NGF receptors. Cross-linking studies reveal the existence of gp75LNGFR and gp140trk homodimers. However, we were unable to detect gp75LNGFR-gp140trk heterodimers. Coexpression in COS cells of wild-type and kinase deficient mutants reveals that gp140trk receptors can undergo intermolecular phosphorylation, indicating the formation of functional homodimers. Moreover, these kinase deficient mutants inhibit NGF-induced signaling through wild-type gp140trk receptors. These results indicate that the functional high affinity NGF receptors consist of gp140trk homodimeric (or oligomeric) complexes.			JING, SQ (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT,RES INST,DEPT MOLEC BIOL,PRINCETON,NJ 08543, USA.							BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; Barbacid Mariano, 1993, P123; BERG MM, 1991, P NATL ACAD SCI USA, V88, P7106, DOI 10.1073/pnas.88.16.7106; BNORMAN JA, 1992, MOL PHARMACOL, V41, P53; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; BOTHWELL MA, 1980, CELL, V21, P857, DOI 10.1016/0092-8674(80)90449-3; BOTHWELLM, 1990, CURR TOP MICROBIOL, V165, P55; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; DUBAU L, 1989, NUCLEIC ACIDS RES, V17, P2873; DURKOP H, 1992, CELL, V68, P421, DOI 10.1016/0092-8674(92)90180-K; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HARLOW E, 1988, ANTIBODIES LABORATOR; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSANG M, 1987, EMBO J, V6, P1197, DOI 10.1002/j.1460-2075.1987.tb02354.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MALLETT S, 1990, EMBO J, V9, P1063, DOI 10.1002/j.1460-2075.1990.tb08211.x; Maniatis T., 1982, MOL CLONING; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MATSUSHIMA H, 1990, MOL CELL BIOL, V10, P5015, DOI 10.1128/MCB.10.9.5015; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RADZIEJEWSKI SM, 1991, CELL, V65, P885; RAGSDALE C, 1991, NATURE, V350, P660, DOI 10.1038/350660a0; REDEMANN N, 1992, MOL CELL BIOL, V12, P491, DOI 10.1128/MCB.12.2.491; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; SUTTER A, 1979, J BIOL CHEM, V254, P5972; TAPLEY P, 1992, ONCOGENE, V7, P371; TSUJIMOTO M, 1985, P NATL ACAD SCI USA, V82, P7626, DOI 10.1073/pnas.82.22.7626; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551	67	416	433	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1067	1079		10.1016/0896-6273(92)90066-M	http://dx.doi.org/10.1016/0896-6273(92)90066-M			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1281417				2022-12-28	WOS:A1992KD71600006
J	USOWICZ, MM; SUGIMORI, M; CHERKSEY, B; LLINAS, R				USOWICZ, MM; SUGIMORI, M; CHERKSEY, B; LLINAS, R			P-TYPE CALCIUM CHANNELS IN THE SOMATA AND DENDRITES OF ADULT CEREBELLAR PURKINJE-CELLS	NEURON			English	Article							CHICK SENSORY NEURONS; CENTRAL-NERVOUS-SYSTEM; OMEGA-CONOTOXIN GVIA; ELECTRO-PHYSIOLOGICAL PROPERTIES; ROOT GANGLION NEURONS; BRAIN MESSENGER-RNA; GUINEA-PIG; CA2+ CHANNELS; PERIPHERAL NEURONS; VERTEBRATE CELLS	The pharmacological and single-channel properties of Ca2+ channels were studied in the somata and dendrites of adult cerebellar Purkinje cells. The Ca2+ channels were exclusively of the high threshold type: low threshold Ca2+ channels were not found. These high threshold channels were not blocked by omega-conotoxin GVIA and were inhibited rather than activated by BAY K 8644. They were therefore pharmacologically distinct from high threshold N- and L-type channels. Funnel web spider toxin was an effective blocker. The channels opened to conductance levels of 9, 14, and 19 pS (in 110 mM Ba2+). These slope conductances were in the range of those reported for N- and L-type channels. Our results are in agreement with previous reports suggesting that Ca2+ channels in Purkinje cells can be classified as P-type channels according to their pharmacology. The results also suggest that distinctions among Ca2+ channel types based on the single-channel conductance are not definitive.			USOWICZ, MM (corresponding author), NYU MED CTR, DEPT PHYSIOL & BIOPHYS, NEW YORK, NY 10016 USA.			Sugimori, Mutsuyuki/0000-0002-2908-3167; Usowicz, Maria/0000-0002-4844-4546	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS013742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009480] Funding Source: NIH RePORTER; NIA NIH HHS [AG 09480] Funding Source: Medline; NINDS NIH HHS [NS 13742] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE T, 1986, NEUROSCI LETT, V71, P203, DOI 10.1016/0304-3940(86)90559-8; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P181, DOI 10.1113/jphysiol.1989.sp017610; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; ARTALEJO CR, 1992, NEURON, V8, P85, DOI 10.1016/0896-6273(92)90110-Y; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BECHEM M, 1988, TRENDS PHARMACOL SCI, V9, P257, DOI 10.1016/0165-6147(88)90156-3; BERTOLINO M, 1992, ANNU REV PHARMACOL, V32, P399, DOI 10.1146/annurev.pa.32.040192.002151; BOLL W, 1985, NEUROSCI LETT, V56, P335, DOI 10.1016/0304-3940(85)90265-4; BOSSU JL, 1989, PFLUG ARCH EUR J PHY, V414, P92, DOI 10.1007/BF00585632; BOSSU JL, 1989, NEUROSCIENCE, V30, P605, DOI 10.1016/0306-4522(89)90155-3; BROWN AM, 1984, NATURE, V311, P570, DOI 10.1038/311570a0; CARBONE E, 1984, BIOPHYS J, V46, P413, DOI 10.1016/S0006-3495(84)84037-0; CARBONE E, 1990, PFLUG ARCH EUR J PHY, V416, P170, DOI 10.1007/BF00370239; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CHERKSEY BD, 1991, ANN NY ACAD SCI, V635, P80, DOI 10.1111/j.1749-6632.1991.tb36483.x; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FEDULOVA SA, 1985, J PHYSIOL-LONDON, V359, P431, DOI 10.1113/jphysiol.1985.sp015594; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HILLMAN D, 1991, P NATL ACAD SCI USA, V88, P7076, DOI 10.1073/pnas.88.16.7076; HILLYARD DR, 1992, NEURON, V9, P69, DOI 10.1016/0896-6273(92)90221-X; HIRANO T, 1989, PFLUG ARCH EUR J PHY, V413, P463, DOI 10.1007/BF00594174; HOCKBERGER PE, 1989, J NEUROSCI, V9, P2272; JONES SW, 1990, J NEUROSCI, V10, P2261; KANEDA M, 1989, BRAIN RES, V497, P187, DOI 10.1016/0006-8993(89)90987-6; KANEDA M, 1990, J NEUROPHYSIOL, V63, P1046, DOI 10.1152/jn.1990.63.5.1046; KANEKO A, 1989, J PHYSIOL-LONDON, V410, P613, DOI 10.1113/jphysiol.1989.sp017551; KASAI H, 1992, J PHYSIOL-LONDON, V448, P161, DOI 10.1113/jphysiol.1992.sp019035; KNAUS HG, 1987, N-S ARCH PHARMACOL, V336, P583; LEONARD JP, 1987, J NEUROSCI, V7, P875; LIN JW, 1990, P NATL ACAD SCI USA, V87, P4538, DOI 10.1073/pnas.87.12.4538; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P569, DOI 10.1113/jphysiol.1981.sp013764; LLINAS R, 1987, MIDWAVES THOUGHTS IN; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MARQUEZE B, 1988, MOL PHARMACOL, V34, P87; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; ODELL TJ, 1991, J PHYSIOL-LONDON, V436, P739, DOI 10.1113/jphysiol.1991.sp018577; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; PORZIG H, 1990, REV PHYSIOL BIOCH P, V114, P209; REGAN LJ, 1989, ANN NY ACAD SCI, V560, P121, DOI 10.1111/j.1749-6632.1989.tb24088.x; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; RICHARD S, 1991, NEUROSCI LETT, V132, P229, DOI 10.1016/0304-3940(91)90308-G; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SUGIMORI M, 1990, P NATL ACAD SCI USA, V87, P5084, DOI 10.1073/pnas.87.13.5084; SULLIVAN JM, 1992, J GEN PHYSIOL, V99, P85, DOI 10.1085/jgp.99.1.85; TAKAHASHI K, 1990, BRIT J PHARMACOL, V100, P705, DOI 10.1111/j.1476-5381.1990.tb14079.x; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; THOMPSON SM, 1991, J PHYSIOL-LONDON, V439, P671, DOI 10.1113/jphysiol.1991.sp018687; TRIGGLE DJ, 1989, TRENDS PHARMACOL SCI, V10, P507, DOI 10.1016/0165-6147(89)90051-5; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; UCHITEL OD, 1992, P NATL ACAD SCI USA, V89, P3330, DOI 10.1073/pnas.89.8.3330; USOWICZ MM, 1990, J PHYSIOL-LONDON, V426, P95, DOI 10.1113/jphysiol.1990.sp018128; WAGNER JA, 1988, J NEUROSCI, V8, P3354; WINEGAR BD, 1990, J PHYSIOL-LONDON, V425, P563, DOI 10.1113/jphysiol.1990.sp018118	70	279	282	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1992	9	6					1185	1199		10.1016/0896-6273(92)90076-P	http://dx.doi.org/10.1016/0896-6273(92)90076-P			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1281419				2022-12-28	WOS:A1992KD71600016
J	BETZ, WJ; BEWICK, GS; RIDGE, RMAP				BETZ, WJ; BEWICK, GS; RIDGE, RMAP			INTRACELLULAR MOVEMENTS OF FLUORESCENTLY LABELED SYNAPTIC VESICLES IN FROG MOTOR-NERVE TERMINALS DURING NERVE-STIMULATION	NEURON			English	Article							NEUROMUSCULAR-JUNCTION; RELEASE; TRANSMITTER; SYNAPSIN	We stained synaptic vesicles in frog motor nerve terminals with FM1-43 and studied changes in the shape and position of vesicle clusters during nerve stimulation. Each stained vesicle cluster appeared as a fluorescent spot. During repetitive nerve stimulation the spots gradually dimmed, most without changing shape or position. Occasionally, however, a spot moved, appearing in some cases to stream toward and coalesce with a neighboring spot. This suggests the existence of translocation mechanisms that can actively move vesicles in a coordinated fashion between vesicle clusters. Within single clusters, we saw no signs of such directed vesicle movements. Flourescent spots in terminals viewed from the side with a confocal microscope did not shrink toward the presynaptic membrane during nerve stimulation, but dimmed uniformly. This suggests that vesicles continuously mix within a cluster during destaining and provides no evidence of active vesicle translocators within single vesicle clusters for moving vesicles to the presynaptic membrane.			BETZ, WJ (corresponding author), UNIV COLORADO,SCH MED,DEPT PHYSIOL,DENVER,CO 80262, USA.		Bewick, Guy/AAL-8214-2021	Bewick, Guy/0000-0001-8266-7797				BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BETZ WJ, 1992, IN PRESS J PHYSL; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; GREENGARD P, 1991, J PHYSL, V436, P257; HEUSER JE, 1989, Q J EXP PHYSIOL CMS, V74, P1051, DOI 10.1113/expphysiol.1989.sp003333; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; SCHROER TA, 1991, ANNU REV PHYSIOL, V53, P629, DOI 10.1146/annurev.ph.53.030191.003213; VALTORTA F, 1990, NEUROSCIENCE, V35, P477, DOI 10.1016/0306-4522(90)90323-V; VALTORTA F, 1988, NEUROSCIENCE, V24, P593, DOI 10.1016/0306-4522(88)90353-3	13	88	88	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1992	9	5					805	813		10.1016/0896-6273(92)90235-6	http://dx.doi.org/10.1016/0896-6273(92)90235-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1418996				2022-12-28	WOS:A1992JY55200002
J	CAMPBELL, RM; PETERSON, AC				CAMPBELL, RM; PETERSON, AC			AN INTRINSIC NEURONAL DEFECT OPERATES IN DYSTONIA-MUSCULORUM - A STUDY OF DT/DT[--]+/+ CHIMERAS	NEURON			English	Article							NEUROFILAMENT PHOSPHORYLATION; MONOCLONAL-ANTIBODIES; NERVOUS-SYSTEM; SCIATIC-NERVE; MOUSE-BRAIN; ADULT-RATS; CELL; MICE; IMMUNOREACTIVITY; MYELINATION	In the mouse mutant dystonia musculorum (dt), peripheral and central sensory axons develop focal swellings and degenerate. To identify the primary cellular target of the mutation, we have analyzed the spinal cords of dt/dt<->+/+ aggregation chimeras. In these chimeras, characteristic swellings appeared only on the axons of mutant genotype neurons; the axons of wild-type neurons, identified by their expression of a transgene-encoded human neurofilament protein, were normal. This direct correlation of genotype and phenotype indicates that the dt mutation acts via a mechanism intrinsic to affected neurons. In addition, we show here that the dt mutation leads to a disorder of neurofilament processing in which phosphorylated neurofilament epitopes accumulate inappropriately in neuronal perikarya.	MCGILL UNIV,ROYAL VICTORIA HOSP,FAC MED,DEPT NEUROL & NEUROSURG,MONTREAL H3A 1A1,QUEBEC,CANADA	McGill University; Royal Victoria Hospital	CAMPBELL, RM (corresponding author), MCGILL UNIV,ROYAL VICTORIA HOSP,FAC MED,DIV EXPTL MED,MOLEC ONCOL GRP,H5-35,MONTREAL H3A 1A1,QUEBEC,CANADA.							ANDERTON BH, 1982, NATURE, V318, P533; BAULAC M, 1987, BRAIN RES, V420, P39, DOI 10.1016/0006-8993(87)90237-X; COLEMAN MP, 1990, J NEUROCHEM, V54, P1548, DOI 10.1111/j.1471-4159.1990.tb01203.x; DAVID S, 1984, J NEUROCYTOL, V13, P961, DOI 10.1007/BF01148596; DOERING LC, 1991, EXP NEUROL, V111, P1, DOI 10.1016/0014-4886(91)90045-E; Duchen L W, 1976, Adv Neurol, V14, P353; DUCHEN LW, 1964, BRAIN, V87, P367, DOI 10.1093/brain/87.2.367; EYER J, 1989, J NEUROCHEM, V52, P1759, DOI 10.1111/j.1471-4159.1989.tb07254.x; FIORI MG, 1988, J SUBMICR CYTOL PATH, V20, P137; GOLD BG, 1989, J NEUROPATH EXP NEUR, V48, P653, DOI 10.1097/00005072-198911000-00007; GOLD BG, 1991, J NEUROPATH EXP NEUR, V50, P615, DOI 10.1097/00005072-199109000-00007; GOLDOWITZ D, 1989, NEURON, V2, P1565, DOI 10.1016/0896-6273(89)90045-7; GOLDOWITZ D, 1982, J NEUROSCI, V2, P1474; GOLDSTEIN ME, 1987, J NEUROSCI, V7, P1586; GREEN MC, 1981, GENETIC VARIANTS STR, P64; HERRUP K, 1979, BRAIN RES, V178, P443, DOI 10.1016/0006-8993(79)90705-4; JANOTA I, 1972, BRAIN, V95, P529, DOI 10.1093/brain/95.3.529; JELLINGER K, 1973, PROGR NEUROPATHOLOGY, V2, P517; JULIEN JP, 1987, GENE DEV, V1, P1085, DOI 10.1101/gad.1.10.1085; KLOSEN P, 1990, BRAIN RES, V526, P259, DOI 10.1016/0006-8993(90)91230-E; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; LACHAPELLE F, 1990, GLIA, V3, P375, DOI 10.1002/glia.440030509; LACHAPELLE F, 1983, DEV NEUROSCI, V6, P325; LEE VMY, 1987, J NEUROSCI, V7, P3474; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MESSER A, 1980, NEUROSCIENCE, V5, P543, DOI 10.1016/0306-4522(80)90051-2; MINTZ B, 1967, SCIENCE, V158, P1484, DOI 10.1126/science.158.3807.1484; MOSS TH, 1981, J NEUROL SCI, V49, P207, DOI 10.1016/0022-510X(81)90079-4; MOSS TH, 1981, ACTA NEUROPATHOL, V53, P51, DOI 10.1007/BF00697184; MOSS TH, 1980, J PHYSL, V200, pP22; MULLEN RJ, 1971, J EXP ZOOL, V178, P165, DOI 10.1002/jez.1401780203; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; PASHAD IM, 1986, BRAIN RES, V363, P315; PETERSON AC, 1985, J NEUROSCI, V5, P1740; PETERSON AC, 1984, J COMP NEUROL, V227, P348, DOI 10.1002/cne.902270305; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; SHAW G, 1988, BRAIN RES, V460, P227, DOI 10.1016/0006-8993(88)90367-8; SICKLES DW, 1989, NEUROTOXICOLOGY, V10, P103; SOTELO C, 1988, NEUROSCIENCE, V27, P403, DOI 10.1016/0306-4522(88)90277-1; STANLEY E, 1983, ANAT REC, V206, P313, DOI 10.1002/ar.1092060310; VIDALSANZ M, 1991, EUR J NEUROSCI, V3, P758, DOI 10.1111/j.1460-9568.1991.tb01671.x; WATSON DF, 1989, J NEUROCHEM, V53, P1818, DOI 10.1111/j.1471-4159.1989.tb09248.x	42	25	25	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					693	703		10.1016/0896-6273(92)90032-9	http://dx.doi.org/10.1016/0896-6273(92)90032-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1389184				2022-12-28	WOS:A1992JT51600010
J	LAMBOLEZ, B; AUDINAT, E; BOCHET, P; CREPEL, F; ROSSIER, J				LAMBOLEZ, B; AUDINAT, E; BOCHET, P; CREPEL, F; ROSSIER, J			AMPA RECEPTOR SUBUNITS EXPRESSED BY SINGLE PURKINJE-CELLS	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; FUNCTIONAL EXPRESSION; SLICE CULTURES; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; MOLECULAR-CLONING; CEREBELLAR SLICES; XENOPUS OOCYTES; RAT; KAINATE	Several subunits of the glutamate receptor of the AMPA subtype have been cloned recently. These subunits, named GluR1, GluR2, GluR3, and GluR4, exist as two splicing variants (flip and flop). We have determined the subset of AMPA receptor subunits expressed by single cerebellar Purkinje cells in culture. This was achieved by combining whole-cell patch-clamp recordings and a molecular analysis, based on the polymerase chain reaction, of the messenger RNAs harvested into the patch pipette at the end of each recording. We found that each single cell expresses the messenger RNAs encoding the following five subunits: the flip and flop versions of GluR1 and GluR2 as well as GluR3flip, GluR2 being the most abundant. In addition, GluR3flop and GluR4flip were scarcely expressed in half of these neurons, and GluR4flop was never detected.	CNRS,NEUROBIOL & NEUROPHARMACOL DEV LAB,F-91405 ORSAY,FRANCE	Centre National de la Recherche Scientifique (CNRS)	LAMBOLEZ, B (corresponding author), CNRS,INST ALFRED FESSARD,F-91190 GIF SUR YVETTE,FRANCE.		Audinat, Etienne/F-4789-2019	Audinat, Etienne/0000-0002-6389-422X; lambolez, bertrand/0000-0002-0653-480X				AUDINAT E, 1990, J PHYSIOL-LONDON, V430, P297, DOI 10.1113/jphysiol.1990.sp018292; BARNARD EA, 1990, TRENDS PHARMACOL SCI, V11, P500, DOI 10.1016/0165-6147(90)90051-9; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CREPEL F, 1982, J PHYSIOL-LONDON, V329, P297, DOI 10.1113/jphysiol.1982.sp014304; DAWSON TL, 1990, MOL PHARMACOL, V38, P779; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; GAHWILER BH, 1984, EXPERIENTIA, V40, P235, DOI 10.1007/BF01947561; GEOFFROY M, 1991, MOL PHARMACOL, V39, P587; Gilliland G., 1990, PCR PROTOCOLS GUIDE, P60; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; ISHIDA AT, 1985, P NATL ACAD SCI USA, V82, P1837, DOI 10.1073/pnas.82.6.1837; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KNOPFEL T, 1990, EUR J NEUROSCI, V2, P726, DOI 10.1111/j.1460-9568.1990.tb00463.x; LAMBOLEZ B, 1991, NEUROSCI LETT, V123, P69, DOI 10.1016/0304-3940(91)90160-U; LECLERC N, 1988, J COMP NEUROL, V273, P399, DOI 10.1002/cne.902730310; LEWIS SA, 1984, P NATL ACAD SCI-BIOL, V81, P2743, DOI 10.1073/pnas.81.9.2743; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MILER RJ, 1991, TRENDS NEUROSCI, V14, P477; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; RANDLE JCR, 1988, MOL CELL BIOCHEM, V80, P121; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SMEYNE RJ, 1991, SCIENCE, V254, P719, DOI 10.1126/science.1948052; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; WANG AM, 1990, PCR PROTOCOLS GUIDE, P70; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; WYLLIE DJA, 1991, J PHYSIOL-LONDON, V432, P235, DOI 10.1113/jphysiol.1991.sp018383	36	446	454	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					247	258		10.1016/0896-6273(92)90164-9	http://dx.doi.org/10.1016/0896-6273(92)90164-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1323310				2022-12-28	WOS:A1992JJ33200007
J	OHTA, K; TAKAGI, S; ASOU, H; FUJISAWA, H				OHTA, K; TAKAGI, S; ASOU, H; FUJISAWA, H			INVOLVEMENT OF NEURONAL CELL-SURFACE MOLECULE B2 IN THE FORMATION OF RETINAL PLEXIFORM LAYERS	NEURON			English	Article							OFF-CENTER RESPONSES; ADHESION MOLECULES; XENOPUS-LAEVIS; GANGLION-CELLS; N-CAM; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; VISUAL CENTERS; BIPOLAR CELLS; OPTIC-NERVE	The B2 molecule is a 220 kd neuronal cell surface protein of Xenopus, recognized by monoclonal antibody B2 (MAb B2). Immunohistochemistry using MAb B2 revealed that the B2 molecule was expessed in both the inner and outer plexiform layers within the neural retina. During development of the neural retina, the B2 molecule first appeared at stages 35/36 in the newly formed plexiform layers. When embryonic eyes were cultured in the presence of anti-B2 antiserum (Fab fragments), the formation of the retinal plexiform layers was impeded. These data suggest that the cell surface molecule B2 plays a role in the development of retinal plexiform layers.	KEIO UNIV, SCH MED, DEPT PHYSIOL, SHINJUKU KU, TOKYO 160, JAPAN; NAGOYA UNIV, SCH SCI, DEPT MOLEC BIOL, CHIKUSA KU, NAGOYA 46401, JAPAN	Keio University; Nagoya University	OHTA, K (corresponding author), KYUSHU UNIV, SCH MED, DEPT MOLEC LIFE SCI, HIGASHI KU, FUKUOKA 812, JAPAN.							BARTSCH U, 1989, J COMP NEUROL, V284, P451, DOI 10.1002/cne.902840310; BUSKIRK DR, 1980, NATURE, V285, P488, DOI 10.1038/285488a0; CHUNG SH, 1975, J EMBRYOL EXP MORPH, V33, P915; CHUONG CM, 1984, J NEUROSCI, V4, P2354; FAISSNER A, 1984, EMBO J, V3, P733, DOI 10.1002/j.1460-2075.1984.tb01876.x; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; FAMIGLIETTI EV, 1977, SCIENCE, V198, P1267, DOI 10.1126/science.73223; FISHER LJ, 1976, DEV BIOL, V50, P402, DOI 10.1016/0012-1606(76)90161-5; FUJISAWA H, 1990, NEUROSCI RES, pS11, DOI 10.1016/0921-8696(90)90025-X; FUJISAWA H, 1989, DEV BIOL, V135, P231, DOI 10.1016/0012-1606(89)90175-9; GRANT P, 1980, J COMP NEUROL, V189, P593, DOI 10.1002/cne.901890403; HALL AK, 1985, DEV BIOL, V110, P39, DOI 10.1016/0012-1606(85)90061-2; HARE WA, 1986, J COMP NEUROL, V252, P130, DOI 10.1002/cne.902520108; HOFFMAN S, 1986, J CELL BIOL, V103, P145, DOI 10.1083/jcb.103.1.145; HOFFMAN S, 1984, P NATL ACAD SCI-BIOL, V81, P6881, DOI 10.1073/pnas.81.21.6881; JACOBSON M, 1968, DEV BIOL, V17, P219, DOI 10.1016/0012-1606(68)90062-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVI G, 1987, J CELL BIOL, V105, P2359, DOI 10.1083/jcb.105.5.2359; Mage M G, 1980, Methods Enzymol, V70, P142; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; RATHJEN FG, 1984, EMBO J, V3, P1; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; RUTISHAUSER U, 1978, J CELL BIOL, V79, P371, DOI 10.1083/jcb.79.2.371; SAKAGUCHI DS, 1984, J COMP NEUROL, V224, P231, DOI 10.1002/cne.902240205; STELL WK, 1977, SCIENCE, V198, P1269, DOI 10.1126/science.201028; SUNSHINE J, 1987, P NATL ACAD SCI USA, V84, P5986, DOI 10.1073/pnas.84.16.5986; TAKAGI S, 1987, DEV BIOL, V122, P90, DOI 10.1016/0012-1606(87)90335-6; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TOKUNAGA F, 1989, ZOOL SCI, V6, P167; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRISLER D, 1986, P NATL ACAD SCI USA, V83, P4194, DOI 10.1073/pnas.83.12.4194	32	42	42	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1992	9	1					151	161		10.1016/0896-6273(92)90230-B	http://dx.doi.org/10.1016/0896-6273(92)90230-B			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1632969				2022-12-28	WOS:A1992JE75600016
J	BERNHARDT, RR; NGUYEN, N; KUWADA, JY				BERNHARDT, RR; NGUYEN, N; KUWADA, JY			GROWTH CONE GUIDANCE BY FLOOR PLATE CELLS IN THE SPINAL-CORD OF ZEBRAFISH EMBRYOS	NEURON			English	Article							NERVOUS-SYSTEM; AXONS; NEURONS; RECOGNITION; ANTIBODIES; EXPRESSION; OUTGROWTH; ORIGIN	The spinal cord of early zebrafish embryos contains a small number of neuronal classes whose growth cones all follow stereotyped, cell-specific pathways to their targets. Two classes of spinal neurons make cell-specific turns at or near the ventral midline of the spinal cord, which is occupied by a single row of midline floor plate cells. We tested whether these cells guide the growth cones by examining embryos missing the midline floor plate cells due either to laser ablation of the cells or to a mutation (cyc-1). In these embryos the growth cones followed both normal and aberrant pathways once near the ventral midline. This suggests that normally the midline floor plate cells do provide guidance cues, but that these cues are not obligatory.			BERNHARDT, RR (corresponding author), UNIV MICHIGAN, DEPT BIOL, ANN ARBOR, MI 48109 USA.		Kuwada, John Y/B-1447-2009		NINDS NIH HHS [NS24848] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024848] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baker RC, 1927, J COMP NEUROL, V44, P1, DOI 10.1002/cne.900440102; BERNHARDT RR, 1990, J COMP NEUROL, V302, P603, DOI 10.1002/cne.903020315; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; CHITNIS AB, 1991, NEURON, V7, P277, DOI 10.1016/0896-6273(91)90266-3; CLARKE JDW, 1991, DEVELOPMENT, V112, P499; DALE N, 1987, PROC R SOC SER B-BIO, V232, P193, DOI 10.1098/rspb.1987.0068; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; EISEN JS, 1991, SCIENCE, V252, P569, DOI 10.1126/science.1708527; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HOLLEY JA, 1987, DEV BIOL, V123, P389, DOI 10.1016/0012-1606(87)90397-6; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; JESSELL TM, 1989, CIBA F SYMP, V144, P255; KARAGOGEOS D, 1991, DEVELOPMENT, V112, P51; KIMMEL CB, 1989, TRENDS GENET, V5, P283, DOI 10.1016/0168-9525(89)90103-0; KUWADA JY, 1990, J COMP NEUROL, V302, P617, DOI 10.1002/cne.903020316; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; KUWADA JY, 1990, J NEUROSCI, V10, P1299; LANDMESSER L, 1986, TRENDS NEUROSCI, V9, P489, DOI 10.1016/0166-2236(86)90156-6; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; MYERS PZ, 1986, J NEUROSCI, V6, P2278; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; PLACZEK M, 1990, DEVELOPMENT, V110, P19; RAPER JA, 1984, J NEUROSCI, V4, P2329; SANES JR, 1990, COLD SH Q B, V55, P419; SCHUBIGER M, 1985, DEV BIOL, V108, P399, DOI 10.1016/0012-1606(85)90043-0; SZARO BG, 1989, DEV BRAIN RES, V48, P87, DOI 10.1016/0165-3806(89)90095-3; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; YAGINUMA H, 1991, J NEUROSCI, V11, P2598	37	89	89	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1992	8	5					869	882		10.1016/0896-6273(92)90201-N	http://dx.doi.org/10.1016/0896-6273(92)90201-N			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1586486	Green Submitted			2022-12-28	WOS:A1992HV46700006
J	MULLE, C; CHOQUET, D; KORN, H; CHANGEUX, JP				MULLE, C; CHOQUET, D; KORN, H; CHANGEUX, JP			CALCIUM INFLUX THROUGH NICOTINIC RECEPTOR IN RAT CENTRAL NEURONS - ITS RELEVANCE TO CELLULAR-REGULATION	NEURON			English	Article								The Ca2+ permeability of a nicotinic acetylcholine receptor (nAChR) in the rat CNS was determined using both current and fluorescence measurements on medial habenula neurons. The elementary slope conductance of the nAChR channel was 11 pS in pure external Ca2+ (100 mM) and 42 pS in standard solution. Ca2+ influx through nAChRs resulted in the rise of cytosolic Ca2+ concentration ([Ca2+]i) to the micromolar range. This increase was maximal under voltage conditions (below -50 mV) in which Ca2+ influx through voltage-activated channels was minimal. Ca2+ influx through nAChRs directly activated a Ca2+-dependent Cl- conductance. In addition, it caused a decrease in the GABA(A) response that outlasted the rise in [Ca2+]i. These results underscore the physiological significance of Ca2+ influx through nAChR channel in the CNS.	INST PASTEUR, DEPT BIOTECHNOL, INSERM, U261, F-75724 PARIS 15, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	MULLE, C (corresponding author), INST PASTEUR, DEPT BIOTECHNOL, CNRS, UA NEUROBIOL MOLEC D1284, F-75724 PARIS 15, FRANCE.		Choquet, Daniel/K-7893-2018; Choquet, Daniel/GOJ-8825-2022; Choquet, Daniel/E-4203-2013	Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Mulle, Christophe/0000-0003-2709-6615				ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BREGESTOVSKI PD, 1979, NATURE, V279, P638, DOI 10.1038/279638a0; CENA V, 1983, NEUROSCIENCE, V10, P1455, DOI 10.1016/0306-4522(83)90126-4; DECKER ER, 1990, J NEUROSCI, V10, P3413; DELORME EM, 1988, J NEUROCHEM, V50, P1248, DOI 10.1111/j.1471-4159.1988.tb10601.x; DENERIS ES, 1991, TRENDS PHARMACOL SCI, V12, P34, DOI 10.1016/0165-6147(91)90486-C; FUXE K, 1987, WENNER GREN CENT INT, V48, P222; GALZI JL, 1991, ANNU REV PHARMACOL, V31, P37, DOI 10.1146/annurev.pa.31.040191.000345; GILBERTSON TA, 1991, SCIENCE, V251, P1613, DOI 10.1126/science.1849316; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLZ RW, 1982, J NEUROCHEM, V39, P635, DOI 10.1111/j.1471-4159.1982.tb07940.x; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; INOUE M, 1986, NATURE, V324, P156, DOI 10.1038/324156a0; JARAMILLO F, 1988, NATURE, V335, P66, DOI 10.1038/335066a0; KATZ B, 1969, J PHYSIOL-LONDON, V203, P689, DOI 10.1113/jphysiol.1969.sp008887; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KILPATRICK DL, 1982, J NEUROCHEM, V38, P427, DOI 10.1111/j.1471-4159.1982.tb08647.x; KOSTYUK PG, 1981, NEUROSCIENCE, V6, P2431, DOI 10.1016/0306-4522(81)90089-0; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1987, J NEUROSCI, V7, P3230; MAYER ML, 1985, J PHYSL, V364, P197; MCDERMOTT AM, 1991, CALCIUM CHANNEL BIOP; MESSING RO, 1989, J NEUROSCI, V9, P507; MILEDI R, 1980, J PHYSIOL-LONDON, V300, P197, DOI 10.1113/jphysiol.1980.sp013158; MULLE C, 1990, J NEUROSCI, V10, P169; MULLE C, 1991, J NEUROSCI, V11, P2588; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OSULLIVAN AJ, 1989, EMBO J, V8, P401, DOI 10.1002/j.1460-2075.1989.tb03391.x; OWEN DG, 1984, NATURE, V311, P567, DOI 10.1038/311567a0; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; ROTZLER S, 1991, NATURE, V349, P337, DOI 10.1038/349337a0; SONTAG JM, 1990, J PHYSIOL-LONDON, V427, P495, DOI 10.1113/jphysiol.1990.sp018184; STELZER A, 1988, SCIENCE, V241, P339, DOI 10.1126/science.2455347; TALEB O, 1987, PFLUG ARCH EUR J PHY, V409, P620, DOI 10.1007/BF00584663; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; VERGARA J, 1985, P NATL ACAD SCI USA, V82, P6352, DOI 10.1073/pnas.82.18.6352; WONNACOTT S, 1990, CIBA F SYMP, V152, P87	41	276	278	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1992	8	1					135	143		10.1016/0896-6273(92)90115-T	http://dx.doi.org/10.1016/0896-6273(92)90115-T			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1309647				2022-12-28	WOS:A1992HB18500012
J	TANABE, Y; MASU, M; ISHII, T; SHIGEMOTO, R; NAKANISHI, S				TANABE, Y; MASU, M; ISHII, T; SHIGEMOTO, R; NAKANISHI, S			A FAMILY OF METABOTROPIC GLUTAMATE RECEPTORS	NEURON			English	Article							LONG-TERM POTENTIATION; AMINO-ACID RECEPTORS; FUNCTIONAL EXPRESSION; PERTUSSIS TOXIN; MOLECULAR-CLONING; ADENYLATE-CYCLASE; XENOPUS OOCYTES; ION CHANNELS; G-PROTEIN; GENES	Three cDNA clones, mGluR2, mGluR3, and mGLuR4, were isolated from a rat brain cDNA library by cross-hybridization with the cDNA for a metabotropic glutamate receptor (mGluR1). The cloned receptors show considerable sequence similarity with mGluR1 and possess a large extracellular domain preceding the seven putative membrane-spanning segments. mGluR2 is expressed in some particular neuronal cells different from those expressing mGluR1 and mediates an efficient inhibition of forskolin-stimulated cAMP formation in cDNA-transfected cells. The mGluRs thus form a novel family of G protein-coupled receptors that differ in their signal transduction and expression patterns.	KYOTO UNIV,FAC MED,DEPT MORPHOL BRAIN SCI,KYOTO 606,JAPAN	Kyoto University	TANABE, Y (corresponding author), KYOTO UNIV,FAC MED,INST IMMUNOL,KYOTO 606,JAPAN.		Shigemoto, Ryuichi/E-3628-2013	Shigemoto, Ryuichi/0000-0001-8761-9444				ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; BASKYS A, 1991, EUR J PHARMACOL, V193, P131, DOI 10.1016/0014-2999(91)90213-A; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; GOH JW, 1989, SCIENCE, V244, P980, DOI 10.1126/science.2543072; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; ITO I, 1988, NEUROSCI LETT, V90, P181, DOI 10.1016/0304-3940(88)90808-7; Ito M, 1990, Neuroreport, V1, P129; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; Nakanishi S, 1990, Recent Prog Horm Res, V46, P59; NICOLETTI F, 1990, J NEUROCHEM, V54, P771, DOI 10.1111/j.1471-4159.1990.tb02317.x; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; OIKAWA S, 1989, BIOCHEM BIOPH RES CO, V164, P39, DOI 10.1016/0006-291X(89)91679-3; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; PEARCE B, 1986, NEUROSCI LETT, V72, P335, DOI 10.1016/0304-3940(86)90537-9; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOEPP D, 1990, TRENDS PHARMACOL SCI, V11, P508, DOI 10.1016/0165-6147(90)90052-A; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; SUGAMA K, 1989, BIOCHIM BIOPHYS ACTA, V1011, P75, DOI 10.1016/0167-4889(89)90081-5; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; UI M, 1984, TRENDS PHARMACOL SCI, V5, P277, DOI 10.1016/0165-6147(84)90444-9; URLAUB G, 1980, P NATL ACAD SCI-BIOL, V77, P4216, DOI 10.1073/pnas.77.7.4216; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WONG SKF, 1990, J BIOL CHEM, V265, P6219	39	961	1023	0	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1992	8	1					169	179		10.1016/0896-6273(92)90118-W	http://dx.doi.org/10.1016/0896-6273(92)90118-W			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1309649				2022-12-28	WOS:A1992HB18500015
J	HOLLIDAY, J; ADAMS, RJ; SEJNOWSKI, TJ; SPITZER, NC				HOLLIDAY, J; ADAMS, RJ; SEJNOWSKI, TJ; SPITZER, NC			CALCIUM-INDUCED RELEASE OF CALCIUM REGULATES DIFFERENTIATION OF CULTURED SPINAL NEURONS	NEURON			English	Article							ROHON-BEARD NEURONS; SYMPATHETIC NEURONS; CA-2+ CHANNELS; RAT-BRAIN; SARCOPLASMIC-RETICULUM; POTASSIUM CURRENTS; SKELETAL-MUSCLE; STORES; EXPRESSION; TRANSIENTS	Voltage-dependent calcium influx has been shown to regulate the differentiation of cultured amphibian spinal neurons. We have examined the transient elevation of intracellular calcium induced by depolarization, using calcium indicators and confocal microscopy with high temporal and spatial resolution. Rapid calcium elevations in both the nucleus and the cytosol are primarily due to calcium-dependent release of calcium from intracellular stores. Depletion of stores associated with the endoplasmic reticulum reduces all transients. Elevations diminish with neuronal maturation. Depletion of stores of intracellular calcium at early times affects neuronal differentiation in a manner similar to the prevention of influx. The results indicate that both influx and release are necessary to promote neuronal differentiation.	UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,CTR MOLEC GENET,LA JOLLA,CA 92093; SALK INST BIOL STUDIES,COMPUTAT NEUROBIOL LAB,SAN DIEGO,CA 92138; SALK INST BIOL STUDIES,HOWARD HUGHES MED INST,SAN DIEGO,CA 92138	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; Howard Hughes Medical Institute; Salk Institute			Sejnowski, Terrence/AAV-5558-2021	Adams, Richard/0000-0003-0280-0901; Spitzer, Nicholas/0000-0002-3523-1103	PHS HHS [15918] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BACCAGLINI PI, 1977, J PHYSIOL-LONDON, V271, P93, DOI 10.1113/jphysiol.1977.sp011992; BENTLEY D, 1991, J NEUROSCI, V11, P1300; BIXBY JL, 1984, DEV BIOL, V106, P89, DOI 10.1016/0012-1606(84)90065-4; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; BRAUN K, 1988, BRAIN RES, V475, P205, DOI 10.1016/0006-8993(88)90609-9; CIMINO M, 1990, DEV BRAIN RES, V54, P43, DOI 10.1016/0165-3806(90)90063-5; COHAN CS, 1987, J NEUROSCI, V7, P3588; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; GISHAN FK, 1988, AM J PHYSIOL, V254, pG74; HENDERSON LP, 1984, J NEUROSCI, V4, P3140; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HOLLIDAY J, 1990, DEV BIOL, V141, P13, DOI 10.1016/0012-1606(90)90098-4; JOHNSON IP, 1989, BRAIN RES, V489, P400, DOI 10.1016/0006-8993(89)90880-9; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KASS GEN, 1989, J BIOL CHEM, V264, P15192; LAMBORGHINI JE, 1979, J COMP NEUROL, V183, P741, DOI 10.1002/cne.901830405; LEBERER E, 1986, BIOCHEM J, V239, P295, DOI 10.1042/bj2390295; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; MATZKE AJM, 1990, FEBS LETT, V271, P161, DOI 10.1016/0014-5793(90)80397-2; MAZZANTI M, 1990, NATURE, V343, P764, DOI 10.1038/343764a0; MILANI D, 1990, CELL CALCIUM, V11, P191, DOI 10.1016/0143-4160(90)90070-B; MINTA A, 1989, J BIOL CHEM, V264, P8171; MOORE GA, 1987, FEBS LETT, V224, P331, DOI 10.1016/0014-5793(87)80479-9; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NEWPORT JW, 1987, ANNU REV BIOCHEM, V56, P535; NICOTERA P, 1989, P NATL ACAD SCI USA, V86, P453, DOI 10.1073/pnas.86.2.453; ODOWD DK, 1988, J NEUROSCI, V8, P792; PEREZ J, 1991, J COMP NEUROL, V303, P225, DOI 10.1002/cne.903030205; PRZYWARA DA, 1991, FASEB J, V5, P217, DOI 10.1096/fasebj.5.2.2004666; RASMUSSEN H, 1984, PHYSIOL REV, V64, P938, DOI 10.1152/physrev.1984.64.3.938; RIBERA AB, 1987, P NATL ACAD SCI USA, V84, P6577, DOI 10.1073/pnas.84.18.6577; ROBERTSON S, 1984, METHOD PHARMACOL, V5, P63, DOI DOI 10.1007/978-1-4684-4778-1_6; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; Smith RM, 1974, CRITICAL STABILITY C, V1-6; Spitzer N.C., 1985, P67; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; SUTKO JL, 1991, J CELL BIOL, V113, P793, DOI 10.1083/jcb.113.4.793; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; VERMA A, 1990, BIOCHEM BIOPH RES CO, V172, P811, DOI 10.1016/0006-291X(90)90747-B; VERMA A, 1990, CELL REGUL, V1, P781, DOI 10.1091/mbc.1.10.781; VIDAL S, 1989, MOL BRAIN RES, V6, P187, DOI 10.1016/0169-328X(89)90053-3; WALICKE PA, 1981, J NEUROSCI, V1, P343; WOZNIAK RW, 1989, J CELL BIOL, V12, P183	43	176	176	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1991	7	5					787	796		10.1016/0896-6273(91)90281-4	http://dx.doi.org/10.1016/0896-6273(91)90281-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1742025				2022-12-28	WOS:A1991GT93900009
J	VOGEL, KS; DAVIES, AM				VOGEL, KS; DAVIES, AM			THE DURATION OF NEUROTROPHIC FACTOR INDEPENDENCE IN EARLY SENSORY NEURONS IS MATCHED TO THE TIME COURSE OF TARGET FIELD INNERVATION	NEURON			English	Article							NERVE GROWTH-FACTOR; NEURAL CREST; FACTOR RECEPTORS; SYMPATHETIC NEURONS; MOLECULAR-CLONING; DEVELOPING SKIN; MESSENGER-RNA; NGF RECEPTOR; LOW-AFFINITY; PC12 CELLS	To investigate how the onset of neurotrophic factor dependence in neurons is coordinated with the arrival of their axons in the target field, we have studied the survival of four populations of cranial sensory neurons whose axons reach their common central target field, the hindbrain, at different times. We show that neurons whose axons reach the hindbrain first survive for a short time in culture before responding to brain-derived neurotrophic factor (BDNF). Neurons whose axons reach the hindbrain later survive longer before responding to BDNF. These differences in survival, which arise prior to gangliogenesis, may play a role in coordinating trophic interactions for cranial sensory neurons.			VOGEL, KS (corresponding author), ST GEORGE HOSP,SCH MED,DEPT ANAT,CRANMER TERR,LONDON SW17 0RE,ENGLAND.		Davies, Alun M/A-4334-2010	Davies, Alun M/0000-0001-5841-8176	NINDS NIH HHS [1F32NS08583-01] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS008583] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AYERLELIEVRE CS, 1982, DEV BIOL, V94, P291, DOI 10.1016/0012-1606(82)90349-9; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; BOCCHINI V, 1969, P NATL ACAD SCI USA, V64, P787, DOI 10.1073/pnas.64.2.787; Coghill GE, 1916, J COMP NEUROL, V26, P247, DOI 10.1002/cne.900260303; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; DAMICOMARTEL A, 1982, AM J ANAT, V163, P351, DOI 10.1002/aja.1001630407; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; DAVIES A, 1984, J COMP NEUROL, V223, P124, DOI 10.1002/cne.902230110; DAVIES AM, 1984, DEV BRAIN RES, V14, P121, DOI 10.1016/0165-3806(84)90015-4; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DAVIES AM, 1985, DEV BIOL, V111, P62, DOI 10.1016/0012-1606(85)90435-X; DAVIES AM, 1987, DEVELOPMENT, V101, P185; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DAVIES AM, 1987, NEUROSCIENCE, V20, P37, DOI 10.1016/0306-4522(87)90004-2; DAVIES AM, 1989, NATURE, V337, P553, DOI 10.1038/337553a0; DOHERTY P, 1988, NEUROSCI LETT, V92, P222, DOI 10.1016/0304-3940(88)90065-1; ERNSBERGER U, 1989, DEV BIOL, V135, P250, DOI 10.1016/0012-1606(89)90177-2; ERNSBERGER U, 1988, DEV BIOL, V126, P420, DOI 10.1016/0012-1606(88)90151-0; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1977, DEV BIOL, V58, P96, DOI 10.1016/0012-1606(77)90076-8; HALLBOOK F, 1990, DEVELOPMENT, V108, P693; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HARPER S, 1990, DEVELOPMENT, V110, P515; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; KALCHEIM C, 1988, DEV BRAIN RES, V41, P79, DOI 10.1016/0165-3806(88)90171-X; KALCHEIM C, 1987, EMBO J, V6, P2871, DOI 10.1002/j.1460-2075.1987.tb02589.x; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; Leah J, 1983, Int J Dev Neurosci, V1, P403, DOI 10.1016/0736-5748(83)90022-9; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDSAY RM, 1990, EUR J NEUROSCI, V2, P389, DOI 10.1111/j.1460-9568.1990.tb00431.x; LINDSAY RM, 1985, DEV BIOL, V112, P30, DOI 10.1016/0012-1606(85)90116-2; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; OPPENHEIM RW, 1985, TRENDS NEUROSCI, V8, P487, DOI 10.1016/0166-2236(85)90175-4; PEARSON J, 1983, DEV BIOL, V96, P32, DOI 10.1016/0012-1606(83)90308-1; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1991, DEVELOPMENT, V112, P813; ROHRER H, 1988, DEV BIOL, V128, P240, DOI 10.1016/0012-1606(88)90286-2; ROHRER H, 1988, DEVELOPMENT, V103, P545; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; Tello J. F., 1923, Travaux du Laboratoire de Recherches Biologiques Universite de Madrid, V21, P1; VERGE VMK, 1989, J NEUROSCI, V9, P914; Windle WF, 1936, J COMP NEUROL, V63, P431, DOI 10.1002/cne.900630304; WYATT S, 1990, NEURON, V4, P421, DOI 10.1016/0896-6273(90)90054-J	53	119	120	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1991	7	5					819	830		10.1016/0896-6273(91)90284-7	http://dx.doi.org/10.1016/0896-6273(91)90284-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1742027				2022-12-28	WOS:A1991GT93900012
J	GOLDSTEIN, SAN; MILLER, C				GOLDSTEIN, SAN; MILLER, C			SITE-SPECIFIC MUTATIONS IN A MINIMAL VOLTAGE-DEPENDENT K+ CHANNEL ALTER ION SELECTIVITY AND OPEN-CHANNEL BLOCK	NEURON			English	Article							POTASSIUM CHANNELS; MEMBRANE-PROTEIN; RAT UTERUS; DROSOPHILA; CLONING; SHAKER; PERMEATION; GENE	MinK is a small membrane protein of 130 amino acids with a single potential membrane-spanning alpha-helical domain. Its expression in Xenopus oocytes induces voltage-dependent, K+-selective channels. Using site-directed mutagenesis of a synthetic gene, we have identified residues in the hydrophobic region of minK that influence both ion selectivity and open-channel block. Single amino acid changes increase the channel's relative permeability for NH4+ and Cs+ without affecting its ability to exclude Na+ and Li+. Blockade by two common K+ channel pore blockers, tetraethylammonium and Cs+, was also modified. These results suggest that an ion selectivity region and binding sites for the pore blockers within the conduction pathway have been modified. We conclude that the gene encoding minK is a structural gene for a K+ channel protein.			GOLDSTEIN, SAN (corresponding author), BRANDEIS UNIV,HOWARD HUGHES MED INST,GRAD DEPT BIOCHEM,WALTHAM,MA 02254, USA.		Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061				BOYLE MB, 1987, SCIENCE, V235, P1221, DOI 10.1126/science.2434999; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CORONADO R, 1979, NATURE, V280, P807, DOI 10.1038/280807a0; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HAUSDORFF SF, 1991, BIOCHEMISTRY-US, V30, P3341, DOI 10.1021/bi00227a025; Hille B, 1975, Membranes, V3, P255; Hille B., IONIC CHANNELS EXCIT; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; PRAGNELL M, 1990, NEURON, V4, P807, DOI 10.1016/0896-6273(90)90207-V; SUGIMOTO T, 1990, J MEMBRANE BIOL, V113, P39, DOI 10.1007/BF01869604; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YELLEN G, 1987, ANNU REV BIOPHYS BIO, V16, P227; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	22	119	122	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1991	7	3					403	408		10.1016/0896-6273(91)90292-8	http://dx.doi.org/10.1016/0896-6273(91)90292-8			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1910787	Green Submitted, Bronze			2022-12-28	WOS:A1991GG88700005
J	OSHEA, KS; LIU, LHJ; DIXIT, VM				OSHEA, KS; LIU, LHJ; DIXIT, VM			THROMBOSPONDIN AND A 140-KD FRAGMENT PROMOTE ADHESION AND NEURITE OUTGROWTH FROM EMBRYONIC CENTRAL AND PERIPHERAL NEURONS AND FROM PC12-CELLS	NEURON			English	Article							NERVOUS-SYSTEM NEURONS; SUBSTRATUM-BOUND FIBRONECTIN; PLATELET THROMBOSPONDIN; EXTRACELLULAR-MATRIX; CELL-ADHESION; GROWTH-FACTOR; POTENT SUBSTRATE; LAMININ; BINDING; ATTACHMENT	The ability of thrombospondin (TSP), an extracellular matrix glycoprotein, and two proteolytic fragments to support adhesion and neurite outgrowth from embryonic dorsal root ganglia, spinal cord neurons, and PC12 cells was examined. Anti-TSP antibodies or a synthetic peptide (GRGDS) containing an RGD cell-binding region was also added to cells plated on TSP. TSP and its 140 kd fragment were more efficient than laminin controls in supporting adhesion. Neurites formed on laminin, on varying concentrations of TSP, and particularly the 140 kd fragment. The amino-terminal heparin-binding domain supported little adhesion and outgrowth. Both adhesion and process outgrowth on TSP were inhibited by addition of anti-TSP antibodies, but not GRGDS.	UNIV MICHIGAN,SCH MED,DEPT PATHOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	OSHEA, KS (corresponding author), UNIV MICHIGAN,SCH MED,DEPT ANAT & CELL BIOL,ANN ARBOR,MI 48109, USA.		dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023867] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-23867] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARONVANEVERCOOREN A, 1982, J NEUROSCI RES, V8, P179, DOI 10.1002/jnr.490080208; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BROWNE PC, 1988, ARCH BIOCHEM BIOPHYS, V265, P534, DOI 10.1016/0003-9861(88)90158-0; DIXIT VM, 1984, J BIOL CHEM, V259, P100; DIXIT VM, 1985, P NATL ACAD SCI USA, V82, P3472, DOI 10.1073/pnas.82.10.3472; DRAGER UC, 1983, P NATL ACAD SCI-BIOL, V80, P6408, DOI 10.1073/pnas.80.20.6408; DUBAND JL, 1986, J CELL BIOL, V102, P160, DOI 10.1083/jcb.102.1.160; FALLON JR, 1985, J CELL BIOL, V100, P198, DOI 10.1083/jcb.100.1.198; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1977, BRAIN RES, V133, P350, DOI 10.1016/0006-8993(77)90770-3; HUNTER DD, 1989, CELL, V59, P905, DOI 10.1016/0092-8674(89)90613-2; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LAHAV J, 1984, EUR J BIOCHEM, V145, P151, DOI 10.1111/j.1432-1033.1984.tb08534.x; LAHAV J, 1982, CELL, V31, P253, DOI 10.1016/0092-8674(82)90425-1; LAWLER J, 1985, J BIOL CHEM, V260, P3762; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LETOURNEAU PC, 1988, J NEUROSCI RES, V21, P286, DOI 10.1002/jnr.490210221; MAJACK RA, 1986, P NATL ACAD SCI USA, V83, P9050, DOI 10.1073/pnas.83.23.9050; MANTHORPE M, 1983, J CELL BIOL, V97, P1882, DOI 10.1083/jcb.97.6.1882; MCKEOWNLONGO PJ, 1984, J CELL BIOL, V98, P22, DOI 10.1083/jcb.98.1.22; MUMBY SM, 1984, J CELL BIOL, V98, P646, DOI 10.1083/jcb.98.2.646; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; NOBLE M, 1984, J NEUROSCI, V4, P1892; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; PRATERCA, 1991, J CELL BIOL, V112, P1031; PROCHOWNIK EV, 1989, J CELL BIOL, V109, P843, DOI 10.1083/jcb.109.2.843; ROBERTS DD, 1987, J CELL BIOL, V104, P131, DOI 10.1083/jcb.104.1.131; ROGERS SL, 1986, DEV BIOL, V113, P429, DOI 10.1016/0012-1606(86)90177-6; ROGERS SL, 1985, J NEUROSCI, V5, P369; ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SILVERSTEIN RL, 1986, J BIOL CHEM, V261, P9959; SILVERSTEIN RL, 1985, J CLIN INVEST, V75, P2065, DOI 10.1172/JCI111926; SILVERSTEIN RL, 1984, J CLIN INVEST, V74, P1625, DOI 10.1172/JCI111578; TARABOLETTI G, 1987, J CELL BIOL, V105, P2409, DOI 10.1083/jcb.105.5.2409; TOMASELLI KJ, 1986, J CELL BIOL, V103, P2659, DOI 10.1083/jcb.103.6.2659; TUCKER GC, 1988, CELL TISSUE RES, V251, P457, DOI 10.1007/BF00215855; VARANI J, 1988, J CLIN INVEST, V81, P1537, DOI 10.1172/JCI113486; VARANI J, 1986, EXP CELL RES, V167, P376, DOI 10.1016/0014-4827(86)90178-3; VISCHER P, 1988, EUR J CELL BIOL, V47, P36; WEHRLE B, 1990, DEVELOPMENT, V110, P401; WUJEK JR, 1987, DEV BRAIN RES, V34, P87, DOI 10.1016/0165-3806(87)90198-2	47	101	102	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					231	237		10.1016/0896-6273(91)90261-W	http://dx.doi.org/10.1016/0896-6273(91)90261-W			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1873028	Green Published			2022-12-28	WOS:A1991GB93300006
J	NISHIMOTO, I; WAGNER, JA; SCHULMAN, H; GARDNER, P				NISHIMOTO, I; WAGNER, JA; SCHULMAN, H; GARDNER, P			REGULATION OF CL- CHANNELS BY MULTIFUNCTIONAL CAM KINASE	NEURON			English	Article								cAMP kinase has been shown to mediate the cAMP pathway for regulation of Cl- channels in lymphocytes, but the mediator of an alternative, Ca2+ pathway has not been identified. We show here that Ca2+ ionophore activates Cl- currents in cell-attached and whole-cell patch-clamp recordings of Jurkat T lymphocytes, but this activation is not direct. The effect of Ca2+ ionophore on whole-cell Cl- currents is inhibited by a specific peptide inhibitor of multifunctional Ca2+/calmodulin-dependent protein kinase (CaM kinase). Furthermore, Cl- channels are activated in excised patches by purified CaM kinase in a fashion that mimics the effect of Ca2+ ionophore in cell-attached recordings. These results suggest that CaM kinase mediates the Ca2+ pathway of Cl- channel activation.	STANFORD UNIV, MED CTR, SCH MED, DEPT PHARMACOL, STANFORD, CA 94305 USA	Stanford University	NISHIMOTO, I (corresponding author), STANFORD UNIV, MED CTR, SCH MED, DEPT MED, STANFORD, CA 94305 USA.				NIDDK NIH HHS [DK41324] Funding Source: Medline; NIGMS NIH HHS [GM40600] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040600] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BOSMA MM, 1989, J PHYSIOL-LONDON, V410, P67, DOI 10.1113/jphysiol.1989.sp017521; BRAHA O, 1990, P NATL ACAD SCI USA, V87, P2040, DOI 10.1073/pnas.87.5.2040; BUBIEN JK, 1990, SCIENCE, V248, P1416, DOI 10.1126/science.2162561; CAHALAN MD, 1987, CELL PHYSL BLOOD; CHEN JH, 1989, SCIENCE, V243, P657, DOI 10.1126/science.2464852; CHENG HC, 1986, J BIOL CHEM, V261, P989; CLIFF WH, 1990, P NATL ACAD SCI USA, V87, P4956, DOI 10.1073/pnas.87.13.4956; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313; COLQUHOUN D, 1981, NATURE, V294, P752, DOI 10.1038/294752a0; DASCAL N, 1985, J PHYSIOL-LONDON, V366, P299, DOI 10.1113/jphysiol.1985.sp015799; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; ERONDU NE, 1985, J NEUROSCI, V5, P3270; EVANS MG, 1986, J PHYSIOL-LONDON, V378, P437, DOI 10.1113/jphysiol.1986.sp016229; FARLEY J, 1986, NATURE, V319, P220, DOI 10.1038/319220a0; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; GARDNER P, 1989, CELL, V59, P15, DOI 10.1016/0092-8674(89)90865-9; GRAY LS, 1986, J IMMUNOL, V136, P3032; GRINSTEIN S, 1982, J GEN PHYSIOL, V80, P801, DOI 10.1085/jgp.80.6.801; GRINSTEIN S, 1983, AM J PHYSIOL, V245, pC160, DOI 10.1152/ajpcell.1983.245.1.C160; GURNEY AM, 1989, NATURE, V341, P65, DOI 10.1038/341065a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; HOCKBERGER PE, 1987, CELL MOL NEUROBIOL, V7, P229, DOI 10.1007/BF00711301; HWANG TC, 1989, SCIENCE, V244, P1351, DOI 10.1126/science.2472005; ITO I, 1988, J CELL PHYSIOL, V134, P155, DOI 10.1002/jcp.1041340120; KENNEDY MB, 1987, CALCIUM CELL CALCIUM, V3, P61; KUNO M, 1986, NATURE, V323, P269, DOI 10.1038/323269a0; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; LEVITAN IB, 1985, J MEMBRANE BIOL, V87, P177, DOI 10.1007/BF01871217; LI M, 1989, SCIENCE, V244, P1353, DOI 10.1126/science.2472006; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; LIPTON SA, 1986, BIOCHIM BIOPHYS ACTA, V856, P59, DOI 10.1016/0005-2736(86)90010-6; MADISON DV, 1986, NATURE, V321, P695, DOI 10.1038/321695a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MARTY A, 1984, J PHYSIOL-LONDON, V357, P293, DOI 10.1113/jphysiol.1984.sp015501; MARUYAMA Y, 1982, NATURE, V299, P159, DOI 10.1038/299159a0; MARUYAMA Y, 1985, BIOCHIM BIOPHYS ACTA, V821, P229, DOI 10.1016/0005-2736(85)90091-4; MATTHEWS G, 1989, J PHYSIOL-LONDON, V418, P131, DOI 10.1113/jphysiol.1989.sp017831; MAYER ML, 1985, J PHYSIOL-LONDON, V364, P217, DOI 10.1113/jphysiol.1985.sp015740; MILEDI R, 1982, PROC R SOC SER B-BIO, V215, P491, DOI 10.1098/rspb.1982.0056; MILEDI R, 1984, J PHYSIOL-LONDON, V357, P173, DOI 10.1113/jphysiol.1984.sp015495; OWEN DG, 1986, J NEUROPHYSIOL, V55, P1115, DOI 10.1152/jn.1986.55.6.1115; OWEN DG, 1984, NATURE, V311, P567, DOI 10.1038/311567a0; PARTRIDGE LD, 1987, PFLUG ARCH EUR J PHY, V410, P627, DOI 10.1007/BF00581323; PAYNE ME, 1983, J BIOL CHEM, V258, P2376; ROSOFF PM, 1988, J BIOL CHEM, V263, P19535; SAKAKIBARA M, 1986, BIOPHYS J, V50, P319, DOI 10.1016/S0006-3495(86)83465-8; SCHLICHTER LC, 1990, PFLUG ARCH EUR J PHY, V416, P413, DOI 10.1007/BF00370748; SCHOUMACHER RA, 1987, NATURE, V330, P752, DOI 10.1038/330752a0; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SCHULMAN H, 1978, P NATL ACAD SCI USA, V75, P5432, DOI 10.1073/pnas.75.11.5432; SCHULMAN H, 1988, ADV SEC MESS PHOSPH, V22, P39; STULL JT, 1986, ENZYMES, V17, P113; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; WALDEN J, 1987, NEUROSCI LETT, V76, P53, DOI 10.1016/0304-3940(87)90191-1; WELSH MJ, 1986, NATURE, V322, P467, DOI 10.1038/322467a0; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593; WOODGETT JR, 1983, EUR J BIOCHEM, V136, P481, DOI 10.1111/j.1432-1033.1983.tb07766.x; WORRELL RT, 1989, AM J PHYSIOL, V256, pC1111, DOI 10.1152/ajpcell.1989.256.6.C1111; YELLEN G, 1982, NATURE, V296, P357, DOI 10.1038/296357a0	63	82	82	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1991	6	4					547	555		10.1016/0896-6273(91)90057-7	http://dx.doi.org/10.1016/0896-6273(91)90057-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	1849722				2022-12-28	WOS:A1991FH80200006
J	PENG, HB; BAKER, LP; CHEN, QM				PENG, HB; BAKER, LP; CHEN, QM			INDUCTION OF SYNAPTIC DEVELOPMENT IN CULTURED MUSCLE-CELLS BY BASIC FIBROBLAST GROWTH-FACTOR	NEURON			English	Article							EXTRACELLULAR-MATRIX; TYROSINE KINASE; ACETYLCHOLINE-RECEPTORS; BASAL LAMINA; PROTEINS; BINDING; AGRIN; SYNAPTOGENESIS; IDENTIFICATION; MOLECULES	The role of basic fibroblast growth factor (bFGF) in signaling the development of the neuromuscular junction was examined. Beads coated with bFGF induced the formation of acetylcholine receptor (AChR) clusters in cultured Xenopus myotomal muscle cells. Tyrphostin, a tyrosine kinase inhibitor, abolished AChR clustering induced by bFGF beads, suggesting a role of tyrosine kinase activation in AChR clustering. Using specific antibodies, we demonstrated the presence of both bFGF and its receptor in the myotomal muscle in vivo during the period of neuromuscular connection. However, similar tissue from older animals with mature neuromuscular junctions showed an apparently truncated form of the bFGF receptor. These data suggest that bFGF may play a role in signaling synaptogenesis in skeletal muscle.	UNIV N CAROLINA,CURRICULUM NEUROBIOL,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill	PENG, HB (corresponding author), UNIV N CAROLINA,DEPT CELL BIOL & ANAT,CHAPEL HILL,NC 27599, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023583] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23583] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MJ, 1983, J CELL BIOL, V97, P1396, DOI 10.1083/jcb.97.5.1396; ANDERSON MJ, 1986, J CELL BIOL, V102, P863, DOI 10.1083/jcb.102.3.863; ASKANAS V, 1985, NEUROSCI LETT, V61, P213, DOI 10.1016/0304-3940(85)90427-6; BAYNE EK, 1984, J CELL BIOL, V99, P1486, DOI 10.1083/jcb.99.4.1486; BENNETT MR, 1983, PHYSIOL REV, V63, P915, DOI 10.1152/physrev.1983.63.3.915; BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; COFFEY RJ, 1987, J CELL PHYSIOL, V132, P143, DOI 10.1002/jcp.1041320120; DAUCHEL MC, 1989, J CELL BIOCHEM, V39, P411, DOI 10.1002/jcb.240390407; DIMARIO J, 1989, SCIENCE, V244, P688, DOI 10.1126/science.2717945; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FLAUMENHAFT R, 1990, J CELL BIOL, V111, P1657; GILBERT SF, 1988, DEV BIOL, P283; GILLESPIE LL, 1989, DEVELOPMENT, V106, P206; GODFREY EW, 1988, J CELL BIOL, V106, P1263, DOI 10.1083/jcb.106.4.1263; GONZALEZ AM, 1990, J CELL BIOL, V110, P753, DOI 10.1083/jcb.110.3.753; HUANG SS, 1988, J BIOL CHEM, V263, P12608; JOHNSON DE, 1990, MOL CELL BIOL, V10, P4728, DOI 10.1128/MCB.10.9.4728; JOSEPHSILVERSTEIN J, 1989, J CELL BIOL, V108, P2459, DOI 10.1083/jcb.108.6.2459; KULLBERG RW, 1977, DEV BIOL, V60, P101, DOI 10.1016/0012-1606(77)90113-0; KUO MD, 1990, J BIOL CHEM, V265, P16455; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LYALL RM, 1989, J BIOL CHEM, V264, P14503; MANSUKHANI A, 1990, P NATL ACAD SCI USA, V87, P4378, DOI 10.1073/pnas.87.11.4378; MCGUIRE PG, 1990, NEURON, V4, P633, DOI 10.1016/0896-6273(90)90121-U; MITRANI E, 1990, DEVELOPMENT, V109, P387; MOSCATELLI D, 1988, J CELL BIOL, V107, P753, DOI 10.1083/jcb.107.2.753; NAKAJIMA Y, 1980, DEV BIOL, V77, P52, DOI 10.1016/0012-1606(80)90456-X; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; PASQUALE EB, 1990, P NATL ACAD SCI USA, V87, P5812, DOI 10.1073/pnas.87.15.5812; PASQUALE EB, 1989, P NATL ACAD SCI USA, V86, P5449, DOI 10.1073/pnas.86.14.5449; PENG HB, 1978, P NATL ACAD SCI USA, V75, P500, DOI 10.1073/pnas.75.1.500; PENG HB, 1982, J NEUROSCI, V2, P1760; PITTMAN RN, 1989, J NEUROSCI, V9, P4269; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; REIST NE, 1989, J CELL BIOL, V109, P1; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; RUIZIALTABA A, 1990, TRENDS GENET, V6, P57; RUTA M, 1989, P NATL ACAD SCI USA, V86, P8722, DOI 10.1073/pnas.86.22.8722; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; SLACK JMW, 1989, DEVELOPMENT, V105, P147; SMITH JC, 1989, DEVELOPMENT, V105, P665; SWENARCHUK LE, 1990, DEVELOPMENT, V110, P51; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ULLRICHN A, 1989, ANN REV NEUROSCI, V12, P103; YAYON A, 1990, P NATL ACAD SCI USA, V87, P5346, DOI 10.1073/pnas.87.14.5346	50	117	117	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1991	6	2					237	246						10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1847064				2022-12-28	WOS:A1991EY70900006
J	BETZ, H				BETZ, H			LIGAND-GATED ION CHANNELS IN THE BRAIN - THE AMINO-ACID RECEPTOR SUPERFAMILY	NEURON			English	Review									MAX PLANCK INST HIRNFORSCH, NEUROCHEM ABT, W-6900 FRANKFURT 71, GERMANY	Max Planck Society	BETZ, H (corresponding author), UNIV HEIDELBERG, ZENTRUM MOLEK BIOL, NEUENHEIMER FELD 282, W-6900 HEIDELBERG, GERMANY.							AKAGI H, 1988, SCIENCE, V242, P270, DOI 10.1126/science.2845580; AKAGI H, 1989, P NATL ACAD SCI USA, V86, P8103, DOI 10.1073/pnas.86.20.8103; AMBAR I, 1988, J NEUROCHEM, V51, P133, DOI 10.1111/j.1471-4159.1988.tb04846.x; BECKER CM, 1989, J NEUROCHEM, V53, P124, DOI 10.1111/j.1471-4159.1989.tb07303.x; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; BECKER CM, 1986, J NEUROSCI, V6, P1358; BETZ H, 1988, NEUROCHEM INT, V13, P137, DOI 10.1016/0197-0186(88)90048-4; BETZ H, 1990, BIOCHEMISTRY-US, V29, P3591, DOI 10.1021/bi00467a001; BLAIR LAC, 1988, SCIENCE, V242, P577, DOI 10.1126/science.2845583; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; BROSE N, 1989, J BIOL CHEM, V264, P9619; BUREAU M, 1990, MOL PHARMACOL, V37, P497; CASALOTTI SO, 1986, J BIOL CHEM, V261, P5013; CHANGEUX JP, 1987, TRENDS PHARMACOL SCI, V8, P459, DOI 10.1016/0165-6147(87)90039-3; CHEN JW, 1988, J BIOL CHEM, V263, P417; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CLAUDIO T, 1989, FRONTIERS MOL BIOL M, P63; DENG L, 1986, BIOCHEM BIOPH RES CO, V138, P1308, DOI 10.1016/S0006-291X(86)80425-9; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; EICHINGER A, 1986, J NEUROCHEM, V46, P173, DOI 10.1111/j.1471-4159.1986.tb12941.x; FOSTER AC, 1984, BRAIN RES REV, V7, P103, DOI 10.1016/0165-0173(84)90020-1; FUCHS K, 1988, NEUROSCI LETT, V90, P314, DOI 10.1016/0304-3940(88)90208-X; FUCHS K, 1989, NEUROSCI LETT, V97, P329, DOI 10.1016/0304-3940(89)90619-8; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GRAHAM D, 1983, EUR J BIOCHEM, V131, P519, DOI 10.1111/j.1432-1033.1983.tb07292.x; GRAHAM D, 1985, BIOCHEMISTRY-US, V24, P990, DOI 10.1021/bi00325a027; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GREGOR P, 1988, EMBO J, V7, P2673, DOI 10.1002/j.1460-2075.1988.tb03120.x; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V330, P25, DOI 10.1038/330025b0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; GUY HR, 1987, TRENDS NEUROSCI, V10, P318, DOI 10.1016/0166-2236(87)90087-7; HAMPSON DR, 1989, J BIOL CHEM, V264, P13329; HAMPSON DR, 1988, J BIOL CHEM, V263, P2500; HENLEY JM, 1989, J NEUROCHEM, V53, P140, DOI 10.1111/j.1471-4159.1989.tb07305.x; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HONORE T, 1989, EUR J PHARM-MOLEC PH, V172, P239, DOI 10.1016/0922-4106(89)90054-0; HUCHO F, 1986, FEBS LETT, V205, P137, DOI 10.1016/0014-5793(86)80881-X; IKIN AF, 1990, BIOCHEMISTRY-US, V29, P2290, DOI 10.1021/bi00461a012; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; KAO PN, 1984, J BIOL CHEM, V259, P1662; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KHRESTCHATISKY M, 1989, NEURON, V3, P745, DOI 10.1016/0896-6273(89)90243-2; KLEIN AU, 1988, NEUROSCI LETT, V95, P359, DOI 10.1016/0304-3940(88)90685-4; KUHSE J, 1990, IN PRESS J BIOL CHEM; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LEVITAN ES, 1988, NEURON, V1, P773, DOI 10.1016/0896-6273(88)90125-0; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MAMALAKI C, 1987, EMBO J, V6, P561, DOI 10.1002/j.1460-2075.1987.tb04791.x; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MCCREA PD, 1987, EMBO J, V6, P3619, DOI 10.1002/j.1460-2075.1987.tb02693.x; MCKERNAN RM, 1989, J NEUROCHEM, V52, P777, DOI 10.1111/j.1471-4159.1989.tb02522.x; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; MOHLER H, 1980, P NATL ACAD SCI-BIOL, V77, P1666, DOI 10.1073/pnas.77.3.1666; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; NODA M, 1983, NATURE, V302, P528, DOI 10.1038/302528a0; NUMA S, 1989, HARVEY LECT, V83, P121; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SCHMITT B, 1987, BIOCHEMISTRY-US, V26, P805, DOI 10.1021/bi00377a022; SCHOCH P, 1985, NATURE, V314, P168, DOI 10.1038/314168a0; SCHOFIELD PR, 1989, FEBS LETT, V244, P361, DOI 10.1016/0014-5793(89)80563-0; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SIEGEL RE, 1988, NEURON, V1, P579, DOI 10.1016/0896-6273(88)90107-9; SIEGHART W, 1980, NATURE, V286, P285, DOI 10.1038/286285a0; SIGEL E, 1984, J BIOL CHEM, V259, P7219; SIGEL E, 1983, J BIOL CHEM, V258, P6965; SONDERS MS, 1990, J BIOL CHEM, V265, P6776; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; STAUBER GB, 1987, EUR J BIOCHEM, V167, P125, DOI 10.1111/j.1432-1033.1987.tb13313.x; STEPHENSON FA, 1982, EUR J BIOCHEM, V123, P291, DOI 10.1111/j.1432-1033.1982.tb19766.x; THOMAS JW, 1981, J BIOL CHEM, V256, P9838; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; WISDEN W, 1988, NEURON, V1, P937, DOI 10.1016/0896-6273(88)90151-1; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x; YMER S, 1990, IN PRESS EMBO J	93	372	374	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1990	5	4					383	392		10.1016/0896-6273(90)90077-S	http://dx.doi.org/10.1016/0896-6273(90)90077-S			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED517	1698394				2022-12-28	WOS:A1990ED51700001
J	HEKIMI, S				HEKIMI, S			A NEURON-SPECIFIC ANTIGEN IN C-ELEGANS ALLOWS VISUALIZATION OF THE ENTIRE NERVOUS-SYSTEM	NEURON			English	Article											HEKIMI, S (corresponding author), MRC,MOLEC BIOL LAB,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.							AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1982, J CELL BIOL, V93, P15, DOI 10.1083/jcb.93.1.15; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1979, J CELL BIOL, V82, P278, DOI 10.1083/jcb.82.1.278; Chalfie M, 1988, NEMATODE CAENORHABDI; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; EDGLEY ML, 1987, GENETIC MAPS, V4, P351; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEKIMI S, 1989, NEURON, V2, P1363, DOI 10.1016/0896-6273(89)90074-3; HEKIMI S, 1989, J NEUROSCI, V9, P996; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; LASEK RJ, 1983, COLD SPRING HARB SYM, V48, P731, DOI 10.1101/SQB.1983.048.01.076; OKAMOTO H, 1985, J NEUROSCI, V5, P643; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; SIDDIQUI SS, 1989, J NEUROSCI, V9, P2963; STERNBERG PW, 1982, DEV BIOL, V93, P181, DOI 10.1016/0012-1606(82)90251-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1987, J CELL BIOL, V105, P41, DOI 10.1083/jcb.105.1.41	26	10	12	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1990	4	6					855	865		10.1016/0896-6273(90)90138-6	http://dx.doi.org/10.1016/0896-6273(90)90138-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK185	1694444				2022-12-28	WOS:A1990DK18500005
J	BLEY, KR; TSIEN, RW				BLEY, KR; TSIEN, RW			INHIBITION OF CA-2+ AND K+ CHANNELS IN SYMPATHETIC NEURONS BY NEUROPEPTIDES AND OTHER GANGLIONIC TRANSMITTERS	NEURON			English	Article											BLEY, KR (corresponding author), STANFORD UNIV,MED CTR,BECKMAN CTR,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 13306-18] Funding Source: Medline; NIGMS NIH HHS [GM 07527-12] Funding Source: Medline; NINDS NIH HHS [NS 24067-03] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1986, J EXP BIOL, V124, P259; ADAMS PR, 1982, NATURE, V296, P746, DOI 10.1038/296746a0; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; AKASU T, 1983, BRAIN RES, V280, P349, DOI 10.1016/0006-8993(83)90066-5; AKASU T, 1983, NEUROSCI LETT, V41, P161, DOI 10.1016/0304-3940(83)90240-9; AKASU T, 1982, NEUROSCI LETT, V29, P41, DOI 10.1016/0304-3940(82)90361-5; AKASU T, 1984, J PHYSIOL-LONDON, V351, P583, DOI 10.1113/jphysiol.1984.sp015264; AKASU T, 1988, PFLUG ARCH EUR J PHY, V411, P80, DOI 10.1007/BF00581650; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; BROWN AM, 1988, AM J PHYSIOL, V254, pH401, DOI 10.1152/ajpheart.1988.254.3.H401; BROWN DA, 1989, J PHYSIOL-LONDON, V413, P469, DOI 10.1113/jphysiol.1989.sp017664; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; BROWN DA, 1985, J PHYSIOL-LONDON, V358, P335, DOI 10.1113/jphysiol.1985.sp015554; BROWN DA, 1987, CELL MOL NEUROBIOL, V7, P255, DOI 10.1007/BF00711303; CASEY PJ, 1990, J BIOL CHEM, V265, P2380; DODD J, 1983, J PHYSIOL-LONDON, V334, P271, DOI 10.1113/jphysiol.1983.sp014494; DOLPHIN AC, 1987, J PHYSIOL-LONDON, V386, P1; DUTAR P, 1988, NEUROSCI LETT, V85, P89, DOI 10.1016/0304-3940(88)90434-X; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; GOH JW, 1987, J PHYSIOL-LONDON, V394, P315, DOI 10.1113/jphysiol.1987.sp016872; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; HORN JP, 1987, J NEUROSCI, V7, P1717; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; IKEDA SR, 1987, NEUROSCI LETT, V81, P123, DOI 10.1016/0304-3940(87)90351-X; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; JONES SW, 1987, NEUROSCI LETT, V74, P309, DOI 10.1016/0304-3940(87)90315-6; JONES SW, 1987, NEUROSCI LETT, V80, P180, DOI 10.1016/0304-3940(87)90650-1; JONES SW, 1989, J GEN PHYSIOL, V94, P151, DOI 10.1085/jgp.94.1.151; JONES SW, 1985, J PHYSIOL-LONDON, V366, P63, DOI 10.1113/jphysiol.1985.sp015785; KOKETSU K, 1984, JPN J PHYSIOL, V34, P945, DOI 10.2170/jjphysiol.34.945; KONGSAMUT S, 1989, ANN NY ACAD SCI, V560, P312, DOI 10.1111/j.1749-6632.1989.tb24112.x; KUFFLER SW, 1983, J PHYSIOL-LONDON, V341, P257, DOI 10.1113/jphysiol.1983.sp014805; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; LANCASTER B, 1987, J PHYSIOL-LONDON, V387, P519, DOI 10.1113/jphysiol.1987.sp016587; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; MARBAN E, 1982, J PHYSIOL-LONDON, V329, P569, DOI 10.1113/jphysiol.1982.sp014320; MARRION NV, 1987, NEUROSCI LETT, V77, P55, DOI 10.1016/0304-3940(87)90606-9; MARTY A, 1985, J PHYSIOL-LONDON, V367, P117, DOI 10.1113/jphysiol.1985.sp015817; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; PANT KK, 1989, NEUROSCI LETT, V100, P243, DOI 10.1016/0304-3940(89)90692-7; PENNEFATHER P, 1985, P NATL ACAD SCI USA, V82, P3040, DOI 10.1073/pnas.82.9.3040; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RODWAY RM, 1989, SCIENCE, V244, P1176; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SCHOFIELD GG, 1988, EUR J PHARMACOL, V151, P131, DOI 10.1016/0014-2999(88)90702-9; SUETAKE K, 1981, BRAIN RES, V205, P436, DOI 10.1016/0006-8993(81)90357-7; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TOKIMASA T, 1984, J AUTONOM NERV SYST, V10, P107, DOI 10.1016/0165-1838(84)90049-3; TOKIMASA T, 1985, BRAIN RES, V344, P134, DOI 10.1016/0006-8993(85)91197-7; TSUJI S, 1987, NEUROSCI LETT, V81, P139, DOI 10.1016/0304-3940(87)90354-5; UI M, 1986, P163; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; WEIGHT FF, 1970, SCIENCE, V170, P755, DOI 10.1126/science.170.3959.755	63	83	83	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1990	4	3					379	391		10.1016/0896-6273(90)90050-P	http://dx.doi.org/10.1016/0896-6273(90)90050-P			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX032	1690565				2022-12-28	WOS:A1990CX03200006
J	DURSO, D; BROPHY, PJ; STAUGAITIS, SM; GILLESPIE, CS; FREY, AB; STEMPAK, JG; COLMAN, DR				DURSO, D; BROPHY, PJ; STAUGAITIS, SM; GILLESPIE, CS; FREY, AB; STEMPAK, JG; COLMAN, DR			PROTEIN ZERO OF PERIPHERAL-NERVE MYELIN - BIOSYNTHESIS, MEMBRANE INSERTION, AND EVIDENCE FOR HOMOTYPIC INTERACTION	NEURON			English	Article									COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA; IST SUPER SANITA, PATHOPHYSIOL ORGANS & SYST LAB, I-00161 ROME, ITALY; UNIV STIRLING, SCH MOLEC & BIOL SCI, DIV CELL BIOL & BIOCHEM, STIRLING FK9 4LA, SCOTLAND; NYU, SCH MED, DEPT CELL BIOL, NEW YORK, NY 10016 USA; SUNY HLTH SCI CTR, DEPT ANAT & CELL BIOL, BROOKLYN, NY 11203 USA	Columbia University; Istituto Superiore di Sanita (ISS); University of Stirling; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	DURSO, D (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT ANAT & CELL BIOL, NEW YORK, NY 10032 USA.			frey, alan/0000-0003-4151-561X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147] Funding Source: NIH RePORTER; NINDS NIH HHS [NS20147] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMERONGEN HM, 1989, J CELL BIOL, V109, P2129, DOI 10.1083/jcb.109.5.2129; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; BRACKENBURY R, 1977, J BIOL CHEM, V252, P6835; BRAUN PE, 1984, MYELIN, P97; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; GOLDMAN BM, 1978, P NATL ACAD SCI USA, V75, P5066, DOI 10.1073/pnas.75.10.5066; GORMAN CM, 1983, NUCLEIC ACIDS RES, V11, P7631, DOI 10.1093/nar/11.21.7631; HATTA K, 1988, J CELL BIOL, V106, P873, DOI 10.1083/jcb.106.3.873; ISHAQUE A, 1980, CAN J BIOCHEM CELL B, V58, P913, DOI 10.1139/o80-125; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; LAI C, 1987, IMMUNOL REV, V100, P129, DOI 10.1111/j.1600-065X.1987.tb00530.x; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LINNEMANN D, 1989, DEV NEUROSCI-BASEL, V11, P149, DOI 10.1159/000111896; LIU CP, 1979, P NATL ACAD SCI USA, V76, P4503, DOI 10.1073/pnas.76.9.4503; MEGE RM, 1988, P NATL ACAD SCI USA, V85, P7274, DOI 10.1073/pnas.85.19.7274; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; OWENS GC, 1989, GLIA, V2, P119, DOI 10.1002/glia.440020208; PODUSLO JF, 1984, J NEUROCHEM, V42, P493, DOI 10.1111/j.1471-4159.1984.tb02705.x; PODUSLO JF, 1985, J NEUROCHEM, V44, P388, DOI 10.1111/j.1471-4159.1985.tb05428.x; RAPAPORT RN, 1981, J NEUROCHEM, V37, P164, DOI 10.1111/j.1471-4159.1981.tb05304.x; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; ROMAN R, 1976, NATURE, V260, P359, DOI 10.1038/260359a0; SAAVEDRA RA, 1989, J MOL EVOL, V29, P149, DOI 10.1007/BF02100113; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SAKAMOTO Y, 1987, J BIOL CHEM, V262, P4208; SALZER JL, 1989, DEV NEUROSCI-BASEL, V11, P377, DOI 10.1159/000111914; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SHIELDS D, 1978, J BIOL CHEM, V253, P3753; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAM JP, 1983, J AM CHEM SOC, V105, P6442, DOI 10.1021/ja00359a014; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAPP BD, 1981, J CELL BIOL, V90, P1, DOI 10.1083/jcb.90.1.1; TRAPP BD, 1988, J CELL BIOL, V107, P675, DOI 10.1083/jcb.107.2.675; TRAPP BD, 1984, J CELL BIOL, V99, P594, DOI 10.1083/jcb.99.2.594; URUSHIHARA H, 1979, DEV BIOL, V70, P206, DOI 10.1016/0012-1606(79)90017-4; UYEMURA K, 1981, NEUROCHEM RES, V6, P959, DOI 10.1007/BF00965027; WAEHNELDT TV, 1986, NEUROCHEM INT, V9, P463, DOI 10.1016/0197-0186(86)90136-1; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; WEBSTER HD, 1971, J CELL BIOL, V48, P348, DOI 10.1083/jcb.48.2.348; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; YU YT, 1982, J NEUROCHEM, V39, P1559, DOI 10.1111/j.1471-4159.1982.tb07988.x	52	204	205	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1990	4	3					449	460		10.1016/0896-6273(90)90057-M	http://dx.doi.org/10.1016/0896-6273(90)90057-M			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX032	1690568				2022-12-28	WOS:A1990CX03200013
J	SCHMUCKER, D; TAUBERT, H; JACKLE, H				SCHMUCKER, D; TAUBERT, H; JACKLE, H			FORMATION OF THE DROSOPHILA LARVAL PHOTORECEPTOR ORGAN AND ITS NEURONAL DIFFERENTIATION REQUIRE CONTINUOUS KRUPPEL GENE ACTIVITY	NEURON			English	Article							GROWTH CONE GUIDANCE; ADHESION MOLECULE; IMMUNOGLOBULIN SUPERFAMILY; MONOCLONAL-ANTIBODIES; GRASSHOPPER EMBRYOS; NEURAL DEVELOPMENT; AXONAL PATHWAYS; FASCICLIN-II; PROTEIN; SEGMENTATION	The Drosophila segmentation gene Kruppel (Kr) is redeployed to play a critical role for the establishment of the larval visual system. Using reporter gene expression conducted by a specific Kr cis-acting element, we were able to trace back the origin of the larval photoreceptor organ, the Bolwig organ, to a single progenitor neuron and to examine Kr function in Bolwig organ development when Kr+ activity is absent from embryos due to specific mutations or reduced by neuron-specific and temporally restricted Kr antisense RNA expression. Our results show that Kr is required for neurons to differentiate into Bolwig organs, for fasciculation of the Bolwig nerve, and for this nerve to follow a specific pathway toward the synaptic targets in the larval brain. The transcription factor encoded by Kr is likely to regulate surface molecules necessary for neuronal cell adhesion and recognition in the developing larval visual system.			SCHMUCKER, D (corresponding author), MAX PLANCK INST BIOPHYS CHEM,MOLEK ENTWICKLUNGSBIOL ABT,FASSBERG,W-3400 GOTTINGEN,GERMANY.							BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; BOLWIG N, 1946, VIDENSK MEDD FRA DAN, V109, P80; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GAUL U, 1987, CELL, V50, P639, DOI 10.1016/0092-8674(87)90037-7; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HARBECKE R, 1989, GENE DEV, V3, P114, DOI 10.1101/gad.3.1.114; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HARTENSTEIN V, 1988, DEVELOPMENT, V102, P869; HEISENBERG M, 1991, STUDIES BRAIN FUNCTI, V10, P809; HOCH M, 1991, EMBO J, V10, P2267, DOI 10.1002/j.1460-2075.1991.tb07763.x; HOCH M, 1990, EMBO J, V9, P2587, DOI 10.1002/j.1460-2075.1990.tb07440.x; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; LANDER AD, 1989, TRENDS NEUROSCI, V12, P189, DOI 10.1016/0166-2236(89)90070-2; LEE KJ, 1991, EMBO J, V10, P817, DOI 10.1002/j.1460-2075.1991.tb08014.x; LICHT JD, 1990, NATURE, V346, P76, DOI 10.1038/346076a0; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; MELZER RR, 1989, Z ZOOL SYST EVOL, V27, P200; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; PANKRATZ MJ, 1990, TRENDS GENET, V6, P287, DOI 10.1016/0168-9525(90)90234-W; Pirrotta V, 1988, VECTORS SURVEY MOL C, P437; POLLOCK JA, 1988, NATURE, V333, P779, DOI 10.1038/333779a0; PREISS A, 1985, NATURE, V313, P27, DOI 10.1038/313027a0; RAPER JA, 1983, J NEUROSCI, V3, P20; RAPER JA, 1983, J NEUROSCI, V3, P31; RAPER JA, 1984, J NEUROSCI, V4, P232; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; ROSENBERG UB, 1985, NATURE, V313, P703, DOI 10.1038/313703a0; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; Sambrook J, 1989, MOL CLONING LABORATO; SAUER F, 1991, NATURE, V353, P563, DOI 10.1038/353563a0; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; STOCKHAUS J, 1990, EMBO J, V9, P3013, DOI 10.1002/j.1460-2075.1990.tb07494.x; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; TIX S, 1989, DEVELOPMENT, V105, P739; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; VANDERKROL AR, 1988, NATURE, V333, P866, DOI 10.1038/333866a0; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; WEIGEL D, 1990, EMBO J, V9, P1199, DOI 10.1002/j.1460-2075.1990.tb08227.x; WIESCHAUS E, 1984, DEV BIOL, V104, P172, DOI 10.1016/0012-1606(84)90046-0; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	54	48	48	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1025	1039		10.1016/0896-6273(92)90063-J	http://dx.doi.org/10.1016/0896-6273(92)90063-J			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1463605				2022-12-28	WOS:A1992KD71600003
J	LEUNG, DW; PARENT, AS; CACHIANES, G; ESCH, F; COULOMBE, JN; NIKOLICS, K; ECKENSTEIN, FP; NISHI, R				LEUNG, DW; PARENT, AS; CACHIANES, G; ESCH, F; COULOMBE, JN; NIKOLICS, K; ECKENSTEIN, FP; NISHI, R			CLONING, EXPRESSION DURING DEVELOPMENT, AND EVIDENCE FOR RELEASE OF A TROPHIC FACTOR FOR CILIARY GANGLION NEURONS	NEURON			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; SIGNAL SEQUENCE; CHICK EYE; CELLS; PURIFICATION; PROTEINS; IDENTIFICATION; CYCLOPHILIN; INNERVATION	Ciliary ganglion (CG) neurons undergo a period of cell death during development that may be regulated by the limited availability of trophic factor produced by their target tissues. We have previously reported the purification of a ciliary neurotrophic factor from adult chick sciatic nerve that we called growth promoting activity (GPA). Here we demonstrate that GPA can be purified and cloned from embryonic day 15 (E15) chick eyes, which contain all the target tissues of the CG. Our studies show the following: GPA mRNA is induced in embryonic chick eyes during the period of CG neuron cell death; GPA mRNA is expressed specifically in the layer of the eye that contains the targets of the CG and in primary cultures of smooth muscle cells isolated from the choroid layer of the eye; and biologically active GPA is released from cells transfected with a GPA cDNA.	OREGON HLTH SCI UNIV,DEPT CARDIOVASC,PORTLAND,OR 97201; ATHENA NEUROSCI,S SAN FRANCISCO,CA 94080	Oregon Health & Science University	LEUNG, DW (corresponding author), GENENTECH INC,460 POINT SAN BRUNO,SAN FRANCISCO,CA 94080, USA.				NEI NIH HHS [EY06352] Funding Source: Medline; NIA NIH HHS [AG07424] Funding Source: Medline; NINDS NIH HHS [NS25767] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG007424, R29AG007424] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; BARBIN G, 1984, J NEUROCHEM, V43, P1468, DOI 10.1111/j.1471-4159.1984.tb05410.x; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; COULOMBE JN, 1991, J NEUROSCI, V11, P553; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; EBENDAL T, 1986, EMBO J, V5, P1483, DOI 10.1002/j.1460-2075.1986.tb04386.x; ECKENSTEIN FP, 1990, NEURON, V4, P623, DOI 10.1016/0896-6273(90)90120-5; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; HELFAND SL, 1978, EXP CELL RES, V113, P39, DOI 10.1016/0014-4827(78)90085-X; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; Jensen M A, 1991, DNA Seq, V1, P233, DOI 10.3109/10425179109020778; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LANDMESSER L, 1974, J PHYSIOL-LONDON, V241, P715, DOI 10.1113/jphysiol.1974.sp010680; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LINGAPPA VR, 1979, NATURE, V281, P117, DOI 10.1038/281117a0; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARWITT R, 1971, BRAIN RES, V25, P317, DOI 10.1016/0006-8993(71)90441-0; MERINEY SD, 1987, J NEUROSCI, V7, P3827; MUESCH A, 1990, TRENDS BIOCHEM SCI, V15, P86, DOI 10.1016/0968-0004(90)90186-F; NISHI R, 1981, J NEUROSCI, V1, P505; NISHI R, 1979, NATURE, V277, P232, DOI 10.1038/277232a0; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARZ K, 1990, NUCLEIC ACIDS RES, V18, P1079, DOI 10.1093/nar/18.4.1079; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; TABE L, 1984, J MOL BIOL, V180, P645, DOI 10.1016/0022-2836(84)90031-7; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; WARD LD, 1991, TECHNIQUES PROTEIN C, V2; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YE RD, 1988, J BIOL CHEM, V263, P4869	37	96	101	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1045	1053		10.1016/0896-6273(92)90126-X	http://dx.doi.org/10.1016/0896-6273(92)90126-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1610564				2022-12-28	WOS:A1992JA42900005
J	MONYER, H; GIFFARD, RG; HARTLEY, DM; DUGAN, LL; GOLDBERG, MP; CHOI, DW				MONYER, H; GIFFARD, RG; HARTLEY, DM; DUGAN, LL; GOLDBERG, MP; CHOI, DW			OXYGEN OR GLUCOSE DEPRIVATION-INDUCED NEURONAL INJURY IN CORTICAL CELL-CULTURES IS REDUCED BY TETANUS TOXIN	NEURON			English	Article							EXCITATORY AMINO-ACIDS; GLUTAMATE NEUROTOXICITY; NMDA RECEPTOR; RAT HIPPOCAMPUS; NERVOUS-SYSTEM; ADENOSINE; RELEASE; ASPARTATE; INVITRO; EXCITOTOXICITY	We examined glutamate-mediated neurotoxicity in cortical cell cultures pretreated with 1-5-mu-g/ml tetanus toxin to attenuate the Ca2+-dependent release of neurotransmitters. Efficacy of the tetanus toxin pretreatment was suggested by blockade of electrical burst activity induced by Mg2+ removal and by reduction of glutamate efflux induced by high K+. Tetanus toxin reduced neuronal injury produced by brief exposure to elevated extracellular K+ or to glutamate, situations in which release of endogenous excitatory neurotransmitter is likely to play a role. Furthermore, although glutamate efflux evoked by anoxic conditions may occur largely via Ca2+-independent transport, tetanus toxin attenuated both glutamate efflux and neuronal injury following combined oxygen and glucose deprivation. With prolonged exposure periods, the neuroprotective efficacy of tetanus toxin was comparable to that of NMDA receptor antagonists. Presynaptic inhibition of Ca2+-dependent glutamate release may be a valuable approach to attenuating hypoxic-ischemic brain injury.	STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROL & NEUROL SCI,STANFORD,CA 94305	Stanford University				Monyer, Hannah/0000-0002-9332-5749; Giffard, Rona/0000-0003-2173-4436; Goldberg, Mark/0000-0003-3534-6979	NINDS NIH HHS [NS26907, NS01425] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001425, R01NS026907] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELE AE, 1990, NEURON, V4, P413, DOI 10.1016/0896-6273(90)90053-I; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BURKE SP, 1988, J NEUROCHEM, V51, P1541, DOI 10.1111/j.1471-4159.1988.tb01123.x; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1987, J NEUROSCI, V7, P357; DUNWIDDIE TV, 1985, INT REV NEUROBIOL, V27, P63, DOI 10.1016/S0074-7742(08)60556-5; EVANS MC, 1987, NEUROSCI LETT, V83, P287, DOI 10.1016/0304-3940(87)90101-7; FELDHOLM BB, 1990, ANN NY ACAD SCI, V604, P276; GOLDBERG MP, 1987, J PHARMACOL EXP THER, V243, P784; GOLDBERG MP, 1988, NEUROSCI LETT, V89, P323, DOI 10.1016/0304-3940(88)90547-2; HABERMANN E, 1986, CURR TOP MICROBIOL I, V129, P94; HARTLEY DM, 1989, J PHARMACOL EXP THER, V250, P752; KAKU DA, 1991, BRAIN RES, V554, P344, DOI 10.1016/0006-8993(91)90214-G; KAUPPINEN RA, 1988, NEUROSCIENCE, V27, P175, DOI 10.1016/0306-4522(88)90228-X; KNIGHT DE, 1989, TRENDS NEUROSCI, V12, P451, DOI 10.1016/0166-2236(89)90095-7; KOH JY, 1987, NEUROLOGY, V37, P319, DOI 10.1212/WNL.37.2.319; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; MACDONALD RL, 1986, J PHYSIOL-LONDON, V370, P75, DOI 10.1113/jphysiol.1986.sp015923; MELDRUM BS, 1987, MED BIOL, V65, P153; MODY I, 1988, NEUROSCI LETT, V93, P73, DOI 10.1016/0304-3940(88)90015-8; MONYER H, 1988, BRAIN RES, V446, P144, DOI 10.1016/0006-8993(88)91304-2; MONYER H, 1989, BRAIN RES, V483, P347, DOI 10.1016/0006-8993(89)90179-0; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; PENNER R, 1986, NATURE, V324, P76, DOI 10.1038/324076a0; PIN JP, 1989, J NEUROSCI, V9, P648; PROCTOR WR, 1987, BRAIN RES, V426, P187, DOI 10.1016/0006-8993(87)90441-0; ROSE K, 1990, NEUROSCI LETT, V115, P313, DOI 10.1016/0304-3940(90)90474-N; ROTHMAN SM, 1987, NEUROSCIENCE, V22, P471, DOI 10.1016/0306-4522(87)90347-2; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SANCHEZPRIETO J, 1988, J NEUROCHEM, V50, P1322, DOI 10.1111/j.1471-4159.1988.tb10611.x; Schousboe A, 1981, Int Rev Neurobiol, V22, P1, DOI 10.1016/S0074-7742(08)60289-5; SIMPSON LL, 1986, ANNU REV PHARMACOL, V26, P427, DOI 10.1146/annurev.pa.26.040186.002235; VANVLIET BJ, 1989, J NEUROCHEM, V52, P1229; VONLUBITZ DKJE, 1988, STROKE, V19, P1133, DOI 10.1161/01.STR.19.9.1133	36	75	79	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					967	973		10.1016/0896-6273(92)90211-U	http://dx.doi.org/10.1016/0896-6273(92)90211-U			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1350203				2022-12-28	WOS:A1992HV46700016
J	MANZONI, O; PREZEAU, L; MARIN, P; DESHAGER, S; BOCKAERT, J; FAGNI, L				MANZONI, O; PREZEAU, L; MARIN, P; DESHAGER, S; BOCKAERT, J; FAGNI, L			NITRIC-OXIDE INDUCED BLOCKADE OF NMDA RECEPTORS	NEURON			English	Article							SOLUBLE GUANYLATE-CYCLASE; CENTRAL NERVOUS-SYSTEM; METHYL-D-ASPARTATE; RELAXING FACTOR; NEURONS; DESENSITIZATION; GLYCINE; STIMULATION; RESPONSES; BRAIN	We studied the effects of nitric oxide (NO)-producing agents on N-methyl-D-aspartate (NMDA) receptor activation in cultured neurons. 3-Morpholino-sydnonimine (SIN-1) blocked both NMDA-induced currents and the associated increase in intracellular Ca2+. The actions of SIN-1 were reversible and suppressed by hemoglobin. A degraded SIN-1 solution that did not release NO was unable to block NMDA receptors. This showed that the SIN-1 effects were due to NO and not to another breakdown product. Similar results were obtained with 1-nitrosopyrrolidine (an NO-containing drug) and with NO released from NaNO2. Pretreatment with hemoglobin potentiated NMDA-induced effects, demonstrating that endogenous NO modulates NMDA receptors. Since NMDA receptor activation induces NO synthesis, these results suggest a feedback inhibition of NMDA receptors by NO under physiological condition.			MANZONI, O (corresponding author), CNRS,CTR PHARMACOL ENDOCRINOL,INSERM,RUE CARDONILLE,F-34094 MONTPELLIER 5,FRANCE.		Manzoni, Olivier/M-7899-2016	Manzoni, Olivier/0000-0002-5579-6208				AIZENMAN E, 1990, NEURON, V5, P841, DOI 10.1016/0896-6273(90)90343-E; AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; BARNARD EA, 1990, TRENDS PHARMACOL SCI, V11, P500, DOI 10.1016/0165-6147(90)90051-9; BARON BM, 1989, J PHARMACOL EXP THER, V250, P162; BOHME E, 1984, ADV CYCLIC NUCL PROT, V17, P259; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Ito M, 1990, Neuroreport, V1, P129; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; MANZONI O, 1992, NEUROREPORT, V3, P77, DOI 10.1097/00001756-199201000-00020; MANZONI OJJ, 1991, EUR J PHARM-MOLEC PH, V207, P231; MARIN P, 1992, IN PRESS EUR J NEURO; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MONAGHAN DT, 1989, ANN REV PHARM TOXICO, V29, P3655; MURPHY DE, 1988, BRIT J PHARMACOL, V95, P932, DOI 10.1111/j.1476-5381.1988.tb11723.x; MYERS PR, 1990, NATURE, V345, P161, DOI 10.1038/345161a0; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; VANVLIET BJ, 1989, J NEUROCHEM, V52, P1229; WEISS S, 1986, P NATL ACAD SCI USA, V83, P2238, DOI 10.1073/pnas.83.7.2238	30	469	474	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					653	662		10.1016/0896-6273(92)90087-T	http://dx.doi.org/10.1016/0896-6273(92)90087-T			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1314618				2022-12-28	WOS:A1992HQ18800005
J	MENCO, BPM; BRUCH, RC; DAU, B; DANHO, W				MENCO, BPM; BRUCH, RC; DAU, B; DANHO, W			ULTRASTRUCTURAL-LOCALIZATION OF OLFACTORY TRANSDUCTION COMPONENTS - THE G-PROTEIN SUBUNIT GOLF-ALPHA AND TYPE-III ADENYLYL CYCLASE	NEURON			English	Article							QUANTITATIVE FREEZE-FRACTURE; NUCLEOTIDE-BINDING-PROTEINS; NASAL RESPIRATORY EPITHELIA; RECEPTOR-CELLS; ION CHANNELS; CYCLIC-AMP; IMMUNOHISTOCHEMICAL LOCALIZATION; CHEMOSENSORY NEURONS; MARKER PROTEIN; CILIA	Electron microscopy and postembedding immunocytochemistry on rapidly frozen, freeze-substituted specimens of rat olfactory epithelia were used to study the subcellular localization of the transduction proteins G(olf-alpha) and type III adenylyl cyclase. Antibody binding sites for both of these proteins occur in the same receptor cell compartments, the distal segments of the olfactory cilia. These segments line the boundary between organism and external environment inside the olfactory part of the nasal cavity. Therefore, they are the receptor cell regions that most likely first encounter odorous compounds. The results presented here provide direct evidence to support the conclusion that the distal segments of the cilia contain the sites of the early events of olfactory transduction.	HOFFMANN LA ROCHE INC,PEPTIDE RES DEPT,NUTLEY,NJ 07110	Roche Holding	MENCO, BPM (corresponding author), NORTHWESTERN UNIV,DEPT NEUROBIOL & PHYSIOL,EVANSTON,IL 60208, USA.			Menco, Bert/0000-0002-0051-1420	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000566] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC00566] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALOUSI AA, 1991, FASEB J, V5, P2300, DOI 10.1096/fasebj.5.9.1650314; ANHOLT RRH, 1989, AM J PHYSIOL, V257, pC1043, DOI 10.1152/ajpcell.1989.257.6.C1043; ANHOLT RRH, 1987, BIOCHEMISTRY-US, V26, P788, DOI 10.1021/bi00377a020; ANHOLT RRH, 1991, CHEM SENSES, V16, P421, DOI 10.1093/chemse/16.5.421; ANHOLT RRH, 1990, BIOCHEMISTRY-US, V29, P4049, DOI 10.1021/bi00469a004; ASANUMA N, 1991, HISTOCHEM J, V23, P83, DOI 10.1007/BF01047112; Bakalyar H A, 1991, Curr Opin Neurobiol, V1, P204, DOI 10.1016/0959-4388(91)90079-M; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BAKALYAR HA, 1991, CURR OPIN NEUROBIOL, V1, P284; BENDAYAN M, 1988, J HISTOCHEM CYTOCHEM, V36, P597, DOI 10.1177/36.6.2452843; Besharse JC., 1990, CILIARY FLAGELLAR ME, P389; BOYLE AG, 1987, COMP BIOCHEM PHYS B, V88, P767, DOI 10.1016/0305-0491(87)90242-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUCH RC, 1987, J BIOL CHEM, V262, P2401; BRUCH RC, 1990, CHEM SENSES, V15, P419, DOI 10.1093/chemse/15.4.419; BRUCH RC, 1991, BRAIN RES, V550, P133, DOI 10.1016/0006-8993(91)90416-S; BRUCH RC, 1988, ANNU REV NUTR, V8, P21, DOI 10.1146/annurev.nu.08.070188.000321; BRUCH RC, 1990, G PROTEINS MEDIATORS, P113; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BURTON PR, 1992, IN PRESS MICROSC RES; CARLEMALM E, 1989, TECHNIQUES IMMUNOCYT, V4, P29; CARR VM, 1991, NEUROSCIENCE, V45, P433, DOI 10.1016/0306-4522(91)90239-K; CARR VM, 1989, J NEUROSCI, V9, P1179; CHEN Z, 1986, J NEUROSCI, V6, P2146; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DOTY RL, 1990, BRAIN RES, V527, P130, DOI 10.1016/0006-8993(90)91070-W; DUNCAN CJ, 1977, EXPERIENTIA, V33, P1310, DOI 10.1007/BF01920150; EDELMAN L, 1988, SCANNING MICROSCOPY, V2, P851; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; FRINGS S, 1991, J GEN PHYSIOL, V97, P1, DOI 10.1085/jgp.97.1.1; GETCHELL TV, 1980, BIOPHYS J, V29, P397, DOI 10.1016/S0006-3495(80)85142-3; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOLD GH, 1987, TRENDS PHARMACOL SCI, V8, P312, DOI 10.1016/0165-6147(87)90126-X; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; JONES DT, 1990, J BIOL CHEM, V265, P2671; JONES DT, 1990, CHEM SENSES, V15, P333, DOI 10.1093/chemse/15.3.333; KAUPP UB, 1991, TRENDS NEUROSCI, V14, P150; KELLENBERGER E, 1991, J MICROSC-OXFORD, V161, P183, DOI 10.1111/j.1365-2818.1991.tb03083.x; Kinnamon SC, 1991, SMELL TASTE HLTH DIS, P145; KLEENE SJ, 1991, J MEMBRANE BIOL, V120, P75, DOI 10.1007/BF01868593; KOLESNIKOV SS, 1990, FEBS LETT, V266, P96, DOI 10.1016/0014-5793(90)81515-P; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; KURAHASHI T, 1991, NEUROREPORT, V2, P5, DOI 10.1097/00001756-199101000-00001; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; KURIHARA K, 1972, BIOCHEM BIOPH RES CO, V48, P30, DOI 10.1016/0006-291X(72)90339-7; LABARCA P, 1988, J BIOENERG BIOMEMBR, V20, P551, DOI 10.1007/BF00768919; LANCET D, 1989, CHEM SENSES, V1, P263; LAZARD D, 1989, BIOCHIM BIOPHYS ACTA, V1013, P68, DOI 10.1016/0167-4889(89)90129-8; LEUNISSEN JLM, 1990, AURION NEWSLETTE OCT; LIDOW MS, 1984, J ULTRA MOL STRUCT R, V86, P18, DOI 10.1016/S0022-5320(84)90092-3; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; LOWE G, 1989, P NATL ACAD SCI USA, V86, P5641, DOI 10.1073/pnas.86.14.5641; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; MANIAFARNELL B, 1990, DEV BRAIN RES, V51, P103, DOI 10.1016/0165-3806(90)90262-W; MARGOLIS FL, 1972, P NATL ACAD SCI USA, V69, P1221, DOI 10.1073/pnas.69.5.1221; MARGOLIS FL, 1982, SCAND J IMMUNOL, V15, P181; MENCO BPM, 1986, J ELECTRON MICR TECH, V4, P177, DOI 10.1002/jemt.1060040302; MENCO BPM, 1989, CELL TISSUE RES, V256, P275; MENCO BPM, 1989, SCANNING MICROSCOPY, V3, P257; MENCO BPM, 1980, CELL TISSUE RES, V211, P5; MENCO BPM, 1980, CELL TISSUE RES, V207, P183; MENCO BPM, 1984, CELL TISSUE RES, V235, P225; MENCO BPM, 1992, IN PRESS MICROSC RES; MENEVSE A, 1977, BIOCHEM BIOPH RES CO, V77, P671, DOI 10.1016/S0006-291X(77)80031-4; MINOR A V, 1973, Neirofiziologiya, V5, P415; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NOVOSELOV VI, 1988, FEBS LETT, V234, P471, DOI 10.1016/0014-5793(88)80140-6; OCONNELL RJ, 1990, CHEM SENSES, V15, P725, DOI 10.1093/chemse/15.6.725; PACE U, 1986, P NATL ACAD SCI USA, V83, P4947, DOI 10.1073/pnas.83.13.4947; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; PARFENOVA EV, 1988, BIOCHEMISTRY-MOSCOW+, V53, P435; PFEUFFER E, 1989, J BIOL CHEM, V264, P18803; PHILLIPS GW, 1991, J HISTOCHEM CYTOCHEM, V39, P625, DOI 10.1177/39.5.2016512; PHILLIPS TE, 1984, J ELECTRON MICR TECH, V1, P9, DOI 10.1002/jemt.1060010103; PYATKINA GA, 1990, J EVOL BIOCHEM PHYS+, V26, P189; REED RR, 1990, CELL, V60, P1, DOI 10.1016/0092-8674(90)90706-K; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; RONNETT GV, 1991, P NATL ACAD SCI USA, V88, P2366, DOI 10.1073/pnas.88.6.2366; ROOF DJ, 1982, J CELL BIOL, V95, P487, DOI 10.1083/jcb.95.2.487; ROOF DJ, 1988, SCIENCE, V241, P845, DOI 10.1126/science.3136548; Shirley S.G., 1990, Seminars in the Neurosciences, V2, P59; SHIRLEY SG, 1986, BIOCHEM J, V240, P605, DOI 10.1042/bj2400605; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; SNYDER SH, 1988, J BIOL CHEM, V263, P13971; SPIEGEL AM, 1991, TRENDS BIOCHEM SCI, V16, P338, DOI 10.1016/0968-0004(91)90139-M; SUZUKI N, 1989, CHEM SENSES, V1, P469; TROTIER D, 1989, CHEM SENSES, V1, P427; VANVEEN T, 1986, P NATL ACAD SCI USA, V83, P912; VODYANOY V, 1991, CHEM SENSES, V16, P175, DOI 10.1093/chemse/16.2.175; ZIEGELBERGER G, 1990, J NEUROSCI, V10, P1217; [No title captured]; [No title captured]; [No title captured]	96	117	120	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					441	453		10.1016/0896-6273(92)90272-F	http://dx.doi.org/10.1016/0896-6273(92)90272-F			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550671				2022-12-28	WOS:A1992HK67500004
J	SWANDULLA, D; HANS, M; ZIPSER, K; AUGUSTINE, GJ				SWANDULLA, D; HANS, M; ZIPSER, K; AUGUSTINE, GJ			ROLE OF RESIDUAL CALCIUM IN SYNAPTIC DEPRESSION AND POSTTETANIC POTENTIATION - FAST AND SLOW CALCIUM SIGNALING IN NERVE-TERMINALS	NEURON			English	Article							SQUID GIANT SYNAPSE; FROG NEUROMUSCULAR-JUNCTION; POST-TETANIC POTENTIATION; TRANSMITTER RELEASE; IDENTIFIED SYNAPSE; MOLLUSCAN NEURONS; INTRACELLULAR PH; ACTIVE ZONES; FACILITATION; CA-2+	Trains of action potentials evoked rises in presynaptic Ca2+ concentration ([Ca2+]i) at the squid giant synapse. These increases in [Ca2+]i were spatially nonuniform during the trains, but rapidly equilibrated after the trains and slowly declined over hundreds of seconds. The trains also elicited synaptic depression and augmentation, both of which developed during stimulation and declined within a few seconds afterward. Microinjection of the Ca2+ buffer EGTA into presynaptic terminals had no effect on transmitter release or synaptic depression. However, EGTA injection effectively blocked both the persistent Ca2+ signals and augmentation. These results suggest that transmitter release is triggered by a large, brief, and sharply localized rise in [Ca2+]i, while augmentation is produced by a smaller, slower, and more diffuse rise in [Ca2+]i.	MARINE BIOL LAB, WOODS HOLE, MA 02543 USA; DUKE UNIV, MED CTR, DEPT NEUROBIOL, DURHAM, NC 27710 USA	Marine Biological Laboratory - Woods Hole; Duke University	SWANDULLA, D (corresponding author), MAX PLANCK INST BIOPHYS CHEM, W-3400 GOTTINGEN, GERMANY.		Augustine, George James/J-9228-2013		NINDS NIH HHS [NS-21624] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021624] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS DJ, 1985, J PHYSIOL-LONDON, V369, P145, DOI 10.1113/jphysiol.1985.sp015893; ADLER EM, 1991, J NEUROSCI, V11, P1496; AHMED Z, 1980, J GEN PHYSIOL, V75, P403, DOI 10.1085/jgp.75.4.403; AHMED Z, 1988, CELL CALCIUM, V9, P57, DOI 10.1016/0143-4160(88)90025-5; ALNAES E, 1975, J PHYSIOL-LONDON, V248, P285, DOI 10.1113/jphysiol.1975.sp010974; AUGUSTINE GJ, 1984, J PHYSIOL-LONDON, V346, P257, DOI 10.1113/jphysiol.1984.sp015020; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; AUGUSTINE GJ, 1989, SECRETION ITS CONTRO, P203; AUGUSTINE GJ, 1986, J PHYSL, V381, P6129; AUGUSTINE GJ, 1991, IN PRESS J PHYSL; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; CHARLTON MP, 1978, J GEN PHYSIOL, V72, P471, DOI 10.1085/jgp.72.4.471; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; CONNOR JA, 1986, J PHYSIOL-LONDON, V375, P625, DOI 10.1113/jphysiol.1986.sp016137; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; DUDEL J, 1981, PFLUG ARCH EUR J PHY, V391, P35, DOI 10.1007/BF00580691; ERULKAR SD, 1978, J PHYSIOL-LONDON, V278, P501, DOI 10.1113/jphysiol.1978.sp012320; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTNICK MJ, 1989, J PHYSIOL-LONDON, V412, P197, DOI 10.1113/jphysiol.1989.sp017611; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; KATZ B, 1970, J PHYSIOL-LONDON, V207, P789, DOI 10.1113/jphysiol.1970.sp009095; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Katz B., 1969, RELEASE NEURAL TRANS; KRETZ R, 1982, P NATL ACAD SCI-BIOL, V79, P5430, DOI 10.1073/pnas.79.17.5430; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LESTER HA, 1970, NATURE, V227, P493, DOI 10.1038/227493a0; LEVTOV A, 1980, J PHYSIOL-LONDON, V309, P247, DOI 10.1113/jphysiol.1980.sp013507; LLINAS R, 1975, P NATL ACAD SCI USA, V72, P187, DOI 10.1073/pnas.72.1.187; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; MAGLEBY KL, 1975, J PHYSIOL-LONDON, V245, P183, DOI 10.1113/jphysiol.1975.sp010840; MAGLEBY KL, 1976, J PHYSIOL-LONDON, V257, P449, DOI 10.1113/jphysiol.1976.sp011378; MILEDI R, 1981, PROC R SOC SER B-BIO, V212, P197, DOI 10.1098/rspb.1981.0034; MILEDI R, 1966, J PHYSIOL-LONDON, V184, P473, DOI 10.1113/jphysiol.1966.sp007927; NEHER E, 1991, IN PRESS J PHYSL; NEHER E, 1989, NEUROMUSCULAR JUNCTI, P65; OHMORI H, 1981, SCIENCE, V213, P1016, DOI 10.1126/science.6267693; POENIE M, 1985, NATURE, V315, P147, DOI 10.1038/315147a0; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; ROSENTHAL J, 1969, J PHYSIOL-LONDON, V203, P121, DOI 10.1113/jphysiol.1969.sp008854; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH SJ, 1987, TRENDS NEUROSCI, V10, P142, DOI 10.1016/0166-2236(87)90039-7; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; SMITH SJ, 1988, CALCIUM ION CHANNEL, P147; STANLEY EF, 1986, J NEUROSCI, V6, P782; TANABE N, 1989, NEUROSCI LETT, V99, P147, DOI 10.1016/0304-3940(89)90280-2; TSIEN RY, 1986, TRENDS BIOCHEM SCI, V11, P450, DOI 10.1016/0968-0004(86)90245-8; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; WEINREICH D, 1971, J PHYSIOL-LONDON, V212, P431, DOI 10.1113/jphysiol.1971.sp009333; ZENGEL JE, 1981, J GEN PHYSIOL, V77, P503, DOI 10.1085/jgp.77.5.503; ZUCKER RS, 1983, J NEUROSCI, V3, P1263; ZUCKER RS, 1983, J GEN PHYSIOL, V81, P355, DOI 10.1085/jgp.81.3.355; ZUCKER RS, 1972, J NEUROPHYSIOL, V35, P621, DOI 10.1152/jn.1972.35.5.621; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032	59	185	185	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1991	7	6					915	926		10.1016/0896-6273(91)90337-Y	http://dx.doi.org/10.1016/0896-6273(91)90337-Y			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1662519				2022-12-28	WOS:A1991GY43800005
J	TAKAHASHI, T; MOMIYAMA, A				TAKAHASHI, T; MOMIYAMA, A			SINGLE-CHANNEL CURRENTS UNDERLYING GLYCINERGIC INHIBITORY POSTSYNAPTIC RESPONSES IN SPINAL NEURONS	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; VISUALLY IDENTIFIED MOTONEURONS; BRAIN-STEM NEURONS; ACETYLCHOLINE-RECEPTOR; PATCH-CLAMP; CEREBELLAR NEURONS; CONDUCTANCE STATES; SYNAPTIC CURRENTS; ION CHANNELS; MUSCLE	Single-channel properties of glycine receptors have been characterized so far only in cultured neurons. To characterize the glycine receptor channels in situ, we applied the patch-clamp technique to spinal neurons in slice preparations. Glycine-gated, single-channel currents were recorded in outside-out patches excised from spinal neurons. In the falling phase of glycinergic inhibitory synaptic currents, single-channel currents were resolved as discrete steps. In both cases, the glycine-gated channels showed similar multiple conductance levels. These results suggest that the receptor channel properties are indistinguishable in the synaptic and extrasynaptic sites. We conclude that multiple conductance states of a receptor channel are the native feature of the glycine receptor in situ.			TAKAHASHI, T (corresponding author), KYOTO UNIV,FAC MED,DEPT PHYSIOL,KYOTO 606,JAPAN.		Takahashi, Tomoyuki/G-5951-2015	Takahashi, Tomoyuki/0000-0002-8771-7666				AKAGI H, 1991, FEBS LETT, V281, P160, DOI 10.1016/0014-5793(91)80383-E; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; CULLCANDY SG, 1982, NATURE, V295, P410, DOI 10.1038/295410a0; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; CURTIS DR, 1974, ERG PHYSIOL BIOL CH, V69, P97; CURTIS DR, 1968, EXP BRAIN RES, V5, P235; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; GOLD MR, 1983, J PHYSIOL-LONDON, V342, P85, DOI 10.1113/jphysiol.1983.sp014841; GOLD MR, 1983, J PHYSIOL-LONDON, V342, P99, DOI 10.1113/jphysiol.1983.sp014842; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HALL PV, 1979, NEUROLOGY, V29, P262, DOI 10.1212/WNL.29.2.262; HAMILL OP, 1983, NATURE, V305, P805, DOI 10.1038/305805a0; HAMILL OP, 1981, NATURE, V294, P462, DOI 10.1038/294462a0; HAYASHI H, 1981, ANN NEUROL, V9, P292, DOI 10.1002/ana.410090313; HUCK S, 1987, NEUROSCI LETT, V79, P103, DOI 10.1016/0304-3940(87)90679-3; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KOJIMA H, 1985, J PHYSIOL-LONDON, V368, P627, DOI 10.1113/jphysiol.1985.sp015880; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; NEHER E, 1976, J PHYSIOL-LONDON, V258, P705, DOI 10.1113/jphysiol.1976.sp011442; SAKMANN B, 1978, NATURE, V276, P401, DOI 10.1038/276401a0; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; SCHUETZE SM, 1978, P NATL ACAD SCI USA, V75, P520, DOI 10.1073/pnas.75.1.520; SMITH SM, 1989, J MEMBRANE BIOL, V108, P45, DOI 10.1007/BF01870424; TAKAHASHI T, 1978, PROC R SOC SER B-BIO, V202, P417, DOI 10.1098/rspb.1978.0076; TAKAHASHI T, 1990, J PHYSIOL-LONDON, V423, P27, DOI 10.1113/jphysiol.1990.sp018009; TAKEUCHI A, 1975, NEUROPHARMACOLOGY, V14, P619, DOI 10.1016/0028-3908(75)90084-2; TWYMAN RE, 1991, J PHYSIOL-LONDON, V435, P303, DOI 10.1113/jphysiol.1991.sp018512; WERMAN R, 1968, J NEUROPHYSIOL, V31, P81, DOI 10.1152/jn.1968.31.1.81; WHITE WF, 1982, NATURE, V298, P655, DOI 10.1038/298655a0; YOUNG AB, 1973, P NATL ACAD SCI USA, V70, P2832, DOI 10.1073/pnas.70.10.2832	37	57	58	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					965	969		10.1016/0896-6273(91)90341-V	http://dx.doi.org/10.1016/0896-6273(91)90341-V			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1722412				2022-12-28	WOS:A1991GY43800009
J	VYKLICKY, L; PATNEAU, DK; MAYER, ML				VYKLICKY, L; PATNEAU, DK; MAYER, ML			MODULATION OF EXCITATORY SYNAPTIC TRANSMISSION BY DRUGS THAT REDUCE DESENSITIZATION AT AMPA KAINATE RECEPTORS	NEURON			English	Article							AMINO-ACID RECEPTORS; CULTURED HIPPOCAMPAL-NEURONS; QUISQUALATE RECEPTORS; SINGLE-CHANNEL; GLUTAMATE RECEPTORS; CONCANAVALIN-A; CURRENTS; ACTIVATION; VOLTAGE; ACETYLCHOLINE	Desensitization at AMPA/kainate receptors has been proposed to contribute to the decay of excitatory synaptic currents. We examined the action of aniracetam, wheat germ agglutinin (WGA), and concanavalin A (Con A), drugs that act via separate mechanisms to reduce desensitization evoked by L-glutamate in rat hippocampal neurons. The decay of excitatory synaptic currents, and sucrose-evoked miniature excitatory postsynaptic currents (EPSCs) was slowed 2- to 3-fold by aniracetam. In contrast, WGA increased the EPSC decay time constant only 1.3-fold and Con A had no effect. Aniracetam increased the magnitude of stimulus-evoked EPSCs 1.9-fold; variance analysis suggests a postsynaptic mechanism of action. WGA and Con A reduced EPSC amplitude via a presynaptic mechanism. Aniracetam increased the burst length of L-glutamate-activated single-channel responses. Simulations suggest that aniracetam either slows entry into a desensitized state or decreases the closing rate constant for ion channel gating.	CZECHOSLOVAK ACAD SCI, INST PHYSIOL, CS-11142 PRAGUE 1, CZECHOSLOVAKIA	Czech Academy of Sciences	VYKLICKY, L (corresponding author), NICHHD, NEUROPHYSIOL & BIOPHYS SECT, DEV NEUROBIOL LAB, BETHESDA, MD 20892 USA.		Mayer, Mark/AAE-7356-2019; Vyklicky, Ladislav/C-1851-2012; Mayer, Mark L/H-5500-2013	Mayer, Mark/0000-0003-4378-8451; Vyklicky, Ladislav/0000-0002-0015-0098; 				ALDRICH RW, 1987, J NEUROSCI, V7, P418; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; CLEMENTS JD, 1990, J NEUROSCI METH, V31, P75, DOI 10.1016/0165-0270(90)90012-5; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; DUDEL J, 1990, BIOPHYS J, V57, P533, DOI 10.1016/S0006-3495(90)82569-8; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; EL-HAJJ FULEIHAN G, 1991, ENDOCRINOLOGY, V128, P2931, DOI 10.1210/endo-128-6-2931; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; ISAACSON JS, 1991, IN PRESS P NATL ACAD; ITO I, 1990, J PHYSIOL-LONDON, V424, P533, DOI 10.1113/jphysiol.1990.sp018081; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; KUNO M, 1986, NATURE, V323, P269, DOI 10.1038/323269a0; MACDONALD RL, 1989, J PHYSIOL-LONDON, V417, P483, DOI 10.1113/jphysiol.1989.sp017814; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P351, DOI 10.1113/jphysiol.1989.sp017725; McLachlan E M, 1978, Int Rev Physiol, V17, P49; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P162, DOI 10.1152/jn.1989.61.1.162; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; SHINOZAKI H, 1979, BRAIN RES, V161, P493, DOI 10.1016/0006-8993(79)90678-4; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; WATHEY JC, 1979, BIOPHYS J, V27, P145, DOI 10.1016/S0006-3495(79)85208-X; ZORUMSKI CF, 1990, NEURON, V5, P61, DOI 10.1016/0896-6273(90)90033-C	37	220	220	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1991	7	6					971	984		10.1016/0896-6273(91)90342-W	http://dx.doi.org/10.1016/0896-6273(91)90342-W			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1684903				2022-12-28	WOS:A1991GY43800010
J	COVARRUBIAS, M; WEI, A; SALKOFF, L				COVARRUBIAS, M; WEI, A; SALKOFF, L			SHAKER, SHAL, SHAB, AND SHAW EXPRESS INDEPENDENT K+ CURRENT SYSTEMS	NEURON			English	Article							POTASSIUM-CHANNEL PROTEINS; XENOPUS-OOCYTES; RAT-BRAIN; HETEROMULTIMERIC CHANNELS; DROSOPHILA MUSCLE; GENE FAMILY; NEURONS; CLONING; CDNA; DIVERSITY	Although many K+ channel genes encoding homologous subunits have been cloned, a central question remains: how do these subunits associate to produce the diversity of K+ currents observed in living cells? Previous work has shown that different subunits encoded by the Shaker gene subfamily are able to form heteromultimers, which add to the diversity of currents. However, the unrestrained mixing of subunits from all genes to form hybrid channels would be undersirable for some cells that clearly require functionally discrete K+ currents. We show that Drosophila Shaker, Shal, Shab, and Shaw subunits form functional homomultimers, but that a molecular barrier to heteropolymerization is present. Coexpression of all four K+ channel systems does not alter their individual properties in any way. These experiments also demonstrate that multiple, independent A-current systems together with multiple, independent delayed rectifier systems can coexist in single cells.	WASHINGTON UNIV, SCH MED, DEPT GENET, ST LOUIS, MO 63110 USA	Washington University (WUSTL)	COVARRUBIAS, M (corresponding author), WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63110 USA.			Covarrubias, Manuel/0000-0002-0881-4143	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024785] Funding Source: NIH RePORTER; NINDS NIH HHS [1 RO1NS24785-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS DJ, 1980, ANNU REV NEUROSCI, V3, P141, DOI 10.1146/annurev.ne.03.030180.001041; BADER CR, 1985, J PHYSIOL-LONDON, V366, P129, DOI 10.1113/jphysiol.1985.sp015789; BAKER K, 1990, NEURON, V4, P129, DOI 10.1016/0896-6273(90)90449-P; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; MCCORMACK K, 1990, BIOCHEM BIOPH RES CO, V171, P1361, DOI 10.1016/0006-291X(90)90836-C; MCCORMACK T, 1990, P NATL ACAD SCI USA, V87, P5227, DOI 10.1073/pnas.87.13.5227; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; PAK MD, 1991, J NEUROSCI, V11, P869; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SALKOFF L, 1983, TRENDS NEUROSCI, V6, P128, DOI 10.1016/0166-2236(83)90065-6; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SOLC CK, 1988, J NEUROSCI, V8, P2556; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WU CF, 1985, J NEUROSCI, V5, P2626; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; ZAGOTTA WN, 1988, J NEUROSCI, V8, P4765; ZHONG Y, 1991, SCIENCE, V252, P1562, DOI 10.1126/science.2047864	29	239	242	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1991	7	5					763	773		10.1016/0896-6273(91)90279-9	http://dx.doi.org/10.1016/0896-6273(91)90279-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1742024				2022-12-28	WOS:A1991GT93900007
J	INUZUKA, H; MIYATANI, S; TAKEICHI, M				INUZUKA, H; MIYATANI, S; TAKEICHI, M			R-CADHERIN - A NOVEL CA2+-DEPENDENT CELL CELL-ADHESION MOLECULE EXPRESSED IN THE RETINA	NEURON			English	Article							N-CADHERIN; NEURITE OUTGROWTH; XENOPUS EMBRYOS; AXONAL GUIDANCE; OPTIC-NERVE; CDNA; HISTOGENESIS; GENE	cDNAs encoding a novel member of the cadherin cell adhesion receptor family were cloned. This cadherin is expressed in the retina of the chicken and is termed R-cadherin. It is similar to other cadherins in its primary structure, but most resembles N-cadherin, showing 74% amino acid identity. Cells expressing R-cadherin can adhere to those expressing N-cadherin when mixed, but they form homotypic clusters within their chimeric aggregates. In the development of the neural retina, R-cadherin begins to be expressed around embryonic day 8 in both neuronal and glial cells, and this expression continues up to the hatching stage. The pattern of the expression of R-cadherin was different from that of N-cadherin, suggesting distinctive roles in retinal morphogenesis.			INUZUKA, H (corresponding author), KYOTO UNIV,FAC SCI,DEPT BIOPHYS,SAKYO KU,KYOTO 606,JAPAN.		Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378				BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DRAZBA J, 1990, DEV BIOL, V138, P82, DOI 10.1016/0012-1606(90)90178-L; FREGIEN N, 1986, GENE, V48, P1, DOI 10.1016/0378-1119(86)90346-X; FUJIMORI T, 1990, DEVELOPMENT, V110, P97; GALLIN WJ, 1987, P NATL ACAD SCI USA, V84, P2808, DOI 10.1073/pnas.84.9.2808; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; HATTA K, 1988, J CELL BIOL, V106, P873, DOI 10.1083/jcb.106.3.873; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRAYANEK S, 1981, DEV BIOL, V84, P41, DOI 10.1016/0012-1606(81)90368-7; LETOURNEAU PC, 1990, DEV BIOL, V138, P430, DOI 10.1016/0012-1606(90)90209-2; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; REICHARDT LF, 1991, IN PRESS COLD SPRING; SILVER J, 1981, J COMP NEUROL, V202, P521, DOI 10.1002/cne.902020406; SUZUKI S, 1991, IN PRESS CELL REG; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TAKEICHI M, 1991, IN PRESS COLD SPRING; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3	28	206	211	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1991	7	1					69	79		10.1016/0896-6273(91)90075-B	http://dx.doi.org/10.1016/0896-6273(91)90075-B			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1712604				2022-12-28	WOS:A1991FY48100007
J	SNUTCH, TP; TOMLINSON, WJ; LEONARD, JP; GILBERT, MM				SNUTCH, TP; TOMLINSON, WJ; LEONARD, JP; GILBERT, MM			DISTINCT CALCIUM CHANNELS ARE GENERATED BY ALTERNATIVE SPLICING AND ARE DIFFERENTIALLY EXPRESSED IN THE MAMMALIAN CNS	NEURON			English	Article							CHICK SENSORY NEURONS; RAT-BRAIN; POTASSIUM-CHANNEL; SKELETAL-MUSCLE; MESSENGER-RNAS; SODIUM-CHANNEL; DIHYDROPYRIDINE RECEPTOR; FUNCTIONAL EXPRESSION; GATING PROPERTIES; DROSOPHILA	A number of pharmacologically and electrophysiologically distinct voltage-dependent Ca2+ channels have been identified in mammalian neurons. Two rat brain Ca2+ channel alpha-1 subunits (rbC-I and rbC-II) have been isolated by molecular cloning and shown to be highly related (95%) to the cardiac dihydropyridine-sensitive Ca2+ channel. The rbC-II protein is distinct from rbC-I in that it contains a 3 amino acid insert in the putative cytoplasmic loop between domains II and III and a 28 amino acid substitution corresponding to the third transmembrane segment (S3) of the fourth domain. We show that rbC-I and rbC-II transcripts are generated by alternative splicing and that they are differentially expressed in the rat CNS.	UNIV BRITISH COLUMBIA,DEPT NEUROSCI,VANCOUVER V6T 1W5,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT ZOOL,VANCOUVER V6T 1W5,BC,CANADA; UNIV ILLINOIS,DEPT BIOL SCI,CHICAGO,IL 60680	University of British Columbia; University of British Columbia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	SNUTCH, TP (corresponding author), UNIV BRITISH COLUMBIA,BIOTECHNOL LAB,VANCOUVER V6T 1W5,BC,CANADA.		Leonard, John/M-4379-2014; Tuluc, Petronel/C-2527-2011; Snutch, Terrance P/L-3464-2019	Leonard, John/0000-0002-5083-1115; Snutch, Terrance P/0000-0001-5182-1296	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS026432] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-26432] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CARBONE E, 1984, BIOPHYS J, V46, P413, DOI 10.1016/S0006-3495(84)84037-0; CATTERALL WA, 1988, J BIOL CHEM, V263, P3535; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORTES R, 1984, J NEURAL TRANSM, V60, P169, DOI 10.1007/BF01249092; CRISTIE M, 1989, SCIENCE, V244, P221; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FEDULOVA SA, 1985, J PHYSIOL-LONDON, V359, P431, DOI 10.1113/jphysiol.1985.sp015594; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; KOCH WJ, 1989, FEBS LETT, V250, P386, DOI 10.1016/0014-5793(89)80761-6; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEONARD JP, 1987, J NEUROSCI, V7, P875; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MCKEOWN M, 1990, GENETIC ENG, V12; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	50	335	349	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1991	7	1					45	57		10.1016/0896-6273(91)90073-9	http://dx.doi.org/10.1016/0896-6273(91)90073-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1648941				2022-12-28	WOS:A1991FY48100005
J	BERNHEIM, L; BEECH, DJ; HILLE, B				BERNHEIM, L; BEECH, DJ; HILLE, B			A DIFFUSIBLE 2ND MESSENGER MEDIATES ONE OF THE PATHWAYS COUPLING RECEPTORS TO CALCIUM CHANNELS IN RAT SYMPATHETIC NEURONS	NEURON			English	Article							PROTEIN KINASE-C; GUANOSINE 3',5'-MONOPHOSPHATE; SYNAPTIC TRANSMISSION; MUSCARINIC RECEPTOR; MODULATION; CA-2+; GANGLIA; ACTIVATION; CELLS; NEUROTRANSMITTERS	Muscarinic and alpha-adrenergic suppression of current through Ca2 channels was studied in adult rat superior cervical ganglion neurons using whole-cell and cell-attached configurations of the patch-clamp technique. Oxotremorine methiodide suppressed I(Ca) by both a rapid (<< 1 s) and a slow (> 4 s) process, whereas norepinephrine suppressed I(Ca) only by a rapid process. The slow muscarinic suppression could be prevented by adding 20 mM BAPTA, a Ca2+ chelator, to the recording pipette, whereas the adrenergic suppression was not affected. Muscarinic, but not alpha-adrenergic, receptors can couple to Ca2+ channels by a second messenger capable of diffusing into an on-cell patch. This signal seems not to be carried by intracellular Ca2+, cGMP, cAMP, or protein kinase C.			BERNHEIM, L (corresponding author), UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195, USA.			Beech, David/0000-0002-7683-9422	NINDS NIH HHS [NS 08174] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BLEY KR, 1990, NEURON, V4, P379, DOI 10.1016/0896-6273(90)90050-P; BLINKS JR, 1982, PROG BIOPHYS MOL BIO, V40, P1, DOI 10.1016/0079-6107(82)90011-6; BONE EA, 1985, BIOCHEM J, V227, P263, DOI 10.1042/bj2270263; BOSMA MM, 1990, G PROTEINS SIGNAL TR, P43; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BRIGGS CA, 1982, CELL MOL NEUROBIOL, V2, P129, DOI 10.1007/BF00711078; BROWN DA, 1980, BRIT J PHARMACOL, V70, P577, DOI 10.1111/j.1476-5381.1980.tb09777.x; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; GALVAN M, 1982, BRAIN RES, V244, P135, DOI 10.1016/0006-8993(82)90911-8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HOKIN LE, 1966, J NEUROCHEM, V13, P179; HORWITZ J, 1985, J PHARMACOL EXP THER, V233, P235; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; JONES SW, 1989, J GEN PHYSIOL, V94, P151, DOI 10.1085/jgp.94.1.151; KEBABIAN JW, 1975, J PHARMACOL EXP THER, V193, P474; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; NAKANO H, 1987, J ANTIBIOT, V40, P706, DOI 10.7164/antibiotics.40.706; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RANE SG, 1986, P NATL ACAD SCI USA, V83, P184, DOI 10.1073/pnas.83.1.184; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; SCHOFIELD GG, 1988, EUR J PHARMACOL, V151, P131, DOI 10.1016/0014-2999(88)90702-9; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; SONG SY, 1989, BRAIN RES, V494, P383, DOI 10.1016/0006-8993(89)90609-4; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; WEIGHT FF, 1974, SCIENCE, V186, P942, DOI 10.1126/science.186.4167.942; YANAGIHARA N, 1991, J NEUROCHEM, V56, P294, DOI 10.1111/j.1471-4159.1991.tb02595.x; YATANI A, 1989, SCIENCE, V245, P71, DOI 10.1126/science.2544999	38	210	211	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1991	6	6					859	867		10.1016/0896-6273(91)90226-P	http://dx.doi.org/10.1016/0896-6273(91)90226-P			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	1647174				2022-12-28	WOS:A1991FT94900001
J	DOZE, VA; COHEN, GA; MADISON, DV				DOZE, VA; COHEN, GA; MADISON, DV			SYNAPTIC LOCALIZATION OF ADRENERGIC DISINHIBITION IN THE RAT HIPPOCAMPUS	NEURON			English	Article							PYRAMIDAL CELLS-INVITRO; ACTIVITY-DEPENDENT DISINHIBITION; LACUNOSUM-MOLECULARE INTERNEURONS; GABAB RECEPTORS; POSTSYNAPTIC CURRENTS; BETA-RECEPTOR; NOREPINEPHRINE; NEURONS; CA1; NORADRENALINE	Norepinephrine is an endogenous neurotransmitter that reduces synaptic inhibition onto pyramidal neurons in the hippocampus by an action at an alpha-adrenergic receptor. The physiological mechanism of this disinhibition was previously not known, except that it occurred at a site presynaptic to the inhibited pyramidal cell. In this paper we present evidence that adrenergic disinhibition is restricted to the early phase of the evoked inhibitory postsynaptic potential in area CA1 of the hippocampus. The locus of disinhibition does not appear to reside in the interneuronal terminal, axon, or cell body. Instead, adrenergic agonists appear to reduce evoked synaptic inhibition by depressing excitatory synapses that activate the interneuron.			DOZE, VA (corresponding author), STANFORD UNIV,MED CTR,SCH MED,BECKMAN CTR MOLEC & GENET MED,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.		; Madison, Daniel/F-9341-2017	Doze, Van/0000-0002-5288-9564; Madison, Daniel/0000-0002-0718-5373				ADEJARE A, 1988, J MED CHEM, V31, P1972, DOI 10.1021/jm00118a019; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; ALGER BE, 1984, J NEUROPHYSIOL, V52, P892, DOI 10.1152/jn.1984.52.5.892; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P125, DOI 10.1113/jphysiol.1982.sp014256; ALGER BE, 1980, BRAIN RES, V200, P195, DOI 10.1016/0006-8993(80)91108-7; ANDERSEN P, 1980, J PHYSIOL-LONDON, V305, P279, DOI 10.1113/jphysiol.1980.sp013363; ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P608, DOI 10.1152/jn.1964.27.4.608; ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P592, DOI 10.1152/jn.1964.27.4.592; BOWERY NG, 1983, BRIT J PHARMACOL, V78, P191, DOI 10.1111/j.1476-5381.1983.tb09380.x; Chauvel P, 1986, Adv Neurol, V44, P475; CHEN QX, 1990, J PHYSIOL-LONDON, V420, P207, DOI 10.1113/jphysiol.1990.sp017908; COLLINGRIDGE G, 1988, NEUROL NEUR, V46, P171; COOPER JR, 1986, CNS ASPECTS BIOCH BA, V2, P259; CURET O, 1988, BRAIN RES, V475, P35, DOI 10.1016/0006-8993(88)90196-5; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; DAVIES SN, 1989, PROC R SOC SER B-BIO, V236, P373, DOI 10.1098/rspb.1989.0028; DEISZ RA, 1989, J PHYSIOL-LONDON, V412, P513, DOI 10.1113/jphysiol.1989.sp017629; DINGLEDINE R, 1980, BRAIN RES, V185, P277, DOI 10.1016/0006-8993(80)91068-9; DOERNER D, 1988, NEURON, V1, P693, DOI 10.1016/0896-6273(88)90168-7; DUTAR P, 1988, NEURON, V1, P585, DOI 10.1016/0896-6273(88)90108-0; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; Ferrendelli J A, 1986, Adv Neurol, V44, P393; GAHWILER BH, 1985, P NATL ACAD SCI USA, V82, P1558, DOI 10.1073/pnas.82.5.1558; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HAAS HL, 1982, J PHYSIOL-LONDON, V329, P541, DOI 10.1113/jphysiol.1982.sp014318; HARRISON NL, 1990, J PHYSIOL-LONDON, V422, P433, DOI 10.1113/jphysiol.1990.sp017993; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P225, DOI 10.1152/jn.1961.24.3.225; KAWAGUCHI Y, 1988, EXP BRAIN RES, V72, P494; KERR DIB, 1988, NEUROSCI LETT, V92, P92, DOI 10.1016/0304-3940(88)90748-3; KNOWLES WD, 1981, J NEUROSCI, V1, P318; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1988, J NEUROSCI, V8, P1400; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; LAMBERT NA, 1989, NEUROSCI LETT, V107, P125, DOI 10.1016/0304-3940(89)90803-3; LEUNG PPH, 1988, CAN J PHYSIOL PHARM, V66, P814, DOI 10.1139/y88-129; LOY R, 1980, J COMP NEUROL, V189, P699, DOI 10.1002/cne.901890406; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; MADISON DV, 1988, BRAIN RES, V442, P131, DOI 10.1016/0006-8993(88)91440-0; MCCARREN M, 1985, J NEUROPHYSIOL, V53, P557, DOI 10.1152/jn.1985.53.2.557; MCCARREN M, 1988, J NEUROPHYSIOL, V398, P123; MEINVILLE JM, 1987, NEUROPHARMACOLOGY, V26, P779; MODY I, 1983, CAN J PHYSIOL PHARM, V61, P841, DOI 10.1139/y83-129; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; MUELLER AL, 1981, BRAIN RES, V214, P113, DOI 10.1016/0006-8993(81)90442-X; MYNLIEFF M, 1988, NEUROPHARMACOLOGY, V27, P391, DOI 10.1016/0028-3908(88)90148-7; NEWBERRY NR, 1984, J PHYSIOL-LONDON, V348, P239, DOI 10.1113/jphysiol.1984.sp015107; NEWBERRY NR, 1985, J PHYSIOL-LONDON, V360, P161, DOI 10.1113/jphysiol.1985.sp015610; NICOLL RA, 1980, NATURE, V287, P22, DOI 10.1038/287022a0; OTIS TS, 1991, IN PRESS BRAIN RES; PANG K, 1987, BRAIN RES, V425, P146, DOI 10.1016/0006-8993(87)90493-8; ROPERT N, 1990, J PHYSIOL-LONDON, V428, P707, DOI 10.1113/jphysiol.1990.sp018236; SAH P, 1990, J PHYSIOL-LONDON, V430, P605, DOI 10.1113/jphysiol.1990.sp018310; SCHWARTZKROIN PA, 1985, J COMP NEUROL, V232, P205, DOI 10.1002/cne.902320206; SCHWARTZKROIN PA, 1980, BRAIN RES, V183, P61, DOI 10.1016/0006-8993(80)90119-5; SEGAL M, 1974, BRAIN RES, V72, P79, DOI 10.1016/0006-8993(74)90652-0; SEGAL M, 1974, BRAIN RES, V72, P99, DOI 10.1016/0006-8993(74)90653-2; SEGAL M, 1981, BRAIN RES, V206, P107, DOI 10.1016/0006-8993(81)90104-9; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P524, DOI 10.1152/jn.1989.61.3.524; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; N-S ARCH PHARMACOL, V318, P259	65	88	89	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1991	6	6					889	900		10.1016/0896-6273(91)90229-S	http://dx.doi.org/10.1016/0896-6273(91)90229-S			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	1675862				2022-12-28	WOS:A1991FT94900004
J	PATNEAU, DK; MAYER, ML				PATNEAU, DK; MAYER, ML			KINETIC-ANALYSIS OF INTERACTIONS BETWEEN KAINATE AND AMPA - EVIDENCE FOR ACTIVATION OF A SINGLE RECEPTOR IN MOUSE HIPPOCAMPAL-NEURONS	NEURON			English	Article							AMINO-ACID RECEPTORS; SELECTIVE GLUTAMATE RECEPTORS; EMBRYONIC CHICK MOTONEURONS; METHYL-D-ASPARTATE; QUISQUALATE RECEPTORS; XENOPUS OOCYTES; ACETYLCHOLINE-RECEPTORS; FUNCTIONAL EXPRESSION; VOLTAGE-CLAMP; BINDING-SITES	AMPA but not kainate produces a rapidly desensitizing response in mouse hippocampal neurons. The characteristic action of these agonists appears to arise from activation of a single receptor with active and desensitized states, for which AMPA and kainate have different relative affinity. The equilibrium potency of a series of five agonists that produce rapidly desensitizing responses at non-NMDA receptors (EC50 1-mu-M to 4 mM) was similar to their equilibrium potency for block of kainate responses. Increasing the concentration of kainate overcame such block, but in the presence of AMPA the rate of activation of responses to kainate was slowed. Conversely, in the presence of kainate the amplitude of rapidly desensitizing responses evoked by AMPA was reduced, and the rate of onset of desensitization was slowed.			PATNEAU, DK (corresponding author), NIH,DEV NEUROBIOL LAB,NEUROPHYSIOL & BIOPHYS SECT,BLDG 36,ROOM 2A21,BETHESDA,MD 20892, USA.		Mayer, Mark/AAE-7356-2019; Mayer, Mark L/H-5500-2013	Mayer, Mark/0000-0003-4378-8451; 				AIZENMAN E, 1988, J PHYSIOL-LONDON, V396, P75, DOI 10.1113/jphysiol.1988.sp016951; ANIS NA, 1981, J PHYSIOL-LONDON, V312, P345, DOI 10.1113/jphysiol.1981.sp013632; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P227; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BOYD ND, 1987, J PHYSIOL-LONDON, V389, P45, DOI 10.1113/jphysiol.1987.sp016646; CACHELIN AB, 1989, J PHYSIOL-LONDON, V415, P159, DOI 10.1113/jphysiol.1989.sp017717; CHARPENTIER N, 1990, EUR J PHARM-MOLEC PH, V189, P241, DOI 10.1016/0922-4106(90)90117-G; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CULLCANDY SG, 1989, J PHYSIOL-LONDON, V415, P555, DOI 10.1113/jphysiol.1989.sp017736; FELTZ A, 1982, J PHYSIOL-LONDON, V322, P257, DOI 10.1113/jphysiol.1982.sp014036; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; HUGANIR RL, 1989, CRIT REV BIOCHEM MOL, V24, P183, DOI 10.3109/10409238909082553; ISHIDA AT, 1985, P NATL ACAD SCI USA, V82, P1837, DOI 10.1073/pnas.82.6.1837; ITO I, 1990, J PHYSIOL-LONDON, V424, P533, DOI 10.1113/jphysiol.1990.sp018081; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KISKIN NI, 1990, EUR J NEUROSCI, V2, P461, DOI 10.1111/j.1460-9568.1990.tb00437.x; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; LERMA J, 1989, P NATL ACAD SCI USA, V86, P2083, DOI 10.1073/pnas.86.6.2083; LLANO I, 1988, P NATL ACAD SCI USA, V85, P3221, DOI 10.1073/pnas.85.9.3221; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MAYER ML, 1991, IN PRESS EXCITATORY; MONAGHAN DT, 1983, NATURE, V306, P176, DOI 10.1038/306176a0; MURPHY SN, 1989, MOL PHARMACOL, V35, P671; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; OBRIEN RJ, 1986, J NEUROSCI, V6, P3275; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P162, DOI 10.1152/jn.1989.61.1.162; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PEROUANSKY M, 1989, J NEUROSCI, V9, P70; RAINBOW TC, 1984, BRAIN RES, V309, P173, DOI 10.1016/0006-8993(84)91025-4; RASSENDREN FA, 1989, NEUROSCI LETT, V99, P333, DOI 10.1016/0304-3940(89)90469-2; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VERDOORN TA, 1988, MOL PHARMACOL, V34, P298; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; ZORUMSKI CF, 1988, J NEUROSCI, V8, P4277	44	231	232	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					785	798		10.1016/0896-6273(91)90175-Y	http://dx.doi.org/10.1016/0896-6273(91)90175-Y			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1673850				2022-12-28	WOS:A1991FM52200011
J	MACKINNON, R; HEGINBOTHAM, L; ABRAMSON, T				MACKINNON, R; HEGINBOTHAM, L; ABRAMSON, T			MAPPING THE RECEPTOR-SITE FOR CHARYBDOTOXIN, A PORE-BLOCKING POTASSIUM CHANNEL INHIBITOR	NEURON			English	Article							CA-2+-ACTIVATED K+ CHANNEL; HIGH-CONDUCTANCE; VOLTAGE; DROSOPHILA; DIVERSITY; BRAIN	The Shaker K+ channel belongs to a family of structurally related voltage-activated cation channels that play a central role in cellular electrical signaling. By studying multiple site-directed mutants of the Shaker K+ channel, a region that forms the binding site for a pore-blocking scorpion toxin has been identified. The region contains a sequence that is highly conserved among cloned K+ channels and may contribute to the formation of the ion conduction pore.	HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115	Harvard University; Harvard Medical School	MACKINNON, R (corresponding author), HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43949] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GIMENEZGALLEGO G, 1988, P NATL ACAD SCI USA, V85, P3329, DOI 10.1073/pnas.85.10.3329; GUY HR, 1989, MONOVALENT CATIONS B; Hille B, 1984, IONIC CHANNELS EXCIT; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LUCCHESI K, 1989, J MEMBRANE BIOL, V109, P269, DOI 10.1007/BF01870284; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8087, DOI 10.1021/bi00446a019; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; MASSEFSKI W, 1990, SCIENCE, V249, P521, DOI 10.1126/science.1696395; MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; MOCZYDLOWSKI E, 1988, J MEMBRANE BIOL, V105, P95, DOI 10.1007/BF02009164; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471	26	207	211	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1990	5	6					767	771		10.1016/0896-6273(90)90335-D	http://dx.doi.org/10.1016/0896-6273(90)90335-D			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ381	1702643				2022-12-28	WOS:A1990EQ38100003
J	MATTSON, MP				MATTSON, MP			ANTIGENIC CHANGES SIMILAR TO THOSE SEEN IN NEUROFIBRILLARY TANGLES ARE ELICITED BY GLUTAMATE AND CA-2+ INFLUX IN CULTURED HIPPOCAMPAL-NEURONS	NEURON			English	Article									UNIV KENTUCKY, DEPT ANAT & NEUROBIOL, LEXINGTON, KY 40536 USA	University of Kentucky	MATTSON, MP (corresponding author), UNIV KENTUCKY, SANDERS BROWN RES CTR AGING, LEXINGTON, KY 40536 USA.		Mattson, Mark P/F-6038-2012					ALGHOUL WM, 1989, BRAIN RES, V481, P361, DOI 10.1016/0006-8993(89)90815-9; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; BENOWITZ LI, 1989, J NEUROSCI, V9, P990; CACERES A, 1984, J NEUROSCI, V4, P394; CARLSON N, 1987, J CELL BIOL, V104, P547, DOI 10.1083/jcb.104.3.547; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; DEBONI U, 1985, J NEUROL SCI, V68, P105, DOI 10.1016/0022-510X(85)90093-0; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; HAMRE KM, 1989, NEUROSCI LETT, V98, P264, DOI 10.1016/0304-3940(89)90411-4; HOOPER MW, 1976, AM J PATHOL, V85, P1; HYMAN BT, 1988, ANN NEUROL, V23, P371, DOI 10.1002/ana.410230410; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; JOACHIM CL, 1987, ANN NEUROL, V22, P514, DOI 10.1002/ana.410220411; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; KOSIK KS, 1988, J NEUROCHEM, V51, P587, DOI 10.1111/j.1471-4159.1988.tb01079.x; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; LOVE S, 1988, J NEUROPATH EXP NEUR, V47, P393, DOI 10.1097/00005072-198807000-00001; LYNCH G, 1986, SYNAPSES CIRCUITS BE; MANETTO V, 1988, P NATL ACAD SCI USA, V85, P4501, DOI 10.1073/pnas.85.12.4501; MARAGOS WF, 1987, TRENDS NEUROSCI, V10, P65, DOI 10.1016/0166-2236(87)90025-7; MATTSON MP, 1989, MECH AGEING DEV, V50, P103, DOI 10.1016/0047-6374(89)90010-9; MATTSON MP, 1988, INT J DEV NEUROSCI, V6, P439, DOI 10.1016/0736-5748(88)90050-0; MATTSON MP, 1988, J NEUROSCI RES, V21, P447, DOI 10.1002/jnr.490210236; MATTSON MP, 1989, BRAIN RES, V490, P110, DOI 10.1016/0006-8993(89)90436-8; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MATTSON MP, 1988, NEURON, V1, P865, DOI 10.1016/0896-6273(88)90134-1; MATTSON MP, 1989, J NEUROSCI, V9, P1223; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MATTSON MP, 1990, IN PRESS CURRENT ASP, V2; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; NADLER JV, 1981, NEUROSCIENCE, V6, P2505, DOI 10.1016/0306-4522(81)90096-8; PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033; SCHWARCZ R, 1984, LIFE SCI, V35, P19, DOI 10.1016/0024-3205(84)90148-6; SELKOE DJ, 1989, ANNU REV NEUROSCI, V12, P463, DOI 10.1146/annurev.ne.12.030189.002335; SHANKAR SK, 1989, ANN NEUROL, V25, P146, DOI 10.1002/ana.410250207; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; STERNBERGER NH, 1985, P NATL ACAD SCI USA, V82, P4274, DOI 10.1073/pnas.82.12.4274; VANHOESEN GW, 1986, PROG BRAIN RES, V70, P321; WHITSON JS, 1989, SCIENCE, V243, P1488, DOI 10.1126/science.2928783; WISNIEWSKI HM, 1987, ALZHEIMERS DISEASE P, P87; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; WOLOZIN B, 1987, ANN NEUROL, V22, P521, DOI 10.1002/ana.410220412; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; YOUNG AB, 1987, J NEURAL TRANSM, P147	50	233	244	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1990	4	1					105	117		10.1016/0896-6273(90)90447-N	http://dx.doi.org/10.1016/0896-6273(90)90447-N			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM297	1690014				2022-12-28	WOS:A1990CM29700010
J	CHO, KO; HUNT, CA; KENNEDY, MB				CHO, KO; HUNT, CA; KENNEDY, MB			THE RAT-BRAIN POSTSYNAPTIC DENSITY FRACTION CONTAINS A HOMOLOG OF THE DROSOPHILA DISKS-LARGE TUMOR SUPPRESSOR PROTEIN	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL NERVOUS-SYSTEM; AMINO-ACID SEQUENCE; SIGNAL TRANSDUCTION; GUANYLATE KINASE; BINDING PROTEIN; CALMODULIN; DNA; IDENTIFICATION; JUNCTIONS	In CNS synapses, the synaptic junctional complex with associated postsynaptic density is presumed to contain proteins responsible for adhesion between pre- and postsynaptic membranes and for postsynaptic signal transduction. We have found that a prominent, brain-specific protein (PSD-95) enriched in the postsynaptic density fraction from rat brain is highly similar to the Drosophila lethal(1)discs-large-1 (dlg) tumor suppressor protein. The dlg protein is associated with septate junctions in developing flies and contains a guanylate kinase domain that is required for normal control of cell division. The sequence similarity between dlg and PSD-95 suggests that molecular mechanisms critical for growth control in developing organisms may also regulate synapse formation, stabilization, or function in the adult brain.			CHO, KO (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.		Cho, Kyung-Ok/C-1705-2011	Cho, Kyung-Ok/0000-0002-0760-2560; Kennedy, Mary/0000-0003-1369-0525				AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; AGHAJANIAN G. K., 1967, BRAIN RES, V6, P716, DOI 10.1016/0006-8993(67)90128-X; ASUBEL FM, 1989, CURRENT PROTOCOLS MO; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BERGER A, 1989, EUR J BIOCHEM, V184, P433, DOI 10.1111/j.1432-1033.1989.tb15035.x; BIGGS J, 1988, GENE DEV, V2, P1333, DOI 10.1101/gad.2.10.1333; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; BLOMBERG F, 1977, J CELL BIOL, V74, P204, DOI 10.1083/jcb.74.1.204; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAY P, 1986, P NATL ACAD SCI USA, V83, P8893, DOI 10.1073/pnas.83.23.8893; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; BRYANT PJ, 1992, CELL, V68, P621, DOI 10.1016/0092-8674(92)90136-Z; BULLEIT RF, 1988, NEURON, V1, P63, DOI 10.1016/0896-6273(88)90210-3; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARLIN RK, 1981, J CELL BIOL, V89, P449, DOI 10.1083/jcb.89.3.449; CARLIN RK, 1983, J CELL BIOL, V96, P443, DOI 10.1083/jcb.96.2.443; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; COTMAN CW, 1974, J CELL BIOL, V63, P441, DOI 10.1083/jcb.63.2.441; DEAROLF CR, 1988, DEV BIOL, V129, P159, DOI 10.1016/0012-1606(88)90170-4; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DRUBIN DG, 1990, NATURE, V343, P288, DOI 10.1038/343288a0; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GREENOUGH WT, 1988, TRENDS NEUROSCI, V11, P142, DOI 10.1016/0166-2236(88)90139-7; GURD JW, 1980, CAN J BIOCHEM CELL B, V58, P941, DOI 10.1139/o80-129; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; HARLOW E, 1988, ANTIBODIES; HAYES NVL, 1991, J NEUROCHEM, V57, P397, DOI 10.1111/j.1471-4159.1991.tb03766.x; HORN G, 1985, J NEUROSCI, V5, P3161; KELLY PT, 1978, J CELL BIOL, V79, P173, DOI 10.1083/jcb.79.1.173; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KENNEDY MB, 1990, COLD SH Q B, V55, P101; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; LEHTO VP, 1988, NATURE, V334, P388, DOI 10.1038/334388a0; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MATUS AI, 1978, PROC R SOC SER B-BIO, V203, P135, DOI 10.1098/rspb.1978.0097; Noirot-Timothee C., 1980, International Review of Cytology, V63, P97, DOI 10.1016/S0074-7696(08)61758-1; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; PAWSON T, 1992, NATURE, V356, P285, DOI 10.1038/356285a0; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; PONTE P, 1984, NUCLEIC ACIDS RES, V12, P1687, DOI 10.1093/nar/12.3.1687; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; RUFF P, 1991, P NATL ACAD SCI USA, V88, P6595, DOI 10.1073/pnas.88.15.6595; RUGGIERI R, 1991, NATURE, V353, P390, DOI 10.1038/353390a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SAMPEDRO MN, 1981, J CELL BIOL, V90, P675, DOI 10.1083/jcb.90.3.675; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIEKEVITZ P, 1985, P NATL ACAD SCI USA, V82, P3494, DOI 10.1073/pnas.82.10.3494; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; STEHLE T, 1990, J MOL BIOL, V211, P249, DOI 10.1016/0022-2836(90)90024-G; STEWART M, 1972, DEV BIOL, V27, P71, DOI 10.1016/0012-1606(72)90113-3; STUDIER WF, 1990, METHOD ENZYMOL, V185, P60, DOI DOI 10.1016/0076-6879(90)85008-C; TENG DHF, 1991, NATURE, V353, P437, DOI 10.1038/353437a0; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; WALTERS BB, 1975, NATURE, V257, P496, DOI 10.1038/257496a0; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	70	1001	1024	0	34	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1992	9	5					929	942		10.1016/0896-6273(92)90245-9	http://dx.doi.org/10.1016/0896-6273(92)90245-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1419001				2022-12-28	WOS:A1992JY55200012
J	GORDON, SE; BRAUTIGAN, DL; ZIMMERMAN, AL				GORDON, SE; BRAUTIGAN, DL; ZIMMERMAN, AL			PROTEIN PHOSPHATASES MODULATE THE APPARENT AGONIST AFFINITY OF THE LIGHT-REGULATED ION CHANNEL IN RETINAL RODS	NEURON			English	Article							GMP-ACTIVATED CHANNEL; CGMP-DEPENDENT CONDUCTANCE; CYCLIC-GMP; OUTER SEGMENTS; PHOSPHODIESTERASE ACTIVATION; PLASMA-MEMBRANE; VERTEBRATE PHOTORECEPTORS; CATALYTIC SUBUNIT; PHOSPHOPROTEIN PHOSPHATASES; RHODOPSIN PHOSPHORYLATION	Ion channels directly activated by cGMP mediate the light response in retinal rods. Several components of the enzyme cascade controlling cGMP concentration are regulated, but there are no accepted mechanisms for modulation of the response of the channel to cGMP. Here we report evidence that in excised patches an endogenous protein phosphatase converts the channel from a state with low cGMP sensitivity to a state with almost 3 orders of magnitude higher sensitivity in the predicted physiological range of cGMP concentration. The action of this endogenous phosphatase was blocked by specific serine/threonine phosphatase inhibitors (microcystin-LR, okadaic acid, and calyculin A). An increase in apparent agonist affinity also was produced by addition of purified protein phosphatase 1. In contrast, protein phosphatase 2A decreased apparent agonist affinity, suggesting that two phosphorylation sites may regulate the agonist sensitivity of the channel in a reciprocal manner. This regulation may be involved in fine-tuning the light response or in light or dark adaptation.	BROWN UNIV,BIOCHEM SECT,PROVIDENCE,RI 02912	Brown University	GORDON, SE (corresponding author), BROWN UNIV,PHYSIOL SECT,PROVIDENCE,RI 02912, USA.				NATIONAL EYE INSTITUTE [R01EY007774] Funding Source: NIH RePORTER; NEI NIH HHS [EY-07774] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARSHAVSKY VY, 1991, J BIOL CHEM, V266, P18530; ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BIERNBAUM MS, 1991, VISUAL NEUROSCI, V7, P499, DOI 10.1017/S0952523800009780; BINDER BM, 1989, J BIOL CHEM, V264, P8857; BRAUTIGAN DL, 1985, J BIOL CHEM, V260, P4295; BRAUTIGAN DL, 1989, ARCH BIOCHEM BIOPHYS, V275, P44, DOI 10.1016/0003-9861(89)90348-2; CERVETTO L, 1988, J PHYSIOL-LONDON, V406, P181, DOI 10.1113/jphysiol.1988.sp017375; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COLAMARTINO G, 1991, J PHYSIOL-LONDON, V440, P189, DOI 10.1113/jphysiol.1991.sp018703; CORSON DW, 1990, P NATL ACAD SCI USA, V87, P6823, DOI 10.1073/pnas.87.17.6823; COTE RH, 1986, J BIOL CHEM, V261, P2965; DETWILER PB, 1992, IN PRESS CURR OPIN N; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; ERTEL EA, 1990, P NATL ACAD SCI USA, V87, P4226, DOI 10.1073/pnas.87.11.4226; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FAIN GL, 1990, TRENDS NEUROSCI, V13, P378, DOI 10.1016/0166-2236(90)90023-4; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FILATOV GN, 1989, FEBS LETT, V245, P185, DOI 10.1016/0014-5793(89)80218-2; FOWLES C, 1989, BIOCHEMISTRY-US, V28, P9385, DOI 10.1021/bi00450a020; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; GRUPPUSO PA, 1989, AM J PHYSIOL, V256, pE49, DOI 10.1152/ajpendo.1989.256.1.E49; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMM H, 1990, J GEN PHYSIOL, V95, P545, DOI 10.1085/jgp.95.3.545; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; Hille B., 1992, IONIC CHANNELS EXCIT; HONKANEN RE, 1990, J BIOL CHEM, V265, P19401; ILDEFONSE M, 1991, J MEMBRANE BIOL, V123, P133, DOI 10.1007/BF01998084; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; LAMB TD, 1980, NATURE, V287, P349, DOI 10.1038/287349a0; LAMB TD, 1987, J OPT SOC AM A, V4, P2295, DOI 10.1364/JOSAA.4.002295; LAMB TD, 1990, NEUROSCIENCES, V2, P3; LEE RH, 1991, INVEST OPHTH VIS SCI, V32, P1054; LEVITAN IB, 1988, ANNU REV NEUROSCI, V11, P119, DOI 10.1146/annurev.neuro.11.1.119; LIEBMAN PA, 1980, NATURE, V287, P734, DOI 10.1038/287734a0; MARGOLIS RN, 1987, ADV PROT PHOSPHATASE, V4, P1; MATTHEWS G, 1987, J PHYSIOL-LONDON, V389, P691, DOI 10.1113/jphysiol.1987.sp016678; MCNAUGHTON PA, 1990, PHYSIOL REV, V70, P847, DOI 10.1152/physrev.1990.70.3.847; MILLER JL, 1986, BIOCHEMISTRY-US, V25, P4983, DOI 10.1021/bi00366a002; MILLER WH, 1990, INVEST OPHTH VIS SCI, V31, P1664; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P415, DOI 10.1021/bi00428a001; PUGH EN, 1990, VISION RES, V30, P1923, DOI 10.1016/0042-6989(90)90013-B; REINHART PH, 1991, J NEUROSCI, V11, P1627; RISPOLI G, 1992, IN PRESS SIGNAL TRAN; SITARAMAYYA A, 1983, J BIOL CHEM, V258, P1205; STERN JH, 1986, P NATL ACAD SCI USA, V83, P1163, DOI 10.1073/pnas.83.4.1163; STRYER L, 1991, J BIOL CHEM, V266, P10711; USUI H, 1983, J BIOL CHEM, V258, P455; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Yau K W, 1991, Curr Opin Neurobiol, V1, P252, DOI 10.1016/0959-4388(91)90086-M; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; YAU KW, 1985, NATURE, V317, P252, DOI 10.1038/317252a0; YOSHIZAWA S, 1990, J CANCER RES CLIN, V116, P609, DOI 10.1007/BF01637082; ZIMMERMAN AL, 1985, P NATL ACAD SCI USA, V82, P8813, DOI 10.1073/pnas.82.24.8813; ZIMMERMAN AL, 1992, J PHYSIOL-LONDON, V449, P759, DOI 10.1113/jphysiol.1992.sp019112; ZIMMERMAN AL, 1986, NATURE, V321, P70, DOI 10.1038/321070a0; ZIMMERMAN AL, 1988, BIOPHYS J, V54, P351, DOI 10.1016/S0006-3495(88)82966-7	62	125	125	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					739	748		10.1016/0896-6273(92)90036-D	http://dx.doi.org/10.1016/0896-6273(92)90036-D			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1382474				2022-12-28	WOS:A1992JT51600014
J	SHYJAN, AW; DESAUVAGE, FJ; GILLETT, NA; GOEDDEL, DV; LOWE, DG				SHYJAN, AW; DESAUVAGE, FJ; GILLETT, NA; GOEDDEL, DV; LOWE, DG			MOLECULAR-CLONING OF A RETINA-SPECIFIC MEMBRANE GUANYLYL CYCLASE	NEURON			English	Article							NATRIURETIC PEPTIDE RECEPTOR; HEAT-STABLE ENTEROTOXIN; ROD OUTER SEGMENTS; ESCHERICHIA-COLI; ACTIVITY REQUIRES; ENZYME SUBUNITS; PORCINE BRAIN; EXPRESSION; ATRIAL; ACTIVATION	We have isolated and characterized cDNA clones encoding the human retinal guanylyl cyclase (retGC), a novel member of the membrane guanylyl cyclase gene family. Like other membrane guanylyl cyclases,the 1101 aa retGC is predicted to have a hydrophobic amino-terminal signal sequence followed by a large extracellular domain, a single membrane spanning domain, a kinase homology domain, and a guanylyl cyclase catalytic domain. In contrast to other membrane guanylyl cyclases, such as natriuretic peptide receptors, retGC has a relatively high basal level of activity when expressed in human 293 cells. cGMP production by retGC is unaffected by any of the known natriuretic peptides. In situ hybridization analysis of a variety of rhesus monkey tissues showed retGC transcripts to be localized exclusively along the retinal outer nuclear layer, corresponding to the nuclei of the rod and cone photoreceptor cells. Our results suggest that retGC may synthesize cGMP required for recovery of the dark state after phototransduction.	GENENTECH INC,DEPT SAFETY EVALUAT,SAN FRANCISCO,CA 94080	Roche Holding; Genentech	SHYJAN, AW (corresponding author), GENENTECH INC,DEPT MOLEC BIOL,460 POINT SAN BRUNO BLVD,SAN FRANCISCO,CA 94080, USA.		de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584				BENNETT BD, 1991, J BIOL CHEM, V266, P23060; BRANN MR, 1986, FEBS LETT, V200, P275, DOI 10.1016/0014-5793(86)81151-6; BUECHLER WA, 1991, BIOCHEM BIOPH RES CO, V174, P351, DOI 10.1016/0006-291X(91)90527-E; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DESAUVAGE FJ, 1991, J BIOL CHEM, V266, P17912; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; EMANUEL JR, 1988, J BIOL CHEM, V263, P7726; FLEISCHMAN D, 1979, BIOCHEMISTRY-US, V18, P5060, DOI 10.1021/bi00590a006; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; HAKKI S, 1990, BIOCHEMISTRY-US, V29, P1088, DOI 10.1021/bi00456a035; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARTENECK C, 1991, FEBS LETT, V292, P217, DOI 10.1016/0014-5793(91)80871-Y; HARTENECK C, 1990, FEBS LETT, V272, P221, DOI 10.1016/0014-5793(90)80489-6; HAYASHI F, 1991, P NATL ACAD SCI USA, V88, P4746, DOI 10.1073/pnas.88.11.4746; IGNARRO LJ, 1990, PHARMACOL TOXICOL, V67, P1, DOI 10.1111/j.1600-0773.1990.tb00772.x; INAGAMI T, 1989, J BIOL CHEM, V264, P3043; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; KOESLING D, 1990, FEBS LETT, V266, P128, DOI 10.1016/0014-5793(90)81523-Q; KOESLING D, 1988, FEBS LETT, V239, P29, DOI 10.1016/0014-5793(88)80539-8; KOLLER KJ, 1992, MOL CELL BIOL, V12, P2581, DOI 10.1128/MCB.12.6.2581; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; KUNO T, 1986, J BIOL CHEM, V261, P1470; LAMBRECHT HG, 1991, EMBO J, V10, P793, DOI 10.1002/j.1460-2075.1991.tb08011.x; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; LOWE DG, 1990, NUCLEIC ACIDS RES, V18, P3412, DOI 10.1093/nar/18.11.3412; NAKANE M, 1990, J BIOL CHEM, V265, P16841; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; SCHULZ S, 1989, FASEB J, V3, P2026, DOI 10.1096/fasebj.3.9.2568301; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SINGH S, 1988, NATURE, V334, P708, DOI 10.1038/334708a0; STRYER L, 1991, J BIOL CHEM, V266, P10711; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; TOHDA M, 1991, J NEUROCHEM, V57, P714, DOI 10.1111/j.1471-4159.1991.tb03804.x; TREISMAN JE, 1988, MOL CELL BIOL, V8, P1570, DOI 10.1128/MCB.8.4.1570; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; WALDMAN SA, 1986, INFECT IMMUN, V51, P320, DOI 10.1128/IAI.51.1.320-326.1986; WILCOX JN, 1991, MOL CELL BIOL, V11, P3454, DOI 10.1128/MCB.11.7.3454; YUEN PST, 1992, ANNU REV NEUROSCI, V15, P193	48	205	207	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					727	737		10.1016/0896-6273(92)90035-C	http://dx.doi.org/10.1016/0896-6273(92)90035-C			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1356371				2022-12-28	WOS:A1992JT51600013
J	FOSTER, CD; CHUNG, SK; ZAGOTTA, WN; ALDRICH, RW; LEVITAN, IB				FOSTER, CD; CHUNG, SK; ZAGOTTA, WN; ALDRICH, RW; LEVITAN, IB			A PEPTIDE DERIVED FROM THE SHAKER-B K+ CHANNEL PRODUCES SHORT AND LONG BLOCKS OF RECONSTITUTED CA2+-DEPENDENT K+ CHANNELS	NEURON			English	Article							ACTIVATED POTASSIUM CHANNELS; CHARYBDOTOXIN BLOCK; INACTIVATION GATE; LIPID BILAYERS; RAT-BRAIN; DROSOPHILA; LOCUS; MECHANISMS; MODULATION; COMPONENT	A 20 amino acid synthetic peptide, corresponding to the amino-terminal region of the Shaker B (ShB) K+ channel and responsible for its fast inactivation, can block large conductance Ca2+-dependent K+ channels from rat brain and muscle. The ShB inactivation peptide produces two kinetically distinct blocking events in these channels. At lower concentrations, it produces short blocks, and at higher concentrations long-lived blocks also appear. The L7E mutant peptide produces only infrequent short blocks (no long-lived blocks) at a much higher concentration. Internal tetraethylammonium competes with the peptide for the short block, which is also relieved by K+ influx. These results suggest that the peptide induces the short block by binding within the pore of Ca2+-dependent K+ channels. The long block is not affected by increased K+ influx, indicating that the binding site mediating this block may be different from that involved in the short block. The short block of Ca2+-dependent K+ channels and the inactivation of Shaker exhibit similar characteristics with respect to blocking affinity and open pore blockade. This suggests a conserved binding region for the peptide in the pore regions of these very different classes of K+ channel.	BRANDEIS UNIV,CTR COMPLEX SYST,WALTHAM,MA 02254; STANFORD UNIV,MED CTR,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305	Brandeis University; Howard Hughes Medical Institute; Stanford University; Stanford University	FOSTER, CD (corresponding author), BRANDEIS UNIV,GRAD DEPT BIOCHEM,WALTHAM,MA 02254, USA.				NINDS NIH HHS [NS17910, NS23294] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017910, R01NS023294] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; LANCASTER B, 1991, J NEUROSCI, V11, P23; LECHLEITER JD, 1988, NEURON, V1, P227, DOI 10.1016/0896-6273(88)90143-2; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MAUE RA, 1987, J GEN PHYSIOL, V90, P95, DOI 10.1085/jgp.90.1.95; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; REINHART PH, 1991, J NEUROSCI, V11, P1627; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TORO L, 1990, J GEN PHYSIOL, V96, P373, DOI 10.1085/jgp.96.2.373; TORO L, 1992, NEURON, V9, P237, DOI 10.1016/0896-6273(92)90163-8; VERGARA C, 1984, BIOPHYS J, V45, P73, DOI 10.1016/S0006-3495(84)84114-4; VILLARROEL A, 1988, PFLUG ARCH EUR J PHY, V413, P118, DOI 10.1007/BF00582521; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	25	51	51	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					229	236		10.1016/0896-6273(92)90162-7	http://dx.doi.org/10.1016/0896-6273(92)90162-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1497892				2022-12-28	WOS:A1992JJ33200005
J	SMITH, KE; BORDEN, LA; HARTIG, PR; BRANCHEK, T; WEINSHANK, RL				SMITH, KE; BORDEN, LA; HARTIG, PR; BRANCHEK, T; WEINSHANK, RL			CLONING AND EXPRESSION OF A GLYCINE TRANSPORTER REVEAL COLOCALIZATION WITH NMDA RECEPTORS	NEURON			English	Article							PLASMA-MEMBRANE VESICLES; AMINO-ACIDS; SPINAL-CORD; RAT; BRAIN; MOUSE; CELLS; GENE	A complementary DNA clone encoding a transporter for glycine has been isolated from rat brain, and its functional properties have been examined in mammalian cells. The transporter displays high affinity for glycine (K(M) almost-equal-to 100-mu-M) and is dependent on external Na+ and Cl-. Northern blot analysis indicates that the distribution of the mRNA encoding the glycine transporter is restricted to the nervous system. In situ hybridization data are consistent with roles for the transporter in both glycine neurotransmission and glycine modulation of N-methyl-D-aspartate (NMDA) receptors in the hippocampus. The identification of this transporter therefore opens the study of the molecular mechanisms underlying both inhibitory glycinergic transmission and NMDA-mediated excitatory transmission.			SMITH, KE (corresponding author), SYNAPT PHARMACEUT CORP,215 COLL RD,PARAMUS,NJ 07652, USA.							Aprison M. H., 1990, GLYCINE NEUROTRANSMI, P1; BECKER CM, 1990, FASEB J, V4, P2767, DOI 10.1096/fasebj.4.10.2165011; BENNETT JP, 1974, LIFE SCI, V15, P1045, DOI 10.1016/S0024-3205(74)80002-0; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; CHRISTENSEN HN, 1984, BIOCHIM BIOPHYS ACTA, V779, P255, DOI 10.1016/0304-4157(84)90012-1; CHRISTENSEN HN, 1981, BIOCHEM BIOPH RES CO, V98, P102, DOI 10.1016/0006-291X(81)91875-1; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; CORTES R, 1990, GLYCINE TRANSMISSION, P240; DALY EC, 1990, GLYCINE NEUROTRANSMI, P25; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELIPE A, 1990, BIOSCIENCE REP, V10, P209, DOI 10.1007/BF01116580; FLETCHER EJ, 1990, GLYCINE NEUROTRANSMI, P193; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; GUNDLACH AL, 1990, FASEB J, V4, P2761, DOI 10.1096/fasebj.4.10.2165010; HANDELMANN GE, 1989, PHARMACOL BIOCHEM BE, V34, P823, DOI 10.1016/0091-3057(89)90281-5; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; HORN AS, 1990, PROG NEUROBIOL, V34, P387, DOI 10.1016/0301-0082(90)90033-D; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KAYANO T, 1990, J BIOL CHEM, V265, P13276; KILTY JE, 1991, SCIENCE, V254, P578, DOI 10.1126/science.1948035; KUMAR KN, 1991, NATURE, V354, P70, DOI 10.1038/354070a0; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; LOPEZCORCUERA B, 1989, EUR J BIOCHEM, V181, P519, DOI 10.1111/j.1432-1033.1989.tb14754.x; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; MAYOR F, 1981, BIOCHEM J, V198, P535, DOI 10.1042/bj1980535; MONOGHAN DT, 1990, GLYCINE TRANSMISSION, P219; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MOSELEY RH, 1988, AM J PHYSIOL, V255, pG253, DOI 10.1152/ajpgi.1988.255.2.G253; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIMADA S, 1991, SCIENCE, V254, P576, DOI 10.1126/science.1948034; VANDENPOL AN, 1988, J NEUROSCI, V8, P472; ZAFRA F, 1989, BIOCHEM J, V258, P403, DOI 10.1042/bj2580403	36	389	399	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					927	935		10.1016/0896-6273(92)90207-T	http://dx.doi.org/10.1016/0896-6273(92)90207-T			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1534013				2022-12-28	WOS:A1992HV46700012
J	SAKMANN, B				SAKMANN, B			ELEMENTARY STEPS IN SYNAPTIC TRANSMISSION REVEALED BY CURRENTS THROUGH SINGLE ION CHANNELS	NEURON			English	Article											SAKMANN, B (corresponding author), MAX PLANCK INST MED RES, ZELLPHYSIOL ABT, W-6900 HEIDELBERG 1, GERMANY.							ANDERSON CR, 1973, J PHYSIOL-LONDON, V235, P655, DOI 10.1113/jphysiol.1973.sp010410; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P227; ATKINS PW, 1983, PRINCIPLES PHYSICAL; AXELSSON J, 1959, J PHYSIOL-LONDON, V147, P178, DOI 10.1113/jphysiol.1959.sp006233; BETZ H, 1990, BIOCHEMISTRY-US, V29, P3591, DOI 10.1021/bi00467a001; BETZ W, 1973, J PHYSIOL-LONDON, V230, P673, DOI 10.1113/jphysiol.1973.sp010211; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BUSCH C, 1990, COLD SH Q B, V55, P69; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COLQUHOUN D, 1977, PROC R SOC SER B-BIO, V199, P231, DOI 10.1098/rspb.1977.0137; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V446, pP183; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; ECCLES JC, 1963, PRIX NOBEL 1963, P261; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FRANKE C, 1987, NEUROSCI LETT, V77, P199, DOI 10.1016/0304-3940(87)90586-6; HAMILL OP, 1983, NATURE, V305, P805, DOI 10.1038/305805a0; HAMILL OP, 1981, NATURE, V294, P462, DOI 10.1038/294462a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B, 1984, IONIC CHANNELS EXCIT; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JONAS P, 1992, J PHYSIOL-LONDON, V446, pP515; JONAS P, 1992, IN PRES SJ PHYSL; KARLIN A, 1991, HARVEY LECT, V85, P71; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; KATZ B, 1969, SHERRINGTON LECTURES, V10; Katz B., 1966, NERVE MUSCLE SYNAPSE; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KHODOROVA A, 1992, J PHYSIOL-LONDON, V446, pP516; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MICHLER A, 1980, DEV BIOL, V80, P1, DOI 10.1016/0012-1606(80)90494-7; Miledi R., 1989, FIDIA RES FDN NEUROS, VVolume 3, P57; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; NEHER E, 1978, PFLUG ARCH EUR J PHY, V375, P219, DOI 10.1007/BF00584247; NEHER E, 1976, NATURE, V253, P705; NEHER E, 1991, PRIX NOBEL 1991; NUMA S, 1989, HARVEY LECT, V83, P121; NUMBERGER M, 1991, EMBO J, V10, P2957, DOI 10.1002/j.1460-2075.1991.tb07846.x; SAKMANN B, 1978, NATURE, V276, P401, DOI 10.1038/276401a0; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; SAKMANN B, 1985, NATURE, V318, P538, DOI 10.1038/318538a0; SAKMANN B, 1989, Q J EXP PHYSIOL CMS, V74, P1107, DOI 10.1113/expphysiol.1989.sp003336; SAKMANN B, 1983, J NEURAL TRANSM, P83; SAKMANN B, 1992, FIDIA RES F NEUROSCI, V6, P53; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERN P, 1992, IN PRESS J PHYSL; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; VILLARROEL A, 1992, BIOPHYS J, V62, P196, DOI 10.1016/S0006-3495(92)81805-2; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; WITZEMANN V, 1987, FEBS LETT, V223, P104, DOI 10.1016/0014-5793(87)80518-5; WITZEMANN V, 1989, FEBS LETT, V242, P419, DOI 10.1016/0014-5793(89)80514-9; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125; WITZEMANN V, 1991, FEBS LETT, V282, P259, DOI 10.1016/0014-5793(91)80490-T; WITZEMANN V, 1990, EUR J BIOCHEM, V194, P437, DOI 10.1111/j.1432-1033.1990.tb15637.x	70	25	25	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1992	8	4					613	629		10.1016/0896-6273(92)90084-Q	http://dx.doi.org/10.1016/0896-6273(92)90084-Q			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1373631				2022-12-28	WOS:A1992HQ18800002
J	KAVANAUGH, MP; HURST, RS; YAKEL, J; VARNUM, MD; ADELMAN, JP; NORTH, RA				KAVANAUGH, MP; HURST, RS; YAKEL, J; VARNUM, MD; ADELMAN, JP; NORTH, RA			MULTIPLE SUBUNITS OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL CONTRIBUTE TO THE BINDING-SITE FOR TETRAETHYLAMMONIUM	NEURON			English	Article							SENSITIVE ION CHANNELS; XENOPUS OOCYTES	RNAs encoding a wild-type (RBK1) and a mutant (RBK1(Y379V,V381T);RBK1*) subunit of voltage-dependent potassium channels were injected into Xenopus oocytes. When expressed separately, they made homotetrameric channels that differed about 100-fold in sensitivity to tetraethylammonium (TEA). Mixtures of channels having one, two, or three low affinity subunits were expressed by injecting various proportions of RBK1 and RBK1* RNAs. The affinity for TEA of these three channel species was deduced by fitting concentration-response curves for the inhibition of potassium currents. DNAs were also concatenated to construct a sequence that encoded two connected subunits, and channels that contained four, two, or no TEA-sensitive subunits were expressed. The results suggest that bound TEA interacts simultaneously with all four subunits.			KAVANAUGH, MP (corresponding author), OREGON HLTH SCI UNIV,INST VOLLUM,PORTLAND,OR 97201, USA.		North, Richard/GQA-6156-2022	Yakel, Jerrel/0000-0001-5463-674X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003160, R37DA003160] Funding Source: NIH RePORTER; NIDA NIH HHS [DA03160] Funding Source: Medline; NINDS NIH HHS [NS28504] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HILLE B, 1967, J GEN PHYSIOL, V50, P1287, DOI 10.1085/jgp.50.5.1287; HURST RS, 1991, MOL PHARMACOL, V40, P572; ISAACOFF EY, 1990, NATURE, V345, P530; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; STANFIELD PR, 1983, REV PHYSIOL BIOCH P, V97, P1, DOI 10.1007/BFb0035345; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	19	138	139	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					493	497		10.1016/0896-6273(92)90277-K	http://dx.doi.org/10.1016/0896-6273(92)90277-K			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550674				2022-12-28	WOS:A1992HK67500009
J	GROVE, EA; KIRKWOOD, TBL; PRICE, J				GROVE, EA; KIRKWOOD, TBL; PRICE, J			NEURONAL PRECURSOR CELLS IN THE RAT HIPPOCAMPAL-FORMATION CONTRIBUTE TO MORE THAN ONE CYTOARCHITECTONIC AREA	NEURON			English	Article							MEDIATED GENE-TRANSFER; CEREBRAL-CORTEX; RECOMBINANT RETROVIRUS; MONOCLONAL-ANTIBODY; MIGRATION PATTERNS; CORTICAL AREAS; LINEAGE; MONKEY; ORGANIZATION; CONNECTIONS	We have tested the hypothesis that cell lineage restriction boundaries define the borders between cytoarchitectonic areas in the cerebral cortex. Clonally related cells were identified using a retroviral marking technique, and the dispersion of neuronal clones was examined with respect to the transitions between cortical areas. We chose to study the hippocampal formation because we found that clones of hippocampal neurons, unlike those in neocortex, are compact and readily identifiable in the adult and that transitions between areas in the hippocampus are sharp relative to the spread of a typical clone. We conclude, contrary to the hypothesis, that clones of neurons transgress the boundaries between areas in the hippocampal formation, that border-crossing clones are observed as frequently as would be expected if clones spread freely over the hippocampus with no constraint imposed by area borders, and that different types of pyramidal neurons, characteristic of different areas, may appear in a single clone.			GROVE, EA (corresponding author), NATL INST MED RES,RIDGEWAY,MILL HILL,LONDON NW7 1AA,ENGLAND.		Price, Jack/G-9510-2011					ALTMAN J, 1990, J COMP NEUROL, V301, P343, DOI 10.1002/cne.903010303; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; AUSTIN CP, 1990, DEVELOPMENT, V110, P713; BARBE MF, 1991, J NEUROSCI, V11, P519; Bayer S.A, 1985, RAT NERVOUS SYSTEM, V1, P335; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; BEDDINGTON RSP, 1989, DEVELOPMENT, V106, P37; BLACKSTAD TW, 1956, J COMP NEUROL, V105, P417, DOI 10.1002/cne.901050305; BRADY DR, 1991, J COMP NEUROL, V305, P489, DOI 10.1002/cne.903050311; Brodmann K, 1909, VERGLEICHENDE LOKALI; CHANG FLF, 1986, J COMP NEUROL, V244, P401, DOI 10.1002/cne.902440311; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; GOLDOWITZ D, 1989, NEURON, V3, P705, DOI 10.1016/0896-6273(89)90239-0; HAUG FMS, 1973, ADV ANAT EMBRYOL CEL, V47, P1; JHAVERI S, 1991, P NATL ACAD SCI USA, V88, P4489, DOI 10.1073/pnas.88.10.4489; LEVITT P, 1984, SCIENCE, V223, P299, DOI 10.1126/science.6199842; LORENTEDENO R, 1949, PHYSIOLOGY NERVOUS S, P288; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; Nauta W., 1986, FUNDAMENTAL NEUROANA; OLEARY DDM, 1989, J NEUROSCI, V9, P2230; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PRICE J, 1992, BRAIN PATHOL, V2, P23; PRICE J, 1988, DEVELOPMENT, V104, P473; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1978, POSTGRAD MED J, V54, P25; Rosene D. L., 1987, CEREB CORTEX, V6, P345, DOI DOI 10.1007/978-1-4615-6616-8_9; SANES JR, 1989, TRENDS NEUROSCI, V12, P21, DOI 10.1016/0166-2236(89)90152-5; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; van Essen D.C., 1985, P259; VEAZEY RB, 1982, J COMP NEUROL, V207, P135, DOI 10.1002/cne.902070204; WAECHTER RV, 1972, BRAIN RES, V46, P235, DOI 10.1016/0006-8993(72)90018-2; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WISE SP, 1978, J COMP NEUROL, V178, P187, DOI 10.1002/cne.901780202; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; WOODHAMS PL, 1989, J NEUROSCI, V9, P2170; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0; Zilles K., 1985, RAT NERVOUS SYSTEM F, V1, P375; ZIMMER J, 1978, J COMP NEUROL, V179, P581, DOI 10.1002/cne.901790309	46	39	39	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1992	8	2					217	229		10.1016/0896-6273(92)90289-P	http://dx.doi.org/10.1016/0896-6273(92)90289-P			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1739459				2022-12-28	WOS:A1992HE93000003
J	LEE, CJ; DAYANITHI, G; NORDMANN, JJ; LEMOS, JR				LEE, CJ; DAYANITHI, G; NORDMANN, JJ; LEMOS, JR			POSSIBLE ROLE DURING EXOCYTOSIS OF A CA2+-ACTIVATED CHANNEL IN NEUROHYPOPHYSEAL GRANULES	NEURON			English	Article							PEPTIDERGIC NERVE-TERMINALS; SECRETORY GRANULES; GAP-JUNCTIONS; ION CHANNELS; PHOSPHOLIPID-VESICLES; SYNAPTIC VESICLES; HORMONE-RELEASE; PLANAR BILAYER; FUSION EVENTS; PATCH-CLAMP	Ion channels from bovine neurohypophysial granules were incorporated into artificial lipid bilayers. The larger amplitude channel is permeable to cations and exhibits multiple conductances. The channel opens only in the presence of free Ca2+, but is inhibited by relatively high Ca2+ concentrations. Release of vasopressin from permeabilized neurohypophysial terminals also shows a similar biphasic dependence on Ca2+. Release is selectively inhibited by low concentrations of the long-chain alcohol octanol, but not by high concentrations of ethanol, as is the neurosecretory granule Ca2+-activated cation channel. Furthermore, Ca2+-evoked release and channel activity are both inhibited by the long-chain tetraethylammonium analogs decamethonium and decyl-triethyl ammonium bromide. The close correlation between channel and release properties lead us to conclude that the Ca2+-activated channel is involved in peptide secretion.	WORCESTER FDN EXPTL BIOL INC,SHREWSBURY,MA 01545; CNRS,CTR NEUROCHIM,F-67084 STRASBOURG,FRANCE	Worcester Foundation for Biomedical Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			Dayanithi, Govindan/H-3131-2014; Dayanithi, Govindan/F-6068-2016	Dayanithi, Govindan/0000-0002-1009-7809; Dayanithi, Govindan/0000-0002-1009-7809	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029470] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29470] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; ALMERS W, 1990, ANNU REV PHYSIOL, V52, P607, DOI 10.1146/annurev.ph.52.030190.003135; AMMANN D, 1987, PFLUG ARCH EUR J PHY, V409, P223, DOI 10.1007/BF00583469; ARMSTRONG CM, 1975, QUART REV BIOPH, V7, P179; AUGUSTINE GJ, 1988, J PHYSIOL-LONDON, V398, P149, DOI 10.1113/jphysiol.1988.sp017035; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; BRECKENRIDGE LJ, 1987, P NATL ACAD SCI USA, V84, P1945, DOI 10.1073/pnas.84.7.1945; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; BRETHES D, 1987, P NATL ACAD SCI USA, V84, P1439, DOI 10.1073/pnas.84.5.1439; CAZALIS M, 1987, J PHYSIOL-LONDON, V390, P71, DOI 10.1113/jphysiol.1987.sp016687; CAZALIS M, 1985, J PHYSIOL-LONDON, V369, P45, DOI 10.1113/jphysiol.1985.sp015887; COHEN FS, 1982, SCIENCE, V217, P458, DOI 10.1126/science.6283637; COHEN FS, 1984, J CELL BIOL, V98, P1054, DOI 10.1083/jcb.98.3.1054; CORONADO R, 1983, BIOPHYS J, V43, P231, DOI 10.1016/S0006-3495(83)84343-4; CORONADO R, 1986, ANNU REV BIOPHYS BIO, V15, P259; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DOUGLASS WW, 1964, J PHYSIOL-LONDON, V172, P1; FEINSTEIN A, 1986, ANN REV PHYSL, V48, P163; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; FOHR KJ, 1992, IN PRESS METH ENZYMO; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; LATORRE R, 1985, ANNU REV BIOPHYS BIO, V14, P79, DOI 10.1146/annurev.biophys.14.1.79; LEMOS JR, 1989, NEURON, V2, P1419, DOI 10.1016/0896-6273(89)90187-6; LEMOS JR, 1986, NATURE, V319, P410, DOI 10.1038/319410a0; LEMOS JR, 1986, J EXP BIOL, V124, P53; LEMOS JR, 1989, SECRETION ITS CONTRO, P334; LOEWENSTEIN WR, 1987, CELL, V48, P725, DOI 10.1016/0092-8674(87)90067-5; LOWE AW, 1988, J CELL BIOL, V106, P51, DOI 10.1083/jcb.106.1.51; MA J, 1988, SCIENCE, V242, P99, DOI 10.1126/science.2459777; NARAHASHI T, 1991, ANN NY ACAD SCI, V625, P26, DOI 10.1111/j.1749-6632.1991.tb33827.x; NEYTON J, 1985, NATURE, V317, P731; NORDMANN JJ, 1979, NEUROSCIENCE, V4, P1367, DOI 10.1016/0306-4522(79)90164-7; NORDMANN JJ, 1986, J NEUROCHEM, V47, P1534, DOI 10.1111/j.1471-4159.1986.tb00791.x; RAHAMIMOFF R, 1988, P NATL ACAD SCI USA, V85, P5310, DOI 10.1073/pnas.85.14.5310; RAMON F, 1986, PROG BIOPHYS MOL BIO, V48, P127, DOI 10.1016/0079-6107(86)90010-6; SHAHIN SH, 1989, AM J PHYSIOL, pC658; SHERMAN D, 1982, P NATL ACAD SCI USA, V79, P476; SHERMAN D, 1982, BIOCHEMISTRY-US, V21, P687; SILLEN LG, 1971, CHEM SOC LOND S, V1, P1; SPRAY DC, 1985, ANNU REV PHYSIOL, V47, P281, DOI 10.1146/annurev.ph.47.030185.001433; SPRAY DC, 1986, P NATL ACAD SCI USA, V83, P3533, DOI 10.1073/pnas.83.10.3533; SPRUCE AE, 1989, NATURE, V342, P555, DOI 10.1038/342555a0; STANLEY EF, 1988, NEUROSCIENCE, V25, P1035, DOI 10.1016/0306-4522(88)90056-5; STUENKEL EL, 1990, BRAIN RES, V529, P96, DOI 10.1016/0006-8993(90)90815-S; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; VEENSTRA RD, 1986, SCIENCE, V233, P972, DOI 10.1126/science.2426781; WANG G, 1992, IN PRESS J PHYSL; WANG XM, 1991, BRAIN RES, V551, P338, DOI 10.1016/0006-8993(91)90954-T; WOODBURY DJ, 1988, BIOPHYS J, V54, P1053, DOI 10.1016/S0006-3495(88)83042-X; WOODBURY DJ, 1989, J MEMBRANE BIOL, V109, P145, DOI 10.1007/BF01870853; YOUNG JDE, 1987, CELL, V48, P733, DOI 10.1016/0092-8674(87)90071-7; ZIMMERBERG J, 1987, P NATL ACAD SCI USA, V84, P1585, DOI 10.1073/pnas.84.6.1585	54	31	31	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1992	8	2					335	342		10.1016/0896-6273(92)90299-S	http://dx.doi.org/10.1016/0896-6273(92)90299-S			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1310862				2022-12-28	WOS:A1992HE93000013
J	ERNFORS, P; BENGZON, J; KOKAIA, Z; PERSSON, H; LINVALL, O				ERNFORS, P; BENGZON, J; KOKAIA, Z; PERSSON, H; LINVALL, O			INCREASED LEVELS OF MESSENGER-RNAS FOR NEUROTROPHIC FACTORS IN THE BRAIN DURING KINDLING EPILEPTOGENESIS	NEURON			English	Article							NERVE GROWTH-FACTOR; CHOLINE-ACETYLTRANSFERASE ACTIVITY; RAT HIPPOCAMPAL-FORMATION; PREVENTS NEURONAL DEATH; AMINO-ACID RECEPTORS; METHYL-D-ASPARTATE; BASAL FOREBRAIN; SYNAPTIC REORGANIZATION; REGIONAL DISTRIBUTION; MOLECULAR-CLONING	Kindling, induced by repeated subconvulsive electrical or chemical stimulations leads to progressive and permanent amplification of seizure activity, culminating in generalized seizures. We report that kindling induced by electrical stimulation in the ventral hippocampus leads to a marked and transient increase of mRNA for NGF and BDNF in the dentate gyrus, the parietal cortex, and the piriform cortex. BDNF mRNA increased also in the pyramidal layer of hippocampus and in the amygdaloid complex. No change was seen in the level of HDNF/NT-3 mRNA. The increased expression of NGF and BDNF mRNAs was not influenced by pretreatment with the NMDA receptor antagonist MK801, but was partially blocked by the quisqualate, AMPA receptor antagonist NBQX. The presumed subsequent increase of the trophic factors themselves may be important for kindling-associated plasticity in specific neuronal systems in the hippocampus, which could promote hyperexcitability and contribute to the development of epileptic syndromes.	UNIV LUND HOSP, DEPT NEUROL, RESTORAT NEUROL UNIT, S-22185 LUND, SWEDEN	Lund University; Skane University Hospital	ERNFORS, P (corresponding author), KAROLINSKA INST, DEPT MED BIOCHEM, MOLEC NEUROBIOL LAB, S-10401 STOCKHOLM 60, SWEDEN.		Kokaia, Zaal/AAL-6009-2020	Kokaia, Zaal/0000-0003-2296-2449; Bengzon, Johan/0000-0001-6536-2107	NIA NIH HHS [AG 04418] Funding Source: Medline; NINDS NIH HHS [NS 09199] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS009199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BALLERIN M, 1991, IN PESS EXP NEUROL; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; CAIN DP, 1983, BRAIN RES, V260, P135, DOI 10.1016/0006-8993(83)90774-6; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; COLLINS F, 1985, J NEUROSCI, V5, P2809; CROUCHER MJ, 1989, BRAIN RES, V501, P58, DOI 10.1016/0006-8993(89)91026-3; CRUTCHER KA, 1987, BRAIN RES REV, V12, P203, DOI 10.1016/0165-0173(87)90013-0; DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700; DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4; Ebendal T, 1989, Prog Growth Factor Res, V1, P143, DOI 10.1016/0955-2235(89)90008-2; ERNFORS P, 1989, P NATL ACAD SCI USA, V86, P4756, DOI 10.1073/pnas.86.12.4756; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; FRIEDMAN WJ, 1991, IN PRESS J NEUROSCI; FRIEDMAN WJ, 1991, IN PRESS EUR J NEURO; FUNABASHI T, 1988, BRAIN RES, V458, P132, DOI 10.1016/0006-8993(88)90504-5; GALL C, 1991, MOL BRAIN RES, V9, P113, DOI 10.1016/0169-328X(91)90136-L; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GASTAUT H, 1975, EPILEPSIA, V16, P457, DOI 10.1111/j.1528-1157.1975.tb06073.x; GEINISMAN Y, 1988, P NATL ACAD SCI USA, V85, P3260, DOI 10.1073/pnas.85.9.3260; GILBERT ME, 1988, BRAIN RES, V463, P90, DOI 10.1016/0006-8993(88)90530-6; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; HAGG T, 1990, J NEUROSCI, V10, P3087; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEFTI F, 1984, BRAIN RES, V293, P305, DOI 10.1016/0006-8993(84)91237-X; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HONEGGER P, 1982, DEV BRAIN RES, V3, P229, DOI 10.1016/0165-3806(82)90023-2; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; IBANEZ C, 1991, IN PRESS EMBO J; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; KOKAIA M, 1989, BRAIN RES, V491, P398, DOI 10.1016/0006-8993(89)90079-6; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LOTHMAN EW, 1985, BRAIN RES, V360, P83, DOI 10.1016/0006-8993(85)91223-5; LU B, 1989, EXP NEUROL, V104, P191, DOI 10.1016/0014-4886(89)90029-0; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MARTINEZ HJ, 1987, BRAIN RES, V412, P295, DOI 10.1016/0006-8993(87)91136-X; MCNAMARA JO, 1988, NEUROPHARMACOLOGY, V27, P563, DOI 10.1016/0028-3908(88)90176-1; MCNAMARA JO, 1984, ANN NEUROL, V16, pS72, DOI 10.1002/ana.410160712; MESSENHEIMER JA, 1979, EXP NEUROL, V64, P469, DOI 10.1016/0014-4886(79)90225-5; MOBLEY WC, 1985, SCIENCE, V229, P284, DOI 10.1126/science.2861660; MOBLEY WC, 1989, NEURON, V3, P655, DOI 10.1016/0896-6273(89)90276-6; MORRELL F, 1986, KINDLING, V3, P17; MORRISETT RA, 1989, BRAIN RES, V496, P25, DOI 10.1016/0006-8993(89)91048-2; PETERSON DW, 1983, BRAIN RES, V275, P169, DOI 10.1016/0006-8993(83)90431-6; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; REPRESA A, 1989, NEUROSCI LETT, V99, P345, DOI 10.1016/0304-3940(89)90471-0; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SATO K, 1988, BRAIN RES, V463, P12, DOI 10.1016/0006-8993(88)90521-5; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; THOENEN H, 1987, REV PHYSIOL BIOCH P, V109, P145, DOI 10.1007/BFb0031026; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; WESTERBERG V, 1987, EXP NEUROL, V95, P194, DOI 10.1016/0014-4886(87)90017-3; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WHITTEMORE SR, 1987, BRAIN RES REV, V12, P439, DOI 10.1016/0165-0173(87)90008-7; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; YEH GC, 1989, P NATL ACAD SCI USA, V86, P8157, DOI 10.1073/pnas.86.20.8157; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; [No title captured]	75	548	560	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1991	7	1					165	176		10.1016/0896-6273(91)90084-D	http://dx.doi.org/10.1016/0896-6273(91)90084-D			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1829904				2022-12-28	WOS:A1991FY48100016
J	MCPHERSON, PS; KIM, YK; VALDIVIA, H; KNUDSON, CM; TAKEKURA, H; FRANZINIARMSTRONG, C; CORONADO, R; CAMPBELL, KP				MCPHERSON, PS; KIM, YK; VALDIVIA, H; KNUDSON, CM; TAKEKURA, H; FRANZINIARMSTRONG, C; CORONADO, R; CAMPBELL, KP			THE BRAIN RYANODINE RECEPTOR - A CAFFEINE-SENSITIVE CALCIUM RELEASE CHANNEL	NEURON			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CA-2+ RELEASE; NEURONS INVITRO; INOSITOL TRISPHOSPHATE; SYMPATHETIC NEURONS; MEMBRANES; PROTEINS; IDENTIFICATION; SOLUBILIZATION	The release of stored Ca2+ from intracellular pools triggers a variety of important neuronal processes. Physiological and pharmacological evidence has indicated the presence of caffeine-sensitive intracellular pools that are distinct from the well-characterized inositol 1,4,5,-trisphosphate (IP3)-gated pools. Here we report that the brain ryanodine receptor functions as a caffeine- and ryanodine-sensitive Ca2+ release channel that is distinct from the brain IP3 receptor. The brain ryanodine receptor has been purified 6700-fold with no change in [H-3]ryanodine binding affinity and shown to be a homotetramer composed of an approximately 500 kd protein subunit, which is identified by anti-peptide antibodies against the skeletal and cardiac muscle ryanodine receptors. Our results demonstrate that the brain ryanodine receptor functions as a caffeine-sensitive Ca2+ release channel and thus is the likely gating mechanism for intracellular caffeine-sensitive Ca2+ pools in neurons.	UNIV WISCONSIN,SCH MED,DEPT PHYSIOL,MADISON,WI 53706; UNIV PENN,DEPT BIOL & ANAT,PHILADELPHIA,PA 19104	University of Wisconsin System; University of Wisconsin Madison; University of Pennsylvania	MCPHERSON, PS (corresponding author), UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,PROGRAM NEUROSCI,IOWA CITY,IA 52242, USA.			Campbell, Kevin/0000-0003-2066-5889; Knudson, Charles Michael/0000-0003-3964-5466	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039265] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL39265] Funding Source: Medline; NIGMS NIH HHS [GM36853] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON K, 1989, J BIOL CHEM, V264, P1329; ASHLEY RH, 1989, J MEMBRANE BIOL, V111, P179, DOI 10.1007/BF01871781; BENNETT J, 1986, BRIT MED BULL, V42, P385, DOI 10.1093/oxfordjournals.bmb.a072156; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; CAMPBELL KP, 1987, J BIOL CHEM, V262, P6460; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DUPONT G, 1990, CELL REGUL, V1, P853, DOI 10.1091/mbc.1.11.853; ELLISMAN MH, 1990, NEURON, V5, P135, DOI 10.1016/0896-6273(90)90304-X; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; GLAUM SR, 1990, J PHARMACOL EXP THER, V253, P1293; GORKA J, 1989, PEPTIDE RES, V2, P1; HENKART M, 1976, J CELL BIOL, V70, P338, DOI 10.1083/jcb.70.2.338; IMAGAWA T, 1987, J BIOL CHEM, V262, P16636; IMAGAWA T, 1989, J BIOCHEM-TOKYO, V106, P342, DOI 10.1093/oxfordjournals.jbchem.a122855; INUI M, 1987, J BIOL CHEM, V262, P15637; KENNEDY MB, 1989, TRENDS NEUROSCI, V12, P417, DOI 10.1016/0166-2236(89)90089-1; KOSTYUK PG, 1991, NEWS PHYSIOL SCI, V6, P6; KUBA K, 1981, J THEOR BIOL, V93, P1009, DOI 10.1016/0022-5193(81)90352-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI FA, 1989, J BIOL CHEM, V264, P16776; LATTANZIO FA, 1987, J BIOL CHEM, V262, P2711; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTINEZSERRANO A, 1989, BIOCHEM BIOPH RES CO, V161, P965, DOI 10.1016/0006-291X(89)91337-5; MCPHERSON PS, 1990, J BIOL CHEM, V265, P18454; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MILLER RJ, 1988, TRENDS NEUROSCI, V11, P415, DOI 10.1016/0166-2236(88)90191-9; MURPHY SN, 1989, MOL PHARMACOL, V35, P671; NABAUER M, 1989, SCIENCE, V244, P800, DOI 10.1126/science.2543067; NAKAI J, 1990, FEBS LETT, V271, P169, DOI 10.1016/0014-5793(90)80399-4; OTSU K, 1990, J BIOL CHEM, V265, P13472; PESSAH IN, 1990, MOL PHARMACOL, V37, P503; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; ROBY FA, 1989, ANAL BIOCHEM, V177, P373; ROUSSEAU E, 1987, AM J PHYSIOL, V253, P364; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; THAYER SA, 1988, J NEUROSCI, V8, P4089; THAYER SA, 1988, MOL PHARMACOL, V34, P664; TOTH PT, 1990, CELL CALCIUM, V11, P557, DOI 10.1016/0143-4160(90)90009-J; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAKUI M, 1990, CELL, V63, P1025, DOI 10.1016/0092-8674(90)90505-9; ZUCKER RS, 1986, SCIENCE, V231, P574, DOI 10.1126/science.2868525	47	357	361	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1991	7	1					17	25		10.1016/0896-6273(91)90070-G	http://dx.doi.org/10.1016/0896-6273(91)90070-G			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1648939				2022-12-28	WOS:A1991FY48100002
J	GAO, WQ; HEINTZ, N; HATTEN, ME				GAO, WQ; HEINTZ, N; HATTEN, ME			CEREBELLAR GRANULE CELL NEUROGENESIS IS REGULATED BY CELL CELL-INTERACTIONS INVITRO	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; GLUTAMIC-ACID DECARBOXYLASE; NEURONS INVITRO; MONOCLONAL-ANTIBODIES; ADHESION RECEPTORS; RAT CEREBELLUM; BRAIN-REGIONS; DIFFERENTIATION; PROLIFERATION	When CNS precursor cells purified from the external germinal layer of the early postnatal mouse cerebellum are cultured in cellular reaggregates, DNA synthesis increased 10-fold above that of cells dispersed in a monolayer or embedded in a collagen matrix. Dividing precursor cells gave rise to neurons immunopositive for the neural antigens N-CAM, L1, and TAG-1, but not to astroglial cells immunopositive for glial filament protein. Moreover, proliferating precursor cells did not generate other types of cerebellar neurons, as judged by the lack of expression of glutamic acid decarboxylase, the synthetic enzyme for gamma-amino-n-butyric acid. By contrast, the addition of astroglial cells, or astroglial cell membranes, to cellular reaggregates of granule cell neuroblasts arrested precursor cell DNA synthesis in a dosedependent manner. These results suggest that homotypic contact interactions among CNS neural progenitors control precursor cell proliferation and fate in generative zones of developing brain.	COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; ROCKEFELLER UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10021	Columbia University; Howard Hughes Medical Institute; Rockefeller University	GAO, WQ (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032, USA.							ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ALTMAN J, 1978, J COMP NEUROL, V179, P23, DOI 10.1002/cne.901790104; ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; BAPTISTA CA, 1990, NATURE, V346, P855, DOI 10.1038/346855a0; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CEPKO CL, 1989, ANNU REV NEUROSCI, V12, P47, DOI 10.1146/annurev.ne.12.030189.000403; CHANG YC, 1988, J NEUROSCI, V8, P2123; COHENCORY S, 1989, EXP NEUROL, V105, P104, DOI 10.1016/0014-4886(89)90177-5; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; FOLKMAN J, 1988, AM J PATHOL, V130, P393; FONNUM F, 1970, BRAINR ES, V20, P59; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; FUJITA H, 1964, Z ZELLFORSCH MIK ANA, V64, P262; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; FUJITA S, 1967, J CELL BIOL, V32, P277, DOI 10.1083/jcb.32.2.277; FUJITA S, 1963, J COMP NEUROL, V120, P37, DOI 10.1002/cne.901200104; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GASSER UE, 1990, P NATL ACAD SCI USA, V87, P4543, DOI 10.1073/pnas.87.12.4543; GOTTLIEB DI, 1986, P NATL ACAD SCI USA, V83, P8808, DOI 10.1073/pnas.83.22.8808; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; GREGORY WA, 1988, J NEUROSCI, V8, P1728; HALLONET MER, 1990, DEVELOPMENT, V108, P19; HATTEN ME, 1984, J NEUROSCI, V4, P1343; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTEN ME, 1987, J CELL BIOL, V104, P1353, DOI 10.1083/jcb.104.5.1353; HATTEN ME, 1984, J CELL BIOL, V98, P193, DOI 10.1083/jcb.98.1.193; HATTEN ME, 1981, J CELL BIOL, V90, P622, DOI 10.1083/jcb.90.3.622; HATTEN ME, 1978, EXP CELL RES, V113, P111, DOI 10.1016/0014-4827(78)90092-7; HINDS JW, 1971, Z ZELLFORSCH MIK ANA, V115, P226, DOI 10.1007/BF00391127; HIS W, 1989, ABHANDL MATH PHYS KO, V26, P313; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; JAN YN, 1990, TRENDS NEUROSCI, V13, P493, DOI 10.1016/0166-2236(90)90083-M; KELLY JS, 1975, BRAIN RES, V85, P255, DOI 10.1016/0006-8993(75)90078-5; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Le Douarin N.M., 1982, NEURAL CREST; MCLAUGHLIN BJ, 1975, BRAIN RES, V85, P355, DOI 10.1016/0006-8993(75)90813-6; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; PATTERSON PH, 1978, ANNU REV NEUROSCI, V1, P1, DOI 10.1146/annurev.ne.01.030178.000245; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Ramon y Cajal S., 1911, HISTOLOGIE SYSTEME N; RAMONYCAJAL S, 1889, REV TRIM HISTOL NORM; RATHJEN FG, 1984, EMBO J, V3, P1; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; SAITO K, 1974, P NATL ACAD SCI USA, V71, P269, DOI 10.1073/pnas.71.2.269; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; SALTON SRJ, 1983, J NEUROSCI, V3, P441; SAUER FC, 1935, J COMP NEUROL, V63, P12; SAUER ME, 1959, EXP CELL RES, V16, P1, DOI 10.1016/0014-4827(59)90189-2; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; SIEBERBLUM M, 1980, DEV BIOL, V80, P96, DOI 10.1016/0012-1606(80)90501-1; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1990, ANNU REV CELL BIOL, V6, P359, DOI 10.1146/annurev.cellbio.6.1.359; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; STITT TN, 1990, NEURON, V5, P639, DOI 10.1016/0896-6273(90)90218-5; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; WAECHTER RV, 1972, BRAIN RES, V46, P235, DOI 10.1016/0006-8993(72)90018-2; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; 1970, ANAT REC, V166, P257	67	240	247	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					705	715		10.1016/0896-6273(91)90168-Y	http://dx.doi.org/10.1016/0896-6273(91)90168-Y			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	2025426				2022-12-28	WOS:A1991FM52200004
J	OTSUKA, AJ; JEYAPRAKASH, A; GARCIAANOVEROS, J; LAN, ZT; FISK, G; HARTSHORNE, T; FRANCO, R; BORN, T				OTSUKA, AJ; JEYAPRAKASH, A; GARCIAANOVEROS, J; LAN, ZT; FISK, G; HARTSHORNE, T; FRANCO, R; BORN, T			THE C-ELEGANS UNC-104 GENE ENCODES A PUTATIVE KINESIN HEAVY-CHAIN LIKE PROTEIN	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; BOVINE BRAIN KINESIN; FAST AXONAL-TRANSPORT; SQUID GIANT-AXON; INTRACELLULAR-TRANSPORT; ELECTRON-MICROSCOPY; NERVOUS-SYSTEM; ELEMENT TC1; ATPASE; IDENTIFICATION	Mutations in the unc-104 gene of the nematode C. elegans result in uncoordinated and slow movement. Transposon insertions in three unc-104 alleles (e2184, rh1016, and rh1017) were used as physical markers to clone the unc-104 gene. DNA sequence analysis of unc-104 cDNAs revealed an open reading frame capable of encoding a 1584 amino acid protein with similarities to kinesin heavy chain. The similarities are greatest in the amino-terminal ATPase and microtubule-binding domains. Although the primary sequence relatedness to kinesin is weak in the remainder of the molecule, the predicted secondary structure and regional isoelectric points are similar to kinesin heavy chain.	UNIV CALIF BERKELEY,DEPT GENET,BERKELEY,CA 94720	University of California System; University of California Berkeley	OTSUKA, AJ (corresponding author), ILLINOIS STATE UNIV,DEPT BIOL,NORMAL,IL 61761, USA.			Garcia-Anoveros, Jaime/0000-0001-6561-9048	NICHD NIH HHS [T32-HDO-7299] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007299] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; AMOS LA, 1987, J CELL SCI, V87, P105; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; BRENNER S, 1974, GENETICS, V77, P71; BRENNER S, 1973, BRIT MED BULL, V29, P269, DOI 10.1093/oxfordjournals.bmb.a071019; COLLINS J, 1987, NATURE, V328, P726, DOI 10.1038/328726a0; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922; EMMONS SW, 1984, CELL, V36, P599, DOI 10.1016/0092-8674(84)90339-8; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; ENOS AP, 1990, CELL, V60, P1019, DOI 10.1016/0092-8674(90)90350-N; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; GRIFFIN JW, 1988, ANN NEUROL, V23, P3, DOI 10.1002/ana.410230103; HAGEN I, 1990, NATURE, V347, P563; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; HISANAGA S, 1989, CELL MOTIL CYTOSKEL, V12, P264, DOI 10.1002/cm.970120407; HODGKIN J, 1979, GENETICS, V91, P67; HOLLENBECK PJ, 1988, PROTOPLASMA, V145, P145, DOI 10.1007/BF01349352; KELLY RB, 1988, NEURON, V1, P431, DOI 10.1016/0896-6273(88)90174-2; KOSIK KS, 1990, J BIOL CHEM, V265, P3278; KUZNETSOV SA, 1989, J BIOL CHEM, V264, P589; KUZNETSOV SA, 1988, EMBO J, V7, P353, DOI 10.1002/j.1460-2075.1988.tb02820.x; KUZNETSOV SA, 1986, P NATL ACAD SCI USA, V83, P8530, DOI 10.1073/pnas.83.22.8530; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; LASEK RJ, 1985, NATURE, V316, P645, DOI 10.1038/316645a0; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LYE RJ, 1987, CELL, V51, P309, DOI 10.1016/0092-8674(87)90157-7; MACLEOD AR, 1981, NATURE, V291, P386, DOI 10.1038/291386a0; Maniatis T., 1982, MOL CLONING; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; MCINTOSH JR, 1989, J BIOL CHEM, V264, P6001; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Otsuka A.J., 1987, UCLA (University of California Los Angeles) Symposia on Molecular and Cellular Biology New Series, V51, P665; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; ROSENZWEIG B, 1983, NUCLEIC ACIDS RES, V11, P4201, DOI 10.1093/nar/11.12.4201; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAXTON WM, 1988, P NATL ACAD SCI USA, V85, P1109, DOI 10.1073/pnas.85.4.1109; SCHOLEY JM, 1989, NATURE, V338, P355, DOI 10.1038/338355a0; SHEETZ MP, 1989, TRENDS NEUROSCI, V12, P474, DOI 10.1016/0166-2236(89)90099-4; SINGER II, 1987, J CELL BIOL, V104, P573, DOI 10.1083/jcb.104.3.573; SULSTON JE, 1974, GENETICS, V77, P95; VALE RD, 1987, ANNU REV CELL BIOL, V3, P347, DOI 10.1146/annurev.cb.03.110187.002023; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; VALE RD, 1985, CELL, V40, P449, DOI 10.1016/0092-8674(85)90159-X; WAGNER MC, 1989, CELL MOTIL CYTOSKEL, V12, P195, DOI 10.1002/cm.970120403; WARNER FD, 1989, CELL MOVEMENT, V2, P277; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; YANG JT, 1990, SCIENCE, V249, P42, DOI 10.1126/science.2142332; ZHANG P, 1990, CELL, V62, P1053, DOI 10.1016/0092-8674(90)90383-P	59	187	191	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1991	6	1					113	122		10.1016/0896-6273(91)90126-K	http://dx.doi.org/10.1016/0896-6273(91)90126-K			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1846075				2022-12-28	WOS:A1991EU27800011
J	JOHNSTON, IG; PALADINO, T; GURD, JW; BROWN, IR				JOHNSTON, IG; PALADINO, T; GURD, JW; BROWN, IR			MOLECULAR-CLONING OF SC1 - A PUTATIVE BRAIN EXTRACELLULAR-MATRIX GLYCOPROTEIN SHOWING PARTIAL SIMILARITY TO OSTEONECTIN BM40 SPARC	NEURON			English	Article									UNIV TORONTO,DEPT BIOCHEM,TORONTO M1C 1A4,ONTARIO,CANADA	University of Toronto	JOHNSTON, IG (corresponding author), UNIV TORONTO,DEPT ZOOL,SCARBOROUGH CAMPUS,TORONTO M1C 1A4,ONTARIO,CANADA.							ACHESON A, 1986, J CELL BIOL, V102, P151, DOI 10.1083/jcb.102.1.151; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BEESLEY PW, 1987, BRAIN RES, V408, P65, DOI 10.1016/0006-8993(87)90359-3; BEESLEY PW, 1989, IN PRESS COMP BIOCH; BITTIGER H, 1974, NATURE, V249, P370, DOI 10.1038/249370a0; BOLANDER ME, 1988, P NATL ACAD SCI USA, V85, P2919, DOI 10.1073/pnas.85.9.2919; BULLOCK S, 1988, J NEUROCHEM, V51, P442, DOI 10.1111/j.1471-4159.1988.tb01058.x; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEZARDIN P, 1988, EUR J BIOCHEM, V175, P275, DOI 10.1111/j.1432-1033.1988.tb14194.x; COTMAN CW, 1974, J CELL BIOL, V62, P236, DOI 10.1083/jcb.62.1.236; COTMAN CW, 1972, J CELL BIOL, V55, P696, DOI 10.1083/jcb.55.3.696; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DESILVA NS, 1979, BRAIN RES, V165, P283, DOI 10.1016/0006-8993(79)90560-2; DZIADEK M, 1986, EUR J BIOCHEM, V161, P455, DOI 10.1111/j.1432-1033.1986.tb10466.x; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINDLAY DM, 1988, BIOCHEMISTRY-US, V27, P1483, DOI 10.1021/bi00405a013; FU SC, 1983, J NEUROCHEM, V41, P1726, DOI 10.1111/j.1471-4159.1983.tb00886.x; GREENWALD I, 1985, CELL, V43, P583, DOI 10.1016/0092-8674(85)90230-2; GRUMET M, 1985, P NATL ACAD SCI USA, V82, P8075, DOI 10.1073/pnas.82.23.8075; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GURD JW, 1980, CAN J BIOCHEM CELL B, V58, P941, DOI 10.1139/o80-129; GURD JW, 1977, BIOCHEMISTRY-US, V16, P369, DOI 10.1021/bi00622a005; GURD JW, 1985, BRAIN RES, V333, P385, DOI 10.1016/0006-8993(85)91599-9; GURD JW, 1989, NEUROBIOLOGY GLYCOCO, P219; HATTEN ME, 1982, J NEUROSCI, V2, P1195; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HILL IE, 1988, BRAIN RES, V461, P27, DOI 10.1016/0006-8993(88)90722-6; HOFFMAN S, 1988, J CELL BIOL, V106, P519, DOI 10.1083/jcb.106.2.519; HOLLAND PWH, 1987, J CELL BIOL, V105, P473, DOI 10.1083/jcb.105.1.473; HUMPHRIES MJ, 1988, J CELL BIOL, V106, P1289, DOI 10.1083/jcb.106.4.1289; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; IVANOV TR, 1989, NEUROCHEM RES, V14, P129, DOI 10.1007/BF00969627; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; KELLY PT, 1984, BIOL GLYCOPROTEINS, P323; KENNEDY MB, 1983, P NATL ACAD SCI USA, V80, P7375; Kretsinger R H, 1979, Adv Cyclic Nucleotide Res, V11, P1; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDER AD, 1985, P NATL ACAD SCI USA, V82, P2183, DOI 10.1073/pnas.82.7.2183; LANKATBUTTGEREIT B, 1988, FEBS LETT, V236, P352, DOI 10.1016/0014-5793(88)80054-1; LETOURNEAU PC, 1988, DEV BIOL, V125, P135, DOI 10.1016/0012-1606(88)90066-8; LIESI P, 1985, EMBO J, V4, P1163, DOI 10.1002/j.1460-2075.1985.tb03755.x; LIESI P, 1983, J CELL BIOL, V96, P920, DOI 10.1083/jcb.96.3.920; LINDSTROM J, 1987, MOL NEUROBIOL, V1, P281, DOI 10.1007/BF02935740; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MANN K, 1987, FEBS LETT, V218, P167, DOI 10.1016/0014-5793(87)81040-2; MANTHORPE M, 1983, J CELL BIOL, V97, P1882, DOI 10.1083/jcb.97.6.1882; MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x; MASON IJ, 1986, EMBO J, V5, P1831, DOI 10.1002/j.1460-2075.1986.tb04434.x; MCLOON SC, 1988, J NEUROSCI, V8, P1981; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERSOHN E, 1987, J CELL BIOL, V105, P569, DOI 10.1083/jcb.105.1.569; PRICE J, 1985, J NEUROSCI, V5, P2205; RATHJEN FG, 1984, EMBO J, V3, P1; RODGERS SL, 1983, DEV BIOL, V98, P212; ROSTAS JAP, 1979, BRAIN RES, V168, P151, DOI 10.1016/0006-8993(79)90133-1; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPRANG GK, 1987, MOL BRAIN RES, V3, P89, DOI 10.1016/0169-328X(87)90049-0; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; STENNER DD, 1986, P NATL ACAD SCI USA, V83, P6892, DOI 10.1073/pnas.83.18.6892; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347; TRACY RP, 1988, INT J BIOCHEM, V20, P653, DOI 10.1016/0020-711X(88)90159-0; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; TURNER DC, 1987, DEV BIOL, V121, P510, DOI 10.1016/0012-1606(87)90187-4; WAHL GM, 1987, METHOD ENZYMOL, V152, P399; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; YOUNG MF, 1986, NUCLEIC ACIDS RES, V14, P4483, DOI 10.1093/nar/14.11.4483; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	79	99	102	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1990	4	1					165	176		10.1016/0896-6273(90)90452-L	http://dx.doi.org/10.1016/0896-6273(90)90452-L			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM297	1690015				2022-12-28	WOS:A1990CM29700015
J	HATTA, K				HATTA, K			ROLE OF THE FLOOR PLATE IN AXONAL PATTERNING IN THE ZEBRAFISH CNS	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH CONES; SPINAL-CORD; NEURAL-TUBE; GUIDANCE; EMBRYOS; EXPRESSION; HINDBRAIN; NEURONS; SPECIFICATION	To determine the role of the floor plate (FP) in CNS development, I have used labeling techniques, including immunolabeling, to analyze cyclops mutant embryos, which lack the FP. Except for the anterior brain, the mutant phenotype is almost exclusively confined to the vicinity of the ventral CNS midline. In the midbrain, the number of ventral neurons is reduced and cell patterning is disturbed. In contrast, the neuronal arrangement in the spinal cord is almost normal, including in particular both primary and secondary motoneurons. Longitudinal axonal bundles are disorganized in both the brain and spinal cord. Laser ablating the FP in wild-type embryos locally phenocopies cyclops axonal disturbances, and transplanting wild-type FP precursor cells into mutants locally rescues the disturbances. These results demonstrate a significant role for the FP in pathfinding and fasciculation by axons in situ, especially during their longitudinal courses.			HATTA, K (corresponding author), UNIV OREGON, INST NEUROSCI, EUGENE, OR 97403 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NCRR NIH HHS [1 S10 RR01756-0] Funding Source: Medline; NICHD NIH HHS [HD22486] Funding Source: Medline; NINDS NIH HHS [NS17903] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERNHARDT RR, 1992, NEURON, V8, P869, DOI 10.1016/0896-6273(92)90201-N; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CLARKE JDW, 1991, DEVELOPMENT, V112, P499; COLE GJ, 1991, NEURON, V7, P1007, DOI 10.1016/0896-6273(91)90345-Z; DAVIS CA, 1991, DEVELOPMENT, V111, P287; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Eaton R.C., 1984, P213; EISEN JS, 1989, NEURON, V2, P1097, DOI 10.1016/0896-6273(89)90234-1; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; HATTA K, 1991, DEVELOPMENT, V112, P821; HATTA K, 1990, SCIENCE, V250, P802, DOI 10.1126/science.1978412; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; HIRANO S, 1991, SCIENCE, V251, P310, DOI 10.1126/science.1987648; JESSELL TM, 1989, CIBA F SYMP, V144, P255; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P1595; KIMMEL CB, 1985, J COMP NEUROL, V233, P365, DOI 10.1002/cne.902330306; KIMMEL CB, 1990, NEURON, V4, P535, DOI 10.1016/0896-6273(90)90111-R; KUWADA JY, 1990, J NEUROSCI, V10, P1299; METCALFE WK, 1990, DEVELOPMENT, V110, P491; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; MYERS PZ, 1985, J COMP NEUROL, V236, P555, DOI 10.1002/cne.902360411; PLACZEK M, 1991, DEVELOPMENT, P105; SCHABTACH E, 1974, J CELL BIOL, V61, P261, DOI 10.1083/jcb.61.1.261; SMITH JC, 1985, DIFFERENTIATION, V29, P109, DOI 10.1111/j.1432-0436.1985.tb00302.x; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; STAHL B, 1990, COLD SPRING HARB SYM, V55, P351; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; VANSTRAATEN HWM, 1988, ANAT EMBRYOL, V177, P317; WESTERFIELD M, 1989, ZEBRAFISH BOOK GUIDE; YAGINUMA H, 1991, J NEUROSCI, V11, P2598; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V	36	157	158	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1992	9	4					629	642		10.1016/0896-6273(92)90027-B	http://dx.doi.org/10.1016/0896-6273(92)90027-B			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1382472				2022-12-28	WOS:A1992JT51600005
J	MACKLER, SA; BROOKS, BP; EBERWINE, JH				MACKLER, SA; BROOKS, BP; EBERWINE, JH			STIMULUS-INDUCED COORDINATE CHANGES IN MESSENGER-RNA ABUNDANCE IN SINGLE POSTSYNAPTIC HIPPOCAMPAL CA1 NEURONS	NEURON			English	Article							LONG-TERM POTENTIATION; RECEPTOR ALPHA-SUBUNIT; IMMEDIATE EARLY GENES; RAT HIPPOCAMPUS; SYNAPTIC TRANSMISSION; TYROSINE-HYDROXYLASE; PERFORANT PATH; NERVOUS-SYSTEM; PROTEIN-KINASE; SPINAL-CORD	The molecular effects of use-dependent changes in synaptic transmission were studied in individual CA1 pyramidal neurons from rat hippocampal slices. Potentiation of excitatory postsynaptic currents was associated with coordinate changes in the relative abundance of several mRNAs 30 min to 3 hr after stimulation. There was a 300% increase in calcium/calmodulin-dependent protein kinase II mRNA levels concordant with a 50% decrease in protein kinase C beta-1 isoform mRNA. A 2-fold increase in zif-268 mRNA was seen, while increases in c-fos and c-jun mRNA levels were inconsistent. Gamma-aminobutyric acid A receptor beta-1 subunit mRNA levels increased 3-fold. Potentiation-induced changes were prevented by N-methyl-D-aspartate receptor blockade. Changes in mRNA abundance in individual cells, with synaptic and glial interactions intact, combine to produce a molecular fingerprint of a potentiated CA1 neuron.	UNIV PENN,MED CTR,DEPT PSYCHIAT,PHILADELPHIA,PA 19104	University of Pennsylvania	MACKLER, SA (corresponding author), UNIV PENN,MED CTR,DEPT PHARMACOL,PHILADELPHIA,PA 19104, USA.		Eberwine, James/B-2247-2010		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009900, R01AG009900] Funding Source: NIH RePORTER; NIA NIH HHS [AG9900] Funding Source: Medline; NIGMS NIH HHS [5T32GM07170] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE K, 1991, NEUROSCI LETT, V125, P166, DOI 10.1016/0304-3940(91)90018-O; ABE K, 1991, BRAIN RES, V547, P171; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BIGUET NF, 1989, NEUROSCI LETT, V104, P189, DOI 10.1016/0304-3940(89)90353-4; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; CHAVEZNORIEGA LE, 1989, NEUROSCI LETT, V104, P58, DOI 10.1016/0304-3940(89)90329-7; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; EBERWINE J, 1992, IN PRESS METH ENZYMO; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FOSSOM LH, 1991, MOL PHARMACOL, V40, P193; GOH JW, 1989, SCIENCE, V244, P980, DOI 10.1126/science.2543072; GOLDMAN D, 1988, NEURON, V1, P329, DOI 10.1016/0896-6273(88)90081-5; HEGINBOTHAM LR, 1991, J NEUROSCI, V11, P2519; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; LOMO T, 1966, ACTA PHYSIOL SCAND, VS 68, P128; LOWENSTEIN DH, 1991, NEURON, V6, P627, DOI 10.1016/0896-6273(91)90065-8; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OFFORD J, 1989, NEURON, V2, P1447, DOI 10.1016/0896-6273(89)90190-6; PITLER TA, 1990, BRAIN RES, V534, P257, DOI 10.1016/0006-8993(90)90137-Z; SCHLATTER LK, 1991, MOL ENDOCRINOL, V6, P132; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; TERLAU H, 1990, EUR J NEUROSCI, V2, P973, DOI 10.1111/j.1460-9568.1990.tb00009.x; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; WILLIAMS S, 1988, SCIENCE, V242, P84, DOI 10.1126/science.2845578; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; WISDEN W, 1988, NEURON, V1, P937, DOI 10.1016/0896-6273(88)90151-1	41	109	113	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					539	548		10.1016/0896-6273(92)90191-F	http://dx.doi.org/10.1016/0896-6273(92)90191-F			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1388031				2022-12-28	WOS:A1992JM57100015
J	VANDENBERG, RJ; HANDFORD, CA; SCHOFIELD, PR				VANDENBERG, RJ; HANDFORD, CA; SCHOFIELD, PR			DISTINCT AGONIST-BINDING AND ANTAGONIST-BINDING SITES ON THE GLYCINE RECEPTOR	NEURON			English	Article								The distinction between receptor-binding sites for agonists and antagonists underpins the pharmacological differences between these two classes of ligands. In the glycine receptor, antagonist (strychnine) binding requires an interaction with residues Lys-200 and Tyr-202. We now demonstrate that the agonist-binding site of this receptor is located at the residue Thr-204. The agonist-binding site interaction is thus likely to be mediated by hydrogen bonding and not by ionic interactions. Our results demonstrate that, in contrast to other studies of ligand-gated ion channel receptors, agonist- and antagonist-binding sites are composed of distinct amino acid residues.			VANDENBERG, RJ (corresponding author), GARVAN INST MED RES, DARLINGHURST, NSW 2010, AUSTRALIA.		Vandenberg, Robert John/E-6018-2016; Schofield, Peter/C-9669-2011	Vandenberg, Robert John/0000-0003-1523-4814; Schofield, Peter/0000-0003-2967-9662				AKAGI H, 1988, NEUROSCI LETT, V95, P262, DOI 10.1016/0304-3940(88)90668-4; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; COCKCROFT VB, 1990, PROTEINS, V8, P386, DOI 10.1002/prot.340080412; COHEN JB, 1991, J BIOL CHEM, V266, P23354; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; CUTTING GR, 1991, P NATL ACAD SCI USA, V88, P2673, DOI 10.1073/pnas.88.7.2673; CZAJKOWSKI C, 1991, J BIOL CHEM, V266, P22603; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; GALZI JL, 1991, P NATL ACAD SCI USA, V88, P5051, DOI 10.1073/pnas.88.11.5051; GALZI JL, 1990, J BIOL CHEM, V265, P10430; GALZI JL, 1991, ANNU REV PHARMACOL, V31, P37, DOI 10.1146/annurev.pa.31.040191.000345; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GOMEZ AR, 1989, BIOCHEM BIOPH RES CO, V160, P374, DOI 10.1016/0006-291X(89)91666-5; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; KROGSGAARDLARSEN P, 1982, J NEUROCHEM, V39, P1319, DOI 10.1111/j.1471-4159.1982.tb12573.x; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; MARVIZON JCG, 1986, MOL PHARMACOL, V30, P590; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; RUIZGOMEZ A, 1990, BIOCHEMISTRY-US, V29, P7033, DOI 10.1021/bi00482a012; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SIMMONDS MA, 1985, BRIT J PHARMACOL, V84, P631, DOI 10.1111/j.1476-5381.1985.tb16143.x; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; VANDENBERG RJ, 1992, P NATL ACAD SCI USA, V89, P1765, DOI 10.1073/pnas.89.5.1765; YOUNG AB, 1974, MOL PHARMACOL, V10, P790; YOUNG AB, 1974, P NATL ACAD SCI USA, V71, P2246, DOI 10.1073/pnas.71.6.2246	37	124	126	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1992	9	3					491	496		10.1016/0896-6273(92)90186-H	http://dx.doi.org/10.1016/0896-6273(92)90186-H			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1326295				2022-12-28	WOS:A1992JM57100010
J	HARRIS, WA; MESSERSMITH, SL				HARRIS, WA; MESSERSMITH, SL			2 CELLULAR INDUCTIONS INVOLVED IN PHOTORECEPTOR DETERMINATION IN THE XENOPUS RETINA	NEURON			English	Article							DROSOPHILA RETINA; COMPOUND EYE; DIFFERENTIATION; CELLS; LINEAGE; INVITRO; BRIDE; MOUSE; GENE	Cellular determination in the Xenopus retina is not a strict consequence of cell lineage or cell birthdate. This suggests that a retinal cell gets its fate by either local cellular interactions, diffusible factors, or an indeterminate stochastic mechanism. We have performed an in vitro experiment in which cellular contact is controlled to test the first possibility directly. We use these experiments to demonstrate that two cellular inductions are involved in photoreceptor determination in vitro and that these inductions also occur during development in the retina in vivo. The first interaction is responsible for biasing cells toward either a generic photoreceptor or a cone fate, while the second directs cells toward a rod cell fate.	UNIV CALIF SAN DIEGO, CTR MOLEC GENET, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego	HARRIS, WA (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA.							ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; HAFEN E, 1991, DEVELOPMENT, P123; HARMAN AM, 1989, NEUROSCIENCE, V28, P219, DOI 10.1016/0306-4522(89)90246-7; HARRIS W A, 1991, Current Biology, V1, P120, DOI 10.1016/0960-9822(91)90297-A; HARRIS WA, 1991, NEURON, V6, P499, DOI 10.1016/0896-6273(91)90053-3; HEWITT AT, 1990, EXP EYE RES, V50, P79; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUNTER DD, 1992, NEURON, V8, P399, DOI 10.1016/0896-6273(92)90269-J; KARPILOW J, 1989, GENE DEV, V3, P1834, DOI 10.1101/gad.3.12a.1834; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; LAIRD DW, 1988, INVEST OPHTH VIS SCI, V29, P419; LAVAIL MM, 1991, J COMP NEUROL, V309, P86, DOI 10.1002/cne.903090107; LAWRENCE PA, 1979, DEV BIOL, V71, P142, DOI 10.1016/0012-1606(79)90088-5; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; PITTACK C, 1991, DEVELOPMENT, V113, P577; REH TA, 1989, J NEUROSCI, V9, P4179; REH TA, 1987, NATURE, V330, P68, DOI 10.1038/330068a0; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; REPKA A, 1992, IN PRESS DEV; ROHLICH P, 1989, J COMP NEUROL, V290, P105, DOI 10.1002/cne.902900107; SPARROW JR, 1990, DEV BRAIN RES, V51, P69, DOI 10.1016/0165-3806(90)90259-2; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; VENKATESH TR, 1985, TRENDS NEUROSCI, V8, P251, DOI 10.1016/0166-2236(85)90098-0; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WATANABE T, 1992, DEVELOPMENT, V239, P1142; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WIKLER KC, 1989, J COMP NEUROL, V297, P1; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	37	118	119	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1992	9	2					357	372		10.1016/0896-6273(92)90174-C	http://dx.doi.org/10.1016/0896-6273(92)90174-C			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1497898				2022-12-28	WOS:A1992JJ33200017
J	GIANOTTI, C; NUNZI, MG; GISPEN, WH; CORRADETTI, R				GIANOTTI, C; NUNZI, MG; GISPEN, WH; CORRADETTI, R			PHOSPHORYLATION OF THE PRESYNAPTIC PROTEIN B-50 (GAP-43) IS INCREASED DURING ELECTRICALLY INDUCED LONG-TERM POTENTIATION	NEURON			English	Article							RAT HIPPOCAMPAL SLICES; KINASE-C SUBSTRATE; SYNAPTIC TRANSMISSION; PLASMA-MEMBRANES; PYRAMIDAL CELLS; DENTATE GYRUS; GROWTH CONES; AMINO-ACIDS; RELEASE; PHOSPHOPROTEIN	The protein B-50 (F1, GAP-43) is a presynaptic-specific substrate of protein kinase C, functionally related to neurotransmitter release. An increase in phosphorylation of this protein has been proposed as a molecular mechanism underlying long-term potentiation (LTP). B-50 phosphorylation measured by quantitative immunoprecipitation in rat hippocampal slices incubated in the presence of radiolabeled inorganic phosphate was increased for at least 1 hr after the induction of LTP in the CA1 region. No significant changes in B-50 phosphorylation were observed in untetanized slices stimulated at low frequency. The direct demonstration of an increased phosphorylation of the protein B-50 during LTP is consistent with the hypothesis that presynaptic mechanisms contribute to maintenance of LTP.	UNIV UTRECHT,RUDOLF MAGNUS INST,3521 GD UTRECHT,NETHERLANDS; UNIV FLORENCE,DEPT PRECLIN & CLIN PHARMACOL,I-50134 FLORENCE,ITALY	Utrecht University; University of Florence	GIANOTTI, C (corresponding author), FIDIA RES LABS,VIA PONTE FABBRICA 3A,I-35031 ABANO TERME,ITALY.		Corradetti, Renato/A-1604-2008	Corradetti, Renato/0000-0002-2588-0484				AKERS RF, 1985, BRAIN RES, V334, P147, DOI 10.1016/0006-8993(85)90576-1; AKERS RF, 1986, SCIENCE, V231, P587, DOI 10.1126/science.3003904; ALOYO YJ, 1982, PROG BRAIN RES, V54, P303; ANDREASEN TJ, 1983, BIOCHEMISTRY-US, V22, P4618; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BENOWITZ LI, 1987, TRENDS NEUROSCI, V10, P527, DOI 10.1016/0166-2236(87)90135-4; BLISS T V P, 1988, P3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1986, J PHYSIOL-LONDON, V377, P391, DOI 10.1113/jphysiol.1986.sp016193; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPAGNE MV, 1989, J NEUROCYTOL, V18, P479, DOI 10.1007/BF01474544; CHAN SY, 1986, J NEUROSCI, V6, P3618; CHAVEZNORIEGA LE, 1989, NEUROSCI LETT, V104, P58, DOI 10.1016/0304-3940(89)90329-7; COGGINS PJ, 1991, J NEUROCHEM, V56, P1095, DOI 10.1111/j.1471-4159.1991.tb11398.x; COLLEY PA, 1989, BRAIN RES, V495, P205, DOI 10.1016/0006-8993(89)90214-X; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CORRADETTI R, 1983, J NEUROCHEM, V41, P1518, DOI 10.1111/j.1471-4159.1983.tb00858.x; CORRADETTI R, 1989, BRIT J PHARMACOL, V98, P1376, DOI 10.1111/j.1476-5381.1989.tb12687.x; DEGRAAN PNE, 1988, NEUROSCI RES COMMUN, V3, P175; DEGRAAN PNE, 1990, J NEUROCHEM, V55, P2139; DEGRAAN PNE, 1989, J NEUROCHEM, V52, P17; DEKKER LV, 1989, J NEUROCHEM, V52, P24, DOI 10.1111/j.1471-4159.1989.tb10893.x; DEKKER LV, 1989, NATURE, V342, P74, DOI 10.1038/342074a0; GISPEN WH, 1985, BRAIN RES, V328, P381, DOI 10.1016/0006-8993(85)91054-6; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; LIN Y, 1990, TRENDS PHARMACOL SCI, V11, P107; LINDEN DJ, 1989, BRAIN RES REV, V14, P279, DOI 10.1016/0165-0173(89)90004-0; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; LYNCH MA, 1989, NEUROSCIENCE, V30, P693, DOI 10.1016/0306-4522(89)90162-0; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; NADLER JV, 1976, NATURE, V260, P538, DOI 10.1038/260538a0; NELSON RB, 1989, BRAIN RES, V497, P30, DOI 10.1016/0006-8993(89)90966-9; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OESTREICHER AB, 1986, BRAIN RES, V375, P267, DOI 10.1016/0006-8993(86)90747-X; OESTREICHER AB, 1983, J NEUROCHEM, V41, P331, DOI 10.1111/j.1471-4159.1983.tb04747.x; OLDS JL, 1989, SCIENCE, V245, P866, DOI 10.1126/science.2772638; POCKETT S, 1991, NEUROSCI LETT, V121, P81, DOI 10.1016/0304-3940(91)90654-C; REYMANN KG, 1988, BRAIN RES, V461, P388, DOI 10.1016/0006-8993(88)90274-0; SCHWARTZKROIN PA, 1975, BRAIN RES, V89, P107, DOI 10.1016/0006-8993(75)90138-9; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023	45	165	165	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					843	848		10.1016/0896-6273(92)90198-M	http://dx.doi.org/10.1016/0896-6273(92)90198-M			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1534012	Green Submitted			2022-12-28	WOS:A1992HV46700003
J	NEWLAND, CF; ADELMAN, JP; TEMPEL, BL; ALMERS, W				NEWLAND, CF; ADELMAN, JP; TEMPEL, BL; ALMERS, W			REPULSION BETWEEN TETRAETHYLAMMONIUM IONS IN CLONED VOLTAGE-GATED POTASSIUM CHANNELS	NEURON			English	Article							GRAMICIDIN-A CHANNEL; CALCIUM CHANNELS; XENOPUS OOCYTES; CONDUCTANCE; PERMEATION; MUSCLE; PORE; SELECTIVITY; EXPRESSION; MEMBRANE	Tetraethylammonium ion (TEA+) blocks voltage-gated K+ channels by acting at two sites located at opposite ends of the aqueous pore. This allowed us to test two predictions made by models of ion permeation, namely that K+ channels can be simultaneously occupied by multiple ions and that the ions repel each other. We show that externally applied TEA+ antagonize block by internal TEA+ and vice versa. The antagonism is less than predicted for competitive binding, hence TEA+ may occupy both sites simultaneously. External TEA+ and internal TEA+ reduce each others affinity 4- to 5-fold. In addition, K+ antagonizes block by TEA+ at the opposite side of the membrane, and external TEA+ antagonizes is block by internal Ba2+. The antagonism between ions applied at opposite sides of the membrane may be common to all cations binding to K+ channels.	UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195; VET ADM MED CTR,SEATTLE,WA 98108; OREGON HLTH SCI UNIV,INST VOLLUM,PORTLAND,OR 97201	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR017803, R01AR017803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028504, R01NS027206] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR17803] Funding Source: Medline; NINDS NIH HHS [NS28504-01, NS27206] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; ALMERS W, 1986, FORTSCHR ZOOL, V33, P61; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1982, J GEN PHYSIOL, V80, P663, DOI 10.1085/jgp.80.5.663; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; BLATZ AL, 1984, J GEN PHYSIOL, V84, P1, DOI 10.1085/jgp.84.1.1; CHANDY KG, 1991, NATURE, V352, P26, DOI 10.1038/352026b0; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CHRISTIE MJ, 1990, NEURON, V2, P405; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; HILLE B, 1967, J GEN PHYSIOL, V50, P1287, DOI 10.1085/jgp.50.5.1287; HILLE B, 1984, IONIC CHANNELS EXCIT, P280; HLADKY SB, 1979, MEMBRANE TRANSPORT P, V3, P89; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; JAN LY, 1990, TRENDS NEUROSCI, V13, P415, DOI 10.1016/0166-2236(90)90123-R; JORDAN PC, 1984, J MEMBRANE BIOL, V78, P91, DOI 10.1007/BF01869197; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; KIRSCH GE, 1991, AM J PHYSIOL, V261, pC583, DOI 10.1152/ajpcell.1991.261.4.C583; KOSTYUK PG, 1983, J MEMBRANE BIOL, V76, P83, DOI 10.1007/BF01871455; LANGS DA, 1988, SCIENCE, V241, P188, DOI 10.1126/science.2455345; LEVITT DG, 1978, BIOPHYS J, V22, P221, DOI 10.1016/S0006-3495(78)85486-1; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; NEYTON J, 1988, J GEN PHYSIOL, V92, P549, DOI 10.1085/jgp.92.5.549; SPRUCE AE, 1987, J PHYSIOL-LONDON, V393, P467, DOI 10.1113/jphysiol.1987.sp016833; STANFIELD PR, 1983, REV PHYSIOL BIOCH P, V97, P1, DOI 10.1007/BFb0035345; STUHMER W, 1991, ANNU REV BIOPHYS BIO, V20, P65, DOI 10.1146/annurev.biophys.20.1.65; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; URRY DW, 1983, SCIENCE, V221, P1064, DOI 10.1126/science.221.4615.1064; URRY DW, 1982, P NATL ACAD SCI-BIOL, V79, P390, DOI 10.1073/pnas.79.2.390; VEATCH WR, 1980, J MOL BIOL, V143, P411, DOI 10.1016/0022-2836(80)90220-X; WALLACE BA, 1983, BIOPOLYMERS, V22, P397, DOI 10.1002/bip.360220152; WALLACE BA, 1988, SCIENCE, V241, P182, DOI 10.1126/science.2455344; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1984, J GEN PHYSIOL, V84, P1557; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	40	34	34	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					975	982		10.1016/0896-6273(92)90212-V	http://dx.doi.org/10.1016/0896-6273(92)90212-V			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1586488				2022-12-28	WOS:A1992HV46700017
J	EISEN, JS				EISEN, JS			THE ROLE OF INTERACTIONS IN DETERMINING CELL FATE OF 2 IDENTIFIED MOTONEURONS IN THE EMBRYONIC ZEBRAFISH	NEURON			English	Article							SELECT APPROPRIATE PATHWAYS; NERVOUS-SYSTEM; GROWTH CONES; CHICK-EMBRYO; NEURONS; LEECH; DEATH; LINEAGE; SYNAPSES; ABSENCE	The role of cellular interactions in determining the fates of two identified motoneurons in the embryonic zebrafish was investigated by transplanting individual motoneurons from labeled donor embryos to unlabeled hosts. The results suggest that although these cells normally adopt different fates, they form an equivalence group in which one fate is primary and the other is secondary. Both cells are able to adopt the primary fate. A cell that has adopted the secondary fate can be induced to switch to the primary fate by ablating the cell that has adopted the primary fate, even many hours after axogenesis. Although interactions between the two cells appear to regulate which cell adopts the secondary fate, these interactions seem to be independent of neuromuscular activity.			EISEN, JS (corresponding author), UNIV OREGON, INST NEUROSCI, EUGENE, OR 97403 USA.				NINDS NIH HHS [NS23915, NS01476, BNS8553146] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K04NS001476, R56NS023915, R01NS023915] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG DL, 1983, J NEUROSCI, V3, P1414, DOI 10.1523/jneurosci.03-07-01414.1983; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DOE CQ, 1985, DEV BIOL, V111, P206, DOI 10.1016/0012-1606(85)90446-4; EISEN JS, 1991, NEURON, V6, P767, DOI 10.1016/0896-6273(91)90173-W; EISEN JS, 1990, J NEUROSCI, V10, P34; EISEN JS, 1989, NEURON, V2, P1097, DOI 10.1016/0896-6273(89)90234-1; EISEN JS, 1991, SCIENCE, V252, P569, DOI 10.1126/science.1708527; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; GRUNWALD DJ, 1988, DEV BIOL, V126, P115, DOI 10.1016/0012-1606(88)90245-X; KELEHER GP, 1990, P NATL ACAD SCI USA, V87, P8457, DOI 10.1073/pnas.87.21.8457; Kimble J., 1979, Cell lineage, stem cells and cell determination. (Proc. Internat. Workshop on cell lineage, stem cells and cell determination, Seillac, France, 20-24 May 1979. - Inserm Symposium No.10), P59; KIMMEL CB, 1990, NEUROSCI IN, P561; KIMMEL CB, 1987, DEV BIOL, V124, P269, DOI 10.1016/0012-1606(87)90478-7; KUWADA JY, 1985, DEV BIOL, V110, P114, DOI 10.1016/0012-1606(85)90069-7; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; MACAGNO ER, 1987, J NEUROSCI, V7, P1911; MARTINDALE MQ, 1990, DEV BIOL, V139, P210, DOI 10.1016/0012-1606(90)90289-U; MILLER JP, 1979, SCIENCE, V206, P702, DOI 10.1126/science.386514; MYERS PZ, 1986, J NEUROSCI, V6, P2278; NISHIDA H, 1989, DEV BIOL, V132, P355, DOI 10.1016/0012-1606(89)90232-7; OPPENHEIM RW, 1982, NATURE, V295, P57, DOI 10.1038/295057a0; OPPENHEIM RW, 1988, SCIENCE, V240, P919, DOI 10.1126/science.3363373; PIKE SH, 1990, J NEUROSCI, V10, P44; PITTMAN R, 1979, J COMP NEUROL, V187, P425, DOI 10.1002/cne.901870210; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; PURVES D, 1985, PRINCIPLES NEURAL DE, P144; SHANKLAND M, 1984, DEV BIOL, V106, P326, DOI 10.1016/0012-1606(84)90231-8; TAGHERT PH, 1984, NATURE, V307, P163, DOI 10.1038/307163a0; WEISBLAT DA, 1984, DEV BIOL, V101, P326, DOI 10.1016/0012-1606(84)90146-5; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; WESTERFIELD M, 1990, NEURON, V4, P867, DOI 10.1016/0896-6273(90)90139-7	32	32	32	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB	1992	8	2					231	240		10.1016/0896-6273(92)90290-T	http://dx.doi.org/10.1016/0896-6273(92)90290-T			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1739460				2022-12-28	WOS:A1992HE93000004
J	GOULDING, EH; NGAI, J; KRAMER, RH; COLICOS, S; AXEL, R; SIEGELBAUM, SA; CHESS, A				GOULDING, EH; NGAI, J; KRAMER, RH; COLICOS, S; AXEL, R; SIEGELBAUM, SA; CHESS, A			MOLECULAR-CLONING AND SINGLE-CHANNEL PROPERTIES OF THE CYCLIC-NUCLEOTIDE GATED CHANNEL FROM CATFISH OLFACTORY NEURONS	NEURON			English	Article							INDUCED CURRENT FLUCTUATIONS; SENSITIVE ADENYLATE-CYCLASE; DEPENDENT PROTEIN-KINASE; OUTER SEGMENT MEMBRANE; GENE ACTIVATOR PROTEIN; FUNCTIONAL EXPRESSION; POTASSIUM CHANNEL; CALCIUM CHANNELS; SODIUM-CHANNEL; PREDICTED STRUCTURES	We have cloned a functional cDNA encoding the cyclic nucleotide-gated channel selectively expressed in catfish olfactory sensory neurons. The cyclic nucleotide-gated channels share sequence and structural features with the family of voltage-gated ion channels. This homology is most evident in transmembrane region S4, the putative voltage sensor domain, and the H5 domain, thought to form the channel pore. We have characterized the single-channel properties of the cloned catfish channel and compared these properties with the channel in native catfish olfactory sensory neurons. The channel is activated equally well by cAMP and cGMP, shows only a slight voltage dependence of gating, and exhibits a pH- and voltage-dependent subconductance state similar to that observed for the voltage-gated L-type calcium channel.	COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT PHARMACOL,NEW YORK,NY 10032	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	GOULDING, EH (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT PHYSIOL & CELLULAR BIOPHYS,NEW YORK,NY 10032, USA.			Axel, Richard/0000-0002-3141-4076	NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015174] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 15174] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; BOEKHOFF I, 1990, EMBO J, V9, P2453, DOI 10.1002/j.1460-2075.1990.tb07422.x; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HAMILL OP, 1981, NATURE, V294, P462, DOI 10.1038/294462a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMILL OP, 1983, NATURE, V305, P385; HANKE W, 1988, P NATL ACAD SCI USA, V85, P94, DOI 10.1073/pnas.85.1.94; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HAYNES L, 1985, NATURE, V317, P61, DOI 10.1038/317061a0; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HUNTER M, 1987, NATURE, V327, P522, DOI 10.1038/327522a0; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KROUSE ME, 1986, NATURE, V319, P58, DOI 10.1038/319058a0; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; LUCCHESI K, 1990, NEURON, V2, P141; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Maniatis T., 1982, MOL CLONING; MATTHEWS G, 1988, J PHYSIOL-LONDON, V403, P389, DOI 10.1113/jphysiol.1988.sp017255; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAKAMURA T, 1987, NATURE, V325, P342; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P695, DOI 10.1113/jphysiol.1988.sp016942; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PIETROBON D, 1989, J GEN PHYSIOL, V94, P1, DOI 10.1085/jgp.94.1.1; PIETROBON D, 1988, NATURE, V333, P373, DOI 10.1038/333373a0; PRODHOM B, 1989, J GEN PHYSIOL, V94, P23, DOI 10.1085/jgp.94.1.23; PRODHOM B, 1987, NATURE, V329, P243, DOI 10.1038/329243a0; REED RR, 1990, CELL, V60, P1, DOI 10.1016/0092-8674(90)90706-K; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; WEBER IT, 1989, BIOCHEMISTRY-US, V28, P6122, DOI 10.1021/bi00440a059; WEBER IT, 1987, BIOCHEMISTRY-US, V26, P343, DOI 10.1021/bi00376a003; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZIMMERMAN AL, 1986, NATURE, V321, P70, DOI 10.1038/321070a0; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	61	205	207	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1992	8	1					45	58		10.1016/0896-6273(92)90107-O	http://dx.doi.org/10.1016/0896-6273(92)90107-O			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1370374				2022-12-28	WOS:A1992HB18500004
J	CHENG, B; MATTSON, MP				CHENG, B; MATTSON, MP			NGF AND BFGF PROTECT RAT HIPPOCAMPAL AND HUMAN CORTICAL-NEURONS AGAINST HYPOGLYCEMIC DAMAGE BY STABILIZING CALCIUM HOMEOSTASIS	NEURON			English	Article							NERVE-GROWTH-FACTOR; RECEPTOR MESSENGER-RNA; CHOLINERGIC NEURONS; NEUROTROPHIC FACTOR; MOLECULAR-CLONING; BRAIN; EXPRESSION; CELLS; CULTURE; SYSTEM	NGF and bFGF have recently been shown to have biological activity in central neurons, but their normal functions and mechanisms of action are unknown. Since central neurons are particularly vulnerable to hypoglycemia that occurs with ischemia or insulin overdose, we tested the hypothesis that growth factors can protect neurons against hypoglycemic damage. NGF and bFGF each prevented glucose deprivation-induced neuronal damage in human cerebral cortical and rat hippocampal cell cultures (EGF was ineffective). Protection was afforded when the growth factors were administered before (NGF and bFGF) or up to 12 hr following (NGF) the onset of hypoglycemia. Direct measurements of intracellular calcium levels and manipulations of calcium influx demonstrated that sustained elevations in intracellular calcium levels mediated the hypoglycemic damage. NGF and bFGF each prevented the hypoglycemia-induced elevations of intracellular calcium. These findings indicate that growth factors can stabilize neuronal calcium homeostasis in central neurons and thereby protect them against environmental insults.	UNIV KENTUCKY, DEPT ANAT & NEUROBIOL, LEXINGTON, KY 40536 USA	University of Kentucky	CHENG, B (corresponding author), UNIV KENTUCKY, SANDERS BROWN RES CTR AGING, LEXINGTON, KY 40536 USA.		Mattson, Mark P/F-6038-2012					ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; BAIRD A, 1986, RECENT PROG HORM RES, V42, P143; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BARINAGA M, 1991, SCIENCE, V252, P505, DOI 10.1126/science.1850547; BUCK CR, 1987, P NATL ACAD SCI USA, V84, P3060, DOI 10.1073/pnas.84.9.3060; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CHALAZONITIS A, 1987, P NATL ACAD SCI USA, V84, P289, DOI 10.1073/pnas.84.1.289; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; ERNFORS P, 1991, INT J DEV NEUROSCI, V9, P57, DOI 10.1016/0736-5748(91)90073-U; FINKLESTEIN SP, 1988, BRAIN RES, V460, P253, DOI 10.1016/0006-8993(88)90370-8; GREENE LA, 1980, ANNU REV NEUROSCI, V3, P353, DOI 10.1146/annurev.ne.03.030180.002033; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARTIKKA J, 1988, J NEUROSCI, V8, P2967; HEFTI F, 1989, NEUROBIOL AGING, V10, P515, DOI 10.1016/0197-4580(89)90118-8; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON EM, 1987, BIOCHEM PHARMACOL, V36, P4189, DOI 10.1016/0006-2952(87)90658-7; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; KNUSEL B, 1990, J NEUROSCI, V10, P558; KOH S, 1989, EXP NEUROL, V106, P209, DOI 10.1016/0014-4886(89)90154-4; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1986, TRENDS NEUROSCI, V9, P473, DOI 10.1016/0166-2236(86)90152-9; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MARTINEZ HJ, 1985, P NATL ACAD SCI USA, V82, P7777, DOI 10.1073/pnas.82.22.7777; MASIAKOWSKI P, 1988, P NATL ACAD SCI USA, V85, P1277, DOI 10.1073/pnas.85.4.1277; MATTSON MP, 1988, INT J DEV NEUROSCI, V6, P439, DOI 10.1016/0736-5748(88)90050-0; MATTSON MP, 1990, BRAIN RES, V522, P204, DOI 10.1016/0006-8993(90)91462-P; MATTSON MP, 1990, INT J DEV NEUROSCI, V8, P399, DOI 10.1016/0736-5748(90)90073-B; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MATTSON MP, 1991, BRAIN RES, V565, P94, DOI 10.1016/0006-8993(91)91740-R; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; MATTSON MP, 1991, BRAIN RES, V542, P97, DOI 10.1016/0006-8993(91)91003-J; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MATTSON MP, 1992, IN PRESS EXP GERONTO; MONYER H, 1989, BRAIN RES, V483, P347, DOI 10.1016/0006-8993(89)90179-0; MORRISON RS, 1988, J NEUROSCI RES, V21, P71, DOI 10.1002/jnr.490210111; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; PIORO EP, 1990, NEUROSCIENCE, V34, P57, DOI 10.1016/0306-4522(90)90304-M; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; STREIT J, 1990, PFLUG ARCH EUR J PHY, V416, P368, DOI 10.1007/BF00370742; TAKAHASHI M, 1985, BRAIN RES, V341, P381, DOI 10.1016/0006-8993(85)91079-0; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P1950, DOI 10.1073/pnas.83.6.1950; THOENEN H, 1987, REV PHYSIOL BIOCH P, V109, P145, DOI 10.1007/BFb0031026; TUSZYNSKI MH, 1990, J NEUROSCI, V10, P3604; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WALICKE PA, 1989, J BIOL CHEM, V264, P4120; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551; YANKNER BA, 1990, P NATL ACAD SCI USA, V87, P9020, DOI 10.1073/pnas.87.22.9020	59	457	477	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1991	7	6					1031	1041		10.1016/0896-6273(91)90347-3	http://dx.doi.org/10.1016/0896-6273(91)90347-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1662517				2022-12-28	WOS:A1991GY43800015
J	OWENS, GC; BUNGE, RP				OWENS, GC; BUNGE, RP			SCHWANN-CELLS INFECTED WITH A RECOMBINANT RETROVIRUS EXPRESSING MYELIN-ASSOCIATED GLYCOPROTEIN ANTISENSE RNA DO NOT FORM MYELIN	NEURON			English	Article							ADHESION MOLECULES L1; PERIPHERAL MYELIN; CARBOHYDRATE EPITOPE; RIBONUCLEIC-ACID; BASIC-PROTEIN; SCIATIC-NERVE; GROWTH-FACTOR; N-CAM; INVITRO; AXONS	To elucidate the role of myelin-associated glycoprotein (MAG) in the axon-Schwann cell interaction leading to myelination, neonatal rodent Schwann cells were infected in vitro with a recombinant retrovirus expressing MAG antisense RNA or MAG sense RNA. Stably infected Schwann cells and uninfected cells were then cocultured with purified sensory neurons under conditions permitting extensive myelination in vitro. A proportion of the Schwann cells infected with the MAG antisense virus did not myelinate axons and expressed lower levels of MAG than control myelinating Schwann cells, as measured by immunofluorescence. Electron microscopy revealed that the affected cells failed to segregate large axons and initiate a myelin spiral despite having formed a basal lamina, which normally triggers Schwann cell differentiation. Cells infected with the MAG sense virus formed normal compact myelin. These observations strongly suggest that MAG is the critical Schwann cell component induced by neuronal interaction that initiates peripheral myelination.	UNIV MIAMI, SCH MED, MIAMI PROJECT, MIAMI, FL 33136 USA	University of Miami	OWENS, GC (corresponding author), WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63110 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009923] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 09923] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; BENDER MA, 1987, J VIROL, V61, P1639, DOI 10.1128/JVI.61.5.1639-1646.1987; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; BUNGE MB, 1982, DEV BIOL, V92, P449, DOI 10.1016/0012-1606(82)90190-7; BUNGE MB, 1989, SCIENCE, V243, P229, DOI 10.1126/science.2492115; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHAN YL, 1984, J BIOL CHEM, V259, P224; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; EMERMAN M, 1986, NUCLEIC ACIDS RES, V14, P9381, DOI 10.1093/nar/14.23.9381; GEREN BETTY BEN, 1954, EXPTL CELL RES, V7, P558, DOI 10.1016/S0014-4827(54)80098-X; GODA S, 1991, J NEUROCHEM, V56, P1354, DOI 10.1111/j.1471-4159.1991.tb11432.x; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HEILES HBJ, 1988, BIOTECHNIQUES, V6, P978; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KATSUKI M, 1988, SCIENCE, V241, P593, DOI 10.1126/science.2456614; KIM SK, 1985, CELL, V42, P129, DOI 10.1016/S0092-8674(85)80108-2; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LANGFORD LA, 1990, ACTA NEUROPATHOL, V80, P514, DOI 10.1007/BF00294612; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1988, DEVELOPMENT, V102, P499; MANIATIS T, 1982, MOL CLONING LABORATO, P173; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; MCKINNON RD, 1987, MOL CELL BIOL, V7, P2148, DOI 10.1128/MCB.7.6.2148; MIRSKY R, 1980, J CELL BIOL, V84, P483, DOI 10.1083/jcb.84.3.483; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; NIEKE J, 1985, DIFFERENTIATION, V30, P141, DOI 10.1111/j.1432-0436.1985.tb00525.x; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; OWENS GC, 1991, J NEUROCHEM, V56, P1030, DOI 10.1111/j.1471-4159.1991.tb02025.x; OWENS GC, 1990, GLIA, V3, P118, DOI 10.1002/glia.440030205; OWENS GC, 1989, GLIA, V2, P119, DOI 10.1002/glia.440020208; OWENS GC, 1990, J CELL BIOL, V111, P1171, DOI 10.1083/jcb.111.3.1171; OWENS GC, 1991, DEVELOPMENT, V112, P639; PEDEN KWC, 1990, ANN NY ACAD SCI, V605, P286, DOI 10.1111/j.1749-6632.1990.tb42402.x; PEDRAZA L, 1990, J CELL BIOL, V111, P2651, DOI 10.1083/jcb.111.6.2651; PETERS A., 1959, QUART JOUR EXPTL PHYSIOL, V44, P117; POLTORAK M, 1987, J CELL BIOL, V105, P1893, DOI 10.1083/jcb.105.4.1893; PORTER S, 1987, P NATL ACAD SCI USA, V84, P7768, DOI 10.1073/pnas.84.21.7768; RANSCHT B, 1987, J NEUROSCI, V7, P2936; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; SALZER JL, 1987, J CELL BIOL, V104, P957, DOI 10.1083/jcb.104.4.957; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SEILHEIMER B, 1989, J CELL BIOL, V109, P3095, DOI 10.1083/jcb.109.6.3095; SEILHEIMER B, 1987, EMBO J, V6, P1611, DOI 10.1002/j.1460-2075.1987.tb02408.x; TRAPP BD, 1982, J CELL BIOL, V92, P877, DOI 10.1083/jcb.92.3.877; WEBSTER HDF, 1973, DEV BIOL, V32, P401, DOI 10.1016/0012-1606(73)90250-9; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; WOOD PM, 1975, NATURE, V256, P662, DOI 10.1038/256662a0; WOOD PM, 1990, J NEUROSCI, V10, P3635	50	82	85	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1991	7	4					565	575		10.1016/0896-6273(91)90369-B	http://dx.doi.org/10.1016/0896-6273(91)90369-B			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1718333				2022-12-28	WOS:A1991GM95400005
J	ZILBERTER, YI; UTESHEV, VV; SOKOLOVA, SN; MOTIN, LG; EREMJAN, HH				ZILBERTER, YI; UTESHEV, VV; SOKOLOVA, SN; MOTIN, LG; EREMJAN, HH			POTENTIATION OF GLUTAMATE-ACTIVATED CURRENTS IN ISOLATED HIPPOCAMPAL-NEURONS	NEURON			English	Article											ZILBERTER, YI (corresponding author), MOSCOW GEN PATHOL & PATHOL PHYSIOL INST,BALTIJSKAJA 8,MOSCOW 125315,USSR.							ANWYL R, 1989, TRENDS PHARMACOL SCI, V10, P236, DOI 10.1016/0165-6147(89)90268-X; ANWYL R, 1988, BRAIN RES, V459, P192, DOI 10.1016/0006-8993(88)90304-6; ASCHER P, 1988, J PHYSL, V399, P248; BASHIR ZI, 1990, J PHYSIOL-LONDON, V425, pP23; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; CHIZHMAKOV IV, 1989, NEUROSCI LETT, V99, P131, DOI 10.1016/0304-3940(89)90277-2; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; ERRINGTON ML, 1987, NEUROSCIENCE, V20, P279, DOI 10.1016/0306-4522(87)90019-4; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KOSTYUK PG, 1981, J NEUROSCI METH, V4, P201, DOI 10.1016/0165-0270(81)90032-7; LARSON J, 1988, BRAIN RES, V441, P111, DOI 10.1016/0006-8993(88)91388-1; MADISON DV, 1988, J PHYSIOL-LONDON, V398, pP18; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MARCHENKO S, 1983, NEUROSCI LETT, V35, P41; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; MULLER D, 1989, BRAIN RES, V477, P396, DOI 10.1016/0006-8993(89)91435-2; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; REYMANN KG, 1988, BRAIN RES, V461, P388, DOI 10.1016/0006-8993(88)90274-0	26	17	17	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1990	5	5					597	602		10.1016/0896-6273(90)90214-Z	http://dx.doi.org/10.1016/0896-6273(90)90214-Z			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ868	1977422				2022-12-28	WOS:A1990EJ86800004
J	BLUMENFELD, H; SPIRA, ME; KANDEL, ER; SIEGELBAUM, SA				BLUMENFELD, H; SPIRA, ME; KANDEL, ER; SIEGELBAUM, SA			FACILITATORY AND INHIBITORY TRANSMITTERS MODULATE CALCIUM INFLUX DURING ACTION-POTENTIALS IN APLYSIA SENSORY NEURONS	NEURON			English	Article									COLUMBIA UNIV,HOWARD HUGHES MED INST,DEPT PHARMACOL,NEW YORK,NY 10032	Columbia University; Howard Hughes Medical Institute	BLUMENFELD, H (corresponding author), COLUMBIA UNIV,CTR NEUROBIOL & BEHAV,HOWARD HUGHES MED INST,NEW YORK,NY 10032, USA.		Spira, Micha/B-6470-2012					ABRAMS TW, 1984, P NATL ACAD SCI-BIOL, V81, P7956, DOI 10.1073/pnas.81.24.7956; ALVAREZLEEFMANS FJ, 1984, J PHYSIOL-LONDON, V354, P303, DOI 10.1113/jphysiol.1984.sp015377; ANGLISTER L, 1982, DEV BIOL, V94, P351, DOI 10.1016/0012-1606(82)90353-0; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; AXELROD J, 1988, TRENDS NEUROSCI, V11, P117, DOI 10.1016/0166-2236(88)90157-9; BELARDETTI F, 1986, P NATL ACAD SCI USA, V83, P7094, DOI 10.1073/pnas.83.18.7094; BELARDETTI F, 1987, NATURE, V325, P153, DOI 10.1038/325153a0; BELARDETTI F, 1988, RECEPTOR RECEPTOR IN, P454; BERRIDGE MJ, 1988, PROC R SOC SER B-BIO, V234, P359, DOI 10.1098/rspb.1988.0054; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; BOLL W, 1985, NEUROSCI LETT, V56, P335, DOI 10.1016/0304-3940(85)90265-4; BOYLE MB, 1984, P NATL ACAD SCI-BIOL, V81, P7642, DOI 10.1073/pnas.81.23.7642; BRAHA O, 1990, P NATL ACAD SCI USA, V87, P2040, DOI 10.1073/pnas.87.5.2040; BREZINA V, 1987, J PHYSIOL-LONDON, V388, P565, DOI 10.1113/jphysiol.1987.sp016632; BREZINA V, 1987, J PHYSIOL-LONDON, V382, P267, DOI 10.1113/jphysiol.1987.sp016367; BURGOYNE RD, 1989, NATURE, V342, P72, DOI 10.1038/342072a0; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Conner J.A., 1982, Lectures on Mathematics in the Life Sciences, V15, P79; CONNOR JA, 1986, P NATL ACAD SCI USA, V83, P6179, DOI 10.1073/pnas.83.16.6179; DALE N, 1990, J PHYSIOL-LONDON, V421, P203, DOI 10.1113/jphysiol.1990.sp017941; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; DUTAR P, 1988, NEUROSCI LETT, V85, P89, DOI 10.1016/0304-3940(88)90434-X; EDMONDS B, 1990, IN PRESS SCIENCE; ENDO M, 1975, P JPN ACAD, V51, P479, DOI 10.2183/pjab1945.51.479; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; FEIN A, 1988, NATURE, V331, P437, DOI 10.1038/331437a0; FINK LA, 1988, J NEUROSCI, V8, P2544; GINGRICH KJ, 1985, J NEUROPHYSIOL, V53, P652, DOI 10.1152/jn.1985.53.3.652; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HOCHNER B, 1986, P NATL ACAD SCI USA, V83, P8794, DOI 10.1073/pnas.83.22.8794; HOCKBERGER PE, 1989, J NEUROSCI, V9, P2272; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; IRVINE RF, 1982, BIOCHEM J, V204, P3, DOI 10.1042/bj2040003; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Katz B., 1969, SHERRINGTON LECT; KENNEDY MB, 1989, TRENDS NEUROSCI, V12, P417, DOI 10.1016/0166-2236(89)90089-1; KLEIN M, 1978, P NATL ACAD SCI USA, V75, P3512, DOI 10.1073/pnas.75.7.3512; KLEIN M, 1982, P NATL ACAD SCI-BIOL, V79, P5713, DOI 10.1073/pnas.79.18.5713; KLEIN M, 1980, J EXP BIOL, V89, P117; KLEIN M, 1980, P NATL ACAD SCI-BIOL, V77, P6912, DOI 10.1073/pnas.77.11.6912; KOSTYUK PG, 1989, J MEMBRANE BIOL, V110, P11, DOI 10.1007/BF01870988; KUBA K, 1980, J PHYSIOL-LONDON, V298, P251, DOI 10.1113/jphysiol.1980.sp013079; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; KUNZE DL, 1971, NATURE-NEW BIOL, V229, P229, DOI 10.1038/newbio229229a0; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; LLANO I, 1987, J PHYSIOL-LONDON, V394, P239, DOI 10.1113/jphysiol.1987.sp016868; LLINAS P, 1985, P NATIONAL ACADEMY S, V77, P7039; MANSONHING H, 1989, NATURE, V341, P237, DOI 10.1038/341237a0; MILLER RJ, 1985, TRENDS NEUROSCI, V8, P463, DOI 10.1016/0166-2236(85)90169-9; NEERING JR, 1984, NATURE, V309, P158; OGDEN TE, 1978, SCIENCE, V201, P469, DOI 10.1126/science.663670; PAYNE R, 1986, J GEN PHYSIOL, V88, P107, DOI 10.1085/jgp.88.1.107; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; RAYPORT SG, 1986, J NEUROSCI, V6, P759; ROSS WN, 1989, ANNU REV PHYSIOL, V51, P491, DOI 10.1146/annurev.physiol.51.1.491; RUSSELL JM, 1972, SCIENCE, V175, P1475, DOI 10.1126/science.175.4029.1475; RYDQVIST B, 1986, ACTA PHYSIOL SCAND, V127, P499, DOI 10.1111/j.1748-1716.1986.tb07934.x; SACKTOR TC, 1990, P NATL ACAD SCI USA, V87, P2036, DOI 10.1073/pnas.87.5.2036; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; SAWADA M, 1989, J NEUROPHYSIOL, V61, P302, DOI 10.1152/jn.1989.61.2.302; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SCHACHER S, 1985, J NEUROSCI, V5, P2028; SHUSTER MJ, 1985, NATURE, V313, P392, DOI 10.1038/313392a0; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SILVER RA, 1990, NATURE, V343, P751, DOI 10.1038/343751a0; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; SPENCER AN, 1989, NATURE, V340, P636, DOI 10.1038/340636a0; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; THAYER SA, 1988, J NEUROSCI, V8, P4089; THAYER SA, 1988, MOL PHARMACOL, V34, P664; THOMPSON S, 1988, J NEUROSCI, V8, P1929; TILLOTSON D, 1980, NATURE, V286, P816, DOI 10.1038/286816a0; VOLTERRA A, 1988, P NATL ACAD SCI USA, V85, P7810, DOI 10.1073/pnas.85.20.7810; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	84	68	69	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1990	5	4					487	499		10.1016/0896-6273(90)90088-W	http://dx.doi.org/10.1016/0896-6273(90)90088-W			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED517	1976321				2022-12-28	WOS:A1990ED51700012
J	KALMAN, D; WONG, B; HORVAI, AE; CLINE, MJ; OLAGUE, PH				KALMAN, D; WONG, B; HORVAI, AE; CLINE, MJ; OLAGUE, PH			NERVE GROWTH-FACTOR ACTS THROUGH CAMP-DEPENDENT PROTEIN-KINASE TO INCREASE THE NUMBER OF SODIUM-CHANNELS IN PC12 CELLS	NEURON			English	Article									UNIV CALIF LOS ANGELES,DEPT HEMATOL ONCOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles	KALMAN, D (corresponding author), UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024, USA.				NCI NIH HHS [CA50275] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050275] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ANDERSON DJ, 1985, CELL, V42, P649, DOI 10.1016/0092-8674(85)90122-9; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BARCHI RL, 1988, ANNU REV NEUROSCI, V11, P455, DOI 10.1146/annurev.ne.11.030188.002323; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BLENIS J, 1986, EMBO J, V5, P3441, DOI 10.1002/j.1460-2075.1986.tb04667.x; BOCCHINI V, 1969, P NATL ACAD SCI USA, V64, P787, DOI 10.1073/pnas.64.2.787; CAPECCHI MR, 1980, CELL, V22, P479, DOI 10.1016/0092-8674(80)90358-X; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHANG A, 1986, J NEUROCHEM, V47, P1885, DOI 10.1111/j.1471-4159.1986.tb13103.x; CHENG HC, 1986, J BIOL CHEM, V261, P989; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; COMB M, 1987, TRENDS NEUROSCI, V10, P473, DOI 10.1016/0166-2236(87)90103-2; CREMINS J, 1986, J CELL BIOL, V103, P887, DOI 10.1083/jcb.103.3.887; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; DAY RN, 1989, J BIOL CHEM, V264, P431; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; DOLPHIN AC, 1988, TRENDS NEUROSCI, V11, P287, DOI 10.1016/0166-2236(88)90085-9; FOURNIER A, 1987, NATURE, V330, P767, DOI 10.1038/330767a0; FREUND JE, 1980, MATH STATISTICS; GANONG BR, 1986, P NATL ACAD SCI USA, V83, P1184, DOI 10.1073/pnas.83.5.1184; GOLDIN AL, 1986, P NATL ACAD SCI USA, V83, P7503, DOI 10.1073/pnas.83.19.7503; GORMAN C, 1983, SCIENCE, V221, P551, DOI 10.1126/science.6306768; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; GROVE JR, 1987, SCIENCE, V238, P530; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HALL FL, 1988, J BIOL CHEM, V263, P4460; HAMA T, 1986, P NATL ACAD SCI USA, V83, P2353, DOI 10.1073/pnas.83.8.2353; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEPLER JR, 1988, J BIOL CHEM, V263, P7610; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HORN R, 1983, BIOPHYS J, V43, P207, DOI 10.1016/S0006-3495(83)84341-0; HORN R, 1984, J GEN PHYSIOL, V84, P505, DOI 10.1085/jgp.84.4.505; IGNATIUS MJ, 1985, J NEUROSCI, V5, P343; JACKSON MB, 1986, BIOPHYS J, V49, P663, DOI 10.1016/S0006-3495(86)83693-1; KOIZUMI S, 1988, J NEUROSCI, V8, P715; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; LACAL JC, 1987, SCIENCE, V238, P533, DOI 10.1126/science.2821623; LAKSHMANAN J, 1978, BIOCHEM BIOPH RES CO, V82, P767, DOI 10.1016/0006-291X(78)90848-3; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; MANDEL G, 1988, P NATL ACAD SCI USA, V85, P924, DOI 10.1073/pnas.85.3.924; Maniatis T., 1982, MOL CLONING; Martin BR, 1987, METABOLIC REGULATION; MCTIGUE M, 1985, J BIOL CHEM, V260, P9047; MEIRI KF, 1988, J NEUROSCI, V8, P2571; MURDOCH GH, 1982, SCIENCE, V218, P1315, DOI 10.1126/science.6293056; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; OFFORD J, 1989, NEURON, V2, P1447, DOI 10.1016/0896-6273(89)90190-6; OLAGUE PH, 1985, J NEUROSCI RES, V13, P301, DOI 10.1002/jnr.490130120; OLAGUE PH, 1980, P NATL ACAD SCI-BIOL, V77, P1701, DOI 10.1073/pnas.77.3.1701; PIGEON D, 1987, J BIOL CHEM, V262, P6155; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; RUDY B, 1987, J NEUROSCI, V7, P1613; RUDY B, 1982, J NEUROSCI, V2, P1405; SALKOFF L, 1987, SCIENCE, V237, P744, DOI 10.1126/science.2441469; SALKOFF L, 1987, TRENDS NEUROSCI, V10, P521; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SCHMIDT J, 1985, P NATL ACAD SCI USA, V82, P4847, DOI 10.1073/pnas.82.14.4847; SCOTT JD, 1986, P NATL ACAD SCI USA, V83, P1613, DOI 10.1073/pnas.83.6.1613; SHERMAN SJ, 1985, J NEUROSCI, V5, P1570; SIGAL IS, 1988, ADV SEC MESS PHOSPH, V21, P193; SIMONSEN CC, 1986, MOL GENETICS MAMMALI, P99; STUHMER W, 1987, EUR BIOPHYS J BIOPHY, V14, P131, DOI 10.1007/BF00253837; SUGIMOTO Y, 1988, J BIOL CHEM, V263, P12102; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TRAYNOR AE, 1984, DEV BRAIN RES, V14, P205; TRAYNOR AE, 1982, J NEUROCHEM, V39, P1677, DOI 10.1111/j.1471-4159.1982.tb08002.x; VANDENBERG CA, 1984, J GEN PHYSIOL, V84, P535, DOI 10.1085/jgp.84.4.535; VARON S, 1967, BIOCHEMISTRY-US, V6, P2202, DOI 10.1021/bi00859a043; WALSH DA, 1971, J BIOL CHEM, V246, P1977; WHITEHOUSE S, 1983, J BIOL CHEM, V258, P3682	79	84	84	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1990	4	3					355	366		10.1016/0896-6273(90)90048-K	http://dx.doi.org/10.1016/0896-6273(90)90048-K			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX032	1690563				2022-12-28	WOS:A1990CX03200004
J	HOLTZMAN, DM; LI, YW; PARADA, LF; KINSMAN, S; CHEN, CK; VALLETTA, JS; ZHOU, J; LONG, JB; MOBLEY, WC				HOLTZMAN, DM; LI, YW; PARADA, LF; KINSMAN, S; CHEN, CK; VALLETTA, JS; ZHOU, J; LONG, JB; MOBLEY, WC			P140TRK MESSENGER-RNA MARKS NGF-RESPONSIVE FOREBRAIN NEURONS - EVIDENCE THAT TRK GENE-EXPRESSION IS INDUCED BY NGF	NEURON			English	Article								Nerve growth factor (NGF) appears to act as a neurotrophic factor for basal forebrain and caudate-putamen cholinergic neurons. The mechanism by which NGF transduces its signal in these neurons is yet to be defined. Recent data indicate that the product of the trk gene, p140trk, is a critical component of the NGF receptor. Herein, we show that p140trk mRNA is highly restricted in its distribution in the adult rat forebrain, that it is present in cholinergic neurons, and that most if not all cholinergic neurons contain p140trk mRNA. Furthermore, induction of trk expression by NGF suggests that neurotrophin-mediated up-regulation of their receptor tyrosine kinases is an important feature of their actions and that neurotrophins may regulate the activity of responsive neurons through increasing the level of their receptors.	UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, NEUROSCI PROGRAM, SAN FRANCISCO, CA 94143 USA; NCI, FREDERICK CANC RES & DEV CTR, BASIC RES PROGRAM, ADV BIOSCI LAB, FREDERICK, MD 21701 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA; KENNEDY KRIEGER INST, BALTIMORE, MD 21205 USA; WALTER REED ARMY MED CTR, NEUROPHARMACOL BRANCH, DEPT MED NEUROSCI, WASHINGTON, DC 20307 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Johns Hopkins University; Kennedy Krieger Institute; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	HOLTZMAN, DM (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT NEUROL, SAN FRANCISCO, CA 94143 USA.		Parada, luis F/B-9400-2014		NIA NIH HHS [AG10672, AG00445-02] Funding Source: Medline; NINDS NIH HHS [NS24054] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG010672] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTAR CA, 1991, P NATL ACAD SCI USA, V88, P281, DOI 10.1073/pnas.88.1.281; AUBURGER G, 1987, DEV BIOL, V120, P322, DOI 10.1016/0012-1606(87)90235-1; BERND P, 1984, J BIOL CHEM, V259, P5509; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; BOWMAN LH, 1981, NUCLEIC ACIDS RES, V9, P4951, DOI 10.1093/nar/9.19.4951; CAVICCHIOLI L, 1989, EUR J NEUROSCI, V1, P258, DOI 10.1111/j.1460-9568.1989.tb00793.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; ESCANDON E, 1990, DEV BIOL, V142, P293, DOI 10.1016/0012-1606(90)90350-R; GAGE FH, 1989, NEURON, V2, P1177, DOI 10.1016/0896-6273(89)90184-0; GNAHN H, 1983, DEV BRAIN RES, V9, P45, DOI 10.1016/0165-3806(83)90107-4; GREEN SH, 1986, J BIOL CHEM, V261, P5316; HAGG T, 1989, NEUROSCIENCE, V30, P95, DOI 10.1016/0306-4522(89)90356-4; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEFTI F, 1986, NEUROSCI LETT, V69, P37, DOI 10.1016/0304-3940(86)90410-6; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HEUER JG, 1990, DEV BIOL, V137, P287, DOI 10.1016/0012-1606(90)90255-H; HIGGINS GA, 1989, NEURON, V3, P247, DOI 10.1016/0896-6273(89)90038-X; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HOLTZMAN DM, 1992, P NATL ACAD SCI USA, V89, P1383, DOI 10.1073/pnas.89.4.1383; HOLTZMAN DM, 1992, EMBO J, V11, P619, DOI 10.1002/j.1460-2075.1992.tb05094.x; HOSANG M, 1987, EMBO J, V6, P1197, DOI 10.1002/j.1460-2075.1987.tb02354.x; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSTON MV, 1987, NEUROCHEM RES, V12, P985, DOI 10.1007/BF00970927; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KOH S, 1991, J COMP NEUROL, V313, P494, DOI 10.1002/cne.903130310; KORDOWER JH, 1989, NEUROBIOL AGING, V10, P287, DOI 10.1016/0197-4580(89)90068-7; KORSCHING S, 1985, EMBO J, V4, P1389, DOI 10.1002/j.1460-2075.1985.tb03791.x; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LARGE TH, 1986, SCIENCE, V234, P352, DOI 10.1126/science.3764415; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LINDSAY RM, 1990, EUR J NEUROSCI, V2, P389, DOI 10.1111/j.1460-9568.1990.tb00431.x; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MEAKIN SO, 1991, P NATL ACAD SCI USA, V88, P5862, DOI 10.1073/pnas.88.13.5862; MILLER FD, 1991, J CELL BIOL, V112, P303, DOI 10.1083/jcb.112.2.303; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; MOBLEY WC, 1985, SCIENCE, V229, P284, DOI 10.1126/science.2861660; MOBLEY WC, 1986, MOL BRAIN RES, V1, P53, DOI 10.1016/0169-328X(86)90020-3; MOBLEY WC, 1989, NEURON, V3, P655, DOI 10.1016/0896-6273(89)90276-6; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RAGSDALE C, 1991, NATURE, V350, P660, DOI 10.1038/350660a0; RICHARDSON PM, 1986, J NEUROSCI, V6, P2312; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; Sambrook J, 1989, MOL CLONING LABORATO; SARIOLA H, 1991, SCIENCE, V254, P571, DOI 10.1126/science.1658930; SCHUBERT D, 1978, BRAIN RES, V155, P196, DOI 10.1016/0006-8993(78)90325-6; SEHGAL A, 1989, NUCLEIC ACIDS RES, V17, P5623, DOI 10.1093/nar/17.14.5623; SHELTON DL, 1986, P NATL ACAD SCI USA, V83, P2714, DOI 10.1073/pnas.83.8.2714; SPRINGER JE, 1990, CELL MOL NEUROBIOL, V10, P33, DOI 10.1007/BF00733633; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; SUTTER A, 1979, J BIOL CHEM, V254, P5972; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P159, DOI 10.1073/pnas.88.1.159; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WHITTEMORE SR, 1986, P NATL ACAD SCI USA, V83, P817, DOI 10.1073/pnas.83.3.817; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; YAN Q, 1988, J NEUROSCI, V8, P3481	76	368	377	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1992	9	3					465	478		10.1016/0896-6273(92)90184-F	http://dx.doi.org/10.1016/0896-6273(92)90184-F			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1524827				2022-12-28	WOS:A1992JM57100008
J	WANG, YS; MACKE, JP; MERBS, SL; ZACK, DJ; KLAUNBERG, B; BENNETT, J; GEARHART, J; NATHANS, J				WANG, YS; MACKE, JP; MERBS, SL; ZACK, DJ; KLAUNBERG, B; BENNETT, J; GEARHART, J; NATHANS, J			A LOCUS-CONTROL REGION ADJACENT TO THE HUMAN RED AND GREEN VISUAL PIGMENT GENES	NEURON			English	Article							BETA-GLOBIN GENE; HUMAN COLOR-VISION; TRANSGENIC MICE; DEVELOPMENTAL REGULATION; MOLECULAR-GENETICS; BOVINE RHODOPSIN; MOUSE RETINA; EXPRESSION; DELETION; SEQUENCE	Deletion of sequences 5' of the human red and green pigment gene array results in blue cone monochromacy, a disorder in which both red and green cone function are absent. To test whether these sequences are required for transcription of the adjacent visual pigment genes in cone photoreceptors, we produced transgenic mice carrying sequences upstream of the red and green pigment genes fused to a beta-galactosidase reporter. The patterns of transgene expression indicate that the human sequences direct expression to both long and short wave-sensitive cones in the mouse retina and that a region between 3.1 kb and 3.7 kb 5' of the red pigment gene transcription initiation site is essential for expression. Sequences within this region are highly conserved among humans, mice, and cattle, even though the latter two species have only a single visual pigment gene at this locus. These experiments suggest a model in which an interaction between the conserved 5' region and either the red or the green pigment gene promoter determines which of the two genes a given cone expresses.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,WILMER OPHTHALMOL INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	WANG, YS (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205, USA.			Nathans, Jeremy/0000-0001-8106-5460; Zack, Don/0000-0002-7966-1973				Boynton R. M., 1979, HUMAN COLOR VISION; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; CURTIN P, 1985, J CLIN INVEST, V76, P1554, DOI 10.1172/JCI112136; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; FEIL R, 1990, GENOMICS, V6, P367, DOI 10.1016/0888-7543(90)90578-I; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HOGAN B, 1986, MANIPULATING MOUSE G; IBBOTSON RE, 1992, P ROY SOC B-BIOL SCI, V247, P145, DOI 10.1098/rspb.1992.0021; JACOBS GH, 1987, P NATL ACAD SCI USA, V84, P2545, DOI 10.1073/pnas.84.8.2545; KOLLIAS G, 1986, CELL, V46, P89, DOI 10.1016/0092-8674(86)90862-7; KUWATA O, 1990, FEBS LETT, V272, P128, DOI 10.1016/0014-5793(90)80465-U; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; MAGRAM J, 1985, NATURE, V315, P338, DOI 10.1038/315338a0; MCLOON SC, 1991, J NEUROSCI, V11, P1470; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; PESCHON JJ, 1987, P NATL ACAD SCI USA, V84, P5316, DOI 10.1073/pnas.84.15.5316; RABACCHI SA, 1990, DEVELOPMENT, V109, P521; RYAN TM, 1989, GENE DEV, V3, P314, DOI 10.1101/gad.3.3.314; Sambrook J, 1989, MOL CLONING LABORATO; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAKAO M, 1988, VISION RES, V28, P471, DOI 10.1016/0042-6989(88)90169-1; TARAMELLI R, 1986, NUCLEIC ACIDS RES, V14, P7017, DOI 10.1093/nar/14.17.7017; TOKUNAGA F, 1990, BIOCHEM BIOPH RES CO, V173, P1212, DOI 10.1016/S0006-291X(05)80915-5; TOWNES TM, 1985, EMBO J, V4, P1715, DOI 10.1002/j.1460-2075.1985.tb03841.x; TRISLER GD, 1981, P NATL ACAD SCI-BIOL, V78, P2145, DOI 10.1073/pnas.78.4.2145; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; VANDERPLOEG LHT, 1980, NATURE, V283, P637, DOI 10.1038/283637a0; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4	39	354	362	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					429	440		10.1016/0896-6273(92)90181-C	http://dx.doi.org/10.1016/0896-6273(92)90181-C			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1524826				2022-12-28	WOS:A1992JM57100005
J	GILBERT, CD				GILBERT, CD			HORIZONTAL INTEGRATION AND CORTICAL DYNAMICS	NEURON			English	Review							CAT VISUAL-CORTEX; MONKEY STRIATE CORTEX; DEPENDENT NEURONAL OSCILLATIONS; POSTERIOR PARIETAL NEURONS; CROSS-CORRELATION ANALYSIS; PRIMARY AUDITORY-CORTEX; MACAQUE MONKEY; MOTOR CORTEX; AREA-MT; FUNCTIONAL ARCHITECTURE				GILBERT, CD (corresponding author), ROCKEFELLER UNIV,NEW YORK,NY 10021, USA.							ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; BADCOCK DR, 1985, VISION RES, V25, P1259, DOI 10.1016/0042-6989(85)90041-0; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BLASDEL GG, 1984, J NEUROSCI, V4, P880; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; BUTLER TW, 1978, VISION RES, V18, P1387, DOI 10.1016/0042-6989(78)90231-6; CALFORD MB, 1988, NATURE, V332, P446, DOI 10.1038/332446a0; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; CORBETTA M, 1991, J NEUROSCI, V11, P2383; CRANE HD, 1983, SCIENCE, V221, P1078, DOI 10.1126/science.221.4615.1078; CRICK F, 1990, COLD SH Q B, V55, P953; DEFELIPE J, 1986, NEUROSCIENCE, V17, P991, DOI 10.1016/0306-4522(86)90075-8; DEVALOIS RL, 1980, ANNU REV PSYCHOL, V31, P309, DOI 10.1146/annurev.ps.31.020180.001521; DEVOR M, 1978, NATURE, V276, P75, DOI 10.1038/276075a0; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; EYSEL UT, 1981, EXP BRAIN RES, V41, P256; FREUND TF, 1989, J COMP NEUROL, V289, P315, DOI 10.1002/cne.902890211; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; GIFFIN K, 1991, NEURON, V6, P321, DOI 10.1016/0896-6273(91)90242-R; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; GILBERT CD, 1975, J COMP NEUROL, V163, P81, DOI 10.1002/cne.901630106; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GOLDMAN PS, 1977, BRAIN RES, V122, P393, DOI 10.1016/0006-8993(77)90453-X; GRAY CM, 1990, EUR J NEUROSCI, V2, P607, DOI 10.1111/j.1460-9568.1990.tb00450.x; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; GULYAS B, 1987, J NEUROPHYSIOL, V57, P1767, DOI 10.1152/jn.1987.57.6.1767; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HOWARD IP, 1986, HDB PERCEPTION HUMAN, V1; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; IMIG TJ, 1981, J COMP NEUROL, V203, P1, DOI 10.1002/cne.902030102; IMIG TJ, 1978, J COMP NEUROL, V182, P637, DOI 10.1002/cne.901820406; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; JONES EG, 1978, J COMP NEUROL, V181, P591; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kanizsa G., 1979, ESSAYS GESTALT PERCE; KATZ LC, 1989, J NEUROSCI, V9, P1389; KRAUSKOPF J, 1961, AM J PSYCHOL, V80, P632; LABERGE D, 1990, J NEUROSCI, V10, P613; Land E. H., 1974, Proceedings of the Royal Institution of Great Britain, P23; LEHKY SR, 1990, PROC R SOC SER B-BIO, V240, P251, DOI 10.1098/rspb.1990.0037; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P2830; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; LUND JS, 1973, J COMP NEUROL, V147, P455, DOI 10.1002/cne.901470404; MAFFEI L, 1973, VISION RES, V13, P1255, DOI 10.1016/0042-6989(73)90201-0; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; MATURANA HUMBERTO R., 1960, JOUR GEN PHYSIOL, V43, P129, DOI 10.1085/jgp.43.6.129; MAUNSELL JHR, 1989, NEURAL MECHANISMS VI, P223; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; MERZENICH MM, 1988, NEUROBIOLOGY NEOCORT, P41; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOSES Y, 1990, BIOL CYBERN, V63, P463, DOI 10.1007/BF00199579; MOUNTCASTLE VB, 1987, J NEUROSCI, V7, P2239; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; NEWSOME WT, 1985, EXP BRAIN RES, V58, P392; NEWSOME WT, 1985, J NEUROSCI, V5, P825; PARADISO MA, 1991, VISION RES, V31, P1221, DOI 10.1016/0042-6989(91)90047-9; PETERSEN SE, 1989, EXP BRAIN RES, V76, P267; PETET MW, 1992, IN PRESS P NATL ACAD; PRINCE DA, 1988, NEUROBIOLOGY NEOCORT, P153; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; ROBINSON DL, 1991, J NEUROPHYSIOL, V66, P485, DOI 10.1152/jn.1991.66.2.485; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Rockland KS, 1982, BRAIN RES, V169, P19; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; SANES JN, 1988, P NATL ACAD SCI USA, V85, P2003, DOI 10.1073/pnas.85.6.2003; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1334, DOI 10.1152/jn.1976.39.6.1334; SCHWARTZKROIN PA, 1978, BRAIN RES, V157, P1, DOI 10.1016/0006-8993(78)90991-5; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; SPITZER H, 1990, EXP BRAIN RES, V38, P120; SPORNS O, 1991, P NATL ACAD SCI USA, V88, P129, DOI 10.1073/pnas.88.1.129; TANAKA K, 1986, J NEUROSCI, V6, P134; TIGGES J, 1981, J COMP NEUROL, V202, P539, DOI 10.1002/cne.902020407; TSO DY, 1988, J NEUROSCI, V8, P1712; TSO DY, 1986, J NEUROSCI, V6, P1160; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; VONDERMALSBURG C, 1986, BIOL CYBERN, V54, P29, DOI 10.1007/BF00337113; WALL PD, 1976, J PHYSIOL-LONDON, V255, P321, DOI 10.1113/jphysiol.1976.sp011282; WEINBERG RJ, 1990, J COMP NEUROL, V300, P113, DOI 10.1002/cne.903000108; WELLER RE, 1984, J COMP NEUROL, V228, P81, DOI 10.1002/cne.902280109; WESTHEIMER G, 1986, J PHYSIOL-LONDON, V370, P619, DOI 10.1113/jphysiol.1986.sp015954; WESTHEIMER G, 1977, VISION RES, V17, P941, DOI 10.1016/0042-6989(77)90069-4; WESTHEIMER G, 1976, J OPT SOC AM, V66, P332, DOI 10.1364/JOSA.66.000332; WESTHEIMER G, 1990, VISION RES, V30, P1913, DOI 10.1016/0042-6989(90)90167-J; YARBUS A. L., 1957, BIOFIZIKA [TRANSL], V2, P683; ZEKI S, 1983, NEUROSCIENCE, V9, P741, DOI 10.1016/0306-4522(83)90265-8; ZEKI SM, 1976, PROC R SOC SER B-BIO, V193, P199, DOI 10.1098/rspb.1976.0040; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0; [No title captured]	104	344	348	1	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					1	13		10.1016/0896-6273(92)90215-Y	http://dx.doi.org/10.1016/0896-6273(92)90215-Y			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1632964				2022-12-28	WOS:A1992JE75600001
J	DUGICHDJORDJEVIC, MM; TOCCO, G; WILLOUGHBY, DA; NAJM, I; PASINETTI, G; THOMPSON, RF; BAUDRY, M; LAPCHAK, PA; HEFTI, F				DUGICHDJORDJEVIC, MM; TOCCO, G; WILLOUGHBY, DA; NAJM, I; PASINETTI, G; THOMPSON, RF; BAUDRY, M; LAPCHAK, PA; HEFTI, F			BDNF MESSENGER-RNA EXPRESSION IN THE DEVELOPING RAT-BRAIN FOLLOWING KAINIC ACID-INDUCED SEIZURE ACTIVITY	NEURON			English	Article							NEUROTROPHIC FACTOR; DENTATE GYRUS; FASCIA DENTATA; CHOLINERGIC INNERVATION; HIPPOCAMPAL FORMATION; DAMAGE SYNDROME; GANGLION-CELLS; NEURONS; RECEPTORS; FOREBRAIN	Brain-derived neurotrophic factor (BDNF) mRNA expression was studied in the hippocampus at various developmental stages in normal rats and following kainic acid (KA)-induced seizure activity. Systemic administration of KA strongly elevated BDNF mRNA levels in all hippocampal subregions after postnatal day 21. In contrast, even though KA induced intense behavioral seizure activity at postnatal day 8, the seizures were not associated with elevations of BDNF mRNA levels, indicating a clear dissociation between behavioral seizures and increases in BDNF mRNA levels and contradicting the view that BDNF mRNA expression is principally regulated by neuronal activity. In the dentate gyrus at postnatal day 13, intense BDNF mRNA expression was limited to a defined area at the border between granule cell and molecular layers, suggesting the possibility that segregation of BDNF mRNA into defined subcellular compartments may play a role in establishing the well-delineated patterns of innervation in the hippocampus.	UNIV SO CALIF, DEPT BIOL SCI, LOS ANGELES, CA 90089 USA	University of Southern California	DUGICHDJORDJEVIC, MM (corresponding author), UNIV SO CALIF, ETHEL PERCY ANDRUS GERONTOL CTR, DIV NEUROGERONTOL, LOS ANGELES, CA 90089 USA.		Najm, Imad/R-2143-2019; Lapchak, Paul/P-1845-2019	Lapchak, Paul/0000-0003-4413-7554; Najm, Imad/0000-0001-5192-2089	NIA NIH HHS [AG10480, AG09793] Funding Source: Medline; NINDS NIH HHS [NS22933] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010480, P01AG009793] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; BENARI Y, 1990, TRENDS NEUROSCI, V13, P312, DOI 10.1016/0166-2236(90)90135-W; BLISS TVP, 1974, J PHYSL, V329, pP92; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.neuro.11.1.61; CRAIN B, 1973, BRAIN RES, V63, P195, DOI 10.1016/0006-8993(73)90088-7; DAVENPORT CJ, 1990, EXP NEUROL, V109, P180, DOI 10.1016/0014-4886(90)90072-Z; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DUGICHDJORDJEVIC MM, 1992, NEUROSCIENCE, V47, P303, DOI 10.1016/0306-4522(92)90246-X; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; FRICKE R, 1977, J COMP NEUROL, V173, P231, DOI 10.1002/cne.901730203; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; HEFTI F, 1992, IN PRESS NEUROTROPHI; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; INSEL TR, 1990, NEUROSCIENCE, V35, P31, DOI 10.1016/0306-4522(90)90117-M; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503; KALCHEIM C, 1987, EMBO J, V6, P2871, DOI 10.1002/j.1460-2075.1987.tb02589.x; KANAYAIDA S, 1989, NEUROSCI LETT, V101, P23, DOI 10.1016/0304-3940(89)90434-5; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; LAPCHAK PA, 1992, IN PRESS TREATMENT D; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; LOY R, 1977, BRAIN RES, V121, P229, DOI 10.1016/0006-8993(77)90149-4; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MATTHEWS DA, 1974, DEV BIOL, V36, P130, DOI 10.1016/0012-1606(74)90196-1; MILLER LP, 1990, NEUROSCIENCE, V35, P45, DOI 10.1016/0306-4522(90)90118-N; MILNER TA, 1983, DEV BRAIN RES, V8, P343, DOI 10.1016/0165-3806(83)90017-2; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; NADLER JV, 1981, J COMP NEUROL, V196, P549, DOI 10.1002/cne.901960404; NADLER JV, 1974, DEV BIOL, V36, P142, DOI 10.1016/0012-1606(74)90197-3; NITECKA L, 1984, NEUROSCIENCE, V13, P1073, DOI 10.1016/0306-4522(84)90289-6; PASINETTI GM, 1989, PHARMACOL RES, V21, P299, DOI 10.1016/S1043-6618(89)80008-8; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; SHELTON DL, 1979, BRAIN RES, V163, P263, DOI 10.1016/0006-8993(79)90354-8; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; TREMBLAY E, 1984, NEUROSCIENCE, V13, P1051, DOI 10.1016/0306-4522(84)90288-4; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZIMMER J, 1978, J COMP NEUROL, V179, P581, DOI 10.1002/cne.901790309	53	162	162	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1992	8	6					1127	1138		10.1016/0896-6273(92)90133-X	http://dx.doi.org/10.1016/0896-6273(92)90133-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1610567				2022-12-28	WOS:A1992JA42900012
J	MATHIE, A; BERNHEIM, L; HILLE, B				MATHIE, A; BERNHEIM, L; HILLE, B			INHIBITION OF N-TYPE AND L-TYPE CALCIUM CHANNELS BY MUSCARINIC RECEPTOR ACTIVATION IN RAT SYMPATHETIC NEURONS	NEURON			English	Article							CHICK SENSORY NEURONS; CA-CHANNEL; MODULATION; CURRENTS; RELEASE; CA-2+; NORADRENALINE; SOMATOSTATIN; CELLS	Modulation of N- and L-type Ca2+ channels by oxotremorine-M (oxo-M) acting on muscarinic receptors and norepinephrine (NE) acting on alpha-adrenergic receptors was studied in superior cervical ganglion neurons. Oxo-M depresses dihydropyridine-augmented tail currents in whole-cell recordings, whereas NE does not. This modulation of L-type Ca2+ channels by oxo-M is abolished by adding 20 mM BAPTA to the pipette solution. Oxo-M, acting via a diffusible messenger, reduces the probability of opening of single N- and L-type channels recorded in cell-attached patches. We conclude that a diffusible messenger signaling pathway activated by oxo-M inhibits both N- and L-type Ca2+ channels, whereas a membrane-delimited pathway activated by oxo-M and NE inhibits only N-type Ca2+ channels.	UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195	University of Washington; University of Washington Seattle			Mathie, Alistair/K-7198-2019	Mathie, Alistair/0000-0001-6094-2890	FIC NIH HHS [F05-TWO4457] Funding Source: Medline; NINDS NIH HHS [NS 08174] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F05TW004457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BLEY KR, 1990, NEURON, V4, P379, DOI 10.1016/0896-6273(90)90050-P; BROWN AM, 1991, FASEB J, V5, P2175, DOI 10.1096/fasebj.5.8.1708737; CAULFIELD MP, 1991, NEUROSCI LETT, V127, P165, DOI 10.1016/0304-3940(91)90785-R; COLQUHOUN D, 1983, SINGLE CHANNEL RECOR, P345; DOLPHIN AC, 1991, BIOCHIM BIOPHYS ACTA, V1091, P68, DOI 10.1016/0167-4889(91)90224-L; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; EDMONDS B, 1990, SCIENCE, V250, P1142, DOI 10.1126/science.2174573; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; JONES SW, 1990, J NEUROSCI, V10, P2261; KONGSAMUT S, 1989, ANN NY ACAD SCI, V560, P312, DOI 10.1111/j.1749-6632.1989.tb24112.x; LACERDA AE, 1989, J GEN PHYSIOL, V93, P1243, DOI 10.1085/jgp.93.6.1243; LANGER SZ, 1981, PHARMACOL REV, V32, P337; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MILLER RJ, 1990, FASEB J, V4, P3291, DOI 10.1096/fasebj.4.15.1979294; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; PLUMMER MR, 1991, NATURE, V351, P657, DOI 10.1038/351657a0; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; SAH DWY, 1990, J NEUROSCI, V10, P136; SCOTT RH, 1987, NATURE, V330, P760, DOI 10.1038/330760a0; SURPRENANT A, 1990, J PHYSIOL-LONDON, V431, P585, DOI 10.1113/jphysiol.1990.sp018349; SWANDULLA D, 1991, TRENDS NEUROSCI, V14, P46, DOI 10.1016/0166-2236(91)90018-P; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313	40	105	105	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					907	914		10.1016/0896-6273(92)90205-R	http://dx.doi.org/10.1016/0896-6273(92)90205-R			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1316767				2022-12-28	WOS:A1992HV46700010
J	MULLE, C; LENA, C; CHANGEUX, JP				MULLE, C; LENA, C; CHANGEUX, JP			POTENTIATION OF NICOTINIC RECEPTOR RESPONSE BY EXTERNAL CALCIUM IN RAT CENTRAL NEURONS	NEURON			English	Article							SYMPATHETIC-GANGLION NEURONS; ACETYLCHOLINE-RECEPTOR; DIVALENT-CATIONS; ENDPLATE CHANNELS; POTASSIUM CHANGES; AMINO-ACIDS; CURRENTS; CONDUCTANCE; PROTEIN; CELLS	Nicotinic acetylcholine receptor (nAChR) responses of rat medial habenular neurons are potentiated up to 3.5-fold by increasing the concentration of external Ca2+ in the millimolar range. This effect, independent of voltage, is probably due to the binding of Ca2+ to an external site. External Ca2+ decreases nAChR single-channel conductance at negative but not positive potentials, and it markedly enhances the frequency of opening of acetylcholine activated channels. The potentiating effect of Ca2+ is mimicked by Ba2+ and Sr2+, but barely by Mg2+. These data support the existence of positively acting allosteric sites for Ca2+, distinct from those involved in the decrease of single-channel conductance. A model in which external Ca2+ changes the properties of activation of the nAChR appears consistent with these data.			MULLE, C (corresponding author), INST PASTEUR, DEPT BIOTECHNOL, NEUROBIOL MOLEC LAB, CNRS, UA D1284, F-75724 PARIS 15, FRANCE.		Léna, Clément/T-8458-2018; Léna, Clément/P-6929-2019; , clement/ADN-8076-2022; Léna, Clément/ABE-4862-2021	Léna, Clément/0000-0002-1431-7717; Léna, Clément/0000-0002-1431-7717; Léna, Clément/0000-0002-1431-7717; Mulle, Christophe/0000-0003-2709-6615				ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BENNINGER C, 1980, BRAIN RES, V187, P165, DOI 10.1016/0006-8993(80)90502-8; BREGESTOVSKI PD, 1979, NATURE, V279, P638, DOI 10.1038/279638a0; CHANGEUX JP, 1981, HARVEY LECT, V75, P85; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COLQUHOUN D, 1988, J PHYSL, V395, P151; CONNOR EA, 1985, BRAIN RES, V339, P227, DOI 10.1016/0006-8993(85)90087-3; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; DECKER ER, 1990, J NEUROSCI, V10, P3413; DENERIS ES, 1991, TRENDS PHARMACOL SCI, V12, P34, DOI 10.1016/0165-6147(91)90486-C; DOWNING JEG, 1987, P NATL ACAD SCI USA, V84, P7739, DOI 10.1073/pnas.84.21.7739; FIEBER LA, 1991, J PHYSIOL-LONDON, V434, P215, DOI 10.1113/jphysiol.1991.sp018466; GALZI JL, 1991, ANNU REV PHARMACOL, V31, P37, DOI 10.1146/annurev.pa.31.040191.000345; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; INOUE M, 1986, NATURE, V324, P156, DOI 10.1038/324156a0; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; LIPTON SA, 1987, PFLUG ARCH EUR J PHY, V410, P37, DOI 10.1007/BF00581893; LUETJE CW, 1991, J NEUROSCI, V11, P837; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; MATHIE A, 1990, J PHYSIOL-LONDON, V427, P625, DOI 10.1113/jphysiol.1990.sp018191; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MILEDI R, 1980, J PHYSIOL-LONDON, V300, P197, DOI 10.1113/jphysiol.1980.sp013158; MULLE C, 1990, J NEUROSCI, V10, P169; MULLE C, 1991, J NEUROSCI, V11, P2588; MULLE C, 1992, NEURON, V8, P135, DOI 10.1016/0896-6273(92)90115-T; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; OWEN DG, 1984, NATURE, V311, P567, DOI 10.1038/311567a0; PETERS JA, 1988, EUR J PHARMACOL, V151, P491, DOI 10.1016/0014-2999(88)90550-X; PUMAIN R, 1987, CAN J PHYSIOL PHARM, V65, P1067, DOI 10.1139/y87-168; PUMAIN R, 1985, J NEUROPHYSIOL, V53, P1; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; STELZER A, 1988, SCIENCE, V241, P339, DOI 10.1126/science.2455347; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S	38	165	167	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1992	8	5					937	945		10.1016/0896-6273(92)90208-U	http://dx.doi.org/10.1016/0896-6273(92)90208-U			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1586487				2022-12-28	WOS:A1992HV46700013
J	WELSH, MJ; ANDERSON, MP; RICH, DP; BERGER, HA; DENNING, GM; OSTEDGAARD, LS; SHEPPARD, DN; CHENG, SH; GREGORY, RJ; SMITH, AE				WELSH, MJ; ANDERSON, MP; RICH, DP; BERGER, HA; DENNING, GM; OSTEDGAARD, LS; SHEPPARD, DN; CHENG, SH; GREGORY, RJ; SMITH, AE			CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR - A CHLORIDE CHANNEL WITH NOVEL REGULATION	NEURON			English	Review							GENE; IDENTIFICATION; TRANSPORT; EXPRESSION; CAMP		GENZYME CORP, FRAMINGHAM, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation	WELSH, MJ (corresponding author), UNIV IOWA, COLL MED, HOWARD HUGHES MED INST, DEPT INTERNAL MED, DEPT PHYSIOL & BIOPHYS, IOWA CITY, IA 52242 USA.		Sheppard, David N/AAV-4187-2021; Cheng, Seng H/AAC-6564-2022	Sheppard, David N/0000-0001-5533-9130; Berger, Herbert/0000-0003-4383-2643; Anderson, Matthew/0000-0003-4602-1811; Welsh, Michael/0000-0002-1646-6206; Ostedgaard, Lynda/0000-0001-7717-3442				AMES GF, 1990, FEMS MICROBIOL LETT, V75, P429, DOI 10.1016/S0168-6445(05)80008-7; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; ANDERSON MP, IN PRESS AM J PHYSL; ARISPE N, 1992, P NATL ACAD SCI USA, V89, P1539, DOI 10.1073/pnas.89.5.1539; ASHCROFT SJH, 1990, CELL SIGNAL, V2, P197, DOI 10.1016/0898-6568(90)90048-F; BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; BEAR C E, 1992, Biophysical Journal, V61, pA127; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BEAR CE, 1991, J BIOL CHEM, V266, P19142; BEAR CE, 1992, AM J PHYSIOL, V262, pC251, DOI 10.1152/ajpcell.1992.262.1.C251; BERGER HA, 1991, J CLIN INVEST, V88, P1422, DOI 10.1172/JCI115450; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; CLIFF WH, 1990, P NATL ACAD SCI USA, V87, P4956, DOI 10.1073/pnas.87.13.4956; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; FRIZZELL RA, 1990, CURRENT TOPICS MEMBR, V37, P247; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KERPPOLA RE, 1992, J BIOL CHEM, V267, P2329; MARINO CR, 1991, J CLIN INVEST, V88, P712, DOI 10.1172/JCI115358; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; MIMURA CS, 1991, P NATL ACAD SCI USA, V88, P84, DOI 10.1073/pnas.88.1.84; QUINTON PM, 1990, NATURE, V347, P226, DOI 10.1038/347226a0; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1991, P NATL ACAD SCI USA, V88, P7500, DOI 10.1073/pnas.88.17.7500; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; TABCHARANI JA, 1990, FEBS LETT, V270, P157, DOI 10.1016/0014-5793(90)81257-O; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; TILLY BC, IN PRESS J BIOL CHEM; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; Tsui L C, 1991, Adv Hum Genet, V20, P153; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; ZHANG JT, 1991, J BIOL CHEM, V266, P18224	48	210	219	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1992	8	5					821	829		10.1016/0896-6273(92)90196-K	http://dx.doi.org/10.1016/0896-6273(92)90196-K			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1375035				2022-12-28	WOS:A1992HV46700001
J	BEECH, DJ; BERNHEIM, L; HILLE, B				BEECH, DJ; BERNHEIM, L; HILLE, B			PERTUSSIS TOXIN AND VOLTAGE DEPENDENCE DISTINGUISH MULTIPLE PATHWAYS MODULATING CALCIUM CHANNELS OF RAT SYMPATHETIC NEURONS	NEURON			English	Article							NEUROTRANSMITTER RECEPTORS; GANGLION NEURONS; BINDING-PROTEINS; ION CHANNELS; ACETYLCHOLINE; INHIBITION; CURRENTS; CELLS; MODES	Agonist-induced suppression of current in voltage-gated Ca2+ channels was studied in rat sympathetic neurons. We have previously distinguished two intracellular signaling pathways used by muscarinic agonists to suppress neuronal Ca2+ current-one fast and membrane delimited, the other slow and acting via a diffusible second messenger. We now show that the fast pathway is sensitive mainly to pertussis toxin and shifts the gating of Ca2+ channels to more positive voltages (voltage dependent). The slow pathway is pertussis toxin insensitive and depresses currents at all test potentials (voltage independent). Muscarinic agonists may also activate a pertussis toxin-insensitive fast pathway. Alpha-adrenergic agonists use the fast pertussis toxin-sensitive and the fast insensitive pathways, but not the slow one.	UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195	University of Washington; University of Washington Seattle				Beech, David/0000-0002-7683-9422	NINDS NIH HHS [NS 08174] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASHKENAZI A, 1989, TRENDS PHARM SCI S, V10, P16; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BLEY KR, 1990, NEURON, V2, P379; BROWN DA, 1989, J PHYSIOL-LONDON, V413, P469, DOI 10.1113/jphysiol.1989.sp017664; CARBONE E, 1989, PROG BIOPHYS MOL BIO, V54, P31, DOI 10.1016/0079-6107(89)90008-4; DOLPHIN AC, 1991, BIOCHIM BIOPHYS ACTA, V1091, P68, DOI 10.1016/0167-4889(91)90224-L; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; GALVAN M, 1982, BRAIN RES, V244, P135, DOI 10.1016/0006-8993(82)90911-8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTZELL HC, 1988, PROG BIOPHYS MOL BIO, V52, P165, DOI 10.1016/0079-6107(88)90014-4; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; JONES SW, 1991, BIOPHYS J, V60, P502, DOI 10.1016/S0006-3495(91)82077-X; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; MARRION NV, 1987, NEUROSCI LETT, V77, P55, DOI 10.1016/0304-3940(87)90606-9; MATTESON DR, 1986, J GEN PHYSIOL, V87, P161, DOI 10.1085/jgp.87.1.161; MCCORMICK DA, 1989, TRENDS NEUROSCI, V12, P215, DOI 10.1016/0166-2236(89)90125-2; MILLIGAN G, 1988, BIOCHEM J, V255, P1; NATHANSON NM, 1987, ANNU REV NEUROSCI, V10, P195, DOI 10.1146/annurev.ne.10.030187.001211; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; SONG SY, 1989, BRAIN RES, V494, P383, DOI 10.1016/0006-8993(89)90609-4; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TSIEN RW, 1987, NEUROMODULATION BIOC, P206; WANKE E, 1987, P NATL ACAD SCI USA, V84, P4313, DOI 10.1073/pnas.84.12.4313; YUE DT, 1990, P NATL ACAD SCI USA, V87, P753, DOI 10.1073/pnas.87.2.753	33	186	191	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1992	8	1					97	106		10.1016/0896-6273(92)90111-P	http://dx.doi.org/10.1016/0896-6273(92)90111-P			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1346090				2022-12-28	WOS:A1992HB18500008
J	KRAMER, RH; KACZMAREK, LK; LEVITAN, ES				KRAMER, RH; KACZMAREK, LK; LEVITAN, ES			NEUROPEPTIDE INHIBITION OF VOLTAGE-GATED CALCIUM CHANNELS MEDIATED BY MOBILIZATION OF INTRACELLULAR CALCIUM	NEURON			English	Article							THYROTROPIN-RELEASING-HORMONE; PROTEIN KINASE-C; CLONAL PITUITARY-CELLS; GH3 CELLS; SENSORY NEURONS; WHOLE-CELL; CURRENTS; ACTIVATION; MODULATION; CA-2+	Many neurotransmitters and hormones regulate secretion from endocrine cells and neurons by modulating voltage-gated Ca2+ channels. One proposed mechanism of neurotransmitter inhibition involves protein kinase C, activated by diacylgycerol, a product of phosphotidylinositol hydrolysis. Here we show that thyrotropin-releasing hormone (TRH), a neuropeptide that modulates hormone secretion from pituitary tumor cells, inhibits Ca2+ channels via the other limb of the phosphotidylinositol signaling system: TRH causes inositol trisphosphate-triggered Ca2+ release from intracellular organelles, thus causing Ca2+-dependent inactivation of Ca2+ channels. Elevation of intracellular Ca2+ concentration is coincident with the onset of TRH-induced inhibition and is necessary and sufficient for its occurrence. The inhibition is blocked by introducing Ca2+ buffers into cells and mimicked by a variety of agents that mobilize Ca2+. Treatments that suppress protein kinase C have no effect on the inhibition. Hence inactivation of Ca2+ channels occurs not only as a result of Ca2+ influx through plasma membrane channels, but also via neurotransmitter-induced Ca2+ mobilization. This phenomenon may be common but overlooked because of the routine use of Ca2+ buffers in patch-clamp electrodes.	COLUMBIA UNIV COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510	Columbia University; Yale University	KRAMER, RH (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032, USA.		Tuluc, Petronel/C-2527-2011					ALBERT PR, 1984, J BIOL CHEM, V259, P5350; ARMSTRONG D, 1987, P NATL ACAD SCI USA, V84, P2518, DOI 10.1073/pnas.84.8.2518; ARMSTRONG D, 1988, CALCIUM ION CHANNEL, P215; BALLESTER R, 1985, J BIOL CHEM, V260, P5194; BAUER CK, 1990, J PHYSIOL-LONDON, V429, P169, DOI 10.1113/jphysiol.1990.sp018250; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BENHAM CD, 1989, J PHYSIOL-LONDON, V415, P143, DOI 10.1113/jphysiol.1989.sp017716; BURGOYNE RD, 1989, NATURE, V342, P72, DOI 10.1038/342072a0; DUBINSKY JM, 1985, P NATL ACAD SCI USA, V82, P4282, DOI 10.1073/pnas.82.12.4282; DUFY B, 1979, SCIENCE, V204, P509, DOI 10.1126/science.107590; DUFY B, 1987, ENDOCRINOLOGY, V121, P793, DOI 10.1210/endo-121-2-793; DUFY B, 1986, BIOCHEM BIOPH RES CO, V137, P338; ECKERT R, 1984, PROG BIOPHYS MOL BIO, V44, P215, DOI 10.1016/0079-6107(84)90009-9; FISHER SK, 1987, J NEUROCHEM, V48, P999, DOI 10.1111/j.1471-4159.1987.tb05618.x; GERSHENGORN MC, 1986, ANNU REV PHYSIOL, V48, P515; GERSHENGORN MC, 1989, SECRETION ITS CONTRO, P1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HOCKBERGER P, 1989, NATURE, V338, P340, DOI 10.1038/338340a0; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; KALMAN D, 1988, J GEN PHYSIOL, V92, P531, DOI 10.1085/jgp.92.4.531; KORN SJ, 1989, J GEN PHYSIOL, V94, P789, DOI 10.1085/jgp.94.5.789; LEVITAN ES, 1990, NATURE, V348, P545, DOI 10.1038/348545a0; MARCHETTI C, 1988, AM J PHYSIOL, V254, pC206, DOI 10.1152/ajpcell.1988.254.1.C206; MASON WT, 1988, J EXP BIOL, V139, P287; MATTESON DR, 1986, J GEN PHYSIOL, V87, P161, DOI 10.1085/jgp.87.1.161; MOLLARD P, 1988, J BIOL CHEM, V263, P19570; OZAWA S, 1986, PHYSIOL REV, V66, P887, DOI 10.1152/physrev.1986.66.4.887; PAUPARDINTRITSCH D, 1986, J NEUROSCI, V6, P2715; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RANE SG, 1986, P NATL ACAD SCI USA, V83, P184, DOI 10.1073/pnas.83.1.184; RITCHIE AK, 1987, J PHYSIOL-LONDON, V385, P611, DOI 10.1113/jphysiol.1987.sp016510; SIMASKO SM, 1988, AM J PHYSIOL, V254, pE328, DOI 10.1152/ajpendo.1988.254.3.E328; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THAYER SA, 1988, J NEUROSCI, V8, P4089; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; VACHER P, 1989, AM J PHYSIOL, V257, pE203, DOI 10.1152/ajpendo.1989.257.2.E203; WINICOV I, 1988, J BIOL CHEM, V263, P12179; YATANI A, 1989, SCIENCE, V245, P71, DOI 10.1126/science.2544999	42	67	67	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					557	563		10.1016/0896-6273(91)90058-8	http://dx.doi.org/10.1016/0896-6273(91)90058-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	1849723				2022-12-28	WOS:A1991FH80200007
J	SELKOE, DJ				SELKOE, DJ			THE MOLECULAR PATHOLOGY OF ALZHEIMERS-DISEASE	NEURON			English	Review							PAIRED HELICAL FILAMENTS; BETA-PROTEIN-PRECURSOR; SHARE ANTIGENIC DETERMINANTS; BRAIN AMYLOID DEPOSITS; SENILE PLAQUE NEURITES; NEUROFIBRILLARY TANGLES; MESSENGER-RNA; TAU-PROTEIN; CEREBRAL AMYLOIDOSIS; PREAMYLOID DEPOSITS				SELKOE, DJ (corresponding author), HARVARD UNIV,BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,SCH MED,BOSTON,MA 02115, USA.							ABRAHAM CR, 1990, NEUROBIOL AGING, V11, P123, DOI 10.1016/0197-4580(90)90045-2; ABRAHAM CR, 1989, NEUROSCIENCE, V32, P715, DOI 10.1016/0306-4522(89)90292-3; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; ANDERTON BH, 1982, NATURE, V298, P84, DOI 10.1038/298084a0; BAHMANYAR S, 1987, SCIENCE, V237, P77, DOI 10.1126/science.3299701; BOWEN DM, 1988, AGE, V11, P104, DOI 10.1007/BF02431748; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; BRION JP, 1985, ADV APPLIED NEUROLOG, P164; CASTANO EM, 1986, BIOCHEM BIOPH RES CO, V141, P782, DOI 10.1016/S0006-291X(86)80241-8; COHEN ML, 1988, P NATL ACAD SCI USA, V85, P1227, DOI 10.1073/pnas.85.4.1227; CORIA F, 1988, LAB INVEST, V58, P454; CORK LC, 1986, J NEUROPATH EXP NEUR, V45, P56, DOI 10.1097/00005072-198601000-00005; DAMATO RJ, 1987, ANN NEUROL, V22, P229, DOI 10.1002/ana.410220207; DAVIES P, 1980, NATURE, V288, P279, DOI 10.1038/288279a0; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; EIDELBERG D, 1987, BRAIN, V110, P993, DOI 10.1093/brain/110.4.993; EIKELENBOOM P, 1982, ACTA NEUROPATHOL, V57, P239, DOI 10.1007/BF00685397; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GIACCONE G, 1989, NEUROSCI LETT, V97, P232, DOI 10.1016/0304-3940(89)90169-9; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOREVIC PD, 1986, J NEUROPATH EXP NEUR, V45, P647, DOI 10.1097/00005072-198611000-00004; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P493; HART MN, 1988, AM J PATHOL, V132, P167; HIGGINS GA, 1988, P NATL ACAD SCI USA, V85, P1297, DOI 10.1073/pnas.85.4.1297; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; IHARA Y, 1981, P JPN ACAD B-PHYS, V57, P152, DOI 10.2183/pjab.57.152; IHARA Y, 1983, NATURE, V304, P727, DOI 10.1038/304727a0; ISHII T, 1984, ACTA NEUROPATHOL, V63, P296, DOI 10.1007/BF00687336; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; IVERSEN LL, 1983, NEUROSCI LETT, V39, P95, DOI 10.1016/0304-3940(83)90171-4; JOACHIM C, 1991, AM J PATHOL, V138, P373; JOACHIM CL, 1988, BRAIN RES, V474, P100, DOI 10.1016/0006-8993(88)90673-7; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; JOACHIM CL, 1989, AM J PATHOL, V135, P309; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; KIRSCHNER DA, 1986, P NATL ACAD SCI USA, V83, P503, DOI 10.1073/pnas.83.2.503; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KLIER FG, 1990, BRAIN RES, V515, P336, DOI 10.1016/0006-8993(90)90619-M; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; KOWALL NW, 1988, ANN NEUROL, V23, P105, DOI 10.1002/ana.410230202; KSIEZAKREDING H, 1988, J BIOL CHEM, V263, P7943; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MANN DMA, 1989, NEUROBIOL AGING, V10, P397, DOI 10.1016/0197-4580(89)90073-0; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCGEER PL, 1989, CAN J NEUROL SCI, V16, P516, DOI 10.1017/S0317167100029863; MIYAKAWA T, 1982, VIRCHOWS ARCH B, V40, P121, DOI 10.1007/BF02932857; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; MOTTE J, 1989, ACTA NEUROPATHOL, V77, P535, DOI 10.1007/BF00687256; NUKINA N, 1987, P NATL ACAD SCI USA, V84, P3415, DOI 10.1073/pnas.84.10.3415; NUKINA N, 1988, NEUROSCI LETT, V87, P240, DOI 10.1016/0304-3940(88)90455-7; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; OGOMORI K, 1989, AM J PATHOL, V134, P243; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033; PODLISNY MB, 1991, IN PRESS AM J PATHOL; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; PRICE DL, 1986, ANNU REV NEUROSCI, V9, P489; PROBST A, 1989, ACTA NEUROPATHOL, V77, P430, DOI 10.1007/BF00687379; RASOOL CG, 1984, BRAIN RES, V310, P249; RASOOL CG, 1986, ANN NEUROL, V20, P482, DOI 10.1002/ana.410200407; ROSSOR MN, 1984, BRIT MED J, V288, P961, DOI 10.1136/bmj.288.6422.961; ROZEMULLER JM, 1990, NEUROSCI LETT, V119, P75, DOI 10.1016/0304-3940(90)90759-3; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SALBAUM JM, 1988, EMBO J, V7, P2807, DOI 10.1002/j.1460-2075.1988.tb03136.x; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHUBERT D, 1988, SCIENCE, V241, P223, DOI 10.1126/science.2968652; SCHUBERT D, 1989, NEURON, V3, P689, DOI 10.1016/0896-6273(89)90237-7; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; SELKOE DJ, 1989, NEUROBIOL AGING, V10, P387, DOI 10.1016/0197-4580(89)90072-9; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; SHIVERS BD, 1988, EMBO J, V7, P1365, DOI 10.1002/j.1460-2075.1988.tb02952.x; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SINHA S, 1990, J BIOL CHEM, V265, P8983; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; SNOW AD, 1988, AM J PATHOL, V133, P456; STERNBERGER NH, 1985, P NATL ACAD SCI USA, V82, P4274, DOI 10.1073/pnas.82.12.4274; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STRUBLE RG, 1987, J NEUROPATH EXP NEUR, V46, P567, DOI 10.1097/00005072-198709000-00006; TAGLIAVINI F, 1988, NEUROSCI LETT, V93, P191, DOI 10.1016/0304-3940(88)90080-8; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TERRY RD, 1963, J NEUROPATH EXP NEUR, V22, P629, DOI 10.1097/00005072-196310000-00005; UEDA K, 1990, J NEUROSCI, V10, P3295; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; VANNOSTRAND WE, 1989, NATURE, V341, P546; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WHITSON JS, 1989, SCIENCE, V243, P1488, DOI 10.1126/science.2928783; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WISNIEWSKI H, 1970, LAB INVEST, V23, P287; WISNIEWSKI HM, 1973, J NEUROPATH EXP NEUR, V32, P566, DOI 10.1097/00005072-197310000-00007; WISNIEWSKI HM, 1989, CAN J NEUROL SCI, V16, P535, DOI 10.1017/S0317167100029887; WISNIEWSKI K, 1979, ANN NEUROL, V5, P288, DOI 10.1002/ana.410050311; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040; YAMADA T, 1987, BIOCHEM BIOPH RES CO, V149, P665, DOI 10.1016/0006-291X(87)90419-0; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V77, P113; YAMAGUCHI H, 1990, BRAIN RES, V508, P320, DOI 10.1016/0006-8993(90)90416-9; YAMAGUCHI H, 1989, ACTA NEUROPATHOL, V77, P314, DOI 10.1007/BF00687584; YAMAGUCHI H, 1989, AM J PATHOL, V135, P593; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; ZHANG H, 1989, P NATL ACAD SCI USA, V86, P8045, DOI 10.1073/pnas.86.20.8045	122	2196	2352	3	298	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					487	498		10.1016/0896-6273(91)90052-2	http://dx.doi.org/10.1016/0896-6273(91)90052-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	1673054				2022-12-28	WOS:A1991FH80200001
J	KEY, B; AKESON, RA				KEY, B; AKESON, RA			DELINEATION OF OLFACTORY PATHWAYS IN THE FROG NERVOUS-SYSTEM BY UNIQUE GLYCOCONJUGATES AND N-CAM GLYCOFORMS	NEURON			English	Article							CELL-ADHESION MOLECULE; NEURONAL GROWTH CONES; VERTEBRATE NEURAL DEVELOPMENT; MONOCLONAL-ANTIBODY BINDING; GRASSHOPPER EMBRYOS; SYNTHETIC PEPTIDES; SIALYLATION STATE; XENOPUS-LAEVIS; SPINAL-CORD; GLYCOPROTEIN	The olfactory neuroepithelium, which contains the primary sensory olfactory neurons, continually undergoes neurogenesis and axonal outgrowth throughout life. We describe here several new olfactory system-specific glycoforms of the neural cell adhesion molecule N-CAM in the frog, R. catesbeiana. Using immunochemical methods for in situ localization, we show that the lectin dolichos biflorus agglutinin (DBA) and two monoclonal antibodies, 9OE and 3A6, detect three unique N-CAM forms present on primary sensory olfactory axons. In addition, DBA and monoclonal antibody 9OE recognize glycoconjugates and/or N-CAM glycoforms expressed specifically in discrete central olfactory pathways and regions in frog brain. This is a novel example of unique adhesion molecule forms present in a chain of two neurons within a vertebrate neural pathway. Together these glycoconjugates and N-CAM glycoforms may participate in cellular interactions associated with olfactory system pathway formation and renewal.			KEY, B (corresponding author), CHILDRENS HOSP RES FDN,DIV BASIC RES,CINCINNATI,OH 45229, USA.			Key, Brian/0000-0002-1150-3848	NICHD NIH HHS [HD-21065] Funding Source: Medline; NIDCD NIH HHS [DC-00347] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021065] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BREEN KC, 1988, DEVELOPMENT, V104, P147; BREEN KC, 1987, J NEUROCHEM, V48, P1486, DOI 10.1111/j.1471-4159.1987.tb05690.x; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; COLE GJ, 1987, NEUROSCI LETT, V78, P227, DOI 10.1016/0304-3940(87)90638-0; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EDELMAN GM, 1988, BIOCHEMISTRY-US, V27, P3533, DOI 10.1021/bi00410a001; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; GOWER HJ, 1988, CELL, V55, P55; GRAZIADEI PP, 1973, TISSUE CELL, V5, P113, DOI 10.1016/S0040-8166(73)80010-2; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; Herrick CJ, 1921, J COMP NEUROL, V33, P213, DOI 10.1002/cne.900330303; Herrick CJ, 1927, J COMP NEUROL, V43, P231, DOI 10.1002/cne.900430204; HODGES RS, 1988, J BIOL CHEM, V263, P11768; HOFFMAN HH, 1963, J COMP NEUROL, V120, P317, DOI 10.1002/cne.901200208; HOFFMANN A, 1973, ACTA ANAT, V84, P416; HOLDER N, 1987, DEVELOPMENT, V99, P577; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; KATZ MJ, 1979, J COMP NEUROL, V183, P817, DOI 10.1002/cne.901830409; KELLER F, 1989, NEURON, V3, P551, DOI 10.1016/0896-6273(89)90265-1; KEY B, 1990, J CELL BIOL, V110, P1729, DOI 10.1083/jcb.110.5.1729; KEY B, 1990, DEV BRAIN RES, V57, P103, DOI 10.1016/0165-3806(90)90190-A; KEY B, 1986, NEUROSCIENCE, V18, P507, DOI 10.1016/0306-4522(86)90171-5; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; LEVI G, 1987, J CELL BIOL, V105, P2359, DOI 10.1083/jcb.105.5.2359; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; MOLDAY RS, 1985, BIOCHEMISTRY-US, V24, P776, DOI 10.1021/bi00324a036; PLENDL J, 1988, ANAT EMBRYOL, V177, P459, DOI 10.1007/BF00304744; POLLERBERG EG, 1985, J CELL BIOL, V101, P1921, DOI 10.1083/jcb.101.5.1921; RAPER JA, 1984, J NEUROSCI, V4, P2329; RAPER JA, 1983, J NEUROSCI, V3, P31; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; REYES AA, 1991, IN PRESS MOL CELL BI; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; SANTONI MJ, 1989, EMBO J, V8, P385, DOI 10.1002/j.1460-2075.1989.tb03389.x; SINGER M, 1979, J COMP NEUROL, V185, P1, DOI 10.1002/cne.901850102; SMALL SJ, 1987, J CELL BIOL, V105, P2335, DOI 10.1083/jcb.105.5.2335; SMALL SJ, 1990, J CELL BIOL, V111, P2089, DOI 10.1083/jcb.111.5.2089; SMALL SJ, 1988, NEURON, V1, P1007, DOI 10.1016/0896-6273(88)90158-4; STALLCUP WB, 1985, J NEUROSCI, V5, P1090; SUNSHINE J, 1987, P NATL ACAD SCI USA, V84, P5986, DOI 10.1073/pnas.84.16.5986; TAKAGI S, 1987, DEV BIOL, V122, P90, DOI 10.1016/0012-1606(87)90335-6; THOMPSON J, 1989, GENE DEV, V3, P348, DOI 10.1101/gad.3.3.348; WALSH FS, 1989, DEVELOPMENT, V105, P803; WILLIAMS RK, 1985, J CELL BIOL, V101, P36, DOI 10.1083/jcb.101.1.36; WIRSIG CR, 1986, BRAIN RES, V385, P10, DOI 10.1016/0006-8993(86)91541-6; YAVIN E, 1983, J NEUROSCI RES, V9, P229, DOI 10.1002/jnr.490090302; ZIPSER B, 1989, NEURON, V3, P621, DOI 10.1016/0896-6273(89)90272-9	52	91	91	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					381	396		10.1016/0896-6273(91)90247-W	http://dx.doi.org/10.1016/0896-6273(91)90247-W			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	2001285				2022-12-28	WOS:A1991FC47000007
J	YUSTE, R; KATZ, LC				YUSTE, R; KATZ, LC			CONTROL OF POSTSYNAPTIC CA2+ INFLUX IN DEVELOPING NEOCORTEX BY EXCITATORY AND INHIBITORY NEUROTRANSMITTERS	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL NERVOUS-SYSTEM; VISUAL-CORTEX; SYNAPTIC TRANSMISSION; NMDA RECEPTORS; HIPPOCAMPAL-NEURONS; PYRAMIDAL CELLS; CALCIUM; CAT; ANTAGONIST	We assessed the pathways by which excitatory and inhibitory neurotransmitters elicit postsynaptic changes in [Ca2+]i in brain slices of developing rat and cat neocortex, using fura 2. Glutamate, NMDA, and quisqualate transiently elevated [Ca2+]i in all neurons. While the quisqualate response relied exclusively on voltage-gated Ca2+ channels, almost all of the NMDA-induced Ca2+ influx was via the NMDA ionophore itself, rather than through voltage-gated Ca2+ channels. Glutamate itself altered [Ca2+]i almost exclusively via the NMDA receptor. Furthermore, synaptically induced Ca2+ entry relied almost completely on NMDA receptor activation, even with low-frequency stimulation. The inhibitory neurotransmitter GABA also increased [Ca2+]i, probably via voltage-sensitive Ca2+ channels, whereas the neuromodulator acetylcholine caused Ca2+ release from intracellular stores via a muscarinic receptor. Low concentrations of these agonists produced nonperiodic [Ca2+]i oscillations, which were temporally correlated in neighboring cells. Optical recording with Ca2+-sensitive indicators may thus permit the visualization of functional networks in developing cortical circuits.	ROCKEFELLER UNIV,NEUROBIOL LAB,NEW YORK,NY 10021	Rockefeller University								ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; ARMSTRONGJAMES M, 1970, Z ZELLFORSCH MIKROSK, V10, P559; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BEAR MF, 1990, J NEUROSCI, V10, P909; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CONNOR JA, 1987, J NEUROSCI, V7, P1384; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; COULTER DA, 1989, ANN NEUROL, V25, P582, DOI 10.1002/ana.410250610; CURTIS DR, 1971, BRAIN RES, V34, P301, DOI 10.1016/0006-8993(71)90283-6; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; ECKERT R, 1984, PROG BIOPHYS MOL BIO, V44, P215, DOI 10.1016/0079-6107(84)90009-9; FOX K, 1989, J NEUROSCI, V9, P2443; GRINVALD A, 1988, PHYSIOL REV, V68, P1285, DOI 10.1152/physrev.1988.68.4.1285; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; JANIGRO D, 1988, DEV BRAIN RES, V41, P171, DOI 10.1016/0165-3806(88)90180-0; JENSEN AM, 1990, J NEUROSCI, V10, P1165; KATZ LC, 1987, J NEUROSCI, V7, P1223; KRIEGSTEIN AR, 1987, DEV BRAIN RES, V34, P161, DOI 10.1016/0165-3806(87)90206-9; KRNJEVIC K, 1987, J MIND BEHAV, V8, P537; LEVRAM V, 1987, BIOPHYS J, V52, P571, DOI 10.1016/S0006-3495(87)83246-0; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, TRENDS NEUROSCI, V12, P444, DOI 10.1016/0166-2236(89)90094-5; MAYER ML, 1985, J PHYSIOL-LONDON, V361, P65, DOI 10.1113/jphysiol.1985.sp015633; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MAYER ML, 1987, J NEUROSCI, V7, P3230; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V393, P743, DOI 10.1113/jphysiol.1987.sp016851; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; NEHER E, 1988, FEBS LETT, V240, P88, DOI 10.1016/0014-5793(88)80345-4; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P925, DOI 10.1152/jn.1965.28.5.925; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; RINK TJ, 1989, TRENDS NEUROSCI, V12, P43, DOI 10.1016/0166-2236(89)90133-1; ROSS WN, 1990, PROC R SOC SER B-BIO, V240, P173, DOI 10.1098/rspb.1990.0032; SCHARFMAN HE, 1985, BRAIN RES, V358, P385, DOI 10.1016/0006-8993(85)90990-4; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P287, DOI 10.1113/jphysiol.1975.sp011055; SILLITO AM, 1977, J PHYSIOL-LONDON, V273, P775, DOI 10.1113/jphysiol.1977.sp012123; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P2834, DOI 10.1073/pnas.85.8.2834; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; UDIN SB, 1990, SCIENCE, V249, P669, DOI 10.1126/science.2166343; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; WIGSTROM H, 1986, ACTA PHYSIOL SCAND, V126, P317, DOI 10.1111/j.1748-1716.1986.tb07822.x; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	58	480	490	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					333	344		10.1016/0896-6273(91)90243-S	http://dx.doi.org/10.1016/0896-6273(91)90243-S			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1672071				2022-12-28	WOS:A1991FC47000003
J	DOHERTY, P; ROWETT, LH; MOORE, SE; MANN, DA; WALSH, FS				DOHERTY, P; ROWETT, LH; MOORE, SE; MANN, DA; WALSH, FS			NEURITE OUTGROWTH IN RESPONSE TO TRANSFECTED N-CAM AND N-CADHERIN REVEALS FUNDAMENTAL DIFFERENCES IN NEURONAL RESPONSIVENESS TO CAMS	NEURON			English	Article							CELL-ADHESION MOLECULE; RETINAL GANGLION-CELLS; CENTRAL NERVOUS-SYSTEM; HOMOPHILIC BINDING; SCHWANN-CELLS; MUSCLE; EXPRESSION; EXTENSION; GUIDANCE; LAMININ	Different neuronal populations were used to compare the neurite outgrowth-promoting activities of N-CAM and N-cadherin expressed via gene transfer on the surface of nonneuronal cells. In contrast to a previously reported developmental loss of retinal ganglion cell responsiveness to N-CAM, these cells exhibited an increased and maintained responsiveness to N-cadherin over the same developmental period (E6-E11). N-CAM and N-cadherin responses could be specifically inhibited by their own antibodies, but not by antisera to the beta-1 integrin family or the L1/G4 glycoprotein. Cerebellar neurons showed qualitative differences in the nature of the dose-response curves for transfected N-CAM expression (highly cooperative) versus N-cadherin expression (linear). In addition "subthreshold" levels of N-CAM expression, which do not normally support neurite outgrowth, did so when coexpressed with functional levels of N-cadherin. These studies show fundamental differences in neuronal responsiveness to cell adhesion molecules and suggest a more dynamic regulation for N-CAM-dependent neurite outgrowth than for N-cadherin-dependent outgrowth.			DOHERTY, P (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT EXPTL PATHOL,LONDON BRIDGE,LONDON SE1 9RT,ENGLAND.		Doherty, Patrick/A-8752-2008	Mann, Derek/0000-0003-0950-243X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARONVANEVERCOOREN A, 1982, J NEUROSCI RES, V8, P179, DOI 10.1002/jnr.490080208; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BLASCHUK OW, 1990, J MOL BIOL, V211, P679, DOI 10.1016/0022-2836(90)90065-T; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; COHEN CS, 1989, CELLULAR BASIS NEURO, P79; COHEN J, 1986, NATURE, V322, P465, DOI 10.1038/322465a0; COLE GJ, 1986, J CELL BIOL, V102, P403, DOI 10.1083/jcb.102.2.403; DICKSON G, 1987, CELL, V50, P1119, DOI 10.1016/0092-8674(87)90178-4; DICKSON G, 1986, J NEUROCHEM, V46, P610; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; DOHERTY P, 1989, J CELL BIOL, V109, P789, DOI 10.1083/jcb.109.2.789; Doherty P, 1989, CURR OPIN CELL BIOL, V1, P1102, DOI 10.1016/S0955-0674(89)80057-2; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; GOWER HJ, 1988, CELL, V55, P955, DOI 10.1016/0092-8674(88)90241-3; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; HATTA K, 1985, P NATL ACAD SCI USA, V82, P2789, DOI 10.1073/pnas.82.9.2789; HATTA K, 1988, J CELL BIOL, V106, P873, DOI 10.1083/jcb.106.3.873; HAYASHI Y, 1990, J CELL BIOL, V110, P175, DOI 10.1083/jcb.110.1.175; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; JAFFE SH, 1990, P NATL ACAD SCI USA, V87, P3589, DOI 10.1073/pnas.87.9.3589; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANKFORD KL, 1988, P NATL ACAD SCI USA, V85, P4567, DOI 10.1073/pnas.85.12.4567-a; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LIPTON SA, 1988, SCIENCE, V239, P1293, DOI 10.1126/science.3344435; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; MARTINI R, 1988, J CELL BIOL, V106, P1735, DOI 10.1083/jcb.106.5.1735; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MATSUNAGA M, 1988, NEURON, V1, P289, DOI 10.1016/0896-6273(88)90077-3; MOORE SE, 1985, EMBO J, V4, P623, DOI 10.1002/j.1460-2075.1985.tb03675.x; MOORE SE, 1987, J CELL BIOL, V105, P1377, DOI 10.1083/jcb.105.3.1377; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; PATEL K, 1989, INT J CANCER, V44, P573, DOI 10.1002/ijc.2910440402; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0; RUTISHAUSER U, 1983, J CELL BIOL, V97, P145, DOI 10.1083/jcb.97.1.145; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1987, TRENDS GENET, V3, P213, DOI 10.1016/0168-9525(87)90238-1; TAKEICHI M, 1988, TRENDS GENET, V10, P639; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; WALSH FS, 1990, J NEUROCHEM, V55, P805, DOI 10.1111/j.1471-4159.1990.tb04563.x; WALSH FS, 1989, NATURE, V339, P516, DOI 10.1038/339516a0; [No title captured]	55	166	172	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1991	6	2					247	258		10.1016/0896-6273(91)90360-C	http://dx.doi.org/10.1016/0896-6273(91)90360-C			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1993122				2022-12-28	WOS:A1991EY70900007
J	REGAN, LJ; SAH, DWY; BEAN, BP				REGAN, LJ; SAH, DWY; BEAN, BP			CA2+ CHANNELS IN RAT CENTRAL AND PERIPHERAL NEURONS - HIGH-THRESHOLD CURRENT RESISTANT TO DIHYDROPYRIDINE BLOCKERS AND OMEGA-CONOTOXIN	NEURON			English	Article							CHICK SENSORY NEURONS; MULTIPLE CALCIUM CHANNELS; HIGH-AFFINITY BINDING; SYNAPTIC TRANSMISSION; ATRIAL CELLS; 2 KINDS; ANTAGONISTS; RELEASE; SYNAPTOSOMES; BLOCKING	Block of Ca2+ channel current by dihydropyridines and by omega-conotoxin (omega-CgTx) was studied in a variety of freshly dissociated rat neurons. In most neurons, including those from dorsal root ganglia, sympathetic ganglia, spinal cord, cerebral cortex, and hippocampus, nitrendipine and omega-CgTx each blocked a fraction of the high-threshold current, but a substantial fraction of current remained even when the two blockers were applied together at saturating concentrations. An extreme case was cerebellar Purkinje neurons, in which very little current was blocked by either nitrendipine or omega-CgTx. These results demonstrate the existence in mammalian neurons of high-threshold channels that are resistant to both omega-CgTx and dihydropyridine blockers. Such channels might underlie instances of synaptic transmission and other processes that depend on Ca2+ entry but are not sensitive to these blockers.			REGAN, LJ (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL035043, R44HL035043] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL35043] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABELE AE, 1990, NEURON, V4, P413, DOI 10.1016/0896-6273(90)90053-I; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P181, DOI 10.1113/jphysiol.1989.sp017610; ANDERSON AJ, 1987, NEUROSCI LETT, V82, P177, DOI 10.1016/0304-3940(87)90125-X; AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; ARMSTRONG CM, 1985, SCIENCE, V227, P65, DOI 10.1126/science.2578071; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; BEAN BP, 1990, J NEUROSCI, V10, P1; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; BOLAND LM, 1990, J PHYSIOL-LONDON, V420, P223, DOI 10.1113/jphysiol.1990.sp017909; BOLL W, 1985, NEUROSCI LETT, V56, P335, DOI 10.1016/0304-3940(85)90265-4; CARBONE E, 1990, NEUROSCI LETT, V111, P315, DOI 10.1016/0304-3940(90)90281-D; CARBONE E, 1990, PFLUG ARCH EUR J PHY, V416, P170, DOI 10.1007/BF00370239; DOCHERTY RJ, 1986, NEUROSCI LETT, V70, P110, DOI 10.1016/0304-3940(86)90447-7; FEDULOVA SA, 1985, J PHYSIOL-LONDON, V359, P431, DOI 10.1113/jphysiol.1985.sp015594; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HESS P, 1984, NATURE, V311, P58; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; HUME JR, 1985, J PHARMACOL EXP THER, V234, P134; JONES SW, 1990, J NEUROSCI, V10, P2261; KAMIYA H, 1988, NEUROSCI LETT, V91, P84, DOI 10.1016/0304-3940(88)90253-4; KERR LM, 1984, NATURE, V308, P282, DOI 10.1038/308282a0; KONGSAMUT S, 1989, ANN NY ACAD SCI, V560, P312, DOI 10.1111/j.1749-6632.1989.tb24112.x; KUAN YF, 1986, EUR J PHARMACOL, V130, P273, DOI 10.1016/0014-2999(86)90278-5; LEONARD JP, 1987, J NEUROSCI, V7, P875; LIN JW, 1990, P NATL ACAD SCI USA, V87, P4538, DOI 10.1073/pnas.87.12.4538; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MARQUEZE B, 1988, MOL PHARMACOL, V34, P87; MCCARTHY RT, 1989, J GEN PHYSIOL, V94, P669, DOI 10.1085/jgp.94.4.669; MCCARTHY RT, 1989, NIMODIPINE CENTRAL N, P35; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; OGURA A, 1984, BRAIN RES, V301, P323, DOI 10.1016/0006-8993(84)91101-6; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; PERNEY TM, 1986, P NATL ACAD SCI USA, V83, P6656, DOI 10.1073/pnas.83.17.6656; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANE SG, 1987, PFLUG ARCH EUR J PHY, V409, P361, DOI 10.1007/BF00583789; REYNOLDS IJ, 1986, P NATL ACAD SCI USA, V83, P8804, DOI 10.1073/pnas.83.22.8804; SAH DWY, 1990, J NEUROSCI, V10, P136; SANGUINETTI MC, 1986, J GEN PHYSIOL, V88, P369, DOI 10.1085/jgp.88.3.369; SANGUINETTI MC, 1984, CIRC RES, V55, P336, DOI 10.1161/01.RES.55.3.336; SEABROOK GR, 1989, BRIT J PHARMACOL, V97, P1125, DOI 10.1111/j.1476-5381.1989.tb12570.x; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; SUSZKIW JB, 1989, J NEUROCHEM, V52, P1260, DOI 10.1111/j.1471-4159.1989.tb01874.x; SUSZKIW JB, 1986, J NEUROSCI, V6, P1349; SWANDULLA D, 1988, J GEN PHYSIOL, V92, P197, DOI 10.1085/jgp.92.2.197; TOSELLI M, 1990, NEUROSCI LETT, V112, P70, DOI 10.1016/0304-3940(90)90324-3; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; UEHARA A, 1985, J GEN PHYSIOL, V85, P621, DOI 10.1085/jgp.85.5.621; UEMATSU D, 1989, STROKE, V20, P1531, DOI 10.1161/01.STR.20.11.1531; USOWICZ MM, 1990, J PHYSIOL-LONDON, V426, P95, DOI 10.1113/jphysiol.1990.sp018128; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; YATANI A, 1985, CIRC RES, V56, P868, DOI 10.1161/01.RES.56.6.868; YU C, 1988, EXP BRAIN RES, V71, P467, DOI 10.1007/BF00248740	60	474	477	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1991	6	2					269	280		10.1016/0896-6273(91)90362-4	http://dx.doi.org/10.1016/0896-6273(91)90362-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1847065				2022-12-28	WOS:A1991EY70900009
J	GAGE, FH; FISHER, LJ				GAGE, FH; FISHER, LJ			INTRACEREBRAL GRAFTING - A TOOL FOR THE NEUROBIOLOGIST	NEURON			English	Review							ADRENAL-MEDULLA GRAFTS; CENTRAL NERVOUS-SYSTEM; ACID-LESIONED STRIATUM; UNILATERAL NEOSTRIATAL LESIONS; MESENCEPHALIC RAPHE NEURONS; FIMBRIA-FORNIX TRANSECTION; GENETICALLY MODIFIED CELLS; AREA BRAIN GRAFTS; ADULT-RAT-BRAIN; SUBSTANTIA NIGRA				GAGE, FH (corresponding author), UNIV CALIF SAN DIEGO, SCH MED, DEPT NEUROSCI, LA JOLLA, CA 92093 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS028121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006088, R37AG008514, R01AG008514] Funding Source: NIH RePORTER; NIA NIH HHS [AG08514, AG06088] Funding Source: Medline; NINDS NIH HHS [NS28121] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguayo A.J., 1985, SYNAPTIC PLASTICITY, P457; BANKIEWICZ KS, 1988, PROGR BRAIN RES, V78, P543; BECKER JB, 1988, BRAIN RES, V462, P401, DOI 10.1016/0006-8993(88)90573-2; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; BOHN MC, 1987, SCIENCE, V237, P913, DOI 10.1126/science.2887034; BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; CHARLTON HM, 1987, ANN ENDOCRINOL-PARIS, V48, P378; CLARKE DJ, 1988, NEUROSCIENCE, V24, P791, DOI 10.1016/0306-4522(88)90067-X; COFFEY PJ, 1989, P NATL ACAD SCI USA, V86, P7248, DOI 10.1073/pnas.86.18.7248; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; CRUTCHER KA, 1990, NEUROBIOL AGING, V11, P175, DOI 10.1016/0197-4580(90)90543-9; DAS GD, 1980, AM J ANAT, V158, P135, DOI 10.1002/aja.1001580204; DECKEL AW, 1983, EUR J PHARMACOL, V93, P287; DUNNETT SB, 1988, NEUROSCIENCE, V24, P813, DOI 10.1016/0306-4522(88)90069-3; DUNNETT SB, 1987, BRAIN RES, V415, P63, DOI 10.1016/0006-8993(87)90269-1; DUNNETT SB, 1983, ACTA PHYSIOL SCAND, P29; DUNNETT SB, 1990, EUR J NEUROSCI, V2, P567, DOI 10.1111/j.1460-9568.1990.tb00448.x; DUNNETT SB, 1981, BRAIN RES, V229, P209, DOI 10.1016/0006-8993(81)90759-9; FISHER LJ, 1991, IN PRESS NEURON; FOSTER GA, 1988, EXP BRAIN RES, V70, P225, DOI 10.1007/BF00248349; FOSTER GA, 1985, EXP BRAIN RES, V60, P427; FREED CR, 1990, ARCH NEUROL-CHICAGO, V10, P1268; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; FREED WJ, 1983, BIOL PSYCHIAT, V18, P1205; FREED WJ, 1986, J NEUROSURG, V65, P664, DOI 10.3171/jns.1986.65.5.0664; FREUND TF, 1985, J NEUROSCI, V5, P603; GAGE FH, 1986, NEUROSCIENCE, V17, P89, DOI 10.1016/0306-4522(86)90227-7; GAGE FH, 1986, ANNU REV PHYSIOL, V48, P447; GAGE FH, 1987, NEUROSCIENCE, V23, P795, DOI 10.1016/0306-4522(87)90159-X; GAGE FH, 1983, ACTA PHYSIOL SCAND, P67; GAGE FH, 1986, NEUROSCIENCE, V19, P241, DOI 10.1016/0306-4522(86)90018-7; GIBSON MJ, 1984, ENDOCRINOLOGY, V114, P1938, DOI 10.1210/endo-114-5-1938; GIBSON MJ, 1984, SCIENCE, V225, P949, DOI 10.1126/science.6382608; HALLAS BH, 1980, AM J ANAT, V158, P147, DOI 10.1002/aja.1001580205; HARRIS WA, 1989, NATURE, V339, P218, DOI 10.1038/339218a0; HEFTI F, 1986, J NEUROSCI, V6, P2155; HORELLOU P, 1990, EUR J NEUROSCI, V2, P116, DOI 10.1111/j.1460-9568.1990.tb00389.x; ISACSON O, 1984, NATURE, V311, P458, DOI 10.1038/311458a0; ISACSON O, 1986, P NATL ACAD SCI USA, V83, P2728, DOI 10.1073/pnas.83.8.2728; ISACSON O, 1989, EXP BRAIN RES, V75, P213; JENNES L, 1986, NEUROSCIENCE, V18, P403, DOI 10.1016/0306-4522(86)90162-4; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; KEIRSTEAD SA, 1989, SCIENCE, V246, P255, DOI 10.1126/science.2799387; KIRSCHNER N, 1975, HDB ENDOCRINOLOGY, V6, P342; KLASSEN H, 1987, P NATL ACAD SCI USA, V84, P6958, DOI 10.1073/pnas.84.19.6958; KOKORIS GJ, 1987, NEUROSCIENCE, V22, P159, DOI 10.1016/0306-4522(87)90206-5; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LUND RD, 1987, ANN NY ACAD SCI, V495, P227, DOI 10.1111/j.1749-6632.1987.tb23678.x; MADRAZO I, 1988, NEW ENGL J MED, V318, P51; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCCONNELL SK, 1985, SCIENCE, V229, P1268, DOI 10.1126/science.4035355; MCGEER EG, 1976, NATURE, V263, P517, DOI 10.1038/263517a0; NIETOSAMPEDRO M, 1984, P NATL ACAD SCI-BIOL, V81, P6250, DOI 10.1073/pnas.81.19.6250; NIETOSAMPEDRO M, 1983, J NEUROSCI, V3, P2219; OLEARY DDM, 1989, J NEUROSCI, V9, P2230; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; PERLOW MJ, 1987, BRAIN RES, V415, P158, DOI 10.1016/0006-8993(87)90280-0; PETERSON DI, 1989, NEUROLOGY, V39, P235, DOI 10.1212/WNL.39.2.235; PRITZEL M, 1986, EXP BRAIN RES, V65, P112; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; SCHWAB ME, 1985, J NEUROSCI, V5, P2415; SEIGER A, 1985, NEURAL GRAFTING MAMM, P71; SOTELO C, 1986, P NATL ACAD SCI USA, V83, P1135, DOI 10.1073/pnas.83.4.1135; STENEVI U, 1976, BRAIN RES, V114, P1, DOI 10.1016/0006-8993(76)91003-9; STROMBERG I, 1985, EXP BRAIN RES, V60, P335; STROMBERG I, 1990, J NEUROSCI RES, V25, P405, DOI 10.1002/jnr.490250318; Tello F, 1911, REV CLIN MADRID, V5, P292; Tello J.F., 1911, TRAB LAB INVEST BIOL, V9, P123; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; WICTORIN K, 1989, NEUROSCIENCE, V30, P297, DOI 10.1016/0306-4522(89)90255-8; WICTORIN K, 1989, NEUROSCIENCE, V30, P313, DOI 10.1016/0306-4522(89)90256-X; WICTORIN K, 1988, NEUROSCIENCE, V27, P547, DOI 10.1016/0306-4522(88)90288-6; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; WIDNER H, 1988, BRAIN RES REV, V13, P287, DOI 10.1016/0165-0173(88)90010-0; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; WOLFF JA, 1989, P NATL ACAD SCI USA, V86, P9011, DOI 10.1073/pnas.86.22.9011	82	99	110	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1991	6	1					1	12		10.1016/0896-6273(91)90116-H	http://dx.doi.org/10.1016/0896-6273(91)90116-H			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1986771				2022-12-28	WOS:A1991EU27800001
J	SELLECK, SB; STELLER, H				SELLECK, SB; STELLER, H			THE INFLUENCE OF RETINAL INNERVATION ON NEUROGENESIS IN THE 1ST OPTIC GANGLION OF DROSOPHILA	NEURON			English	Article							VISUAL-SYSTEM; CELLULAR INTERACTIONS; PHOTORECEPTOR CELLS; MONOCLONAL-ANTIBODY; PATTERN FORMATION; NERVOUS-SYSTEM; LOCUS ELAV; MELANOGASTER; NEURONS; GENE	We have examined the influence of retinal innervation on the development of target neurons in the first optic ganglion, the lamina, of D. melanogaster. Mitotically active lamina precursor cells (LPCs), which normally produce lamina neurons, are absent in mutants that lack retinal innervation, while other proliferative centers appear unaffected. Reducing the number of innervating photoreceptor axons results in fewer mitotic LPCs. In glass mutants photoreceptors project to abnormal locations and LPCs are found adjacent to these aberrant projections. We conclude that the arrival of photoreceptor axons in the larval brain initiates, directly or indirectly, cell division to produce lamina neurons. Our results provide an explanation for how the synchronous development of these two interacting systems is coordinated.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	SELLECK, SB (corresponding author), MIT,HOWARD HUGHES MED INST,DEPT BRAIN & COGNIT SCI,CAMBRIDGE,MA 02139, USA.				NINDS NIH HHS [R01-NS26451] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026451] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASHBURNER M, 1989, DROSOPHILA LABORATOR; BAPTISTA CA, 1990, NATURE, V346, P855, DOI 10.1038/346855a0; BASLER K, 1989, SCIENCE, V243, P931, DOI 10.1126/science.2493159; BIER E, 1988, SCIENCE, V240, P913, DOI 10.1126/science.3129785; BIRDGES CB, 1923, CARNEGIE I WASH PUBL, V327, P188; BLEST AS, 1980, NEUROANATOMICAL TECH; BRAITENBERG V, 1967, EXP BRAIN RES, V3, P271; CAMPOS AR, 1987, EMBO J, V6, P425, DOI 10.1002/j.1460-2075.1987.tb04772.x; CAMPOSORTEGA JA, 1977, ROUX ARCH DEV BIOL, V181, P227, DOI 10.1007/BF00848423; CLINE TW, 1978, GENETICS, V90, P683; DELONG GR, 1962, J COMP NEUROL, V118, P205, DOI 10.1002/cne.901180207; FISCHBACH KF, 1984, DEV BIOL, V104, P219, DOI 10.1016/0012-1606(84)90050-2; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FISCHBACH KF, 1983, DEV BIOL, V95, P1, DOI 10.1016/0012-1606(83)90002-7; FROHLICH A, 1982, J NEUROCYTOL, V11, P159, DOI 10.1007/BF01258010; HEISENBERG M, 1984, VISION DROSOPHILA; HEUMANN D, 1980, EXP BRAIN RES, V38, P75; HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; KANKEL DR, 1980, GENETICS BIOL DROS D, V2; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; KOLLROS JJ, 1982, J COMP NEUROL, V205, P171, DOI 10.1002/cne.902050208; LEVIMONTALCINI R, 1949, J COMP NEUROL, V91, P209, DOI 10.1002/cne.900910204; LOPRESTI V, 1973, P NATL ACAD SCI USA, V70, P433, DOI 10.1073/pnas.70.2.433; MACAGNO ER, 1979, DEV BIOL, V73, P206, DOI 10.1016/0012-1606(79)90064-2; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MEINERTZHAGEN IA, 1974, CIBA F S, V29, P265; MEINERTZHAGEN IA, 1973, DEV NEUROBIOLOGY ART, P51; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; Nordlander R. H., 1969, Wilhelm Roux Archiv fur Entwicklungsmechanik der Organismen, V163, P197, DOI 10.1007/BF00576929; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Power ME, 1943, J EXP ZOOL, V94, P33, DOI 10.1002/jez.1400940103; PURVES D, 1985, PRINCIPLES NEURAL DE; RATNER N, 1988, P NATL ACAD SCI USA, V85, P6992, DOI 10.1073/pnas.85.18.6992; Ready D.F., 1986, P97; READY DF, 1989, TRENDS NEUROSCI, V12, P102, DOI 10.1016/0166-2236(89)90166-5; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; RENFRANZ PJ, 1989, DEV BIOL, V136, P411, DOI 10.1016/0012-1606(89)90267-4; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; ROBINOW S, 1990, THESIS BRANDEIS U WA; RUBIN GM, 1989, CELL, V57, P519, DOI 10.1016/0092-8674(89)90120-7; SHATOURY H. H., 1956, JOUR EMBRYOL AND EXPTL MORPHOL, V4, P240; SHAW SR, 1986, P NATL ACAD SCI USA, V83, P7961, DOI 10.1073/pnas.83.20.7961; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Sved J, 1986, DROSOPH INF SERV, V63, P169; TOMLINSON A, 1988, DEVELOPMENT, V104, P183; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TRUJILLO.O, 1965, J ULTRA MOL STRUCT R, V13, P1, DOI 10.1016/S0022-5320(65)80086-7; TRUJILLOCENOZ O, 1966, J ULTRA MOL STRUCT R, V16, P395, DOI 10.1016/S0022-5320(66)80071-0; TRUJILLOCENOZ O, 1973, J ULTRA MOL STRUCT R, V42, P554, DOI 10.1016/S0022-5320(73)80027-9; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5; WILLIAMS RW, 1988, ANNU REV NEUROSCI, V11, P423, DOI 10.1146/annurev.neuro.11.1.423; WOOLSEY TA, 1981, DEV PERCEPTION PSYCH, V1, P259; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2; ZIPURSKY SL, 1985, P NATL ACAD SCI USA, V82, P1855, DOI 10.1073/pnas.82.6.1855	61	152	153	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1991	6	1					83	99		10.1016/0896-6273(91)90124-I	http://dx.doi.org/10.1016/0896-6273(91)90124-I			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1898850				2022-12-28	WOS:A1991EU27800009
J	LIEBER, T; WESLEY, CS; ALCAMO, E; HASSEL, B; KRANE, JF; CAMPOSORTEGA, JA; YOUNG, MW				LIEBER, T; WESLEY, CS; ALCAMO, E; HASSEL, B; KRANE, JF; CAMPOSORTEGA, JA; YOUNG, MW			SINGLE AMINO-ACID SUBSTITUTIONS IN EGF-LIKE ELEMENTS OF NOTCH AND DELTA-MODIFY DROSOPHILA DEVELOPMENT AND AFFECT CELL-ADHESION INVITRO	NEURON			English	Article							EPIDERMAL GROWTH-FACTOR; HUMAN ERYTHROCYTE ANKYRIN; CYCLE CONTROL PROTEINS; NEUROGENIC GENE-DELTA; TRANSMEMBRANE PROTEIN; HOMOLOGOUS GENES; C-ELEGANS; KAPPA-B; MELANOGASTER; LOCUS	Notch locus EGF-like element mutations spl, altering eye development, and Ax(E2), affecting wing and sensilla development, are modified by mutations at Delta. It is shown that two allele-specific suppressors of spl involve single amino acid substitutions in the 4th (Dl(sup5)) and 9th (Dl(sup4)) EGF-like elements of the Delta protein. Cultured cells producing spl or Ax(E2) aggregate with cells producing wild-type Delta or Dl(sup5) protein, and Dl(sup5)-producing cells adhere to cells producing wild-type Notch protein. However, spl, Ax(E2), and Dl(sup5) are each defective in promoting these cell affinities, as none of the mutant proteins can compete with the corresponding wild-type proteins for formation of cell aggregates. Thus, widely separated EGF-like elements of Notch and Delta appear to participate in functional molecular interactions between the proteins. Dl(sup5) does not improve adhesiveness of spl in vitro, so suppression in vivo may involve altered developmental signaling by spl-Dl(sup5) complexes, rather than modified cell adhesion.	ROCKEFELLER UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10021; UNIV COLOGNE,INST ENTWICKLUNGSPHYSIOL,W-5000 COLOGNE 41,GERMANY	Howard Hughes Medical Institute; Rockefeller University; University of Cologne	LIEBER, T (corresponding author), ROCKEFELLER UNIV,GENET LAB,1230 YORK AVE,NEW YORK,NY 10021, USA.		Krane, Jeffrey/AAJ-7099-2020; , 机智的马小跳和机智的羊不愁/ABC-5169-2020		NIGMS NIH HHS [GM5-25103] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREWS BJ, 1989, NATURE, V342, P830, DOI 10.1038/342830a0; ASHBURNER M, 1989, DROSOPHILA LABORATOR; AUSTIN J, 1989, CELL, V58, P565, DOI 10.1016/0092-8674(89)90437-6; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; BRAND M, 1990, ROUX ARCH DEV BIOL, V198, P275, DOI 10.1007/BF00377394; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; DAVIS LD, 1991, J BIOL CHEM, V26, P11163; DECELIS JF, 1991, P NATL ACAD SCI USA, V88, P632, DOI 10.1073/pnas.88.2.632; DELACONCHA A, 1988, GENETICS, V118, P499; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; Dietrich U, 1984, J Neurogenet, V1, P315, DOI 10.3109/01677068409107094; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; GILLARD S, 1986, P NATL ACAD SCI USA, V83, P5573, DOI 10.1073/pnas.83.15.5573; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; HAENLIN M, 1990, DEVELOPMENT, V110, P905; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HARTENSTEIN V, 1986, ROUX ARCH DEV BIOL, V195, P210, DOI 10.1007/BF02438953; HARTLEY DA, 1987, EMBO J, V6, P3407, DOI 10.1002/j.1460-2075.1987.tb02664.x; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; JOHANSEN KM, 1989, J CELL BIOL, V109, P2427, DOI 10.1083/jcb.109.5.2427; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KIDD S, 1989, GENE DEV, V3, P1113, DOI 10.1101/gad.3.8.1113; KIDD S, 1992, IN PRESS CELL, V71; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KOPCZYNSKI CC, 1988, GENE DEV, V2, P1723, DOI 10.1101/gad.2.12b.1723; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; LAMBERT S, 1990, P NATL ACAD SCI USA, V87, P1730, DOI 10.1073/pnas.87.5.1730; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; LINDSLEY D, 1985, DROS INFO SERV, V62; LINDSLEY D, 1990, DROS INFO SERV, V68; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; PALKA J, 1990, DEVELOPMENT, V109, P169; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; RIO DC, 1986, CELL, V44, P21, DOI 10.1016/0092-8674(86)90481-2; RUHOLA H, 1991, CELL, V66, P433; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; VASSIN H, 1985, J NEUROGENET, V2, P291, DOI 10.3109/01677068509102325; VASSIN H, 1987, GENETICS, V116, P433; VASSIN H, 1987, EMBO J, V6, P3431, DOI 10.1002/j.1460-2075.1987.tb02666.x; WELSHONS WJ, 1956, DROF INF SERV, V30, P79; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; YOCHEM J, 1989, CELL, V58, P553, DOI 10.1016/0092-8674(89)90436-4; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0	55	112	112	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1992	9	5					847	859		10.1016/0896-6273(92)90238-9	http://dx.doi.org/10.1016/0896-6273(92)90238-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1418999				2022-12-28	WOS:A1992JY55200005
J	BEDLACK, RS; WEI, MD; LOEW, LM				BEDLACK, RS; WEI, MD; LOEW, LM			LOCALIZED MEMBRANE DEPOLARIZATIONS AND LOCALIZED CALCIUM INFLUX DURING ELECTRIC FIELD-GUIDED NEURITE GROWTH	NEURON			English	Article								Our study explores the mechanisms behind neurite galvanotropism. Using phase, differential interference contrast and ratiometric fluorescence microscopy, we reveal four responses of N1E-115 mouse neuroblastoma cells to 0.1-1.0 mV/mu-m uniform DC electric fields: cathode-directed neurite initiation and elongation, cathode-biased growth cone filopodial protrusions, transient cathode-localized calcium increases, and persistent cathode-localized membrane depolarizations. These newly demonstrated events are temporally and spatially correlated, suggesting that they are causally related. The calcium increases are prevented by calcium channel blockers and by the removal of extracellular calcium. We therefore propose that the observed field-induced membrane depolarizations activate voltage-dependent calcium channels, resulting in cathode-localized calcium influx. This, in turn, may initiate the observed cathode-biased growth cone filopodial protrusions, followed by the cathode-directed neurite elongation.	UNIV CONNECTICUT, CTR HLTH, DEPT PHYSIOL, FARMINGTON, CT 06030 USA	University of Connecticut	BEDLACK, RS (corresponding author), UNIV CONNECTICUT, NEUROSCI PROGRAM, FARMINGTON, CT 06030 USA.			Loew, Leslie/0000-0002-1851-4646; Bedlack, Richard/0000-0003-4666-7495	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035063] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES05973] Funding Source: Medline; NIGMS NIH HHS [GM35063] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUDESIRK G, 1990, DEV BRAIN RES, V55, P109, DOI 10.1016/0165-3806(90)90111-B; AUDIGIER SMP, 1988, P NATL ACAD SCI USA, V85, P2859, DOI 10.1073/pnas.85.8.2859; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BORGENS RB, 1982, INT REV CYTOL, V76, P245, DOI 10.1016/S0074-7696(08)61793-3; BORGENS RB, 1987, SCIENCE, V238, P366, DOI 10.1126/science.3659920; CHEN TH, 1978, PLANTA, V140, P63, DOI 10.1007/BF00389381; CONNOR JA, 1986, P NATL ACAD SCI USA, V83, P6179, DOI 10.1073/pnas.83.16.6179; DAVENPORT RW, 1992, NEURON, V9, P405, DOI 10.1016/0896-6273(92)90179-H; FLUHLER E, 1985, BIOCHEMISTRY-US, V24, P5749, DOI 10.1021/bi00342a010; GOLDBERG DJ, 1986, J CELL BIOL, V103, P1921, DOI 10.1083/jcb.103.5.1921; GOLDBERG DJ, 1988, J NEUROSCI, V8, P2596; GROSS D, 1986, BIOPHYS J, V50, P339, DOI 10.1016/S0006-3495(86)83467-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNDERSEN R, 1980, J CELL BIOL, V375, P55; HASSNER A, 1984, J ORG CHEM, V49, P2546, DOI 10.1021/jo00188a006; HENZI V, 1992, NEUROSCIENCE, V46, P251, DOI 10.1016/0306-4522(92)90049-8; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; JAFFE LF, 1977, ANNU REV BIOPHYS BIO, V6, P445, DOI 10.1146/annurev.bb.06.060177.002305; JAFFE LF, 1977, NATURE, V265, P600, DOI 10.1038/265600a0; JAFFE LF, 1979, J EXP ZOOL, V209, P115, DOI 10.1002/jez.1402090114; KATER S, 1990, MOL ASPECTS DEV AGIN, P217; KIMHI Y, 1976, P NATL ACAD SCI USA, V73, P462, DOI 10.1073/pnas.73.2.462; LANKFORD KL, 1991, CELL MOTIL CYTOSKEL, V20, P7, DOI 10.1002/cm.970200103; LEFCORT F, 1989, J CELL BIOL, V108, P1737, DOI 10.1083/jcb.108.5.1737; MARSH G, 1946, CELL COMP PHYSL, V27, P139; MATTSON MP, 1988, J NEUROSCI RES, V21, P447, DOI 10.1002/jnr.490210236; MATTSON MP, 1987, J NEUROSCI, V7, P4034; MCCAIG CD, 1989, J CELL SCI, V93, P723; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P55, DOI 10.1113/jphysiol.1986.sp016105; MCCAIG CD, 1987, DEVELOPMENT, V100, P31; MCCAIG CD, 1989, J CELL SCI, V93, P715; MONTANA V, 1989, BIOCHEMISTRY-US, V28, P4536, DOI 10.1021/bi00437a003; MOOLENAAR WH, 1977, SCIENCE, V196, P331, DOI 10.1126/science.557842; NARAHASHI T, 1987, J PHYSIOL-LONDON, V383, P231; PATEL N, 1982, J NEUROSCI, V2, P483; POLITIS MJ, 1989, NEUROSURGERY, V25, P71, DOI 10.1227/00006123-198907000-00012; POLITIS MJ, 1988, EXP BRAIN RES, V71, P223; POLITIS MJ, 1988, J TRAUMA, V28, P1548, DOI 10.1097/00005373-198811000-00005; POO MM, 1979, BIOPHYS J, V26, P1, DOI 10.1016/S0006-3495(79)85231-5; REHDER V, 1991, J NEUROBIOL, V22, P499, DOI 10.1002/neu.480220506; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; ROSS WN, 1988, P NATL ACAD SCI USA, V85, P4075, DOI 10.1073/pnas.85.11.4075; SILVER RA, 1989, J NEUROSCI, V9, P4007; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; WANG R, 1990, J PHARMACOL EXP THER, V254, P1006; Weiss P, 1934, J EXP ZOOL, V68, P393, DOI 10.1002/jez.1400680304; WESSELLS NK, 1978, EXP CELL RES, V115, P111, DOI 10.1016/0014-4827(78)90408-1	47	152	154	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1992	9	3					393	403		10.1016/0896-6273(92)90178-G	http://dx.doi.org/10.1016/0896-6273(92)90178-G			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1524823				2022-12-28	WOS:A1992JM57100002
J	SHENG, M; TSAUR, ML; JAN, YN; JAN, LY				SHENG, M; TSAUR, ML; JAN, YN; JAN, LY			SUBCELLULAR SEGREGATION OF 2 A-TYPE K+ CHANNEL PROTEINS IN RAT CENTRAL NEURONS	NEURON			English	Article							LONG-TERM POTENTIATION; TRANSIENT POTASSIUM CURRENT; DEPENDENT SODIUM-CHANNELS; SHAKER LOCUS; HIPPOCAMPAL-NEURONS; MAMMALIAN BRAIN; XENOPUS-OOCYTES; NERVOUS-SYSTEM; VOLTAGE-CLAMP; HETEROMULTIMERIC CHANNELS	In the mammalian nervous system, K+ channels regulate diverse aspects of neuronal function and are encoded by a large set of K+ channel genes. The roles of different K+ channel proteins could be dictated by their localization to specific subcellular domains. We report that two K+ channel polypeptides, Kv1.4 and Kv4.2, which form transient (A-type) K+ channels when expressed in Xenopus oocytes, are segregated in rat central neurons. Kv1.4 protein is targeted to axons and possibly terminals, while Kv4.2 is concentrated in dendrites and somata. This differential distribution implies distinct roles for these channel proteins in vivo. Their localizations suggest that Kv1.4 and Kv4.2 may regulate synaptic transmission via presynaptic, or postsynaptic mechanisms, respectively.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	SHENG, M (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.			Sheng, Morgan/0000-0002-8703-5366; Jan, Lily/0000-0003-3938-8498	NIMH NIH HHS [MH48200] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048200] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAMS TW, 1988, TRENDS NEUROSCI, V11, P128, DOI 10.1016/0166-2236(88)90137-3; AGHAJANIAN GK, 1985, NATURE, V315, P501, DOI 10.1038/315501a0; AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; ANGELIDES KJ, 1988, J CELL BIOL, V106, P1911, DOI 10.1083/jcb.106.6.1911; ATKINS PT, 1990, NATURE, V344, P240; AWAN KA, 1991, NEUROSCIENCE, V40, P29, DOI 10.1016/0306-4522(91)90172-K; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; Bayer S.A, 1985, RAT NERVOUS SYSTEM, V1, P335; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BLACK JA, 1990, TRENDS NEUROSCI, V13, P48, DOI 10.1016/0166-2236(90)90068-L; BRAMHAM CR, 1988, BRAIN RES, V449, P352, DOI 10.1016/0006-8993(88)91052-9; BYRNE JH, 1987, PHYSIOL REV, V67, P329, DOI 10.1152/physrev.1987.67.2.329; CASSELL JF, 1986, J PHYSIOL-LONDON, V374, P273, DOI 10.1113/jphysiol.1986.sp016079; CHEN QX, 1991, J NEUROSCI, V11, P337; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; CONNOR JA, 1975, J NEUROPHYSIOL, V38, P922, DOI 10.1152/jn.1975.38.4.922; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; DAHL D, 1990, EXP BRAIN RES, V83, P172; DAUT J, 1973, NATURE-NEW BIOL, V246, P193, DOI 10.1038/newbio246193a0; DREWE JA, 1992, J NEUROSCI, V12, P538; DUBOIS JM, 1983, PROG BIOPHYS MOL BIO, V42, P1, DOI 10.1016/0079-6107(83)90002-0; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; HAGIWARA S, 1959, J PHYSIOL-LONDON, V148, P161, DOI 10.1113/jphysiol.1959.sp006279; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; HAUG FMS, 1973, ADV ANAT EMBRYOL CEL, V47, P1; HEIMER L, 1985, RAT NERVOUS SYSTEM F, V1, P37; Hille B., 1991, IONIC CHANNELS EXCIT; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V146, P219, DOI 10.1002/cne.901460206; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Ito M, 1984, CEREBELLUM NEURAL CO; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; KACZMAREK LK, 1984, J NEUROPHYSIOL, V52, P340, DOI 10.1152/jn.1984.52.2.340; KAHLE JS, 1989, BRAIN RES, V482, P159, DOI 10.1016/0006-8993(89)90554-4; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MCCORMACK K, 1990, BIOCHEM BIOPH RES CO, V171, P1361, DOI 10.1016/0006-291X(90)90836-C; NAKAJIMA Y, 1986, P NATL ACAD SCI USA, V83, P3022, DOI 10.1073/pnas.83.9.3022; NEHER E, 1971, J GEN PHYSIOL, V58, P36, DOI 10.1085/jgp.58.1.36; NELSON TJ, 1990, SCIENCE, V247, P1479, DOI 10.1126/science.2108498; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; Palay S. L., 1974, CEREBELLAR CORTEX CY; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; POMPEIANO M, 1992, J NEUROSCI, V12, P440; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; ROBERDS SL, 1991, P NATL ACAD SCI USA, V88, P1798, DOI 10.1073/pnas.88.5.1798; ROGAWSKI MA, 1985, TRENDS NEUROSCI, V8, P214, DOI 10.1016/0166-2236(85)90082-7; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SCHROTER KH, 1991, FEBS LETT, V278, P211, DOI 10.1016/0014-5793(91)80119-N; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SCHWARZ TL, 1990, NEURON, V4, P119, DOI 10.1016/0896-6273(90)90448-O; SEGAL M, 1984, J NEUROSCI, V4, P604; SHIMAHARA T, 1981, NEUROSCI LETT, V24, P139, DOI 10.1016/0304-3940(81)90237-8; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; STRONG JA, 1984, J NEUROSCI, V4, P2772; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; TSENGCRANK JCL, 1990, FEBS LETT, V268, P63, DOI 10.1016/0014-5793(90)80973-M; WEISS RE, 1986, J GEN PHYSIOL, V87, P955, DOI 10.1085/jgp.87.6.955; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; WITER MP, 1989, HIPPOCAMPUS NEW VIST; WONDERLIN WF, 1991, P NATL ACAD SCI USA, V88, P4391, DOI 10.1073/pnas.88.10.4391; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	77	420	427	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					271	284		10.1016/0896-6273(92)90166-B	http://dx.doi.org/10.1016/0896-6273(92)90166-B			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1497894				2022-12-28	WOS:A1992JJ33200009
J	TSAUR, ML; SHENG, M; LOWENSTEIN, DH; JAN, YN; JAN, LY				TSAUR, ML; SHENG, M; LOWENSTEIN, DH; JAN, YN; JAN, LY			DIFFERENTIAL EXPRESSION OF K+ CHANNEL MESSENGER-RNAS IN THE RAT-BRAIN AND DOWN-REGULATION IN THE HIPPOCAMPUS FOLLOWING SEIZURES	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL NERVOUS-SYSTEM; RECEPTOR GENE FAMILY; POTASSIUM-CHANNEL; FUNCTIONAL EXPRESSION; XENOPUS-OOCYTES; MOLECULAR FRAMEWORK; GLUTAMATE RECEPTORS; ION CHANNELS; C-FOS	K+ channels are major determinants of membrane excitability. Differences in neuronal excitability within the nervous system may arise from differential expression of K+ channel genes, regulated spatially in a cell type-specific manner, or temporally in response to neuronal activity. We have compared the distribution of mRNAs of three K+ channel genes, Kv1.1, Kv1.2, and Kv4.2 in rat brain, and examined activity-dependent changes following treatment with the convulsant drug pentylenetetrazole. Both regional and cell type-specific differences of K+ channel gene expression were found. In addition, seizure activity caused a reduction of Kv1.2 and Kv4.2 mRNAs in the dentate granule cells of the hippocampus, raising the possibility that K+ channel gene regulation may play a role in long-term neuronal plasticity.	HOWARD HUGHES MED INST,DEPT BIOCHEM,COCONUT GROVE,FL 33133; UNIV CALIF SAN FRANCISCO,DEPT NEUROL,EPILEPSY RES LAB,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco	TSAUR, ML (corresponding author), HOWARD HUGHES MED INST,DEPT PHYSIOL,COCONUT GROVE,FL 33133, USA.			Jan, Lily/0000-0003-3938-8498; Sheng, Morgan/0000-0002-8703-5366; Jan, Yuh Nung/0000-0003-1367-6299	NIMH NIH HHS [MH 48200] Funding Source: Medline; NINDS NIH HHS [NS 01424] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001424] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMS TW, 1988, TRENDS NEUROSCI, V11, P128, DOI 10.1016/0166-2236(88)90137-3; AMARAL DG, 1978, J COMP NEUROL, V182, P851, DOI 10.1002/cne.901820508; AURBERG S, 1981, BRAIN RES, V212, P287; AWAN KA, 1991, NEUROSCIENCE, V40, P29, DOI 10.1016/0306-4522(91)90172-K; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BELARDETTI F, 1987, NATURE, V325, P153, DOI 10.1038/325153a0; BERGER TW, 1980, BRAIN RES, V215, P329; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BYRNE JH, 1980, J NEUROPHYSIOL, V43, P651, DOI 10.1152/jn.1980.43.3.651; BYRNE JH, 1987, PHYSIOL REV, V67, P329, DOI 10.1152/physrev.1987.67.2.329; CASTELLUCCI VF, 1988, NEURON, V1, P321, DOI 10.1016/0896-6273(88)90080-3; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; CHANDY KG, 1991, NATURE, V352, P26, DOI 10.1038/352026b0; CHANDY KG, 1990, SCIENCE, V247, P973, DOI 10.1126/science.2305265; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; DALLMAN MF, 1987, RECENT PROG HORM RES, V43, P113; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; DOUGLASS J, 1990, J IMMUNOL, V144, P4841; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; EVANS RM, 1989, NEURON, V2, P1105, DOI 10.1016/0896-6273(89)90177-3; FARLEY J, 1986, NATURE, V319, P220, DOI 10.1038/319220a0; FELDBLUM S, 1990, NEURON, V5, P361, DOI 10.1016/0896-6273(90)90172-C; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GALL C, 1990, P NATL ACAD SCI USA, V87, P7643, DOI 10.1073/pnas.87.19.7643; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GETTING PA, 1983, J NEUROPHYSIOL, V49, P1036, DOI 10.1152/jn.1983.49.4.1036; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GOLDMAN D, 1987, CELL, V48, P965, DOI 10.1016/0092-8674(87)90705-7; GRUPE A, 1990, EMBO J, V9, P1749, DOI 10.1002/j.1460-2075.1990.tb08299.x; Hille B., 1991, IONIC CHANNELS EXCIT; IADAROLA MJ, 1986, BRAIN RES, V365, P185, DOI 10.1016/0006-8993(86)90738-9; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; JAN LY, 1990, TRENDS NEUROSCI, V13, P415, DOI 10.1016/0166-2236(90)90123-R; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KING GL, 1985, J NEUROPHYSIOL, V54, P1295, DOI 10.1152/jn.1985.54.5.1295; KLEIN M, 1980, P NATL ACAD SCI-BIOL, V77, P6912, DOI 10.1073/pnas.77.11.6912; LAROCHE S, 1989, NEUROSCIENCE, V28, P375, DOI 10.1016/0306-4522(89)90184-X; LATORRE R, 1984, ANNU REV PHYSIOL, V46, P485; LOWENSTEIN DH, 1991, NEURON, V6, P627, DOI 10.1016/0896-6273(91)90065-8; LOY R, 1980, J COMP NEUROL, V189, P699, DOI 10.1002/cne.901890406; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; MCCORMACK T, 1990, P NATL ACAD SCI USA, V87, P5227, DOI 10.1073/pnas.87.13.5227; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; MCNAMARA JO, 1988, TRENDS NEUROSCI, V11, P33, DOI 10.1016/0166-2236(88)90047-1; MOORE RY, 1975, J COMP NEUROL, V164, P171, DOI 10.1002/cne.901640203; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MOSKO S, 1973, J COMP NEUROL, V152, P163, DOI 10.1002/cne.901520204; NAKAJIMA Y, 1986, P NATL ACAD SCI USA, V83, P3022, DOI 10.1073/pnas.83.9.3022; NARANJO JR, 1991, NEURON, V6, P607, DOI 10.1016/0896-6273(91)90063-6; NELSON TJ, 1990, SCIENCE, V247, P1479, DOI 10.1126/science.2108498; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PAULMICHL M, 1991, P NATL ACAD SCI USA, V88, P7892, DOI 10.1073/pnas.88.17.7892; PHILIPSON LH, 1991, P NATL ACAD SCI USA, V88, P53, DOI 10.1073/pnas.88.1.53; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; PRAGNELL M, 1990, NEURON, V4, P807, DOI 10.1016/0896-6273(90)90207-V; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; ROBERDS SL, 1991, P NATL ACAD SCI USA, V88, P1798, DOI 10.1073/pnas.88.5.1798; ROGAWSKI MA, 1985, TRENDS NEUROSCI, V8, P214, DOI 10.1016/0166-2236(85)90082-7; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SAFFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795, DOI 10.1073/pnas.85.20.7795; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SCHROTER KH, 1991, FEBS LETT, V278, P211, DOI 10.1016/0014-5793(91)80119-N; SEQUIER JM, 1988, P NATL ACAD SCI USA, V85, P7815, DOI 10.1073/pnas.85.20.7815; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SIEGEL RE, 1988, NEURON, V1, P579, DOI 10.1016/0896-6273(88)90107-9; SLOVITER RS, 1987, J COMP NEUROL, V256, P42, DOI 10.1002/cne.902560105; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; STEWARD O, 1991, P NATL ACAD SCI USA, V88, P6819, DOI 10.1073/pnas.88.15.6819; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TEMPEL BL, 1988, NATURE, V10, P131; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WHITE JD, 1987, J NEUROSCI, V7, P753; YLINEN AMA, 1991, P NATL ACAD SCI USA, V88, P7650, DOI 10.1073/pnas.88.17.7650; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037	99	174	177	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1055	1067		10.1016/0896-6273(92)90127-Y	http://dx.doi.org/10.1016/0896-6273(92)90127-Y			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1610565				2022-12-28	WOS:A1992JA42900006
J	RUEGG, MA; TSIM, KWK; HORTON, SE; KROGER, S; ESCHER, G; GENSCH, EM; MCMAHAN, UJ				RUEGG, MA; TSIM, KWK; HORTON, SE; KROGER, S; ESCHER, G; GENSCH, EM; MCMAHAN, UJ			THE AGRIN GENE CODES FOR A FAMILY OF BASAL LAMINA PROTEINS THAT DIFFER IN FUNCTION AND DISTRIBUTION	NEURON			English	Article								We isolated two cDNAs that encode isoforms of agrin, the basal lamina protein that mediates the motor neuron-induced aggregation of acetylcholine receptors on muscle fibers at the neuromuscular junction. Both proteins are the result of alternative splicing of the product of the agrin gene, but, unlike agrin, they are inactive in standard acetylcholine receptor aggregation assays. They lack one (agrin-related protein 1) or two (agrin-related protein 2) regions in agrin that are required for its activity. Expression studies provide evidence that both proteins are present in the nervous system and muscle and that, in muscle, myofibers and Schwann cells synthesize the agrin-related proteins while the axon terminals of motor neurons are the sole source of agrin.			RUEGG, MA (corresponding author), STANFORD UNIV, MED CTR, SCH MED, DEPT NEUROBIOL, STANFORD, CA 94305 USA.		Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Escher, Gerard/0000-0002-9515-4736; Kroger, Stephan/0000-0002-4626-1690; Tsim, Karl/0000-0003-4808-1674				BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BURDEN SJ, 1979, J CELL BIOL, V82, P412, DOI 10.1083/jcb.82.2.412; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GODFREY EW, 1991, EXP CELL RES, V195, P99, DOI 10.1016/0014-4827(91)90504-N; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GODFREY EW, 1988, J CELL BIOL, V106, P1263, DOI 10.1083/jcb.106.4.1263; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; KNAACK D, 1986, J CELL BIOL, V102, P795, DOI 10.1083/jcb.102.3.795; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MCMAHAN UJ, 1984, J CELL BIOL, V98, P1453, DOI 10.1083/jcb.98.4.1453; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; NASTUK MA, 1991, NEURON, V7, P807, DOI 10.1016/0896-6273(91)90283-6; NEW HV, 1986, NATURE, V323, P809, DOI 10.1038/323809a0; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; OH TH, 1982, J NEUROSCI RES, V8, P535, DOI 10.1002/jnr.490080239; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PENG HB, 1981, NATURE, V292, P831, DOI 10.1038/292831a0; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; REIST NE, 1992, IN PRESS NEURON; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; USDIN TB, 1986, J CELL BIOL, V103, P493, DOI 10.1083/jcb.103.2.493; VOGEL Z, 1983, J NEUROSCI, V3, P1058; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1985, NATURE, V315, P574, DOI 10.1038/315574a0; WALLACE BG, 1986, J CELL BIOL, V102, P783, DOI 10.1083/jcb.102.3.783	37	232	238	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1992	8	4					691	699		10.1016/0896-6273(92)90090-Z	http://dx.doi.org/10.1016/0896-6273(92)90090-Z			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1314621	Green Published			2022-12-28	WOS:A1992HQ18800008
J	SYED, NI; RIDGWAY, RL; LUKOWIAK, K; BULLOCH, AGM				SYED, NI; RIDGWAY, RL; LUKOWIAK, K; BULLOCH, AGM			TRANSPLANTATION AND FUNCTIONAL-INTEGRATION OF AN IDENTIFIED RESPIRATORY INTERNEURON IN LYMNAEA-STAGNALIS	NEURON			English	Article								The possibility that damaged neural circuitries can be repaired through grafting has raised questions regarding the cellular mechanisms required for functional integration of transplanted neurons. Invertebrate models offer the potential to examine such mechanisms at the resolution of single identified neurons within well-characterized neural networks. Here it is reported that a specific deficit in the respiratory behavior of a pulmonate mollusc, caused by the ablation of a solitary interneuron, can be restored by grafting an identical donor interneuron. The transplanted interneuron not only survives and extends neurites within the host nervous system, but under specific conditions forms synapses with appropriate target neurons and is physiologically integrated into the host's circuitry, thereby restoring normal behavior.	UNIV CALGARY, FAC MED, NEUROSCI RES GRP, CALGARY T2N 4N1, ALBERTA, CANADA	University of Calgary	SYED, NI (corresponding author), UNIV CALGARY, FAC MED, DEPT MED PHYSIOL, CALGARY T2N 4N1, ALBERTA, CANADA.							BACKLUND EO, 1985, J NEUROSURG, V62, P169, DOI 10.3171/jns.1985.62.2.0169; BENJAMIN PR, 1981, COMP BIOCHEM PHYS A, V70, P293, DOI 10.1016/0300-9629(81)90182-1; BENJAMIN PR, 1988, LYMNAEA S BIOL HUNG, V36, P247; BENJAMIN PR, 1987, MODEL NEURAL NETWORK, P87; BERDAN RC, 1987, SYNAPSE, V1, P304, DOI 10.1002/syn.890010404; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; BJORKLUND A, 1991, TRENDS NEUROSCI, V14, P319, DOI 10.1016/0166-2236(91)90154-M; BJORKLUND A, 1984, ANNU REV NEUROSCI, V7, P279, DOI 10.1146/annurev.ne.07.030184.001431; BOHN MC, 1987, SCIENCE, V237, P913, DOI 10.1126/science.2887034; CAMARDO J, 1983, J NEUROSCI, V3, P2614; DUNNETT SB, 1990, EUR J NEUROSCI, V2, P567, DOI 10.1111/j.1460-9568.1990.tb00448.x; DUNNETT SB, 1987, J EXP BIOL, V132, P265; FIANDACA MS, 1991, TRANSPLANTATION, V51, P549, DOI 10.1097/00007890-199103000-00001; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; GAGE FH, 1991, NEURON, V6, P1, DOI 10.1016/0896-6273(91)90116-H; GAGE FH, 1989, FRONT CLIN NEUROSCI, V6, P211; GIBBS RB, 1987, NEUROSCIENCE, V21, P699, DOI 10.1016/0306-4522(87)90031-5; GOMOT P, 1990, CAN J ZOOL, V68, P1505, DOI 10.1139/z90-223; GUTHRIE DM, 1969, J EXP BIOL, V50, P255; HADLEY RD, 1985, J NEUROSCI, V5, P3145; ISACSON O, 1984, NATURE, V311, P458, DOI 10.1038/311458a0; JONES JD, 1961, COMP BIOCHEM PHYSIOL, V4, P1, DOI 10.1016/0010-406X(61)90042-1; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LOW WC, 1982, NATURE, V300, P260, DOI 10.1038/300260a0; MATTSON MP, 1988, J NEUROBIOL, V19, P239, DOI 10.1002/neu.480190306; MILLER JD, 1991, J NEUROBIOL, V22, P431, DOI 10.1002/neu.480220502; MOFFETT S, 1981, J EXP ZOOL, V216, P321, DOI 10.1002/jez.1402160214; Moffett S.B., 1988, Symposia Biologica Hungarica, V36, P213; MURPHY AD, 1980, BRAIN RES, V186, P251, DOI 10.1016/0006-8993(80)90974-9; MURPHY AD, 1978, BRAIN RES, V156, P322, DOI 10.1016/0006-8993(78)90512-7; MURPHY AD, 1985, J NEUROBIOL, V16, P137, DOI 10.1002/neu.480160206; PAGE TL, 1982, SCIENCE, V216, P73, DOI 10.1126/science.216.4541.73; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; RIDGWAY RL, 1991, J NEUROBIOL, V22, P377, DOI 10.1002/neu.480220406; SEGAL M, 1988, PROG BRAIN RES, V78, P95; SOTELO C, 1987, NEUROSCIENCE, V20, P1, DOI 10.1016/0306-4522(87)90002-9; SYED NI, 1991, J EXP BIOL, V158, P37; SYED NI, 1991, J COMP PHYSIOL A, V169, P541; SYED NI, 1989, COMP BIOCHEM PHYS A, V93, P633, DOI 10.1016/0300-9629(89)90024-8; SYED NI, 1991, J COMP PHYSIOL A, V169, P557; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; TESSLER A, 1991, ANN NEUROL, V29, P115, DOI 10.1002/ana.410290202; VINING EP, 1985, J NEUROBIOL, V16, P283, DOI 10.1002/neu.480160404; WONG RG, 1981, J NEUROSCI, V1, P1008; ZHANG RJ, 1983, DEV BRAIN RES, V8, P131, DOI 10.1016/0165-3806(83)90164-5; ZHANG RJ, 1989, SCI CHINA SER B, V32, P88; ZHOU CF, 1989, NEUROSCIENCE, V32, P349, DOI 10.1016/0306-4522(89)90083-3; [No title captured]	48	124	125	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1992	8	4					767	774		10.1016/0896-6273(92)90097-W	http://dx.doi.org/10.1016/0896-6273(92)90097-W			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1314624				2022-12-28	WOS:A1992HQ18800015
J	HALEY, JE; WILCOX, GL; CHAPMAN, PF				HALEY, JE; WILCOX, GL; CHAPMAN, PF			THE ROLE OF NITRIC-OXIDE IN HIPPOCAMPAL LONG-TERM POTENTIATION	NEURON			English	Article							PROTEIN-KINASE ACTIVITY; RELAXING FACTOR; ENHANCEMENT; STIMULATION; ACTIVATION; INHIBITORS; INDUCTION; BRAIN	Long-term potentiation is a long-lasting use-dependent increase in the strength of synaptic connections. We investigated the role of nitric oxide (NO) in determining the duration of potentiation induced by high frequency stimulation of afferents in the CA1 region of the rat hippocampus. The calcium/calmodulin-dependent production of NO can be initiated by activation of excitatory aminoacid receptors and results in increased levels of cGMP in target cells. Here we report that only a relatively short-term potentiation can be induced in the presence of nitro-L-arginine methyl ester (L-NAME), an NO synthase inhibitor. The effects of L-NAME on the duration of potentiation are partially reversed by coadministration of L-arginine, a precursor of neuronal NO, and by dibutyryl cGMP. Hemoglobin, which binds extracellular NO, also shortens the duration of stimulus-induced potentiation. The results suggest a role for NO in the maintenance of activity-dependent synaptic enhancements, possibly via the generation of cGMP.	UNIV MINNESOTA, DEPT PHARMACOL, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	HALEY, JE (corresponding author), UNIV MINNESOTA, DEPT PSYCHOL, MINNEAPOLIS, MN 55455 USA.			Wilcox, George/0000-0002-6411-0423; Haley, Jane/0000-0001-6178-2673	NIDA NIH HHS [R01-DA-04274] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004274] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BLISS T V P, 1988, P3; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; EAST SJ, 1991, NEUROSCI LETT, V123, P17, DOI 10.1016/0304-3940(91)90147-L; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; IGNARRO LJ, 1986, J PHARMACOL EXP THER, V237, P893; KELSO SR, 1986, SCIENCE, V232, P85, DOI 10.1126/science.3952501; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; REYMANN KG, 1988, BRAIN RES, V440, P305, DOI 10.1016/0006-8993(88)91000-1; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125, DOI 10.1016/0165-6147(91)90526-X; SOUTHAM E, 1991, EUR J NEUROSCI, V3, P379, DOI 10.1111/j.1460-9568.1991.tb00825.x; TSIEN RW, 1990, ADV SEC MESS PHOSPH, V24, P101	25	453	463	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1992	8	2					211	216		10.1016/0896-6273(92)90288-O	http://dx.doi.org/10.1016/0896-6273(92)90288-O			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1371216				2022-12-28	WOS:A1992HE93000002
J	CHEN, L; HUANG, LYM				CHEN, L; HUANG, LYM			SUSTAINED POTENTIATION OF NMDA RECEPTOR MEDIATED GLUTAMATE RESPONSES THROUGH ACTIVATION OF PROTEIN-KINASE-C BY A MU-OPIOID	NEURON			English	Article							LONG-TERM POTENTIATION; DORSAL HORN NEURONS; RAT SPINAL-CORD; CENTRAL NERVOUS-SYSTEM; ROOT GANGLION NEURONS; AMINO-ACID RECEPTORS; CALCIUM CHANNELS; GENE-EXPRESSION; D-ASPARTATE; CELLS	mu-Opioids, such as morphine and certain enkephalin analogs, are known to modulate glutamate-evoked activity in dorsal horn neurons in the spinal cord and caudal brain stem. Yet the molecular mechanism by which this modulation occurs is not understood. We examined the interactions between glutamate and a selective mu-opioid receptor agonist, D-Ala2-MePhe4-Gly-ol5-enkephalin (DAGO), in spinal trigeminal neurons in thin medullary slices of rats. DAGO caused a sustained increase in glutamate-activated currents that are mediated by N-methyl-D-aspartate receptors. Intracellularly applied protein kinase C (PKC) mimics the effect of DAGO, and a specific PKC inhibitor interrupts the sustained potentiation produced by DAGO. Thus, PKC plays a key role in mediating the action of mu-opioid peptides.	UNIV TEXAS, MED BRANCH, DEPT PHYSIOL & BIOPHYS, GALVESTON, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	CHEN, L (corresponding author), UNIV TEXAS, MED BRANCH, INST MARINE BIOMED INST, GALVESTON, TX 77550 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K04NS001050, R01NS023061] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23061, NS01050] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AANONSEN LM, 1990, PAIN, V41, P309, DOI 10.1016/0304-3959(90)90008-2; AANONSEN LM, 1987, J PHARMACOL EXP THER, V243, P9; ASHER P, 1988, J PHYSL, V399, P247; BARKER JL, 1978, CHARACTERISTICS FUNC, V5, P87; BATTAGLIA G, 1988, J COMP NEUROL, V277, P302, DOI 10.1002/cne.902770210; Bell R M, 1986, Methods Enzymol, V124, P353; CHEN L, 1990, NEUROSCI LETT, V110, P66, DOI 10.1016/0304-3940(90)90788-B; CHERUBINI E, 1985, P NATL ACAD SCI USA, V82, P1860, DOI 10.1073/pnas.82.6.1860; CHO HJ, 1988, NEUROSCI LETT, V84, P125, DOI 10.1016/0304-3940(88)90395-3; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; CRAIN SM, 1990, TRENDS PHARMACOL SCI, V11, P77, DOI 10.1016/0165-6147(90)90322-Y; DAUGHERTY PM, 1991, IN PRESS PAIN; DUBNER R, 1983, ANNU REV NEUROSCI, V6, P381, DOI 10.1146/annurev.ne.06.030183.002121; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FIELDS HL, 1987, PAIN, P133; GERBER G, 1989, J NEUROSCI, V9, P3606; GERBER G, 1989, NEUROSCI LETT, V106, P211, DOI 10.1016/0304-3940(89)90228-0; GROSS RA, 1987, P NATL ACAD SCI USA, V84, P5469, DOI 10.1073/pnas.84.15.5469; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; HUANG LYM, 1989, J PHYSIOL-LONDON, V411, P161, DOI 10.1113/jphysiol.1989.sp017566; IADAROLA MJ, 1988, PAIN, V35, P313, DOI 10.1016/0304-3959(88)90141-8; JAHR CE, 1985, J NEUROSCI, V5, P2281; KAJANDER KC, 1990, PEPTIDES, V11, P719, DOI 10.1016/0196-9781(90)90187-A; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; LINDEN DJ, 1989, BRAIN RES REV, V14, P279, DOI 10.1016/0165-0173(89)90004-0; LOH HH, 1990, ANNU REV PHARMACOL, V30, P123; MACDERMOTT AB, 1986, J NEUROSCI, V7, P3230; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MADISON DV, 1988, J PHYSL, V398, P122; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NISHIMORI T, 1988, J COMP NEUROL, V274, P142, DOI 10.1002/cne.902740113; NORTH RA, 1986, TRENDS NEUROSCI, V9, P114; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PAN ZZ, 1990, J PHYSIOL-LONDON, V427, P519, DOI 10.1113/jphysiol.1990.sp018185; POTASHNER SJ, 1984, J NEUROCHEM, V42, P1135, DOI 10.1111/j.1471-4159.1984.tb12722.x; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; REZEL HR, 1963, METHOD ENZYMOL, V6, P211; RUDA MA, 1988, P NATL ACAD SCI USA, V85, P622, DOI 10.1073/pnas.85.2.622; SCHNEIDER SP, 1985, BRAIN RES, V360, P339, DOI 10.1016/0006-8993(85)91251-X; SCHROEDER JE, 1991, NEURON, V6, P13, DOI 10.1016/0896-6273(91)90117-I; Segal M, 1988, NIDA Res Monogr, V82, P133; SIGGINS GR, 1981, P NATL ACAD SCI-BIOL, V78, P5235, DOI 10.1073/pnas.78.8.5235; SKILLING SR, 1988, J NEUROCHEM, V51, P127, DOI 10.1111/j.1471-4159.1988.tb04845.x; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; SURPRENANT A, 1990, J PHYSIOL-LONDON, V431, P585, DOI 10.1113/jphysiol.1990.sp018349; TATSUMI H, 1990, J NEUROSCI, V10, P1675; TORTELLA FC, 1988, TRENDS PHARMACOL SCI, V9, P366, DOI 10.1016/0165-6147(88)90256-8; TSUNOO A, 1986, P NATL ACAD SCI USA, V83, P9832, DOI 10.1073/pnas.83.24.9832; UEDA H, 1988, P NATL ACAD SCI USA, V85, P7013, DOI 10.1073/pnas.85.18.7013; VANHOLDE KE, 1971, PHYSICAL BIOCH, P79; WESTLUND KN, 1989, NEUROSCI LETT, V96, P13, DOI 10.1016/0304-3940(89)90235-8; WILLCOCKSON WS, 1986, J NEUROSCI, V6, P2509; WILLIAMS JT, 1982, NATURE, V299, P74, DOI 10.1038/299074a0; WILLIS WD, 1985, PAIN SYSTEM NEURAL B, P145; WOOLF CJ, 1982, BRAIN RES, V242, P77, DOI 10.1016/0006-8993(82)90497-8; YAKSH TL, 1985, ANNU REV PHARMACOL, V25, P433, DOI 10.1146/annurev.pa.25.040185.002245; YAMAMOTO D, 1988, J PHYSIOL-LONDON, V400, P691, DOI 10.1113/jphysiol.1988.sp017144; YOSHIMURA M, 1990, J PHYSIOL-LONDON, V430, P315, DOI 10.1113/jphysiol.1990.sp018293	64	457	464	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					319	326		10.1016/0896-6273(91)90270-A	http://dx.doi.org/10.1016/0896-6273(91)90270-A			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1678615				2022-12-28	WOS:A1991GB93300015
J	GU, YP; HUANG, LYM				GU, YP; HUANG, LYM			BLOCK OF KAINATE RECEPTOR CHANNELS BY CA2+ IN ISOLATED SPINAL TRIGEMINAL NEURONS OF RAT	NEURON			English	Article							AMINO-ACID RECEPTORS; MOUSE CENTRAL NEURONS; METHYL-D-ASPARTATE; HIPPOCAMPAL-NEURONS; ACTIVATED CHANNELS; CALCIUM CHANNELS; ACETYLCHOLINE-RECEPTOR; NEUROMUSCULAR-JUNCTION; XENOPUS OOCYTES; METAL-CATIONS	Compared with N-methyl-D-aspartate-activated channels, the interaction of Ca2+ with kainate-activated or with quisqualate-activated channels is not well understood. We have studied the effect of Ca2+ on kainate-activated currents in isolated trigeminal neurons and found that Ca2+ inhibits kainate responses. This inhibition occurs not because Ca2+ changes the affinity of kainate to its receptor, but because Ca2+ blocks monovalent cation permeation through kainate-activated channels. This Ca2+ block gives rise to the outward rectification of the kainate responses.	UNIV TEXAS, MED BRANCH, DEPT PHYSIOL & BIOPHYS, GALVESTON, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	GU, YP (corresponding author), UNIV TEXAS, MED BRANCH, INST MARINE BIOMED, GALVESTON, TX 77550 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K04NS001050, R01NS023061] Funding Source: NIH RePORTER; NINDS NIH HHS [NS01050, NS23061] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; AKAIKE N, 1986, J PHYSL, V379, P717; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P207; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P227; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; CHOI DW, 1988, J NEUROSCI, V8, P185; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; CULLCANDY SG, 1989, J PHYSIOL-LONDON, V415, P555, DOI 10.1113/jphysiol.1989.sp017736; DECKER ER, 1990, J NEUROSCI, V10, P3413; DUBNER R, 1983, ANNU REV NEUROSCI, V6, P381, DOI 10.1146/annurev.ne.06.030183.002121; Eyring H., 1949, REC CHEM PROGR, V100, P100; GARTHWAITE G, 1987, NEUROSCI LETT, V83, P241, DOI 10.1016/0304-3940(87)90093-0; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; HUANG LYM, 1978, J GEN PHYSIOL, V71, P397, DOI 10.1085/jgp.71.4.397; HUANG LYM, 1989, J PHYSIOL-LONDON, V411, P161, DOI 10.1113/jphysiol.1989.sp017566; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; LEWIS CA, 1983, P NATL ACAD SCI-BIOL, V80, P6110, DOI 10.1073/pnas.80.19.6110; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; LEWIS CA, 1979, MEMBRANE TRANSPORT P, V3, P133; LUMB RF, 1953, J PHYS CHEM-US, V57, P690, DOI 10.1021/j150508a021; MADDERMOTT AB, 1986, J NEUROSCI, V7, P3230; MARTELL AE, 1964, STABILITY CONSTANTS, V17, P458; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P162, DOI 10.1152/jn.1989.61.1.162; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PITZER KS, 1974, J AM CHEM SOC, V96, P5701, DOI 10.1021/ja00825a004; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; TAKEUCHI N, 1963, J PHYSIOL-LONDON, V167, P141, DOI 10.1113/jphysiol.1963.sp007137; VERDOORN TA, 1988, MOL PHARMACOL, V34, P298; VLACHOVA V, 1987, J PHYSIOL-LONDON, V386, P425, DOI 10.1113/jphysiol.1987.sp016542	42	49	49	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1991	6	5					777	784		10.1016/0896-6273(91)90174-X	http://dx.doi.org/10.1016/0896-6273(91)90174-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	1709024				2022-12-28	WOS:A1991FM52200010
J	LAI, C; LEMKE, G				LAI, C; LEMKE, G			AN EXTENDED FAMILY OF PROTEIN-TYROSINE KINASE GENES DIFFERENTIALLY EXPRESSED IN THE VERTEBRATE NERVOUS-SYSTEM	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; NICOTINIC ACETYLCHOLINE-RECEPTOR; CELL-CELL-INTERACTION; PDGF RECEPTOR; C-KIT; PHOSPHOTYROSINE ANTIBODY; NEURONAL DIFFERENTIATION; DROSOPHILA-MELANOGASTER; INSITU HYBRIDIZATION; SEVENLESS PROTEIN	We have used PCR to identify 13 novel protein-tyrosine kinase genes (tyro-1 to -13), six of which (tyro-1 to -6) are preferentially expressed in the developing vertebrate nervous system. The tyro-2 and tyro-9 genes encode kinase domains that exhibit strong amino acid sequence similarity to the equivalent regions of the receptors for EGF and FGF, respectively, and may encode novel receptors for these or related polypeptide ligands. The tyro-1 to-6 genes are all expressed during central nervous system neurogenesis and exhibit distinct and highly regionalized patterns of expression in the adult brain. Together with recent studies in invertebrates, these data are consistent with the hypothesis that protein-tyrosine kinases play a central role in neural development.	Scripps Res Inst, RES INST, LA JOLLA, CA 92037 USA	Scripps Research Institute	LAI, C (corresponding author), SALK INST BIOL STUDIES, MOLEC NEUROBIOL LAB, LA JOLLA, CA 92037 USA.							BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BASLER K, 1988, TRENDS GENET, V4, P74, DOI 10.1016/0168-9525(88)90044-3; BASLER K, 1988, CELL, V54, P299; BOWTELL DDL, 1989, P NATL ACAD SCI USA, V86, P6245, DOI 10.1073/pnas.86.16.6245; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GREGORY RJ, 1987, MOL CELL BIOL, V7, P2119, DOI 10.1128/MCB.7.6.2119; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HAO QL, 1989, MOL CELL BIOL, V9, P1587, DOI 10.1128/MCB.9.4.1587; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HOUSER CR, 1980, BRAIN RES, V200, P341, DOI 10.1016/0006-8993(80)90925-7; HUNTER T, 1990, N HORIZ TH, P119; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KALCHEIM C, 1989, DEV BIOL, V134, P1, DOI 10.1016/0012-1606(89)90072-9; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KORNBLUTH S, 1988, MOL CELL BIOL, V8, P5541, DOI 10.1128/MCB.8.12.5541; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; KRUH GD, 1986, SCIENCE, V234, P1545, DOI 10.1126/science.3787260; LEE KH, 1990, MOL CELL BIOL, V10, P2237, DOI 10.1128/MCB.10.5.2237; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LETWIN K, 1988, ONCOGENE, V3, P621; LINDBERG RA, 1990, MOL CELL BIOL, V10, P6316, DOI 10.1128/MCB.10.12.6316; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; Mugnaini E, 1985, HDB CHEM NEUROANATOM, P436; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; PANG DT, 1988, P NATL ACAD SCI USA, V85, P762, DOI 10.1073/pnas.85.3.762; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; ROEBROEK AJM, 1985, EMBO J, V4, P2897, DOI 10.1002/j.1460-2075.1985.tb04020.x; ROTHWELL VM, 1987, ONCOGENE RES, V1, P311; RUBIN GM, 1989, CELL, V57, P519, DOI 10.1016/0092-8674(89)90120-7; RUTA M, 1988, ONCOGENE, V3, P9; SAFRAN A, 1990, ONCOGENE, V5, P635; SHIBUYA M, 1990, ONCOGENE, V5, P519; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SPRENGER F, 1989, NATURE, V338, P478, DOI 10.1038/338478a0; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; STEVENS LM, 1990, NATURE, V346, P660, DOI 10.1038/346660a0; TOGARI A, 1985, J NEUROSCI, V5, P307; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WAGNER JA, 1986, J CELL BIOL, V103, P1363, DOI 10.1083/jcb.103.4.1363; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WEINMASTER G, 1990, EMBO J, V9, P915, DOI 10.1002/j.1460-2075.1990.tb08189.x; WILKS AF, 1989, P NATL ACAD SCI USA, V86, P1603, DOI 10.1073/pnas.86.5.1603; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	77	417	480	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY	1991	6	5					691	704		10.1016/0896-6273(91)90167-X	http://dx.doi.org/10.1016/0896-6273(91)90167-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	2025425				2022-12-28	WOS:A1991FM52200003
J	BENNETT, MVL; BARRIO, LC; BARGIELLO, TA; SPRAY, DC; HERTZBERG, E; SAEZ, JC				BENNETT, MVL; BARRIO, LC; BARGIELLO, TA; SPRAY, DC; HERTZBERG, E; SAEZ, JC			GAP-JUNCTIONS - NEW TOOLS, NEW ANSWERS, NEW QUESTIONS	NEURON			English	Review							LOW-RESISTANCE JUNCTIONS; SINGLE-CHANNEL CURRENTS; RAT-LIVER; INTERCELLULAR COMMUNICATION; HORIZONTAL CELLS; 2ND MESSENGERS; PROTEIN; CONDUCTANCE; MEMBRANE; PERMEABILITY				BENNETT, MVL (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461, USA.			Spray, David/0000-0001-8368-5073	NICHD NIH HHS [HD-04248] Funding Source: Medline; NIGMS NIH HHS [GM-30667] Funding Source: Medline; NINDS NIH HHS [NS-07512] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD004248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030667] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABNEY JR, 1987, BIOPHYS J, V52, P441, DOI 10.1016/S0006-3495(87)83233-2; ATKINSON MM, 1986, J MEMBRANE BIOL, V91, P53, DOI 10.1007/BF01870214; Auerbach A A, 1969, J Gen Physiol, V53, P211; AZARNIA R, 1981, J MEMBRANE BIOL, V63, P133, DOI 10.1007/BF01969454; BAKER ME, 1990, CELL, V60, P185, DOI 10.1016/0092-8674(90)90731-S; BENNETT MVL, 1981, TRENDS NEUROSCI, V4, P159, DOI 10.1016/0166-2236(81)90053-9; BENNETT MVL, 1988, GAP JUNCTIONS, P287; BEYER EC, 1989, J CELL BIOL, V108, P595, DOI 10.1083/jcb.108.2.595; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; BEYER EC, 1988, GAP JUNCTIONS, P167; BRECKENRIDGE LJ, 1987, P NATL ACAD SCI USA, V84, P1945, DOI 10.1073/pnas.84.7.1945; BURT JM, 1988, AM J PHYSIOL, V254, pH1206, DOI 10.1152/ajpheart.1988.254.6.H1206; BURT JM, 1988, P NATL ACAD SCI USA, V85, P3431, DOI 10.1073/pnas.85.10.3431; BURT JM, 1989, CIRC RES, V65, P829, DOI 10.1161/01.RES.65.3.829; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHANG CC, 1985, P NATL ACAD SCI USA, V82, P5360, DOI 10.1073/pnas.82.16.5360; CHANSON M, 1988, AM J PHYSIOL, V255, pC699, DOI 10.1152/ajpcell.1988.255.5.C699; CHE M, 1989, Biology of Reproduction, V40, P143; CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584; COLE WC, 1986, AM J PHYSIOL, V251, pC411, DOI 10.1152/ajpcell.1986.251.3.C411; COWAN D, 1990, BRAIN RES, V509, P1, DOI 10.1016/0006-8993(90)90301-Q; COWAN D, 1990, BRAIN RES, P1754; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; DAHL G, 1987, SCIENCE, V236, P1290, DOI 10.1126/science.3035715; DEMELLO WC, 1988, GAP JUNCTIONS, V252, P611; DERMIETZEL R, 1984, EMBO J, V3, P2261, DOI 10.1002/j.1460-2075.1984.tb02124.x; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; DEVRIES SH, 1989, J PHYSIOL-LONDON, V414, P351, DOI 10.1113/jphysiol.1989.sp017692; DUPONT E, 1989, J MEMBRANE BIOL, V108, P247, DOI 10.1007/BF01871739; EBIHARA L, 1989, SCIENCE, V243, P1194, DOI 10.1126/science.2466337; EGHBALI B, 1990, P NATL ACAD SCI USA, V87, P1328, DOI 10.1073/pnas.87.4.1328; EHRING GR, 1988, GAP JUNCTIONS, P335; EPSTEIN ML, 1977, EXP CELL RES, V104, P25, DOI 10.1016/0014-4827(77)90064-7; EPSTEIN ML, 1977, J CELL BIOL, V75, P769, DOI 10.1083/jcb.75.3.769; FISHMAN GI, 1990, J CELL BIOL, V111, P589, DOI 10.1083/jcb.111.2.589; Furshpan E J, 1968, Curr Top Dev Biol, V3, P95; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P289, DOI 10.1113/jphysiol.1959.sp006143; GIAUME C, 1987, J PHYSIOL-LONDON, V386, P91, DOI 10.1113/jphysiol.1987.sp016524; GIMLICH RL, 1988, J CELL BIOL, V107, P1065, DOI 10.1083/jcb.107.3.1065; GIMLICH RL, 1990, J CELL BIOL, V110, P597, DOI 10.1083/jcb.110.3.597; GINZBERG RD, 1985, CELL TISSUE RES, V239, P477; GIRSCH SJ, 1985, J MEMBRANE BIOL, V83, P217, DOI 10.1007/BF01868696; GOODENOUGH DA, 1988, J CELL BIOL, V107, P1817, DOI 10.1083/jcb.107.5.1817; GOODENOUGH DA, 1980, J CELL BIOL, V86, P576, DOI 10.1083/jcb.86.2.576; GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9; GRASSI F, 1986, CELL BIOL INT REP, V10, P631, DOI 10.1016/0309-1651(86)90140-2; Hanna R.B., 1985, P23; HANNA RB, 1984, CELL TISSUE RES, V235, P243; HARRIS AL, 1983, J NEUROSCI, V3, P79; HARRIS AL, 1981, J GEN PHYSIOL, V77, P95, DOI 10.1085/jgp.77.1.95; HERTZBERG EL, 1985, P NATL ACAD SCI USA, V82, P2412, DOI 10.1073/pnas.82.8.2412; HERTZBERG EL, 1979, J BIOL CHEM, V254, P2138; HERTZBERG EL, 1988, J BIOL CHEM, V263, P19105; KEANE RW, 1988, J CELL BIOL, V106, P1307, DOI 10.1083/jcb.106.4.1307; KESSLER JA, 1985, GAP JUNCTIONS, P231; KISTLER J, 1988, NATURE, V331, P721, DOI 10.1038/331721a0; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUMAR NM, 1986, J CELL BIOL, V103, P767, DOI 10.1083/jcb.103.3.767; LARSEN WJ, 1983, TISSUE CELL, V15, P645, DOI 10.1016/0040-8166(83)90041-1; LIN JW, 1988, J NEUROSCI, V8, P1302; Llinas R., 1985, P337; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; MAKOWSKI L, 1977, J CELL BIOL, V74, P629, DOI 10.1083/jcb.74.2.629; MAKOWSKI L, 1988, ADV CELL BIOL, V2, P119; MATSUMOTO A, 1988, J NEUROSCI, V8, P4177; MAZET F, 1985, CIRC RES, V56, P195, DOI 10.1161/01.RES.56.2.195; MCMAHON DG, 1989, P NATL ACAD SCI USA, V86, P7639, DOI 10.1073/pnas.86.19.7639; MEGE RM, 1988, P NATL ACAD SCI USA, V85, P7274, DOI 10.1073/pnas.85.19.7274; MILKS LC, 1988, EMBO J, V7, P2967, DOI 10.1002/j.1460-2075.1988.tb03159.x; MILLER T, 1988, BIOSCIENCE REP, V8, P455, DOI 10.1007/BF01121644; MILLHAUSER GL, 1990, BIOPHYS J, V57, P857, DOI 10.1016/S0006-3495(90)82605-9; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; NAGY JI, 1988, GAP JUNCTIONS, P375; NEVEU MJ, 1990, CANCER COMMUN, V2, P21; NEYTON J, 1985, NATURE, V317, P331, DOI 10.1038/317331a0; NICHOLSON B, 1987, NATURE, V329, P732, DOI 10.1038/329732a0; NICHOLSON BJ, 1985, J BIOL CHEM, V260, P6514; NICHOLSON BJ, 1988, GAP JUNCTIONS, P207; OBAID AL, 1983, J MEMBRANE BIOL, V73, P69, DOI 10.1007/BF01870342; PAUL DL, 1986, J CELL BIOL, V103, P123, DOI 10.1083/jcb.103.1.123; PFANNER N, 1990, J CELL BIOL, V110, P955, DOI 10.1083/jcb.110.4.955; PICCOLINO M, 1984, J NEUROSCI, V4, P2477; RAO Y, 1990, NATURE, V345, P163, DOI 10.1038/345163a0; RISEK B, 1990, J CELL BIOL, V110, P269, DOI 10.1083/jcb.110.2.269; ROOK MB, 1988, AM J PHYSIOL, V255, pH770, DOI 10.1152/ajpheart.1988.255.4.H770; ROOK MB, 1989, PFLUG ARCH EUR J PHY, V414, P95, DOI 10.1007/BF00585633; SAEZ JC, 1986, P NATL ACAD SCI USA, V83, P2473, DOI 10.1073/pnas.83.8.2473; SAEZ JC, 1990, EUR J BIOCHEM, V192, P263, DOI 10.1111/j.1432-1033.1990.tb19223.x; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SAEZ JC, 1989, AM J PHYSIOL, V257, pC1, DOI 10.1152/ajpcell.1989.257.1.C1; SAEZ JC, 1990, RANSDUCTION BIOL SYS, P231; SCHWARZMANN G, 1981, SCIENCE, V213, P551, DOI 10.1126/science.7244653; SHERIDAN JD, 1970, J CELL BIOL, V45, P91, DOI 10.1083/jcb.45.1.91; SOMOGYI R, 1988, PFLUG ARCH EUR J PHY, V412, P54, DOI 10.1007/BF00583731; SPRAY DC, 1985, ANNU REV PHYSIOL, V47, P281, DOI 10.1146/annurev.ph.47.030185.001433; SPRAY DC, 1990, AM J PHYSIOL, V258, pC195, DOI 10.1152/ajpcell.1990.258.2.C195; SPRAY DC, 1991, IN PRESS AM J PHYSL; SPRAY DC, 1991, GATING GAP JUNCTION, P97; SWENSON KI, 1989, CELL, V57, P145, DOI 10.1016/0092-8674(89)90180-3; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; TRAUB O, 1987, EUR J CELL BIOL, V43, P48; TRAUB O, 1989, J CELL BIOL, V108, P1039, DOI 10.1083/jcb.108.3.1039; TROSKO JE, 1988, GAP JUNCTIONS, P435; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; VEENSTRA RD, 1988, AM J PHYSIOL, V254, pH170, DOI 10.1152/ajpheart.1988.254.1.H170; VERSELIS VK, 1991, BIOPHYS J, V59, P114, DOI 10.1016/S0006-3495(91)82204-4; WEINBERG RA, 1989, CANCER RES, V49, P3713; YAMAMOTO T, 1990, BRAIN RES, V508, P313, DOI 10.1016/0006-8993(90)90415-8; YAMASAKI H, 1988, GAP JUNCTIONS, P449; YANCEY SB, 1989, J CELL BIOL, V108, P2241, DOI 10.1083/jcb.108.6.2241; ZAMPIGHI GA, 1989, J CELL BIOL, V108, P2255, DOI 10.1083/jcb.108.6.2255; ZHANG JT, 1989, J CELL BIOL, V109, P3391, DOI 10.1083/jcb.109.6.3391	113	918	922	0	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					305	320		10.1016/0896-6273(91)90241-Q	http://dx.doi.org/10.1016/0896-6273(91)90241-Q			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1848077				2022-12-28	WOS:A1991FC47000001
J	COX, JA; FELDER, CC; HENNEBERRY, RC				COX, JA; FELDER, CC; HENNEBERRY, RC			DIFFERENTIAL EXPRESSION OF EXCITATORY AMINO-ACID RECEPTOR SUBTYPES IN CULTURED CEREBELLAR NEURONS	NEURON			English	Article									NIMH,PHARMACOL SECT,CELL BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	COX, JA (corresponding author), NINCDS,MOLEC NEUROBIOL SECT,MOLEC BIOL LAB,BETHESDA,MD 20205, USA.			Felder, Christian/0000-0003-1134-8881				BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BRENNEMAN DE, 1990, DEV BRAIN RES, V51, P63, DOI 10.1016/0165-3806(90)90258-Z; COTMAN CW, 1981, ADV BIOCHEM PSYCHOPH, P1; COWAN WM, 1967, J EXP ZOOL, V164, P267, DOI 10.1002/jez.1401640210; COX JA, 1989, BRAIN RES, V499, P267, DOI 10.1016/0006-8993(89)90774-9; COYLE JT, 1981, NEUROSCI RES PROG B, V19, P331; CURRIE AN, 1980, BRAIN RES, V100, P474; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; GALLO V, 1987, J NEUROSCI, V7, P2203; GALLO V, 1986, J NEUROSCI RES, V15, P289, DOI 10.1002/jnr.490150302; GUTHRIE PB, 1987, BRAIN RES, V420, P313, DOI 10.1016/0006-8993(87)91252-2; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; KEMP JA, 1987, TRENDS PHARMACOL SCI, V8, P414, DOI 10.1016/0165-6147(87)90223-9; KINGSBURY AE, 1985, DEV BRAIN RES, V17, P17, DOI 10.1016/0165-3806(85)90128-2; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; LASHER RS, 1972, BRAIN RES, V41, P428; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; LYSKO PG, 1989, BRAIN RES, V499, P258, DOI 10.1016/0006-8993(89)90773-7; MARAGOS WF, 1987, TRENDS NEUROSCI, V10, P65, DOI 10.1016/0166-2236(87)90025-7; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCGEER EG, 1976, NATURE, V263, P517, DOI 10.1038/263517a0; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; NICOLETTI F, 1986, J NEUROSCI, V6, P1905; NOVELLI A, 1987, DEV BRAIN RES, V34, P307, DOI 10.1016/0165-3806(87)90219-7; NOVELLI A, 1988, BRAIN RES, V451, P205, DOI 10.1016/0006-8993(88)90765-2; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OLNEY JW, 1971, EXP BRAIN RES, V14, P61; OLVERMAN HJ, 1984, NATURE, V307, P460, DOI 10.1038/307460a0; OLVERMAN HJ, 1986, EUR J PHARMACOL, V131, P161, DOI 10.1016/0014-2999(86)90533-9; PALMER E, 1988, MOL BRAIN RES, V4, P161, DOI 10.1016/0169-328X(88)90008-3; SCOTT BS, 1970, EXP NEUROL, V27, P16, DOI 10.1016/0014-4886(70)90197-4; SLADECZEK F, 1988, TRENDS NEUROSCI, V11, P545, DOI 10.1016/0166-2236(88)90183-X; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; THANGNIPON W, 1983, DEV BRAIN RES, V11, P177, DOI 10.1016/0165-3806(83)90215-8; WEISS S, 1989, BRAIN RES, V491, P189, DOI 10.1016/0006-8993(89)90104-2; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	39	73	73	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1990	4	6					941	947		10.1016/0896-6273(90)90147-8	http://dx.doi.org/10.1016/0896-6273(90)90147-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK185	1972886				2022-12-28	WOS:A1990DK18500014
J	HORTSCH, M; BIEBER, AJ; PATEL, NH; GOODMAN, CS				HORTSCH, M; BIEBER, AJ; PATEL, NH; GOODMAN, CS			DIFFERENTIAL SPLICING GENERATES A NERVOUS-SYSTEM - SPECIFIC FORM OF DROSOPHILA NEUROGLIAN	NEURON			English	Article									UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	HORTSCH, M (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,BERKELEY,CA 94720, USA.			Hortsch, Michael/0000-0002-3750-737X; Patel, Nipam/0000-0003-4328-654X	NICHD NIH HHS [HD21294] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021294, R37HD021294] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; BARBAS JA, 1988, EMBO J, V7, P625, DOI 10.1002/j.1460-2075.1988.tb02856.x; BARTHELS D, 1987, EMBO J, V6, P907, DOI 10.1002/j.1460-2075.1987.tb04837.x; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DANILOFF JK, 1986, J NEUROSCI, V6, P739; DICKSON G, 1987, CELL, V50, P1119, DOI 10.1016/0092-8674(87)90178-4; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; FAISSNER A, 1985, EMBO J, V4, P3105, DOI 10.1002/j.1460-2075.1985.tb04052.x; FAISSNER A, 1984, DEV BRAIN RES, V15, P69, DOI 10.1016/0165-3806(84)90141-X; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISCHER G, 1986, J NEUROSCI, V6, P605; FRAIL DE, 1984, J BIOL CHEM, V259, P4857; FUSHIKI S, 1986, DEV BRAIN RES, V24, P153, DOI 10.1016/0165-3806(86)90183-5; GRUMET M, 1984, P NATL ACAD SCI-BIOL, V81, P7989, DOI 10.1073/pnas.81.24.7989; GRUMET M, 1984, J CELL BIOL, V98, P1746, DOI 10.1083/jcb.98.5.1746; GRUMET M, 1988, J CELL BIOL, V106, P487, DOI 10.1083/jcb.106.2.487; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HORTSCH M, 1985, J BIOL CHEM, V260, P9137; JACOBS JR, 1989, NEURON, V2, P1625; JACOBS JR, 1989, J NEUROSCI, V9, P2402; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MACKIE K, 1989, J NEUROSCI, V9, P1883; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MURRAY BA, 1986, J CELL BIOL, V102, P189, DOI 10.1083/jcb.102.1.189; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NATZLE JE, 1984, DEV BIOL, V104, P187, DOI 10.1016/0012-1606(84)90047-2; Oi V.T., 1980, SELECTED METHODS CEL, P351; OWENS GC, 1987, P NATL ACAD SCI USA, V84, P294, DOI 10.1073/pnas.84.1.294; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PERSOHN E, 1987, J CELL BIOL, V105, P569, DOI 10.1083/jcb.105.1.569; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; PRINCE JT, 1989, J NEUROSCI, V9, P876; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; RATHJEN FG, 1984, EMBO J, V3, P1; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; SALTON SRJ, 1983, J NEUROSCI, V3, P441; SALTON SRJ, 1983, J NEUROSCI, V3, P2420; SALZER JL, 1987, J CELL BIOL, V104, P957, DOI 10.1083/jcb.104.4.957; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTONI MJ, 1989, EMBO J, V8, P385, DOI 10.1002/j.1460-2075.1989.tb03389.x; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SEILHEIMER B, 1989, J CELL BIOL, V108, P1909, DOI 10.1083/jcb.108.5.1909; SHIMOYAMA Y, 1989, J CELL BIOL, V109, P1787, DOI 10.1083/jcb.109.4.1787; SMALL SJ, 1988, NEURON, V1, P1007, DOI 10.1016/0896-6273(88)90158-4; SORKIN BC, 1984, SCIENCE, V225, P1476, DOI 10.1126/science.6474186; STALLCUP WB, 1985, P NATL ACAD SCI USA, V82, P1276, DOI 10.1073/pnas.82.4.1276; THOMPSON J, 1989, GENE DEV, V3, P348, DOI 10.1101/gad.3.3.348; THOR G, 1987, EMBO J, V6, P2581, DOI 10.1002/j.1460-2075.1987.tb02548.x; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	62	139	141	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1990	4	5					697	709		10.1016/0896-6273(90)90196-M	http://dx.doi.org/10.1016/0896-6273(90)90196-M			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE975	1693086				2022-12-28	WOS:A1990DE97500005
J	LESTER, RAJ; JAHR, CE				LESTER, RAJ; JAHR, CE			QUISQUALATE RECEPTOR-MEDIATED DEPRESSION OF CALCIUM CURRENTS IN HIPPOCAMPAL-NEURONS	NEURON			English	Article											LESTER, RAJ (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201, USA.				NINDS NIH HHS [NS21419] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021419] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANWYL R, 1989, TRENDS PHARMACOL SCI, V10, P236, DOI 10.1016/0165-6147(89)90268-X; ARMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117, DOI 10.1016/0166-2236(89)90168-9; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BELLES B, 1988, PFLUG ARCH EUR J PHY, V411, P353, DOI 10.1007/BF00587713; BROWN AM, 1988, AM J PHYSIOL, V254, pH401, DOI 10.1152/ajpheart.1988.254.3.H401; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; DOERNER D, 1988, J NEUROSCI, V8, P4069; DOLPHIN AC, 1987, J PHYSIOL-LONDON, V386, P1; DUNLAP K, 1987, TRENDS NEUROSCI, V10, P241, DOI 10.1016/0166-2236(87)90166-4; FISCHMEISTER R, 1987, J PHYSIOL-LONDON, V387, P453, DOI 10.1113/jphysiol.1987.sp016584; FURUYA S, 1989, J PHYSIOL-LONDON, V414, P539, DOI 10.1113/jphysiol.1989.sp017702; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOH JW, 1989, SCIENCE, V244, P980, DOI 10.1126/science.2543072; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HESCHELER J, 1987, EUR J BIOCHEM, V165, P261, DOI 10.1111/j.1432-1033.1987.tb11436.x; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KALMAN D, 1988, J GEN PHYSIOL, V92, P531, DOI 10.1085/jgp.92.4.531; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; LESTER RAJ, 1989, MOL PHARMACOL, V35, P565; LEWIS DL, 1986, P NATL ACAD SCI USA, V83, P9035, DOI 10.1073/pnas.83.23.9035; LYNCH MA, 1988, NEUROSCI LETT, V84, P291, DOI 10.1016/0304-3940(88)90523-X; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; MURPHY SN, 1989, MOL PHARMACOL, V35, P671; NICOLETTI F, 1986, P NATL ACAD SCI USA, V83, P1931, DOI 10.1073/pnas.83.6.1931; PALMER E, 1988, MOL BRAIN RES, V4, P161, DOI 10.1016/0169-328X(88)90008-3; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SAGIEISENBERG R, 1989, TRENDS BIOCHEM SCI, V14, P355, DOI 10.1016/0968-0004(89)90001-7; SCHOEPP DD, 1988, BIOCHEM PHARMACOL, V37, P4299, DOI 10.1016/0006-2952(88)90610-7; SCHOEPP DD, 1988, J NEUROCHEM, V50, P1605, DOI 10.1111/j.1471-4159.1988.tb03050.x; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; SLADECZEK F, 1988, TRENDS NEUROSCI, V11, P545, DOI 10.1016/0166-2236(88)90183-X; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; TOSELLI M, 1989, PFLUG ARCH EUR J PHY, V413, P319, DOI 10.1007/BF00583548; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390	42	183	184	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1990	4	5					741	749		10.1016/0896-6273(90)90200-Y	http://dx.doi.org/10.1016/0896-6273(90)90200-Y			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE975	1971515				2022-12-28	WOS:A1990DE97500009
J	SIMMONS, MA; BECKER, JB; MATHER, RJ				SIMMONS, MA; BECKER, JB; MATHER, RJ			DESENSITIZATION OF THE INHIBITION OF THE M-CURRENT IN SYMPATHETIC NEURONS - EFFECTS OF ATP ANALOGS, POLYANIONS, AND MULTIPLE AGONIST APPLICATIONS	NEURON			English	Article											SIMMONS, MA (corresponding author), MARSHALL UNIV,SCH MED,DEPT PHARMACOL,HUNTINGTON,WV 25755, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS025999, R55NS025999, R01NS025999] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-25999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; BENOVIC JL, 1989, J BIOL CHEM, V264, P6707; BENOVIC JL, 1985, J BIOL CHEM, V260, P7094; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; BROWN DA, 1987, CELL MOL NEUROBIOL, V7, P255, DOI 10.1007/BF00711303; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; FISCHMEISTER R, 1987, J PHYSIOL-LONDON, V387, P453, DOI 10.1113/jphysiol.1987.sp016584; GRATECOS D, 1974, BIOCHEM BIOPH RES CO, V58, P960, DOI 10.1016/S0006-291X(74)80237-8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; JONES SW, 1985, J PHYSIOL-LONDON, V366, P63, DOI 10.1113/jphysiol.1985.sp015785; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; KUHN H, 1978, BIOCHEMISTRY-US, V17, P4389; KWATRA MM, 1987, J BIOL CHEM, V262, P16314; KWATRA MM, 1989, BIOCHEMISTRY-US, V28, P4543, DOI 10.1021/bi00437a005; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; LOHSE MJ, 1989, P NATL ACAD SCI USA, V86, P3011, DOI 10.1073/pnas.86.9.3011; MOSKOWITZ MA, 1987, J NEUROSCI, V7, P2344; OTERO AS, 1988, SCIENCE, V242, P443, DOI 10.1126/science.3051383; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; SHICHI H, 1978, J BIOL CHEM, V253, P7040; SIBLEY DR, 1984, J BIOL CHEM, V259, P9742; SMITH MA, 1984, MOL CELL ENDOCRINOL, V37, P311, DOI 10.1016/0303-7207(84)90101-1; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032	30	27	28	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1990	4	4					557	562		10.1016/0896-6273(90)90113-T	http://dx.doi.org/10.1016/0896-6273(90)90113-T			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB168	1691006				2022-12-28	WOS:A1990DB16800008
J	KUWAJIMA, G; FUTATSUGI, A; NIINOBE, M; NAKANISHI, S; MIKOSHIBA, K				KUWAJIMA, G; FUTATSUGI, A; NIINOBE, M; NAKANISHI, S; MIKOSHIBA, K			2 TYPES OF RYANODINE RECEPTORS IN MOUSE-BRAIN - SKELETAL-MUSCLE TYPE EXCLUSIVELY IN PURKINJE-CELLS AND CARDIAC-MUSCLE TYPE IN VARIOUS NEURONS	NEURON			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; HIPPOCAMPAL PYRAMIDAL NEURONS; SENSITIVE CALCIUM CHANNELS; SARCOPLASMIC-RETICULUM; FUNCTIONAL EXPRESSION; MICROSOMAL-MEMBRANES; CHICKEN CEREBELLUM; COMPLEMENTARY-DNA; P400 PROTEIN; LOCALIZATION	Two types of ryanodine receptors, channels for Ca2+ release from intracellular stores, are known. We detected the skeletal muscle type only in cerebellum by immunoblot analysis of microsomes and partially purified proteins. The cardiac muscle type was found in all parts of the mouse brain. Immunohistochemical study showed that the cardiac muscle type was localized mainly at the somata of most neurons. Analysis of mutant cerebella suggested that the skeletal muscle type was present exclusively in Purkinje cells. These results suggest that Ca2+-induced Ca2+ release, probably mediated by the cardiac muscle receptor, functions generally in various neurons, whereas depolarization-induced Ca2+ release, probably mediated by the skeletal muscle receptor, functions specifically in Purkinje cells.	OSAKA UNIV,INST PROT RES,DIV REGULAT MACROMOLEC FUNCT,SUITA,OSAKA 565,JAPAN; UNIV TOKYO,INST MED SCI,DEPT MOLEC NEUROBIOL,MINATO KU,TOKYO 108,JAPAN; JAPAN TOBACCO INC,PHARMACEUT BASIC RES LABS,KANAZAWA KU,YOKOHAMA 236,JAPAN	Osaka University; University of Tokyo; Japan Tobacco Inc.	KUWAJIMA, G (corresponding author), SHIONOGI INST MED SCI,2-5-1 MISHIMA,SETTSU,OSAKA 566,JAPAN.		Mikoshiba, Katsuhiko/N-7943-2015					AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AIREY JA, 1990, J BIOL CHEM, V265, P14187; ASHLEY RH, 1989, J MEMBRANE BIOL, V111, P179, DOI 10.1007/BF01871781; BENNETT J, 1986, BRIT MED BULL, V42, P385, DOI 10.1093/oxfordjournals.bmb.a072156; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; ELLISMAN MH, 1990, NEURON, V5, P135, DOI 10.1016/0896-6273(90)90304-X; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GLAUM SR, 1990, J PHARMACOL EXP THER, V253, P1293; HENZI V, 1992, NEUROSCIENCE, V46, P251, DOI 10.1016/0306-4522(92)90049-8; HERRUP K, 1983, DEV BRAIN RES, V11, P267, DOI 10.1016/0165-3806(83)90225-0; HERRUP K, 1979, BRAIN RES, V178, P443, DOI 10.1016/0006-8993(79)90705-4; IMAGAWA T, 1989, J BIOCHEM-TOKYO, V106, P342, DOI 10.1093/oxfordjournals.jbchem.a122855; KAPRIELIAN Z, 1989, MOL BRAIN RES, V6, P55, DOI 10.1016/0169-328X(89)90028-4; KAWAI T, 1971, BRAIN RES, V540, P331; KITAGAWA T, 1982, METHODS IMMUNOLOGICA, V11, P3529; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; MAEDA N, 1989, DEV BIOL, V133, P67, DOI 10.1016/0012-1606(89)90297-2; MARTINEZSERRANO A, 1989, BIOCHEM BIOPH RES CO, V161, P965, DOI 10.1016/0006-291X(89)91337-5; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MICHELANGELI F, 1991, BIOCHEM J, V275, P555, DOI 10.1042/bj2750555; MIKOSHIBA K, 1986, TRH SPINOCEREBELLAR, V1, P125; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; MURPHY SN, 1989, MOL PHARMACOL, V35, P671; NABAUER M, 1989, SCIENCE, V244, P800, DOI 10.1126/science.2543067; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; NAKANISHI S, 1992, IN PRESS NEUROSCI RE; OSU K, 1990, J BIOL CHEM, V265, P13472; PADUA RA, 1991, BRAIN RES, V542, P135, DOI 10.1016/0006-8993(91)91007-N; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; VOLPE P, 1990, NEURON, V5, P713, DOI 10.1016/0896-6273(90)90225-5; VOLPE P, 1991, EMBO J, V10, P3183, DOI 10.1002/j.1460-2075.1991.tb04880.x; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; ZIMANYI I, 1991, BRAIN RES, V561, P181, DOI 10.1016/0006-8993(91)91594-Q; ZUCKER RS, 1986, SCIENCE, V231, P574, DOI 10.1126/science.2868525	44	133	135	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1133	1142		10.1016/0896-6273(92)90071-K	http://dx.doi.org/10.1016/0896-6273(92)90071-K			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1334420				2022-12-28	WOS:A1992KD71600011
J	TAKAHASHI, T; MOMIYAMA, A; HIRAI, K; HISHINUMA, F; AKAGI, H				TAKAHASHI, T; MOMIYAMA, A; HIRAI, K; HISHINUMA, F; AKAGI, H			FUNCTIONAL CORRELATION OF FETAL AND ADULT FORMS OF GLYCINE RECEPTORS WITH DEVELOPMENTAL-CHANGES IN INHIBITORY SYNAPTIC RECEPTOR CHANNELS	NEURON			English	Article							GAMMA-AMINOBUTYRIC ACID; CULTURED SPINAL NEURONS; CENTRAL NERVOUS-SYSTEM; RAT-BRAIN; ACETYLCHOLINE-RECEPTOR; CONDUCTANCE STATES; CHLORIDE CHANNELS; BINDING SUBUNIT; MESSENGER-RNAS; CORD	Functional maturation of the nicotinic acetylcholine receptor is executed by its gamma-to-epsilon subunit switching. The glycine receptor also has fetal (alpha2) and adult (alpha1) isoforms. However, whether subunit switching is responsible for developmental changes in glycine receptor function is not known. We recorded single-channel currents from homomeric glycine receptors expressed in Xenopus oocytes with cRNAs encoding the alpha2 or alpha1 subunits and compared them with those recorded from native glycine receptors in rat spinal neurons at various ontogenic periods. The mean channel life times of the alpha1 and mature glycine receptors were equally short, whereas both the alpha2 and fetal receptors showed a significantly longer open time. Consistent with these results, the decay time of the glycinergic inhibitory postsynaptic currents (IPSCs) in spinal neurons became shorter during postnatal development. We conclude that developmental switching of alpha subunits may accelerate the kinetics of IPSCs.	MITSUBISHI KASEI INST LIFE SCI,DEPT MOLEC BIOL,MACHIDA,TOKYO 194,JAPAN; GUNMA UNIV,SCH MED,DEPT PHARMACOL,MAEBASHI,GUNMA 371,JAPAN	Gunma University	TAKAHASHI, T (corresponding author), KYOTO UNIV,FAC MED,DEPT PHYSIOL,KYOTO 606,JAPAN.		Takahashi, Tomoyuki/G-5951-2015	Takahashi, Tomoyuki/0000-0002-8771-7666				AKAGI H, 1991, NEUROSCI RES, V11, P28, DOI 10.1016/0168-0102(91)90064-6; AKAGI H, 1991, FEBS LETT, V281, P160, DOI 10.1016/0014-5793(91)80383-E; AKAGI H, 1988, SCIENCE, V242, P270, DOI 10.1126/science.2845580; ANDERSON CR, 1973, J PHYSIOL-LONDON, V235, P655, DOI 10.1113/jphysiol.1973.sp010410; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; CULLCANDY SG, 1986, J PHYSIOL-LONDON, V374, P179, DOI 10.1113/jphysiol.1986.sp016074; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; CURTIS DR, 1968, EXP BRAIN RES, V5, P235; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; GOLD MR, 1983, J PHYSIOL-LONDON, V342, P85, DOI 10.1113/jphysiol.1983.sp014841; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HAMILL OP, 1983, NATURE, V305, P805, DOI 10.1038/305805a0; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; KUHSE J, 1990, J BIOL CHEM, V265, P22317; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; SAKMANN B, 1978, NATURE, V276, P401, DOI 10.1038/276401a0; SMITH SM, 1989, J MEMBRANE BIOL, V108, P45, DOI 10.1007/BF01870424; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; TAKAHASHI T, 1990, J PHYSIOL-LONDON, V423, P27, DOI 10.1113/jphysiol.1990.sp018009; TAKAHASHI T, 1991, NEURON, V7, P965, DOI 10.1016/0896-6273(91)90341-V; TAKAHASHI T, 1992, J PHYSIOL-LONDON, V450, P593, DOI 10.1113/jphysiol.1992.sp019145; TWYMAN RE, 1991, J PHYSIOL-LONDON, V435, P303, DOI 10.1113/jphysiol.1991.sp018512; WERMAN R, 1968, J NEUROPHYSIOL, V31, P81, DOI 10.1152/jn.1968.31.1.81; YOUNG AB, 1973, P NATL ACAD SCI USA, V70, P2832, DOI 10.1073/pnas.70.10.2832	31	247	250	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1155	1161		10.1016/0896-6273(92)90073-M	http://dx.doi.org/10.1016/0896-6273(92)90073-M			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1281418				2022-12-28	WOS:A1992KD71600013
J	DISTEFANO, PS; FRIEDMAN, B; RADZIEJEWSKI, C; ALEXANDER, C; BOLAND, P; SCHICK, CM; LINDSAY, RM; WIEGAND, SJ				DISTEFANO, PS; FRIEDMAN, B; RADZIEJEWSKI, C; ALEXANDER, C; BOLAND, P; SCHICK, CM; LINDSAY, RM; WIEGAND, SJ			THE NEUROTROPHINS BDNF, NT-3, AND NGF DISPLAY DISTINCT PATTERNS OF RETROGRADE AXONAL-TRANSPORT IN PERIPHERAL AND CENTRAL NEURONS	NEURON			English	Article							NERVE GROWTH-FACTOR; RETINAL GANGLION-CELLS; EMBRYO SPINAL-CORD; SENSORY NEURONS; FACTOR RECEPTOR; CHICK-EMBRYO; MOLECULAR-CLONING; DEVELOPING RATS; MESSENGER-RNA; FACTOR FAMILY	The pattern of retrograde axonal transport of the target-derived neurotrophic molecule, nerve growth factor (NGF), correlates with its trophic actions in adult neurons. We have determined that the NGF-related neurotrophins, brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), are also retrogradely transported by distinct populations of peripheral and central nervous system neurons in the adult. All three I-125-labeled neurotrophins are retrogradely transported to sites previously shown to contain neurotrophin-responsive neurons as assessed in vitro, such as dorsal root ganglion and basal forebrain neurons. The patterns of transport also indicate the existence of neuronal populations that selectively transport NT-3 and/or BDNF, but not NGF, such as spinal cord motor neurons, neurons in the entorhinal cortex, thalamus, and neurons within the hippocampus itself. Our observations suggest that neurotrophins are transported by overlapping as well as distinct populations of neurons when injected into a given target field. Retrograde transport may thus be predictive of neuronal types selectively responsive to either BDNF or NT-3 in the adult, as first demonstrated for NGF.			DISTEFANO, PS (corresponding author), REGENERON PHARMACEUT INC,777 OLD SAW MILL RIVER RD,TARRYTOWN,NY 10591, USA.		Lindsay, Ronald/GQP-8001-2022					ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BOCCHINI V, 1969, P NATL ACAD SCI USA, V64, P787, DOI 10.1073/pnas.64.2.787; CIUDAD CJ, 1988, J BIOL CHEM, V263, P16274; COWAN WM, 1972, BRAIN RES, V37, P21, DOI 10.1016/0006-8993(72)90344-7; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; JOHNSON EM, 1987, J NEUROSCI, V7, P923; JOHNSON EM, 1978, BRAIN RES, V150, P319, DOI 10.1016/0006-8993(78)90283-4; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KALCHEIM C, 1987, EMBO J, V6, P2871, DOI 10.1002/j.1460-2075.1987.tb02589.x; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KORSCHING S, 1983, NEUROSCI LETT, V39, P1, DOI 10.1016/0304-3940(83)90155-6; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MARCHALONIS JJ, 1969, BIOCHEM J, V113, P299, DOI 10.1042/bj1130299; OPPENHEIM RW, 1982, J COMP NEUROL, V210, P174, DOI 10.1002/cne.902100208; PALMATIER MA, 1984, J NEUROSCI, V4, P751; RAIVICH G, 1987, J COMP NEUROL, V256, P229, DOI 10.1002/cne.902560204; RAIVICH G, 1985, EMBO J, V4, P637, DOI 10.1002/j.1460-2075.1985.tb03677.x; RICHARDSON PM, 1984, J NEUROSCI, V4, P1683; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; SCHWAB ME, 1979, BRAIN RES, V168, P473, DOI 10.1016/0006-8993(79)90303-2; SEILER M, 1984, BRAIN RES, V300, P33, DOI 10.1016/0006-8993(84)91338-6; SNIDER WD, 1989, ANN NEUROL, V26, P489, DOI 10.1002/ana.410260402; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STOCKEL K, 1975, BRAIN RES, V85, P337; STOCKEL K, 1975, BRAIN RES, V89, P1; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; WAYNE DB, 1988, DEV BIOL, V127, P220, DOI 10.1016/0012-1606(88)90203-5; YAN Q, 1988, NEURON, V1, P335; YAN Q, 1988, J NEUROSCI, V8, P3481; YIP HK, 1983, J NEUROSCI, V3, P2172; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	48	674	684	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					983	993		10.1016/0896-6273(92)90213-W	http://dx.doi.org/10.1016/0896-6273(92)90213-W			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1375039				2022-12-28	WOS:A1992HV46700018
J	ITASAKI, N; NAKAMURA, H				ITASAKI, N; NAKAMURA, H			ROSTROCAUDAL POLARITY OF THE TECTUM IN BIRDS - CORRELATION OF EN GRADIENT AND TOPOGRAPHIC ORDER IN RETINOTECTAL PROJECTION	NEURON			English	Article							CHICK OPTIC TECTUM; RETINAL AXONS; NERVOUS-SYSTEM; VISUAL CENTERS; GUIDANCE; EXPRESSION; TARGET; BRAIN; GENE; NEUROEPITHELIUM	Rostrocaudal polarity of the tectum is first detectable at embryonic day 2 (E2) in the chick by the rostrocaudal gradient of en expression. When ectopic tectum is produced by heterotopic transplantation at E2 in the diencephalon, the gradient of en expression is inverted from the host polarity by environmental influences. Here we report that the retinal fibers project to the ectopic tectum in a topographic order in accord with the inverted gradient of en expression. Moreover, if ectopic tectum was produced at E3, when the en pattern was preserved, the retinotectal projection pattern was also in accord with the en pattern, suggesting that rostrocaudal polarity of retinotectal order follows en expression patterns.	HIROSHIMA UNIV,SCH MED,DEPT ANAT,HIROSHIMA 734,JAPAN	Hiroshima University	ITASAKI, N (corresponding author), KYOTO PREFECTURAL UNIV MED,DEPT BIOL,13-2 NISHITAKATSUKASA CHO,KITA KU,KYOTO 603,JAPAN.			Itasaki, Nobue/0000-0003-0587-9141				ADAMS JC, 1981, J HISTOCHEM CYTOCHEM, V29, P775, DOI 10.1177/29.6.7252134; ALVARADOMALLART RM, 1990, DEV BIOL, V139, P75, DOI 10.1016/0012-1606(90)90280-V; ALVARADOMALLART RM, 1984, DEV BIOL, V103, P378, DOI 10.1016/0012-1606(84)90326-9; BONHOEFFER F, 1982, EMBO J, V1, P427, DOI 10.1002/j.1460-2075.1982.tb01186.x; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; CLINE HT, 1990, J NEUROSCI, V10, P1197; CROSSLAND WJ, 1974, J COMP NEUROL, V155, P127, DOI 10.1002/cne.901550202; CROSSLAND WJ, 1979, J COMP NEUROL, V185, P87, DOI 10.1002/cne.901850106; EHRLICH D, 1984, J COMP NEUROL, V223, P592, DOI 10.1002/cne.902230410; FAWCETT JW, 1985, TRENDS NEUROSCI, V8, P201, DOI 10.1016/0166-2236(85)90079-7; FUJISAWA H, 1989, DEV BIOL, V135, P231, DOI 10.1016/0012-1606(89)90175-9; FUJISAWA H, 1987, DEV GROWTH DIFFER, V29, P105; GARDNER CA, 1988, J NEUROSCI RES, V21, P426, DOI 10.1002/jnr.490210234; GARDNER CA, 1991, DEVELOPMENT, V113, P1037; GOLDBERG S, 1974, DEV BIOL, V36, P24, DOI 10.1016/0012-1606(74)90188-2; GOLDBERG S, 1972, J COMP NEUROL, V146, P507, DOI 10.1002/cne.901460406; HALFTER W, 1985, J COMP NEUROL, V232, P466, DOI 10.1002/cne.902320405; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HANKIN M, 1991, TRENDS NEUROSCI, V14, P224, DOI 10.1016/0166-2236(91)90118-E; HANKIN MH, 1990, DEV BIOL, V138, P136, DOI 10.1016/0012-1606(90)90183-J; HANKIN MH, 1987, J COMP NEUROL, V263, P455, DOI 10.1002/cne.902630310; HARRIS WA, 1986, NATURE, V320, P266, DOI 10.1038/320266a0; HARRIS WA, 1989, NATURE, V339, P218, DOI 10.1038/339218a0; HUNT P, 1991, CELL, V66, P1075, DOI 10.1016/0092-8674(91)90029-X; ICHIJO H, 1990, DEVELOPMENT, V110, P331; ITASAKI N, 1991, DEVELOPMENT, V113, P1133; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; KELLY JP, 1972, BRAIN RES, V42, P263, DOI 10.1016/0006-8993(72)90530-6; KOBAYASHI T, 1990, DEV BRAIN RES, V57, P29, DOI 10.1016/0165-3806(90)90181-W; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MARTINEZ S, 1990, DEV BIOL, V139, P432, DOI 10.1016/0012-1606(90)90312-7; MARTINEZ S, 1991, NEURON, V6, P971, DOI 10.1016/0896-6273(91)90237-T; MATSUNO T, 1991, DEV BRAIN RES, V58, P265, DOI 10.1016/0165-3806(91)90014-A; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; NAKAMURA H, 1990, BRAIN RES, V511, P122, DOI 10.1016/0006-8993(90)90231-Y; OLEARY DDM, 1986, J NEUROSCI, V6, P3692; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; RAGER G, 1979, EXP BRAIN RES, V35, P213, DOI 10.1007/BF00236612; SCHMIDT JT, 1978, J COMP NEUROL, V177, P257, DOI 10.1002/cne.901770206; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SILVER J, 1984, DEV BIOL, V106, P485, DOI 10.1016/0012-1606(84)90248-3; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; TAKAGI S, 1987, DEV BIOL, V122, P90, DOI 10.1016/0012-1606(87)90335-6; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; THANOS S, 1983, J COMP NEUROL, V219, P420, DOI 10.1002/cne.902190404; THANOS S, 1987, J COMP NEUROL, V261, P155, DOI 10.1002/cne.902610114; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; WALTER J, 1990, TRENDS NEUROSCI, V13, P447, DOI 10.1016/0166-2236(90)90097-T; YOON MG, 1976, J PHYSIOL-LONDON, V257, P621, DOI 10.1113/jphysiol.1976.sp011388	54	76	76	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					787	798		10.1016/0896-6273(92)90099-Y	http://dx.doi.org/10.1016/0896-6273(92)90099-Y			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1348950				2022-12-28	WOS:A1992HQ18800017
J	TAUSSIG, R; SANCHEZ, S; RIFO, M; GILMAN, AG; BELARDETTI, F				TAUSSIG, R; SANCHEZ, S; RIFO, M; GILMAN, AG; BELARDETTI, F			INHIBITION OF THE OMEGA-CONOTOXIN-SENSITIVE CALCIUM CURRENT BY DISTINCT G-PROTEINS	NEURON			English	Article							BINDING REGULATORY PROTEINS; GLIOMA HYBRID-CELLS; PERTUSSIS TOXIN; NG108-15 CELLS; ALPHA-SUBUNITS; ADENYLATE-CYCLASE; VERTEBRATE CELLS; ESCHERICHIA-COLI; WHOLE-CELL; CYCLIC-AMP	Leu-enkephalin (Leu-Enk), norepinephrine (NE), somatostatin (SS), and bradykinin (BK) decrease the voltage-dependent calcium current in NG108-15 cells. Here we have investigated whether distinct G proteins, or a G protein common to all of the pathways, mediates this inhibition. We found that pertussis toxin (PTX) reduced all of these transmitter actions, except that of BK. To examine which of the PTX-sensitive pathways is transduced by G(oA), we constructed an NG108-15 cell line that stably expresses a mutant, PTX-resistant alpha-subunit of G(oA). After treatment with PTX, the mutant G(oA-alpha) rescued the Leu-Enk and NE pathways but not the SS pathway. At least three different G proteins can transduce receptor-mediated inhibition of calcium currents in nerve cells. The effects of these G proteins appear to converge on the omega-conotoxin GVIA-sensitive calcium current.			TAUSSIG, R (corresponding author), UNIV TEXAS,MED CTR,DEPT PHARMACOL,DALLAS,TX 75235, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034497, R01GM034497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS025186] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34497] Funding Source: Medline; NINDS NIH HHS [NS25186] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BROWN DA, 1988, J PHYSIOL-LONDON, V397, P167, DOI 10.1113/jphysiol.1988.sp016994; DOCHERTY RJ, 1988, J PHYSIOL-LONDON, V398, P33, DOI 10.1113/jphysiol.1988.sp017027; DOLPHIN AC, 1990, ANNU REV PHYSIOL, V52, P243; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FUKUDA K, 1988, NATURE, V335, P355, DOI 10.1038/335355a0; GARIBAY JLR, 1991, BIOCHIM BIOPHYS ACTA, V1094, P193, DOI 10.1016/0167-4889(91)90008-L; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRANDT R, 1986, FEBS LETT, V196, P279, DOI 10.1016/0014-5793(86)80263-0; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P316; HARRIS BA, 1985, SCIENCE, V229, P1274, DOI 10.1126/science.3839937; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HIGASHIDA H, 1990, P ROY SOC B-BIOL SCI, V242, P68, DOI 10.1098/rspb.1990.0105; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HSIA JA, 1984, J BIOL CHEM, V259, P1086; HUS WH, 1990, J BIOL CHEM, V265, P11220; JACKSON TR, 1987, EMBO J, V6, P49, DOI 10.1002/j.1460-2075.1987.tb04717.x; JONES DT, 1987, J BIOL CHEM, V262, P1421; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KOCH BD, 1985, J BIOL CHEM, V260, P3138; KORN SJ, 1989, J GEN PHYSIOL, V94, P789, DOI 10.1085/jgp.94.5.789; KRAMER RH, 1991, NEURON, V6, P557, DOI 10.1016/0896-6273(91)90058-8; KUROSE H, 1983, J BIOL CHEM, V258, P4870; LINDER ME, 1990, J BIOL CHEM, V265, P8243; LOGOTHETIS DE, 1988, P NATL ACAD SCI USA, V85, P5814, DOI 10.1073/pnas.85.16.5814; MCFADZEAN I, 1989, NEURON, V3, P177, DOI 10.1016/0896-6273(89)90030-5; MULLANEY I, 1988, BIOCHEM J, V256, P649, DOI 10.1042/bj2560649; MUMBY S, 1988, J BIOL CHEM, V263, P2020; MUMBY SM, 1986, P NATL ACAD SCI USA, V83, P265, DOI 10.1073/pnas.83.2.265; PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363; PANG IH, 1990, J BIOL CHEM, V265, P18707; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; Sambrook J, 1989, MOL CLONING LABORATO; SHEN SZ, 1991, PFLUGERS ARCH, V418, P614; SIEGELBAUM SA, 1983, TRENDS NEUROSCI, V6, P307, DOI 10.1016/0166-2236(83)90145-5; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STERNWEIS PC, 1990, TRENDS NEUROSCI, V13, P122, DOI 10.1016/0166-2236(90)90002-R; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P6477, DOI 10.1073/pnas.87.17.6477; STRATHMANN M, 1989, P NATL ACAD SCI USA, V86, P7407, DOI 10.1073/pnas.86.19.7407; SURPRENANT A, 1990, J PHYSIOL-LONDON, V431, P585, DOI 10.1113/jphysiol.1990.sp018349; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAUSSIG R, 1985, J COMP NEUROL, V238, P53, DOI 10.1002/cne.902380105; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TSUNOO A, 1986, P NATL ACAD SCI USA, V83, P9832, DOI 10.1073/pnas.83.24.9832; VANDONGEN AMJ, 1988, SCIENCE, V242, P1433, DOI 10.1126/science.3144040; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0	61	139	139	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					799	809		10.1016/0896-6273(92)90100-R	http://dx.doi.org/10.1016/0896-6273(92)90100-R			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1348951				2022-12-28	WOS:A1992HQ18800018
J	SECHRIST, J; BRONNERFRASER, M				SECHRIST, J; BRONNERFRASER, M			BIRTH AND DIFFERENTIATION OF RETICULAR NEURONS IN THE CHICK HINDBRAIN - ONTOGENY OF THE 1ST NEURONAL POPULATION	NEURON			English	Article							FLUORESCENT-HISTOCHEMICAL MARKER; AVIAN NEURAL PLATE; SPINAL-CORD; BRAIN-STEM; NEUROFILAMENT PROTEIN; TEMPORAL PATTERN; NERVOUS-SYSTEM; NF-M; ORIGIN; TIME	To understand better early neuronal birth and differentiation in higher vertebrates, we have examined the time when presumptive neurons in the chick embryo first withdraw from the cell cycle and express neurofilaments. Hindbrain reticular neurons arise prior to the definitive streak stage of gastrulation and represent the first neuronal population to be born. The birth of hindbrain reticular neurons and spinal interneurons occurs in a rostrocaudal sequence that closely parallels regression of Hensen's node. More rostral brain stem neurons are born shortly after those in the hindbrain. Neurofilament expression in reticular neuroblasts first occurs by the 7-somite stage, followed by axon outgrowth by the 15-somite stage. When neural plate morphogenesis is inhibited, neurofilament expression occurs on schedule in neurons that are undergoing or have completed terminal mitosis. Our results suggest that the inductive cues governing the birth and initial differentiation of reticular neurons are imparted by gastrulation and early neurulation.			SECHRIST, J (corresponding author), UNIV CALIF IRVINE,CTR DEV BIOL,IRVINE,CA 92717, USA.			Bronner, Marianne/0000-0003-4274-1862	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025138] Funding Source: NIH RePORTER; NICHD NIH HHS [HD25138] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTMAN J, 1980, J COMP NEUROL, V194, P1, DOI 10.1002/cne.901940102; ANGEVINE JB, 1970, ANAT REC, V166, P257, DOI 10.1002/ar.1091660214; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BENNETT GS, 1988, J NEUROSCI RES, V21, P376, DOI 10.1002/jnr.490210229; BENNETT GS, 1985, DEV BIOL, V107, P107, DOI 10.1016/0012-1606(85)90380-X; Cowdry EV, 1914, AM J ANAT, V15, P389, DOI 10.1002/aja.1000150402; ENGLAND MA, 1973, EXPERIENTIA, V29, P1267, DOI 10.1007/BF01935110; FISHER KS, 1978, IN VITRO CELL DEV B, V14, P878; FUJITA S, 1963, J COMP NEUROL, V120, P37, DOI 10.1002/cne.901200104; Gallera J., 1971, Adv Morphogen, V9, P149; GLOVER JC, 1991, J NEUROBIOL, V22, P353, DOI 10.1002/neu.480220405; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HARTENSTEIN V, 1989, NEURON, V3, P399, DOI 10.1016/0896-6273(89)90200-6; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Holmes W, 1943, ANAT REC, V86, P157, DOI 10.1002/ar.1090860205; KEANE RW, 1984, DEV BIOL, V103, P38, DOI 10.1016/0012-1606(84)90005-8; KELLER R, 1975, DEV BIOL, V42, P2222; KINTNER CR, 1987, DEVELOPMENT, V99, P311; LAMBORGHINI JE, 1980, J COMP NEUROL, V189, P323, DOI 10.1002/cne.901890208; LANGMAN J, 1966, J COMP NEUROL, V127, P399, DOI 10.1002/cne.901270308; LANGMAN J, 1970, J COMP NEUROL, V138, P419, DOI 10.1002/cne.901380403; LAYER PG, 1990, DEVELOPMENT, V109, P613; LEE H, 1974, J EMBRYOL EXP MORPH, V32, P835; LEE VMY, 1987, J NEUROSCI, V7, P3474; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MADEN M, 1991, DEVELOPMENT, V111, P35; MARTIN A, 1965, J EMBRYOL EXP MORPH, V14, P25; MCCONNELL JA, 1980, J COMP NEUROL, V192, P769, DOI 10.1002/cne.901920410; MCCONNELL JA, 1981, J COMP NEUROL, V200, P273, DOI 10.1002/cne.902000207; MENDELSON B, 1986, J COMP NEUROL, V251, P160, DOI 10.1002/cne.902510203; Nicolet G., 1971, Adv Morphogen, V9, P231; NORNES HO, 1979, DEV NEUROSCI-BASEL, V2, P101, DOI 10.1159/000112444; NORNES HO, 1974, BRAIN RES, V73, P121, DOI 10.1016/0006-8993(74)91011-7; PHELPS PE, 1990, DEV BRAIN RES, V56, P63, DOI 10.1016/0165-3806(90)90165-U; Pierce E T, 1973, Prog Brain Res, V40, P53; PITUELLO F, 1990, CELL DIFFER DEV, V32, P71, DOI 10.1016/0922-3371(90)90101-2; Ramon y Cajal S, 1960, STUDIES VERTEBRATE N; RAO B, 1968, ROUXS ARCH ENTWICKLU, V160, P187; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROTHMAN TP, 1978, DEV BIOL, V65, P322, DOI 10.1016/0012-1606(78)90030-1; SCHOENWOLF GC, 1990, J EXP ZOOL, V255, P323, DOI 10.1002/jez.1402550309; SCHOENWOLF GC, 1989, DEVELOPMENT, V105, P17; SCHOENWOLF GC, 1989, DEVELOPMENT, V106, P427; SECHRIST JW, 1969, AM J ANAT, V124, P117, DOI 10.1002/aja.1001240108; SECHRIST JW, 1974, STAIN TECHNOL, V49, P297, DOI 10.3109/10520297409116995; SIDMAN RL, 1970, CONT RES METHODS NEU, P252; SPRATT NT, 1952, J EXP ZOOL, V120, P109, DOI 10.1002/jez.1401200105; STEFANELLI A, 1951, Q REV BIOL, V26, P17, DOI 10.1086/397880; SUZUKI A, 1975, DEV GROWTH DIFFER, V17, P343; TAM PPL, 1989, DEVELOPMENT, V107, P55; Tello J. F., 1923, Travaux du Laboratoire de Recherches Biologiques Universite de Madrid, V21, P1; VAESSEN MJ, 1990, DEVELOPMENT, V110, P371; VARGASLIZARDI P, 1974, DEV BIOL, V38, P220, DOI 10.1016/0012-1606(74)90002-5; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475; WILT FH, 1972, DEV BIOL, V28, P443; Windle WF, 1936, J COMP NEUROL, V63, P431, DOI 10.1002/cne.900630304; YAGINUMA H, 1990, DEVELOPMENT, V108, P705	58	59	59	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					947	963		10.1016/0896-6273(91)90340-6	http://dx.doi.org/10.1016/0896-6273(91)90340-6			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1764246				2022-12-28	WOS:A1991GY43800008
J	PHILLIPS, HS; HAINS, JM; ARMANINI, M; LARAMEE, GR; JOHNSON, SA; WINSLOW, JW				PHILLIPS, HS; HAINS, JM; ARMANINI, M; LARAMEE, GR; JOHNSON, SA; WINSLOW, JW			BDNF MESSENGER-RNA IS DECREASED IN THE HIPPOCAMPUS OF INDIVIDUALS WITH ALZHEIMERS-DISEASE	NEURON			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; BASAL FOREBRAIN; HUMAN-BRAIN; REGIONAL DISTRIBUTION; CHOLINERGIC NEURONS; NUCLEUS BASALIS; FACTOR RECEPTOR; EXPRESSION; NGF	In recent years, nerve growth factor (NGF) has gained attention as a potential therapeutic agent for Alzheimer's disease (AD). To study the expression of NGF and its homologs, brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3), postmortem samples of hippocampus from AD and control donors were examined by in situ hybridization. Hybridization signal for BDNF, but not NGF or NT-3, was decreased in samples of hippocampus from donors with AD. Decreased transcript abundance of BDNF mRNA in hippocampi of individuals with AD was verified by an RNAase protection assay. These results suggest the possibility that decreased expression of BDNF may contribute to the progression of cell death in AD.	UNIV SO CALIF,ETHEL PERCY ANDRUS GERONTOL CTR,LOS ANGELES,CA 90089	University of Southern California	PHILLIPS, HS (corresponding author), GENENTECH INC,DEPT DEV BIOL,S SAN FRANCISCO,CA 94080, USA.							ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; ARAUJO DM, 1988, J NEUROCHEM, V50, P1914, DOI 10.1111/j.1471-4159.1988.tb02497.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLEMAN PD, 1987, NEUROBIOL AGING, V8, P521, DOI 10.1016/0197-4580(87)90127-8; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; GOEDERT M, 1989, MOL BRAIN RES, V5, P1, DOI 10.1016/0169-328X(89)90011-9; Goedert M, 1986, Brain Res, V387, P85; HEFTI F, 1989, NEUROBIOL AGING, V10, P75, DOI 10.1016/S0197-4580(89)80014-4; HEFTI F, 1989, NEUROBIOL AGING, V10, P515, DOI 10.1016/0197-4580(89)90118-8; HEMPERLY JJ, 1990, J MOL NEUROSCI, V2, P71, DOI 10.1007/BF02876913; HIGGINS GA, 1989, EXP NEUROL, V106, P222, DOI 10.1016/0014-4886(89)90155-6; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; KORDOWER JH, 1989, NEUROBIOL AGING, V10, P67, DOI 10.1016/S0197-4580(89)80013-2; KORSCHING S, 1985, EMBO J, V4, P1389, DOI 10.1002/j.1460-2075.1985.tb03791.x; LEE JJ, 1987, METHOD ENZYMOL, V152, P633; MARX J, 1990, SCIENCE, V247, P408, DOI 10.1126/science.2405484; PALMER AM, 1990, FASEB J, V4, P2745, DOI 10.1096/fasebj.4.10.2165009; PERRY E K, 1990, Alzheimer Disease and Associated Disorders, V4, P1, DOI 10.1097/00002093-199040100-00001; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SAKURADA T, 1990, BRAIN RES, V521, P329, DOI 10.1016/0006-8993(90)91561-T; SHELTON DL, 1986, P NATL ACAD SCI USA, V83, P2714, DOI 10.1073/pnas.83.8.2714; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341	25	752	778	0	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1991	7	5					695	702		10.1016/0896-6273(91)90273-3	http://dx.doi.org/10.1016/0896-6273(91)90273-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1742020				2022-12-28	WOS:A1991GT93900001
J	CHO, KO; WALL, JB; PUGH, PC; ITO, M; MUELLER, SA; KENNEDY, MB				CHO, KO; WALL, JB; PUGH, PC; ITO, M; MUELLER, SA; KENNEDY, MB			THE ALPHA-SUBUNIT OF TYPE-II CA2+ CALMODULIN-DEPENDENT PROTEIN-KINASE IS HIGHLY CONSERVED IN DROSOPHILA	NEURON			English	Article							LONG-TERM POTENTIATION; CA-2+ CALMODULIN; CALCIUM-CALMODULIN; MOLECULAR-CLONING; CA-2+-INDEPENDENT ACTIVITY; POSTSYNAPTIC DENSITY; DNA TRANSFECTION; BRAIN; EXPRESSION; AUTOPHOSPHORYLATION	A monoclonal antibody against rat brain type II Ca2+/calmodulin-dependent protein kinase (CaM kinase) precipitates three proteins from Drosophila heads with apparent molecular weights similar to those of the subunits of the rat brain kinase. Fly heads also contain a CaM kinase activity that becomes partially independent of Ca2+ after autophosphorylation, as does the rat brain kinase. We have isolated a Drosophila cDNA encoding an amino acid sequence that is 77% identical to the sequence of the rat-alpha-subunit. All known autophosphorylation sites are conserved, including the site that controls Ca2+-independent activity. The gene encoding the cDNA is located between 102E and F on the fourth chromosome. The protein product of this gene is expressed at much higher levels in the fly head than in the body. Thus, both the amino acid sequence and the tissue specificity of the mammalian kinase are highly conserved in Drosophila.			CHO, KO (corresponding author), CALTECH,DIV BIOL,216-76,PASADENA,CA 91125, USA.		Cho, Kyung-Ok/C-1705-2011	Pugh, Phyllis/0000-0001-7500-7117; Cho, Kyung-Ok/0000-0002-0760-2560; Kennedy, Mary/0000-0003-1369-0525				ASHBURNER M, 1989, DROSOPHILA LABORATOR; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; BENNETT MK, 1987, P NATL ACAD SCI USA, V84, P1794, DOI 10.1073/pnas.84.7.1794; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BULLEIT RF, 1988, NEURON, V1, P63, DOI 10.1016/0896-6273(88)90210-3; DUDAI Y, 1988, ANNU REV NEUROSCI, V11, P537, DOI 10.1146/annurev.ne.11.030188.002541; ENGELS WR, 1986, FOCUS, V8, P6; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FONG YL, 1989, J BIOL CHEM, V264, P1759; FOSTER JL, 1988, J BIOL CHEM, V263, P1676; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANLEY RM, 1987, SCIENCE, V237, P293, DOI 10.1126/science.3037704; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; ITOH N, 1986, P NATL ACAD SCI USA, V83, P4081, DOI 10.1073/pnas.83.11.4081; ITOH N, 1985, DROS INF SERVICE, V61, P89; KALDERON D, 1988, GENE DEV, V2, P1539, DOI 10.1101/gad.2.12a.1539; KELLY LE, 1981, COMP BIOCHEM PHYS B, V69, P61, DOI 10.1016/0305-0491(81)90209-1; KENNEDY M B, 1990, P101; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Maniatis T., 1982, MOL CLONING; MCGUINNESS TL, 1985, J BIOL CHEM, V260, P1696; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MOGAMI K, 1982, J BIOCHEM-TOKYO, V91, P643, DOI 10.1093/oxfordjournals.jbchem.a133736; MOLLOY SS, 1991, P NATL ACAD SCI USA, V88, P4756, DOI 10.1073/pnas.88.11.4756; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; PATTON BL, 1990, J BIOL CHEM, V265, P11204; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; QUINN WG, 1984, BIOL LEARNING, P197; ROSENTHAL A, 1987, EMBO J, V6, P433, DOI 10.1002/j.1460-2075.1987.tb04773.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; TOBIMATSU T, 1988, J BIOL CHEM, V263, P16082; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; WILLMUND R, 1986, P NATL ACAD SCI USA, V83, P9789, DOI 10.1073/pnas.83.24.9789; YAMAUCHI T, 1989, J BIOL CHEM, V264, P19108; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZHANG H, 1988, NUCLEIC ACIDS RES, V16, P1220, DOI 10.1093/nar/16.3.1220	58	60	62	1	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1991	7	3					439	450		10.1016/0896-6273(91)90296-C	http://dx.doi.org/10.1016/0896-6273(91)90296-C			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1910789				2022-12-28	WOS:A1991GG88700009
J	YARFITZ, S; NIEMI, GA; MCCONNELL, JL; FITCH, CL; HURLEY, JB				YARFITZ, S; NIEMI, GA; MCCONNELL, JL; FITCH, CL; HURLEY, JB			A G-BETA PROTEIN IN THE DROSOPHILA COMPOUND EYE IS DIFFERENT FROM THAT IN THE BRAIN	NEURON			English	Article							ROD OUTER SEGMENTS; NERVOUS-SYSTEM; GAMMA-SUBUNITS; ALPHA-SUBUNIT; GENE ENCODES; RETINAL ROD; PHOTORECEPTOR CELLS; VISUAL EXCITATION; MOLECULAR-CLONING; PHOSPHOLIPASE-C	A G protein-beta-subunit gene (Gbe) is expressed only in the eyes of adult D. melanogaster. This gene was identified by probing a Drosophila head cDNA expression library with monoclonal antibodies to a previously characterized Drosophila G protein-beta-subunit (Gbb). Immunoblot and Northern analyses demonstrate that Gbe protein and mRNA is not present in Drosophila mutants that lack eyes. Immunocytochemical and in situ hybridization analyses further demonstrate that Gbe is expressed in the eyes but not in the brain, whereas Gbb is abundantly expressed in the brain. The Gbe product is approximately 45% identical to previously identified G-beta-subunits and defines a new G-beta-class. Its localization suggests a possible role in phototransduction.	UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195	University of Washington; University of Washington Seattle	YARFITZ, S (corresponding author), UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195, USA.							BLINDER D, 1989, CELL, V56, P479, DOI 10.1016/0092-8674(89)90250-X; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BLUMENFELD A, 1985, P NATL ACAD SCI USA, V82, P7116, DOI 10.1073/pnas.82.20.7116; BODKIN DK, 1985, J VIROL METHODS, V10, P45, DOI 10.1016/0166-0934(85)90087-4; BROWN JE, 1984, NATURE, V311, P160, DOI 10.1038/311160a0; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CODINA J, 1986, FEBS LETT, V207, P187, DOI 10.1016/0014-5793(86)81486-7; COLE GM, 1990, MOL CELL BIOL, V10, P510, DOI 10.1128/MCB.10.2.510; DESOUSA SM, 1989, J BIOL CHEM, V264, P18544; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6939, DOI 10.1073/pnas.84.19.6939; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; DIETZEL C, 1987, CELL, V50, P1001, DOI 10.1016/0092-8674(87)90166-8; DONGHEE K, 1989, NATURE, V337, P557; ENGELS WR, 1986, FOCUS, V8, P6; FEIN A, 1986, SCIENCE, V232, P1543, DOI 10.1126/science.3487116; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISCHBACH KF, 1983, DEV BIOL, V95, P1, DOI 10.1016/0012-1606(83)90002-7; FONG HKW, 1987, P NATL ACAD SCI USA, V84, P3792, DOI 10.1073/pnas.84.11.3792; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; FREISSMUTH M, 1989, FASEB J, V3, P2125, DOI 10.1096/fasebj.3.10.2546847; FUNG BKK, 1983, J BIOL CHEM, V258, P495; GUILLEMOT F, 1989, P NATL ACAD SCI USA, V86, P4594, DOI 10.1073/pnas.86.12.4594; HARLOW E, 1988, ANTIBODIES; HARTLEY DA, 1988, CELL, V55, P785, DOI 10.1016/0092-8674(88)90134-1; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HSU SM, 1982, J HISTOCHEM CYTOCHEM, V30, P1079, DOI 10.1177/30.10.6182185; HURLEY JB, 1987, ANNU REV PHYSIOL, V49, P793; HUYNH TV, 1985, DNA CLONING PRACTICA; HYDE DR, 1990, P NATL ACAD SCI USA, V87, P1008, DOI 10.1073/pnas.87.3.1008; JELSEMA CL, 1987, P NATL ACAD SCI USA, V84, P3623, DOI 10.1073/pnas.84.11.3623; KATADA T, 1987, J BIOL CHEM, V262, P11897; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LEREA CL, 1986, SCIENCE, V234, P77, DOI 10.1126/science.3529395; LEVINE MA, 1990, P NATL ACAD SCI USA, V87, P2329, DOI 10.1073/pnas.87.6.2329; Maniatis T., 1982, MOL CLONING; MANNING DR, 1990, ADP RIBOSYLATING TOX, P349; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pak W.L., 1978, P553; PANG IH, 1990, J BIOL CHEM, V265, P18707; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PROVOST NM, 1988, J BIOL CHEM, V263, P12070; QUAN F, 1989, P NATL ACAD SCI USA, V86, P4321, DOI 10.1073/pnas.86.11.4321; RENFRANZ PJ, 1989, DEV BIOL, V136, P411, DOI 10.1016/0012-1606(89)90267-4; RYBA NJP, 1991, BIOCHEM J, V273, P225, DOI 10.1042/bj2730225; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; Selinger Z., 1987, Progress in Clinical and Biological Research, V249, P169; SMITH DP, 1990, P NATL ACAD SCI USA, V87, P1003, DOI 10.1073/pnas.87.3.1003; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SPINDLER KR, 1984, J VIROL, V49, P132, DOI 10.1128/JVI.49.1.132-141.1984; THAMBI NC, 1989, J BIOL CHEM, V264, P18552; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TOYOSHIMA S, 1990, J BIOL CHEM, V265, P14842; TSUDA M, 1987, PHOTOCHEM PHOTOBIOL, V45, P915, DOI 10.1111/j.1751-1097.1987.tb07903.x; VANDERVOORN L, 1990, J MOL BIOL, V213, P17, DOI 10.1016/S0022-2836(05)80118-4; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; YARFITZ S, 1988, P NATL ACAD SCI USA, V85, P7134, DOI 10.1073/pnas.85.19.7134; YOCHEM J, 1987, J MOL BIOL, V195, P233, DOI 10.1016/0022-2836(87)90646-2; ZUCKER CS, 1985, CELL, V40, P851	65	61	62	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1991	7	3					429	438		10.1016/0896-6273(91)90295-B	http://dx.doi.org/10.1016/0896-6273(91)90295-B			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1910788				2022-12-28	WOS:A1991GG88700008
J	QU, ZC; MORITZ, E; HUGANIR, RL				QU, ZC; MORITZ, E; HUGANIR, RL			REGULATION OF TYROSINE PHOSPHORYLATION OF THE NICOTINIC ACETYLCHOLINE-RECEPTOR AT THE RAT NEUROMUSCULAR-JUNCTION	NEURON			English	Article											QU, ZC (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024418] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 24418] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBUQUERQUE EX, 1986, FEBS LETT, V199, P113, DOI 10.1016/0014-5793(86)81235-2; BEVAN S, 1977, J PHYSIOL-LONDON, V267, P195, DOI 10.1113/jphysiol.1977.sp011808; BRENNER HR, 1983, J PHYSIOL-LONDON, V337, P159, DOI 10.1113/jphysiol.1983.sp014617; BROCKES JP, 1975, P NATL ACAD SCI USA, V72, P1368, DOI 10.1073/pnas.72.4.1368; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; CHANGEUX JP, 1984, SCIENCE, V225, P1333; COTTON PC, 1983, MOL CELL BIOL, V3, P1157, DOI 10.1128/MCB.3.6.1157; EUSEBI F, 1985, J CELL BIOL, V100, P1339, DOI 10.1083/jcb.100.4.1339; FISCHBACH GD, 1980, J PHYSIOL-LONDON, V303, P125, DOI 10.1113/jphysiol.1980.sp013275; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; GU Y, 1988, J BIOL CHEM, V263, P12878; HALL ZW, 1985, J NEUROSCI, V5, P730; HIRANO AA, 1988, J NEUROCHEM, V50, P1147; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HUGANIR RL, 1986, NATURE, V321, P774, DOI 10.1038/321774a0; HUGANIR RL, 1982, J BIOL CHEM, V257, P9372; HUGANIR RL, 1989, CRIT REV BIOCHEM MOL, V24, P183, DOI 10.3109/10409238909082553; HUGANIR RL, 1983, P NATL ACAD SCI-BIOL, V80, P1130, DOI 10.1073/pnas.80.4.1130; HUGANIR RL, 1984, P NATL ACAD SCI USA, V81, P6963; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; MIDDLETON P, 1988, J NEUROSCI, V8, P3405; MIDDLETON P, 1986, P NATL ACAD SCI USA, V83, P4967, DOI 10.1073/pnas.83.13.4967; MILES K, 1989, NEURON, V2, P1517, DOI 10.1016/0896-6273(89)90198-0; MILES K, 1987, P NATL ACAD SCI USA, V84, P6591, DOI 10.1073/pnas.84.18.6591; MILES K, 1988, MOL NEUROBIOL, V2, P91, DOI 10.1007/BF02935341; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MULLE C, 1988, P NATL ACAD SCI USA, V85, P5728, DOI 10.1073/pnas.85.15.5728; OHTSUKA M, 1984, INT J CANCER, V34, P855, DOI 10.1002/ijc.2910340618; PANG DT, 1988, P NATL ACAD SCI USA, V85, P762, DOI 10.1073/pnas.85.3.762; SAFRAN A, 1987, J BIOL CHEM, V262, P10506; SAKMANN B, 1978, NATURE, V276, P401, DOI 10.1038/276401a0; SALPETER MM, 1987, VERTEBRATE NEUROMUSC, P55; SCHUETZE SM, 1985, P NATL ACAD SCI USA, V82, P2533, DOI 10.1073/pnas.82.8.2533; SCHUETZE SM, 1987, ANNU REV NEUROSCI, V10, P403, DOI 10.1146/annurev.ne.10.030187.002155; SMITH MM, 1987, P NATL ACAD SCI USA, V84, P6601, DOI 10.1073/pnas.84.18.6601; SMITH MM, 1989, J BIOL CHEM, V264, P12813; SOBEL A, 1977, EUR J BIOCHEM, V80, P215, DOI 10.1111/j.1432-1033.1977.tb11874.x; SUDOL M, 1986, MOL CELL BIOL, V6, P2839, DOI 10.1128/MCB.6.8.2839; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG JYJ, 1988, ANAL BIOCHEM, V172, P1, DOI 10.1016/0003-2697(88)90403-4; WITZEMANN V, 1987, FEBS LETT, V223, P104, DOI 10.1016/0014-5793(87)80518-5; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YEE GH, 1987, J BIOL CHEM, V262, P16748; ZAVOICO GB, 1984, BIOCHIM BIOPHYS ACTA, V770, P225, DOI 10.1016/0005-2736(84)90134-2	46	99	100	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1990	4	3					367	378		10.1016/0896-6273(90)90049-L	http://dx.doi.org/10.1016/0896-6273(90)90049-L			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX032	1690564				2022-12-28	WOS:A1990CX03200005
J	CHAO, MV				CHAO, MV			NEUROTROPHIN RECEPTORS - A WINDOW INTO NEURONAL DIFFERENTIATION	NEURON			English	Review							NERVE GROWTH-FACTOR; PROTEIN-TYROSINE KINASE; TRK PROTOONCOGENE PRODUCT; TUMOR-NECROSIS-FACTOR; HIGH-AFFINITY RECEPTORS; MOLECULAR-CLONING; NGF RECEPTOR; PC12 CELLS; SIGNAL TRANSDUCTION; FACTOR FAMILY				CHAO, MV (corresponding author), CORNELL UNIV, MED CTR, COLL MED, DEPT CELL BIOL & ANAT, DIV HEMATOL ONCOL, NEW YORK, NY 10021 USA.			Chao, Moses/0000-0002-6969-3744				BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BATTLEMAN DS, 1992, IN PRESS J NEUROSCI; BERG MM, 1991, P NATL ACAD SCI USA, V88, P7106, DOI 10.1073/pnas.88.16.7106; BERG MM, 1992, J BIOL CHEM, V267, P13; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; Black I.B., 1990, Current Topics in Developmental Biology, V24, P161; BOTHWELL M, 1991, CURR TOP MICROBIOL, V165, P55; BUCK CR, 1987, P NATL ACAD SCI USA, V84, P3060, DOI 10.1073/pnas.84.9.3060; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHAN J, 1991, ONCOGENE, V6, P1057; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; COULIER F, 1990, MOL CELL BIOL, V10, P4202, DOI 10.1128/MCB.10.8.4202; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DURKOP H, 1992, CELL, V68, P421, DOI 10.1016/0092-8674(92)90180-K; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; FEINSTEIN DL, 1990, FEBS LETT, V272, P7, DOI 10.1016/0014-5793(90)80437-N; FRAZIER WA, 1972, SCIENCE, V176, P482, DOI 10.1126/science.176.4034.482; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GODFREY EW, 1986, J NEUROSCI, V6, P2543; GRANT AJ, 1992, P NATL ACAD SCI USA, V89, P2165, DOI 10.1073/pnas.89.6.2165; GREEN SH, 1986, J BIOL CHEM, V261, P5316; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HATTEN ME, 1988, J CELL BIOL, V101, P1511; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HEMPSTEAD BL, 1992, IN PRESS NEURON; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HOLTZMAN DM, 1992, NEURON, V9, P465, DOI 10.1016/0896-6273(92)90184-F; HOSANG M, 1985, J BIOL CHEM, V260, P655; HUGANIR RL, 1984, P NATL ACAD SCI-BIOL, V81, P6968, DOI 10.1073/pnas.81.22.6968; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JANSSEN JWG, 1991, ONCOGENE, V6, P2113; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON EM, 1987, J NEUROSCI, V7, P923; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KLARLUND JK, 1985, CELL, V41, P707, DOI 10.1016/S0092-8674(85)80051-9; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNUSEL B, 1992, J NEUROCHEM, V59, P715, DOI 10.1111/j.1471-4159.1992.tb09427.x; KOIZUMI S, 1988, J NEUROSCI, V8, P715; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LHOTAK V, 1991, MOL CELL BIOL, V11, P2496, DOI 10.1128/MCB.11.5.2496; LINDBERG RA, 1990, MOL CELL BIOL, V10, P6316, DOI 10.1128/MCB.10.12.6316; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MALLETT S, 1990, EMBO J, V9, P1063, DOI 10.1002/j.1460-2075.1990.tb08211.x; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MASSAGUE J, 1981, J BIOL CHEM, V256, P9419; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MATSUSHIMA H, 1990, MOL CELL BIOL, V10, P5015, DOI 10.1128/MCB.10.9.5015; MATTHEWS W, 1991, P NATL ACAD SCI USA, V88, P9026, DOI 10.1073/pnas.88.20.9026; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MEAKIN SO, 1992, P NATL ACAD SCI USA, V89, P2374, DOI 10.1073/pnas.89.6.2374; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MORRISON RS, 1987, SCIENCE, V238, P72, DOI 10.1126/science.3498986; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; OHMICHI M, 1991, CELL REGUL, V2, P691, DOI 10.1091/mbc.2.9.691; PANG DT, 1988, P NATL ACAD SCI USA, V85, P762, DOI 10.1073/pnas.85.3.762; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PASQUALE EB, 1991, CELL REGUL, V2, P523, DOI 10.1091/mbc.2.7.523; PATIL N, 1990, NEURON, V4, P437, DOI 10.1016/0896-6273(90)90056-L; PLEASURE SJ, 1990, P NATL ACAD SCI USA, V87, P8496, DOI 10.1073/pnas.87.21.8496; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RECIOPINTO E, 1986, J NEUROSCI, V6, P1211; RESCIGNO J, 1991, ONCOGENE, V6, P1909; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; ROSNET O, 1991, ONCOGENE, V6, P1641; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; RUTA M, 1988, ONCOGENE, V3, P9; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SAJJADI FG, 1991, NEW BIOL, V3, P769; SARIOLA H, 1991, SCIENCE, V254, P571, DOI 10.1126/science.1658930; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SCHNEIDER R, 1991, ONCOGENE, V6, P1807; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; SUTTER A, 1979, J BIOL CHEM, V254, P5972; TANIUCHI M, 1988, J NEUROSCI, V8, P664; TERMAN BI, 1991, ONCOGENE, V6, P1677; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TOGARI A, 1985, J NEUROSCI, V5, P307; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; WAGNER JA, 1991, CURR TOP MICROBIOL, V165, P95; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WHEELER EF, 1992, J NEUROSCI, V12, P930; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; WRIGHT EM, 1992, NEURON, V9, P139, DOI 10.1016/0896-6273(92)90229-7; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551; YAN Q, 1988, J NEUROSCI, V8, P3481	139	700	719	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1992	9	4					583	593		10.1016/0896-6273(92)90023-7	http://dx.doi.org/10.1016/0896-6273(92)90023-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1327010				2022-12-28	WOS:A1992JT51600001
J	MARTIN, LJ; BLACKSTONE, CD; HUGANIR, RL; PRICE, DL				MARTIN, LJ; BLACKSTONE, CD; HUGANIR, RL; PRICE, DL			CELLULAR-LOCALIZATION OF A METABOTROPIC GLUTAMATE RECEPTOR IN RAT-BRAIN	NEURON			English	Article							AMINO-ACID RECEPTOR; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; PYRAMIDAL CELLS; NERVOUS-SYSTEM; BIPOLAR CELLS; TRANS-ACPD; G-PROTEIN; EXPRESSION; DEPRESSION	In rat brain, the cellular localization of a phosphoinositide-linked metabotropic glutamate receptor(mGluR1-alpha) was demonstrated using antibodies that recognize the C-terminus of the receptor. mGluR1-alpha, a 142 kd protein, is enriched within the olfactory bulb, stratum oriens of CA1 and polymorph layer of dentate gyrus in hippocampus, globus pallidus, thalamus, substantia nigra, superior colliculus, and cerebellum. Lower levels of mGluR1-alpha are present within neocortex, striatum, amygdala, hypothalamus, and medulla. Dendrites, spines, and neuronal cell bodies contain mGluR1-alpha. mGluR1-alpha is not detectable in presynaptic terminals. mGluR1-alpha and ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor subunits show differential distributions, but in Purkinje cells, mGluR1-alpha and specific AMPA receptor subunits colocalize. The postsynaptic distribution of mGluR1-alpha is consistent with postulated physiological roles of this subtype of glutamate receptor.	JOHNS HOPKINS UNIV,SCH MED,NEUROPATHOL LAB,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	MARTIN, LJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020471, P01NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER; NIA NIH HHS [AG05146] Funding Source: Medline; NIGMS NIH HHS [GM07309] Funding Source: Medline; NINDS NIH HHS [NS20471] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASKYS A, 1991, EUR J PHARMACOL, V193, P131, DOI 10.1016/0014-2999(91)90213-A; BLACKSTONE CD, 1989, P NATL ACAD SCI USA, V86, P4316, DOI 10.1073/pnas.86.11.4316; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CHA JHJ, 1990, NEUROSCI LETT, V113, P78, DOI 10.1016/0304-3940(90)90498-X; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P28; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; DESAI MA, 1991, J NEUROPHYSIOL, V66, P40, DOI 10.1152/jn.1991.66.1.40; FROTSCHER M, 1984, NEUROSCI LETT, V46, P137, DOI 10.1016/0304-3940(84)90431-2; FURUYA S, 1989, J PHYSIOL-LONDON, V414, P539, DOI 10.1113/jphysiol.1989.sp017702; Gasic G P, 1991, Curr Opin Neurobiol, V1, P20, DOI 10.1016/0959-4388(91)90006-S; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; HWANG PM, 1990, SCIENCE, V249, P802, DOI 10.1126/science.1975122; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; LEVEY AI, 1986, J HISTOCHEM CYTOCHEM, V34, P1449, DOI 10.1177/34.11.2430010; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; PALMER E, 1989, EUR J PHARMACOL, V166, P585, DOI 10.1016/0014-2999(89)90383-X; ROSS CA, 1990, TRENDS NEUROSCI, V13, P216, DOI 10.1016/0166-2236(90)90163-5; SALT TE, 1991, EUR J NEUROSCI, V3, P1104, DOI 10.1111/j.1460-9568.1991.tb00045.x; SANDOVAL ME, 1978, NEUROSCIENCE, V3, P199, DOI 10.1016/0306-4522(78)90101-X; SCHOEPP DD, 1990, TRENDS PHARMACOL SCI, V11, P74; SEQUIER JM, 1990, EUR J NEUROSCI, V2, P1118, DOI 10.1111/j.1460-9568.1990.tb00023.x; SHIELLS RA, 1990, P ROY SOC B-BIOL SCI, V242, P91, DOI 10.1098/rspb.1990.0109; STRATTON KR, 1990, EUR J PHARMACOL, V186, P357, DOI 10.1016/0014-2999(90)90461-E; STRATTON KR, 1989, EUR J PHARMACOL, V173, P235, DOI 10.1016/0014-2999(89)90529-3; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; YOUNG AB, 1974, BRAIN RES, V73, P1, DOI 10.1016/0006-8993(74)91002-6	37	478	500	2	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					259	270		10.1016/0896-6273(92)90165-A	http://dx.doi.org/10.1016/0896-6273(92)90165-A			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1323311				2022-12-28	WOS:A1992JJ33200008
J	MCGEHEE, DS; GOY, MF; OXFORD, GS				MCGEHEE, DS; GOY, MF; OXFORD, GS			INVOLVEMENT OF THE NITRIC-OXIDE CYCLIC-GMP PATHWAY IN THE DESENSITIZATION OF BRADYKININ RESPONSES OF CULTURED RAT SENSORY NEURONS	NEURON			English	Article							BETA-ADRENERGIC-RECEPTOR; ROOT GANGLION NEURONS; MACROPHAGE CYTO-TOXICITY; IMINO-NITROGEN OXIDATION; L-ARGININE DEIMINASE; PROTEIN KINASE-C; GUANYLATE-CYCLASE; CYCLIC-GMP; SODIUM-NITROPRUSSIDE; TISSUE PREPARATIONS	Bradykinin (BK) excites a subset of dorsal root ganglion neurons by inducing an inward cation current (I(BK)) that strongly desensitizes and is accompanied by elevations in cGMP. We have examined the links between cGMP metabolism and I(BK). The BK dose dependencies of I(BK) activation, desensitization, and cGMP production are comparable. Stimulation (with sodium nitroprusside [NP] or 8-bromo-cGMP [8Br-cGMP]) or inhibition (with methylene blue, hemoglobin, and nitric oxide synthase [NOS] inhibitors) of cGMP levels did not mimic or diminish I(BK). However, desensitization was affected by the following agents: first, desensitization was enhanced by NP and reduced by NOS inhibitors. Second, the effects of NOS inhibitors could be overcome by 8Br-cGMP or L-arginine. Third, 8Br-cGMP modification of desensitization required receptor occupancy. We conclude that the NO-cGMP pathway affects a component of I(BK) desensitization at the receptor or G protein level.	UNIV N CAROLINA,CURRICULUM NEUROBIOL,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill	MCGEHEE, DS (corresponding author), UNIV N CAROLINA,DEPT PHYSIOL,CHAPEL HILL,NC 27599, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS025915, R01NS018788, P01NS023804] Funding Source: NIH RePORTER; NINDS NIH HHS [NS25915, NS18788, NS23804] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; BACCAGLINI PI, 1983, P NATL ACAD SCI-BIOL, V80, P594, DOI 10.1073/pnas.80.2.594; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BLEAKMAN D, 1990, MOL PHARMACOL, V38, P785; BURGESS GM, 1989, J NEUROCHEM, V53, P1212, DOI 10.1111/j.1471-4159.1989.tb07417.x; BURGESS GM, 1989, J NEUROSCI, V9, P3314; CARLSON KE, 1989, J BIOL CHEM, V264, P13298; DRAY A, 1988, NEUROSCI LETT, V91, P301, DOI 10.1016/0304-3940(88)90697-0; EAST SJ, 1990, EUR J PHARMACOL, V184, P311, DOI 10.1016/0014-2999(90)90623-E; EWALD DA, 1989, NEURON, V2, P1185, DOI 10.1016/0896-6273(89)90185-2; GAMMON CM, 1989, J NEUROCHEM, V53, P95, DOI 10.1111/j.1471-4159.1989.tb07299.x; GIBSON QH, 1957, J PHYSIOL-LONDON, V136, P507, DOI 10.1113/jphysiol.1957.sp005777; GOYMF, 1991, J NEUROSCI, V14, P293; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARADA H, 1990, NEUROSCI LETT, V113, P47, DOI 10.1016/0304-3940(90)90492-R; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; HIRATA M, 1990, J BIOL CHEM, V265, P1268; IGNARRO LJ, 1986, J PHARMACOL EXP THER, V237, P893; KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P23; KIEDROWSKI L, 1991, NEUROPHARMACOLOGY, V30, P1241, DOI 10.1016/0028-3908(91)90171-7; KOCH GG, 1985, ENCY STATISTICAL SCI, V5, P136; KUO JF, 1978, ANNU REV PHARMACOL, V18, P341, DOI 10.1146/annurev.pa.18.040178.002013; KWATRA MM, 1989, BIOCHEMISTRY-US, V28, P4543, DOI 10.1021/bi00437a005; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; LINDSAY RM, 1987, J PHYSIOL-LONDON, V309, pP74; MCGEHEE D S, 1991, Molecular and Cellular Neuroscience, V2, P21, DOI 10.1016/1044-7431(91)90036-N; OXFORD GS, 1989, J PHYSIOL-LONDON, V410, P587, DOI 10.1113/jphysiol.1989.sp017550; PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; REBER BFX, 1992, PFLUG ARCH EUR J PHY, V420, P213, DOI 10.1007/BF00374993; REGOLI D, 1980, PHARMACOL REV, V32, P1; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; SIMMON LN, 1973, ADV CYCL NUCL RES, V3, P225; STEINER AL, 1972, J BIOL CHEM, V247, P1106; STRULOVICI B, 1984, SCIENCE, V225, P837, DOI 10.1126/science.6089331; THAYER SA, 1988, J NEUROSCI, V8, P4089; WOLSING DH, 1991, J PHARMACOL EXP THER, V257, P621; WOOD PM, 1976, BRAIN RES, V115, P361, DOI 10.1016/0006-8993(76)90355-3; YOUNG S, 1987, BIOCHEM J, V244, P775, DOI 10.1042/bj2440775	42	70	72	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					315	324		10.1016/0896-6273(92)90170-I	http://dx.doi.org/10.1016/0896-6273(92)90170-I			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1323313				2022-12-28	WOS:A1992JJ33200013
J	GATCHALIAN, CL; EISEN, JS				GATCHALIAN, CL; EISEN, JS			PATHWAY SELECTION BY ECTOPIC MOTONEURONS IN EMBRYONIC ZEBRAFISH	NEURON			English	Article							NEURONAL GROWTH CONES; RAT SPINAL-CORD; VERTEBRATE EMBRYO; CELL RECOGNITION; NERVOUS-SYSTEM; GUIDANCE; OUTGROWTH; SURFACES; MUTATION	Primary motoneurons in embryonic zebrafish innervate cell-specific muscles. During pathfinding, motoneuronal growth cones encounter three distinct regions: a common pathway, a choice point, and separate cell-specific pathways. To learn whether the order in which these regions are encountered influences pathway choice, we transplanted individual motoneurons to the choice point region. These cells selected their appropriate cell-specific pathways. Thus, the sequence in which pathway regions are encountered may not be important for accurate path-finding, and the cell-specific pathways may be delineated by distinct cues that individual growth cones recognize. Moreover, these cues are unlikely to be general ones, since primary sensory neurons transplanted to the same location do not extend growth cones along the motoneuronal pathways.			GATCHALIAN, CL (corresponding author), UNIV OREGON,DEPT NEUROSCI,EUGENE,OR 97403, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K04NS001476] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29315, NS01476] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACKLIN SE, 1990, J NEUROSCI, V10, P1082; ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; BANKER GA, 1988, INTRINSIC DETERMINAN, P61; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; EISEN JS, 1991, NEURON, V6, P767, DOI 10.1016/0896-6273(91)90173-W; EISEN JS, 1990, J NEUROSCI, V10, P34; EISEN JS, 1992, NEURON, V8, P231, DOI 10.1016/0896-6273(92)90290-T; EISEN JS, 1991, SCIENCE, V252, P569, DOI 10.1126/science.1708527; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; EISEN JS, 1989, NEURON, V2, P1098; FORMAN D, 1980, NATURE, V286, P492, DOI 10.1038/286492a0; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; GRUNWALD DJ, 1988, DEV BIOL, V126, P115, DOI 10.1016/0012-1606(88)90245-X; GURDON JB, 1988, NATURE, V336, P772, DOI 10.1038/336772a0; HALPERN ME, 1991, J NEUROSCI, V11, P3227; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HEASMAN J, 1985, PHILOS T ROY SOC B, V312, P145, DOI 10.1098/rstb.1985.0184; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P19, DOI 10.1098/rspb.1981.0080; LANDMESSER LT, 1988, MESSAGE MIND, P121; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; METCALFE WK, 1990, DEVELOPMENT, V110, P491; MYERS PZ, 1986, J NEUROSCI, V6, P2278; RAPER JA, 1983, J NEUROSCI, V3, P31; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TOMASELLI KJ, 1986, J CELL BIOL, V103, P2659, DOI 10.1083/jcb.103.6.2659; WESTERFIELD M, 1988, TRENDS NEUROSCI, V11, P18, DOI 10.1016/0166-2236(88)90044-6	31	19	19	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1992	9	1					105	112		10.1016/0896-6273(92)90225-3	http://dx.doi.org/10.1016/0896-6273(92)90225-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1632965				2022-12-28	WOS:A1992JE75600011
J	ISHIHARA, T; SHIGEMOTO, R; MORI, K; TAKAHASHI, K; NAGATA, S				ISHIHARA, T; SHIGEMOTO, R; MORI, K; TAKAHASHI, K; NAGATA, S			FUNCTIONAL EXPRESSION AND TISSUE DISTRIBUTION OF A NOVEL RECEPTOR FOR VASOACTIVE INTESTINAL POLYPEPTIDE	NEURON			English	Article							ADENYLATE-CYCLASE; PEPTIDE RECEPTORS; LIGAND-BINDING; RAT LUNG; VIP; NEURONS; LOCALIZATION; PURIFICATION; SECRETION; GANGLION	Vasoactive intestinal polypeptide (VIP), a 28 amino acid peptide hormone, plays many physiological roles in the peripheral and central nerve systems. A functional cDNA clone of the VIP receptor was isolated from a rat lung cDNA library by cross-hybridization with the secretin receptor cDNA. VIP bound the cloned VIP receptor expressed in mouse COP cells and stimulated adenylate cyclase through the cloned receptor. The rat VIP receptor consists of 459 amino acids with a calculated M(r) of 52,054 and contains seven transmembrane segments. It is structurally related to the secretin, calcitonin, and parathyroid hormone receptors, suggesting that they constitute a new subfamily of the G(s) protein-coupled receptors. VIP receptor mRNA was detected in various rat tissues including liver, lung, intestines, and brain. In situ hybridization revealed that VIP receptor mRNA is widely distributed in neuronal cells of the adult rat brain, with a relatively high expression in the cerebral cortex and hippocampus.	UNIV TOKYO,FAC SCI,DEPT BIOPHYS & BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN; KYOTO UNIV,FAC MED,DEPT MORPHOL BRAIN SCI,KYOTO 606,JAPAN	University of Tokyo; Kyoto University	ISHIHARA, T (corresponding author), OSAKA BIOSCI INST,6-2-4 FURUEDAI,SUITA,OSAKA 565,JAPAN.		Nagata, Shigekazu/AAG-3203-2019; Shigemoto, Ryuichi/E-3628-2013	Nagata, Shigekazu/0000-0001-9758-8426; Shigemoto, Ryuichi/0000-0001-8761-9444; Mori, Kensaku/0000-0001-7853-9370				BALDINO F, 1989, J MOL NEUROSCI, V1, P199; BARBEZAT GO, 1971, SCIENCE, V174, P422, DOI 10.1126/science.174.4007.422; BRUGGER CH, 1991, J BIOL CHEM, V27, P18358; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COUVINEAU A, 1990, J BIOL CHEM, V265, P13386; FUKUNAGA R, 1990, P NATL ACAD SCI USA, V87, P8702, DOI 10.1073/pnas.87.22.8702; GOZES I, 1989, MOL NEUROBIOL, V3, P201, DOI 10.1007/BF02740606; HOKFELT T, 1980, NATURE, V284, P515, DOI 10.1038/284515a0; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; ITOH N, 1983, NATURE, V304, P547, DOI 10.1038/304547a0; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KAISER PK, 1990, NEURON, V5, P373, DOI 10.1016/0896-6273(90)90173-D; KAWATANI M, 1985, SCIENCE, V229, P879, DOI 10.1126/science.3895438; KOVES K, 1990, ENDOCRINOLOGY, V127, P264; LABURTHE M, 1978, P NATL ACAD SCI USA, V75, P2772, DOI 10.1073/pnas.75.6.2772; LEROUX P, 1984, ENDOCRINOLOGY, V114, P1506, DOI 10.1210/endo-114-5-1506; LIBERT F, 1989, SCIENCE, V244, P569, DOI 10.1126/science.2541503; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; LUNDBERG JM, 1982, NATURE, V295, P147, DOI 10.1038/295147a0; MAGISTRETTI PJ, 1981, P NATL ACAD SCI-BIOL, V78, P6535, DOI 10.1073/pnas.78.10.6535; MAGISTRETTI PJ, 1990, TRENDS PHARMACOL SCI, V11, P250, DOI 10.1016/0165-6147(90)90253-5; MALHOTRA RK, 1988, J BIOL CHEM, V263, P2123; MARTIN JL, 1987, NEUROSCIENCE, V23, P539, DOI 10.1016/0306-4522(87)90075-3; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; PINCUS DW, 1990, NATURE, V343, P564, DOI 10.1038/343564a0; PIPER PJ, 1970, NATURE, V225, P1144, DOI 10.1038/2251144a0; PROVOW S, 1987, ENDOCRINOLOGY, V120, P2442, DOI 10.1210/endo-120-6-2442; ROBBERECHT P, 1990, ARCH INT PHARMACOD T, V303, P51; ROBBERECHT P, 1991, AM J PHYSIOL, V260, pG97, DOI 10.1152/ajpgi.1991.260.1.G97; ROSELLIN G, 1986, PEPTIDES S1, V7, P89; SAID SI, 1986, J ENDOCRINOL INVEST, V9, P191, DOI 10.1007/BF03348097; Sambrook J, 1989, MOL CLONING LABORATO; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SREEDHARAN SP, 1991, P NATL ACAD SCI USA, V88, P4986, DOI 10.1073/pnas.88.11.4986; TATEMOTO K, 1981, P NATL ACAD SCI-BIOL, V78, P6603, DOI 10.1073/pnas.78.11.6603; TYNDALL C, 1981, NUCLEIC ACIDS RES, V9, P6231, DOI 10.1093/nar/9.23.6231; VANDERMEERS A, 1984, FEBS LETT, V166, P273, DOI 10.1016/0014-5793(84)80094-0; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	42	755	768	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					811	819		10.1016/0896-6273(92)90101-I	http://dx.doi.org/10.1016/0896-6273(92)90101-I			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1314625				2022-12-28	WOS:A1992HQ18800019
J	PALCZEWSKI, K; RISPOLI, G; DETWILER, PB				PALCZEWSKI, K; RISPOLI, G; DETWILER, PB			THE INFLUENCE OF ARRESTIN (48K PROTEIN) AND RHODOPSIN KINASE ON VISUAL TRANSDUCTION	NEURON			English	Article							ROD OUTER SEGMENTS; LIGHT-DEPENDENT PHOSPHORYLATION; FROG PHOTORECEPTOR-MEMBRANES; CYCLIC-GMP PHOSPHODIESTERASE; 48-KDA PROTEIN; DISK MEMBRANES; CGMP PHOSPHODIESTERASE; PHOTOEXCITED RHODOPSIN; S-ANTIGEN; ACTIVATION	The shutoff of the phototransduction cascade in retinal rods requires the inactivation of light-activated rhodopsin. The underlying mechanisms were studied in functionally intact detached rod outer segments by testing the effect of either sangivamycin, an inhibitor of rhodopsin kinase, or phytic acid, an inhibitor of 48K protein binding to phosphorylated rhodopsin, on light responses recorded in whole-cell voltage clamp. The results suggest that isomerized rhodopsin is inactivated fully by multiple phosphorylation and that the binding of 48K protein accelerates recovery by quenching partially phosphorylated rhodopsin. Higher concentrations of sangivamycin cause changes in the light response that cannot be explained by selective inhibition of rhodopsin kinase and suggest that other protein kinases are needed for normal rod function.	UNIV WASHINGTON,SCH MED,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195	University of Washington; University of Washington Seattle	PALCZEWSKI, K (corresponding author), GOOD SAMARITAN HOSP,RS DOW NEUROL SCI INST,PORTLAND,OR 97209, USA.			Detwiler, Peter/0000-0003-3910-2023	NEI NIH HHS [EY02048, EY08061] Funding Source: Medline; NATIONAL EYE INSTITUTE [R29EY008061, R01EY008061, R01EY002048] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BENNETT N, 1988, BIOCHEMISTRY-US, V27, P1710, DOI 10.1021/bi00405a049; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BINDER BM, 1989, J BIOL CHEM, V264, P8857; BOWNDS D, 1972, NATURE-NEW BIOL, V237, P125, DOI 10.1038/newbio237125a0; BROEKHUYSE RM, 1987, CURR EYE RES, V6, P607, DOI 10.3109/02713688709025220; FRANK RN, 1975, BIOCHEMISTRY-US, V14, P5110, DOI 10.1021/bi00694a014; HAMM H, 1990, J GEN PHYSIOL, V95, P545, DOI 10.1085/jgp.95.3.545; HAYASHI F, 1987, BIOCHEM BIOPH RES CO, V148, P54, DOI 10.1016/0006-291X(87)91075-8; HERMOLIN J, 1982, J GEN PHYSIOL, V79, P633, DOI 10.1085/jgp.79.4.633; HOFMANN KP, 1986, PHOTOBIOCH PHOTOBIOP, V13, P309; KAHLERT M, 1991, BIOPHYS J, V59, P375, DOI 10.1016/S0006-3495(91)82231-7; KAPOOR CL, 1984, BIOCHEM BIOPH RES CO, V122, P1397, DOI 10.1016/0006-291X(84)91246-4; KELLEHER DJ, 1985, J CYCLIC NUCL PROT, V10, P579; KELLEHER DJ, 1986, J BIOL CHEM, V261, P4749; KUHN H, 1973, BIOCHEMISTRY-US, V12, P2495; KUHN H, 1972, FEBS LETT, V20, P1, DOI 10.1016/0014-5793(72)80002-4; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; KUHN H, 1981, NEUROCHEM INT, V1, P269; LEE RH, 1981, BIOCHEMISTRY-US, V20, P7532, DOI 10.1021/bi00529a031; LIEBMAN PA, 1980, NATURE, V287, P734, DOI 10.1038/287734a0; LIEBMAN PA, 1979, VISION RES, V19, P375, DOI 10.1016/0042-6989(79)90097-X; LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P532; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; LOOMIS CR, 1988, J BIOL CHEM, V263, P1682; MANGINI NJ, 1988, INVEST OPHTH VIS SCI, V29, P1221; MILLER JL, 1986, BIOCHEMISTRY-US, V25, P4983, DOI 10.1021/bi00366a002; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P415, DOI 10.1021/bi00428a001; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; PALCZEWSKI K, 1990, BIOCHEMISTRY-US, V29, P6276, DOI 10.1021/bi00478a024; PALCZEWSKI K, 1988, BIOCHEMISTRY-US, V27, P2306, DOI 10.1021/bi00407a010; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P4201; PALCZEWSKI K, 1991, IN PRESS FEBS LETT; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; RISPOLI G, 1990, SENSORY TRANSDUCTION, P157; SAFFER JD, 1981, MOL PHARMACOL, V20, P211; SAKMANN B, 1983, SINGLE CHANNEL RECOR; SATHER WA, 1987, P NATL ACAD SCI USA, V84, P9290, DOI 10.1073/pnas.84.24.9290; SATHER WA, 1988, THESIS U WASHINGTON; SHICHI H, 1978, J BIOL CHEM, V253, P7040; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; SITARAMAYYA A, 1977, NEUROCHEM RES, V2, P1, DOI 10.1007/BF00966017; SITARAMAYYA A, 1983, J BIOL CHEM, V258, P1205; SITARAMAYYA A, 1986, BIOCHEMISTRY-US, V25, P5460, DOI 10.1021/bi00367a017; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671; YAU KW, 1985, NATURE, V317, P252, DOI 10.1038/317252a0; ZICK Y, 1987, J BIOL CHEM, V262, P10259; ZUCKERMAN R, 1986, FEBS LETT, V207, P35, DOI 10.1016/0014-5793(86)80008-4	50	95	95	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1992	8	1					117	126		10.1016/0896-6273(92)90113-R	http://dx.doi.org/10.1016/0896-6273(92)90113-R			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1309646				2022-12-28	WOS:A1992HB18500010
J	COLE, GJ; MCCABE, CF				COLE, GJ; MCCABE, CF			IDENTIFICATION OF A DEVELOPMENTALLY REGULATED KERATAN SULFATE PROTEOGLYCAN THAT INHIBITS CELL-ADHESION AND NEURITE OUTGROWTH	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CHICK-EMBRYO; MONOCLONAL-ANTIBODIES; POTENT SUBSTRATE; SOMITE CELLS; N-CADHERIN; BRAIN; FIBRONECTIN; MOLECULES; BINDING	Monoclonal antibodies have been used to identify a 320 kd keratan sulfate proteoglycan that is primarily expressed in the embryonic chick nervous system. Immunohistochemical localization of the proteoglycan shows that it is expressed by putative midline barrier structures in the developing chick central nervous system. When added to laminin or neural cell adhesion molecule that has been adsorbed onto nitrocellulose-coated dishes, the proteoglycan abolishes cell attachment and neurite outgrowth on these adhesive substrata. This effect can be reversed by keratanase treatment and incubation with a monoclonal antibody that recognizes the keratan sulfate chains of the proteoglycan. These data suggest that this neural keratan sulfate proteoglycan plays an important role in the modulation of neuronal cell adhesion during embryonic brain development.			COLE, GJ (corresponding author), MED UNIV S CAROLINA,DEPT ANAT & CELL BIOL,CHARLESTON,SC 29425, USA.				NATIONAL EYE INSTITUTE [R29EY007130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026087] Funding Source: NIH RePORTER; NEI NIH HHS [EY07130] Funding Source: Medline; NINDS NIH HHS [NS26087] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER R, 1979, DEV BIOL, V69, P424, DOI 10.1016/0012-1606(79)90302-6; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURG M, 1990, ARCH BIOCHEM BIOPHYS, V276, P396, DOI 10.1016/0003-9861(90)90738-K; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; CARSON DD, 1988, J CELL BIOL, V107, P2425, DOI 10.1083/jcb.107.6.2425; CATERSON B, 1983, J BIOL CHEM, V258, P8848; COLE GJ, 1989, NEURON, V2, P1157, DOI 10.1016/0896-6273(89)90182-7; COLE GJ, 1986, DEV BRAIN RES, V26, P133, DOI 10.1016/0165-3806(86)90015-5; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; FUNDERBURGH JL, 1986, DEV BIOL, V116, P267, DOI 10.1016/0012-1606(86)90130-2; FUNDERBURGH JL, 1987, J BIOL CHEM, V262, P11634; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GRIERSON JP, 1990, DEV BRAIN RES, V55, P11, DOI 10.1016/0165-3806(90)90100-D; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HANTAZAMBROISE D, 1987, J NEUROSCI, V7, P2293; HASCALL VC, 1983, LIMB DEV REGENERAT B, P3; IIJIMA N, 1991, J NEUROCHEM, V56, P706, DOI 10.1111/j.1471-4159.1991.tb08207.x; JENKINS HG, 1988, J NEUROCHEM, V51, P1634, DOI 10.1111/j.1471-4159.1988.tb01134.x; JOST CJ, 1991, J BIOL CHEM, V266, P13336; KNOX P, 1979, J CELL SCI, V40, P77; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; KRUSIUS T, 1986, J BIOL CHEM, V261, P8237; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; LANDER AD, 1985, P NATL ACAD SCI USA, V82, P2183, DOI 10.1073/pnas.82.7.2183; LANDER AD, 1985, J CELL BIOL, V101, P898, DOI 10.1083/jcb.101.3.898; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; MARGOLIS RU, 1989, DEV NEUROSCI-BASEL, V11, P276, DOI 10.1159/000111906; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MORI K, 1990, P NATL ACAD SCI USA, V87, P5489, DOI 10.1073/pnas.87.14.5489; MORRIS JE, 1984, ARCH BIOCHEM BIOPHYS, V235, P127, DOI 10.1016/0003-9861(84)90261-3; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; OOHIRA A, 1991, J NEUROSCI, V11, P822; PERRIS R, 1991, DEVELOPMENT, V111, P583; PERRIS R, 1987, J CELL BIOL, V105, P2511, DOI 10.1083/jcb.105.6.2511; PETTMANN B, 1989, DISSECTION TISSUE CU, P223; PETTWAY Z, 1990, DEV BIOL, V142, P335, DOI 10.1016/0012-1606(90)90354-L; RICH AM, 1981, NATURE, V293, P224, DOI 10.1038/293224a0; ROGERS SL, 1985, J NEUROSCI, V5, P369; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; SILVER J, 1987, J NEUROSCI, V7, P2264; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; STERN CD, 1986, J EMBRYOL EXP MORPH, V91, P209; STERN CD, 1987, DEVELOPMENT, V99, P261; TOSNEY KW, 1990, EXP NEUROL, V109, P75, DOI 10.1016/S0014-4886(05)80010-X; TOSNEY KW, 1988, DEV BIOL, V127, P266, DOI 10.1016/0012-1606(88)90314-4; TOSNEY KW, 1991, BIOESSAYS, V13, P17	53	162	168	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					1007	1018		10.1016/0896-6273(91)90345-Z	http://dx.doi.org/10.1016/0896-6273(91)90345-Z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1764241				2022-12-28	WOS:A1991GY43800013
J	LLANO, I; DREESSEN, J; KANO, M; KONNERTH, A				LLANO, I; DREESSEN, J; KANO, M; KONNERTH, A			INTRADENDRITIC RELEASE OF CALCIUM INDUCED BY GLUTAMATE IN CEREBELLAR PURKINJE-CELLS	NEURON			English	Article							INOSITOL PHOSPHOLIPID-METABOLISM; ELECTRO-PHYSIOLOGICAL PROPERTIES; AMINO-ACID RECEPTOR; HIPPOCAMPAL-NEURONS; RYANODINE RECEPTOR; SYNAPTIC CURRENTS; PUTATIVE RECEPTOR; CLIMBING FIBER; SLICE CULTURES; INVITRO	The ability of excitatory amino acids to induce increases in the intracellular Ca2+ concentration ([Ca2+]i) of cerebellar Purkinje cells was examined by digital fluorescence ratio imaging of voltage-clamped Purkinje cells dialyzed with the Ca2+ indicator fura-2. Purkinje cells responded with large inward currents accompanied by increases in dendritic [Ca2+]i when challenged with the excitatory amino acid agonists glutamate and quisqualate. The rise in [Ca2+]i was transient and reached peak values of several hundred nanomolar. The response subsisted in the absence of extracellular Ca2+, a condition that eliminates Ca2+ entry through voltage-gated Ca2+ channels, indicating that Ca2+ arose in large part from an intracellular compartment. In support of this hypothesis, only the first agonist application elicited a [Ca2+]i increase in slices maintained in Ca2+-free medium, as expected if the intracellular stores become depleted. These results indicate that metabotropic glutamate receptors are functional in Purkinje cells and point to glutamate as a possible modulator of [Ca2+]i in these neurons.	MAX PLANCK INST BIOPHYS CHEM, W-3400 GOTTINGEN, GERMANY	Max Planck Society	LLANO, I (corresponding author), ECOLE NORM SUPER, NEUROBIOL LAB, F-75231 PARIS 05, FRANCE.			Kano, Masanobu/0000-0002-0725-3292				BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BLACKSTONE CD, 1989, P NATL ACAD SCI USA, V86, P4316, DOI 10.1073/pnas.86.11.4316; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FISHER SK, 1987, J NEUROCHEM, V48, P999, DOI 10.1111/j.1471-4159.1987.tb05618.x; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; FURUYA S, 1989, J PHYSIOL-LONDON, V414, P539, DOI 10.1113/jphysiol.1989.sp017702; GAHWILER BH, 1989, J PHYSIOL-LONDON, V417, P105; GILBERTSON TA, 1991, SCIENCE, V251, P1613, DOI 10.1126/science.1849316; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; Ito M, 1990, Neuroreport, V1, P129; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; KNOPFEL T, 1990, EUR J NEUROSCI, V2, P726, DOI 10.1111/j.1460-9568.1990.tb00463.x; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LLANO I, 1988, P NATL ACAD SCI USA, V85, P3221, DOI 10.1073/pnas.85.9.3221; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LLINAS R, 1990, FID RES FDN, V4, P1; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MAYER ML, 1990, TRENDS PHARMACOL SCI, V11, P254, DOI 10.1016/0165-6147(90)90254-6; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; NICOLETTI F, 1986, J NEUROCHEM, V46, P40, DOI 10.1111/j.1471-4159.1986.tb12922.x; NICOLETTI F, 1986, J NEUROSCI, V6, P1905; PALMER E, 1989, EUR J PHARMACOL, V166, P585, DOI 10.1016/0014-2999(89)90383-X; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; SUGIMORI M, 1990, P NATL ACAD SCI USA, V87, P5084, DOI 10.1073/pnas.87.13.5084; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; WORLEY PF, 1989, J NEUROSCI, V9, P339	39	127	129	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1991	7	4					577	583		10.1016/0896-6273(91)90370-F	http://dx.doi.org/10.1016/0896-6273(91)90370-F			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1681831				2022-12-28	WOS:A1991GM95400006
J	ACHESON, A; BARKER, PA; ALDERSON, RF; MILLER, FD; MURPHY, RA				ACHESON, A; BARKER, PA; ALDERSON, RF; MILLER, FD; MURPHY, RA			DETECTION OF BRAIN-DERIVED NEUROTROPHIC FACTOR-LIKE ACTIVITY IN FIBROBLASTS AND SCHWANN-CELLS - INHIBITION BY ANTIBODIES TO NGF	NEURON			English	Article							NERVE GROWTH-FACTOR; RETINAL GANGLION-CELLS; MOUSE SUBMANDIBULAR GLANDS; SENSORY NEURONS INVIVO; SYMPATHETIC INNERVATION; PERIPHERAL-NERVE; MESSENGER-RNA; SCIATIC-NERVE; SURVIVAL; RAT	mRNA coding for brain-derived neurotrophic factor (BDNF) has been detected in cultured L929 fibroblasts, rat dermal fibroblasts, and sciatic nerve Schwann cells, as well as in rat skin. Medium conditioned by cultured fibroblasts and Schwann cells also stimulates neurite growth from retinal explants and promotes the survival in culture of BDNF-responsive sensory neurons; biological activity is abolished by antibodies raised against NGF. These results suggest that molecules with BDNF-like activity may be produced by cells in the peripheral nervous system and that the BDNF-like activity in fibroblasts and Schwann cells is derived from molecules immunologically related to NGF. In support of this concept, antibodies against NGF have been found to reduce the biological activity of recombinant BDNF in culture and to cross-react with BDNF on Western blots.	REGENERON PHARMACEUT INC, NEUROBIOL PROGRAM, TARRYTOWN, NY 10591 USA	Regeneron	ACHESON, A (corresponding author), UNIV ALBERTA, FAC MED, DEPT ANAT & CELL BIOL, EDMONTON T6G 2H7, ALBERTA, CANADA.							ACHESON A, 1987, EXP CELL RES, V170, P56, DOI 10.1016/0014-4827(87)90116-9; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BANDTLOW CE, 1987, EMBO J, V6, P891, DOI 10.1002/j.1460-2075.1987.tb04835.x; BARDE YA, 1980, P NATL ACAD SCI-BIOL, V77, P1199, DOI 10.1073/pnas.77.2.1199; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DAVIES AM, 1986, NATURE, V319, P497, DOI 10.1038/319497a0; EDGAR D, 1984, EMBO J, V3, P1463, DOI 10.1002/j.1460-2075.1984.tb01997.x; GOSPODAROWICZ D, 1975, J BIOL CHEM, V250, P2515; GREENE LA, 1980, ANNU REV NEUROSCI, V3, P353, DOI 10.1146/annurev.ne.03.030180.002033; GUERINA NG, 1986, BIOCHEMISTRY-US, V25, P754, DOI 10.1021/bi00352a003; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; HEUMANN R, 1984, EMBO J, V3, P3183, DOI 10.1002/j.1460-2075.1984.tb02277.x; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; JOHNSON EM, 1986, TRENDS NEUROSCI, V9, P33, DOI 10.1016/0166-2236(86)90012-3; JOHNSON EM, 1980, SCIENCE, V210, P916, DOI 10.1126/science.7192014; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MILLER FD, 1987, J CELL BIOL, V105, P3065, DOI 10.1083/jcb.105.6.3065; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MURPHY RA, 1977, P NATL ACAD SCI USA, V74, P4496, DOI 10.1073/pnas.74.10.4496; OGER J, 1974, P NATL ACAD SCI USA, V71, P1554, DOI 10.1073/pnas.71.4.1554; PANTAZIS NJ, 1983, BIOCHEMISTRY-US, V22, P4264, DOI 10.1021/bi00287a016; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; RICHARDSON PM, 1982, BRAIN RES, V246, P57, DOI 10.1016/0006-8993(82)90141-X; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1989, DEV BIOL, V136, P296, DOI 10.1016/0012-1606(89)90256-X; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SHELTON DL, 1984, P NATL ACAD SCI-BIOL, V81, P7951, DOI 10.1073/pnas.81.24.7951; SIMINOSKI K, 1987, ENDOCRINOLOGY, V121, P1432, DOI 10.1210/endo-121-4-1432; SIMINOSKI K, 1987, BRAIN RES, V435, P273, DOI 10.1016/0006-8993(87)91610-6; SMITH AP, 1968, BIOCHEMISTRY-US, V7, P3259, DOI 10.1021/bi00849a032; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; THANOS S, 1989, EUR J NEUROSCI, V1, P19, DOI 10.1111/j.1460-9568.1989.tb00770.x; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; VOGEL Z, 1972, P NATL ACAD SCI USA, V69, P3180, DOI 10.1073/pnas.69.11.3180; WATSON AY, 1985, ANAT REC, V213, P365, DOI 10.1002/ar.1092130302; YOUNG M, 1975, SCIENCE, V187, P361, DOI 10.1126/science.1167427	49	274	279	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1991	7	2					265	275		10.1016/0896-6273(91)90265-2	http://dx.doi.org/10.1016/0896-6273(91)90265-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1873030				2022-12-28	WOS:A1991GB93300010
J	VERHAGE, M; MCMAHON, HT; GHIJSEN, WEJM; BOOMSMA, F; SCHOLTEN, G; WIEGANT, VM; NICHOLLS, DG				VERHAGE, M; MCMAHON, HT; GHIJSEN, WEJM; BOOMSMA, F; SCHOLTEN, G; WIEGANT, VM; NICHOLLS, DG			DIFFERENTIAL RELEASE OF AMINO-ACIDS, NEUROPEPTIDES, AND CATECHOLAMINES FROM ISOLATED NERVE-TERMINALS	NEURON			English	Article							GAMMA-AMINOBUTYRIC ACID; RAT-BRAIN SYNAPTOSOMES; DENSE-CORED VESICLES; CYTOSOLIC FREE CA-2+; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; CALCIUM ENTRY; GLUTAMATE RELEASE; DOPAMINE RELEASE; DEPOLARIZATION	We have investigated transmitter release from small and large dense-core vesicles in nerve terminals isolated from guinea pig hippocampus. Small vesicles are found in clusters near the active zone, and large dense-core vesicles are located at ectopic sites. The abilities of Ca2+ channel activation and uniform elevation of Ca2+ concentration (with ionophores) to evoke secretion of representative amino acids, catecholamines, and neuropeptides were compared. For a given increase in Ca2+ concentration, ionophore was less effective than Ca2+ channel activation in releasing amino acids, but not in releasing cholecystokinin-8. Titration of the average Ca2+ concentration showed that the Ca2+ affinity for cholecystokinin-8 secretion was higher than that for amino acids. Catecholamine release showed intermediate behavior. It is concluded that neuropeptide release is triggered by small elevations in the Ca2+ concentration in the bulk cytoplasm, whereas secretion of amino acids requires higher elevations, as produced in the vicinity of Ca2+ channels.	UNIV AMSTERDAM,DEPT EXPTL ZOOL,AMSTERDAM,NETHERLANDS; UNIV DUNDEE,DEPT BIOCHEM,DUNDEE DD1 4HN,SCOTLAND; ERASMUS UNIV,DEPT INTERNAL MED,3000 DR ROTTERDAM,NETHERLANDS; STATE UNIV UTRECHT,RUDOLF MAGNUS INST PHARMACOL,UTRECHT,NETHERLANDS	University of Amsterdam; University of Dundee; Erasmus University Rotterdam; Utrecht University			Oka, Yoshitaka/C-9670-2010; NICHOLLS, DAVID G/K-4300-2012	Oka, Yoshitaka/0000-0002-3482-3051; verhage, matthijs/0000-0002-6085-7503	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKERMAN KEO, 1981, EUR J BIOCHEM, V115, P67; BARTFAI T, 1988, ANNU REV PHARMACOL, V28, P285, DOI 10.1146/annurev.pa.28.040188.001441; BLAU L, 1988, BIOCHEMISTRY-US, V27, P5661, DOI 10.1021/bi00415a040; BUMA P, 1989, ACTA MORPHOL NEER SC, V26, P81; DASILVA FHL, 1990, PHYSIOL REV, V70, P453, DOI 10.1152/physrev.1990.70.2.453; DEBELLEROCHE JS, 1977, J NEUROCHEM, V29, P335; DOCKRAY GJ, 1980, BRAIN RES, V188, P155, DOI 10.1016/0006-8993(80)90564-8; DRAPEAU P, 1983, J NEUROSCI, V3, P703; FLOOR E, 1983, BRAIN RES, V279, P321, DOI 10.1016/0006-8993(83)90202-0; GALL C, 1984, BRAIN RES, V306, P73, DOI 10.1016/0006-8993(84)90357-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HENRY SHC, 1984, P NATL ACAD SCI USA, V81, P6526; HOCHNER B, 1989, NATURE, V342, P433, DOI 10.1038/342433a0; IGARASHI Y, 1988, NEUROPEPTIDES, V14, P71; KAUPPINEN RA, 1988, NEUROSCIENCE, V27, P175, DOI 10.1016/0306-4522(88)90228-X; KLEIN RL, 1982, NEUROSCIENCE, V7, P2255, DOI 10.1016/0306-4522(82)90135-X; KOSAKA T, 1985, J COMP NEUROL, V239, P420, DOI 10.1002/cne.902390408; LUNDBERG JM, 1989, NEUROSCIENCE, V28, P475, DOI 10.1016/0306-4522(89)90193-0; MCMAHON HT, 1991, J NEUROCHEM, V56, P86, DOI 10.1111/j.1471-4159.1991.tb02566.x; NACHSHEN DA, 1987, J PHYSIOL-LONDON, V387, P415, DOI 10.1113/jphysiol.1987.sp016581; NICHOLLS DG, 1989, J NEUROCHEM, V52, P331, DOI 10.1111/j.1471-4159.1989.tb09126.x; PARNAS I, 1988, BIOPHYS CHEM, V29, P85, DOI 10.1016/0301-4622(88)87027-3; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SLOVITER RS, 1987, J COMP NEUROL, V256, P42, DOI 10.1002/cne.902560105; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; TERRIAN DM, 1988, BRAIN RES BULL, V21, P343, DOI 10.1016/0361-9230(88)90146-3; TIBBS GR, 1989, J NEUROCHEM, V53, P1693, DOI 10.1111/j.1471-4159.1989.tb09232.x; TURNER TJ, 1989, BIOCHEMISTRY-US, V28, P586, DOI 10.1021/bi00428a026; VANDERHOORN FAJ, 1989, J CHROMATOGR-BIOMED, V487, P17, DOI 10.1016/S0378-4347(00)83003-0; VERHAGE M, 1988, J NEUROCHEM, V51, P1667, DOI 10.1111/j.1471-4159.1988.tb01143.x; VERHAGE M, 1991, J NEUROCHEM, V56, P1394, DOI 10.1111/j.1471-4159.1991.tb11437.x; VERHAGE M, 1989, J NEUROCHEM, V53, P1188, DOI 10.1111/j.1471-4159.1989.tb07413.x; VERHAGE M, 1991, IN PRESS NEUROSCIENC; WILKINSON RJ, 1989, NEUROCHEM INT, V15, P191, DOI 10.1016/0197-0186(89)90100-9; WOODWARD JJ, 1988, BRAIN RES, V475, P141, DOI 10.1016/0006-8993(88)90207-7; ZHU PC, 1986, NEUROSCIENCE, V19, P43, DOI 10.1016/0306-4522(86)90004-7; ZUCKER RS, 1983, J NEUROSCI, V3, P1263; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032; ZUCKER RS, 1988, NATURE, V335, P360, DOI 10.1038/335360a0	40	290	292	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					517	524		10.1016/0896-6273(91)90054-4	http://dx.doi.org/10.1016/0896-6273(91)90054-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	2015091				2022-12-28	WOS:A1991FH80200003
J	ZORAN, MJ; DOYLE, RT; HAYDON, PG				ZORAN, MJ; DOYLE, RT; HAYDON, PG			TARGET CONTACT REGULATES THE CALCIUM RESPONSIVENESS OF THE SECRETORY MACHINERY DURING SYNAPTOGENESIS	NEURON			English	Article							ELECTRICAL CONNECTIONS; CHEMICAL CONNECTIONS; GROWTH CONES; HELISOMA; CULTURE; NEURONS; RELEASE; ACETYLCHOLINE; SYNAPSES; CELL	Neuron B19 of Helisoma is selective in synaptogenesis. Presynaptic mechanisms underlying this selectivity were tested. Acetylcholine-sensitive assay cells were micro-manipulated into contact with B19 somata to assess its secretory state. Prior to appropriate muscle target contact, spontaneous synaptic currents were detected; however, action potential-evoked release of neurotransmitter was detected only following hours of muscle contact. Photolysis of a calcium cage, DM-nitrophen, accelerated the frequency of synaptic currents in muscle-contacted, but not novel neuron-contacted, B19 somata. These studies demonstrate that contact with appropriate target muscle enhances the responsiveness of this neuron's secretory machinery to internal calcium levels, thereby imparting the presynaptic cell with the ability to couple action potentials with neurotransmitter release.			ZORAN, MJ (corresponding author), IOWA STATE UNIV SCI & TECHNOL,DEPT ZOOL & GENET,AMES,IA 50011, USA.				NINDS NIH HHS [R01 NS24233] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024233] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARECHIGA H, 1986, J EXP BIOL, V126, P15; CAMARDO J, 1983, J NEUROSCI, V3, P2614; CHOW I, 1985, J NEUROSCI, V5, P1076; COHAN CS, 1987, J NEUROSCI, V5, P1076; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; EASTER SS, 1985, SCIENCE, V230, P507, DOI 10.1126/science.4048944; EVERS J, 1989, J NEUROSCI, V9, P1523; HADLEY RD, 1985, J NEUROSCI, V5, P3145; HADLEY RD, 1983, J NEUROSCI, V3, P924; HAYDON PG, 1988, J NEUROSCI, V8, P1032; HAYDON PG, 1988, J NEUROBIOL, V19, P636, DOI 10.1002/neu.480190706; HAYDON PG, 1988, NEURON, V1, P919, DOI 10.1016/0896-6273(88)90149-3; HAYDON PG, 1990, J PHYSIOL-PARIS, V84, P111; HAYDON PG, 1989, NEURON, V2, P1483, DOI 10.1016/0896-6273(89)90194-3; HAYDON PG, 1990, IN PRESS CELLULAR MO; HAYDON PG, 1985, J NEUROSCI RES, V13, P285; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; LOCKERBIE R O, 1985, Developmental Brain Research, V21, P265, DOI 10.1016/0165-3806(85)90215-9; MINTA A, 1989, J BIOL CHEM, V264, P8171; SCHACHER S, 1985, J NEUROSCI, V5, P2851; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; TAKAHASHI T, 1987, J NEUROSCI, V7, P473; TAYLOR J, 1989, J NEUROCHEM, V53, P834, DOI 10.1111/j.1471-4159.1989.tb11780.x; VYKLICKY L, 1988, J EXP BIOL, V134, P17; ZORAN MJ, 1989, J EXP BIOL, V142, P225; ZORANMJ, 1990, DEV BIOL, V138, P202	28	32	32	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1991	6	1					145	151		10.1016/0896-6273(91)90129-N	http://dx.doi.org/10.1016/0896-6273(91)90129-N			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1670920				2022-12-28	WOS:A1991EU27800014
J	NAWA, H; PATTERSON, PH				NAWA, H; PATTERSON, PH			SEPARATION AND PARTIAL CHARACTERIZATION OF NEUROPEPTIDE-INDUCING FACTORS IN HEART CELL CONDITIONED MEDIUM	NEURON			English	Article									CALTECH,DIV BIOL,PASADENA,CA 91125	California Institute of Technology								ADLER JE, 1985, P NATL ACAD SCI USA, V82, P4296, DOI 10.1073/pnas.82.12.4296; ADLER JE, 1989, P NATL ACAD SCI USA, V86, P1080, DOI 10.1073/pnas.86.3.1080; ADLER JE, 1984, SCIENCE, V225, P1449; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; BARBE YA, 1982, EMBO J, V5, P549; BARBIN G, 1984, J NEUROCHEM, V43, P1468, DOI 10.1111/j.1471-4159.1984.tb05410.x; BLACK IB, 1988, HDB CHEM NEUROANATOM, V6, P51; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALVO FO, 1985, BIOCHEMISTRY-US, V24, P1953, DOI 10.1021/bi00329a023; COVARRUBIAS M, 1989, J GEN PHYSIOL, V93, P765, DOI 10.1085/jgp.93.5.765; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FIBBE WE, 1986, BLOOD, V68, P1316; FUKADA K, 1985, P NATL ACAD SCI USA, V82, P8795, DOI 10.1073/pnas.82.24.8795; FUKADA K, 1980, NATURE, V287, P553, DOI 10.1038/287553a0; HAWROT E, 1979, METHOD ENZYMOL, V53, P574; HAYASHI M, 1983, NEUROSCIENCE, V10, P31, DOI 10.1016/0306-4522(83)90078-7; KESSLER JA, 1984, DEV BIOL, V106, P61, DOI 10.1016/0012-1606(84)90061-7; KESSLER JA, 1986, P NATL ACAD SCI USA, V83, P3528, DOI 10.1073/pnas.83.10.3528; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDIS SC, 1983, DEV BIOL, V98, P349, DOI 10.1016/0012-1606(83)90365-2; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; MAINS RE, 1973, J CELL BIOL, V59, P329, DOI 10.1083/jcb.59.2.329; MANTHORPE M, 1986, BRAIN RES, V367, P282, DOI 10.1016/0006-8993(86)91603-3; MCMANAMAN JL, 1988, J BIOL CHEM, V263, P5890; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MUDGE AW, 1981, NATURE, V292, P764, DOI 10.1038/292764a0; NAWA H, 1990, NEURON, V4; NISHI R, 1981, J NEUROSCI, V1, P505; PATTERSON PH, 1977, DEV BIOL, V56, P263, DOI 10.1016/0012-1606(77)90269-X; PATTERSON PH, 1978, ANNU REV NEUROSCI, V1, P1, DOI 10.1146/annurev.ne.01.030178.000245; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SAH DWY, 1987, J NEUROSCI, V7, P391; SWERTS JP, 1983, DEV BIOL, V100, P1, DOI 10.1016/0012-1606(83)90195-1; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; VESTERBERG O, 1966, ACTA CHEM SCAND, V20, P820, DOI 10.3891/acta.chem.scand.20-0820; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WEBER MJ, 1981, J BIOL CHEM, V256, P3347; WOLINSKY EJ, 1985, J NEUROSCI, V5, P1497; WONG V, 1987, P NATL ACAD SCI USA, V84, P8726, DOI 10.1073/pnas.84.23.8726; ZHU Z, 1989, J BIOL CHEM, V264, P6550	43	105	105	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1990	4	2					269	277		10.1016/0896-6273(90)90101-K	http://dx.doi.org/10.1016/0896-6273(90)90101-K			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT254	1968344				2022-12-28	WOS:A1990CT25400009
J	CLARK, GD; HAPPEL, LT; ZORUMSKI, CF; BAZAN, NG				CLARK, GD; HAPPEL, LT; ZORUMSKI, CF; BAZAN, NG			ENHANCEMENT OF HIPPOCAMPAL EXCITATORY SYNAPTIC TRANSMISSION BY PLATELET-ACTIVATING-FACTOR	NEURON			English	Article							LONG-TERM POTENTIATION; ARACHIDONIC-ACID; FATTY-ACID; ELECTROCONVULSIVE SHOCK; FACTOR PAF; RAT-BRAIN; ANTAGONIST; ISCHEMIA; NEURONS; MODULATION	The biologically active lipid platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine; PAF) is a mediator of inflammatory and immune responses, and it accumulates in the brain during convulsions or ischemia. We have examined whether PAF may play a second messenger role in the central nervous system by studying effects on synaptic transmission in cultured hippocampal neurons. Carbamyl-PAF, a nonhydrolyzable PAF analog with a similar pharmacologic profile, augmented glutamate-mediated, evoked excitatory synaptic transmission and increased the frequency of spontaneous miniature excitatory synaptic events without increasing their amplitude or altering their time course. This compound had no significant effect on gamma-aminobutyric acid-mediated inhibitory synaptic responses. Lyso-PAF, the biologically inactive metabolic intermediate, had no effect on synaptic transmission. Moreover, the enhancement of excitatory synaptic transmission by carbamyl-PAF was blocked by a PAF receptor antagonist. These results indicate a specific presynaptic effect of PAF in enhancing excitatory synaptic transmission in cultured rat hippocampal neurons.	LOUISIANA STATE UNIV, MED CTR, SCH MED, DEPT NEUROSURG, NEW ORLEANS, LA 70112 USA; LOUISIANA STATE UNIV, MED CTR, SCH MED, DEPT OPHTHALMOL, NEW ORLEANS, LA 70112 USA; LOUISIANA STATE UNIV, MED CTR, SCH MED, DEPT PEDIAT, NEW ORLEANS, LA 70112 USA; LOUISIANA STATE UNIV, MED CTR, SCH MED, DEPT PHYSIOL, NEW ORLEANS, LA 70112 USA; LOUISIANA STATE UNIV, MED CTR, SCH MED, CTR NEUROSCI, NEW ORLEANS, LA 70112 USA; WASHINGTON UNIV, SCH MED, DEPT PSYCHIAT, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63110 USA	Louisiana State University System; Louisiana State University System; Louisiana State University System; Louisiana State University System; Louisiana State University System; Washington University (WUSTL); Washington University (WUSTL)	CLARK, GD (corresponding author), LOUISIANA STATE UNIV, MED CTR, SCH MED, DEPT NEUROL, NEW ORLEANS, LA 70112 USA.		Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH000964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS104133, R01NS023002] Funding Source: NIH RePORTER; NIMH NIH HHS [MH00964] Funding Source: Medline; NINDS NIH HHS [NS23002, NS04133] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARAI A, 1992, EUR J NEUROSCI, V4, P411, DOI 10.1111/j.1460-9568.1992.tb00890.x; BAZAN NG, 1991, LIPIDS, V26, P1236, DOI 10.1007/BF02536539; BAZAN NG, 1989, ANN NY ACAD SCI, V559, P1; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; BAZAN NG, 1971, LIPIDS, V6, P211, DOI 10.1007/BF02533041; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BIRKLE DL, 1988, J NEUROCHEM, V51, P1900, DOI 10.1111/j.1471-4159.1988.tb01175.x; BIRKLE DL, 1987, J NEUROCHEM, V48, P1768, DOI 10.1111/j.1471-4159.1987.tb05735.x; BITO H, 1992, NEURON, V9, P285, DOI 10.1016/0896-6273(92)90167-C; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; BUSSOLINO F, 1986, J BIOL CHEM, V261, P6502; CLARK GD, 1990, NEUROSCIENCE, V39, P787, DOI 10.1016/0306-4522(90)90261-2; DELCERRO S, 1990, BEHAV NEURAL BIOL, V54, P213, DOI 10.1016/0163-1047(90)90595-W; FORSYTHE ID, 1988, J NEUROSCI, V8, P3733; GILBOE DD, 1991, J NEUROCHEM, V56, P311, DOI 10.1111/j.1471-4159.1991.tb02597.x; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; KORNECKI E, 1988, SCIENCE, V240, P1792, DOI 10.1126/science.3381103; KUMAR R, 1988, BIOCHIM BIOPHYS ACTA, V963, P375, DOI 10.1016/0005-2760(88)90304-9; LAFITTE MLP, 1980, ARCH INT PHARMACOD T, V243, P236; LINDSBERG PJ, 1990, STROKE, V21, P1452, DOI 10.1161/01.STR.21.10.1452; MARCHESELLI VL, 1990, J BIOL CHEM, V265, P9140; NAKAJIMA T, 1991, FEBS LETT, V289, P239, DOI 10.1016/0014-5793(91)81079-N; NAKAJIMA Y, 1986, P NATL ACAD SCI USA, V83, P3022, DOI 10.1073/pnas.83.9.3022; PANETTA T, 1987, BIOCHEM BIOPH RES CO, V149, P580, DOI 10.1016/0006-291X(87)90407-4; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; SNYDER F, 1990, AM J PHYSIOL, V259, pC697, DOI 10.1152/ajpcell.1990.259.5.C697; SPINNEWYN B, 1987, PROSTAGLANDINS, V34, P337, DOI 10.1016/0090-6980(87)90079-7; THIO L, 1992, IN PRESS J NEUROPHYS; VANDERKLOOT W, 1991, PROG NEUROBIOL, V36, P93, DOI 10.1016/0301-0082(91)90019-W; WILLIAMS JH, 1989, NEUROSCI LETT, V107, P301, DOI 10.1016/0304-3940(89)90835-5; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; YAMADA KA, 1989, J NEUROSCI, V9, P3230; YOON KW, 1991, J NEUROSCI, V11, P1375; YUE TL, 1991, J PHARMACOL EXP THER, V257, P374; YUE TL, 1990, J NEUROCHEM, V54, P1809, DOI 10.1111/j.1471-4159.1990.tb01239.x	36	192	196	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1992	9	6					1211	1216		10.1016/0896-6273(92)90078-R	http://dx.doi.org/10.1016/0896-6273(92)90078-R			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1334422				2022-12-28	WOS:A1992KD71600018
J	KULLMANN, DM; PERKEL, DJ; MANABE, T; NICOLL, RA				KULLMANN, DM; PERKEL, DJ; MANABE, T; NICOLL, RA			CA2+ ENTRY VIA POSTSYNAPTIC VOLTAGE-SENSITIVE CA2+ CHANNELS CAN TRANSIENTLY POTENTIATE EXCITATORY SYNAPTIC TRANSMISSION IN THE HIPPOCAMPUS	NEURON			English	Article							LONG-TERM POTENTIATION; METHYL-D-ASPARTATE; PROTEIN KINASE-C; DENDRITIC SPINES; RAT HIPPOCAMPUS; CALCIUM; NEURONS; CA1; ACTIVATION; RECEPTORS	We have studied the role of Ca2+ entry via voltage-sensitive Ca2+ channels in long-term potentiation (LTP) in the CA1 region of the hippocampus. Repeated depolarizing pulses, in the presence of the NMDA receptor antagoniSt D-APV and without synaptic stimulation, resulted in a potentiation of excitatory postsynaptic potentials (EPSPs) or currents (EPSCs). This depolarization-induced potentiation was augmented in raised extracellular Ca2+ and was blocked by intracellular BAPTA, a Ca2+ chelator, or by nifedipine, a Ca2+ channel antagonist, indicating that the effect was mediated by Ca2+ entry via voltage-sensitive Ca2+ channels. Although the peak potentiation could be as large as 3-fold, the EPSP(C)s decayed back to baseline values within approximately 30 min. However, synaptic activation paired with depolarizing pulses in the presence of D-APV converted the transient potentiation into a sustained form. These results indicate that a rise in postsynaptic Ca2+ via voltage-sensitive Ca2+ channels can transiently potentiate synaptic transmission, but that another factor associated with synaptic transmission may be required for LTP.	UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	KULLMANN, DM (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT PHARMACOL, SAN FRANCISCO, CA 94143 USA.		Kullmann, Dimitri M/A-3162-2009	Kullmann, Dimitri M/0000-0001-6696-3545				ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; ANIKSZTEJN L, 1992, EUR J NEUROSCI, V4, P500, DOI 10.1111/j.1460-9568.1992.tb00900.x; ANWYL R, 1989, TRENDS PHARMACOL SCI, V10, P236, DOI 10.1016/0165-6147(89)90268-X; ASZTELY F, 1991, BRAIN RES, V558, P153, DOI 10.1016/0006-8993(91)90734-D; BASKYS A, 1991, J PHYSIOL-LONDON, V444, P687, DOI 10.1113/jphysiol.1991.sp018901; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS T V P, 1988, P3; BORTOLOTTO ZA, 1992, EUR J PHARMACOL, V214, P297, DOI 10.1016/0014-2999(92)90135-Q; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; FORSCHER P, 1985, J GEN PHYSIOL, V85, P743, DOI 10.1085/jgp.85.5.743; GROVER LM, 1992, NEUROSCIENCE, V49, P7, DOI 10.1016/0306-4522(92)90072-A; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; GUSTAFSSON B, 1989, EUR J NEUROSCI, V1, P382, DOI 10.1111/j.1460-9568.1989.tb00803.x; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; GUSTAFSSON B, 1990, SEMIN NEUROSCI, V2, P321; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; LAGERCRANTZ H, 1976, NEUROSCIENCE, V1, P81, DOI 10.1016/0306-4522(76)90002-6; LINDEN DJ, 1989, BRAIN RES REV, V14, P279, DOI 10.1016/0165-0173(89)90004-0; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MADISON DV, 1986, NATURE, V321, P695, DOI 10.1038/321695a0; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, TRENDS NEUROSCI, V12, P444, DOI 10.1016/0166-2236(89)90094-5; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MCGUINNESS N, 1991, NEUROREPORT, V2, P688, DOI 10.1097/00001756-199111000-00014; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NICOLL RA, 1981, J NEUROSCI METH, V4, P153, DOI 10.1016/0165-0270(81)90049-2; OROURKE B, 1992, SCIENCE, V257, P245, DOI 10.1126/science.1321495; OSTERRIEDER W, 1982, NATURE, V298, P576, DOI 10.1038/298576a0; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; TAUBE JS, 1986, BRAIN RES, V379, P275, DOI 10.1016/0006-8993(86)90781-X; THIBAULT O, 1989, BRAIN RES, V476, P170, DOI 10.1016/0006-8993(89)91553-9; VOLKNANDT W, 1986, J NEUROCHEM, V47, P1449, DOI 10.1111/j.1471-4159.1986.tb00778.x; WANG JH, 1992, P NATL ACAD SCI USA, V89, P2576, DOI 10.1073/pnas.89.7.2576; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V123, P519, DOI 10.1111/j.1748-1716.1985.tb07621.x; ZHENG F, 1992, NEURON, V9, P163, DOI 10.1016/0896-6273(92)90231-2	47	204	205	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1992	9	6					1175	1183		10.1016/0896-6273(92)90075-O	http://dx.doi.org/10.1016/0896-6273(92)90075-O			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1361129				2022-12-28	WOS:A1992KD71600015
J	ISHII, N; WADSWORTH, WG; STERN, BD; CULOTTI, JG; HEDGECOCK, EM				ISHII, N; WADSWORTH, WG; STERN, BD; CULOTTI, JG; HEDGECOCK, EM			UNC-6, A LAMININ-RELATED PROTEIN, GUIDES CELL AND PIONEER AXON MIGRATIONS IN C-ELEGANS	NEURON			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; BASEMENT-MEMBRANE PROTEIN; RETINAL GANGLION-CELLS; CAENORHABDITIS-ELEGANS; BASAL LAMINA; B1 CHAIN; NEUROMUSCULAR-JUNCTION; TRANSPOSABLE ELEMENT; MULTIDOMAIN PROTEIN; DROSOPHILA LAMININ	The unc-6 gene is required for the guidance of pioneer axons and migrating cells along the body wall in C. elegans. In mutants, dorsal and ventral migrations are disrupted, but longitudinal movements are largely unaffected. The gene was tagged for molecular cloning by two independent transposon insertions. Based on genomic and cDNA sequencing, the gene encodes a novel laminin-related protein, UNC-6 (591 amino acids). The N-terminus is homologous to the N-termini (i.e., domains VI, V-1, V-2, and V-3) of laminin subunits, while the C-terminus is a unique domain. We propose that UNC-6 is a component of an extracellular matrix cue that guides dorsoventral migrations on the epidermis.	TOKAI UNIV, SCH MED, DEPT MOLEC BIOL, ISEHARA, KANAGAWA 25911, JAPAN; JOHNS HOPKINS UNIV, DEPT BIOL, BALTIMORE, MD 21218 USA; MT SINAI HOSP, RES INST, DEPT MOLEC IMMUNOL & NEUROBIOL, TORONTO M5G 1X5, ONTARIO, CANADA	Tokai University; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	ISHII, N (corresponding author), ROCHE INST MOLEC BIOL, DEPT CELL & DEV BIOL, NUTLEY, NJ 07110 USA.		Culotti, Joseph/G-6467-2013; Wadsworth, William G/N-7866-2014	Wadsworth, William G/0000-0003-3824-2948; Culotti, Joseph/0000-0001-6325-4612	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026295, R37NS026295] Funding Source: NIH RePORTER; NINDS NIH HHS [NS26295] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON H, 1988, DEVELOPMENT, V104, P601; BARLOW DP, 1984, EMBO J, V3, P2355, DOI 10.1002/j.1460-2075.1984.tb02140.x; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BEVERELY SM, 1990, CURRENT PROTOCOLS MO; BRONNERFRASER M, 1988, J CELL BIOL, V106, P1321, DOI 10.1083/jcb.106.4.1321; BUETTNER HM, 1991, DEV BIOL, V145, P266, DOI 10.1016/0012-1606(91)90125-M; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; CHI HC, 1989, J BIOL CHEM, V264, P1543; COHEN J, 1986, NATURE, V322, P465, DOI 10.1038/322465a0; COLLINS J, 1987, NATURE, V328, P726, DOI 10.1038/328726a0; CONDIC ML, 1989, NEURON, V3, P427, DOI 10.1016/0896-6273(89)90202-X; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; FISHELSONZ, 1991, MOL IMMUNOL, V28, P545; GILBERT W, 1987, COLD SPRING HARB SYM, V52, P901, DOI 10.1101/SQB.1987.052.01.098; GOODMAN SL, 1989, DEVELOPMENT CAMB, V106, P795; GRANT P, 1989, DEV BIOL, V133, P502, DOI 10.1016/0012-1606(89)90053-5; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; HAGG T, 1989, NEURON, V3, P721, DOI 10.1016/0896-6273(89)90241-9; HALFTER W, 1987, J NEUROSCI, V7, P3712; HAMMARBACK JA, 1988, DEV BIOL, V126, P29, DOI 10.1016/0012-1606(88)90235-7; HAVILAND DL, 1991, J BIOL CHEM, V266, P11818; Hedgecock E.M., 1990, Seminars in the Neurosciences, V2, P159; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; KALLUNKI T, 1991, J BIOL CHEM, V266, P221; KOUZIKOLIAKOS K, 1989, J BIOL CHEM, V264, P17971; LETOURNEAU PC, 1988, DEV BIOL, V125, P135, DOI 10.1016/0012-1606(88)90066-8; LEUNGHAGESTEIJN C, 1992, IN PRESS CELL; LIESI P, 1988, DEV BIOL, V130, P774, DOI 10.1016/0012-1606(88)90366-1; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MANN K, 1989, EMBO J, V8, P65, DOI 10.1002/j.1460-2075.1989.tb03349.x; MARTINEZ E, 1991, EMBO J, V10, P263, DOI 10.1002/j.1460-2075.1991.tb07946.x; MCKENNA MP, 1988, DEV BIOL, V130, P232, DOI 10.1016/0012-1606(88)90429-0; MCLOON SC, 1988, J NEUROSCI, V8, P1981; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MONTELL DJ, 1989, J CELL BIOL, V109, P2441, DOI 10.1083/jcb.109.5.2441; MONTELL DJ, 1988, CELL, V53, P463, DOI 10.1016/0092-8674(88)90166-3; MORI I, 1988, P NATL ACAD SCI USA, V85, P861, DOI 10.1073/pnas.85.3.861; MORI I, 1988, GENETICS, V120, P397; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; OCALAN M, 1988, DEV BIOL, V125, P158, DOI 10.1016/0012-1606(88)90068-1; OGAWA K, 1988, J BIOL CHEM, V263, P8384; OZKAYNAK E, 1987, BIOTECHNIQUES, V5, P770; PAULSSON M, 1985, EMBO J, V4, P309, DOI 10.1002/j.1460-2075.1985.tb03630.x; PERRIS R, 1989, COMM DEV NEUROBIOL, V1, P61; PLACZEK M, 1990, DEVELOPMENT, V110, P19; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; RUVKUN G, 1991, CELL, V64, P475, DOI 10.1016/0092-8674(91)90227-P; SANDROCK AW, 1987, SCIENCE, V237, P1605, DOI 10.1126/science.3306923; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARTHY PV, 1990, J CELL BIOL, V110, P2099, DOI 10.1083/jcb.110.6.2099; SASAKI M, 1987, J BIOL CHEM, V262, P17111; SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935; SASAKI M, 1988, J BIOL CHEM, V263, P16536; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; TRAUT TW, 1988, P NATL ACAD SCI USA, V85, P2944, DOI 10.1073/pnas.85.9.2944; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VUOLTEENAHO R, 1990, J BIOL CHEM, V265, P15611; WETSEL RA, 1988, BIOCHEMISTRY-US, V27, P1474, DOI 10.1021/bi00405a012; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YAMAMOTO T, 1988, J NEUROL SCI, V84, P1, DOI 10.1016/0022-510X(88)90169-4; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; ZHOU FC, 1990, DEV BRAIN RES, V55, P191, DOI 10.1016/0165-3806(90)90200-I; [No title captured]	72	429	440	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1992	9	5					873	881		10.1016/0896-6273(92)90240-E	http://dx.doi.org/10.1016/0896-6273(92)90240-E			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1329863				2022-12-28	WOS:A1992JY55200007
J	OHMICHI, M; DECKER, SJ; SALTIEL, AR				OHMICHI, M; DECKER, SJ; SALTIEL, AR			ACTIVATION OF PHOSPHATIDYLINOSITOL-3 KINASE BY NERVE GROWTH-FACTOR INVOLVES INDIRECT COUPLING OF THE TRK PROTOONCOGENE WITH SRC HOMOLOGY-2 DOMAINS	NEURON			English	Article							PHOSPHOLIPASE-C-GAMMA; FACTOR-I RECEPTOR; STIMULATES TYROSINE PHOSPHORYLATION; PC12 PHEOCHROMOCYTOMA CELLS; COOH-TERMINAL TRUNCATION; GAP-ASSOCIATED PROTEINS; HUMAN INSULIN-RECEPTOR; PDGF BETA-RECEPTOR; EGF RECEPTOR; SIGNAL TRANSDUCTION	Growth factor receptor tyrosine kinases can form stable associations with intracellular proteins that contain src homology (SH) 2 domains, including the p85 regulatory subunit of phosphatidylinositol (PI)-3 kinase. The activation of this enzyme by growth factors is evaluated in PC12 pheochromocytoma cells and NIH 3T3 fibroblasts expressing the pp140c-trk nerve growth factor (NGF) receptor (3T3-c-trk). NGF causes the rapid stimulation of PI-3 kinase activity detected in anti-phosphotyrosine, but not in anti-trk, immunoprecipitates. This effect coincides with the tyrosine phosphorylation of two proteins, with molecular masses of of 100 kd and 110 kd, that coimmunoprecipitate with p85. Similar phosphorylation patterns are induced when an immobilized fusion protein containing the amino-terminal SH2 domain of p85 is used to precipitate tyrosine-phosphorylated proteins. Thus, although NGF produces the rapid activation of PI-3 kinase through a mechanism that involves tyrosine phosphorylation, there is no evidence for tyrosine phosphorylation of p85, or for its ligand-dependent association with the NGF receptor. Perhaps another phosphoprotein may link the NGF receptor to this enzyme.	UNIV MICHIGAN,SCH MED,DEPT MICROBIOL,ANN ARBOR,MI 48109; WARNER LAMBERT PARKE DAVIS,DIV PHARMACEUT RES,DEPT SIGNAL TRANSDUCT,ANN ARBOR,MI 48105	University of Michigan System; University of Michigan; Pfizer	OHMICHI, M (corresponding author), UNIV MICHIGAN,SCH MED,DEPT PHYSIOL,ANN ARBOR,MI 48109, USA.		Saltiel, Alan/L-3632-2019	Saltiel, Alan/0000-0002-9726-9828	NCI NIH HHS [CA37754] Funding Source: Medline; NIDDK NIH HHS [DK33804] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R23DK033804, R01DK033804] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALETTA JM, 1988, J CELL BIOL, V106, P1573, DOI 10.1083/jcb.106.5.1573; ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BJORGE JD, 1990, P NATL ACAD SCI USA, V87, P3816, DOI 10.1073/pnas.87.10.3816; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; COUGHLIN SR, 1989, SCIENCE, V243, P1191; DECKER SJ, 1990, J BIOL CHEM, V265, P7009; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; ENDEMANN G, 1990, J BIOL CHEM, V265, P396; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; FUKUI Y, 1991, ONCOGENE, V6, P407; HALEGOUA S, 1980, CELL, V22, P571, DOI 10.1016/0092-8674(80)90367-0; HAMA T, 1986, P NATL ACAD SCI USA, V83, P2353, DOI 10.1073/pnas.83.8.2353; HEASLEY LE, 1989, MOL PHARMACOL, V35, P331; HEASLEY LE, 1989, J BIOL CHEM, V264, P8646; HU P, 1992, MOL CELL BIOL, V12, P981, DOI 10.1128/MCB.12.3.981; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KAPLAN DR, 1991, SCIENCE, V252, P552; KAZLAUSKAS A, 1990, EMBO J, V9, P3279, DOI 10.1002/j.1460-2075.1990.tb07527.x; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KIM UH, 1991, J BIOL CHEM, V266, P1359; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V86, P8232, DOI 10.1073/pnas.86.21.8232; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRETH GE, 1985, J CELL BIOL, V100, P677, DOI 10.1083/jcb.100.3.677; LEE KY, 1985, MOL PHARMACOL, V28, P220; MAEGAWA H, 1988, J BIOL CHEM, V263, P8912; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; MATSUDA Y, 1987, J BIOL CHEM, V262, P2832; MCCLAIN DA, 1988, J BIOL CHEM, V263, P8904; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; MIYASAKA T, 1991, P NATL ACAD SCI USA, V88, P2653, DOI 10.1073/pnas.88.7.2653; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; NAKANISHI N, 1985, J BIOL CHEM, V260, P7791; OHMICHI M, 1992, BIOCHEMISTRY-US, V31, P4034, DOI 10.1021/bi00131a019; OHMICHI M, 1991, J BIOL CHEM, V266, P14858; OHMICHI M, 1992, J BIOL CHEM, V267, P14604; OHMICHI M, 1991, BIOCHEM BIOPH RES CO, V179, P217, DOI 10.1016/0006-291X(91)91357-I; OHMICHI M, 1992, IN PRESS J BIOL CHEM; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; RAWLAND EA, 1987, J BIOL CHEM, V262, P7504; REEDIJK M, 1990, MOL CELL BIOL, V10, P5601, DOI 10.1128/MCB.10.11.5601; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SALTIEL AR, 1991, MOL CELL ENDOCRINOL, V81, pC197, DOI 10.1016/0303-7207(91)90198-2; SHURTLEFF SA, 1990, EMBO J, V9, P2415, DOI 10.1002/j.1460-2075.1990.tb07417.x; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; VARTICOVSKI L, 1989, NATURE, V342, P699, DOI 10.1038/342699a0; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; VULLIET PR, 1989, J BIOL CHEM, V264, P16292; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WHITMAN M, 1987, BIOCHEM J, V247, P165, DOI 10.1042/bj2470165	65	120	121	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1992	9	4					769	777		10.1016/0896-6273(92)90039-G	http://dx.doi.org/10.1016/0896-6273(92)90039-G			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1382475	Green Submitted			2022-12-28	WOS:A1992JT51600017
J	SCHLESSINGER, J; ULLRICH, A				SCHLESSINGER, J; ULLRICH, A			GROWTH-FACTOR SIGNALING BY RECEPTOR TYROSINE KINASES	NEURON			English	Review									MAX PLANCK INST BIOCHEM, W-8033 MARTINSRIED, GERMANY	Max Planck Society	SCHLESSINGER, J (corresponding author), NYU MED CTR, DEPT PHARMACOL, NEW YORK, NY 10016 USA.							ADAMS JM, 1992, ONCOGENE, V7, P611; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; BACKER JM, 1992, IN PRESS EMBO J; BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; BURGESS WH, 1990, MOL CELL BIOL, V10, P4770, DOI 10.1128/MCB.10.9.4770; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; CANALS F, 1992, BIOCHEMISTRY-US, V31, P4493, DOI 10.1021/bi00133a016; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; FRANTL WJ, 1992, CELL, V69, P413; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENFIELD C, 1989, EMBO J, V8, P4115, DOI 10.1002/j.1460-2075.1989.tb08596.x; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HELDIN CH, 1991, TRENDS BIOCHEM SCI, V16, P450, DOI 10.1016/0968-0004(91)90175-U; HONEGGER AM, 1989, P NATL ACAD SCI USA, V86, P925, DOI 10.1073/pnas.86.3.925; HONEGGER AM, 1990, MOL CELL BIOL, V10, P4035, DOI 10.1128/MCB.10.8.4035; HORVITZ HR, 1991, NATURE, V351, P535, DOI 10.1038/351535a0; HU P, 1992, MOL CELL BIOL, V12, P981, DOI 10.1128/MCB.12.3.981; HURWITZ DR, 1991, J BIOL CHEM, V266, P22035; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KASHISHIAN A, 1992, EMBO J, V11, P1373, DOI 10.1002/j.1460-2075.1992.tb05182.x; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; KAZLAUSKAS A, 1990, EMBO J, V9, P3279, DOI 10.1002/j.1460-2075.1990.tb07527.x; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LAMMERS R, 1990, J BIOL CHEM, V265, P16886; LAX I, 1991, J BIOL CHEM, V266, P13828; LEHMANN JM, 1990, NUCLEIC ACIDS RES, V18, P1048, DOI 10.1093/nar/18.4.1048; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MARGOLIS B, 1992, CELL GROWTH DIFFER, V3, P73; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; MARGOLIS B, 1992, IN PRESS P NATL ACAD; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MAYER BJ, 1990, P NATL ACAD SCI USA, V87, P2638, DOI 10.1073/pnas.87.7.2638; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MOHAMMADI M, 1992, IN PRESS NATURE; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; REDEMANN N, 1992, MOL CELL BIOL, V12, P491, DOI 10.1128/MCB.12.2.491; ROTIN D, 1992, J BIOL CHEM, V267, P9678; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SEEDORF K, 1992, IN PRESS MOL CELL BI; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SHURTLEFF SA, 1990, EMBO J, V9, P2415, DOI 10.1002/j.1460-2075.1990.tb07417.x; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; SUH PG, 1988, P NATL ACAD SCI USA, V85, P5419, DOI 10.1073/pnas.85.15.5419; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TOGARI A, 1985, J NEUROSCI, V5, P307; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANDERGEER P, 1991, MOL CELL BIOL, V11, P4698, DOI 10.1128/MCB.11.9.4698; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WAGNER JA, 1991, CURR TOP MICROBIOL, V165, P95; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WEBER W, 1984, J BIOL CHEM, V259, P4631	88	1400	1516	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1992	9	3					383	391		10.1016/0896-6273(92)90177-F	http://dx.doi.org/10.1016/0896-6273(92)90177-F			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1326293				2022-12-28	WOS:A1992JM57100001
J	COHEN, GA; DOZE, VA; MADISON, DV				COHEN, GA; DOZE, VA; MADISON, DV			OPIOID INHIBITION OF GABA RELEASE FROM PRESYNAPTIC TERMINALS OF RAT HIPPOCAMPAL INTERNEURONS	NEURON			English	Article							CA1 PYRAMIDAL NEURONS; ELECTRO-PHYSIOLOGICAL INTERACTIONS; POSTSYNAPTIC CURRENTS; SYNAPTIC TRANSMISSION; SLICE PREPARATION; CEREBRAL-CORTEX; PATCH-CLAMP; AREA CA1; ENKEPHALIN; RECEPTORS	Opiates and the opioid peptide enkephalin can cause indirect excitation of principal cortical neurons by reducing inhibitory synaptic transmission mediated by GABAergic interneurons. The mechanism by which opioids mediate these effects on interneurons is unknown, but enkephalin hyperpolarizes the somatic membrane potential of a variety of neurons in the brain, including hippocampal interneurons. We now report a new, more direct mechanism for the opioid-mediated reduction in synaptic inhibition. The enkephalin analog D-Ala2-Met5-enkephalinamide (DALA) decreases the frequency of miniature, action potential-independent, spontaneous GABAergic inhibitory postsynaptic currents (IPSCs) without causing a change in their amplitude. Thus, we conclude that DALA inhibits the action potential-independent release of GABA through a direct action on interneuronal synaptic terminals. In contrast, DALA reduces the amplitude of action potential-evoked, GABA-mediated IPSCs, as well as decreases their frequency. This suggests that the opioid-mediated inhibition of non-action potential-dependent GABA release reveals a mechanism that contributes to reducing action potential-evoked GABA release, thereby decreasing synaptic inhibition.			COHEN, GA (corresponding author), STANFORD UNIV,MED CTR,SCH MED,BECKMAN CTR MOLEC & GENET MED,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305, USA.		; Madison, Daniel/F-9341-2017	Doze, Van/0000-0002-5288-9564; Madison, Daniel/0000-0002-0718-5373				ALGER BE, 1980, BRAIN RES, V200, P195, DOI 10.1016/0006-8993(80)91108-7; BARKER JL, 1988, J PHYSIOL-LONDON, V403, P41, DOI 10.1113/jphysiol.1988.sp017237; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BOSTOCK E, 1984, J PHARMACOL EXP THER, V231, P512; BRENNAN MJW, 1980, LIFE SCI, V27, P1097, DOI 10.1016/0024-3205(80)90035-1; CHAVKIN C, 1988, OPIOIDS HIPPOCAMPUS, P94; CHAVKIN C, 1988, OPIATE RECEPTORS, P273; COLLINGRIDGE G, 1988, NEUROL NEUR, V46, P171; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; CORRIGALL WA, 1983, PHARMACOL BIOCHEM BE, V18, P255, DOI 10.1016/0091-3057(83)90371-4; CORRIGALL WA, 1980, BRAIN RES, V192, P227, DOI 10.1016/0006-8993(80)91022-7; CRAIN BJ, 1986, J COMP NEUROL, V246, P170, DOI 10.1002/cne.902460203; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; DAVIES SN, 1989, PROC R SOC SER B-BIO, V236, P373, DOI 10.1098/rspb.1989.0028; DINGLEDINE R, 1981, J NEUROSCI, V1, P1022; DOZE VA, 1991, NEURON, V6, P889, DOI 10.1016/0896-6273(91)90229-S; DUNWIDDIE T, 1980, BRAIN RES, V184, P311, DOI 10.1016/0006-8993(80)90801-X; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FAN SG, 1982, BRAIN RES, V235, P265, DOI 10.1016/0006-8993(82)91006-X; HENDERSON G, 1983, BR MED B, V39, P57; HILL RG, 1977, J PHYSL, V272, P50; JOHNSON SW, 1992, J NEUROSCI, V12, P483; LACAILLE JC, 1987, J NEUROSCI, V7, P1979; LAMBERT NA, 1991, NEUROSCI LETT, V124, P101, DOI 10.1016/0304-3940(91)90831-D; LEE HK, 1980, BRAIN RES, V184, P331, DOI 10.1016/0006-8993(80)90802-1; LYNCH GS, 1981, EXP NEUROL, V71, P527, DOI 10.1016/0014-4886(81)90030-3; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MANSOUR A, 1987, J NEUROSCI, V7, P2445; MARTINEZ JL, 1979, BEHAV NEURAL BIOL, V26, P128, DOI 10.1016/S0163-1047(79)92499-3; MASUKAWA LM, 1982, BRAIN RES, V249, P271, DOI 10.1016/0006-8993(82)90061-0; MCLEAN S, 1987, J COMP NEUROL, V255, P497, DOI 10.1002/cne.902550403; MIENVILLE JM, 1987, NEUROPHARMACOLOGY, V26, P779, DOI 10.1016/0028-3908(87)90242-5; NATHAN T, 1990, NEUROSCI LETT, V110, P309, DOI 10.1016/0304-3940(90)90865-7; NICOLL RA, 1977, P NATL ACAD SCI USA, V74, P2584, DOI 10.1073/pnas.74.6.2584; NICOLL RA, 1980, NATURE, V287, P22, DOI 10.1038/287022a0; OTIS TS, 1992, J NEUROPHYSIOL, V67, P227, DOI 10.1152/jn.1992.67.1.227; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; OTIS TS, 1992, IN PRESS NEUROSCIENC; PANG K, 1989, NEUROPHARMACOLOGY, V28, P1175, DOI 10.1016/0028-3908(89)90208-6; Press WP, 1986, NUMERICAL RECIPES, P472; RANDALL A, 1992, IN PRESS ION CHANNEL, V3; ROBINSON JH, 1981, BRAIN RES, V224, P375, DOI 10.1016/0006-8993(81)90867-2; ROPERT N, 1990, J PHYSIOL-LONDON, V428, P707, DOI 10.1113/jphysiol.1990.sp018236; SAH P, 1990, J PHYSIOL-LONDON, V430, P605, DOI 10.1113/jphysiol.1990.sp018310; SCHROEDER JE, 1991, NEURON, V6, P13, DOI 10.1016/0896-6273(91)90117-I; SCHWARTZKROIN PA, 1978, BRAIN RES, V157, P1, DOI 10.1016/0006-8993(78)90991-5; SEGAL M, 1984, J NEUROPHYSIOL, V52, P469, DOI 10.1152/jn.1984.52.3.469; SEGAL M, 1988, OPIOIDS HIPPOCAMPUS, P133; SIGGINS GR, 1981, P NATL ACAD SCI-BIOL, V78, P5235, DOI 10.1073/pnas.78.8.5235; VANDERKLOOT W, 1991, PROG NEUROBIOL, V36, P93, DOI 10.1016/0301-0082(91)90019-W; WIMPEY TL, 1991, NEURON, V6, P281, DOI 10.1016/0896-6273(91)90363-5; ZIEGLGANSBERGER W, 1979, SCIENCE, V205, P415, DOI 10.1126/science.451610	54	239	241	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					325	335		10.1016/0896-6273(92)90171-9	http://dx.doi.org/10.1016/0896-6273(92)90171-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1497896				2022-12-28	WOS:A1992JJ33200014
J	FREMEAU, RT; CARON, MG; BLAKELY, RD				FREMEAU, RT; CARON, MG; BLAKELY, RD			MOLECULAR-CLONING AND EXPRESSION OF A HIGH-AFFINITY L-PROLINE TRANSPORTER EXPRESSED IN PUTATIVE GLUTAMATERGIC PATHWAYS OF RAT-BRAIN	NEURON			English	Article							AMINO-ACID RECEPTORS; MEMBRANE-VESICLES; HIPPOCAMPAL-FORMATION; NUCLEOTIDE-SEQUENCE; LEUCINE-ZIPPER; GLIAL-CELLS; PROTEIN; GENE; CARRIER; IDENTIFICATION	We have used the polymerase chain reaction (PCR) with degenerate oligonucleotides derived from two conserved regions of the norepinephrine and gamma-aminobutyric acid transporters to identify novel Na+-dependent transporters in rat brain. One PCR product hybridized to a 4.0 kb RNA concentrated in subpopulations of putative glutamatergic neurons including mitral cells of the olfactory bulb, pyramidal cells of layer V of the cerebral cortex, pyramidal cells of the piriform cortex, and pyramidal cells of field CA3 of the hippocampus. Transient expression of the cognate cDNA conferred Na+-dependent L-proline uptake in HeLa cells that was saturable (K(m) = 9.7-mu-M) and exhibited a pharmacological profile similar to that for high affinity L-proline transport in rat brain slices. The cloned transporter cDNA predicts a 637 aa protein with 12 putative transmembrane domains and exhibits 44%-45% amino acid sequence identity with other members of the emerging family of neurotransmitter transporters. These findings support a synaptic role for L-proline in specific excitatory pathways in the CNS.	DUKE UNIV,MED CTR,DEPT CELL BIOL & MED,DURHAM,NC 27710; DUKE UNIV,MED CTR,HOWARD HUGHES MED INST LABS,DURHAM,NC 27710; EMORY UNIV,SCH MED,DEPT ANAT & CELL BIOL,ATLANTA,GA 30322; EMORY UNIV,SCH MED,PROGRAM NEUROSCI,ATLANTA,GA 30322	Duke University; Duke University; Emory University; Emory University	FREMEAU, RT (corresponding author), DUKE UNIV,MED CTR,DEPT NEUROBIOL,DURHAM,NC 27710, USA.				NIMH NIH HHS [2P50-MH 40159] Funding Source: Medline; NINDS NIH HHS [NS 19576] Funding Source: Medline; NCIRD CDC HHS [IP-53-NIH 44211] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH040159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCIRD CDC HHS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDRICH RW, 1990, NATURE, V345, P475, DOI 10.1038/345475a0; AULT B, 1987, BRIT J PHARMACOL, V92, P319, DOI 10.1111/j.1476-5381.1987.tb11326.x; AXELROD J, 1971, SCIENCE, V173, P598, DOI 10.1126/science.173.3997.598; BALCAR VJ, 1976, BRAIN RES, V102, P143, DOI 10.1016/0006-8993(76)90580-1; BENNETT JP, 1974, LIFE SCI, V15, P1045, DOI 10.1016/S0024-3205(74)80002-0; BENNETT JP, 1972, SCIENCE, V178, P997, DOI 10.1126/science.178.4064.997; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BRIDGES RJ, 1991, J MED CHEM, V34, P717, DOI 10.1021/jm00106a037; CASADO M, 1991, J NEUROCHEM, V57, P1185, DOI 10.1111/j.1471-4159.1991.tb08278.x; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHERKIN A, 1981, BRAIN RES, V223, P455, DOI 10.1016/0006-8993(81)91164-1; CHERKIN A, 1976, SCIENCE, V193, P242, DOI 10.1126/science.945612; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; COOL DR, 1991, J BIOL CHEM, V266, P15750; CORDERO ML, 1991, EUR J PHARM-MOLEC PH, V208, P179, DOI 10.1016/0922-4106(91)90070-X; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FELIX D, 1974, PFLUG ARCH EUR J PHY, V350, P135, DOI 10.1007/BF00586233; Felix D, 1976, Adv Biochem Psychopharmacol, V15, P165; FREMEAU RT, 1990, EMBO J, V9, P3533, DOI 10.1002/j.1460-2075.1990.tb07562.x; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GIACOBINI E, 1983, HDB NEUROCHEMISTRY, P583; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; HAMMERMAN MR, 1977, J BIOL CHEM, V252, P591; HAUPTMANN M, 1983, FEBS LETT, V161, P301, DOI 10.1016/0014-5793(83)81029-1; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HENDERSON PJF, 1990, RES MICROBIOL, V141, P316, DOI 10.1016/0923-2508(90)90005-B; HENZI V, 1992, IN PRESS MOL PHARM; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HWANG SM, 1983, J NEUROCHEM, V40, P317, DOI 10.1111/j.1471-4159.1983.tb11285.x; IVERSEN LL, 1978, HDB PSYCHOPHARMAC, P41; JOHNSON JL, 1984, BRAIN RES, V323, P247, DOI 10.1016/0006-8993(84)90295-6; Kanner BI, 1989, CURR OPIN CELL BIOL, V1, P735, DOI 10.1016/0955-0674(89)90042-2; KANNER BI, 1980, BIOCHIM BIOPHYS ACTA, V600, P185, DOI 10.1016/0005-2736(80)90423-X; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KAWABATA Y, 1980, J BIOCHEM-TOKYO, V88, P281; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KILTY J, 1991, SCIENCE, V254, P78; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUHAR MJ, 1973, LIFE SCI, V13, P1623, DOI 10.1016/0024-3205(73)90110-0; KUHAR MJ, 1978, J NEUROCHEM, V30, P15, DOI 10.1111/j.1471-4159.1978.tb07029.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LIBERT F, 1989, SCIENCE, V244, P569, DOI 10.1126/science.2541503; LODISH HF, 1988, TRENDS BIOCHEM SCI, V13, P332, DOI 10.1016/0968-0004(88)90101-6; LOGAN WJ, 1971, NATURE, V234, P297, DOI 10.1038/234297b0; MCCORMACK K, 1989, NATURE, V340, P103, DOI 10.1038/340103a0; McGeer E. G., 1983, GLUTAMINE GLUTAMATE, P3; MIRCHEFF AK, 1982, J MEMBRANE BIOL, V64, P113, DOI 10.1007/BF01870773; NADLER JV, 1987, J NEUROCHEM, V49, P1155; NADLER JV, 1976, NATURE, V260, P538, DOI 10.1038/260538a0; NADLER JV, 1988, BRAIN RES, V456, P68; NADLER JV, 1992, IN PRESS HIPPOCAMPUS; NAKAO T, 1987, MOL GEN GENET, V208, P70, DOI 10.1007/BF00330424; NGSEE JK, 1991, J BIOL CHEM, V266, P2675; NICKOLSON VJ, 1982, J NEUROCHEM, V38, P289, DOI 10.1111/j.1471-4159.1982.tb10885.x; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; Ottersen OP, 1984, HDB CHEM NEUROANATOM, V3, P141; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; PETERSON NA, 1972, J NEUROCHEM, V19, P1423, DOI 10.1111/j.1471-4159.1972.tb05086.x; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROSS HJ, 1984, BRAIN RES, V295, P155, DOI 10.1016/0006-8993(84)90826-6; Schousboe A, 1981, Int Rev Neurobiol, V22, P1, DOI 10.1016/S0074-7742(08)60289-5; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; SEGAL M, 1976, BRIT J PHARMACOL, V58, P341, DOI 10.1111/j.1476-5381.1976.tb07710.x; SHIMADA S, 1991, SCIENCE, V254, P576, DOI 10.1126/science.1948034; Snyder S H, 1973, Neurosci Res (N Y), V5, P131; SNYDER S H, 1970, Biological Psychiatry, V2, P367; SNYDER SH, 1991, NATURE, V354, P187, DOI 10.1038/354187a0; STEVENS BR, 1984, ANNU REV PHYSIOL, V46, P417; STORMMATHISEN J, 1979, NEUROSCIENCE, V4, P1237, DOI 10.1016/0306-4522(79)90154-4; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; THOMPSON SG, 1985, J NEUROCHEM, V45, P1791, DOI 10.1111/j.1471-4159.1985.tb10535.x; TIEDGE H, 1991, DNA CELL BIOL, V10, P143, DOI 10.1089/dna.1991.10.143; VANHARRE.A, 1973, J NEUROCHEM, V20, P947; VANHARREVELD A, 1980, J NEUROBIOL, V11, P519, DOI 10.1002/neu.480110603; VANHARREVELD A, 1981, NEUROSCIENCE, V6, P2495, DOI 10.1016/0306-4522(81)90095-6; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WHITE MK, 1989, NATURE, V340, P103, DOI 10.1038/340103b0; WRIGHT EM, 1984, J BIOL CHEM, V259, P4993; YAZYU H, 1984, J BIOL CHEM, V259, P4320; YONEDA Y, 1982, BRAIN RES, V239, P479, DOI 10.1016/0006-8993(82)90523-6; ZARZECKI P, 1975, BRAIN RES, V89, P187, DOI 10.1016/0006-8993(75)90150-X	87	213	219	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					915	926		10.1016/0896-6273(92)90206-S	http://dx.doi.org/10.1016/0896-6273(92)90206-S			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1350201				2022-12-28	WOS:A1992HV46700011
J	GRAY, DB; BRUSES, JL; PILAR, GR				GRAY, DB; BRUSES, JL; PILAR, GR			DEVELOPMENTAL SWITCH IN THE PHARMACOLOGY OF CA2+ CHANNELS COUPLED TO ACETYLCHOLINE-RELEASE	NEURON			English	Article								The pharmacological specificity of Ca2+ channel-secretion coupling in acetylcholine (ACh) and somatostatin (SOM) release was studied in the chick eye choroid neuromuscular junctions and in dissociated ciliary ganglion (CG) neurons. ACh secretion changes in development from stage (St) 40, when release is dihydropyridine (DHP) and partially omega-conotoxin (omega-CgTX) sensitive, to posthatch, when release is insensitive to DHPs but sensitive to omega-CgTX. St 40 CG neurons cultured with striated muscle have release properties similar to those of St 40 iris and choroid but different from those of St 34 neurons, which are neither DHP nor omega-CgTX sensitive. SOM (also coreleased from posthatch choroid terminals) can inhibit ACh release in both posthatch and St 40 choroids, suggesting that the SOM receptor interacts with both DHP-sensitive and -insensitive channels.			GRAY, DB (corresponding author), UNIV CONNECTICUT, DEPT PHYSIOL & NEUROBIOL, STORRS, CT 06269 USA.				NINDS NIH HHS [NS 10338, NS07324] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007324, R01NS010338] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BADER CR, 1983, DEV BIOL, V98, P515, DOI 10.1016/0012-1606(83)90381-0; BARRES BA, 1989, J NEUROSCI, V9, P3169; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BROSIUS DC, 1990, SYNAPSE, V5, P313, DOI 10.1002/syn.890050408; CHERKSEY BD, 1991, ANN NY ACAD SCI, V635, P80, DOI 10.1111/j.1749-6632.1991.tb36483.x; CREAN G, 1982, J PHYSL, V331, P97; DUNLAP K, 1987, TRENDS NEUROSCI, V10, P241, DOI 10.1016/0166-2236(87)90166-4; FRIES JL, 1982, PEPTIDES, V3, P811, DOI 10.1016/0196-9781(82)90020-1; GOTTMANN K, 1988, J NEUROSCI, V8, P3722; GOVONI S, 1990, J NEURAL TRANSM-GEN, V80, P1, DOI 10.1007/BF01245019; GRAY DB, 1987, DEV BIOL, V119, P290, DOI 10.1016/0012-1606(87)90230-2; GRAY DB, 1991, ANN NY ACAD SCI, V635, P408, DOI 10.1111/j.1749-6632.1991.tb36511.x; GRAY DB, 1990, J NEUROSCI, V10, P2687; GRAY DB, 1989, J NEUROSCI, V9, P1683; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HOLZ GG, 1988, J NEUROSCI, V8, P463; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; JONES SW, 1990, J NEUROSCI, V10, P2261; KANO M, 1989, DEV BRAIN RES, V47, P101, DOI 10.1016/0165-3806(89)90112-0; KOCH TR, 1988, DIS COLON RECTUM, V31, P198, DOI 10.1007/BF02552546; KONGSAMUT S, 1986, P NATL ACAD SCI USA, V83, P2243, DOI 10.1073/pnas.83.7.2243; LANDMESSER L, 1972, J PHYSIOL-LONDON, V222, P691, DOI 10.1113/jphysiol.1972.sp009822; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MCCOBB DP, 1989, NEURON, V2, P1633, DOI 10.1016/0896-6273(89)90052-4; MERINEY SD, 1987, J NEUROSCI, V7, P3827; MILLER RJ, 1988, TRENDS NEUROSCI, V11, P415, DOI 10.1016/0166-2236(88)90191-9; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; ODOWD DK, 1988, J NEUROSCI, V8, P792; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; PILAR G, 1981, J PHYSIOL-LONDON, V321, P175, DOI 10.1113/jphysiol.1981.sp013978; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; SCROGGS RS, 1991, J NEUROSCI, V11, P1334; SHER E, 1991, NEUROSCIENCE, V42, P301, DOI 10.1016/0306-4522(91)90376-Y; SILVER RA, 1990, NATURE, V343, P751, DOI 10.1038/343751a0; SIMONCINI L, 1988, SCIENCE, V242, P1572, DOI 10.1126/science.2849207; STANLEY EF, 1990, P NATL ACAD SCI USA, V87, P9683, DOI 10.1073/pnas.87.24.9683; TAKAHASHI M, 1985, BRAIN RES, V341, P381, DOI 10.1016/0006-8993(85)91079-0; TAKAHASHI T, 1987, J NEUROSCI, V7, P473; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TUTTLE JB, 1980, BRAIN RES, V183, P161, DOI 10.1016/0006-8993(80)90127-4; TUTTLE JB, 1982, DYNAMICS CHOLINERGIC, P879; VACA K, 1979, J GEN PHYSIOL, V73, P605, DOI 10.1085/jgp.73.5.605; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; YAARI Y, 1987, SCIENCE, V235, P680, DOI 10.1126/science.2433765	48	40	40	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1992	8	4					715	724		10.1016/0896-6273(92)90092-R	http://dx.doi.org/10.1016/0896-6273(92)90092-R			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1348949				2022-12-28	WOS:A1992HQ18800010
J	HWANG, PM; GLATT, CE; BREDT, DS; YELLEN, G; SNYDER, SH				HWANG, PM; GLATT, CE; BREDT, DS; YELLEN, G; SNYDER, SH			A NOVEL K+ CHANNEL WITH UNIQUE LOCALIZATIONS IN MAMMALIAN BRAIN - MOLECULAR-CLONING AND CHARACTERIZATION	NEURON			English	Article							DEPENDENT POTASSIUM CHANNEL; RAT-BRAIN; TASTE TRANSDUCTION; SHAKER LOCUS; GENE FAMILY; DROSOPHILA; EXPRESSION; CELLS; DIVERSITY; COMPONENTS	Using a cDNA library prepared from circumvallate papillae of rat tongue, we have identified, cloned, and sequenced a novel K+ channel, designated cdrk. The cdrk channel appears to be a member of the Shab subfamily, most closely resembling drk1. Electrophysiologic analysis of expressed cdrk channels reveals delayed rectifier properties similar to those of drk1 channels. Localizations of cdrk mRNA in rat brain and peripheral tissues, assessed by in situ hybridization and Northern blot analysis, differ from any other reported K+ channels. In the brain cdrk mRNA is most concentrated in granule cells of the olfactory bulb and cerebellum. In peripheral tissues, mRNAs for cdrk and drk1 are reciprocally localized, indicating that the K+ channel properties contributed by mammalian Shab homologs may be important in a variety of excitable tissues.	JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PHARMACOL & MOLEC SCI,BALTIMORE,MD 21205; HOWARD HUGHES MED INST,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute	HWANG, PM (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.			Yellen, Gary/0000-0003-4228-7866	NIDA NIH HHS [DA-00074, DA-00266] Funding Source: Medline; NIGMS NIH HHS [GM-07309] Funding Source: Medline; NINDS NIH HHS [R01 NS029693] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AWAN KA, 1991, NEUROSCIENCE, V40, P29, DOI 10.1016/0306-4522(91)90172-K; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BIGIANI AR, 1991, SCIENCE, V252, P126, DOI 10.1126/science.2011748; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CASTLE NA, 1989, TRENDS NEUROSCI, V12, P59, DOI 10.1016/0166-2236(89)90137-9; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HWANG PM, 1990, P NATL ACAD SCI USA, V87, P7395, DOI 10.1073/pnas.87.19.7395; KINNAMON SC, 1988, TRENDS NEUROSCI, V11, P491, DOI 10.1016/0166-2236(88)90010-0; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; MCCORMACK T, 1990, P NATL ACAD SCI USA, V87, P5227, DOI 10.1073/pnas.87.13.5227; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; PAK MD, 1991, J NEUROSCI, V11, P869; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PEVSNER J, 1988, P NATL ACAD SCI USA, V85, P2383, DOI 10.1073/pnas.85.7.2383; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; ROBERDS SL, 1991, P NATL ACAD SCI USA, V88, P1798, DOI 10.1073/pnas.88.5.1798; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SEQUIER JM, 1990, FEBS LETT, V263, P163, DOI 10.1016/0014-5793(90)80729-3; SPIELMAN AI, 1989, BRAIN RES, V503, P326, DOI 10.1016/0006-8993(89)91684-3; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7	40	113	114	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					473	481		10.1016/0896-6273(92)90275-I	http://dx.doi.org/10.1016/0896-6273(92)90275-I			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550672				2022-12-28	WOS:A1992HK67500007
J	DULAC, C; TROPAK, MB; CAMERONCURRY, P; ROSSIER, J; MARSHAK, DR; RODER, J; LEDOUARIN, NM				DULAC, C; TROPAK, MB; CAMERONCURRY, P; ROSSIER, J; MARSHAK, DR; RODER, J; LEDOUARIN, NM			MOLECULAR CHARACTERIZATION OF THE SCHWANN-CELL MYELIN PROTEIN, SMP - STRUCTURAL SIMILARITIES WITHIN THE IMMUNOGLOBULIN SUPERFAMILY	NEURON			English	Article							ADHESION MOLECULE; N-CAM; NERVOUS-SYSTEM; EXTRACELLULAR-MATRIX; MONOCLONAL-ANTIBODY; BINDING-PROPERTIES; GENE SUPERFAMILY; GLYCOPROTEIN MAG; NEURAL ADHESION; MESSENGER-RNAS	The Schwann cell myelin protein (SMP), previously defined in quail and chick by a monoclonal antibody, is in vivo exclusively expressed by myelinating and nonmyelinating Schwann cells and oligodendrocytes. The isolation of the complete nucleotide sequence of SMP is reported here. The predicted polypeptide chain reveals that SMP is a transmembrane molecule of the immunoglobulin superfamily showing sequence similarities with several surface glycoproteins expressed in the nervous and immune systems. In spite of a 43.5% overall sequence identity between rat myelin-associated glycoprotein (MAG) and quail SMP, SMP does not seem to be the avian homolog of MAG, since their expression, regulation, and functions are significantly different. Unusual sequence arrangements shared by SMP, MAG, and two lymphoid antigens suggest the existence of a particular subgroup in the immunoglobulin superfamily.	COLL FRANCE, F-94736 NOGENT SUR MARNE, FRANCE; MT SINAI HOSP, SAMUEL LUNENFELD RES INST, TORONTO M5G 1X5, ONTARIO, CANADA; CNRS, PHYSIOL NERVEUSE LAB, F-91198 GIF SUR YVETTE, FRANCE; COLD SPRING HARBOR LAB, COLD SPRING HARBOR, NY 11724 USA	UDICE-French Research Universities; PSL Research University Paris; College de France; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Cold Spring Harbor Laboratory	DULAC, C (corresponding author), CNRS, INST EMBRYOL, F-94736 NOGENT SUR MARNE, FRANCE.		Roder, John/G-6468-2013	Dulac, Catherine/0000-0001-5024-5418				AGUAYO AJ, 1976, J NEUROCYTOL, V5, P565, DOI 10.1007/BF01175570; ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; BARNETT TR, 1989, J CELL BIOL, V108, P267, DOI 10.1083/jcb.108.2.267; BROCKES JP, 1981, J EXP BIOL, V95, P215; BUNGE MB, 1989, DEV NEUROSCI-BASEL, V11, P348, DOI 10.1159/000111911; BURGOON MP, 1991, J CELL BIOL, V112, P1017, DOI 10.1083/jcb.112.5.1017; CAMERONCURRY P, 1989, DEVELOPMENT, V107, P825; CAMERONCURRY P, 1991, EUR J NEUROSCI, V3, P126, DOI 10.1111/j.1460-9568.1991.tb00073.x; CARDWELL MC, 1988, J CELL BIOL, V107, P1551, DOI 10.1083/jcb.107.4.1551; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLE GJ, 1986, NATURE, V320, P445, DOI 10.1038/320445a0; COLE GJ, 1986, J CELL BIOL, V102, P403, DOI 10.1083/jcb.102.2.403; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; DULAC C, 1991, P NATL ACAD SCI USA, V88, P6358, DOI 10.1073/pnas.88.14.6358; DULAC C, 1988, NEURON, V1, P211, DOI 10.1016/0896-6273(88)90141-9; DUPIN E, 1990, P NATL ACAD SCI USA, V87, P1119, DOI 10.1073/pnas.87.3.1119; EDWARDS AM, 1988, MOL CELL BIOL, V8, P2655, DOI 10.1128/MCB.8.6.2655; FAHRIG T, 1987, EMBO J, V6, P2875, DOI 10.1002/j.1460-2075.1987.tb02590.x; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; FUJITA N, 1989, BIOCHEM BIOPH RES CO, V165, P1162, DOI 10.1016/0006-291X(89)92724-1; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GRUMET M, 1984, P NATL ACAD SCI-BIOL, V81, P267, DOI 10.1073/pnas.81.1.267; GUPTA SK, 1990, DEV NEUROSCI-BASEL, V12, P22, DOI 10.1159/000111832; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; JESSEN KR, 1990, DEVELOPMENT, V109, P91; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAI C, 1987, IMMUNOL REV, V100, P129, DOI 10.1111/j.1600-065X.1987.tb00530.x; Le Douarin N.M., 1982, NEURAL CREST; LEDOUARIN N, 1991, GLIA, V4, P175; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; MIRSKY R, 1980, J CELL BIOL, V84, P483, DOI 10.1083/jcb.84.3.483; MONUKI ES, 1990, SCIENCE, V249, P1300, DOI 10.1126/science.1975954; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; PEDRAZA L, 1990, J CELL BIOL, V111, P2651, DOI 10.1083/jcb.111.6.2651; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; POLTORAK M, 1987, J CELL BIOL, V105, P1893, DOI 10.1083/jcb.105.4.1893; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; RATNER N, 1988, P NATL ACAD SCI USA, V85, P6992, DOI 10.1073/pnas.85.18.6992; RIOPELLE RJ, 1986, BRAIN RES, V367, P20, DOI 10.1016/0006-8993(86)91573-8; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SADOUL R, 1990, J NEUROSCI RES, V25, P1, DOI 10.1002/jnr.490250102; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; SALZER JL, 1987, J CELL BIOL, V104, P957, DOI 10.1083/jcb.104.4.957; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOFIELD PR, 1989, EMBO J, V8, P489, DOI 10.1002/j.1460-2075.1989.tb03402.x; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SIMMONS D, 1988, J IMMUNOL, V141, P2797; SIMMONS D, 1988, NATURE, V331, P624, DOI 10.1038/331624a0; SORKIN BC, 1984, SCIENCE, V225, P1476, DOI 10.1126/science.6474186; SPAGNOL G, 1989, J NEUROSCI RES, V24, P137, DOI 10.1002/jnr.490240203; STAMENKOVIC I, 1990, NATURE, V345, P74, DOI 10.1038/345074a0; WILLIAMS AF, 1989, COLD SPRING HARB SYM, V54, P637; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILSON GL, 1991, J EXP MED, V173, P137, DOI 10.1084/jem.173.1.137	68	66	69	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1992	8	2					323	334		10.1016/0896-6273(92)90298-R	http://dx.doi.org/10.1016/0896-6273(92)90298-R			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1739462				2022-12-28	WOS:A1992HE93000012
J	ARTALEJO, CR; PERLMAN, RL; FOX, AP				ARTALEJO, CR; PERLMAN, RL; FOX, AP			OMEGA-CONOTOXIN GVIA BLOCKS A CA2+ CURRENT IN BOVINE CHROMAFFIN CELLS THAT IS NOT OF THE CLASSIC N-TYPE	NEURON			English	Article							SENSITIVE CALCIUM-CHANNEL; CHICK SENSORY NEURONS; DIHYDROPYRIDINE RECEPTOR; SYMPATHETIC NEURONS; SKELETAL-MUSCLE; NEUROTRANSMITTER RELEASE; CA-2+ CHANNELS; MULTIPLE TYPES; T-TYPE; VOLTAGE	Previous studies have identified two components of whole-cell Ca2+ current in bovine chromaffin cells. The "standard" component was activated by single depolarizations, while "facilitation" could be activated by large prepulses or repetitive depolarizations. Neither current component was sensitive to changes in holding potential between -100 and -50 mV; thus neither appeared to be carried by N-type Ca2+ channels. We now report that the facilitation Ca2+ current is insensitive to omega-conotoxin GVIA (omega-CgTx), but that the toxin blocks approximately 50% of the standard Ca2+ current. In some cells the toxin blocks all of the standard Ca2+ current, in others about half of the current, while in others it has no effect. Kinetic differences in current activation are observed after toxin application. These results suggest that the standard component of chromaffin cell Ca2+ current is composed of two pharmacologically distinct channels-one is omega-CgTx sensitive and the other is not. Two kinetically distinct types of 14 pS Ca2+ channels that may correspond to the omega-CgTx-sensitive and -insensitive components were observed in single-channel experiments. Because omega-CgTx blocked Ca2+ channels that were not inactivated by a depolarized holding potential, the commonly used Ca2+ channel categorization scheme may be inadequate to describe the Ca2+ channels found in chromaffin cells.	UNIV CHICAGO,DEPT PEDIAT,CHICAGO,IL 60637; UNIV CHICAGO,JOSEPH P KENNEDY JR MENTAL RETARDAT RES CTR,CHICAGO,IL 60637; UNIV AUTONOMA MADRID,FAC MED,DEPT FARMACOL,MADRID 34,SPAIN	University of Chicago; University of Chicago; Autonomous University of Madrid	ARTALEJO, CR (corresponding author), UNIV CHICAGO,DEPT PHARMACOL & PHYSIOL SCI,CHICAGO,IL 60637, USA.		Perlman, Robert/GZH-2102-2022					ABE T, 1986, NEUROSCI LETT, V71, P203, DOI 10.1016/0304-3940(86)90559-8; ARTALEJO CR, 1991, J PHYSIOL-LONDON, V432, P681, DOI 10.1113/jphysiol.1991.sp018406; ARTALEJO CR, 1990, NATURE, V348, P239, DOI 10.1038/348239a0; ARTALEJO CR, 1991, J PHYSIOL-LONDON, V444, P213, DOI 10.1113/jphysiol.1991.sp018874; BALLESTA JJ, 1989, J NEUROCHEM, V53, P1050, DOI 10.1111/j.1471-4159.1989.tb07394.x; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BROOKS JC, 1977, ENDOCRINOLOGY, V101, P1369, DOI 10.1210/endo-101-5-1369; CHARLTON MP, 1990, BRAIN RES, V525, P133, DOI 10.1016/0006-8993(90)91328-E; COHEN CJ, 1988, P NATL ACAD SCI USA, V85, P2412, DOI 10.1073/pnas.85.7.2412; COHEN MW, 1991, J NEUROSCI, V11, P1032; DUTAR P, 1989, EUR J PHARMACOL, V174, P261, DOI 10.1016/0014-2999(89)90318-X; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; FENWICK EM, 1978, J CELL BIOL, V76, P12, DOI 10.1083/jcb.76.1.12; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; GREENBERG A, 1982, CELL TISSUE RES, V226, P655; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HANS M, 1990, NEUROSCI LETT, V114, P63, DOI 10.1016/0304-3940(90)90429-D; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HOSHI T, 1984, P NATL ACAD SCI-BIOL, V81, P5871, DOI 10.1073/pnas.81.18.5871; JAN CR, 1990, J NEUROCHEM, V54, P355, DOI 10.1111/j.1471-4159.1990.tb13323.x; JONES SW, 1989, J GEN PHYSIOL, V94, P151, DOI 10.1085/jgp.94.1.151; KASAI H, 1988, PFLUG ARCH EUR J PHY, V411, P695, DOI 10.1007/BF00580869; KASAI H, 1987, Neuroscience Research, V4, P228, DOI 10.1016/0168-0102(87)90014-9; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; KONGSAMUT S, 1986, P NATL ACAD SCI USA, V83, P2243, DOI 10.1073/pnas.83.7.2243; KUNZE DL, 1990, J MEMBRANE BIOL, V118, P171, DOI 10.1007/BF01868474; LEVITAN ES, 1990, NATURE, V348, P545, DOI 10.1038/348545a0; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; LLINAS RR, 1989, ANN NY ACAD SCI, V560, P103, DOI 10.1111/j.1749-6632.1989.tb24084.x; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MCCOBB DP, 1991, NEURON, V7, P119, DOI 10.1016/0896-6273(91)90080-J; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MILLER RJ, 1990, INTRACELLULAR CALCIU, P97; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; OWEN PJ, 1989, BRIT J PHARMACOL, V97, P133, DOI 10.1111/j.1476-5381.1989.tb11933.x; PENINGTON NJ, 1991, J NEUROSCI, V11, P3594, DOI 10.1523/jneurosci.11-11-03594.1991; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PLUMMER MR, 1991, NATURE, V351, P657, DOI 10.1038/351657a0; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; REGAN LJ, 1991, J NEUROSCI, V11, P2259; REYNOLDS IJ, 1986, P NATL ACAD SCI USA, V83, P8804, DOI 10.1073/pnas.83.22.8804; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; ROSARIO LM, 1989, NEUROSCIENCE, V29, P735, DOI 10.1016/0306-4522(89)90145-0; SAVTCHENKO AN, 1990, GEN PHYSIOL BIOPHYS, V9, P147; SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639, DOI 10.1113/jphysiol.1992.sp018944; SHER E, 1990, CANCER RES, V50, P3892; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; TANABE T, 1990, NATURE, V344, P451, DOI 10.1038/344451a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TANG CM, 1988, SCIENCE, V240, P213, DOI 10.1126/science.2451291; THAYER SA, 1987, MOL PHARMACOL, V32, P579; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; VARADI M, 1991, NATURE, V352, P159	61	102	111	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1992	8	1					85	95		10.1016/0896-6273(92)90110-Y	http://dx.doi.org/10.1016/0896-6273(92)90110-Y			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1309652				2022-12-28	WOS:A1992HB18500007
J	GOEDERT, M; SPILLANTINI, MG; CAIRNS, NJ; CROWTHER, RA				GOEDERT, M; SPILLANTINI, MG; CAIRNS, NJ; CROWTHER, RA			TAU-PROTEINS OF ALZHEIMER PAIRED HELICAL FILAMENTS - ABNORMAL PHOSPHORYLATION OF ALL 6 BRAIN ISOFORMS	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; NEUROFIBRILLARY TANGLES; DISEASE; IDENTIFICATION; LOCALIZATION; DOMAINS; CORE	Preparations of dispersed paired helical filaments(PHFs) from the brains of Alzheimer's disease and Down's syndrome patients display on gels three principal bands corresponding to abnormally modified forms of the microtubule-associated protein tau. Interpretation of the pattern is difficult because there are six tau isoforms in normal brain and phosphorylation changes their mobility. By enzymatic dephosphorylation at high temperature, we have shifted the three abnormal bands obtained from dispersed PHFs to align with the six nonphosphorylated tau isoforms. By using antibodies specific for some of the inserts that distinguish the various isoforms and label PHFs, we have established a correspondence between PHFs, abnormal bands, and isoforms. This identification of isoforms is a necessary step in unravelling the molecular pathogenesis of PHFs.	INST PSYCHIAT,DEPT NEUROPATHOL,LONDON SE5 8AF,ENGLAND	University of London; King's College London	GOEDERT, M (corresponding author), MRC,MOLEC BIOL LAB,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.		Cairns, Nigel/AAB-9713-2020	Cairns, Nigel/0000-0001-9858-3344				AIZAWA H, 1989, J BIOL CHEM, V264, P5885; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; Brion J. P., 1985, ARCH BIOL BRUX, V95, P229; BRION JP, 1991, BIOCHEM J, V273, P127, DOI 10.1042/bj2730127; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; ENNULAT DJ, 1989, J BIOL CHEM, V264, P5327; FLAMENT S, 1990, BRAIN RES, V516, P15, DOI 10.1016/0006-8993(90)90891-E; FLAMENT S, 1989, FEBS LETT, V247, P213, DOI 10.1016/0014-5793(89)81337-7; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HANGER DP, 1991, BIOCHEM J, V275, P99, DOI 10.1042/bj2750099; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; JERVIS GA, 1948, AM J PSYCHIAT, V105, P102, DOI 10.1176/ajp.105.2.102; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; NOVAK M, 1991, P NATL ACAD SCI USA, V88, P5837, DOI 10.1073/pnas.88.13.5837; PROBST A, 1982, ACTA NEUROPATHOL, V57, P75, DOI 10.1007/BF00688880; RUBENSTEIN R, 1986, BRAIN RES, V372, P80, DOI 10.1016/0006-8993(86)91460-5; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; von Braunmuhl A., 1957, HDB SPZIELLEN PATHOL, V13, P337; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040	37	924	961	0	45	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1992	8	1					159	168		10.1016/0896-6273(92)90117-V	http://dx.doi.org/10.1016/0896-6273(92)90117-V			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1530909				2022-12-28	WOS:A1992HB18500014
J	HAGG, T; QUON, D; HIGAKI, J; VARON, S				HAGG, T; QUON, D; HIGAKI, J; VARON, S			CILIARY NEUROTROPHIC FACTOR PREVENTS NEURONAL DEGENERATION AND PROMOTES LOW AFFINITY NGF RECEPTOR EXPRESSION IN THE ADULT-RAT CNS	NEURON			English	Article							NERVE GROWTH-FACTOR; FIMBRIA-FORNIX TRANSECTION; CHOLINERGIC NEURONOTROPHIC FACTORS; BASAL FOREBRAIN; MESSENGER-RNA; MEDIAL SEPTUM; ACETYLTRANSFERASE ACTIVITY; ASTROGLIAL CELLS; PERIPHERAL-NERVE; TROPHIC ACTIVITY	Recombinant human ciliary neurotrophic factor (CNTF) was infused for 2 weeks into the lateral ventricle of fimbria-fornix transected adult rats, and its effects were compared with those of purified mouse nerve growth factor (NGF). We provide evidence that CNTF can prevent degeneration and atrophy of almost all injured medial septum neurons (whereas NGF protects only the cholinergic ones). CNTF is also involved in up-regulation of immunostainable low affinity NGF receptor (LNGFR) in cholinergic medial septum and neostriatal neurons and in a population of lateral septum neurons. In contrast to NGF, CNTF did not stimulate choline acetyltransferase in the lesioned septum and normal neostriatum (pointing to different mechanisms for the regulation of choline acetyltransferase and LNGFR), cause hypertrophy of septal or neostriatal cholinergic neurons, or cause sprouting of LNGFR-positive (cholinergic) septal fibers.	CALIF BIOTECHNOL INC,MT VIEW,CA 94043		HAGG, T (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,0601,LA JOLLA,CA 92093, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016349] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-16349] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER R, 1982, DEV BIOL, V92, P470, DOI 10.1016/0012-1606(82)90192-0; ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; ADLER R, 1980, CURR TOP DEV BIOL, V16, P207; ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BATCHELOR PE, 1989, J COMP NEUROL, V284, P187, DOI 10.1002/cne.902840204; CAVICCHIOLI L, 1989, EUR J NEUROSCI, V1, P258, DOI 10.1111/j.1460-9568.1989.tb00793.x; DAWBARN D, 1988, NEUROSCI LETT, V94, P138, DOI 10.1016/0304-3940(88)90284-4; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; FURUKAWA S, 1986, BIOCHEM BIOPH RES CO, V136, P57, DOI 10.1016/0006-291X(86)90876-4; FUSCO M, 1989, NEUROSCIENCE, V33, P47, DOI 10.1016/0306-4522(89)90309-6; GAGE FH, 1988, J COMP NEUROL, V269, P147, DOI 10.1002/cne.902690112; GAGE FH, 1986, NEUROSCIENCE, V19, P241, DOI 10.1016/0306-4522(86)90018-7; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; HAGG T, 1990, J NEUROSCI, V10, P3087; HAGG T, 1989, BRAIN RES, V505, P29, DOI 10.1016/0006-8993(89)90112-1; HAGG T, 1989, NEUROSCIENCE, V30, P95, DOI 10.1016/0306-4522(89)90356-4; HAGG T, 1990, EXP NEUROL, V109, P153, DOI 10.1016/0014-4886(90)90069-5; HAGG T, 1988, EXP NEUROL, V101, P303, DOI 10.1016/0014-4886(88)90013-1; HAGG T, 1991, EXP NEUROL, V112, P79, DOI 10.1016/0014-4886(91)90116-T; HAGG T, 1990, COMMENTS DEV NEUROBI, V1, P157; HALLEWELL RA, 1980, GENE, V9, P27, DOI 10.1016/0378-1119(80)90165-1; HEDREEN JC, 1985, J HISTOCHEM CYTOCHEM, V33, P134, DOI 10.1177/33.2.2578498; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEFTI F, 1989, NEUROBIOL AGING, V10, P515, DOI 10.1016/0197-4580(89)90118-8; HIGGINS GA, 1989, NEURON, V3, P247, DOI 10.1016/0896-6273(89)90038-X; HOFMANN HD, 1988, J NEUROCHEM, V51, P109, DOI 10.1111/j.1471-4159.1988.tb04842.x; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KNUSEL B, 1988, J NEUROSCI RES, V21, P365, DOI 10.1002/jnr.490210228; KOHLER C, 1984, ANAT EMBRYOL, V170, P1, DOI 10.1007/BF00319452; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LAM A, 1991, GENE, V102, P271, DOI 10.1016/0378-1119(91)90089-T; LANDA KB, 1980, DEV BIOL, V74, P401, DOI 10.1016/0012-1606(80)90441-8; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LILLIEN LE, 1990, J CELL BIOL, V111, P635, DOI 10.1083/jcb.111.2.635; LIN LFH, 1990, J BIOL CHEM, V265, P8942; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LJUNGDAHL A, 1978, NEUROSCIENCE, V3, P861, DOI 10.1016/0306-4522(78)90116-1; MANTHORPE M, 1986, DEV BRAIN RES, V25, P191, DOI 10.1016/0165-3806(86)90208-7; MANTHORPE M, 1986, BRAIN RES, V367, P282, DOI 10.1016/0006-8993(86)91603-3; MANTHORPE M, 1981, DEV BIOL, V85, P156, DOI 10.1016/0012-1606(81)90245-1; MANTHORPE M, 1982, J NEUROCHEM, V38, P415, DOI 10.1111/j.1471-4159.1982.tb08645.x; MANTHORPE M, 1989, NERVE GROWTH FACTORS, P135; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MONTERO CN, 1988, J NEUROSCI, V8, P2986; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; OTTO D, 1989, J NEUROSCI RES, V22, P83, DOI 10.1002/jnr.490220111; PETERSON GM, 1987, NEUROSCI LETT, V76, P140, DOI 10.1016/0304-3940(87)90705-1; PETTMANN B, 1988, J NEUROSCI, V8, P3624; RAIVICH G, 1987, J NEUROCYTOL, V16, P689, DOI 10.1007/BF01637660; RENDE M, IN PRESS GLIA; RENDE M, 1992, IN PRESS J COMP NEUR; RICHARDSON PM, 1986, J NEUROSCI, V6, P2312; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RUDGE JS, 1987, DEV BRAIN RES, V32, P103, DOI 10.1016/0165-3806(87)90143-X; RUDGE JS, 1985, DEV BRAIN RES, V19, P161, DOI 10.1016/0165-3806(85)90188-9; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SCHONFELD AR, 1985, BRAIN RES, V336, P297, DOI 10.1016/0006-8993(85)90655-9; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SONNENFELD KH, 1985, J NEUROSCI, V5, P1717; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; TANIUCHI M, 1988, J NEUROSCI, V8, P664; VAHLSING HL, 1991, BRAIN RES, V552, P320, DOI 10.1016/0006-8993(91)90098-G; VAHLSING HL, 1989, EXP NEUROL, V105, P233, DOI 10.1016/0014-4886(89)90125-8; VARON S, 1989, NEURAL REGENERATION, V6, P101; VARON S, 1972, METHODS TECHNIQUES N, P203; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WHITTEMORE SR, 1987, BRAIN RES REV, V12, P439, DOI 10.1016/0165-0173(87)90008-7; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; WILLIAMS LR, 1984, INT J DEV NEUROSCI, V2, P177, DOI 10.1016/0736-5748(84)90009-1; WILLIAMS LR, 1989, BRAIN RES, V498, P243, DOI 10.1016/0006-8993(89)91103-7; WOOD SJ, 1990, EUR J NEUROSCI, V2, P650, DOI 10.1111/j.1460-9568.1990.tb00454.x	76	194	198	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1992	8	1					145	158		10.1016/0896-6273(92)90116-U	http://dx.doi.org/10.1016/0896-6273(92)90116-U			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1309648				2022-12-28	WOS:A1992HB18500013
J	DEMO, SD; YELLEN, G				DEMO, SD; YELLEN, G			THE INACTIVATION GATE OF THE SHAKER K+ CHANNEL BEHAVES LIKE AN OPEN-CHANNEL BLOCKER	NEURON			English	Article							POTASSIUM CHANNELS; CHARYBDOTOXIN BLOCK; HIGH-CONDUCTANCE; SODIUM CHANNEL; AXONS	Following voltage-dependent activation, Drosophila Shaker K+ channels enter a nonconducting, inactivated state. This process has been proposed to occur by a "ball-and-chain" mechanism, in which the N-terminus of the protein behaves like a blocker tethered to the cytoplasmic side of the channel and directly occludes the pore to cause inactivation. To complement the ample evidence for the involvement of the N-terminus, we sought evidence that it blocks the pore directly. We found that inactivation exhibits several distinctive properties of pore blockade. First, recovery was speeded by increased external K+ concentrations, just as blockade can be relieved by trans-permeant ions. Second, single-channel experiments show that the channel reopens from the inactivated state upon repolarization. These openings were usually required for recovery, as though the blocking particle must exit the pore before the channel can close.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205	Johns Hopkins University	DEMO, SD (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205, USA.			Yellen, Gary/0000-0003-4228-7866	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS029693, NS29693] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG CM, 1966, J GEN PHYSIOL, V50, P491, DOI 10.1085/jgp.50.2.491; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P473, DOI 10.1113/jphysiol.1952.sp004718; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, IN PRESS NEURON; JACKSON MB, 1986, BIOPHYS J, V49, P663, DOI 10.1016/S0006-3495(86)83693-1; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; Press W., 1986, NUMERICAL RECIPES; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SLESINGER A, 1991, J PHYSL, V435, P101; SWENSON RP, 1981, NATURE, V328, P313; YELLEN G, 1984, J GEN PHYSIOL, V84, P187, DOI 10.1085/jgp.84.2.187; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; [No title captured]	26	270	270	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1991	7	5					743	753		10.1016/0896-6273(91)90277-7	http://dx.doi.org/10.1016/0896-6273(91)90277-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1742023	hybrid			2022-12-28	WOS:A1991GT93900005
J	MCKERNAN, RM; QUIRK, K; PRINCE, R; COX, PA; GILLARD, NP; RAGAN, CI; WHITING, P				MCKERNAN, RM; QUIRK, K; PRINCE, R; COX, PA; GILLARD, NP; RAGAN, CI; WHITING, P			GABA-A RECEPTOR SUBTYPES IMMUNOPURIFIED FROM RAT-BRAIN WITH ALPHA SUBUNIT-SPECIFIC ANTIBODIES HAVE UNIQUE PHARMACOLOGICAL PROPERTIES	NEURON			English	Article							AMINOBUTYRIC ACIDA-RECEPTOR; A RECEPTOR; BENZODIAZEPINE RECEPTORS; FUNCTIONAL EXPRESSION; GAMMA-2 SUBUNIT; BOVINE BRAIN; BETA-SUBUNIT; SEQUENCE; PROTEIN; IDENTIFICATION	The unique cytoplasmic loop regions of the alpha-1, alpha-2, alpha-3, and alpha-5 subunits of the GABA(A) receptor were expressed in bacteria and used to produce subunit-specific polyclonal antisera. Antibodies immobilized on protein A-Sepharose were used to isolate naturally occurring alpha-specific populations of GABA(A) receptors from rat brain that retained the ability to bind [H-3]muscimol, [H-3]flunitrazepam, [H-3]Ro15-1788, and [I-125]iodoclonazepam with high affinity. Pharmacological characterization of these subtypes revealed marked differences between the isolated receptor populations and was generally in agreement with the reported pharmacological profiles of GABA(A) receptors in cells transiently transfected with alpha-1-beta-1-gamma-2, alpha-2-beta-1-gamma-2, alpha-3-beta-1-gamma-2, and alpha-5-beta-1-gamma-2 combinations of subunits. Additional subtypes were also identified that bind [H-3]muscimol but do not bind benzodiazepines with high affinity. The majority of GABA(A) receptor oligomers contains only a single type of alpha-subunit, and we conclude that alpha-1, alpha-2, alpha-3, and alpha-5 subunits exist in vivo in combination with the beta-subunit and gamma-2 subunit.			MCKERNAN, RM (corresponding author), MERCK SHARP & DOHME LTD,DEPT BIOCHEM,NEUROSCI RES CTR,TERLINGS PK,EASTWICK RD,HARLOW CM20 2QR,ESSEX,ENGLAND.							BENKE D, 1991, J BIOL CHEM, V266, P4478; BUREAU M, 1990, MOL PHARMACOL, V37, P497; DIEHL RE, 1990, J BIOL CHEM, V265, P5946; DUGGAN MJ, 1990, J BIOL CHEM, V265, P3831; DUGGAN MJ, 1989, J NEUROCHEM, V53, P132, DOI 10.1111/j.1471-4159.1989.tb07304.x; EWART M, 1990, J CELL BIOL, V110, P2043; FUCHS K, 1990, FEBS LETT, V261, P52, DOI 10.1016/0014-5793(90)80634-U; FUCHS K, 1988, NEUROSCI LETT, V90, P314, DOI 10.1016/0304-3940(88)90208-X; HARLOW E, 1988, ANTIBODIES LABORATOR, P309; KHRESTCHATISKY M, 1989, NEURON, V3, P745, DOI 10.1016/0896-6273(89)90243-2; KIRKNESS EF, 1988, BIOCHEM J, V256, P291, DOI 10.1042/bj2560291; KOFUJI P, 1991, J NEUROCHEM, V56, P713, DOI 10.1111/j.1471-4159.1991.tb08209.x; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MALHERBE P, 1990, FEBS LETT, V260, P261, DOI 10.1016/0014-5793(90)80118-3; MALHERBE P, 1990, J NEUROSCI, V10, P2330; MCKERNAN RM, 1990, J NEUROCHEM, V54, P924, DOI 10.1111/j.1471-4159.1990.tb02339.x; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHOEPFER R, 1989, FEBS LETT, V257, P393, DOI 10.1016/0014-5793(89)81580-7; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SEQUIER JM, 1988, P NATL ACAD SCI USA, V85, P7815, DOI 10.1073/pnas.85.20.7815; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SIEGHART W, 1989, TRENDS PHARMACOL SCI, V10, P407, DOI 10.1016/0165-6147(89)90189-2; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; STEPHENSON FA, 1988, BIOCHEM J, V249, P21, DOI 10.1042/bj2490021; STEPHENSON FA, 1990, J BIOL CHEM, V265, P21160; STEPHENSON FA, 1989, BIOCHEM J, V264, P199, DOI 10.1042/bj2640199; STEPHENSON FA, 1989, FEBS LETT, V243, P358, DOI 10.1016/0014-5793(89)80161-9; VANBLANKENFELD G, 1990, NEUROSCI LETT, V115, P269; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WHITING P, 1990, P NATL ACAD SCI USA, V87, P9966, DOI 10.1073/pnas.87.24.9966; WHITING PJ, 1991, MOL BRAIN RES, V10, P61, DOI 10.1016/0169-328X(91)90057-5; WILSONSHAW D, 1991, FEBS LETT, V284, P211, DOI 10.1016/0014-5793(91)80687-X; YMER S, 1990, EMBO J, V9, P3261, DOI 10.1002/j.1460-2075.1990.tb07525.x; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x	40	219	221	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1991	7	4					667	676		10.1016/0896-6273(91)90379-E	http://dx.doi.org/10.1016/0896-6273(91)90379-E			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1657058				2022-12-28	WOS:A1991GM95400015
J	RANSCHT, B; DOURSZIMMERMANN, MT				RANSCHT, B; DOURSZIMMERMANN, MT			T-CADHERIN, A NOVEL CADHERIN CELL-ADHESION MOLECULE IN THE NERVOUS-SYSTEM LACKS THE CONSERVED CYTOPLASMIC REGION	NEURON			English	Article							UVOMORULIN-CATENIN COMPLEX; IMMUNOGLOBULIN SUPERFAMILY; GLYCOSYL-PHOSPHATIDYLINOSITOL; NEURITE OUTGROWTH; RETINAL AXONS; GENE FAMILY; N-CADHERIN; BETA-ACTIN; MEMBER; SEQUENCE	We have characterized T-cadherin, a glycoprotein of 95 kd from chick embryo brain by expression cloning and sequencing of corresponding cDNAs. The nucleotide sequence predicts a novel cadherin cell adhesion molecule in the nervous system. Surprisingly, the isolated cDNAs do not encode the cytoplasmic region conserved in other cadherin subclasses. Biochemical analysis revealed that this truncated (T) cadherin is attached to the neuronal plasma membrane through a glycosyl phosphatidylinositol anchor. T-cadherin is a component of different neuronal populations and is expressed in a temporally and spatially restricted pattern during axon growth. These results are consistant with a putative role of T-cadherin in axon growth and guidance.			RANSCHT, B (corresponding author), LA JOLLA CANC RES FDN,LA JOLLA,CA 92037, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NICHD NIH HHS [HD25938] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DAVIES JA, 1990, NEURON, V2, P11; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DOHERTY P, 1991, NEURON, V6, P247, DOI 10.1016/0896-6273(91)90360-C; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GALLIN WJ, 1987, P NATL ACAD SCI USA, V84, P2802; Geiger B, 1989, CURR OPIN CELL BIOL, V1, P103, DOI 10.1016/S0955-0674(89)80045-6; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HATTA K, 1988, J CELL BIOL, V106, P873, DOI 10.1083/jcb.106.3.873; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; KEMLER R, 1989, BIOESSAYS, V11, P88, DOI 10.1002/bies.950110403; KOST TA, 1983, NUCLEIC ACIDS RES, V11, P8287, DOI 10.1093/nar/11.23.8287; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; LOW MG, 1987, BIOCHEM J, V244, P1; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MOSS DJ, 1989, J CELL SCI, V93, P85; MOSS DJ, 1983, EUR J BIOCHEM, V135, P291, DOI 10.1111/j.1432-1033.1983.tb07651.x; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; NOSE A, 1987, EMBO J, V6, P3655, DOI 10.1002/j.1460-2075.1987.tb02698.x; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; RANSCHT B, 1991, DEVELOPMENT, V111, P15; RANSCHT B, 1984, J CELL BIOL, V99, P1803, DOI 10.1083/jcb.99.5.1803; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; RINGWALD M, 1987, EMBO J, V6, P3647, DOI 10.1002/j.1460-2075.1987.tb02697.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUH R, 1986, P NATL ACAD SCI USA, V83, P1364, DOI 10.1073/pnas.83.5.1364; SEEGER MA, 1988, CELL, V55, P589, DOI 10.1016/0092-8674(88)90217-6; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; TAGUCHI R, 1980, BIOCHIM BIOPHYS ACTA, V619, P48; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VESTWEBER D, 1984, CELL DIFFER DEV, V15, P269, DOI 10.1016/0045-6039(84)90084-8; VOLK T, 1990, DEV BIOL, V139, P314, DOI 10.1016/0012-1606(90)90301-X; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; WHEELOCK MJ, 1987, J CELL BIOCHEM, V34, P187, DOI 10.1002/jcb.240340305; YOUNG RA, 1985, GENETIC ENG PRINCIPL, V7, P29	61	273	292	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1991	7	3					391	402		10.1016/0896-6273(91)90291-7	http://dx.doi.org/10.1016/0896-6273(91)90291-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1654948	Bronze			2022-12-28	WOS:A1991GG88700004
J	PORTEUS, MH; BULFONE, A; CIARANELLO, RD; RUBENSTEIN, JLR				PORTEUS, MH; BULFONE, A; CIARANELLO, RD; RUBENSTEIN, JLR			ISOLATION AND CHARACTERIZATION OF A NOVEL CDNA CLONE ENCODING A HOMEODOMAIN THAT IS DEVELOPMENTALLY REGULATED IN THE VENTRAL FOREBRAIN	NEURON			English	Article							LIMB DEVELOPMENT; DROSOPHILA EMBRYOS; BASAL GANGLIA; RAT-BRAIN; GENE; EXPRESSION; SPECIFICATION; SEGMENTATION; MURINE; EMBRYOGENESIS	A complementary DNA, Tes-1, of a novel homeodomain protein has been cloned, and its pattern of expression has been characterized. It is a structural homolog of Distal-less, a homeodomain-encoding gene in D. melanogaster. Its expression is developmentally regulated and is limited to structures in the head. Within the central nervous system of the midgestation mouse embryo, it is expressed exclusively in the ventral forebrain. It is likely that Tes-1 plays a regulatory role in the development of this complex neural structure.	STANFORD UNIV, MED CTR,SCH MED,DEPT PSYCHIAT & BEHAV SCI, NANCY PRITZKER DEV & MOLEC NEUROBIOL LAB, STANFORD, CA 94305 USA	Stanford University								BASTIAN H, 1990, EMBO J, V9, P1839, DOI 10.1002/j.1460-2075.1990.tb08309.x; Battey, 1986, BASIC METHODS MOL BI; BERGQUIST H, 1954, J COMP NEUROL, V100, P627, DOI 10.1002/cne.901000308; BRONCKERS ALJJ, 1988, CELL TISSUE RES, V252, P631, DOI 10.1007/BF00216651; COHEN SM, 1989, EMBO J, V8, P2045, DOI 10.1002/j.1460-2075.1989.tb03613.x; COHEN SM, 1990, NATURE, V343, P173, DOI 10.1038/343173a0; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GOLDMANRAKIC PS, 1990, TRENDS NEUROSCI, V13, P241, DOI 10.1016/0166-2236(90)90103-H; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HAYASHI S, 1990, CELL, V63, P883, DOI 10.1016/0092-8674(90)90492-W; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; JOHNS MA, 1986, ANN NY ACAD SCI, V474, P148, DOI 10.1111/j.1749-6632.1986.tb28007.x; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; Junqueira L.C., 1986, BASIC HISTOLOGY, V5th ed.; KESSEL M, 1990, CELL, V61, P301, DOI 10.1016/0092-8674(90)90810-2; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LENOIR D, 1986, J NEUROSCI, V6, P522; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MACKENZIE A, 1991, DEVELOPMENT, V111, P269; MALICKI J, 1990, CELL, V63, P961, DOI 10.1016/0092-8674(90)90499-5; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; PARENT A, 1990, TRENDS NEUROSCI, V13, P254, DOI 10.1016/0166-2236(90)90105-J; PLACZEK M, 1990, SCIENCE, V250, P985, DOI 10.1126/science.2237443; PORTEUS MH, IN PRESS MOL BRAIN R; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RUGH R, 1990, MOUSE ITS REPRODUCTI; SADLER TW, 1985, LANGMANS MED EMBRYOL; Sambrook J, 1989, MOL CLONING LABORATO; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SUNKEL CE, 1987, ROUX ARCH DEV BIOL, V196, P124, DOI 10.1007/BF00402034; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; ZOELLER RT, 1989, PEPTIDES, V10, P415	39	208	214	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1991	7	2					221	229		10.1016/0896-6273(91)90260-7	http://dx.doi.org/10.1016/0896-6273(91)90260-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1678612				2022-12-28	WOS:A1991GB93300005
J	FU, WM; POO, MM				FU, WM; POO, MM			ATP POTENTIATES SPONTANEOUS TRANSMITTER RELEASE AT DEVELOPING NEUROMUSCULAR SYNAPSES	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; TORPEDO ELECTRIC ORGAN; MUSCLE-CELLS; EMBRYONIC NEURONS; SKELETAL-MUSCLE; CHICK MYOTUBES; PROTEIN-KINASE; GROWTH CONES; CALCIUM; TRIPHOSPHATE	Extracellular application of ATP, a substance co-stored and co-released with acetylcholine in peripheral nervous systems, potentiates the spontaneous secretion of acetylcholine at developing neuromuscular synapses in Xenopus cell culture, as shown by a marked increase in the frequency of spontaneous synaptic currents recorded in the postsynaptic muscle cell. The effect of ATP is apparently mediated by the activation of cytosolic protein kinases and requires the influx of Ca2+ through the plasma membrane. Since spontaneous acetylcholine release is known to regulate the development of contractile properties of the postsynaptic muscle cell, extracellular ATP may serve as a positive trophic factor at developing neuromuscular synapses.	COLUMBIA UNIV, DEPT BIOL SCI, NEW YORK, NY 10027 USA	Columbia University				FU, WEN-MEI/0000-0003-4157-8987	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 22764] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BOYD IA, 1968, J PHYSIOL-LONDON, V199, P115, DOI 10.1113/jphysiol.1968.sp008642; BURNSTOCK G, 1987, ENCY NEUROSCIENCE, V2, P1015; CHOW I, 1985, J NEUROSCI, V5, P1076; COCKCROFT S, 1989, FEBS LETT, V245, P25, DOI 10.1016/0014-5793(89)80184-X; DECKER ER, 1990, J NEUROSCI, V10, P3413; DOWDALL JJ, 1974, BIOCHEM, V140, P1; ECKKERT R, 1983, PHYSL EXCITABLE CELL; EVERS J, 1989, J NEUROSCI, V9, P1523; FRANK E, 1987, TRENDS NEUROSCI, V10, P188, DOI 10.1016/0166-2236(87)90143-3; GURNEY ME, 1984, NATURE, V307, P546, DOI 10.1038/307546a0; HAGGBLAD J, 1987, NEUROSCI LETT, V74, P199, DOI 10.1016/0304-3940(87)90149-2; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEILBRONN E, 1989, NEUROMUSCULAR JUNCTI, P395; HENDERSON CE, 1981, P NATL ACAD SCI-BIOL, V78, P2625, DOI 10.1073/pnas.78.4.2625; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; HUME RI, 1986, J NEUROSCI, V6, P681; KIDOKORO Y, 1988, P NATL ACAD SCI USA, V85, P1978, DOI 10.1073/pnas.85.6.1978; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; LAUFER R, 1987, EMBO J, V6, P901, DOI 10.1002/j.1460-2075.1987.tb04836.x; MEUNIER FM, 1975, NATURE, V257, P407, DOI 10.1038/257407a0; MULLE C, 1988, P NATL ACAD SCI USA, V85, P5728, DOI 10.1073/pnas.85.15.5728; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; OPPENHEIM RW, 1988, CIBA F S, V138, P143; PENG HB, 1984, J CELL BIOL, V98, P550, DOI 10.1083/jcb.98.2.550; PURVES D, 1986, TRENDS NEUROSCI, V9, P486, DOI 10.1016/0166-2236(86)90155-4; RIBEIRO JA, 1975, BRIT J PHARMACOL, V54, P213, DOI 10.1111/j.1476-5381.1975.tb06931.x; SALMONS S, 1976, NATURE, V263, P30, DOI 10.1038/263030a0; SANES DH, 1989, NEURON, V2, P1237, DOI 10.1016/0896-6273(89)90308-5; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SILINSKY EM, 1983, NATURE, V305, P327, DOI 10.1038/305327a0; SILINSKY EM, 1973, NATURE, V243, P404, DOI 10.1038/243404a0; Smith D.O., 1986, P357; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; TABTI N, 1990, PROGR BRAIN RES, V84, P63; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; USDIN TB, 1986, J CELL BIOL, V103, P493, DOI 10.1083/jcb.103.2.493; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; ZIMMERMANN H, 1978, NEUROSCIENCE, V3, P827, DOI 10.1016/0306-4522(78)90035-0	44	70	72	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1991	6	5					837	843		10.1016/0896-6273(91)90179-4	http://dx.doi.org/10.1016/0896-6273(91)90179-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	2025429				2022-12-28	WOS:A1991FM52200015
J	HARDIE, RC; VOSS, D; PONGS, O; LAUGHLIN, SB				HARDIE, RC; VOSS, D; PONGS, O; LAUGHLIN, SB			NOVEL POTASSIUM CHANNELS ENCODED BY THE SHAKER LOCUS IN DROSOPHILA PHOTORECEPTORS	NEURON			English	Article							VOLTAGE-CLAMP ANALYSIS; XENOPUS OOCYTES; ACTION-POTENTIALS; SODIUM-CHANNEL; PATCH-CLAMP; K-CHANNELS; GENE; MUSCLE; CDNA; CURRENTS	The Shaker gene, responsible for A-type potassium channels in Drosophila muscle, encodes a large family of transcripts capable of generating a variety of kinetically distinct A channels when expressed in oocytes. We describe a distinct class of A channel encoded by the Shaker gene in a novel preparation of dissociated Drosophila photoreceptors. Whole-cell recordings reveal a rapidly inactivating A current that is absent in Shaker mutants and that can be readily isolated in cell-attached patches. Although very similar to their muscle counterparts, the photoreceptor A channels show a striking 40-50 mV negative shift in their voltage-operating range. Two mutations (Sh(E62) T(1;Y)W32), which exclude only certain classes of Shaker transcripts, were used to show that photoreceptor A channels are encoded by multiple transcripts distinct from those encoding muscle A channels, while PCR techniques identified four transcripts (ShA1, ShA2, ShG1, and ShG2) in mRNA from dissected retina.	RUHR UNIV BOCHUM,LEHRSTUHL BIOCHEM,W-4630 BOCHUM,GERMANY	Ruhr University Bochum	HARDIE, RC (corresponding author), UNIV CAMBRIDGE,DEPT ZOOL,CAMBRIDGE CB2 3EJ,ENGLAND.			Hardie, Roger/0000-0001-5531-3264; Laughlin, Simon/0000-0003-4659-6543				ATKINS PT, 1990, NATURE, V344, P240; BAKER K, 1990, NEURON, V4, P129, DOI 10.1016/0896-6273(90)90449-P; BAUMANN A, 1987, EMBO J, V6, P3419, DOI 10.1002/j.1460-2075.1987.tb02665.x; BAUMANN A, 1989, NATO ASI SER, V32, P231; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; FERRUS A, 1990, GENETICS, V125, P383; GAUTAM M, 1990, NEURON, V5, P67, DOI 10.1016/0896-6273(90)90034-D; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HAUGLAND FN, 1990, J NEUROSCI, V10, P1357; Hille B, 1984, IONIC CHANNELS EXCIT; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; IVERSON LE, 1990, J NEUROSCI, V10, P2903; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; LICHTINGHAGEN R, 1990, EMBO J, V9, P4399, DOI 10.1002/j.1460-2075.1990.tb07890.x; Maniatis T., 1982, MOL CLONING; MCKINNON R, 1990, SCIENCE, V250, P276; MULLER R, 1990, THESIS RUHR U BOCHUM; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PEROZO E, 1989, J GEN PHYSIOL, V93, P1195, DOI 10.1085/jgp.93.6.1195; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Sakmann B, 1983, SINGLE CHANNEL RECOR, P37; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; SALKOFF L, 1983, COLD SPRING HARB SYM, V48, P221, DOI 10.1101/SQB.1983.048.01.025; SALKOFF LB, 1983, J PHYSIOL-LONDON, V337, P687, DOI 10.1113/jphysiol.1983.sp014649; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SCHWARZ TL, 1990, NEURON, V4, P119, DOI 10.1016/0896-6273(90)90448-O; SOLC CK, 1988, J NEUROSCI, V8, P2256; STOCKER M, 1990, P NATL ACAD SCI USA, V87, P8903, DOI 10.1073/pnas.87.22.8903; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANOUYE MA, 1985, J NEUROGENET, V2, P253, DOI 10.3109/01677068509102322; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TIMPE LC, 1987, J NEUROSCI, V7, P1307; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TSACOPOULOS M, 1988, P NATL ACAD SCI USA, V85, P8727, DOI 10.1073/pnas.85.22.8727; WU CF, 1985, J NEUROSCI, V5, P2626; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, J NEUROSCI, V10, P1799; ZAGOTTA WN, 1989, NEURON, V3, P773, DOI 10.1016/0896-6273(89)90246-8; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; ZAGOTTA WN, 1988, J NEUROSCI, V8, P4765	55	73	74	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					477	486		10.1016/0896-6273(91)90255-X	http://dx.doi.org/10.1016/0896-6273(91)90255-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	2001287				2022-12-28	WOS:A1991FC47000015
J	LIU, YC; CHAPMAN, ER; STORM, DR				LIU, YC; CHAPMAN, ER; STORM, DR			TARGETING OF NEUROMODULIN (GAP-43) FUSION PROTEINS TO GROWTH CONES IN CULTURED RAT EMBRYONIC NEURONS	NEURON			English	Article							CALMODULIN-BINDING-PROTEIN; AXONALLY TRANSPORTED PROTEINS; AMINO-ACID SEQUENCE; NERVE GROWTH; KINASE-C; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; P-57; LOCALIZATION; MEMBRANES	Neuromodulin (GAP-43) is a membrane protein that is transported to neuronal growth cones. Zuber and co-workers have proposed that the N-terminal 10 amino acid sequence of neuromodulin is sufficient to target proteins to growth cones. We demonstrate that a neuromodulin-beta-galactosidase fusion protein is transported to growth cones of cultured rat neurons, whereas a fusion protein containing the N-terminal 10 amino acids of neuromodulin and beta-galactosidase is not. A mutant neuromodulin lacking cysteines 3 and 4, the palmitylation sites required for membrane attachment, does not target beta-galactosidase to growth cones. We conclude that membrane attachment is required for growth cone accumulation and that structural elements, in addition to the first 10 amino acids of neuromodulin, may be required for growth cone targeting.			LIU, YC (corresponding author), UNIV WASHINGTON,SCH MED,DEPT PHARMACOL,SEATTLE,WA 98195, USA.			Chapman, Edwin/0000-0001-9787-8140	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033708, T32GM007270] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-07270, GM 33708] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKERS RF, 1987, J NEUROSCI, V7, P3976; ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; ALEXANDER KA, 1988, J BIOL CHEM, V263, P7544; ANDREASEN TJ, 1983, BIOCHEMISTRY-US, V22, P4615, DOI 10.1021/bi00289a001; BAIZER L, 1990, MOL BRAIN RES, V7, P61, DOI 10.1016/0169-328X(90)90074-N; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BASI GS, 1987, CELL, V49, P785, DOI 10.1016/0092-8674(87)90616-7; BENOWITZ LI, 1983, J NEUROSCI, V3, P2153; BLACK MM, 1980, J CELL BIOL, V86, P616, DOI 10.1083/jcb.86.2.616; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; CACERES A, 1986, J NEUROSCI, V6, P714; CASADABAN MJ, 1983, METHOD ENZYMOL, V100, P293; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CIMLER BM, 1985, J BIOL CHEM, V260, P784; CIMLER BM, 1987, J BIOL CHEM, V262, P12158; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DEKKER LV, 1989, NATURE, V342, P74, DOI 10.1038/342074a0; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; GOSLIN K, 1990, J NEUROSCI, V10, P588; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HAMMERSCHLAG R, 1982, J CELL BIOL, V93, P568, DOI 10.1083/jcb.93.3.568; KOENIG E, 1985, J NEUROSCI, V5, P715; KOSIK KS, 1988, NEURON, V1, P127, DOI 10.1016/0896-6273(88)90196-1; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LABATE ME, 1989, NEURON, V3, P299, DOI 10.1016/0896-6273(89)90254-7; LIU YC, 1990, TRENDS PHARMACOL SCI, V11, P107; MASURE HR, 1986, BIOCHEMISTRY-US, V25, P7553, DOI 10.1021/bi00371a044; MEIRI KF, 1988, J NEUROSCI, V8, P2571; NG SC, 1988, NEURON, V1, P133, DOI 10.1016/0896-6273(88)90197-3; PARDEE AB, 1959, J MOL BIOL, V1, P165, DOI 10.1016/S0022-2836(59)80045-0; PERRY GW, 1990, J NEUROSCI, V10, P3439; PICARD D, 1987, EMBO J, V6, P333; ROSENTHAL A, 1987, EMBO J, V6, P3641, DOI 10.1002/j.1460-2075.1987.tb02696.x; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SKENE JHP, 1986, SCIENCE, V233, P783, DOI 10.1126/science.3738509; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; SKENE JHP, 1981, J CELL BIOL, V89, P96, DOI 10.1083/jcb.89.1.96; STONE GC, 1987, AXONAL TRANSPORT, P15; VANHOOFF COM, 1989, J CELL BIOL, V108, P1115, DOI 10.1083/jcb.108.3.1115; WAKIM BT, 1987, BIOCHEMISTRY-US, V26, P7466, DOI 10.1021/bi00397a040; WILLARD M, 1974, P NATL ACAD SCI USA, V71, P2183, DOI 10.1073/pnas.71.6.2183; ZUBER MX, 1989, NATURE, V341, P345, DOI 10.1038/341345a0	46	67	67	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					411	420		10.1016/0896-6273(91)90249-Y	http://dx.doi.org/10.1016/0896-6273(91)90249-Y			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1825782				2022-12-28	WOS:A1991FC47000009
J	SHYNG, SL; XU, R; SALPETER, MM				SHYNG, SL; XU, R; SALPETER, MM			CYCLIC-AMP STABILIZES THE DEGRADATION OF ORIGINAL JUNCTIONAL ACETYLCHOLINE-RECEPTORS IN DENERVATED MUSCLE	NEURON			English	Article							MESSENGER-RNA LEVELS; SKELETAL-MUSCLE; NEUROMUSCULAR-JUNCTIONS; IMMUNOLOGICAL EVIDENCE; ALPHA-SUBUNIT; GAMMA-SUBUNIT; BRAIN EXTRACT; RAT MUSCLE; CELLS; PHOSPHORYLATION	We used mouse diaphragm muscle in organ culture to study the stabilization of aceytlcholine receptor (AChR) degradation at denervated neuromuscular junctions. After denervation, the degradation rate of the AChRs present prior to denervation (slowly degrading, or R(s), AChRs) accelerates from the predenervation degradation half-life (t1/2) of approximately 8-10 days to a t1/2 of approximately 2-3 days. We report that addition to the organ culture medium of pharmacological agents that elevate cytoplasmic cAMP levels (forskolin, dibutryl cAMP, and 8-bromo-cAMP reversed the change in t1/2 caused by denervation, whereas addition of 1,9-dideoxyforskolin, a forskolin analog that does not elevate cytoplasmic cAMP levels, did not reverse the effect of denervation. The degradation rate of AChRs in primary myotube cultures and that of the newly synthesized AChRs in denervated muscle were little affected by forskolin or dibutyryl cAMP. The possibility is raised that the modulation of R(s) AChR degradation by innervation may be mediated by cAMP.	CORNELL UNIV,DIV BIOL SCI,NEUROBIOL & BEHAV SECT,ITHACA,NY 14853	Cornell University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009315] Funding Source: NIH RePORTER; NINDS NIH HHS [NS09315] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AVILA OL, 1989, J NEUROSCI, V9, P2902; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; BETZ H, 1979, NATURE, V278, P749, DOI 10.1038/278749a0; BEVAN S, 1983, J PHYSIOL-LONDON, V336, P159, DOI 10.1113/jphysiol.1983.sp014574; BLOSSER JC, 1980, J BIOL CHEM, V253, P3088; BREHM P, 1988, DEV BIOL, V129, P1, DOI 10.1016/0012-1606(88)90156-X; BRENNER HR, 1989, J PHYSIOL-LONDON, V410, P501, DOI 10.1113/jphysiol.1989.sp017546; BRENNER HR, 1990, NATURE, V344, P544, DOI 10.1038/344544a0; BRETT RS, 1982, BRAIN RES, V233, P133, DOI 10.1016/0006-8993(82)90935-0; COHEN MW, 1990, J PHYSIOL-LONDON, V426, P281, DOI 10.1113/jphysiol.1990.sp018138; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; FISCHBACH GD, 1980, J PHYSIOL-LONDON, V303, P125, DOI 10.1113/jphysiol.1980.sp013275; FONTAINE B, 1987, J CELL BIOL, V105, P1337, DOI 10.1083/jcb.105.3.1337; FUMAGALLI G, 1990, NEURON, V4, P563, DOI 10.1016/0896-6273(90)90114-U; GOLDMAN D, 1988, NEURON, V1, P329, DOI 10.1016/0896-6273(88)90081-5; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; GUU Y, 1990, NEURON, V5, P147; HENDERSON LP, 1987, J GEN PHYSIOL, V89, P999, DOI 10.1085/jgp.89.6.999; HSIE AW, 1975, J BIOL CHEM, V250, P984; HUGANIR RL, 1986, NATURE, V321, P774, DOI 10.1038/321774a0; HUGANIR RL, 1989, CRIT REV BIOCHEM MOL, V24, P183, DOI 10.3109/10409238909082553; KAUKEL E, 1972, BIOCHEM BIOPH RES CO, V46, P1011, DOI 10.1016/S0006-291X(72)80242-0; KNAACK D, 1985, P NATL ACAD SCI USA, V82, P575, DOI 10.1073/pnas.82.2.575; LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442, DOI 10.1016/S0165-6147(89)80008-2; LEVITT TA, 1981, NATURE, V291, P239, DOI 10.1038/291239a0; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MONTAGUE W, 1971, BIOCHEM J, V122, P115, DOI 10.1042/bj1220115; REINESS CG, 1981, DEV BIOL, V84, P247, DOI 10.1016/0012-1606(81)90392-4; ROSS AF, 1987, J BIOL CHEM, V262, P14640; ROTZLER S, 1990, J CELL BIOL, V111, P655, DOI 10.1083/jcb.111.2.655; SAKMANN B, 1978, NATURE, V276, P401, DOI 10.1038/276401a0; SALPETER MM, 1982, J CELL BIOL, V93, P417, DOI 10.1083/jcb.93.2.417; SALPETER MM, 1986, J CELL BIOL, V103, P1399, DOI 10.1083/jcb.103.4.1399; SALPETER MM, 1985, PROG NEUROBIOL, V25, P297, DOI 10.1016/0301-0082(85)90018-8; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; SHYNG SL, 1990, J NEUROSCI, V10, P3905, DOI 10.1523/JNEUROSCI.10-12-03905.1990; STANLEY EF, 1981, EXP NEUROL, V73, P390, DOI 10.1016/0014-4886(81)90274-0; STEINBACH JH, 1979, P NATL ACAD SCI USA, V76, P3547, DOI 10.1073/pnas.76.7.3547; WETZEL DM, 1991, IN PRESS MUSCLE NERV; WITZEMANN V, 1987, FEBS LETT, V223, P104, DOI 10.1016/0014-5793(87)80518-5	40	48	49	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					469	475		10.1016/0896-6273(91)90254-W	http://dx.doi.org/10.1016/0896-6273(91)90254-W			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1848083				2022-12-28	WOS:A1991FC47000014
J	BARRES, BA; KOROSHETZ, WJ; CHUN, LLY; COREY, DP				BARRES, BA; KOROSHETZ, WJ; CHUN, LLY; COREY, DP			ION CHANNEL EXPRESSION BY WHITE MATTER GLIA - THE TYPE-1 ASTROCYTE	NEURON			English	Article									HOWARD HUGHES MED INST, NEUROSCI GRP, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, DEPT NEUROL, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, DEPT NEUROSURG, BOSTON, MA 02114 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	BARRES, BA (corresponding author), HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA.			Corey, David/0000-0003-4497-6016	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021269, F32NS007970, R01NS022059] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-22059, NS-21269, F32 NS-07970] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aidley D. J., 1971, PHYSL EXCITABLE CELL; BAKER M, 1987, J PHYSIOL-LONDON, V383, P45; BALLANYI K, 1987, J PHYSIOL-LONDON, V382, P159, DOI 10.1113/jphysiol.1987.sp016361; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BARRES BA, 1989, NEURON, V2, P1375, DOI 10.1016/0896-6273(89)90076-7; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; BARRES BA, 1989, J NEUROSCI, V9, P3169; BARRES BA, 1988, GLIA, V1, P10, DOI 10.1002/glia.440010104; BARRES BA, 1990, NEUROLOGY NEUROBIOLO, P213; BARTLETT PF, 1981, BRAIN RES, V204, P339, DOI 10.1016/0006-8993(81)90593-X; BEVAN S, 1985, NATURE, V315, P229, DOI 10.1038/315229a0; BEVAN S, 1985, PROC R SOC SER B-BIO, V225, P299, DOI 10.1098/rspb.1985.0063; BREW H, 1986, NATURE, V324, P466, DOI 10.1038/324466a0; Bunge R. P., 1984, PERIPHERAL NEUROPATH, P378; BUTT AM, 1989, GLIA, V2, P470, DOI 10.1002/glia.440020609; CASSAB GI, 1987, J CELL BIOL, V105, P2581, DOI 10.1083/jcb.105.6.2581; CHIU SY, 1984, NATURE, V311, P156, DOI 10.1038/311156a0; CHIU SY, 1987, J PHYSIOL-LONDON, V386, P181, DOI 10.1113/jphysiol.1987.sp016529; COLES JA, 1989, GLIA, V2, P287, DOI 10.1002/glia.440020502; Corey D.P., 1983, SINGLE CHANNEL RECOR, P53; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CULLCANDY SG, 1988, J PHYSIOL-LONDON, V400, P189, DOI 10.1113/jphysiol.1988.sp017117; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; ENG DL, 1990, J PHYSIOL-LONDON, V421, P185, DOI 10.1113/jphysiol.1990.sp017940; FFRENCHCONSTANT C, 1986, NATURE, V323, P335, DOI 10.1038/323335a0; FOSTER RE, 1982, DEV BRAIN RES, V3, P371, DOI 10.1016/0165-3806(82)90005-0; GRAY PTA, 1986, PROC R SOC SER B-BIO, V228, P267, DOI 10.1098/rspb.1986.0055; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; JACK JJB, 1975, ELECTRIC CURRENT FLO; KARWOSKI CJ, 1989, SCIENCE, V244, P578, DOI 10.1126/science.2785716; KUFFLER SW, 1967, PROC R SOC SER B-BIO, V168, P1, DOI 10.1098/rspb.1967.0047; KUFFLER SW, 1966, J NEUROPHYSIOL, V29, P768; LILLIEN LE, 1990, NEURON, V4, P525, DOI 10.1016/0896-6273(90)90110-2; LIM R, 1973, EXP CELL RES, V79, P243, DOI 10.1016/0014-4827(73)90512-0; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; MILLER RH, 1989, ANNU REV NEUROSCI, V12, P517, DOI 10.1146/annurev.ne.12.030189.002505; MILLER RH, 1984, J NEUROSCI, V4, P585; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; MILLER RH, 1989, EUR J NEUROSCI, V1, P172, DOI 10.1111/j.1460-9568.1989.tb00785.x; NEWMAN EA, 1986, ANN NY ACAD SCI, V481, P273, DOI 10.1111/j.1749-6632.1986.tb27158.x; NEWMAN EA, 1984, NATURE, V309, P155, DOI 10.1038/309155a0; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; PELLEGRINO RG, 1984, PROC R SOC SER B-BIO, V222, P155, DOI 10.1098/rspb.1984.0056; PERRY VH, 1983, J COMP NEUROL, V219, P356, DOI 10.1002/cne.902190309; Peters A., 1976, FINE STRUCTURE NERVO; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1984, DEV BIOL, V106, P53, DOI 10.1016/0012-1606(84)90060-5; RAFF MC, 1983, J NEUROSCI, V3, P1289; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAFF MC, 1979, BRAIN RES, V174, P283, DOI 10.1016/0006-8993(79)90851-5; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; RANSOM BR, 1985, J NEUROSCI, V5, P532; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; SESHI B, 1986, ANAL BIOCHEM, V157, P331, DOI 10.1016/0003-2697(86)90634-2; SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973; SHUMAN S, 1988, J NEUROCHEM, V50, P190, DOI 10.1111/j.1471-4159.1988.tb13248.x; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; SOBUE G, 1986, BRAIN RES, V362, P23, DOI 10.1016/0006-8993(86)91394-6; SONTHEIMER H, 1988, GLIA, V1, P328, DOI 10.1002/glia.440010505; SUAREZ I, 1989, J NEUROCYTOL, V18, P577, DOI 10.1007/BF01187078; TANG CM, 1979, J GEN PHYSIOL, V74, P629, DOI 10.1085/jgp.74.5.629; TRACHTENBERG M C, 1970, Science (Washington D C), V167, P1248, DOI 10.1126/science.167.3922.1248; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; WILSON GF, 1990, J NEUROSCI, V10, P1615; WU DK, 1983, J CYCLIC NUCL PROT, V9, P59	71	254	258	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1990	5	4					527	544		10.1016/0896-6273(90)90091-S	http://dx.doi.org/10.1016/0896-6273(90)90091-S			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED517	1698397				2022-12-28	WOS:A1990ED51700015
J	BOURGOUIN, C; LUNDGREN, SE; THOMAS, JB				BOURGOUIN, C; LUNDGREN, SE; THOMAS, JB			APTEROUS IS A DROSOPHILA LIM DOMAIN GENE REQUIRED FOR THE DEVELOPMENT OF A SUBSET OF EMBRYONIC MUSCLES	NEURON			English	Article							MEDIATED ENHANCER DETECTION; HOMEOBOX-CONTAINING GENE; CAENORHABDITIS-ELEGANS; NEURONAL DEVELOPMENT; NERVOUS-SYSTEM; MEC-3 GENE; EXPRESSION; SEQUENCE; PROTEIN; EMBRYOGENESIS	The recently discovered LIM motif is found in a set of homeodomain-containing proteins thought to mediate the generation of particular cell types. Of the four LIM domain family members described to date, mec-3 and lin-11 determine cell lineages in C. elegans. Isl-1 and Xlim-1 may play similar roles in vertebrates. We have identified a Drosophila member of this class, the product of the apterous (ap) gene. During embryogenesis, ap is expressed in a small subset of fusing mesodermal precursors that give rise to 6 muscles in each abdominal hemisegment and in 5 neurons within each corresponding CNS hemisegment. Lack of ap function results in loss of ap-expressing muscles, while misexpression of ap using a heterologous promoter produces ectopic muscles.	SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,SAN DIEGO,CA 92138	Salk Institute			Bourgouin, Catherine/F-1253-2014	Bourgouin, Catherine/0000-0002-9209-845X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040613] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40613] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BATE CM, 1976, J EMBRYOL EXP MORPH, V35, P107; BATE M, 1990, DEVELOPMENT, V110, P791; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BODMER R, 1990, DEVELOPMENT, V110, P661; BODMER R, 1987, WILHELM ROUXS ARCH D, V96, P69; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; BOULAY JL, 1987, NATURE, V330, P395, DOI 10.1038/330395a0; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; BUTTERWORTH FM, 1965, GENETICS, V52, P1153; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Crossley AC, 1978, GENETICS BIOL DROS B, V2, P499; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DOHRMANN C, 1990, GENE DEV, V4, P2098, DOI 10.1101/gad.4.12a.2098; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; GHYSEN A, 1986, ROUX ARCH DEV BIOL, V195, P281, DOI 10.1007/BF00376060; HAN KH, 1989, CELL, V56, P573, DOI 10.1016/0092-8674(89)90580-1; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; JACOBS JR, 1989, NEURON, V2, P1625; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KILCHHERR F, 1986, NATURE, V321, P493, DOI 10.1038/321493a0; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; LI PM, 1991, P NATL ACAD SCI USA, V88, P9210, DOI 10.1073/pnas.88.20.9210; Lindsley D.L., 1968, GENETIC VARIATIONS D; LIS JT, 1983, CELL, V35, P403, DOI 10.1016/0092-8674(83)90173-3; Maniatis T., 1982, MOL CLONING; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; MICHELSON AM, 1990, GENE DEV, V4, P2086, DOI 10.1101/gad.4.12a.2086; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PATEL NH, 1992, NATURE, V357, P339, DOI 10.1038/357339a0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pirrotta V, 1988, VECTORS SURVEY MOL C, P437; Roberts D. B, 1986, DROSOPHILA PRACTICAL; ROBERTSON HM, 1988, GENETICS, V118, P461; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; VIGOREAUX JO, 1987, GENE DEV, V1, P1161, DOI 10.1101/gad.1.10.1161; WAY JC, 1991, GENE DEV, V5, P2199, DOI 10.1101/gad.5.12a.2199; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	57	222	225	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					549	561		10.1016/0896-6273(92)90192-G	http://dx.doi.org/10.1016/0896-6273(92)90192-G			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1524829				2022-12-28	WOS:A1992JM57100016
J	FARBER, DB; DANCIGER, JS; AGUIRRE, G				FARBER, DB; DANCIGER, JS; AGUIRRE, G			THE BETA-SUBUNIT OF CYCLIC-GMP PHOSPHODIESTERASE MESSENGER-RNA IS DEFICIENT IN CANINE ROD CONE DYSPLASIA-1	NEURON			English	Article							RD-MOUSE; RETINAL DEGENERATION; IRISH SETTERS; ALPHA-SUBUNIT; RHODOPSIN PHOSPHORYLATION; CGMP-PHOSPHODIESTERASE; PHOTORECEPTOR CELLS; SEQUENCE-ANALYSIS; G-PROTEIN; TRANSDUCIN	Irish setter dogs affected with rod-cone dysplasia 1 have elevated levels of retinal cGMP resulting from deficient rod-specific cGMP phosphodiesterase (cGMP PDE) activity. We investigated the mRNAs coding for the three subunits of cGMP PDE and for the proteins involved in the activation/deactivation of this enzyme in the retinas of developing affected and control dogs. While the photoreceptor cells are viable in the diseased retinas, opsin, transducin alpha-1 and beta-1, 48 and 33 kd proteins, and cGMP PDE-alpha and gamma-mRNAs have normal transcript sizes and levels. In contrast, a different pattern of cGMP PDE-beta mRNAs with lower than normal concentrations is present in the developing affected retinas prior to degeneration. Our observations suggest that an abnormality involving cGMP PDE-beta expression is implicated in rod-cone dysplasia 1.	UNIV CALIF LOS ANGELES,SCH MED,DEPT OPHTHALMOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH VET MED,MED GENET SECT,LOS ANGELES,CA 90024; UNIV PENN,SCH MED,SCHEIE EYE INST,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT OPHTHALMOL,PHILADELPHIA,PA 19104	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	FARBER, DB (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,JULES STEIN EYE INST,LOS ANGELES,CA 90024, USA.			Farber, Debora/0000-0002-3207-697X	NATIONAL EYE INSTITUTE [R01EY008285, R01EY001244, R01EY006855, U01EY006855] Funding Source: NIH RePORTER; NEI NIH HHS [EY-06855, EY08285, EY01244] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABE T, 1990, GENE, V91, P209, DOI 10.1016/0378-1119(90)90090-E; ACLAND GM, 1989, EXP EYE RES, V49, P983, DOI 10.1016/S0014-4835(89)80021-1; AGUIRRE G, 1982, EXP EYE RES, V35, P625, DOI 10.1016/S0014-4835(82)80075-4; AGUIRRE G, 1978, SCIENCE, V201, P1133, DOI 10.1126/science.210508; AGUIRRE G, 1976, T AM ACAD OPHTHALMOL, V81, P667; BARBEHENN E, 1988, EXP EYE RES, V46, P149, DOI 10.1016/S0014-4835(88)80073-3; BOWES C, 1987, EXP EYE RES, V45, P467, DOI 10.1016/S0014-4835(87)80058-1; BOWES C, 1989, P NATL ACAD SCI USA, V86, P9722, DOI 10.1073/pnas.86.24.9722; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DANCIGER M, 1990, EXP EYE RES, V51, P185, DOI 10.1016/0014-4835(90)90071-2; DANCIGER M, 1990, INVEST OPHTH VIS SCI, V31, P1427; FARBER DB, 1976, J CYCLIC NUCL PROT, V2, P139; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; FARBER DB, 1987, DEGENERATIVE RETINAL, P53; FARBER DB, 1986, RETINA MODEL CELL 1, P239; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; LOCHRIE MA, 1985, SCIENCE, V228, P96, DOI 10.1126/science.3856323; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; PARRY HB, 1953, BRIT J OPHTHALMOL, V37, P487, DOI 10.1136/bjo.37.8.487; ROSEN KM, 1990, BIOTECHNIQUES, V8, P398; SCHMIDT SY, 1985, INVEST OPHTH VIS SCI, V26, P679; SCHMIDT SY, 1986, INVEST OPHTH VIS SCI, V27, P1551; SHUSTER TA, 1986, INVEST OPHTH VIS SCI, V27, P264; TAKEMOTO DJ, 1986, BIOCHEM BIOPH RES CO, V135, P1022, DOI 10.1016/0006-291X(86)91030-2; TANABE T, 1985, NATURE, V315, P242, DOI 10.1038/315242a0; TUTEJA N, 1988, FEBS LETT, V232, P182, DOI 10.1016/0014-5793(88)80413-7; WISTOW GJ, 1986, FEBS LETT, V196, P23, DOI 10.1016/0014-5793(86)80207-1	30	80	80	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1992	9	2					349	356		10.1016/0896-6273(92)90173-B	http://dx.doi.org/10.1016/0896-6273(92)90173-B			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ332	1323314				2022-12-28	WOS:A1992JJ33200016
J	MALENKA, RC; LANCASTER, B; ZUCKER, RS				MALENKA, RC; LANCASTER, B; ZUCKER, RS			TEMPORAL LIMITS ON THE RISE IN POSTSYNAPTIC CALCIUM REQUIRED FOR THE INDUCTION OF LONG-TERM POTENTIATION	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; EXCITATORY AMINO-ACIDS; HIPPOCAMPAL-NEURONS; SYNAPTIC TRANSMISSION; DIVALENT-CATIONS; BLOCKS INDUCTION; RAT HIPPOCAMPUS; DENSITY PROTEIN; CA-2+; ACTIVATION	The induction of long-term potentiation (LTP) in hippocampal CA1 pyramidal cells requires a rise in postsynaptic intracellular Ca2+ concentration ([Ca2+]i). To determine the time for which Ca2+ must remain elevated to induce LTP, the photolabile Ca2+ buffer diazo-4 was used to limit the duration of the rise in postsynaptic [Ca2+]i following a tetanus. The affinity of diazo-4 for Ca2+ increases approximately 1600-fold upon flash photolysis, permitting almost instantaneous buffering of [Ca2+]i without disturbing resting [Ca2+]i prior to the flash. Photolysis of diazo-4 1 s following the start of the tetanus blocked LTP, while delaying photolysis for more than 2 s had no discernible effect on LTP. Photolyzing diazo-4 at intermediate delays (1.5-2 s) or reducing photolysis of diazo-4 often resulted in short-term potentiation (STP). These results indicate that a tetanus-induced rise in post-synaptic [Ca2+]i lasting at most 2-2.5 s is sufficient to generate LTP. Smaller increases or shorter duration rises in [Ca2+]i may result in STP.	UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	MALENKA, RC (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT PSYCHIAT, SAN FRANCISCO, CA 94143 USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343	NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH045334, K02MH000942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015114] Funding Source: NIH RePORTER; NIMH NIH HHS [MH00942, MH45334] Funding Source: Medline; NINDS NIH HHS [NS15114] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS SR, 1989, J AM CHEM SOC, V111, P7957, DOI 10.1021/ja00202a042; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; ANWYL R, 1989, BRAIN RES, V503, P148, DOI 10.1016/0006-8993(89)91716-2; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; COLEMAN PA, 1989, J NEUROPHYSIOL, V61, P218, DOI 10.1152/jn.1989.61.1.218; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; GUSTAFSSON B, 1988, TRENDS NEUROSCI, V11, P156, DOI 10.1016/0166-2236(88)90142-7; HARVEY J, 1992, IN PRESS NEUROSCI LE; HOLMES WR, 1990, J NEUROPHYSIOL, V63, P1148, DOI 10.1152/jn.1990.63.5.1148; IZUMI Y, 1987, NEUROSCI LETT, V77, P176, DOI 10.1016/0304-3940(87)90582-9; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALENKA RC, 1990, SEMIN NEUROSCI, V2, P335; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MILLERHANCE WC, 1988, J BIOL CHEM, V263, P13979; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; OBENAUS A, 1989, NEUROSCI LETT, V98, P172, DOI 10.1016/0304-3940(89)90505-3; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; TAYLOR DA, 1989, J BIOL CHEM, V264, P6207; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; ZADOR A, 1990, P NATL ACAD SCI USA, V87, P6718, DOI 10.1073/pnas.87.17.6718	34	190	192	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1992	9	1					121	128		10.1016/0896-6273(92)90227-5	http://dx.doi.org/10.1016/0896-6273(92)90227-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE756	1632966				2022-12-28	WOS:A1992JE75600013
J	FINKBEINER, S				FINKBEINER, S			CALCIUM WAVES IN ASTROCYTES FILLING IN THE GAPS	NEURON			English	Article							INTERCELLULAR COMMUNICATION; CELLS; PROPAGATION; ACTIVATION; FERTILIZATION; ANESTHETICS; RECEPTORS; JUNCTIONS; MYOCYTES; CULTURES	Stimulus-evoked cellular responses are sometimes organized in the form of propagating waves of cytoplasmic Ca2+ increase. Ca2+ waves can be elicited in cultured astrocytes by the neurotransmitter glutamate; however, the propagation mechanism is unknown. Here, qualitative and quantitative features of propagation suggest that astrocytic Ca2+ waves are mediated by an intracellular signal that crosses intercellular junctions. The role of gap junctions in cell-cell Ca2+ wave propagation was specifically tested. Functional gap junctions were demonstrated using a noninvasive fluorescence recovery method and the gap junction blockers halothane and octanol. Gap junction closure prevented intracellular waves from propagating between cells without affecting the velocity of the intracellular wave itself. The pivotal role played by the gap junction creates the potential for dynamic changes in glial connectivity and long-range glial signaling.			FINKBEINER, S (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEUROBIOL SECT,NEW HAVEN,CT 06511, USA.				NIGMS NIH HHS [2 T32 GM07205-16] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERS JJ, 1988, GLIA, V1, P371, DOI 10.1002/glia.440010604; BACKX PH, 1989, J GEN PHYSIOL, V93, P963, DOI 10.1085/jgp.93.5.963; Berg H.C., 2018, RANDOM WALKS BIOL, P5, DOI [10.1515/9781400820023-004, DOI 10.1515/9781400820023-004]; BERRIDGE MJ, 1991, CELL CALCIUM, V12, P63, DOI 10.1016/0143-4160(91)90009-4; Bevan S., 1990, SEMIN NEUROSCI, V2, P467; BREHM P, 1989, NEURON, V3, P191, DOI 10.1016/0896-6273(89)90032-9; BROOKER G, 1990, P NATL ACAD SCI USA, V87, P2813, DOI 10.1073/pnas.87.7.2813; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CORNELLBELL AH, 1991, CELL CALCIUM, V12, P185, DOI 10.1016/0143-4160(91)90020-F; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DUNLAP K, 1987, NATURE, V325, P60, DOI 10.1038/325060a0; FORSCHER P, 1987, J NEUROSCI, V7, P3600; GILKEY JC, 1978, J CELL BIOL, V76, P448, DOI 10.1083/jcb.76.2.448; GIUAME C, 1991, P NATL ACAD SCI USA, V88, P5577; HAROOTUNIAN AT, 1991, CELL CALCIUM, V12, P153, DOI 10.1016/0143-4160(91)90017-9; ISHIDE N, 1990, AM J PHYSIOL, V259, pH940, DOI 10.1152/ajpheart.1990.259.3.H940; JACOB R, 1990, CELL CALCIUM, V11, P241, DOI 10.1016/0143-4160(90)90075-6; JAFFE LF, 1991, P NATL ACAD SCI USA, V88, P9883, DOI 10.1073/pnas.88.21.9883; JOHNSTON MF, 1980, NATURE, V286, P498, DOI 10.1038/286498a0; KATSUOKA M, 1989, ANESTHESIOLOGY, V70, P954, DOI 10.1097/00000542-198906000-00012; KETTENMANN H, 1988, GLIA, V1, P64, DOI 10.1002/glia.440010108; KETTENMANN H, 1983, J NEUROSCI, V3, P506; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; MASSA PT, 1985, NEUROSCIENCE, V14, P695, DOI 10.1016/0306-4522(85)90320-3; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; MIRONOV SL, 1990, J THEOR BIOL, V146, P87, DOI 10.1016/S0022-5193(05)80045-1; MIYAZAKI S, 1986, DEV BIOL, V118, P259, DOI 10.1016/0012-1606(86)90093-X; MURPHY S, 1987, NEUROSCIENCE, V22, P381, DOI 10.1016/0306-4522(87)90342-3; NIJOUT HF, 1990, P R SOC LOND B, V239, P81; ROONEY TA, 1990, J BIOL CHEM, V265, P10792; ROONEY TA, 1991, PHARMACOL THERAPEUT, V49, P223, DOI 10.1016/0163-7258(91)90056-R; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SANDERSON MJ, 1990, CELL REGUL, V1, P585, DOI 10.1091/mbc.1.8.585; SANDERSON MJ, 1988, AM J PHYSIOL, V254, pC63, DOI 10.1152/ajpcell.1988.254.1.C63; SPEKSNIJDER JE, 1990, J CELL BIOL, V110, P1589, DOI 10.1083/jcb.110.5.1589; Spray, 1985, GAP JUNCTIONS, P167; STAGG RB, 1990, ENDOCR REV, V11, P302, DOI 10.1210/edrv-11-2-302; SWANN K, 1986, J CELL BIOL, V103, P2333, DOI 10.1083/jcb.103.6.2333; TAKAMATSU T, 1990, FASEB J, V4, P1519, DOI 10.1096/fasebj.4.5.2307330; WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495; WHEELER DM, 1988, ANESTHESIOLOGY, V69, P578, DOI 10.1097/00000542-198810000-00019; WINFREE AT, 1980, GEOMETRY BIOL TIME, P300	43	270	275	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1101	1108		10.1016/0896-6273(92)90131-V	http://dx.doi.org/10.1016/0896-6273(92)90131-V			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1351732				2022-12-28	WOS:A1992JA42900010
J	REIST, NE; WERLE, MJ; MCMAHAN, UJ				REIST, NE; WERLE, MJ; MCMAHAN, UJ			AGRIN RELEASED BY MOTOR NEURONS INDUCES THE AGGREGATION OF ACETYLCHOLINE-RECEPTORS AT NEUROMUSCULAR-JUNCTIONS	NEURON			English	Article							NEWLY FORMED SYNAPSES; SYNAPTIC SITES; REGENERATING MUSCLE; BASAL LAMINA; MOLECULES; CLUSTERS; NERVE; ACCUMULATION; CULTURES; MYOTUBES	To test the hypothesis that agrin mediates motor neuron-induced aggregation of acetylcholine receptors (AChRs) in skeletal muscle fibers and to determine whether the agrin active in this process is released by motor neurons, we raised polyclonal antibodies to purified ray agrin that blocked its receptor aggregating activity. When the antibodies were applied to chick motor neuron-chick myotube cocultures, they inhibited the formation of AChR aggregates at and near neuromuscular contacts, demonstrating that agrin plays a role in the induction of the aggregates. Rat motor neurons, like chick motor neurons, induce AChR aggregates on chick myotubes. This effect was not inhibited by our antibodies, indicating that, although the antibodies inhibited the activity of chick agrin, they did not have a similar effect on rat agrin. We conclude that agrin released by rat motor neurons induced the chick myotubes to aggregate AChRs.	STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305	Stanford University				Reist, Noreen/0000-0002-1647-3166				BURDEN SJ, 1979, J CELL BIOL, V82, P412, DOI 10.1083/jcb.82.2.412; DELAPORTE S, 1986, DEV BIOL, V116, P69, DOI 10.1016/0012-1606(86)90044-8; DOHRMANN U, 1986, DEV BIOL, V118, P209, DOI 10.1016/0012-1606(86)90089-8; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FISCHBACH GD, 1972, DEV BIOL, V28, P407, DOI 10.1016/0012-1606(72)90023-1; FRANK E, 1979, J CELL BIOL, V83, P143, DOI 10.1083/jcb.83.1.143; MAGILLSOLC C, 1990, J EXP BIOL, V153, P1; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MCMAHAN UJ, 1984, J CELL BIOL, V98, P1453, DOI 10.1083/jcb.98.4.1453; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V50, P407; MILES K, 1987, P NATL ACAD SCI USA, V84, P6591, DOI 10.1073/pnas.84.18.6591; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; REIST NE, 1990, THESIS STANFORD U ST; ROLE LW, 1985, J NEUROSCI, V5, P2197; RUBIN LL, 1985, P NATL ACAD SCI USA, V82, P7121, DOI 10.1073/pnas.82.20.7121; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SCHNAAR RL, 1981, J NEUROSCI, V1, P204; SYTKOWSKI AJ, 1973, P NATL ACAD SCI USA, V70, P270, DOI 10.1073/pnas.70.1.270; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V	23	211	217	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1992	8	5					865	868		10.1016/0896-6273(92)90200-W	http://dx.doi.org/10.1016/0896-6273(92)90200-W			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV467	1316763				2022-12-28	WOS:A1992HV46700005
J	ASSAD, JA; SHEPHERD, GMG; COREY, DP				ASSAD, JA; SHEPHERD, GMG; COREY, DP			TIP-LINK INTEGRITY AND MECHANICAL TRANSDUCTION IN VERTEBRATE HAIR-CELLS	NEURON			English	Article							MECHANOELECTRICAL TRANSDUCTION; GUINEA-PIG; STEREOCILIA; ADAPTATION; BUNDLE; SELECTIVITY; DEPENDENCE; CHANNELS; STIMULATION; MEMBRANE	An attractive hypothesis for hair-cell transduction is that fine, filamentous "tip links" pull directly on mechanically sensitive ion channels located dt the tips of the stereocilia. We tested the involvement of tip links in the transduction process by treating bundles with a BAPTA-buffered, low-Ca2+ saline (10(-9) M). BAPTA abolished the transduction current in a few hundred milliseconds. BAPTA treatment for a few seconds eliminated the tip links observed by either scanning or transmission electron microscopy. BAPTA also eliminated the voltage-dependent movement and caused a positive bundle displacement of 133 nm, in quantitative agreement with a model for regulation of tension. We conclude that tip links convey tension to the transduction channels of hair cells.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114; HOWARD HUGHES MED INST,NEUROSCI GRP,COCONUT GROVE,FL 33133	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute			Shepherd, Gordon/F-2679-2010	Corey, David/0000-0003-4497-6016	NIDCD NIH HHS [DC-00304] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000304] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1992, IN PRESS J NEUROSCI; BAGGERSJOBACK D, 1973, J NEUROCYTOL, V2, P329, DOI 10.1007/BF01104034; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; COREY DP, 1980, J NEUROSCI METH, V3, P183, DOI 10.1016/0165-0270(80)90025-4; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; EATOCK RA, 1987, J NEUROSCI, V7, P2821; FORGE A, 1988, J NEUROCYTOL, V17, P325, DOI 10.1007/BF01187855; HACOHEN N, 1989, J NEUROSCI, V9, P3988; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; HOLTON T, 1986, J PHYSIOL-LONDON, V375, P195, DOI 10.1113/jphysiol.1986.sp016113; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; Kimura R S, 1966, Acta Otolaryngol, V61, P55, DOI 10.3109/00016486609127043; OHMORI H, 1988, J PHYSIOL-LONDON, V399, P115; OSBORNE MP, 1990, ACTA OTO-LARYNGOL, V110, P37, DOI 10.3109/00016489009122513; PICKLES JO, 1987, HEARING RES, V25, P173, DOI 10.1016/0378-5955(87)90089-X; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; PICKLES JO, 1990, HEARING RES, V50, P139, DOI 10.1016/0378-5955(90)90040-V; PICKLES JO, 1989, HEARING RES, V41, P31, DOI 10.1016/0378-5955(89)90176-7; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; SAND O, 1975, J COMP PHYSIOL, V102, P27, DOI 10.1007/BF00657483; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018	32	380	387	0	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1991	7	6					985	994		10.1016/0896-6273(91)90343-X	http://dx.doi.org/10.1016/0896-6273(91)90343-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY438	1764247				2022-12-28	WOS:A1991GY43800011
J	STANLEY, EF				STANLEY, EF			SINGLE CALCIUM CHANNELS ON A CHOLINERGIC PRESYNAPTIC NERVE-TERMINAL	NEURON			English	Article							CHICK SENSORY NEURONS; CILIARY GANGLION; SYMPATHETIC NEURONS; PERIPHERAL NEURONS; VERTEBRATE CELLS; OMEGA-CONOTOXIN; EVOKED RELEASE; SUBSTANCE-P; CA-CHANNEL; CURRENTS	The calyx-type synapse of the chick ciliary ganglion Was used to examine single calcium channels in a vertebrate cholinergic presynaptic nerve terminal by means of the cell-attached, patch-clamp technique. Calcium channels were recorded on the internal, transmitter-release face of the nerve terminal, but were not detected on the external face. These channels were recruited at -30 mV, with maximum activation at about +30 mV, and were sometimes clustered at high densities. Single-channel conductance estimates with voltage-pulse or -ramp techniques gave values of 11-14 pS with 110 mM barium, which is in the intermediate, N-type range for calcium channels on a control neuron. This nerve terminal calcium channel, termed the N(PT)-type, may link action potentials to transmitter release at many vertebrate fast-transmitting synapses.			STANLEY, EF (corresponding author), NINCDS,BIOPHYS LAB,BETHESDA,MD 20892, USA.							AOSAKI T, 1989, PFLUG ARCH EUR J PHY, V414, P150, DOI 10.1007/BF00580957; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; COHEN MW, 1991, J NEUROSCI, V11, P1032; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.ne.13.030190.002005; HEUSER JE, 1974, J NEUROCYTOL, V3, P109, DOI 10.1007/BF01111936; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; HOLZ GG, 1988, J NEUROSCI, V8, P463; KASAI H, 1987, Neuroscience Research, V4, P228, DOI 10.1016/0168-0102(87)90014-9; KERR LM, 1984, NATURE, V308, P282, DOI 10.1038/308282a0; LEMOS JR, 1989, NEURON, V2, P1419, DOI 10.1016/0896-6273(89)90187-6; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; LOUDES C, 1988, BRAIN RES, V456, P324, DOI 10.1016/0006-8993(88)90235-1; MAGRASSI L, 1987, J NEUROSCI, V7, P1207; MARTIN AR, 1989, NEUROSCI LETT, V105, P14, DOI 10.1016/0304-3940(89)90004-9; MCCLESKEY EW, 1987, P NATL ACAD SCI USA, V84, P4327, DOI 10.1073/pnas.84.12.4327; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; NEHER I, 1983, SINGLE CHANNEL RECOR, P37; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; PERNEY TM, 1986, P NATL ACAD SCI USA, V83, P6656, DOI 10.1073/pnas.83.17.6656; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; RANE SG, 1987, PFLUG ARCH EUR J PHY, V409, P361, DOI 10.1007/BF00583789; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; STANLEY EF, 1987, BRAIN RES, V421, P367, DOI 10.1016/0006-8993(87)91309-6; STANLEY EF, 1991, J NEUROSCI, V11, P985; STANLEY EF, 1989, BRAIN RES, V505, P341, DOI 10.1016/0006-8993(89)91465-0; STANLEY EF, 1990, P NATL ACAD SCI USA, V87, P9683, DOI 10.1073/pnas.87.24.9683; SUSZKIW JB, 1989, J NEUROCHEM, V52, P1260, DOI 10.1111/j.1471-4159.1989.tb01874.x; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; YOSHIKAMI D, 1989, ANN NY ACAD SCI, V560, P230, DOI 10.1111/j.1749-6632.1989.tb24100.x	35	84	84	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	OCT	1991	7	4					585	591		10.1016/0896-6273(91)90371-6	http://dx.doi.org/10.1016/0896-6273(91)90371-6			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1657055				2022-12-28	WOS:A1991GM95400007
J	NAKATA, T; IWAMOTO, A; NODA, Y; TAKEMURA, R; YOSHIKURA, H; HIROKAWA, N				NAKATA, T; IWAMOTO, A; NODA, Y; TAKEMURA, R; YOSHIKURA, H; HIROKAWA, N			PREDOMINANT AND DEVELOPMENTALLY REGULATED EXPRESSION OF DYNAMIN IN NEURONS	NEURON			English	Article							MECHANOCHEMICAL ENZYME; INFLUENZA-VIRUS; PROTEINS; RAT; LOCALIZATION; MICROTUBULES; CORTEX; MOTOR; GENE	We have cloned a cDNA for dynamin, a 100 kd microtubule-associated motor protein whose 5' region contains a GTP-binding motif homologous to that of the Mx proteins, from a rat brain library and analyzed its expression. Dynamin mRNA is 3.6 kb and is preferentially expressed in the brain after postnatal day 7, parallel to the developmental increase of the protein. In situ hybridization revealed high levels of dynamin transcripts in neural cells in the cerebellar cortex, hippocampus (particularly in the CA3 area), and cerebral cortex. The transcripts appeared in cerebellar granular cells only after they had ceased dividing and had migrated to the inner granular layer. We show that dynamin is expressed predominantly in neural cells after elongation of their processes, suggesting a role especially in mature neurons.	UNIV TOKYO,SCH MED,DEPT BACTERIOL,TOKYO 113,JAPAN; OKINAKA MEM INST MED SCI,TOKYO,JAPAN	University of Tokyo	NAKATA, T (corresponding author), UNIV TOKYO,SCH MED,DEPT ANAT & CELL BIOL,7-3-1 HONGO,TOKYO 113,JAPAN.							ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B; BALTIMORE D, 1988, NATURE, V335, P395, DOI 10.1038/335395a0; BLOOM GS, 1984, J CELL BIOL, V98, P320, DOI 10.1083/jcb.98.1.320; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HAMMERSCHLAG R, 1988, BASIC NEUROCHEMISTRY, P457; HIROKAWA N, 1991, NEURONAL CYTOSKELETO, P5; HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; LEGENDRE N, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P49; LINDENMANN J, 1962, VIROLOGY, V16, P203, DOI 10.1016/0042-6822(62)90297-0; Maniatis T., 1982, MOL CLONING; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; Minkwitz H G, 1976, J Hirnforsch, V17, P213; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; RICHTERLANDSBERG C, 1986, J CELL BIOL, V102, P821, DOI 10.1083/jcb.102.3.821; RITCHIE AK, 1979, J PHYSIOL-LONDON, V286, P541, DOI 10.1113/jphysiol.1979.sp012636; ROTHMAN JH, 1990, CELL, V61, P1063, DOI 10.1016/0092-8674(90)90070-U; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATOYOSHITAKE R, 1989, NEURON, V3, P229, DOI 10.1016/0896-6273(89)90036-6; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Staeheli P, 1987, Interferon, V8, P1; TAKEMURA R, 1991, IN PRESS NEUROSCIENC; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; VALE RD, 1990, CELL, V60, P883, DOI 10.1016/0092-8674(90)90334-B; VALLEE RB, 1990, ANNU REV BIOCHEM, V59, P909, DOI 10.1146/annurev.biochem.59.1.909; WISE SP, 1979, NEUROSCIENCE, V4, P1275, DOI 10.1016/0306-4522(79)90157-X; WOODHAMS PL, 1989, J NEUROSCI, V9, P2170; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2	30	86	86	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1991	7	3					461	469		10.1016/0896-6273(91)90298-E	http://dx.doi.org/10.1016/0896-6273(91)90298-E			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1832879	Bronze			2022-12-28	WOS:A1991GG88700011
J	STANFIELD, BB				STANFIELD, BB			THE CORTICOSPINAL TRACT ATTAINS A NORMAL CONFIGURATION IN THE ABSENCE OF MYELIN - OBSERVATIONS IN JIMPY MUTANT MICE	NEURON			English	Article							RAT SPINAL-CORD; NEURITE GROWTH; PYRAMIDAL TRACT; NERVOUS-SYSTEM; CELL-ADHESION; WHITE MATTER; GRAY-MATTER; CNS MYELIN; PROTEIN; INHIBITORS	The corticospinal projection was examined in dysmyelinated, jimpy mice and in unaffected littermates following cortical injections of either wheat germ agglutinin conjugated to horseradish peroxidase or biocytin. Corticospinal axons in both phenotypes traverse the medulla within a well-defined pyramidal tract, decussate within several fascicles at the spinomedullary junction, and extend down the spinal cord in a compact bundle in the ventral-most part of the dorsal funiculus. Very few labeled fibers are seen separated from the main bundle. This normal configuration of the corticospinal tract is attained despite the virtual absence of CNS myelin in jimpy mice. It seems unlikely then that the myelin normally present in fiber bundles adjacent to this relatively late emerging projection can significantly influence pathway selection during its development.			STANFIELD, BB (corresponding author), NIMH,CTR ANM,NEUROPHYSIOL LAB,POOLESVILLE,MD 20837, USA.							[Anonymous], MYELIN; BARTLETT WP, 1986, J NEUROSCI, V6, P2802; Berry M, 1982, Bibl Anat, P1; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; CHIQUET M, 1989, TRENDS NEUROSCI, V12, P1, DOI 10.1016/0166-2236(89)90144-6; CRUTCHER KA, 1989, EXP NEUROL, V104, P39, DOI 10.1016/0014-4886(89)90007-1; DELASSALLE A, 1981, J NEUROSCI RES, V6, P303, DOI 10.1002/jnr.490060305; FARKASBARGETON E, 1972, ACTA NEUROPATHOL, V21, P272, DOI 10.1007/BF00685135; GRIBNAU AAM, 1986, ANAT EMBRYOL, V175, P101, DOI 10.1007/BF00315460; HUDSON LD, 1987, P NATL ACAD SCI USA, V84, P1454, DOI 10.1073/pnas.84.5.1454; JOOSTEN EAJ, 1989, NEUROSCIENCE, V31, P439, DOI 10.1016/0306-4522(89)90386-2; JOOSTEN EAJ, 1990, NEUROSCIENCE, V38, P675, DOI 10.1016/0306-4522(90)90061-8; JOOSTEN EAJ, 1989, ANAT EMBRYOL, V179, P449, DOI 10.1007/BF00319587; KING MA, 1989, BRAIN RES, V497, P361, DOI 10.1016/0006-8993(89)90281-3; KNAPP PE, 1986, J NEUROSCI, V6, P2813; KRAUSRUPPERT R, 1973, J NEUROPATH EXP NEUR, V32, P197, DOI 10.1097/00005072-197304000-00002; MEIER C, 1975, J NEUROL SCI, V26, P517, DOI 10.1016/0022-510X(75)90053-2; MEIER C, 1974, J NEUROPATH EXP NEUR, V33, P343, DOI 10.1097/00005072-197407000-00001; MEIER C, 1974, ACTA NEUROPATHOL, V27, P349, DOI 10.1007/BF00690699; MESULAM MM, 1978, J HISTOCHEM CYTOCHEM, V26, P105; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P9264; PATTERSON PH, 1988, NEURON, V1, P264; PHILLIPS RJS, 1954, Z INDUKT ABSTAMM VER, V86, P322, DOI 10.1007/BF00312228; PIPPENGER MA, 1990, DEV BRAIN RES, V55, P43, DOI 10.1016/0165-3806(90)90104-7; PRIVATA, 1972, ACTA NEUROPATHOL, V21, P282; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; ROSENFELD J, 1984, INT J DEV NEUROSCI, V2, P21, DOI 10.1016/0736-5748(84)90056-X; SAVIO T, 1990, P NATL ACAD SCI USA, V87, P4130, DOI 10.1073/pnas.87.11.4130; SAVIO T, 1989, J NEUROSCI, V9, P1126; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHREYER DJ, 1982, NEUROSCIENCE, V7, P1837, DOI 10.1016/0306-4522(82)90001-X; SCHWAB ME, 1990, TRENDS NEUROSCI, V13, P452, DOI 10.1016/0166-2236(90)90098-U; SCHWAB ME, 1989, J NEUROCYTOL, V18, P161, DOI 10.1007/BF01206659; SCHWAB ME, 1991, J NEUROSCI, V11, P709; SCHWAB ME, 1990, EXP NEUROL, V109, P2, DOI 10.1016/S0014-4886(05)80003-2; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; SCHWAB ME, 1991, DISCUS NEUROSCI, V7, P49; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; SKOFFRP, 1981, BRAIN RES, V212, P175; VALVERDE F, 1966, Z ZELLFORSCH MIK ANA, V71, P297, DOI 10.1007/BF00332585	41	18	18	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					249	256		10.1016/0896-6273(91)90263-Y	http://dx.doi.org/10.1016/0896-6273(91)90263-Y			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1908251				2022-12-28	WOS:A1991GB93300008
J	STRUHL, K				STRUHL, K			MECHANISMS FOR DIVERSITY IN GENE-EXPRESSION PATTERNS	NEURON			English	Review							CENTRAL NERVOUS-SYSTEM; DNA-BINDING PROTEINS; NF-KAPPA-B; TRANSCRIPTIONAL REGULATION; GLUCOCORTICOID RECEPTOR; YEAST; ACTIVATOR; REPRESSOR; SEQUENCE; ASSOCIATION				STRUHL, K (corresponding author), HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115, USA.							BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BENDER A, 1987, CELL, V50, P681, DOI 10.1016/0092-8674(87)90326-6; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; GILMORE TD, 1990, CELL, V62, P841, DOI 10.1016/0092-8674(90)90257-F; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HAI T, 1989, GENE DEV, P2083; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; KARCH F, 1990, GENE DEV, V4, P1573, DOI 10.1101/gad.4.9.1573; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; MCKAY RDG, 1982, P NATL ACAD SCI-BIOL, V79, P6747, DOI 10.1073/pnas.79.21.6747; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; OLESEN JT, 1990, GENE DEV, V4, P1714, DOI 10.1101/gad.4.10.1714; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SCHMID W, 1989, EMBO J, V8, P2257, DOI 10.1002/j.1460-2075.1989.tb08350.x; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; STRUHL K, 1989, ANNU REV BIOCHEM, V58, P1051, DOI 10.1146/annurev.bi.58.070189.005155; SUTCLIFFE JG, 1988, ANNU REV NEUROSCI, V11, P157, DOI 10.1146/annurev.ne.11.030188.001105; TSAI SY, 1989, CELL, V57, P443, DOI 10.1016/0092-8674(89)90919-7; YANYEN HF, 1990, CELL, V62, P105	33	109	109	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					177	181		10.1016/0896-6273(91)90256-Y	http://dx.doi.org/10.1016/0896-6273(91)90256-Y			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1873025				2022-12-28	WOS:A1991GB93300001
J	HALL, AK; LANDIS, SC				HALL, AK; LANDIS, SC			EARLY COMMITMENT OF PRECURSOR CELLS FROM THE RAT SUPERIOR CERVICAL-GANGLION TO NEURONAL OR NONNEURONAL FATES	NEURON			English	Article							NEURAL CREST CELLS; CHICKEN OPTIC TECTUM; NERVOUS-SYSTEM; RECOMBINANT RETROVIRUS; MONOCLONAL-ANTIBODY; LINEAGE ANALYSIS; SYMPATHETIC NEURONS; COMMON PROGENITOR; SCHWANN-CELLS; DIFFERENTIATION	To determine whether postmigratory neural crest cells retain the capacity to give rise to multiple cell types, the conal progeny of embryonic rat superior cervical ganglion (SCG) cells were examined in culture. Double labeling with BrdU and neurofilament antibodies demonstrated that neuron precursors from the E14.5 SCG continued to proliferate for several days in culture. Using the BAG retrovirus to examine the progeny of single cells, we obtained several kinds of distinct clones from SCG cultures after 3 days. At E14.5, during peak neurogenesis in vivo, neuron-containing clones composed of one to seven cells were common. At E17.5, after neurons have been born in vivo, most clones in vitro contained flat cells, primarily reflecting glial cell division. Even in cultures from E13.5 ganglia, mixed clones containing neurons and flat cells were rarely observed. These observations suggest that neuronal and nonneuronal cell precursors are specified during or before early gangliogenesis.			HALL, AK (corresponding author), CASE WESTERN RESERVE UNIV,SCH MED,DEPT NEUROSCI,CLEVELAND,OH 44106, USA.			Hall, Alison/0000-0002-7237-7945	NINDS NIH HHS [NS08457, NS023678] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023678, F32NS008457] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; BRONNERFRASER M, 1989, NEURON, V3, P755, DOI 10.1016/0896-6273(89)90244-4; CHRISTIE GA, 1962, J MORPHOL, V114, P263; COCHARD P, 1978, P NATL ACAD SCI USA, V75, P2986, DOI 10.1073/pnas.75.6.2986; DICICCOBLOOM E, 1990, J CELL BIOL, V110, P2073, DOI 10.1083/jcb.110.6.2073; DICICCOBLOOM E, 1988, P NATL ACAD SCI USA, V85, P4066, DOI 10.1073/pnas.85.11.4066; DUPIN E, 1990, P NATL ACAD SCI USA, V87, P1119, DOI 10.1073/pnas.87.3.1119; ERICKSON CA, 1989, DEV BIOL, V134, P112, DOI 10.1016/0012-1606(89)90082-1; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FIELDS KL, 1985, NEUROSCIENCE, V15, P877, DOI 10.1016/0306-4522(85)90085-5; FRANK E, 1991, IN PRESS DEVELOPMENT; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; GILOH H, 1982, SCIENCE, V217, P1252, DOI 10.1126/science.7112126; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; GRAY GE, 1988, P NATL ACAD SCI USA, V85, P7356, DOI 10.1073/pnas.85.19.7356; HALL AK, 1991, J NEUROSCI, V11, P472; HAWROT E, 1979, METHOD ENZYMOL, V53, P574; HENDRY IA, 1976, J NEUROCYTOL, V5, P351, DOI 10.1007/BF01175120; HENDRY IA, 1977, J NEUROCYTOL, V6, P299, DOI 10.1007/BF01175193; HOUCK DW, 1985, CYTOMETRY, V6, P531, DOI 10.1002/cyto.990060607; JESSEN KR, 1990, DEVELOPMENT, V109, P91; KUMAR S, 1991, IN PRESS J NEUROSCI; Le Douarin N.M., 1982, NEURAL CREST; LEDOUARI.NM, 1974, DEV BIOL, V41, P162, DOI 10.1016/0012-1606(74)90291-7; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; PENG WW, 1982, SCIENCE, V215, P1102, DOI 10.1126/science.7063842; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; ROHRER H, 1987, J NEUROSCI, V7, P3739; ROHRER H, 1986, J NEUROSCI, V6, P2616; ROTHMAN TP, 1980, P NATL ACAD SCI-BIOL, V77, P6221, DOI 10.1073/pnas.77.10.6221; ROTHMAN TP, 1978, DEV BIOL, V65, P322, DOI 10.1016/0012-1606(78)90030-1; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SEIBERBLUM M, 1980, DEV BIOL, V80, P96; SNIDER WD, 1988, J NEUROSCI, V8, P2628; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VAYSSE PJJ, 1990, NEURON, V5, P227, DOI 10.1016/0896-6273(90)90160-H; YAN Q, 1988, J NEUROSCI, V8, P3481	39	40	40	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAY	1991	6	5					741	752		10.1016/0896-6273(91)90171-U	http://dx.doi.org/10.1016/0896-6273(91)90171-U			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM522	2025427				2022-12-28	WOS:A1991FM52200007
J	CANNON, SC; BROWN, RH; COREY, DP				CANNON, SC; BROWN, RH; COREY, DP			A SODIUM-CHANNEL DEFECT IN HYPERKALEMIC PERIODIC PARALYSIS - POTASSIUM-INDUCED FAILURE OF INACTIVATION	NEURON			English	Article							NEURO-BLASTOMA CELLS; SKELETAL-MUSCLE; ADYNAMIA EPISODICA; IDENTIFICATION; EXPRESSION; DYSTROPHY; MYOTONIA; CHLORIDE; AXONS; GENE	Hyperkalemic periodic analysis (HPP) is an autosomal dominant disorder characterized by episodic weakness lasting minutes to days in association with a mild elevation in serum K+. In vitro measurements of whole-cell currents in HPP muscle have demonstrated a persistent, tetrodotoxin-sensitive Na+ current, and we have recently shown by linkage analysis that the Na+ channel alpha-subunit gene may contain the HPP mutation. In this study, we have made patch-clamp recordings from cultured HPP myotubes and found a defect in the normal voltage-dependent inactivation of Na+ channels. Moderate elevation of extracellular K+ favors an aberrant gating mode in a small fraction of the channels that is characterized by persistent reopenings and prolonged dwell times in the open state. The Na+ current, through noninactivating channels, may cause the skeletal muscle weakness in HPP by depolarizing the cell, thereby inactivating normal Na+ channels, which are then unable to generate an action potential. Thus the dominant expression of HPP is manifest by inactivation of the wild-type Na+ channel through the influence of the mutant gene product on membrane voltage.	HARVARD UNIV,SCH MED,BOSTON,MA 02114; CHARLESTOWN NEUROSCI CTR,DAY NEUROMUSCULAR RES LAB,BOSTON,MA 02129; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,PROGRAM NEUROSCI,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	CANNON, SC (corresponding author), MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114, USA.		Cannon, Stephen/V-5343-2019	Cannon, Stephen/0000-0001-8428-3690; Corey, David/0000-0003-4497-6016				ALDRICH RW, 1987, J NEUROSCI, V7, P418; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; CREUTZFELDT O, 1963, ELECTROEN CLIN NEURO, V15, P508, DOI 10.1016/0013-4694(63)90071-3; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; FENWICK EM, 1982, J PHYSL, V359, P431; FILL M, 1990, BIOPHYS J, V57, P471, DOI 10.1016/S0006-3495(90)82563-7; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; FRANKE C, 1990, J PHYSIOL-LONDON, V425, P391, DOI 10.1113/jphysiol.1990.sp018110; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; GAMSTORP I, 1956, ACTA PAEDIATR STOC S, V108, P1; GONOI T, 1986, MOL PHARMACOL, V29, P347; GONOI T, 1985, J NEUROSCI, V5, P2559; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KIRSCH GE, 1989, J GEN PHYSIOL, V93, P67, DOI 10.1085/jgp.93.1.67; LEHMANNHORN F, 1990, MUSCLE NERVE, V13, P528, DOI 10.1002/mus.880130609; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P363, DOI 10.1002/mus.880100414; LEHMANNHORN F, 1983, MUSCLE NERVE, V6, P133; LEV AA, 1987, J BIOL CHEM, V262, P15817; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; OXFORD GS, 1978, J GEN PHYSIOL, V71, P227, DOI 10.1085/jgp.71.3.227; PATLAK J, 1982, J GEN PHYSIOL, V79, P333, DOI 10.1085/jgp.79.3.333; PATLAK J, 1968, J GEN PHYSIOL, V197, P233; PATLAK JB, 1986, J GEN PHYSIOL, V87, P305, DOI 10.1085/jgp.87.2.305; PATLAK JB, 1989, J GEN PHYSIOL, V94, P279, DOI 10.1085/jgp.94.2.279; REUTER H, 1968, J PHYSIOL-LONDON, V197, P233, DOI 10.1113/jphysiol.1968.sp008557; RIORDAN JR, 1989, SCIENCE, V245, P1066; RUDEL R, 1985, TRENDS NEUROSCI, V8, P467, DOI 10.1016/0166-2236(85)90171-7; RUDEL R, 1989, MUSCLE NERVE, V12, P281; SCHEUER T, 1990, SCIENCE, V247, P854, DOI 10.1126/science.2154850; SCHOUKIMAS JJ, 1980, BIOPHYS J, V47, P709; SCHOUMACHER RA, 1987, NATURE, V330, P752, DOI 10.1038/330752a0; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; WEISS RE, 1986, SCIENCE, V233, P361, DOI 10.1126/science.2425432; WELSH MJ, 1986, NATURE, V322, P467, DOI 10.1038/322467a0	38	167	168	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					619	626		10.1016/0896-6273(91)90064-7	http://dx.doi.org/10.1016/0896-6273(91)90064-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	1849724				2022-12-28	WOS:A1991FH80200013
J	MEAKIN, SO; SHOOTER, EM				MEAKIN, SO; SHOOTER, EM			MOLECULAR INVESTIGATIONS ON THE HIGH-AFFINITY NERVE GROWTH-FACTOR RECEPTOR	NEURON			English	Article							PC12 PHEOCHROMOCYTOMA CELLS; HUMAN NGF RECEPTOR; MONOCLONAL-ANTIBODIES; SCHWANN-CELLS; GENE-TRANSFER; TYROSINE PHOSPHORYLATION; SURFACE RECEPTORS; V-SRC; EXPRESSION; DIFFERENTIATION	Nerve growth factor (NGF) receptors have been investigated by means of affinity labeling with I-125-NGF and chemical cross-linking. Two distinct NGF-receptor complexes are detected on PC12 cells; these correspond to 100 kd and 158 kd for the low-affinity (LNGFR) and the high-affinity (HNGFR) receptors, respectively. Interestingly, three different antibodies directed against distinct epitopes on the LNGFR immunoprecipitate the low- but not the high-affinity NGF-receptor complex. Although the identities of the signaling molecules in the HNGFR are unknown, antibodies to the src, ras, raf-1, and yes products fail to immunoprecipitate either receptor complex, suggesting that these molecules are not a part of, or tightly coupled to, either receptor type. Phosphotyrosine residues are found exclusively on the HNGFR complex, suggesting that tyrosine phosphorylation may be one of the initiating events in the NGF-induced signal transduction cascade.			MEAKIN, SO (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305, USA.		Meakin, Susan/K-8823-2013	Meakin, Susan/0000-0003-2469-6615				ALEMA S, 1985, NATURE, V316, P557, DOI 10.1038/316557a0; ALLENDOERFER KL, 1990, P NATL ACAD SCI USA, V87, P187, DOI 10.1073/pnas.87.1.187; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cb.04.110188.002201; BERND P, 1984, J BIOL CHEM, V259, P5509; BOTHWELL MA, 1980, CELL, V21, P857, DOI 10.1016/0092-8674(80)90449-3; BRUCK C, 1986, METHOD ENZYMOL, V121, P587; BUXSER S, 1985, J BIOL CHEM, V260, P1917; CARTERSU C, 1989, J BIOL CHEM, V264, P18654; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; DARLING TL, 1984, METHODS SERUM FREE C, P79; DISTEFANO PS, 1988, J NEUROSCI, V8, P231; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; EVELETH DD, 1988, NEURON, V1, P929, DOI 10.1016/0896-6273(88)90150-X; FABRICANT RN, 1977, P NATL ACAD SCI USA, V74, P565, DOI 10.1073/pnas.74.2.565; FRACKELTON AR, 1983, MOL CELL BIOL, V3, P1343, DOI 10.1128/MCB.3.8.1343; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GREEN SH, 1986, J BIOL CHEM, V261, P5316; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GROB PM, 1985, J BIOL CHEM, V260, P8044; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HALEGOUA S, 1990, IN PRESS CURRENT TOP; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARADA N, 1990, P NATL ACAD SCI USA, V87, P857, DOI 10.1073/pnas.87.3.857; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HEUER JG, 1990, DEV BIOL, V137, P287, DOI 10.1016/0012-1606(90)90255-H; HOSANG M, 1987, EMBO J, V6, P1197, DOI 10.1002/j.1460-2075.1987.tb02354.x; HOSANG M, 1985, J BIOL CHEM, V260, P655; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; KAMPS MP, 1988, ONCOGENE, V2, P305; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KUMAR S, 1990, IN PRESS J NEUROSCI, V7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MARANO N, 1987, J NEUROCHEM, V48, P225, DOI 10.1111/j.1471-4159.1987.tb13151.x; MASSAGUE J, 1981, J BIOL CHEM, V256, P9419; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; PFEIFFER SE, 1972, P NATL ACAD SCI USA, V69, P2885, DOI 10.1073/pnas.69.10.2885; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; SARAGOVI H, 1990, P NATL ACAD SCI USA, V87, P11, DOI 10.1073/pnas.87.1.11; SATOH T, 1988, MOL CELL BIOL, V8, P3546, DOI 10.1128/MCB.8.8.3546; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHATTEMAN GC, 1988, J NEUROSCI, V8, P860; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SHARON M, 1990, P NATL ACAD SCI USA, V87, P4869, DOI 10.1073/pnas.87.12.4869; SHIMUZU A, 1985, NUCLEIC ACIDS RES, V13, P1505, DOI 10.1093/nar/13.5.1505; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SPRANG SR, 1990, TRENDS BIOCHEM SCI, V15, P366, DOI 10.1016/0968-0004(90)90228-4; SUTTER A, 1979, J BIOL CHEM, V254, P5972; SUTTER A, 1979, TRANSMEMBRANE SIGNAL, P659; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VALE RD, 1985, METHOD ENZYMOL, V109, P21; VALE RD, 1985, J NEUROSCI, V5, P2762; WELCHER AA, 1990, IN PRESS P NATL ACAD; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; YAN Q, 1988, J NEUROSCI, V8, P3481; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; ZIMMERMANN A, 1978, J SUPRAMOL STR CELL, V9, P351, DOI 10.1002/jss.400090306	78	136	140	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1991	6	1					153	163		10.1016/0896-6273(91)90130-R	http://dx.doi.org/10.1016/0896-6273(91)90130-R			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU278	1702649				2022-12-28	WOS:A1991EU27800015
J	MORIMOTO, BH; KOSHLAND, DE				MORIMOTO, BH; KOSHLAND, DE			INDUCTION AND EXPRESSION OF LONG-TERM AND SHORT-TERM NEUROSECRETORY POTENTIATION IN A NEURAL CELL-LINE	NEURON			English	Article							PROTEIN-KINASE ACTIVITY; SYNAPTIC TRANSMISSION; DENTATE GYRUS; NMDA RECEPTORS; RELEASE; ANTAGONISTS; BINDING; LTP	In a neural cell line, the secretion of excitatory amino acids in response to a depolarizing stimulus is potentiated by the addition of serotonin. The duration of this potentiation is dependent on the strength of the stimulus. Persistent secretory potentiation induced by a strong stimulus requires the activation of both serotonin and NMDA receptors. Inhibiting the NMDA receptor during serotonin presentation prevented the induction of potentiation. The temporal characteristic of the potentiation is correlated with the elevation of cAMP levels. Serotonin exposure while inhibiting NMDA receptors results in a transient elevation of cAMP levels, whereas coactivation with NMDA and serotonin results in a persistent elevation of cAMP. Thus, it is possible to obtain potentiation of secretion in a single cell either transiently or persistently. The timing of potentiated responses in this system is of the same magnitude as that in similar systems used as models for short-term and long-term memory.			MORIMOTO, BH (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,DIV BIOCHEM & MOLEC BIOL,BERKELEY,CA 94720, USA.				NIDDK NIH HHS [DK09765] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK009765, R01DK009765] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKERS RF, 1986, SCIENCE, V231, P587, DOI 10.1126/science.3003904; BARINAGA M, 1990, SCIENCE, V248, P1603, DOI 10.1126/science.1973002; BLISS TVP, 1986, J PHYSIOL-LONDON, V377, P391, DOI 10.1113/jphysiol.1986.sp016193; BLISS TVP, 1983, J PHYSIOL-LONDON, V334, P475, DOI 10.1113/jphysiol.1983.sp014507; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; CHILDS AM, 1988, EUR J PHARMACOL, V145, P81, DOI 10.1016/0014-2999(88)90352-4; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.neuro.11.1.61; DOLPHIN AC, 1982, NATURE, V297, P496, DOI 10.1038/297496a0; FOSTER AC, 1984, BRAIN RES REV, V7, P103, DOI 10.1016/0165-0173(84)90020-1; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; FRIED RC, 1978, J CELL BIOL, V78, P685, DOI 10.1083/jcb.78.3.685; HEBB DO, 1949, ORG BEHAVIOR; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; Kapp B.S., 1986, LEARN MEMORY, P299; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KOSHLAND DE, 1983, TRENDS NEUROSCI, V6, P133, DOI 10.1016/0166-2236(83)90066-8; LENDAHL U, 1990, TRENDS NEUROSCI, V13, P132, DOI 10.1016/0166-2236(90)90004-T; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; LYNCH MA, 1985, NEUROSCI LETT, V62, P123, DOI 10.1016/0304-3940(85)90295-2; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MCFADDEN PN, 1990, NEURON, V4, P615, DOI 10.1016/0896-6273(90)90119-Z; MCFADDEN PN, 1990, P NATL ACAD SCI USA, V87, P2013; MORIMOTO BH, 1990, P NATL ACAD SCI USA, V87, P3518, DOI 10.1073/pnas.87.9.3518; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; PEROUTKA SJ, 1988, TRENDS NEUROSCI, V11, P496, DOI 10.1016/0166-2236(88)90011-2; SIMAN R, 1987, SYNAPTIC FUNCTION, P519; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; WATKINS JC, 1987, TRENDS NEUROSCI, V10, P265, DOI 10.1016/0166-2236(87)90171-8; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	34	128	131	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1990	5	6					875	880		10.1016/0896-6273(90)90347-I	http://dx.doi.org/10.1016/0896-6273(90)90347-I			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ381	1980069				2022-12-28	WOS:A1990EQ38100015
J	BETTLER, B; BOULTER, J; HERMANSBORGMEYER, I; OSHEAGREENFIELD, A; DENERIS, ES; MOLL, C; BORGMEYER, U; HOLLMANN, M; HEINEMANN, S				BETTLER, B; BOULTER, J; HERMANSBORGMEYER, I; OSHEAGREENFIELD, A; DENERIS, ES; MOLL, C; BORGMEYER, U; HOLLMANN, M; HEINEMANN, S			CLONING OF A NOVEL GLUTAMATE RECEPTOR SUBUNIT, GLUR5 - EXPRESSION IN THE NERVOUS-SYSTEM DURING DEVELOPMENT	NEURON			English	Article									SALK INST BIOL STUDIES,GENE EXPRESS LAB,SAN DIEGO,CA 92138	Salk Institute	BETTLER, B (corresponding author), SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,SAN DIEGO,CA 92138, USA.		bettler, bernhard/AAO-8018-2020; Borgmeyer, Uwe/D-4662-2012	Borgmeyer, Uwe/0000-0003-3727-4083; Bettler, Bernhard/0000-0003-0842-8207	NINDS NIH HHS [NS28709-01, NS11549] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028709, R01NS011549] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AAS P, 1989, EUR J PHARMACOL, V164, P93, DOI 10.1016/0014-2999(89)90235-5; AGRAWAL SG, 1986, BRIT J PHARMACOL, V87, P345, DOI 10.1111/j.1476-5381.1986.tb10823.x; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; FOSTER AC, 1984, BRAIN RES REV, V7, P103, DOI 10.1016/0165-0173(84)90020-1; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; HALL ZW, 1987, TRENDS NEUROSCI, V10, P99, DOI 10.1016/0166-2236(87)90049-X; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KOZAK M, 1983, MICROBIOL REV, V47, P1; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; LOVINGER DM, 1988, NEUROSCI LETT, V94, P314, DOI 10.1016/0304-3940(88)90037-7; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MORONI F, 1986, NEUROSCI LETT, V68, P57, DOI 10.1016/0304-3940(86)90229-6; Niimi K, 1962, TOKUSHIMA J EXP MED, V8, P203; OLNEY JW, 1989, DRUG DEVELOP RES, V17, P299, DOI 10.1002/ddr.430170406; PAPKE RL, 1989, NEURON, V3, P589, DOI 10.1016/0896-6273(89)90269-9; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PURVES D, 1985, PRINCIPLES NEURAL DE; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; RUGH R, 1968, MOUSE ITS REPRODUCTI; SCHOFIELD PR, 1990, TRENDS NEUROSCI, V13, P8, DOI 10.1016/0166-2236(90)90052-C; SHANNON HE, 1989, J PHARMACOL EXP THER, V251, P518; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; STRANGE PG, 1988, BIOCHEM J, V249, P309, DOI 10.1042/bj2490309; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WOO CC, 1987, J COMP NEUROL, V263, P113, DOI 10.1002/cne.902630110; YONEDA Y, 1986, BRAIN RES, V383, P387, DOI 10.1016/0006-8993(86)90046-6	44	558	571	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1990	5	5					583	595		10.1016/0896-6273(90)90213-Y	http://dx.doi.org/10.1016/0896-6273(90)90213-Y			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ868	1977421				2022-12-28	WOS:A1990EJ86800003
J	HUGANIR, RL; GREENGARD, P				HUGANIR, RL; GREENGARD, P			REGULATION OF NEUROTRANSMITTER RECEPTOR DESENSITIZATION BY PROTEIN-PHOSPHORYLATION	NEURON			English	Review									ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021	Rockefeller University	HUGANIR, RL (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,HOWARD HUGHES MED INST,BALTIMORE,MD 21205, USA.							ADAMO S, 1985, FEBS LETT, V190, P161, DOI 10.1016/0014-5793(85)80449-X; ALBUQUERQUE EX, 1986, FEBS LETT, V199, P113, DOI 10.1016/0014-5793(86)81235-2; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; BENOVIC JL, 1987, J BIOL CHEM, V262, P9026; BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cb.04.110188.002201; BENOVIC JL, 1987, J BIOL CHEM, V262, P17251; BENOVIC JL, 1985, J BIOL CHEM, V260, P7094; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BENOVIC JL, 1986, NATURE, V322, P869; BOULTER J, 1990, J BIOL CHEM, V265, P4472; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BOUVIER M, 1987, J BIOL CHEM, V262, P3106; BROWNING MD, 1990, P NATL ACAD SCI USA, V87, P1315, DOI 10.1073/pnas.87.4.1315; CHANGEUX JP, 1984, SCIENCE, V225, P1333; CHEUNG AH, 1989, MOL PHARMACOL, V34, P132; CLAPHAM DE, 1984, J PHYSIOL-LONDON, V347, P255, DOI 10.1113/jphysiol.1984.sp015065; CLARK RB, 1989, MOL PHARMACOL, V36, P343; CLAUDIO T, 1983, P NATL ACAD SCI-BIOL, V80, P1111, DOI 10.1073/pnas.80.4.1111; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; DECAMILLI P, 1990, IN PRESS ANN REV CEL, V6; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; DOWNING JEG, 1987, P NATL ACAD SCI USA, V84, P7739, DOI 10.1073/pnas.84.21.7739; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; EUSEBI F, 1985, J CELL BIOL, V100, P1339, DOI 10.1083/jcb.100.4.1339; GORDON AS, 1977, NATURE, V267, P539, DOI 10.1038/267539a0; GREENGARD P, 1978, SCIENCE, V199, P146, DOI 10.1126/science.22932; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HANLEY MR, 1980, MOL PHARMACOL, V18, P78; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Heinemann S., 1987, P45; HEMMINGS HC, 1989, FASEB J, V3, P1583, DOI 10.1096/fasebj.3.5.2493406; HEUSCHNEIDER G, 1989, P NATL ACAD SCI USA, V86, P2938, DOI 10.1073/pnas.86.8.2938; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; HOSHI T, 1988, SCIENCE, V240, P1652, DOI 10.1126/science.2454506; HUGANIR RL, 1986, NATURE, V321, P774, DOI 10.1038/321774a0; HUGANIR RL, 1983, P NATL ACAD SCI-BIOL, V80, P1130, DOI 10.1073/pnas.80.4.1130; HUGANIR RL, 1987, TRENDS PHARMACOL SCI, V8, P472, DOI 10.1016/0165-6147(87)90041-1; HUGANIR RL, 1984, P NATL ACAD SCI USA, V81, P6963; HUGANIR RL, 1989, CRIT REV BIOCHEM MOL, V24, P182; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KAO PN, 1984, J BIOL CHEM, V259, P1662; KELLEHER DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4316, DOI 10.1073/pnas.81.14.4316; KIRKNESS EF, 1989, BIOCHEM J, V259, P613, DOI 10.1042/bj2590613; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; KUHN H, 1978, BIOCHEMISTRY-US, V17, P4389; Kuhn H, 1984, PROGR RETINAL RES, V3, P123; KWATRA MM, 1986, J BIOL CHEM, V261, P2429; KWATRA MM, 1987, J BIOL CHEM, V262, P16314; KWATRA MM, 1989, BIOCHEMISTRY-US, V28, P4543, DOI 10.1021/bi00437a005; LEEBLUNDBERG LMF, 1987, J BIOL CHEM, V262, P3098; LINDSTROM J, 1987, MOL NEUROBIOL, V1, P281, DOI 10.1007/BF02935740; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; MARGIOTTA JF, 1987, P NATL ACAD SCI USA, V84, P8155, DOI 10.1073/pnas.84.22.8155; MIDDLETON P, 1988, J NEUROSCI, V8, P3405; MIDDLETON P, 1986, P NATL ACAD SCI USA, V83, P4967, DOI 10.1073/pnas.83.13.4967; MILES K, 1989, NEURON, V2, P1517, DOI 10.1016/0896-6273(89)90198-0; MILES K, 1987, P NATL ACAD SCI USA, V84, P6591, DOI 10.1073/pnas.84.18.6591; MILLER C, 1989, NEURON, V2, P1195, DOI 10.1016/0896-6273(89)90304-8; MULLE C, 1988, P NATL ACAD SCI USA, V85, P5728, DOI 10.1073/pnas.85.15.5728; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; PORTER NM, 1990, IN PRESS NEURON; QU ZC, 1990, NEURON, V4, P367, DOI 10.1016/0896-6273(90)90049-L; RICHARDSON RM, 1990, BIOCHEMISTRY-US, V29, P8555, DOI 10.1021/bi00489a008; ROLE LW, 1984, P NATL ACAD SCI-BIOL, V81, P2924, DOI 10.1073/pnas.81.9.2924; ROSENBAUM LC, 1987, BIOCHEMISTRY-US, V26, P8183, DOI 10.1021/bi00399a024; ROSS A, 1988, J CELL BIOL, V107, P1139, DOI 10.1083/jcb.107.3.1139; ROSS AF, 1987, J BIOL CHEM, V262, P14640; SAFRAN A, 1987, J BIOL CHEM, V262, P10506; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SIBLEY DR, 1985, J BIOL CHEM, V260, P3883; SIBLEY DR, 1984, BIOCHEM BIOPH RES CO, V121, P973, DOI 10.1016/0006-291X(84)90772-1; SIBLEY DR, 1984, J BIOL CHEM, V259, P9742; SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192; SIMMONS LK, 1990, NEURON, V4, P393, DOI 10.1016/0896-6273(90)90051-G; SMITH MM, 1987, P NATL ACAD SCI USA, V84, P6601, DOI 10.1073/pnas.84.18.6601; SMITH MM, 1989, J BIOL CHEM, V264, P12813; STADEL JM, 1983, P NATL ACAD SCI-BIOL, V80, P3173, DOI 10.1073/pnas.80.11.3173; STALLCUP WB, 1980, P NATL ACAD SCI-BIOL, V77, P634, DOI 10.1073/pnas.77.1.634; STRADER CD, 1987, CELL, V49, P855, DOI 10.1016/0092-8674(87)90623-4; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; STRASSER RH, 1986, BIOCHEMISTRY-US, V25, P1371, DOI 10.1021/bi00354a027; SWEETNAM PM, 1988, J NEUROCHEM, V51, P1274, DOI 10.1111/j.1471-4159.1988.tb03097.x; TEHRANI MHJ, 1989, SYNAPSE, V4, P126, DOI 10.1002/syn.890040206; TEICHBERG VI, 1977, NATURE, V267, P540, DOI 10.1038/267540a0; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; WAGONER PK, 1988, SCIENCE, V240, P1655, DOI 10.1126/science.2454507; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; YEE GH, 1987, J BIOL CHEM, V262, P16748	98	436	440	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1990	5	5					555	567		10.1016/0896-6273(90)90211-W	http://dx.doi.org/10.1016/0896-6273(90)90211-W			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ868	1699566				2022-12-28	WOS:A1990EJ86800001
J	NAKANISHI, N; SHNEIDER, NA; AXEL, R				NAKANISHI, N; SHNEIDER, NA; AXEL, R			A FAMILY OF GLUTAMATE RECEPTOR GENES - EVIDENCE FOR THE FORMATION OF HETEROMULTIMERIC RECEPTORS WITH DISTINCT CHANNEL PROPERTIES	NEURON			English	Article									COLUMBIA UNIV COLL PHYS & SURG, HOWARD HUGHES MED INST, NEW YORK, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	NAKANISHI, N (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT BIOCHEM & MOLEC BIOPHYS, NEW YORK, NY 10032 USA.		Shneider, Neil/ABF-5751-2020	Shneider, Neil/0000-0002-3223-7366; Axel, Richard/0000-0002-3141-4076	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P227; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CLAUDIO T, 1983, P NATL ACAD SCI-BIOL, V80, P1111, DOI 10.1073/pnas.80.4.1111; CULLCANDY SG, 1989, J PHYSIOL-LONDON, V415, P555, DOI 10.1113/jphysiol.1989.sp017736; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DINGLEDINE R, 1988, CRIT REV NEUROBIOL, V4, P1; GILLILAND GL, 1981, J MOL BIOL, V146, P341, DOI 10.1016/0022-2836(81)90392-2; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; ISHIDA AT, 1985, P NATL ACAD SCI USA, V82, P1837, DOI 10.1073/pnas.82.6.1837; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KAO PN, 1986, J BIOL CHEM, V261, P8085; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MAO B, 1982, J BIOL CHEM, V257, P1131; MASTERS PS, 1981, J BACTERIOL, V147, P805, DOI 10.1128/JB.147.3.805-819.1981; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MAYER ML, 1987, J NEUROSCI, V7, P3230; MAYER ML, 1984, J PHYSIOL-LONDON, V354, P29, DOI 10.1113/jphysiol.1984.sp015360; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; NEWCOMER ME, 1979, J BIOL CHEM, V254, P7529; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; NOHNO T, 1986, MOL GEN GENET, V205, P260, DOI 10.1007/BF00430437; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; NUMA S, 1989, HARVEY LECT, V83, P121; OBERTHUR W, 1986, EMBO J, V5, P1815, DOI 10.1002/j.1460-2075.1986.tb04431.x; OBRIEN RJ, 1986, J NEUROSCI, V6, P3275; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P162, DOI 10.1152/jn.1989.61.1.162; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PUSTELL JM, 1988, NUCLEIC ACIDS RES, V16, P1813, DOI 10.1093/nar/16.5.1813; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; RANDLE JCR, 1988, MOL CELL BIOCHEM, V80, P121; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; VERDOORN TA, 1988, MOL PHARMACOL, V34, P298; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121	53	489	504	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1990	5	5					569	581		10.1016/0896-6273(90)90212-X	http://dx.doi.org/10.1016/0896-6273(90)90212-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ868	1699567	Green Accepted			2022-12-28	WOS:A1990EJ86800002
J	VERDOORN, TA; DRAGUHN, A; YMER, S; SEEBURG, PH; SAKMANN, B				VERDOORN, TA; DRAGUHN, A; YMER, S; SEEBURG, PH; SAKMANN, B			FUNCTIONAL-PROPERTIES OF RECOMBINANT RAT GABA-A RECEPTORS DEPEND UPON SUBUNIT COMPOSITION	NEURON			English	Article									UNIV HEIDELBERG,CTR MOLEC BIOL,MOLEC NEUROENDOCRINOL LAB,W-6900 HEIDELBERG,GERMANY	Ruprecht Karls University Heidelberg	VERDOORN, TA (corresponding author), MAX PLANCK INST MED RES,ZELLPHYSIOL ABT,W-6900 HEIDELBERG 1,GERMANY.							ALLEN CN, 1987, BRAIN RES, V410, P159, DOI 10.1016/S0006-8993(87)80039-2; BERNASCONI CF, 1976, RELAXATION KINETICS, P20; BLAIR LAC, 1988, SCIENCE, V242, P577, DOI 10.1126/science.2845583; BORMANN J, 1983, J PHYSIOL-LONDON, V341, pP9; BORMANN J, 1985, P NATL ACAD SCI USA, V82, P2168, DOI 10.1073/pnas.82.7.2168; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; GRAY R, 1985, J NEUROPHYSIOL, V54, P134, DOI 10.1152/jn.1985.54.1.134; HAMILL OP, 1983, NATURE, V305, P805, DOI 10.1038/305805a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; KHRESTCHATISKY M, 1989, NEURON, V3, P745, DOI 10.1016/0896-6273(89)90243-2; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LEVITAN ES, 1988, NEURON, V1, P773, DOI 10.1016/0896-6273(88)90125-0; LOLAIT SJ, 1989, FEBS LETT, V246, P145, DOI 10.1016/0014-5793(89)80271-6; MACDONALD RL, 1989, J PHYSL, V410, P4796; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MOSS SJ, 1990, IN PRESS EUR J PHARM; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; NIELSEN M, 1980, NATURE, V286, P606, DOI 10.1038/286606a0; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SCHOFIELD PR, 1989, TRENDS PHARMACOL SCI, V10, P476, DOI 10.1016/0165-6147(89)90041-2; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SEQUIER JM, 1988, P NATL ACAD SCI USA, V85, P7815, DOI 10.1073/pnas.85.20.7815; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SIEGHART W, 1980, NATURE, V286, P285, DOI 10.1038/286285a0; SMITH SM, 1989, J MEMBRANE BIOL, V180, P45; STEINBACH JH, 1989, TRENDS NEUROSCI, V12, P3, DOI 10.1016/0166-2236(89)90145-8; WISDEN W, 1988, NEURON, V1, P937, DOI 10.1016/0896-6273(88)90151-1; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x	36	544	559	1	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1990	4	6					919	928		10.1016/0896-6273(90)90145-6	http://dx.doi.org/10.1016/0896-6273(90)90145-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK185	1694446				2022-12-28	WOS:A1990DK18500012
J	LOEB, DM; TSAO, H; COBB, MH; GREENE, LA				LOEB, DM; TSAO, H; COBB, MH; GREENE, LA			NGF AND OTHER GROWTH-FACTORS INDUCE AN ASSOCIATION BETWEEN ERK1 AND THE NGF RECEPTOR, GP-140(PROTOTRK)	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; MYELIN BASIC-PROTEIN; TRK PROTOONCOGENE PRODUCT; SERINE THREONINE KINASE; PDGF BETA-RECEPTOR; NEUROTROPHIC FACTOR; TYROSINE PHOSPHORYLATION; PC12 CELLS; LOW-AFFINITY; STRUCTURAL PROTEINS	As detected by coimmunoprecipitation from PC12 cells, NGF induces rapid association between ERK1 (a growth factor-activated serine/threonine protein kinase) and gp140prototrk NGF receptors. In contrast, no such association is found with the closely related ERK2. Anti-trk immunocomplexes generated from NGF-treated cells also contain protein kinase activity that shares many properties with soluble ERK1. The association of both ERK1 protein and ERK-like kinase activity with gp140prototrk is maximal by 5 min of NGF treatment, persists for approximately 1 hr, and subsequently declines by 18 hr. Treatment with either basic fibroblast growth factor, epidermal growth factor, or orthovanadate also leads to association of FRK1 with gp140prototrk without tyrosine phosphorylation of the latter. The interaction between ERK1 and gp140prototrk may prove relevant to the NGF mechanism.	COLUMBIA UNIV,COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235	Columbia University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	LOEB, DM (corresponding author), COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032, USA.			Cobb, Melanie/0000-0003-0833-5473	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034128, R01DK034128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016036] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 34128] Funding Source: Medline; NIGMS NIH HHS [GM07367] Funding Source: Medline; NINDS NIH HHS [NS16036] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALETTA JM, 1990, TROPHIC FACTORS NERV, P203; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BOULTON TG, 1991, BIOCHEMISTRTY, V302, P78; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; CONTRERAS ML, 1987, J NEUROCHEM, V48, P1466, DOI 10.1111/j.1471-4159.1987.tb05687.x; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GOMEZ N, 1991, NATURE, V353; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1983, J CELL BIOL, V96, P76, DOI 10.1083/jcb.96.1.76; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HALEGOUA S, 1980, CELL, V22, P571, DOI 10.1016/0092-8674(80)90367-0; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAPLAN D, 1991, NATURE, V350, P160; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KRIS RM, 1985, CELL, V40, P619, DOI 10.1016/0092-8674(85)90210-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LANDRETH GE, 1985, J CELL BIOL, V262, P2832; LAZAROVICI P, 1989, J NEUROSCI RES, V23, P1, DOI 10.1002/jnr.490230102; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVI A, 1991, ANNU REV PHARMACOL, V31, P205; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MATSUDA Y, 1986, J NEUROCHEM, V47, P1728, DOI 10.1111/j.1471-4159.1986.tb13081.x; MIYASAKA T, 1991, P NATL ACAD SCI USA, V88, P2653, DOI 10.1073/pnas.88.7.2653; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MUNOZ G, 1990, ANAL BIOCHEM, V190, P233, DOI 10.1016/0003-2697(90)90185-C; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; NORTHWOOD IC, 1991, J BIOL CHEM, V266, P15266; PANDIELLAALONSO A, 1986, FEBS LETT, V208, P48, DOI 10.1016/0014-5793(86)81529-0; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; ROWLAND EA, 1987, J BIOL CHEM, V262, P7504; SANGHERA JS, 1990, FEBS LETT, V273, P223, DOI 10.1016/0014-5793(90)81090-B; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P865; TSAO H, 1990, J BIOL CHEM, V265, P15471; TSAO H, 1991, J BIOL CHEM, V266, P12981; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; Volonte C, 1990, GROWTH FACTORS, V2, P321; VULLIET PR, 1989, J BIOL CHEM, V264, P16292	59	98	99	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1053	1065		10.1016/0896-6273(92)90065-L	http://dx.doi.org/10.1016/0896-6273(92)90065-L			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1463607				2022-12-28	WOS:A1992KD71600005
J	KOLODKIN, AL; MATTHES, DJ; OCONNOR, TP; PATEL, NH; ADMON, A; BENTLEY, D; GOODMAN, CS				KOLODKIN, AL; MATTHES, DJ; OCONNOR, TP; PATEL, NH; ADMON, A; BENTLEY, D; GOODMAN, CS			FASCICLIN-IV - SEQUENCE, EXPRESSION, AND FUNCTION DURING GROWTH CONE GUIDANCE IN THE GRASSHOPPER EMBRYO	NEURON			English	Article							HOMOPHILIC ADHESION MOLECULE; GENETIC-ANALYSIS; PIONEER NEURONS; IMMUNOGLOBULIN SUPERFAMILY; DROSOPHILA-MELANOGASTER; II GLYCOPROTEINS; AXONAL PATHWAY; BASAL LAMINA; CELL; RECOGNITION	Monoclonal antibody 6F8 was used to characterize and clone fasciclin IV, a new axonal glycoprotein in the grasshopper, and to study its function during growth cone guidance. Fasciclin IV is dynamically expressed on a subset of axon pathways in the developing CNS and on circumferential bands of epithelial cells in developing limb buds. One of these bands corresponds to the location where the growth cones of the Ti1 pioneer neurons make a characteristic turn while extending toward the CNS. Embryos cultured in the 6F8 antibody or Fab exhibit aberrant formation of this axon pathway. cDNA sequence analysis suggests that fasciclin IV has a signal sequence; long extracellular, transmembrane, and short cytoplasmic domains; and shows no homology with any protein in the available data bases. Thus, fasciclin IV appears to be a novel integral membrane protein that functions in growth cone guidance.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV NEUROBIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	KOLODKIN, AL (corresponding author), UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, BERKELEY, CA 94720 USA.		Matthes, David/N-3529-2017	Matthes, David/0000-0002-0198-9661; Patel, Nipam/0000-0003-4328-654X; Admon, Arie/0000-0003-0504-3950				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BASTIANI MJ, 1986, J NEUROSCI, V6, P3518; BASTIANI MJ, 1984, J NEUROSCI, V4, P2311; BASTIANI MJ, 1986, J NEUROSCI, V6, P3542; BASTIANI MJ, 1992, IN PRESS DEV BIOL; BENTLEY D, 1983, NATURE, V304, P62, DOI 10.1038/304062a0; BENTLEY D, 1979, J EMBRYOL EXP MORPH, V54, P47; BENTLEY D, 1992, NERVE GROWTH CONE, P265; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BLAIR SS, 1987, J NEUROSCI, V7, P4165; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CAUDY M, 1987, DEV BIOL, V119, P454, DOI 10.1016/0012-1606(87)90049-2; CHANG WS, 1992, DEVELOPMENT, V114, P507; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CONDIC ML, 1989, NEURON, V3, P427, DOI 10.1016/0896-6273(89)90202-X; CONDIC ML, 1989, J NEUROSCI, V9, P2687; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; DULAC S, 1986, J NEUROSCI, V6, P3532; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; GOODMAN CS, 1981, J NEUROSCI, V1, P94, DOI 10.1523/JNEUROSCI.01-01-00094.1981; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; JACOBS JR, 1989, J NEUROSCI, V9, P2402; JAY DG, 1990, NATURE, V348, P548, DOI 10.1038/348548a0; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KLOSE M, 1989, SCIENCE, V245, P982, DOI 10.1126/science.2772651; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LEFCORT F, 1987, DEV BIOL, V119, P466, DOI 10.1016/0012-1606(87)90050-9; LEFCORT F, 1989, J CELL BIOL, V108, P1737, DOI 10.1083/jcb.108.5.1737; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; NORBECK BA, 1990, ROUX ARCH DEV BIOL, V198, P395, DOI 10.1007/BF00376158; NORBECK BA, 1991, ROUX ARCH DEV BIOL, V199, P476, DOI 10.1007/BF01705784; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; RAPER JA, 1984, J NEUROSCI, V4, P2329; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SINGER MA, 1992, IN PRESS DEV BIOL; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; SNOW PM, 1988, P NATL ACAD SCI USA, V85, P5291, DOI 10.1073/pnas.85.14.5291; SPINDLER KR, 1984, J VIROL, V49, P132, DOI 10.1128/JVI.49.1.132-141.1984; TAGHERT PH, 1982, NEUROSCI RES PROG B, V20, P813; VONHEIJNE G, 1983, EUR J IMMUNOL, V11, P18; WANG LS, 1992, J CELL BIOL, V118, P163, DOI 10.1083/jcb.118.1.163; WANG LS, 1992, NEURON, V8, P701, DOI 10.1016/0896-6273(92)90091-Q; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0	55	313	324	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1992	9	5					831	845		10.1016/0896-6273(92)90237-8	http://dx.doi.org/10.1016/0896-6273(92)90237-8			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY552	1418998				2022-12-28	WOS:A1992JY55200004
J	PAPE, HC; MAGER, R				PAPE, HC; MAGER, R			NITRIC-OXIDE CONTROLS OSCILLATORY ACTIVITY IN THALAMOCORTICAL NEURONS	NEURON			English	Article								Nitric oxide (NO) is considered a diffusible messenger involved in neuronal communication, although the postsynaptic target cells of NO action and the associated biological function in the CNS are still a matter of controversy. Within the discrete pattern of NO-synthesizing neurons in the brain, NO synthase is specifically colocalized with the cholinergic brain stem-thalamic system, which is thought to regulate the state-dependent activity of the thalamocortical circuit. Here we report evidence indicating that the release of NO onto thalamocortical neurons results in an alteration in voltage dependence of the hyperpolarization-activated cation conductance, probably mediated via the cGMP system. NO selectively dampens oscillatory neuronal activity, indicating a rapidly diffusing signaling mechanism that controls the functional state of the thalamocortical network.			PAPE, HC (corresponding author), RUHR UNIV BOCHUM, FAK MED, NEUROPHYSIOL ABT, W-4630 BOCHUM, GERMANY.							ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; BEAVO JA, 1988, ADV SEC MESS PHOSPH, V22, P1; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BUZSAKI G, 1990, NEUROSCIENCE, V36, P1, DOI 10.1016/0306-4522(90)90345-5; CRUNELLI V, 1987, J PHYSIOL-LONDON, V390, P243, DOI 10.1113/jphysiol.1987.sp016697; DOSSI RC, 1992, J PHYSIOL-LONDON, V447, P215, DOI 10.1113/jphysiol.1992.sp018999; FEELISCH M, 1989, J CARDIOVASC PHARM, V14, pS13, DOI 10.1097/00005344-198906152-00004; FEELISCH M, 1987, EUR J PHARMACOL, V139, P19, DOI 10.1016/0014-2999(87)90493-6; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GLOOR P, 1988, TRENDS NEUROSCI, V11, P63, DOI 10.1016/0166-2236(88)90166-X; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; IGNARRO LJ, 1990, PHARMACOL TOXICOL, V67, P1, DOI 10.1111/j.1600-0773.1990.tb00772.x; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; JOHNSON RA, 1989, MOL PHARMACOL, V35, P681; KAYAMA Y, 1992, BRAIN RES, V569, P210, DOI 10.1016/0006-8993(92)90632-J; KNOWLES RG, 1990, BIOCHEM J, V269, P207, DOI 10.1042/bj2690207; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P569, DOI 10.1113/jphysiol.1981.sp013764; MANZONI O, 1992, NEUROREPORT, V3, P77, DOI 10.1097/00001756-199201000-00020; MARTIN W, 1985, J PHARMACOL EXP THER, V232, P708; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332; MCCORMICK DA, 1988, NATURE, V334, P246, DOI 10.1038/334246a0; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MCCORMICK DA, 1992, IN PRESS PROG NEUROB; MONCADA S, 1991, PHARMACOL REV, V43, P109; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; PAPE HC, 1992, J PHYSIOL-LONDON, V447, P729, DOI 10.1113/jphysiol.1992.sp019026; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125, DOI 10.1016/0165-6147(91)90526-X; SOLTESZ I, 1991, J PHYSIOL-LONDON, V441, P175, DOI 10.1113/jphysiol.1991.sp018745; SOUTHAM E, 1991, NEUROREPORT, V2, P658, DOI 10.1097/00001756-199111000-00006; SOUTHAM E, 1991, J NEUROCHEM, V56, P2072, DOI 10.1111/j.1471-4159.1991.tb03468.x; SOUTHAM E, 1991, NEUROSCI LETT, V130, P107, DOI 10.1016/0304-3940(91)90239-P; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1990, J NEUROSCI, V10, P2541; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; STERIADE M, 1991, J NEUROSCI, V11, P3200; STERIADE M, 1985, J NEUROPHYSIOL, V54, P1473, DOI 10.1152/jn.1985.54.6.1473; Steriade M, 1990, THALMIC OSCILLATIONS; TANAYAMA S, 1974, XENOBIOTICA, V4, P175, DOI 10.3109/00498257409049357; VINCENT SR, 1992, TRENDS NEUROSCI, V15, P108, DOI 10.1016/0166-2236(92)90021-Y; VINCENT SR, 1992, NEUROSCIENCE, V46, P755, DOI 10.1016/0306-4522(92)90184-4	50	195	198	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	1992	9	3					441	448		10.1016/0896-6273(92)90182-D	http://dx.doi.org/10.1016/0896-6273(92)90182-D			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1326294				2022-12-28	WOS:A1992JM57100006
J	PIXLEY, SK				PIXLEY, SK			CNS GLIAL-CELLS SUPPORT INVITRO SURVIVAL, DIVISION, AND DIFFERENTIATION OF DISSOCIATED OLFACTORY NEURONAL PROGENITOR CELLS	NEURON			English	Article							MARKER PROTEIN; RECEPTOR-CELLS; SENSORY NEURONS; NERVE-SECTION; EPITHELIUM; SYSTEM; RAT; NEUROGENESIS; MICE; REGENERATION	Olfactory receptor neurons (ORNs) are replaced and differentiate in adult animals, but differentiation in dissociated cell culture has not been demonstrated. To test whether contact with the CNS regulates maturation, neonatal rat olfactory cells were grown on a culture substrate or on CNS astrocytes. Mature ORNs, immunopositive for olfactory marker protein (OMP), disappeared rapidly from both systems. Neurons positive for neuron-specific tubulin (immature and mature) disappeared from substrate-only cultures, but remained abundant in the cocultures. OMP-positive neurons reappeared after 10 days in vitro. Pulse labeling with [H-3]thymidine showed extensive neurogenesis of both immature and mature olfactory neurons. This demonstrates, in vitro, both division and differentiation of olfactory progenitor cells.			PIXLEY, SK (corresponding author), UNIV CINCINNATI,COLL MED,DEPT ANAT & CELL BIOL,CINCINNATI,OH 45267, USA.			Pixley, Sarah/0000-0003-2713-4263	NIDCD NIH HHS [DC00347] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAKER H, 1989, J COMP NEUROL, V285, P246, DOI 10.1002/cne.902850207; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BARBER PC, 1988, MOL NEUROBIOLOGY OLF, P185; BAYER SA, 1991, NEUROCORTICAL DEV, P228; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; CAMARA CG, 1984, BRAIN RES, V308, P63, DOI 10.1016/0006-8993(84)90917-X; CHUAH MI, 1991, DEV BRAIN RES, V60, P123, DOI 10.1016/0165-3806(91)90040-P; CHUAH MI, 1985, BRAIN RES, V338, P259, DOI 10.1016/0006-8993(85)90155-6; CHUAH MI, 1983, J NEUROSCI, V3, P2197; CHUAH MI, 1988, J NEUROSCI RES, V20, P84, DOI 10.1002/jnr.490200112; COON HG, 1989, P NATL ACAD SCI USA, V86, P1703, DOI 10.1073/pnas.86.5.1703; COSTANZO RM, 1983, J COMP NEUROL, V215, P370, DOI 10.1002/cne.902150403; COSTANZO RM, 1985, BRAIN RES, V361, P258, DOI 10.1016/0006-8993(85)91297-1; DEAR TN, 1991, EMBO J, V10, P2813, DOI 10.1002/j.1460-2075.1991.tb07830.x; DOUCETTE R, 1990, GLIA, V3, P433, DOI 10.1002/glia.440030602; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; FARBMAN AI, 1977, ANAT REC, V189, P187, DOI 10.1002/ar.1091890206; GEISERT EE, 1989, NEUROSCI LETT, V102, P137, DOI 10.1016/0304-3940(89)90068-2; GONZALES F, 1985, J NEUROSCI METH, V14, P77, DOI 10.1016/0165-0270(85)90118-9; GRAZIADEI GAM, 1977, J HISTOCHEM CYTOCHEM, V25, P1311; GRAZIADEI GAM, 1983, BRAIN RES, V262, P303; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; GRAZIADEI GAM, 1988, BRAIN RES, V455, P401; GRAZIADEI GAM, 1980, NEUROSCIENCE, V5, P1239; Graziadei P. P., 1978, DEV SENSORY SYSTEMS, V9, P55; GRAZIADEI PP, 1971, Z ZELLFORSCH MIK ANA, V116, P305, DOI 10.1007/BF00330630; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; GRAZIADEI PPC, 1980, J NEUROCYTOL, V9, P145, DOI 10.1007/BF01205155; GRAZIADEI PPC, 1980, BRAIN RES, V201, P39, DOI 10.1016/0006-8993(80)90773-8; GRAZIADEI PPC, 1986, J COMP NEUROL, V247, P344, DOI 10.1002/cne.902470305; HARDING J, 1977, BRAIN RES, V132, P11, DOI 10.1016/0006-8993(77)90703-X; HARDING JW, 1978, BRAIN RES, V140, P271, DOI 10.1016/0006-8993(78)90460-2; HARLOW E, 1988, ANTIBODIES LABORATOR; HINDS JW, 1984, ANAT REC, V210, P375, DOI 10.1002/ar.1092100213; HURRT ME, 1988, TOXICOL APPL PHARM, V94, P311; ITOH K, 1979, BRAIN RES, V175, P341, DOI 10.1016/0006-8993(79)91013-8; LEVEY MS, 1991, J NEUROSCI, V11, P3556; LEVISON SW, 1991, CULTURING NERVE CELL, P309; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; MARGOLIS FL, 1985, TRENDS NEUROSCI, V8, P542, DOI 10.1016/0166-2236(85)90192-4; MARGOLIS FL, 1974, BRAIN RES, V81, P469, DOI 10.1016/0006-8993(74)90844-0; MIRAGALL F, 1982, BRAIN RES, V329, P245; MOULTON DG, 1974, ANN NY ACAD SCI, V237, P52, DOI 10.1111/j.1749-6632.1974.tb49843.x; NOBLE M, 1984, NEUROSCI LETT, V45, P193, DOI 10.1016/0304-3940(84)90098-3; PIXLEY SK, 1990, DEV BRAIN RES, V53, P125, DOI 10.1016/0165-3806(90)90132-I; PIXLEY SK, 1992, IN PRESS GLIA; RONNETT GV, 1991, J NEUROSCI, V11, P1243; SAMANEN DW, 1984, J COMP NEUROL, V225, P201, DOI 10.1002/cne.902250206; SCHUBERT D, 1982, P NATL ACAD SCI USA, V82, P7782; SIMMONS PA, 1981, J NEUROPHYSIOL, V45, P529, DOI 10.1152/jn.1981.45.3.529; Simpson-Herren L., 1987, TECHNIQUES CELL CYCL, P1; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; TROMBLEY PQ, 1991, J NEUROSCI, V11, P435; VERHAAGEN J, 1990, J NEUROSCI RES, V26, P31, DOI 10.1002/jnr.490260105; WRIGHT JW, 1982, SCIENCE, V216, P322, DOI 10.1126/science.7063891	56	95	97	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1191	1204		10.1016/0896-6273(92)90139-5	http://dx.doi.org/10.1016/0896-6273(92)90139-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1610570				2022-12-28	WOS:A1992JA42900018
J	PRIOR, P; SCHMITT, B; GRENNINGLOH, G; PRIBILLA, I; MULTHAUP, G; BEYREUTHER, K; MAULET, Y; WERNER, P; LANGOSCH, D; KIRSCH, J; BETZ, H				PRIOR, P; SCHMITT, B; GRENNINGLOH, G; PRIBILLA, I; MULTHAUP, G; BEYREUTHER, K; MAULET, Y; WERNER, P; LANGOSCH, D; KIRSCH, J; BETZ, H			PRIMARY STRUCTURE AND ALTERNATIVE SPLICE VARIANTS OF GEPHYRIN, A PUTATIVE GLYCINE RECEPTOR TUBULIN LINKER PROTEIN	NEURON			English	Article							RAT SPINAL-CORD; CENTRAL-NERVOUS-SYSTEM; AMINO-ACID SEQUENCE; ACETYLCHOLINE-RECEPTORS; CENTRAL SYNAPSES; BETA-SUBUNIT; PURIFICATION; IDENTIFICATION; CHROMATOGRAPHY; HETEROGENEITY	A 93 kd polypeptide associated with the mammalian inhibitory glycine receptor (GlyR) is localized at central synapses and binds with high affinity to polymerized tubulin. This protein, named gephyrin (from the Greek gamma-epsilon-phi-upsilon-rho-alpha, bridge), is thought to anchor the GlyR to subsynaptic microtubules. Here we report its primary structure deduced from cDNA and show that corresponding transcripts are found in all rat tissues examined. In brain, at least five different gephyrin mRNAs are generated by alternative splicing. Expression of gephyrin cDNAs in 293 kidney cells yields polypeptides reactive with a gephyrin-specific antibody, which coprecipitate with polymerized tubulin. Thus, gephyrin may define a novel type of microtubule-associated protein involved in membrane protein-cytoskeleton interactions.	UNIV HEIDELBERG,ZENTRUM MOLEK BIOL,W-6900 HEIDELBERG,GERMANY	Ruprecht Karls University Heidelberg	PRIOR, P (corresponding author), MAX PLANCK INST HIRNFORSCH,NEUROCHEM ABT,DEUTSCHORDENSTR 46,W-6000 FRANKFURT 71,GERMANY.		Maulet, Yves/AAC-3207-2019	Maulet, Yves/0000-0002-3162-0435				ALTSCHULER RA, 1986, BRAIN RES, V369, P316, DOI 10.1016/0006-8993(86)90542-1; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; GORMAN CM, 1989, VIROLOGY, V171, P377, DOI 10.1016/0042-6822(89)90605-3; GRAHAM D, 1985, BIOCHEMISTRY-US, V24, P990, DOI 10.1021/bi00325a027; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Heuser JE, 1977, HDB PHYSL, VI, P261; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KUHSE J, 1991, FEBS LETT, V283, P73, DOI 10.1016/0014-5793(91)80557-J; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGOSCH D, 1990, EUR J BIOCHEM, V194, P1, DOI 10.1111/j.1432-1033.1990.tb19419.x; LANGOSCH D, 1992, FEBS LETT, V298, P113, DOI 10.1016/0014-5793(92)80034-E; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LEUBE RE, 1988, EMBO J, V11, P3261; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; NAAS E, 1991, BRAIN RES, V561, P139, DOI 10.1016/0006-8993(91)90758-N; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; NOHNO T, 1988, J BACTERIOL, V170, P4097, DOI 10.1128/jb.170.9.4097-4102.1988; OLEK AJ, 1983, CELL, V34, P255, DOI 10.1016/0092-8674(83)90156-3; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peters A., 1976, FINE STRUCTURE NERVO; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; PUIA G, 1990, NEURON, V4, P759, DOI 10.1016/0896-6273(90)90202-Q; RIENITZ A, 1989, EMBO J, V8, P2879, DOI 10.1002/j.1460-2075.1989.tb08436.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMITT B, 1987, BIOCHEMISTRY-US, V26, P805, DOI 10.1021/bi00377a022; TRILLER A, 1990, New Biologist, V2, P637; TRILLER A, 1987, J CELL BIOL, V104, P947, DOI 10.1083/jcb.104.4.947; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; WERNER W, 1991, NATURE, V351, P742; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x	43	280	285	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUN	1992	8	6					1161	1170		10.1016/0896-6273(92)90136-2	http://dx.doi.org/10.1016/0896-6273(92)90136-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA429	1319186	hybrid			2022-12-28	WOS:A1992JA42900015
J	MARTINOU, JC; MARTINOU, I; KATO, AC				MARTINOU, JC; MARTINOU, I; KATO, AC			CHOLINERGIC DIFFERENTIATION FACTOR (CDF/LIF) PROMOTES SURVIVAL OF ISOLATED RAT EMBRYONIC MOTONEURONS INVITRO	NEURON			English	Article							NERVE GROWTH-FACTOR; CILIARY NEUROTROPHIC FACTOR; MYOTUBE-CONDITIONED MEDIUM; SPINAL-CORD NEURONS; SKELETAL-MUSCLE POLYPEPTIDE; LEUKEMIA-INHIBITORY FACTOR; PERITONEAL MAST-CELLS; 2 DISTINCT ACTIVITIES; ACETYLTRANSFERASE ACTIVITY; SYMPATHETIC NEURONS	We present evidence that the cholinergic differentiation factor (CDF), originally purified from cardiac and skeletal muscle cell-conditioned medium and found to be identical to leukemia inhibitory factor (LIF), promotes survival of embryonic day 14 rat motoneurons in vitro. These neurons were retrogradely labeled with the fluorescent tracer Dil and enriched on a density gradient or purified to homogeneity by fluorescence-activated cell sorting. Subnanomolar concentrations of CDF/LIF supported the survival of 85% of the motoneurons that would have died between days 1 and 4 of culture. The enhanced survival was accompanied by a 4-fold increase in choline acetyltransferase (ChAT) activity per culture. CDF/LIF also increased ChAT activity in dorsal spinal cord cultures, but had no detectable effect on ChAT levels in septal or striatal neuronal cultures. For comparison, other neurotrophic molecules were tested on motoneuron cultures. Ciliary neurotrophic factor had effects on motoneuron survival similar to those of CDF/LIF, whereas basic fibroblast growth factor was somewhat less effective. Nerve growth factor had no effect on the survival of rat motoneurons.	CTR MED UNIV GENEVA,DEPT PHARMACOL,CH-1211 GENEVA 4,SWITZERLAND	University of Geneva	MARTINOU, JC (corresponding author), CTR MED UNIV GENEVA,DIV CLIN NEUROPHYSIOL,CH-1211 GENEVA 4,SWITZERLAND.			martinou, Jean-claude/0000-0002-9847-2051				ALLAN EH, 1990, J CELL PHYSIOL, V145, P110, DOI 10.1002/jcp.1041450116; ALOE L, 1977, BRAIN RES, V133, P358, DOI 10.1016/0006-8993(77)90772-7; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BARBER RP, 1984, J COMP NEUROL, V229, P329, DOI 10.1002/cne.902290305; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BENNETT MR, 1980, BRAIN RES, V190, P537, DOI 10.1016/0006-8993(80)90295-4; BLOCHGALLEGO E, 1991, DEVELOPMENT, V111, P221; BRUNI A, 1982, FEBS LETT, V138, P190, DOI 10.1016/0014-5793(82)80438-9; CALOF AL, 1985, NEUROSCI LETT, V59, P183, DOI 10.1016/0304-3940(85)90197-1; CALOF AL, 1984, DEV BIOL, V106, P194, DOI 10.1016/0012-1606(84)90075-7; CHANG JY, 1990, J NEUROCHEM, V55, P436, DOI 10.1111/j.1471-4159.1990.tb04155.x; DELOULME C, 1991, NEUROSCIENCE, V42, P561; DOHRMANN U, 1986, DEV BIOL, V118, P209, DOI 10.1016/0012-1606(86)90089-8; DRIBIN LB, 1980, DEV BIOL, V74, P184, DOI 10.1016/0012-1606(80)90060-3; ERKMAN L, 1989, DEV BIOL, V132, P375, DOI 10.1016/0012-1606(89)90234-0; FERRARI G, 1989, DEV BIOL, V133, P140, DOI 10.1016/0012-1606(89)90305-9; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; FONTANA A, 1982, J NEUROIMMUNOL, V2, P73, DOI 10.1016/0165-5728(82)90076-5; FONTANA A, 1982, J NEUROIMMUNOL, V2, P55, DOI 10.1016/0165-5728(82)90075-3; FREIDIN M, 1991, P NATL ACAD SCI USA, V88, P3200, DOI 10.1073/pnas.88.8.3200; FUKADA K, 1985, P NATL ACAD SCI USA, V82, P8795, DOI 10.1073/pnas.82.24.8795; GIESS MC, 1984, J NEUROSCI, V4, P1442; GILLER EL, 1977, J CELL BIOL, V74, P16, DOI 10.1083/jcb.74.1.16; GIULIAN D, 1988, J NEUROSCI, V8, P709; GOUGH NM, 1989, CANCER CELL-MON REV, V1, P77; GURNEY ME, 1986, SCIENCE, V234, P566, DOI 10.1126/science.3764429; HARTIKKA J, 1988, J NEUROSCI RES, V21, P352, DOI 10.1002/jnr.490210227; HENDERSON CE, 1983, NATURE, V302, P609, DOI 10.1038/302609a0; HILTON DJ, 1991, J CELL PHYSIOL, V146, P207, DOI 10.1002/jcp.1041460204; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; HORI T, 1988, BRAIN RES BULL, V20, P75, DOI 10.1016/0361-9230(88)90010-X; KATO AC, 1985, J NEUROSCI, V5, P2750; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; MARTINEZ HJ, 1985, P NATL ACAD SCI USA, V82, P7777, DOI 10.1073/pnas.82.22.7777; MARTINOU JC, 1989, J NEUROSCI, V9, P3645; MATHIEU C, 1984, NEUROSCIENCE, V13, P1373, DOI 10.1016/0306-4522(84)90306-3; MATSUDA H, 1988, P NATL ACAD SCI USA, V85, P6508, DOI 10.1073/pnas.85.17.6508; MCMANAMAN JL, 1990, NEURON, V4, P891, DOI 10.1016/0896-6273(90)90142-3; MCMANAMAN JL, 1988, J BIOL CHEM, V263, P5890; METCALF D, 1992, IN PRESS CIBA F S, V167; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; NAWA H, 1990, COLD SH Q B, V55, P247; NAWA H, 1991, J NEUROCHEM, V56, P2147, DOI 10.1111/j.1471-4159.1991.tb03479.x; OBRIEN RJ, 1986, J NEUROSCI, V6, P3265; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059; PATTERSON PH, 1977, DEV BIOL, V56, P263, DOI 10.1016/0012-1606(77)90269-X; PATTERSON PH, 1992, IN PRESS CURR OPIN N; PATTERSON PH, 1992, IN PRESS CIBA F S, V167; PEARCE FL, 1986, J PHYSIOL-LONDON, V372, P379, DOI 10.1113/jphysiol.1986.sp016014; PHELPS PE, 1990, J COMP NEUROL, V291, P9, DOI 10.1002/cne.902910103; PHELPS PE, 1984, J COMP NEUROL, V229, P347, DOI 10.1002/cne.902290306; RAYNAUD B, 1987, DEV BIOL, V119, P305, DOI 10.1016/0012-1606(87)90036-4; SCHNAAR RL, 1981, J NEUROSCI, V1, P204; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SMITH RG, 1985, J CELL BIOL, V101, P1608, DOI 10.1083/jcb.101.4.1608; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; WEBER M, 1981, J BIOL CHEM, V246, P3447; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641	66	245	261	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1992	8	4					737	744		10.1016/0896-6273(92)90094-T	http://dx.doi.org/10.1016/0896-6273(92)90094-T			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ188	1567622				2022-12-28	WOS:A1992HQ18800012
J	LOGOTHETIS, DE; MOVAHEDI, S; SATLER, C; LINDPAINTNER, K; NADALGINARD, B				LOGOTHETIS, DE; MOVAHEDI, S; SATLER, C; LINDPAINTNER, K; NADALGINARD, B			INCREMENTAL REDUCTIONS OF POSITIVE CHARGE WITHIN THE S4 REGION OF A VOLTAGE-GATED K+ CHANNEL RESULT IN CORRESPONDING DECREASES IN GATING CHARGE	NEURON			English	Article							POTASSIUM-CHANNEL; SODIUM-CHANNEL; FUNCTIONAL EXPRESSION; RAT-BRAIN; GENE FAMILY; CLONING; CDNA; DROSOPHILA; EXISTENCE; DIVERSITY	The S4 region of voltage-dependent ion channels is involved in the voltage-sensing mechanism of channel activation. Previous studies in fast inactivating channels have used non-steady-state measurements and thus have not allowed the quantitative assessment of activation parameters. Using site-directed mutagenesis and voltage-clamp recordings in a noninactivating channel (RCK1), we demonstrate that stepwise reductions of positive charge within the S4 region correlate with a progressive decrease in the channel's overall gating valence. In addition to testing for electrostatic behavior of individual charged residues, our study was designed to probe non-electrostatic influences on charge movement. We provide evidence that individual charged residues behave differentially in response to the electric field, so that purely electrostatic influences cannot fully account for the gating movement of certain charges.	HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	LOGOTHETIS, DE (corresponding author), CHILDRENS HOSP MED CTR,DEPT QUANTUM CHEM,HOWARD HUGHES MED INST,BOSTON,MA 02115, USA.							Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BEZANILLA F, 1991, SCIENCE, V254, P679, DOI 10.1126/science.1948047; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; DOUGLASS J, 1990, J IMMUNOL, V144, P4841; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GRUPE A, 1990, EMBO J, V9, P1749, DOI 10.1002/j.1460-2075.1990.tb08299.x; GURDON JB, 1983, METHOD ENZYMOL, V101, P370; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; Hille B, 1984, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; KEYNES RD, 1974, J PHYSIOL-LONDON, V239, P393, DOI 10.1113/jphysiol.1974.sp010575; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STEVENS CF, 1987, PROTEINS EXCITABLE M, P99; STUHMER W, 1991, PFLUG ARCH EUR J PHY, V418, P423, DOI 10.1007/BF00550881; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; TSENGCRANK JCL, 1990, FEBS LETT, V268, P63, DOI 10.1016/0014-5793(90)80973-M; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P9	37	133	134	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1992	8	3					531	540		10.1016/0896-6273(92)90281-H	http://dx.doi.org/10.1016/0896-6273(92)90281-H			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550676				2022-12-28	WOS:A1992HK67500013
J	BREDT, DS; SNYDER, SH				BREDT, DS; SNYDER, SH			NITRIC-OXIDE, A NOVEL NEURONAL MESSENGER	NEURON			English	Review							MAMMALIAN NITRATE BIOSYNTHESIS; RAT ANOCOCCYGEUS MUSCLE; MONOMETHYL-L-ARGININE; CYCLIC-GMP; HUNTINGTONS-DISEASE; GUANYLATE-CYCLASE; ENDOTHELIAL-CELLS; NADPH-DIAPHORASE; RELAXING FACTOR; SMOOTH-MUSCLE		JOHNS HOPKINS UNIV,INST MED,DEPT PHARMACOL & MOLEC SCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,INST MED,DEPT PSYCHIAT & BEHAV SCI,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University	BREDT, DS (corresponding author), JOHNS HOPKINS UNIV,INST MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-00266, DA271-90-7408] Funding Source: Medline; NIMH NIH HHS [MH-18501] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; BREDT DS, 1991, UNPUB J BIOL CHEM; BRESLOW MJ, 1987, AM J PHYSIOL, V252, pH521, DOI 10.1152/ajpheart.1987.252.3.H521; BRESLOW MJ, IN PRESS EUR J PHARM; BULT H, 1990, NATURE, V345, P346, DOI 10.1038/345346a0; BURNSTOCK G, 1972, BRIT J PHARMACOL, V46, P234, DOI 10.1111/j.1476-5381.1972.tb06868.x; CHANPALAY V, 1979, P NATL ACAD SCI USA, V76, P1485, DOI 10.1073/pnas.76.3.1485; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; DESAI KM, 1991, NATURE, V351, P477, DOI 10.1038/351477a0; DEVENTE J, 1989, BRAIN RES, V504, P332, DOI 10.1016/0006-8993(89)91380-2; DWYER MA, 1991, BIOCHEM BIOPH RES CO, V176, P1136, DOI 10.1016/0006-291X(91)90403-T; FEELISCH M, 1987, EUR J PHARMACOL, V139, P19, DOI 10.1016/0014-2999(87)90493-6; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; FERRENDELLI JA, 1974, J NEUROCHEM, V22, P535, DOI 10.1111/j.1471-4159.1974.tb06890.x; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GARG UC, 1991, J BIOL CHEM, V266, P9; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1989, EUR J PHARM-MOLEC PH, V172, P413, DOI 10.1016/0922-4106(89)90023-0; GARTHWAITE J, 1991, IN PRESS 2ND P INT C; GIBSON A, 1990, BRIT J PHARMACOL, V99, P602, DOI 10.1111/j.1476-5381.1990.tb12976.x; GILLESPIE JS, 1989, BRIT J PHARMACOL, V98, P1080, DOI 10.1111/j.1476-5381.1989.tb12650.x; GOYAL RK, 1980, NATURE, V288, P378, DOI 10.1038/288378a0; GREEN LC, 1981, P NATL ACAD SCI-BIOL, V78, P7764, DOI 10.1073/pnas.78.12.7764; GREEN LC, 1981, SCIENCE, V212, P56, DOI 10.1126/science.6451927; HAGLUND L, 1984, NATURE, V307, P259, DOI 10.1038/307259a0; HIBBS JB, 1987, J IMMUNOL, V138, P550; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; IGNARRO LJ, 1990, BIOCHEM BIOPH RES CO, V170, P843, DOI 10.1016/0006-291X(90)92168-Y; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; IYENGAR R, 1987, P NATL ACAD SCI USA, V84, P6369, DOI 10.1073/pnas.84.18.6369; KOH JY, 1986, SCIENCE, V234, P73, DOI 10.1126/science.2875522; LI CG, 1990, EUR J PHARMACOL, V191, P303; LINDEN DJ, 1991, IN PRESS EUR J NEURO; MARKS GS, 1991, TRENDS PHARMACOL SCI, V12, P185, DOI 10.1016/0165-6147(91)90544-3; MAYER B, 1991, FEBS LETT, V288, P187, DOI 10.1016/0014-5793(91)81031-3; Murad F, 1978, Adv Cyclic Nucleotide Res, V9, P145; MURPHY S, 1990, J NEUROCHEM, V55, P349, DOI 10.1111/j.1471-4159.1990.tb08860.x; MURPHY TH, 1991, J NEUROCHEM, V56, P990, DOI 10.1111/j.1471-4159.1991.tb02019.x; NAKANE M, 1983, BRAIN RES, V273, P9, DOI 10.1016/0006-8993(83)91088-0; NOWICKI JP, IN PRESS EUR J PHARM; ODELL TJ, 1991, IN PRESS P NATL ACAD; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P5193, DOI 10.1073/pnas.87.13.5193; RAMAGOPAL MV, 1989, EUR J PHARMACOL, V174, P297, DOI 10.1016/0014-2999(89)90325-7; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; THOMAS E., 1964, ACTA NEUROPATHOL, V3, P238; TODA N, 1990, BIOCHEM BIOPH RES CO, V170, P308, DOI 10.1016/0006-291X(90)91275-W; TRAKSHEL GM, 1988, ARCH BIOCHEM BIOPHYS, V260, P732, DOI 10.1016/0003-9861(88)90503-6; TTTRUP A, 1991, AM J PHYSIOL, V260, pG385; UEMURA Y, 1990, ANN NEUROL, V27, P620, DOI 10.1002/ana.410270606; WAGNER DA, 1983, P NATL ACAD SCI-BIOL, V80, P4518, DOI 10.1073/pnas.80.14.4518; WARNER M, 1988, J NEUROCHEM, V50, P1057, DOI 10.1111/j.1471-4159.1988.tb10573.x; YUI Y, 1991, J BIOL CHEM, V266, P12544	65	1782	1826	0	28	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1992	8	1					3	11		10.1016/0896-6273(92)90104-L	http://dx.doi.org/10.1016/0896-6273(92)90104-L			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1370373				2022-12-28	WOS:A1992HB18500001
J	NASTUK, MA; LIETH, E; MA, JY; CARDASIS, CA; MOYNIHAN, EB; MCKECHNIE, BA; FALLON, JR				NASTUK, MA; LIETH, E; MA, JY; CARDASIS, CA; MOYNIHAN, EB; MCKECHNIE, BA; FALLON, JR			THE PUTATIVE AGRIN RECEPTOR BINDS LIGAND IN A CALCIUM-DEPENDENT MANNER AND AGGREGATES DURING AGRIN-INDUCED ACETYLCHOLINE-RECEPTOR CLUSTERING	NEURON			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; TORPEDO ELECTRIC ORGAN; CULTURED MUSCLE-CELLS; SYNAPTIC SITES; MOUSE MUSCLE; BASAL LAMINA; NEUROMUSCULAR-JUNCTIONS; MESSENGER-RNA; MOLECULES; SURFACE	Agrin derived from Torpedo electric organ induces the clustering of acetylcholine receptors (AChRs) on cultured myotubes. As a first step toward characterizing the plasma membrane receptor for agrin, we have examined agrin binding to cultured myotubes. Agrin binding is saturable as measured by radioimmunoassay and, like agrin-induced AChR clustering, requires extracellular calcium. Immunofluorescence shows that on myotubes incubated with agrin at 4-degrees-C, agrin binds in a uniform, finely punctate pattern that correlates poorly with the distribution of AChRs. Myotubes stimulated with agrin at 37-degrees-C for greater-than-or-equal-to 2 hr show a coclustering of agrin binding sites and AChRs. By contrast, if anti-AChR antibodies are used either to cluster or to internalize AChRs, the distribution and number of agrin binding sites remain unchanged. The aggregation and calcium dependence of the putative agrin receptor may represent important control points in postsynaptic differentiation.	UNIV MASSACHUSETTS,DEPT CELL BIOL,WORCESTER,MA 01605	University of Massachusetts System; University of Massachusetts Worcester	NASTUK, MA (corresponding author), WORCESTER FDN EXPTL BIOL INC,NEUROBIOL GRP,SHREWSBURY,MA 01545, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001852] Funding Source: NIH RePORTER; NICHD NIH HHS [HD23924, R01 HD023924] Funding Source: Medline; NINDS NIH HHS [NS01852] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANTHONY DT, 1988, J CELL BIOL, V106, P1713, DOI 10.1083/jcb.106.5.1713; BAYNE EK, 1984, J CELL BIOL, V99, P1486, DOI 10.1083/jcb.99.4.1486; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BRETSCHER MS, 1985, EMBO J, V4, P1941, DOI 10.1002/j.1460-2075.1985.tb03874.x; BUONANNO A, 1986, J BIOL CHEM, V261, P1452; BURSZTAJN S, 1989, P NATL ACAD SCI USA, V86, P2928, DOI 10.1073/pnas.86.8.2928; COLE GJ, 1986, J CELL BIOL, V102, P403, DOI 10.1083/jcb.102.2.403; DEVREOTES PN, 1975, J CELL BIOL, V65, P335, DOI 10.1083/jcb.65.2.335; FALLON JR, 1985, NATURE, V315, P571, DOI 10.1038/315571a0; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; FRAIL DE, 1989, NEURON, V2, P1077, DOI 10.1016/0896-6273(89)90232-8; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; HARRIS AJ, 1971, PROC R SOC SER B-BIO, V177, P541, DOI 10.1098/rspb.1971.0046; HARRIS DA, 1989, NATURE, V337, P173, DOI 10.1038/337173a0; HENDERSON LP, 1984, J NEUROSCI, V4, P3140; HERNDON ME, 1990, NEURON, V4, P949, DOI 10.1016/0896-6273(90)90148-9; INESTROSA NC, 1983, EXP CELL RES, V147, P393, DOI 10.1016/0014-4827(83)90221-5; JACOB MH, 1986, J CELL BIOL, V103, P205, DOI 10.1083/jcb.103.1.205; KLAGSBRUN M, 1985, P NATL ACAD SCI USA, V82, P805, DOI 10.1073/pnas.82.3.805; KUHL U, 1982, DEV BIOL, V93, P344, DOI 10.1016/0012-1606(82)90122-1; LIETH E, 1991, IN PRESS DEV BIOL; LIETH E, 1989, ASSEMBLY NERVOUS SYS, P213; LORIES V, 1989, J BIOL CHEM, V264, P7009; LORING RH, 1987, J NEUROSCI, V7, P2153; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MCMAHAN UJ, 1984, J CELL BIOL, V98, P1453, DOI 10.1083/jcb.98.4.1453; MCMAHAN UJ, 1971, PROC R SOC SER B-BIO, V177, P485, DOI 10.1098/rspb.1971.0044; MERLIE JP, 1985, NATURE, V317, P66, DOI 10.1038/317066a0; NITKIN RM, 1990, J CELL BIOL, V111, P1161, DOI 10.1083/jcb.111.3.1161; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; RATNER N, 1985, J CELL BIOL, V101, P744, DOI 10.1083/jcb.101.3.744; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; ROLE LW, 1985, J NEUROSCI, V5, P2197; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; STOLLBERG J, 1990, J NEUROSCI, V10, P247; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; TZARTOS SJ, 1986, FEBS LETT, V196, P91, DOI 10.1016/0014-5793(86)80220-4; WALLACE BC, 1989, J NEUROSCI, V10, P3576; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	45	68	69	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	NOV	1991	7	5					807	818		10.1016/0896-6273(91)90283-6	http://dx.doi.org/10.1016/0896-6273(91)90283-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1660286				2022-12-28	WOS:A1991GT93900011
J	AIGAKI, T; FLEISCHMANN, I; CHEN, PS; KUBLI, E				AIGAKI, T; FLEISCHMANN, I; CHEN, PS; KUBLI, E			ECTOPIC EXPRESSION OF SEX PEPTIDE ALTERS REPRODUCTIVE-BEHAVIOR OF FEMALE DROSOPHILA-MELANOGASTER	NEURON			English	Article							MALE ACCESSORY-GLANDS; DROSOPHILA-MELANOGASTER; INSECT REPRODUCTION; HEAT-SHOCK; ESTERASE-6; DISSECTION; COURTSHIP; MOSAICS; GENE	Sex peptide, a secreted component of the male accessory glands, has been shown to induce behavioral and physiological changes in mated Drosophila. We transformed flies with a hybrid gene containing an hsp70 promoter fused to a cDNA encoding sex peptide. Heat-induced ectopic expression of the peptide in transgenic virgin females altered their reproductive behavior, in the presence of courting males, to that observed in mated females. This demonstrates that the peptide is functional as expected. Time course studies revealed that the behavioral change appeared earlier than the stimulated ovulation. We have also introduced a modified sex peptide gene that is driven by the yp1 enhancer, conferring expression in adult females, and shown that these flies refuse mating constitutively in the presence of courting males and lay unfertilized eggs at the rate of mated females.	UNIV ZURICH, INST ZOOL, CH-8057 ZURICH, SWITZERLAND	University of Zurich	AIGAKI, T (corresponding author), TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL, DEPT EXPTL BIOL, TOKYO 173, JAPAN.							ARTAVANISTSAKONAS S, 1979, CELL, V17, P9, DOI 10.1016/0092-8674(79)90290-3; BAUMANN H, 1974, J INSECT PHYSIOL, V20, P2347, DOI 10.1016/0022-1910(74)90022-5; BIENZ M, 1988, CELL, V53, P567, DOI 10.1016/0092-8674(88)90573-9; BURNET B, 1973, J INSECT PHYSIOL, V19, P2421, DOI 10.1016/0022-1910(73)90245-X; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; CHEN PS, 1984, ANNU REV ENTOMOL, V29, P233, DOI 10.1146/annurev.en.29.010184.001313; CHEN PS, 1991, ANN SOC ENTOMOL FR, V27, P231; CONNOLLY K, 1973, BEHAVIOUR, V44, P142, DOI 10.1163/156853973X00364; COOK RM, 1970, DROSOPH INF SERVICE, V45, P128; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; Davey KG, 1985, COMPREHENSIVE INSECT, V1, P1; FOWLER GL, 1973, ADV GENET, V17, P293, DOI 10.1016/S0065-2660(08)60173-X; FUCHS MS, 1970, J INSECT PHYSIOL, V16, P931, DOI 10.1016/0022-1910(70)90223-4; GARABEDIAN MJ, 1986, CELL, V45, P859, DOI 10.1016/0092-8674(86)90560-X; GARCIABELLIDO A, 1964, Z NATURFORSCH PT B, VB 19, P491; Gillott C., 1988, P319; HALL JC, 1979, GENETICS, V92, P437; HALL JC, 1986, TRENDS NEUROSCI, V9, P414, DOI 10.1016/0166-2236(86)90135-9; HALL JC, 1980, BASIC LIFE SCI, V14, P425; HIHARA F, 1981, Zoological Magazine (Tokyo), V90, P307; INGMANBAKER J, 1980, BIOCHEM GENET, V18, P809, DOI 10.1007/BF00484595; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; LEAHY M. GERALD, 1967, LIFE SCI, V6, P151; LEOPOLD RA, 1976, ANNU REV ENTOMOL, V21, P199, DOI 10.1146/annurev.en.21.010176.001215; LEOPOLD RA, 1971, J EXP ZOOL, V176, P353, DOI 10.1002/jez.1401760310; LOHER W, 1981, P NATL ACAD SCI-BIOL, V78, P7835, DOI 10.1073/pnas.78.12.7835; MANE SD, 1983, SCIENCE, V222, P419, DOI 10.1126/science.222.4622.419; MANNING A, 1967, ANIM BEHAV, V15, P239, DOI 10.1016/0003-3472(67)90006-1; MANNING A, 1962, NATURE, V194, P252, DOI 10.1038/194252a0; MONSMA SA, 1990, DEV BIOL, V142, P465, DOI 10.1016/0012-1606(90)90368-S; OBARA Y, 1975, Zoological Magazine (Tokyo), V84, P71; Raabe M., 1987, ADV INSECT PHYSIOL, V19, P29, DOI 10.1016/S0065- 2806(08)60100-9; RICHMOND RC, 1980, SCIENCE, V207, P1483, DOI 10.1126/science.6767273; RIEMANN JG, 1969, ANN ENTOMOL SOC AM, V62, P828, DOI 10.1093/aesa/62.4.828; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SIMCOX AA, 1985, MOL CELL BIOL, V5, P3397, DOI 10.1128/MCB.5.12.3397; Spieth H.T., 1983, Genetics and Biology of Drosophila, V3c, P223; SUGAWARA T, 1979, J COMP PHYSIOL, V130, P191, DOI 10.1007/BF00614605; SZABAD J, 1982, GENETICS, V100, P61; TOMPKINS L, 1983, GENETICS, V103, P179; TOMPKINS L, 1989, PERSPECTIVES NEURAL, P229; VANDERMEER RK, 1986, J INSECT PHYSIOL, V32, P681, DOI 10.1016/0022-1910(86)90109-5; WHALEN M, 1986, GENETICS, V114, P77	44	212	215	3	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1991	7	4					557	563		10.1016/0896-6273(91)90368-A	http://dx.doi.org/10.1016/0896-6273(91)90368-A			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM954	1931051				2022-12-28	WOS:A1991GM95400004
J	LOPEZ, GA; JAN, YN; JAN, LY				LOPEZ, GA; JAN, YN; JAN, LY			HYDROPHOBIC SUBSTITUTION MUTATIONS IN THE S4-SEQUENCE ALTER VOLTAGE-DEPENDENT GATING IN SHAKER K+-CHANNELS	NEURON			English	Article							RHODOBACTER-SPHAEROIDES R-26; POTASSIUM-CHANNEL; SODIUM-CHANNEL; ELECTROPHORUS-ELECTRICUS; DROSOPHILA MUSCLE; XENOPUS OOCYTES; MOLECULAR-MODEL; SH5 MUTATION; GENE FAMILY; RAT-BRAIN	Voltage-activated Na+, Ca2+, and K+ channels contain a common motif, the S4 sequence, characterized by a basic residue at every third position interspersed mainly with hydrophobic residues. The S4 sequence is proposed to function as the voltage sensor and to move in response to membrane depolarization, triggering conformational changes that open the channel. This hypothesis has been tested in previous studies which revealed that mutations of the S4 basic residues often shift the curve of voltage dependence of activation along the voltage axis. We find that comparable or larger shifts are caused by conservative substitutions of hydrophobic residues in the S4 sequence of the Shaker K+ channel. We suggest that the S4 structure plays an essential role in determining the relative stabilities of the closed and open states of the channel.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	LOPEZ, GA (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.		lopez, george/W-4435-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015963] Funding Source: NIH RePORTER; NINDS NIH HHS [NS15963] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAHAM DJ, 1987, PROTEINS, V2, P130, DOI 10.1002/prot.340020207; ARMSTRONG CM, 1990, P NATL ACAD SCI USA, V87, P7579, DOI 10.1073/pnas.87.19.7579; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1987, SCIENCE, V236, P712, DOI 10.1126/science.2437654; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; BEZANILLA F, 1982, NATURE, V296, P657, DOI 10.1038/296657a0; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GAUTAM M, 1990, NEURON, V5, P67, DOI 10.1016/0896-6273(90)90034-D; GILSON MK, 1986, BIOPOLYMERS, V25, P2097, DOI 10.1002/bip.360251106; GILSON MK, 1988, PROTEINS, V3, P32, DOI 10.1002/prot.340030104; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GRUPE A, 1990, EMBO J, V9, P1479; GURDON JB, 1983, METHOD ENZYMOL, V101, P370; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; Hille B, 1984, IONIC CHANNELS EXCIT; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; KARPUSAS M, 1989, P NATL ACAD SCI USA, V86, P8237, DOI 10.1073/pnas.86.21.8237; KOMIYA H, 1988, P NATL ACAD SCI USA, V85, P9012, DOI 10.1073/pnas.85.23.9012; KOSOWER EM, 1985, FEBS LETT, V182, P234, DOI 10.1016/0014-5793(85)80306-9; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; LICHTINGHAGEN R, 1990, EMBO J, V9, P4399, DOI 10.1002/j.1460-2075.1990.tb07890.x; LO DC, 1991, NEURON, V6, P31, DOI 10.1016/0896-6273(91)90119-K; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MATTHEW JB, 1985, ANNU REV BIOPHYS BIO, V14, P387; MAYER ML, 1988, J PHYSIOL-LONDON, V396, P417, DOI 10.1113/jphysiol.1988.sp016970; MCCORMACK K, 1989, NATURE, V340, P103, DOI 10.1038/340103a0; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; MCCORMACK T, 1990, P NATL ACAD SCI USA, V87, P5227, DOI 10.1073/pnas.87.13.5227; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; MIERENDORF RC, 1987, METHOD ENZYMOL, V152, P556; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; PFAFFINGER PJ, 1991, J NEUROSCI, V11, P918; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; RIBERA AB, 1990, NEURON, V5, P691, DOI 10.1016/0896-6273(90)90223-3; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; ROYER WE, 1990, SCIENCE, V249, P518, DOI 10.1126/science.2382132; RUSSELL AJ, 1987, J MOL BIOL, V193, P803, DOI 10.1016/0022-2836(87)90360-3; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; YEATES TO, 1987, P NATL ACAD SCI USA, V84, P6438, DOI 10.1073/pnas.84.18.6438; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, J NEUROSCI, V10, P1799; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243	64	125	133	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					327	336		10.1016/0896-6273(91)90271-Z	http://dx.doi.org/10.1016/0896-6273(91)90271-Z			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1873032				2022-12-28	WOS:A1991GB93300016
J	JOHNSTON, PA; ARCHER, BT; ROBINSON, K; MIGNERY, GA; JAHN, R; SUDHOF, TC				JOHNSTON, PA; ARCHER, BT; ROBINSON, K; MIGNERY, GA; JAHN, R; SUDHOF, TC			RAB3A ATTACHMENT TO THE SYNAPTIC VESICLE MEMBRANE MEDIATED BY A CONSERVED POLYISOPRENYLATED CARBOXY-TERMINAL SEQUENCE	NEURON			English	Article							GTP-BINDING PROTEIN; RAS-LIKE PROTEIN; SECRETION; FAMILY; BRAIN; SYNAPTOPHYSIN; LOCALIZATION; EXPRESSION; TISSUE; GENE	rab3A is a small neuronal GTP-binding protein specifically localized to synaptic vesicles. Membrane-bound rab3A behaves like an intrinsic membrane protein in vitro, but reversibly dissociates from synaptic vesicles after exocytosis in vivo. Here we demonstrate that rab3A is attached to synaptic vesicle membranes by a carboxy-terminal Cys-X-Cys sequence that is posttranslationally modified. This modification is inhibited by compactin in a mevalonate-dependent manner, suggesting that the Cys-X-Cys sequence represents a novel polyisoprenylation sequence. Isolation of a rab3 homolog from D. melanogaster reveals high evolutionary conservation of rab3A, including its carboxy-terminal Cys-X-Cys sequence. The posttranslational modifications of soluble and membrane-bound rab3A are biochemically different, but both require the carboxy-terminal Cys-X-Cys sequence and are faithfully reproduced in nonneuronal cells. Our results suggest that the carboxy-terminal Cys-X-Cys sequence of rab3A is polyisoprenylated and is used as its regulatable membrane anchor. Furthermore, the hydrophobic modification of rab3A and its correct intracellular targeting to synaptic vesicles are independent, presumably consecutive events.	UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235; MAX PLANCK INST PSYCHIAT,NEUROCHEM ABT,W-8033 MARTINSRIED,GERMANY	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Max Planck Society				Jahn, Reinhard/0000-0003-1542-3498				BORDIER C, 1981, J BIOL CHEM, V256, P1604; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURSTEIN E, 1989, MOL CELL BIOL, V9, P4807, DOI 10.1128/MCB.9.11.4807; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; JOHNSTON PA, 1989, EMBO J, V8, P2863, DOI 10.1002/j.1460-2075.1989.tb08434.x; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; MATSUI Y, 1988, J BIOL CHEM, V263, P11071; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; MOLENAAR CMT, 1988, EMBO J, V7, P971, DOI 10.1002/j.1460-2075.1988.tb02903.x; PERIN MS, 1991, J BIOL CHEM, V266, P615; REISS Y, 1991, P NATL ACAD SCI USA, V88, P732, DOI 10.1073/pnas.88.3.732; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANO K, 1989, BIOCHEM BIOPH RES CO, V158, P377, DOI 10.1016/S0006-291X(89)80058-0; SUDHOF TC, 1990, J BIOL CHEM, V265, P7849; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; TOUCHOT N, 1987, P NATL ACAD SCI USA, V84, P8210, DOI 10.1073/pnas.84.23.8210; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; YAMANE HK, 1991, P NATL ACAD SCI USA, V88, P286, DOI 10.1073/pnas.88.1.286; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394	33	89	91	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JUL	1991	7	1					101	109		10.1016/0896-6273(91)90078-E	http://dx.doi.org/10.1016/0896-6273(91)90078-E			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1648935				2022-12-28	WOS:A1991FY48100010
J	WILCOX, BJ; UNNERSTALL, JR				WILCOX, BJ; UNNERSTALL, JR			EXPRESSION OF ACIDIC FIBROBLAST GROWTH-FACTOR MESSENGER-RNA IN THE DEVELOPING AND ADULT-RAT BRAIN	NEURON			English	Article							NUCLEOTIDE-SEQUENCE; HIPPOCAMPAL-NEURONS; NEURITE EXTENSION; FACTOR PROMOTES; SURVIVAL; CULTURE; CELLS; PROTEIN; INVITRO; CLONE	We have localized acidic fibroblast growth factor (aFGF) mRNA in the developing and adult rat brain using in situ hybridization histochemistry. Prenatally, hybridization to aFGF mRNA was observed throughout the brain, with the strongest signal associated with cells of the developing cortical plate. Postnatally, labeling was localized to specific neuronal populations. In the hippocampus, labeling of the pyramidal cell layer and dentate granule cells was observed and became progressively more intense with maturation. Labeling was also observed in both the external and internal granule cell layers of the developing cerebellum. Pyramidal cells of the neocortex as well as neurons of the substantia nigra and locus ceruleus also express aFGF. This pattern persists into adulthood, although the intensity of the labeling is significantly reduced in the adult brain. These patterns of hybridization correlate with specific developmental events and suggest that aFGF plays a significant role in both central nervous system development and neuronal viability in the adult brain.	CASE WESTERN RESERVE UNIV,CTR ALZHEIMER,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,DEPT PHARMACOL,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,CLEVELAND,OH 44106	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	WILCOX, BJ (corresponding author), CASE WESTERN RESERVE UNIV,DEPT NEUROL,CLEVELAND,OH 44106, USA.				PHS HHS [1P50A68012-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; ALTERIO J, 1988, FEBS LETT, V242, P41, DOI 10.1016/0014-5793(88)80981-5; ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FERRARI G, 1989, DEV BIOL, V133, P140, DOI 10.1016/0012-1606(89)90305-9; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; GOODRICH SP, 1989, NUCLEIC ACIDS RES, V17, P2867, DOI 10.1093/nar/17.7.2867; GOSPODAROWICZ D, 1986, MOL CELL ENDOCRINOL, V46, P187, DOI 10.1016/0303-7207(86)90001-8; HALLEY C, 1988, NUCLEIC ACIDS RES, V16, P10913, DOI 10.1093/nar/16.22.10913; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; JAYE M, 1986, SCIENCE, V233, P541, DOI 10.1126/science.3523756; LOGAN A, 1988, MOL CELL ENDOCRINOL, V58, P275, DOI 10.1016/0303-7207(88)90164-5; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; MURPHY PR, 1990, MOL ENDOCRINOL, V4, P196, DOI 10.1210/mend-4-2-196; NEUFELD G, 1986, J BIOL CHEM, V261, P5631; NEUFELD G, 1985, J BIOL CHEM, V260, P3860; OTTO D, 1990, J NEUROSCI, V10, P1912; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PETTMANN B, 1986, NEUROSCI LETT, V68, P175, DOI 10.1016/0304-3940(86)90137-0; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Sambrook J, 1989, MOL CLONING LABORATO; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; SCHUBERT D, 1987, J CELL BIOL, V104, P635, DOI 10.1083/jcb.104.3.635; SHERWOOD NM, 1970, STEREOTAXIC ATLAS DE; SIEGEL RE, 1989, METHODS NEUROSCIENCE, V1, P136; SNGH SC, 1977, ANAT EMBRYOL, V151, P183; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WEINER HL, 1989, P NATL ACAD SCI USA, V86, P2683, DOI 10.1073/pnas.86.8.2683; WHITTEMORE SR, 1988, J NEUROSCI RES, V20, P403, DOI 10.1002/jnr.490200402; WINKLES JA, 1987, P NATL ACAD SCI USA, V84, P7124, DOI 10.1073/pnas.84.20.7124	38	106	107	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					397	409		10.1016/0896-6273(91)90248-X	http://dx.doi.org/10.1016/0896-6273(91)90248-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC470	1705808				2022-12-28	WOS:A1991FC47000008
J	XIA, ZG; REFSDAL, CD; MERCHANT, KM; DORSA, DM; STORM, DR				XIA, ZG; REFSDAL, CD; MERCHANT, KM; DORSA, DM; STORM, DR			DISTRIBUTION OF MESSENGER-RNA FOR THE CALMODULIN-SENSITIVE ADENYLATE-CYCLASE IN RAT-BRAIN - EXPRESSION IN AREAS ASSOCIATED WITH LEARNING AND MEMORY	NEURON			English	Article							LONG-TERM POTENTIATION; VISUAL-CORTEX; TRANSMITTER RELEASE; GLUCOSE TRANSPORTER; CELLULAR MECHANISM; REGULATORY PROTEIN; SLICE PREPARATION; MUTANT RUTABAGA; SENSORY NEURONS; BOVINE BRAIN	The Drosophila learning mutant, rutabaga, is deficient in the calmodulin-sensitive adenylate cyclase, and studies of associative learning in Aplysia have implicated this enzyme in neuroplasticity. Therefore, the distribution of mRNA encoding the calmodulin-sensitive adenylate cyclase in rat brain was examined by in situ hybridization. mRNA for this enzyme is expressed in specific areas of brain that have been implicated in learning and memory, including the neocortex, the hippocampus, and the olfactory system. The presence of mRNA for this enzyme in the pyramidal and granule cells of the hippocampal formation provides evidence that it is found in neurons. These data are consistent with the proposal that the calmodulin-sensitive adenylate cyclase plays an important role in learning and memory.	VET ADM MED CTR,CTR GERIATR RES EDUC & CLIN,SEATTLE,WA 98108; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle	XIA, ZG (corresponding author), UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020311, R01NS020498] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 20498, NS 20311] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMS TW, 1988, TRENDS NEUROSCI, V11, P128, DOI 10.1016/0166-2236(88)90137-3; ALEXANDER MJ, 1989, P NATL ACAD SCI USA, V86, P5202, DOI 10.1073/pnas.86.13.5202; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; AVDONIN PV, 1978, DOKL AKAD NAUK SSSR+, V238, P726; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BARVOSKY K, 1984, MOL PHARMACOL, V25, P256; BENARI Y, 1990, TRENDS NEUROSCI, V13, P312, DOI 10.1016/0166-2236(90)90135-W; BRANN MR, 1987, FEBS LETT, V222, P191, DOI 10.1016/0014-5793(87)80218-1; BROSTROM CO, 1975, P NATL ACAD SCI USA, V72, P64, DOI 10.1073/pnas.72.1.64; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; CHEN CN, 1986, P NATL ACAD SCI USA, V83, P9313, DOI 10.1073/pnas.83.24.9313; CHEUNG Y, 1982, HDB EXPO PHARM, V58, P301; COOPER DMF, 1990, BRAIN RES, V523, P143, DOI 10.1016/0006-8993(90)91648-Z; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; DOLLER HJ, 1985, BRAIN RES, V333, P305, DOI 10.1016/0006-8993(85)91584-7; DUDAI Y, 1988, ANNU REV NEUROSCI, V11, P537, DOI 10.1146/annurev.ne.11.030188.002541; DUDAI Y, 1984, NEUROSCI LETT, V47, P119, DOI 10.1016/0304-3940(84)90416-6; DUDAI Y, 1985, J NEUROCHEM, V45, P355, DOI 10.1111/j.1471-4159.1985.tb03996.x; ELIOT LS, 1989, P NATL ACAD SCI USA, V86, P9564, DOI 10.1073/pnas.86.23.9564; FEANY MB, 1990, P NATL ACAD SCI USA, V87, P2795, DOI 10.1073/pnas.87.7.2795; GEHLERT DR, 1985, EUR J PHARMACOL, V106, P223; GREEN DA, 1982, J CYCLIC NUCL PROT, V8, P337; GREENBERG SM, 1987, NATURE, V329, P62, DOI 10.1038/329062a0; GROSS MK, 1987, J BIOL CHEM, V262, P8672; HARRISON JK, 1988, J NEUROCHEM, V51, P345, DOI 10.1111/j.1471-4159.1988.tb01045.x; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; HEIDEMAN W, 1982, P NATL ACAD SCI-BIOL, V79, P1462, DOI 10.1073/pnas.79.5.1462; HOPKINS WF, 1988, J NEUROPHYSIOL, V59, P667, DOI 10.1152/jn.1988.59.2.667; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KANTER ED, 1990, BRAIN RES, V525, P175, DOI 10.1016/0006-8993(90)91337-G; KLEIN M, 1986, P NATL ACAD SCI USA, V83, P7994, DOI 10.1073/pnas.83.20.7994; KOMATSU Y, 1981, NEUROSCI LETT, V26, P269, DOI 10.1016/0304-3940(81)90144-0; KOMATSU Y, 1988, J NEUROPHYSIOL, V59, P124, DOI 10.1152/jn.1988.59.1.124; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LARGENT BL, 1988, P NATL ACAD SCI USA, V85, P2864, DOI 10.1073/pnas.85.8.2864; LAVIS VR, 1987, J BIOL CHEM, V262, P14571; LEVITZKI A, 1987, TRENDS PHARMACOL SCI, V8, P299, DOI 10.1016/0165-6147(87)90122-2; LIVINGSTONE MS, 1985, P NATL ACAD SCI USA, V82, P5992, DOI 10.1073/pnas.82.17.5992; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MAY DC, 1985, J BIOL CHEM, V260, P5829; MINOCHERHOMJEE AEVM, 1987, BIOCHEMISTRY-US, V26, P4444, DOI 10.1021/bi00388a038; MOLLNER S, 1988, EUR J BIOCHEM, V171, P265, DOI 10.1111/j.1432-1033.1988.tb13785.x; MORK A, 1990, EUR J PHARMACOL, V175, P237, DOI 10.1016/0014-2999(90)90560-S; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; NESTLER EJ, 1983, NATURE, V305, P583, DOI 10.1038/305583a0; OLIANAS MC, 1990, J NEUROCHEM, V55, P1083, DOI 10.1111/j.1471-4159.1990.tb04603.x; PERKINS AT, 1988, BRAIN RES, V439, P222; PIASCIK MT, 1983, J BIOL CHEM, V258, P913; POAT JA, 1988, P NATL ACAD SCI USA, V85, P3216, DOI 10.1073/pnas.85.9.3216; RACINE RJ, 1983, BRAIN RES, V260, P217, DOI 10.1016/0006-8993(83)90676-5; ROSENBERG GB, 1987, J BIOL CHEM, V262, P7623; ROSENBERG GB, 1987, METH ENZYMNOL, V1139, P776; ROSS EM, 1980, ANNU REV BIOCHEM, V49, P533; SEAMON K, 1981, J BIOL CHEM, V256, P9799; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SHANAHAN MF, 1987, J BIOL CHEM, V262, P5978; STANTON PK, 1985, J NEUROSCI, V5, P2169; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; TOTA MR, 1990, MOL PHARMACOL, V37, P950; VALVERDE I, 1979, SCIENCE, V206, P225, DOI 10.1126/science.225798; WALTERS ET, 1983, SCIENCE, V219, P405, DOI 10.1126/science.6294834; WESTCOTT KR, 1979, P NATL ACAD SCI USA, V76, P204, DOI 10.1073/pnas.76.1.204; WILSON RC, 1979, BRAIN RES, V176, P65, DOI 10.1016/0006-8993(79)90870-9; WORLEY PF, 1986, P NATL ACAD SCI USA, V83, P4053, DOI 10.1073/pnas.83.11.4053; YEAGER RE, 1985, BIOCHEMISTRY-US, V24, P3776, DOI 10.1021/bi00335a054; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	68	206	208	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	MAR	1991	6	3					431	443		10.1016/0896-6273(91)90251-T	http://dx.doi.org/10.1016/0896-6273(91)90251-T			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FC470	2001286				2022-12-28	WOS:A1991FC47000011
J	HESTRIN, S; SAH, P; NICOLL, RA				HESTRIN, S; SAH, P; NICOLL, RA			MECHANISMS GENERATING THE TIME COURSE OF DUAL COMPONENT EXCITATORY SYNAPTIC CURRENTS RECORDED IN HIPPOCAMPAL SLICES	NEURON			English	Article									UNIV CALIF SAN FRANCISCO, DEPT PHARMACOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	HESTRIN, S (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA.		Sah, Pankaj/C-8175-2009; Hestrin, Shaul/F-4410-2010	Sah, Pankaj/0000-0001-5063-1589	NIMH NIH HHS [MH38256, MH0037] Funding Source: Medline; NINDS NIH HHS [NS24205] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038256, R01MH038256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024205] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS PR, 1976, J PHYSIOL-LONDON, V260, P531, DOI 10.1113/jphysiol.1976.sp011530; ANDREASEN M, 1989, J PHYSIOL-LONDON, V414, P317, DOI 10.1113/jphysiol.1989.sp017690; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P207; BARKER JL, 1979, PROC R SOC SER B-BIO, V206, P319, DOI 10.1098/rspb.1979.0108; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BENVENISTE M, 1990, J NEUROPHYSIOL, V63, P1373, DOI 10.1152/jn.1990.63.6.1373; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V399, P283; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CRAWFORD AC, 1977, J PHYSIOL-LONDON, V268, P711, DOI 10.1113/jphysiol.1977.sp011878; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; DALE N, 1985, J PHYSIOL-LONDON, V363, P35, DOI 10.1113/jphysiol.1985.sp015694; DINGLEDINE R, 1985, J PHYSIOL-LONDON, V366, P387, DOI 10.1113/jphysiol.1985.sp015804; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FABER DS, 1982, J NEUROPHYSIOL, V48, P654, DOI 10.1152/jn.1982.48.3.654; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; Ghez C., 1985, VOLUNTARY MOVEMENT, P493; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hille B, 1984, IONIC CHANNELS EXCIT; HOWE JR, 1988, PROC R SOC SER B-BIO, V233, P407, DOI 10.1098/rspb.1988.0030; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JOHNSTON GAR, 1979, J NEUROCHEM, V32, P121, DOI 10.1111/j.1471-4159.1979.tb04518.x; JOHNSTON GAR, 1980, J NEUROCHEM, V34, P241, DOI 10.1111/j.1471-4159.1980.tb04650.x; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; LESTER RAJ, 1990, IN PRESS NATURE; MACDERMOTT AB, 1980, J GEN PHYSIOL, V75, P39, DOI 10.1085/jgp.75.1.39; MACDONALD JF, 1987, J NEUROPHYSIOL, V58, P251, DOI 10.1152/jn.1987.58.2.251; MAGLEBY KL, 1975, J PHYSIOL-LONDON, V244, P467, DOI 10.1113/jphysiol.1975.sp010808; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MAYER ML, 1989, ION TRANSPORT, P183; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; RANG HP, 1981, J PHYSIOL-LONDON, V311, P23, DOI 10.1113/jphysiol.1981.sp013571; REYNOLDS IJ, 1988, MOL PHARMACOL, V33, P581; SAH P, 1990, IN PRESS J PHYSL; SAVADA S, 1985, EXP BRAIN RES, V60, P323; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2	46	299	301	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1990	5	3					247	253		10.1016/0896-6273(90)90162-9	http://dx.doi.org/10.1016/0896-6273(90)90162-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ279	1976014				2022-12-28	WOS:A1990DZ27900003
J	SHENG, M; GREENBERG, ME				SHENG, M; GREENBERG, ME			THE REGULATION AND FUNCTION OF C-FOS AND OTHER IMMEDIATE EARLY GENES IN THE NERVOUS-SYSTEM	NEURON			English	Review											SHENG, M (corresponding author), HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOLEC GENET,BOSTON,MA 02115, USA.			Sheng, Morgan/0000-0002-8703-5366				ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; AUDIGIER SMP, 1988, P NATL ACAD SCI USA, V85, P2859, DOI 10.1073/pnas.85.8.2859; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; BLACK IB, 1987, SCIENCE, V236, P1263, DOI 10.1126/science.2884727; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOS TJ, 1989, ONCOGENE, V4, P123; CASTELLUCCI VF, 1988, NEURON, V1, P321, DOI 10.1016/0896-6273(88)90080-3; CHANGELIAN PS, 1989, P NATL ACAD SCI USA, V86, P377, DOI 10.1073/pnas.86.1.377; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; COMB M, 1987, TRENDS NEUROSCI, V10, P473, DOI 10.1016/0166-2236(87)90103-2; COMB M, 1986, NATURE, V323, P353, DOI 10.1038/323353a0; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; CURRAN T, 1986, P NATL ACAD SCI USA, V83, P8521, DOI 10.1073/pnas.83.22.8521; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; DOUGLAS RM, 1988, MOL BRAIN RES, V4, P259, DOI 10.1016/0169-328X(88)90033-2; DRAGUNOW M, 1988, BRAIN RES, V440, P252, DOI 10.1016/0006-8993(88)90993-6; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; DWARKI VJ, 1990, EMBO J, V9, P225, DOI 10.1002/j.1460-2075.1990.tb08099.x; EIDEN LE, 1984, NATURE, V312, P661, DOI 10.1038/312661a0; FISCHERCOLBRIE R, 1988, P NATL ACAD SCI USA, V85, P3240, DOI 10.1073/pnas.85.9.3240; FISHER SK, 1987, J NEUROCHEM, V48, P999, DOI 10.1111/j.1471-4159.1987.tb05618.x; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GILMAN MZ, 1988, GENE DEV, V2, P394, DOI 10.1101/gad.2.4.394; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GOLDMAN D, 1988, NEURON, V1, P329, DOI 10.1016/0896-6273(88)90081-5; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KLARSFELD A, 1989, NEURON, V2, P1229, DOI 10.1016/0896-6273(89)90307-3; KLEY N, 1987, J BIOL CHEM, V262, P4083; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KUJUBU DA, 1987, ONCOGENE, V1, P257; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LEONARD DGB, 1988, J CELL BIOL, V106, P181, DOI 10.1083/jcb.106.1.181; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; LIM RW, 1987, ONCOGENE, V1, P263; LINDENBAUM MH, 1988, J BIOL CHEM, V263, P5662; MACHIDA CM, 1989, NEURON, V2, P1587, DOI 10.1016/0896-6273(89)90047-0; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MASIAKOWSKI P, 1988, P NATL ACAD SCI USA, V85, P1277, DOI 10.1073/pnas.85.4.1277; MERLIE JP, 1984, J CELL BIOL, V99, P332, DOI 10.1083/jcb.99.1.332; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MIZUNO A, 1989, NEUROSCI LETT, V98, P272, DOI 10.1016/0304-3940(89)90412-6; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MORGAN JI, 1988, CELL CALCIUM, V9, P303, DOI 10.1016/0143-4160(88)90011-5; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MORRIS BJ, 1988, P NATL ACAD SCI USA, V85, P3226, DOI 10.1073/pnas.85.9.3226; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NEUBERG M, 1989, NATURE, V338, P589, DOI 10.1038/338589a0; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; OFFORD J, 1989, NEURON, V2, P1447, DOI 10.1016/0896-6273(89)90190-6; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; PRENTICE HM, 1987, EMBO J, V6, P1859, DOI 10.1002/j.1460-2075.1987.tb02444.x; PRYWES R, 1986, CELL, V47, P777, DOI 10.1016/0092-8674(86)90520-9; RANSONE LJ, 1989, GENE DEV, V3, P770, DOI 10.1101/gad.3.6.770; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RIABOWOL KT, 1988, MOL CELL BIOL, V8, P1670, DOI 10.1128/MCB.8.4.1670; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; SAFFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795, DOI 10.1073/pnas.85.20.7795; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; SEZKELY AM, 1989, MOL PHARMACOL, V35, P401; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; TSUKADA T, 1987, J BIOL CHEM, V262, P8743; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; VONDREDEN G, 1988, NEUROENDOCRINOLOGY, V47, P32, DOI 10.1159/000124887; WATSON MA, 1989, MOL CELL BIOL, V9, P4213, DOI 10.1128/MCB.9.10.4213; White J D, 1987, Brain Res, V427, P21; YAMAMOTO KK, 1990, CELL, V60, P611, DOI 10.1016/0092-8674(90)90664-Z; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	113	2109	2166	6	141	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1990	4	4					477	485		10.1016/0896-6273(90)90106-P	http://dx.doi.org/10.1016/0896-6273(90)90106-P			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB168	1969743				2022-12-28	WOS:A1990DB16800001
J	CORNEL, E; HOLT, C				CORNEL, E; HOLT, C			PRECOCIOUS PATHFINDING - RETINAL AXONS CAN NAVIGATE IN AN AXONLESS BRAIN	NEURON			English	Article							NEURONAL GROWTH CONES; CELL-ADHESION MOLECULES; GRASSHOPPER EMBRYOS; XENOPUS EMBRYOS; EXPRESSION PATTERN; ZEBRAFISH EMBRYOS; PERIPHERAL-NERVE; PIONEER NEURONS; DROSOPHILA; PATHWAYS	The developing axons of retinal ganglion cells follow a stereotyped trajectory through the diencephalon to the optic tectum. In Xenopus, this trajectory closely parallels that of a preexisting fiber tract, the tract of the postoptic commissure (TPOC). This tract comprises part of the early CNS scaffold and has been proposed to play a critical role in guiding the later growing optic axons. We have tested this possibility using heterochronic and xenoplastic transplants of eye primordia to force optic axons to enter the brain before scaffold tracts have arisen in the forebrain. We show that optic axons can navigate appropriately in the absence of the TPOC or any other axons, indicating that axonal pathfinding cues are present in the axonless neuroepithelial sheet. We suggest that molecularly distinct heterogeneities within the neuroepithelium are used for pathfinding by early and late developing axons alike in normal development.			CORNEL, E (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.			Holt, Christine Elizabeth/0000-0003-2829-121X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023780] Funding Source: NIH RePORTER; NINDS NIH HHS [NS23780] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASTIANI MJ, 1985, TRENDS NEUROSCI, V8, P257, DOI 10.1016/0166-2236(85)90099-2; BASTIANI MJ, 1984, J NEUROSCI, V4, P2311; Bordzilovskaya N.P., 1979, AXOLOTL NEWSL, V7, P2; BOVOLENTA P, 1987, J NEUROSCI, V7, P1447; BRUN RB, 1981, DEV BIOL, V88, P192, DOI 10.1016/0012-1606(81)90229-3; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; CHITNIS AB, 1991, NEURON, V7, P277, DOI 10.1016/0896-6273(91)90266-3; COHEN J, 1987, DEV BIOL, V122, P407, DOI 10.1016/0012-1606(87)90305-8; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EAGLESON GW, 1990, J NEUROBIOL, V21, P427, DOI 10.1002/neu.480210305; EASTER SS, 1989, DEVELOPMENT, V107, P553; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GIMLICH RL, 1984, DEV BIOL, V104, P117, DOI 10.1016/0012-1606(84)90042-3; GOODMAN CS, 1982, S SOC DEV BIOL, V40, P275; HARRIS WA, 1986, NATURE, V320, P266, DOI 10.1038/320266a0; HARRIS WA, 1989, NATURE, V339, P218, DOI 10.1038/339218a0; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HARRIS WA, 1991, NEURON, V6, P499, DOI 10.1016/0896-6273(91)90053-3; Harris WA, 1984, J NEUROGENET, V1, P127, DOI 10.3109/01677068409107078; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HOLT CE, 1984, J NEUROSCI, V4, P1130; HOLT CE, 1989, J NEUROSCI, V9, P3125; KESHISHIAN H, 1983, DEV BIOL, V96, P116, DOI 10.1016/0012-1606(83)90316-0; KLOSE M, 1989, SCIENCE, V245, P982, DOI 10.1126/science.2772651; KOTRLA KJ, 1984, NATURE, V311, P151, DOI 10.1038/311151a0; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; KUWADA JY, 1990, J NEUROSCI, V10, P1299; LEVI G, 1987, J CELL BIOL, V105, P2359, DOI 10.1083/jcb.105.5.2359; LIESI P, 1988, DEV BIOL, V130, P774, DOI 10.1016/0012-1606(88)90366-1; LOPRESTI V, 1973, P NATL ACAD SCI USA, V70, P433, DOI 10.1073/pnas.70.2.433; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PIKE SH, 1992, DEVELOPMENT, V114, P825; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; RAPER JA, 1984, J NEUROSCI, V4, P2329; RAPER JA, 1983, J NEUROSCI, V3, P31; SCHUBIGER M, 1985, DEV BIOL, V108, P399, DOI 10.1016/0012-1606(85)90043-0; SILVER J, 1984, DEV BIOL, V106, P485, DOI 10.1016/0012-1606(84)90248-3; TAYLOR JSH, 1991, DEVELOPMENT S, V2, P95; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; TIX S, 1989, DEVELOPMENT, V107, P855; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WILSON SW, 1991, DEVELOPMENT, V112, P723; WILSON SW, 1990, DEVELOPMENT, V108, P121; [No title captured]	49	62	62	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1001	1011		10.1016/0896-6273(92)90061-H	http://dx.doi.org/10.1016/0896-6273(92)90061-H			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1281416				2022-12-28	WOS:A1992KD71600001
J	HARISH, OE; POO, MM				HARISH, OE; POO, MM			RETROGRADE MODULATION AT DEVELOPING NEUROMUSCULAR SYNAPSES - INVOLVEMENT OF G PROTEIN AND ARACHIDONIC-ACID CASCADE	NEURON			English	Article							GENE-RELATED PEPTIDE; ACETYLCHOLINE-RECEPTORS; TRANSMITTER RELEASE; 2ND MESSENGERS; MUSCLE-CELLS; METABOLITES; CULTURE; NEURONS; APLYSIA; ACTIVATION	Intracellular loading of nonhydrolyzable GTP analogs into innervated muscle cells in Xenopus cultures led to a marked increase in the frequency of spontaneous synaptic currents (SSCs), while extracellular application of the drugs at the same concentration was without effect. The increase in SSC frequency appeared to be unrelated to changes in the muscle membrane sensitivity toward acetylcholine (ACh), but resulted from an elevated spontaneous ACh secretion from the presynaptic nerve terminal. Postsynaptic loading of arachidonic acid (AA) produced a similar effect as the GTP analogs, and the potentiation effect of both GTP analogs and AA was reversed by an inhibitor of AA metabolism, AA861. Further studies indicate that a lipoxygenase metabolite, 5-HPETE, appears to be a likely candidate for the retrograde factor involved in modulating ACh secretion. These results suggest that G protein activation of the AA cascade in the postsynaptic cell could produce a retrograde signal to modulate transmitter secretion from the presynaptic nerve terminal at developing synapses.			HARISH, OE (corresponding author), COLUMBIA UNIV, DEPT BIOL SCI, NEW YORK, NY 10021 USA.				NINDS NIH HHS [NS 22764] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN F, 1991, NEURON, V6, P101, DOI 10.1016/0896-6273(91)90125-J; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; ASHIDA Y, 1983, PROSTAGLANDINS, V26, P955, DOI 10.1016/0090-6980(83)90157-0; AXELROD J, 1988, TRENDS NEUROSCI, V11, P117, DOI 10.1016/0166-2236(88)90157-9; DAN Y, 1992, SCIENCE, V256, P1570, DOI 10.1126/science.1317971; EVERS J, 1989, J NEUROSCI, V9, P1523; FLURI GS, 1990, PFLUG ARCH EUR J PHY, V417, P149, DOI 10.1007/BF00370692; FONTAINE B, 1986, NEUROSCI LETT, V71, P59, DOI 10.1016/0304-3940(86)90257-0; FU WM, 1991, NEURON, V6, P837, DOI 10.1016/0896-6273(91)90179-4; GURNEY ME, 1984, NATURE, V307, P546, DOI 10.1038/307546a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARPER JF, 1988, ADV SEC MESS PHOSPH, V22, P193; HENDERSON CE, 1981, P NATL ACAD SCI-BIOL, V78, P2625, DOI 10.1073/pnas.78.4.2625; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; KIDOKORO Y, 1988, P NATL ACAD SCI USA, V85, P1978, DOI 10.1073/pnas.85.6.1978; LAUFER R, 1987, EMBO J, V6, P901, DOI 10.1002/j.1460-2075.1987.tb04836.x; LUETJE CW, 1988, J NEUROCHEM, V50, P1775, DOI 10.1111/j.1471-4159.1988.tb02478.x; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; OPPENHEIM RW, 1988, SCIENCE, V240, P919, DOI 10.1126/science.3363373; PIOMELLI D, 1991, NATURE, V353, P164, DOI 10.1038/353164a0; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; PIOMELLI D, 1987, J NEUROSCI, V7, P3675; PIOMELLI D, 1989, P NATL ACAD SCI USA, V86, P1721, DOI 10.1073/pnas.86.5.1721; PURVES D, 1985, PRINCIPLES NEURAL DE, P289; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; SPRAY DC, 1990, AM J PHYSIOL, V258, pC195, DOI 10.1152/ajpcell.1990.258.2.C195; Tabti N., 1991, CULTURING NERVE CELL, P137; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470	31	51	51	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1992	9	6					1201	1209		10.1016/0896-6273(92)90077-Q	http://dx.doi.org/10.1016/0896-6273(92)90077-Q			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1334421				2022-12-28	WOS:A1992KD71600017
J	MIYAKAWA, H; ROSS, WN; JAFFE, D; CALLAWAY, JC; LASSERROSS, N; LISMAN, JE; JOHNSTON, D				MIYAKAWA, H; ROSS, WN; JAFFE, D; CALLAWAY, JC; LASSERROSS, N; LISMAN, JE; JOHNSTON, D			SYNAPTICALLY ACTIVATED INCREASES IN CA2+ CONCENTRATION IN HIPPOCAMPAL CA1 PYRAMIDAL CELLS ARE PRIMARILY DUE TO VOLTAGE-GATED CA2+ CHANNELS	NEURON			English	Article							LONG-TERM POTENTIATION; SOURCE-DENSITY ANALYSIS; MOSSY-FIBER SYNAPSES; CALCIUM CHANNELS; PURKINJE-CELLS; NEURONS; RECEPTOR; STIMULATION; DENDRITES; TRANSMISSION	Changes in intracellular Ca2+ concentration ([Ca2+]i) in the soma and dendrites of hippocampal CA1 pyramidal neurons were measured using intracellularly injected fura-2. A large component of the [Ca2+]i elevation caused by high frequency stimulation of the Schaffer collaterals was correlated with the Na+ spikes triggered by the excitatory postsynaptic potentials (EPSPs). These spikes were generated in the soma and proximal dendrites and stimulated Ca2+ entry through voltage-gated Ca2+ channels. Suppressing spikes by hyperpolarizing the soma or by injecting QX-314 revealed a smaller nonspike component of Ca2+ entry. A substantial fraction of this component was mediated by the action of the EPSPs on voltage-gated Ca2+ channels, because it persisted in 2-amino-5-phosphonovaleric acid and because it was usually reduced when Ca2+ channel activity was suppressed by hyperpolarization. Ca2+ entry through the N-methyl-D-aspartate receptor channel could not be detected with certainty, perhaps because it was highly localized.	NEW YORK MED COLL,DEPT PHYSIOL,VALHALLA,NY 10595; BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030; BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254; BRANDEIS UNIV,CTR COMPLEX SYST,WALTHAM,MA 02254	New York Medical College; Baylor College of Medicine; Brandeis University; Brandeis University	MIYAKAWA, H (corresponding author), YAMAGATA UNIV,SCH MED,DEPT PHYSIOL,YAMAGATA 99023,JAPAN.				NIMH NIH HHS [MH48432] Funding Source: Medline; NINDS NIH HHS [NS16295, R01 NS016295, NS27337] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027337, R01NS016295] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; BEAR MF, 1992, J NEUROPHYSIOL, V67, P841, DOI 10.1152/jn.1992.67.4.841; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; BROCHER S, 1992, P NATL ACAD SCI USA, V89, P123, DOI 10.1073/pnas.89.1.123; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; GILBERTSON TA, 1991, SCIENCE, V251, P1613, DOI 10.1126/science.1849316; GROVER LM, 1992, NEUROSCIENCE, V49, P7, DOI 10.1016/0306-4522(92)90072-A; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; ITO K, 1989, BIOMED RES-TOKYO, V10, P111; JAFFE D, 1990, J NEUROPHYSIOL, V64, P948, DOI 10.1152/jn.1990.64.3.948; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; KOMATSU Y, 1992, J NEUROPHYSIOL, V67, P401, DOI 10.1152/jn.1992.67.2.401; KUDO Y, 1988, NEUROSCI LETT, V85, P345, DOI 10.1016/0304-3940(88)90590-3; LASSERROSS N, 1992, P ROY SOC B-BIOL SCI, V247, P35, DOI 10.1098/rspb.1992.0006; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LOSSERROSS N, 1991, J NEUROSCI METH, V36, P253; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MASUKAWA LM, 1984, J NEUROSCI, V4, P217; MILEDI R, 1980, J PHYSIOL-LONDON, V300, P197, DOI 10.1113/jphysiol.1980.sp013158; MINTA A, 1989, J BIOL CHEM, V264, P19449; MIYAKAWA H, 1986, BRAIN RES, V399, P303, DOI 10.1016/0006-8993(86)91520-9; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; MULLER W, 1992, NEURON, V8, P135; MURPHY SN, 1988, P NATL ACAD SCI USA, V85, P8737, DOI 10.1073/pnas.85.22.8737; NEHER E, 1992, NEURON, V8, P605, DOI 10.1016/0896-6273(92)90083-P; OGURA A, 1990, NEUROSCI RES, V9, P103, DOI 10.1016/0168-0102(90)90026-B; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; RICHARDSON TL, 1987, J NEUROPHYSIOL, V58, P981, DOI 10.1152/jn.1987.58.5.981; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SCHARFMAN HE, 1985, BRAIN RES, V331, P267, DOI 10.1016/0006-8993(85)91552-5; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; TURNER RW, 1991, J NEUROSCI, V11, P2270; WICKENS JR, 1991, NEUROSCI LETT, V130, P128, DOI 10.1016/0304-3940(91)90244-N; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; XIE XP, 1992, J NEUROPHYSIOL, V67, P1009, DOI 10.1152/jn.1992.67.4.1009	49	221	221	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1992	9	6					1163	1173		10.1016/0896-6273(92)90074-N	http://dx.doi.org/10.1016/0896-6273(92)90074-N			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KD716	1361128				2022-12-28	WOS:A1992KD71600014
J	CARROLL, SL; SILOSSANTIAGO, I; FRESE, SE; RUIT, KG; MILBRANDT, J; SNIDER, WD				CARROLL, SL; SILOSSANTIAGO, I; FRESE, SE; RUIT, KG; MILBRANDT, J; SNIDER, WD			DORSAL-ROOT GANGLION NEURONS EXPRESSING TRK ARE SELECTIVELY SENSITIVE TO NGF DEPRIVATION INUTERO	NEURON			English	Article							NERVE GROWTH-FACTOR; TYROSINE KINASE RECEPTOR; NEUROTROPHIC FACTOR; SENSORY NEURONS; PROTOONCOGENE PRODUCT; DEVELOPING RAT; MESSENGER-RNA; LOW-AFFINITY; PC12 CELLS; SURVIVAL	In utero immune deprivation of the neurotrophic molecule nerve growth factor (NGF) results in the death of most, but not all, mammalian dorsal root ganglion (DRG) neurons. The recent identification of trk, trkB, and trkC as the putative high affinity receptors for NGF, brain-derived neurotrophic factor, and neurotrophin-3, respectively, has allowed an examination of whether their expression by DRG neurons correlates with differential sensitivity to immune deprivation of NGF. In situ hybridization demonstrates that virtually all neurons expressing trk are lost during in utero NGF deprivation. Most, if not all, neurons expressing trkB and trkC survive this treatment. In contrast, the low affinity NGF receptor, p75NGFR, is expressed in both NGF deprivation-resistant and -sensitive neurons. These experiments show that DRG neurons expressing trk require NGF for survival. Furthermore, at least some of the DRG neurons that do not require NGF express the high affinity receptor for another neurotrophin. Finally, these experiments provide evidence that trk, and not p75NGFR, is the primary effector of NGF action in vivo.	WASHINGTON UNIV, SCH MED, DEPT INTERNAL MED, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT NEUROL & NEUROL SURG, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	CARROLL, SL (corresponding author), WASHINGTON UNIV, SCH MED, DEPT PATHOL, DIV LAB MED, ST LOUIS, MO 63110 USA.			Milbrandt, Jeffrey/0000-0002-5477-7689; Carroll, Steven/0000-0001-6714-4373	NIDDK NIH HHS [5 T32 D DK07296-12] Funding Source: Medline; NINDS NIH HHS [R01 NS-25936, R01 NS26224-03] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026224, R01NS025936] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON A, 1987, EXP CELL RES, V170, P56, DOI 10.1016/0014-4827(87)90116-9; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BOTHWELL M, 1991, CELL, V65, P915, DOI 10.1016/0092-8674(91)90540-F; Brown AG, 1981, ORG SPINAL CORD; DAVIES AM, 1986, J NEUROSCI, V6, P1897; DAVIES AM, 1986, NATURE, V319, P497, DOI 10.1038/319497a0; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; ERNFORS P, 1991, EUR J NEUROSCI, V3, P953, DOI 10.1111/j.1460-9568.1991.tb00031.x; FENTON EL, 1970, EXP CELL RES, V59, P383, DOI 10.1016/0014-4827(70)90645-2; GOEDERT M, 1984, P NATL ACAD SCI-BIOL, V81, P1580, DOI 10.1073/pnas.81.5.1580; GORIN PD, 1979, P NATL ACAD SCI USA, V76, P5382, DOI 10.1073/pnas.76.10.5382; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOSANG M, 1987, EMBO J, V6, P1197, DOI 10.1002/j.1460-2075.1987.tb02354.x; JOHNSON EM, 1986, TRENDS NEUROSCI, V9, P33, DOI 10.1016/0166-2236(86)90012-3; JOHNSON EM, 1983, NEUROSCIENCE, V8, P631, DOI 10.1016/0306-4522(83)90204-X; JOHNSON EM, 1989, BRAIN RES, V478, P166, DOI 10.1016/0006-8993(89)91491-1; JOHNSON EM, 1980, SCIENCE, V210, P916, DOI 10.1126/science.7192014; KALCHEIM C, 1987, EMBO J, V6, P2871, DOI 10.1002/j.1460-2075.1987.tb02589.x; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1990, DEVELOPMENT, V109, P845; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; RADEKE MJ, 1991, NEURON, V7, P141, DOI 10.1016/0896-6273(91)90082-B; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RITTER AM, 1991, NATURE, V350, P500, DOI 10.1038/350500a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; SUTTER A, 1979, J BIOL CHEM, V254, P5972; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; VERGE VM, 1992, J NEUROCYTOL, V18, P583; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; Willis WD, 1991, SENSORY MECH SPINAL; YAN Q, 1987, DEV BIOL, V121, P139, DOI 10.1016/0012-1606(87)90147-3	50	119	119	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1992	9	4					779	788		10.1016/0896-6273(92)90040-K	http://dx.doi.org/10.1016/0896-6273(92)90040-K			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT516	1389185				2022-12-28	WOS:A1992JT51600018
J	DAVENPORT, RW; KATER, SB				DAVENPORT, RW; KATER, SB			LOCAL INCREASES IN INTRACELLULAR CALCIUM ELICIT LOCAL FILOPODIAL RESPONSES IN HELISOMA NEURONAL GROWTH CONES	NEURON			English	Article							APPLIED ELECTRIC-FIELD; NEURITE GROWTH; NERVE GROWTH; IDENTIFIED NEURONS; RELEASE; CELL; MOTILITY; CA-2+; SYNAPTOGENESIS; ACTIVATION	Highly localized changes in intracellular Ca2+ concentration ([Ca2+]i) can be evoked in neuronal growth cones; these are followed by local changes in filopodia. Focally applied electric fields evoked spatially restricted, high magnitude increases in growth cone [Ca2+]i. The earliest and greatest increases were localized to small regions within a growth cone. Such fields also produced characteristic changes in the disposition of filopodia: both filopodial length and number were significantly increased on the cathode side of growth cones. The requirement for extracellular Ca2+ and the strong correlation between the evoked rise in (Ca2+]i and the changes in filopodia (r = 0.98) indicate that cathode stimulation results in local Ca2+ influx, leading to locally increased [Ca2+]i and local changes in filopodial behavior.			DAVENPORT, RW (corresponding author), COLORADO STATE UNIV,DEPT ANAT & NEUROBIOL,PROGRAM NEURONAL GROWTH & DEV,FT COLLINS,CO 80523, USA.				NINDS NIH HHS [NS24683] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024683] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; ALKON DL, 1988, SCIENCE, V239, P998, DOI 10.1126/science.2830669; BANDTLOW C, 1990, J NEUROSCI, V10, P3837, DOI 10.1523/JNEUROSCI.10-12-03837.1990; BANDTLOW CE, 1992, IN PRESS SCIENCE; BEDLACK RS, 1992, NEURON, V9, P393, DOI 10.1016/0896-6273(92)90178-G; BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BRAY D, 1982, CELL BEHAVIOR, P298; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; CALLEWAERT G, 1988, P NATL ACAD SCI USA, V85, P2009, DOI 10.1073/pnas.85.6.2009; COHAN CS, 1986, SCIENCE, V232, P1638, DOI 10.1126/science.3715470; COOPER MS, 1985, J NEUROSCI RES, V13, P223, DOI 10.1002/jnr.490130116; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; FORSCHER P, 1989, TRENDS NEUROSCI, V12, P468, DOI 10.1016/0166-2236(89)90098-2; GOLDBERG DJ, 1988, J NEUROSCI, V8, P2596; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; HAYDON PG, 1987, J NEUROBIOL, V18, P197, DOI 10.1002/neu.480180206; HAYDON PG, 1984, SCIENCE, V226, P561, DOI 10.1126/science.6093252; HAYDON PG, 1989, NEURON, V2, P1483, DOI 10.1016/0896-6273(89)90194-3; HEIDEMANN SR, 1990, J CELL BIOL, V111, P1949, DOI 10.1083/jcb.111.5.1949; JAFFE LF, 1991, P NATL ACAD SCI USA, V88, P9883, DOI 10.1073/pnas.88.21.9883; KATER SB, 1991, J NEUROSCI, V11, P891; LECHLEITER JD, 1992, CELL, V69, P283, DOI 10.1016/0092-8674(92)90409-6; MATTSON MP, 1988, J NEUROSCI RES, V21, P447, DOI 10.1002/jnr.490210236; MCCAIG CD, 1991, EXP PHYSIOL, V76, P473, DOI 10.1113/expphysiol.1991.sp003514; MCCAIG CD, 1989, J CELL SCI, V93, P723; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P55, DOI 10.1113/jphysiol.1986.sp016105; NAKAI J, 1959, Z ZELLFORSCH MIK ANA, V51, P108, DOI 10.1007/BF00345083; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; PATEL NB, 1984, J NEUROSCI, V4, P2939; PATEL NB, 1986, IONIC CURRENTS DEV, P271; POO M, 1992, NERVE GROWTH CONE, P231; REHDER V, 1992, J NEUROSCI, V12, P3175, DOI 10.1523/JNEUROSCI.12-08-03175.1992; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; ROSS WN, 1988, P NATL ACAD SCI USA, V85, P4075, DOI 10.1073/pnas.85.11.4075; SILVER RA, 1990, NATURE, V343, P751, DOI 10.1038/343751a0; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH SJ, 1992, NERVE GROWTH CONE, P19; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; THAYER SA, 1988, MOL PHARMACOL, V34, P664; WONG RG, 1984, BRAIN RES, V292, P81, DOI 10.1016/0006-8993(84)90892-8; WONG RG, 1981, J NEUROSCI, V1, P1008	44	110	110	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1992	9	3					405	416		10.1016/0896-6273(92)90179-H	http://dx.doi.org/10.1016/0896-6273(92)90179-H			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM571	1524824				2022-12-28	WOS:A1992JM57100003
J	STOYKOVA, AS; STERRER, S; ERSELIUS, JR; HATZOPOULOS, AK; GRUSS, P				STOYKOVA, AS; STERRER, S; ERSELIUS, JR; HATZOPOULOS, AK; GRUSS, P			MINI-OCT AND OCT-2C - 2 NOVEL, FUNCTIONALLY DIVERSE MURINE OCT-2 GENE-PRODUCTS ARE DIFFERENTIALLY EXPRESSED IN THE CNS	NEURON			English	Article							DNA-BINDING-PROTEINS; HEAVY-CHAIN PROMOTER; TRANSCRIPTION FACTOR; POU-DOMAIN; IMMUNOGLOBULIN GENES; OCTAMER MOTIF; MOUSE EMBRYOGENESIS; HISTONE H2B; HELA-CELLS; B-CELLS	We report that two novel alternatively spliced products of the murine Oct-2 gene encode Mini-Oct (Oct-2d), a protein consisting of almost only the POU domain, and Oct-2c, a protein lacking the last 12 amino acids of Oct-2a. Ectopic expression in HeLa cells shows that Oct-2c is a transactivator, whereas Mini-Oct fails to transactivate if the octamer motif is in a promotor position next to TATA box. Mini-Oct can repress the transcriptional signal generated by endogenous octamer factors in F9 cells. It seems that Mini-Oct has the potential to serve as a transcriptional modulator for genes regulated by different octamer-binding factors. In situ hybridization reveals that Mini-Oct expression follows the general pattern of other known Oct-2 transcripts. However, it is absent from the Purkinje cell layer in the cerebellum of adult mice, and strong expression is observed in the developing nasal neuroepithelium and primary spermatids. Differential expression patterns of the Oct-2 transcripts with different transactivation/repression capacities of the encoded proteins may have a specific role in gene expression in the developing nervous system and in adult brain.			STOYKOVA, AS (corresponding author), MAX PLANCK INST BIOPHYS CHEM, DEPT MOLEC CELL BIOL, W-3400 GOTTINGEN, GERMANY.		Hatzopoulos, Antonis/D-2049-2010; Hatzopoulos, Antonis/X-2043-2019	Hatzopoulos, Antonis/0000-0001-5610-0017				ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BAUMRUKER T, 1988, GENE DEV, V2, P1400, DOI 10.1101/gad.2.11.1400; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; CARBON P, 1987, CELL, V51, P71, DOI 10.1016/0092-8674(87)90011-0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; DENT CL, 1991, MOL CELL BIOL, V11, P3925, DOI 10.1128/MCB.11.8.3925; DONY C, 1987, EMBO J, V6, P2965, DOI 10.1002/j.1460-2075.1987.tb02602.x; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GERSTER T, 1990, EMBO J, V9, P1635, DOI 10.1002/j.1460-2075.1990.tb08283.x; Graziadei PPC, 1978, NEURONAL PLASTICITY, P131; HABERLY LB, 1989, TRENDS NEUROSCI, V12, P258, DOI 10.1016/0166-2236(89)90025-8; HATZOPOULOS A K, 1988, P43; HATZOPOULOS AK, 1990, DEVELOPMENT, V109, P349; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HIGGINS GA, 1987, IN SITU HYBRIDIZATIO, P146; HOGAN B, 1986, MANIPULATING MOUSE E, P228; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JOHNSON WA, 1990, NATURE, V343, P467, DOI 10.1038/343467a0; KEMP LM, 1990, NEURON, V4, P215, DOI 10.1016/0896-6273(90)90096-X; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LANDOLFI NF, 1986, NATURE, V323, P548, DOI 10.1038/323548a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LEBOWITZ JH, 1989, GENE DEV, V3, P1625, DOI 10.1101/gad.3.10.1625; LEBOWITZ JH, 1988, GENE DEV, V2, P1227, DOI 10.1101/gad.2.10.1227; LENARDO MJ, 1989, SCIENCE, V243, P544, DOI 10.1126/science.2536195; MANGIN M, 1986, EMBO J, V5, P987, DOI 10.1002/j.1460-2075.1986.tb04313.x; MATTHIAS P, 1989, NUCLEIC ACIDS RES, V17, P6418, DOI 10.1093/nar/17.15.6418; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; MULLERIMMERGLUCK MM, 1990, EMBO J, V9, P1625, DOI 10.1002/j.1460-2075.1990.tb08282.x; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; PICARD D, 1985, EMBO J, V4, P2831, DOI 10.1002/j.1460-2075.1985.tb04011.x; POELLINGER L, 1989, NATURE, V337, P573, DOI 10.1038/337573a0; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; ROSNER MH, 1991, CELL, V64, P1103, DOI 10.1016/0092-8674(91)90265-Z; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; SCHREIBER E, 1990, NUCLEIC ACIDS RES, V18, P5495, DOI 10.1093/nar/18.18.5495; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; Schreiber E., 1989, TISSUE SPECIFIC GENE, P33; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; SIVE HL, 1986, P NATL ACAD SCI USA, V83, P6382, DOI 10.1073/pnas.83.17.6382; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; STAUDT LM, 1988, SCIENCE, V241, P577, DOI 10.1126/science.3399892; STOYKOVA AS, 1979, J NEUROCHEM, V33, P931, DOI 10.1111/j.1471-4159.1979.tb09923.x; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; TREACY MN, 1991, NATURE, V350, P577, DOI 10.1038/350577a0; VERRIJZER CP, 1990, EMBO J, V9, P1883, DOI 10.1002/j.1460-2075.1990.tb08314.x; WESTIN G, 1987, NUCLEIC ACIDS RES, V15, P6787, DOI 10.1093/nar/15.17.6787; WIRTH T, 1991, NUCLEIC ACIDS RES, V19, P43, DOI 10.1093/nar/19.1.43; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	72	69	73	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1992	8	3					541	558		10.1016/0896-6273(92)90282-I	http://dx.doi.org/10.1016/0896-6273(92)90282-I			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK675	1550677	Green Submitted			2022-12-28	WOS:A1992HK67500014
J	SAKIMURA, K; MORITA, T; KUSHIYA, E; MISHINA, M				SAKIMURA, K; MORITA, T; KUSHIYA, E; MISHINA, M			PRIMARY STRUCTURE AND EXPRESSION OF THE GAMMA-2 SUBUNIT OF THE GLUTAMATE RECEPTOR CHANNEL SELECTIVE FOR KAINATE	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL PYRAMIDAL CELLS; PROTEIN-KINASE ACTIVITY; EXCITATORY AMINO-ACIDS; FUNCTIONAL EXPRESSION; KAINIC ACID; CONCANAVALIN-A; ACETYLCHOLINE-RECEPTOR; MOLECULAR-STRUCTURE	The presence and primary structure of a novel subunit of the mouse glutamate receptor channel, designated as gamma-2, have been revealed by cloning and sequencing the CDNA. The gamma-2 subunit has structural characteristics common to the neurotransmitter-gated ion channel family and shares a high amino acid sequence identity with the rat KA-1 subunit, thus constituting the gamma-subfamily of the glutamate receptor channel. Expression of the gamma-2 subunit together with the beta-2 subunit in Xenopus oocytes yields functional glutamate receptor channels selective for kainate.			SAKIMURA, K (corresponding author), NIIGATA UNIV, BRAIN RES INST, DEPT NEUROPHARMACOL, NIIGATA 951, JAPAN.							AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; CONTITRONCONI BM, 1982, ANNU REV BIOCHEM, V51, P491, DOI 10.1146/annurev.bi.51.070182.002423; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GURDON JB, 1974, CONTROL GENE EXPRESS; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KONARSKA MM, 1984, CELL, V38, P731, DOI 10.1016/0092-8674(84)90268-X; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MATHERS DA, 1976, NATURE, V259, P409, DOI 10.1038/259409a0; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MISHINA M, 1991, BIOCHEM BIOPH RES CO, V180, P813, DOI 10.1016/S0006-291X(05)81137-4; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MORITA T, 1992, MOL BRAIN RES; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; NODA M, 1983, NATURE, V302, P528, DOI 10.1038/302528a0; OLNEY JW, 1990, ANNU REV PHARMACOL, V30, P47; PEARSON RB, 1985, J BIOL CHEM, V260, P4471; ROBINSON JH, 1981, BRAIN RES, V221, P117, DOI 10.1016/0006-8993(81)91067-2; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; SHINOZAKI H, 1979, BRAIN RES, V161, P493, DOI 10.1016/0006-8993(79)90678-4; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7	52	164	169	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1992	8	2					267	274		10.1016/0896-6273(92)90293-M	http://dx.doi.org/10.1016/0896-6273(92)90293-M			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE930	1310861				2022-12-28	WOS:A1992HE93000007
J	BURNASHEV, N; MONYER, H; SEEBURG, PH; SAKMANN, B				BURNASHEV, N; MONYER, H; SEEBURG, PH; SAKMANN, B			DIVALENT ION PERMEABILITY OF AMPA RECEPTOR CHANNELS IS DOMINATED BY THE EDITED FORM OF A SINGLE SUBUNIT	NEURON			English	Article								Functionally diverse GluR channels of the AMPA subtype are generated by the assembly of GluR-A, -B, -C, and -D subunits into homo- and heteromeric channels. The GluR-beta-subunit is dominant in determining functional properties of heteromeric AMPA receptors. This subunit exists in developmentally distinct edited and unedited forms, GluR-B(R) and GluR-B(Q), which differ in a single amino acid in transmembrane segment TM2 (Q/R site). Homomeric GluR-B(R) channels expressed in 293 cells display a low divalent permeability, whereas homomeric GluR-B(Q) and GluR-D channels exhibit a high divalent permeability. Mutational analysis revealed that both the positive charge and the size of the amino acid side chain located at the Q/R site control the divalent permeability of homomeric channels. Coexpression of Q/R site arginine- and glutamine-containing subunits generates cells with varying divalent permeabilities depending on the amounts of expression vectors used for cell transfection. Intermediate divalent permeabilities were traced to the presence of both divalent permeant homomeric and impermeant heteromeric channels. It is suggested that the positive charge contributed by the arginine of the edited GluR-B(R) subunit determines low divalent permeability in heteromeric GluR channels and that changes in GluR-B(R) expression regulate the AMPA receptor-dependent divalent permeability of a cell.	UNIV HEIDELBERG, CTR MOLEC BIOL, MOLEC NEUROENDOCRINOL LAB, W-6900 HEIDELBERG, GERMANY	Ruprecht Karls University Heidelberg	BURNASHEV, N (corresponding author), MAX PLANCK INST MED RES, ZELLPHYSIOL ABT, W-6900 HEIDELBERG 1, GERMANY.		Burnashev, Nail/G-4056-2013	Monyer, Hannah/0000-0002-9332-5749				ASCHER P, 1988, J PHYSIOL-LONDON, V399, P227; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; GILBERTSON TA, 1991, SCIENCE, V251, P1613, DOI 10.1126/science.1849316; GU YP, 1991, NEURON, V6, P777, DOI 10.1016/0896-6273(91)90174-X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; JONAS P, 1991, J PHYSIOL-LONDON, V438, pP321; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KHODOROVA A, 1992, IN PRESS J PHYSL; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; OZAWA S, 1991, J NEUROPHYSIOL, V66, P2, DOI 10.1152/jn.1991.66.1.2; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829	27	881	895	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1992	8	1					189	198		10.1016/0896-6273(92)90120-3	http://dx.doi.org/10.1016/0896-6273(92)90120-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB185	1370372				2022-12-28	WOS:A1992HB18500017
J	MERCER, EH; HOYLE, GW; KAPUR, RP; BRINSTER, RL; PALMITER, RD				MERCER, EH; HOYLE, GW; KAPUR, RP; BRINSTER, RL; PALMITER, RD			THE DOPAMINE BETA-HYDROXYLASE GENE PROMOTER DIRECTS EXPRESSION OF ESCHERICHIA-COLI LACZ TO SYMPATHETIC AND OTHER NEURONS IN ADULT TRANSGENIC MICE	NEURON			English	Article							PHENYLETHANOLAMINE-N-METHYLTRANSFERASE; CATECHOLAMINERGIC TC CELLS; RAT SWEAT GLANDS; TYROSINE-HYDROXYLASE; TRANSIENT EXPRESSION; IMMUNOREACTIVE NEURONS; ENTERIC NEURONS; GANGLION; HYPOTHALAMUS; INNERVATION	Dopamine beta-hydroxylase (DBH) catalyzes the final step in the biosynthesis of norepinephrine, the principal classic neurotransmitter of peripheral sympathetic neurons. We have shown that 5.8 kb of 5' upstream region from a cloned human DBH gene promoter is sufficient to direct expression of the E. coli lacZ gene in transgenic mice to neurons of the locus ceruleus and other classic noradrenergic brain stem nuclei, sympathetic ganglion neurons, and adrenal chromaffin cells. lacZ expression was also observed in neurons of the enteric system, the retina, some sensory and all cranial parasympathetic ganglia, and some diencephalic and telencephalic brain nuclei. The expression pattern of the transgene in DBH-immunonegative sites overlapped with many sites where expression of tyrosine hydroxylase or phenylethanolamine N-methyltransferase, two other catecholamine biosynthetic enzymes, has been reported.	UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA; UNIV PENN, SCH VET MED, REPROD PHYSIOL LAB, PHILADELPHIA, PA 19104 USA	University of Washington; University of Washington Seattle; University of Pennsylvania	MERCER, EH (corresponding author), UNIV WASHINGTON, HOWARD HUGHES MED INST, SEATTLE, WA 98195 USA.		Mercer, Eric H/AAX-6173-2021	Mercer, Eric H/0000-0002-6737-765X; Brinster, Ralph/0000-0003-1408-7656	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD009172, R37HD009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-09172] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07270] Funding Source: Medline; NINDS NIH HHS [NS-29018] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON CR, 1988, NEUROSCI LETT, V93, P164, DOI 10.1016/0304-3940(88)90075-4; BAETGE G, 1989, DEV BIOL, V132, P189, DOI 10.1016/0012-1606(89)90217-0; BAETGE G, 1990, DEV BIOL, V141, P353, DOI 10.1016/0012-1606(90)90391-U; BERGER B, 1985, DEV BRAIN RES, V23, P141, DOI 10.1016/0165-3806(85)90013-6; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; BJORKLUND H, 1985, J NEUROSCI, V5, P1633; BONNEROT C, 1987, P NATL ACAD SCI USA, V84, P6795, DOI 10.1073/pnas.84.19.6795; BRINSTER RL, 1981, CELL, V27, P223, DOI 10.1016/0092-8674(81)90376-7; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; CASADABAN MJ, 1983, METHOD ENZYMOL, V100, P293; COYLE JT, 1974, J NEUROCHEM, V22, P923, DOI 10.1111/j.1471-4159.1974.tb04316.x; DESCARRIES L, 1986, J COMP NEUROL, V249, P511, DOI 10.1002/cne.902490407; FOSTER GA, 1985, BRAIN RES, V330, P183, DOI 10.1016/0006-8993(85)90025-3; FUXE K, 1971, PROGR BRAIN RES, V34, P127; GOLDSTEIN M, 1971, EXPERIENTIA, V27, P951, DOI 10.1007/BF02135767; GRZANNA R, 1978, BRAIN RES, V151, P206, DOI 10.1016/0006-8993(78)90966-6; HESS EJ, 1991, NEURON, V6, P123, DOI 10.1016/0896-6273(91)90127-L; HOKFELT T, 1984, HDB CHEM NEUROANAT 1, V2, P157; Hokfelt T., 1984, CLASSICAL NEUROTRANS, V2, P277; IKENO T, 1977, MOL CELL BIOCHEM, V18, P117, DOI 10.1007/BF00280277; JAEGER CB, 1983, DEV BRAIN RES, V11, P128, DOI 10.1016/0165-3806(83)90208-0; JOH TH, 1973, MOL PHARMACOL, V9, P117; JONAKAIT GM, 1984, DEV BIOL, V101, P51, DOI 10.1016/0012-1606(84)90116-7; JULIEN JP, 1987, GENE DEV, V1, P1085, DOI 10.1101/gad.1.10.1085; KATZ DM, 1983, P NATL ACAD SCI-BIOL, V80, P3526, DOI 10.1073/pnas.80.11.3526; KOBAYASHI K, 1989, NUCLEIC ACIDS RES, V17, P1089, DOI 10.1093/nar/17.3.1089; LAMOUROUX A, 1987, EMBO J, V6, P3931, DOI 10.1002/j.1460-2075.1987.tb02734.x; LANDIS SC, 1987, J NEUROSCI, V7, P3574; Landis SC, 1988, HDB CHEM NEUROANATOM, V6, P65; LANFORD RE, 1988, MOL CELL BIOL, V8, P2722, DOI 10.1128/MCB.8.7.2722; LEBLANC G, 1986, J NEUROSCI, V6, P260; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; MCGOWAN R, 1989, GENE DEV, V3, P1669, DOI 10.1101/gad.3.11.1669; MCHUGH EM, 1985, J BIOL CHEM, V260, P4409; MEZEY E, 1989, P NATL ACAD SCI USA, V86, P347, DOI 10.1073/pnas.86.1.347; MILNER TA, 1986, J NEUROSCI, V6, P2585; MOLINOFF PB, 1971, J PHARMACOL EXP THER, V178, P425; OSBORNE NN, 1988, NEUROSCI RES, pS197, DOI 10.1016/0921-8696(88)90017-5; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PARK DH, 1986, J NEUROSCI, V6, P1108; PESCHON JJ, 1987, P NATL ACAD SCI USA, V84, P5316, DOI 10.1073/pnas.84.15.5316; PRICE J, 1983, NATURE, V301, P241, DOI 10.1038/301241a0; RUGGIERO DA, 1985, J COMP NEUROL, V239, P127, DOI 10.1002/cne.902390202; RUGGIERO DA, 1984, J COMP NEUROL, V223, P556, DOI 10.1002/cne.902230408; SATOH J, 1990, DEV BRAIN RES, V53, P1, DOI 10.1016/0165-3806(90)90119-J; SCHOTZINGER RJ, 1990, NEURON, V5, P91, DOI 10.1016/0896-6273(90)90037-G; STRACK AM, 1989, BRAIN RES, V491, P274, DOI 10.1016/0006-8993(89)90063-2; STRACK AM, 1989, BRAIN RES, V491, P156, DOI 10.1016/0006-8993(89)90098-X; SWANSON LW, 1975, J COMP NEUROL, V163, P467, DOI 10.1002/cne.901630406; TEITELMAN G, 1981, DEV BIOL, V86, P348, DOI 10.1016/0012-1606(81)90192-5; VINCENT SR, 1988, J COMP NEUROL, V268, P584, DOI 10.1002/cne.902680408; WALLACE EF, 1973, P NATL ACAD SCI USA, V70, P2253, DOI 10.1073/pnas.70.8.2253; WUENSCHELL CW, 1990, NEURON, V4, P595, DOI 10.1016/0896-6273(90)90117-X; YAMAUCHI A, 1971, J ANAT, V110, P435; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4; ZAREMBA S, 1981, J BIOL CHEM, V256, P2310	56	259	266	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1991	7	5					703	716		10.1016/0896-6273(91)90274-4	http://dx.doi.org/10.1016/0896-6273(91)90274-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT939	1742021				2022-12-28	WOS:A1991GT93900002
J	BALDWIN, TJ; TSAUR, ML; LOPEZ, GA; JAN, YN; JAN, LY				BALDWIN, TJ; TSAUR, ML; LOPEZ, GA; JAN, YN; JAN, LY			CHARACTERIZATION OF A MAMMALIAN CDNA FOR AN INACTIVATING VOLTAGE-SENSITIVE K+ CHANNEL	NEURON			English	Article							TRANSIENT OUTWARD CURRENT; SHAKER POTASSIUM CHANNELS; CARDIAC PURKINJE-FIBERS; XENOPUS-OOCYTES; RAT-BRAIN; ION CHANNELS; CULTURED HIPPOCAMPAL; MOLECULAR-CLONING; DROSOPHILA MUSCLE; NERVOUS-SYSTEM	A cDNA clone encoding a K+ channel polypeptide with 72% amino acid sequence identity to Drosophila Shal was isolated from rat hippocampus. Functional expression of the cDNA in Xenopus oocytes generated 4-amino-pyridine-sensitive K+ channels displaying rapid inactivation kinetics. The fastest component of inactivation was slowed by the deletion of 3 basic residues in the aminoterminal region. Northern blots revealed that the mRNA encoding this K+ channel polypeptide was expressed at a similar level in the brain and in the heart. In situ hybridization revealed that the mRNA encoding this K+ channel appeared concentrated in the hippocampus, dentate gyrus, and habenular nucleus in the brain. Thus, this K+ channel polypeptide is likely to form some of the A-type K+ channels expressed in the mammalian nervous system and heart.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	BALDWIN, TJ (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.		lopez, george/W-4435-2019	Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299				AGHAJANIAN GK, 1985, NATURE, V315, P501, DOI 10.1038/315501a0; AITKEN A, 1990, IDENTIFICATION PROTE; ATKINS PT, 1990, NATURE, V344, P240; BACANER MB, 1986, P NATL ACAD SCI USA, V83, P2223, DOI 10.1073/pnas.83.7.2223; BAKER K, 1990, NEURON, V4, P129, DOI 10.1016/0896-6273(90)90449-P; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; BYRNE JH, 1980, J NEUROPHYSIOL, V43, P651, DOI 10.1152/jn.1980.43.3.651; CASSELL JF, 1986, J PHYSIOL-LONDON, V374, P273, DOI 10.1113/jphysiol.1986.sp016079; CHANDY KG, 1990, SCIENCE, V247, P973, DOI 10.1126/science.2305265; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; CONNOR JA, 1978, FED PROC, V37, P2139; COOK NS, 1988, TRENDS PHARMACOL SCI, V9, P21, DOI 10.1016/0165-6147(88)90238-6; CORABOEUF E, 1982, PFLUG ARCH EUR J PHY, V392, P352, DOI 10.1007/BF00581631; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; DAUT J, 1973, NATURE-NEW BIOL, V246, P193, DOI 10.1038/newbio246193a0; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; ESCANDE D, 1987, AM J PHYSIOL, V252, pH142, DOI 10.1152/ajpheart.1987.252.1.H142; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GETTING PA, 1983, J NEUROPHYSIOL, V49, P1036, DOI 10.1152/jn.1983.49.4.1036; GILES WR, 1985, J PHYSIOL-LONDON, V368, P243, DOI 10.1113/jphysiol.1985.sp015856; GIRGIS SI, 1988, NUCLEIC ACIDS RES, V16, P10371, DOI 10.1093/nar/16.21.10371; GRUPE A, 1990, EMBO J, V9, P1749, DOI 10.1002/j.1460-2075.1990.tb08299.x; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GURDON JB, 1983, METHOD ENZYMOL, V101, P370; HAGIWARA S, 1959, J PHYSIOL-LONDON, V148, P161, DOI 10.1113/jphysiol.1959.sp006279; Hille B, 1984, IONIC CHANNELS EXCIT; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; IMAIZUMI Y, 1987, AM J PHYSIOL, V253, pH704, DOI 10.1152/ajpheart.1987.253.3.H704; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; JOSEPHSON IR, 1984, CIRC RES, V54, P157, DOI 10.1161/01.RES.54.2.157; KACZMAREK LK, 1984, J NEUROPHYSIOL, V52, P340, DOI 10.1152/jn.1984.52.2.340; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KENYON JL, 1987, J GEN PHYSIOL, V89, P921, DOI 10.1085/jgp.89.6.921; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE CC, 1988, SCIENCE, V239, P1288, DOI 10.1126/science.3344434; LEVITAN IB, 1985, J MEMBRANE BIOL, V87, P177, DOI 10.1007/BF01871217; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MATTESON DR, 1988, BIOPHYS J, V53, P641, DOI 10.1016/S0006-3495(88)83143-6; MCCORMACK T, 1990, P NATL ACAD SCI USA, V87, P5227, DOI 10.1073/pnas.87.13.5227; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; NAKAJIMA Y, 1986, P NATL ACAD SCI USA, V83, P3022, DOI 10.1073/pnas.83.9.3022; NAKAYAMA T, 1985, CIRC RES, V57, P65, DOI 10.1161/01.RES.57.1.65; NAKAYAMA T, 1988, CIRC RES, V62, P162, DOI 10.1161/01.RES.62.1.162; NEHER E, 1971, J GEN PHYSIOL, V58, P36, DOI 10.1085/jgp.58.1.36; NELSON TJ, 1990, SCIENCE, V247, P1479, DOI 10.1126/science.2108498; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; ROBERDS SL, 1991, P NATL ACAD SCI USA, V88, P1798, DOI 10.1073/pnas.88.5.1798; ROGAWSKI MA, 1985, TRENDS NEUROSCI, V8, P214, DOI 10.1016/0166-2236(85)90082-7; RUDY B, 1988, NEURON, V1, P649, DOI 10.1016/0896-6273(88)90164-X; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAYERS JR, 1989, PROTEIN FUNCTION PRA, P279; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SEGAL M, 1984, J NEUROSCI, V4, P604; SOLC CK, 1987, SCIENCE, V236, P1094, DOI 10.1126/science.2437657; STRONG JA, 1984, J NEUROSCI, V4, P2772; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TIMPE LC, 1987, J NEUROSCI, V7, P1307; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TSENG GN, 1989, CIRC RES, V64, P633, DOI 10.1161/01.RES.64.4.633; TSENGCRANK JCL, 1990, FEBS LETT, V268, P63, DOI 10.1016/0014-5793(90)80973-M; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315; WU CF, 1985, J NEUROSCI, V5, P2626; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243	89	202	205	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	SEP	1991	7	3					471	483		10.1016/0896-6273(91)90299-F	http://dx.doi.org/10.1016/0896-6273(91)90299-F			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG887	1840649	Bronze			2022-12-28	WOS:A1991GG88700012
J	BAZAN, JF				BAZAN, JF			NEUROPOIETIC CYTOKINES IN THE HEMATOPOIETIC FOLD	NEURON			English	Article							COLONY-STIMULATING FACTOR; CILIARY NEUROTROPHIC FACTOR; NEURONAL DIFFERENTIATION FACTOR; LEUKEMIA INHIBITORY FACTOR; RAT SYMPATHETIC NEURONS; CELL CONDITIONED MEDIUM; CENTRAL NERVOUS-SYSTEM; GROWTH-FACTOR; MOLECULAR-CLONING; HUMAN INTERLEUKIN-6	Among the molecules that determine the developmental fate of sympathetic neurons f rom noradrenergic to cholinergic function are two apparently unrelated proteins, cholinergic differentiation factor and ciliary neurotrophic factor (CDF and CNTF, respectively). The present work suggests a structural basis for their functional overlap: sequence pattern-matching and predictive structure analysis contends that CDF and CNTF are homologous and share a common helical framework. An integrated CDF/CNTF profile also reveals similar sequence/structure motifs in a group of hematopoietic cytokines composed of granulocyte colony-stimulating factor, interleukin-6, and a novel factor called oncostatin M; a more distant relationship is indicated with interleukin-3 and interferons-alpha/beta. Evolutionary ties between neuropoietic and hematopoietic cytokines predict a distinctive tertiary architecture for the uncharacterized CDF and CNTF receptors. The intertwined cytokine/receptor networks signal a closer relationship between the molecular mechanisms underlying neuro- and hematopoiesis.			BAZAN, JF (corresponding author), UNIV CALIF SAN FRANCISCO, SCH MED, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA.		Bazan, J. Fernando/B-4562-2010					ABDELMEGUID SS, 1987, P NATL ACAD SCI USA, V84, P6434, DOI 10.1073/pnas.84.18.6434; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; ANDERSON DJ, 1989, TRENDS NEUROSCI, V12, P83, DOI 10.1016/0166-2236(89)90160-4; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BAZAN JF, 1990, CELL, V61, P753, DOI 10.1016/0092-8674(90)90182-E; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BAZAN JF, 1989, BIOCHEM BIOPH RES CO, V164, P788, DOI 10.1016/0006-291X(89)91528-3; BECK G, 1989, BIOESSAYS, V11, P62, DOI 10.1002/bies.950110206; BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561; CHANG JY, 1990, J NEUROCHEM, V55, P436, DOI 10.1111/j.1471-4159.1990.tb04155.x; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; CLARKLEWIS I, 1988, P NATL ACAD SCI USA, V85, P7897, DOI 10.1073/pnas.85.21.7897; CLOGSTON CL, 1989, ARCH BIOCHEM BIOPHYS, V272, P144, DOI 10.1016/0003-9861(89)90205-1; COHEN FE, 1986, BIOCHEMISTRY-US, V25, P266, DOI 10.1021/bi00349a037; CRAWFORD IP, 1987, PROTEINS, V2, P118, DOI 10.1002/prot.340020206; CUNNINGHAM BC, 1990, SCIENCE, V250, P1709, DOI 10.1126/science.2270485; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DAMORE PA, 1990, CANCER METAST REV, V9, P227, DOI 10.1007/BF00046362; Demaeyer E., 1988, INTERFERONS OTHER RE; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOVER GA, 1991, CELL, V65, P9, DOI 10.1016/0092-8674(91)90401-J; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; ERKMAN L, 1989, DEV BIOL, V132, P375, DOI 10.1016/0012-1606(89)90234-0; FARRAR WL, 1989, BLOOD, V73, P137; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; FREI K, 1986, J IMMUNOL, V137, P3521; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; FUKADA K, 1985, P NATL ACAD SCI USA, V82, P8795, DOI 10.1073/pnas.82.24.8795; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GOUGH NM, 1989, CANCER CELL-MON REV, V1, P77; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HOOPER C, 1990, J NIH RES, V2, P54; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; IDA N, 1989, BIOCHEM BIOPH RES CO, V165, P728, DOI 10.1016/S0006-291X(89)80027-0; IMPROTA T, 1988, EXP CELL RES, V179, P1, DOI 10.1016/0014-4827(88)90342-4; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; JOHNSON MS, 1990, J MOL EVOL, V30, P43, DOI 10.1007/BF02102452; KAMEGAI M, 1990, NEURON, V4, P429, DOI 10.1016/0896-6273(90)90055-K; KANAKURA Y, 1990, BLOOD, V76, P706; KRUTTGEN A, 1990, FEBS LETT, V262, P323, DOI 10.1016/0014-5793(90)80219-9; KUGA T, 1989, BIOCHEM BIOPH RES CO, V159, P103, DOI 10.1016/0006-291X(89)92410-8; Lallier T., 1990, Seminars in Developmental Biology, V1, P35; LAM A, 1991, IN PRESS GENE; LANDIS SC, 1990, TRENDS NEUROSCI, V13, P344, DOI 10.1016/0166-2236(90)90147-3; LANDIS SC, 1981, TRENDS NEUROSCI, V4, P172, DOI 10.1016/0166-2236(81)90056-4; LARSSON I, 1978, INFECT IMMUN, V22, P786, DOI 10.1128/IAI.22.3.786-789.1978; Le Douarin N.M., 1982, NEURAL CREST; LEUTZ A, 1989, EMBO J, V8, P175, DOI 10.1002/j.1460-2075.1989.tb03362.x; LILLIEN LE, 1990, NEURON, V5, P111, DOI 10.1016/0896-6273(90)90301-U; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LINSLEY PS, 1990, MOL CELL BIOL, V10, P1882, DOI 10.1128/MCB.10.5.1882; LJUNGDAHL A, 1989, J NEUROSCI RES, V24, P451, DOI 10.1002/jnr.490240316; LU HS, 1989, ARCH BIOCHEM BIOPHYS, V268, P81, DOI 10.1016/0003-9861(89)90567-5; MALIK N, 1989, MOL CELL BIOL, V9, P2847, DOI 10.1128/MCB.9.7.2847; MALIPIERO UV, 1990, J IMMUNOL, V144, P3816; MARTINOU JC, 1989, J NEUROSCI, V9, P3645; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; METCALF D, 1989, LEUKEMIA, V3, P349; MILLAR DA, 1989, ENDEAVOUR, V13, P72, DOI 10.1016/0160-9327(89)90005-7; MORRISONGRAHAM K, 1989, TRENDS GENET, V5, P116, DOI 10.1016/0168-9525(89)90042-5; NAGATA S, 1989, BIOESSAYS, V10, P113, DOI 10.1002/bies.950100405; NAWA H, 1990, NEURON, V4, P269, DOI 10.1016/0896-6273(90)90101-K; NAWA H, 1991, IN PRESS COLD SPRING; NISHIMURA C, 1991, EUR J BIOCHEM, V196, P377, DOI 10.1111/j.1432-1033.1991.tb15827.x; OLSSON T, 1989, J NEUROSCI, V9, P3870; PARK LS, 1989, J BIOL CHEM, V264, P5420; PATTERSON PH, 1990, CELL, V62, P1035, DOI 10.1016/0092-8674(90)90379-S; PATTERSON PH, 1978, ANNU REV NEUROSCI, V1, P1, DOI 10.1146/annurev.ne.01.030178.000245; PAUL WE, 1989, CELL, V57, P521, DOI 10.1016/0092-8674(89)90121-9; PEARL LH, 1987, NATURE, V329, P351, DOI 10.1038/329351a0; PIETSCH T, 1990, KLIN PADIATR, V202, P235, DOI 10.1055/s-2007-1025526; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; PRESNELL SR, 1989, P NATL ACAD SCI USA, V86, P6592, DOI 10.1073/pnas.86.17.6592; RAO MS, 1990, NEURON, V5, P899, DOI 10.1016/0896-6273(90)90350-O; RAO MS, 1990, DEV BIOL, V139, P65, DOI 10.1016/0012-1606(90)90279-R; REICHARDT LF, 1977, NATURE, V270, P147, DOI 10.1038/270147a0; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; ROHRER H, 1990, EUR J NEUROSCI, V2, P1005, DOI 10.1111/j.1460-9568.1990.tb00013.x; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SATOH T, 1988, MOL CELL BIOL, V8, P3546, DOI 10.1128/MCB.8.8.3546; Schwarz R, 1979, ATLAS PROTEIN SEQUEN, P353, DOI DOI 10.2307/2408678; SENDA T, 1990, P JPN ACAD B-PHYS, V66, P77, DOI 10.2183/pjab.66.77; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; SQUINTO SP, 1990, NEURON, V5, P757, DOI 10.1016/0896-6273(90)90334-C; STAHL J, 1990, J BIOL CHEM, V265, P8833; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Swofford D.L., 1989, PAUP PHYLOGENETIC AN; Swofford David L., 1990, P411; TEDESCHI B, 1986, J CELL BIOL, V102, P2244, DOI 10.1083/jcb.102.6.2244; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; WEBER MJ, 1981, J BIOL CHEM, V256, P3447; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0; YASUKAWA K, 1987, EMBO J, V6, P2939, DOI 10.1002/j.1460-2075.1987.tb02598.x	106	473	495	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1991	7	2					197	208		10.1016/0896-6273(91)90258-2	http://dx.doi.org/10.1016/0896-6273(91)90258-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1714745				2022-12-28	WOS:A1991GB93300003
J	SHARPE, CR				SHARPE, CR			RETINOIC ACID CAN MIMIC ENDOGENOUS SIGNALS INVOLVED IN TRANSFORMATION OF THE XENOPUS NERVOUS-SYSTEM	NEURON			English	Article							DEVELOPING CHICK LIMB; NEURAL INDUCTION; LOCAL APPLICATION; LAEVIS; EXPRESSION; RECEPTOR; GENES; IDENTIFICATION; ANTERIOR; ECTODERM	In the frog Xenopus laevis, signals from the mesoderm divert part of the ectoderm from an epidermal to a neural fate. In the course of neural induction, the neurectoderm also acquires anterior-posterior polarity. In this report, the early expression of two genes, XlHbox6 and the neurofilament gene XIF6, is examined. The pattern of expression of the two genes seen in the tailbud embryo develops progressively over a 4 hr period following gastrulation. Physiological concentrations of retinoic acid can mimic this effect in isolated embryonic explants, consistent with the involvement of retinoic acid, or a closely related molecule, in localizing gene expression along the anterior-posterior axis of the neural tube.	UNIV CAMBRIDGE,DEPT ZOOL,MOLEC EMBRYOL RES GRP,CANC RES CAMPAIGN,CAMBRIDGE CB2 3EJ,ENGLAND	CRUK Cambridge Institute; University of Cambridge				Sharpe, Colin/0000-0002-5022-0840				ALTABA ARI, 1990, DEVELOPMENT, V108, P595; BENBROOK D, 1988, NATURE, V333, P669, DOI 10.1038/333669a0; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; BRIVANLOU AH, 1989, DEVELOPMENT, V106, P611; BROCKES JP, 1989, NEURON, V2, P1285, DOI 10.1016/0896-6273(89)90066-4; CHO KWY, 1990, GENE DEV, V4, P1910, DOI 10.1101/gad.4.11.1910; DIXON JE, 1989, DEVELOPMENT, V106, P749; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GIMLICH RL, 1983, NATURE, V306, P471, DOI 10.1038/306471a0; Gurdon J.B., 1977, Methods Cell Biol, V16, P125; Hamburger V, 1988, HERITAGE EXPT EMBRYO; JACOBSON M, 1986, DEV BIOL, V116, P524, DOI 10.1016/0012-1606(86)90153-3; KELLER RE, 1976, DEV BIOL, V51, P118, DOI 10.1016/0012-1606(76)90127-5; KINTNER CR, 1987, DEVELOPMENT, V99, P311; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; KRUST A, 1989, P NATL ACAD SCI USA, V86, P5310, DOI 10.1073/pnas.86.14.5310; MADEN M, 1982, NATURE, V295, P672, DOI 10.1038/295672a0; MADEN M, 1989, DEVELOPMENT, V107, P109; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MOHUN TJ, 1984, NATURE, V311, P716, DOI 10.1038/311716a0; NIAZI I A, 1978, Folia Biologica (Cracow), V26, P3; NIEUWKOOP P. D., 1958, ACTA EMBRYOL MORPH EXPTL, V2, P13; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NIEUWKOOP PIETER D., 1955, EXPTL CELL RES SUPPL, V3, P262; PETKOVICH M, 1987, NATURE, V330, P4444; RAGSDALE CW, 1989, NATURE, V341, P654, DOI 10.1038/341654a0; RICHTER K, 1988, P NATL ACAD SCI USA, V85, P8086, DOI 10.1073/pnas.85.21.8086; SAVAGE R, 1989, DEV BIOL, V133, P157, DOI 10.1016/0012-1606(89)90307-2; SAXEN L, 1989, International Journal of Developmental Biology, V33, P21; SHARPE CR, 1990, BIOESSAYS, V12, P591, DOI 10.1002/bies.950121206; SHARPE CR, 1988, DEVELOPMENT, V103, P269; SHARPE CR, 1989, DEVELOPMENT, V107, P701; SHARPE CR, 1987, CELL, V50, P749, DOI 10.1016/0092-8674(87)90333-3; SHARPE CR, 1990, DEVELOPMENT, V109, P765; SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; SMITH SM, 1989, DEVELOPMENT, V107, P121; SUMMERBELL D, 1983, J EMBRYOL EXP MORPH, V78, P269; THALLER C, 1987, NATURE, V327, P625, DOI 10.1038/327625a0; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; TOIVONEN S, 1955, EXP CELL RES, P346; WAGNER M, 1990, NATURE, V345, P819, DOI 10.1038/345819a0; WRIGHT CVE, 1990, DEVELOPMENT, V109, P225; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0	46	84	84	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	AUG	1991	7	2					239	247		10.1016/0896-6273(91)90262-X	http://dx.doi.org/10.1016/0896-6273(91)90262-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB933	1678613				2022-12-28	WOS:A1991GB93300007
J	HAMMARBACK, JA; OBAR, RA; HUGHES, SM; VALLEE, RB				HAMMARBACK, JA; OBAR, RA; HUGHES, SM; VALLEE, RB			MAP1B IS ENCODED AS A POLYPROTEIN THAT IS PROCESSED TO FORM A COMPLEX N-TERMINAL MICROTUBULE-BINDING DOMAIN	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; PUTATIVE STRUCTURAL PROTEIN; ADENOSINE-TRIPHOSPHATASE; GEL-ELECTROPHORESIS; MOLECULAR-STRUCTURE; SEQUENCE-ANALYSIS; MESSENGER-RNAS; LIGHT CHAIN; TAU-PROTEIN; BRAIN	Microtubule-associated protein 1B (MAP1B), an abundant developmentally regulated neuronal protein, is a stoichiometric complex of a heavy chain and two light chains (light chain 1 and light chain 3). We find that light chain 1 is encoded within the 3' end of a previously reported MAP1B heavy chain cDNA. Amino acid sequencing, epitope mapping, Northern blotting, and Southern blotting indicate that the light chain and heavy chain are encoded by the same mRNA within the same open reading frame. In addition, amino acid sequencing of a 120 kd microtubule-binding and light chain-binding fragment of the heavy chain reveals that light chain 1 binds near the heavy chain N-terminus. Together these data indicate that the heavy chain and light chain 1 are produced by proteolytic processing of a MAP1B polyprotein and form a complex microtubule-binding domain.	WORCESTER FDN EXPTL BIOL INC, CELL BIOL GRP, SHREWSBURY, MA 01545 USA	Worcester Foundation for Biomedical Research					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026701] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26701, GM10943] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGELL N, 1988, P NATL ACAD SCI USA, V85, P3693, DOI 10.1073/pnas.85.11.3693; AIZAWA H, 1990, J BIOL CHEM, V265, P13849; BERKOWITZ SA, 1977, BIOCHEMISTRY-US, V16, P5610, DOI 10.1021/bi00644a035; BLOOM GS, 1984, J CELL BIOL, V98, P320, DOI 10.1083/jcb.98.1.320; BLOOM GS, 1983, J CELL BIOL, V96, P1523, DOI 10.1083/jcb.96.6.1523; BLOOM GS, 1985, P NATL ACAD SCI USA, V82, P5404, DOI 10.1073/pnas.82.16.5404; CALVERT R, 1985, EMBO J, V4, P1171, DOI 10.1002/j.1460-2075.1985.tb03756.x; CALVERT RA, 1987, NEUROSCIENCE, V23, P131, DOI 10.1016/0306-4522(87)90277-6; CHAPIN SJ, 1991, J CELL SCI, V98, P27; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DWORKINRASTL E, 1984, CELL, V39, P321, DOI 10.1016/0092-8674(84)90010-2; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARNER CC, 1990, J NEUROCHEM, V55, P146, DOI 10.1111/j.1471-4159.1990.tb08832.x; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HIRATA R, 1990, J BIOL CHEM, V265, P6726; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; KIRSCH J, 1990, FEBS LETT, V262, P259, DOI 10.1016/0014-5793(90)80205-W; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUZNETSOV SA, 1986, J CELL BIOL, V102, P1060, DOI 10.1083/jcb.102.3.1060; KUZNETSOV SA, 1987, FEBS LETT, V212, P145, DOI 10.1016/0014-5793(87)81574-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM KS, 1979, J BIOL CHEM, V254, P1713; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LEWIS SA, 1986, J CELL BIOL, V102, P2106, DOI 10.1083/jcb.102.6.2106; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LUCA FC, 1986, P NATL ACAD SCI USA, V83, P1006, DOI 10.1073/pnas.83.4.1006; LUND PK, 1985, J BIOL CHEM, V260, P7609; Maniatis T., 1982, MOL CLONING; MONIA BP, 1989, J BIOL CHEM, V264, P4093; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; OLMSTED JB, 1986, METHOD ENZYMOL, V134, P467; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; RECHSTEINER M, 1987, ANNU REV CELL BIOL, V3, P1, DOI 10.1146/annurev.cb.03.110187.000245; RIEDERER B, 1986, J NEUROCYTOL, V15, P763, DOI 10.1007/BF01625193; RIENITZ A, 1989, EMBO J, V8, P2879, DOI 10.1002/j.1460-2075.1989.tb08436.x; SAFAEI R, 1989, J NEUROCHEM, V52, P1871, DOI 10.1111/j.1471-4159.1989.tb07270.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATOYOSHITAKE R, 1989, NEURON, V3, P229, DOI 10.1016/0896-6273(89)90036-6; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; SNYDER M, 1987, METHOD ENZYMOL, V154, P107; SONDEREGGER P, 1982, ANAL BIOCHEM, V122, P298, DOI 10.1016/0003-2697(82)90285-8; TUCKER RP, 1988, J COMP NEUROL, V271, P44, DOI 10.1002/cne.902710106; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; VALLEE RB, 1986, METHOD ENZYMOL, V134, P104; VALLEE RB, 1983, P NATL ACAD SCI-BIOL, V80, P1342, DOI 10.1073/pnas.80.5.1342; VALLEE RB, 1985, MICROTUBULES MICROTU, P129	50	95	96	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1991	7	1					129	139		10.1016/0896-6273(91)90081-A	http://dx.doi.org/10.1016/0896-6273(91)90081-A			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY481	1712602				2022-12-28	WOS:A1991FY48100013
J	MULLER, W; CONNOR, JA				MULLER, W; CONNOR, JA			CHOLINERGIC INPUT UNCOUPLES CA-2+ FROM K+ CONDUCTANCE ACTIVATION AND AMPLIFIES INTRADENTRITIC CA-2+ CHANGES IN HIPPOCAMPAL-NEURONS	NEURON			English	Article							LONG-TERM POTENTIATION; PYRAMIDAL CELLS; RAT HIPPOCAMPUS; NUCLEUS BASALIS; CALCIUM; ACETYLCHOLINE; INDUCTION; CHANNELS; INVITRO; ACETYLTRANSFERASE	Muscarinic synaptic activation is known to be involved in cortical arousal as well as learning. Although simple increases in the electrical responsiveness of neurons might be the basis of arousal, the linkage of muscarinic transmission to the synaptic plasticity that might underlie learning is lacking. Most models of synaptic plasticity involve postsynaptic Ca2+ changes as a trigger for subsequent processes. We imaged muscarinic effects on free Ca2+ accumulation during intracellular recordings from CA3 pyramidal neurons in the guinea pig hippocampal slice. Muscarinic activation, either by repetitive stimulation of cholinergic fibers or by bath-applied carbachol, strongly increased intradendritic Ca2+ accumulation during directly evoked repetitive firing, in part by blocking a Ca2+-dependent K+ conductance. The effects of repetitive stimulation of cholinergic fibers were enhanced by the acetylcholine-esterase blocker eserine and blocked by the muscarinic antagonist atropine. These findings demonstrate a novel muscarinic reinforcement of Ca2+ changes during excitation, which are probably significant for synapse modification.			MULLER, W (corresponding author), ROCHE INST MOLEC BIOL, DEPT NEUROSCI, ROCHE RES CTR, NUTLEY, NJ 07110 USA.							ALGER BE, 1980, SCIENCE, V210, P1122, DOI 10.1126/science.7444438; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BENARI Y, 1981, NEUROSCIENCE, V6, P2445, DOI 10.1016/0306-4522(81)90091-9; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; BLITZER RD, 1990, NEUROSCI LETT, V119, P207, DOI 10.1016/0304-3940(90)90835-W; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; BURGARD EC, 1990, NEUROSCI LETT, V116, P34, DOI 10.1016/0304-3940(90)90382-J; COLE AE, 1984, J PHYSIOL-LONDON, V352, P173, DOI 10.1113/jphysiol.1984.sp015285; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; FROTSCHER M, 1985, J COMP NEUROL, V239, P237, DOI 10.1002/cne.902390210; GAGE FH, 1984, SCIENCE, V225, P533, DOI 10.1126/science.6539949; GAHWILER BH, 1987, NEUROSCI LETT, V76, P301, DOI 10.1016/0304-3940(87)90419-8; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HOTSON JR, 1980, J NEUROPHYSIOL, V43, P409, DOI 10.1152/jn.1980.43.2.409; HOUSER CR, 1983, BRAIN RES, V266, P97, DOI 10.1016/0006-8993(83)91312-4; KNOPFEL T, 1990, P NATL ACAD SCI USA, V87, P4083, DOI 10.1073/pnas.87.11.4083; LANCASTER B, 1991, J NEUROSCI, V11, P23; LEWIS PR, 1967, BRAIN, V90, P521, DOI 10.1093/brain/90.3.521; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MECK WH, 1987, J NEUROSCI, V7, P3505; MEECH RW, 1974, J PHYSIOL-LONDON, V237, P259, DOI 10.1113/jphysiol.1974.sp010481; MISGELD U, 1986, PFLUG ARCH EUR J PHY, V407, P482, DOI 10.1007/BF00657504; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; MULLER W, 1988, EXP BRAIN RES, V72, P287; MULLER W, 1986, NEUROSCI LETT, V67, P107, DOI 10.1016/0304-3940(86)90381-2; NAKAJIMA Y, 1986, P NATL ACAD SCI USA, V83, P3022, DOI 10.1073/pnas.83.9.3022; NILSSON OG, 1987, EXP BRAIN RES, V67, P195, DOI 10.1007/BF00269466; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; RICHARDSON RT, 1988, TRENDS NEUROSCI, V11, P264, DOI 10.1016/0166-2236(88)90107-5; SCHWARTZKROIN PA, 1980, SCIENCE, V210, P1125, DOI 10.1126/science.6777871; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; TOSELLI M, 1989, PFLUG ARCH EUR J PHY, V413, P319, DOI 10.1007/BF00583548; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	38	96	98	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1991	6	6					901	905		10.1016/0896-6273(91)90230-W	http://dx.doi.org/10.1016/0896-6273(91)90230-W			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT949	2054187				2022-12-28	WOS:A1991FT94900005
J	MARRION, NV; ZUCKER, RS; MARSH, SJ; ADAMS, PR				MARRION, NV; ZUCKER, RS; MARSH, SJ; ADAMS, PR			MODULATION OF M-CURRENT BY INTRACELLULAR CA2+	NEURON			English	Article							BULLFROG SYMPATHETIC NEURONS; CYTOSOLIC CALCIUM-CONCENTRATION; SENSITIVE K+ CURRENT; SMOOTH-MUSCLE CELLS; MUSCARINIC SUPPRESSION; HIPPOCAMPAL-NEURONS; CHANNEL MODULATION; CA-2+ TRANSIENTS; INHIBITION; FURA-2	I(M) is a voltage- and time-dependent K+ current that is suppressed by muscarinic receptor activation. I(M) augmentation following agonist washout was blocked by heavily buffering [Ca2+]i using BAPTA. Although I(M) is not primarily Ca2+ dependent, small increases in [Ca2+]i by photolysis of the "caged" Ca2+ chelator nitr-5 or by evoking action potentials augmented, while larger increases inhibited, I(M). Raising [Ca2+]i for prolonged periods, by nitr-5 photolysis, reduced its sensitivity to agonist, leaving a poorly reversible response. These results suggest that I(M) can be regulated by physiologically relevant changes in [Ca2+]i, placing I(M) in a unique position to modulate cell excitability.	SUNY STONY BROOK,DEPT NEUROBIOL & BEHAV,STONY BROOK,NY 11794; UNIV CALIF BERKELEY,DEPT PHYSIOL ANAT,BERKELEY,CA 94720; UNIV LONDON UNIV COLL,DEPT PHARMACOL,LONDON WC1E 6BT,ENGLAND	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Berkeley; University of London; University College London	MARRION, NV (corresponding author), SUNY STONY BROOK,HOWARD HUGHES MED INST,STONY BROOK,NY 11794, USA.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343; Adams, Paul/0000-0001-8063-0560				ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P263, DOI 10.1113/jphysiol.1982.sp014412; ADAMS PR, 1982, NATURE, V296, P746, DOI 10.1038/296746a0; ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; ADAMS SR, 1988, J AM CHEM SOC, V110, P3212, DOI 10.1021/ja00218a034; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P221, DOI 10.1113/jphysiol.1989.sp017612; BECKER PL, 1987, AM J PHYSIOL, V253, pC613, DOI 10.1152/ajpcell.1987.253.4.C613; Brown D A, 1988, Ion Channels, V1, P55; BROWN DA, 1989, J PHYSIOL-LONDON, V413, P469, DOI 10.1113/jphysiol.1989.sp017664; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; BROWN DA, 1987, CELL MOL NEUROBIOL, V7, P255, DOI 10.1007/BF00711303; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; GRONICH JH, 1990, BIOCHEM J, V271, P37, DOI 10.1042/bj2710037; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GURNEY AM, 1989, NATURE, V341, P65, DOI 10.1038/341065a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HOCKBERGER PE, 1989, J NEUROSCI, V9, P2272; HUANG KP, 1989, TRENDS NEUROSCI, V12, P425, DOI 10.1016/0166-2236(89)90091-X; JACQUIN T, 1988, P NATL ACAD SCI USA, V85, P948, DOI 10.1073/pnas.85.3.948; JONES SW, 1987, J PHYSIOL-LONDON, V389, P605, DOI 10.1113/jphysiol.1987.sp016674; KOKETSU K, 1982, BRAIN RES, V243, P369, DOI 10.1016/0006-8993(82)90263-3; KUBA K, 1980, J PHYSIOL-LONDON, V298, P251, DOI 10.1113/jphysiol.1980.sp013079; KUFFLER SW, 1983, J PHYSIOL-LONDON, V341, P257, DOI 10.1113/jphysiol.1983.sp014805; LANDO L, 1989, J GEN PHYSIOL, V93, P1017, DOI 10.1085/jgp.93.6.1017; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; MARRION NV, 1989, BRIT J PHARMACOL, V98, P557, DOI 10.1111/j.1476-5381.1989.tb12630.x; MINTA A, 1989, J BIOL CHEM, V264, P8171; MOORE SD, 1988, SCIENCE, V239, P278, DOI 10.1126/science.2892268; OSULLIVAN AJ, 1989, EMBO J, V8, P401, DOI 10.1002/j.1460-2075.1989.tb03391.x; PENNEFATHER P, 1985, P NATL ACAD SCI USA, V82, P3040, DOI 10.1073/pnas.82.9.3040; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; SCHWEITZER P, 1990, NATURE, V346, P464, DOI 10.1038/346464a0; SILVER RA, 1989, J NEUROSCI, V9, P4007; SIMS SM, 1988, SCIENCE, V239, P190, DOI 10.1126/science.2827305; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; TOKIMASA T, 1985, BRAIN RES, V337, P386, DOI 10.1016/0006-8993(85)90081-2; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; VANSCHARRENBURG GJ, 1985, BIOCHEMISTRY-US, V24, P332; WILLIAMS DA, 1985, NATURE, V318, P558, DOI 10.1038/318558a0	43	93	93	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	APR	1991	6	4					533	545		10.1016/0896-6273(91)90056-6	http://dx.doi.org/10.1016/0896-6273(91)90056-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH802	1901717				2022-12-28	WOS:A1991FH80200005
J	WIMPEY, TL; CHAVKIN, C				WIMPEY, TL; CHAVKIN, C			OPIOIDS ACTIVATE BOTH AN INWARD RECTIFIER AND A NOVEL VOLTAGE-GATED POTASSIUM CONDUCTANCE IN THE HIPPOCAMPAL-FORMATION	NEURON			English	Article							RAT HIPPOCAMPUS; GUINEA-PIG; NEURONS; BINDING; OPIATE; PEPTIDES; CALCIUM; ENKEPHALINS; INHIBITION; RECEPTORS	Opioid receptors were found to activate two different types of membrane potassium conductance in acutely dissociated neurons from the CA1/subiculum regions of the adult rat hippocampal formation. Opioid-responsive neurons were distinguished based on their morphology and electrophysiological responses. In one population of neurons having a multipolar, nonpyramidal cell shape, mu-selective opioid agonists increased an inward rectifying potassium current. Opioid activation of the inward rectifying conductance resulted in small outward potassium currents at resting membrane potentials and increased inward currents at hyperpolarized potentials. In a second population of nonpyramidal neurons, mu-opioid agonists increased a novel voltage-gated potassium current. This current was blocked by internal CsCl2, unaffected by external BaCl2 or CdCl2, irreversibly activated by intracellular GTP-gamma-S, and inactivated by sustained depolarization. In contrast to the inward rectifying conductance, the voltage-gated conductance was not activated at resting membrane potentials or hyperpolarized potentials. The opioid-activated, voltage-gated conductance represents a new class of G protein-regulated potassium current in the brain.			WIMPEY, TL (corresponding author), UNIV WASHINGTON,SCH MED,DEPT PHARMACOL,SEATTLE,WA 98195, USA.		Chavkin, Charles/G-2797-2010		NIDA NIH HHS [DA-04123] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004123] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ATTALI B, 1989, J BIOL CHEM, V264, P347; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; CHANG KJ, 1983, J PHARMACOL EXP THER, V227, P403; CRAIN BJ, 1986, J COMP NEUROL, V246, P170, DOI 10.1002/cne.902460203; CRAIN SM, 1990, TRENDS NEUROSCI, V11, P78; DINGLEDINE R, 1980, J NEUROSCI METH, V2, P323, DOI 10.1016/0165-0270(80)90002-3; DOERNER D, 1988, J NEUROSCI, V8, P4069; FINCH DM, 1988, J NEUROSCI, V8, P2213; FINCH DM, 1983, BRAIN RES, V271, P201, DOI 10.1016/0006-8993(83)90283-4; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KOSTERLITZ HW, 1980, BRIT J PHARMACOL, V68, P333, DOI 10.1111/j.1476-5381.1980.tb10422.x; LEE HK, 1980, BRAIN RES, V184, P331, DOI 10.1016/0006-8993(80)90802-1; LOOSE MD, 1990, BRAIN RES, V513, P15, DOI 10.1016/0006-8993(90)91084-T; MACDONALD RL, 1986, J PHYSIOL-LONDON, V377, P237, DOI 10.1113/jphysiol.1986.sp016184; MADISON DV, 1988, J PHYSIOL-LONDON, V398, P123, DOI 10.1113/jphysiol.1988.sp017033; MCLEAN S, 1987, J COMP NEUROL, V255, P497, DOI 10.1002/cne.902550403; MOORE SD, 1988, SCIENCE, V239, P278, DOI 10.1126/science.2892268; NEUMAIER JF, 1989, BRAIN RES, V493, P292, DOI 10.1016/0006-8993(89)91164-5; NUMANN RE, 1987, J PHYSIOL-LONDON, V393, P331, DOI 10.1113/jphysiol.1987.sp016826; SEGAL M, 1986, J NEUROPHYSIOL, V55, P751, DOI 10.1152/jn.1986.55.4.751; SURPRENANT A, 1988, PROC R SOC SER B-BIO, V234, P85, DOI 10.1098/rspb.1988.0039; TATSUMI H, 1990, J NEUROSCI, V10, P1675; UEDA H, 1988, P NATL ACAD SCI USA, V85, P7013, DOI 10.1073/pnas.85.18.7013; WAGNER JJ, 1990, NEUROSCIENCE, V37, P45, DOI 10.1016/0306-4522(90)90190-F; WERZ MA, 1983, NEUROSCI LETT, V42, P173, DOI 10.1016/0304-3940(83)90402-0; WILLIAMS JT, 1988, J NEUROSCI, V8, P4299; WIMPEY TL, 1990, NEUROSCI LETT, V110, P349, DOI 10.1016/0304-3940(90)90872-7; WUARIN JP, 1990, NEUROSCIENCE, V36, P291, DOI 10.1016/0306-4522(90)90426-5; ZIEGLGANSBERGER W, 1979, SCIENCE, V205, P415, DOI 10.1126/science.451610	30	148	154	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	FEB	1991	6	2					281	289		10.1016/0896-6273(91)90363-5	http://dx.doi.org/10.1016/0896-6273(91)90363-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY709	1993123				2022-12-28	WOS:A1991EY70900010
J	MAY, PC; LAMPERTETCHELLS, M; JOHNSON, SA; POIRIER, J; MASTERS, JN; FINCH, CE				MAY, PC; LAMPERTETCHELLS, M; JOHNSON, SA; POIRIER, J; MASTERS, JN; FINCH, CE			DYNAMICS OF GENE-EXPRESSION FOR A HIPPOCAMPAL GLYCOPROTEIN ELEVATED IN ALZHEIMERS-DISEASE AND IN RESPONSE TO EXPERIMENTAL LESIONS IN RAT	NEURON			English	Article							SULFATED GLYCOPROTEIN-2; MOLECULAR-CLONING; MESSENGER-RNA; COMPLEMENT; CELLS; INDUCTION; PLAQUES; PROTEIN; ACID	A hippocampal poly(A) RNA, pADHC-9, was cloned by differential screening of a human hippocampal cDNA library. By RNA blot analysis, pADHC-9 was elevated 2-fold in Alzheimer's disease hippocampus. In situ analyses identified pADHC-9 expression in pyramidal and nonpyramidal cells of the hippocampus and entorhinal cortex. Nucleotide sequence analysis identified pADHC-9 as a potential human homolog of rat sulfated glycoprotein 2 (SGP-2). SGP-2 expression increased in rat hippocampus following experimental lesions that mimic intrinsic neuronal loss and/or deafferentation. The function of pADHC-9 in brain has not been defined, but in serum, a similar protein inhibits complement-dependent cytolysis. Increased expression of pADHC-9 in Alzheimer's disease hippocampus may be a compensatory response mounted to retard a complement-driven neurodegenerative cascade.	UNIV SO CALIF,ETHEL PERCY ANDRUS GERONTOL CTR,LOS ANGELES,CA 90089; UNIV SO CALIF,DEPT BIOL SCI,LOS ANGELES,CA 90089	University of Southern California; University of Southern California					NIA NIH HHS [AG05142] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BETTUZZI S, 1989, BIOCHEM J, V257, P293, DOI 10.1042/bj2570293; BUTTYAN R, 1989, MOL CELL BIOL, V9, P3473, DOI 10.1128/MCB.9.8.3473; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLLARD MW, 1987, BIOCHEMISTRY-US, V26, P3297, DOI 10.1021/bi00386a008; Cotman C W, 1988, Adv Neurol, V47, P313; COTMAN CW, 1984, SCIENCE, V225, P1287, DOI 10.1126/science.6382610; DUGUID JR, 1989, P NATL ACAD SCI USA, V86, P7260, DOI 10.1073/pnas.86.18.7260; EIKELENBOOM P, 1989, VIRCHOWS ARCH B, V56, P259; GEDDES JW, 1990, NEUROSCI LETT, V109, P54, DOI 10.1016/0304-3940(90)90537-J; GEDDES JW, 1985, SCIENCE, V230, P1179, DOI 10.1126/science.4071042; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HOFFMAN PN, 1988, P NATL ACAD SCI USA, V85, P4530, DOI 10.1073/pnas.85.12.4530; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; ISHII T, 1984, ACTA NEUROPATHOL, V63, P296, DOI 10.1007/BF00687336; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; JOHNSON SA, 1988, EXP NEUROL, V102, P264, DOI 10.1016/0014-4886(88)90104-5; KIRSZBAUM L, 1989, EMBO J, V8, P711, DOI 10.1002/j.1460-2075.1989.tb03430.x; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Maniatis T., 1982, MOL CLONING; MANN DMA, 1985, MECH AGEING DEV, V31, P213, DOI 10.1016/0047-6374(85)90092-2; MAY PC, 1989, CAN J NEUROL SCI, V16, P473, DOI 10.1017/S0317167100029796; MCGEER PL, 1989, CAN J NEUROL SCI, V16, P516, DOI 10.1017/S0317167100029863; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; POIRIER J, 1990, P NATL ACAD SCI USA, V87, P303, DOI 10.1073/pnas.87.1.303; POIRIER J, 1990, IN PRESS MOL BRAIN R; ROGERS J, 1988, NEUROBIOL AGING, V9, P330; WOLOZIN B, 1988, P NATL ACAD SCI USA, V85, P6202, DOI 10.1073/pnas.85.16.6202; [No title captured]	29	305	308	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	DEC	1990	5	6					831	839		10.1016/0896-6273(90)90342-D	http://dx.doi.org/10.1016/0896-6273(90)90342-D			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ381	1702645				2022-12-28	WOS:A1990EQ38100010
J	CHARNET, P; LABARCA, C; LEONARD, RJ; VOGELAAR, NJ; CZYZYK, L; GOUIN, A; DAVIDSON, N; LESTER, HA				CHARNET, P; LABARCA, C; LEONARD, RJ; VOGELAAR, NJ; CZYZYK, L; GOUIN, A; DAVIDSON, N; LESTER, HA			AN OPEN-CHANNEL BLOCKER INTERACTS WITH ADJACENT TURNS OF ALPHA-HELICES IN THE NICOTINIC ACETYLCHOLINE-RECEPTOR	NEURON			English	Article									CALTECH,DIV CHEM & CHEM ENGN,PASADENA,CA 91125	California Institute of Technology	CHARNET, P (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.			Vogelaar, Nancy/0000-0002-6860-9600; Charnet, Pierre/0000-0003-4692-528X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS008083, R01NS011756] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-8083, NS-11756] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS DJ, 1981, J GEN PHYSIOL, V78, P593, DOI 10.1085/jgp.78.6.593; ADAMS PR, 1977, J PHYSIOL-LONDON, V268, P291, DOI 10.1113/jphysiol.1977.sp011858; ADAMS PR, 1978, P NATL ACAD SCI USA, V75, P2994, DOI 10.1073/pnas.75.6.2994; ADLER M, 1979, J GEN PHYSIOL, V74, P129, DOI 10.1085/jgp.74.1.129; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; DANI JA, 1989, J NEUROSCI, V9, P884; DANI JA, 1989, TRENDS NEUROSCI, V12, P125, DOI 10.1016/0166-2236(89)90049-0; GERO A, 1956, SCIENCE, V123, P100, DOI 10.1126/science.123.3186.100; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GIRAUDAT J, 1987, BIOCHEMISTRY-US, V26, P2410, DOI 10.1021/bi00383a003; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Hille B, 1984, IONIC CHANNELS EXCIT; HONDEGHEM LM, 1984, ANNU REV PHARMACOL, V24, P387, DOI 10.1146/annurev.pa.24.040184.002131; HUCHO F, 1986, FEBS LETT, V205, P137, DOI 10.1016/0014-5793(86)80881-X; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Korolkovas A., 1970, ESSENTIALS MOL PHARM; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; MILLER C, 1989, NEURON, V2, P1195, DOI 10.1016/0896-6273(89)90304-8; NEHER E, 1983, J PHYSIOL-LONDON, V339, P663, DOI 10.1113/jphysiol.1983.sp014741; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; RITCHIE JM, 1966, ANNU REV PHARMACOLOG, V6, P405, DOI 10.1146/annurev.pa.06.040166.002201; Ritchie JM, 1985, PHARMACOL BASIS THER, P302; SPIVAK CE, 1982, MOL PHARMACOL, V21, P351; THOMAS KA, 1982, P NATL ACAD SCI-BIOL, V79, P4843, DOI 10.1073/pnas.79.16.4843; TOYOSHIMA C, 1988, NATURE, V336, P247, DOI 10.1038/336247a0; UNWIN PNT, 1988, J CELL BIOL, V107, P1123	30	178	178	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0896-6273			NEURON	Neuron	JAN	1990	4	1					87	95		10.1016/0896-6273(90)90445-L	http://dx.doi.org/10.1016/0896-6273(90)90445-L			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM297	1690017				2022-12-28	WOS:A1990CM29700008
